PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ware, RE; Davis, BR; Schultz, WH; Brown, RC; Aygun, B; Sarnaik, S; Odame, I; Fuh, B; George, A; Owen, W; Luchtman-Jones, L; Rogers, ZR; Hilliard, L; Gauger, C; Piccone, C; Lee, MT; Kwiatkowski, JL; Jackson, S; Miller, ST; Roberts, C; Heeney, MM; Kalfa, TA; Nelson, S; Imran, H; Nottage, K; Alvarez, O; Rhodes, M; Thompson, AA; Rothman, JA; Helton, KJ; Roberts, D; Coleman, J; Bonner, MJ; Kutlar, A; Patel, N; Wood, J; Piller, L; Wei, P; Luden, J; Mortier, NA; Stuber, SE; Luban, NLC; Cohen, AR; Pressel, S; Adams, RJ				Ware, Russell E.; Davis, Barry R.; Schultz, William H.; Brown, R. Clark; Aygun, Banu; Sarnaik, Sharada; Odame, Isaac; Fuh, Beng; George, Alex; Owen, William; Luchtman-Jones, Lori; Rogers, Zora R.; Hilliard, Lee; Gauger, Cynthia; Piccone, Connie; Lee, Margaret T.; Kwiatkowski, Janet L.; Jackson, Sherron; Miller, Scott T.; Roberts, Carla; Heeney, Matthew M.; Kalfa, Theodosia A.; Nelson, Stephen; Imran, Hamayun; Nottage, Kerri; Alvarez, Ofelia; Rhodes, Melissa; Thompson, Alexis A.; Rothman, Jennifer A.; Helton, Kathleen J.; Roberts, Donna; Coleman, Jamie; Bonner, Melanie J.; Kutlar, Abdullah; Patel, Niren; Wood, John; Piller, Linda; Wei, Peng; Luden, Judy; Mortier, Nicole A.; Stuber, Susan E.; Luban, Naomi L. C.; Cohen, Alan R.; Pressel, Sara; Adams, Robert J.			Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial	LANCET			English	Article							SILENT CEREBRAL INFARCTS; IRON OVERLOAD; DISEASE; STROKE; PREVENTION; ULTRASONOGRAPHY; PHLEBOTOMY; THERAPY; SWITCH; RATES	Background For children with sickle cell anaemia and high transcranial doppler (TCD) flow velocities, regular blood transfusions can effectively prevent primary stroke, but must be continued indefinitely. The efficacy of hydroxycarbamide (hydroxyurea) in this setting is unknown; we performed the TWiTCH trial to compare hydroxyurea with standard transfusions. Methods TWiTCH was a multicentre, phase 3, randomised, open-label, non-inferiority trial done at 26 paediatric hospitals and health centres in the USA and Canada. We enrolled children with sickle cell anaemia who were aged 4-16 years and had abnormal TCD fl ow velocities (>= 200 cm/s) but no severe vasculopathy. After screening, eligible participants were randomly assigned 1: 1 to continue standard transfusions (standard group) or hydroxycarbamide (alternative group). Randomisation was done at a central site, stratified by site with a block size of four, and an adaptive randomisation scheme was used to balance the covariates of baseline age and TCD velocity. The study was open-label, but TCD examinations were read centrally by observers masked to treatment assignment and previous TCD results. Participants assigned to standard treatment continued to receive monthly transfusions to maintain 30% sickle haemoglobin or lower, while those assigned to the alternative treatment started oral hydroxycarbamide at 20 mg/kg per day, which was escalated to each participant's maximum tolerated dose. The treatment period lasted 24 months from randomisation. The primary study endpoint was the 24 month TCD velocity calculated from a general linear mixed model, with the non-inferiority margin set at 15 cm/s. The primary analysis was done in the intention-totreat population and safety was assessed in all patients who received at least one dose of assigned treatment. This study is registered with ClinicalTrials.gov, number NCT01425307. Findings Between Sept 20, 2011, and April 17, 2013, 159 patients consented and enrolled in TWiTCH. 121 participants passed screening and were then randomly assigned to treatment (61 to transfusions and 60 to hydroxycarbamide). At the first scheduled interim analysis, non-inferiority was shown and the sponsor terminated the study. Final model-based TCD velocities were 143 cm/s (95% CI 140-146) in children who received standard transfusions and 138 cm/s (135-142) in those who received hydroxycarbamide, with a difference of 4.54 (0.10-8.98). Non-inferiority (p= 8.82 x 10(-16)) and post-hoc superiority (p= 0.023) were met. Of 29 new neurological events adjudicated centrally by masked reviewers, no strokes were identified, but three transient ischaemic attacks occurred in each group. Magnetic resonance brain imaging and angiography (MRI and MRA) at exit showed no new cerebral infarcts in either treatment group, but worsened vasculopathy in one participant who received standard transfusions. 23 severe adverse events in nine (15%) patients were reported for hydroxycarbamide and ten serious adverse events in six (10%) patients were reported for standard transfusions. The most common serious adverse event in both groups was vaso-occlusive pain (11 events in five [8%] patients with hydroxycarbamide and three events in one [2%] patient for transfusions). Interpretation For high-risk children with sickle cell anaemia and abnormal TCD velocities who have received at least 1 year of transfusions, and have no MRA-defined severe vasculopathy, hydroxycarbamide treatment can substitute for chronic transfusions to maintain TCD velocities and help to prevent primary stroke.	[Ware, Russell E.; Schultz, William H.; Kalfa, Theodosia A.; Mortier, Nicole A.; Stuber, Susan E.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Davis, Barry R.; Piller, Linda; Wei, Peng; Pressel, Sara] Univ Texas Houston, Sch Publ Hlth, Houston, TX USA; [Brown, R. Clark] Emory Univ, Atlanta, GA 30322 USA; [Aygun, Banu] Cohen Childrens Med Ctr, New Hyde Pk, NY USA; [Sarnaik, Sharada] Wayne State Univ, Detroit, MI USA; [Odame, Isaac] Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Fuh, Beng] E Carolina Univ, Greenville, NC 27858 USA; [George, Alex] Baylor Coll Med, Houston, TX 77030 USA; [Owen, William] Childrens Hosp Kings Daughters, Norfolk, VA USA; [Luchtman-Jones, Lori; Luban, Naomi L. C.] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Rogers, Zora R.] UT Southwestern, Dallas, TX USA; [Hilliard, Lee] Univ Alabama Birmingham, Birmingham, AL USA; [Gauger, Cynthia] Nemours Childrens Clin, Jacksonville, FL USA; [Piccone, Connie] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Lee, Margaret T.] Columbia Univ, New York, NY USA; [Kwiatkowski, Janet L.; Cohen, Alan R.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Jackson, Sherron; Roberts, Donna; Luden, Judy] Med Univ S Carolina, Columbia, SC USA; [Miller, Scott T.] State Univ New York Downstate, Brooklyn, NY USA; [Roberts, Carla] Univ S Carolina, Columbia, SC 29208 USA; [Heeney, Matthew M.] Boston Childrens Hosp, Boston, MA USA; [Nelson, Stephen] Childrens Hosp & Clin Minnesota, Minneapolis, MN USA; [Imran, Hamayun] Univ S Alabama, Mobile, AL 36688 USA; [Nottage, Kerri; Helton, Kathleen J.; Coleman, Jamie] St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA; [Alvarez, Ofelia] Univ Miami, Miami, FL USA; [Rhodes, Melissa] Univ Mississippi, Jackson, MS 39216 USA; [Thompson, Alexis A.] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA; [Rothman, Jennifer A.; Bonner, Melanie J.] Duke Univ, Med Ctr, Durham, NC USA; [Kutlar, Abdullah; Patel, Niren] Georgia Regents Univ, Augusta, GA USA; [Wood, John] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA	Cincinnati Children's Hospital Medical Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Emory University; Northwell Health; North Shore University Hospital; Steven & Alexandra Cohen Children's Medical Center of New York; Wayne State University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of North Carolina; East Carolina University; Baylor College of Medicine; Children's National Health System; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Alabama System; University of Alabama Birmingham; Case Western Reserve University; Columbia University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Medical University of South Carolina; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Harvard University; Boston Children's Hospital; Children's Hospitals & Clinics of Minnesota; University of South Alabama; St Jude Children's Research Hospital; University of Miami; University of Mississippi; Ann & Robert H. Lurie Children's Hospital of Chicago; Duke University; University System of Georgia; Augusta University; Children's Hospital Los Angeles	Ware, RE (corresponding author), Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA.	russell.ware@cchmc.org	Wei, Peng/X-2306-2019; Adams, Robert/GPW-8528-2022	Wei, Peng/0000-0001-7758-6116; Rothman, Jennifer/0000-0003-1582-2886; Kalfa, Theodosia/0000-0002-0426-9686	National Heart, Lung, and Blood Institute, National Institutes of Health; National Heart, Lung, and Blood Institute [R01 HL-095647, R01 HL-095511]; Data Coordinating Centre at the University of Texas School of Public Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095647, R01HL095511] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Data Coordinating Centre at the University of Texas School of Public Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Heart, Lung, and Blood Institute, National Institutes of Health.; This clinical trial was supported by the National Heart, Lung, and Blood Institute through grants R01 HL-095647 (REW) and R01 HL-095511 (BRD). Hydroxyurea is not approved by the US FDA for use in children with sickle cell anaemia, and the TWiTCH trial was performed under FDA IND #67289 with cross-reference to FDA IND #111926. We thank all staff at the Medical Coordinating Centre at Cincinnati Children's Hospital and the Data Coordinating Centre at the University of Texas School of Public Health for their support throughout the study. We acknowledge the assistance of Ronald Helms and Nancy Yovetich in the design of the study. FerriScan R2-MRI was provided at discount by Resonance Health (Claremont, WA, Australia). We also appreciate the efforts of all health-care providers, and especially the nursing staff, at each participating institution. We especially recognise the eager participation and time commitments made by the children and families who enrolled in this study.	ADAMS R, 1992, NEW ENGL J MED, V326, P605, DOI 10.1056/NEJM199202273260905; Adams RJ, 2005, NEW ENGL J MED, V353, P2769; Adams RJ, 1998, NEW ENGL J MED, V339, P5, DOI 10.1056/NEJM199807023390102; Almeida CB, 2015, BLOOD, V126, P711, DOI 10.1182/blood-2014-12-616250; Armstrong FD, 2013, PEDIATRICS, V131, pE406, DOI 10.1542/peds.2012-0283; Aygun B, 2015, BRIT J HAEMATOL, V169, P262, DOI 10.1111/bjh.13280; Aygun B, 2012, AM J HEMATOL, V87, P428, DOI 10.1002/ajh.23105; Bernaudin F, 2011, BLOOD, V117, P1130, DOI 10.1182/blood-2010-06-293514; Brambilla DJ, 2007, PEDIATR BLOOD CANCER, V49, P318, DOI 10.1002/pbc.21142; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; DeBaun MR, 2014, NEW ENGL J MED, V371, P699, DOI 10.1056/NEJMoa1401731; Flanagan JM, 2013, BLOOD, V121, P3237, DOI 10.1182/blood-2012-10-464156; Flanagan JM, 2011, BLOOD, V117, P6681, DOI 10.1182/blood-2011-01-332205; Greenway A, 2011, AM J HEMATOL, V86, P357, DOI 10.1002/ajh.21986; Gulbis B, 2005, BLOOD, V105, P2685, DOI 10.1182/blood-2004-07-2704; Heeney MM, 2008, PEDIATR CLIN N AM, V55, P483, DOI 10.1016/j.pcl.2008.02.003; Helton KJ, 2014, BLOOD, V124, P891, DOI 10.1182/blood-2013-12-545186; Hulbert ML, 2011, BLOOD, V117, P772, DOI 10.1182/blood-2010-01-261123; Kwiatkowski JL, 2011, PEDIATR BLOOD CANCER, V56, P777, DOI 10.1002/pbc.22951; Ohene-Frempong K, 1998, BLOOD, V91, P288; Raphael JL, 2008, PEDIATR BLOOD CANCER, V51, P647, DOI 10.1002/pbc.21677; Reboussin DM, 2000, CONTROL CLIN TRIALS, V21, P190, DOI 10.1016/S0197-2456(00)00057-X; Reeves SL, 2015, CLIN PEDIATR, V54, P336, DOI 10.1177/0009922814553429; Wang WC, 2011, LANCET, V377, P1663, DOI 10.1016/S0140-6736(11)60355-3; Ware RE, 2004, J PEDIATR-US, V145, P346, DOI 10.1016/j.jpeds.2004.04.058; Ware RE, HEMATOLOGY IN PRESS; Ware RE, 2011, PEDIATR BLOOD CANCER, V57, P1011, DOI 10.1002/pbc.23145; Ware RE, 2010, BLOOD, V115, P5300, DOI 10.1182/blood-2009-04-146852; Yawn BP, 2014, JAMA-J AM MED ASSOC, V312, P1033, DOI 10.1001/jama.2014.10517; Zimmerman SA, 2007, BLOOD, V110, P1043, DOI 10.1182/blood-2006-11-057893	30	269	272	1	37	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 13	2016	387	10019					661	670		10.1016/S0140-6736(15)01041-7	http://dx.doi.org/10.1016/S0140-6736(15)01041-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD3QH	26670617	Green Accepted, Green Submitted			2022-12-28	WOS:000369837100025
J	Gostin, LO; Friedman, EA				Gostin, Lawrence O.; Friedman, Eric A.			The Sustainable Development Goals One-Health in the World's Development Agenda	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence O.; Friedman, Eric A.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				Deen TUN, 2015, IPS; Gostin Lawrence O, 2013, Yale J Health Policy Law Ethics, V13, P1; Institute for Health Metrics and Evaluation, FIN GLOB HLTH 2014 S; Rippin N, 2013, PROGR PROSPECTS LESS; Schmidt H, 2015, LANCET, V386, P928, DOI 10.1016/S0140-6736(15)60244-6; United Nations Conference on Trade and Development, 2014, WORLD INV REP 2014 I; World Health Organization World Bank, MON PROGR UN HLTH CO	7	22	22	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 29	2015	314	24					2621	2622		10.1001/jama.2015.16281	http://dx.doi.org/10.1001/jama.2015.16281			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ2MR	26660329				2022-12-28	WOS:000366939800013
J	Mckee, M; Gilmore, AB				Mckee, Martin; Gilmore, Anna B.			TOBACCO CONTROL European watchdog is failing to hold tobacco industry to account over smuggling	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Mckee, Martin] London Sch Hyg & Trop Med, European Publ Hlth, London WC1H 9SH, England; [Gilmore, Anna B.] Univ Bath, Dept Hlth, Publ Hlth, Bath BA2 7AY, Avon, England	University of London; London School of Hygiene & Tropical Medicine; University of Bath	Mckee, M (corresponding author), London Sch Hyg & Trop Med, European Publ Hlth, London WC1H 9SH, England.	Martin.McKee@lshtm.ac.uk	gilmore, anna B/I-7130-2012; Mckee, Martin/E-6673-2018; McKee, Marc D/E-2187-2011	gilmore, anna B/0000-0003-0281-1248; Mckee, Martin/0000-0002-0121-9683; McKee, Marc D/0000-0001-8349-965X	Economic and Social Research Council [ES/G007489/1] Funding Source: researchfish; Medical Research Council [MR/K023195/1] Funding Source: researchfish	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Aries Q, 2015, BIG TOBACCO TRIES PU; Aries Q, UN AGENCY GIVES EU T; Connett D, 2015, INDEPENDENT; Gilmore AB, 2013, TOB CONTROL, DOI [10.1136/tobaccocontrol-2013-051240, DOI 10.1136/T0BACCOCONTROL-2013-051240]; Gilmore Anna B, 2015, Lancet, V385, P1029, DOI 10.1016/S0140-6736(15)60312-9; Joossens L, 2015, TOB CONTROL, DOI [10.1136/tobaccocontrol-2014-052218, DOI 10.1136/T0BACCOCONTROL-2014-052218]; Joossens L, 2014, TOB CONTROL, V23, pE3, DOI 10.1136/tobaccocontrol-2012-050796; Joossens L, 2012, TOB CONTROL, V21, P230, DOI 10.1136/tobaccocontrol-2011-050205; Rowell A, 2014, TOB CONTROL, V23, pE35, DOI 10.1136/tobaccocontrol-2013-051397; Teffer P., 2015, WILL EU RENEW 1 25BN; Teffer P., 2015, EU SLEUTHS IGNORE SP	11	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 29	2015	351								h6973	10.1136/bmj.h6973	http://dx.doi.org/10.1136/bmj.h6973			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA4OQ	26714869	Green Accepted, Green Published			2022-12-28	WOS:000367779700005
J	Ballance, CJ; Schafer, VM; Home, JP; Szwer, DJ; Webster, SC; Allcock, DTC; Linke, NM; Harty, TP; Craik, DPLA; Stacey, DN; Steane, AM; Lucas, DM				Ballance, C. J.; Schaefer, V. M.; Home, J. P.; Szwer, D. J.; Webster, S. C.; Allcock, D. T. C.; Linke, N. M.; Harty, T. P.; Craik, D. P. L. Aude; Stacey, D. N.; Steane, A. M.; Lucas, D. M.			Hybrid quantum logic and a test of Bell's inequality using two different atomic isotopes	NATURE			English	Article							VIOLATION; MEMORY	Entanglement is one of the most fundamental properties of quantum mechanics(1-3), and is the key resource for quantum information processing(4,5) (QIP). Bipartite entangled states of identical particles have been generated and studied in several experiments, and post-selected or heralded entangled states involving pairs of photons, single photons and single atoms, or different nuclei in the solid state, have also been produced(6-12). Here we use a deterministic quantum logic gate to generate a 'hybrid' entangled state of two trapped-ion qubits held in different isotopes of calcium, perform full tomography of the state produced, and make a test of Bell's inequality with non-identical atoms. We use a laser-driven two-qubit gate(13), whose mechanism is insensitive to the qubits' energy splittings, to produce a maximally entangled state of one Ca-40(+) qubit and one Ca-43(+) qubit, held 3.5 micrometres apart in the same ion trap, with 99.8 +/- 0.6 per cent fidelity. We test the CHSH (Clauser-Horne-Shimony-Holt)(14) version of Bell's inequality for this novel entangled state and find that it is violated by 15 standard deviations; in this test, we close the detection loophole(8) but not the locality loophole(7). Mixed-species quantum logic is a powerful technique for the construction of a quantum computer based on trapped ions, as it allows protection of memory qubits while other qubits undergo logic operations or are used as photonic interfaces to other processing units(15,16). The entangling gate mechanism used here can also be applied to qubits stored in different atomic elements; this would allow both memory and logic gate errors caused by photon scattering to be reduced below the levels required for fault-tolerant quantum error correction, which is an essential prerequisite for general-purpose quantum computing.	[Ballance, C. J.; Schaefer, V. M.; Home, J. P.; Szwer, D. J.; Webster, S. C.; Allcock, D. T. C.; Linke, N. M.; Harty, T. P.; Craik, D. P. L. Aude; Stacey, D. N.; Steane, A. M.; Lucas, D. M.] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England	University of Oxford	Ballance, CJ (corresponding author), Univ Oxford, Dept Phys, Clarendon Lab, Parks Rd, Oxford OX1 3PU, England.	c.ballance@physics.ox.ac.uk	Allcock, David/C-7582-2013	Allcock, David/0000-0002-7317-5560; Ballance, Chris/0000-0002-9654-9510; Schafer, Vera/0000-0002-1000-3737; Home, Jonathan/0000-0002-4093-1550; Prado Lopes Aude Craik, Diana/0000-0002-9443-8315; Szwer, David/0000-0002-1518-9075; Linke, Norbert/0000-0001-5655-9258	UK EPSRC 'Networked Quantum Information Technology' Hub; US Army Research Office [W911NF-14-1-0217]; Engineering and Physical Sciences Research Council [EP/M013243/1] Funding Source: researchfish; EPSRC [EP/M013243/1] Funding Source: UKRI	UK EPSRC 'Networked Quantum Information Technology' Hub; US Army Research Office; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the UK EPSRC 'Networked Quantum Information Technology' Hub and the US Army Research Office (contract W911NF-14-1-0217). D.M.L. thanks A. Castillo and E. A. Castillo for their hospitality while revising the manuscript.	ASPECT A, 1982, PHYS REV LETT, V49, P91, DOI 10.1103/PhysRevLett.49.91; Ballance C. J., 2014, THESIS; Ballance C. J., 2014, HIGH FIDELITY 3 QUBI; Bell JS., 1964, PHYS, V1, P195, DOI [10.1103/PhysicsPhysiqueFizika.1.195, 10.1103/Physics-PhysiqueFizika.1.195, DOI 10.1103/PHYSICSPHYSIQUEFIZIKA.1.195]; Blatt R, 2008, NATURE, V453, P1008, DOI 10.1038/nature07125; Christensen BG, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.130406; DEUTSCH D, 1985, P ROY SOC LOND A MAT, V400, P97, DOI 10.1098/rspa.1985.0070; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; EKERT AK, 1991, PHYS REV LETT, V67, P661, DOI 10.1103/PhysRevLett.67.661; Fowler AG, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.032324; FREEDMAN SJ, 1972, PHYS REV LETT, V28, P938, DOI 10.1103/PhysRevLett.28.938; Giustina M, 2013, NATURE, V497, P227, DOI 10.1038/nature12012; Harty TP, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.220501; Hensen B, 2015, NATURE, V526, P682, DOI 10.1038/nature15759; Hume DB, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.120502; Langer C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.060502; Lanyon BP, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.100403; Leibfried D, 2003, NATURE, V422, P412, DOI 10.1038/nature01492; Matsukevich DN, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.150404; McDonnell MJ, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.153601; Moehring DL, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.090410; Monroe C, 2013, SCIENCE, V339, P1164, DOI 10.1126/science.1231298; Pfaff W, 2013, NAT PHYS, V9, P29, DOI [10.1038/nphys2444, 10.1038/NPHYS2444]; Rowe MA, 2001, NATURE, V409, P791, DOI 10.1038/35057215; Schmidt PO, 2005, SCIENCE, V309, P749, DOI 10.1126/science.1114375; Schrodinger E, 1935, P CAMB PHILOS SOC, V31, P555, DOI 10.1017/S0305004100013554	32	64	65	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2015	528	7582					384	+		10.1038/nature16184	http://dx.doi.org/10.1038/nature16184			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY8SM	26672554	Green Submitted			2022-12-28	WOS:000366678600049
J	Davies, M				Davies, Marika			Medicolegal aspects of working while unwell	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Davies, Marika] Med Protect Soc Ltd, London, England		Davies, M (corresponding author), Med Protect Soc Ltd, London, England.	marika.davies@medicalprotection.org							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 10	2015	351								h6721	10.1136/bmj.h6721	http://dx.doi.org/10.1136/bmj.h6721			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY5TG	26657279				2022-12-28	WOS:000366469700010
J	Nathues, A; Hoffmann, M; Schaefer, M; Le Corre, L; Reddy, V; Platz, T; Cloutis, EA; Christensen, U; Kneissl, T; Li, JY; Mengel, K; Schmedemann, N; Schaefer, T; Russell, CT; Applin, DM; Buczkowski, DL; Izawa, MRM; Keller, HU; O'Brien, DP; Pieters, CM; Raymond, CA; Ripken, J; Schenk, PM; Schmidt, BE; Sierks, H; Sykes, MV; Thangjam, GS; Vincent, JB				Nathues, A.; Hoffmann, M.; Schaefer, M.; Le Corre, L.; Reddy, V.; Platz, T.; Cloutis, E. A.; Christensen, U.; Kneissl, T.; Li, J. -Y.; Mengel, K.; Schmedemann, N.; Schaefer, T.; Russell, C. T.; Applin, D. M.; Buczkowski, D. L.; Izawa, M. R. M.; Keller, H. U.; O'Brien, D. P.; Pieters, C. M.; Raymond, C. A.; Ripken, J.; Schenk, P. M.; Schmidt, B. E.; Sierks, H.; Sykes, M. V.; Thangjam, G. S.; Vincent, J. -B.			Sublimation in bright spots on (1) Ceres	NATURE			English	Article							WATER-VAPOR; ASTEROIDS; VESTA; CONDENSATION; EVOLUTION	The dwarf planet (1) Ceres, the largest object in the main asteroid belt(1) with a mean diameter of about 950 kilometres, is located at a mean distance from the Sun of about 2.8 astronomical units (one astronomical unit is the Earth-Sun distance). Thermal evolution models suggest that it is a differentiated body with potential geological activity(2,3). Unlike on the icy satellites of Jupiter and Saturn, where tidal forces are responsible for spewing briny water into space, no tidal forces are acting on Ceres. In the absence of such forces, most objects in the main asteroid belt are expected to be geologically inert. The recent discovery(4) of water vapour absorption near Ceres and previous detection of bound water and OH near and on Ceres (refs 5-7) have raised interest in the possible presence of surface ice. Here we report the presence of localized bright areas on Ceres from an orbiting imager(8). These unusual areas are consistent with hydrated magnesium sulfates mixed with dark background material, although other compositions are possible. Of particular interest is a bright pit on the floor of crater Occator that exhibits probable sublimation of water ice, producing haze clouds inside the crater that appear and disappear with a diurnal rhythm. Slow-moving condensed-ice or dust particles(9,10) may explain this haze. We conclude that Ceres must have accreted material from beyond the 'snow line' 11, which is the distance from the Sun at which water molecules condense.	[Nathues, A.; Hoffmann, M.; Schaefer, M.; Le Corre, L.; Reddy, V.; Platz, T.; Christensen, U.; Schaefer, T.; Ripken, J.; Sierks, H.; Thangjam, G. S.; Vincent, J. -B.] Max Planck Inst Solar Syst Res, Gottingen, Germany; [Le Corre, L.; Reddy, V.; Li, J. -Y.; O'Brien, D. P.; Sykes, M. V.] Planetary Sci Inst, Tucson, AZ USA; [Cloutis, E. A.; Applin, D. M.; Izawa, M. R. M.] Univ Winnipeg, Winnipeg, MB R3B 2E9, Canada; [Kneissl, T.; Schmedemann, N.] Free Univ Berlin, Berlin, Germany; [Mengel, K.] Tech Univ Clausthal, D-38678 Clausthal Zellerfeld, Germany; [Russell, C. T.] Univ Calif Los Angeles, Los Angeles, CA USA; [Buczkowski, D. L.] Johns Hopkins Univ, Laurel, MD USA; [Izawa, M. R. M.] Royal Ontario Museum, Toronto, ON M5S 2C6, Canada; [Keller, H. U.] TU Braunschweig, Braunschweig, Germany; [Pieters, C. M.] Brown Univ, Providence, RI 02912 USA; [Raymond, C. A.] CALTECH, Jet Prop Lab, Pasadena, CA USA; [Schenk, P. M.] Lunar & Planetary Inst, Houston, TX 77058 USA; [Schmidt, B. E.] Georgia Inst Technol, Atlanta, GA 30332 USA	Max Planck Society; University of Winnipeg; Free University of Berlin; TU Clausthal; University of California System; University of California Los Angeles; Johns Hopkins University; Royal Ontario Museum; Braunschweig University of Technology; Brown University; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University System of Georgia; Georgia Institute of Technology	Nathues, A (corresponding author), Max Planck Inst Solar Syst Res, Gottingen, Germany.	Nathues@mps.mpg.de	Nathues, Andreas/AAW-4340-2020; Thangjam, Guneshwar/P-1489-2017; Platz, Thomas/F-7539-2013; Russell, Christopher T/E-7745-2012	Thangjam, Guneshwar/0000-0001-5697-112X; Platz, Thomas/0000-0002-1253-2034; Russell, Christopher T/0000-0003-1639-8298; Le Corre, Lucille/0000-0003-0349-7932; Schmidt, Britney Elyce/0000-0001-7376-8510; Li, Jian-Yang/0000-0003-3841-9977	Max Planck Society; German Space Agency, DLR	Max Planck Society(Max Planck Society); German Space Agency, DLR(Helmholtz AssociationGerman Aerospace Centre (DLR))	We thank the Dawn operations team for the development, cruise, orbital insertion and operations of the Dawn spacecraft at Ceres. We also thank the FC operations team, especially P. G. Gutierrez-Marques, I. Hall and I. Buttner. The FC project is financially supported by the Max Planck Society and the German Space Agency, DLR.	AHEARN MF, 1992, ICARUS, V98, P54, DOI 10.1016/0019-1035(92)90206-M; Bishop J. L., 2014, LUNAR PLANET SCI C, V45; Blinn J. F., 1982, Computer Graphics, V16, P21, DOI 10.1145/965145.801255; Bowling T. J., 2015, P ASTR SCI C 2015; Castillo-Rogez JC, 2010, ICARUS, V205, P443, DOI 10.1016/j.icarus.2009.04.008; Cintala M. J., 1980, LPI, VXI, P140; Ehlmann BL, 2013, SPACE SCI REV, V174, P329, DOI 10.1007/s11214-012-9930-0; Gounelle M., 2014, GEOSCI WORLD, V7, P29; Hansen CJ, 2006, SCIENCE, V311, P1422, DOI 10.1126/science.1121254; Kneissl T, 2011, PLANET SPACE SCI, V59, P1243, DOI 10.1016/j.pss.2010.03.015; Kuppers M, 2014, NATURE, V505, P525, DOI 10.1038/nature12918; LEBOFSKY LA, 1981, ICARUS, V48, P453, DOI 10.1016/0019-1035(81)90055-5; Martin RG, 2012, MON NOT R ASTRON SOC, V425, pL6, DOI 10.1111/j.1745-3933.2012.01290.x; McCord TB, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2004JE002244; Michael GG, 2012, ICARUS, V218, P169, DOI 10.1016/j.icarus.2011.11.033; Michael GG, 2010, EARTH PLANET SC LETT, V294, P223, DOI 10.1016/j.epsl.2009.12.041; Milliken RE, 2007, ICARUS, V189, P550, DOI 10.1016/j.icarus.2007.02.017; Nathues A, 2014, ICARUS, V239, P222, DOI 10.1016/j.icarus.2014.06.003; Platz T, 2013, ICARUS, V225, P806, DOI 10.1016/j.icarus.2013.04.021; Reddy V., 2015, LUNAR PLANET SCI C, V46; Reddy V, 2012, SCIENCE, V336, P700, DOI 10.1126/science.1219088; Rivkin AS, 2003, METEORIT PLANET SCI, V38, P1383, DOI 10.1111/j.1945-5100.2003.tb00321.x; Roth L, 2014, SCIENCE, V343, P171, DOI 10.1126/science.1247051; Russell C. T., 2012, DAWN MISSION MINOR P; Schenk P., 2015, EUR PLAN SCI C 2015, V10; Schmedemann N, 2014, PLANET SPACE SCI, V103, P104, DOI 10.1016/j.pss.2014.04.004; Schmedemann N., 2015, LUNAR PLANET SCI C, V46; Schmidt J, 2008, NATURE, V451, P685, DOI 10.1038/nature06491; Sierks H, 2011, SPACE SCI REV, V163, P263, DOI 10.1007/s11214-011-9745-4; Sierks H., 2012, DAWN MISSION MINOR P, P263; SODERBLOM LA, 1990, SCIENCE, V250, P410, DOI 10.1126/science.250.4979.410; VILAS F, 1992, ICARUS, V100, P85, DOI 10.1016/0019-1035(92)90020-8; Williams NR, 2015, ICARUS, V252, P175, DOI 10.1016/j.icarus.2014.12.005; YAMAMOTO T, 1985, ASTRON ASTROPHYS, V152, pL17	34	104	105	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2015	528	7581					237	+		10.1038/nature15754	http://dx.doi.org/10.1038/nature15754			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9VH	26659183				2022-12-28	WOS:000366053300035
J	Arie, S				Arie, Sophie			CONFLICTS OF INTEREST The device industry and payments to doctors	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sarie@bmj.com						Ethical MedTech, MEDTECH COD; MedTech Europe, 2015, COD ETH BUS PRACT	2	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 7	2015	351								h6182	10.1136/bmj.h6182	http://dx.doi.org/10.1136/bmj.h6182			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY5SM	26643475				2022-12-28	WOS:000366467700001
J	Shen, B				Shen, Ben			A New Golden Age of Natural Products Drug Discovery	CELL			English	Editorial Material							ARTEMISININ; IVERMECTIN; QINGHAOSU	The 2015 Nobel Prize in Physiology or Medicine has been awarded to William C. Campbell, Satoshi Omura, and Youyou Tu for the discovery of avermectins and artemisinin, respectively, therapies that revolutionized the treatment of devastating parasite diseases. With the recent technological advances, a New Golden Age of natural products drug discovery is dawning.	[Shen, Ben] Scripps Res Inst, Dept Chem, Jupiter, FL 33458 USA; [Shen, Ben] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Shen, Ben] Scripps Res Inst, Nat Prod Lib Initiat, Jupiter, FL 33458 USA; [Shen, Ben] Cent S Univ, Xiangya Int Acad Translat Med, Changsha 410013, Hunan, Peoples R China	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Central South University	Shen, B (corresponding author), Scripps Res Inst, Dept Chem, Jupiter, FL 33458 USA.	shenb@scripps.edu			NATIONAL CANCER INSTITUTE [R01CA106150, R01CA078747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114353, R01GM115575] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA078747, R01 CA106150] Funding Source: Medline; NIGMS NIH HHS [R01 GM114353, R01 GM115575] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bouslimani A, 2014, NAT PROD REP, V31, P718, DOI 10.1039/c4np00044g; Charlop-Powers Z, 2014, P NATL ACAD SCI USA, V111, P3757, DOI 10.1073/pnas.1318021111; Ikeda H, 1999, P NATL ACAD SCI USA, V96, P9509, DOI 10.1073/pnas.96.17.9509; KLAYMAN DL, 1985, SCIENCE, V228, P1049, DOI 10.1126/science.3887571; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Omura S, 2004, NAT REV MICROBIOL, V2, P984, DOI 10.1038/nrmicro1048; Omura S, 2014, TRENDS PARASITOL, V30, P445, DOI 10.1016/j.pt.2014.07.005; Omura S, 2011, TETRAHEDRON, V67, P6420, DOI 10.1016/j.tet.2011.03.117; Paddon CJ, 2013, NATURE, V496, P528, DOI 10.1038/nature12051; Rudolf J. D., J IND MICROBIOL BIOT; Tu YY, 2011, NAT MED, V17, P1217, DOI 10.1038/nm.2471	13	380	409	5	173	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 6	2015	163	6					1297	1300		10.1016/j.cell.2015.11.031	http://dx.doi.org/10.1016/j.cell.2015.11.031			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SE	26638061	Green Accepted, Bronze			2022-12-28	WOS:000366044800007
J	Kirby, T				Kirby, Tony			Evan Wood-bringing change to addiction medicine	LANCET			English	Biographical-Item																		WOOD EH, PUBLICATION LIST	1	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 28	2015	386	10009					2131	2131		10.1016/S0140-6736(15)01057-0	http://dx.doi.org/10.1016/S0140-6736(15)01057-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX8YW	26638954				2022-12-28	WOS:000365992600016
J	Watts, G				Watts, Geoff			Herbert Michael Gilles Obituary	LANCET			English	Biographical-Item																		GILLES, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 21	2015	386	10008					2052	2052		10.1016/S0140-6736(15)00965-4	http://dx.doi.org/10.1016/S0140-6736(15)00965-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX8XF	26713340	Bronze			2022-12-28	WOS:000365987600015
J	Ganz, PA; Cecchini, RS; Julian, TB; Margolese, RG; Costantino, JP; Vallow, LA; Albain, KS; Whitworth, PW; Cianfrocca, ME; Brufsky, AM; Gross, HM; Soori, GS; Hopkins, JO; Fehrenbacher, L; Sturtz, K; Wozniak, TF; Seay, TE; Mamounas, EP; Wolmark, N				Ganz, Patricia A.; Cecchini, Reena S.; Julian, Thomas B.; Margolese, Richard G.; Costantino, Joseph P.; Vallow, Laura A.; Albain, Kathy S.; Whitworth, Patrick W.; Cianfrocca, Mary E.; Brufsky, Adam M.; Gross, Howard M.; Soori, Gamini S.; Hopkins, Judith O.; Fehrenbacher, Louis; Sturtz, Keren; Wozniak, Timothy F.; Seay, Thomas E.; Mamounas, Eleftherios P.; Wolmark, Norman			Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial	LANCET			English	Article							SURGICAL ADJUVANT BREAST; QUALITY-OF-LIFE; CANCER PREVENTION TRIAL; FIRST-LINE THERAPY; BOWEL PROJECT P-1; RADIATION-THERAPY; SHORT-FORM; WOMEN; COMBINATION; SYMPTOMS	Background The NSABP B-35 trial compared 5 years of treatment with anastrozole versus tamoxifen for reducing subsequent occurrence of breast cancer in postmenopausal patients with ductal carcinoma in situ. This report assesses the effect of these drugs on quality of life and symptoms. Methods The study was done at 333 hospitals in North America. Postmenopausal women with hormone-positive ductal carcinoma in situ treated by lumpectomy with clear resection margins and whole breast irradiation were randomly assigned to receive either tamoxifen (20 mg/day) or anastrazole (1 mg/day) for 5 years, stratified by age (<60 years vs >= 60 years). Patients and investigators were masked to treatment allocation. Patients completed questionnaires at baseline and every 6 months thereafter for 6 years. The primary outcomes were SF-12 physical and mental health component scale scores, and vasomotor symptoms (as per the BCPT symptom scale). Secondary outcomes were vaginal symptoms and sexual functioning. Exploratory outcomes were musculoskeletal pain, bladder symptoms, gynaecological symptoms, cognitive symptoms, weight problems, vitality, and depression. We did the analyses by intention to treat, including patients who completed questionnaires at baseline and at least once during follow-up. This study is registered with ClinicalTrials.gov, NCT00053898. Findings Between Jan 6, 2003, and June 15, 2006, 3104 patients were enrolled in the study, of whom 1193 were included in the quality-of-life substudy: 601 assigned to tamoxifen and 592 assigned to anastrozole. We detected no significant difference between treatment groups for: physical health scores (mean severity score 46.72 for tamoxifen vs 45.85 for anastrozole; p= 0.20), mental health scores (52.38 vs 51.48; p= 0.38), energy and fatigue (58.34 vs 57.54; p= 0.86), or symptoms of depression (6.19 vs 6.39; p= 0.46) over 5 years. Vasomotor symptoms (1.33 vs 1.17; p= 0.011), difficulty with bladder control (0.96 vs 0.80; p= 0.0002), and gynaecological symptoms (0.29 vs 0.18; p< 0.0001) were significantly more severe in the tamoxifen group than in the anastrozole group. Musculoskeletal pain (1.50 vs 1.72; p= 0.0006) and vaginal symptoms (0.76 vs 0.86; p= 0.035) were significantly worse in the anastrozole group than in the tamoxifen group. Sexual functioning did not differ significantly between the two treatments (43.65 vs 45.29; p= 0.56). Younger age was significantly associated with more severe vasomotor symptoms (mean severity score 1.45 for age < 60 years vs 0.65 for age >= 60 years; p= 0.0006), vaginal symptoms (0.98 vs 0.65; p< 0.0001), weight problems (1.32 vs 1.02; p< 0.0001), and gynaecological symptoms (0.26 vs 0.22; p= 0.014). Interpretation Given the similar efficacy of tamoxifen and anastrozole for women older than age 60 years, decisions about treatment should be informed by the risk for serious adverse health effects and the symptoms associated with each drug. For women younger than 60 years old, treatment decisions might be driven by efficacy (favouring anastrozole); however, if the side-effects of anastrozole are intolerable, then switching to tamoxifen is a good alternative.	[Ganz, Patricia A.; Julian, Thomas B.; Margolese, Richard G.; Vallow, Laura A.; Albain, Kathy S.; Whitworth, Patrick W.; Cianfrocca, Mary E.; Brufsky, Adam M.; Gross, Howard M.; Soori, Gamini S.; Hopkins, Judith O.; Fehrenbacher, Louis; Sturtz, Keren; Wozniak, Timothy F.; Seay, Thomas E.; Mamounas, Eleftherios P.; Wolmark, Norman] NRG Oncol Natl Surg Adjuvant Breast & Bowel Proje, Pittsburgh, PA USA; [Ganz, Patricia A.] Univ Calif Los Angeles, Los Angeles, CA USA; [Cecchini, Reena S.; Costantino, Joseph P.] NRG Oncol, Pittsburgh, PA USA; [Cecchini, Reena S.; Costantino, Joseph P.] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15261 USA; [Julian, Thomas B.; Wolmark, Norman] Allegheny Gen Hosp, Allegheny Canc Ctr, Dept Surg Oncol, Pittsburgh, PA 15212 USA; [Margolese, Richard G.] McGill Univ, Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada; [Vallow, Laura A.] Mayo Clin, Dept Radiat Oncol, Jacksonville, FL 32224 USA; [Albain, Kathy S.; Cianfrocca, Mary E.] Southwest Oncol Grp, San Antonio, TX USA; [Albain, Kathy S.] Loyola Univ, Sch Med, Stritch Sch Med, Chicago, IL 60611 USA; [Whitworth, Patrick W.] Amer Coll Surg Oncol, Alliance Clin Trials Oncol, Chicago, IL USA; [Whitworth, Patrick W.] Nashville Breast Ctr, Nashville, TN USA; [Cianfrocca, Mary E.] Amer Coll Radiol Imaging Network, Eastern Cooperat Oncol Grp, Philadelphia, PA USA; [Cianfrocca, Mary E.] Banner MD Anderson Canc Ctr, Dept Hematol Oncol, Gilbert, AZ USA; [Brufsky, Adam M.] Univ Pittsburgh, Magee Womens Hosp, Dept Hematol, Pittsburgh, PA 15213 USA; [Gross, Howard M.] Dayton Phys, Dayton, OH USA; [Soori, Gamini S.] Missouri Valley Canc Consortium, Omaha, NE USA; [Hopkins, Judith O.] NCI, Southeast Clin Oncol Res Consortium, Community Oncol Res Program, Winston Salem, NC USA; [Hopkins, Judith O.] Forsyth Reg Canc Ctr, Dept Hematol Oncol, Winston Salem, NC USA; [Fehrenbacher, Louis] Kaiser Permanente, Dept Med Oncol, Northern Calif Vallejo, CA USA; [Sturtz, Keren] Colorado Canc Res Program, Dept Med Oncol, Denver, CO USA; [Wozniak, Timothy F.] Christiana Care Hlth Syst, Community Clin Oncol Program, Wilmington, DE USA; [Seay, Thomas E.] Atlanta Reg Community Clin Oncol Program, Atlanta, GA USA; [Mamounas, Eleftherios P.] Orlando Hlth, UF Hlth Canc Ctr, Orlando, FL USA	University of California System; University of California Los Angeles; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Surgical Adjuvant Breast & Bowel Project; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Allegheny General Hospital; McGill University; Mayo Clinic; Southwest Oncology Group; Loyola University Chicago; American College of Radiology; Banner Research; Banner Health; University of Texas System; UTMD Anderson Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Kaiser Permanente; Christiana Care Health System	Ganz, PA (corresponding author), Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90049 USA.	pganz@mednet.ucla.edu	Cecchini, Rubens/D-9811-2013; Brufsky, Adam/AAE-7470-2020	Cecchini, Rubens/0000-0001-9941-2344; Brufsky, Adam/0000-0001-8080-7960; Cecchini, Reena/0000-0002-9075-9357; Ganz, Patricia/0000-0002-1841-4143	US National Cancer Institute; AstraZeneca Pharmaceuticals; NATIONAL CANCER INSTITUTE [U24CA114732, UG1CA189805, U10CA180868, U10CA180822, UG1CA189867, UG1CA189974, U24CA196067] Funding Source: NIH RePORTER	US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); AstraZeneca Pharmaceuticals(AstraZeneca); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	US National Cancer Institute, AstraZeneca Pharmaceuticals.	American Cancer Society, 2015, BREAST CANC FACTS FI; ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Baum M, 2002, LANCET, V359, P2131; Bonneterre J, 2000, J CLIN ONCOL, V18, P3748, DOI 10.1200/JCO.2000.18.22.3748; Cella D, 2008, BREAST CANCER RES TR, V109, P515, DOI 10.1007/s10549-007-9682-9; Cella D, 2006, BREAST CANCER RES TR, V100, P273, DOI 10.1007/s10549-006-9260-6; Day R, 1999, J CLIN ONCOL, V17, P2659, DOI 10.1200/JCO.1999.17.9.2659; Fallowfield L, 2004, J CLIN ONCOL, V22, P4261, DOI 10.1200/JCO.2004.08.029; Fisher B, 1999, LANCET, V353, P1993, DOI 10.1016/S0140-6736(99)05036-9; Fisher B, 2001, SEMIN ONCOL, V28, P400, DOI 10.1053/sonc.2001.26151; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; FISHER B, 1993, NEW ENGL J MED, V328, P1581, DOI 10.1056/NEJM199306033282201; Fisher B, 1998, J CLIN ONCOL, V16, P441, DOI 10.1200/JCO.1998.16.2.441; GANZ PA, 1995, JNCI-J NATL CANCER I, V87, P1372, DOI 10.1093/jnci/87.18.1372; Ganz Patricia A., 2010, Journal of the National Cancer Institute Monographs, P218, DOI 10.1093/jncimonographs/lgq029; Gierisch JM, 2014, ANN INTERN MED, V160, P484, DOI 10.7326/M13-2548; Land SR, 2006, JAMA-J AM MED ASSOC, V295, P2742, DOI 10.1001/jama.295.23.joc60075; Margolese RG, 2015, LANCET; Nabholtz JM, 2000, J CLIN ONCOL, V18, P3758, DOI 10.1200/JCO.2000.18.22.3758; Narod SA, 2015, JAMA ONCOL, V1, P888, DOI 10.1001/jamaoncol.2015.2510; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Sherbourne CD, 1992, MEASURING FUNCTIONIN, P195; Stanton AL, 2005, JNCI-J NATL CANCER I, V97, P448, DOI 10.1093/jnci/dji069; The Health Institute, 1993, SF 36 HLTH SURVEY MA; Vogel VG, 2006, JAMA-J AM MED ASSOC, V295, P2727, DOI 10.1001/jama.295.23.joc60074; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003	26	51	52	0	19	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	2016	387	10021					857	865		10.1016/S0140-6736(15)01169-1	http://dx.doi.org/10.1016/S0140-6736(15)01169-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE9RA	26686960	Green Accepted			2022-12-28	WOS:000370974400030
J	Miossec, P				Miossec, Pierre			Progress in the treatment of juvenile dermatomyositis	LANCET			English	Editorial Material							IMMATURE MUSCLE PRECURSORS; TOLL-LIKE RECEPTOR-3; MYOSITIS; THERAPY		[Miossec, Pierre] Univ Lyon, Edouard Herriot Hosp, Dept Clin Immunol & Rheumatol, F-69437 Lyon, France; [Miossec, Pierre] Univ Lyon, Edouard Herriot Hosp, Immunogen & Inflammat Res Unit, F-69437 Lyon, France	CHU Lyon; CHU Lyon	Miossec, P (corresponding author), Univ Lyon, Edouard Herriot Hosp, Dept Clin Immunol & Rheumatol, F-69437 Lyon, France.; Miossec, P (corresponding author), Univ Lyon, Edouard Herriot Hosp, Immunogen & Inflammat Res Unit, F-69437 Lyon, France.	miossec@univ-lyon1.fr						Chevrel G, 2003, J NEUROIMMUNOL, V137, P125, DOI 10.1016/S0165-5728(03)00032-8; HECKMATT J, 1989, LANCET, V1, P1063, DOI 10.1016/S0140-6736(89)92456-2; Lundberg IE, 2014, CURR OPIN RHEUMATOL, V26, P704, DOI 10.1097/BOR.0000000000000109; MILLER LC, 1992, ARTHRITIS RHEUM, V35, P1143, DOI 10.1002/art.1780351006; Ravelli A, 2010, ARTHRIT CARE RES, V62, P63, DOI 10.1002/acr.20015; RUPERTO N, 2015, LANCET; Ruperto N, 2008, ARTHRIT RHEUM-ARTHR, V59, P4, DOI 10.1002/art.23248; Tournadre A, 2010, ARTHRITIS RHEUM-US, V62, P2144, DOI 10.1002/art.27465; Tournadre A, 2013, NAT REV RHEUMATOL, V9, P438, DOI 10.1038/nrrheum.2013.26; Tournadre A, 2012, ARTHRITIS RHEUM-US, V64, P533, DOI 10.1002/art.33350	10	2	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 13	2016	387	10019					627	628		10.1016/S0140-6736(15)01023-5	http://dx.doi.org/10.1016/S0140-6736(15)01023-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD3QH	26645191				2022-12-28	WOS:000369837100007
J	Li, LJ; O'Farrell, ECT; Loh, KP; Eda, G; Ozyilmaz, B; Neto, AHC				Li, L. J.; O'Farrell, E. C. T.; Loh, K. P.; Eda, G.; Ozyilmaz, B.; Neto, A. H. Castro			Controlling many-body states by the electric-field effect in a two-dimensional material	NATURE			English	Article							SUPERLATTICE FORMATION; TRANSITION; SUPERCONDUCTIVITY; TRANSPORT; GRAPHENE	To understand the complex physics of a system with strong electron-electron interactions, the ideal is to control and monitor its properties while tuning an external electric field applied to the system (the electric-field effect). Indeed, complete electric-field control of many-body states in strongly correlated electron systems is fundamental to the next generation of condensed matter research and devices(1-3). However, the material must be thin enough to avoid shielding of the electric field in the bulk material. Two-dimensional materials do not experience electrical screening, and their charge-carrier density can be controlled by gating. Octahedral titanium diselenide (1T-TiSe2) is a prototypical two-dimensional material that reveals a charge-density wave (CDW) and superconductivity in its phase diagram(4), presenting several similarities with other layered systems such as copper oxides(5), iron pnictides(6), and crystals of rare-earth elements and actinide atoms(7). By studying 1T-TiSe2 single crystals with thicknesses of 10 nanometres or less, encapsulated in two-dimensional layers of hexagonal boron nitride, we achieve unprecedented control over the CDW transition temperature (tuned from 170 kelvin to 40 kelvin), and over the superconductivity transition temperature (tuned from a quantum critical point at 0 kelvin up to 3 kelvin). Electrically driving TiSe2 over different ordered electronic phases allows us to study the details of the phase transitions between many-body states. Observations of periodic oscillations of magnetoresistance induced by the Little-Parks effect show that the appearance of superconductivity is directly correlated with the spatial texturing of the amplitude and phase of the superconductivity order parameter, corresponding to a two-dimensional matrix of superconductivity. We infer that this superconductivity matrix is supported by a matrix of incommensurate CDW states embedded in the commensurate CDW states. Our results show that spatially modulated electronic states are fundamental to the appearance of two-dimensional superconductivity.	[Li, L. J.; O'Farrell, E. C. T.; Loh, K. P.; Eda, G.; Ozyilmaz, B.; Neto, A. H. Castro] Natl Univ Singapore, Ctr Adv Mat 2D, Singapore 117546, Singapore; [Li, L. J.; O'Farrell, E. C. T.; Loh, K. P.; Eda, G.; Ozyilmaz, B.; Neto, A. H. Castro] Natl Univ Singapore, Graphene Res Ctr, Singapore 117546, Singapore; [Li, L. J.; O'Farrell, E. C. T.; Eda, G.; Ozyilmaz, B.; Neto, A. H. Castro] Natl Univ Singapore, Dept Phys, Singapore 117542, Singapore; [Li, L. J.; Loh, K. P.; Eda, G.] Natl Univ Singapore, Dept Chem, Singapore 117543, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Neto, AHC (corresponding author), Natl Univ Singapore, Ctr Adv Mat 2D, Singapore 117546, Singapore.	phycastr@nus.edu.sg	Castro Neto, Antonio/C-8363-2014; Oezyilmaz, Barbaros/G-1683-2012; Eda, Goki/G-1511-2012; Eda, Goki/W-4806-2019; Loh, Kian Ping/M-3122-2016; O'Farrell, Eoin/H-6711-2012	Castro Neto, Antonio/0000-0003-0613-4010; Oezyilmaz, Barbaros/0000-0001-7665-4578; Eda, Goki/0000-0002-1575-8020; Eda, Goki/0000-0002-1575-8020; Loh, Kian Ping/0000-0002-1491-743X; O'Farrell, Eoin/0000-0003-2216-8958	MOE [R-143-000-556-112]; National Research Foundation (NRF) [NRF-NRFF2011-02]; NRF, Prime Minister's Office, Singapore under Competitive Research Programme (CRP award) [NRF-CRP9-2011-3]; SMF-NUS Research Horizons Award; CRP award [NRF-CRP6-2010-05]	MOE(Ministry of Higher Education & Scientific Research (MHESR)); National Research Foundation (NRF); NRF, Prime Minister's Office, Singapore under Competitive Research Programme (CRP award); SMF-NUS Research Horizons Award; CRP award	We thank L. Q. Chu, T. H. Ren, J. Y. Tan, J. Wu and H. Schmidt for experimental assistance, and S. Natarajan for assistance in preparing the manuscript. A.H.C.N. acknowledges many discussions with A. K. Geim and a private communication with P. Abbamonte. K.P.L. acknowledges a MOE Tier 1 grant, "2-D crystals as a platform for optoelectronics (R-143-000-556-112)". G.E. acknowledges a National Research Foundation (NRF) Research Fellowship (NRF-NRFF2011-02). B.O. acknowledges support by the NRF, Prime Minister's Office, Singapore, under its Competitive Research Programme (CRP award number NRF-CRP9-2011-3), and the SMF-NUS Research Horizons Award 2009-Phase II. A.H.C.N acknowledges the CRP award, "Novel 2D materials with tailored properties: beyond graphene" (NRF-CRP6-2010-05). All authors acknowledge the NRF, Prime Minister's Office, Singapore, under its Medium-Sized Centre Programme.	Agterberg DF, 2008, NAT PHYS, V4, P639, DOI 10.1038/nphys999; Aubin H, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.094521; Bollinger AT, 2011, NATURE, V472, P458, DOI 10.1038/nature09998; BURK B, 1991, PHYS REV LETT, V66, P3040, DOI 10.1103/PhysRevLett.66.3040; Castro Neto AH, 2001, PHYS REV LETT, V86, P4382, DOI 10.1103/PhysRevLett.86.4382; Caviglia AD, 2008, NATURE, V456, P624, DOI 10.1038/nature07576; Daghero D, 2010, SUPERCOND SCI TECH, V23, DOI 10.1088/0953-2048/23/4/043001; DISALVO FJ, 1976, PHYS REV B, V14, P4321, DOI 10.1103/PhysRevB.14.4321; FISHER ME, 1968, PHYS REV LETT, V20, P665, DOI 10.1103/PhysRevLett.20.665; FISHER MPA, 1990, PHYS REV LETT, V65, P923, DOI 10.1103/PhysRevLett.65.923; Fradkin E, 2015, REV MOD PHYS, V87, P457, DOI 10.1103/RevModPhys.87.457; Gallagher P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7437; HARRIS AB, 1974, J PHYS C SOLID STATE, V7, P1671, DOI 10.1088/0022-3719/7/9/009; HOLY JA, 1977, PHYS REV B, V16, P3628, DOI 10.1103/PhysRevB.16.3628; Joe YI, 2014, NAT PHYS, V10, P421, DOI [10.1038/NPHYS2935, 10.1038/nphys2935]; Kashiwaya S, 2000, REP PROG PHYS, V63, P1641, DOI 10.1088/0034-4885/63/10/202; Kotov VN, 2012, REV MOD PHYS, V84, P1067, DOI 10.1103/RevModPhys.84.1067; Li SY, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.107001; Mason N, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.220505; Mayorov AS, 2011, NANO LETT, V11, P2396, DOI 10.1021/nl200758b; MCMILLAN WL, 1976, PHYS REV B, V14, P1496, DOI 10.1103/PhysRevB.14.1496; MCMILLAN WL, 1975, PHYS REV B, V12, P1197, DOI 10.1103/PhysRevB.12.1197; MINNHAGEN P, 1987, REV MOD PHYS, V59, P1001, DOI 10.1103/RevModPhys.59.1001; NETO AHC, 2000, PHYS REV B, V62, P14975; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Parendo KA, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.197004; Pfleiderer C, 2001, NATURE, V414, P427, DOI 10.1038/35106527; Pu J, 2012, NANO LETT, V12, P4013, DOI 10.1021/nl301335q; Reyren N, 2007, SCIENCE, V317, P1196, DOI 10.1126/science.1146006; Sachdev S., 1999, QUANTUM PHASE TRANSI; Shen KM, 2008, MATER TODAY, V11, P14, DOI 10.1016/S1369-7021(08)70175-5; Stewart GR, 2011, REV MOD PHYS, V83, P1589, DOI 10.1103/RevModPhys.83.1589; STEWART GR, 1984, REV MOD PHYS, V56, P755, DOI 10.1103/RevModPhys.56.755; Tinkham M., 1975, INTRO SUPERCONDUCTIV; Ueno K, 2008, NAT MATER, V7, P855, DOI 10.1038/nmat2298; Wang QH, 2012, NAT NANOTECHNOL, V7, P699, DOI [10.1038/nnano.2012.193, 10.1038/NNANO.2012.193]; YAZDANI A, 1995, PHYS REV LETT, V74, P3037, DOI 10.1103/PhysRevLett.74.3037; Yu YJ, 2015, NAT NANOTECHNOL, V10, P270, DOI [10.1038/NNANO.2014.323, 10.1038/nnano.2014.323]	39	318	323	33	719	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 14	2016	529	7585					185	U129		10.1038/nature16175	http://dx.doi.org/10.1038/nature16175			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA7WK	26700810	Green Submitted			2022-12-28	WOS:000368015700031
J	Metcalf, JL; Xu, ZZ; Weiss, S; Lax, S; Van Treuren, W; Hyde, ER; Song, SJ; Amir, A; Larsen, P; Sangwan, N; Haarmann, D; Humphrey, GC; Ackermann, G; Thompson, LR; Lauber, C; Bibat, A; Nicholas, C; Gebert, MJ; Petrosino, JF; Reed, SC; Gilbert, JA; Lynne, AM; Bucheli, SR; Carter, DO; Knight, R				Metcalf, Jessica L.; Xu, Zhenjiang Zech; Weiss, Sophie; Lax, Simon; Van Treuren, Will; Hyde, Embriette R.; Song, Se Jin; Amir, Amnon; Larsen, Peter; Sangwan, Naseer; Haarmann, Daniel; Humphrey, Greg C.; Ackermann, Gail; Thompson, Luke R.; Lauber, Christian; Bibat, Alexander; Nicholas, Catherine; Gebert, Matthew J.; Petrosino, Joseph F.; Reed, Sasha C.; Gilbert, Jack A.; Lynne, Aaron M.; Bucheli, Sibyl R.; Carter, David O.; Knight, Rob			Microbial community assembly and metabolic function during mammalian corpse decomposition	SCIENCE			English	Article							TERRESTRIAL ECOSYSTEMS; BIODIVERSITY; SUCCESSION; CARRION	Vertebrate corpse decomposition provides an important stage in nutrient cycling in most terrestrial habitats, yet microbially mediated processes are poorly understood. Here we combine deep microbial community characterization, community-level metabolic reconstruction, and soil biogeochemical assessment to understand the principles governing microbial community assembly during decomposition of mouse and human corpses on different soil substrates. We find a suite of bacterial and fungal groups that contribute to nitrogen cycling and a reproducible network of decomposers that emerge on predictable time scales. Our results show that this decomposer community is derived primarily from bulk soil, but key decomposers are ubiquitous in low abundance. Soil type was not a dominant factor driving community development, and the process of decomposition is sufficiently reproducible to offer new opportunities for forensic investigations.	[Metcalf, Jessica L.; Song, Se Jin] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Metcalf, Jessica L.; Xu, Zhenjiang Zech; Hyde, Embriette R.; Song, Se Jin; Amir, Amnon; Humphrey, Greg C.; Ackermann, Gail; Thompson, Luke R.; Knight, Rob] Univ Calif San Diego, Dept Pediat, San Diego, CA 92037 USA; [Weiss, Sophie] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80303 USA; [Lax, Simon; Larsen, Peter; Sangwan, Naseer; Gilbert, Jack A.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Lax, Simon; Gilbert, Jack A.] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL USA; [Van Treuren, Will] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Larsen, Peter; Sangwan, Naseer; Gilbert, Jack A.] Argonne Natl Lab, Biosci Div, Argonne, IL 60439 USA; [Sangwan, Naseer; Gilbert, Jack A.] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Haarmann, Daniel; Lynne, Aaron M.; Bucheli, Sibyl R.] Sam Houston State Univ, Dept Biol Sci, Huntsville, TX 77340 USA; [Lauber, Christian] Ecole Polytech Fed Lausanne, Nestle Inst Hlth Sci, CH-1015 Lausanne, Switzerland; [Bibat, Alexander; Nicholas, Catherine; Gebert, Matthew J.] Univ Colorado, BioFrontiers Inst, Boulder, CO 80303 USA; [Petrosino, Joseph F.] Baylor Coll Med, Dept Mol Virol & Microbiol, Alkek Ctr Metagen & Microbiome Res, Houston, TX 77030 USA; [Reed, Sasha C.] US Geol Survey, Southwest Biol Sci Ctr, Moab, UT 84532 USA; [Gilbert, Jack A.] Marine Biol Lab, Woods Hole, MA 02543 USA; [Carter, David O.] Chaminade Univ Honolulu, Div Nat Sci & Math, Forens Sci Unit, Lab Forens Taphon, Honolulu, HI 96816 USA; [Knight, Rob] Univ Calif San Diego, Dept Comp Sci & Engn, San Diego, CA 92037 USA	University of Colorado System; University of Colorado Boulder; University of California System; University of California San Diego; University of Colorado System; University of Colorado Boulder; University of Chicago; University of Chicago; Stanford University; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago; Texas State University System; Sam Houston State University; Nestle SA; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Colorado System; University of Colorado Boulder; Baylor College of Medicine; United States Department of the Interior; United States Geological Survey; Marine Biological Laboratory - Woods Hole; University of California System; University of California San Diego	Metcalf, JL (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.	jessica.metcalf@colorado.edu; robknight@ucsd.edu	Xu, Zhenjiang Zech/F-6493-2012; Carter, David O/AAD-6617-2021; Gilbert, Jack/AAF-3270-2019; Petrosino, Joseph F./AAF-1621-2019; Reed, Sasha C/ABE-9476-2020; Thompson, Luke R./Z-3344-2019; Facility, BioFrontiers Next Generation Sequencing/AAJ-8616-2020	Xu, Zhenjiang Zech/0000-0003-1080-024X; Reed, Sasha C/0000-0002-8597-8619; Thompson, Luke R./0000-0002-3911-1280; Carter, David/0000-0003-1885-5237; Sangwan, Naseer/0000-0002-2407-769X; Knight, Rob/0000-0002-0975-9019	Office of Justice Programs National Institute of Justice [NIJ-2011-DN-BX-K533, NIJ-2012-DN-BX-K023]; NIH Building Research Infrastructure and Capacity Program [P789097-876]; National Human Genome Research Institute [3 R01 HG004872-03S2]; NIH [5 U01 HG004866-04]; Templeton Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004872, U01HG004866] Funding Source: NIH RePORTER	Office of Justice Programs National Institute of Justice; NIH Building Research Infrastructure and Capacity Program; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Templeton Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The data reported in this paper are available in the Qiita database (http://qiita.ucsd.edu/) (accession numbers 10141 to 10143 and 10321) and the European Bioinformatics Institute European Nucleotide Archive (www.ebi.ac.uk/ena) (accession numbers ERP012866, ERP012879, ERP012880, and ERP012894). We thank the donors and their families for their contribution to scientific research; the STAFS Facility at SHSU and the Molecular, Cellular, and Developmental Biology Transgenic Facility at the University of Colorado, Boulder, for providing the space and opportunity for this research; N. Fierer, J. Zelikova, and J. Leff for assistance with project logistics and data processing; and the Mountain Research Station and Shortgrass Steppe Long Term Ecological Research for permission to collect soils. Mice were euthanized humanely under approved protocol no. 08-04-ACK-01 (principal investigator G.A.). This research was funded by the Office of Justice Programs National Institute of Justice Awards NIJ-2011-DN-BX-K533 (J.L.M., D.O.C., R.K.) and NIJ-2012-DN-BX-K023 (S.R.B. and A.M.L.). Research capacity and infrastructure at Chaminade University of Honolulu is supported by NIH Building Research Infrastructure and Capacity Program P789097-876. W.V.T. and S.W. were supported by the National Human Genome Research Institute grant 3 R01 HG004872-03S2, and NIH grant 5 U01 HG004866-04. J.L.M. was partially supported by a Templeton Foundation grant (R.K. and V. McKenzie). Use of trade, product, or firm names is for informational purposes only and does not constitute an endorsement by the U.S. government. J.F.P. is Chief Scientific Officer and Founder of Diversigen; C.N. is an employee of miRagen Therapeutics; and R.K. is Chief Science Officer and employee of Biota Technology, a member of the Scientific Advisory Panel at Temasek Life Sciences Laboratory, and a speaker at Nestec, Nestle Research Center.	Amendt J, 2007, INT J LEGAL MED, V121, P90, DOI 10.1007/s00414-006-0086-x; Barton P.S., 2015, CARRION ECOLOGY EVOL, P273, DOI DOI 10.1201/B18819; Barton PS, 2013, OECOLOGIA, V171, P761, DOI 10.1007/s00442-012-2460-3; Carter DO, 2007, NATURWISSENSCHAFTEN, V94, P12, DOI 10.1007/s00114-006-0159-1; Evans W.E.D, 1963, CHEM DEATH; Gilbert JA, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002020; Hyde ER, 2015, INT J LEGAL MED, V129, P661, DOI 10.1007/s00414-014-1128-4; Kaspari M, 2008, ECOL LETT, V11, P35, DOI 10.1111/j.1461-0248.2007.01124.x; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Metcalf JL, 2013, ELIFE, V2, DOI 10.7554/eLife.01104; Moore JC, 2004, ECOL LETT, V7, P584, DOI 10.1111/j.1461-0248.2004.00606.x; Parmenter RR, 2009, ECOL MONOGR, V79, P637, DOI 10.1890/08-0972.1; Pechal JL, 2014, INT J LEGAL MED, V128, P193, DOI 10.1007/s00414-013-0872-1; Swift M.J., 1979, DECOMPOSITION TERRES, V5; [No title captured]	15	265	285	25	320	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 8	2016	351	6269					158	162		10.1126/science.aad2646	http://dx.doi.org/10.1126/science.aad2646			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XQ	26657285				2022-12-28	WOS:000367806500038
J	Aylett, CHS; Sauer, E; Imseng, S; Boehringer, D; Hall, MN; Ban, N; Maier, T				Aylett, Christopher H. S.; Sauer, Evelyn; Imseng, Stefan; Boehringer, Daniel; Hall, Michael N.; Ban, Nenad; Maier, Timm			STRUCTURAL BIOLOGY Architecture of human mTOR complex 1	SCIENCE			English	Article							PEPTIDYL-PROLYL ISOMERASE; CELL-GROWTH; IMMUNOSUPPRESSANT FK506; MAMMALIAN PROTEIN; BINDING PARTNER; DIRECT TARGET; RAG GTPASES; TOS MOTIF; RAPAMYCIN; RAPTOR	Target of rapamycin (TOR), a conserved protein kinase and central controller of cell growth, functions in two structurally and functionally distinct complexes: TORC1 and TORC2. Dysregulation of mammalian TOR (mTOR) signaling is implicated in pathologies that include diabetes, cancer, and neurodegeneration. We resolved the architecture of human mTORC1 (mTOR with subunits Raptor and mLST8) bound to FK506 binding protein (FKBP)-rapamycin, by combining cryo-electron microscopy at 5.9 angstrom resolution with crystallographic studies of Chaetomium thermophilum Raptor at 4.3 angstromresolution. The structure explains how FKBP-rapamycin and architectural elements of mTORC1 limit access to the recessed active site. Consistent with a role in substrate recognition and delivery, the conserved amino-terminal domain of Raptor is juxtaposed to the kinase active site.	[Aylett, Christopher H. S.; Boehringer, Daniel; Ban, Nenad] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Sauer, Evelyn; Imseng, Stefan; Hall, Michael N.; Maier, Timm] Univ Basel, Biozentrum, Basel, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel	Hall, MN (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.	m.hall@unibas.ch; ban@mol.biol.ethz.ch; timm.maier@unibas.ch	Maier, Timm/A-8835-2016	Maier, Timm/0000-0002-7459-1363; Hall, Michael N/0000-0002-2998-0757	ETH Zurich postdoctoral fellowship; European Molecular Biology Organization; People Program (Marie Curie Actions; REA grant) [328159]; European Research Council; Swiss National Science Foundation via the National Centre of Excellence in RNA and Disease [138262, R'Equip 145023]	ETH Zurich postdoctoral fellowship; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); People Program (Marie Curie Actions; REA grant); European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation via the National Centre of Excellence in RNA and Disease	We thank the ETH Zurich Scientific Center for Optical and Electron Microscopy (ScopeM) for access to EM facilities, P. Tittmann for technical support, T. Sharpe for size exclusion chromatography multi-angle laser light scattering analysis, the Biozentrum Proteomics Core Facility for mass spectrometric protein identification, the beamline staff at Swiss Light Source beamlines X06SA and X06DA for crystallographic support, and H. S. T. Bukhari for 3D modelling in Maya. C.H.S.A. was supported by an ETH Zurich postdoctoral fellowship and a European Molecular Biology Organization long-term fellowship. E.S. was supported by a fellowship from the People Program (Marie Curie Actions; REA grant agreement number 328159). This work was supported by the European Research Council funding to M.N.H. and N.B., and by the Swiss National Science Foundation via the National Centre of Excellence in RNA and Disease, project funding 138262 and R'Equip 145023. The cryo-EM density maps representing mTORC1 have been deposited in the EM Databank as EMD-3212 and EMD-3213 and the corresponding model in the Protein Data Bank as PDB ID 5FLC. The crystal structure of CtRaptor has been deposited in the Protein Data Bank as PDB ID 5EF5.	ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; CHEN J, 1995, P NATL ACAD SCI USA, V92, P4947, DOI 10.1073/pnas.92.11.4947; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; Choo AY, 2009, CELL CYCLE, V8, P567, DOI 10.4161/cc.8.4.7659; Dazert E, 2011, CURR OPIN CELL BIOL, V23, P744, DOI 10.1016/j.ceb.2011.09.003; Foster KG, 2010, J BIOL CHEM, V285, P80, DOI 10.1074/jbc.M109.029637; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Gaubitz C, 2015, MOL CELL, V58, P977, DOI 10.1016/j.molcel.2015.04.031; Ginalski K, 2004, TRENDS BIOCHEM SCI, V29, P522, DOI 10.1016/j.tibs.2004.08.006; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; HARDING MW, 1989, NATURE, V341, P758, DOI 10.1038/341758a0; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; KEITH CT, 1995, SCIENCE, V270, P50, DOI 10.1126/science.270.5233.50; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Knutson BA, 2010, J STRUCT BIOL, V170, P354, DOI 10.1016/j.jsb.2010.01.002; KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Menon S, 2008, Oncogene, V27 Suppl 2, pS43, DOI 10.1038/onc.2009.352; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; SIEKIERKA JJ, 1989, NATURE, V341, P755, DOI 10.1038/341755a0; Wullschleger S, 2005, J BIOL CHEM, V280, P30697, DOI 10.1074/jbc.M505553200; Yang HJ, 2013, NATURE, V497, P217, DOI 10.1038/nature12122; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	40	215	227	3	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2016	351	6268					48	52		10.1126/science.aaa3870	http://dx.doi.org/10.1126/science.aaa3870			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ8QM	26678875				2022-12-28	WOS:000367364200038
J	Sun, C; Wade, MT; Lee, Y; Orcutt, JS; Alloatti, L; Georgas, MS; Waterman, AS; Shainline, JM; Avizienis, RR; Lin, S; Moss, BR; Kumar, R; Pavanello, F; Atabaki, AH; Cook, HM; Ou, AJ; Leu, JC; Chen, YH; Asanovic, K; Ram, RJ; Popovic, MA; Stojanovic, VM				Sun, Chen; Wade, Mark T.; Lee, Yunsup; Orcutt, Jason S.; Alloatti, Luca; Georgas, Michael S.; Waterman, Andrew S.; Shainline, Jeffrey M.; Avizienis, Rimas R.; Lin, Sen; Moss, Benjamin R.; Kumar, Rajesh; Pavanello, Fabio; Atabaki, Amir H.; Cook, Henry M.; Ou, Albert J.; Leu, Jonathan C.; Chen, Yu-Hsin; Asanovic, Krste; Ram, Rajeev J.; Popovic, Milos A.; Stojanovic, Vladimir M.			Single-chip microprocessor that communicates directly using light	NATURE			English	Article							PERFORMANCE; MODULATOR; NETWORKS	Data transport across short electrical wires is limited by both bandwidth and power density, which creates a performance bottleneck for semiconductor microchips in modern computer systems-from mobile phones to large-scale data centres. These limitations can be overcome(1-3) by using optical communications based on chip-scale electronic-photonic systems(4-7) enabled by silicon-based nanophotonic devices(8). However, combining electronics and photonics on the same chip has proved challenging, owing to microchip manufacturing conflicts between electronics and photonics. Consequently, current electronic-photonic chips(9-11) are limited to niche manufacturing processes and include only a few optical devices alongside simple circuits. Here we report an electronic-photonic system on a single chip integrating over 70 million transistors and 850 photonic components that work together to provide logic, memory, and interconnect functions. This system is a realization of a microprocessor that uses on-chip photonic devices to directly communicate with other chips using light. To integrate electronics and photonics at the scale of a microprocessor chip, we adopt a 'zero-change' approach to the integration of photonics. Instead of developing a custom process to enable the fabrication of photonics(12), which would complicate or eliminate the possibility of integration with state-of-the-art transistors at large scale and at high yield, we design optical devices using a standard microelectronics foundry process that is used for modern microprocessors(13-16). This demonstration could represent the beginning of an era of chip-scale electronic-photonic systems with the potential to transform computing system architectures, enabling more powerful computers, from network infrastructure to data centres and supercomputers.	[Sun, Chen; Lee, Yunsup; Waterman, Andrew S.; Avizienis, Rimas R.; Lin, Sen; Cook, Henry M.; Ou, Albert J.; Asanovic, Krste; Stojanovic, Vladimir M.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Sun, Chen; Orcutt, Jason S.; Alloatti, Luca; Georgas, Michael S.; Moss, Benjamin R.; Atabaki, Amir H.; Leu, Jonathan C.; Chen, Yu-Hsin; Ram, Rajeev J.] MIT, Cambridge, MA 02139 USA; [Wade, Mark T.; Shainline, Jeffrey M.; Kumar, Rajesh; Pavanello, Fabio; Popovic, Milos A.] Univ Colorado, Boulder, CO 80309 USA	University of California System; University of California Berkeley; Massachusetts Institute of Technology (MIT); University of Colorado System; University of Colorado Boulder	Stojanovic, VM (corresponding author), Univ Calif Berkeley, Berkeley, CA 94720 USA.	krste@berkeley.edu; rajeev@mit.edu; milos.popovic@colorado.edu; vlada@berkeley.edu	Shainline, Jeffrey/AAA-2594-2022; Popović, Miloš A./AAC-6940-2020; Pavanello, Fabio/D-7096-2018; Alloatti, Luca/A-3817-2015	Popović, Miloš A./0000-0002-8048-0678; Pavanello, Fabio/0000-0002-6889-2012; Kumar, Rajesh/0000-0001-9460-4988; Alloatti, Luca/0000-0002-1245-4179	DARPA POEM [HR0011-11-C-0100]; DARPA PERFECT [HR0011-12-2-0016]; Berkeley Wireless Research Center; UC Berkeley ASPIRE Lab; MIT CICS; National Science Foundation; FCRP IFC; Trusted Foundry; Intel; Santec; NSERC	DARPA POEM; DARPA PERFECT; Berkeley Wireless Research Center; UC Berkeley ASPIRE Lab; MIT CICS; National Science Foundation(National Science Foundation (NSF)); FCRP IFC; Trusted Foundry; Intel(Intel Corporation); Santec; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	We thank S. Twigg, Q. Nguyen, and M. Moreto Planas for help with processor infrastructure, A. Srinivasan for help with photodetector characterization, and S. Han for help with chip photos. This work was supported by DARPA POEM award HR0011-11-C-0100, led by J. Shah and DARPA PERFECT award HR0011-12-2-0016, led by J. Cross. We thank M. Casper, J. Torneden, and the team at the Kansas City Plant for their support of our design submissions over the years leading up to this work. Support is also acknowledged from the Berkeley Wireless Research Center, UC Berkeley ASPIRE Lab, MIT CICS, National Science Foundation, FCRP IFC, Trusted Foundry, Intel, Santec, and NSERC. The views expressed are those of the authors and do not reflect the official policy or position of the DoD or the US Government.	Alloatti L, 2015, APPL PHYS LETT, V107, DOI 10.1063/1.4927393; Asaad SW, 2013, IBM J RES DEV, V57, DOI 10.1147/JRD.2012.2227577; Assefa S., 2011, OPT FIB COMM C OPT S; Batten C, 2009, IEEE MICRO, V29, P8, DOI 10.1109/MM.2009.60; Beamer S, 2010, CONF PROC INT SYMP C, P129, DOI 10.1145/1816038.1815978; Buckwalter JF, 2012, IEEE J SOLID-ST CIRC, V47, P1309, DOI 10.1109/JSSC.2012.2189835; Chen Sun, 2015, 2015 Symposium on VLSI Circuits (VLSI Circuits), pC122, DOI 10.1109/VLSIC.2015.7231348; Dupuis N., 2014, OPT FIB COMM C OPT S; GOODMAN JW, 1984, P IEEE, V72, P850, DOI 10.1109/PROC.1984.12943; Kalla R, 2010, IEEE MICRO, V30, P7, DOI 10.1109/MM.2010.38; Kopp C, 2011, IEEE J SEL TOP QUANT, V17, P498, DOI 10.1109/JSTQE.2010.2071855; Lee S, 2007, INT EL DEVICES MEET, P255, DOI 10.1109/IEDM.2007.4418916; Lee Y, 2014, PROC EUR SOLID-STATE, P199, DOI 10.1109/ESSCIRC.2014.6942056; McCalpin J., 1995, STREAM SUSTAINABLE M; Meade R, 2014, S VLSI TECH; Miller DAB, 2000, P IEEE, V88, P728, DOI 10.1109/5.867687; Narasimha A., 2008, OPT FIB COMM C OPT S; Narasimha S, 2006, INT EL DEVICES MEET, P423; Orcutt JS, 2012, OPT EXPRESS, V20, P12222, DOI 10.1364/OE.20.012222; Orcutt JS, 2010, IEEE PHOTONIC TECH L, V22, P544, DOI 10.1109/LPT.2010.2041445; Padmaraju K, 2012, OPT EXPRESS, V20, P27999, DOI 10.1364/OE.20.027999; Pavarelli N, 2014, PROC SPIE, V9133, DOI 10.1117/12.2058559; Roger A., 2006, ELECT DES, V54; Selvaraja SK, 2010, IEEE J SEL TOP QUANT, V16, P316, DOI 10.1109/JSTQE.2009.2026550; Shacham A, 2008, IEEE T COMPUT, V57, P1246, DOI 10.1109/TC.2008.78; Shainline JM, 2013, OPT LETT, V38, P2657, DOI 10.1364/OL.38.002657; SOREF RA, 1987, IEEE J QUANTUM ELECT, V23, P123, DOI 10.1109/JQE.1987.1073206; Sun C, 2015, IEEE J SOLID-ST CIRC, V50, P828, DOI 10.1109/JSSC.2014.2382101; Takahashi O., 2008, 2008 IEEE International Solid-State Circuits Conference - Digest of Technical Papers, P86; Vantrease D, 2008, CONF PROC INT SYMP C, P153, DOI 10.1109/ISCA.2008.35; Wade MT, 2014, 2014 OPTICAL FIBER COMMUNICATIONS CONFERENCE AND EXHIBITION (OFC); Wade MT, 2015, OPT INTERCONNECT C, P46, DOI 10.1109/OIC.2015.7115679; Waterman A., 2014, UCBEECS201454, VI; Wendel D., 2010, P IEEE INT SOL STAT, P102; Xu QF, 2005, NATURE, V435, P325, DOI 10.1038/nature03569; Young IA, 2010, IEEE J SOLID-ST CIRC, V45, P235, DOI 10.1109/JSSC.2009.2034444	36	767	812	43	544	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2015	528	7583					534	+		10.1038/nature16454	http://dx.doi.org/10.1038/nature16454			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ3GH	26701054	Green Submitted			2022-12-28	WOS:000366991900048
J	Jiao, NZ; Legendre, L; Robinson, C; Thomas, H; Luo, YW; Dang, HY; Liu, JH; Zhang, R; Tang, K; Luo, TW; Li, C; Wang, XX; Zhang, CL				Jiao, Nianzhi; Legendre, Louis; Robinson, Carol; Thomas, Helmuth; Luo, Ya-Wei; Dang, Hongyue; Liu, Jihua; Zhang, Rui; Tang, Kai; Luo, Tingwei; Li, Chao; Wang, Xiaoxue; Zhang, Chuanlun			Comment on "Dilution limits dissolved organic carbon utilization in the deep ocean"	SCIENCE			English	Editorial Material							SEQUESTRATION		[Jiao, Nianzhi; Luo, Ya-Wei; Dang, Hongyue; Zhang, Rui; Tang, Kai; Luo, Tingwei] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China; [Jiao, Nianzhi; Luo, Ya-Wei; Dang, Hongyue; Liu, Jihua; Zhang, Rui; Tang, Kai; Luo, Tingwei] Xiamen Univ, Inst Marine Microbes & Ecospheres, Xiamen, Peoples R China; [Legendre, Louis] Univ Paris 06, Sorbonne Univ, CNRS, Lab Oceanog Villefranche,Observ Oceanol, F-06230 Villefranche Sur Mer, France; [Robinson, Carol] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Thomas, Helmuth] Dalhousie Univ, Dept Oceanog, Halifax, NS, Canada; [Liu, Jihua] Shandong Univ, Inst Marine Sci & Technol, Jinan, Peoples R China; [Li, Chao] China Univ Geosci, State Key Lab Biogeol & Environm Geol, Wuhan 430074, Peoples R China; [Wang, Xiaoxue] Chinese Acad Sci, South China Sea Inst Oceanol, Guangzhou, Guangdong, Peoples R China; [Zhang, Chuanlun] Tongji Univ, Shanghai 200092, Peoples R China	Xiamen University; Xiamen University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; University of East Anglia; Dalhousie University; Shandong University; China University of Geosciences; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Tongji University	Jiao, NZ (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China.	jiao@xmu.edu.cn; legendre@obs-vlfr.fr; carol.robinson@uea.ac.uk; helmuth.thomas@posteo.org	Luo, Ya-Wei/C-9990-2016; Luo, Tingwei/B-7425-2012; Robinson, Carol/AAW-1857-2021; Dang, Hongyue/H-6577-2019; Robinson, Carol/F-7649-2011	Luo, Ya-Wei/0000-0001-6106-7901; Robinson, Carol/0000-0003-3033-4565; Robinson, Carol/0000-0003-3033-4565; Li, Chao/0000-0001-9861-661X				Arrieta JM, 2015, SCIENCE, V348, P331, DOI 10.1126/science.1258955; BARBER RT, 1968, NATURE, V220, P274, DOI 10.1038/220274a0; Hugler M, 2011, ANNU REV MAR SCI, V3, P261, DOI 10.1146/annurev-marine-120709-142712; Jiao N, 2014, BIOGEOSCIENCES, V11, P5285, DOI 10.5194/bg-11-5285-2014; Jiao N, 2010, NAT REV MICROBIOL, V8, P593, DOI 10.1038/nrmicro2386; Lechtenfeld OJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7711; Stahl DA, 2012, ANNU REV MICROBIOL, V66, P83, DOI 10.1146/annurev-micro-092611-150128; Strom SL, 1997, LIMNOL OCEANOGR, V42, P1364, DOI 10.4319/lo.1997.42.6.1364; Weinbauer MG, 2011, MICROBIAL CARBON PUM, P54, DOI DOI 10.1126/SCIENCE.OPMS.SB0001	9	19	28	8	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2015	350	6267								10.1126/science.aab2713	http://dx.doi.org/10.1126/science.aab2713			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY7LY	26680188				2022-12-28	WOS:000366591100043
J	Kogleck, L				Kogleck, Larissa			BUILDING A POWERHOUSE	NATURE			English	Editorial Material																			0	0	0	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2015	528	7582					S166	S167		10.1038/528S166a	http://dx.doi.org/10.1038/528S166a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY8SM	26673022	Bronze			2022-12-28	WOS:000366678600010
J	Orthwein, A; Noordermeer, SM; Wilson, MD; Landry, S; Enchev, RI; Sherker, A; Munro, M; Pinder, J; Salsman, J; Dellaire, G; Xia, B; Peter, M; Durocher, D				Orthwein, Alexandre; Noordermeer, Sylvie M.; Wilson, Marcus D.; Landry, Sebastien; Enchev, Radoslav I.; Sherker, Alana; Munro, Meagan; Pinder, Jordan; Salsman, Jayme; Dellaire, Graham; Xia, Bing; Peter, Matthias; Durocher, Daniel			A mechanism for the suppression of homologous recombination in G1 cells	NATURE			English	Article							STRAND BREAK REPAIR; DNA-END RESECTION; 11 USP11; 53BP1; PALB2; DAMAGE; CYCLE; ACCUMULATION; INHIBITION; INTERACTS	DNA repair by homologous recombination(1) is highly suppressed in G1 cells(2,3) to ensure that mitotic recombination occurs solely between sister chromatids(4). Although many homologous recombination factors are cell-cycle regulated, the identity of the events that are both necessary and sufficient to suppress recombination in G1 cells is unknown. Here we report that the cell cycle controls the interaction of BRCA1 with PALB2-BRCA2 to constrain BRCA2 function to the S/G2 phases in human cells. We found that the BRCA1-interaction site on PALB2 is targeted by an E3 ubiquitin ligase composed of KEAP1, a PALB2-interacting protein(5), in complex with cullin-3 (CUL3)-RBX1 (ref.6). PALB2 ubiquitylation suppresses its interaction with BRCA1 and is counteracted by the deubiquitylase USP11, which is itself under cell cycle control. Restoration of the BRCA1-PALB2 interaction combined with the activation of DNA-end resection is sufficient to induce homologous recombination in G1, as measured by RAD51 recruitment, unscheduled DNA synthesis and a CRISPR-Cas9-based gene-targeting assay. We conclude that the mechanism prohibiting homologous recombination in G1 minimally consists of the suppression of DNA-end resection coupled with a multi-step block of the recruitment of BRCA2 to DNA damage sites that involves the inhibition of BRCA1-PALB2-BRCA2 complex assembly. We speculate that the ability to induce homologous recombination in G1 cells with defined factors could spur the development of gene-targeting applications in non-dividing cells.	[Orthwein, Alexandre; Noordermeer, Sylvie M.; Wilson, Marcus D.; Landry, Sebastien; Sherker, Alana; Munro, Meagan; Durocher, Daniel] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Enchev, Radoslav I.; Peter, Matthias] ETH, Inst Biochem, Dept Biol, CH-8093 Zurich, Switzerland; [Sherker, Alana; Durocher, Daniel] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada; [Pinder, Jordan; Salsman, Jayme; Dellaire, Graham] Dalhousie Univ, Dept Pathol, Halifax, NS B3H 4R2, Canada; [Pinder, Jordan; Salsman, Jayme; Dellaire, Graham] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 4R2, Canada; [Xia, Bing] Rutgers State Univ, Rutgers Canc Inst New Jersey, Dept Radiat Oncol, New Brunswick, NJ 08901 USA; [Xia, Bing] Rutgers State Univ, Robert Wood Johnson Med Sch, New Brunswick, NJ 08901 USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Toronto; Dalhousie University; Dalhousie University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center	Durocher, D (corresponding author), Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	durocher@lunenfeld.ca	Durocher, Daniel/A-7733-2010; Dellaire, Graham/L-9948-2014; Noordermeer, Sylvie M/T-8095-2017; Noordermeer, Sylvie M/F-3517-2012	Durocher, Daniel/0000-0003-3863-8635; Dellaire, Graham/0000-0002-3466-6316; Noordermeer, Sylvie M/0000-0003-2737-9690; Noordermeer, Sylvie M/0000-0003-2737-9690; Orthwein, Alexandre/0000-0002-7350-3413; Peter, Matthias/0000-0002-2160-6824; Sherker, Alana/0000-0001-5827-4678; Wilson, Marcus/0000-0001-9551-5514	Dutch Cancer Society (KWF); Human Frontier Science Program fellowship; Ontario Graduate Scholarship; Marie Curie postdoctoral fellowship; Beatrice Hunter Cancer Research Institute (BHCRI); Harvey Graham Cancer Research Fund as part of the Terry Fox Foundation Strategic Health Research Training Program in Cancer Research at the Canadian Institutes of Health Research (CIHR); Krembil Foundation; CIHR [FDN143343, MOP84260]; NATIONAL CANCER INSTITUTE [R01CA138804] Funding Source: NIH RePORTER	Dutch Cancer Society (KWF)(KWF Kankerbestrijding); Human Frontier Science Program fellowship(Human Frontier Science Program); Ontario Graduate Scholarship(Ontario Graduate Scholarship); Marie Curie postdoctoral fellowship(European Commission); Beatrice Hunter Cancer Research Institute (BHCRI); Harvey Graham Cancer Research Fund as part of the Terry Fox Foundation Strategic Health Research Training Program in Cancer Research at the Canadian Institutes of Health Research (CIHR); Krembil Foundation; CIHR(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to R. Szilard and X.-D. Zhu for critical reading of the manuscript; to D. Lo, M. Canny and J. Young for help on the project. We also thank B. Larsen and M. Tucholska for technical support, J. Stark for the U2OS DR-GFP cells, R. Greenberg for the U2OS 256 cells, F. Sicheri for ubiquitin reagents, F. Shao for the KEAP1 bacterial expression vector and D. Cortez for USP11 cDNA. A.O. is a Scholar of the Terry Fox Foundation Strategic Training Initiative for Excellence in Radiation Research for the 21st Century (EIRR21); S.M.N. receives a postdoctoral fellowship from the Dutch Cancer Society (KWF); M.D.W. holds a long-term Human Frontier Science Program fellowship; A.S. receives an Ontario Graduate Scholarship. R.I.E. was funded by a Marie Curie postdoctoral fellowship. J.P. was supported by the Beatrice Hunter Cancer Research Institute (BHCRI) with funds provided by the Harvey Graham Cancer Research Fund as part of the Terry Fox Foundation Strategic Health Research Training Program in Cancer Research at the Canadian Institutes of Health Research (CIHR). G.D. is a Senior Scientist of the BHCRI. D.D. is the Thomas Kierans Chair in Mechanisms of Cancer Development and a Canada Research Chair (Tier 1) in the Molecular Mechanisms of Genome Integrity. Work was supported by a Grant-in-Aid from the Krembil Foundation (to D.D.) and CIHR grants FDN143343 (to D.D.) and MOP84260 (to G.D.).	Bhattacharyya A, 2000, J BIOL CHEM, V275, P23899, DOI 10.1074/jbc.C000276200; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Cui JX, 2010, SCIENCE, V329, P1215, DOI 10.1126/science.1193844; Enchev RI, 2015, NAT REV MOL CELL BIO, V16, P30, DOI 10.1038/nrm3919; Enchev RI, 2010, STRUCTURE, V18, P518, DOI 10.1016/j.str.2010.02.008; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Feng L, 2013, J BIOL CHEM, V288, P11135, DOI 10.1074/jbc.M113.457440; Fradet-Turcotte A, 2013, NATURE, V499, P50, DOI 10.1038/nature12318; Genschik P, 2013, EMBO J, V32, P2307, DOI 10.1038/emboj.2013.173; Hartlerode A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016501; Hendriks IA, 2015, J BIOL CHEM, V290, P15526, DOI 10.1074/jbc.M114.618132; Huertas P, 2009, J BIOL CHEM, V284, P9558, DOI 10.1074/jbc.M808906200; Jasin M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012740; Juang YC, 2012, MOL CELL, V45, P384, DOI 10.1016/j.molcel.2012.01.011; Li ML, 2012, TRENDS BIOCHEM SCI, V37, P418, DOI 10.1016/j.tibs.2012.06.007; Long L, 2014, METHODS, V70, P134, DOI 10.1016/j.ymeth.2014.07.006; Ma JL, 2012, MOL CELL BIOL, V32, P1506, DOI 10.1128/MCB.06271-11; Orthwein A, 2014, SCIENCE, V344, P189, DOI 10.1126/science.1248024; Panier S, 2013, NAT REV MOL CELL BIO, V14, P661, DOI 10.1038/nrm3659; Panier S, 2012, MOL CELL, V47, P383, DOI 10.1016/j.molcel.2012.05.045; Park JY, 2014, BBA-REV CANCER, V1846, P263, DOI 10.1016/j.bbcan.2014.06.003; Pinder J, 2015, NUCLEIC ACIDS RES, V43, P9379, DOI 10.1093/nar/gkv993; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181; Schoenfeld AR, 2004, MOL CELL BIOL, V24, P7444, DOI 10.1128/MCB.24.17.7444-7455.2004; Simhadri S, 2014, J BIOL CHEM, V289, P24617, DOI 10.1074/jbc.M114.566141; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Sy SMH, 2009, P NATL ACAD SCI USA, V106, P7155, DOI 10.1073/pnas.0811159106; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Tang JB, 2013, NAT STRUCT MOL BIOL, V20, P317, DOI 10.1038/nsmb.2499; Wiltshire TD, 2010, J BIOL CHEM, V285, P14565, DOI 10.1074/jbc.M110.104745; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Yamane A, 2013, CELL REP, V3, P138, DOI 10.1016/j.celrep.2012.12.006; Yin LM, 2000, BIOCHEMISTRY-US, V39, P10001, DOI 10.1021/bi0007019; Zhang F, 2012, J CELL SCI, V125, P6049, DOI 10.1242/jcs.111872; Zhang F, 2009, CURR BIOL, V19, P524, DOI 10.1016/j.cub.2009.02.018; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573	39	305	314	1	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2015	528	7582					422	+		10.1038/nature16142	http://dx.doi.org/10.1038/nature16142			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY8SM	26649820	Green Accepted			2022-12-28	WOS:000366678600058
J	Storkey, J; Macdonald, AJ; Poulton, PR; Scott, T; Kohler, IH; Schnyder, H; Goulding, KWT; Crawley, MJ				Storkey, J.; Macdonald, A. J.; Poulton, P. R.; Scott, T.; Koehler, I. H.; Schnyder, H.; Goulding, K. W. T.; Crawley, M. J.			Grassland biodiversity bounces back from long-term nitrogen addition	NATURE			English	Article							ROTHAMSTED-EXPERIMENTAL-STATION; SPECIES RICHNESS; DEPOSITION; UK; CESSATION; RECOVERY	The negative effect of increasing atmospheric nitrogen (N) pollution on grassland biodiversity is now incontrovertible(1-3). However, the recent introduction of cleaner technologies in the UK has led to reductions in the emissions of nitrogen oxides, with concomitant decreases in N deposition(4). The degree to which grassland biodiversity can be expected to 'bounce back' in response to these improvements in air quality is uncertain, with a suggestion that long-term chronic N addition may lead to an alternative low biodiversity state5. Here we present evidence from the 160-year-old Park Grass Experiment at Rothamsted Research, UK6, that shows a positive response of biodiversity to reducing N addition from either atmospheric pollution or fertilizers. The proportion of legumes, species richness and diversity increased across the experiment between 1991 and 2012 as both wet and dry N deposition declined. Plots that stopped receiving inorganic N fertilizer in 1989 recovered much of the diversity that had been lost, especially if limed. There was no evidence that chronic N addition has resulted in an alternative low biodiversity state on the Park Grass plots, except where there has been extreme acidification, although it is likely that the recovery of plant communities has been facilitated by the twice-yearly mowing and removal of biomass. This may also explain why a comparable response of plant communities to reduced N inputs has yet to be observed in the wider landscape.	[Storkey, J.; Macdonald, A. J.; Poulton, P. R.; Scott, T.; Goulding, K. W. T.] Rothamsted Res, Harpenden AL5 2JQ, Herts, England; [Koehler, I. H.; Schnyder, H.] Tech Univ Munich, Lehrstuhl Grunlandlehre, D-85354 Freising Weihenstephan, Germany; [Crawley, M. J.] Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, Ascot SL5 7PY, Berks, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Technical University of Munich; Imperial College London	Storkey, J (corresponding author), Rothamsted Res, Harpenden AL5 2JQ, Herts, England.	jonathan.storkey@rothamsted.ac.uk	Schnyder, Hans/B-7089-2011; Scott, Tony/C-1291-2016; Scott, Tony/AAY-8995-2021; Goulding, Keith WT/B-2635-2012	Schnyder, Hans/0000-0002-0139-7535; Scott, Tony/0000-0002-6631-0672; Scott, Tony/0000-0002-6631-0672; Goulding, Keith WT/0000-0002-6465-1465; Kohler, Iris/0000-0002-0662-9729; Storkey, Jonathan/0000-0003-1094-8914; Macdonald, Andrew/0000-0002-1785-4892	UK Biotechnology and Biological Sciences Research Council (BBSRC); Lawes Agricultural Trust; Deutsche Forschungsgemeinschaft (DFG) [SCHN 557/5-1]; BBSRC [BBS/E/C/00005198, BBS/E/C/00004980, BBS/E/C/00005196, BBS/E/C/00005999, BBS/E/C/00004962, BBS/E/C/00005189] Funding Source: UKRI; NERC [NE/J011568/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00004980, BBS/E/C/00005196, BBS/E/C/00004962, BBS/E/C/00006004, BBS/E/C/00005999, BBS/E/C/00005189] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Lawes Agricultural Trust; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank the large teams of people who were involved in the vegetation sampling and sorting between 1991 and 2012, and J. Leps and P. Smilauer for their advice on the multivariate analysis. Park Grass is supported by the UK Biotechnology and Biological Sciences Research Council (BBSRC) and the Lawes Agricultural Trust. The wet N deposition (precipitation chemistry) data set for 1992-2013 was provided courtesy of the UK Environmental Change Network (ECN). I.H.K. was supported by Deutsche Forschungsgemeinschaft (DFG SCHN 557/5-1).	Blake L, 1999, EUR J SOIL SCI, V50, P401, DOI 10.1046/j.1365-2389.1999.00253.x; Clark CM, 2008, NATURE, V451, P712, DOI 10.1038/nature06503; Clark CM, 2010, ECOLOGY, V91, P3620, DOI 10.1890/09-1268.1; Crawley MJ, 2005, AM NAT, V165, P179, DOI 10.1086/427270; DODD ME, 1994, FOLIA GEOBOT PHYTOTX, V29, P321, DOI 10.1007/BF02882911; Dupre C, 2010, GLOBAL CHANGE BIOL, V16, P344, DOI 10.1111/j.1365-2486.2009.01982.x; Fowler D., 2005, WATER AIR SOIL POLLU, V4, P9, DOI [10.1007/s11267-005-3009-9, DOI 10.1007/S11267-005-3009-9, DOI 10.1007/S11267-004-3009-1]; Goulding KWT, 1998, NEW PHYTOL, V139, P49, DOI 10.1046/j.1469-8137.1998.00182.x; GOULDING KWT, 1986, WATER AIR SOIL POLL, V29, P27, DOI 10.1007/BF00149327; Hall D.J., 1986, PRECIPITATION COLLEC; Isbell F, 2013, ECOL LETT, V16, P454, DOI 10.1111/ele.12066; Maskell LC, 2010, GLOBAL CHANGE BIOL, V16, P671, DOI 10.1111/j.1365-2486.2009.02022.x; Payne R., 2011, INTRO GENSTAT COMMAN; Power SA, 2006, GLOBAL CHANGE BIOL, V12, P1241, DOI 10.1111/j.1365-2486.2006.01161.x; Ro TAP, 2012, REV TRANSBOUNDARY AI; SILVERTOWN J, 1994, ECOLOGY, V75, P2430, DOI 10.2307/1940896; Silvertown J, 2006, J ECOL, V94, P801, DOI 10.1111/j.1365-2745.2006.01145.x; Smart SM, 2012, ECOL INDIC, V20, P51, DOI 10.1016/j.ecolind.2012.01.022; Smilauer P., 2014, MULTIVARIATE ANAL EC, V5; Smith RI, 2000, ATMOS ENVIRON, V34, P3757, DOI 10.1016/S1352-2310(99)00517-8; Stevens CJ, 2010, ENVIRON POLLUT, V158, P2940, DOI 10.1016/j.envpol.2010.06.006; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; Terry AC, 2004, J APPL ECOL, V41, P897, DOI 10.1111/j.0021-8901.2004.00955.x; van den Berg LJL, 2011, GLOBAL CHANGE BIOL, V17, P1871, DOI 10.1111/j.1365-2486.2010.02345.x; Williams E. D., 1978, BOT COMPOSITION PA 2, P31; Zhao FJ, 2003, J ENVIRON QUAL, V32, P33, DOI 10.2134/jeq2003.0033	26	104	117	10	359	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2015	528	7582					401	+		10.1038/nature16444	http://dx.doi.org/10.1038/nature16444			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY8SM	26633635				2022-12-28	WOS:000366678600053
J	Gorna, R; Klingen, N; Senga, K; Soucat, A; Takemi, K				Gorna, Robin; Klingen, Nicole; Senga, Kunio; Soucat, Agnes; Takemi, Keizo			Women's, children's, and adolescents' health needs universal health coverage	LANCET			English	Editorial Material									[Gorna, Robin] WHO, Partnership Maternal Newborn & Child Hlth, CH-1211 Geneva 27, Switzerland; [Klingen, Nicole] World Bank Grp, Washington, DC USA; [Senga, Kunio] Save Children Japan, Tokyo, Japan; [Soucat, Agnes] WHO, CH-1211 Geneva 27, Switzerland; [Takemi, Keizo] House Councillors, Tokyo, Japan	World Health Organization; The World Bank; Save the Children; World Health Organization	Gorna, R (corresponding author), WHO, Partnership Maternal Newborn & Child Hlth, CH-1211 Geneva 27, Switzerland.	gornar@who.int			World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		[Anonymous], 2015, GLOB STRAT WOM CHILD; Garrett L, 2009, LANCET, V374, P1294, DOI 10.1016/S0140-6736(09)61503-8; Gorna R, 2014, LANCET, V384, pE58, DOI 10.1016/S0140-6736(14)62260-1; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Kutzin J, 2012, B WORLD HEALTH ORGAN, V90, P867, DOI 10.2471/BLT.12.113654; Lagomarsino G, 2012, LANCET, V380, P933, DOI 10.1016/S0140-6736(12)61147-7; McPake B, 2011, HEALTH POLICY PLANN, V26, pII104, DOI 10.1093/heapol/czr064; Quick Jonathan, 2014, PLoS Med, V11, pe1001580, DOI 10.1371/journal.pmed.1001580; Stenberg K, 2014, LANCET, V383, P1333, DOI 10.1016/S0140-6736(13)62231-X; The Partnership for Maternal Newborn & Child Health, 2015, 2015 ACC REP STRENGT; WHO, 2015, STAT IN REPR MAT NEW; World Health Organization (WHO), 2014, MAK FAIR CHOIC PATH; Yates R, 2010, B WORLD HEALTH ORGAN, V88, P474, DOI 10.2471/BLT.09.074401	13	1	1	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 12	2015	386	10011					2371	2372		10.1016/S0140-6736(15)01176-9	http://dx.doi.org/10.1016/S0140-6736(15)01176-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CY3EE	26700516				2022-12-28	WOS:000366290400009
J	Clevers, H				Clevers, Hans			What is an adult stem cell?	SCIENCE			English	Editorial Material							MAMMARY-GLAND; HOMEOSTASIS; EPITHELIUM; REPAIR; CRYPT		[Clevers, Hans] Hubrecht Inst, Dept Dev Biol & Stem Cell Res, Utrecht, Netherlands; [Clevers, Hans] Univ Med Ctr, Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Clevers, H (corresponding author), Hubrecht Inst, Dept Dev Biol & Stem Cell Res, Utrecht, Netherlands.	h.clevers@hubrecht.eu						Brack AS, 2012, CELL STEM CELL, V10, P504, DOI 10.1016/j.stem.2012.04.001; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Doupe DP, 2012, SCIENCE, V337, P1091, DOI 10.1126/science.1218835; Jaks V, 2010, EXP CELL RES, V316, P1422, DOI 10.1016/j.yexcr.2010.03.014; Klein AM, 2010, CELL STEM CELL, V7, P214, DOI 10.1016/j.stem.2010.05.017; Leushacke M, 2013, CELL REP, V5, P349, DOI 10.1016/j.celrep.2013.09.025; Rios AC, 2014, NATURE, V506, P322, DOI 10.1038/nature12948; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Stange DE, 2013, CELL, V155, P357, DOI 10.1016/j.cell.2013.09.008; Stanger BZ, 2015, ANNU REV PHYSIOL, V77, P179, DOI 10.1146/annurev-physiol-021113-170255; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Strand DW, 2015, ENDOCR-RELAT CANCER, V22, pT187, DOI 10.1530/ERC-15-0195; Tata PR, 2013, NATURE, V503, P218, DOI 10.1038/nature12777; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Wang DS, 2015, NATURE, V517, P81, DOI 10.1038/nature13851	18	76	83	6	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2015	350	6266					1319	1320		10.1126/science.aad7016	http://dx.doi.org/10.1126/science.aad7016			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1JL	26659043				2022-12-28	WOS:000366162400022
J	Oxtoby, K				Oxtoby, Kathy			Why doctors need to resist "presenteeism"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												kathyoxtoby@blueyonder.co.uk						Health and Social Care Information Centre, 2015, NHS SICKN ABS RAT JA	1	5	5	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 9	2015	351								h6720	10.1136/bmj.h6720	http://dx.doi.org/10.1136/bmj.h6720			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY5SX	26656746				2022-12-28	WOS:000366468800017
J	Turner, PJ; Southern, J; Andrews, NJ; Miller, E; Erlewyn-Lajeunesse, M				Turner, Paul J.; Southern, Jo; Andrews, Nick J.; Miller, Elizabeth; Erlewyn-Lajeunesse, Michel		SNIFFLE-2 Study Investigators	Safety of live attenuated influenza vaccine in young people with egg allergy: multicentre prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NONRECOMMENDED CHILDREN YOUNGER; POSTMARKETING EVALUATION; FOOD ANAPHYLAXIS; INTRANASAL; EFFICACY; GUIDELINES; FREQUENCY; COMMITTEE; ASTHMA; LAIV	STUDY QUESTION How safe is live attenuated influenza vaccine (LAIV), which contains egg protein, in young people with egg allergy? METHODS In this open label, phase IV intervention study, 779 young people (2-18 years) with egg allergy were recruited from 30 UK allergy centres and immunised with LAIV. The cohort included 270 (34.7%) young people with previous anaphylaxis to egg, of whom 157 (20.1%) had experienced respiratory and/or cardiovascular symptoms. 445 (57.1%) had doctor diagnosed asthma or recurrent wheeze. Participants were observed for at least 30 minutes after vaccination and followed-up by telephone 72 hours later. Participants with a history of recurrent wheeze or asthma underwent further follow-up four weeks later. The main outcome measure was incidence of an adverse event within two hours of vaccination in young people with egg allergy. STUDY ANSWER AND LIMITATIONS No systemic allergic reactions occurred (upper 95% confidence interval for population 0.47% and in participants with anaphylaxis to egg 1.36%). Nine participants (1.2%, 95% CI 0.5% to 2.2%) experienced mild symptoms, potentially consistent with a local, IgE mediated allergic reaction. Delayed events potentially related to the vaccine were reported in 221 participants. 62 participants (8.1%, 95% CI for population 6.3% to 10.3%) experienced lower respiratory tract symptoms within 72 hours, including 29 with parent reported wheeze. No participants were admitted to hospital. No increase in lower respiratory tract symptoms occurred in the four weeks after vaccination (assessed with asthma control test). The study cohort may represent young people with more severe allergy requiring specialist input, since they were recruited from secondary and tertiary allergy centres. WHAT THIS STUDY ADDS LAIV is associated with a low risk of systemic allergic reactions in young people with egg allergy. The vaccine seems to be well tolerated in those with well controlled asthma or recurrent wheeze.	[Turner, Paul J.] Univ London Imperial Coll Sci Technol & Med, Paediat Sect, London W2 1PG, England; [Turner, Paul J.; Southern, Jo; Andrews, Nick J.; Miller, Elizabeth] Publ Hlth England, Immunisat Hepatitis & Blood Safety Dept, London, England; [Erlewyn-Lajeunesse, Michel] Southampton Univ Hosp, Paediatr Allergy & Immunol, Southampton, Hants, England	Imperial College London; Public Health England; University of Southampton	Turner, PJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Paediat Sect, London W2 1PG, England.	p.turner@imperial.ac.uk		Turner, Paul/0000-0001-9862-5161; Schwarze, Jurgen/0000-0002-6899-748X; Erlewyn-Lajeunesse, Michel/0000-0003-1982-1397; Cohen, Jonathan/0000-0003-1004-5598; Snape, Matthew/0000-0003-0531-5426	Department of Health policy research programme (National Vaccine Evaluation Consortium) [039/0031]; Medical Research Council [MR/K010468/1]; Department of Health through the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre; NIHR Clinical Research Networks; MRC [MR/K010468/1] Funding Source: UKRI	Department of Health policy research programme (National Vaccine Evaluation Consortium); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health through the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); NIHR Clinical Research Networks; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This report is independent research commissioned and funded by the Department of Health policy research programme (National Vaccine Evaluation Consortium, 039/0031). The views expressed in this publication are those of the author(s) and not necessarily those of the Department of Health. PJT is in receipt of a clinician scientist award (MR/K010468/1) funded by the Medical Research Council and has received research support from the Department of Health through the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Imperial College London Healthcare NHS Trust. The study received additional local support through the NIHR Clinical Research Networks, with additional funding for the Edinburgh site from Health Protection Scotland and the Belfast site from Health & Social Care Services in Northern Ireland. The study design and data collection were performed independently of the funder; data analysis was performed in conjunction with Public Health England, who also contributed to the writing of this report. The study chief investigators (PJT and MEL) had full access to all the data in the study, and final responsibility for the decision to submit for publication. The sponsor of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.	Ambrose CS, 2012, EUR J CLIN MICROBIOL, V31, P2549, DOI 10.1007/s10096-012-1595-9; Ambrose CS, 2012, VACCINE, V30, P886, DOI 10.1016/j.vaccine.2011.11.104; Ambrose CS, 2011, INFLUENZA OTHER RESP, V5, P389, DOI 10.1111/j.1750-2659.2011.00243.x; Baguelin M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001527; Baxter R, 2012, VACCINE, V30, P2989, DOI 10.1016/j.vaccine.2012.02.039; Belshe RB, 2008, VACCINE, V26, pD10, DOI 10.1016/j.vaccine.2008.06.083; Belshe RB, 2007, NEW ENGL J MED, V356, P685, DOI 10.1056/NEJMoa065368; Bousquet PJ, 2009, J ALLERGY CLIN IMMUN, V123, P1349, DOI 10.1016/j.jaci.2009.02.033; Des Roches A, 2014, J ALLERGY CLIN IMMUN, V3, P138; Des Roches A, 2012, J ALLERGY CLIN IMMUN, V130, P1213, DOI 10.1016/j.jaci.2012.07.046; Eller E., ANN ALLERGY ASTHMA I; European Medicines Agency, 2015, SUMM PROD CHAR FLUEN; Gaglani MJ, 2008, PEDIATR INFECT DIS J, V27, P444, DOI 10.1097/INF.0b013e3181660c2e; Grohskopf LA, 2015, AM J TRANSPLANT, V15, P2767, DOI [10.15585/mmwr.mm6430a3, 10.1111/ajt.13505]; Hill DJ, 2004, PEDIAT ALLERG IMM-UK, V15, P435, DOI 10.1111/j.1399-3038.2004.00188.x; Izurieta HS, 2005, JAMA-J AM MED ASSOC, V294, P2720, DOI 10.1001/jama.294.21.2720; Jia CE, 2013, J ALLERGY CLIN IMMUN, V131, P695, DOI 10.1016/j.jaci.2012.08.023; Johansson SGO, 2004, J ALLERGY CLIN IMMUN, V113, P832, DOI 10.1016/j.jaci.2003.12.591; Kelso JM, 2012, CURR OPIN ALLERGY CL, V12, P383, DOI 10.1097/ACI.0b013e328354395d; Muraro A, 2014, ALLERGY, V69, P1026, DOI 10.1111/all.12437; NHS England, NAT FLU IMM PROGR 20; Nwaru BI, 2014, ALLERGY, V69, P992, DOI 10.1111/all.12423; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Public Health England, 2014, INFL GREEN BOOK; Ruggeberg JU, 2007, VACCINE, V25, P5675, DOI 10.1016/j.vaccine.2007.02.064; Sampson HA, 2001, J ALLERGY CLIN IMMUN, V107, P891, DOI 10.1067/mai.2001.114708; Simons FER, 2011, WORLD ALLERGY ORGAN, V4, P13, DOI 10.1097/WOX.0b013e318211496c; Tennis P, 2012, VACCINE, V30, P6099, DOI 10.1016/j.vaccine.2012.07.031; Tennis P, 2011, VACCINE, V29, P4947, DOI 10.1016/j.vaccine.2011.04.113; Turner PJ, 2015, J ALLERGY CLIN IMMUN, V136, P376, DOI 10.1016/j.jaci.2014.12.1925; Turner PJ, 2015, J ALLERGY CLIN IMMUN, V135, P956, DOI 10.1016/j.jaci.2014.10.021; Turner PJ, 2015, J ALLER CL IMM-PRACT, V3, P312, DOI 10.1016/j.jaip.2014.11.017; Umasunthar T, 2015, CLIN EXP ALLERGY, V45, P1621, DOI 10.1111/cea.12477; Umasunthar T, 2013, CLIN EXP ALLERGY, V43, P1333, DOI 10.1111/cea.12211; Vyas D, 2016 ANN M AM AC ALL	35	33	43	1	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 8	2015	351								h6291	10.1136/bmj.h6291	http://dx.doi.org/10.1136/bmj.h6291			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY5SV	26645895	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000366468600003
J	Perkel, JM				Perkel, Jeffrey M.			ANNOTATING THE SCHOLARLY WEB	NATURE			English	Editorial Material														Perkel, Jeffrey/0000-0001-5699-1008					0	13	13	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					153	154		10.1038/528153a	http://dx.doi.org/10.1038/528153a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX3NO	26632591	Bronze			2022-12-28	WOS:000365606000070
J	Rohwer, F; Segall, AM				Rohwer, Forest; Segall, Anca M.			In retrospect A century of phage lessons	NATURE			English	Editorial Material							VIRUSES		[Rohwer, Forest; Segall, Anca M.] San Diego State Univ, Dept Biol, Viral Informat Inst, San Diego, CA 92182 USA	California State University System; San Diego State University	Rohwer, F (corresponding author), San Diego State Univ, Dept Biol, Viral Informat Inst, San Diego, CA 92182 USA.	frohwer@gmail.com; asegall@mail.sdsu.edu	Rohwer, Forest/AAC-5315-2019	Segall, Anca/0000-0002-8454-5248; Rohwer, Forest/0000-0003-1548-5429				Barr JJ, 2013, P NATL ACAD SCI USA, V110, P10771, DOI 10.1073/pnas.1305923110; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Craigie R, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006890; Georgopoulos C, 2006, GENETICS, V174, P1699, DOI 10.1534/genetics.104.68262; Hendrix RW, 2000, TRENDS MICROBIOL, V8, P504, DOI 10.1016/S0966-842X(00)01863-1; HERSHEY AD, 1952, J GEN PHYSIOL, V36, P39, DOI 10.1085/jgp.36.1.39; Hu B, 2015, P NATL ACAD SCI USA, V112, pE4919, DOI 10.1073/pnas.1501064112; Luria SE, 1943, GENETICS, V28, P491; NASH HA, 1981, ANNU REV GENET, V15, P143, DOI 10.1146/annurev.ge.15.120181.001043; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Ruska H, 1940, NATURWISSENSCHAFTEN, V28, P45, DOI DOI 10.1007/BF01486931; SANGER F, 1978, J MOL BIOL, V125, P225, DOI 10.1016/0022-2836(78)90346-7; Sharon I, 2011, ISME J, V5, P1178, DOI 10.1038/ismej.2011.2; Twort FW, 1915, LANCET, V2, P1241, DOI 10.1016/s0140-6736(01)20383-3; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000	16	29	35	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					46	48		10.1038/528046a	http://dx.doi.org/10.1038/528046a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX3NO	26632584				2022-12-28	WOS:000365606000045
J	Kuypers, MMM				Kuypers, Marcel M. M.			A division of labour combined	NATURE			English	Editorial Material							NITRITE; NITRIFICATION; BACTERIA; OCEAN		[Kuypers, Marcel M. M.] Max Planck Inst Marine Mikrobiol, Biogeochem Dept, D-28359 Bremen, Germany	Max Planck Society	Kuypers, MMM (corresponding author), Max Planck Inst Marine Mikrobiol, Biogeochem Dept, D-28359 Bremen, Germany.	mkuypers@mpi-bremen.de						Costa E, 2006, TRENDS MICROBIOL, V14, P213, DOI 10.1016/j.tim.2006.03.006; Daims H, 2015, NATURE, V528, P504, DOI 10.1038/nature16461; Ettwig KF, 2010, NATURE, V464, P543, DOI 10.1038/nature08883; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Griffin BM, 2007, SCIENCE, V316, P1870, DOI 10.1126/science.1139478; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Lucker S, 2010, P NATL ACAD SCI USA, V107, P13479, DOI 10.1073/pnas.1003860107; Ravishankara AR, 2009, SCIENCE, V326, P123, DOI 10.1126/science.1176985; Strous M, 1999, NATURE, V400, P446, DOI 10.1038/22749; Thompson AW, 2012, SCIENCE, V337, P1546, DOI 10.1126/science.1222700; van Kessel MAHJ, 2015, NATURE, V528, P555, DOI 10.1038/nature16459; Winogradsky S., 1890, ANN I PASTEUR, V4, P213; Wuchter C, 2006, P NATL ACAD SCI USA, V103, P12317, DOI 10.1073/pnas.0600756103	13	15	16	5	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2015	528	7583					487	488		10.1038/528487a	http://dx.doi.org/10.1038/528487a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ3GH	26701051				2022-12-28	WOS:000366991900038
J	Prado, MTP; Cepeda-Jimenez, CM				Perez Prado, Maria Teresa; Cepeda-Jimenez, Carmen M.			Strength ceiling smashed for light metals	NATURE			English	Editorial Material							MAGNESIUM; PRECIPITATION		[Perez Prado, Maria Teresa; Cepeda-Jimenez, Carmen M.] IMDEA Mat Inst, Madrid 28906, Spain	IMDEA Materials Institute	Prado, MTP (corresponding author), IMDEA Mat Inst, Madrid 28906, Spain.	teresa.perez.prado@imdea.org; carmen.cepeda@imdea.org	Cepeda-Jiménez, Carmen M/T-5318-2017; Perez-Prado, Maria Teresa/M-2050-2014	Cepeda-Jiménez, Carmen M/0000-0001-7704-7411; Perez-Prado, Maria Teresa/0000-0003-0758-2851				Chen LY, 2015, NATURE, V528, P539, DOI 10.1038/nature16445; Deschamps A, 1998, ACTA MATER, V47, P293, DOI 10.1016/S1359-6454(98)00296-1; Ferguson JB, 2012, MAT SCI ENG A-STRUCT, V558, P193, DOI 10.1016/j.msea.2012.07.111; Helms H, 2007, INT J LIFE CYCLE ASS, V12, P58, DOI 10.1065/lca2006.07.258; Mang T., 2011, IND TRIBOLOGY; Nie JF, 2012, METALL MATER TRANS A, V43A, P3891, DOI 10.1007/s11661-012-1217-2; Sillekens WH, 2014, METALL MATER TRANS A, V45A, P3349, DOI 10.1007/s11661-014-2321-2	7	11	12	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2015	528	7583					486	487		10.1038/528486a	http://dx.doi.org/10.1038/528486a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ3GH	26701050				2022-12-28	WOS:000366991900037
J	Graves, JAM				Graves, Jennifer A. Marshall			In retrospect: Twenty-five years of the sex-determining gene	NATURE			English	Editorial Material							SRY-RELATED GENE; CAMPOMELIC DYSPLASIA; DETERMINING REGION; Y-CHROMOSOME; EVOLUTION; REVERSAL; MARSUPIALS; SEQUENCES; MUTATIONS; PROTEIN		[Graves, Jennifer A. Marshall] La Trobe Univ, Sch Life Sci, Bundoora, Vic 3086, Australia; [Graves, Jennifer A. Marshall] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia	La Trobe University; Australian National University	Graves, JAM (corresponding author), La Trobe Univ, Sch Life Sci, Bundoora, Vic 3086, Australia.	j.graves@latrobe.edu.au		Graves, Jennifer/0000-0001-6480-7856				Aitken RJ, 2002, NATURE, V415, P963, DOI 10.1038/415963a; BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; CHARLESWORTH B, 1991, SCIENCE, V251, P1030, DOI 10.1126/science.1998119; Eggers S, 2014, NAT REV ENDOCRINOL, V10, P673, DOI 10.1038/nrendo.2014.163; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; FOSTER JW, 1992, NATURE, V359, P531, DOI 10.1038/359531a0; FOSTER JW, 1994, P NATL ACAD SCI USA, V91, P1927, DOI 10.1073/pnas.91.5.1927; Graves JAM, 2006, CELL, V124, P901, DOI 10.1016/j.cell.2006.02.024; HARLEY VR, 1994, MOL REPROD DEV, V39, P184, DOI 10.1002/mrd.1080390211; Hughes JF, 2005, NATURE, V437, P101, DOI 10.1038/nature04101; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; KOOPMAN P, 1989, NATURE, V342, P940, DOI 10.1038/342940a0; Kuroiwa A, 2011, CHROMOSOME RES, V19, P635, DOI 10.1007/s10577-011-9223-6; Ohnesorg T, 2014, SEX DEV, V8, P262, DOI 10.1159/000357956; PAGE DC, 1987, CELL, V51, P1091, DOI 10.1016/0092-8674(87)90595-2; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; SINCLAIR AH, 1988, NATURE, V336, P780, DOI 10.1038/336780a0; Sutton E, 2011, J CLIN INVEST, V121, P328, DOI 10.1172/JCI42580; Veyrunes F, 2008, GENOME RES, V18, P965, DOI 10.1101/gr.7101908; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8	20	2	3	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2015	528	7582					343	+		10.1038/528343a	http://dx.doi.org/10.1038/528343a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY8SM	26672550				2022-12-28	WOS:000366678600041
J	Limb, M				Limb, Matthew			CONFLICTS OF INTEREST IN RESEARCH Scientists take first steps to form united front over interactions with global food industry	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												limb@btinternet.com							0	2	2	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 17	2015	351								h6859	10.1136/bmj.h6859	http://dx.doi.org/10.1136/bmj.h6859			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ4MS	26680776				2022-12-28	WOS:000367077900006
J	Bernhardt, J; Lindley, RI; Lalor, E; Ellery, F; Chamberlain, J; Van Holsteyn, J; Collier, JM; Dewey, HM; Parsons, B; Moodie, M; Lennon, S; Donnan, GA; Thrift, AG; Churilov, L; Langhorne, P				Bernhardt, Julie; Lindley, Richard I.; Lalor, Erin; Ellery, Fiona; Chamberlain, Jan; Van Holsteyn, John; Collier, Janice M.; Dewey, Helen M.; Parsons, Brooke; Moodie, Marjory; Lennon, Sheila; Donnan, Geoffrey A.; Thrift, Amanda G.; Churilov, Leonid; Langhorne, Peter		AVERT Collaboration Grp	CHRISTMAS 2015: PROFESSIONAL CONSIDERATIONS AVERT(2) (a very early rehabilitation trial, a very effective reproductive trigger): retrospective observational analysis of the number of babies born to trial staff	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								Objective To report the number of participants needed to recruit per baby born to trial staff during AVERT, a large international trial on acute stroke, and to describe trial management consequences. Design Retrospective observational analysis. Setting 56 acute stroke hospitals in eight countries. Participants 1074 trial physiotherapists, nurses, and other clinicians. Outcome measures Number of babies born during trial recruitment per trial participant recruited. Results With 198 site recruitment years and 2104 patients recruited during AVERT, 120 babies were born to trial staff. Births led to an estimated 10% loss in time to achieve recruitment. Parental leave was linked to six trial site closures. The number of participants needed to recruit per baby born was 17.5 (95% confidence interval 14.7 to 21.0); additional trial costs associated with each birth were estimated at 5736 Australian dollars on average. Conclusion The staff absences registered in AVERT owing to parental leave led to delayed trial recruitment and increased costs, and should be considered by trial investigators when planning research and estimating budgets. However, the celebration of new life became a highlight of the annual AVERT collaborators' meetings and helped maintain a cohesive collaborative group.	[Bernhardt, Julie] Florey Inst Neurosci & Mental Hlth, NHMRC Natl Hlth & Med Res Council, Ctr Res Excellence Stroke Rehabil & Brain Recover, Stroke Div, Heidelberg, Vic 3084, Australia; [Lindley, Richard I.] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Lindley, Richard I.] Univ Sydney, Westmead Hosp, Sch Clin, Sydney, NSW 2006, Australia; [Lalor, Erin] Natl Stroke Fdn, Melbourne, Vic, Australia; [Ellery, Fiona; Chamberlain, Jan; Collier, Janice M.; Parsons, Brooke] Florey Inst Neurosci & Mental Hlth, Heidelberg, Vic, Australia; [Van Holsteyn, John] La Trobe Univ, Sch Nursing & Midwifery, Melbourne, Vic, Australia; [Dewey, Helen M.] Monash Univ, Eastern Hlth Clin Sch, Box Hill, Vic, Australia; [Moodie, Marjory] Deakin Univ, Fac Hlth, Deakin Hlth Econ, Burwood, Vic, Australia; [Lennon, Sheila] Flinders Univ S Australia, Repatriat Gen Hosp, Adelaide, SA, Australia; [Donnan, Geoffrey A.; Churilov, Leonid] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Thrift, Amanda G.] Monash Univ, Monash Hlth, Sch Clin Sci, Stroke & Ageing Res Ctr,Dept Med, Clayton, Vic, Australia; [Langhorne, Peter] Univ Glasgow, Glasgow Royal Infirm, Glasgow G31 2ER, Lanark, Scotland	Florey Institute of Neuroscience & Mental Health; George Institute for Global Health; University of Sydney; University of Sydney; Florey Institute of Neuroscience & Mental Health; La Trobe University; Monash University; Deakin University; Flinders University South Australia; Florey Institute of Neuroscience & Mental Health; Monash University; University of Glasgow	Bernhardt, J (corresponding author), Florey Inst Neurosci & Mental Hlth, NHMRC Natl Hlth & Med Res Council, Ctr Res Excellence Stroke Rehabil & Brain Recover, Stroke Div, Heidelberg, Vic 3084, Australia.	Julie.Bernhardt@florey.edu.au	FRACP, Tissa Wijeratne MD PhD/I-2086-2019; Macleod, Malcolm Robert/B-2052-2010; Hankey, Graeme J/H-4968-2014; Thrift, Amanda/I-6251-2012; Rosbergen, Ingrid/AAN-2516-2021; Collier, Janice M/K-4563-2015; Lindley, Richard/B-8148-2013; Collier, Janice/S-6179-2019; Askim, Torunn/B-7655-2017; Bernhardt, Julie/F-9538-2015	FRACP, Tissa Wijeratne MD PhD/0000-0002-1701-7111; Macleod, Malcolm Robert/0000-0001-9187-9839; Hankey, Graeme J/0000-0002-6044-7328; Thrift, Amanda/0000-0001-8533-4170; Rosbergen, Ingrid/0000-0002-3576-2721; Collier, Janice M/0000-0003-2950-4870; Lindley, Richard/0000-0002-0104-5679; Donnan, Geoffrey/0000-0001-6324-3403; Lennon, Sheila/0000-0001-5434-0893; Ellery, Fiona/0000-0002-7302-1895; Linden, Thomas KA/0000-0002-2444-8892; Askim, Torunn/0000-0002-9818-9272; Blacker, David/0000-0003-0046-9776; Bernhardt, Julie/0000-0002-2787-8484; Kwan, Joseph/0000-0003-4635-3322; Cloud, Geoffrey/0000-0002-8365-6907	Australian National Health and Medical Research Council (NHMRC); Singapore Health; Chest Heart and Stroke Scotland; Northern Ireland Chest Heart and Stroke; UK Stroke Association; UK National Institute of Health Research	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Singapore Health; Chest Heart and Stroke Scotland; Northern Ireland Chest Heart and Stroke; UK Stroke Association; UK National Institute of Health Research(National Institute for Health Research (NIHR))	Australian National Health and Medical Research Council (NHMRC), Singapore Health, Chest Heart and Stroke Scotland, Northern Ireland Chest Heart and Stroke, UK Stroke Association, UK National Institute of Health Research. The funders were not involved in the design or conduct of the study; the collection, management, analysis, and interpretation of the data; or the preparation, review or approval of the manuscript. The content of this paper is solely the responsibility of the authors and does not reflect the views of the funders.	Australian Institute of Health and Welfare, 2013, 52 HWL AUSTR I HLTH; Bernhardt J, 2006, INT J STROKE, V1, P169, DOI 10.1111/j.1747-4949.2006.00044.x; Bernhardt J, 2015, LANCET, V386, P46, DOI 10.1016/S0140-6736(15)60690-0; Bernhardt J, 2015, INT J STROKE, V10, P23, DOI 10.1111/ijs.12423; Castles FG, 2003, J EUR SOC POLICY, V13, P209, DOI 10.1177/09589287030133001; Christensen H, 2010, BRIT J PSYCHIAT, V196, P126, DOI 10.1192/bjp.bp.109.068635; Heslehurst N, 2010, INT J OBESITY, V34, P420, DOI 10.1038/ijo.2009.250; Information Services Division, 2015, Q UPD STAFF POST VAC; The Australian Human Rights Commission, 2014, PREGN RET WORK NATL	9	2	4	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 11	2015	351								h6432	10.1136/bmj.h6432	http://dx.doi.org/10.1136/bmj.h6432			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY5TJ	26658193	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000366470100003
J	Dance, A				Dance, Amber			MICROMANAGEMENT WITH LIGHT	NATURE			English	Editorial Material							PROTEIN; SYSTEM											Courchet J, 2013, CELL, V153, P1510, DOI 10.1016/j.cell.2013.05.021; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Motta-Mena LB, 2014, NAT CHEM BIOL, V10, P196, DOI [10.1038/NCHEMBIO.1430, 10.1038/nchembio.1430]; Nihongaki Y, 2015, NAT BIOTECHNOL, V33, P755, DOI 10.1038/nbt.3245; Nihongaki Y, 2015, CHEM BIOL, V22, P169, DOI 10.1016/j.chembiol.2014.12.011; Spillane M, 2013, CELL REP, V5, P1564, DOI 10.1016/j.celrep.2013.11.022; Strickland D, 2012, NAT METHODS, V9, P379, DOI [10.1038/NMETH.1904, 10.1038/nmeth.1904]; Toettcher JE, 2013, CELL, V155, P1422, DOI 10.1016/j.cell.2013.11.004; van Bergeijk P, 2015, NATURE, V518, P111, DOI 10.1038/nature14128; Yazawa M, 2009, NAT BIOTECHNOL, V27, P941, DOI 10.1038/nbt.1569	11	6	6	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2015	528	7581					291	294		10.1038/528291a	http://dx.doi.org/10.1038/528291a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX9VH	26659189	Bronze			2022-12-28	WOS:000366053300047
J	Neilson, J; O'Neill, F; Dawoud, D; Crean, P				Neilson, Julie; O'Neill, Frank; Dawoud, Dalia; Crean, Peter		Guideline Dev Grp	GUIDELINES Intravenous fluids in children and young people: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Neilson, Julie; O'Neill, Frank; Dawoud, Dalia] Natl Clin Guideline Ctr, London, England; [Dawoud, Dalia] Cairo Univ, Fac Pharm, Cairo, Egypt; [Crean, Peter] Royal Belfast Hosp Sick Children, Belfast, Antrim, North Ireland	Egyptian Knowledge Bank (EKB); Cairo University	Neilson, J (corresponding author), Natl Clin Guideline Ctr, London, England.	Julie.neilson@rcplondon.ac.uk	Dawoud, Dalia M/N-9741-2019	Dawoud, Dalia M/0000-0002-2105-1937				[Anonymous], 2009, DIARRHOEA VOMITING C; Joint Formulary Committee, 2015, BRIT NAT FORM CHILDR; Moritz ML, 2010, PEDIATR NEPHROL, V25, P1225, DOI 10.1007/s00467-009-1323-6; National Institute for Health and Care Excellence, 2013, INTR FLUID THER 16S; National Institute for Health and Care Excellence, 2015, INTR FLUIDS THER CHI; National Patient Safety Agency, 2007, RED RISK HYP ADM INT; National Patient Safety Agency, 2014, TEMPL PRESCR INTR IN	7	12	11	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 9	2015	351								h6388	10.1136/bmj.h6388	http://dx.doi.org/10.1136/bmj.h6388			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY5SX	26662119				2022-12-28	WOS:000366468800002
J	DeJong, C; Lucey, CR; Dudley, RA				DeJong, Colette; Lucey, Catherine R.; Dudley, R. Adams			Incorporating a New Technology While Doing No Harm, Virtually	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[DeJong, Colette] Univ Calif San Francisco, San Francisco Sch Med, Ctr Healthcare Value, Philip R Lee Inst Hlth Policy Studies,, San Francisco, CA 94118 USA; [Lucey, Catherine R.] Univ Calif San Francisco, San Francisco Sch Med, Educ, San Francisco, CA 94118 USA; [Dudley, R. Adams] Univ Calif San Francisco, San Francisco Sch Med, Ctr Healthcare Value, Philip R Lee Inst Hlth Policy Studies,Dept Med, San Francisco, CA 94118 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Dudley, RA (corresponding author), Univ Calif San Francisco, Dept Med, Ctr Healthcare Value, Philip R Lee Inst Hlth Policy Studies, POB 0936,3333 Calif,Ste 265, San Francisco, CA 94118 USA.	adams.dudley@ucsf.edu			NCATS NIH HHS [TL1 TR000144] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000144] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		DeJong C, 2014, JAMA-J AM MED ASSOC, V311, P1287, DOI 10.1001/jama.2014.1026; Federation of State Medical Boards, MOD POL APPR US TEL; Federation of State Medical Boards, INT MED LIC COMP; Steinbrook R, 2014, JAMA-J AM MED ASSOC, V312, P695, DOI 10.1001/jama.2014.9809	4	25	25	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 8	2015	314	22					2351	2352		10.1001/jama.2015.13572	http://dx.doi.org/10.1001/jama.2015.13572			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX8XT	26647252				2022-12-28	WOS:000365989100005
J	Golub, RM				Golub, Robert M.			At What Cost? Medical Education 2016	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RESIDENTS; PHYSICIANS; STUDENTS; PATTERNS; CARE		[Golub, Robert M.] JAMA, Chicago, IL 60611 USA		Golub, RM (corresponding author), JAMA, 330 N Wabash Ave, Chicago, IL 60611 USA.	robert.golub@jamanetwork.org						Berwick DM, 2008, HEALTH AFFAIR, V27, P759, DOI 10.1377/hlthaff.27.3.759; Chen C, 2014, JAMA-J AM MED ASSOC, V312, P2385, DOI 10.1001/jama.2014.15973; Coutinho AJ, 2015, JAMA-J AM MED ASSOC, V314, P2364, DOI 10.1001/jama.2015.13734; Davis DA, 2006, JAMA-J AM MED ASSOC, V296, P1094, DOI 10.1001/jama.296.9.1094; DeJong C, 2015, JAMA-J AM MED ASSOC, V314, P2351, DOI 10.1001/jama.2015.13572; Eckenfels EJ, 1997, ANN BEHAV SCI MED ED, V4, P11; Elnicki DM, 1999, ACAD MED, V74, pS99, DOI 10.1097/00001888-199910000-00053; George DR, 2015, JAMA-J AM MED ASSOC, V314, P2345, DOI 10.1001/jama.2015.13652; Gupta R, 2015, JAMA-J AM MED ASSOC, V314, P2349, DOI 10.1001/jama.2015.13574; Ioannides KLH, 2015, JAMA-J AM MED ASSOC, V314, P2411, DOI 10.1001/jama.2015.16476; Korenstein D, 2015, JAMA-J AM MED ASSOC, V314, P2359, DOI 10.1001/jama.2015.15406; Mata DA, 2015, JAMA-J AM MED ASSOC, V314, P2373, DOI 10.1001/jama.2015.15845; McCarthy CP, 2015, JAMA-J AM MED ASSOC, V314, P2347, DOI 10.1001/jama.2015.13570; Pitts SR, 2014, JAMA-J AM MED ASSOC, V312, P2394, DOI 10.1001/jama.2014.16172; Reifler DR, 2015, JAMA-J AM MED ASSOC, V314, P2355, DOI 10.1001/jama.2015.14670; Schwenk TL, 2015, JAMA-J AM MED ASSOC, V314, P2357, DOI 10.1001/jama.2015.15408; Schwenk TL, 2010, JAMA-J AM MED ASSOC, V304, P1181, DOI 10.1001/jama.2010.1300; Stammen LA, 2015, JAMA-J AM MED ASSOC, V314, P2384, DOI 10.1001/jama.2015.16353; Warner DO, 2013, JAMA-J AM MED ASSOC, V310, P2289, DOI 10.1001/jama.2013.281954; West CP, 2011, JAMA-J AM MED ASSOC, V306, P952, DOI 10.1001/jama.2011.1247	20	4	4	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 8	2015	314	22					2361	2363		10.1001/jama.2015.16546	http://dx.doi.org/10.1001/jama.2015.16546			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX8XT	26647257				2022-12-28	WOS:000365989100010
J	Mccoy, RG; Van Houten, HK; Ross, JS; Montori, VM; Shah, ND				McCoy, Rozalina G.; Van Houten, Holly K.; Ross, Joseph S.; Montori, Victor M.; Shah, Nilay D.			HbA(1c) overtesting and overtreatment among US adults with controlled type 2 diabetes, 2001-13: observational population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SEVERE HYPOGLYCEMIA; CARE; MORTALITY; ASSOCIATION; OUTCOMES; IMPACT	STUDY QUESTION What is the extent and effect of excessive testing for glycated hemoglobin (HbA(1c)) among adults with controlled type 2 diabetes? METHODS A retrospective analysis of data from a national administrative claims database included commercially insured individuals in the USA, 2001-13. Study patients were aged 18 years or older, had type 2 diabetes with stable glycemic control (two consecutive tests showing HbA(1c)<7.0% within 24 months), did not use insulin, had no history of severe hypoglycemia or hyperglycemia, and were not pregnant. HbA(1c) testing frequency was measured within 24 months after the second (index) HbA(1c) test, and classified as guideline recommended (<= 2 times/year), frequent (3-4 times/year), and excessive (>= 5 times/year). Changes in treatment regimen were ascertained within three months of the index test. STUDY ANSWER AND LIMITATIONS Of 31 545 patients in the study cohort (mean age 58 years; mean index HbA(1c) 6.2%), HbA(1c) testing frequency was excessive in 6% and frequent in 55%. Despite good glycemic control at baseline, treatment was further intensified by addition of glucose lowering drugs or insulin in 8.4% of patients (comprising 13%, 9%, and 7% of those tested excessively, frequently, and per guidelines, respectively; P<0.001). Compared with guideline recommended testing, excessive testing was associated with treatment intensification (odds ratio 1.35 (95% confidence interval 1.22 to 1.50)). Excessive testing rates remained unchanged in 2001-08, but fell significantly after 2009. The odds of excessive testing was 46% lower in 2011 than in 2001-02. The study population is not representative of all US patients with type 2 diabetes because it was restricted to commercially insured adults with stable and controlled diabetes not receiving insulin treatment. The study design did not capture the underuse of HbA(1c) testing. WHAT THIS STUDY ADDS In this US cohort of adults with stable and controlled type 2 diabetes, more than 60% received too many HbA(1c) tests, a practice associated with potential overtreatment with hypoglycemic drugs. Excessive testing contributes to the growing problem of waste in healthcare and increased patient burden in diabetes management.	[McCoy, Rozalina G.] Mayo Clin, Dept Med, Div Primary Care Internal Med, Rochester, MN 55905 USA; [McCoy, Rozalina G.; Van Houten, Holly K.; Shah, Nilay D.] Mayo Clin, Dept Hlth Sci Res, Div Hlth Care Policy & Res, Rochester, MN 55905 USA; [Van Houten, Holly K.] Mayo Clin, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, Rochester, MN 55905 USA; [Ross, Joseph S.] Yale Univ, Sch Med, Dept Internal Med, Sect Gen Internal Med, New Haven, CT 06510 USA; [Ross, Joseph S.] Yale Univ, Sch Med, Dept Internal Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06510 USA; [Ross, Joseph S.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Montori, Victor M.] Mayo Clin, Dept Med, Div Endocrinol Metab & Nutr, Rochester, MN 55905 USA; [Montori, Victor M.] Mayo Clin, Knowledge & Evaluat Res Unit, Rochester, MN 55905 USA; [Shah, Nilay D.] Optum Labs, Cambridge, MA USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Yale University; Yale University; Yale University; Mayo Clinic; Mayo Clinic; Optum	Mccoy, RG (corresponding author), Mayo Clin, Dept Med, Div Primary Care Internal Med, Rochester, MN 55905 USA.	mccoy.rozalina@mayo.edu		Montori, Victor/0000-0003-0595-2898; Ross, Joseph/0000-0002-9218-3320	Agency for Healthcare Research and Quality [R18HS18339]; AcademyHealth Delivery System Science Fellowship; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R18HS018339] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AcademyHealth Delivery System Science Fellowship; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	NDS is funded partly by the Agency for Healthcare Research and Quality (R18HS18339). RGM was supported partly by the AcademyHealth Delivery System Science Fellowship (2013). The funders had no role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.	Akan P, 2007, J EVAL CLIN PRACT, V13, P21, DOI 10.1111/j.1365-2753.2006.00641.x; [Anonymous], 2015, DIABETES CARE, V38, pS5, DOI 10.2337/dc15-S004; AXTADAM P, 1993, MED CARE, V31, P784, DOI 10.1097/00005650-199309000-00003; Bentley TGK, 2008, MILBANK Q, V86, P629, DOI 10.1111/j.1468-0009.2008.00537.x; Berard LD, 2013, CAN J DIABETES, V37, pS35, DOI 10.1016/j.jcjd.2013.01.017; Bonds Denise E, 2010, BMJ, V340, pb4909, DOI 10.1136/bmj.b4909; Centers for Medicare and Medicaid Services Physician Quality Reporting System, 2015, REG REP; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Colla CH, 2015, BMJ QUAL SAF, V24, P149, DOI 10.1136/bmjqs-2014-003087; Alonso-Cerezo MC, 2009, CLIN CHEM LAB MED, V47, P1461, DOI 10.1515/CCLM.2009.335; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Driskell OJ, 2012, CLIN CHEM, V58, P906, DOI 10.1373/clinchem.2011.176487; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Garber AJ, 2015, ENDOCR PRACT, V21, P438, DOI 10.4158/EP15693.CS; Ginde Adit A, 2008, BMC Endocr Disord, V8, P4, DOI 10.1186/1472-6823-8-4; Glasziou PP, 2008, ANN INTERN MED, V148, P656, DOI 10.7326/0003-4819-148-9-200805060-00005; Institute of Medicine, 2001, CROSSING QUALITY CHA; International Diabetes Federation, 2012, GLOB GUID TYP 2 DIAB; Ismail-Beigi F, 2010, LANCET, V376, P419, DOI 10.1016/S0140-6736(10)60576-4; Janssens PMW, 2010, CLIN CHIM ACTA, V411, P1596, DOI 10.1016/j.cca.2010.07.022; Laxmisan A, 2011, AM J MED, V124, P342, DOI 10.1016/j.amjmed.2010.10.019; Lewis S, 1997, INT J TECHNOL ASSESS, V13, P501, DOI 10.1017/S0266462300009971; McCoy RG, 2013, ENDOCR PRACT, P1; McCoy RG, 2012, DIABETES CARE, V35, P1897, DOI 10.2337/dc11-2054; McEwen LN, 2007, DIABETES CARE, V30, P1736, DOI 10.2337/dc07-0305; National Committee for Quality Assurance, HEDIS 2009; National Institute for Health and Care Excellence, 2009, TYP 2 DIAB MAN TYP 2; National Priorities Partnership, 2008, NAT PRIOR GOALS ALIG; Pivovarov R, 2014, J AM MED INFORM ASSN, V21, P1038, DOI 10.1136/amiajnl-2013-002592; Rang M, 1972, Can Med Assoc J, V106, P122; Reithof M, 2012, DIAGN MAN TYP 2 DIAB; Romano MJ, 2015, JAMA INTERN MED, V175, P1148, DOI 10.1001/jamainternmed.2015.1340; Song Z, 2011, NEW ENGL J MED, V365, P909, DOI 10.1056/NEJMsa1101416; Turnbull FM, 2009, DIABETOLOGIA, V52, P2288, DOI 10.1007/s00125-009-1470-0; U.S. Department of Veteran Affairs & Department of Defense, 2010, VA DOD CLIN PRACT GU; Wallace PJ, 2014, HEALTH AFFAIR, V33, P1187, DOI 10.1377/hlthaff.2014.0038; Yasaitis LC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111119; Zoungas S, 2010, NEW ENGL J MED, V363, P1410, DOI 10.1056/NEJMoa1003795	38	43	43	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 8	2015	351								h6138	10.1136/bmj.h6138	http://dx.doi.org/10.1136/bmj.h6138			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY5SV	26646052	Green Published, hybrid			2022-12-28	WOS:000366468600002
J	Eckert, D; Jauzac, M; HuanYuan, S; Kneib, JP; Erben, T; Israel, H; Jullo, E; Klein, M; Massey, R; Richard, J; Tchernin, C				Eckert, Dominique; Jauzac, Mathilde; HuanYuan, Shan; Kneib, Jean-Paul; Erben, Thomas; Israel, Holger; Jullo, Eric; Klein, Matthias; Massey, Richard; Richard, Johan; Tchernin, Celine			Warm-hot baryons comprise 5-10 per cent of filaments in the cosmic web	NATURE			English	Article							HUBBLE-FRONTIER-FIELDS; LARGE-SCALE FILAMENT; INTERGALACTIC MEDIUM; GALAXY CLUSTERS; CHANDRA VIEW; DARK-MATTER; ABELL 2744; CATALOG; MERGER; GAS	Observations of the cosmic microwave background indicate that baryons account for 5 per cent of the Universe's total energy content(1). In the local Universe, the census of all observed baryons falls short of this estimate by a factor of two(2,3). Cosmological simulations indicate that the missing baryons have not condensed into virialized haloes, but reside throughout the filaments of the cosmic web (where matter density is larger than average) as a low-density plasma at temperatures of 10(5)-10(7) kelvin, known as the warm-hot intergalactic medium(3-6). There have been previous claims of the detection of warm-hot baryons along the line of sight to distant blazars(7-10) and of hot gas between interacting clusters(11-14). These observations were, however, unable to trace the large-scale filamentary structure, or to estimate the total amount of warm-hot baryons in a representative volume of the Universe. Here we report X-ray observations of filamentary structures of gas at 10(7) kelvin associated with the galaxy cluster Abell 2744. Previous observations of this cluster15 were unable to resolve and remove coincidental X-ray point sources. After subtracting these, we find hot gas structures that are coherent over scales of 8 megaparsecs. The filaments coincide with over-densities of galaxies and dark matter, with 5-10 per cent of their mass in baryonic gas. This gas has been heated up by the cluster's gravitational pull and is now feeding its core. Our findings strengthen evidence for a picture of the Universe in which a large fraction of the missing baryons reside in the filaments of the cosmic web.	[Eckert, Dominique; Tchernin, Celine] Univ Geneva, Dept Astron, CH-1290 Versoix, Switzerland; [Eckert, Dominique] INAF IASF Milano, I-20133 Milan, Italy; [Jauzac, Mathilde; Israel, Holger; Massey, Richard] Univ Durham, Dept Phys, Inst Computat Cosmol, Durham DH1 3LE, England; [Jauzac, Mathilde] Univ KwaZulu Natal, Sch Math Sci, Astrophys & Cosmol Res Unit, ZA-4041 Durban, South Africa; [HuanYuan, Shan; Kneib, Jean-Paul] Observ Sauverny, Ecole Polytech Fed Lausanne, Astrophys Lab, CH-1290 Versoix, Switzerland; [Kneib, Jean-Paul; Jullo, Eric] Aix Marseille Univ, CNRS, UMR 7326, LAM, F-13388 Marseille, France; [Erben, Thomas; Klein, Matthias] Argelander Inst Astron, D-53121 Bonn, Germany; [Richard, Johan] Univ Lyon 1, CRAL, Observ Lyon, F-69561 St Genis Laval, France	University of Geneva; Istituto Nazionale Astrofisica (INAF); Durham University; University of Kwazulu Natal; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Aix-Marseille Universite; University of Bonn; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Eckert, D (corresponding author), Univ Geneva, Dept Astron, Chemin Ecogia 16, CH-1290 Versoix, Switzerland.	Dominique.Eckert@unige.ch	Kneib, Jean-Paul/A-7919-2015; Jauzac, Mathilde/B-1966-2015; Shan, Huanyuan/G-3353-2015; Massey, Richard/D-1300-2016	Kneib, Jean-Paul/0000-0002-4616-4989; Shan, Huanyuan/0000-0001-8534-837X; Richard, Johan/0000-0001-5492-1049; Eckert, Dominique/0000-0001-7917-3892; Tchernin, Celine/0000-0003-4219-3683; Jauzac, Mathilde/0000-0003-1974-8732; Massey, Richard/0000-0002-6085-3780	ESA Member States; NASA; UK Science and Technology Facilities Council [ST/L00075X/1, ST/H005234/1]; Leverhulme trust [PLP-2011-003]; Royal Society; ERC advanced grant LIDA; CNRS; Marie Curie International Incoming Fellowship within the 7th European Community Framework Programme; NSFC of China [11103011]; Deutsche Forschungsgemeinschaft through the Transregional Collaborative Research Centre [TR 33]; CNES; ERC starting grant CALENDS; Science and Technology Facilities Council [ST/L00075X/1] Funding Source: researchfish; STFC [ST/L00075X/1] Funding Source: UKRI	ESA Member States(European Space Agency); NASA(National Aeronautics & Space Administration (NASA)); UK Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Leverhulme trust(Leverhulme Trust); Royal Society(Royal Society of London); ERC advanced grant LIDA; CNRS(Centre National de la Recherche Scientifique (CNRS)); Marie Curie International Incoming Fellowship within the 7th European Community Framework Programme(European Commission); NSFC of China(National Natural Science Foundation of China (NSFC)); Deutsche Forschungsgemeinschaft through the Transregional Collaborative Research Centre(German Research Foundation (DFG)); CNES(Centre National D'etudes Spatiales); ERC starting grant CALENDS; Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	Work reported here is based on observations obtained with XMM-Newton, an ESA science mission with instruments and contributions directly funded by ESA Member States and NASA. D.E. thanks F. Vazza, S. Paltani and S. Molendi for discussions. We thank H. Ebeling, M. Limousin, B. Clement, H. Atek, D. Harvey, E. Egami, M. Rexroth and P. Natarajan for help with writing the XMM-Newton proposal. M.J., H. I. and R.M. acknowledge support from the UK Science and Technology Facilities Council (grant numbers ST/L00075X/1, ST/H005234/1), the Leverhulme trust (grant number PLP-2011-003) and the Royal Society. J.-P.K. acknowledges support from the ERC advanced grant LIDA and from CNRS. H.Y.S. acknowledges support by a Marie Curie International Incoming Fellowship within the 7th European Community Framework Programme, and NSFC of China under grant 11103011. T.E. was supported by the Deutsche Forschungsgemeinschaft through the Transregional Collaborative Research Centre TR 33 'The Dark Universe'. E.J. was supported by CNES. J.R. acknowledges support from the ERC starting grant CALENDS.	Bertin E, 1996, ASTRON ASTROPHYS SUP, V117, P393, DOI 10.1051/aas:1996164; Bond JR, 1996, NATURE, V380, P603, DOI 10.1038/380603a0; Boschin W, 2006, ASTRON ASTROPHYS, V449, P461, DOI 10.1051/0004-6361:20054408; Braglia F, 2007, ASTRON ASTROPHYS, V470, P425, DOI 10.1051/0004-6361:20077257; Branchini E, 2009, ASTROPHYS J, V697, P328, DOI 10.1088/0004-637X/697/1/328; Buote DA, 2009, ASTROPHYS J, V695, P1351, DOI 10.1088/0004-637X/695/2/1351; Casertano S, 2000, ASTRON J, V120, P2747, DOI 10.1086/316851; Cen RY, 1999, ASTROPHYS J, V514, P1, DOI 10.1086/306949; Dave R, 2001, ASTROPHYS J, V552, P473, DOI 10.1086/320548; De Luca A, 2004, ASTRON ASTROPHYS, V419, P837, DOI 10.1051/0004-6361:20034421; Dietrich JP, 2007, ASTRON ASTROPHYS, V470, P821, DOI 10.1051/0004-6361:20077281; Dolag K, 2006, MON NOT R ASTRON SOC, V370, P656, DOI 10.1111/j.1365-2966.2006.10511.x; Eckert D, 2014, ASTRON ASTROPHYS, V570, DOI 10.1051/0004-6361/201424259; Eckert D, 2011, ASTRON ASTROPHYS, V526, DOI 10.1051/0004-6361/201015856; Erben T, 2005, ASTRON NACHR, V326, P432, DOI 10.1002/asna.200510396; Erben T, 2013, MON NOT R ASTRON SOC, V433, P2545, DOI 10.1093/mnras/stt928; Fang T, 2007, ASTROPHYS J, V670, P992, DOI 10.1086/522560; Fukugita M, 1998, ASTROPHYS J, V503, P518, DOI 10.1086/306025; Gheller C, 2015, MON NOT R ASTRON SOC, V453, P1164, DOI 10.1093/mnras/stv1646; Hoekstra H, 2000, ASTROPHYS J, V532, P88, DOI 10.1086/308556; Ibaraki Y, 2014, ASTRON ASTROPHYS, V562, DOI 10.1051/0004-6361/201322806; Israel H, 2010, ASTRON ASTROPHYS, V520, DOI 10.1051/0004-6361/200913667; Jauzac M, 2015, MON NOT R ASTRON SOC, V452, P1437, DOI 10.1093/mnras/stv1402; Jauzac M, 2015, MON NOT R ASTRON SOC, V446, P4132, DOI 10.1093/mnras/stu2425; Jauzac M, 2012, MON NOT R ASTRON SOC, V426, P3369, DOI 10.1111/j.1365-2966.2012.21966.x; Jullo E, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/12/447; Jullo E, 2014, MON NOT R ASTRON SOC, V437, P3969, DOI 10.1093/mnras/stt2207; Kalberla PMW, 2005, ASTRON ASTROPHYS, V440, P775, DOI 10.1051/0004-6361:20041864; Kempner JC, 2004, MON NOT R ASTRON SOC, V349, P385, DOI 10.1111/j.1365-2966.2004.07534.x; Kull A, 1999, ASTRON ASTROPHYS, V341, P23; Leauthaud A, 2007, ASTROPHYS J SUPPL S, V172, P219, DOI 10.1086/516598; Leccardi A, 2008, ASTRON ASTROPHYS, V487, P461, DOI 10.1051/0004-6361:200810113; Luppino GA, 1997, ASTROPHYS J, V475, P20, DOI 10.1086/303508; McCammon D, 2002, ASTROPHYS J, V576, P188, DOI 10.1086/341727; Merten J, 2011, MON NOT R ASTRON SOC, V417, P333, DOI 10.1111/j.1365-2966.2011.19266.x; Moretti A, 2003, ASTROPHYS J, V588, P696, DOI 10.1086/374335; Nicastro F, 2013, ASTROPHYS J, V769, DOI 10.1088/0004-637X/769/2/90; Owers MS, 2011, ASTROPHYS J, V728, DOI 10.1088/0004-637X/728/1/27; Planck Collaboration XIII, 2015, PREPRINT; Rhodes J, 2000, ASTROPHYS J, V536, P79, DOI 10.1086/308902; Scharf C, 2000, ASTROPHYS J, V528, pL73, DOI 10.1086/312435; Schirmer M, 2013, ASTROPHYS J SUPPL S, V209, DOI 10.1088/0067-0049/209/2/21; Shan HY, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/1/56; Shull JM, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/1/23; Smith RK, 2001, ASTROPHYS J, V556, pL91, DOI 10.1086/322992; Snowden SL, 2008, ASTRON ASTROPHYS, V478, P615, DOI 10.1051/0004-6361:20077930; Springel V, 2006, NATURE, V440, P1137, DOI 10.1038/nature04805; Takei Y, 2007, ASTROPHYS J, V655, P831, DOI 10.1086/510278; Werner N, 2008, ASTRON ASTROPHYS, V482, pL29, DOI 10.1051/0004-6361:200809599; Zappacosta L, 2010, ASTROPHYS J, V717, P74, DOI 10.1088/0004-637X/717/1/74; Zappacosta L, 2002, ASTRON ASTROPHYS, V394, P7, DOI 10.1051/0004-6361:20021104	54	110	110	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					105	+		10.1038/nature16058	http://dx.doi.org/10.1038/nature16058			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX3NO	26632589	Green Accepted, Green Submitted			2022-12-28	WOS:000365606000056
J	Wardle, J; von Wagner, C; Kralj-Hans, I; Halloran, SP; Smith, SG; McGregor, LM; Vart, G; Howe, R; Snowball, J; Handley, G; Logan, RF; Rainbow, S; Smith, S; Thomas, MC; Counsell, N; Morris, S; Duffy, SW; Hackshaw, A; Moss, S; Atkin, W; Raine, R				Wardle, Jane; von Wagner, Christian; Kralj-Hans, Ines; Halloran, Stephen P.; Smith, Samuel G.; McGregor, Lesley M.; Vart, Gemma; Howe, Rosemary; Snowball, Julia; Handley, Graham; Logan, Richard F.; Rainbow, Sandra; Smith, Steve; Thomas, Mary C.; Counsell, Nicholas; Morris, Steve; Duffy, Stephen W.; Hackshaw, Allan; Moss, Sue; Atkin, Wendy; Raine, Rosalind			Effects of evidence-based strategies to reduce the socioeconomic gradient of uptake in the English NHS Bowel Cancer Screening Programme (ASCEND): four cluster-randomised controlled trials	LANCET			English	Article							PRIMARY-CARE PRACTITIONER; COLORECTAL-CANCER; INFORMATION LEAFLET; PARTICIPATION; ENGLAND; DEPRIVATION; ENDORSEMENT; INTENTION; FRAMEWORK; BELIEFS	Background Uptake in the national colorectal cancer screening programme in England varies by socioeconomic status. We assessed four interventions aimed at reducing this gradient, with the intention of improving the health benefits of screening. Methods All people eligible for screening (men and women aged 60-74 years) across England were included in four cluster-randomised trials. Randomisation was based on day of invitation. Each trial compared the standard information with the standard information plus the following supplementary interventions: trial 1 (November, 2012), a supplementary leaflet summarising the gist of the key information; trial 2 (March, 2012), a supplementary narrative leaflet describing people's stories; trial 3 (June, 2013), general practice endorsement of the programme on the invitation letter; and trial 4 (July-August, 2013) an enhanced reminder letter with a banner that reiterated the screening off er. Socioeconomic status was defined by the Index of Multiple Deprivation score for each home address. The primary outcome was the socioeconomic status gradient in uptake across deprivation quintiles. This study is registered, number ISRCTN74121020. Findings As all four trials were embedded in the screening programme, loss to follow-up was minimal (less than 0.5%). Trials 1 (n=163 525) and 2 (n=150 417) showed no effects on the socioeconomic gradient of uptake or overall uptake. Trial 3 (n=265 434) showed no effect on the socioeconomic gradient but was associated with increased overall uptake (adjusted odds ratio [ OR] 1.07, 95% CI 1.04-1.10, p<0.0001). In trial 4 (n=168 480) a significant interaction was seen with socioeconomic status gradient (p=0.005), with a stronger effect in the most deprived quintile (adjusted OR 1.11, 95% CI 1.04-1.20, p=0.003) than in the least deprived (1.00, 0.94-1.06, p=0.98). Overall uptake was also increased (1.07, 1.03-1.11, p=0.001). Interpretation Of four evidence-based interventions, the enhanced reminder letter reduced the socioeconomic gradient in screening uptake, but further reducing inequalities in screening uptake through written materials alone will be challenging. Copyright (C) Wardle et al. Open Access article distributed under the terms of CC BY.	[Wardle, Jane; von Wagner, Christian; Smith, Samuel G.; McGregor, Lesley M.; Vart, Gemma] UCL, Dept Epidemiol & Publ Hlth, Canc Res Ctr UK, London WC1E 6BT, England; [Thomas, Mary C.; Morris, Steve; Raine, Rosalind] UCL, Dept Appl Hlth Res, Canc Res Ctr UK, London WC1E 6BT, England; [Counsell, Nicholas; Hackshaw, Allan] UCL, Canc Trials Ctr, London WC1E 6BT, England; [Kralj-Hans, Ines] Kings Coll London, Inst Psychiat Psychol & Neurosci, Kings Clin Trials Unit, Dept Biostat, London WC2R 2LS, England; [Halloran, Stephen P.; Snowball, Julia] Royal Surrey Cty Hosp NHS Fdn Trust, NHS Bowel Canc Screening Programme Southern Hub, Guildford, Surrey, England; [Halloran, Stephen P.] Royal Surrey Cty Hosp NHS Fdn Trust, Guildford, Surrey, England; [Halloran, Stephen P.] Univ Surrey, Guildford GU2 5XH, Surrey, England; [Smith, Samuel G.; Duffy, Stephen W.; Moss, Sue] Queen Mary Univ London, Wolfson Inst Prevent Med, London, England; [Howe, Rosemary; Atkin, Wendy] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England; [Handley, Graham] Trust Queen Elizabeth Hosp, Gateshead Hlth NHS Fdn Trust, Bowel Canc Screening Programme, North East Hub, Gateshead, England; [Logan, Richard F.] Univ Nottingham Hosp, NHS Bowel Canc Screening Programme, Eastern Hub, Nottingham NG7 2UH, England; [Rainbow, Sandra] Northwick Pk & St Marks Hosp, London Hub, NHS Bowel Canc Screening Hub, Harrow, Middx, England; [Smith, Steve] Hosp St Cross, Univ Hosp Coventry & Warwickshire NHS Trust, NHS Bowel Canc Screening Programme, Midlands & North West Hub, Rugby, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; King's College London; Royal Surrey County Hospital; Royal Surrey County Hospital; University of Surrey; University of London; Queen Mary University London; Imperial College London; University of Nottingham; Imperial College London	von Wagner, C (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Gower St, London WC1E 6BT, England.	c.wagner@ucl.ac.uk		Snowball, Julia/0000-0002-8454-9046; Kralj-Hans, Ines/0000-0001-7401-6281; McGregor, Lesley M./0000-0002-7093-1391; Counsell, Nicholas/0000-0002-0688-9192; Howe, Rosemary/0000-0001-9283-0666; Smith, Samuel/0000-0003-1983-4470; Morris, Stephen/0000-0002-5828-3563; Raine, Rosalind/0000-0003-0904-749X; Von Wagner, Christian/0000-0002-7971-0691	National Institute for Health Research (NIHR) [RP-PG-0609-10106]; NIHR Collaboration for Leadership in Applied Health Research and Care (CLAHRC) North Thames; NIHR; Cancer Research UK [14134, 16894, 17965] Funding Source: researchfish; National Institute for Health Research [RP-PG-0609-10106] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR Collaboration for Leadership in Applied Health Research and Care (CLAHRC) North Thames; NIHR(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	We dedicate this Article in memory of Professor Jane Wardle (1950-2015). This study is funded by the National Institute for Health Research (NIHR) Programme Grants for Applied Research Programme (RP-PG-0609-10106) and partly supported by the NIHR Collaboration for Leadership in Applied Health Research and Care (CLAHRC) North Thames (MCT and RR). We thank the managers of the screening hubs and staff at Real Digital International, Croydon, UK, for their oversight and management of the interventions. We thank Paul Greliak and Cecily Palmer for their contributions to the trial and project management, respectively, and Helen Seaman for her comments on earlier drafts of this paper. We thank the Health and Social Care Information Centre for guidance on formatting of the general practice endorsement and enhanced reminder letters. We also thank our community partners (Age UK, Community Health and Learning Foundation, Beating Bowel Cancer, Social Action for Health) and our patients' representatives for their help with developing and pretesting the intervention materials. This is a summary of independent research funded by the NIHR. The views expressed are those of the authors and not necessarily those of the National Health Service, NIHR, or UK Department of Health.	Ahmed NU, 2010, CANCER EPIDEM BIOMAR, V19, P1790, DOI 10.1158/1055-9965.EPI-10-0141; Bang JY, 2012, J PUBLIC HEALTH-UK, V34, P532, DOI 10.1093/pubmed/fds019; Camilloni L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-464; Campbell MJ, 2007, STAT MED, V26, P2, DOI 10.1002/sim.2731; Cancer Research UK, 2014, BOW CANC MORT STAT; Cole SR, 2007, J MED SCREEN, V14, P73, DOI 10.1258/096914107781261927; Cole SR, 2002, J MED SCREEN, V9, P147, DOI 10.1136/jms.9.4.147; Department for Business Innovation & Skills, 2012, 2011 SKILLS LIF SURV; Department for Communities and Local Government, 2010, IND DEPR 2010; Digby J, 2013, J MED SCREEN, V20, P80, DOI 10.1177/0969141313497197; Ferlay J, 2013, IARC CANCERBASE; General Medical Council, 2008, CONS PAT DOCT MAK DE; Huber PJ, 1967, BERK S MATH STAT PRO, V1, P221; Kobayashi LC, 2014, PREV MED, V61, P100, DOI 10.1016/j.ypmed.2013.11.012; Kreuter MW, 2007, ANN BEHAV MED, V33, P221, DOI 10.1007/BF02879904; Logan RFA, 2012, GUT, V61, P1439, DOI 10.1136/gutjnl-2011-300843; Lyratzopoulos G, 2015, CANCER EPIDEM BIOMAR, V24, P720, DOI 10.1158/1055-9965.EPI-14-0969; Maheswaran R, 2006, J EPIDEMIOL COMMUN H, V60, P208, DOI 10.1136/jech.200X.038398; McGregor LM, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1167-3; Moss S, 2015, GUT, V64, pA1, DOI 10.1136/gutjnl-2015-309861.2; Palmer CK, 2014, BRIT J CANCER, V110, P1705, DOI 10.1038/bjc.2014.125; Puffer S, 2003, BMJ-BRIT MED J, V327, P785, DOI 10.1136/bmj.327.7418.785; REYNA VF, 1995, LEARN INDIVID DIFFER, V7, P1, DOI 10.1016/1041-6080(95)90031-4; Smith SG, 2015, HEALTH EXPECT, V18, P703, DOI 10.1111/hex.12117; Smith SG, 2015, J BEHAV MED, V38, P261, DOI 10.1007/s10865-014-9596-z; Smith SG, 2013, PATIENT EDUC COUNS, V93, P619, DOI 10.1016/j.pec.2013.08.013; von Wagner C, 2011, EPIDEMIOL REV, V33, P135, DOI 10.1093/epirev/mxq018; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Whyte S, 2012, COLORECTAL DIS, V14, pe547, DOI 10.1111/j.1463-1318.2012.03014.x; Wolf MS, 2011, ARCH INTERN MED, V171, P300, DOI 10.1001/archinternmed.2011.39; Zajac IT, 2010, J MED SCREEN, V17, P19, DOI 10.1258/jms.2010.009101	31	95	95	0	19	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 20	2016	387	10020					751	759		10.1016/S0140-6736(15)01154-X	http://dx.doi.org/10.1016/S0140-6736(15)01154-X			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DE1WU	26680217	Green Published, hybrid			2022-12-28	WOS:000370418000034
J	Heeney, MM; Hoppe, CC; Abboud, MR; Inusa, B; Kanter, J; Ogutu, B; Brown, PB; Heath, LE; Jakubowski, JA; Zhou, C; Zamoryakhin, D; Agbenyega, T; Colombatti, R; Hassab, HM; Nduba, VN; Oyieko, JN; Robitaille, N; Segbefia, CI; Rees, DC				Heeney, Matthew M.; Hoppe, Carolyn C.; Abboud, Miguel R.; Inusa, Baba; Kanter, Julie; Ogutu, Bernhards; Brown, Patricia B.; Heath, Lori E.; Jakubowski, Joseph A.; Zhou, Chunmei; Zamoryakhin, Dmitry; Agbenyega, Tsiri; Colombatti, Raffaella; Hassab, Hoda M.; Nduba, Videlis N.; Oyieko, Janet N.; Robitaille, Nancy; Segbefia, Catherine I.; Rees, David C.		DOVE Investigators	A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLATELET ACTIVATION; ANTIPLATELET AGENT; CLINICAL-TRIALS; YOUNG-CHILDREN; RISK-FACTORS; DISEASE; PAIN; ANEMIA; MULTICENTER; CLOPIDOGREL	BACKGROUND Sickle cell anemia is an inherited blood disorder that is characterized by painful vaso-occlusive crises, for which there are few treatment options. Platelets mediate intercellular adhesion and thrombosis during vaso-occlusion in sickle cell anemia, which suggests a role for antiplatelet agents in modifying disease events. METHODS Children and adolescents 2 through 17 years of age with sickle cell anemia were randomly assigned to receive oral prasugrel or placebo for 9 to 24 months. The primary end point was the rate of vaso-occlusive crisis, a composite of painful crisis or acute chest syndrome. The secondary end points were the rate of sickle cell-related pain and the intensity of pain, which were assessed daily with the use of pain diaries. RESULTS A total of 341 patients underwent randomization at 51 sites in 13 countries across the Americas, Europe, Asia, and Africa. The rate of vaso-occlusive crisis events per person-year was 2.30 in the prasugrel group and 2.77 in the placebo group (rate ratio, 0.83; 95% confidence interval, 0.66 to 1.05; P = 0.12). There were no significant differences between the groups in the secondary end points of diary-reported events. The safety end points, including the frequency of bleeding events requiring medical intervention, of hemorrhagic and nonhemorrhagic adverse events that occurred while patients were taking prasugrel or placebo, and of discontinuations due to prasugrel or placebo, did not differ significantly between the groups. CONCLUSIONS Among children and adolescents with sickle cell anemia, the rate of vaso-occlusive crisis was not significantly lower among those who received prasugrel than among those who received placebo. There were no significant between-group differences in the safety findings. (Funded by Daiichi Sankyo and Eli Lilly; ClinicalTrials.gov number, NCT01794000.)	[Heeney, Matthew M.] Dana Farber Boston Childrens Canc & Blood Disorde, Boston, MA USA; [Hoppe, Carolyn C.] UCSF Benioff Childrens Hosp Oakland, Oakland, CA USA; [Abboud, Miguel R.] Amer Univ Beirut, Dept Pediat & Adolescent Med, Beirut, Lebanon; [Inusa, Baba] Evelina Childrens Hosp, London, England; [Inusa, Baba] Guys & St Thomas Hosp, London, England; [Zamoryakhin, Dmitry] Daiichi Sankyo Dev, London, England; [Rees, David C.] Kings Coll Hosp London, Denmark Hill, London SE5 8RX, England; [Kanter, Julie] Med Univ S Carolina, Dept Pediat, Div Pediat Hematol Oncol, Charleston, SC USA; [Ogutu, Bernhards] Kenya Govt Med Res Ctr, US Army Med Res Unit Kenya, Malaria Resistance, Kisumu, Kenya; [Oyieko, Janet N.] Kenya Govt Med Res Ctr, Walter Reed Project, Kisumu, Kenya; [Nduba, Videlis N.] Kenya Govt Med Res Ctr, Ctr Global Hlth Res & Publ Hlth Collaborat, Kisumu, Kenya; [Brown, Patricia B.; Heath, Lori E.; Jakubowski, Joseph A.; Zhou, Chunmei] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Agbenyega, Tsiri] Kwame Nkrumah Univ Sci & Technol, Kumasi, Ghana; [Segbefia, Catherine I.] Korle Bu Teaching Hosp, Sch Med & Dent, Dept Child Hlth, Accra, Ghana; [Colombatti, Raffaella] Azienda Ospedaliera Univ Padua, Clin Pediat Hematol Oncol, Padua, Italy; [Hassab, Hoda M.] Univ Alexandria, Clin Res Ctr, Alexandria, Egypt; [Robitaille, Nancy] Ctr Hosp Univ St Justine, Div Hematol Oncol, Dept Pediat, Montreal, PQ, Canada	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; American University of Beirut; Guy's & St Thomas' NHS Foundation Trust; Daiichi Sankyo Company Limited; King's College Hospital NHS Foundation Trust; King's College Hospital; Medical University of South Carolina; Kenya Medical Research Institute; Kenya Medical Research Institute; Kenya Medical Research Institute; Eli Lilly; Kwame Nkrumah University Science & Technology; University of Padua; Azienda Ospedaliera - Universita di Padova; Egyptian Knowledge Bank (EKB); Alexandria University; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Heeney, MM (corresponding author), 300 Longwood Ave,Mail Stop BCH3054, Boston, MA 02115 USA.	matthew.heeney@childrens.harvard.edu	Cesaro, Simone/I-3272-2019; Hassan, Tamer Hasan/V-4331-2017; Robitaille, Nancy/AAA-8418-2022; Colombatti, Raffaella/D-2910-2017; Estepp, Jeremie H/N-8109-2018; TANTAWY, AZZA/AHD-6330-2022; kindi, Salam Al/Q-5172-2019; Rees, David/B-6789-2011; Darwish, Ahmad/O-7500-2018; Inusa, Baba/R-7447-2017	Cesaro, Simone/0000-0002-8698-9547; Hassan, Tamer Hasan/0000-0003-0538-0439; Colombatti, Raffaella/0000-0001-9797-0457; Estepp, Jeremie H/0000-0002-2257-0421; TANTAWY, AZZA/0000-0003-1834-7427; mansour, ahmed/0000-0001-6959-1003; Zamoryakhin, Dmitry/0000-0001-8632-5890; Dampier, Carlton/0000-0002-7738-2620; Rees, David/0000-0003-3647-1050; Darwish, Ahmad/0000-0002-1835-1867; Inusa, Baba/0000-0003-2643-765X	Daiichi Sankyo; Eli Lilly	Daiichi Sankyo(Daiichi Sankyo Company Limited); Eli Lilly(Eli Lilly)	Funded by Daiichi Sankyo and Eli Lilly; ClinicalTrials.gov number, NCT01794000.	Archer N, 2015, AM J HEMATOL, V90, P934, DOI 10.1002/ajh.24116; Ataga Kenneth I, 2007, Hematology Am Soc Hematol Educ Program, P91; Ballas SK, 2012, BLOOD, V120, P3647, DOI 10.1182/blood-2012-04-383430; Berde CB, 2012, PEDIATRICS, V129, P354, DOI 10.1542/peds.2010-3591; BEURLINGHARBURY C, 1989, AM J HEMATOL, V31, P237, DOI 10.1002/ajh.2830310404; Cabannes R, 1984, Agents Actions Suppl, V15, P199; Frenette PS, 2007, J CLIN INVEST, V117, P850, DOI 10.1172/JCI30920; Fuggle P, 1996, ARCH DIS CHILD, V75, P199, DOI 10.1136/adc.75.3.199; Gil KM, 2000, CHILD HEALTH CARE, V29, P225, DOI 10.1207/S15326888CHC2904_1; Hicks CL, 2001, PAIN, V93, P173, DOI 10.1016/S0304-3959(01)00314-1; Hoppe CC, 2015, PEDIAT BLOOD CANC; Jacob E, 2005, J PAIN SYMPTOM MANAG, V29, P392, DOI 10.1016/j.jpainsymman.2004.07.006; Jakubowski JA, 2007, CARDIOVASC DRUG REV, V25, P357, DOI 10.1111/j.1527-3466.2007.00027.x; Jakubowski JA, 2013, BRIT J CLIN PHARMACO, V75, P1433, DOI 10.1111/bcp.12042; Lee SP, 2006, ARTERIOSCL THROM VAS, V26, P1626, DOI 10.1161/01.ATV.0000220374.00602.a2; Li JS, 2008, CIRCULATION, V117, P553, DOI 10.1161/CIRCULATIONAHA.107.715821; Maikler V E, 2001, J Soc Pediatr Nurs, V6, P161, DOI 10.1111/j.1744-6155.2001.tb00240.x; McGrath PJ, 2008, J PAIN, V9, P771, DOI 10.1016/j.jpain.2008.04.007; Niitsu Y, 2005, SEMIN THROMB HEMOST, V31, P184, DOI 10.1055/s-2005-869524; OSAMO NO, 1981, ACTA HAEMATOL-BASEL, V66, P102, DOI 10.1159/000207105; PLATT OS, 1991, NEW ENGL J MED, V325, P11, DOI 10.1056/NEJM199107043250103; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Smith WR, 2008, ANN INTERN MED, V148, P94, DOI 10.7326/0003-4819-148-2-200801150-00004; Styles L, 2015, J PEDIAT HEMATOL ONC, V37, P1, DOI 10.1097/MPH.0000000000000291; Tantry US, 2013, J AM COLL CARDIOL, V62, P2261, DOI 10.1016/j.jacc.2013.07.101; Tomer A, 2004, J BIOL REG HOMEOS AG, V18, P172; Vichinsky EP, 2014, EMERGING THERAPIES T, P181; Wang WC, 2011, LANCET, V377, P1663, DOI 10.1016/S0140-6736(11)60355-3; Wessel DL, 2013, NEW ENGL J MED, V368, P2377, DOI 10.1056/NEJMoa1114588; Wun T, 1997, J LAB CLIN MED, V129, P507, DOI 10.1016/S0022-2143(97)90005-6; Wun T, 1998, BRIT J HAEMATOL, V100, P741, DOI 10.1046/j.1365-2141.1998.00627.x; Wun T, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-17; Yawn BP, 2014, JAMA-J AM MED ASSOC, V312, P1033, DOI 10.1001/jama.2014.10517	34	90	93	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 18	2016	374	7					625	635		10.1056/NEJMoa1512021	http://dx.doi.org/10.1056/NEJMoa1512021			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD9ER	26644172	Bronze, Green Published			2022-12-28	WOS:000370229000008
J	Kovachy, T; Asenbaum, P; Overstreet, C; Donnelly, CA; Dickerson, SM; Sugarbaker, A; Hogan, JM; Kasevich, MA				Kovachy, T.; Asenbaum, P.; Overstreet, C.; Donnelly, C. A.; Dickerson, S. M.; Sugarbaker, A.; Hogan, J. M.; Kasevich, M. A.			Quantum superposition at the half-metre scale	NATURE			English	Article							CHOICE GEDANKEN EXPERIMENT; ATOMIC INTERFEROMETRY; LIGHT; TIME	The quantum superposition principle allows massive particles to be delocalized over distant positions. Though quantum mechanics has proved adept at describing the microscopic world, quantum superposition runs counter to intuitive conceptions of reality and locality when extended to the macroscopic scale(1), as exemplified by the thought experiment of Schrodinger's cat(2). Matter-wave interferometers(3), which split and recombine wave packets in order to observe interference, provide a way to probe the superposition principle on macroscopic scales(4) and explore the transition to classical physics(5). In such experiments, large wave-packet separation is impeded by the need for long interaction times and large momentum beam splitters, which cause susceptibility to dephasing and decoherence(1). Here we use light-pulse atom interferometry(6,7) to realize quantum interference with wave packets separated by up to 54 centimetres on a timescale of 1 second. These results push quantum superposition into a new macroscopic regime, demonstrating that quantum superposition remains possible at the distances and timescales of everyday life. The sub-nanokelvin temperatures of the atoms and a compensation of transverse optical forces enable a large separation while maintaining an interference contrast of 28 per cent. In addition to testing the superposition principle in a new regime, large quantum superposition states are vital to exploring gravity with atom interferometers in greater detail. We anticipate that these states could be used to increase sensitivity in tests of the equivalence principle(8-12), measure the gravitational Aharonov-Bohm effect(13), and eventually detect gravitational waves(14) and phase shifts associated with general relativity(12).	[Kovachy, T.; Asenbaum, P.; Overstreet, C.; Donnelly, C. A.; Dickerson, S. M.; Sugarbaker, A.; Hogan, J. M.; Kasevich, M. A.] Stanford Univ, Dept Phys, Stanford, CA 94305 USA	Stanford University	Kasevich, MA (corresponding author), Stanford Univ, Dept Phys, Stanford, CA 94305 USA.	kasevich@stanford.edu		Overstreet, Chris/0000-0002-1430-9581; Asenbaum, Peter/0000-0002-3126-2164; Hogan, Jason/0000-0003-1218-2692	Fannie and John Hertz Foundation; NSF GRFP; Stanford Graduate Fellowship; NASA GSFC [NNX11AM31A]	Fannie and John Hertz Foundation; NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); Stanford Graduate Fellowship(Stanford University); NASA GSFC(National Aeronautics & Space Administration (NASA))	We thank S.-w. Chiow for discussions and contributions to the apparatus. T.K. acknowledges support from the Fannie and John Hertz Foundation, T.K. and C.A.D. from the NSF GRFP, and T.K. and C.O. from the Stanford Graduate Fellowship. This work was supported in part by NASA GSFC grant no. NNX11AM31A.	Arndt M, 2014, NAT PHYS, V10, P271, DOI [10.1038/nphys2863, 10.1038/NPHYS2863]; ASPECT A, 1982, PHYS REV LETT, V49, P1804, DOI 10.1103/PhysRevLett.49.1804; Bassi A, 2013, REV MOD PHYS, V85, P471, DOI 10.1103/RevModPhys.85.471; Bonnin A, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.043615; BORDE CJ, 1989, PHYS LETT A, V140, P10, DOI 10.1016/0375-9601(89)90537-9; BORDE CJ, 1981, J PHYS-PARIS, V42, P15, DOI 10.1051/jphyscol:1981802; Brezger B, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.100404; Chiow SW, 2012, OPT LETT, V37, P3861, DOI 10.1364/OL.37.003861; Chiow SW, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.130403; Chung KY, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.016002; Cronin AD, 2009, REV MOD PHYS, V81, P1051, DOI 10.1103/RevModPhys.81.1051; Dickerson SM, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.083001; Dimopoulos S, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.042003; Dimopoulos S, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.122002; Eibenberger S, 2013, PHYS CHEM CHEM PHYS, V15, P14696, DOI 10.1039/c3cp51500a; Foster GT, 2002, OPT LETT, V27, P951, DOI 10.1364/OL.27.000951; Geiger R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1479; Giustina M, 2013, NATURE, V497, P227, DOI 10.1038/nature12012; Greene W.H., 2012, ECONOMETRIC ANAL; Gupta S, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.140401; Hohensee MA, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.230404; Jacques V, 2007, SCIENCE, V315, P966, DOI 10.1126/science.1136303; Julsgaard B, 2001, NATURE, V413, P400, DOI 10.1038/35096524; KASEVICH M, 1992, APPL PHYS B-PHOTO, V54, P321, DOI 10.1007/BF00325375; KASEVICH M, 1991, PHYS REV LETT, V67, P181, DOI 10.1103/PhysRevLett.67.181; Kovachy T, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.143004; Kuhn CCN, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/7/073035; Lan SY, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.090402; Ma XS, 2012, NATURE, V489, P269, DOI 10.1038/nature11472; Manning AG, 2015, NAT PHYS, V11, P539, DOI 10.1038/NPHYS3343; McGuirk JM, 2000, PHYS REV LETT, V85, P4498, DOI 10.1103/PhysRevLett.85.4498; Muller H, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.180405; Muntinga H, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.093602; Nimmrichter S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.160403; Parazzoli LP, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.230401; Peters A, 2001, METROLOGIA, V38, P25, DOI 10.1088/0026-1394/38/1/4; Rosi G, 2014, NATURE, V510, P518, DOI 10.1038/nature13433; Schlippert D, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.203002; Schrodinger E, 1935, NATURWISSENSCHAFTEN, V23, P807, DOI 10.1007/BF01491891; Sugarbaker A, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.113002; Szigeti SS, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/2/023009; Zawisky M, 2002, NUCL INSTRUM METH A, V481, P406, DOI 10.1016/S0168-9002(01)01253-0; Zych M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1498	44	209	211	8	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2015	528	7583					530	+		10.1038/nature16155	http://dx.doi.org/10.1038/nature16155			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ3GH	26701053				2022-12-28	WOS:000366991900047
J	Gutjahr, C; Gobbato, E; Choi, J; Riemann, M; Johnston, MG; Summers, W; Carbonnel, S; Mansfield, C; Yang, SY; Nadal, M; Acosta, I; Takano, M; Jiao, WB; Schneeberger, K; Kelly, KA; Paszkowski, U				Gutjahr, Caroline; Gobbato, Enrico; Choi, Jeongmin; Riemann, Michael; Johnston, Matthew G.; Summers, William; Carbonnel, Samy; Mansfield, Catherine; Yang, Shu-Yi; Nadal, Marina; Acosta, Ivan; Takano, Makoto; Jiao, Wen-Biao; Schneeberger, Korbinian; Kelly, Krystyna A.; Paszkowski, Uta			Rice perception of symbiotic arbuscular mycorrhizal fungi requires the karrikin receptor complex	SCIENCE			English	Article							CA2+ SPIKING; STRIGOLACTONES; RESPONSES; PROTEIN; IDENTIFICATION; GERMINATION; IMMUNITY; DWARF14; FAMILY; GROWTH	In terrestrial ecosystems, plants take up phosphate predominantly via association with arbuscular mycorrhizal fungi (AMF). We identified loss of responsiveness to AMF in the rice (Oryza sativa) mutant hebiba, reflected by the absence of physical contact and of characteristic transcriptional responses to fungal signals. Among the 26 genes deleted in hebiba, DWARF 14 LIKE is, the one responsible for loss of symbiosis. It encodes an alpha/beta-fold hydrolase, that is a component of an intracellular receptor complex involved in the detection of the smoke compound karrikin. Our finding reveals an unexpected plant recognition strategy for AMF and a previously unknown signaling link between symbiosis and plant development.	[Gutjahr, Caroline; Yang, Shu-Yi; Nadal, Marina; Paszkowski, Uta] Univ Lausanne, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland; [Gutjahr, Caroline; Carbonnel, Samy] Univ Munich, Fac Biol, Genet, Bioctr Martinsried, D-82152 Martinsried, Germany; [Gobbato, Enrico; Choi, Jeongmin; Johnston, Matthew G.; Summers, William; Mansfield, Catherine; Kelly, Krystyna A.; Paszkowski, Uta] Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England; [Riemann, Michael; Takano, Makoto] Natl Inst Agrobiol Sci, Div Plant Sci, Tsukuba, Ibaraki 3058602, Japan; [Riemann, Michael] Karlsruhe Inst Technol, Inst Bot, Mol Cell Biol, D-76131 Karlsruhe, Germany; [Acosta, Ivan; Jiao, Wen-Biao; Schneeberger, Korbinian] Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany	University of Lausanne; University of Munich; University of Cambridge; National Institute of Agrobiological Sciences - Japan; Helmholtz Association; Karlsruhe Institute of Technology; Max Planck Society	Paszkowski, U (corresponding author), Univ Lausanne, Dept Plant Mol Biol, Biophore Bldg, CH-1015 Lausanne, Switzerland.	up220@cam.ac.uk	Schneeberger, Korbinian/U-6329-2019; Acosta, Ivan/Q-2274-2018; CARBONNEL, Samy/AAF-1182-2021; Gutjahr, Caroline/H-8390-2013	Schneeberger, Korbinian/0000-0002-5512-0443; Acosta, Ivan/0000-0001-7080-3384; CARBONNEL, Samy/0000-0003-2564-7161; Gutjahr, Caroline/0000-0001-6163-745X; Jiao, Wen-Biao/0000-0001-8355-2959; Riemann, Michael/0000-0003-0287-2112; Paszkowski, Uta/0000-0002-7279-7632; Johnston, Matthew/0000-0003-1141-6135	German National Academic Foundation (Studienstiftung des Deutschen Volkes); Roche Research Foundation; German Research Council (DFG) [GU1423/1-1]; Isaac Newton Trust [RG74108]; UK Biotechnology and Biological Sciences Research Council [PDAG/223 T39]; Collaborative Research Center "Molecular mechanisms regulating yield and yield stability in plants" of the German Research Council (DFG) [SFB924]; Swiss National Science Foundation [PP00A-110874, PP00P3-130704]; Gatsby Charitable Foundation [RG60824]	German National Academic Foundation (Studienstiftung des Deutschen Volkes); Roche Research Foundation; German Research Council (DFG)(German Research Foundation (DFG)); Isaac Newton Trust; UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Collaborative Research Center "Molecular mechanisms regulating yield and yield stability in plants" of the German Research Council (DFG)(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Gatsby Charitable Foundation	We thank J. Gheyselinck for technical assistance; P. Nick (Karlsruhe Institute of Technology, Germany) for providing hebiba and Nihonmasari wild-type seeds; M. Nakazono (University of Nagoya, Japan) for providing d3 and Shiokari wild-type seeds; J. Kyozuka (Graduate School of Agriculture and Life Sciences, University of Tokyo) for d14 seeds and the D14L RNAi line Ri43; and M. Ni (University of Minnesota, USA) for providing Arabidopsis htl-2 seeds. T. Hardcastle helped by enhancing R/Bioconduct or package baySeq to enable the RNA-seq time course analysis. M. Meyer instructed the carbon-dioxide treatment of R. irregularis. C.G. received Ph.D. fellowships from the German National Academic Foundation (Studienstiftung des Deutschen Volkes), the Roche Research Foundation, and the German Research Council (DFG) (GU1423/1-1). E.G. was supported by the Isaac Newton Trust grant RG74108. J.C. is a European Molecular Biology Organization Long-Term Fellow (ALTF 117-2014), and W.S. is a UK Biotechnology and Biological Sciences Research Council-Doctoral Training Partnership scholar, supported by grant PDAG/223 T39. S.C. was funded by the Collaborative Research Center SFB924 "Molecular mechanisms regulating yield and yield stability in plants" of the German Research Council (DFG). Research in the U.P. laboratories was supported by the Swiss National Science Foundation "professeur boursier" grants PP00A-110874 and PP00P3-130704, and by the Gatsby Charitable Foundation grant RG60824. C.G., E.G., J.C., K.A.K., and U.P. designed the experiments. C.G., E.G., J.C., M.G.J., W.S., S.C., C.M., S.-Y.Y. M.N., and I.A. performed the experiments. K.A.K., W.-B.J., and K.S. performed bioinformatics and statistical analysis of the RNA-seq data. M. R. and M. T. provided access to unpublished mapping information. C.G., E.G., K.A.K., and U.P. wrote the manuscript. The supplementary materials contain additional data. The RNA-seq data have been deposited in ArrayExpress with accession number E-MTAB-4072. The authors declare no conflict of interest.	Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; Arite T, 2009, PLANT CELL PHYSIOL, V50, P1416, DOI 10.1093/pcp/pcp091; Camps C, 2015, NEW PHYTOL, V208, P224, DOI 10.1111/nph.13427; Chabaud M, 2011, NEW PHYTOL, V189, P347, DOI 10.1111/j.1469-8137.2010.03464.x; Chiwocha SDS, 2009, PLANT SCI, V177, P252, DOI 10.1016/j.plantsci.2009.06.007; Delaux PM, 2012, NEW PHYTOL, V195, P857, DOI 10.1111/j.1469-8137.2012.04209.x; Flematti GR, 2004, SCIENCE, V305, P977, DOI 10.1126/science.1099944; Genre A, 2013, NEW PHYTOL, V198, P179, DOI 10.1111/nph.12146; Gough C, 2011, MOL PLANT MICROBE IN, V24, P867, DOI 10.1094/MPMI-01-11-0019; Guo YX, 2013, P NATL ACAD SCI USA, V110, P8284, DOI 10.1073/pnas.1306265110; Gutjahr C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123422; Gutjahr C, 2013, ANNU REV CELL DEV BI, V29, P593, DOI 10.1146/annurev-cellbio-101512-122413; Gutjahr C, 2008, PLANT CELL, V20, P2989, DOI 10.1105/tpc.108.062414; Hamiaux C, 2012, CURR BIOL, V22, P2032, DOI 10.1016/j.cub.2012.08.007; Hu ZY, 2010, PLANT CELL PHYSIOL, V51, P1136, DOI 10.1093/pcp/pcq075; Maillet F, 2011, NATURE, V469, P58, DOI 10.1038/nature09622; Marcel S, 2010, PLANT CELL, V22, P3177, DOI 10.1105/tpc.110.078048; Miyata K, 2014, PLANT CELL PHYSIOL, V55, P1864, DOI 10.1093/pcp/pcu129; Nadal M, 2013, CURR OPIN PLANT BIOL, V16, P473, DOI 10.1016/j.pbi.2013.06.005; Nordstrom KJV, 2013, NAT BIOTECHNOL, V31, P325, DOI 10.1038/nbt.2515; Oldroyd GED, 2013, NAT REV MICROBIOL, V11, P252, DOI 10.1038/nrmicro2990; Riemann M, 2013, PLANT J, V74, P226, DOI 10.1111/tpj.12115; Scaffidi A, 2014, PLANT PHYSIOL, V165, P1221, DOI 10.1104/pp.114.240036; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd; Sun XD, 2011, MOL PLANT, V4, P116, DOI 10.1093/mp/ssq055; Toh S, 2014, CHEM BIOL, V21, P988, DOI 10.1016/j.chembiol.2014.07.005; Waters MT, 2014, PLANT J, V79, P623, DOI 10.1111/tpj.12430; Waters MT, 2012, DEVELOPMENT, V139, P1285, DOI 10.1242/dev.074567; Yoshida S, 2012, NEW PHYTOL, V196, P1208, DOI 10.1111/j.1469-8137.2012.04339.x; Zhang XW, 2015, PLANT J, V81, P258, DOI 10.1111/tpj.12723; Zhao LH, 2015, CELL RES, V25, P1219, DOI 10.1038/cr.2015.122	31	134	134	11	216	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2015	350	6267					1521	1524		10.1126/science.aac9715	http://dx.doi.org/10.1126/science.aac9715			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY7LY	26680197				2022-12-28	WOS:000366591100057
J	McGhee, K; Phillips, N				McGhee, Karen; Phillips, Nicky			Nature Index 2015 China	NATURE			English	Editorial Material																			0	2	2	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2015	528	7582					S165	S165		10.1038/528S165a	http://dx.doi.org/10.1038/528S165a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY8SM	26673021	Bronze			2022-12-28	WOS:000366678600009
J	Otchy, TM; Wolff, SBE; Rhee, JY; Pehlevan, C; Kawai, R; Kempf, A; Gobes, SMH; Olveczky, BP				Otchy, Timothy M.; Wolff, Steffen B. E.; Rhee, Juliana Y.; Pehlevan, Cengiz; Kawai, Risa; Kempf, Alexandre; Gobes, Sharon M. H.; Oelveczky, Bence P.			Acute off-target effects of neural circuit manipulations	NATURE			English	Article							HOMEOSTATIC PLASTICITY; MEMORY CONSOLIDATION; ZEBRA FINCHES; MOTOR CORTEX; IN-VIVO; SONGBIRD; NETWORKS; NUCLEUS; LESIONS; MODEL	Rapid and reversible manipulations of neural activity in behaving animals are transforming our understanding of brain function. An important assumption underlying much of this work is that evoked behavioural changes reflect the function of the manipulated circuits. We show that this assumption is problematic because it disregards indirect effects on the independent functions of downstream circuits. Transient inactivations of motor cortex in rats and nucleus interface (Nif) in songbirds severely degraded task-specific movement patterns and courtship songs, respectively, which are learned skills that recover spontaneously after permanent lesions of the same areas. We resolve this discrepancy in songbirds, showing that Nif silencing acutely affects the function of HVC, a downstream song control nucleus. Paralleling song recovery, the off-target effects resolved within days of Nif lesions, a recovery consistent with homeostatic regulation of neural activity in HVC. These results have implications for interpreting transient circuit manipulations and for understanding recovery after brain lesions.	[Otchy, Timothy M.; Wolff, Steffen B. E.; Rhee, Juliana Y.; Kawai, Risa; Kempf, Alexandre; Gobes, Sharon M. H.; Oelveczky, Bence P.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Otchy, Timothy M.] Harvard Univ, Program Neurosci, Cambridge, MA 02138 USA; [Pehlevan, Cengiz] Simons Fdn, Ctr Computat Biol, New York, NY 10010 USA; [Oelveczky, Bence P.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University	Olveczky, BP (corresponding author), Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA.	olveczky@fas.harvard.edu	Core, Vector/CAF-4832-2022	Pehlevan, Cengiz/0000-0001-9767-6063; Rhee, Juliana/0000-0002-4942-8126; Gobes, Sharon/0000-0001-9598-7116; Olveczky, Bence/0000-0003-2499-2705	McKnight Scholars Award; HSFP fellowship; EMBO fellowship; NRSA fellowship; Rubicon fellowship from the Netherlands Organization for Scientific Research	McKnight Scholars Award; HSFP fellowship; EMBO fellowship(European Molecular Biology Organization (EMBO)); NRSA fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rubicon fellowship from the Netherlands Organization for Scientific Research	We thank E. Soucy and J. Greenwood for technical assistance. We are grateful to M. Meister, J. Sanes, N. Uchida, K. Blum, A. Dhawale, M. Josch, A. Kampff, and E. Feinberg for their feedback on our manuscript. This work was supported by a McKnight Scholars Award to B.P.O., HSFP and EMBO fellowships to S.B.E.W., an NRSA fellowship to R.K., and a Rubicon fellowship from the Netherlands Organization for Scientific Research to S.M.H.G.	Ali F, 2013, NEURON, V80, P494, DOI 10.1016/j.neuron.2013.07.049; Allen TA, 2008, J NEUROSCI METH, V171, P30, DOI 10.1016/j.jneumeth.2008.01.033; Aronov D, 2008, SCIENCE, V320, P630, DOI 10.1126/science.1155140; BENDER DB, 1990, EXP BRAIN RES, V79, P467; Cardin JA, 2005, J NEUROPHYSIOL, V93, P2157, DOI 10.1152/jn.01001.2004; Carrera E, 2014, BRAIN, V137, P2408, DOI 10.1093/brain/awu101; Fee MS, 2010, ILAR J, V51, P362, DOI 10.1093/ilar.51.4.362; FEENEY DM, 1986, STROKE, V17, P817, DOI 10.1161/01.STR.17.5.817; Fiete IR, 2010, NEURON, V65, P563, DOI 10.1016/j.neuron.2010.02.003; Golowasch J, 1999, NEURAL COMPUT, V11, P1079, DOI 10.1162/089976699300016359; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hahnloser RHR, 2007, J NEUROPHYSIOL, V97, P423, DOI 10.1152/jn.00547.2006; Honey CJ, 2008, HUM BRAIN MAPP, V29, P802, DOI 10.1002/hbm.20579; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Immelmann K., 1969, P61; Kawai R, 2015, NEURON, V86, P800, DOI 10.1016/j.neuron.2015.03.024; Keck T, 2013, NEURON, V80, P327, DOI 10.1016/j.neuron.2013.08.018; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Levin HS., 2000, CEREBRAL REORGANIZAT; Lomber SG, 1999, J NEUROSCI METH, V86, P109, DOI 10.1016/S0165-0270(98)00160-5; London M, 2010, NATURE, V466, P123, DOI 10.1038/nature09086; Long MA, 2008, NATURE, V456, P189, DOI 10.1038/nature07448; Long MA, 2010, NATURE, V468, P394, DOI 10.1038/nature09514; Maldonado MA, 2008, NEUROREHAB NEURAL RE, V22, P250, DOI 10.1177/1545968307308551; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; MARTIN JH, 1991, NEUROSCI LETT, V127, P160, DOI 10.1016/0304-3940(91)90784-Q; MCCASLAND JS, 1987, J NEUROSCI, V7, P23; Miyashita T, 2008, NEUROBIOL LEARN MEM, V89, P269, DOI 10.1016/j.nlm.2007.08.012; Naie K, 2011, J NEUROPHYSIOL, V106, P291, DOI 10.1152/jn.01035.2010; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; Olveczky BP, 2005, PLOS BIOL, V3, P902, DOI 10.1371/journal.pbio.0030153; Peters AJ, 2014, NATURE, V510, P263, DOI 10.1038/nature13235; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Poddar R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083171; Ravbar P, 2012, J NEUROSCI, V32, P3422, DOI 10.1523/JNEUROSCI.3740-11.2012; Roberts TF, 2012, NAT NEUROSCI, V15, P1454, DOI 10.1038/nn.3206; Schmidt MF, 2004, ANN NY ACAD SCI, V1016, P171, DOI 10.1196/annals.1298.014; Shobe J, 2002, NEUROBIOL LEARN MEM, V77, P291, DOI 10.1006/nlme.2001.4022; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; SICCOLI MM, 2008, REV EUR J NEUROL, V15, P565, DOI DOI 10.1111/J.1468-1331.2008.02119.X; SIMPSON HB, 1990, J NEUROSCI, V10, P1541; Stoltz S, 1999, BEHAV BRAIN RES, V106, P127, DOI 10.1016/S0166-4328(99)00100-X; Taha SA, 2006, J NEUROSCI, V26, P217, DOI 10.1523/JNEUROSCI.3227-05.2006; Talwar SK, 2001, J NEUROPHYSIOL, V85, P2350, DOI 10.1152/jn.2001.85.6.2350; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Thoby-Brisson M, 2002, J NEUROPHYSIOL, V88, P2942, DOI 10.1152/jn.00482.2001; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Van Peppen RPS, 2004, CLIN REHABIL, V18, P833, DOI 10.1191/0269215504cr843oa; van Vreeswijk C, 1998, NEURAL COMPUT, V10, P1321, DOI 10.1162/089976698300017214; van Welie I, 2004, P NATL ACAD SCI USA, V101, P5123, DOI 10.1073/pnas.0307711101; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; Watt Alanna J, 2010, Front Synaptic Neurosci, V2, P5, DOI 10.3389/fnsyn.2010.00005; Wilke M, 2010, J NEUROSCI, V30, P8650, DOI 10.1523/JNEUROSCI.0953-10.2010; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	58	207	207	2	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2015	528	7582					358	+		10.1038/nature16442	http://dx.doi.org/10.1038/nature16442			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY8SM	26649821				2022-12-28	WOS:000366678600044
J	[Anonymous]				[Anonymous]			A GUIDE TO THE NATURE INDEX	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2015	528	7582					S190	S190		10.1038/528S190a	http://dx.doi.org/10.1038/528S190a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY8SM	26673028	Bronze			2022-12-28	WOS:000366678600016
J	Giesinger, K; Hamilton, DF; Erschbamer, M; Jost, B; Giesinger, JM				Giesinger, Karlmeinrad; Hamilton, David F.; Erschbamer, Matthias; Jost, Bernhard; Giesinger, Johannes M.			CHRISTMAS 2015: PROFESSIONAL CONSIDERATIONS Black medicine: an observational study of doctors' coffee purchasing patterns at work	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CONSUMPTION; RISK; CAFFEINE; DISEASE; TEA	Objective To evaluate doctors' coffee consumption at work and differences between specialties. Design Single centre retrospective cohort study. Setting Large teaching hospital in Switzerland. Participants 766 qualified doctors (425 men, 341 women) from all medical specialties (201 internal medicine, 76 general surgery, 67 anaesthetics, 54 radiology, 48 orthopaedics, 43 gynaecology, 36 neurology, 23 neurosurgery, 96 other specialties). Data source Staff purchasing history from staff canteens' electronic payment system linked to separate anonymised personal data from the human resource database. Main outcome measure Numbers of coffees purchased per person per year. Results 84% (644) of doctors purchased coffee at one of the hospital canteens. 70 772 coffees were consumed by doctors in 2014. There was a significant association between specialty and yearly coffee purchasing (F=12.45; P<0.01). On average orthopaedic surgeons purchased the most coffee per person per year (mean 189, SD 136) followed by radiologists (177, SD 191) and general surgeons (167, SD 138). Anaesthetists purchased the least coffee (39, SD 48). Male doctors bought significantly more coffees per person per year (128 (SD 140) v 86 (SD 86), t=-4.66, P<0.01) and twice as many espressos as female doctors (mean 27 (SD 46) v 10 (SD 19), t=-6.54, P<0.01). Hierarchical position was associated with coffee purchasing (F=4.55; P=0.04). Senior consultants (>5 years' experience) bought most coffees per person per year (140, SD 169) and junior doctors and registrars bought fewest (95, SD 85). Propensity of buying rounds also increased with hierarchical position (chi(2)=556.24; P<0.01), with heads of departments buying more rounds than junior doctors (30% v 15%). Conclusions Doctors commonly use coffee as a stimulant. Substantial variation exists between specialties. Surgeons drink notably more coffee than physicians, with orthopaedic surgeons consuming the greatest amount in the communal cafeteria setting, though this might reflect social tendencies rather than caffeine dependency. Hierarchical position is positively correlated with coffee consumption and generosity with regard to buying rounds of coffee.	[Giesinger, Karlmeinrad; Erschbamer, Matthias; Jost, Bernhard] Kantonsspital, Dept Orthopaed & Traumatol, CH-9007 St Gallen, Switzerland; [Hamilton, David F.] Univ Edinburgh, Dept Orthopaed Surg, Edinburgh EH16 4SA, Midlothian, Scotland; [Giesinger, Johannes M.] Med Univ Innsbruck, Dept Psychiat & Psychotherapy, A-6020 Innsbruck, Austria	Kantonsspital Aarau AG (KSA); Kantonsspital St. Gallen; University of Edinburgh; Medical University of Innsbruck	Giesinger, K (corresponding author), Kantonsspital, Dept Orthopaed & Traumatol, CH-9007 St Gallen, Switzerland.	karlmeinrad.giesinger@kssg.ch	Hamilton, David F/J-7186-2019	Hamilton, David F/0000-0001-9060-9255				CareerBuilder, CAREERBUILDER DUNK D; Cornelis MC, 2007, CURR OPIN LIPIDOL, V18, P13, DOI 10.1097/MOL.0b013e3280127b04; Crippa A, 2014, AM J EPIDEMIOL, V180, P763, DOI 10.1093/aje/kwu194; Demura S., 2013, Food and Nutrition Sciences, V4, P748, DOI 10.4236/fns.2013.47096; Mesas AE, 2011, AM J CLIN NUTR, V94, P1113, DOI 10.3945/ajcn.111.016667; Andersen LF, 2006, AM J CLIN NUTR, V83, P1039, DOI 10.1093/ajcn/83.5.1039; Giovannucci E, 1998, AM J EPIDEMIOL, V147, P1043, DOI 10.1093/oxfordjournals.aje.a009398; Iso H, 2006, ANN INTERN MED, V144, P554, DOI 10.7326/0003-4819-144-8-200604180-00005; Lopez-Garcia E, 2014, CLIN NUTR, V33, P143, DOI 10.1016/j.clnu.2013.04.004; Lucas M, 2014, WORLD J BIOL PSYCHIA, V15, P377, DOI 10.3109/15622975.2013.795243; Palacios N, 2012, MOVEMENT DISORD, V27, P1276, DOI 10.1002/mds.25076; Queensland Government QH, QUEENSL HLTH FAT RIS; Ray J, 1738, TRAVELS LOW COUNTRIE; Rossfeld R, 2002, GENUSS NUCHTERNHEIT; Ruhl CE, 2005, GASTROENTEROLOGY, V129, P1928, DOI 10.1053/j.gastro.2005.08.056; Steffen M, 2012, J HYPERTENS, V30, P2245, DOI 10.1097/HJH.0b013e3283588d73; Tifferet S, 2013, HUM ETHOL B, V28, P5; Weinberg BA, 2002, WORLD CAFFEINE SCI C	18	11	11	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 16	2015	351								h6446	10.1136/bmj.h6446	http://dx.doi.org/10.1136/bmj.h6446			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ4MP	26676463	Green Published, hybrid			2022-12-28	WOS:000367077600007
J	Brune, H				Brune, Harald			In the wake of collision	SCIENCE			English	Editorial Material							MECHANISM; PT(111)		[Brune, Harald] Ecole Polytech Fed Lausanne, Inst Condensed Matter Phys, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Brune, H (corresponding author), Ecole Polytech Fed Lausanne, Inst Condensed Matter Phys, Stn 3, CH-1015 Lausanne, Switzerland.	harald.brune@epf.ch	Brune, Harald/E-7284-2017	Brune, Harald/0000-0003-4459-3111				BRUNE H, 1992, PHYS REV LETT, V68, P624, DOI 10.1103/PhysRevLett.68.624; Brune H., 2001, PHYS COVERED SOLID 1, VIII, P217; Bunermann O, 2015, SCIENCE, V350, P1346, DOI 10.1126/science.aad4972; Golibrzuch K, 2015, ANNU REV PHYS CHEM, V66, P399, DOI 10.1146/annurev-physchem-040214-121958; Golzhauser A, 1996, PHYS REV LETT, V77, P1334, DOI 10.1103/PhysRevLett.77.1334; Janke SM, 2015, J CHEM PHYS, V143, DOI 10.1063/1.4931669; Kisiel M, 2011, NAT MATER, V10, P119, DOI 10.1038/nmat2936; Rittmeyer SP, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.046102; Wintterlin J, 1996, PHYS REV LETT, V77, P123, DOI 10.1103/PhysRevLett.77.123	9	1	1	2	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2015	350	6266					1321	1321		10.1126/science.aad8005	http://dx.doi.org/10.1126/science.aad8005			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1JL	26659044	Green Published			2022-12-28	WOS:000366162400023
J	Okhovat, M; Berrio, A; Wallace, G; Ophir, AG; Phelps, SM				Okhovat, Mariam; Berrio, Alejandro; Wallace, Gerard; Ophir, Alexander G.; Phelps, Steven M.			Sexual fidelity trade-offs promote regulatory variation in the prairie vole brain	SCIENCE			English	Article							MICROTUS-OCHROGASTER; SOCIAL-ORGANIZATION; MATING SYSTEMS; HUMAN GENOME; EVOLUTION; VASOPRESSIN; POPULATION; MECHANISMS; STRATEGIES; SELECTION	Individual variation in social behavior seems ubiquitous, but we know little about how it relates to brain diversity. Among monogamous prairie voles, levels of vasopressin receptor ( encoded by the gene avpr1a) in brain regions related to spatial memory predict male space use and sexual fidelity in the field. We find that trade-offs between the benefits of male fidelity and infidelity are reflected in patterns of territorial intrusion, offspring paternity, avpr1a expression, and the evolutionary fitness of alternative avpr1a alleles. DNA variation at the avpr1a locus includes polymorphisms that reliably predict the epigenetic status and neural expression of avpr1a, and patterns of DNA diversity demonstrate that avpr1a regulatory variation has been favored by selection. In prairie voles, trade-offs in the fitness consequences of social behaviors seem to promote neuronal and molecular diversity.	[Okhovat, Mariam; Berrio, Alejandro; Wallace, Gerard; Phelps, Steven M.] Univ Texas Austin, Dept Integrat Biol, Univ Stn 1, Austin, TX 78712 USA; [Ophir, Alexander G.] Cornell Univ, Dept Psychol, Ithaca, NY 14853 USA	University of Texas System; University of Texas Austin; Cornell University	Phelps, SM (corresponding author), Univ Texas Austin, Dept Integrat Biol, Univ Stn 1, Campus Code C0930, Austin, TX 78712 USA.	sphelps@mail.utexas.edu	Berrio, Alejandro/Q-6261-2018	Berrio, Alejandro/0000-0003-1259-2181	NSF [IOS-0316451, IOS-1355188]; NIH [R21 HD059092]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD059092] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [1355188] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors thank Z. Dehghani, L. O'Connell, and A. Sidik for help with molecular work. T. Juenger, M. Ryan, M. Wayne, and three anonymous reviewers provided valuable feedback. Funded by NSF grant IOS-0316451, NIH grant R21 HD059092, and NSF grant IOS-1355188 to S.M.P. Data presented in this manuscript are available in the Dryad Digital Repository (accession no. doi:10.5061/dryad.74s05). Sequencing data from our ChIP-seq experiment are available through the National Center for Biotechnology Information (GEO accession no. GSE73670).	Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Aggleton JP, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0565; Bales KL, 2007, NEUROSCIENCE, V144, P38, DOI 10.1016/j.neuroscience.2006.09.009; CARTER CS, 1986, ADV STUD BEHAV, V16, P109, DOI 10.1016/S0065-3454(08)60189-8; Cushing BS, 2005, NEUROSCI BIOBEHAV R, V29, P1089, DOI 10.1016/j.neubiorev.2005.04.001; De Vries GJ, 2006, NEUROSCIENCE, V138, P947, DOI 10.1016/j.neuroscience.2005.07.050; Ellis BJ, 2005, DEV PSYCHOPATHOL, V17, P303, DOI 10.1017/S0954579405050157; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Getz LL, 2001, J MAMMAL, V82, P22, DOI 10.1644/1545-1542(2001)082<0022:TFYOPF>2.0.CO;2; GETZ LL, 1993, J MAMMAL, V74, P44, DOI 10.2307/1381904; GROSS MR, 1991, PHILOS T R SOC B, V332, P59, DOI 10.1098/rstb.1991.0033; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; HUDSON RR, 1987, GENETICS, V116, P153; Keller MC, 2006, BEHAV BRAIN SCI, V29, P385, DOI 10.1017/S0140525X06009095; Kokko H, 2006, PHILOS T R SOC B, V361, P319, DOI 10.1098/rstb.2005.1784; MCGUIRE B, 1990, CAN J ZOOL, V68, P391, DOI 10.1139/z90-056; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ophir AG, 2008, ANIM BEHAV, V75, P1143, DOI 10.1016/j.anbehav.2007.09.022; Ophir AG, 2008, P NATL ACAD SCI USA, V105, P1249, DOI 10.1073/pnas.0709116105; PFENNIG DW, 1992, EVOLUTION, V46, P1408, DOI 10.1111/j.1558-5646.1992.tb01133.x; Phelps S. M., 2009, COGNITIVE ECOLOGY; Phelps SM, 2003, J COMP NEUROL, V466, P564, DOI 10.1002/cne.10902; Phelps SM, 2010, NEUROPHARMACOLOGY, V58, P17, DOI 10.1016/j.neuropharm.2009.06.043; RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; Streatfeild CA, 2011, ANIM BEHAV, V82, P1387, DOI 10.1016/j.anbehav.2011.09.023; TAJIMA F, 1989, GENETICS, V123, P585; Verweij KJH, 2012, EVOLUTION, V66, P3238, DOI 10.1111/j.1558-5646.2012.01679.x; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327	31	86	88	3	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2015	350	6266					1371	1374		10.1126/science.aac5791	http://dx.doi.org/10.1126/science.aac5791			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1JL	26659055				2022-12-28	WOS:000366162400041
J	Romani, L; Whitfeld, MJ; Koroivueta, J; Kama, M; Wand, H; Tikoduadua, L; Tuicakau, M; Koroi, A; Andrews, R; Kaldor, JM; Steer, AC				Romani, Lucia; Whitfeld, Margot J.; Koroivueta, Josefa; Kama, Mike; Wand, Handan; Tikoduadua, Lisi; Tuicakau, Meciusela; Koroi, Aminiasi; Andrews, Ross; Kaldor, John M.; Steer, Andrew C.			Mass Drug Administration for Scabies Control in a Population with Endemic Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SINGLE-DOSE IVERMECTIN; PERMETHRIN CREAM; COMMUNITY; ONCHOCERCIASIS; CHILDREN; BRAZIL; MANAGEMENT; MORBIDITY; IMPETIGO; ILLNESS	BACKGROUND Scabies is an underrecognized cause of illness in many developing countries. It is associated with impetigo, which can lead to serious systemic complications. We conducted a trial of mass drug administration for scabies control in Fiji. METHODS We randomly assigned three island communities to one of three different interventions for scabies control: standard care involving the administration of permethrin to affected persons and their contacts (standard-care group), mass administration of permethrin (permethrin group), or mass administration of ivermectin (ivermectin group). The primary outcome was the change in the prevalence of scabies and of impetigo from baseline to 12 months. RESULTS A total of 2051 participants were enrolled; 803 were in the standard-care group, 532 in the permethrin group, and 716 in the ivermectin group. From baseline to 12 months, the prevalence of scabies declined significantly in all groups, with the greatest reduction seen in the ivermectin group. The prevalence declined from 36.6% to 18.8% in the standard-care group (relative reduction in prevalence, 49%; 95% confidence interval [CI], 37 to 60), from 41.7% to 15.8% in the permethrin group (relative reduction, 62%; 95% CI, 49 to 75), and from 32.1% to 1.9% in the ivermectin group (relative reduction, 94%; 95% CI, 83 to 100). The prevalence of impetigo also declined in all groups, with the greatest reduction seen in the ivermectin group. The prevalence declined from 21.4% to 14.6% in the standard-care group (relative reduction, 32%; 95% CI, 14 to 50), from 24.6% to 11.4% in the permethrin group (relative reduction, 54%; 95% CI, 35 to 73), and from 24.6% to 8.0% in the ivermectin group (relative reduction, 67%; 95% CI, 52 to 83). Adverse events were mild and were reported more frequently in the ivermectin group than in the permethrin group (15.6% vs. 6.8%). CONCLUSIONS Mass drug administration, particularly the administration of ivermectin, was efficacious for the control of scabies and impetigo.	[Romani, Lucia; Wand, Handan; Kaldor, John M.] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Whitfeld, Margot J.] St Vincents Hosp, Dept Dermatol, Sydney, NSW 2010, Australia; [Andrews, Ross] Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT 0909, Australia; [Steer, Andrew C.] Univ Melbourne, Ctr Int Child Hlth, Melbourne, Vic, Australia; [Steer, Andrew C.] Murdoch Childrens Res Inst, Grp Streptococcal Res Grp A, Melbourne, Vic, Australia; [Steer, Andrew C.] Royal Childrens Hosp, Dept Gen Med, Melbourne, Vic, Australia; [Koroivueta, Josefa] Minist Women Children & Poverty Alleviat, Suva, Fiji; [Kama, Mike; Tikoduadua, Lisi; Tuicakau, Meciusela; Koroi, Aminiasi] Minist Hlth, Suva, Fiji	University of New South Wales Sydney; Kirby Institute; St Vincents Hospital Sydney; Charles Darwin University; Menzies School of Health Research; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Steer, AC (corresponding author), Royal Childrens Hosp, Ctr Int Child Hlth, Flemington Rd, Parkville, Vic 3052, Australia.	andrew.steer@rch.org.au	Romani, Lucia/AAY-5005-2021	Romani, Lucia/0000-0001-9038-5300	Australian National Health and Medical Research Council; Australian New Zealand Clinical Trials Registry [ACTRN12613000474752]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian New Zealand Clinical Trials Registry	Funded by the Australian National Health and Medical Research Council; Australian New Zealand Clinical Trials Registry number, ACTRN12613000474752.	Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; [Anonymous], 1995, World Health Organ Tech Rep Ser, V852, P1; [Anonymous], 2009, 2007 CENS POP HOUS L; [Anonymous], 2015, SCAB; [Anonymous], 2007, COCHRANE DATABASE SY; [Anonymous], 2015, TASK FORC GLOB HLTH; Basanez MG, 2008, LANCET INFECT DIS, V8, P310, DOI 10.1016/S1473-3099(08)70099-9; Centers for Disease Control and Prevention, 2015, GLOB NTD PROGR; Central Australian Rural Practitioners Association, 2012, CARPA STAND TREATM M; Chosidow O, 2006, NEW ENGL J MED, V354, P1718, DOI 10.1056/NEJMcp052784; Currie B, 1997, LANCET, V350, P1551, DOI 10.1016/S0140-6736(05)63983-9; Currie BJ, 2010, NEW ENGL J MED, V362, P717, DOI 10.1056/NEJMct0910329; Currie BJ, 2004, CLIN INFECT DIS, V39, pE8, DOI 10.1086/421776; Engelman D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002167; Engelman D, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-106; Gardner MJ, 1994, STAT CONFIDENCE, P51; Gardon J, 1997, LANCET, V350, P18, DOI 10.1016/S0140-6736(96)11094-1; HAY RJ, 1994, BRIT MED J, V309, P848, DOI 10.1136/bmj.309.6958.848; Heukelbach J, 2005, BRIT J DERMATOL, V153, P150, DOI 10.1111/j.1365-2133.2005.06591.x; Heukelbach J, 2006, LANCET, V367, P1767, DOI 10.1016/S0140-6736(06)68772-2; Jackson A, 2007, TROP MED INT HEALTH, V12, P493, DOI 10.1111/j.1365-3156.2006.01809.x; La Vincente S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000444; Lawrence G, 2005, B WORLD HEALTH ORGAN, V83, P34; Leung V, 2011, CAN J INFECT DIS MED, V22, P143, DOI 10.1155/2011/698494; Mackenzie Charles D, 2003, Filaria J, V2 Suppl 1, pS5, DOI 10.1186/1475-2883-2-S1-S5; Marti H, 1996, AM J TROP MED HYG, V55, P477, DOI 10.4269/ajtmh.1996.55.477; Mittal Asit, 2013, Indian Dermatol Online J, V4, P52, DOI 10.4103/2229-5178.105486; Mohammed KA, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-299; Romani L, 2015, LANCET INFECT DIS, V15, P960, DOI 10.1016/S1473-3099(15)00132-2; Romani L, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003452; Scientific Working Group on Serious Adverse Events in Loa Loa endemic areas, 2004, FILARIA J SUPPL 1, V2, pS2; Steer AC, 2009, B WHO, V87; Steer AC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000467; Steer AC, 2009, B WORLD HEALTH ORGAN, V87, P173, DOI 10.2471/BLT.08.052712; TAPLIN D, 1991, LANCET, V337, P1016, DOI 10.1016/0140-6736(91)92669-S; Thomas Mark, 2005, N Z Med J, V118, pU1492; Twum-Danso NAY, 2003, TROP MED INT HEALTH, V8, P820, DOI 10.1046/j.1365-3156.2003.01091.x; Usha V, 2000, J AM ACAD DERMATOL, V42, P236, DOI 10.1016/S0190-9622(00)90131-2; VERMA BL, 1990, INT J EPIDEMIOL, V19, P169, DOI 10.1093/ije/19.1.169; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Walter B, 2011, ARCH DERMATOL, V147, P468, DOI 10.1001/archdermatol.2011.51; Walton SF, 2007, CLIN MICROBIOL REV, V20, P268, DOI 10.1128/CMR.00042-06; WHO, 2005, WHOFCHCAH0512; Wong LCF, 2001, MED J AUSTRALIA, V175, P367, DOI 10.5694/j.1326-5377.2001.tb143620.x; Worth C, 2012, INT J DERMATOL, V51, P275, DOI 10.1111/j.1365-4632.2011.05017.x	45	154	155	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 10	2015	373	24					2305	2313		10.1056/NEJMoa1500987	http://dx.doi.org/10.1056/NEJMoa1500987			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY0QW	26650152	Bronze			2022-12-28	WOS:000366111600005
J	Yamashita, F; Fukuyama, E; Mizoguchi, K; Takizawa, S; Xu, SQ; Kawakata, H				Yamashita, Futoshi; Fukuyama, Eiichi; Mizoguchi, Kazuo; Takizawa, Shigeru; Xu, Shiqing; Kawakata, Hironori			Scale dependence of rock friction at high work rate	NATURE			English	Article							SLIP RATES; CARBONATE FAULTS; HIGH-VELOCITY; SEISMIC SLIP; STICK-SLIP; EARTHQUAKE; STRENGTH; NUCLEATION; GABBRO; LUBRICATION	Determination of the frictional properties of rocks is crucial for an understanding of earthquake mechanics, because most earthquakes are caused by frictional sliding along faults. Prior studies using rotary shear apparatus(1-13) revealed a marked decrease in frictional strength, which can cause a large stress drop and strong shaking, with increasing slip rate and increasing work rate. (The mechanical work rate per unit area equals the product of the shear stress and the slip rate.) However, those important findings were obtained in experiments using rock specimens with dimensions of only several centimetres, which are much smaller than the dimensions of a natural fault (of the order of 1,000 metres). Here we use a large-scale biaxial friction apparatus with metre-sized rock specimens to investigate scale-dependent rock friction. The experiments show that rock friction in metre-sized rock specimens starts to decrease at a work rate that is one order of magnitude smaller than that in centimetre-sized rock specimens. Mechanical, visual and material observations suggest that slip-evolved stress heterogeneity on the fault accounts for the difference. On the basis of these observations, we propose that stress-concentrated areas exist in which frictional slip produces more wear materials (gouge) than in areas outside, resulting in further stress concentrations at these areas. Shear stress on the fault is primarily sustained by stress-concentrated areas that undergo a high work rate, so those areas should weaken rapidly and cause the macroscopic frictional strength to decrease abruptly. To verify this idea, we conducted numerical simulations assuming that local friction follows the frictional properties observed on centimetre-sized rock specimens. The simulations reproduced the macroscopic frictional properties observed on the metre-sized rock specimens. Given that localized stress concentrations commonly occur naturally, our results suggest that a natural fault may lose its strength faster than would be expected from the properties estimated from centimetre-sized rock samples.	[Yamashita, Futoshi; Fukuyama, Eiichi; Mizoguchi, Kazuo; Takizawa, Shigeru; Xu, Shiqing; Kawakata, Hironori] Natl Res Inst Earth Sci & Disaster Prevent NIED, Tsukuba, Ibaraki 3050006, Japan; [Mizoguchi, Kazuo] Cent Res Inst Elect Power Ind, Abiko, Chiba 2701194, Japan; [Kawakata, Hironori] Ritsumeikan Univ, Coll Sci & Engn, Kusatsu 5258577, Japan	National Research Institute for Earth Science & Disaster Resilience; Central Research Institute of Electric Power Industry - Japan; Ritsumeikan University	Yamashita, F (corresponding author), Natl Res Inst Earth Sci & Disaster Prevent NIED, Tsukuba, Ibaraki 3050006, Japan.	yamafuto@bosai.go.jp	Xu, Shiqing/P-1461-2019; Xu, Shiqing/V-6726-2018; Kawakata, Hironori/AAX-3405-2021	Xu, Shiqing/0000-0001-5968-1320; Xu, Shiqing/0000-0001-5968-1320; Kawakata, Hironori/0000-0002-4907-5594; Yamashita, Futoshi/0000-0001-9938-3766; Fukuyama, Eiichi/0000-0002-9405-9155	NIED; JSPS KAKENHI [23340131]	NIED; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank A. Schubnel and F. X. Passelegue for help with some of the experiments. We thank G. C. McLaskey for comments. Reviews by Z. Reches improved the manuscript. This study was supported by the NIED research project entitled "Development of monitoring and forecasting technology for crustal activity" and JSPS KAKENHI grant number 23340131.	Beeler N, 2012, J STRUCT GEOL, V38, P77, DOI 10.1016/j.jsg.2011.11.013; Boatwright J., 1986, EARTHQUAKE SOURCE ME, V37, P37; Boneh Y, 2014, PURE APPL GEOPHYS, V171, P3125, DOI 10.1007/s00024-014-0801-3; Boneh Y, 2013, EARTH PLANET SC LETT, V381, P127, DOI 10.1016/j.epsl.2013.08.050; Bouchon M, 2013, NAT GEOSCI, V6, P299, DOI [10.1038/ngeo1770, 10.1038/NGEO1770]; Bouchon M, 2011, SCIENCE, V331, P877, DOI 10.1126/science.1197341; Brown KM, 2012, NATURE, V488, P638, DOI 10.1038/nature11370; BYERLEE J, 1978, PURE APPL GEOPHYS, V116, P615, DOI 10.1007/BF00876528; Di Toro G, 2004, NATURE, V427, P436, DOI 10.1038/nature02249; Di Toro G, 2011, NATURE, V471, P494, DOI 10.1038/nature09838; DIETERICH JH, 1992, TECTONOPHYSICS, V211, P115, DOI 10.1016/0040-1951(92)90055-B; DIETERICH JH, 1978, J GEOPHYS RES, V83, P3940, DOI 10.1029/JB083iB08p03940; Fukuyama E., 2014, 81 NAT RES I EARTH S, P15; Goldsby DL, 2011, SCIENCE, V334, P216, DOI 10.1126/science.1207902; Goldsby DL, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015240; Han R, 2007, SCIENCE, V316, P878, DOI 10.1126/science.1139763; Han R, 2011, GEOLOGY, V39, P599, DOI 10.1130/G31842.1; Han R, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2008JB006136; Hirose T, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003207; Kato A, 2012, SCIENCE, V335, P705, DOI 10.1126/science.1215141; Lockner DA, 2011, NATURE, V472, P82, DOI 10.1038/nature09927; McLaskey GC, 2014, J GEOPHYS RES-SOL EA, V119, P6323, DOI 10.1002/2014JB011220; McLaskey GC, 2013, J GEOPHYS RES-SOL EA, V118, P2982, DOI 10.1002/jgrb.50232; Mizoguchi K, 2010, INT J ROCK MECH MIN, V47, P1363, DOI 10.1016/j.ijrmms.2010.08.013; Nielsen S, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005122; Ohnaka M, 1999, J GEOPHYS RES-SOL EA, V104, P817, DOI 10.1029/1998JB900007; Reches Z, 2010, NATURE, V467, P452, DOI 10.1038/nature09348; Tsutsumi A, 1997, GEOPHYS RES LETT, V24, P699, DOI 10.1029/97GL00503; Ujiie K, 2013, SCIENCE, V342, P1211, DOI 10.1126/science.1243485; Yoshida S, 2001, GEOPHYS RES LETT, V28, P451, DOI 10.1029/2000GL012211	30	34	34	7	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2015	528	7581					254	257		10.1038/nature16138	http://dx.doi.org/10.1038/nature16138			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9VH	26659187				2022-12-28	WOS:000366053300039
J	George, DR; Green, MJ				George, Daniel R.; Green, Michael J.			Lessons Learned From Comics Produced by Medical Students Art of Darkness	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[George, Daniel R.; Green, Michael J.] Penn State Coll Med, Dept Humanities, Hershey, PA 17033 USA; [Green, Michael J.] Penn State Coll Med, Dept Med, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Green, MJ (corresponding author), Penn State Coll Med, Dept Humanities, 500 Univ Dr, Hershey, PA 17033 USA.	mjg15@psu.edu	Green, Martin A/H-7567-2012	Green, Martin A/0000-0002-8860-396X; Green, Michael/0000-0002-4828-4749				Association of American Medical Colleges, MED SCH GRAD QUEST 2; Cohen JJ, 2015, JAMA-J AM MED ASSOC, V313, P1839, DOI 10.1001/jama.2015.3736; DeAngelis CD, 2015, JAMA-J AM MED ASSOC, V313, P1837, DOI 10.1001/jama.2015.3597; Green MJ, 2015, ACAD MED, V90, P774, DOI 10.1097/ACM.0000000000000703; King S, 2011, DANSE MACABRE, P13; Myers KR, 2012, ACAD MED, V87, P1132, DOI 10.1097/ACM.0b013e31825cee9b; Ofri D, 2015, ACAD MED, V90, P1005, DOI 10.1097/ACM.0000000000000672; Porath C, 2013, HARVARD BUS REV, V91, P114; Shanafelt TD, 2012, ARCH INTERN MED, V172, P1377, DOI 10.1001/archinternmed.2012.3199	9	17	17	2	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 8	2015	314	22					2345	2346		10.1001/jama.2015.13652	http://dx.doi.org/10.1001/jama.2015.13652			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX8XT	26647249				2022-12-28	WOS:000365989100002
J	Murray, E; Cho, JH; Goodwin, D; Ku, T; Swaney, J; Kim, SY; Choi, H; Park, YG; Park, JY; Hubbert, A; Mccue, M; Vassallo, S; Bakh, N; Frosch, MP; Wedeen, VJ; Seung, HS; Chung, K				Murray, Evan; Cho, Jae Hun; Goodwin, Daniel; Ku, Taeyun; Swaney, Justin; Kim, Sung-Yon; Choi, Heejin; Park, Young-Gyun; Park, Jeong-Yoon; Hubbert, Austin; McCue, Margaret; Vassallo, Sara; Bakh, Naveed; Frosch, Matthew P.; Wedeen, Van J.; Seung, H. Sebastian; Chung, Kwanghun			Simple, Scalable Proteomic Imaging for High-Dimensional Profiling of Intact Systems	CELL			English	Article							GLUTARALDEHYDE FIXATION; PYRAMIDAL NEURONS; CELL-MEMBRANE; BRAIN; CALRETININ; FORMALDEHYDE; PARVALBUMIN; RESOLUTION; CALBINDIN; TISSUES	Combined measurement of diverse molecular and anatomical traits that span multiple levels remains a major challenge in biology. Here, we introduce a simple method that enables proteomic imaging for scalable, integrated, high-dimensional phenotyping of both animal tissues and human clinical samples. This method, termed SWITCH, uniformly secures tissue architecture, native biomolecules, and antigenicity across an entire system by synchronizing the tissue preservation reaction. The heat-and chemical-resistant nature of the resulting framework permits multiple rounds (>20) of relabeling. We have performed 22 rounds of labeling of a single tissue with precise co-registration of multiple datasets. Furthermore, SWITCH synchronizes labeling reactions to improve probe penetration depth and uniformity of staining. With SWITCH, we performed combinatorial protein expression profiling of the human cortex and also interrogated the geometric structure of the fiber pathways in mouse brains. Such integrated high-dimensional information may accelerate our understanding of biological systems at multiple levels.	[Murray, Evan; McCue, Margaret; Chung, Kwanghun] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Murray, Evan; Ku, Taeyun; Kim, Sung-Yon; Choi, Heejin; Park, Young-Gyun; Park, Jeong-Yoon; Vassallo, Sara; Chung, Kwanghun] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Cho, Jae Hun; Swaney, Justin; Hubbert, Austin; Bakh, Naveed; Chung, Kwanghun] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Ku, Taeyun; Choi, Heejin; Park, Young-Gyun; Park, Jeong-Yoon; McCue, Margaret; Vassallo, Sara; Chung, Kwanghun] MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Goodwin, Daniel; Seung, H. Sebastian] Simons Ctr Data Anal, New York, NY 10010 USA; [Frosch, Matthew P.] Massachusetts Gen Hosp, Dept Pathol, CS Kubik Lab Neuropathol, Boston, MA 02114 USA; [Frosch, Matthew P.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Wedeen, Van J.] Massachusetts Gen Hosp, Dept Radiol, Charlestown, MA 02129 USA; [Wedeen, Van J.] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Seung, H. Sebastian] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Seung, H. Sebastian] Princeton Univ, Dept Comp Sci, Princeton, NJ 08544 USA; [Chung, Kwanghun] Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; [Chung, Kwanghun] MIT, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Northwell Health; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Princeton University; Princeton University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Chung, K (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	khchung@mit.edu	Ku, Taeyun/T-7080-2019; Kim, Sung-Yon/AAO-8405-2020; Swaney, Justin/H-1437-2016; Frosch, Matthew P/ABD-7456-2021; Park, Young-Gyun/AAS-5614-2021; Chung, Kwanghun/H-7714-2014	Kim, Sung-Yon/0000-0003-0791-7308; Swaney, Justin/0000-0002-4830-9133; Frosch, Matthew P/0000-0002-3940-9861; Chung, Kwanghun/0000-0002-8167-3340; Ku, Taeyun/0000-0001-9447-7579; Park, Jeong Yoon/0000-0002-3728-7784	Simons Postdoctoral Fellowship; Life Sciences Research Foundation; Burroughs Wellcome Fund Career Awards at the Scientific Interface; Searle Scholars Program; Michael J. Fox Foundation; DARPA; JPB Foundation (PIIF and PNDRF); NIH [1-U01-NS090473-01]; Massachusetts Alzheimer Disease Research Center [5 P50 AG005134]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB019940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [DP2ES027992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS090473] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005134] Funding Source: NIH RePORTER	Simons Postdoctoral Fellowship; Life Sciences Research Foundation; Burroughs Wellcome Fund Career Awards at the Scientific Interface(Burroughs Wellcome Fund); Searle Scholars Program; Michael J. Fox Foundation; DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); JPB Foundation (PIIF and PNDRF); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts Alzheimer Disease Research Center; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the entire Chung laboratory for support and helpful discussions. S.-Y.K. was supported by the Simons Postdoctoral Fellowship and the Life Sciences Research Foundation. K.C. was supported by Burroughs Wellcome Fund Career Awards at the Scientific Interface, the Searle Scholars Program, the Michael J. Fox Foundation, DARPA, the JPB Foundation (PIIF and PNDRF), and NIH (1-U01-NS090473-01). M.P.F. was supported in part by the Massachusetts Alzheimer Disease Research Center (5 P50 AG005134). Resources that may help enable general users to establish the methodology are freely available online. (www.chunglabresources.org).	Alivisatos AP, 2013, SCIENCE, V339, P1284, DOI 10.1126/science.1236939; Anelli R, 2005, J NEUROCYTOL, V34, P369, DOI 10.1007/s11068-006-8724-2; Angelo M, 2014, NAT MED, V20, P436, DOI 10.1038/nm.3488; Baleriola J, 2014, CELL, V158, P1159, DOI 10.1016/j.cell.2014.07.001; Bloom S, 2014, JARO-J ASSOC RES OTO, V15, P603, DOI 10.1007/s10162-014-0453-0; CAMPBELL MJ, 1989, J COMP NEUROL, V282, P191, DOI 10.1002/cne.902820204; Chung K, 2013, NAT METHODS, V10, P508, DOI [10.1038/nmeth.2481, 10.1038/NMETH.2481]; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Darlington PJ, 2008, J NEUROCHEM, V104, P1201, DOI 10.1111/j.1471-4159.2007.05043.x; de Sousa AA, 2010, CEREB CORTEX, V20, P966, DOI 10.1093/cercor/bhp158; DeFelipe J, 1999, J COMP NEUROL, V412, P515, DOI 10.1002/(SICI)1096-9861(19990927)412:3<515::AID-CNE10>3.0.CO;2-1; Friedman M, 1996, J AGR FOOD CHEM, V44, P631, DOI 10.1021/jf950394r; Giesen C, 2014, NAT METHODS, V11, P417, DOI [10.1038/NMETH.2869, 10.1038/nmeth.2869]; Gonchar Yuri, 2007, Front Neuroanat, V1, P3, DOI 10.3389/neuro.05.003.2007; HOPWOOD D, 1970, HISTOCHEMISTRY, V24, P50, DOI 10.1007/BF00310003; HOPWOOD D, 1972, HISTOCHEM J, V4, P267, DOI 10.1007/BF01005005; HOPWOOD D, 1967, J ANAT, V101, P83; Kamata N, 1996, BIOSCI BIOTECH BIOCH, V60, P25, DOI 10.1271/bbb.60.25; Kasthuri N, 2015, CELL, V162, P648, DOI 10.1016/j.cell.2015.06.054; Keller S, 2006, J AM CHEM SOC, V128, P1279, DOI 10.1021/ja056389d; Kim KK, 2009, J BIOL CHEM, V284, P31052, DOI 10.1074/jbc.M109.052969; Kim SY, 2015, P NATL ACAD SCI USA, V112, pE6274, DOI 10.1073/pnas.1510133112; Leuba G, 1998, EXP NEUROL, V152, P278, DOI 10.1006/exnr.1998.6838; Manzo C, 2014, SCI REP-UK, V4, DOI 10.1038/srep04354; McCaslin AFH, 2011, J CEREBR BLOOD F MET, V31, P795, DOI 10.1038/jcbfm.2010.204; MIAN IS, 1991, J MOL BIOL, V217, P133, DOI 10.1016/0022-2836(91)90617-F; Micheva KD, 2010, NEURON, V68, P639, DOI 10.1016/j.neuron.2010.09.024; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Oka Y, 2015, NATURE, V520, P349, DOI 10.1038/nature14108; Pickrell AM, 2015, NEURON, V87, P371, DOI 10.1016/j.neuron.2015.06.034; Rah JC, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00177; Renier N, 2014, CELL, V159, P896, DOI 10.1016/j.cell.2014.10.010; Richardson DS, 2015, CELL, V162, P246, DOI 10.1016/j.cell.2015.06.067; ROOZEMOND RC, 1969, J HISTOCHEM CYTOCHEM, V17, P482, DOI 10.1177/17.7.482; SCHLESSINGER J, 1977, SCIENCE, V195, P307, DOI 10.1126/science.556653; Steinman L, 1999, NEURON, V24, P511, DOI 10.1016/S0896-6273(00)81107-1; Sung HW, 1996, BIOMATERIALS, V17, P1405, DOI 10.1016/0142-9612(96)87282-6; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Thomas C, 2014, P NATL ACAD SCI USA, V111, P16574, DOI 10.1073/pnas.1405672111; Tomer R, 2014, NAT PROTOC, V9, P1682, DOI 10.1038/nprot.2014.123; Tomer R, 2012, NAT METHODS, V9, P755, DOI [10.1038/NMETH.2062, 10.1038/nmeth.2062]; Yuste R, 2015, NAT REV NEUROSCI, V16, P487, DOI 10.1038/nrn3962; Zuccaro E, 2013, NAT CELL BIOL, V15, P572, DOI 10.1038/ncb2750	43	259	268	9	69	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 6	2015	163	6					1500	1514		10.1016/j.cell.2015.11.025	http://dx.doi.org/10.1016/j.cell.2015.11.025			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SE	26638076	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000366044800022
J	Collis, E; Mather, H				Collis, Emily; Mather, Harriet			Nausea and vomiting in palliative care	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CHEMOTHERAPY-INDUCED NAUSEA; ADVANCED CANCER; DOUBLE-BLIND; RELEASE METOCLOPRAMIDE; INTRACTABLE NAUSEA; REFRACTORY NAUSEA; MANAGEMENT; OLANZAPINE; PLACEBO; ONDANSETRON		[Collis, Emily] Cent & North West London NHS Fdn, Islington ELiPSe, Palliat Med, London, England; [Collis, Emily] Cent & North West London NHS Fdn, UCLH & HCA Palliat Care Serv, Palliat Med, London, England; [Mather, Harriet] Mt Vernon Hosp, Dept Palliat Med, Palliat Med, Northwood HA6 2RN, Middx, England		Collis, E (corresponding author), Cent & North West London NHS Fdn, Islington ELiPSe, Palliat Med, London, England.	emily.collis@nhs.net						Andrews PLR, 2014, EUR J PHARMACOL, V722, P108, DOI 10.1016/j.ejphar.2013.09.072; Ang SK, 2010, AM J HOSP PALLIAT ME, V27, P219, DOI 10.1177/1049909110361228; Atkinson SR, 2014, J PALLIAT MED, V17, P503, DOI 10.1089/jpm.2014.0030; Bentley A, 2001, PALLIATIVE MED, V15, P247, DOI 10.1191/026921601678576239; Benze G, 2012, SCHMERZ, V26, P500, DOI 10.1007/s00482-012-1216-7; Brooksbank MA, 2002, PALLIATIVE MED, V16, P520, DOI 10.1191/0269216302pm590oa; Bruera E, 2000, J PAIN SYMPTOM MANAG, V19, P427, DOI 10.1016/S0885-3924(00)00138-X; BRUERA ED, 1994, CANCER, V74, P3204, DOI 10.1002/1097-0142(19941215)74:12<3204::AID-CNCR2820741220>3.0.CO;2-G; Bruera E, 2013, J CLIN ONCOL, V31, P111, DOI 10.1200/JCO.2012.44.6518; Buchanan D, 2007, PALLIATIVE MED, V21, P725, DOI 10.1177/0269216307083383; Critchley P, 2001, J PAIN SYMPTOM MANAG, V22, P631, DOI 10.1016/S0885-3924(01)00323-2; Currow DC, 2015, J PAIN SYMPTOM MANAG, V49, P814, DOI 10.1016/j.jpainsymman.2014.09.013; Currow DC, 1997, J PAIN SYMPTOM MANAG, V13, P302, DOI 10.1016/S0885-3924(97)00079-1; Darvill E, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009420.pub2; Davis MP, 2008, EXPERT OPIN INV DRUG, V17, P85, DOI 10.1517/13543784.17.1.85; Dietrich Jorg, 2011, Expert Rev Clin Pharmacol, V4, P233, DOI 10.1586/ecp.11.1; Dietz I, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-2; Eisenchlas JH, 2005, PALLIATIVE MED, V19, P71, DOI 10.1191/0269216305pm972oa; Feuer DJ., 2000, COCHRANE DB SYST REV, V2000; General Medical Council, 2010, TREATM CAR END LIF G; Glare P, 2011, CLIN INTERV AGING, V6, P243, DOI 10.2147/CIA.S13109; Gordon P, 2014, EUR J PHARMACOL, V722, P187, DOI 10.1016/j.ejphar.2013.10.010; Hardy J, 2002, SUPPORT CARE CANCER, V10, P231, DOI 10.1007/s00520-001-0332-1; Hardy JR, 2010, J PAIN SYMPTOM MANAG, V40, P111, DOI 10.1016/j.jpainsymman.2009.11.321; Harris DG, 2010, BRIT MED BULL, V96, P175, DOI 10.1093/bmb/ldq031; Jackson W Clay, 2003, J Palliat Med, V6, P251, DOI 10.1089/109662103764978506; Jordan K, 2014, EUR J PHARMACOL, V722, P197, DOI 10.1016/j.ejphar.2013.09.073; Kaneishi K, 2012, J PAIN SYMPTOM MANAG, V44, P604, DOI 10.1016/j.jpainsymman.2011.10.023; Kennett A, 2005, SUPPORT CARE CANCER, V13, P715, DOI 10.1007/s00520-004-0768-1; Laval G, 2006, J PAIN SYMPTOM MANAG, V31, P502, DOI 10.1016/j.jpainsymman.2005.10.009; Lowery L, 2014, PALLIATIVE MED, V28, P990, DOI 10.1177/0269216314530180; Macleod AD, 2000, J PAIN SYMPTOM MANAG, V20, P388, DOI 10.1016/S0885-3924(00)00205-0; Mercadante S, 2004, J PAIN SYMPTOM MANAG, V28, P412, DOI 10.1016/j.jpainsymman.2004.01.007; Mystakidou, 1997, Oncologist, V2, P319; Mystakidou K, 1998, J PAIN SYMPTOM MANAG, V15, P176, DOI 10.1016/S0885-3924(97)00349-7; Passik SD, 2002, J PAIN SYMPTOM MANAG, V23, P526, DOI 10.1016/S0885-3924(02)00391-3; Perkins P, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006271.pub2; Saito M, 2009, LANCET ONCOL, V10, P115, DOI 10.1016/S1470-2045(08)70313-9; Srivastava M, 2003, J PAIN SYMPTOM MANAG, V25, P578, DOI 10.1016/S0885-3924(03)00143-X; Stephenson J, 2006, SUPPORT CARE CANCER, V14, P348, DOI 10.1007/s00520-005-0897-1; Teriaky A, 2012, SAUDI J GASTROENTERO, V18, P95, DOI 10.4103/1319-3767.93808	41	14	14	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 3	2015	351								h6249	10.1136/bmj.h6249	http://dx.doi.org/10.1136/bmj.h6249			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX9EZ	26635303				2022-12-28	WOS:000366009100003
J	Feder, HM; Rigos, L; Teti, K				Feder, Henry M., Jr.; Rigos, Louis; Teti, Kristopher			Pott's disease in a Connecticut toddler	LANCET			English	Editorial Material									[Feder, Henry M., Jr.] Connecticut Childrens Med Ctr, Farmington, CT 06030 USA; [Feder, Henry M., Jr.] Univ Connecticut, Med Ctr, Farmington, CT 06030 USA; [Rigos, Louis; Teti, Kristopher] Connecticut Childrens Med Ctr, Hartford, CT USA	Connecticut Children's Medical Center; University of Connecticut; Connecticut Children's Medical Center	Feder, HM (corresponding author), Connecticut Childrens Med Ctr, Farmington, CT 06030 USA.; Feder, HM (corresponding author), Univ Connecticut, Med Ctr, Farmington, CT 06030 USA.	feder@uchc.edu							0	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 30	2016	388	10043					504	504		10.1016/S0140-6736(15)01043-0	http://dx.doi.org/10.1016/S0140-6736(15)01043-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DS2EK	26686958				2022-12-28	WOS:000380559400030
J	DeBaun, MR; Kirkham, FJ				DeBaun, Michael R.; Kirkham, Fenella J.			New option for primary stroke prevention in sickle cell anaemia	LANCET			English	Editorial Material							NIGERIAN CHILDREN; DISEASE		[DeBaun, Michael R.] Vanderbilt Univ, Sch Med, Dept Pediat & Med, Div Hematol Oncol, Nashville, TN 37232 USA; [DeBaun, Michael R.] Vanderbilt Univ, Sch Med, Vanderbilt Meharry Sickle Cell Ctr Excellence, Nashville, TN 37232 USA; [Kirkham, Fenella J.] UCL Inst Child Hlth, Dev Neurosci, London, England	Vanderbilt University; Vanderbilt University; University of London; University College London	DeBaun, MR (corresponding author), Vanderbilt Univ, Sch Med, Dept Pediat & Med, Div Hematol Oncol, Nashville, TN 37232 USA.; DeBaun, MR (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Meharry Sickle Cell Ctr Excellence, Nashville, TN 37232 USA.	M.DeBaun@vanderbilt.edu	Kirkham, Fenella/C-2442-2009	Kirkham, Fenella/0000-0002-2443-7958				ADAMS RJ, 1998, NEW ENGL J MED, V339, P5, DOI [DOI 10.1056/NEJM199807023390102, 10.1056/NEJM199807023390102]; Adams RJ, 2007, ARCH NEUROL-CHICAGO, V64, P1567, DOI 10.1001/archneur.64.11.1567; Galadanci NA, 2015, PEDIATR BLOOD CANCER, V62, P395, DOI 10.1002/pbc.25289; Kwiatkowski JL, 2011, PEDIATR BLOOD CANCER, V56, P777, DOI 10.1002/pbc.22951; Lagunju IA, 2013, PEDIATR BLOOD CANCER, V60, P1940, DOI 10.1002/pbc.24698; Lee MT, 2006, BLOOD, V108, P847, DOI 10.1182/blood-2005-10-009506; Piel FB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001484; Ware RE, 2015, LANCET; Wood JC, 2016, BRIT J HAEMATOL, V172, P122, DOI 10.1111/bjh.13791	9	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 13	2016	387	10019					626	627		10.1016/S0140-6736(15)01130-7	http://dx.doi.org/10.1016/S0140-6736(15)01130-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD3QH	26670618	Green Submitted, Green Accepted			2022-12-28	WOS:000369837100006
J	Tan, J; Pieper, K; Piccoli, L; Abdi, A; Foglierini, M; Geiger, R; Tully, CM; Jarrossay, D; Ndungu, FM; Wambua, J; Bejon, P; Fregni, CS; Fernandez-Rodriguez, B; Barbieri, S; Bianchi, S; Marsh, K; Thathy, V; Corti, D; Sallusto, F; Bull, P; Lanzavecchia, A				Tan, Joshua; Pieper, Kathrin; Piccoli, Luca; Abdi, Abdirahman; Foglierini, Mathilde; Geiger, Roger; Tully, Claire Maria; Jarrossay, David; Ndungu, Francis Maina; Wambua, Juliana; Bejon, Philip; Fregni, Chiara Silacci; Fernandez-Rodriguez, Blanca; Barbieri, Sonia; Bianchi, Siro; Marsh, Kevin; Thathy, Vandana; Corti, Davide; Sallusto, Federica; Bull, Peter; Lanzavecchia, Antonio			A LAIR1 insertion generates broadly reactive antibodies against malaria variant antigens	NATURE			English	Article							PLASMODIUM-FALCIPARUM; V(D)J RECOMBINASE; LIFE-CYCLE; GENE; TRANSPOSITION; DELETIONS; LYMPHOMA; TARGETS; SURFACE; GENOME	Plasmodium falciparum antigens expressed on the surface of infected erythrocytes are important targets of naturally acquired immunity against malaria, but their high number and variability provide the pathogen with a powerful means of escape from host antibodies(1-4). Although broadly reactive antibodies against these antigens could be useful as therapeutics and in vaccine design, their identification has proven elusive. Here we report the isolation of human monoclonal antibodies that recognize erythrocytes infected by different P. falciparum isolates and opsonize these cells by binding to members of the RIFIN family. These antibodies acquired broad reactivity through a novel mechanism of insertion of a large DNA fragment between the V and DJ segments. The insert, which is both necessary and sufficient for binding to RIFINs, encodes the entire 98 amino acid collagen-binding domain of LAIR1, an immunoglobulin superfamily inhibitory receptor encoded on chromosome 19. In each of the two donors studied, the antibodies are produced by a single expanded B-cell clone and carry distinct somatic mutations in the LAIR1 domain that abolish binding to collagen and increase binding to infected erythrocytes. These findings illustrate, with a biologically relevant example, a novel mechanism of antibody diversification by interchromosomal DNA transposition and demonstrate the existence of conserved epitopes that may be suitable candidates for the development of a malaria vaccine.	[Tan, Joshua; Pieper, Kathrin; Piccoli, Luca; Foglierini, Mathilde; Geiger, Roger; Jarrossay, David; Fregni, Chiara Silacci; Fernandez-Rodriguez, Blanca; Barbieri, Sonia; Sallusto, Federica; Lanzavecchia, Antonio] Univ Svizzera Italiana, Inst Res Biomed, Via Vincenzo Vela 6, CH-6500 Bellinzona, Switzerland; [Tan, Joshua; Abdi, Abdirahman; Tully, Claire Maria; Ndungu, Francis Maina; Wambua, Juliana; Bejon, Philip; Marsh, Kevin; Thathy, Vandana; Bull, Peter] CGMRC, KEMRI Wellcome Trust Res Programme, POB 230, Kilifi 80108, Kenya; [Tan, Joshua; Bejon, Philip; Marsh, Kevin; Bull, Peter] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England; [Geiger, Roger; Lanzavecchia, Antonio] Swiss Fed Inst Technol, Inst Microbiol, Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland; [Bianchi, Siro; Corti, Davide] Humabs BioMed SA, CH-6500 Bellinzona, Switzerland	Universita della Svizzera Italiana; University of Oxford; Swiss Federal Institutes of Technology Domain; ETH Zurich	Lanzavecchia, A (corresponding author), Univ Svizzera Italiana, Inst Res Biomed, Via Vincenzo Vela 6, CH-6500 Bellinzona, Switzerland.; Bull, P (corresponding author), CGMRC, KEMRI Wellcome Trust Res Programme, POB 230, Kilifi 80108, Kenya.; Bull, P (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England.; Lanzavecchia, A (corresponding author), Swiss Fed Inst Technol, Inst Microbiol, Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland.	pb642@cam.ac.uk; lanzavecchia@irb.usi.ch	Ndungu, Francis Maina/C-2199-2019	Ndungu, Francis Maina/0000-0002-8977-0030; Thathy, Vandana/0000-0001-7797-8638; Foglierini, Mathilde/0000-0001-7538-4262; Piccoli, Luca/0000-0002-1085-6502; Geiger, Roger/0000-0002-8016-1669; de la Rosa (nee Pieper), Kathrin/0000-0003-4809-3157; Bianchi, Siro/0000-0002-5100-8905; Bull, Peter/0000-0002-7674-6752	European Research Council [250348, 670955]; Swiss National Science Foundation [160279]; Swiss Vaccine Research Institute; Wellcome Trust [084535, 077092, 084538, 084113/Z/07/Z, 084378/Z/07/A, 092741, 099811]; Helmut Horten Foundation; MRC [G1002624] Funding Source: UKRI; Medical Research Council [G1002624] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Vaccine Research Institute; Wellcome Trust(Wellcome TrustEuropean Commission); Helmut Horten Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank M. Nussenzweig for providing reagents for antibody cloning and expression. This work was supported by the European Research Council (grant no. 250348 IMMUNExplore and 670955 BROADimmune), the Swiss National Science Foundation (grant no. 160279), the Swiss Vaccine Research Institute and the Wellcome Trust (grant no. 084535, 077092, 084538, 084113/Z/07/Z, 084378/Z/07/A, 092741 and 099811). A.L. is supported by the Helmut Horten Foundation. This paper is published with the permission of the Director of Kenya Medical Research Institute (KEMRI).	Brondijk THC, 2010, BLOOD, V115, P1364, DOI 10.1182/blood-2009-10-246322; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; Chan JA, 2014, CELL MOL LIFE SCI, V71, P3633, DOI 10.1007/s00018-014-1614-3; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Goel S, 2015, NAT MED, V21, P314, DOI 10.1038/nm.3812; Hu JZ, 2015, CELL, V163, P947, DOI 10.1016/j.cell.2015.10.016; Kepler TB, 2014, CELL HOST MICROBE, V16, P304, DOI 10.1016/j.chom.2014.08.006; Kuppers R, 1999, NEW ENGL J MED, V341, P1520; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Messier TL, 2003, EMBO J, V22, P1381, DOI 10.1093/emboj/cdg137; Meyaard L, 2008, J LEUKOCYTE BIOL, V83, P799, DOI 10.1189/jlb.0907609; Onozawa M, 2014, P NATL ACAD SCI USA, V111, P7729, DOI 10.1073/pnas.1321889111; Reynaud CA, 2003, NAT IMMUNOL, V4, P631, DOI 10.1038/ni0703-631; Robbiani DF, 2015, CELL, V162, P727, DOI 10.1016/j.cell.2015.07.019; Scherf A, 2008, ANNU REV MICROBIOL, V62, P445, DOI 10.1146/annurev.micro.61.080706.093134; Teng G, 2015, CELL, V162, P751, DOI 10.1016/j.cell.2015.07.009; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; Vaandrager JW, 2000, BLOOD, V96, P1947, DOI 10.1182/blood.V96.5.1947.h8001947_1947_1952; Wilson PC, 1998, J EXP MED, V187, P59, DOI 10.1084/jem.187.1.59	19	102	104	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 7	2016	529	7584					105	+		10.1038/nature16450	http://dx.doi.org/10.1038/nature16450			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6VY	26700814	Green Accepted			2022-12-28	WOS:000367944900036
J	Arie, S				Arie, Sophie			PRIMARY CARE Why are Dutch GPs so much happier?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sarie@bmj.com		Damoiseaux, Roger/0000-0001-8052-0302					0	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 29	2015	351								h6870	10.1136/bmj.h6870	http://dx.doi.org/10.1136/bmj.h6870			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA4OQ	26715177				2022-12-28	WOS:000367779700002
J	Doudna, J				Doudna, Jennifer			My whirlwind year with CRISPR	NATURE			English	Editorial Material									[Doudna, Jennifer] Univ Calif Berkeley, Mol & Cell Biol, Berkeley, CA 94720 USA; [Doudna, Jennifer] Univ Calif Berkeley, Chem, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Doudna, J (corresponding author), Univ Calif Berkeley, Mol & Cell Biol, Berkeley, CA 94720 USA.	doudna@berkeley.edu						Baltimore D, 2015, SCIENCE, V348, P36, DOI 10.1126/science.aab1028; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Lanphier E, 2015, NATURE, V519, P410, DOI 10.1038/519410a; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884	10	21	25	0	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2015	528	7583					469	471		10.1038/528469a	http://dx.doi.org/10.1038/528469a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ3GH	26701037	Bronze			2022-12-28	WOS:000366991900024
J	Masui, K; Lin, HH; Sievers, J; Anderson, CJ; Chang, TC; Chen, XL; Ganguly, A; Jarvis, M; Kuo, CY; Li, YC; Liao, YW; McLaughlin, M; Pen, UL; Peterson, JB; Roman, A; Timbie, PT; Voytek, T; Yadav, JK				Masui, Kiyoshi; Lin, Hsiu-Hsien; Sievers, Jonathan; Anderson, Christopher J.; Chang, Tzu-Ching; Chen, Xuelei; Ganguly, Apratim; Jarvis, Miranda; Kuo, Cheng-Yu; Li, Yi-Chao; Liao, Yu-Wei; McLaughlin, Maura; Pen, Ue-Li; Peterson, Jeffrey B.; Roman, Alexander; Timbie, Peter T.; Voytek, Tabitha; Yadav, Jaswant K.			Dense magnetized plasma associated with a fast radio burst	NATURE			English	Article							COSMOLOGICAL DISTANCES; REIONIZATION HISTORY; FARADAY-ROTATION; NEUTRON-STARS; TO 0.8; DISPERSION; ORIGIN; ENVIRONMENT; GALAXY	Fast radio bursts are bright, unresolved, non-repeating, broadband, millisecond flashes, found primarily at high Galactic latitudes, with dispersion measures much larger than expected for a Galactic source(1-7). The inferred all-sky burst rate(8) is comparable to the core-collapse supernova rate(9) out to redshift 0.5. If the observed dispersion measures are assumed to be dominated by the intergalactic medium, the sources are at cosmological distances with redshifts of 0.2 to 1 (refs 10 and 11). These parameters are consistent with a wide range of source models(12-17). One fast burst(6) revealed circular polarization of the radio emission, but no linear polarization was detected, and hence no Faraday rotation measure could be determined. Here we report the examination of archival data revealing Faraday rotation in the fast radio burst FRB 110523. Its radio flux and dispersion measure are consistent with values from previously reported bursts and, accounting for a Galactic contribution to the dispersion and using a model of intergalactic electron density(10), we place the source at a maximum redshift of 0.5. The burst has a much higher rotation measure than expected for this line of sight through the Milky Way and the intergalactic medium, indicating magnetization in the vicinity of the source itself or within a host galaxy. The pulse was scattered by two distinct plasma screens during propagation, which requires either a dense nebula associated with the source or a location within the central region of its host galaxy. The detection in this instance of magnetization and scattering that are both local to the source favours models involving young stellar populations such as magnetars over models involving the mergers of older neutron stars, which are more likely to be located in low-density regions of the host galaxy.	[Masui, Kiyoshi] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; [Masui, Kiyoshi; Pen, Ue-Li] Canadian Inst Adv Res, CIFAR Program Cosmol & Grav, Toronto, ON M5G 1Z8, Canada; [Lin, Hsiu-Hsien; Peterson, Jeffrey B.; Roman, Alexander; Voytek, Tabitha] Carnegie Mellon Univ, Dept Phys, McWilliams Ctr Cosmol, Pittsburgh, PA 15213 USA; [Sievers, Jonathan; Voytek, Tabitha] Univ KwaZulu Natal, Sch Chem & Phys, Astrophys & Cosmol Res Unit, ZA-4001 Durban, South Africa; [Sievers, Jonathan] Natl Inst Theoret Phys NITheP, KZN Node, ZA-4001 Durban, South Africa; [Anderson, Christopher J.; Timbie, Peter T.] Univ Wisconsin, Dept Phys, Madison, WI 53706 USA; [Chang, Tzu-Ching; Kuo, Cheng-Yu; Liao, Yu-Wei] Acad Sinica, Inst Astron & Astrophys, Taipei 10617, Taiwan; [Chen, Xuelei; Li, Yi-Chao] Chinese Acad Sci, Natl Astron Observ, Beijing 100012, Peoples R China; [Chen, Xuelei] Peking Univ, Ctr High Energy Phys, Beijing 100871, Peoples R China; [Ganguly, Apratim] Univ KwaZulu Natal, Astrophys & Cosmol Res Unit, Sch Math Stat & Comp Sci, ZA-4001 Durban, South Africa; [Jarvis, Miranda] Univ Toronto, Dept Astron & Astrophys, Toronto, ON M5S 3H4, Canada; [Kuo, Cheng-Yu] Natl Sun Yat Sen Univ, Dept Phys, Kaohsiung 804, Taiwan; [McLaughlin, Maura] W Virginia Univ, Dept Phys & Astron, Morgantown, WV 26506 USA; [Pen, Ue-Li] Canadian Inst Theoret Astrophys, Toronto, ON M5S 3H8, Canada; [Pen, Ue-Li] Perimeter Inst, Waterloo, ON N2L 2Y5, Canada; [Yadav, Jaswant K.] Indian Inst Sci Educ & Res Mohali, Sas Nagar, Manauli, India	University of British Columbia; Canadian Institute for Advanced Research (CIFAR); Carnegie Mellon University; University of Kwazulu Natal; University of Wisconsin System; University of Wisconsin Madison; Academia Sinica - Taiwan; Chinese Academy of Sciences; National Astronomical Observatory, CAS; Peking University; University of Kwazulu Natal; University of Toronto; National Sun Yat Sen University; West Virginia University; Perimeter Institute for Theoretical Physics; Indian Institute of Science Education & Research (IISER) - Mohali	Masui, K (corresponding author), Univ British Columbia, Dept Phys & Astron, 6224 Agr Rd, Vancouver, BC V6T 1Z1, Canada.	kiyo@physics.ubc.ca	Pen, Ue-Li/GWV-1294-2022; Peterson, Jeffrey/O-4794-2014	Pen, Ue-Li/0000-0003-2155-9578; Peterson, Jeffrey/0000-0003-1340-818X; Yadav, Jaswant/0000-0002-9543-683X; Ganguly, Apratim/0000-0001-7394-0755; McLaughlin, Maura/0000-0001-7697-7422; Chang, Tzu-Ching/0000-0001-5929-4187; Sievers, Jonathan/0000-0001-6903-5074; Anderson, Christopher/0000-0001-6156-4449; Masui, Kiyoshi/0000-0002-4279-6946; Jarvis, Miranda E./0000-0002-1460-6762	CIFAR Global Scholars Program; MoST [103-2112-M-001-002-MY3]; MOST 863 programme [2012AA121701]; CAS [XDB09000000]; NSFC [11373030]; NSF [1211781, 1211777]	CIFAR Global Scholars Program; MoST; MOST 863 programme; CAS(Chinese Academy of Sciences); NSFC(National Natural Science Foundation of China (NSFC)); NSF(National Science Foundation (NSF))	K.M. is supported by the CIFAR Global Scholars Program. T.-C.C. acknowledges support from MoST grant 103-2112-M-001-002-MY3. X.C. and Y.-C.L. are supported by MOST 863 programme 2012AA121701, CAS XDB09000000 and NSFC 11373030. P.T.T. acknowledges support from NSF Award 1211781. J.B.P. acknowledges support from NSF Award 1211777. Computations were performed on the General Purpose Cluster supercomputer at the SciNet HPC Consortium.	Alam S, 2015, ASTROPHYS J SUPPL S, V219, DOI 10.1088/0067-0049/219/1/12; Burke-Spolaor S, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/1/19; Chang TC, 2010, NATURE, V466, P463, DOI 10.1038/nature09187; Connor L., 2015, PREPRINT; Cordes J. M., 2002, PREPRINT; Dennison B, 2014, MON NOT R ASTRON SOC, V443, pL11, DOI 10.1093/mnrasl/slu072; Falcke H, 2014, ASTRON ASTROPHYS, V562, DOI 10.1051/0004-6361/201321996; Geng JJ, 2015, ASTROPHYS J, V809, DOI 10.1088/0004-637X/809/1/24; HAMILTON PA, 1987, MON NOT R ASTRON SOC, V224, P1073, DOI 10.1093/mnras/224.4.1073; Inoue S, 2004, MON NOT R ASTRON SOC, V348, P999, DOI 10.1111/j.1365-2966.2004.07359.x; Ioka K, 2003, ASTROPHYS J, V598, pL79, DOI 10.1086/380598; Johnson MD, 2012, ASTROPHYS J, V755, DOI 10.1088/0004-637X/755/2/179; Katz J. I., 2015, PREPRINT; Keane EF, 2012, MON NOT R ASTRON SOC, V425, pL71, DOI 10.1111/j.1745-3933.2012.01306.x; Kulkarni SR, 2014, ASTROPHYS J, V797, DOI 10.1088/0004-637X/797/1/70; Loeb A, 2014, MON NOT R ASTRON SOC, V439, pL46, DOI 10.1093/mnrasl/slt177; Lorimer DR, 2007, SCIENCE, V318, P777, DOI 10.1126/science.1147532; Lorimer D. R., 2004, HDB PULSAR ASTRONOMY; Lyubarsky Y, 2014, MON NOT R ASTRON SOC, V442, pL9, DOI 10.1093/mnrasl/slu046; Macquart JP, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/2/125; Maoz D, 2015, MON NOT R ASTRON SOC, V454, P2183, DOI 10.1093/mnras/stv2105; Oppermann N, 2015, ASTRON ASTROPHYS, V575, DOI 10.1051/0004-6361/201423995; Petroff E, 2015, MON NOT R ASTRON SOC, V447, P246, DOI 10.1093/mnras/stu2419; RADHAKRISHNAN V, 1969, ASTROPHYS LETT, V3, P225; Rane A., 2015, MON NOT R ASTRON SOC; Ravi V, 2015, ASTROPHYS J LETT, V799, DOI 10.1088/2041-8205/799/1/L5; Spitler LG, 2014, ASTROPHYS J, V790, DOI 10.1088/0004-637X/790/2/101; Taylor J. H., 1974, Astronomy and Astrophysics Supplement Series, V15, P367; TAYLOR JH, 1993, ASTROPHYS J, V411, P674, DOI 10.1086/172870; Taylor M, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/2/135; Thornton D, 2013, SCIENCE, V341, P53, DOI 10.1126/science.1236789; Tuntsov AV, 2014, MON NOT R ASTRON SOC, V441, pL26, DOI 10.1093/mnrasl/slu039; Widrow LM, 2002, REV MOD PHYS, V74, P775, DOI 10.1103/RevModPhys.74.775; Yasuda N, 2001, ASTRON J, V122, P1104, DOI 10.1086/322093	36	259	265	1	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2015	528	7583					523	+		10.1038/nature15769	http://dx.doi.org/10.1038/nature15769			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ3GH	26633633	Green Submitted			2022-12-28	WOS:000366991900045
J	Shtasel, DL; Freudenreich, O; Baggett, TP				Shtasel, Derri L.; Freudenreich, Oliver; Baggett, Travis P.			Case 40-2015: A 40-Year-Old Homeless Woman with Headache, Hypertension, and Psychosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SCHIZOPHRENIA		[Shtasel, Derri L.; Freudenreich, Oliver] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Baggett, Travis P.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Shtasel, Derri L.; Freudenreich, Oliver] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Baggett, Travis P.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Shtasel, DL (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA.		Shtasel, Derri/AAL-5661-2020	Shtasel, Derri/0000-0002-8932-8066				Alakeson V, 2010, HEALTH AFFAIR, V29, P867, DOI 10.1377/hlthaff.2010.0080; [Anonymous], 1997, OUT SHADOWS CONFRONT; Dixon L, 2000, PSYCHIATR SERV, V51, P759, DOI 10.1176/appi.ps.51.6.759; Freudenreich O, 2009, EARLY INTERV PSYCHIA, V3, P10, DOI 10.1111/j.1751-7893.2008.00105.x; Goering P., 2014, NATL FINAL REPORT CR; Hackett ML, 2014, LANCET NEUROL, V13, P525, DOI [10.1016/s1474-4422(14)70016-X, 10.1016/S1474-4422(14)70016-X]; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; Kahn RS, 2013, JAMA PSYCHIAT, V70, P1107, DOI 10.1001/jamapsychiatry.2013.155; Keefe RSE, 2007, ARCH GEN PSYCHIAT, V64, P633, DOI 10.1001/archpsyc.64.6.633; Meagher DJ, 2007, BRIT J PSYCHIAT, V190, P135, DOI 10.1192/bjp.bp.106.023911; Sheedy CK., 2009, HHS PUBL, VSMA0; Substance Abuse and Mental Health Services Administration, 2014, REC REC SUPP; Tsemberis S, 2000, PSYCHIATR SERV, V51, P487, DOI 10.1176/appi.ps.51.4.487	13	2	2	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 24	2015	373	26					2563	2570		10.1056/NEJMcpc1405204	http://dx.doi.org/10.1056/NEJMcpc1405204			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ7SG	26699172				2022-12-28	WOS:000367299700012
J	Valtolina, G; Burchianti, A; Amico, A; Neri, E; Xhani, K; Seman, JA; Trombettoni, A; Smerzi, A; Zaccanti, M; Inguscio, M; Roati, G				Valtolina, Giacomo; Burchianti, Alessia; Amico, Andrea; Neri, Elettra; Xhani, Klejdja; Seman, Jorge Amin; Trombettoni, Andrea; Smerzi, Augusto; Zaccanti, Matteo; Inguscio, Massimo; Roati, Giacomo			Josephson effect in fermionic superfluids across the BEC-BCS crossover	SCIENCE			English	Article							DOUBLE-WELL; FLOW; OSCILLATIONS; SOLITONS	The Josephson effect is a macroscopic quantum phenomenon that reveals the broken symmetry associated with any superfluid state. Here we report on the observation of the Josephson effect between two fermionic superfluids coupled through a thin tunneling barrier. We show that the relative population and phase are canonically conjugate dynamical variables throughout the crossover from the molecular Bose-Einstein condensate (BEC) to the Bardeen-Cooper-Schrieffer (BCS) superfluid regime. For larger initial excitations from equilibrium, the dynamics of the superfluids become dissipative, which we ascribe to the propagation of vortices through the superfluid bulk. Our results highlight the robust nature of resonant superfluids.	[Valtolina, Giacomo; Burchianti, Alessia; Amico, Andrea; Neri, Elettra; Xhani, Klejdja; Seman, Jorge Amin; Smerzi, Augusto; Zaccanti, Matteo; Roati, Giacomo] CNR, Ist Nazl Ott, I-50019 Sesto Fiorentino, Italy; [Valtolina, Giacomo; Burchianti, Alessia; Amico, Andrea; Neri, Elettra; Xhani, Klejdja; Smerzi, Augusto; Zaccanti, Matteo; Inguscio, Massimo; Roati, Giacomo] European Lab Nonlinear Spect LENS, I-50019 Sesto Fiorentino, Italy; [Valtolina, Giacomo] Scuola Normale Super Pisa, Fac Math & Nat Sci, I-56126 Pisa, Italy; [Amico, Andrea; Neri, Elettra; Inguscio, Massimo] Univ Florence, Dept Phys & Astron, I-50019 Sesto Fiorentino, Italy; [Trombettoni, Andrea] CNR, Ist Officina Mat, I-34136 Trieste, Italy; [Trombettoni, Andrea] Scuola Int Super Studi Avanzati, I-34136 Trieste, Italy; [Smerzi, Augusto] Quantum Sci & Technol Arcetri, I-50125 Florence, Italy; [Inguscio, Massimo] Ist Nazl Ric Metrol, I-10135 Turin, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale di Ottica (INO-CNR); Scuola Normale Superiore di Pisa; University of Florence; Consiglio Nazionale delle Ricerche (CNR); Istituto Officina dei Materiali (IOM-CNR); International School for Advanced Studies (SISSA); Istituto Nazionale Astrofisica (INAF); Istituto Nazionale di Ricerca Metrologica (INRIM)	Roati, G (corresponding author), CNR, Ist Nazl Ott, I-50019 Sesto Fiorentino, Italy.	giacomo.roati@ino.it	Zaccanti, Matteo/D-2474-2014; Roati, Giacomo/AFZ-0793-2022; Seman Harutinian, Jorge Amin/AAG-2885-2019	Zaccanti, Matteo/0000-0001-6214-4921; NERI, ELETTRA/0000-0001-6355-8165; Valtolina, Giacomo/0000-0002-5497-958X; BURCHIANTI, Alessia/0000-0001-9294-4057; Seman Harutinian, Jorge Amin/0000-0003-1473-8869; Trombettoni, Andrea/0000-0002-1108-4727; Xhani, Klejdja/0000-0003-0713-8523; Inguscio, Massimo/0000-0001-8152-8103	European Research Council [307032 QuFerm2D]	European Research Council(European Research Council (ERC)European Commission)	We acknowledge inspiring discussions with F. Dalfovo, A. Recati, and W. Zwerger. We thank C. Fort, A. Trenkwalder, A. Morales, and T. Macri for collaboration at the initial stage of this work. We especially acknowledge the LENS Quantum Gases group. This work was supported under European Research Council grant no. 307032 QuFerm2D.	Abad M, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/40005; Albiez M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.010402; ANDERSON PW, 1966, REV MOD PHYS, V38, P298, DOI 10.1103/RevModPhys.38.298; Astrakharchik GE, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.230405; Barone A., 1982, PHYS APPL JOSEPHSON; Bulgac A, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.025301; Burchianti A, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.043408; Cataliotti FS, 2001, SCIENCE, V293, P843, DOI 10.1126/science.1062612; Chen QJ, 2005, PHYS REP, V412, P1, DOI 10.1016/j.physrep.2005.02.005; Chin JK, 2006, NATURE, V443, P961, DOI 10.1038/nature05224; Davis JC, 2002, REV MOD PHYS, V74, P741, DOI 10.1103/RevModPhys.74.741; Finazzi S, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.245301; Forbes MM, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.043638; Gandolfi S, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.041601; Grimm R., 2008, ULTRA COLD FERMI GAS; Hoskinson E, 2006, NAT PHYS, V2, P23, DOI 10.1038/nphys190; Hufner S, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/6/062501; JOSEPHSON BD, 1962, PHYS LETT, V1, P251, DOI 10.1016/0031-9163(62)91369-0; Kohstall C, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/6/065027; Komineas S, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.043617; Ku MJH, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.065301; Ku MJH, 2012, SCIENCE, V335, P563, DOI 10.1126/science.1214987; LeBlanc LJ, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.025302; Leggett AJ, 2006, QUANTUM LIQUIDS BOSE; Levy S, 2007, NATURE, V449, P579, DOI 10.1038/nature06186; Manini N, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.033625; Meier F, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.033610; Miller DE, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.070402; Piazza F, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/4/043008; Salasnich L, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.043609; Scherpelz P, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.125301; Schumm T, 2005, NAT PHYS, V1, P57, DOI 10.1038/nphys125; Sidorenkov LA, 2013, NATURE, V498, P78, DOI 10.1038/nature12136; Smerzi A, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.023613; Smerzi A, 1997, PHYS REV LETT, V79, P4950, DOI 10.1103/PhysRevLett.79.4950; Spuntarelli A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.040401; Stadler D, 2012, NATURE, V491, P736, DOI 10.1038/nature11613; Sukhatme K, 2001, NATURE, V411, P280, DOI 10.1038/35077024; Varoquaux E, 2015, REV MOD PHYS, V87, P803, DOI 10.1103/RevModPhys.87.803; Weimer W, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.095301; Wright KC, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.025302; Yefsah T, 2013, NATURE, V499, P426, DOI 10.1038/nature12338; Zapata I, 1998, PHYS REV A, V57, pR28, DOI 10.1103/PhysRevA.57.R28; Zou P, 2014, J LOW TEMP PHYS, V177, P240, DOI 10.1007/s10909-014-1209-2; Zurn G, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.135301; Zwerger W, 2012, LECT NOTES PHYS; Zwierlein M. W., 2014, INT SERIES MONOGRAPH, V157, P269	48	107	107	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2015	350	6267					1505	1508		10.1126/science.aac9725	http://dx.doi.org/10.1126/science.aac9725			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY7LY	26680193	Green Submitted			2022-12-28	WOS:000366591100053
J	Gibson, PG; Vertigan, AE				Gibson, Peter G.; Vertigan, Anne E.			Management of chronic refractory cough	BMJ-BRITISH MEDICAL JOURNAL			English	Review							URGE-TO-COUGH; IRRITABLE LARYNX SYNDROME; VOCAL FOLD MOTION; DOUBLE-BLIND; VOICE CHARACTERISTICS; RESPIRATORY SYMPTOMS; SENSORY NEUROPATHY; SPEECH PATHOLOGY; IDIOPATHIC COUGH; MUSCULAR TENSION	Chronic refractory cough (CRC) is defined as a cough that persists despite guideline based treatment. It is seen in 20-46% of patients presenting to specialist cough clinics and it has a substantial impact on quality of life and healthcare utilization. Several terms have been used to describe this condition, including the recently introduced term cough hypersensitivity syndrome. Key symptoms include a dry irritated cough localized around the laryngeal region. Symptoms are not restricted to cough and can include globus, dyspnea, and dysphonia. Chronic refractory cough has factors in common with laryngeal hypersensitivity syndromes and chronic pain syndromes, and these similarities help to shed light on the pathophysiology of the condition. Its pathophysiology is complex and includes cough reflex sensitivity, central sensitization, peripheral sensitization, and paradoxical vocal fold movement. Chronic refractory cough often occurs after a viral infection. The diagnosis is made once the main diseases that cause chronic cough have been excluded (or treated) and cough remains refractory to medical treatment. Several treatments have been developed over the past decade. These include speech pathology interventions using techniques adapted from the treatment of hyperfunctional voice disorders, as well as the use of centrally acting neuromodulators such as gabapentin and pregabalin. Potential new treatments in development also show promise.	[Gibson, Peter G.] Univ Newcastle, John Hunter Hosp, Hunter Med Res Inst, Ctr Asthma & Resp Dis,Dept Resp & Sleep Med, Newcastle, NSW 2010, Australia; [Vertigan, Anne E.] Univ Newcastle, John Hunter Hosp, Hunter Med Res Inst, Ctr Asthma & Resp Dis,Speech Pathol Dept,Hunter R, Newcastle, NSW 2010, Australia	Hunter Medical Research Institute; John Hunter Hospital; University of Newcastle; Hunter Medical Research Institute; John Hunter Hospital; University of Newcastle	Gibson, PG (corresponding author), Univ Newcastle, John Hunter Hosp, Hunter Med Res Inst, Ctr Asthma & Resp Dis,Dept Resp & Sleep Med, Newcastle, NSW 2010, Australia.	peter.gibson@hnehealth.nsw.gov.au	gibson, peter/G-6194-2014	gibson, peter/0000-0001-5865-489X				Abdul-Hussein M, 2015, J CLIN GASTROENTEROL; Abdullah H, 2014, THORAX, V69, P46, DOI 10.1136/thoraxjnl-2013-203894; Abdulqawi R, 2015, LANCET, V385, P1198, DOI 10.1016/S0140-6736(14)61255-1; Altman KW, 2015, LARYNGOSCOPE, V125, P1675, DOI 10.1002/lary.25186; Andrianopoulos MV, 2000, J VOICE, V14, P607, DOI 10.1016/S0892-1997(00)80016-8; Angsuwarangsee T, 2002, J VOICE, V16, P333, DOI 10.1016/S0892-1997(02)00105-4; Forrest LA, 2012, LARYNGOSCOPE, V122, P844, DOI 10.1002/lary.23176; Aviv JE, 1998, DYSPHAGIA, V13, P87, DOI 10.1007/PL00009561; Bastian RW, 2006, OTOLARYNG HEAD NECK, V135, P17, DOI 10.1016/j.otohns.2006.02.003; Birrell MA, 2014, J ALLERGY CLIN IMMUN, V133, P679, DOI 10.1016/j.jaci.2013.12.003; Birring SS, 2008, EUR RESPIR J, V31, P1013, DOI 10.1183/09031936.00057407; Birring SS, 2003, THORAX, V58, P339, DOI 10.1136/thorax.58.4.339; Birring SS, 2011, AM J RESP CRIT CARE, V183, P708, DOI 10.1164/rccm.201007-1017CI; Britt H, 2008, GEN PRACTICE ACTIVIT; Brown KK, 2006, CHEST, V129, p180S, DOI 10.1378/chest.129.1_suppl.180S; Canning BJ, 2014, CHEST, V146, P1633, DOI 10.1378/chest.14-1481; Cerveri I, 2003, EUR RESPIR J, V22, P413, DOI 10.1183/09031936.03.00121103; Chamberlain S, 2013, PULM PHARMACOL THER, V26, P524, DOI 10.1016/j.pupt.2013.03.012; Chamberlain SAF, 2015, LUNG, V193, P401, DOI 10.1007/s00408-015-9701-2; Chung KF, 2008, LANCET, V371, P1364, DOI 10.1016/S0140-6736(08)60595-4; Chung KF, 2014, J THORAC DIS, V6, pS699, DOI 10.3978/j.issn.2072-1439.2014.08.41; Chung KF, 2015, CURR OPIN PHARMACOL, V22, P29, DOI 10.1016/j.coph.2015.03.002; Cohen SM, 2013, OTOLARYNG HEAD NECK, V148, P374, DOI 10.1177/0194599812471817; Coultas DB, 2001, AM J RESP CRIT CARE, V164, P372, DOI 10.1164/ajrccm.164.3.2004029; CULLINAN P, 1992, RESP MED, V86, P143, DOI 10.1016/S0954-6111(06)80231-3; Davenport PW, 2002, EUR RESPIR REV, V12, P249; Dicpinigaitis PV, 2006, CHEST, V130, P1839, DOI 10.1378/chest.130.6.1839; Dicpinigaitis PV, 1998, RESPIRATION, V65, P86, DOI 10.1159/000029232; Dicpinigaitis PV, 1998, J CLIN PHARMACOL, V38, P364, DOI 10.1002/j.1552-4604.1998.tb04436.x; DIPEDE C, 1991, CHEST, V99, P916, DOI 10.1378/chest.99.4.916; Eckerblad J, 2014, HEART LUNG, V43, P351, DOI 10.1016/j.hrtlng.2014.04.004; Everett Caroline F, 2007, Cough, V3, P5, DOI 10.1186/1745-9974-3-5; Ford AC, 2006, THORAX, V61, P975, DOI 10.1136/thx.2006.060087; French CL, 1998, ARCH INTERN MED, V158, P1657, DOI 10.1001/archinte.158.15.1657; French CT, 2015, CHEST, V148, P32, DOI 10.1378/chest.15-0164; Gibson P, 2016, CHEST, V149, P27, DOI 10.1378/chest.15-1496; Gibson PG, 2010, MED J AUSTRALIA, V192, P265, DOI 10.5694/j.1326-5377.2010.tb03504.x; Groneberg DA, 2004, AM J RESP CRIT CARE, V170, P1276, DOI 10.1164/rccm.200402-174OC; Halum SL, 2009, LARYNGOSCOPE, V119, P1844, DOI 10.1002/lary.20553; Haque RA, 2005, CHEST, V127, P1710, DOI 10.1378/chest.127.5.1710; Hilton E, 2015, RESP MED, V109, P701, DOI 10.1016/j.rmed.2015.03.011; HOLMES PW, 1992, RESP MED, V86, P425, DOI 10.1016/S0954-6111(06)80010-7; Hope-Gill BDM, 2003, AM J RESP CRIT CARE, V168, P995, DOI 10.1164/rccm.200304-597OC; Hull JH, 2015, PULM PHARMACOL THER, V35, P111, DOI 10.1016/j.pupt.2015.08.008; IRWIN RS, 1990, AM REV RESPIR DIS, V141, P640, DOI 10.1164/ajrccm/141.3.640; Irwin RS, 1998, CHEST, V114, p133S, DOI 10.1378/chest.114.2_Supplement.133S; Janson C, 2001, EUR RESPIR J, V18, P647, DOI 10.1183/09031936.01.00098701; Jeyakumar A, 2006, LARYNGOSCOPE, V116, P2108, DOI 10.1097/01.mlg.0000244377.60334.e3; Johnstone KJ, 2013, COCHRANE DB SYST REV, V3; Khalid S, 2014, J ALLERGY CLIN IMMUN, V134, P56, DOI 10.1016/j.jaci.2014.01.038; Kohno S, 2006, RESPIROLOGY, V11, pS135, DOI 10.1111/j.1400-1843.2006.00920.x; Lalloo UG, 1998, EUR RESPIR J, V11, P702; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Lee B, 2005, ANN OTO RHINOL LARYN, V114, P253, DOI 10.1177/000348940511400401; Leech J, 2013, AM J RESP CRIT CARE, V188, P1069, DOI 10.1164/rccm.201306-1079OC; Mathers-Schmidt BA, 2001, AM J SPEECH-LANG PAT, V10, P111, DOI 10.1044/1058-0360(2001/012); Mazzone SB, 2005, J PHYSIOL-LONDON, V569, P559, DOI 10.1113/jphysiol.2005.093153; Mazzone SB, 2007, AM J RESP CRIT CARE, V176, P327, DOI 10.1164/rccm.200612-1856OC; Mazzone Stuart B, 2013, Cough, V9, P7, DOI 10.1186/1745-9974-9-7; McGarvey L, 2013, PULM PHARMACOL THER, V26, P528, DOI 10.1016/j.pupt.2013.05.001; McGarvey Lorcan P A, 2006, Cough, V2, P4, DOI 10.1186/1745-9974-2-4; Mintz S, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.10.046; Molassiotis A, 2010, RESP MED, V104, P934, DOI 10.1016/j.rmed.2010.02.010; Morice AH, 2006, THORAX, V61, pI1, DOI 10.1136/thx.2006.065144; Morice AH, 2007, EUR RESPIR J, V29, P1256, DOI 10.1183/09031936.00101006; Morice AH, 2007, AM J RESP CRIT CARE, V175, P312, DOI 10.1164/rccm.200607-892OC; Morice AH, 2014, EUR RESPIR J, V44, P1149, DOI 10.1183/09031936.00217813; Morice AH, 2014, EUR RESPIR J, V44, P1132, DOI 10.1183/09031936.00218613; Morice AH, 2012, LUNG, V190, P3, DOI 10.1007/s00408-011-9351-y; Morice AH, 2010, LUNG, V188, pS87, DOI 10.1007/s00408-009-9185-z; Morrison M, 1999, J VOICE, V13, P447, DOI 10.1016/S0892-1997(99)80049-6; MORRISON MD, 1983, J OTOLARYNGOL, V12, P302; MORRISON MD, 1993, ACTA OTO-LARYNGOL, V113, P428, DOI 10.3109/00016489309135839; Morrison M, 2010, CAN J SPEECH-LANG PA, V34, P282; Murry T, 2004, LARYNGOSCOPE, V114, P1341, DOI 10.1097/00005537-200408000-00005; Murry T, 2010, LARYNGOSCOPE, V120, P1576, DOI 10.1002/lary.20985; Murry T, 2010, OTOLARYNG CLIN N AM, V43, P73, DOI 10.1016/j.otc.2009.11.004; NATHADWARAWALA KM, 1992, J NEUROL NEUROSUR PS, V55, P822, DOI 10.1136/jnnp.55.9.822; Norris BK, 2010, ANN OTO RHINOL LARYN, V119, P188, DOI 10.1177/000348941011900307; O'Neill J, 2010, PULM PHARMACOL THER, V26, P476; Pacheco A, 2014, THORAX, V69, P881, DOI 10.1136/thoraxjnl-2014-205661; Patel AS, 2011, CHRON RESP DIS, V8, P253, DOI 10.1177/1479972311422547; Pavord ID, 2008, LANCET, V371, P1375, DOI 10.1016/S0140-6736(08)60596-6; Pizzichini M M, 1999, Can Respir J, V6, P323; Prudon B, 2005, CHEST, V127, P550, DOI 10.1378/chest.127.2.550; Raghu G, 2012, NEW ENGL J MED, V366, P1968, DOI 10.1056/NEJMoa1113354; Raj A. A., 2009, V187, P311, DOI 10.1007/978-3-540-79842-2_16; Ribeiro M, 2007, ANN ALLERG ASTHMA IM, V99, P61, DOI 10.1016/S1081-1206(10)60623-0; Ryan NM, 2012, LANCET, V380, P1583, DOI 10.1016/S0140-6736(12)60776-4; Ryan NM, 2012, RESP MED, V106, P138, DOI 10.1016/j.rmed.2011.10.007; Ryan Nicole M, 2010, Cough, V6, P5, DOI 10.1186/1745-9974-6-5; Ryan Nicole M, 2009, Cough, V5, P4, DOI 10.1186/1745-9974-5-4; Ryan NM, 2009, LARYNGOSCOPE, V119, P640, DOI 10.1002/lary.20114; Ryerson CJ, 2011, RESPIROLOGY, V16, P969, DOI 10.1111/j.1440-1843.2011.01996.x; Rytila P, 2008, EUR RESPIR J, V32, P989, DOI 10.1183/09031936.00062307; Sarani B, 2002, J CLIN GASTROENTEROL, V34, P200, DOI 10.1097/00004836-200203000-00002; Schappert S M, 1994, Vital Health Stat 13, P1; Shaheen NJ, 2011, ALIMENT PHARM THER, V33, P225, DOI 10.1111/j.1365-2036.2010.04511.x; Shembel AC, 2013, LARYNGOSCOPE, V123, P1931, DOI 10.1002/lary.23916; Smith JA, 2010, GASTROENTEROLOGY, V139, P754, DOI 10.1053/j.gastro.2010.06.050; Song WJ, 2015, EUR RESPIR J, V45, P1479, DOI 10.1183/09031936.00218714; Vertigan AE, 2006, THORAX, V61, P1065, DOI 10.1136/thx.2006.064337; Vertigan AE, 2008, FOLIA PHONIATR LOGO, V60, P210, DOI 10.1159/000136902; Vertigan AE, 2007, J MED SPEECH-LANG PA, V15, P189; Vertigan AE, 2007, FOLIA PHONIATR LOGO, V59, P256, DOI 10.1159/000104464; Vertigan AE, 2007, J VOICE, V21, P361, DOI 10.1016/j.jvoice.2005.12.008; Vertigan AE, 2016, CHEST, V149, P639, DOI 10.1378/chest.15-1271; Vertigan Anne E, 2014, Cough, V10, P1, DOI 10.1186/1745-9974-10-1; Vertigan AE, 2013, RESPIROLOGY, V18, P948, DOI 10.1111/resp.12103; Vertigan AE, 2012, LUNG, V190, P35, DOI 10.1007/s00408-011-9333-0; Vertigan AE, 2011, J VOICE, V25, P596, DOI 10.1016/j.jvoice.2010.07.009; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Xu XH, 2013, WORLD J GASTROENTERO, V19, P4386, DOI 10.3748/wjg.v19.i27.4386; Zemp E, 1999, AM J RESP CRIT CARE, V159, P1257, DOI 10.1164/ajrccm.159.4.9807052	114	62	67	2	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 14	2015	351								h5590	10.1136/bmj.h5590	http://dx.doi.org/10.1136/bmj.h5590			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ4KY	26666537				2022-12-28	WOS:000367073200001
J	Bang, A				Bang, Abhay			Health insurance, assurance, and empowerment in India	LANCET			English	Editorial Material									[Bang, Abhay] SEARCH, Gadchiroli 442605, Maharashtra, India		Bang, A (corresponding author), SEARCH, Gadchiroli 442605, Maharashtra, India.	search.gad@gmail.com						Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; Centres for Disease Control and Prevention, FAST STATS HLTH EXP; Debroy B, 2015, LANCET, V386, pE56, DOI 10.1016/S0140-6736(15)01173-3; GoM, 2013, REP HIGH LEV COMM BA; [Government of India Press Information Bureau], 2014, ROLL OUT NAT HLTH AS; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Ministry of Health and Family Welfare, 2014, NAT HLTH POL 2015 DR; National Rural Health Mission, 2011, OP GUID HOM BAS NEON; Patel V, 2015, LANCET, V386, P2422, DOI 10.1016/S0140-6736(15)00955-1; Planning Commission of India, 2012, REP WORK GROUP TERT; Planning commission of India, 2013, 12 5 YEAR PLAN 2012; Planning Commission of India, 2011, HIGH LEV EXP GROUP R; Santosh Sawalkar, 2013, Economic and Political Weekly, V48, P19; WHO(World Health Organization), 2008, CLOS GAP GEN COMM SO	14	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 12	2015	386	10011					2372	+		10.1016/S0140-6736(15)01174-5	http://dx.doi.org/10.1016/S0140-6736(15)01174-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CY3EE	26700517				2022-12-28	WOS:000366290400010
J	Jenkinson, A				Jenkinson, Andrew			CHRISTMAS 2015: PROFESSIONAL CONSIDERATIONS Death of a proverb	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Jenkinson, Andrew] Musgrove Pk Hosp, Taunton, Somerset, England	Musgrove Park Hospital	Jenkinson, A (corresponding author), Musgrove Pk Hosp, Taunton, Somerset, England.	aojenkinson@googlemail.com						Garisto Juan D, 2009, Cases J, V2, P127, DOI 10.1186/1757-1626-2-127	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 11	2015	351								h6226	10.1136/bmj.h6226	http://dx.doi.org/10.1136/bmj.h6226			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY5TJ	26655031				2022-12-28	WOS:000366470100002
J	Rudolph, ML; Lekic, V; Lithgow-Bertelloni, C				Rudolph, Maxwell L.; Lekic, Vedran; Lithgow-Bertelloni, Carolina			Viscosity jump in Earth's mid-mantle	SCIENCE			English	Article							WHOLE-MANTLE; SEISMIC TOMOGRAPHY; PLATE MOTION; FLOW MODELS; INVERSION; CONVECTION; STRATIFICATION; HETEROGENEITY; OBSERVABLES; TRANSITION	The viscosity structure of Earth's deep mantle affects the thermal evolution of Earth, the ascent of mantle plumes, settling of subducted oceanic lithosphere, and the mixing of compositional heterogeneities in the mantle. Based on a reanalysis of the long-wavelength nonhydrostatic geoid, we infer viscous layering of the mantle using a method that allows us to avoid a priori assumptions about its variation with depth. We detect an increase in viscosity at 800- to 1200-kilometers depth, far greater than the depth of the mineral phase transformations that define the mantle transition zone. The viscosity increase is coincident in depth with regions where seismic tomography has imaged slab stagnation, plume deflection, and changes in large-scale structure and offers a simple explanation of these phenomena.	[Rudolph, Maxwell L.] Portland State Univ, Dept Geol, Portland, OR 97207 USA; [Lekic, Vedran] Univ Maryland, Dept Geol, College Pk, MD 20742 USA; [Lithgow-Bertelloni, Carolina] UCL, Dept Earth Sci, London WC1E 6BT, England	Portland State University; University System of Maryland; University of Maryland College Park; University of London; University College London	Rudolph, ML (corresponding author), Portland State Univ, Dept Geol, POB 751, Portland, OR 97207 USA.	maxwell.rudolph@pdx.edu	Lithgow-Bertelloni, Carolina/P-3952-2019; Lekic, Vedran/I-8121-2012; Lithgow-Bertelloni, Carolina/C-4827-2011; Rudolph, Maxwell/AAT-7673-2021	Lithgow-Bertelloni, Carolina/0000-0003-0924-6587; Lekic, Vedran/0000-0002-3548-272X; Lithgow-Bertelloni, Carolina/0000-0003-0924-6587; Rudolph, Maxwell/0000-0001-7721-4224	NSF [EAR/1135452]; Natural Environment Research Council [NE/K006061/1]; Packard Science and Engineering Fellowship; Division Of Earth Sciences [1352214] Funding Source: National Science Foundation; NERC [NE/K006061/1] Funding Source: UKRI	NSF(National Science Foundation (NSF)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Packard Science and Engineering Fellowship; Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank T. Becker and C. O'Neill for developing and releasing the source code to HC and the Computational Infrastructure for Geodynamics (geodynamics.org) for distributing software, Y. Ricard for enlightening discussion, and three anonymous reviewers. This project was initiated at the 2014 CIDER workshop at the Kavli Institute for Theoretical Physics, University of California, Santa Barbara. This work was supported by NSF grant EAR/1135452 and Natural Environment Research Council NE/K006061/1, as well as a Packard Science and Engineering Fellowship to V.L. All data are available in the manuscript and supplementary materials. The GRACE gravity model GGM05S can be obtained at: ftp://ftp.csr.utexas.edu/pub/grace.	Ammann MW, 2011, EARTH PLANET SC LETT, V302, P393, DOI 10.1016/j.epsl.2010.12.031; Ammann MW, 2010, NATURE, V465, P462, DOI 10.1038/nature09052; Becker TW, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000168; Bolfan-Casanova N, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017182; Boschi L, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049281; Chambat F, 2010, GEOPHYS J INT, V183, P727, DOI 10.1111/j.1365-246X.2010.04771.x; Cserepes L, 1997, GEOPHYS RES LETT, V24, P181, DOI 10.1029/96GL03917; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; FORTE AM, 1991, J GEOPHYS RES-SOL EA, V96, P20131, DOI 10.1029/91JB01709; French SW, 2014, GEOPHYS J INT, V199, P1303, DOI 10.1093/gji/ggu334; French SW, 2015, NATURE, V525, P95, DOI 10.1038/nature14876; Frost DJ, 2004, NATURE, V428, P409, DOI 10.1038/nature02413; Fukao Y, 2013, J GEOPHYS RES-SOL EA, V118, P5920, DOI 10.1002/2013JB010466; Ghosh A, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL040426; JORDAN TH, 1993, SCIENCE, V261, P1427, DOI 10.1126/science.261.5127.1427; Kellogg LH, 1999, SCIENCE, V283, P1881, DOI 10.1126/science.283.5409.1881; Kido M, 1998, PHYS EARTH PLANET IN, V107, P307, DOI 10.1016/S0031-9201(98)00077-6; King SD, 2015, GEOLOGY, V43, P231, DOI 10.1130/G36320.1; KING SD, 1992, GEOPHYS RES LETT, V19, P1551, DOI 10.1029/92GL01700; Marquardt H, 2015, NAT GEOSCI, V8, P311, DOI 10.1038/NGEO2393; Mitrovica JX, 2004, EARTH PLANET SC LETT, V225, P177, DOI 10.1016/j.epsl.2004.06.005; Moucha R, 2007, GEOPHYS J INT, V169, P113, DOI 10.1111/j.1365-246X.2006.03225.x; Obayashi M, 2013, GEOPHYS RES LETT, V40, P5652, DOI 10.1002/2013GL057401; Paulson A, 2007, GEOPHYS J INT, V171, P497, DOI 10.1111/J.1365-246X.2007.03556.X; Paulson A, 2007, GEOPHYS J INT, V168, P1195, DOI 10.1111/j.1365-246X.2006.03222.x; RICARD Y, 1989, J GEOPHYS RES-SOLID, V94, P13739, DOI 10.1029/JB094iB10p13739; Rickers F, 2013, EARTH PLANET SC LETT, V367, P39, DOI 10.1016/j.epsl.2013.02.022; Sambridge M, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2011.0547; Stixrude L, 2007, EARTH PLANET SC LETT, V263, P45, DOI 10.1016/j.epsl.2007.08.027; van der Hilst RD, 1999, SCIENCE, V283, P1885, DOI 10.1126/science.283.5409.1885; Wen LX, 1997, EARTH PLANET SC LETT, V146, P367, DOI 10.1016/S0012-821X(96)00238-5; Wentzcovitch RM, 2009, P NATL ACAD SCI USA, V106, P8447, DOI 10.1073/pnas.0812150106; Zhong SJ, 2001, J GEOPHYS RES-SOL EA, V106, P703, DOI 10.1029/2000JB900364	33	146	147	1	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2015	350	6266					1349	1352		10.1126/science.aad1929	http://dx.doi.org/10.1126/science.aad1929			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1JL	26659053	Green Submitted			2022-12-28	WOS:000366162400036
J	Oxtoby, K				Oxtoby, Kathy			Why doctors don't take sick leave	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												kathyoxtoby@blueyonder.co.uk						Health and Social Care Information Centre, 2015, NHS SICKN ABS RAT JA; Stephenson J, 2009, BMJ CAREERS	2	7	7	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 9	2015	351								h6719	10.1136/bmj.h6719	http://dx.doi.org/10.1136/bmj.h6719			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY5SX	26656508				2022-12-28	WOS:000366468800016
J	Reichwald, K; Petzold, A; Koch, P; Downie, BR; Hartmann, N; Pietsch, S; Baumgart, M; Chalopin, D; Felder, M; Bens, M; Sahm, A; Szafranski, K; Taudien, S; Groth, M; Arisi, I; Weise, A; Bhatt, SS; Sharma, V; Kraus, JM; Schmid, F; Priebe, S; Liehr, T; Gorlach, M; Than, ME; Hiller, M; Kestler, HA; Volff, JN; Schartl, M; Cellerino, A; Englert, C; Platzer, M				Reichwald, Kathrin; Petzold, Andreas; Koch, Philipp; Downie, Bryan R.; Hartmann, Nils; Pietsch, Stefan; Baumgart, Mario; Chalopin, Domitille; Felder, Marius; Bens, Martin; Sahm, Arne; Szafranski, Karol; Taudien, Stefan; Groth, Marco; Arisi, Ivan; Weise, Anja; Bhatt, Samarth S.; Sharma, Virag; Kraus, Johann M.; Schmid, Florian; Priebe, Steffen; Liehr, Thomas; Goerlach, Matthias; Than, Manuel E.; Hiller, Michael; Kestler, Hans A.; Volff, Jean-Nicolas; Schartl, Manfred; Cellerino, Alessandro; Englert, Christoph; Platzer, Matthias			Insights into Sex Chromosome Evolution and Aging from the Genome of a Short-Lived Fish	CELL			English	Article							SPECIES NOTHOBRANCHIUS-FURZERI; AFRICAN ANNUAL FISHES; LIFE-SPAN; CAENORHABDITIS-ELEGANS; VERTEBRATE MODEL; GENE-EXPRESSION; C-ELEGANS; TGF-BETA; PROVIDES INSIGHTS; NUCLEAR LAMINA	The killifish Nothobranchius furzeri is the shortest-lived vertebrate that can be bred in the laboratory. Its rapid growth, early sexual maturation, fast aging, and arrested embryonic development (diapause) make it an attractive model organism in biomedical research. Here, we report a draft sequence of its genome that allowed us to uncover an intra-species Y chromosome polymorphism representing-in real time-different stages of sex chromosome formation that display features of early mammalian XY evolution "in action." Our data suggest that gdf6Y, encoding a TGF-beta family growth factor, is the master sex-determining gene in N. furzeri. Moreover, we observed genomic clustering of aging-related genes, identified genes under positive selection, and revealed significant similarities of gene expression profiles between diapause and aging, particularly for genes controlling cell cycle and translation. The annotated genome sequence is provided as an online resource (http://www.nothobranchius.info/NFINgb).	[Reichwald, Kathrin; Petzold, Andreas; Koch, Philipp; Downie, Bryan R.; Hartmann, Nils; Pietsch, Stefan; Baumgart, Mario; Felder, Marius; Bens, Martin; Sahm, Arne; Szafranski, Karol; Taudien, Stefan; Groth, Marco; Goerlach, Matthias; Than, Manuel E.; Kestler, Hans A.; Cellerino, Alessandro; Englert, Christoph; Platzer, Matthias] Fritz Lipmann Inst FLI, Leibniz Inst Aging, D-07745 Jena, Germany; [Chalopin, Domitille; Volff, Jean-Nicolas] Univ Lyon 1, Inst Genom Fonct Lyon, Ecole Normale Super Lyon, CNRS,UMR5242, F-69364 Lyon, France; [Arisi, Ivan] European Brain Res Inst EBRI Rita Levi Montalcini, Genom Facil, I-00143 Rome, Italy; [Weise, Anja; Bhatt, Samarth S.; Liehr, Thomas] Univ Jena, Jena Univ Hosp, Inst Human Genet, D-07743 Jena, Germany; [Sharma, Virag; Hiller, Michael] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Sharma, Virag; Hiller, Michael] Max Planck Inst Phys Komplexer Syst, D-01307 Dresden, Germany; [Kraus, Johann M.; Schmid, Florian; Kestler, Hans A.] Univ Ulm, Med Syst Biol, D-89069 Ulm, Germany; [Schmid, Florian] Ulm Univ GSC270, Int Grad Sch Mol Med, D-89069 Ulm, Germany; [Priebe, Steffen] Hans Knoell Inst HKI, Leibniz Inst Nat Product Res & Infect Biol, D-07745 Jena, Germany; [Kestler, Hans A.; Englert, Christoph] Univ Jena, Fac Biol & Pharm, D-07743 Jena, Germany; [Schartl, Manfred] Univ Wurzburg, Dept Physiol Chem, Bioctr, D-97074 Wurzburg, Germany; [Schartl, Manfred] Univ Hosp Wuerzburg, Comprehens Canc Ctr Mainfranken, D-97074 Wurzburg, Germany; [Cellerino, Alessandro] Scuola Normale Super Pisa, Lab Biol, I-56126 Pisa, Italy	Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Friedrich Schiller University of Jena; Max Planck Society; Max Planck Society; Ulm University; Ulm University; Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; University of Wurzburg; University of Wurzburg; Scuola Normale Superiore di Pisa	Platzer, M (corresponding author), Fritz Lipmann Inst FLI, Leibniz Inst Aging, D-07745 Jena, Germany.	matthias.platzer@leibniz-fli.de	Cellerino, Alessandro/AAJ-7453-2020; Bhatt, Samarth/H-2892-2019; Liehr, Thomas/H-2852-2019; Kestler, Hans A./D-5799-2012; Weise, Anja/H-6669-2019; Cellerino, Alessandro/AAB-4398-2020; Sahm, Arne/AAG-3842-2019; Arisi, Ivan/AAM-1152-2021	Cellerino, Alessandro/0000-0003-3834-0097; Bhatt, Samarth/0000-0001-5706-4572; Liehr, Thomas/0000-0003-1672-3054; Kestler, Hans A./0000-0002-4759-5254; Weise, Anja/0000-0003-3988-8919; Cellerino, Alessandro/0000-0003-3834-0097; Sahm, Arne/0000-0002-7330-1790; Arisi, Ivan/0000-0002-0536-2508; Baumgart, Mario/0000-0001-8172-1595; Groth, Marco/0000-0002-9199-8990; Bens, Martin/0000-0001-7940-6668; Schartl, Manfred/0000-0001-9882-5948; Koch, Philipp/0000-0003-2825-7943; Sharma, Virag/0000-0003-4086-4105; Englert, Christoph/0000-0002-5931-3189	Leibniz Association [PAKT-2006-FLI, SAW-2012-FLI]; German Research Foundation (DFG) [RE 3505/1-1, HA 6214/2-1, SFB 1074, Z1]; German Federal Ministry of Education and Research (BMBF) [0315581A/C, 031A099, 0315894A]; European Community's Seventh Framework Program (FP7) [602783]; Italian Ministry of Higher Education (FIRB) [RBAP10L8TY]	Leibniz Association; German Research Foundation (DFG)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European Community's Seventh Framework Program (FP7); Italian Ministry of Higher Education (FIRB)	We thank Silke Foerste, Ivonne Goerlich, Ivonne Heinze, Christin Hahn, Cornelia Luge, Sabine Matz, Martin Neumann, and Bernd Senf for technical assistance. We thank Karl Lenhard Rudolph for discussions and Cornelia Platzer for critical reading of the manuscript. This work was supported by the Leibniz Association (WGL: PAKT-2006-FLI to C.E. and M.P., and SAW-2012-FLI to M.P.), the German Research Foundation (DFG: RE 3505/1-1 to K.R., HA 6214/2-1 to N.H., and SFB 1074 project Z1 to H.A.K.), the German Federal Ministry of Education and Research (BMBF: JenAge 0315581A/C to A.C., C.E., and M.P.; 031A099 to M.H.; Gerontosys II, Forschungskern SyStaR, project ID 0315894A to H.A.K.), the European Community's Seventh Framework Program (FP7/2007-2013 under grant agreement 602783 to H.A.K.), and the Italian Ministry of Higher Education (FIRB: RBAP10L8TY to I.A.).	Bartakova V, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-196; Baumgart M, 2015, BIOGERONTOLOGY, V16, P63, DOI 10.1007/s10522-014-9535-y; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Blazek R, 2013, EVODEVO, V4, DOI 10.1186/2041-9139-4-24; Cellerino A., 2015, BIOL REV CAMB PHILOS; Chandra T, 2015, CELL REP, V10, P471, DOI 10.1016/j.celrep.2014.12.055; Chen SL, 2014, NAT GENET, V46, P253, DOI 10.1038/ng.2890; Clelland ES, 2011, GEN COMP ENDOCR, V171, P211, DOI 10.1016/j.ygcen.2011.01.009; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; Di Cicco E, 2011, EXP GERONTOL, V46, P249, DOI 10.1016/j.exger.2010.10.011; Dorn A, 2011, MOL PHYLOGENET EVOL, V61, P739, DOI 10.1016/j.ympev.2011.06.010; Dorn A, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0210-3; Ellegren H, 2003, BIOESSAYS, V25, P163, DOI 10.1002/bies.10228; Genade T, 2005, AGING CELL, V4, P223, DOI 10.1111/j.1474-9726.2005.00165.x; GLAZ J, 2001, SCAN STAT; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Haas BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r7; Harel I, 2015, CELL, V160, P1013, DOI 10.1016/j.cell.2015.01.038; Hartmann N, 2012, DEV DYNAM, V241, P1133, DOI 10.1002/dvdy.23789; Hartmann N, 2011, AGING CELL, V10, P824, DOI 10.1111/j.1474-9726.2011.00723.x; Hartmann N, 2009, MECH AGEING DEV, V130, P290, DOI 10.1016/j.mad.2009.01.003; Hofer-Warbinek R, 2004, CELL DEATH DIFFER, V11, P1317, DOI 10.1038/sj.cdd.4401502; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Josso N, 2003, TRENDS ENDOCRIN MET, V14, P91, DOI 10.1016/S1043-2760(03)00005-5; JUBB R A, 1971, Journal of the American Killifish Association, V8, P12; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kikuchi K, 2013, DEV DYNAM, V242, P339, DOI 10.1002/dvdy.23927; Kirschner J, 2012, AGING CELL, V11, P252, DOI 10.1111/j.1474-9726.2011.00780.x; Koch P, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku210; Kondo M, 2006, GENOME RES, V16, P815, DOI 10.1101/gr.5016106; Kotzsch A, 2009, EMBO J, V28, P937, DOI 10.1038/emboj.2009.37; Krieglstein K, 2012, CELL TISSUE RES, V347, P5, DOI 10.1007/s00441-011-1278-3; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Luo SJ, 2010, CELL, V143, P299, DOI 10.1016/j.cell.2010.09.013; McElwee JJ, 2004, J BIOL CHEM, V279, P44533, DOI 10.1074/jbc.M406207200; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meller CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075837; Mishima Y, 2006, CURR BIOL, V16, P2135, DOI 10.1016/j.cub.2006.08.086; Morrish BC, 2002, REPRODUCTION, V124, P447, DOI 10.1530/rep.0.1240447; Myosho T, 2012, GENETICS, V191, P163, DOI 10.1534/genetics.111.137497; Nanda I, 2014, CHROMOSOMA, V123, P373, DOI 10.1007/s00412-014-0455-z; Ng'oma E, 2014, AGING-US, V6, P468, DOI 10.18632/aging.100660; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Otsuka F, 2011, MOL REPROD DEV, V78, P9, DOI 10.1002/mrd.21265; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Petzold A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-185; Podrabsky JE, 2012, CELL CYCLE, V11, P1697, DOI 10.4161/cc.19881; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Reichwald K, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r16; Rondeau EB, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-452; Santoni D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057707; Shaw WM, 2007, CURR BIOL, V17, P1635, DOI 10.1016/j.cub.2007.08.058; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Terzibasi E, 2007, EXP GERONTOL, V42, P81, DOI 10.1016/j.exger.2006.06.039; Terzibasi E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003866; Thevenin A, 2014, NUCLEIC ACIDS RES, V42, P9854, DOI 10.1093/nar/gku667; Tozzini ET, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-77; Tozzini ET, 2012, AGING CELL, V11, P241, DOI 10.1111/j.1474-9726.2011.00781.x; Valdesalicil S, 2003, P ROY SOC B-BIOL SCI, V270, pS189, DOI 10.1098/rsbl.2003.0048; Valenzano DR, 2011, G3-GENES GENOM GENET, V1, P531, DOI 10.1534/g3.111.001271; Valenzano DR, 2009, GENETICS, V183, P1385, DOI 10.1534/genetics.109.108670; Volff JN, 2007, SEX DEV, V1, P85, DOI 10.1159/000100030; Wang J, 2003, DEVELOPMENT, V130, P1621, DOI 10.1242/dev.00363; Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zullo JM, 2012, CELL, V149, P1474, DOI 10.1016/j.cell.2012.04.035	76	162	167	4	71	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 6	2015	163	6					1527	1538		10.1016/j.cell.2015.10.071	http://dx.doi.org/10.1016/j.cell.2015.10.071			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SE	26638077	Bronze			2022-12-28	WOS:000366044800023
J	Quaglioni, S				Quaglioni, Sofia			NUCLEAR PHYSICS Close encounters of the alpha kind	NATURE			English	Editorial Material							CHIRAL LAGRANGIANS; FORCES		[Quaglioni, Sofia] Lawrence Livermore Natl Lab, Nucl & Chem Sci Div, Phys & Life Sci Directorate, Livermore, CA 94551 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Quaglioni, S (corresponding author), Lawrence Livermore Natl Lab, Nucl & Chem Sci Div, Phys & Life Sci Directorate, Livermore, CA 94551 USA.	quaglioni1@llnl.gov	Elhatisari, serdar/X-5059-2019; Quaglioni, Sofia/AAS-5907-2020	Elhatisari, serdar/0000-0002-7951-1991; Quaglioni, Sofia/0000-0002-7512-605X				Elhatisari S, 2015, NATURE, V528, P111, DOI 10.1038/nature16067; Hoyle F., 1954, ASTROPHYS J SUPPL S, V1, P121, DOI 10.1086/190005; Hubbard J., 1959, J PHYS REV LETT, V3, P77; Lonardoni D, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.092301; Romero-Redondo C, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.032503; Rutherford E., 1899, LONDON EDINBURGH DUB, V47, P109; SALPETER EE, 1952, ASTROPHYS J, V115, P326, DOI 10.1086/145546; Stratonovich R. L., 1957, DOKL AKAD NAUK SSSR, V115, P1097; WEINBERG S, 1991, NUCL PHYS B, V363, P3, DOI 10.1016/0550-3213(91)90231-L; WEINBERG S, 1990, PHYS LETT B, V251, P288, DOI 10.1016/0370-2693(90)90938-3	12	1	1	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					42	43		10.1038/528042a	http://dx.doi.org/10.1038/528042a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX3NO	26632583	Green Submitted			2022-12-28	WOS:000365606000042
J	Lane, R				Lane, Richard			Suzanne Petroni: pushing equity for girls and young women	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 21	2015	386	10008					2049	2049		10.1016/S0140-6736(15)00963-0	http://dx.doi.org/10.1016/S0140-6736(15)00963-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX8XF	26700384	Bronze			2022-12-28	WOS:000365987600013
J	Wechalekar, AD; Gillmore, JD; Hawkins, PN				Wechalekar, Ashutosh D.; Gillmore, Julian D.; Hawkins, Philip N.			Systemic amyloidosis	LANCET			English	Review							STEM-CELL TRANSPLANTATION; LIGHT-CHAIN AMYLOIDOSIS; LEUKOCYTE CHEMOTACTIC FACTOR-2; HIGH-DOSE MELPHALAN; DOMINO LIVER-TRANSPLANTATION; TWICE-WEEKLY BORTEZOMIB; MARROW PLASMA-CELLS; AL AMYLOIDOSIS; CARDIAC AMYLOIDOSIS; P-COMPONENT	Tissue deposition of protein fibrils causes a group of rare diseases called systemic amyloidoses. This Seminar focuses on changes in their epidemiology, the current approach to diagnosis, and advances in treatment. Systemic light chain (AL) amyloidosis is the most common of these conditions, but wild-type transthyretin cardiac amyloidosis (ATTRwt) is increasingly being diagnosed. Typing of amyloid fibrils, a critical determinant of therapy, has improved with the wide availability of laser capture and mass spectrometry from fixed histological tissue sections. Specific and accurate evaluation of cardiac amyloidosis is now possible using cardiac magnetic resonance imaging and cardiac repurposing of bone scintigraphy tracers. Survival in AL amyloidosis has improved markedly as novel chemotherapy agents have become available, but challenges remain in advanced disease. Early diagnosis, a key to better outcomes, still remains elusive. Broadening the amyloid-specific therapeutic landscape to include RNA inhibitors, fibril formation stabilisers and inhibitors, and immunotherapeutic targeting of amyloid deposits holds promise to transform outcomes in systemic amyloidoses.	[Wechalekar, Ashutosh D.; Gillmore, Julian D.; Hawkins, Philip N.] UCL, Natl Amyloidosis Ctr, Royal Free Campus,Rowland Hill St, London NW3 2PF, England	University of London; University College London	Wechalekar, AD (corresponding author), UCL, Natl Amyloidosis Ctr, Royal Free Campus,Rowland Hill St, London NW3 2PF, England.	a.wechalekar@ucl.ac.uk						Abdelfatah MM, 2014, AMYLOID, V21, P136, DOI 10.3109/13506129.2014.885894; Adams D, 2013, THER ADV NEUROL DISO, V6, P129, DOI 10.1177/1756285612470192; Antoni G, 2013, J NUCL MED, V54, P213, DOI 10.2967/jnumed.111.102053; Antonini TM, 2013, AM J TRANSPLANT, V13, P2734, DOI 10.1111/ajt.12378; Arbustini E, 1997, AMYLOID, V4, P157, DOI 10.3109/13506129709014380; Banypersad SM, 2013, CIRC-CARDIOVASC IMAG, V6, P34, DOI 10.1161/CIRCIMAGING.112.978627; Benson MD, 2008, KIDNEY INT, V74, P218, DOI 10.1038/ki.2008.152; Berk JL, 2013, JAMA-J AM MED ASSOC, V310, P2658, DOI 10.1001/jama.2013.283815; Bochtler T, 2011, BLOOD, V117, P3809, DOI 10.1182/blood-2010-02-268987; Bodin K, 2010, NATURE, V468, P93, DOI 10.1038/nature09494; Bokhari S, 2013, CIRC-CARDIOVASC IMAG, V6, P195, DOI 10.1161/CIRCIMAGING.112.000132; BONAR L, 1969, P SOC EXP BIOL MED, V131, P1373; Buss SJ, 2012, J AM COLL CARDIOL, V60, P1067, DOI 10.1016/j.jacc.2012.04.043; Castano A, 2012, AMYLOID, V19, P41, DOI 10.3109/13506129.2011.638682; Chen WG, 2012, CURR CARDIOL REP, V14, P226, DOI 10.1007/s11886-011-0239-5; Coelho T, 2013, NEW ENGL J MED, V369, P819, DOI 10.1056/NEJMoa1208760; Coelho T, 2012, NEUROLOGY, V79, P785, DOI 10.1212/WNL.0b013e3182661eb1; Comenzo RL, 2012, LEUKEMIA, V26, P2317, DOI 10.1038/leu.2012.100; Comenzo RL, 2002, BLOOD, V99, P4276, DOI 10.1182/blood.V99.12.4276; de Carvalho M, 2002, AMYLOID, V9, P126, DOI 10.3109/13506120208995245; Dember LM, 2007, NEW ENGL J MED, V356, P2349, DOI 10.1056/NEJMoa065644; Deshmukh M, 2009, J CLIN PATHOL, V62, P724, DOI 10.1136/jcp.2009.065474; Dimopoulos MA, 2011, BLOOD, V118, P827, DOI 10.1182/blood-2011-05-355115; Dispenzieri A, 2006, BLOOD, V107, P3378, DOI 10.1182/blood-2005-07-2922; Dispenzieri A, 2004, J CLIN ONCOL, V22, P3751, DOI 10.1200/JCO.2004.03.029; Dispenzieri A, 2013, BONE MARROW TRANSPL, V48, P1302, DOI 10.1038/bmt.2013.53; Dispenzieri A, 2007, BLOOD, V109, P465, DOI 10.1182/blood-2006-07-032987; Dispenzieri A, 2012, BLOOD, V119, P5397, DOI 10.1182/blood-2012-02-413161; Dorbala S, 2014, EUR J NUCL MED MOL I, V41, P1652, DOI 10.1007/s00259-014-2787-6; Dubrey SW, 2012, QJM-INT J MED, V105, P617, DOI 10.1093/qjmed/hcr259; Ericzon BG, 2008, TRANSPL P, V40, P1130, DOI 10.1016/j.transproceed.2008.03.020; Esplin BL, 2013, CURR PROB CARDIOLOGY, V38, P53, DOI 10.1016/j.cpcardiol.2012.11.002; Falk RH, 2005, CIRCULATION, V112, P2047, DOI 10.1161/CIRCULATIONAHA.104.489187; Foli A, 2011, AMYLOID, V18, P80, DOI 10.3109/13506129.2011.574354029; Fuchs U, 2005, AM J TRANSPLANT, V5, P1159, DOI 10.1111/j.1600-6143.2005.00805.x; Gertz MA, 2013, BONE MARROW TRANSPL, V48, P557, DOI 10.1038/bmt.2012.170; Gertz MA, 2011, BONE MARROW TRANSPL, V46, P970, DOI 10.1038/bmt.2010.234; Gertz MA, 2005, AM J HEMATOL, V79, P319, DOI 10.1002/ajh.20381; GERTZ MA, 1991, J LAB CLIN MED, V118, P33; Gertz MA, 2012, ONCOLOGY-NY, V26, P152; Gillmore JD, 2006, AM J TRANSPLANT, V6, P2342, DOI 10.1111/j.1600-6143.2006.01507.x; Gillmore JD, 2010, BLOOD, V115, P4313, DOI 10.1182/blood-2010-01-261750; Gillmore JD, 2010, BRIT J HAEMATOL, V148, P760, DOI 10.1111/j.1365-2141.2009.08036.x; Gillmore JD, 2009, J AM SOC NEPHROL, V20, P444, DOI 10.1681/ASN.2008060614; GLENNER GG, 1974, ANNU REV MED, V25, P131, DOI 10.1146/annurev.me.25.020174.001023; Hamour IM, 2008, AM J TRANSPLANT, V8, P1056, DOI 10.1111/j.1600-6143.2008.02162.x; HAWKINS PN, 1990, NEW ENGL J MED, V323, P508, DOI 10.1056/NEJM199008233230803; Hellman U, 2008, AMYLOID, V15, P181, DOI 10.1080/13506120802193720; Hemminki K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-974; HOLMGREN G, 1994, J MED GENET, V31, P351, DOI 10.1136/jmg.31.5.351; Hongo M, 2002, AM HEART J, V144, P122, DOI 10.1067/mhj.2002.123115; Hrncic R, 2000, AM J PATHOL, V157, P1239, DOI 10.1016/S0002-9440(10)64639-1; Hutt DF, 2014, EUR HEART J-CARD IMG, V15, P1289, DOI 10.1093/ehjci/jeu107; Jaccard A, 2007, NEW ENGL J MED, V357, P1083, DOI 10.1056/NEJMoa070484; Jacobson DR, 1997, NEW ENGL J MED, V336, P466, DOI 10.1056/NEJM199702133360703; Johnson SM, 2012, J MOL BIOL, V421, P185, DOI 10.1016/j.jmb.2011.12.060; Kastritis E, 2012, BLOOD, V119, P5384, DOI 10.1182/blood-2011-12-396903; Kastritis E, 2010, J CLIN ONCOL, V28, P1031, DOI 10.1200/JCO.2009.23.8220; Kisilevsky R, 2002, J MOL NEUROSCI, V19, P45, DOI 10.1007/s12031-002-0009-3; Kisilevsky R, 2007, AMYLOID, V14, P21, DOI 10.1080/13506120601116419; Kolstoe SE, 2010, P NATL ACAD SCI USA, V107, P20483, DOI 10.1073/pnas.1008255107; Kourelis TV, 2013, J CLIN ONCOL, V31, P4319, DOI 10.1200/JCO.2013.50.8499; Kristen AV, 2010, BLOOD, V116, P2455, DOI 10.1182/blood-2010-02-267708; Kuemmerle-Deschner JB, 2011, ANN RHEUM DIS, V70, P2095, DOI 10.1136/ard.2011.152728; Kumar SK, 2012, BLOOD, V119, P4860, DOI 10.1182/blood-2012-01-407791; Kyle RA, 2010, LEUKEMIA, V24, P1121, DOI 10.1038/leu.2010.60; KYLE RA, 1992, BLOOD, V79, P1817; Lachmann HJ, 2007, NEW ENGL J MED, V356, P2361, DOI 10.1056/NEJMoa070265; Lachmann HJ, 2009, NEW ENGL J MED, V360, P2416, DOI 10.1056/NEJMoa0810787; Lachmann HJ, 2006, CURR OPIN PHARMACOL, V6, P214, DOI 10.1016/j.coph.2005.10.005; Lachmann HJ, 2003, BRIT J HAEMATOL, V122, P78, DOI 10.1046/j.1365-2141.2003.04433.x; Landau H, 2013, LEUKEMIA, V27, P823, DOI 10.1038/leu.2012.274; Lane T, 2013, ARTHRITIS RHEUM-US, V65, P1116, DOI 10.1002/art.37827; Larsen CP, 2010, KIDNEY INT, V77, P816, DOI 10.1038/ki.2010.9; Lekakis J, 2003, AMYLOID, V10, P117, DOI 10.3109/13506120309041733; Liao RL, 2001, CIRCULATION, V104, P1594, DOI 10.1161/circ.104.14.1594; Maceira AM, 2005, CIRCULATION, V111, P186, DOI 10.1161/01.CIR.0000152819.97857.9D; Mekinian A, 2010, AM J MED, V123, P864, DOI 10.1016/j.amjmed.2010.03.022; Merlini G, 2004, NETH J MED, V62, P104; Merlini G, 2012, BLOOD, V120, DOI 10.1182/blood.V120.21.731.731; Merlini G, 2012, BLOOD, V119, P4343, DOI 10.1182/blood-2012-03-413112; Mikhael JR, 2012, BLOOD, V119, P4391, DOI 10.1182/blood-2011-11-390930; Miller SR, 2004, LAB INVEST, V84, P545, DOI 10.1038/labinvest.3700059; Moreau P, 2010, BLOOD, V116, P4777, DOI 10.1182/blood-2010-07-294405; Murphy C, 2011, AMYLOID, V18, P223, DOI 10.3109/13506129.2011.574354084; Murphy CL, 2010, AM J KIDNEY DIS, V56, P1100, DOI 10.1053/j.ajkd.2010.08.013; Nakamura T, 2010, CLIN RHEUMATOL, V29, P1395, DOI 10.1007/s10067-010-1469-4; Nilsson KPR, 2010, AM J PATHOL, V176, P563, DOI 10.2353/ajpath.2010.080797; Obici L, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13580; Obici L, 2011, ANN RHEUM DIS, V70, P1511, DOI 10.1136/ard.2010.143438; Paiva B, 2009, HAEMATOL-HEMATOL J, V94, P1599, DOI 10.3324/haematol.2009.009100; Palladini G, 2004, BLOOD, V103, P2936, DOI 10.1182/blood-2003-08-2788; Palladini G, 2007, BLOOD, V110, P787, DOI 10.1182/blood-2007-02-076034; Palladini G, 2014, BLOOD, V124, P2325, DOI 10.1182/blood-2014-04-570010; Palladini G, 2013, HAEMATOLOGICA, V98, P433, DOI 10.3324/haematol.2012.073593; Palladini G, 2012, J CLIN ONCOL, V30, P4541, DOI 10.1200/JCO.2011.37.7614; Palladini G, 2010, BLOOD, V116, P3426, DOI 10.1182/blood-2010-05-286567; Palladini G, 2009, CLIN CHEM, V55, P499, DOI 10.1373/clinchem.2008.117143; Pepys MB, 2002, NATURE, V417, P254, DOI 10.1038/417254a; PEPYS MB, 1994, P NATL ACAD SCI USA, V91, P5602, DOI 10.1073/pnas.91.12.5602; Perugini E, 2005, J AM COLL CARDIOL, V46, P1076, DOI 10.1016/j.jacc.2005.05.073; Pettersson T, 2012, ANN MED, V44, P109, DOI 10.3109/07853890.2010.548399; Pinney JH, 2013, BRIT J HAEMATOL, V161, P525, DOI 10.1111/bjh.12286; Pinney JH, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000098; Pinney Jennifer H, 2012, Subcell Biochem, V65, P541, DOI 10.1007/978-94-007-5416-4_20; Pradotto L, 2012, MUSCLE NERVE, V45, P918, DOI 10.1002/mus.23265; Rapezzi C, 2008, J AM COLL CARDIOL, V51, P1509, DOI 10.1016/j.jacc.2007.12.038; Rapezzi C, 2011, EUR J NUCL MED MOL I, V38, P470, DOI 10.1007/s00259-010-1642-7; Reece DE, 2011, BLOOD, V118, P865, DOI 10.1182/blood-2011-02-334227; Reece DE, 2009, BLOOD, V114, P1489, DOI 10.1182/blood-2009-02-203398; Reilly MM, 1996, BRAIN PATHOL, V6, P163, DOI 10.1111/j.1750-3639.1996.tb00798.x; REILLY MM, 1995, J NEUROL NEUROSUR PS, V59, P45, DOI 10.1136/jnnp.59.1.45; Richards DB, 2015, NEW ENGL J MED, V373, P1106, DOI 10.1056/NEJMoa1504942; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; Rowczenio D, 2011, AM J PATHOL, V179, P1978, DOI 10.1016/j.ajpath.2011.06.024; Sanchorawala V, 2005, BONE MARROW TRANSPL, V36, P597, DOI 10.1038/sj.bmt.1705106; Sanchorawala V, 2015, BIOL BLOOD MARROW TR, V21, P1445, DOI 10.1016/j.bbmt.2015.04.001; Sanchorawala V, 2010, BLOOD, V116, P1990, DOI 10.1182/blood-2010-07-295485; Sattianayagam PT, 2012, J INTERN MED, V272, P36, DOI 10.1111/j.1365-2796.2011.02470.x; Sattianayagam P, 2011, GASTROENTEROLOGY, V140, pS963; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schonland SO, 2012, BLOOD, V119, P488, DOI 10.1182/blood-2011-06-358507; Sekijima Y, 2006, AMYLOID, V13, P236, DOI 10.1080/13506120600960882; Sekijima Y, 2011, HUM PATHOL, V42, P1785, DOI 10.1016/j.humpath.2011.03.004; Selvanayagam JB, 2007, J AM COLL CARDIOL, V50, P2101, DOI 10.1016/j.jacc.2007.08.028; Shi JR, 2010, P NATL ACAD SCI USA, V107, P4188, DOI 10.1073/pnas.0912263107; Sipe JD, 2014, AMYLOID, V21, P221, DOI 10.3109/13506129.2014.964858; Sipe JD, 2012, AMYLOID, V19, P167, DOI 10.3109/13506129.2012.734345; Skinner M, 2004, ANN INTERN MED, V140, P85, DOI 10.7326/0003-4819-140-2-200401200-00008; Solomon A, 2003, CLIN CANCER RES, V9, p3831S; Sousa A, 1995, AM J MED GENET, V60, P512, DOI 10.1002/ajmg.1320600606; Stangou AJ, 1998, TRANSPLANTATION, V66, P229, DOI 10.1097/00007890-199807270-00016; Stangou AJ, 2010, BLOOD, V115, P2998, DOI 10.1182/blood-2009-06-223792; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; TAN SY, 1994, HISTOPATHOLOGY, V25, P403, DOI 10.1111/j.1365-2559.1994.tb00001.x; Tanskanen M, 2008, ANN MED, V40, P232, DOI 10.1080/07853890701842988; TENNENT GA, 1995, P NATL ACAD SCI USA, V92, P4299, DOI 10.1073/pnas.92.10.4299; Cibeira MT, 2011, BLOOD, V118, P4346, DOI 10.1182/blood-2011-01-330738; Valleix S, 2012, NEW ENGL J MED, V366, P2276, DOI 10.1056/NEJMoa1201356; Venner CP, 2014, LEUKEMIA, V28, P2304, DOI 10.1038/leu.2014.218; Venner CP, 2012, BLOOD, V119, P4387, DOI 10.1182/blood-2011-10-388462; Wall JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052686; Wall JS, 2010, BLOOD, V116, P2241, DOI 10.1182/blood-2010-03-273797; Wechalekar AD, 2009, HAEMATOL-HEMATOL J, V94, P222; Wechalekar AD, 2012, INT AM S; Wechalekar A, 2011, BLOOD, V118, P454, DOI 10.1182/blood.V118.21.995.995; Wechalekar AD, 2008, HAEMATOLOGICA, V93, P295, DOI 10.3324/haematol.11627; Wechalekar AD, 2007, BLOOD, V109, P457, DOI 10.1182/blood-2006-07-035352; Wechalekar AD, 2013, BLOOD, V121, P3420, DOI 10.1182/blood-2012-12-473066	149	434	458	3	105	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 25	2016	387	10038					2641	2654		10.1016/S0140-6736(15)01274-X	http://dx.doi.org/10.1016/S0140-6736(15)01274-X			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP3JX	26719234				2022-12-28	WOS:000378390500032
J	Rockwood, K				Rockwood, Kenneth			What can we expect of health in old age?	LANCET			English	Editorial Material							FRAILTY; LIFE; DEMENTIA; DISEASE; DEATH; RISK		[Rockwood, Kenneth] Dalhousie Univ, Dept Med, Halifax, NS B3H 1C6, Canada; [Rockwood, Kenneth] Univ Manchester, Inst Brain Behav & Mental Hlth, Manchester, Lancs, England	Dalhousie University; University of Manchester	Rockwood, K (corresponding author), Dalhousie Univ, Dept Med, Halifax, NS B3H 1C6, Canada.; Rockwood, K (corresponding author), Univ Manchester, Inst Brain Behav & Mental Hlth, Manchester, Lancs, England.	kenneth.rockwood@dal.ca	Rockwood, Kenneth/AAD-8951-2019					Anstey KJ, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0084-z; Brayne C, 2014, LANCET NEUROL, V13, P532, DOI 10.1016/S1474-4422(14)70098-5; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Falk H, 2014, AGE AGEING, V43, P636, DOI 10.1093/ageing/afu018; Fontana L, 2014, NATURE, V511, P405, DOI 10.1038/511405a; Howlett SE, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0171-9; Jagger C., 2015, LANCET; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Romero-Ortuno R, 2014, AGE AGEING, V43, P222, DOI 10.1093/ageing/aft115; Song XW, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0054-5; Steptoe A, 2014, CAN MED ASSOC J, V186, pE150, DOI 10.1503/cmaj.131155; Theou O, 2015, AGE AGEING, V44, P471, DOI 10.1093/ageing/afv010; Young J, 2015, AGE AGEING, V44, P182, DOI 10.1093/ageing/afu174	13	6	7	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 20	2016	387	10020					730	731		10.1016/S0140-6736(15)01022-3	http://dx.doi.org/10.1016/S0140-6736(15)01022-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DE1WU	26680215	hybrid			2022-12-28	WOS:000370418000009
J	Micali, G; Lacarrubba, F				Micali, Giuseppe; Lacarrubba, Francesco			Phthiriasis Palpebrarum in a Child	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Micali, Giuseppe; Lacarrubba, Francesco] Univ Catania, Catania, Italy	University of Catania	Micali, G (corresponding author), Univ Catania, Catania, Italy.	cldermct@gmail.com		MICALI, Giuseppe/0000-0002-5157-3939					0	4	4	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 31	2015	373	27					E35	E35		10.1056/NEJMicm1501675	http://dx.doi.org/10.1056/NEJMicm1501675			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ8UH	26716931				2022-12-28	WOS:000367374100012
J	Lambertini, M; Boni, L; Michelotti, A; Gamucci, T; Scotto, T; Gori, S; Giordano, M; Garrone, O; Levaggi, A; Poggio, F; Giraudi, S; Bighin, C; Vecchio, C; Sertoli, MR; Pronzato, P; Del Mastro, L				Lambertini, Matteo; Boni, Luca; Michelotti, Andrea; Gamucci, Teresa; Scotto, Tiziana; Gori, Stefania; Giordano, Monica; Garrone, Ornella; Levaggi, Alessia; Poggio, Francesca; Giraudi, Sara; Bighin, Claudia; Vecchio, Carlo; Sertoli, Mario Roberto; Pronzato, Paolo; Del Mastro, Lucia		GIM Study Grp	Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							YOUNG-WOMEN; FERTILITY PRESERVATION; PREMENOPAUSAL PATIENTS; HORMONE AGONISTS; TAMOXIFEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ANTAGONISM; CONSENSUS; OUTCOMES	IMPORTANCE Whether the administration of luteinizing hormone-releasing hormone analogues (LHRHa) during chemotherapy is a reliable strategy to preserve ovarian function is controversial owing to both the lack of data on long-term ovarian function and pregnancies and the safety concerns about the potential negative interactions between endocrine therapy and chemotherapy. OBJECTIVE To evaluate long-term results of LHRHa-induced ovarian suppression during breast cancer chemotherapy. DESIGN, SETTING, AND PARTICIPANTS Parallel, randomized, open-label, phase 3 superiority trial conducted at 16 Italian sites. Between October 2003 and January 2008, 281 premenopausal women with stage I to III hormone receptor-positive or hormone receptor-negative breast cancer were enrolled. Last annual follow-up was June 3, 2014. INTERVENTIONS Patients were randomized to receive adjuvant or neoadjuvant chemotherapy alone (control group) or chemotherapy plus triptorelin (LHRHa group). MAIN OUTCOMES AND MEASURES The primary planned end point was incidence of chemotherapy-induced early menopause. Post hoc end points were long-term ovarian function (evaluated by yearly assessment of menstrual activity and defined as resumed by the occurrence of at least 1 menstrual cycle), pregnancies, and disease-free survival (DFS). RESULTS A total of 281 women (median age, 39 [range, 24-45] years) were randomized. Median follow-up was 7.3 years (interquartile range, 6.3-8.2 years). The 5-year cumulative incidence estimate of menstrual resumption was 72.6%(95% CI, 65.7%-80.3%) among the 148 patients in the LHRHa group and 64.0%(95% CI, 56.2%-72.8%) among the 133 patients in the control group (hazard ratio [HR], 1.28 [95% CI, 0.98-1.68]; P =.07; age-adjusted HR, 1.48 [95% CI, 1.12-1.95]; P =.006). Eight pregnancies (5-year cumulative incidence estimate of pregnancy, 2.1% [95% CI, 0.7%-6.3%]) occurred in the LHRHa group and 3 (5-year cumulative incidence estimate of pregnancy, 1.6%[95% CI, 0.4%-6.2%]) in the control group (HR, 2.56 [95% CI, 0.68-9.60]; P =.14; age-adjusted HR, 2.40 [95% CI, 0.62-9.22]; P =.20). Five-year DFS was 80.5%(95% CI, 73.1%-86.1%) in the LHRHa group and 83.7%(95% CI, 76.1%-89.1%) in the control group (LHRHa vs control: HR, 1.17 [95% CI, 0.72-1.92]; P =.52). CONCLUSIONS AND RELEVANCE Among premenopausal women with either hormone receptor-positive or hormone receptor-negative breast cancer, concurrent administration of triptorelin and chemotherapy, compared with chemotherapy alone, was associated with higher long-term probability of ovarian function recovery, without a statistically significant difference in pregnancy rate. There was no statistically significant difference in DFS for women assigned to triptorelin and those assigned to chemotherapy alone, although study power was limited.	[Lambertini, Matteo; Poggio, Francesca; Bighin, Claudia; Pronzato, Paolo] Ist Nazl Ric Canc, IRCCS AOU San Martino IST, Dept Med Oncol, UO Oncol Med A, I-16132 Genoa, Italy; [Boni, Luca] AOU Careggi, Ctr Coordinamento Sperimentaz Clin, Florence, Italy; [Boni, Luca] Ist Toscano Tumori, Florence, Italy; [Michelotti, Andrea] Univ Pisana, Azienda Osped, Dipartimento Oncol Trapianti & Nuove Tecnol, UO Oncol Med 1,Osped S Chiara, Pisa, Italy; [Gamucci, Teresa] Osped SS Trinita, Dept Oncol, Sora, Italy; [Scotto, Tiziana] Osped Civile, UO Oncol Med, Sassari, Italy; [Gori, Stefania] Osped Santa Maria Misericordia, SC Oncol Med, Perugia, Italy; [Gori, Stefania] Osped Sacro Cuore Don Calabria, UOC Oncol Med, Negrar Verona, Italy; [Giordano, Monica] Azienda Osped S Anna, SC Oncol, Como, Italy; [Garrone, Ornella] Osped Insegnamento S Croce & Carle, Dipartimento Oncol, Cuneo, Italy; [Levaggi, Alessia; Giraudi, Sara; Del Mastro, Lucia] Ist Nazl Ric Canc, UO Sviluppo Terapie Innovat, Dept Med Oncol, IRCCS AOU San Martino IST, I-16132 Genoa, Italy; [Vecchio, Carlo] Ist Nazl Ric Canc, IRCCS AOU San Martino IST, Dept Surg Oncol, Chirurg Senol U1E, I-16132 Genoa, Italy; [Sertoli, Mario Roberto] Ist Nazl Ric Canc, IRCCS AOU San Martino IST, Dept Med Oncol, Clin Oncol Med, I-16132 Genoa, Italy	University of Genoa; IRCCS AOU San Martino IST; University of Florence; Azienda Ospedaliero Universitaria Careggi; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; University of Pisa; Azienda Ospedaliero Universitaria Pisana; Hospital Santa Maria della Misericordia; IRCCS Sacro Cuore Don Calabria; Ospedale Sant'Anna di Como; University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS AOU San Martino IST	Del Mastro, L (corresponding author), IRCCS AOU San Martino IST, UO Sviluppo Terapie Innovat, Largo Rosanna Benzi 10, I-16132 Genoa, Italy.	lucia.delmastro@hsanmartino.it	GORI, Stefania/AAB-4802-2022; Poggio, Francesca/AAC-2258-2019; Pronzato, Paolo/AAB-1455-2020; Boni, Luca/ABI-6243-2020; Garrone, Ornella/AAC-5978-2022; Del Mastro, Lucia/J-6163-2016; Garrone, Ornella/HHS-9402-2022; Levaggi, Alessia/AAB-9346-2019; GORI, Stefania/N-8827-2016; Lambertini, Matteo/T-2563-2017	GORI, Stefania/0000-0001-6320-405X; Poggio, Francesca/0000-0002-4518-2827; Pronzato, Paolo/0000-0001-8203-2564; Boni, Luca/0000-0003-2217-4047; Garrone, Ornella/0000-0001-7359-5410; Del Mastro, Lucia/0000-0002-9546-5841; GORI, Stefania/0000-0001-6320-405X; Lambertini, Matteo/0000-0003-1797-5296; BIGHIN, Claudia/0000-0001-9956-0216; Levaggi, Alessia/0000-0003-1007-9173	Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy; Associazione Italiana per la Ricerca sul Cancro (AIRC), Italy	Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy; Associazione Italiana per la Ricerca sul Cancro (AIRC), Italy(Fondazione AIRC per la ricerca sul cancro)	The study was sponsored by the Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy, and partly supported by a grant from the Associazione Italiana per la Ricerca sul Cancro (AIRC), Italy. Triptorelin used in the study was provided by Ipsen, Milan, Italy.	Albain KS, 2009, LANCET, V374, P2055, DOI 10.1016/S0140-6736(09)61523-3; Arriagada R, 2005, ANN ONCOL, V16, P389, DOI 10.1093/annonc/mdi085; Badawy A, 2009, FERTIL STERIL, V91, P694, DOI 10.1016/j.fertnstert.2007.12.044; Bedoschi G, 2013, CURR BREAST CANCER R, V5, P302, DOI 10.1007/s12609-013-0123-y; Coates AS, 2015, ANN ONCOL, V26, P1533, DOI 10.1093/annonc/mdv221; Collins LC, 2012, BREAST CANCER RES TR, V131, P1061, DOI 10.1007/s10549-011-1872-9; Copson E, 2013, JNCI-J NATL CANCER I, V105, P978, DOI 10.1093/jnci/djt134; Del Mastro L, 2011, JAMA-J AM MED ASSOC, V306, P269, DOI 10.1001/jama.2011.991; Elgindy EA, 2013, OBSTET GYNECOL, V121, P78, DOI [10.1097/AOG.0b013e31827374e2, http://10.1097/AOG.0b013e31827374e2]; Francis PA, 2015, NEW ENGL J MED, V372, P436, DOI 10.1056/NEJMoa1412379; Gerber B, 2011, J CLIN ONCOL, V29, P2334, DOI 10.1200/JCO.2010.32.5704; GOLDENBERG GJ, 1985, BIOCHEM PHARMACOL, V34, P763, DOI 10.1016/0006-2952(85)90755-5; GOLDHIRSCH A, 1990, ANN ONCOL, V1, P30; Howard-Anderson J, 2012, JNCI-J NATL CANCER I, V104, P386, DOI 10.1093/jnci/djr541; Karimi-Zarchi M, 2014, EUR J GYNAECOL ONCOL, V35, P59; Leonard RC, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.590; Loren AW, 2013, J CLIN ONCOL, V31, P2500, DOI 10.1200/JCO.2013.49.2678; Moore HCF, 2015, NEW ENGL J MED, V372, P923, DOI 10.1056/NEJMoa1413204; Munhoz RR, 2016, JAMA ONCOL, V2, P65, DOI 10.1001/jamaoncol.2015.3251; Munster PN, 2012, J CLIN ONCOL, V30, P533, DOI 10.1200/JCO.2011.34.6890; National Comprehensive Cancer Network (NCCN), 2016, NCCN GUID BREAST CAN; Pagani O, 2014, NEW ENGL J MED, V371, P107, DOI 10.1056/NEJMoa1404037; Partridge AH, 2014, BREAST, V23, P209, DOI 10.1016/j.breast.2014.03.011; Peccatori FA, 2013, ANN ONCOL, V24, P160, DOI 10.1093/annonc/mdt199; Rivkin SE, 1996, J CLIN ONCOL, V14, P46, DOI 10.1200/JCO.1996.14.1.46; Ruddy KJ, 2014, J CLIN ONCOL, V32, P1151, DOI 10.1200/JCO.2013.52.8877; Rugo HS, 2011, JAMA-J AM MED ASSOC, V306, P312, DOI 10.1001/jama.2011.1019; Song GP, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0667-8; Sverrisdottir A, 2009, BREAST CANCER RES TR, V117, P561, DOI 10.1007/s10549-009-0313-5; Swain SM, 2010, NEW ENGL J MED, V362, P2053, DOI 10.1056/NEJMoa0909638; Turner NH, 2013, ANN ONCOL, V24, P2224, DOI 10.1093/annonc/mdt196; WOODS KE, 1994, BIOCHEM PHARMACOL, V47, P1449, DOI 10.1016/0006-2952(94)90346-8	32	144	159	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 29	2015	314	24					2632	2640		10.1001/jama.2015.17291	http://dx.doi.org/10.1001/jama.2015.17291			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ2MR	26720025	Bronze			2022-12-28	WOS:000366939800018
J	Behar, SM; Baehrecke, EH				Behar, Samuel M.; Baehrecke, Eric H.			Autophagy is not the answer	NATURE			English	Editorial Material							MYCOBACTERIUM-TUBERCULOSIS; INFLAMMATION; MACROPHAGES; APOPTOSIS; VITAMIN; PATHWAY		[Behar, Samuel M.] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01655 USA; [Baehrecke, Eric H.] Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Behar, SM (corresponding author), Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01655 USA.	samuel.behar@umassmed.edu; eric.baehrecke@umassmed.edu		Behar, Samuel/0000-0002-3374-6699	NIAID NIH HHS [R01 AI098637] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI098637] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Bhatt K, 2007, J CLIN IMMUNOL, V27, P347, DOI 10.1007/s10875-007-9084-0; Castillo EF, 2012, P NATL ACAD SCI USA, V109, pE3168, DOI 10.1073/pnas.1210500109; Chang TK, 2013, NAT CELL BIOL, V15, P1067, DOI 10.1038/ncb2804; Deretic V, 2012, TRENDS CELL BIOL, V22, P397, DOI 10.1016/j.tcb.2012.04.008; Fabri M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003045; Fabri M, 2009, CELL HOST MICROBE, V6, P201, DOI 10.1016/j.chom.2009.08.008; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Kimmey JM, 2015, NATURE, V528, P565, DOI 10.1038/nature16451; Liu PT, 2007, J IMMUNOL, V179, P2060, DOI 10.4049/jimmunol.179.4.2060; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Shravage BV, 2013, DEVELOPMENT, V140, P1321, DOI 10.1242/dev.089490; Watson RO, 2012, CELL, V150, P803, DOI 10.1016/j.cell.2012.06.040; Young MM, 2012, J BIOL CHEM, V287, P12455, DOI 10.1074/jbc.M111.309104; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482	16	19	21	2	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2015	528	7583					482	483		10.1038/nature16324	http://dx.doi.org/10.1038/nature16324			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ3GH	26649822				2022-12-28	WOS:000366991900034
J	Ulaganathan, VK; Sperl, B; Rapp, UR; Ullrich, A				Ulaganathan, Vijay K.; Sperl, Bianca; Rapp, Ulf R.; Ullrich, Axel			Germline variant FGFR4 p.G388R exposes a membrane-proximal STAT3 binding site	NATURE			English	Article							GLY388ARG POLYMORPHISM; ARG388 ALLELE; CANCER; GROWTH; METAANALYSIS; PROGRESSION; SUFFICIENT; PROGNOSIS; RECEPTOR; DOMAINS	Variant rs351855-G/A is a commonly occurring single-nucleotide polymorphism of coding regions in exon 9 of the fibroblast growth factor receptor FGFR4 (CD334) gene (c.1162G>A). It results in an amino-acid change at codon 388 from glycine to arginine (p.Gly388Arg) in the transmembrane domain of the receptor. Despite compelling genetic evidence for the association of this common variant with cancers of the bone(1), breast(2), colon(3), prostate(4,5), skin(6), lung(7,8), head and neck(9), as well as soft-tissue sarcomas and non-Hodgkin lymphoma, the underlying biological mechanism has remained elusive. Here we show that substitution of the conserved glycine 388 residue to a charged arginine residue alters the transmembrane spanning segment and exposes a membrane-proximal cytoplasmic signal transducer and activator of transcription 3 (STAT3) binding site Y-390-(P) XXQ(393). We demonstrate that such membrane-proximal STAT3 binding motifs in the germline of type I membrane receptors enhance STAT3 tyrosine phosphorylation by recruiting STAT3 proteins to the inner cell membrane. Remarkably, such germline variants frequently co-localize with somatic mutations in the Catalogue of Somatic Mutations in Cancer (COSMIC) database. Using Fgfr4 single nucleotide polymorphism knock-in mice and transgenic mouse models for breast and lung cancers, we validate the enhanced STAT3 signalling induced by the FGFR4 Arg388-variant in vivo. Thus, our findings elucidate the molecular mechanism behind the genetic association of rs351855 with accelerated cancer progression and suggest that germline variants of cell-surface molecules that recruit STAT3 to the inner cell membrane are a significant risk for cancer prognosis and disease progression.	[Ulaganathan, Vijay K.; Sperl, Bianca; Ullrich, Axel] Max Planck Inst Biochem, Dept Mol Biol, D-82152 Martinsried, Germany; [Rapp, Ulf R.] Max Planck Inst Heart & Lung Res, Mol Mech Lung Canc, D-61231 Bad Nauheim, Germany	Max Planck Society; Max Planck Society	Ullrich, A (corresponding author), Max Planck Inst Biochem, Dept Mol Biol, Klopferspitz 18, D-82152 Martinsried, Germany.	ulaganat@biochem.mpg.de; ullrich@biochem.mpg.de	Ulaganathan, Vijay Kumar/AAO-6077-2020	Ulaganathan, Vijay Kumar/0000-0002-4717-6228	NHLBI [HL-102923, HL-102924, HL-102925, HL-102926, HL-103010]	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank the NHLBI GO Exome Sequencing Project and its ongoing studies, which produced and provided exome variant calls for comparison: the Lung GO Sequencing Project (HL-102923), the WHI Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926) and the Heart GO Sequencing Project (HL-103010). We also thank N. Nagaraj for the help with quantitative proteomics and T. W. J. Gadella for providing us pmTurquoise2-N1 and C1 plasmids. We acknowledge T. Mayr for helping us by providing Fgfr4 knock-in mice for preliminary experiments, and R. Hornberger for technical assistance. We thank M. Sibilia for providing the Egfr knockout and wild-type counterpart MEFs. R. Abraham provided FGFR4 extracellular domain-specific anti-human mAb, clone 4FA6#11. We also acknowledge H. Brandstetter, S. Uebel and M. Spitaler for their assistance and services.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bange J, 2002, CANCER RES, V62, P840; BUSS JE, 1988, MOL CELL BIOL, V8, P3960, DOI 10.1128/MCB.8.9.3960; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Falvella FS, 2009, INT J CANCER, V124, P2880, DOI 10.1002/ijc.24302; Frullanti E, 2011, EUR J CANCER PREV, V20, P340, DOI 10.1097/CEJ.0b013e3283457274; HANCOCK JF, 1991, EMBO J, V10, P4033, DOI 10.1002/j.1460-2075.1991.tb04979.x; Heinzle C, 2012, CANCER RES, V72, P5767, DOI 10.1158/0008-5472.CAN-11-3654; Morimoto Y, 2003, CANCER, V98, P2245, DOI 10.1002/cncr.11778; Parker RA, 2003, AM STAT, V57, P166, DOI 10.1198/0003130031919; ROTIN D, 1992, EMBO J, V11, P559, DOI 10.1002/j.1460-2075.1992.tb05087.x; SANDGREN EP, 1995, CANCER RES, V55, P3915; Shao H, 2004, J BIOL CHEM, V279, P18967, DOI 10.1074/jbc.M314037200; Sharpe HJ, 2010, CELL, V142, P158, DOI 10.1016/j.cell.2010.05.037; Spinola M, 2005, J CLIN ONCOL, V23, P7307, DOI 10.1200/JCO.2005.17.350; Streit S, 2006, BRIT J CANCER, V94, P1879, DOI 10.1038/sj.bjc.6603181; Streit S, 2004, INT J CANCER, V111, P213, DOI 10.1002/ijc.20204; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Xu B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-84; Xu W, 2010, EUR J CANCER, V46, P3332, DOI 10.1016/j.ejca.2010.06.017	20	41	47	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2015	528	7583					570	+		10.1038/nature16449	http://dx.doi.org/10.1038/nature16449			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ3GH	26675719				2022-12-28	WOS:000366991900056
J	Wellbery, C				Wellbery, Caroline			Art-Science Collaborations - Avenues toward Medical Innovation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Wellbery, Caroline] Georgetown Univ, Med Ctr, Dept Family Med, Washington, DC 20007 USA	Georgetown University	Wellbery, C (corresponding author), Georgetown Univ, Med Ctr, Dept Family Med, Washington, DC 20007 USA.							Biddiss E, 2013, HERD-HEALTH ENV RES, V6, P49, DOI 10.1177/193758671300600305; Kandel Eric. R., 2012, THE AGE OF INSIGHT; Peraza-Hernandez EA, 2014, SMART MATER STRUCT, V23, DOI 10.1088/0964-1726/23/9/094001	3	4	4	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 24	2015	373	26					2495	2497		10.1056/NEJMp1509788	http://dx.doi.org/10.1056/NEJMp1509788			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CZ7SG	26699165				2022-12-28	WOS:000367299700005
J	Feinmann, J				Feinmann, Jane			CHRISTMAS APPEAL 2015 Restoring Africa's health systems after Ebola	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jane@janefeinmann.com						Doctors of the World, 2015, EB REB HLTH SERV MOY; Elston JWT, 2016, J PUBLIC HEALTH-UK, V38, P673, DOI 10.1093/pubmed/fdv158; Public Health England, 2015, EB EP UPD 61; Unicef Ministry of Health and Sanitation, 2014, SIERR LEON HLTH FAC	4	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 18	2015	351								h6841	10.1136/bmj.h6841	http://dx.doi.org/10.1136/bmj.h6841			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ4MX	26683005				2022-12-28	WOS:000367078400001
J	Janes, KA				Janes, Kevin A.			Cell-to-Cell Transcript Variability: Seeing Signal in the Noise	CELL			English	Editorial Material							SINGLE; EXPRESSION; NETWORKS	How stochastic is gene expression in mammalian cells? Not very, according to Battich et al., who report that single-cell variability in cytoplasmic mRNAs is remarkably predictable given measurements of a cell's phenotypic state and microenvironment. The noise from transcriptional bursts is buffered by a hallmark of eukaryotes-the nucleus.	[Janes, Kevin A.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22908 USA	University of Virginia	Janes, KA (corresponding author), Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22908 USA.	kjanes@virginia.edu			NATIONAL CANCER INSTITUTE [R01CA194470] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA194470] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Battich N, 2015, CELL, V163, P1596, DOI 10.1016/j.cell.2015.11.018; Buettner F, 2015, NAT BIOTECHNOL, V33, P155, DOI 10.1038/nbt.3102; Dar RD, 2012, P NATL ACAD SCI USA, V109, P17454, DOI 10.1073/pnas.1213530109; Halpern KB, 2015, CELL REP, V13, P2653, DOI 10.1016/j.celrep.2015.11.036; Janes KA, 2013, J CELL SCI, V126, P1913, DOI 10.1242/jcs.112045; Parekh AK, 1993, IEEE ACM T NETWORK, V1, P344, DOI 10.1109/90.234856; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Wang CC, 2014, NAT CELL BIOL, V16, P345, DOI 10.1038/ncb2930; Wang CC, 2012, WIRES SYST BIOL MED, V4, P51, DOI 10.1002/wsbm.159	10	5	5	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2015	163	7					1566	1568		10.1016/j.cell.2015.12.010	http://dx.doi.org/10.1016/j.cell.2015.12.010			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CZ1GN	26687346	Green Accepted, Bronze			2022-12-28	WOS:000366854200002
J	Savage, N				Savage, Neil			Resistance fighters	NATURE			English	Editorial Material																		Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Livraghi L, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0425-1; Muhammad LA, 2015, EXPERT REV ANTICANC, V15, P1049, DOI 10.1586/14737140.2015.1064769; Onstenk W, 2015, EUR UROL, V68, P939, DOI 10.1016/j.eururo.2015.07.007; Steinestel J., 2015, ONCOTARGET, DOI 10.18632/oncotarget.3925; Thompson TC, 2014, ONCOTARGET, V5, P8816, DOI 10.18632/oncotarget.2544	6	5	6	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2015	528	7582					S128	S129		10.1038/528S128a	http://dx.doi.org/10.1038/528S128a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY8SM	26672785				2022-12-28	WOS:000366678600005
J	Schaetz, T				Schaetz, Tobias			QUANTUM PHYSICS Entanglement beyond identical ions	NATURE			English	Editorial Material							VIOLATION; INEQUALITY		[Schaetz, Tobias] Univ Freiburg, Inst Phys, D-79104 Freiburg, Germany	University of Freiburg	Schaetz, T (corresponding author), Univ Freiburg, Inst Phys, D-79104 Freiburg, Germany.	tobias.schaetz@physik.uni-freiburg.de						ASPECT A, 1982, PHYS REV LETT, V49, P91, DOI 10.1103/PhysRevLett.49.91; Ballance CJ, 2015, NATURE, V528, P384, DOI 10.1038/nature16184; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; Hensen B, 2015, NATURE, V526, P682, DOI 10.1038/nature15759; Rowe MA, 2001, NATURE, V409, P791, DOI 10.1038/35057215; Tan TR, 2015, NATURE, V528, P380, DOI 10.1038/nature16186	6	1	1	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2015	528	7582					337	338		10.1038/528337a	http://dx.doi.org/10.1038/528337a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY8SM	26672548				2022-12-28	WOS:000366678600037
J	Chevalier, C; Stojanovic, O; Colin, DJ; Suarez-Zamorano, N; Tarallo, V; Veyrat-Durebex, C; Rigo, D; Fabbiano, S; Stevanovic, A; Hagemann, S; Montet, X; Seimbille, Y; Zamboni, N; Hapfelmeier, S; Trajkovski, M				Chevalier, Claire; Stojanovic, Ozren; Colin, Didier J.; Suarez-Zamorano, Nicolas; Tarallo, Valentina; Veyrat-Durebex, Christelle; Rigo, Dorothee; Fabbiano, Salvatore; Stevanovic, Ana; Hagemann, Stefanie; Montet, Xavier; Seimbille, Yann; Zamboni, Nicola; Hapfelmeier, Siegfried; Trajkovski, Mirko			Gut Microbiota Orchestrates Energy Homeostasis during Cold	CELL			English	Article							BROWN ADIPOSE-TISSUE; OBESITY; ADIPOCYTES; FAT; PROTEIN; MOUSE; MICE	Microbial functions in the host physiology are a result of the microbiota-host co-evolution. We show that cold exposure leads to marked shift of the microbiota composition, referred to as cold microbiota. Transplantation of the cold microbiota to germ-free mice is sufficient to increase insulin sensitivity of the host and enable tolerance to cold partly by promoting the white fat browning, leading to increased energy expenditure and fat loss. During prolonged cold, however, the body weight loss is attenuated, caused by adaptive mechanisms maximizing caloric uptake and increasing intestinal, villi, and microvilli lengths. This increased absorptive surface is transferable with the cold microbiota, leading to altered intestinal gene expression promoting tissue remodeling and suppression of apoptosis-the effect diminished by co-transplanting the most cold-downregulated strain Akkermansia muciniphila during the cold microbiota transfer. Our results demonstrate the microbiota as a key factor orchestrating the overall energy homeostasis during increased demand.	[Chevalier, Claire; Stojanovic, Ozren; Suarez-Zamorano, Nicolas; Tarallo, Valentina; Veyrat-Durebex, Christelle; Rigo, Dorothee; Fabbiano, Salvatore; Stevanovic, Ana; Trajkovski, Mirko] Univ Geneva, Fac Med, Ctr Med Univ CMU, Dept Cell Physiol & Metab, CH-1211 Geneva, Switzerland; [Chevalier, Claire; Stojanovic, Ozren; Suarez-Zamorano, Nicolas; Tarallo, Valentina; Veyrat-Durebex, Christelle; Rigo, Dorothee; Fabbiano, Salvatore; Stevanovic, Ana; Trajkovski, Mirko] Univ Geneva, Ctr Diabet, Fac Med, CH-1211 Geneva, Switzerland; [Colin, Didier J.; Seimbille, Yann] Univ Hosp Geneva, Ctr BioMed Imaging CIBM, CH-1211 Geneva, Switzerland; [Hagemann, Stefanie; Hapfelmeier, Siegfried] Univ Bern, Inst Infect Dis, CH-3010 Bern, Switzerland; [Montet, Xavier] Univ Hosp Geneva, Div Radiol, CH-1211 Geneva, Switzerland; [Zamboni, Nicola] Swiss Fed Inst Technol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Trajkovski, Mirko] Univ Coll London UCL, Inst Struct & Mol Biol, Div Biosci, London WC1E 6BT, England	University of Geneva; University of Geneva; University of Geneva; University of Bern; University of Geneva; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of London; Birkbeck University London; University College London	Trajkovski, M (corresponding author), Univ Geneva, Fac Med, Ctr Med Univ CMU, Dept Cell Physiol & Metab, CH-1211 Geneva, Switzerland.	mirko.trajkovski@unige.ch	Hapfelmeier, Siegfried/B-6005-2011; Montet, Xavier/GMW-9003-2022; Zamboni, Nicola/K-3042-2012; Stojanovic, Ozren/GQQ-1368-2022; Colin, Didier J/GWR-1955-2022	Hapfelmeier, Siegfried/0000-0002-6913-7932; Zamboni, Nicola/0000-0003-1271-1021; Stojanovic, Ozren/0000-0002-9418-3754; Colin, Didier J/0000-0002-7067-8701; Veyrat-Durebex, Christelle/0000-0001-5301-6493; Montet, Xavier/0000-0003-2442-5866; chevalier, claire/0000-0003-0902-0756; Trajkovski, Mirko/0000-0002-3152-9551; Fabbiano, Salvatore/0000-0003-0768-6028; Seimbille, Yann/0000-0002-9736-5318	gnotobiotic research [ERC-2013-StG-281904]; European Research Council under the European Union's Seventh Framework Programme/ERC [336607 (ERC-2013-StG-336607)]; Louis-Jeantet Foundation; Fondation pour Recherches Medicales; Novartis Foundation [14B053]; Swiss National Science Foundation (SNSF) [PP00P3_144886]	gnotobiotic research; European Research Council under the European Union's Seventh Framework Programme/ERC(European Research Council (ERC)); Louis-Jeantet Foundation; Fondation pour Recherches Medicales; Novartis Foundation(Novartis); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	We thank Maria Gustafsson Trajkovska, Claes Wollheim, and Roberto Coppari for discussions and critical reading; Jean-Baptiste Cavin and Andre Bado for sharing expertise in intestinal loop; Christian Darimont for help with bomb calorimetry; Abdessalam Cherkaoui and Jacques Schrenzel for the use of anaerobic incubator; (ERC-2013-StG-281904) to S.H. for partial support of the gnotobiotic research; Mirosava Ilievska for providing antibiotics; Mario Kreutzfeldt and Doron Merkler for help with histology quantifications; and Gabriel Waksman for support. The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC grant agreement 336607 (ERC-2013-StG-336607); the Louis-Jeantet Foundation; Fondation pour Recherches Medicales; Novartis Foundation (14B053); and the Swiss National Science Foundation (SNSF) Professorship (PP00P3_144886) to M.T.	Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Badman MK, 2005, SCIENCE, V307, P1909, DOI 10.1126/science.1109951; Belzer C, 2012, ISME J, V6, P1449, DOI 10.1038/ismej.2012.6; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chou CJ, 2008, NESTLE NUTR WORKS SE, V62, P127, DOI 10.1159/000146256; COUSIN B, 1992, J CELL SCI, V103, P931; El Kaoutari A, 2013, NAT REV MICROBIOL, V11, P497, DOI 10.1038/nrmicro3050; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Farooqi IS, 2005, ANNU REV MED, V56, P443, DOI 10.1146/annurev.med.56.062904.144924; Ferreyra JA, 2014, CELL HOST MICROBE, V16, P770, DOI 10.1016/j.chom.2014.11.003; Ghorbani M, 1997, BIOCHEM PHARMACOL, V54, P121, DOI 10.1016/S0006-2952(97)00162-7; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Guerra C, 2001, J CLIN INVEST, V108, P1205, DOI 10.1172/JCI200113103; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Hausmann M, 2010, INT J INFLAMM, V2010, DOI 10.4061/2010/574568; Kelly CP, 2013, NEW ENGL J MED, V368, P474, DOI 10.1056/NEJMe1214816; Khoruts A, 2014, NAT REV GASTRO HEPAT, V11, P79, DOI 10.1038/nrgastro.2013.231; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Liou AP, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005687; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Murphy KG, 2006, NATURE, V444, P854, DOI 10.1038/nature05484; Obermeier F, 2006, EUR J IMMUNOL, V36, P2691, DOI 10.1002/eji.200535173; Pelletier M, 2002, FEBS LETT, V532, P164, DOI 10.1016/S0014-5793(02)03668-2; Preidis GA, 2015, J NUTR BIOCHEM, V26, P1050, DOI 10.1016/j.jnutbio.2015.04.010; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Spehlmann ME, 2009, CURR OPIN GASTROEN, V25, P92, DOI 10.1097/MOG.0b013e328324f857; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wichmann A, 2013, CELL HOST MICROBE, V14, P582, DOI 10.1016/j.chom.2013.09.012; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; YOUNG P, 1984, FEBS LETT, V167, P10, DOI 10.1016/0014-5793(84)80822-4	35	396	422	26	181	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 6	2015	163	6					1360	1374		10.1016/j.cell.2015.11.004	http://dx.doi.org/10.1016/j.cell.2015.11.004			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SE	26638070	Bronze			2022-12-28	WOS:000366044800016
J	Gupta, GD; Coyaud, E; Goncalves, J; Mojarad, BA; Liu, Y; Wu, QZ; Gheiratmand, L; Comartin, D; Tkach, JM; Cheung, SWT; Bashkurov, M; Hasegan, M; Knight, JD; Lin, ZY; Schueler, M; Hildebrandt, F; Moffat, J; Gingras, AC; Raught, B; Pelletier, L				Gupta, Gagan D.; Coyaud, Etienne; Goncalves, Joao; Mojarad, Bahareh A.; Liu, Yi; Wu, Qianzhu; Gheiratmand, Ladan; Comartin, David; Tkach, Johnny M.; Cheung, Sally W. T.; Bashkurov, Mikhail; Hasegan, Monica; Knight, James D.; Lin, Zhen-Yuan; Schueler, Markus; Hildebrandt, Friedhelm; Moffat, Jason; Gingras, Anne-Claude; Raught, Brian; Pelletier, Laurence			A Dynamic Protein Interaction Landscape of the Human Centrosome-Cilium Interface	CELL			English	Article							CENTRIOLAR SATELLITE; TRANSITION ZONE; CILIOGENESIS; COMPLEX; COMPONENTS; REGULATORS; COOPERATE; TRANSPORT; FLAGELLAR; CPAP	The centrosome is the primary microtubule organizing center of the cells and templates the formation of cilia, thereby operating at a nexus of critical cellular functions. Here, we use proximity-dependent biotinylation (BioID) to map the centrosome-cilium interface; with 58 bait proteins we generate a protein topology network comprising >7,000 interactions. Analysis of interaction profiles coupled with high resolution phenotypic profiling implicates a number of protein modules in centriole duplication, ciliogenesis, and centriolar satellite biogenesis and highlights extensive interplay between these processes. By monitoring dynamic changes in the centrosome-cilium protein interaction landscape during ciliogenesis, we also identify satellite proteins that support cilia formation. Systematic profiling of proximity interactions combined with functional analysis thus provides a rich resource for better understanding human centrosome and cilia biology. Similar strategies may be applied to other complex biological structures or pathways.	[Gupta, Gagan D.; Goncalves, Joao; Mojarad, Bahareh A.; Liu, Yi; Wu, Qianzhu; Gheiratmand, Ladan; Comartin, David; Tkach, Johnny M.; Cheung, Sally W. T.; Bashkurov, Mikhail; Hasegan, Monica; Knight, James D.; Lin, Zhen-Yuan; Gingras, Anne-Claude; Pelletier, Laurence] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Coyaud, Etienne; Raught, Brian] Univ Hlth Network, Princess Margaret Canc Ctr, 101 Coll St, Toronto, ON M5G 1L7, Canada; [Mojarad, Bahareh A.; Liu, Yi; Wu, Qianzhu; Comartin, David; Gingras, Anne-Claude; Pelletier, Laurence] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Raught, Brian] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Moffat, Jason] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 1A8, Canada; [Moffat, Jason] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 1A8, Canada; [Schueler, Markus; Hildebrandt, Friedhelm] Harvard Univ, Boston Childrens Hosp, Div Nephrol, Dept Med,Med Sch, Boston, MA 02115 USA; [Schueler, Markus; Hildebrandt, Friedhelm] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University of Toronto; University of Toronto; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Raught, B (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, 101 Coll St, Toronto, ON M5G 1L7, Canada.	brian.raught@uhnres.utoronto.ca; pelletier@lunenfeld.ca	Schueler, Markus/AAF-6057-2021; COYAUD, Etienne/ABD-9726-2020; Gingras, Anne-Claude/E-9982-2010; Gonçalves, João/P-4778-2017; Gingras, Anne-Claude/ABA-8341-2020; Pelletier, Laurence/F-8858-2013; Moffat, Jason/AAC-1110-2020; Goncalves, Joao/B-2013-2008	COYAUD, Etienne/0000-0002-5893-4557; Gingras, Anne-Claude/0000-0002-6090-4437; Gonçalves, João/0000-0001-5329-0986; Gingras, Anne-Claude/0000-0002-6090-4437; Moffat, Jason/0000-0002-5663-8586; Goncalves, Joao/0000-0002-1245-3715; Gupta, Gagan/0000-0002-1089-965X; Liu, Yi/0000-0003-1308-0567	Fundacao para a Ciencia e a Tecnologia [SFRH/BPD/75847/2011]; Ontario Trillium studentship; Canadian Institutes of Health Research (CIHR) [OGB 137413]; Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2014-06434]; Institute of Genetics; CIHR [MOP119289, MOP130340, MOP-123468, MOP-130507]; NSERC [RGPIN-355644-2008]; ORF-RE5; Krembil Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068306] Funding Source: NIH RePORTER	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Ontario Trillium studentship; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Institute of Genetics; CIHR(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); ORF-RE5; Krembil Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank G. Pereira and O. Gruss for the RAB8A-GFP cell line and SSX2IP antibody, T. McKinnon for help with mouse cDNA synthesis, D. Holmyard for EM assistance, G. Bader for advice on network topology, F. Liu and J.-P. Zhang for expert bioinformatics advice and assistance, T. Srikumar for MS technical assistance, J.-P. Lambert for MED4 constructs, and W. Dunham, G. Hesketh, and J.Y. Youn for sharing unpublished data. We thank D. Durocher, S. Angers, J. Wrana, and L. Attisano for comments on the manuscript. J.G. and B.A.M. were funded by the Fundacao para a Ciencia e a Tecnologia (SFRH/BPD/75847/2011) and an Ontario Trillium studentship. A.-C.G., B.R., and L.P. hold Canada Research Chairs in Functional Proteomics, Proteomics and Molecular Medicine, and Centrosome Biogenesis and Function, respectively. This work was funded by Canadian Institutes of Health Research (CIHR) (OGB 137413), Natural Sciences and Engineering Research Council of Canada (NSERC) (RGPIN-2014-06434), and the Institute of Genetics to A.-C.G., CIHR (MOP119289 and MOP130340) to B.R., and NSERC (RGPIN-355644-2008), CIHR (MOP-123468, MOP-130507), ORF-RE5 and the Krembil Foundation to L.P.	Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; BALCZON R, 1995, J CELL BIOL, V130, P105, DOI 10.1083/jcb.130.1.105; Choi H, 2011, NAT METHODS, V8, P70, DOI 10.1038/NMETH.1541; Comartin D, 2013, CURR BIOL, V23, P1360, DOI 10.1016/j.cub.2013.06.002; Alves-Cruzeiro JMD, 2014, NUCLEIC ACIDS RES, V42, pD430, DOI 10.1093/nar/gkt1126; Edwards M, 2014, NAT REV MOL CELL BIO, V15, P677, DOI 10.1038/nrm3869; Firat-Karalar EN, 2014, CURR BIOL, V24, P664, DOI 10.1016/j.cub.2014.01.067; Garcia-Gonzalo FR, 2011, NAT GENET, V43, P776, DOI 10.1038/ng.891; Godinho SA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0467; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Hori A, 2015, MOL BIOL CELL, V26, P2005, DOI 10.1091/mbc.E14-11-1561; Hsiao YC, 2009, HUM MOL GENET, V18, P3926, DOI 10.1093/hmg/ddp335; Jakobsen L, 2011, EMBO J, V30, P1520, DOI 10.1038/emboj.2011.63; Janke C, 2005, SCIENCE, V308, P1758, DOI 10.1126/science.1113010; Keller LC, 2005, CURR BIOL, V15, P1090, DOI 10.1016/j.cub.2005.05.024; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Klinger M, 2014, MOL BIOL CELL, V25, P495, DOI 10.1091/mbc.E13-09-0526; Kodani A, 2015, ELIFE, V4, DOI 10.7554/eLife.07519; Kubo A, 1999, J CELL BIOL, V147, P969, DOI 10.1083/jcb.147.5.969; Lawo S, 2009, CURR BIOL, V19, P816, DOI 10.1016/j.cub.2009.04.033; Lee JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058589; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Lin YC, 2013, EMBO J, V32, P1141, DOI 10.1038/emboj.2013.56; Lu Q, 2015, NAT CELL BIOL, V17, P531, DOI 10.1038/ncb3155; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nicholas AK, 2010, NAT GENET, V42, P1010, DOI 10.1038/ng.682; Omran H, 2008, NATURE, V456, P611, DOI 10.1038/nature07471; Qin HM, 2004, J CELL BIOL, V164, P255, DOI 10.1083/jcb.200308132; Reiter JF, 2012, EMBO REP, V13, P608, DOI 10.1038/embor.2012.73; Rotty JD, 2013, NAT REV MOL CELL BIO, V14, P7, DOI 10.1038/nrm3492; Seixas C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010704; Sir JH, 2011, NAT GENET, V43, P1147, DOI 10.1038/ng.971; Soulavie F, 2014, MOL BIOL CELL, V25, P1276, DOI 10.1091/mbc.E13-10-0616; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; Staples CJ, 2012, J CELL SCI, V125, P4770, DOI 10.1242/jcs.104059; Stephan R, 2015, DEV CELL, V33, P5, DOI 10.1016/j.devcel.2015.02.003; Tang ZM, 2013, NATURE, V502, P254, DOI 10.1038/nature12606; Tanos BE, 2013, GENE DEV, V27, P163, DOI 10.1101/gad.207043.112; Teo GC, 2014, J PROTEOMICS, V100, P37, DOI 10.1016/j.jprot.2013.10.023; Tollenaere MAX, 2015, CELL MOL LIFE SCI, V72, P11, DOI 10.1007/s00018-014-1711-3; van Dam Teunis Jp, 2013, Cilia, V2, P7, DOI 10.1186/2046-2530-2-7; Williams CL, 2011, J CELL BIOL, V192, P1023, DOI 10.1083/jcb.201012116	42	304	309	3	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 6	2015	163	6					1484	1499		10.1016/j.cell.2015.10.065	http://dx.doi.org/10.1016/j.cell.2015.10.065			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SE	26638075	Green Accepted, Bronze			2022-12-28	WOS:000366044800021
J	Feehally, J				Feehally, John			Glomerulonephritis from a chronically infected implanted device	LANCET			English	Editorial Material									[Feehally, John] Univ Leicester, Dept Infect Immun & Inflammat, Leicester LE1 9HN, Leics, England	University of Leicester	Feehally, J (corresponding author), Univ Leicester, Dept Infect Immun & Inflammat, Leicester LE1 9HN, Leics, England.	jf27@le.ac.uk						BLACK JA, 1965, LANCET, V2, P921; Saritas T, 2015, LANCET, V386, P2363, DOI 10.1016/S0140-6736(15)00822-3	2	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 5	2015	386	10010					2364	2364		10.1016/S0140-6736(15)00826-0	http://dx.doi.org/10.1016/S0140-6736(15)00826-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX8ZB	26681292				2022-12-28	WOS:000365993200037
J	Montanarella, L				Montanarella, Luca			Agricultural policy: Govern our soils	NATURE			English	Editorial Material									[Montanarella, Luca] Commiss European Communities, Joint Res Ctr, I-21020 Ispra, Italy	European Commission Joint Research Centre; EC JRC ISPRA Site	Montanarella, L (corresponding author), Commiss European Communities, Joint Res Ctr, I-21020 Ispra, Italy.	luca.montanarella@jrc.ec.europa.eu	Montanarella, Luca/AAE-7112-2019					Agrabright M. S., 1996, HIST CHANGES SOIL ER; [Anonymous], 2010, 2007 NAT RES INV; Commission of the European Communities, 2006, THEM STRAT SOIL PROT; Dinnissen R., 2014, TERRA INCOGNITA LAND; Global Soil Partnership, 2013, HLTH SOILS FAC GLOB; McBratney A, 2014, GEODERMA, V213, P203, DOI 10.1016/j.geoderma.2013.08.013; Montanarella L, 2009, ADV GEOECOLOGY, P40; Noel S., 2015, REAPING EC ENV BENEF	8	103	114	7	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					32	33		10.1038/528032a	http://dx.doi.org/10.1038/528032a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX3NO	26632574	Bronze			2022-12-28	WOS:000365606000032
J	O'Kane, MJ; Lopez, B				O'Kane, Maurice John; Lopez, Berenice			PRACTICE POINTER Explaining laboratory test results to patients: what the clinician needs to know	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[O'Kane, Maurice John] Western Hlth & Social Care Trust, Altnagelvin Hosp, Londonderry, North Ireland; [Lopez, Berenice] Norfolk & Norwich Univ Hosp Fdn Trust, Norwich, Norfolk, England		O'Kane, MJ (corresponding author), Western Hlth & Social Care Trust, Altnagelvin Hosp, Londonderry, North Ireland.	Maurice.OKane@westerntrust.hscni.net						Ahern DK, 2011, AM J PREV MED, V40, pS162, DOI 10.1016/j.amepre.2011.01.005; Ahmed H, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3996; Brydon WG, 2004, ANN CLIN BIOCHEM, V41, P78, DOI 10.1258/000456304322664753; Christenson K, 2013, J PARTICIPAT MED, V5; de Lusignan S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006021; Fraser CG, 2001, BIOL VARIATION PRINC; Harris E K, 1981, Prog Clin Pathol, V8, P45; MOGADAM M, 1990, ARCH INTERN MED, V150, P1645, DOI 10.1001/archinte.150.8.1645; National Clinical Guideline Center, 2014, LIP MOD CARD RISK AS; National Institute for Health and Care Excellence, 2011, OV CANC REC IN MAN O; Pannall P, 1997, CANC CLIN BIOCH	11	9	9	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 3	2015	351								h5552	10.1136/bmj.h5552	http://dx.doi.org/10.1136/bmj.h5552			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX9EZ	26634382				2022-12-28	WOS:000366009100001
J	Dreyling, M; Jurczak, W; Jerkeman, M; Silva, RS; Rusconi, C; Trneny, M; Offner, F; Caballero, D; Joao, C; Witzens-Harig, M; Hess, G; Bence-Bruckler, I; Cho, SG; Bothos, J; Goldberg, JD; Enny, C; Traina, S; Balasubramanian, S; Bandyopadhyay, N; Sun, S; Vermeulen, J; Rizo, A; Rule, S				Dreyling, Martin; Jurczak, Wojciech; Jerkeman, Mats; Silva, Rodrigo Santucci; Rusconi, Chiara; Trneny, Marek; Offner, Fritz; Caballero, Dolores; Joao, Cristina; Witzens-Harig, Mathias; Hess, Georg; Bence-Bruckler, Isabelle; Cho, Seok-Goo; Bothos, John; Goldberg, Jenna D.; Enny, Christopher; Traina, Shana; Balasubramanian, Sriram; Bandyopadhyay, Nibedita; Sun, Steven; Vermeulen, Jessica; Rizo, Aleksandra; Rule, Simon			Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase study	LANCET			English	Article							BRUTON TYROSINE KINASE; CHRONIC LYMPHOCYTIC-LEUKEMIA; SINGLE-AGENT TEMSIROLIMUS; RESPONSE CRITERIA; FOLLOW-UP; PCI-32765; BTK; BORTEZOMIB; MALIGNANCY; GUIDELINES	Background Mantle-cell lymphoma is an aggressive B-cell lymphoma with a poor prognosis. Both ibrutinib and temsirolimus have shown single-agent activity in patients with relapsed or refractory mantle-cell lymphoma. We undertook a phase 3 study to assess the efficacy and safety of ibrutinib versus temsirolimus in relapsed or refractory mantle-cell lymphoma. Methods This randomised, open-label, multicentre, phase 3 clinical trial enrolled patients with relapsed or refractory mantle-cell lymphoma confirmed by central pathology in 21 countries who had received one or more rituximab-containing treatments. Patients were stratified by previous therapy and simplified mantle-cell lymphoma international prognostic index score, and were randomly assigned with a computer-generated randomisation schedule to receive daily oral ibrutinib 560 mg or intravenous temsirolimus (175 mg on days 1, 8, and 15 of cycle 1; 75 mg on days 1, 8, and 15 of subsequent 21-day cycles). Randomisation was balanced by using randomly permuted blocks. The primary efficacy endpoint was progression-free survival assessed by a masked independent review committee with the primary hypothesis that ibrutinib compared with temsirolimus significantly improves progression-free survival. The analysis followed the intention-to-treat principle. The trial is ongoing and is registered with ClinicalTrials.gov (number NCT01646021) and with the EU Clinical Trials Register, EudraCT (number 2012-000601-74). Findings Between Dec 10, 2012, and Nov 26, 2013, 280 patients were randomised to ibrutinib (n=139) or temsirolimus (n=141). Primary efficacy analysis showed significant improvement in progression-free survival (p<0.0001) for patients treated with ibrutinib versus temsirolimus (hazard ratio 0.43 [95% CI 0.32-0.58]; median progression-free survival 14.6 months [95% CI 10.4-not estimable] vs 6.2 months [4.2-7.9], respectively). Ibrutinib was better tolerated than temsirolimus, with grade 3 or higher treatment-emergent adverse events reported for 94 (68%) versus 121 (87%) patients, and fewer discontinuations of study medication due to adverse events for ibrutinib versus temsirolimus (9 [6%] vs 36 [26%]). Interpretation Ibrutinib treatment resulted in significant improvement in progression-free survival and better tolerability versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma. These data lend further support to the positive benefit-risk ratio for ibrutinib in relapsed or refractory mantle-cell lymphoma.	[Dreyling, Martin] Klinikum Univ Munchen, Dept Med 3, Campus Grosshadern,Marchioninistr 15, D-81377 Munich, Germany; [Jurczak, Wojciech] Jagiellonian Univ, Dept Hematol, Krakow, Poland; [Jerkeman, Mats] Skanes Univ Jukhus, Lund, Sweden; [Silva, Rodrigo Santucci] Inst Ensino E Pesquisa Sao Lucas, Sao Paulo, Brazil; [Rusconi, Chiara] Osped Niguarda Ca Granda, Niguarda Canc Ctr, Dept Hematol & Oncol, Div Hematol, Milan, Italy; [Trneny, Marek] Urol Clin, Klin Hematol, Interni Klin, Vseobecna Fak Nemocnice, Prague, Czech Republic; [Offner, Fritz] UZ Gent, Dept Oncol, Ghent, Belgium; [Caballero, Dolores] Hosp Clin Univ Salamanca, Inst Biosanitario Salamanca, Salamanca, Spain; [Joao, Cristina] Champalimaud Ctr Unknown, Dept Hematol, Lisbon, Portugal; [Joao, Cristina] Inst Portugues Oncol Francisco Gentil, Lisbon, Portugal; [Witzens-Harig, Mathias] Klinikum Ruprechts Karls Univ Heidelberg, Med Klin & Poliklin 5, Heidelberg, Germany; [Hess, Georg] Johannes Gutenberg Univ Mainz, Univ Med Sch, Dept Hematol Oncol & Pneumol, D-55122 Mainz, Germany; [Bence-Bruckler, Isabelle] Ottawa Hosp Gen Campus, Ottawa, ON, Canada; [Cho, Seok-Goo] Seoul St Marys Hosp, Seoul, South Korea; [Bothos, John; Goldberg, Jenna D.; Enny, Christopher; Traina, Shana; Bandyopadhyay, Nibedita; Sun, Steven; Rizo, Aleksandra] Janssen Res & Dev LLC, Raritan, NJ USA; [Balasubramanian, Sriram] Janssen Res & Dev LLC, Spring House, PA USA; [Vermeulen, Jessica] Janssen Res & Dev LLC, Leiden, Netherlands; [Rule, Simon] Derriford Hosp, Plymouth PL6 8DH, Devon, England	University of Munich; Jagiellonian University; Collegium Medicum Jagiellonian University; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; General University Hospital Prague; Ghent University; Ghent University Hospital; Fundacao Champalimaud; Portuguese Institute of Oncology; Ruprecht Karls University Heidelberg; Johannes Gutenberg University of Mainz; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Ottawa; Ottawa Hospital Research Institute; Seoul St. Mary's Hospital; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Derriford Hospital	Dreyling, M (corresponding author), Klinikum Univ Munchen, Dept Med 3, Campus Grosshadern,Marchioninistr 15, D-81377 Munich, Germany.	Martin.Dreyling@med.uni-muenchen.de	Jurczak, Wojciech/L-7645-2019; Jurczak, Wojciech/AAV-7973-2020; Jurczak, Wojciech/ABB-2136-2020; Jurczak, Wojciech/M-1625-2019; Silva, Rodrigo/GXM-7197-2022; Witzens-Harig, Mathias/N-1790-2017	Jurczak, Wojciech/0000-0003-1879-8084; Jurczak, Wojciech/0000-0003-1879-8084; Witzens-Harig, Mathias/0000-0002-2799-4661; Joao, Cristina/0000-0002-3978-766X; Trneny, Marek/0000-0002-6952-6073; Cho, Seok-Goo/0000-0002-5429-4839	Janssen Research Development; Janssen Global Services, LLC	Janssen Research Development; Janssen Global Services, LLC	This study was funded by Janssen Research & Development. Writing assistance was provided by Michelle Olsher (PAREXEL, Hackensack, NJ, USA) and was funded by Janssen Global Services, LLC. We thank the patients who participated in this trial, their families, and the investigators and coordinators at each of the clinical sites. The investigators are listed in the appendix.	Ansell SM, 2008, CANCER-AM CANCER SOC, V113, P508, DOI 10.1002/cncr.23580; Buggy JJ, 2012, INT REV IMMUNOL, V31, P119, DOI 10.3109/08830185.2012.664797; Carter GC, 2008, BLOOD, V112, P828; Cella D., 2005, BLOOD, V106, P750, DOI [10.1182/blood.V106.11.750.750, DOI 10.1182/BLOOD.V106.11.750.750]; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Cinar M, 2013, LEUKEMIA RES, V37, P1271, DOI 10.1016/j.leukres.2013.07.028; Cortelazzo S, 2012, CRIT REV ONCOL HEMAT, V82, P78, DOI 10.1016/j.critrevonc.2011.05.001; de Rooij MFM, 2012, BLOOD, V119, P2590, DOI 10.1182/blood-2011-11-390989; Dreyling M, 2014, ANN ONCOL, V25, P83, DOI 10.1093/annonc/mdu264; Dreyling M, 2013, HEMATOL ONCOL S1, V31, P137; EMA, 2012, EMACHMP20595REV4; Ferrero S, 2013, CURR OPIN ONCOL, V25, P452, DOI 10.1097/CCO.0b013e328363df0b; Fisher RI, 2006, J CLIN ONCOL, V24, P4867, DOI 10.1200/JCO.2006.07.9665; Goy A, 2013, J CLIN ONCOL, V31, P3688, DOI 10.1200/JCO.2013.49.2835; Herman SEM, 2011, BLOOD, V117, P6287, DOI 10.1182/blood-2011-01-328484; Herrmann A, 2009, J CLIN ONCOL, V27, P511, DOI 10.1200/JCO.2008.16.8435; Hess G, 2009, J CLIN ONCOL, V27, P3822, DOI 10.1200/JCO.2008.20.7977; Hlubocky FJ, 2013, LYMPHOMA, V2013, DOI [10.1155/2013/147176, DOI 10.1155/2013/147176]; Honigberg LA, 2010, P NATL ACAD SCI USA, V107, P13075, DOI 10.1073/pnas.1004594107; Hoster E, 2008, BLOOD, V111, P558, DOI 10.1182/blood-2007-06-095331; Khan WN, 2012, J IMMUNOL, V188, P2933, DOI 10.4049/jimmunol.1200490; McKay P, 2012, BRIT J HAEMATOL, V159, P405, DOI 10.1111/bjh.12046; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Ponader S, 2012, BLOOD, V119, P1182, DOI 10.1182/blood-2011-10-386417; Rudelius M, 2006, BLOOD, V108, P1668, DOI 10.1182/blood-2006-04-015586; Wang M, 2014, BLOOD, V124, P4471; Wang ML, 2015, BLOOD, V126, P739, DOI 10.1182/blood-2015-03-635326; Wang ML, 2013, NEW ENGL J MED, V369, P507, DOI 10.1056/NEJMoa1306220; Witzig TE, 2005, J CLIN ONCOL, V23, P5347, DOI 10.1200/JCO.2005.13.466	29	313	323	1	36	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 20	2016	387	10020					770	778		10.1016/S0140-6736(15)00667-4	http://dx.doi.org/10.1016/S0140-6736(15)00667-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE1WU	26673811	Green Published			2022-12-28	WOS:000370418000036
J	Cnattingius, S; Villamor, E				Cnattingius, Sven; Villamor, Eduardo			Weight change between successive pregnancies and risks of stillbirth and infant mortality: a nationwide cohort study	LANCET			English	Article							BODY-MASS INDEX; MATERNAL OBESITY; NEONATAL-MORTALITY; PRETERM BIRTH; OVERWEIGHT; FAT; INFLAMMATION; GAIN	Background Maternal overweight and obesity are risk factors for stillbirth and infant mortality. Whether temporal changes in maternal weight affect these risks is not clear. We aimed to assess whether change of BMI between first and second pregnancies affects risks of stillbirth and infant mortality in the second-born off spring. Methods In a Swedish population-based cohort of women who gave birth to their first and second child between Jan 1, 1992, and Dec 31, 2012, we investigated associations between change in maternal body-mass index (BMI) during early pregnancy from first to second pregnancies and risks of stillbirth and neonatal, postneonatal, and infant mortality after the second pregnancy. Relative risks (RRs) for each outcome according to BMI change categories were calculated with binomial regression. Findings Complete information was available for 456 711 (77.7%) of 587 710 women who had their first and second single births in the study period. Compared with women with a stable BMI (change between -1 kg/m(2) and <1 kg/m(2)) between pregnancies, the adjusted RRs for women who gained at least 4 BMI units between pregnancies were 1.55 (95% CI 1.23-1.96) for stillbirth and 1.29 (1.00-1.67) for infant mortality. Stillbirth risks increased linearly with increased BMI gain. Risks of infant mortality in second pregnancy only increased with BMI gain in women with healthy BMI (<25 kg/m(2)) during first pregnancy; the adjusted RR for healthy weight women who gained 2 to less than 4 BMI units was 1.27 (1.01-1.59) and for those who gained 4 BMI units or more the adjusted RR was 1.60 (1.16-2.22). In overweight women (BMI >= 25 kg/m(2)), weight loss before pregnancy reduced risk of neonatal mortality. Interpretation Our findings emphasise the need to prevent weight gain before pregnancy in healthy and overweight women and that weight loss should be promoted in overweight women.	[Cnattingius, Sven] Karolinska Inst, Karolinska Univ Hosp, Dept Med, Clin Epidemiol Unit, SE-17176 Stockholm, Sweden; [Villamor, Eduardo] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA	Karolinska Institutet; Karolinska University Hospital; University of Michigan System; University of Michigan	Cnattingius, S (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Dept Med, Clin Epidemiol Unit, SE-17176 Stockholm, Sweden.	sven.cnattingius@ki.se			Swedish Research Council for Health, Working Life and Welfare [2014-0073]; Karolinska Institutet	Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Karolinska Institutet(Karolinska Institutet)	This study was supported by the Swedish Research Council for Health, Working Life and Welfare (grant number 2014-0073), and an unrestricted grant from Karolinska Institutet (Distinguished Professor Award to SC). We thank Gunnar Petersson, Karolinska Institutet, for assistance with data extraction and linkage.	Ahonen T, 2012, GENDER MED, V9, P1, DOI 10.1016/j.genm.2012.01.002; Ambeba EJ, 2013, METABOLISM, V62, P1218, DOI 10.1016/j.metabol.2013.04.004; Aune D, 2014, JAMA-J AM MED ASSOC, V311, P1536, DOI 10.1001/jama.2014.2269; Cnattingius S, 2013, JAMA-J AM MED ASSOC, V309, P2362, DOI 10.1001/jama.2013.6295; Dalenius K, PREGNANCY NUTR SURVE; Fontana L, 2007, DIABETES, V56, P1010, DOI 10.2337/db06-1656; Genc MR, 2010, CURR OPIN OBSTET GYN, V22, P116, DOI 10.1097/GCO.0b013e3283374ac8; Guelinckx I, 2008, OBES REV, V9, P140, DOI 10.1111/j.1467-789X.2007.00464.x; Hogberg U, 1997, ACTA OBSTET GYN SCAN, V76, P907, DOI 10.3109/00016349709034900; Huber LRB, 2007, MATERN CHILD HLTH J, V11, P137, DOI 10.1007/s10995-006-0157-0; Janssen I, 2002, AM J CLIN NUTR, V75, P683, DOI 10.1093/ajcn/75.4.683; Johansson S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6572; Lindsay CA, 1997, OBSTET GYNECOL, V89, P377, DOI 10.1016/S0029-7844(96)00517-0; Meehan S, 2014, PEDIATRICS, V133, P863, DOI 10.1542/peds.2013-1480; Mendez MA, 2005, AM J CLIN NUTR, V81, P714; Nohr EA, 2007, OBSTET GYNECOL, V110, P1083, DOI 10.1097/01.AOG.0000286760.46679.f8; Persson M, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001648; Salihu HM, 2008, OBSTET GYNECOL, V111, P1410, DOI 10.1097/AOG.0b013e318173ecd4; Schafer JL., 1997, ANAL INCOMPLETE MULT, DOI 10.1201/9781439821862; Schmatz M, 2010, J PERINATOL, V30, P441, DOI 10.1038/jp.2009.182; Sewell MF, 2007, J REPROD MED, V52, P907; Simmons LE, 2010, SEMIN PERINATOL, V34, P408, DOI 10.1053/j.semperi.2010.09.005; Statistics Sweden, EV SWED REG ED; Statistics Sweden, TABL POP SWED 2009; Stephansson O, 2001, AM J OBSTET GYNECOL, V184, P463, DOI 10.1067/mob.2001.109591; Stothard KJ, 2009, JAMA-J AM MED ASSOC, V301, P636, DOI 10.1001/jama.2009.113; Swedish National Board of Health and Welfare (Socialstyrelsen), CAUS DEATH 2013; Swedish National Board of Health and Welfare (Socialstyrelsen), SUMM CONT QUAL; Torloni MR, 2009, J MATERN-FETAL NEO M, V22, P957, DOI 10.3109/14767050903042561; Villamor E, 2006, LANCET, V368, P1164, DOI 10.1016/S0140-6736(06)69473-7; WACHOLDER S, 1986, AM J EPIDEMIOL, V123, P174, DOI 10.1093/oxfordjournals.aje.a114212; Whiteman VE, 2011, GYNECOL OBSTET INVES, V72, P192, DOI 10.1159/000324375; Whiteman VE, 2011, AM J PERINAT, V28, P67, DOI 10.1055/s-0030-1262905; Wisse BE, 2004, J AM SOC NEPHROL, V15, P2792, DOI 10.1097/01.ASN.0000141966.69934.21; World Health Organization, GLOB DAT BOD MASS IN	35	72	73	2	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 6	2016	387	10018					558	565		10.1016/S0140-6736(15)00990-3	http://dx.doi.org/10.1016/S0140-6736(15)00990-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD3PV	26651225				2022-12-28	WOS:000369835800034
J	Diaz, S; Kattge, J; Cornelissen, JHC; Wright, IJ; Lavorel, S; Dray, S; Reu, B; Kleyer, M; Wirth, C; Prentice, IC; Garnier, E; Bonisch, G; Westoby, M; Poorter, H; Reich, PB; Moles, AT; Dickie, J; Gillison, AN; Zanne, AE; Chave, J; Wright, SJ; Sheremet'ev, SN; Jactel, H; Baraloto, C; Cerabolini, B; Pierce, S; Shipley, B; Kirkup, D; Casanoves, F; Joswig, JS; Gunther, A; Falczuk, V; Ruger, N; Mahecha, MD; Gorne, LD				Diaz, Sandra; Kattge, Jens; Cornelissen, Johannes H. C.; Wright, Ian J.; Lavorel, Sandra; Dray, Stephane; Reu, Bjoern; Kleyer, Michael; Wirth, Christian; Prentice, I. Colin; Garnier, Eric; Boenisch, Gerhard; Westoby, Mark; Poorter, Hendrik; Reich, Peter B.; Moles, Angela T.; Dickie, John; Gillison, Andrew N.; Zanne, Amy E.; Chave, Jerome; Wright, S. Joseph; Sheremet'ev, Serge N.; Jactel, Herve; Baraloto, Christopher; Cerabolini, Bruno; Pierce, Simon; Shipley, Bill; Kirkup, Donald; Casanoves, Fernando; Joswig, Julia S.; Guenther, Angela; Falczuk, Valeria; Rueger, Nadja; Mahecha, Miguel D.; Gorne, Lucas D.			The global spectrum of plant form and function	NATURE			English	Article							HAWAIIAN METROSIDEROS-POLYMORPHA; TRAIT-ENVIRONMENT RELATIONSHIPS; FOLIAR NITROGEN ISOTOPES; LEAF ECONOMICS SPECTRUM; RELATIVE GROWTH-RATE; DRY-MATTER CONTENT; SEED SIZE; PHOTOSYNTHETIC CAPACITY; WIDE-RANGE; TRADE-OFFS	Earth is home to a remarkable diversity of plant forms and life histories, yet comparatively few essential trait combinations have proved evolutionarily viable in today's terrestrial biosphere. By analysing worldwide variation in six major traits critical to growth, survival and reproduction within the largest sample of vascular plant species ever compiled, we found that occupancy of six-dimensional trait space is strongly concentrated, indicating coordination and trade-offs. Three-quarters of trait variation is captured in a two-dimensional global spectrum of plant form and function. One major dimension within this plane reflects the size of whole plants and their parts; the other represents the leaf economics spectrum, which balances leaf construction costs against growth potential. The global plant trait spectrum provides a backdrop for elucidating constraints on evolution, for functionally qualifying species and ecosystems, and for improving models that predict future vegetation based on continuous variation in plant form and function.	[Diaz, Sandra; Falczuk, Valeria; Gorne, Lucas D.] Univ Nacl Cordoba, CONICET, Inst Multidisciplinario Biol Vegetal IMBIV, Casilla Correo 495, RA-5000 Cordoba, Argentina; [Diaz, Sandra; Falczuk, Valeria; Gorne, Lucas D.] Univ Nacl Cordoba, FCEFyN, RA-5000 Cordoba, Argentina; [Kattge, Jens; Wirth, Christian; Boenisch, Gerhard; Joswig, Julia S.; Guenther, Angela; Mahecha, Miguel D.] Max Planck Inst Biogeochem, D-07745 Jena, Germany; [Kattge, Jens; Wirth, Christian; Rueger, Nadja; Mahecha, Miguel D.] German Ctr Integrat Biodivers Res iDiv, D-04103 Leipzig, Germany; [Cornelissen, Johannes H. C.] Vrije Univ, Dept Ecol Sci, Syst Ecol, NL-1081 HV Amsterdam, Netherlands; [Wright, Ian J.; Prentice, I. Colin; Westoby, Mark] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Lavorel, Sandra] Univ Grenoble Alpes, CNRS, UMR 5553, Lab Ecol Alpine, F-38041 Grenoble 9, France; [Dray, Stephane] Univ Lyon 1, CNRS, Lab Biometrie & Biol Evolut, UMR5558, F-69622 Villeurbanne, France; [Reu, Bjoern] Univ Leipzig, Inst Biol, D-04103 Leipzig, Germany; [Reu, Bjoern] Univ Ind Santander, Escuela Biol, Bucaramanga 680002, Colombia; [Kleyer, Michael] Carl von Ossietzky Univ Oldenburg, Inst Biol & Environm Sci, Landscape Ecol Grp, D-26111 Oldenburg, Germany; [Wirth, Christian] Univ Leipzig, Dept Systemat Bot & Funct Biodivers, D-04103 Leipzig, Germany; [Prentice, I. Colin] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, AXA Chair Biosphere & Climate Impacts, Grand Challenges Ecosyst, Ascot SL5 7PY, Berks, England; [Prentice, I. Colin] Univ London Imperial Coll Sci Technol & Med, Environm & Grantham Inst, Climate Change & Environm, Ascot SL5 7PY, Berks, England; [Garnier, Eric] Univ Montpellier, Univ Paul Valery Montpellier, Ctr Ecol Fonct & Evolut,UMR 5175, CNRS,EPHE, F-34293 Montpellier 5, France; [Poorter, Hendrik] Forschungszentrum Julich GmbH, Plant Sci IBG 2, D-52425 Julich, Germany; [Reich, Peter B.] Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA; [Reich, Peter B.] Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW 2751, Australia; [Moles, Angela T.] UNSW Australia, Sch Biol Earth & Environm Sci, Evolut & Ecol Res Ctr, Sydney, NSW 2052, Australia; [Dickie, John] Collections, Ardingly RH17 6TN, W Sussex, England; [Gillison, Andrew N.] Ctr Biodivers Management, Yungaburra, Qld 4884, Australia; [Zanne, Amy E.] George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA; [Zanne, Amy E.] Missouri Bot Garden, Ctr Conservat & Sustainable Dev, St Louis, MO 63121 USA; [Chave, Jerome] CNRS, Lab Evolut & Divers Biol, UMR 5174, F-31062 Toulouse, France; [Chave, Jerome] Univ Toulouse 3, F-31062 Toulouse, France; [Wright, S. Joseph; Rueger, Nadja] Smithsonian Trop Res Inst, Balboa, Ancon, Panama; [Sheremet'ev, Serge N.] Komarov Bot Inst, St Petersburg 197376, Russia; [Jactel, Herve] INRA, UMR1202, BIOGECO, F-33610 Cestas, France; [Jactel, Herve] Univ Bordeaux, BIOGECO, UMR 1202, F-33600 Pessac, France; [Baraloto, Christopher] Florida Int Univ, Dept Biol Sci, Int Ctr Trop Bot, Miami, FL 33199 USA; [Baraloto, Christopher] INRA, UMR Ecol Forets Guyane, Kourou 97310, French Guiana; [Cerabolini, Bruno] Univ Insubria, Dept Theoret & Appl Sci, I-21100 Varese, Italy; [Pierce, Simon] Univ Milan, Dept Agr & Environm Sci DiSAA, I-20133 Milan, Italy; [Shipley, Bill] Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada; [Kirkup, Donald] Royal Bot Gardens Kew, Biodivers Informat & Spatial Anal, Richmond TW9 3AB, Surrey, England; [Casanoves, Fernando] Ctr Agron Trop Invest & Ensenanza CATIE, Unidad Bioestadist, Turrialba 30501, Costa Rica	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; National University of Cordoba; Max Planck Society; Vrije Universiteit Amsterdam; Macquarie University; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Leipzig University; Universidad Industrial de Santander; Carl von Ossietzky Universitat Oldenburg; Leipzig University; Imperial College London; Imperial College London; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Helmholtz Association; Research Center Julich; University of Minnesota System; University of Minnesota Twin Cities; Western Sydney University; University of New South Wales Sydney; George Washington University; Missouri Botanical Gardens; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Smithsonian Institution; Smithsonian Tropical Research Institute; Russian Academy of Sciences; Komarov Botanical Institute, Russian Academy of Sciences; INRAE; UDICE-French Research Universities; Universite de Bordeaux; State University System of Florida; Florida International University; INRAE; University of Insubria; University of Milan; University of Sherbrooke; Royal Botanic Gardens, Kew; CATIE - Centro Agronomico Tropical de Investigacion y Ensenanza	Diaz, S (corresponding author), Univ Nacl Cordoba, CONICET, Inst Multidisciplinario Biol Vegetal IMBIV, Casilla Correo 495, RA-5000 Cordoba, Argentina.	sandra.diaz@unc.edu.ar	Rüger, Nadja/Q-6418-2019; Baraloto, Christopher/ABG-2500-2020; Garnier, Eric/D-1650-2012; Sheremetiev, Serge N/K-4891-2013; Díaz, Sandra/ABE-7349-2020; Poorter, Hendrik/B-8062-2010; Dray, Stéphane/B-4107-2010; Mahecha, Miguel D/F-2443-2010; Moles, Angela T/C-3083-2008; Poorter, Hendrik/Y-2542-2019; Wright, Stuart Joseph/M-3311-2013; Wirth, Christian/A-4446-2016; Pierce, Simon/G-6785-2017; Diaz, Sandra/Q-9804-2018; Shipley, Bill/A-4578-2011; Cerabolini, Bruno Enrico Leone/N-6934-2014; Casanoves, Fernando/I-3588-2016; Kattge, Jens/J-8283-2016; Rüger, Nadja/J-6393-2015; Wright, Ian J/G-4979-2012	Rüger, Nadja/0000-0003-2371-4172; Baraloto, Christopher/0000-0001-7322-8581; Garnier, Eric/0000-0002-9392-5154; Sheremetiev, Serge N/0000-0002-0318-6766; Díaz, Sandra/0000-0003-0012-4612; Poorter, Hendrik/0000-0001-9900-2433; Dray, Stéphane/0000-0003-0153-1105; Mahecha, Miguel D/0000-0003-3031-613X; Moles, Angela T/0000-0003-2041-7762; Poorter, Hendrik/0000-0001-9900-2433; Wright, Stuart Joseph/0000-0003-4260-5676; Pierce, Simon/0000-0003-1182-987X; Shipley, Bill/0000-0002-7026-3880; Cerabolini, Bruno Enrico Leone/0000-0002-3793-0733; Casanoves, Fernando/0000-0001-8765-9382; Kattge, Jens/0000-0002-1022-8469; Rüger, Nadja/0000-0003-2371-4172; Wright, Ian J/0000-0001-8338-9143; Reu, Bjorn/0000-0001-5271-6420; Reich, Peter/0000-0003-4424-662X; Westoby, Mark/0000-0001-7690-4530	TRY initiative on plant traits; DIVERSITAS/Future Earth; German Centre for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig; BACI [ID 640176]; Universidad Nacional de Cordoba; CONICET; FONCyT [PICT 554]; SECyT (Argentina); Leverhulme Trust, UK; Inter-American Institute for Global Change Research (IAI) [SGP-CRA2015]; US National Science Foundation [GEO-1138881]; Direct For Biological Sciences [1234162, 1242531] Funding Source: National Science Foundation	TRY initiative on plant traits; DIVERSITAS/Future Earth; German Centre for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig; BACI; Universidad Nacional de Cordoba; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); FONCyT(FONCyT); SECyT (Argentina)(Secretaria de Ciencia y Tecnologia (SECYT)); Leverhulme Trust, UK(Leverhulme Trust); Inter-American Institute for Global Change Research (IAI); US National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We are grateful to the many researchers who contributed to this study by making their data available, helping to check information, and/or providing comments at various stages. The study was supported by the TRY initiative on plant traits (http://www.try-db.org). The TRY database is hosted at the Max Planck Institute for Biogeochemistry (Jena, Germany) and supported by DIVERSITAS/Future Earth, the German Centre for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig, and BACI (grant ID 640176). The study has also been partially supported by the following institutions and grants to S.Di.: Universidad Nacional de Cordoba and CONICET, FONCyT (PICT 554) and SECyT (Argentina), The Leverhulme Trust, UK, and Inter-American Institute for Global Change Research (IAI) SGP-CRA2015 (supported by US National Science Foundation grant GEO-1138881).	Ackerly D, 2004, ECOL MONOGR, V74, P25, DOI 10.1890/03-4022; Ackerly DD, 1998, AM NAT, V152, P767, DOI 10.1086/286208; Adler PB, 2004, J APPL ECOL, V41, P653, DOI 10.1111/j.0021-8901.2004.00934.x; Adriaenssens S., 2012, THESIS; Albert CH, 2010, J ECOL, V98, P604, DOI 10.1111/j.1365-2745.2010.01651.x; [Anonymous], 2015, ROYAL BOT GARDENS KE; Atkin OK, 1997, PLANT PHYSIOL, V113, P961, DOI 10.1104/pp.113.3.961; Atkin OK, 1999, OECOLOGIA, V120, P544, DOI 10.1007/s004420050889; Auger S, 2013, J VEG SCI, V24, P419, DOI 10.1111/j.1654-1103.2012.01473.x; Bahn M., 1999, LAND USE CHANGES EUR, P247; Bakker C, 2006, PLANT ECOL, V185, P19, DOI 10.1007/s11258-005-9080-5; Bakker C, 2005, PLANT SOIL, V275, P111, DOI 10.1007/s11104-005-0438-1; Baraloto C, 2010, ECOL LETT, V13, P1338, DOI 10.1111/j.1461-0248.2010.01517.x; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beckmann M, 2012, ENVIRON EXP BOT, V75, P173, DOI 10.1016/j.envexpbot.2011.09.010; Ben-Hur E, 2012, ECOL LETT, V15, P1276, DOI 10.1111/j.1461-0248.2012.01850.x; Blonder B, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv049; Blonder B, 2014, GLOBAL ECOL BIOGEOGR, V23, P595, DOI 10.1111/geb.12146; Blonder B, 2013, J ECOL, V101, P981, DOI 10.1111/1365-2745.12102; Blonder B, 2011, ECOL LETT, V14, P91, DOI 10.1111/j.1461-0248.2010.01554.x; Bocanegra-González Kelly Tatiana, 2015, Bol. Cient. Mus. Hist. Nat. Univ. Caldas, V19, P17, DOI 10.17151/bccm.2015.19.1.2; Bond-Lamberty B, 2002, TREE PHYSIOL, V22, P993, DOI 10.1093/treephys/22.14.993; Bond-Lamberty B, 2002, CAN J FOREST RES, V32, P1441, DOI [10.1139/x02-063, 10.1139/X02-063]; Boyce CK, 2009, P ROY SOC B-BIOL SCI, V276, P1771, DOI 10.1098/rspb.2008.1919; Bragazza L, 2009, BIODIVERS CONSERV, V18, P2823, DOI 10.1007/s10531-009-9609-3; Brando PM, 2014, P NATL ACAD SCI USA, V111, P6347, DOI 10.1073/pnas.1305499111; Brown KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024107; Buntgen U, 2014, J VEG SCI, V25, P967, DOI 10.1111/jvs.12165; Burrascano S, 2015, COMMUNITY ECOL, V16, P244, DOI 10.1556/168.2015.16.2.12; Butterfield BJ, 2011, OECOLOGIA, V165, P477, DOI 10.1007/s00442-010-1741-y; Byun C, 2013, J ECOL, V101, P128, DOI 10.1111/1365-2745.12016; Campbell C, 2007, NEW PHYTOL, V176, P375, DOI 10.1111/j.1469-8137.2007.02183.x; Campetella G, 2011, AGR ECOSYST ENVIRON, V145, P38, DOI 10.1016/j.agee.2011.06.025; Carswell FE, 2000, TREE PHYSIOL, V20, P179; Castro-Diez P, 1998, OECOLOGIA, V116, P57, DOI 10.1007/s004420050563; Cavender-Bares J, 2007, TREE PHYSIOL, V27, P611, DOI 10.1093/treephys/27.4.611; Cavender-Bares J, 2006, ECOLOGY, V87, pS109, DOI 10.1890/0012-9658(2006)87[109:PSOFPC]2.0.CO;2; Cerabolini BEL, 2010, PLANT ECOL, V210, P253, DOI 10.1007/s11258-010-9753-6; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Chen YH, 2013, ECOGRAPHY, V36, P178, DOI 10.1111/j.1600-0587.2011.06833.x; Choat B, 2012, NATURE, V491, P752, DOI 10.1038/nature11688; Ciocarlan V, 2009, ILLUSTRATED FLORA RO; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Conti G, 2013, ANN FOREST SCI, V70, P515, DOI 10.1007/s13595-013-0285-9; Conti G, 2013, J ECOL, V101, P18, DOI 10.1111/1365-2745.12012; CONWAY E, 1957, J ECOL, V45, P273, DOI 10.2307/2257089; Coomes DA, 2008, BIOL LETTERS, V4, P302, DOI 10.1098/rsbl.2008.0094; Cornelissen JHC, 1996, J ECOL, V84, P755, DOI 10.2307/2261337; Cornelissen JHC, 1996, J ECOL, V84, P573, DOI 10.2307/2261479; Cornelissen JHC, 2004, FUNCT ECOL, V18, P779, DOI 10.1111/j.0269-8463.2004.00900.x; Cornelissen JHC, 2003, J VEG SCI, V14, P311, DOI 10.1111/j.1654-1103.2003.tb02157.x; Cornelissen JHC, 1999, OECOLOGIA, V118, P248, DOI 10.1007/s004420050725; Cornwell WK, 2007, FUNCT ECOL, V21, P1063, DOI 10.1111/j.1365-2435.2007.01323.x; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Cornwell WK, 2014, J ECOL, V102, P345, DOI 10.1111/1365-2745.12208; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; Craine JM, 2005, ECOLOGY, V86, P12, DOI 10.1890/04-1075; Craine JM, 2012, PLANT SOIL, V356, P395, DOI 10.1007/s11104-012-1141-7; Craine JM, 2011, OECOLOGIA, V165, P1109, DOI 10.1007/s00442-011-1938-8; Craine JM, 2009, NEW PHYTOL, V183, P980, DOI 10.1111/j.1469-8137.2009.02917.x; Craven D, 2007, FOREST ECOL MANAG, V238, P335, DOI 10.1016/j.foreco.2006.10.030; de Araujo A. C., 2012, CD02 LBAECO OAK RIDG; Demey A, 2013, PLANT SOIL, V371, P53, DOI 10.1007/s11104-013-1658-4; Di Rienzo J.A., 2015, INFOSTAT VERSI6N 201, DOI DOI 10.1111/j.1469-8137.2006.01787.x; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; Domingues TF, 2007, PLANT ECOL, V193, P101, DOI 10.1007/s11258-006-9251-z; Domingues TF, 2010, PLANT CELL ENVIRON, V33, P959, DOI 10.1111/j.1365-3040.2010.02119.x; Donoghue MJ, 2005, PALEOBIOLOGY, V31, P77, DOI 10.1666/0094-8373(2005)031[0077:KICASM]2.0.CO;2; Dray S, 2008, COMPUT STAT DATA AN, V52, P2228, DOI 10.1016/j.csda.2007.07.015; Dunbar-Co S, 2009, INT J PLANT SCI, V170, P61, DOI 10.1086/593111; Duong T, 2003, J NONPARAMETR STAT, V15, P17, DOI 10.1080/10485250306039; Duong T, 2007, J STAT SOFTW, V21, P1, DOI 10.18637/jss.v021.i07; Eriksson O, 2000, AM NAT, V156, P47, DOI 10.1086/303367; Everwand G, 2014, ECOSYSTEMS, V17, P1095, DOI 10.1007/s10021-014-9779-z; Fagundez Jaime, 2004, Acta Botanica Malacitana, V29, P215; Farquhar GD, 2002, SILVA FENN, V36, P625, DOI 10.14214/sf.530; Fazayeli F., 2014, INT C MACH LEARN APP; Field C., 1986, EC PLANT FORM FUNCTI, P22; FITTER AH, 1994, J ECOL, V82, P415, DOI 10.2307/2261309; Fonseca CR, 2000, J ECOL, V88, P964, DOI 10.1046/j.1365-2745.2000.00506.x; Frenette-Dussault C, 2012, J VEG SCI, V23, P208, DOI 10.1111/j.1654-1103.2011.01350.x; Freschet GT, 2010, J ECOL, V98, P362, DOI 10.1111/j.1365-2745.2009.01615.x; Fry EL, 2014, J VEG SCI, V25, P248, DOI 10.1111/jvs.12068; Fyllas NM, 2009, BIOGEOSCIENCES, V6, P2677, DOI 10.5194/bg-6-2677-2009; Gachet S, 2005, BIODIVERS CONSERV, V14, P1023, DOI 10.1007/s10531-004-8411-5; Gallagher RV, 2012, J BIOGEOGR, V39, P1757, DOI 10.1111/j.1365-2699.2012.02773.x; Garnier E., 2016, PLANT FUNCTIONAL DIV, V1st, DOI DOI 10.1093/ACPROF:OSO/9780198757368.001.0001; Garnier E, 2007, ANN BOT-LONDON, V99, P967, DOI 10.1093/aob/mcl215; GAUDET CL, 1988, NATURE, V334, P242, DOI 10.1038/334242a0; Gillison AN, 1997, FUNCT ECOL, V11, P775, DOI 10.1046/j.1365-2435.1997.00157.x; Gillison AN., 2013, VEGETATION ECOLOGY, P347, DOI [10.1002/9781118452592.ch12, DOI 10.1002/9781118452592.CH12]; GIVNISH TJ, 1976, AM NAT, V110, P743, DOI 10.1086/283101; Givnish TJ, 2004, AM J BOT, V91, P228, DOI 10.3732/ajb.91.2.228; GIVNISH TJ, 1987, NEW PHYTOL, V106, P131, DOI 10.1111/j.1469-8137.1987.tb04687.x; GREENSLADE PJM, 1983, AM NAT, V122, P352, DOI 10.1086/284140; Grime JP, 2002, J VEG SCI, V13, P457, DOI 10.1111/j.1654-1103.2002.tb02072.x; Grime JP, 1997, OIKOS, V79, P259, DOI 10.2307/3546011; GRIME JP, 1974, NATURE, V250, P26, DOI 10.1038/250026a0; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; GRUBB PJ, 1985, POPULATION STRUCTURE, P595; Guerin GR, 2012, BIOL LETTERS, V8, P882, DOI 10.1098/rsbl.2012.0458; Gutierrez AG, 2012, PERSPECT PLANT ECOL, V14, P243, DOI 10.1016/j.ppees.2012.01.004; Guy AL, 2013, BOTANY, V91, P176, DOI 10.1139/cjb-2012-0162; HAIG D, 1991, EVOL ECOL, V5, P231, DOI 10.1007/BF02214230; Han WX, 2012, GLOBAL ECOL BIOGEOGR, V21, P376, DOI 10.1111/j.1466-8238.2011.00677.x; Han WX, 2005, NEW PHYTOL, V168, P377, DOI 10.1111/j.1469-8137.2005.01530.x; Hao GY, 2010, FUNCT ECOL, V24, P731, DOI 10.1111/j.1365-2435.2010.01724.x; Harfoot MBJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001841; Hickler T., 1999, THESIS; Hill M.O., 2004, PLANTATT ATTRIBUTES; Hoof J, 2008, BIOTROPICA, V40, P113, DOI 10.1111/j.1744-7429.2007.00325.x; Iida Y, 2014, J ECOL, V102, P641, DOI 10.1111/1365-2745.12221; Jongman R. H. G., 1987, DATA ANAL COMMUNITY; Wright SJ, 2010, ECOLOGY, V91, P3664, DOI 10.1890/09-2335.1; Kattge J, 2011, GLOBAL CHANGE BIOL, V17, P2905, DOI 10.1111/j.1365-2486.2011.02451.x; Kattge J, 2009, GLOBAL CHANGE BIOL, V15, P976, DOI 10.1111/j.1365-2486.2008.01744.x; Kazakou E, 2006, FUNCT ECOL, V20, P21, DOI 10.1111/j.1365-2435.2006.01080.x; Kerkhoff AJ, 2006, ECOL LETT, V9, P419, DOI 10.1111/j.1461-0248.2006.00888.x; Kichenin E, 2013, FUNCT ECOL, V27, P1254, DOI 10.1111/1365-2435.12116; Kirkup D, 2005, TAXON, V54, P457, DOI 10.2307/25065373; Kleyer M, 2008, J ECOL, V96, P1266, DOI 10.1111/j.1365-2745.2008.01430.x; Koike F, 2001, J VEG SCI, V12, P327, DOI 10.2307/3236846; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Kuhn I, 2004, DIVERS DISTRIB, V10, P363, DOI 10.1111/j.1366-9516.2004.00106.x; Kurokawa H, 2008, ECOLOGY, V89, P2645, DOI 10.1890/07-1352.1; LAMBERS H, 1992, ADV ECOL RES, V23, P187, DOI 10.1016/S0065-2504(08)60148-8; Laughlin DC, 2011, J ECOL, V99, P1489, DOI 10.1111/j.1365-2745.2011.01885.x; Laughlin DC, 2010, FUNCT ECOL, V24, P493, DOI 10.1111/j.1365-2435.2009.01672.x; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; LEIMAR O, 2001, SELECTION, V2, P65, DOI DOI 10.1556/SELECT.2.2001.1-2.5; LEISHMAN MR, 1994, AM NAT, V143, P890, DOI 10.1086/285638; Li L, 2015, ECOL LETT, V18, P899, DOI 10.1111/ele.12466; LLOYD R M, 1976, American Fern Journal, V66, P1, DOI 10.2307/1546364; Lord JM, 2012, EVOLUTION, V66, P200, DOI 10.1111/j.1558-5646.2011.01425.x; Louault F, 2005, J VEG SCI, V16, P151, DOI 10.1111/j.1654-1103.2005.tb02350.x; Loveys BR, 2003, GLOBAL CHANGE BIOL, V9, P895, DOI 10.1046/j.1365-2486.2003.00611.x; MacArthur R.H., 1967, THEORY ISLAND BIOGEO, DOI DOI 10.1080/00379271.2014.984955; Malhado ACM, 2009, BIOGEOSCIENCES, V6, P1563, DOI 10.5194/bg-6-1563-2009; Manly BFJ, 1997, RANDOMIZATION BOOTST; Manning P, 2009, BASIC APPL ECOL, V10, P300, DOI 10.1016/j.baae.2008.08.004; Medlyn BE, 1999, PLANT CELL ENVIRON, V22, P1475, DOI 10.1046/j.1365-3040.1999.00523.x; Meir P, 2002, PLANT CELL ENVIRON, V25, P343, DOI 10.1046/j.0016-8025.2001.00811.x; Meir P, 2007, PLANT ECOL, V192, P277, DOI 10.1007/s11258-007-9320-y; Mencuccini M, 2003, PLANT CELL ENVIRON, V26, P163, DOI 10.1046/j.1365-3040.2003.00991.x; Meng TT, 2015, BIOGEOSCIENCES, V12, P5339, DOI 10.5194/bg-12-5339-2015; Messier J, 2010, ECOL LETT, V13, P838, DOI 10.1111/j.1461-0248.2010.01476.x; Meziane D, 1999, PLANT CELL ENVIRON, V22, P447, DOI 10.1046/j.1365-3040.1999.00423.x; Milla R, 2011, ANN BOT-LONDON, V107, P455, DOI 10.1093/aob/mcq261; Minden V, 2012, PERSPECT PLANT ECOL, V14, P183, DOI 10.1016/j.ppees.2012.01.002; Minden V, 2011, J VEG SCI, V22, P387, DOI 10.1111/j.1654-1103.2011.01272.x; Moles AT, 2009, J ECOL, V97, P923, DOI 10.1111/j.1365-2745.2009.01526.x; Moles AT, 2004, J ECOL, V92, P384, DOI 10.1111/j.0022-0477.2004.00880.x; Moles AT, 2005, SCIENCE, V307, P576, DOI 10.1126/science.1104863; Moles AT, 2006, OIKOS, V113, P91, DOI 10.1111/j.0030-1299.2006.14194.x; Moretti M, 2009, ECOGRAPHY, V32, P299, DOI 10.1111/j.1600-0587.2008.05524.x; Muller SC, 2007, PLANT ECOL, V189, P1, DOI 10.1007/s11258-006-9162-z; Muller-Landau HC, 2008, J ECOL, V96, P653, DOI 10.1111/j.1365-2745.2008.01399.x; Muller-Landau HC, 2010, P NATL ACAD SCI USA, V107, P4242, DOI 10.1073/pnas.0911637107; Nakahashi CD, 2005, PLANT BIOLOGY, V7, P495, DOI 10.1055/s-2005-865853; New M, 1999, J CLIMATE, V12, P829, DOI 10.1175/1520-0442(1999)012<0829:RTCSTC>2.0.CO;2; Niinemets U, 2001, ECOLOGY, V82, P453, DOI 10.1890/0012-9658(2001)082[0453:GSCCOL]2.0.CO;2; Niinemets U, 2015, NEW PHYTOL, V205, P973, DOI 10.1111/nph.13096; Niklas K.J., 1997, EVOLUTIONARY BIOL PL; Niklas K.J., 1994, PLANT ALLOMETRY SCAL; NIKLAS KJ, 1993, ANN BOT-LONDON, V72, P173, DOI 10.1006/anbo.1993.1096; Ogaya R, 2003, ENVIRON EXP BOT, V50, P137, DOI 10.1016/S0098-8472(03)00019-4; Oksanen J., 2008, VEGAN COMMUNITY ECOL; Onoda Y, 2011, ECOL LETT, V14, P301, DOI 10.1111/j.1461-0248.2010.01582.x; Ordonez JC, 2010, AM NAT, V175, P225, DOI 10.1086/649582; Page CN, 1997, FERNS BRITAIN IRELAN; Pahl AT, 2013, ANN BOT-LONDON, V112, P1921, DOI 10.1093/aob/mct246; Patino S, 2012, BIOGEOSCIENCES, V9, P775, DOI 10.5194/bg-9-775-2012; Paula S., 2009, ECOLOGY, V90, P1420, DOI DOI 10.1890/08-1309.1; Peco B, 2005, BASIC APPL ECOL, V6, P175, DOI 10.1016/j.baae.2005.01.002; Penuelas J, 2010, GLOBAL CHANGE BIOL, V16, P2171, DOI 10.1111/j.1365-2486.2009.02054.x; Peres-Neto PR, 2001, OECOLOGIA, V129, P169, DOI 10.1007/s004420100720; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Pierce S, 2007, PLANT BIOSYST, V141, P337, DOI 10.1080/11263500701627695; Pierce S, 2007, J ECOL, V95, P698, DOI 10.1111/j.1365-2745.2007.01242.x; Pierce S, 2014, PLANT ECOL, V215, P1351, DOI 10.1007/s11258-014-0392-1; Pierce S, 2013, FUNCT ECOL, V27, P1002, DOI 10.1111/1365-2435.12095; Pierce S, 2012, ANN BOT-LONDON, V109, P1047, DOI 10.1093/aob/mcs021; Pillar VD, 2003, J VEG SCI, V14, P323, DOI 10.1658/1100-9233(2003)014[0323:AIMFSP]2.0.CO;2; Pinheiro J., 2020, PACKAGE NLME LINEAR, DOI DOI 10.1016/S0006-3207(01)00201-4; Poorter H, 2009, NEW PHYTOL, V182, P565, DOI 10.1111/j.1469-8137.2009.02830.x; Poorter L, 2008, ECOLOGY, V89, P1908, DOI 10.1890/07-0207.1; Poorter L, 2009, NEW PHYTOL, V181, P890, DOI 10.1111/j.1469-8137.2008.02715.x; Poorter L, 2006, ECOLOGY, V87, P1733, DOI 10.1890/0012-9658(2006)87[1733:LTAGPO]2.0.CO;2; Powers JS, 2010, FUNCT ECOL, V24, P927, DOI 10.1111/j.1365-2435.2010.01701.x; Prentice IC, 2011, NEW PHYTOL, V190, P169, DOI 10.1111/j.1469-8137.2010.03579.x; Preston KA, 2006, NEW PHYTOL, V170, P807, DOI 10.1111/j.1469-8137.2006.01712.x; Price CA, 2007, ECOLOGY, V88, P1132, DOI 10.1890/06-1158; Price CA, 2014, FUNCT ECOL, V28, P1330, DOI 10.1111/1365-2435.12298; Pyankov VI, 1999, NEW PHYTOL, V143, P131, DOI 10.1046/j.1469-8137.1999.00435.x; Quero JL, 2008, FUNCT PLANT BIOL, V35, P725, DOI 10.1071/FP08149; Quested HM, 2003, ECOLOGY, V84, P3209, DOI 10.1890/02-0426; R Development Core Team, 2014, R LANG ENV STAT COMP; Reich PB, 1997, P NATL ACAD SCI USA, V94, P13730, DOI 10.1073/pnas.94.25.13730; Reich PB, 2008, ECOL LETT, V11, P793, DOI 10.1111/j.1461-0248.2008.01185.x; Reich PB, 2009, OECOLOGIA, V160, P207, DOI 10.1007/s00442-009-1291-3; Renteria L, 2005, TREES-STRUCT FUNCT, V19, P431, DOI 10.1007/s00468-004-0402-3; Sack L, 2003, PLANT CELL ENVIRON, V26, P1343, DOI 10.1046/j.0016-8025.2003.01058.x; Sack L, 2006, ECOLOGY, V87, P483, DOI 10.1890/05-0710; Sack L, 2005, NEW PHYTOL, V167, P403, DOI 10.1111/j.1469-8137.2005.01432.x; Sack L, 2004, OIKOS, V107, P110, DOI 10.1111/j.0030-1299.2004.13184.x; Sack L, 2006, AM J BOT, V93, P829, DOI 10.3732/ajb.93.6.829; SALISBURY E, 1974, PROC R SOC SER B-BIO, V186, P83, DOI 10.1098/rspb.1974.0039; Sandel B, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00175.1; Scheiter S, 2013, NEW PHYTOL, V198, P957, DOI 10.1111/nph.12210; Scherer-Lorenzen M, 2007, PERSPECT PLANT ECOL, V9, P53, DOI 10.1016/j.ppees.2007.08.002; Schimper AFW., 1903, PLANT GEOGRAPHY PHYS; Schleicher A, 2011, LANDSCAPE ECOL, V26, P529, DOI 10.1007/s10980-011-9579-1; Schrodt F, 2015, GLOBAL ECOL BIOGEOGR, V24, P1510, DOI 10.1111/geb.12335; SCHULZE E-D, 1976, Madoqua, V9, P5; SCHULZE ED, 1980, OECOLOGIA, V44, P258, DOI 10.1007/BF00572688; Schurr FM, 2007, GLOBAL ECOL BIOGEOGR, V16, P449, DOI 10.1111/j.1466-8238.2006.00293.x; Schweingruber F. H., THE XYLEM DATABASE; Scoffoni C, 2008, PLANT CELL ENVIRON, V31, P1803, DOI 10.1111/j.1365-3040.2008.01884.x; Shan H., 2012, P 29 INT C MACH LEAR; Sheremet'ev S. N., 2005, KMK MOSCOW, V271; Shiodera S, 2008, J TROP ECOL, V24, P121, DOI 10.1017/S0266467407004725; Shipley B, 2000, ECOSCIENCE, V7, P183, DOI 10.1080/11956860.2000.11682587; SHIPLEY B, 1991, FUNCT ECOL, V5, P111, DOI 10.2307/2389561; Shipley B, 2002, NEW PHYTOL, V153, P359, DOI 10.1046/j.0028-646X.2001.00320.x; Shipley B, 2002, FUNCT ECOL, V16, P682, DOI 10.1046/j.1365-2435.2002.00672.x; SHIPLEY B, 1995, FUNCT ECOL, V9, P312, DOI 10.2307/2390579; SOUTHWOOD TRE, 1977, J ANIM ECOL, V46, P337; Spasojevic MJ, 2012, J ECOL, V100, P652, DOI 10.1111/j.1365-2745.2011.01945.x; Stoor A. M., 1996, Feddes Repertorium, V107, P149; Swaine E. K., 2007, THESIS; Tecco PA, 2010, J ECOL, V98, P17, DOI 10.1111/j.1365-2745.2009.01592.x; Theophrastus, 1916, ENQUIRY PLANTS MINOR; THOMPSON K, 1987, NEW PHYTOL, V106, P23; THOMPSON K, 1993, FUNCT ECOL, V7, P236, DOI 10.2307/2389893; Thomson FJ, 2011, J ECOL, V99, P1299, DOI 10.1111/j.1365-2745.2011.01867.x; Tucker SS, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00023.1; *USDA, 2019, PLANTS DAT; Vaieretti MV, 2007, ANN BOT-LONDON, V99, P955, DOI 10.1093/aob/mcm022; van Bodegom PM, 2008, ECOLOGY, V89, P193, DOI 10.1890/07-0390.1; van Bodegom PM, 2014, P NATL ACAD SCI USA, V111, P13733, DOI 10.1073/pnas.1304551110; Vendramini F, 2002, NEW PHYTOL, V154, P147, DOI 10.1046/j.1469-8137.2002.00357.x; Vergutz L., 2012, GLOBAL DATABASE CARB; Vile D., 2005, THESIS, P2; Von Holle B, 2004, OIKOS, V105, P551, DOI 10.1111/j.0030-1299.2004.12597.x; Wand M.P., 1994, KERNEL SMOOTHING; Warming E., 1909, ECOLOGY OF PLANTS; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Weiher E, 1999, J VEG SCI, V10, P609, DOI 10.2307/3237076; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; Westoby M, 1998, PLANT SOIL, V199, P213, DOI 10.1023/A:1004327224729; WHITTAKER R H, 1975, P385; Williams M., 2012, CD09 LBAECO OAK RIDG; Willis CG, 2010, ECOGRAPHY, V33, P565, DOI 10.1111/j.1600-0587.2009.05975.x; Wilson KB, 2000, TREE PHYSIOL, V20, P565; Wirth C., 2009, IMPRINT SPECIES TURN, P81; Wright IJ, 2007, ANN BOT-LONDON, V99, P1003, DOI 10.1093/aob/mcl066; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright JP, 2012, FUNCT ECOL, V26, P1390, DOI 10.1111/1365-2435.12001; Xu LK, 2003, TREE PHYSIOL, V23, P865, DOI 10.1093/treephys/23.13.865; Yguel B, 2011, ECOL LETT, V14, P1117, DOI 10.1111/j.1461-0248.2011.01680.x; Zanne AE, 2010, AM J BOT, V97, P207, DOI 10.3732/ajb.0900178; Zheng W., 1983, SILVA SINICA	263	1352	1414	144	1628	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 14	2016	529	7585					167	+		10.1038/nature16489	http://dx.doi.org/10.1038/nature16489			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA7WK	26700811	Green Published, Green Submitted			2022-12-28	WOS:000368015700027
J	Flavahan, WA; Drier, Y; Liau, BB; Gillespie, SM; Venteicher, AS; Stemmer-Rachamimov, AO; Suva, ML; Bernstein, BE				Flavahan, William A.; Drier, Yotam; Liau, Brian B.; Gillespie, Shawn M.; Venteicher, Andrew S.; Stemmer-Rachamimov, Anat O.; Suva, Mario L.; Bernstein, Bradley E.			Insulator dysfunction and oncogene activation in IDH mutant gliomas	NATURE			English	Article							INTEGRATED GENOMIC ANALYSIS; METHYLATION; EXPRESSION; 2-HYDROXYGLUTARATE; DEMETHYLATION; ARCHITECTURE; MAINTENANCE; PRINCIPLES; LANDSCAPE; PHENOTYPE	Gain-of-function IDH mutations are initiating events that define major clinical and prognostic classes of gliomas(1,2). Mutant IDH protein produces a new onco-metabolite, 2-hydroxyglutarate, which interferes with iron-dependent hydroxylases, including the TET family of 5'-methylcytosine hydroxylases(3-7). TET enzymes catalyse a key step in the removal of DNA methylation(8,9). IDH mutant gliomas thus manifest a CpG island methylator phenotype (G-CIMP)(10,11), although the functional importance of this altered epigenetic state remains unclear. Here we show that human IDH mutant gliomas exhibit hypermethylation at cohesin and CCCTC-binding factor (CTCF)-binding sites, compromising binding of this methylation-sensitive insulator protein. Reduced CTCF binding is associated with loss of insulation between topological domains and aberrant gene activation. We specifically demonstrate that loss of CTCF at a domain boundary permits a constitutive enhancer to interact aberrantly with the receptor tyrosine kinase gene PDGFRA, a prominent glioma oncogene. Treatment of IDH mutant gliomaspheres with a demethylating agent partially restores insulator function and downregulates PDGFRA. Conversely, CRISPR-mediated disruption of the CTCF motif in IDH wild-type gliomaspheres upregulates PDGFRA and increases proliferation. Our study suggests that IDH mutations promote gliomagenesis by disrupting chromosomal topology and allowing aberrant regulatory interactions that induce oncogene expression.	[Flavahan, William A.; Drier, Yotam; Liau, Brian B.; Gillespie, Shawn M.; Venteicher, Andrew S.; Stemmer-Rachamimov, Anat O.; Suva, Mario L.; Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Flavahan, William A.; Drier, Yotam; Liau, Brian B.; Gillespie, Shawn M.; Venteicher, Andrew S.; Stemmer-Rachamimov, Anat O.; Suva, Mario L.; Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA; [Flavahan, William A.; Drier, Yotam; Liau, Brian B.; Gillespie, Shawn M.; Venteicher, Andrew S.; Stemmer-Rachamimov, Anat O.; Suva, Mario L.; Bernstein, Bradley E.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Flavahan, William A.; Drier, Yotam; Liau, Brian B.; Gillespie, Shawn M.; Venteicher, Andrew S.; Suva, Mario L.; Bernstein, Bradley E.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Flavahan, William A.; Drier, Yotam; Liau, Brian B.; Gillespie, Shawn M.; Bernstein, Bradley E.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital	Bernstein, BE (corresponding author), Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.; Bernstein, BE (corresponding author), Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA.; Bernstein, BE (corresponding author), Harvard Univ, Sch Med, Boston, MA 02114 USA.; Bernstein, BE (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Bernstein, BE (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	bernstein.bradley@mgh.harvard.edu	Venteicher, Andrew/AAN-5666-2021; Suva, Mario/AAY-7798-2020; Drier, Yotam/K-5208-2012	Venteicher, Andrew/0000-0003-0643-0493; Suva, Mario/0000-0001-9898-5351; Drier, Yotam/0000-0003-1725-2995; Gillespie, Shawn/0000-0003-1913-0860	American Brain Tumor Association; Jane Coffin Childs fellowship; Howard Hughes Medical Institute; National Brain Tumor Society; National Human Genome Research Institute; NATIONAL CANCER INSTITUTE [DP1CA216873, P50CA165962] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006991] Funding Source: NIH RePORTER	American Brain Tumor Association; Jane Coffin Childs fellowship; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Brain Tumor Society; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank J. Kim, the MGH Neuro Oncology Tissue Repository, and the MGH Pathology Flow Cytometry Core for assistance with clinical samples and analysis, and E. Lander and W. Kaelin for discussions. W.A.F. is supported by a basic research fellowship from the American Brain Tumor Association. B.B.L. is supported by a Jane Coffin Childs fellowship. B.E.B. is an American Cancer Society Research Professor. This research was supported by funds from Howard Hughes Medical Institute, the National Brain Tumor Society and the National Human Genome Research Institute.	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bao SD, 2008, CANCER RES, V68, P6043, DOI 10.1158/0008-5472.CAN-08-1079; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bickmore WA, 2013, CELL, V152, P1270, DOI 10.1016/j.cell.2013.02.001; Brat DJ, 2015, NEW ENGL J MED, V372, P2481, DOI 10.1056/NEJMoa1402121; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cairns RA, 2013, CANCER DISCOV, V3, P730, DOI 10.1158/2159-8290.CD-13-0083; Chi AS, 2012, J NEURO-ONCOL, V110, P89, DOI 10.1007/s11060-012-0938-9; Chudnovsky Y, 2014, CELL REP, V6, P313, DOI 10.1016/j.celrep.2013.12.032; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Costello JF, 1996, CANCER RES, V56, P2405; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; de Laat W, 2012, METHODS, V58, P189, DOI 10.1016/j.ymeth.2012.11.005; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Lai RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089376; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Luchman HA, 2012, NEURO-ONCOLOGY, V14, P184, DOI 10.1093/neuonc/nor207; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pastor WA, 2013, NAT REV MOL CELL BIO, V14, P341, DOI 10.1038/nrm3589; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rheinbay E, 2013, CELL REP, V3, P1567, DOI 10.1016/j.celrep.2013.04.021; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sturm D, 2014, NAT REV CANCER, V14, P92, DOI 10.1038/nrc3655; Suva ML, 2014, CELL, V157, P580, DOI 10.1016/j.cell.2014.02.030; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wakimoto H, 2012, NEURO-ONCOLOGY, V14, P132, DOI 10.1093/neuonc/nor195; Wang H, 2012, GENOME RES, V22, P1680, DOI 10.1101/gr.136101.111; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Zuin J, 2014, P NATL ACAD SCI USA, V111, P996, DOI 10.1073/pnas.1317788111	44	717	740	5	196	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 7	2016	529	7584					110	+		10.1038/nature16490	http://dx.doi.org/10.1038/nature16490			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6VY	26700815	Green Accepted, Green Submitted			2022-12-28	WOS:000367944900037
J	Grimmer, MR; Costello, JF				Grimmer, Matthew R.; Costello, Joseph F.			CANCER Oncogene brought into the loop	NATURE			English	Editorial Material							IDH1; 2-HYDROXYGLUTARATE; METHYLATION; INHIBITOR		[Grimmer, Matthew R.; Costello, Joseph F.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Grimmer, MR; Costello, JF (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94158 USA.	matthew.grimmer@ucsf.edu; joseph.costello@ucsf.edu		Grimmer, Matthew/0000-0001-5184-9168	NATIONAL CANCER INSTITUTE [T32CA151022, F32CA206252] Funding Source: NIH RePORTER; NCI NIH HHS [F32 CA206252, T32 CA151022] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Flavahan WA, 2016, NATURE, V529, P110, DOI 10.1038/nature16490; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Phillips JJ, 2013, BRAIN PATHOL, V23, P565, DOI 10.1111/bpa.12043; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; The Multiple Leiomyoma Consortium, 2002, NATURE GENET, V30, P406; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	15	6	6	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 7	2016	529	7584					34	35		10.1038/nature16330	http://dx.doi.org/10.1038/nature16330			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6VY	26700812	Green Accepted			2022-12-28	WOS:000367944900021
J	Wilbur, MB; Little, S; Szymanski, LM				Wilbur, MaryAnn B.; Little, Sarah; Szymanski, Linda M.			Is Home Birth Safe?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MORTALITY; MORBIDITY		[Wilbur, MaryAnn B.] Johns Hopkins Univ Hosp, Sch Med, Dept Gynecol & Obstet, Div Maternal Fetal Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Wilbur, MB (corresponding author), Johns Hopkins Univ Hosp, Sch Med, Dept Gynecol & Obstet, Div Maternal Fetal Med, Baltimore, MD 21205 USA.							[Anonymous], 2011, Obstet Gynecol, V117, P425, DOI 10.1097/AOG.0b013e31820eee20; Brocklehurst P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7400; de Jonge A, 2015, BJOG-INT J OBSTET GY, V122, P720, DOI 10.1111/1471-0528.13084; Landon MB, 2004, NEW ENGL J MED, V351, P2581, DOI 10.1056/NEJMoa040405; Liu SL, 2007, CAN MED ASSOC J, V176, P455, DOI 10.1503/cmaj.060870; Lothian JA, 2003, J PERINATAL ED, V12, pvi; Magee SR, 2014, J AM BOARD FAM MED, V27, P690, DOI 10.3122/jabfm.2014.05.140014; National Institute for Health and Care Excellence, 2014, INT CAR CAR HLTH WOM; Snowden JM, 2015, NEW ENGL J MED, V373, P2642, DOI 10.1056/NEJMsa1501738	9	3	3	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 31	2015	373	27					2684	2685		10.1056/NEJMclde1513623	http://dx.doi.org/10.1056/NEJMclde1513623			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ8UH	26716921				2022-12-28	WOS:000367374100019
J	Rao, VL; Cifu, AS; Yang, LW				Rao, Vijaya L.; Cifu, Adam S.; Yang, Leslie W.			Pharmacologic Management of Irritable Bowel Syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DOUBLE-BLIND; CONSTIPATION; METAANALYSIS		[Rao, Vijaya L.; Yang, Leslie W.] Univ Chicago, Med Ctr, Sect Gastroenterol Hepatol & Nutr, Chicago, IL 60637 USA; [Cifu, Adam S.] Univ Chicago, Med Ctr, Gen Internal Med Sect, Chicago, IL 60637 USA	University of Chicago; University of Chicago Medical Center; University of Chicago; University of Chicago Medical Center	Cifu, AS (corresponding author), Univ Chicago, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA.	adamcifu@uchicago.edu						Chang L, 2014, GASTROENTEROLOGY, V147, P1149, DOI 10.1053/j.gastro.2014.09.002; Chey WD, 2015, JAMA-J AM MED ASSOC, V313, P949, DOI 10.1001/jama.2015.0954; Chey WD, 2012, AM J GASTROENTEROL, V107, P1702, DOI 10.1038/ajg.2012.254; Ford AC, 2014, AM J GASTROENTEROL, V109, pS2, DOI 10.1038/ajg.2014.187; Kuiken SD, 2003, CLIN GASTROENTEROL H, V1, P219, DOI 10.1053/jcgh.2003.50032; Ladabaum U, 2010, CLIN GASTROENTEROL H, V8, P42, DOI 10.1016/j.cgh.2009.09.008; Lovell RM, 2012, CLIN GASTROENTEROL H, V10, P712, DOI 10.1016/j.cgh.2012.02.029; Menees SB, 2015, AM J GASTROENTEROL, V110, P444, DOI 10.1038/ajg.2015.6; Sultan S, 2013, CLIN GASTROENTEROL H, V11, P329, DOI 10.1016/j.cgh.2013.02.001; Weinberg DS, 2014, GASTROENTEROLOGY, V147, P1146, DOI 10.1053/j.gastro.2014.09.001	10	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 29	2015	314	24					2684	2685		10.1001/jama.2015.16943	http://dx.doi.org/10.1001/jama.2015.16943			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ2MR	26720029				2022-12-28	WOS:000366939800024
J	Myers, CE; Yamada, M; Ji, HT; Yoo, J; Fox, W; Jara-Almonte, J; Savcheva, A; DeLuca, EE				Myers, Clayton E.; Yamada, Masaaki; Ji, Hantao; Yoo, Jongsoo; Fox, William; Jara-Almonte, Jonathan; Savcheva, Antonia; DeLuca, Edward E.			A dynamic magnetic tension force as the cause of failed solar eruptions	NATURE			English	Article							CORONAL MASS EJECTIONS; FLUX ROPE; PROMINENCE ERUPTIONS; TORUS INSTABILITY; KINK INSTABILITY; PLASMA; FLARES; RECONNECTION; EQUILIBRIUM; CATASTROPHE	Coronal mass ejections are solar eruptions driven by a sudden release of magnetic energy stored in the Sun's corona(1). In many cases, this magnetic energy is stored in long-lived, arched structures called magnetic flux ropes(2-5). When a flux rope destabilizes, it can either erupt and produce a coronal mass ejection or fail and collapse back towards the Sun(6-8). The prevailing belief is that the outcome of a given event is determined by a magnetohydrodynamic force imbalance called the torus instability(9-14). This belief is challenged, however, by observations indicating that torus-unstable flux ropes sometimes fail to erupt(15). This contradiction has not yet been resolved because of a lack of coronal magnetic field measurements and the limitations of idealized numerical modelling. Here we report the results of a laboratory experiment(16) that reveal a previously unknown eruption criterion below which torus-unstable flux ropes fail to erupt. We find that such 'failed torus' events occur when the guide magnetic field (that is, the ambient field that runs toroidally along the flux rope) is strong enough to prevent the flux rope from kinking. Under these conditions, the guide field interacts with electric currents in the flux rope to produce a dynamic toroidal field tension force that halts the eruption. This magnetic tension force is missing from existing eruption models, which is why such models cannot explain or predict failed torus events.	[Myers, Clayton E.; Ji, Hantao; Jara-Almonte, Jonathan] Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA; [Myers, Clayton E.; Yamada, Masaaki; Ji, Hantao; Yoo, Jongsoo; Fox, William; Jara-Almonte, Jonathan] Princeton Plasma Phys Lab, Princeton, NJ 08543 USA; [Ji, Hantao] Harbin Inst Technol, Lab Space Environm & Phys Sci, Harbin 150001, Heilongjiang, Peoples R China; [Savcheva, Antonia; DeLuca, Edward E.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA	Princeton University; Princeton University; United States Department of Energy (DOE); Princeton Plasma Physics Laboratory; Harbin Institute of Technology; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution	Myers, CE (corresponding author), Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA.	cmyers@pppl.gov	DeLuca, Edward E/L-7534-2013; Fox, William/GOE-5688-2022; Myers, Clayton/AAA-9500-2022; Jara-Almonte, Jonathan/AAS-6957-2021	DeLuca, Edward E/0000-0001-7416-2895; Fox, William/0000-0001-6289-858X; Myers, Clayton/0000-0003-4539-8406; Jara-Almonte, Jonathan/0000-0003-0760-6198; Yoo, Jongsoo/0000-0003-3881-1995	Department of Energy (DoE) [DE-AC02-09CH11466]; National Science Foundation/DoE Center for Magnetic Self-Organization (CMSO)	Department of Energy (DoE)(United States Department of Energy (DOE)); National Science Foundation/DoE Center for Magnetic Self-Organization (CMSO)	We thank R. Cutler for constructing the flux rope experiment and for myriad technical contributions. We also thank F. Scotti and P. Sloboda for additional technical contributions and R. M. Kulsrud for theoretical discussions. This research is supported by Department of Energy (DoE) contract number DE-AC02-09CH11466 and by the National Science Foundation/DoE Center for Magnetic Self-Organization (CMSO).	Amari T, 2014, NATURE, V514, P465, DOI 10.1038/nature13815; Antiochos SK, 1999, ASTROPHYS J, V510, P485, DOI 10.1086/306563; Bateman G., 1978, MHD INSTABILITIES; Bellan PM, 1998, PHYS PLASMAS, V5, P1991, DOI 10.1063/1.872870; Bergerson WF, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.015004; CHEN J, 1989, ASTROPHYS J, V338, P453, DOI 10.1086/167211; Demoulin P, 2010, ASTROPHYS J, V718, P1388, DOI 10.1088/0004-637X/718/2/1388; Fan Y, 2007, ASTROPHYS J, V668, P1232, DOI 10.1086/521335; FORBES TG, 1991, ASTROPHYS J, V373, P294, DOI 10.1086/170051; Furno I, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.015002; GOLD T, 1960, MON NOT R ASTRON SOC, V120, P89, DOI 10.1093/mnras/120.2.89; Hansen JF, 2001, ASTROPHYS J, V563, pL183, DOI 10.1086/338736; HOOD AW, 1981, GEOPHYS ASTRO FLUID, V17, P297, DOI 10.1080/03091928108243687; Hsu SC, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.215002; JI H, 1995, PHYS REV LETT, V74, P2945, DOI 10.1103/PhysRevLett.74.2945; Ji HS, 2003, ASTROPHYS J, V595, pL135, DOI 10.1086/378178; Joshi NC, 2014, ASTROPHYS J, V787, DOI 10.1088/0004-637X/787/1/11; Kliem B, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.255002; Kliem B, 2014, ASTROPHYS J, V789, DOI 10.1088/0004-637X/789/1/46; KRUSKAL M, 1954, PROC R SOC LON SER-A, V223, P348, DOI 10.1098/rspa.1954.0120; Kunow H, 2006, CORONAL MASS EJECTIO, P12; KUPERUS M, 1974, ASTRON ASTROPHYS, V31, P189; Lemen JR, 2012, SOL PHYS, V275, P17, DOI 10.1007/s11207-011-9776-8; Liu Y, 2008, ASTROPHYS J LETT, V679, pL151, DOI 10.1086/589282; MIKIC Z, 1990, ASTROPHYS J, V361, P690, DOI 10.1086/169232; Moore RL, 2001, ASTROPHYS J, V552, P833, DOI 10.1086/320559; Myers CY, 2015, THESIS; Olmedo O, 2010, ASTROPHYS J, V718, P433, DOI 10.1088/0004-637X/718/1/433; Oz E, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3647567; Ryutov DD, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2180667; SAKURAI T, 1976, PUBL ASTRON SOC JPN, V28, P177; Savcheva A, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/1/15; Shafranov V., 1956, SOV J ATOM ENERGY, V1, P709; Shafranov V.D, 1966, RVPP, V2, P103; Soltwisch H, 2010, PLASMA PHYS CONTR F, V52, DOI 10.1088/0741-3335/52/12/124030; Sun XD, 2015, ASTROPHYS J LETT, V804, DOI 10.1088/2041-8205/804/2/L28; TAYLOR JB, 1986, REV MOD PHYS, V58, P741, DOI 10.1103/RevModPhys.58.741; Titov VS, 1999, ASTRON ASTROPHYS, V351, P707; Torok T, 2005, ASTROPHYS J, V630, pL97, DOI 10.1086/462412; Torok T, 2004, ASTRON ASTROPHYS, V413, pL27, DOI 10.1051/0004-6361:20031691; Tripathi SKP, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.075005; Yamada M, 1997, PHYS PLASMAS, V4, P1936, DOI 10.1063/1.872336; Yoo J, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.215007	43	60	60	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2015	528	7583					526	+		10.1038/nature16188	http://dx.doi.org/10.1038/nature16188			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ3GH	26701052				2022-12-28	WOS:000366991900046
J	Gerstner, ED				Gerstner, E. D.			MENTORSHIP Stewards of China's future	NATURE			English	Editorial Material													Gerstner, Edmund G/B-3351-2008	Gerstner, Edmund G/0000-0003-0369-0767					0	1	1	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2015	528	7582					427	428		10.1038/nj7582-427a	http://dx.doi.org/10.1038/nj7582-427a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY8SM	26682340				2022-12-28	WOS:000366678600059
J	Jonsson, AL; Backhed, F				Jonsson, Annika Lindskog; Backhed, Fredrik			Drug the Bug!	CELL			English	Editorial Material							METABOLISM; MICROBIOTA; PHOSPHATIDYLCHOLINE; ATHEROSCLEROSIS	Microbial metabolism of dietary components has been causally linked to cardiovascular disease and atherosclerosis. Now, Wang et al. demonstrate that inhibition of microbial TMA lyases, essential for production of pro-atherogenic trimethylamines, prevents atherosclerosis in vivo.	[Jonsson, Annika Lindskog; Backhed, Fredrik] Univ Gothenburg, Dept Mol & Clin Med, Wallenberg Lab, SE-41345 Gothenburg, Sweden; [Backhed, Fredrik] Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Sect Metab Receptol & Enteroendocrinol, DK-2200 Copenhagen, Denmark	University of Gothenburg; Novo Nordisk Foundation; University of Copenhagen	Backhed, F (corresponding author), Univ Gothenburg, Dept Mol & Clin Med, Wallenberg Lab, SE-41345 Gothenburg, Sweden.	fredrik.backhed@wlab.gu.se	Backhed, Fredrik/ABE-6613-2020	Backhed, Fredrik/0000-0002-4871-8818				Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Karlsson FH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2266; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Wang ZN, 2015, CELL, V163, P1585, DOI 10.1016/j.cell.2015.11.055; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922	8	8	9	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2015	163	7					1565	1566		10.1016/j.cell.2015.12.005	http://dx.doi.org/10.1016/j.cell.2015.12.005			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CZ1GN	26687345	Bronze			2022-12-28	WOS:000366854200001
J	Wertz, IE; Newton, K; Seshasayee, D; Kusam, S; Lam, C; Zhang, J; Popovych, N; Helgason, E; Schoeffler, A; Jeet, S; Ramamoorthi, N; Kategaya, L; Newman, RJ; Horikawa, K; Ugger, DD; Sandoval, W; Ukund, SM; Zindal, A; Martin, F; Quan, C; Tom, J; Fairbrother, WJ; Townsend, M; Warming, S; DeVoss, J; Liu, JF; Dueber, E; Caplazi, P; Lee, WP; Goodnow, CC; Balazs, M; Yu, KB; Kolumam, G; Dixit, VM				Wertz, Ingrid E.; Newton, Kim; Seshasayee, Dhaya; Kusam, Saritha; Lam, Cynthia; Zhang, Juan; Popovych, Nataliya; Helgason, Elizabeth; Schoeffler, Allyn; Jeet, Surinder; Ramamoorthi, Nandhini; Kategaya, Lorna; Newman, Robert J.; Horikawa, Keisuke; Ugger, Debra D.; Sandoval, Wendy; Ukund, Susmith M.; Zindal, Anuradha; Martin, Flavius; Quan, Clifford; Tom, Jeffrey; Fairbrother, Wayne J.; Townsend, Michael; Warming, Soren; DeVoss, Jason; Liu, Jinfeng; Dueber, Erin; Caplazi, Patrick; Lee, Wyne P.; Goodnow, Christopher C.; Balazs, Mercedesz; Yu, Kebing; Kolumam, Ganesh; Dixit, Vishva M.			Phosphorylation and linear ubiquitin direct A20 inhibition of inflammation	NATURE			English	Article							NF-KAPPA-B; CHAIN ASSEMBLY COMPLEX; ZINC-FINGER 7; CELL-DEATH; POLYUBIQUITIN CHAINS; BINDING PROTEINS; ACTIVATION; ENZYME; RECOGNITION; APOPTOSIS	Inactivation of the TNFAIP3 gene, encoding the A20 protein, is associated with critical inflammatory diseases including multiple sclerosis, rheumatoid arthritis and Crohn's disease. However, the role of A20 in attenuating inflammatory signalling is unclear owing to paradoxical in vitro and in vivo findings. Here we utilize genetically engineered mice bearing mutations in the A20 ovarian tumour (OTU)-type deubiquitinase domain or in the zinc finger-4 (ZnF4) ubiquitin-binding motif to investigate these discrepancies. We find that phosphorylation of A20 promotes cleavage of Lys63-linked polyubiquitin chains by the OTU domain and enhances ZnF4-mediated substrate ubiquitination. Additionally, levels of linear ubiquitination dictate whether A20-deficient cells die in response to tumour necrosis factor. Mechanistically, linear ubiquitin chains preserve the architecture of the TNFR1 signalling complex by blocking A20-mediated disassembly of Lys63-linked polyubiquitin scaffolds. Collectively, our studies reveal molecular mechanisms whereby A20 deubiquitinase activity and ubiquitin binding, linear ubiquitination, and cellular kinases cooperate to regulate inflammation and cell death.	[Wertz, Ingrid E.; Kategaya, Lorna] Genentech Inc, Discovery Oncol, San Francisco, CA 94080 USA; [Wertz, Ingrid E.; Kusam, Saritha; Lam, Cynthia; Popovych, Nataliya; Helgason, Elizabeth; Schoeffler, Allyn; Kategaya, Lorna; Zindal, Anuradha; Quan, Clifford; Tom, Jeffrey; Fairbrother, Wayne J.; Dueber, Erin] Genentech Inc, Early Discovery Biochem, San Francisco, CA 94080 USA; [Newton, Kim; Ugger, Debra D.; Dixit, Vishva M.] Genentech Inc, Physiol Chem, San Francisco, CA 94080 USA; [Seshasayee, Dhaya; Zhang, Juan; Jeet, Surinder; Ramamoorthi, Nandhini; Martin, Flavius; Townsend, Michael; DeVoss, Jason; Lee, Wyne P.; Balazs, Mercedesz] Genentech Inc, Immunol, San Francisco, CA 94080 USA; [Newman, Robert J.; Warming, Soren; Kolumam, Ganesh] Genentech Inc, Mol Biol, San Francisco, CA 94080 USA; [Horikawa, Keisuke] Australian Natl Univ, John Curtin Sch Med Res, Dept Canc Biol & Therapeut, Canberra, ACT 2601, Australia; [Sandoval, Wendy; Yu, Kebing] Genentech Inc, Prot Chem, San Francisco, CA 94080 USA; [Ukund, Susmith M.] Genentech Inc, Structural Biol, San Francisco, CA 94080 USA; [Liu, Jinfeng] Genentech Inc, Bioinformat, San Francisco, CA 94080 USA; [Caplazi, Patrick] Genentech Inc, Pathol, San Francisco, CA 94080 USA; [Goodnow, Christopher C.] Garvan Inst Med Res, Div Immunol, Immunogen Lab, Darlinghurst, NSW 2010, Australia	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Australian National University; John Curtin School of Medical Research; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Garvan Institute of Medical Research	Wertz, IE (corresponding author), Genentech Inc, Discovery Oncol, San Francisco, CA 94080 USA.	ingrid@gene.com; dixit@gene.com	Warming, Soren/ABD-5729-2021; Goodnow, Christopher C/V-8108-2018; dixit, vishva m/A-4496-2012; Horikawa, Keisuke/N-4417-2019; Schoeffler, Allyn/GOE-3900-2022	Goodnow, Christopher C/0000-0001-5296-6155; dixit, vishva m/0000-0001-6983-0326; Schoeffler, Allyn/0000-0002-7112-409X; Caplazi, Patrick/0000-0002-3411-1257; Warming, Soren/0000-0002-5721-0741; Liu, Jinfeng/0000-0002-0343-8222; Helgason, Elizabeth/0000-0002-0397-9125; Horikawa, Keisuke/0000-0002-7381-9450; Townsend, Michael/0000-0003-0240-4562	Genentech Protein Expression Group; Sequencing Facility, Luminex Core Group; Animal Facility and Genotyping Laboratory; Mouse Models Group	Genentech Protein Expression Group; Sequencing Facility, Luminex Core Group; Animal Facility and Genotyping Laboratory; Mouse Models Group	The authors thank J. Ernst, N. Kayagaki, K. O'Rourke, S. Hymowitz, I. Bosanac, E. Varfolomeev, T. Goncharov, M. diAlmagro, Z. Zhang, C. Klijn, D. Bustos, A. Maltzman, K. Wickliffe, J. Heideker, P. Liu, A. Ashkenazi, T.-K. Chang, B. Brasher, and C. Schwerdtfeger for reagents and discussions, A. Ma for A20 null MEFs, and the Genentech Protein Expression Group, Sequencing Facility, Luminex Core Group, Animal Facility and Genotyping Laboratory, J. Z. Solorio and M. Roose-Girma and the Mouse Models Group for dedication and support.	Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Batoulis H, 2014, CLIN EXP IMMUNOL, V175, P41, DOI 10.1111/cei.12209; Bosanac I, 2010, MOL CELL, V40, P548, DOI 10.1016/j.molcel.2010.10.009; Catrysse L, 2014, TRENDS IMMUNOL, V35, P22, DOI 10.1016/j.it.2013.10.005; Daniel S, 2004, BLOOD, V104, P2376, DOI 10.1182/blood-2003-02-0635; De A, 2014, EMBO REP, V15, P775, DOI 10.15252/embr.201338305; Emmerich CH, 2013, P NATL ACAD SCI USA, V110, P15247, DOI 10.1073/pnas.1314715110; Fiil BK, 2013, MOL CELL, V50, P818, DOI 10.1016/j.molcel.2013.06.004; Fritsch J, 2014, MOL CELL BIOL, V34, P3214, DOI 10.1128/MCB.00048-14; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Hadian K, 2011, J BIOL CHEM, V286, P26107, DOI 10.1074/jbc.M111.233163; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; Hoeller D, 2007, MOL CELL, V26, P891, DOI 10.1016/j.molcel.2007.05.014; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Hutti JE, 2007, MOL CELL BIOL, V27, P7451, DOI 10.1128/MCB.01101-07; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Keusekotten K, 2013, CELL, V153, P1312, DOI 10.1016/j.cell.2013.05.014; Koczan D, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2419; Komander D, 2008, BIOCHEM J, V409, P77, DOI 10.1042/BJ20071399; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kreuz S, 2001, MOL CELL BIOL, V21, P3964, DOI 10.1128/MCB.21.12.3964-3973.2001; Kulathu Y, 2009, NAT STRUCT MOL BIOL, V16, P1328, DOI 10.1038/nsmb.1731; Kumari S, 2014, ELIFE, V3, DOI 10.7554/eLife.03422; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lin SC, 2008, J MOL BIOL, V376, P526, DOI 10.1016/j.jmb.2007.11.092; Liuwantara D, 2006, DIABETES, V55, P2491, DOI 10.2337/db06-0142; Lu TT, 2013, IMMUNITY, V38, P896, DOI 10.1016/j.immuni.2013.03.008; Ma A, 2012, NAT REV IMMUNOL, V12, P774, DOI 10.1038/nri3313; Makarova KS, 2000, TRENDS BIOCHEM SCI, V25, P50, DOI 10.1016/S0968-0004(99)01530-3; Metzger MB, 2014, BBA-MOL CELL RES, V1843, P47, DOI 10.1016/j.bbamcr.2013.05.026; Mevissen TET, 2013, CELL, V154, P169, DOI 10.1016/j.cell.2013.05.046; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Onizawa M, 2015, NAT IMMUNOL, V16, P618, DOI 10.1038/ni.3172; Peltzer N, 2014, CELL REP, V9, P153, DOI 10.1016/j.celrep.2014.08.066; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Rickard JA, 2014, ELIFE, V3, DOI 10.7554/eLife.03464; Rivkin E, 2013, NATURE, V498, P318, DOI 10.1038/nature12296; Sato Y, 2009, EMBO J, V28, P2461, DOI 10.1038/emboj.2009.160; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Skaug B, 2011, MOL CELL, V44, P559, DOI 10.1016/j.molcel.2011.09.015; Tokunaga F, 2012, EMBO J, V31, P3856, DOI 10.1038/emboj.2012.241; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Vereecke L, 2010, J EXP MED, V207, P1513, DOI 10.1084/jem.20092474; Verhelst K, 2012, EMBO J, V31, P3845, DOI 10.1038/emboj.2012.240; Walczak H, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-23; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wertz IE, 2011, NATURE, V471, P110, DOI 10.1038/nature09779; Yamaguchi N, 2015, FEBS LETT, V589, P1369, DOI 10.1016/j.febslet.2015.04.022; Yu M, 2015, NATURE, V520, P307, DOI 10.1038/nature14397	50	173	177	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2015	528	7582					370	+		10.1038/nature16165	http://dx.doi.org/10.1038/nature16165			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY8SM	26649818				2022-12-28	WOS:000366678600046
J	York, AG; Williams, KJ; Argus, JP; Zhou, QD; Brar, G; Vergnes, L; Gray, EE; Zhen, AJ; Wu, NC; Yamada, DH; Cunningham, CR; Tarling, EJ; Wilks, MQ; Casero, D; Gray, DH; Yu, AK; Wang, ES; Brooks, DG; Sun, R; Kitchen, SG; Wu, TT; Reue, K; Stetson, DB; Bensinger, SJ				York, Autumn G.; Williams, Kevin J.; Argus, Joseph P.; Zhou, Quan D.; Brar, Gurpreet; Vergnes, Laurent; Gray, Elizabeth E.; Zhen, Anjie; Wu, Nicholas C.; Yamada, Douglas H.; Cunningham, Cameron R.; Tarling, Elizabeth J.; Wilks, Moses Q.; Casero, David; Gray, David H.; Yu, Amy K.; Wang, Eric S.; Brooks, David G.; Sun, Ren; Kitchen, Scott G.; Wu, Ting-Ting; Reue, Karen; Stetson, Daniel B.; Bensinger, Steven J.			Limiting Cholesterol Biosynthetic Flux Spontaneously Engages Type I IFN Signaling	CELL			English	Article							FATTY-ACID SYNTHESIS; FOAM CELL-FORMATION; MYCOBACTERIUM-TUBERCULOSIS; ENDOPLASMIC-RETICULUM; RECEPTOR AGONISTS; INTERFERON; REPLICATION; MACROPHAGES; PATHWAY; 25-HYDROXYCHOLESTEROL	Cellular lipid requirements are achieved through a combination of biosynthesis and import programs. Using isotope tracer analysis, we show that type I interferon (IFN) signaling shifts the balance of these programs by decreasing synthesis and increasing import of cholesterol and long chain fatty acids. Genetically enforcing this metabolic shift in macrophages is sufficient to render mice resistant to viral challenge, demonstrating the importance of reprogramming the balance of these two metabolic pathways in vivo. Unexpectedly, mechanistic studies reveal that limiting flux through the cholesterol biosynthetic pathway spontaneously engages a type I IFN response in a STING-dependent manner. The upregulation of type I IFNs was traced to a decrease in the pool size of synthesized cholesterol and could be inhibited by replenishing cells with free cholesterol. Taken together, these studies delineate a metabolic-inflammatory circuit that links perturbations in cholesterol biosynthesis with activation of innate immunity.	[York, Autumn G.; Argus, Joseph P.; Zhou, Quan D.; Brar, Gurpreet; Wu, Nicholas C.; Yu, Amy K.; Wang, Eric S.; Sun, Ren; Wu, Ting-Ting; Bensinger, Steven J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Williams, Kevin J.; Cunningham, Cameron R.; Gray, David H.; Bensinger, Steven J.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Casero, David; Bensinger, Steven J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Vergnes, Laurent; Reue, Karen] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Zhen, Anjie; Kitchen, Scott G.] Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; [Tarling, Elizabeth J.] Univ Calif Los Angeles, David Geffen Sch Med, Div Cardiol, Los Angeles, CA 90095 USA; [Zhen, Anjie; Kitchen, Scott G.] UCLA AIDS Inst, Los Angeles, CA 90095 USA; [Zhen, Anjie; Kitchen, Scott G.] Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Wu, Nicholas C.; Tarling, Elizabeth J.; Gray, David H.; Reue, Karen] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Stetson, Daniel B.] Univ Washington, Dept Immunol, Seattle, WA 98109 USA; [Wilks, Moses Q.] Massachusetts Gen Hosp, Dept Radiol, Ctr Adv Med Imaging Sci, Boston, MA 02114 USA; [Brooks, David G.] Univ Hlth Network, Princess Margaret Canc Ctr, Immune Therapy Program, Toronto, ON M5G 2M9, Canada; [Brooks, David G.] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; [Brooks, David G.] Immunooncol Discovery Res, Spring House, PA 19477 USA; [Brooks, David G.] Janssen Res & Dev LLC, Spring House, PA 19477 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Washington; University of Washington Seattle; Harvard University; Massachusetts General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc	Bensinger, SJ (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	sbensinger@mednet.ucla.edu	Casero, David/E-7365-2010; Wu, Nicholas/H-3822-2015	Casero, David/0000-0002-7347-3330; Wu, Nicholas/0000-0002-9078-6697; Zhou, Quan/0000-0002-0184-4884; Brooks, David/0000-0001-7763-8764; vergnes, laurent/0000-0002-8804-589X	NCI Cancer Center Support Grant [P3016042-35]; California HIV/AIDS Research Program Training Fellowship [D12-LA-351]; UCLA Dissertation Year Fellowship; NIH CBI Grant [T32 GM008469]; UCLA Molecular Biology Philip Whitcome Pre-Doctoral Fellowship; Interdisciplinary Training in Virology and Gene Therapy Training Grant [NIH T32 AI 060567]; Cancer Research Institute Fellowship Program; NIH [HL 116181, P01 HL028481, P01 HL090553, AI093768, HL126556]; UCLA CTSI-DRC [UL1TR000124]; NCI [RO1 CA177322]; NIDCR [RO1 DE023519]; Lupus Research Institute; NIH NCRR [S10RR026744];  [R01 AI085043]; NATIONAL CANCER INSTITUTE [P01CA177322, R01CA091791] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026744] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL126556, P01HL090553, R00HL118161, P01HL028481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697, R01AI084914, T32AI060567, R01AI085043, R01AI093768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE023519] Funding Source: NIH RePORTER	NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); California HIV/AIDS Research Program Training Fellowship; UCLA Dissertation Year Fellowship; NIH CBI Grant; UCLA Molecular Biology Philip Whitcome Pre-Doctoral Fellowship; Interdisciplinary Training in Virology and Gene Therapy Training Grant; Cancer Research Institute Fellowship Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA CTSI-DRC; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Lupus Research Institute; NIH NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank Drs. Peter Tontonoz, Stephen T. Smale, Jake Lusis, Caius Radu, Thotsophon "Todd'' Taechariyakul, Thuc Le, and Genhong Cheng (UCLA) for kindly providing reagents and thoughtful analysis. We thank the CFAR Virology Core Lab & Tissue Culture/PCR Facility at the UCLA AIDS Institute for their help with PBMC collection. We thank Dr. Robert Damoiseaux at the UCLA Molecular Screening Shared Resource (a core facility supported by the NCI Cancer Center Support Grant P3016042-35 to Judy Gasson). A.G.Y. was supported in part by California HIV/AIDS Research Program Training Fellowship (D12-LA-351) and UCLA Dissertation Year Fellowship. J.P.A. was supported in part by a NIH CBI Grant (T32 GM008469) and UCLA Dissertation Year Fellowship. N.C.W. was supported in part by UCLA Molecular Biology Philip Whitcome Pre-Doctoral Fellowship and UCLA Dissertation Year Fellowship. G.B. was supported by the Interdisciplinary Training in Virology and Gene Therapy Training Grant (NIH T32 AI 060567). E.E.G. was supported in part by Cancer Research Institute Fellowship Program. E.J.T. was supported in part by NIH HL 116181 and UCLA CTSI-DRC UL1TR000124. D.G.B. was supported by R01 AI085043. R.S. and T.-T.W. were supported by NCI RO1 CA177322 and NIDCR RO1 DE023519. K.R. and L.V. were supported in part by NIH P01 HL028481, NIH NCRR S10RR026744, and NIH P01 HL090553. S.J.B. was supported by NIH AI093768, HL126556, and the Lupus Research Institute.	Baek SH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001065; Bard M, 2005, DIAGN MICR INFEC DIS, V52, P285, DOI 10.1016/j.diagmicrobio.2005.03.001; Blanc M, 2013, IMMUNITY, V38, P106, DOI 10.1016/j.immuni.2012.11.004; Blanc M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000598; Castrillo A, 2003, MOL CELL, V12, P805, DOI 10.1016/S1097-2765(03)00384-8; Coppens I, 2013, NAT REV MICROBIOL, V11, P823, DOI 10.1038/nrmicro3139; Das A, 2014, ELIFE, V3, DOI 10.7554/eLife.02882; Dushkin MI, 2013, B EXP BIOL MED+, V156, P49, DOI 10.1007/s10517-013-2275-1; Esposito S, 2014, INT J IMMUNOPATH PH, V27, P491, DOI 10.1177/039463201402700404; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; FUNK JL, 1993, ATHEROSCLEROSIS, V98, P67, DOI 10.1016/0021-9150(93)90224-I; Gilbert C, 2005, VIRAL IMMUNOL, V18, P474, DOI 10.1089/vim.2005.18.474; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Greseth MD, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004021; Griffin JE, 2012, CHEM BIOL, V19, P218, DOI 10.1016/j.chembiol.2011.12.016; Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107; Herker E, 2011, TRENDS ENDOCRIN MET, V22, P241, DOI 10.1016/j.tem.2011.03.004; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Huang YL, 2014, J BIOL CHEM, V289, P3001, DOI 10.1074/jbc.M113.524587; Hughes DJ, 2010, J VIROL, V84, P3949, DOI 10.1128/JVI.02085-09; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Kapadia SB, 2005, P NATL ACAD SCI USA, V102, P2561, DOI 10.1073/pnas.0409834102; Keyel PA, 2012, J IMMUNOL, V189, P4621, DOI 10.4049/jimmunol.1200828; Kidani Y, 2013, NAT IMMUNOL, V14, P489, DOI 10.1038/ni.2570; Liu CI, 2008, SCIENCE, V319, P1391, DOI 10.1126/science.1153018; Liu SY, 2013, IMMUNITY, V38, P92, DOI 10.1016/j.immuni.2012.11.005; Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Ouellet H, 2011, TRENDS MICROBIOL, V19, P530, DOI 10.1016/j.tim.2011.07.009; Parihar SP, 2014, J INFECT DIS, V209, P754, DOI 10.1093/infdis/jit550; Petersen J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003911; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Reboldi A, 2014, SCIENCE, V345, P679, DOI 10.1126/science.1254790; Santos JA, 2014, GENE, V542, P217, DOI 10.1016/j.gene.2014.03.031; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shibata N, 2009, J LIPID RES, V50, pS277, DOI 10.1194/jlr.R800063-JLR200; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; Sun LP, 2007, P NATL ACAD SCI USA, V104, P6519, DOI 10.1073/pnas.0700907104; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Wang ML, 2010, CELL METAB, V12, P166, DOI 10.1016/j.cmet.2010.05.016; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156; White MJ, 2014, CELL, V159, P1549, DOI 10.1016/j.cell.2014.11.036; Williams KJ, 2013, CANCER RES, V73, P2850, DOI 10.1158/0008-5472.CAN-13-0382-T; Yang CD, 2006, J BIOL CHEM, V281, P27816, DOI 10.1074/jbc.M603781200	46	215	218	3	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2015	163	7					1716	1729		10.1016/j.cell.2015.11.045	http://dx.doi.org/10.1016/j.cell.2015.11.045			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CZ1GN	26686653	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000366854200018
J	Ataie, V; Esman, D; Kuo, BPP; Alic, N; Radic, S				Ataie, V.; Esman, D.; Kuo, B. P. -P.; Alic, N.; Radic, S.			Subnoise detection of a fast random event	SCIENCE			English	Article							GENERATION; MICROWAVE	Observation of random, nonrepetitive phenomena is of critical importance in astronomy, spectroscopy, biology, and remote sensing. Heralded by weak signals, hidden in noise, they pose basic detection challenges. In contrast to repetitive waveforms, a single-instance signal cannot be separated from noise through averaging. Here, we show that a fast, randomly occurring event can be detected and extracted from a noisy background without conventional averaging. An isolated 80-picosecond pulse was received with confidence level exceeding 99%, even when accompanied by noise. Our detector relies on instantaneous spectral cloning and a single-step, coherent field processor. The ability to extract fast, subnoise events is expected to increase detection sensitivity in multiple disciplines. Additionally, the new spectral-cloning receiver can potentially intercept communication signals that are presently considered secure.	[Ataie, V.; Esman, D.; Kuo, B. P. -P.; Alic, N.; Radic, S.] Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Radic, S (corresponding author), Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA.	sradic@ucsd.edu			Defense Advanced Research Projects Agency	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This work is funded in part by the Defense Advanced Research Projects Agency. University of California has filed a patent on the method and applications of random signal detection and coherent analysis.	ALLEN JB, 1977, IEEE T ACOUST SPEECH, V25, P235, DOI 10.1109/TASSP.1977.1162950; ANDERSON GW, 1991, P IEEE, V79, P355, DOI 10.1109/5.75091; Ataie V, 2014, J LIGHTWAVE TECHNOL, V32, P840, DOI 10.1109/JLT.2013.2287852; Bres CS, 2012, J LIGHTWAVE TECHNOL, V30, P3192, DOI 10.1109/JLT.2012.2213238; Donaldson WR, 2010, IEEE J QUANTUM ELECT, V46, P191, DOI 10.1109/JQE.2009.2029544; Gardner WA, 2006, SIGNAL PROCESS, V86, P639, DOI 10.1016/j.sigpro.2005.06.016; Jacobsen G., 1994, NOISE DIGITAL OPTICA; Jolly A, 2006, OPT COMMUN, V264, P89, DOI 10.1016/j.optcom.2006.01.057; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Marhic M. E., 2008, OPTICAL PARAMETRIC A; McDonough R. N., 2004, DETECTION SIGNALS NO; Murmann B., 2015, ADC PERFORMANCE SURV; Myslivets E, 2012, OPT EXPRESS, V20, P3331, DOI 10.1364/OE.20.003331; Pendock GJ, 1995, IEEE PHOTONIC TECH L, V7, P1504, DOI 10.1109/68.477296; Rozanov Yu., 1995, PROBABILITY THEORY R; Taylor J.D., 2012, ULTRAWIDEBAND RADAR, P536; Thornton D, 2013, SCIENCE, V341, P53, DOI 10.1126/science.1236789; Tong Z, 2011, NAT PHOTONICS, V5, P430, DOI [10.1038/nphoton.2011.79, 10.1038/NPHOTON.2011.79]; Tong Z, 2013, ADV OPT PHOTONICS, V5, P318, DOI 10.1364/AOP.5.000318; Walden RH, 1999, IEEE J SEL AREA COMM, V17, P539, DOI 10.1109/49.761034; Weitkamp C., 2014, LIDAR RANGE RESOLVED	21	35	37	14	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2015	350	6266					1343	1346		10.1126/science.aac8446	http://dx.doi.org/10.1126/science.aac8446			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1JL	26659052				2022-12-28	WOS:000366162400034
J	Cubitt, TS; Perez-Garcia, D; Wolf, MM				Cubitt, Toby S.; Perez-Garcia, David; Wolf, Michael M.			Undecidability of the spectral gap	NATURE			English	Article							COMPLEXITY; QUANTUM; ANTIFERROMAGNET; LATTICE; STATE	The spectral gap-the energy difference between the ground state and first excited state of a system-is central to quantum many-body physics. Many challenging open problems, such as the Haldane conjecture, the question of the existence of gapped topological spin liquid phases, and the Yang-Mills gap conjecture, concern spectral gaps. These and other problems are particular cases of the general spectral gap problem: given the Hamiltonian of a quantum many-body system, is it gapped or gapless? Here we prove that this is an undecidable problem. Specifically, we construct families of quantum spin systems on a two-dimensional lattice with translationally invariant, nearest-neighbour interactions, for which the spectral gap problem is undecidable. This result extends to undecidability of other low-energy properties, such as the existence of algebraically decaying ground-state correlations. The proof combines Hamiltonian complexity techniques with aperiodic tilings, to construct a Hamiltonian whose ground state encodes the evolution of a quantum phase-estimation algorithm followed by a universal Turing machine. The spectral gap depends on the outcome of the corresponding 'halting problem'. Our result implies that there exists no algorithm to determine whether an arbitrary model is gapped or gapless, and that there exist models for which the presence or absence of a spectral gap is independent of the axioms of mathematics.	[Cubitt, Toby S.] UCL, Dept Comp Sci, London WC1E 6BT, England; [Cubitt, Toby S.] Univ Cambridge, Ctr Math Sci, DAMTP, Cambridge CB3 0WA, England; [Perez-Garcia, David] Univ Complutense Madrid, Fac CC Matemat, Dept Anal Matemat, E-28040 Madrid, Spain; [Perez-Garcia, David] Univ Complutense Madrid, Fac CC Matemat, IMI, E-28040 Madrid, Spain; [Perez-Garcia, David] ICMAT, Madrid 28049, Spain; [Wolf, Michael M.] Tech Univ Munich, Dept Math, D-85748 Garching, Germany	University of London; University College London; University of Cambridge; Complutense University of Madrid; Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias Matematicas (ICMAT); Technical University of Munich	Cubitt, TS (corresponding author), UCL, Dept Comp Sci, Gower St, London WC1E 6BT, England.	t.cubitt@ucl.ac.uk	Perez-Garcia, David/F-7892-2011; Wolf, Michael M/J-8135-2016	Perez-Garcia, David/0000-0003-2990-791X; Wolf, Michael M/0000-0002-1862-6912; Cubitt, Toby/0000-0002-5087-9346	Royal Society; MINECO [MTM2011-26912, PRI-PIMCHI-2011-1071]; Comunidad de Madrid [S2013/ICE-2801]; European Research Council (ERC) under the European Union [648913]; John Templeton Foundation [48322]	Royal Society(Royal Society of London); MINECO(Spanish Government); Comunidad de Madrid(Comunidad de Madrid); European Research Council (ERC) under the European Union(European Research Council (ERC)); John Templeton Foundation	T.S.C. thanks IBM. T.J. Watson Laboratory for their hospitality, and C. Bennett in particular for discussions about this work. T.S.C., D.P.-G. and M.M.W. thank the Isaac Newton Institute for Mathematical Sciences, Cambridge for their hospitality during the programme "Mathematical Challenges in Quantum Information", where part of this work was carried out. T.S.C. is supported by the Royal Society. D.P.G. acknowledges support from MINECO (grant MTM2011-26912 and PRI-PIMCHI-2011-1071), Comunidad de Madrid (grant QUITEMAD+-CM, ref. S2013/ICE-2801) and the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement no. 648913). This work was made possible through the support of grant no. 48322 from the John Templeton Foundation. The opinions expressed in this publication are those of the authors and do not necessarily reflect the views of the John Templeton Foundation.	AFFLECK I, 1988, COMMUN MATH PHYS, V115, P477, DOI 10.1007/BF01218021; Aharonov D, 2009, COMMUN MATH PHYS, V287, P41, DOI 10.1007/s00220-008-0710-3; [Anonymous], 1931, MONATSHEFTE MATH PHY, DOI DOI 10.1007/BF01700692; Balents L, 2010, NATURE, V464, P199, DOI 10.1038/nature08917; Bernstein E, 1997, SIAM J COMPUT, V26, P1411, DOI 10.1137/S0097539796300921; Bravyi S, 2010, J MATH PHYS, V51, DOI 10.1063/1.3490195; Cardy J., 2012, FINITE SIZE SCALING; Cardy J., 1996, SCALING RENORMALIZAT; Cubitt T. S., 2015, UNDECIDABILITY SPECT; Feynman R. P., 1985, OPT NEWS, V11, P11, DOI 10.1364/ON.11.2.000011; GOLINELLI O, 1994, PHYS REV B, V50, P3037, DOI 10.1103/PhysRevB.50.3037; Gottesman D, 2009, ANN IEEE SYMP FOUND, P95, DOI 10.1109/FOCS.2009.22; Han TH, 2012, NATURE, V492, P406, DOI 10.1038/nature11659; Hastings MB, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.104431; Jaffe A., 2006, MILLENNIUM PRIZE PRO, P129; Kempe J, 2006, SIAM J COMPUT, V35, P1070, DOI 10.1137/S0097539704445226; Michalakis S, 2013, COMMUN MATH PHYS, V322, P277, DOI 10.1007/s00220-013-1762-6; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Oliveira R, 2008, QUANTUM INF COMPUT, V8, P900; Poonen B., 2014, INTERPRETING GODEL C, P211; REBBI C, 1983, LATTICE GAUGE THEORI; ROBINSON RM, 1971, INVENT MATH, V12, P177, DOI 10.1007/BF01418780; SCHULTZ TD, 1964, REV MOD PHYS, V36, P856, DOI 10.1103/RevModPhys.36.856; Turing AM, 1937, P LOND MATH SOC, V42, P230, DOI 10.1112/plms/s2-42.1.230; WANG H, 1961, AT&T TECH J, V40, P1; Yan SM, 2011, SCIENCE, V332, P1173, DOI 10.1126/science.1201080	29	101	101	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2015	528	7581					207	211		10.1038/nature16059	http://dx.doi.org/10.1038/nature16059			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9VH	26659181	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000366053300030
J	Glaser, R				Glaeser, Roger			CATALYSIS The complexity of intimacy	NATURE			English	Editorial Material									[Glaeser, Roger] Univ Leipzig, Inst Chem Technol, D-04103 Leipzig, Germany	Leipzig University	Glaser, R (corresponding author), Univ Leipzig, Inst Chem Technol, D-04103 Leipzig, Germany.	roger.glaeser@uni-leipzig.de						GarciaMartinez J, 2015, MESOPOROUS ZEOLITES: PREPARATION, CHARACTERIZATION AND APPLICATIONS, P1, DOI 10.1002/9783527673957; Karger J., 2012, DIFFUSION NANOPOROUS, V2, P807; MARTENS JA, 1995, ANGEW CHEM INT EDIT, V34, P2528, DOI 10.1002/anie.199525281; van Veen J. A. R, 2008, HDB HETEROGENEOUS CA, V6, P2778; WEISZ PB, 1962, ADV CATAL, V13, P137, DOI 10.1016/S0360-0564(08)60287-4; Zecevic J, 2015, NATURE, V528, P245, DOI 10.1038/nature16173	6	8	9	1	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2015	528	7581					197	198		10.1038/528197a	http://dx.doi.org/10.1038/528197a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9VH	26659178				2022-12-28	WOS:000366053300023
J	Minocherhomji, S; Ying, SM; Bjerregaard, VA; Bursomanno, S; Aleliunaite, A; Wu, W; Mankouri, HW; Shen, HH; Liu, Y; Hickson, ID				Minocherhomji, Sheroy; Ying, Songmin; Bjerregaard, Victoria A.; Bursomanno, Sara; Aleliunaite, Aiste; Wu, Wei; Mankouri, Hocine W.; Shen, Huahao; Liu, Ying; Hickson, Ian D.			Replication stress activates DNA repair synthesis in mitosis	NATURE			English	Article							BREAK-INDUCED REPLICATION; COMMON FRAGILE SITES; HOLLIDAY JUNCTION RESOLUTION; HUMAN-CELLS; CHROMOSOMES; MUS81-EME1; REVEALS; ENDONUCLEASE; TRANSMISSION; BUBBLE	Oncogene-induced DNA replication stress has been implicated as a driver of tumorigenesis(1). Many chromosomal rearrangements characteristic of human cancers originate from specific regions of the genome called common fragile sites (CFSs)(2-5). CFSs are difficult-to-replicate loci that manifest as gaps or breaks on metaphase chromosomes (termed CFS 'expression'), particularly when cells have been exposed to replicative stress(6). The MUS81-EME1 structure-specific endonuclease promotes the appearance of chromosome gaps or breaks at CFSs following replicative stress(7-9). Here we show that entry of cells into mitotic prophase triggers the recruitment of MUS81 to CFSs. The nuclease activity of MUS81 then promotes POLD3-dependent DNA synthesis at CFSs, which serves to minimize chromosome mis-segregation and non-disjunction. We propose that the attempted condensation of incompletely duplicated loci in early mitosis serves as the trigger for completion of DNA replication at CFS loci in human cells. Given that this POLD3-dependent mitotic DNA synthesis is enhanced in aneuploid cancer cells that exhibit intrinsically high levels of chromosomal instability (CIN+) and replicative stress, we suggest that targeting this pathway could represent a new therapeutic approach.	[Minocherhomji, Sheroy; Bjerregaard, Victoria A.; Bursomanno, Sara; Aleliunaite, Aiste; Wu, Wei; Mankouri, Hocine W.; Liu, Ying; Hickson, Ian D.] Univ Copenhagen, Panum Inst, Dept Cellular & Mol Med, Ctr Chromosome Stabil & Ctr Hlth Aging, DK-2200 Copenhagen N, Denmark; [Ying, Songmin; Shen, Huahao] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Resp & Crit Care Med, Hangzhou 310009, Zhejiang, Peoples R China; [Ying, Songmin] Zhejiang Univ, Sch Med, Dept Pharmacol, Hangzhou 310058, Zhejiang, Peoples R China; [Shen, Huahao] SKLRD, Guangzhou 510120, Peoples R China	University of Copenhagen; Zhejiang University; Zhejiang University	Shen, HH (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Resp & Crit Care Med, Hangzhou 310009, Zhejiang, Peoples R China.	huahaoshen@163.com; ying@sund.ku.dk; iandh@sund.ku.dk	Hickson, Ian/AAJ-7548-2020	Bjerregaard, Victoria Alexandra/0000-0001-6786-0441; Minocherhomji, Sheroy/0000-0002-1101-4761; Mankouri, Hocine/0000-0003-2092-0907; Hickson, Ian/0000-0002-0583-566X	European Research Council; Danish National Research Foundation; Nordea Foundation; National 1000 Talents Program; National Natural Science Foundation of China [31370901, 81422031]; Zhejiang Provincial Natural Science Foundation of China [LR14H160001]; National Key Scientific and Technology Support Program: Collaborative innovation of Clinical Research for chronic obstructive pulmonary disease and lung cancer [2013BAI09B09]; Danish Medical Research Council	European Research Council(European Research Council (ERC)European Commission); Danish National Research Foundation(Danmarks Grundforskningsfond); Nordea Foundation; National 1000 Talents Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Key Scientific and Technology Support Program: Collaborative innovation of Clinical Research for chronic obstructive pulmonary disease and lung cancer; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank T. Palmai-Pallag, L. Che, B. Tian, M. Xing, X. Geng and T. Wass for technical help. This study was supported by The European Research Council, Danish National Research Foundation and Nordea Foundation (H.W.M., Y.L. and I.D.H.), the National 1000 Talents Program, the National Natural Science Foundation of China (31370901, 81422031), Zhejiang Provincial Natural Science Foundation of China (LR14H160001) (S.Y.), National Key Scientific and Technology Support Program: Collaborative innovation of Clinical Research for chronic obstructive pulmonary disease and lung cancer, no. 2013BAI09B09 (H.S. and S.Y.), and The Danish Medical Research Council (S.M.). I.D.H. is a Qiushi Guest Professor at Zhejiang University.	Arlt MF, 2006, DNA REPAIR, V5, P1126, DOI 10.1016/j.dnarep.2006.05.010; Beaudouin J, 2002, CELL, V108, P83, DOI 10.1016/S0092-8674(01)00627-4; Burrell RA, 2013, NATURE, V494, P492, DOI 10.1038/nature11935; Burrow AA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-59; Castor D, 2013, MOL CELL, V52, P221, DOI 10.1016/j.molcel.2013.08.036; Chan KL, 2009, NAT CELL BIOL, V11, P753, DOI 10.1038/ncb1882; Costantino L, 2014, SCIENCE, V343, P88, DOI 10.1126/science.1243211; Donnianni RA, 2013, P NATL ACAD SCI USA, V110, P13475, DOI 10.1073/pnas.1309800110; Dunlop MG, 2012, NAT GENET, V44, P770, DOI 10.1038/ng.2293; Ehmsen KT, 2008, NUCLEIC ACIDS RES, V36, P2182, DOI 10.1093/nar/gkm1152; GLOVER TW, 1984, HUM GENET, V67, P136, DOI 10.1007/BF00272988; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hanada K, 2007, NAT STRUCT MOL BIOL, V14, P1096, DOI 10.1038/nsmb1313; Harrigan JA, 2011, J CELL BIOL, V193, P97, DOI 10.1083/jcb.201011083; Hirano T, 2012, GENE DEV, V26, P1659, DOI 10.1101/gad.194746.112; Le Beau MM, 1998, HUM MOL GENET, V7, P755, DOI 10.1093/hmg/7.4.755; Le Tallec B, 2013, CELL REP, V4, P420, DOI 10.1016/j.celrep.2013.07.003; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; Lydeard JR, 2007, NATURE, V448, P820, DOI 10.1038/nature06047; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Minocherhomji S, 2014, TRENDS CELL BIOL, V24, P321, DOI 10.1016/j.tcb.2013.11.007; Naim V, 2013, NAT CELL BIOL, V15, P1008, DOI 10.1038/ncb2793; Pedersen RT, 2015, J CELL BIOL, V210, P565, DOI 10.1083/jcb.201502107; Saini N, 2013, NATURE, V502, P389, DOI 10.1038/nature12584; Tedeschi A, 2013, NATURE, V501, P564, DOI 10.1038/nature12471; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Wilson MA, 2013, NATURE, V502, P393, DOI 10.1038/nature12585; Wyatt HDM, 2013, MOL CELL, V52, P234, DOI 10.1016/j.molcel.2013.08.035; Ying SM, 2013, NAT CELL BIOL, V15, P1001, DOI 10.1038/ncb2773	30	321	322	2	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2015	528	7581					286	+		10.1038/nature16139	http://dx.doi.org/10.1038/nature16139			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9VH	26633632				2022-12-28	WOS:000366053300046
J	Dhaliwal, G				Dhaliwal, Gurpreet			The Greatest Generation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PHYSICIANS		[Dhaliwal, Gurpreet] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Dhaliwal, Gurpreet] San Francisco VA Med Ctr, Med Serv, San Francisco, CA USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Dhaliwal, G (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	gurpreet.dhaliwal@ucsf.edu						Arora VM, 2012, JAMA-J AM MED ASSOC, V308, P2195, DOI 10.1001/jama.2012.14584; Chen C, 2014, JAMA-J AM MED ASSOC, V312, P2385, DOI 10.1001/jama.2014.15973; DETSKY AS, 1986, MED CARE, V24, P526, DOI 10.1097/00005650-198606000-00007; ENGEL GL, 1976, JAMA-J AM MED ASSOC, V236, P861, DOI 10.1001/jama.236.7.861; Gallo A, 4 THINGS YOU THOUGHT; Leape LL, 2012, ACAD MED, V87, P845, DOI 10.1097/ACM.0b013e318258338d; Simons D, REMARKABLE FALSE MEM	7	3	3	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 8	2015	314	22					2353	2354		10.1001/jama.2015.10622	http://dx.doi.org/10.1001/jama.2015.10622			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX8XT	26647253				2022-12-28	WOS:000365989100006
J	Davis, FP; Kanno, Y; O'Shea, JJ				Davis, Fred P.; Kanno, Yuka; O'Shea, John J.			A Metabolic Switch for Th17 Pathogenicity	CELL			English	Editorial Material							T-CELLS; DROPLETS	T helper 17 (Th17) cells are critical for host defense but can also drive autoimmunity. This divergent behavior is explored by Gaublomme et al. and Wang et al., who identify inflammation-associated genes by measuring gene expression in nearly 1,000 individual Th17 cells and show that CD5L affects the expression of pro-inflammatory genes by altering lipid synthesis.	[Davis, Fred P.; Kanno, Yuka; O'Shea, John J.] NIAMS, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Davis, FP (corresponding author), NIAMS, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA.	fred.davis@nih.gov; john.oshea@nih.gov	Kanno, Yuka/B-5802-2013	Kanno, Yuka/0000-0001-5668-9319; Davis, Fred/0000-0001-8294-1610				Gaublomme JT, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.009; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Harrington LE, 2006, CURR OPIN IMMUNOL, V18, P349, DOI 10.1016/j.coi.2006.03.017; Kurokawa J, 2010, CELL METAB, V11, P479, DOI 10.1016/j.cmet.2010.04.013; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Schwartzman O, 2015, NAT REV GENET, V16, P716, DOI 10.1038/nrg3980; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Toh ML, 2007, CURR OPIN RHEUMATOL, V19, P284, DOI 10.1097/BOR.0b013e32805e87e0; Wang C, 2015, CELL, V163, DOI 10.1016/j.cell.2015.10.068	10	10	11	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 6	2015	163	6					1308	U304		10.1016/j.cell.2015.11.033	http://dx.doi.org/10.1016/j.cell.2015.11.033			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SE	26638065	Bronze			2022-12-28	WOS:000366044800010
J	Saritas, T; Brandenburg, V; Federico, G; Grone, HJ; Floege, J; Moeller, MJ; Moza, A				Saritas, Turgay; Brandenburg, Vincent; Federico, Giuseppina; Groene, Hermann-Josef; Floege, Juergen; Moeller, Marcus-Johannes; Moza, Ajay			Glomerulonephritis triggered by a chronically infected left ventricular assist device	LANCET			English	Editorial Material							SHUNT NEPHRITIS		[Saritas, Turgay; Floege, Juergen; Moeller, Marcus-Johannes] Univ Hosp RWTH Aachen, Div Nephrol & Immunol, D-52074 Aachen, Germany; [Brandenburg, Vincent] Univ Hosp RWTH Aachen, Div Cardiol, D-52074 Aachen, Germany; [Floege, Juergen; Moeller, Marcus-Johannes] Univ Hosp RWTH Aachen, Ctr Rare Dis, D-52074 Aachen, Germany; [Moza, Ajay] Univ Hosp RWTH Aachen, Dept Thorac & Cardiovasc Surg, D-52074 Aachen, Germany; [Federico, Giuseppina; Groene, Hermann-Josef] German Canc Res Ctr, Dept Cellular & Mol Pathol, Heidelberg, Germany	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ)	Saritas, T (corresponding author), Univ Hosp RWTH Aachen, Div Nephrol & Immunol, D-52074 Aachen, Germany.	tsaritas@ukaachen.de	Turgay, Saritas/AAH-5127-2020	Turgay, Saritas/0000-0002-6691-9218				BLACK JA, 1965, LANCET, V2, P921; Coffin ST, 2015, CARDIORENAL MED, V5, P48, DOI 10.1159/000369589; Haffner D, 1997, NEPHROL DIAL TRANSPL, V12, P1143, DOI 10.1093/ndt/12.6.1143; Kiryluk K, 2008, KIDNEY INT, V73, P1434, DOI 10.1038/ki.2008.8; Nienaber J, 2013, EXPERT REV ANTI-INFE, V11, P201, DOI [10.1586/ERI.12.163, 10.1586/eri.12.163]	5	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 5	2015	386	10010					2363	2364		10.1016/S0140-6736(15)00822-3	http://dx.doi.org/10.1016/S0140-6736(15)00822-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX8ZB	26681291				2022-12-28	WOS:000365993200036
J	Floyd, J; Wu, L; Burgess, DH; Izadnegahdar, R; Mukanga, D; Ghani, AC				Floyd, Jessica; Wu, Lindsey; Burgess, Deborah Hay; Izadnegahdar, Rasa; Mukanga, David; Ghani, Azra C.			Evaluating the impact of pulse oximetry on childhood pneumonia mortality in resource-poor settings	NATURE			English	Article							DEVELOPING-COUNTRIES; COST-EFFECTIVENESS; HEALTH-WORKERS; CHILDREN; AMOXICILLIN; PREVENTION; MANAGEMENT; DISTRICT; GUIDELINES; RESISTANCE	It is estimated that pneumonia is responsible for 15% of childhood deaths worldwide. Recent research has shown that hypoxia and malnutrition are strong predictors of mortality in children hospitalized for pneumonia. It is estimated that 15% of children under 5 who are hospitalized for pneumonia have hypoxaemia and that around 1.5 million children with severe pneumonia require oxygen treatment each year. We developed a deterministic compartmental model that links the care pathway to disease progression to assess the impact of introducing pulse oximetry as a prognostic tool to distinguish severe from non-severe pneumonia in under-5 year olds across 15 countries with the highest burden worldwide. We estimate that, assuming access to supplemental oxygen, pulse oximetry has the potential to avert up to 148,000 deaths if implemented across the 15 countries. By contrast, integrated management of childhood illness alone has a relatively small impact on mortality owing to its low sensitivity. Pulse oximetry can significantly increase the incidence of correctly treated severe cases as well as reduce the incidence of incorrect treatment with antibiotics. We also found that the combination of pulse oximetry with integrated management of childhood illness is highly cost-effective, with median estimates ranging from US$2.97 to $52.92 per disability-adjusted life year averted in the 15 countries analysed. This combination of substantial burden reduction and favourable cost-effectiveness makes pulse oximetry a promising candidate for improving the prognosis for children with pneumonia in resource-poor settings.	[Floyd, Jessica; Wu, Lindsey; Ghani, Azra C.] Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC Ctr Outbreak Anal & Modelling, Dept Infect Dis Epidemiol, London W2 1PG, England; [Wu, Lindsey] Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Immunol & Infect, London WC1E 7HT, England; [Burgess, Deborah Hay; Izadnegahdar, Rasa; Mukanga, David] Bill & Melinda Gates Fdn, Seattle, WA 98109 USA	Imperial College London; University of London; London School of Hygiene & Tropical Medicine; Bill & Melinda Gates Foundation	Floyd, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC Ctr Outbreak Anal & Modelling, Dept Infect Dis Epidemiol, Norfolk Pl, London W2 1PG, England.	jrf1g15@soton.ac.uk; a.ghani@imperial.ac.uk	Floyd, Jessica R/A-8356-2016; Ghani, Azra/B-8560-2009	Floyd, Jessica R/0000-0003-2022-0791; Ghani, Azra/0000-0002-0007-4910; Wu, Lindsey/0000-0001-6552-3716	Bill & Melinda Gates Foundation Diagnostics Modelling Consortium; UK Medical Research Council (MRC); Bill & Melinda Gates Foundation; UK MRC; UK Department for International Development; MRC [MR/K010174/1] Funding Source: UKRI; Medical Research Council [MR/K010174/1B, MR/K010174/1] Funding Source: researchfish	Bill & Melinda Gates Foundation Diagnostics Modelling Consortium; UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the Bill & Melinda Gates Foundation Diagnostics Modelling Consortium. L.W. acknowledges doctoral training funding from the UK Medical Research Council (MRC). A.C.G. acknowledges support from the Bill & Melinda Gates Foundation, the UK MRC and the UK Department for International Development.	Acacio S, 2015, INT J INFECT DIS, V36, P39, DOI 10.1016/j.ijid.2015.05.010; Alistar SS, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-46; [Anonymous], 2013, INT DRUG PRIC IND GU; Breman J. G., 2006, DIS CONTROL PRIORITI; Chinbuah MA, 2013, INT HEALTH, V5, P148, DOI 10.1093/inthealth/ihs008; Duke T, 2008, LANCET, V372, P1328, DOI 10.1016/S0140-6736(08)61164-2; Fu LY, 2006, PEDIATRICS, V118, pE1822, DOI 10.1542/peds.2005-2673; Gandra S, 2014, CLIN MICROBIOL INFEC, V20, P973, DOI 10.1111/1469-0691.12798; Hazir T, 2011, CLIN INFECT DIS, V52, P293, DOI 10.1093/cid/ciq142; International Vacine Access Centre, 2015, PNEUM DIARRH PROGR R; Izadnegahdar R, 2013, LANCET RESP MED, V1, P574, DOI 10.1016/S2213-2600(13)70075-4; Kallander K, 2008, B WORLD HEALTH ORGAN, V86, P332, DOI 10.2471/BLT.07.049353; Kelly JM, 2001, AM J PUBLIC HEALTH, V91, P1617, DOI 10.2105/AJPH.91.10.1617; le Roux DM, 2015, LANCET GLOB HEALTH, V3, pE95, DOI 10.1016/S2214-109X(14)70360-2; Lifebox Foundation, 2015, LIF SAV LIV SAF SURG; Lim Yee-Wei, 2006, Nature, V444 Suppl 1, P9, DOI 10.1038/nature05442; MADICO G, 1995, ARCH PEDIAT ADOL MED, V149, P1259, DOI 10.1001/archpedi.1995.02170240077012; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Nair H, 2013, LANCET, V381, P1380, DOI 10.1016/S0140-6736(12)61901-1; Pitt C, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-9; Reed C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027793; Rudan I, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010401; Sazawal S, 2003, LANCET INFECT DIS, V3, P547, DOI 10.1016/S1473-3099(03)00737-0; Senn N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090990; Sinha A, 2007, LANCET, V369, P389, DOI 10.1016/S0140-6736(07)60195-0; Straus WL, 1998, LANCET, V352, P270, DOI 10.1016/S0140-6736(97)10294-X; Subhi R, 2009, LANCET INFECT DIS, V9, P219, DOI 10.1016/S1473-3099(09)70071-4; UNICEF, 2015, SUPPL CAT; UNICEF WHO World Bank UN-DESA Population Division, 2015, LEV TRENDS CHILD MOR; United Nations' Children's Fund (UNICEF), 2015, STAT WORLDS CHILDR 2; Victora CG, 1999, AM J CLIN NUTR, V70, P309; Walter ND, 2009, B WORLD HEALTH ORGAN, V87, P99, DOI 10.2471/BLT.08.050740; WHO-CHOICE, 2015, HLTH SERV DEL COSTS; World Health Organization, 2015, IMCI CHART BOOKL; World Health Organization/UNICEF, 2015, END PREV CHILD DEATH	35	53	54	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					S53	S59		10.1038/nature16043	http://dx.doi.org/10.1038/nature16043			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX3NO	26633766	Green Submitted, hybrid			2022-12-28	WOS:000365606000011
J	Watts, G				Watts, Geoff			Jane Wardle Obituary	LANCET			English	Biographical-Item																		WARDLE J, PUBLICATION LIST	1	0	0	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 28	2015	386	10009					2138	2138		10.1016/S0140-6736(15)01062-4	http://dx.doi.org/10.1016/S0140-6736(15)01062-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX8YW	26645058				2022-12-28	WOS:000365992600019
J	Smith, ADAC; Tilling, K; Nelson, SM; Lawlor, DA				Smith, Andrew D. A. C.; Tilling, Kate; Nelson, Scott M.; Lawlor, Debbie A.			Live-Birth Rate Associated With Repeat In Vitro Fertilization Treatment Cycles	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IVF; AGE; DISCONTINUATION; CONCEPTION	IMPORTANCE The likelihood of achieving a live birth with repeat in vitro fertilization (IVF) is unclear, yet treatment is commonly limited to 3 or 4 embryo transfers. OBJECTIVE To determine the live-birth rate per initiated ovarian stimulation IVF cycle and with repeated cycles. DESIGN, SETTING, AND PARTICIPANTS Prospective study of 156 947 UK women who received 257 398 IVF ovarian stimulation cycles between 2003 and 2010 and were followed up until June 2012. EXPOSURES In vitro fertilization, with a cycle defined as an episode of ovarian stimulation and all subsequent separate fresh and frozen embryo transfers. MAIN OUTCOMES AND MEASURES Live-birth rate per IVF cycle and the cumulative live-birth rates across all cycles in all women and by age and treatment type. Optimal, prognosis-adjusted, and conservative cumulative live-birth rates were estimated, reflecting 0%, 30%, and 100%, respectively, of women who discontinued due to poor prognosis and having a live-birth rate of 0 had they continued. RESULTS Among the 156 947 women, the median age at start of treatment was 35 years (interquartile range, 32-38; range, 18-55), and the median duration of infertility for all 257 398 cycles was 4 years (interquartile range, 2-6; range, <1-29). In all women, the live-birth rate for the first cycle was 29.5%(95% CI, 29.3%-29.7%). This remained above 20% up to and including the fourth cycle. The cumulative prognosis-adjusted live-birth rate across all cycles continued to increase up to the ninth cycle, with 65.3%(95% CI, 64.8%-65.8%) of women achieving a live birth by the sixth cycle. In women younger than 40 years using their own oocytes, the live-birth rate for the first cycle was 32.3%(95% CI, 32.0%-32.5%) and remained above 20% up to and including the fourth cycle. Six cycles achieved a cumulative prognosis-adjusted live-birth rate of 68.4%(95% CI, 67.8%-68.9%). For women aged 40 to 42 years, the live-birth rate for the first cycle was 12.3%(95% CI, 11.8%-12.8%), with 6 cycles achieving a cumulative prognosis-adjusted live-birth rate of 31.5%(95% CI, 29.7%-33.3%). For women older than 42 years, all rates within each cycle were less than 4%. No age differential was observed among women using donor oocytes. Rates were lower for women with untreated male partner-related infertility compared with those with any other cause, but treatment with either intracytoplasmic sperm injection or sperm donation removed this difference. CONCLUSIONS AND RELEVANCE Among women in the United Kingdom undergoing IVF, the cumulative prognosis-adjusted live-birth rate after 6 cycles was 65.3%, with variations by age and treatment type. These findings support the efficacy of extending the number of IVF cycles beyond 3 or 4.	[Smith, Andrew D. A. C.; Tilling, Kate; Lawlor, Debbie A.] Univ Bristol, MRC, Integrat Epidemiol Unit, Bristol BS8 1BN, Avon, England; [Smith, Andrew D. A. C.; Tilling, Kate; Lawlor, Debbie A.] Univ Bristol, Sch Social & Community Med, Bristol BS8 1BN, Avon, England; [Nelson, Scott M.] Univ Glasgow, Sch Med, Glasgow, Lanark, Scotland	University of Bristol; University of Bristol; University of Glasgow	Lawlor, DA (corresponding author), Univ Bristol, MRC, Integrat Epidemiol Unit, Oakfield House, Bristol BS8 1BN, Avon, England.	d.a.lawlor@bristol.ac.uk	Tilling, Kate/AAY-1578-2021; Smith, Andrew DAC/F-9714-2011	Tilling, Kate/0000-0002-1010-8926; Lawlor, Debbie A/0000-0002-6793-2262	UK Medical Research Council [MC_UU_12013/5, MC_UU_12013/9]; National Institute for Health Research Senior Investigator award [NF-SI-0611-10196]; Wellcome Trust [WT094311MA]; MRC [MC_UU_12013/9, MC_UU_12013/5] Funding Source: UKRI; Medical Research Council [MC_UU_12013/9, MC_UU_12013/5] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10196] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Senior Investigator award; Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Drs Smith, Tilling, and Lawlor work in a unit that receives funding from the UK Medical Research Council (http://www.mrc.ac.uk) (MC_UU_12013/5 and MC_UU_12013/9), and Dr Lawlor receives support from a National Institute for Health Research Senior Investigator award (NF-SI-0611-10196). This work is also supported by a grant from the Wellcome Trust (http://www.wellcome.ac.uk), which pays Dr Smith's' salary (WT094311MA).	Bland JM, 2004, BMJ-BRIT MED J, V328, P1073; Brigham KB, 2013, HUM REPROD, V28, P666, DOI 10.1093/humrep/des418; Centers for Disease Control and Prevention, 2013 ASS REPR TECHN; Crosignani PG, 2015, HUM REPROD, V30, P2243, DOI 10.1093/humrep/dev163; Davies MJ, 2012, NEW ENGL J MED, V366, P1803, DOI 10.1056/NEJMoa1008095; Delvigne A, 2002, HUM REPROD UPDATE, V8, P559, DOI 10.1093/humupd/8.6.559; Dunson DB, 2004, OBSTET GYNECOL, V103, P51, DOI 10.1097/01.AOG.0000100153.24061.45; Elizur SE, 2006, GYNECOL ENDOCRINOL, V22, P25, DOI 10.1080/09513590500453916; Fukuda J, 2001, ACTA OBSTET GYN SCAN, V80, P71, DOI 10.1080/791201838; Gameiro S, 2012, HUM REPROD UPDATE, V18, P652, DOI 10.1093/humupd/dms031; Greenwood M., 1926, REPORTS PUBLIC HLTH, V33, P1; Human Fertilisation and Embryology Authority, FERT TREATM 2013 TRE; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kupka MS, 2014, HUM REPROD, V29, P2099, DOI 10.1093/humrep/deu175; Lawlor DA, 2012, LANCET, V379, P521, DOI 10.1016/S0140-6736(11)61267-1; Luke B, 2012, NEW ENGL J MED, V366, P2483, DOI 10.1056/NEJMoa1110238; Macaldowie A, 2015, ASSISTED REPROD TECH; Maheshwari A, 2011, HUM REPROD UPDATE, V17, P107, DOI 10.1093/humupd/dmq028; Malizia BA, 2009, NEW ENGL J MED, V360, P236, DOI 10.1056/NEJMoa0803072; Margalioth EJ, 2006, HUM REPROD, V21, P3036, DOI 10.1093/humrep/del305; National Institute for Health and Care Excellence (NICE), FERT PROBL ASS TREAT; Nelson SM, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000386; Rothman KJ, 2013, FERTIL STERIL, V99, P1958, DOI 10.1016/j.fertnstert.2013.02.040; Savitz DA, 2002, EPIDEMIOL REV, V24, P91, DOI 10.1093/epirev/mxf006; Sharma V, 2002, FERTIL STERIL, V78, P40, DOI 10.1016/S0015-0282(02)03160-6; Shenfield F, 2010, HUM REPROD, V25, P1361, DOI 10.1093/humrep/deq057; Stern JE, 2010, FERTIL STERIL, V94, P1334, DOI 10.1016/j.fertnstert.2009.05.052; Sunkara SK, 2014, HUM REPROD, V29, P1218, DOI 10.1093/humrep/deu053; Uffalussy JG, FORBES; van Loendersloot LL, 2010, HUM REPROD UPDATE, V16, P577, DOI 10.1093/humupd/dmq015	30	119	123	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 29	2015	314	24					2654	2662		10.1001/jama.2015.17296	http://dx.doi.org/10.1001/jama.2015.17296			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ2MR	26717030	Bronze, Green Submitted, Green Accepted			2022-12-28	WOS:000366939800020
J	Amin, ND; Bai, G; Klug, JR; Bonanomi, D; Pankratz, MT; Gifford, WD; Hinckley, CA; Sternfeld, MJ; Driscoll, SP; Dominguez, B; Lee, KF; Jin, X; Pfaff, SL				Amin, Neal D.; Bai, Ge; Klug, Jason R.; Bonanomi, Dario; Pankratz, Matthew T.; Gifford, Wesley D.; Hinckley, Christopher A.; Sternfeld, Matthew J.; Driscoll, Shawn P.; Dominguez, Bertha; Lee, Kuo-Fen; Jin, Xin; Pfaff, Samuel L.			Loss of motoneuron-specific microRNA-218 causes systemic neuromuscular failure	SCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURONS; SPINAL-CORD; IN-VIVO; HYPEREXCITABILITY; BIOGENESIS; MIR-218; BINDING; DROSHA; FATE	Dysfunction of microRNA (miRNA) metabolism is thought to underlie diseases affecting motoneurons. One miRNA, miR-218, is abundantly and selectively expressed by developing and mature motoneurons. Here we show that mutant mice lacking miR-218 die neonatally and exhibit neuromuscular junction defects, motoneuron hyperexcitability, and progressive motoneuron cell loss, all of which are hallmarks of motoneuron diseases such as amyotrophic lateral sclerosis and spinal muscular atrophy. Gene profiling reveals that miR-218 modestly represses a cohort of hundreds of genes that are neuronally enriched but are not specific to a single neuron subpopulation. Thus, the set of messenger RNAs targeted by miR-218, designated TARGET218, defines a neuronal gene network that is selectively tuned down in motoneurons to prevent neuromuscular failure and neurodegeneration.	[Amin, Neal D.; Bai, Ge; Bonanomi, Dario; Pankratz, Matthew T.; Gifford, Wesley D.; Hinckley, Christopher A.; Sternfeld, Matthew J.; Driscoll, Shawn P.; Pfaff, Samuel L.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Amin, Neal D.; Bai, Ge; Bonanomi, Dario; Pankratz, Matthew T.; Gifford, Wesley D.; Hinckley, Christopher A.; Sternfeld, Matthew J.; Driscoll, Shawn P.; Pfaff, Samuel L.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Amin, Neal D.; Gifford, Wesley D.] Univ Calif San Diego, Med Scientist Training Program, La Jolla, CA 92037 USA; [Amin, Neal D.] UCSD, Biomed Sci Grad Program, La Jolla, CA 92037 USA; [Klug, Jason R.; Jin, Xin] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; [Gifford, Wesley D.] UCSD, Neurosci Grad Program, La Jolla, CA 92037 USA; [Sternfeld, Matthew J.] UCSD, Biol Sci Grad Program, La Jolla, CA 92037 USA; [Dominguez, Bertha; Lee, Kuo-Fen] Salk Inst Biol Studies, Peptide Biol Lab, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Salk Institute	Pfaff, SL (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	pfaff@salk.edu	Bonanomi, Dario/K-3450-2016	Bonanomi, Dario/0000-0003-4517-1244; Pankratz, Matthew/0000-0002-7397-6755; Amin, Neal/0000-0003-2027-1329	National Cancer Institute [P30 CA014195]; National Institute of Neurological Disorders and Stroke (NINDS) [P30 NS072031]; Leona M. and Harry B. Helmsley Charitable Trust; H.A. and Mary K. Chapman Charitable Foundation; NINDS [F31-NS080340-03]; UCSD Medical Scientist Training Program [T32-GM007198]; NIH [R01GM088278, R21NS084254, R01NS054154, R01NS044420, R01NS060833, R01AG0476669]; Marshall Heritage Foundation; Sol Goldman Trust; Clayton Foundation; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088278, T32GM007198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH099571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054154, R01NS044420, P30NS072031, R21NS084254, R01NS037116, R01NS060833, F31NS080340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG047669] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Leona M. and Harry B. Helmsley Charitable Trust; H.A. and Mary K. Chapman Charitable Foundation; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); UCSD Medical Scientist Training Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marshall Heritage Foundation; Sol Goldman Trust; Clayton Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank K. Lettieri, N. White, and M. Gullo for mouse husbandry; Y. Dayn at the Salk Transgenic Core for oocyte injections; C. O'Connor and C. Fitzpatrick at the Salk Flow Cytometry Core for cell sorting; and M. Ku at the Salk Next Generation Sequencing Core for RNA-seq. Salk Core facilities are supported by the National Cancer Institute (grant P30 CA014195), the National Institute of Neurological Disorders and Stroke (NINDS) (grant P30 NS072031), The Leona M. and Harry B. Helmsley Charitable Trust, and the H.A. and Mary K. Chapman Charitable Foundation. N.D.A. is supported by a NINDS fellowship (F31-NS080340-03) and the UCSD Medical Scientist Training Program (grant T32-GM007198). S.L.P. is a Howard Hughes Medical Institute investigator and the Benjamin H. Lewis chair in neuroscience at the Salk Institute. This research is supported by grants from the NIH (R01GM088278, R21NS084254, R01NS054154, R01NS044420, R01NS060833, and R01AG0476669), The Marshall Heritage Foundation, Sol Goldman Trust, and The Clayton Foundation. The Gene Expression Omnibus accession number is GSE75601. N.D.A., S.L.P., and the Salk Institute have filed the following U.S. provisional patent applications: no. 62/168,755 (30 May 2015) and no. 62/166,677 (26 May 2015). The supplementary materials contain additional data.	Alaynick WA, 2011, CELL, V146, P178, DOI 10.1016/j.cell.2011.06.038; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Cheah BC, 2010, CURR MED CHEM, V17, P1942, DOI 10.2174/092986710791163939; Darabid H, 2014, NAT REV NEUROSCI, V15, P703, DOI 10.1038/nrn3821; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Haramati S, 2010, P NATL ACAD SCI USA, V107, P13111, DOI 10.1073/pnas.1006151107; Herranz H, 2010, GENE DEV, V24, P1339, DOI 10.1101/gad.1937010; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; Kawahara Y, 2012, P NATL ACAD SCI USA, V109, P3347, DOI 10.1073/pnas.1112427109; Kwan AC, 2009, J NEUROSCI, V29, P11601, DOI 10.1523/JNEUROSCI.1612-09.2009; Liu HS, 2015, SCI REP-UK, V5, DOI 10.1038/srep12189; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; Lu YF, 2015, EXP CELL RES, V334, P173, DOI 10.1016/j.yexcr.2015.03.027; Ma L, 2007, J NEUROSCI, V27, P6843, DOI 10.1523/JNEUROSCI.1479-07.2007; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Mazzoni EO, 2013, NAT NEUROSCI, V16, P1219, DOI 10.1038/nn.3467; Molyneaux BJ, 2015, NEURON, V85, P275, DOI 10.1016/j.neuron.2014.12.024; Morlando M, 2012, EMBO J, V31, P4502, DOI 10.1038/emboj.2012.319; Paez-Colasante X, 2015, NAT REV NEUROL, V11, P266, DOI 10.1038/nrneurol.2015.57; Thiebes KP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8718; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Turgeon B, 2009, PHYSIOL REV, V89, P1, DOI 10.1152/physrev.00040.2007; van Dongen S, 2008, NAT METHODS, V5, P1023, DOI 10.1038/nmeth.1267; Vidigal JA, 2015, TRENDS CELL BIOL, V25, P137, DOI 10.1016/j.tcb.2014.11.004; Volonte C, 2015, CNS NEUROL DISORD-DR, V14, P194, DOI 10.2174/1871527314666150116125506; Wainger BJ, 2014, CELL REP, V7, P1, DOI 10.1016/j.celrep.2014.03.019; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025	28	93	101	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2015	350	6267					1525	1529		10.1126/science.aad2509	http://dx.doi.org/10.1126/science.aad2509			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY7LY	26680198	Green Accepted, Green Published			2022-12-28	WOS:000366591100058
J	McCullough, J; Clippinger, AK; Talledge, N; Skowyra, ML; Saunders, MG; Naismith, TV; Colf, LA; Afonine, P; Arthur, C; Sundquist, WI; Hanson, PI; Frost, A				McCullough, John; Clippinger, Amy K.; Talledge, Nathaniel; Skowyra, Michael L.; Saunders, Marissa G.; Naismith, Teresa V.; Colf, Leremy A.; Afonine, Pavel; Arthur, Christopher; Sundquist, Wesley I.; Hanson, Phyllis I.; Frost, Adam			Structure and membrane remodeling activity of ESCRT-III helical polymers	SCIENCE			English	Article							PLASMA-MEMBRANE; FILAMENTS; AUTOINHIBITION; FISSION; CHMP3; REVEALS; PATHWAY; VPS4	The endosomal sorting complexes required for transport (ESCRT) proteins mediate fundamental membrane remodeling events that require stabilizing negative membrane curvature. These include endosomal intralumenal vesicle formation, HIV budding, nuclear envelope closure, and cytokinetic abscission. ESCRT-III subunits perform key roles in these processes by changing conformation and polymerizing into membrane-remodeling filaments. Here, we report the 4 angstrom resolution cryogenic electron microscopy reconstruction of a one-start, double-stranded helical copolymer composed of two different human ESCRT-III subunits, charged multivesicular body protein 1B (CHMP1B) and increased sodium tolerance 1 (IST1). The inner strand comprises "open" CHMP1B subunits that interlock in an elaborate domain-swapped architecture and is encircled by an outer strand of "closed" IST1 subunits. Unlike other ESCRT-III proteins, CHMP1B and IST1 polymers form external coats on positively curved membranes in vitro and in vivo. Our analysis suggests how common ESCRT-III filament architectures could stabilize different degrees and directions of membrane curvature.	[McCullough, John; Talledge, Nathaniel; Saunders, Marissa G.; Colf, Leremy A.; Sundquist, Wesley I.; Frost, Adam] Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA; [Clippinger, Amy K.; Skowyra, Michael L.; Naismith, Teresa V.; Hanson, Phyllis I.] Washington Univ, Dept Cell Biol & Physiol, Sch Med, St Louis, MO 63110 USA; [Talledge, Nathaniel; Frost, Adam] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Afonine, Pavel] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Arthur, Christopher] FEI Co, Hillsboro, OR 97124 USA	Utah System of Higher Education; University of Utah; Washington University (WUSTL); University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Thermo Fisher Scientific; FEI Company	Sundquist, WI (corresponding author), Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA.	wes@biochem.utah.edu; phanson22@wustl.edu; adam.frost@ucsf.edu	Skowyra, Michal Leszek/AAS-4850-2020	Skowyra, Michal Leszek/0000-0002-1365-034X; Talledge, Nathaniel/0000-0002-4603-0120; McCullough, John/0000-0001-6836-4394; Frost, Adam/0000-0003-2231-2577; Clippinger, Amy/0000-0001-8891-4509	National Institutes of Health (NIH) through the National Center for Research Resources (NCRR) P41 program [RR17573]; Searle Scholars Program; Jane Coffin Childs Foundation; Phenix Industrial Consortium; American Cancer Society [PF-11-279-01-CCG]; U.S. Department of Energy [DE-AC02-05CH11231]; NIH [2P50GM082545-06, 1DP2GM110772-01, R01GM112080, R01AI051174, 1P01 GM063210, R01GM076686, R01NS050717]; NSF [DGE-1143954]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076686, DP2GM110772, P01GM063210, R01GM112080, P50GM082545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050717] Funding Source: NIH RePORTER	National Institutes of Health (NIH) through the National Center for Research Resources (NCRR) P41 program; Searle Scholars Program; Jane Coffin Childs Foundation; Phenix Industrial Consortium; American Cancer Society(American Cancer Society); U.S. Department of Energy(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Electron microscopy was performed at the University of California, San Francisco, the University of Utah, and the Oregon Health & Science University (OHSU) Multiscale Microscopy Core with technical support from the FEI Living Lab and the OHSU Center for Spatial Systems Biomedicine (OCSSB). We thank B. Carragher, C. Potter, and the National Resource for Automated Molecular Microscopy-which is supported by the National Institutes of Health (NIH) through the National Center for Research Resources (NCRR) P41 program (RR17573)-where some initial imaging studies were performed. We also thank B. Bammes and Direct Electron, LP (San Diego, CA), W. Chiu, and J. Jakana at the National Center for Macromolecular Imaging at Baylor College of Medicine (Houston, Texas), where other images were collected. Computing support was provided by the Center for High Performance Computing at the University of Utah and the NSF Extreme Science and Engineering Development Environment consortium. We also thank C. Hill, F. Whitby, H. Schubert, B. Barad, and J. Fraser for guidance regarding model refinement and validation; D. Eckert for performing analytical ultracentrifugation experiments; J. Iwasa for artwork; M. LaLonde, C. Rodesch, G. Mercenne, and M. Gudheti for help with supporting experiments; and T. Goddard for Chimera 2 developments. We thank R. Roth for deep-etch EM replicas, J. Heuser for sharing deep-etch EM with us and advice, E. Clipperton for CHMP4A mutants, M. Pretz for IST1-myc constructs, and M. Hartstein for artwork. We thank K. Blumer, M. Babst, and other members of our laboratories and colleagues for helpful discussions. This research was supported by the Searle Scholars Program (A.F.); the Jane Coffin Childs Foundation (M.G.S.); the Phenix Industrial Consortium (P.A.); American Cancer Society grant PF-11-279-01-CCG (L.A.C.); U.S. Department of Energy contract DE-AC02-05CH11231 (P.A.); NIH grants 2P50GM082545-06 (A.F.), 1DP2GM110772-01 (A.F.), R01GM112080 (W.I.S. and A.F.), R01AI051174 (W.I.S.), 1P01 GM063210 (P.A.), R01GM076686 (P.I.H.), and R01NS050717 (P.I.H.); and NSF fellowship DGE-1143954 (A. K. C.). All of the expression constructs used in our study have been or will be deposited in the public DNASU plasmid repository (http://dnasu.org/DNASU/Home.jsp). The density map has been deposited in the Electron Microscopy Data Bank (EMD-6461), and the fitted models were deposited in the PDB (3JC1).	Allison R, 2013, J CELL BIOL, V202, P527, DOI 10.1083/jcb.201211045; Bajorek M, 2009, NAT STRUCT MOL BIOL, V16, P754, DOI 10.1038/nsmb.1621; Bodon G, 2011, J BIOL CHEM, V286, P40276, DOI 10.1074/jbc.M111.283671; Buchkovich NJ, 2013, DEV CELL, V27, P201, DOI 10.1016/j.devcel.2013.09.009; Cashikar AG, 2014, ELIFE, V3, DOI 10.7554/eLife.02184; Dimaano C, 2008, MOL BIOL CELL, V19, P465, DOI 10.1091/mbc.E07-08-0747; Dobro MJ, 2013, MOL BIOL CELL, V24, P2319, DOI 10.1091/mbc.E12-11-0785; Effantin G, 2013, CELL MICROBIOL, V15, P213, DOI 10.1111/cmi.12041; Ghazi-Tabatabai S, 2008, STRUCTURE, V16, P1345, DOI 10.1016/j.str.2008.06.010; Guizetti J, 2011, SCIENCE, V331, P1616, DOI 10.1126/science.1201847; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Hanson PI, 2012, ANNU REV CELL DEV BI, V28, P337, DOI 10.1146/annurev-cellbio-092910-154152; Henne WM, 2012, CELL, V151, P356, DOI 10.1016/j.cell.2012.08.039; Hurley JH, 2015, EMBO J, V34, P2398, DOI 10.15252/embj.201592484; Kozlovsky Y, 2003, BIOPHYS J, V85, P85, DOI 10.1016/S0006-3495(03)74457-9; Lata S, 2008, SCIENCE, V321, P1354, DOI 10.1126/science.1161070; Lata S, 2008, J MOL BIOL, V378, P818, DOI 10.1016/j.jmb.2008.03.030; Lin Y, 2005, J BIOL CHEM, V280, P12799, DOI 10.1074/jbc.M413968200; McCullough J, 2013, ANNU REV BIOCHEM, V82, P663, DOI 10.1146/annurev-biochem-072909-101058; Moriscot C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021921; Morita E, 2012, FEBS J, V279, P1399, DOI 10.1111/j.1742-4658.2012.08534.x; Muziol T, 2006, DEV CELL, V10, P821, DOI 10.1016/j.devcel.2006.03.013; Nickerson Daniel P, 2006, J Cell Biol, V175, P715, DOI 10.1083/jcb.200606113; Nickerson DP, 2010, MOL BIOL CELL, V21, P1023, DOI 10.1091/mbc.E09-09-0776; Rue SM, 2008, MOL BIOL CELL, V19, P475, DOI 10.1091/mbc.E07-07-0694; Shen QT, 2014, J CELL BIOL, V206, P763, DOI 10.1083/jcb.201403108; Shim S, 2007, TRAFFIC, V8, P1068, DOI 10.1111/j.1600-0854.2007.00584.x; Stoorvogel W, 1996, J CELL BIOL, V132, P21, DOI 10.1083/jcb.132.1.21; Xiao JY, 2009, MOL BIOL CELL, V20, P3514, DOI 10.1091/mbc.E09-05-0403; Zamborlini A, 2006, P NATL ACAD SCI USA, V103, P19140, DOI 10.1073/pnas.0603788103	30	141	142	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2015	350	6267					1548	1551		10.1126/science.aad8305	http://dx.doi.org/10.1126/science.aad8305			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY7LY	26634441	Green Accepted			2022-12-28	WOS:000366591100064
J	Battich, N; Stoeger, T; Pelkmans, L				Battich, Nico; Stoeger, Thomas; Pelkmans, Lucas			Control of Transcript Variability in Single Mammalian Cells	CELL			English	Article							STOCHASTIC GENE-EXPRESSION; NUCLEAR-PORE COMPLEX; MESSENGER-RNA EXPORT; NOISE; REVEALS; CONSEQUENCES; ORIGINS; NUMBER; YEAST	A central question in biology is whether variability between genetically identical cells exposed to the same culture conditions is largely stochastic or deterministic. Using image-based transcriptomics in millions of single human cells, we find that while variability of cytoplasmic transcript abundance is large, it is for most genes minimally stochastic and can be predicted with multivariate models of the phenotypic state and population context of single cells. Computational multiplexing of these predictive signatures across hundreds of genes revealed a complex regulatory system that controls the observed variability of transcript abundance between individual cells. Mathematical modeling and experimental validation show that nuclear retention and transport of transcripts between the nucleus and the cytoplasm is central to buffering stochastic transcriptional fluctuations in mammalian gene expression. Our work indicates that cellular compartmentalization confines transcriptional noise to the nucleus, thereby preventing it from interfering with the control of single-cell transcript abundance in the cytoplasm.	[Battich, Nico; Stoeger, Thomas; Pelkmans, Lucas] Univ Zurich, Fac Sci, Inst Mol Life Sci, CH-8006 Zurich, Switzerland; [Battich, Nico; Stoeger, Thomas] ETH, Life Sci Zurich Grad Sch, Syst Biol PhD Program, CH-8057 Zurich, Switzerland; [Battich, Nico; Stoeger, Thomas] Univ Zurich, CH-8057 Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Pelkmans, L (corresponding author), Univ Zurich, Fac Sci, Inst Mol Life Sci, CH-8006 Zurich, Switzerland.	lucas.pelkmans@imls.uzh.ch	Battich, Nico/AAL-3955-2020	Battich, Nico/0000-0002-1700-1590; Stoeger, Thomas/0000-0002-5540-4278; Pelkmans, Lucas/0000-0002-6754-9730	SystemsX.ch; Swiss National Science Foundation; University of Zurich; University of Zurich Research Priority Program in Systems Biology and Functional Genomics	SystemsX.ch; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Zurich; University of Zurich Research Priority Program in Systems Biology and Functional Genomics	We thank Y. Yakimovich for help with computational infrastructure, R. Holtackers for help with experiments, J. Patterson for assistance, J. Chao (Friedrich Miescher Institute) and J. Ellenberg (European Molecular Biology Laboratory) for reagents, and all members of the lab for useful comments on the manuscript. L.P. acknowledges financial support for this project from SystemsX.ch, the Swiss National Science Foundation, the University of Zurich, and the University of Zurich Research Priority Program in Systems Biology and Functional Genomics.	Arias AM, 2006, NAT REV GENET, V7, P34, DOI 10.1038/nrg1750; Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Bastos R, 1996, J CELL BIOL, V134, P1141, DOI 10.1083/jcb.134.5.1141; Battich N, 2013, NAT METHODS, V10, P1127, DOI 10.1038/nmeth.2657; Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; BIRD AP, 1995, TRENDS GENET, V11, P94, DOI 10.1016/S0168-9525(00)89009-5; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Culjkovic-Kraljacic B, 2012, CELL REP, V2, P207, DOI 10.1016/j.celrep.2012.07.007; das Neves RP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000560; Deng QL, 2014, SCIENCE, V343, P193, DOI 10.1126/science.1245316; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Frechin M, 2015, NATURE, V523, P88, DOI 10.1038/nature14429; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Graf T, 2008, CELL STEM CELL, V3, P480, DOI 10.1016/j.stem.2008.10.007; Grun D, 2014, NAT METHODS, V11, P637, DOI [10.1038/NMETH.2930, 10.1038/nmeth.2930]; Gut G, 2015, NAT METHODS, V12, P951, DOI [10.1038/NMETH.3545, 10.1038/nmeth.3545]; Halpern KB, 2015, CELL REP, V13, P2653, DOI 10.1016/j.celrep.2015.11.036; Halstead JM, 2015, SCIENCE, V347, P1367, DOI 10.1126/science.aaa3380; Kempe H, 2015, MOL BIOL CELL, V26, P797, DOI 10.1091/mbc.E14-08-1296; Kresnowati MTAP, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100083; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; MacArthur BD, 2009, NAT REV MOL CELL BIO, V10, P672, DOI 10.1038/nrm2766; Martin W, 2006, NATURE, V440, P41, DOI 10.1038/nature04531; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Neuert G, 2013, SCIENCE, V339, P584, DOI 10.1126/science.1231456; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Padovan-Merhar O, 2015, MOL CELL, V58, P339, DOI 10.1016/j.molcel.2015.03.005; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Sanchez A, 2013, SCIENCE, V342, P1188, DOI 10.1126/science.1242975; Schmiedel JM, 2015, SCIENCE, V348, P128, DOI 10.1126/science.aaa1738; Schneider M, 2015, CELL, V162, P1016, DOI 10.1016/j.cell.2015.07.059; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Singh A, 2012, BIOPHYS J, V103, P1087, DOI 10.1016/j.bpj.2012.07.015; Snijder B, 2011, NAT REV MOL CELL BIO, V12, P119, DOI 10.1038/nrm3044; Stoeger T, 2015, METHODS, V85, P44, DOI 10.1016/j.ymeth.2015.05.016; Suter DM, 2011, SCIENCE, V332, P472, DOI 10.1126/science.1198817; Taddei A, 2006, NATURE, V441, P774, DOI 10.1038/nature04845; Weidenfeld I, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp108; Xiong LP, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/1/016005; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514	48	197	201	3	72	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2015	163	7					1596	1610		10.1016/j.cell.2015.11.018	http://dx.doi.org/10.1016/j.cell.2015.11.018			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CZ1GN	26687353	Bronze			2022-12-28	WOS:000366854200009
J	Brody, H				Brody, Herb			Prostate cancer	NATURE			English	Editorial Material																			0	11	12	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2015	528	7582					S117	S117		10.1038/528S117a	http://dx.doi.org/10.1038/528S117a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY8SM	26672779	Bronze			2022-12-28	WOS:000366678600061
J	Mobius, W; Laan, L				Moebius, Wolfram; Laan, Liedewij			Physical and Mathematical Modeling in Experimental Papers	CELL			English	Article							TRANSPORT; EXPLAIN	An increasing number of publications include modeling. Often, such studies help us to gain a deeper insight into the phenomena studied and break down barriers between experimental and theoretical communities. However, combining experimental and theoretical work is challenging for authors, reviewers, and readers. To help maximize the usefulness and impact of combined theoretical and experimental research, this Primer describes the purpose, usefulness, and different types of models and addresses the practical aspect of integrated publications by outlining characteristics of good modeling, presentation, and fruitful collaborations.	[Moebius, Wolfram] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Moebius, Wolfram] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Laan, Liedewij] Delft Univ Technol, Fac Sci Appl, Kavli Inst Nanosci, Dept Bionanosci, NL-2628 CJ Delft, Netherlands	Harvard University; Harvard University; Delft University of Technology	Mobius, W (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	wolfram.moebius@gmail.com; l.laan@tudelft.nl		Moebius, Wolfram/0000-0003-0926-4590; Laan, Liedewij/0000-0002-7138-9004	Human Frontiers Science Program [LT-000739-2010C, RGP0041/2014]	Human Frontiers Science Program(Human Frontier Science Program)	We thank Michael P. Brenner, Jennifer Lippincott-Schwartz, Wallace Marshall, Andrew W. Murray, David R. Nelson, and Rob Phillips for taking the time to be interviewed on the role of models in biological research and for feedback on the manuscript. We are grateful to Jane Kondev and Melanie J. I. Muller for discussions on this topic; Timon Idema, Oskar Hallatschek, Benedikt Obermayer, and Nichole Wespe for critical reading of the manuscript; and Bodo M. Stern for his suggestions on how to communicate our ideas. The authors gratefully acknowledge support from the Human Frontiers Science Program through grant LT-000739-2010C awarded to L.L. and through grant RGP0041/2014.	BERG HC, 1977, BIOPHYS J, V20, P193, DOI 10.1016/S0006-3495(77)85544-6; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; De Boer RJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002593; Fawcett TW, 2012, P NATL ACAD SCI USA, V109, P11735, DOI 10.1073/pnas.1205259109; Foethke D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.76; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Halatek J, 2012, CELL REP, V1, P741, DOI 10.1016/j.celrep.2012.04.005; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; HILLIS WD, 1993, CURR BIOL, V3, P79; Janson ME, 2007, CELL, V128, P357, DOI 10.1016/j.cell.2006.12.030; Laan L, 2012, CELL, V148, P502, DOI 10.1016/j.cell.2012.01.007; Luria SE, 1943, GENETICS, V28, P491; May RM, 2004, SCIENCE, V303, P790, DOI 10.1126/science.1094442; Mayer J, 2010, AM J PHYS, V78, P648, DOI 10.1119/1.3254017; Mobius W, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004615; Muller MJI, 2008, P NATL ACAD SCI USA, V105, P4609, DOI 10.1073/pnas.0706825105; Sciaky N, 1997, J CELL BIOL, V139, P1137, DOI 10.1083/jcb.139.5.1137; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Servedio MR, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002017; Shou WY, 2015, ELIFE, V4, DOI 10.7554/eLife.07158; Tischer C, 2010, BIOPHYS J, V99, P726, DOI 10.1016/j.bpj.2010.05.026	22	17	18	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2015	163	7					1577	1583		10.1016/j.cell.2015.12.006	http://dx.doi.org/10.1016/j.cell.2015.12.006			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CZ1GN	26687351	Bronze			2022-12-28	WOS:000366854200007
J	Tan, JY				Tan, Jiaying			Immunotherapy Meets Microbiota	CELL			English	Editorial Material																		Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329	2	1	6	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2015	163	7					1561	1561		10.1016/j.cell.2015.12.009	http://dx.doi.org/10.1016/j.cell.2015.12.009			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CZ1GN	26687344	Bronze			2022-12-28	WOS:000366854200028
J	Tilman, D; Isbell, F				Tilman, David; Isbell, Forest			BIODIVERSITY Recovery as nitrogen declines	NATURE			English	Editorial Material							RESTORATION; GRASSLAND; EUTROPHICATION; DIVERSITY; CESSATION		[Tilman, David; Isbell, Forest] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Tilman, David] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA	University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Santa Barbara	Tilman, D (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	tilman@umn.edu; isbell@umn.edu	Isbell, Forest/C-6915-2012; Tilman, David/ABD-5309-2021	Isbell, Forest/0000-0001-9689-769X; 				Aerts R, 1995, J APPL ECOL, V32, P827, DOI 10.2307/2404822; Bakker J.P., 1989, NATURE MANAGEMENT GR; Bakker JP, 1999, TRENDS ECOL EVOL, V14, P63, DOI 10.1016/S0169-5347(98)01544-4; Carpenter SR, 1999, ECOL APPL, V9, P751, DOI 10.1890/1051-0761(1999)009[0751:MOEFLS]2.0.CO;2; Clark CM, 2010, ECOLOGY, V91, P3620, DOI 10.1890/09-1268.1; Dalrymple GH, 2003, WETLANDS, V23, P1015, DOI 10.1672/0277-5212(2003)023[1015:PCACAP]2.0.CO;2; Dorland E, 2004, PLANT SOIL, V265, P267, DOI 10.1007/s11104-005-0363-3; Fornara DA, 2012, ECOLOGY, V93, P2030, DOI 10.1890/12-0292.1; Harpole WS, 2007, NATURE, V446, P791, DOI 10.1038/nature05684; Isbell F, 2013, ECOL LETT, V16, P454, DOI 10.1111/ele.12066; Jansen AJM, 1996, VEGETATIO, V126, P73; Li Y, 2001, SOIL SCI, V166, P400, DOI 10.1097/00010694-200106000-00005; Niemeyer M, 2007, BIOL CONSERV, V134, P344, DOI 10.1016/j.biocon.2006.07.013; Smil V, 2000, ANNU REV ENERG ENV, V25, P21, DOI 10.1146/annurev.energy.25.1.21; Smith CS, 2011, CRIT REV ENV SCI TEC, V41, P723, DOI 10.1080/10643389.2010.530913; Smith VH, 1999, ENVIRON POLLUT, V100, P179, DOI 10.1016/S0269-7491(99)00091-3; Storkey J, 2015, NATURE, V528, P401, DOI 10.1038/nature16444; Tilman D, 2011, AM NAT, V178, P355, DOI 10.1086/661245; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494	20	26	32	12	233	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2015	528	7582					336	337		10.1038/nature16320	http://dx.doi.org/10.1038/nature16320			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY8SM	26633634				2022-12-28	WOS:000366678600036
J	Sam, S; Ehrmann, DA				Sam, Susan; Ehrmann, David A.			Hormonal Evaluation of Hyperandrogenism in Women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							POLYCYSTIC-OVARY-SYNDROME; ANDROGEN EXCESS; POSITION STATEMENT		[Sam, Susan] Univ Chicago, Dept Med, Sect Adult & Pediat Endocrinol Diabet & Metab, MC1027,5841 S Maryland Ave, Chicago, IL 60637 USA; Univ Chicago, Dept Pediat, Sect Adult & Pediat Endocrinol Diabet & Metab, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Ehrmann, DA (corresponding author), Univ Chicago, Dept Med, Sect Adult & Pediat Endocrinol Diabet & Metab, MC1027,5841 S Maryland Ave, Chicago, IL 60637 USA.	dehrmann@medicine.bsd.uchicago.edu						Azziz R, 2006, J CLIN ENDOCR METAB, V91, P4237, DOI 10.1210/jc.2006-0178; Dewailly D, 2014, HUM REPROD UPDATE, V20, P334, DOI 10.1093/humupd/dmt061; Dunaif A, 2013, J CLIN ENDOCR METAB, V98, P4325, DOI 10.1210/jc.2013-2040; Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Legro RS, 2013, J CLIN ENDOCR METAB, V98, P4565, DOI 10.1210/jc.2013-2350; Rosner W, 2007, J CLIN ENDOCR METAB, V92, P405, DOI 10.1210/jc.2006-1864; Salley KES, 2007, J CLIN ENDOCR METAB, V92, P4546, DOI 10.1210/jc.2007-1549; Sam S, 2003, TRENDS ENDOCRIN MET, V14, P365, DOI 10.1016/j.tem.2003.08.002	9	4	5	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 15	2015	314	23					2557	2558		10.1001/jama.2015.11612	http://dx.doi.org/10.1001/jama.2015.11612			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY4PV	26670974				2022-12-28	WOS:000366391500023
J	Lake, BM; Salakhutdinov, R; Tenenbaum, JB				Lake, Brenden M.; Salakhutdinov, Ruslan; Tenenbaum, Joshua B.			Human-level concept learning through probabilistic program induction	SCIENCE			English	Article							NEURAL-NETWORKS; MODEL; EXEMPLAR; LANGUAGE	People learning new concepts can often generalize successfully from just a single example, yet machine learning algorithms typically require tens or hundreds of examples to perform with similar accuracy. People can also use learned concepts in richer ways than conventional algorithms-for action, imagination, and explanation. We present a computational model that captures these human learning abilities for a large class of simple visual concepts: handwritten characters from the world's alphabets. The model represents concepts as simple programs that best explain observed examples under a Bayesian criterion. On a challenging one-shot classification task, the model achieves human-level performance while outperforming recent deep learning approaches. We also present several "visual Turing tests" probing the model's creative generalization abilities, which in many cases are indistinguishable from human behavior.	[Lake, Brenden M.] NYU, Ctr Data Sci, New York, NY 10003 USA; [Salakhutdinov, Ruslan] Univ Toronto, Dept Comp Sci, Toronto, ON M5S 3G4, Canada; [Salakhutdinov, Ruslan] Univ Toronto, Dept Stat, Toronto, ON M5S 3G4, Canada; [Tenenbaum, Joshua B.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	New York University; University of Toronto; University of Toronto; Massachusetts Institute of Technology (MIT)	Lake, BM (corresponding author), NYU, Ctr Data Sci, 726 Broadway, New York, NY 10003 USA.	brenden@nyu.edu			NSF Graduate Research Fellowship; Center for Brains, Minds, and Machines - NSF Science and Technology Center [CCF-1231216]; Army Research Office [W911NF-08-1-0242, W911NF-13-1-2012, N000141310333]; Natural Sciences and Engineering Research Council of Canada; Canadian Institute for Advanced Research; Moore-Sloan Data Science Environment at NYU; Office of Naval Research [W911NF-08-1-0242, W911NF-13-1-2012, N000141310333]	NSF Graduate Research Fellowship(National Science Foundation (NSF)); Center for Brains, Minds, and Machines - NSF Science and Technology Center; Army Research Office; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); Moore-Sloan Data Science Environment at NYU; Office of Naval Research(Office of Naval Research)	This work was supported by a NSF Graduate Research Fellowship to B.M.L.; the Center for Brains, Minds, and Machines funded by NSF Science and Technology Center award CCF-1231216; Army Research Office and Office of Naval Research contracts W911NF-08-1-0242, W911NF-13-1-2012, and N000141310333; the Natural Sciences and Engineering Research Council of Canada; the Canadian Institute for Advanced Research; and the Moore-Sloan Data Science Environment at NYU. We thank J. McClelland, T. Poggio and L. Schulz for many valuable contributions and N. Kanwisher for helping us elucidate the three key principles. We are grateful to J. Gross and the Omniglot. com encyclopedia of writing systems for helping to make this data set possible. Online archives are available for visual Turing tests (http://github.com/brendenlake/visual-turing-tests), Omniglot data set (http://github.com/brendenlake/omniglot), and BPL source code (http://github.com/brendenlake/BPL).	BABCOCK MK, 1988, AM J PSYCHOL, V101, P111, DOI 10.2307/1422797; BARSALOU LW, 1983, MEM COGNITION, V11, P211, DOI 10.3758/BF03196968; Bever TG, 2010, BIOLINGUISTICS, V4, P174; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; Braun DA, 2010, BEHAV BRAIN RES, V206, P157, DOI 10.1016/j.bbr.2009.08.031; Chung J, 2015, ADV NEUR IN, V28; Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177; Dechter Eyal, 2013, 23 INT JOINT C ART I; Dehaene S, 2009, READING BRAIN; DUBUISSON MP, 1994, INT C PATT RECOG, P566, DOI 10.1109/ICPR.1994.576361; Eliasmith C, 2012, SCIENCE, V338, P1202, DOI 10.1126/science.1225266; Feldman J, 1997, J MATH PSYCHOL, V41, P145, DOI 10.1006/jmps.1997.1154; Ferry AL, 2010, CHILD DEV, V81, P472, DOI 10.1111/j.1467-8624.2009.01408.x; GEMAN S, 1992, NEURAL COMPUT, V4, P1, DOI 10.1162/neco.1992.4.1.1; Ghahramani Z, 2015, NATURE, V521, P452, DOI 10.1038/nature14541; Goldstone RL, 2003, PERCEPTUAL ORGANIZATION IN VISION: BEHAVIORAL AND NEURAL PERSPECTIVES, P233; Goodman ND, 2011, PSYCHOL REV, V118, P110, DOI 10.1037/a0021336; HARLOW HF, 1949, PSYCHOL REV, V56, P51, DOI 10.1037/h0062474; Hinton G, 2012, IEEE SIGNAL PROC MAG, V29, P82, DOI 10.1109/MSP.2012.2205597; James KH, 2006, NEUROPSYCHOLOGIA, V44, P2937, DOI 10.1016/j.neuropsychologia.2006.06.026; James KH, 2009, J EXP PSYCHOL GEN, V138, P416, DOI 10.1037/a0015836; Jern A, 2013, COGNITIVE PSYCHOL, V66, P85, DOI 10.1016/j.cogpsych.2012.09.003; Kemp C, 2007, DEVELOPMENTAL SCI, V10, P307, DOI 10.1111/j.1467-7687.2007.00585.x; Koch G., 2015, P DEEP LEARN WORKSH, V37; Krizhevsky A., P 25 INT C NEUR INF, P1097; Lake B., 2014, P ANN M COGNITIVE SC, P803; LANDAU B, 1988, COGNITIVE DEV, V3, P299, DOI 10.1016/0885-2014(88)90014-7; LeCun Y, 1989, NEURAL COMPUT, V1, P541, DOI 10.1162/neco.1989.1.4.541; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Liang P., 2010, P 27 INT C MACHINE L, P639; Liu K, 1999, IEEE T PATTERN ANAL, V21, P1095, DOI 10.1109/34.799914; Longcamp M, 2003, NEUROIMAGE, V19, P1492, DOI 10.1016/S1053-8119(03)00088-0; Markman AB, 1998, J EXP PSYCHOL GEN, V127, P331, DOI 10.1037/0096-3445.127.4.331; Markman E. M., 1989, CATEGORIZATION NAMIN; McAllester D. A., 1998, Proceedings of the Eleventh Annual Conference on Computational Learning Theory, P230, DOI 10.1145/279943.279989; Miller GA., 1976, LANGUAGE PERCEPTION; Mnih V, 2015, NATURE, V518, P529, DOI 10.1038/nature14236; Nair V, 2006, ADV NEURAL INFORM PR, P515; Neisser U., 1966, COGNITIVE PSYCHOL; OSHERSON DN, 1981, COGNITION, V9, P35, DOI 10.1016/0010-0277(81)90013-5; Piantadosi ST, 2012, COGNITION, V123, P199, DOI 10.1016/j.cognition.2011.11.005; Revow M, 1996, IEEE T PATTERN ANAL, V18, P592, DOI 10.1109/34.506410; Rule J., 2015, COGSCI, P2051; Salakhutdinov R, 2012, JMLR WORKSHOP C P, P195; Salakhutdinov R, 2013, IEEE T PATTERN ANAL, V35, P1958, DOI 10.1109/TPAMI.2012.269; Smith LB, 2002, PSYCHOL SCI, V13, P13, DOI 10.1111/1467-9280.00403; Treiman R., 2014, CHILDREN LEARN WRITE; Ullman T. D., 2014, P 36 ANN C COGN SCI, P1640; VALIANT LG, 1984, COMMUN ACM, V27, P1134, DOI 10.1145/1968.1972; Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640; WARD TB, 1994, COGNITIVE PSYCHOL, V27, P1, DOI 10.1006/cogp.1994.1010; Williams JJ, 2010, COGNITIVE SCI, V34, P776, DOI 10.1111/j.1551-6709.2010.01113.x; Winston P. H., 1975, PSYCHOL COMPUTER VIS; Xu F, 2007, PSYCHOL REV, V114, P245, DOI 10.1037/0033-295X.114.2.245	60	1051	1122	23	420	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2015	350	6266					1332	1338		10.1126/science.aab3050	http://dx.doi.org/10.1126/science.aab3050			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY1JL	26659050				2022-12-28	WOS:000366162400032
J	Burman, KD; Wartofsky, L				Burman, Kenneth D.; Wartofsky, Leonard			Thyroid Nodules	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ROUTINE MEASUREMENT; SERUM CALCITONIN; BETHESDA SYSTEM; MANAGEMENT; CANCER; NEEDLE; BENIGN; MUTATIONS; DIAGNOSIS; ULTRASOUND	A 40-year-old woman presents with a thyroid nodule, 2.0 cm by 2.0 cm on palpation. The nodule, located on the right side of the gland, was found on routine physical examination. She has no history of childhood radiation exposure or family history of thyroid abnormalities. She reports no symptoms of nervousness, weight loss, palpitation, fatigue, or neck discomfort. Ultrasonography confirms a thyroid nodule, 2.0 cm by 2.0 cm by 2.5 cm (volume, 5.23 cm(3)), on the right side of the gland that does not have ultrasonographic characteristics associated with an increased risk of cancer; there is no cervical adenopathy. How should her case be managed?	[Burman, Kenneth D.] MedStar Washington Hosp Ctr, Endocrine Sect, Washington, DC 20010 USA; Georgetown Univ, Sch Med, Dept Med, Washington, DC USA	MedStar Washington Hospital Center; Georgetown University	Burman, KD (corresponding author), MedStar Washington Hosp Ctr, Endocrine Sect, Rm 2A72,110 Irving St,NW, Washington, DC 20010 USA.	kenneth.d.burman@medstar.net						Alexander EK, 2012, NEW ENGL J MED, V367, P705, DOI 10.1056/NEJMoa1203208; Baloch ZW, 2008, CYTOJOURNAL, V5, DOI 10.1186/1742-6413-5-6; BELFIORE A, 1992, AM J MED, V93, P363, DOI 10.1016/0002-9343(92)90164-7; Bongiovanni M, 2012, ACTA CYTOL, V56, P333, DOI 10.1159/000339959; Cappola AR, 2013, JAMA-J AM MED ASSOC, V309, P1529, DOI 10.1001/jama.2013.3620; Cho JS, 2011, J KOREAN SURG SOC, V81, P380, DOI 10.4174/jkss.2011.81.6.380; Cibas ES, 2009, AM J CLIN PATHOL, V132, P658, DOI 10.1309/AJCPPHLWMI3JV4LA; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Durante C, 2015, JAMA-J AM MED ASSOC, V313, P926, DOI 10.1001/jama.2015.0956; Elisei R, 2004, J CLIN ENDOCR METAB, V89, P163, DOI 10.1210/jc.2003-030550; Eszlinger M, 2014, THYROID, V24, P305, DOI 10.1089/thy.2013.0278; EZZAT S, 1994, ARCH INTERN MED, V154, P1838; Frates MC, 2005, RADIOLOGY, V237, P794, DOI 10.1148/radiol.2373050220; Gara SK, 2015, NEW ENGL J MED, V373, P448, DOI 10.1056/NEJMoa1502449; Gharib H, 2008, EUR J ENDOCRINOL, V159, P493, DOI 10.1530/EJE-08-0135; Gharib H, 2010, J ENDOCRINOL INVEST, V33, P51; Giles WH, 2015, ANN SURG ONCOL, V22, P152, DOI 10.1245/s10434-014-3952-7; Giordano TJ, 2014, HUM PATHOL, V45, P1339, DOI 10.1016/j.humpath.2014.03.010; Haugen BR, 2015, THYROID; Hegedus L, 2004, NEW ENGL J MED, V351, P1764, DOI 10.1056/NEJMcp031436; Hodak SP, 2004, J CLIN ENDOCR METAB, V89, P511, DOI 10.1210/jc.2003-031983; Ito Y, 2012, NAT REV ENDOCRINOL, V8, P9, DOI 10.1038/nrendo.2011.140-c1; Ito Y, 2010, WORLD J SURG, V34, P2333, DOI 10.1007/s00268-010-0712-0; Kamran SC, 2013, J CLIN ENDOCR METAB, V98, P564, DOI 10.1210/jc.2012-2968; Kocjan G, 2011, AM J CLIN PATHOL, V135, P852, DOI 10.1309/AJCPZ33MVMGZKEWU; Kwak JY, 2010, RADIOLOGY, V254, P292, DOI 10.1148/radiol.2541090460; Liu S, 2014, EXP MOL PATHOL, V97, P292, DOI 10.1016/j.yexmp.2014.08.005; Lupoli G, 1999, LANCET, V353, P637, DOI 10.1016/S0140-6736(98)08004-0; Maia FFR, 2012, CLINICS, V67, P945, DOI 10.6061/clinics/2012(08)15; Mandel Susan J, 2004, Endocr Pract, V10, P246; MAZZAFERRI EL, 1992, AM J MED, V93, P359, DOI 10.1016/0002-9343(92)90163-6; MAZZAFERRI EL, 1993, NEW ENGL J MED, V328, P553; Mester JL, 2011, EUR J HUM GENET, V19, P763, DOI 10.1038/ejhg.2011.20; Nagataki S, 2014, CURR OPIN ENDOCRINOL, V21, P384, DOI 10.1097/MED.0000000000000098; Nagy R, 2015, HORM CANCER-US, V6, P13, DOI 10.1007/s12672-014-0205-y; Nikiforov YE, 2011, J CLIN ENDOCR METAB, V96, P3390, DOI 10.1210/jc.2011-1469; Nikiforova MN, 2013, J CLIN ENDOCR METAB, V98, pE1852, DOI 10.1210/jc.2013-2292; Nou E, 2014, J CLIN ENDOCR METAB, V99, P510, DOI 10.1210/jc.2013-3160; Oertel YC, 2007, THYROID, V17, P1061, DOI 10.1089/thy.2007.0159; Pacini F, 1997, J CLIN ENDOCR METAB, V82, P3563, DOI 10.1210/jc.82.11.3563; Ritter K, 2015, J SURG RES, V197, P348, DOI 10.1016/j.jss.2015.04.059; Rowland KJ, 2015, J SURG ONCOL, V111, P51, DOI 10.1002/jso.23769; Sinnott B, 2010, ENDOCR REV, V31, P756, DOI 10.1210/er.2010-0003; Sosa JA, 1998, ANN SURG, V228, P320, DOI 10.1097/00000658-199809000-00005; Tae HJ, 2007, THYROID, V17, P461, DOI 10.1089/thy.2006.0337; Tan GH, 1997, ANN INTERN MED, V126, P226, DOI 10.7326/0003-4819-126-3-199702010-00009; TUNBRIDGE WMG, 1977, CLIN ENDOCRINOL, V7, P481, DOI 10.1111/j.1365-2265.1977.tb01340.x; VANDER JB, 1968, ANN INTERN MED, V69, P537, DOI 10.7326/0003-4819-69-3-537; Wharry LI, 2014, WORLD J SURG, V38, P614, DOI 10.1007/s00268-013-2261-9; Yassa L, 2007, CANCER CYTOPATHOL, V111, P508, DOI 10.1002/cncr.23116	50	133	140	3	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 10	2015	373	24					2347	2356		10.1056/NEJMcp1415786	http://dx.doi.org/10.1056/NEJMcp1415786			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY0QW	26650154				2022-12-28	WOS:000366111600009
J	Coutinho, AJ; Cochrane, A; Stelter, K; Phillips, RL; Peterson, LE				Coutinho, Anastasia J.; Cochrane, Anneli; Stelter, Keith; Phillips, Robert L., Jr.; Peterson, Lars E.			Comparison of Intended Scope of Practice for Family Medicine Residents With Reported Scope of Practice Among Practicing Family Physicians	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRIMARY-CARE; HEALTH; COMPREHENSIVENESS	IMPORTANCE Narrowing of the scope of practice of US family physicians has been well documented. Proposed reasons include changing practice patterns as physicians age, employer restrictions, or generational choices. Determining components of care that remain integral to the practice of family medicine may be informed by assessing gaps between the intended scope of practice of residents and actual scope of practice of family physicians. OBJECTIVE To compare intended scope of practice for American Board of Family Medicine (ABFM) initial certifiers at residency completion with self-reported actual scope of practice of recertifying family physicians. DESIGN AND PARTICIPANTS Cross-sectional data were collected from a practice demographic questionnaire completed by all individuals applying to take the ABFM Maintenance of Certification for Family Physicians examination. Initial certifiers reported intentions and recertifiers reported actual provision of specific clinical activities. All physicians who registered for the 2014 ABFM Maintenance of Certification for Family Physicians examination were included: 3038 initial certifiers and 10 846 recertifiers. EXPOSURES Initially certifying physicians vs recertifying physicians. MAIN OUTCOMES AND MEASURES The Scope of Practice for Primary Care score (scope score), a psychometric scale, was calculated for each physician and ranged from 0 to 30, with higher numbers equating to broader scope of practice. Recertifiers were categorized by decades in practice. RESULTS The final sample included 13 884 family physicians and, because the questionnaire was a required component of the examination application, there was a 100% response rate. Mean scope score was significantly higher for initial certifier intended practice compared with recertifying physicians' reported actual practices (17.7 vs 15.5; difference, 2.2 [95% CI, 2.1-2.3]; P < .001). Compared with recertifiers, initial certifiers were more likely to report intending to provide all clinical services asked except pain management; this included obstetric care (23.7% vs 7.7%; difference, 16.0% [95% CI, 14.4%-17.6%]; P < .001), inpatient care (54.9% vs 33.5%; difference, 21.4%[95% CI, 19.4%-23.4%]; P < .001), and prenatal care (50.2% vs 9.9%; difference, 40.3 [95% CI, 38.5%-42.2%]; P < .001). Similar differences from initial certifiers were present when comparisons were limited to recertifiers in practice for only 1 to 10 years. CONCLUSIONS AND RELEVANCE In this study of family physicians taking ABFM examinations, graduating family medicine residents reported an intention to provide a broader scope of practice than that reported by current practitioners. This pattern suggests that these differences are not generational, but whether they are due to limited practice support, employer constraints, or other causes remains to be determined.	[Coutinho, Anastasia J.] Univ Vermont, Coll Med, Burlington, VT 05405 USA; [Cochrane, Anneli; Phillips, Robert L., Jr.; Peterson, Lars E.] Amer Board Family Med, Lexington, KY 40511 USA; [Stelter, Keith] Univ Minnesota, Dept Family Med & Community Hlth, Minneapolis, MN USA	University of Vermont; University of Minnesota System; University of Minnesota Twin Cities	Peterson, LE (corresponding author), Amer Board Family Med, 1648 McGrathiana Pkwy,Fifth Floor, Lexington, KY 40511 USA.	lpeterson@theabfm.org			ABFM Foundation	ABFM Foundation	Dr Coutinho's work at the ABFM was sponsored by the ABFM Foundation.	American College of Graduate Medical Education, 2014, ACGME PROGR REQ GRAD; Bazemore A, 2015, ANN FAM MED, V13, P206, DOI 10.1370/afm.1787; Bazemore AW, 2012, J AM BOARD FAM MED, V25, P139, DOI 10.3122/jabfm.2012.02.110203; Berwick DM, 2008, HEALTH AFFAIR, V27, P759, DOI 10.1377/hlthaff.27.3.759; Carek PJ, 2012, FAM MED, V44, P539; Chan BTB, 2002, CAN MED ASSOC J, V166, P429; Chen FM, 2006, FAM MED, V38, P423; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Gibson MV, 2007, FAM MED, V39, P178; Greenberg D M, 1994, J Am Board Fam Pract, V7, P25; Grumbach K, 2015, ANN FAM MED, V13, P204, DOI 10.1370/afm.1788; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Kim S, 2003, ACAD MED, V78, P918, DOI 10.1097/00001888-200309000-00017; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; O'Neill Thomas, 2014, J Appl Meas, V15, P227; Peterson LE, 2015, ACAD MED, V90, P1691, DOI 10.1097/ACM.0000000000000774; Peterson LE, 2014, ACAD MED, V89, P840, DOI 10.1097/ACM.0000000000000250; Petterson S, 2011, J AM BOARD FAM MED, V24, P637, DOI 10.3122/jabfm.2011.06.110172; Rasch G., 1960, PROBABILISTIC MODELS; Ringdahl E, 2006, J AM BOARD FAM MED, V19, P404, DOI 10.3122/jabfm.19.4.404; Romero D, 2015, FAM MED, V47, P22; Sinsky CA, 2013, ANN FAM MED, V11, P272, DOI 10.1370/afm.1531; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Tong STC, 2012, J AM BOARD FAM MED, V25, P270, DOI 10.3122/jabfm.2012.03.110256; Wong E, 2010, CAN FAM PHYSICIAN, V56, pE219; Xierali IM, 2013, ANN FAM MED, V11, P14, DOI 10.1370/afm.1461; Xierali IM, 2012, J AM BOARD FAM MED, V25, P406, DOI 10.3122/jabfm.2012.04.110290	27	68	70	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 8	2015	314	22					2364	2372		10.1001/jama.2015.13734	http://dx.doi.org/10.1001/jama.2015.13734			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX8XT	26647258				2022-12-28	WOS:000365989100011
J	McCarthy, CP; McEvoy, J				McCarthy, Cian P.; McEvoy, Johnw.			Pimping in Medical Education Lacking Evidence and Under Threat	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ART		[McCarthy, Cian P.] Natl Univ Ireland Univ Coll Cork, Dept Med, Cork, Ireland; [McEvoy, Johnw.] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21287 USA	University College Cork; Johns Hopkins University	McEvoy, J (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, 600 N Wolfe St,Blalock 524C, Baltimore, MD 21287 USA.	jmcevoy1@jhmi.edu		McEvoy, John/0000-0001-6530-5479				Association of American Medical Colleges, ALL SCH REP; BRANCATI FL, 1989, JAMA-J AM MED ASSOC, V262, P89, DOI 10.1001/jama.262.1.89; Detsky AS, 2009, JAMA-J AM MED ASSOC, V301, P1379, DOI 10.1001/jama.2009.247; Fnais N, 2014, ACAD MED, V89, P817, DOI 10.1097/ACM.0000000000000200; Kost A, 2015, ACAD MED, V90, P20, DOI 10.1097/ACM.0000000000000446; Mavis B, 2014, ACAD MED, V89, P705, DOI 10.1097/ACM.0000000000000199; Scott KM, 2015, MED J AUSTRALIA, V203, P1; Wear D, 2005, TEACH LEARN MED, V17, P184, DOI 10.1207/s15328015tlm1702_14; Zou L, 2011, ACAD RADIOL, V18, P253, DOI 10.1016/j.acra.2010.09.005	9	30	30	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 8	2015	314	22					2347	2348		10.1001/jama.2015.13570	http://dx.doi.org/10.1001/jama.2015.13570			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX8XT	26647250				2022-12-28	WOS:000365989100003
J	James, ND; Sydes, MR; Clarke, NW; Mason, MD; Dearnaley, DP; Spears, MR; Ritchie, AWS; Parker, CC; Russell, JM; Attard, G; de Bono, J; Cross, W; Jones, RJ; Thalmann, G; Amos, C; Matheson, D; Millman, R; Alzouebi, M; Beesley, S; Birtle, AJ; Brock, S; Cathomas, R; Chakraborti, P; Chowdhury, S; Cook, A; Elliott, T; Gale, J; Gibbs, S; Graham, JD; Hetherington, J; Hughes, R; Laing, R; McKinna, F; McLaren, DB; O'Sullivan, JM; Parikh, O; Peedell, C; Protheroe, A; Robinson, AJ; Srihari, N; Srinivasan, R; Staffurth, J; Sundar, S; Tolan, S; Tsang, D; Wagstaff, J; Parmar, MKB				James, Nicholas D.; Sydes, Matthew R.; Clarke, Noel W.; Mason, Malcolm D.; Dearnaley, David P.; Spears, Melissa R.; Ritchie, Alastair W. S.; Parker, Christopher C.; Russell, J. Martin; Attard, Gerhardt; de Bono, Johann; Cross, William; Jones, Rob J.; Thalmann, George; Amos, Claire; Matheson, David; Millman, Robin; Alzouebi, Mymoona; Beesley, Sharon; Birtle, Alison J.; Brock, Susannah; Cathomas, Richard; Chakraborti, Prabir; Chowdhury, Simon; Cook, Audrey; Elliott, Tony; Gale, Joanna; Gibbs, Stephanie; Graham, John D.; Hetherington, John; Hughes, Robert; Laing, Robert; McKinna, Fiona; McLaren, Duncan B.; O'Sullivan, Joe M.; Parikh, Omi; Peedell, Clive; Protheroe, Andrew; Robinson, Angus J.; Srihari, Narayanan; Srinivasan, Rajaguru; Staffurth, John; Sundar, Santhanam; Tolan, Shaun; Tsang, David; Wagstaff, John; Parmar, Mahesh K. B.		STAMPEDE Investigators	Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial	LANCET			English	Article							ANDROGEN-DEPRIVATION THERAPY; OPEN-LABEL; CLINICAL-TRIALS; CHEMOTHERAPY; MITOXANTRONE; PREDNISONE; ENZALUTAMIDE; ESTRAMUSTINE; CABAZITAXEL; DESIGN	Background Long-term hormone therapy has been the standard of care for advanced prostate cancer since the 1940s. STAMPEDE is a randomised controlled trial using a multiarm, multistage platform design. It recruits men with high-risk, locally advanced, metastatic or recurrent prostate cancer who are starting first-line long-term hormone therapy. We report primary survival results for three research comparisons testing the addition of zoledronic acid, docetaxel, or their combination to standard of care versus standard of care alone. Methods Standard of care was hormone therapy for at least 2 years; radiotherapy was encouraged for men with N0M0 disease to November, 2011, then mandated; radiotherapy was optional for men with node-positive non-metastatic (N+M0) disease. Stratified randomisation (via minimisation) allocated men 2:1:1:1 to standard of care only (SOC-only; control), standard of care plus zoledronic acid (SOC + ZA), standard of care plus docetaxel (SOC + Doc), or standard of care with both zoledronic acid and docetaxel (SOC + ZA + Doc). Zoledronic acid (4 mg) was given for six 3-weekly cycles, then 4-weekly until 2 years, and docetaxel (75 mg/m(2)) for six 3-weekly cycles with prednisolone 10 mg daily. There was no blinding to treatment allocation. The primary outcome measure was overall survival. Pairwise comparisons of research versus control had 90% power at 2.5% one-sided a for hazard ratio (HR) 0.75, requiring roughly 400 control arm deaths. Statistical analyses were undertaken with standard log-rank-type methods for time-to-event data, with hazard ratios (HRs) and 95% CIs derived from adjusted Cox models. This trial is registered at ClinicalTrials.gov (NCT00268476) and ControlledTrials.com (ISRCTN78818544). Findings 2962 men were randomly assigned to four groups between Oct 5, 2005, and March 31, 2013. Median age was 65 years (IQR 60-71). 1817 (61%) men had M+ disease, 448 (15%) had N+/X M0, and 697 (24%) had N0M0. 165 (6%) men were previously treated with local therapy, and median prostate-specific antigen was 65 ng/mL (IQR 23-184). Median follow-up was 43 months (IQR 30-60). There were 415 deaths in the control group (347 [84%] prostate cancer). Median overall survival was 71 months (IQR 32 to not reached) for SOC-only, not reached (32 to not reached) for SOC + ZA (HR 0.94, 95% CI 0.79-1.11; p= 0.450), 81 months (41 to not reached) for SOC + Doc (0.78, 0.66-0.93; p= 0.006), and 76 months (39 to not reached) for SOC + ZA + Doc (0.82, 0.69-0.97; p= 0.022). There was no evidence of heterogeneity in treatment effect (for any of the treatments) across prespecified subsets. Grade 3-5 adverse events were reported for 399 (32%) patients receiving SOC, 197 (32%) receiving SOC + ZA, 288 (52%) receiving SOC + Doc, and 269 (52%) receiving SOC + ZA + Doc. Interpretation Zoledronic acid showed no evidence of survival improvement and should not be part of standard of care for this population. Docetaxel chemotherapy, given at the time of long-term hormone therapy initiation, showed evidence of improved survival accompanied by an increase in adverse events. Docetaxel treatment should become part of standard of care for adequately fit men commencing long-term hormone therapy.	[James, Nicholas D.] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [James, Nicholas D.] Univ Birmingham, Sch Med, Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England; [Sydes, Matthew R.; Spears, Melissa R.; Ritchie, Alastair W. S.; Amos, Claire; Matheson, David; Millman, Robin; Parmar, Mahesh K. B.] UCL, MRC Clin Trials Unit, London WC2B 6NH, England; [Clarke, Noel W.] Christie & Salford Royal NHS Fdn Trusts, Dept Urol, Manchester, Lancs, England; [Mason, Malcolm D.; Staffurth, John] Cardiff Univ, Sch Med, Velindre Hosp, Cardiff CF10 3AX, S Glam, Wales; [Dearnaley, David P.; Parker, Christopher C.; Attard, Gerhardt; de Bono, Johann] Inst Canc Res, London SW3 6JB, England; [Dearnaley, David P.; Parker, Christopher C.; Attard, Gerhardt; de Bono, Johann] Royal Marsden NHS Fdn Trust, London, England; [Russell, J. Martin; Jones, Rob J.] Univ Glasgow, Inst Canc Sci, Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland; [Cross, William] Leeds Teaching Hosp NHS Trust, Dept Urol, Leeds, W Yorkshire, England; [Thalmann, George] Univ Hosp Bern, Dept Urol, CH-3010 Bern, Switzerland; [Alzouebi, Mymoona] Weston Pk Hosp, Dept Oncol, Sheffield, S Yorkshire, England; [Alzouebi, Mymoona] Weston Pk Hosp, Dept Oncol, Doncaster, England; [Beesley, Sharon] Maidstone Hlth Author, Kent Oncol Ctr, Maidstone, Kent, England; [Birtle, Alison J.] Royal Preston Hosp, Dept Oncol, Rosemere Canc Ctr, Preston, Lancs, England; [Brock, Susannah] Poole Hosp NHS Fdn Trust, Dept Oncol, Poole, Dorset, England; [Brock, Susannah] Royal Bournemouth Hosp NHS Fdn Trust, Bournemouth, Dorset, England; [Cathomas, Richard] Kantonsspital Graubunden, Chur, Switzerland; [Chakraborti, Prabir] Derby Hosp NHS Fdn Trust, Dept Oncol, Royal Derby Hosp, Derby, England; [Chowdhury, Simon] Guys Hosp, Dept Med Oncol, London SE1 9RT, England; [Cook, Audrey] Cheltenham Gen Hosp, Dept Oncol, Cheltenham, Glos, England; [Cook, Audrey] Hereford Cty Hosp, Hereford, England; [Elliott, Tony] Christie NHS Fdn Trust, Dept Clin Oncol, Manchester, Lancs, England; [Gale, Joanna] Queen Alexandra Hosp, Oncol & Haematol Clin Trials Unit, Portsmouth, Hants, England; [Gibbs, Stephanie] Queens Hosp, Dept Oncol, Romford, Essex, England; [Graham, John D.] Musgrove Pk Hosp, Beacon Ctr, Taunton, Somerset, England; [Hetherington, John] Hull & East Yorkshire Hosp NHS Trust, Dept Urol, Kingston Upon Hull, N Humberside, England; [Hughes, Robert] Mt Vernon Hosp, Mt Vernon Grp, Northwood, Middx, England; [Laing, Robert] Royal Surrey Cty Hosp, Dept Oncol, Guildford, Surrey, England; [McKinna, Fiona] East Sussex Hosp Trust, Dept Oncol, Crowborough, E Sussex, England; [McLaren, Duncan B.] Western Gen Hosp, Dept Oncol, Edinburgh EH4 2XU, Midlothian, Scotland; [O'Sullivan, Joe M.] Queens Univ Belfast, Belfast City Hosp, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland; [Parikh, Omi] East Lancashire Hosp NHS Trust, Dept Oncol, Burnley, East Lancashire, England; [Peedell, Clive] South Tees NHS Trust, Dept Radiotherapy & Oncol, Middlesbrough, Cleveland, England; [Protheroe, Andrew] Churchill Hosp, Dept Oncol, Oxford OX3 7LJ, England; [Robinson, Angus J.] Sussex Canc Ctr, Dept Oncol, Brighton, E Sussex, England; [Srihari, Narayanan] Shrewsbury & Telford Hosp NHS Trust, Dept Oncol, Shrewsbury, Salop, England; [Srinivasan, Rajaguru] Royal Devon & Exeter Hosp, Dept Oncol, Exeter EX2 5DW, Devon, England; [Srinivasan, Rajaguru] Torbay Hosp, Torquay, England; [Sundar, Santhanam] Nottingham Univ Hosp NHS Trust, Dept Oncol, Nottingham, England; [Tolan, Shaun] Clatterbridge Canc Ctr, Dept Radiotherapy & Oncol, Wirral, Merseyside, England; [Tsang, David] Southend Hosp, Dept Oncol, Westcliff On Sea, Essex, England; [Tsang, David] Basildon Hosp, Dept Oncol, Basildon, Essex, England; [Wagstaff, John] South West Wales Canc Inst, Swansea, W Glam, Wales; [Wagstaff, John] Swansea Univ, Coll Med, Swansea, W Glam, Wales	University of Warwick; University of Birmingham; Medical Research Council Clinical Trials Unit; University of London; University College London; Christie NHS Foundation Trust; Cardiff University; Velindre Hospital; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Beatson Oncology Centre; University of Glasgow; University of Leeds; University of Bern; University Hospital of Bern; Weston Park Hospital; Weston Park Hospital; Royal Preston Hospital; Kantonsspital Graubunden; University of Nottingham; Guy's & St Thomas' NHS Foundation Trust; Gloucestershire Hospitals NHS Foundation Trust; Cheltenham General Hospital; Christie NHS Foundation Trust; Portsmouth Hospitals NHS Trust; Queen Alexandra Hospital; Musgrove Park Hospital; Royal Surrey County Hospital; University of Edinburgh; Belfast City Hospital; Queens University Belfast; University of Oxford; University of Exeter; Nottingham University Hospital NHS Trust; Clatterbridge Cancer Centre; Swansea University	Sydes, MR (corresponding author), UCL, MRC Clin Trials Unit, London WC2B 6NH, England.	m.sydes@ucl.ac.uk	Sydes, Matthew/C-3373-2008; Sundar, Santhanam/AAF-3011-2021; Dearnaley, David P/J-2318-2014; Mason, Malcolm D/H-6979-2013; James, Nick/AAL-6802-2020; McLaren, Duncan Bruce/M-3153-2019; Matheson, David/V-4076-2017	Sydes, Matthew/0000-0002-9323-1371; Sundar, Santhanam/0000-0003-0850-5161; Dearnaley, David P/0000-0002-3954-2806; McLaren, Duncan Bruce/0000-0002-9862-4158; Jones, Robert/0000-0002-2904-6980; Engeler, Daniel/0000-0003-1383-4701; Graham, John/0000-0003-3381-9787; Ansari, JAWAHER/0000-0001-5525-548X; Attard, Gerhardt/0000-0002-4811-7983; Herrera, Fernanda/0000-0001-7984-0472; Rentsch, Cyrill/0000-0002-8085-6006; Azzabi, Ashraf/0000-0003-4801-9109; O'Sullivan, Joe/0000-0001-6999-2739; Adeyoju, Adebanji/0000-0003-4010-5985; Rogers, Paul/0000-0003-2593-2595; Jain, Sunjay/0000-0002-6173-4863; de Bono, Johann S/0000-0002-2034-595X; Matheson, David/0000-0002-3695-3167; Camilleri, Philip/0000-0002-2677-5627; Wagstaff, John/0000-0002-1140-5981; James, Nicholas/0000-0002-7314-8204	National Institute for Health Research; Novartis Pharmaceuticals UK Limited; Sanofi-Aventis; Institute of Cancer Research Biomedical Research Centre; Cancer Research UK [13239, 19727, 3804, 12459] Funding Source: researchfish; Medical Research Council [MC_UU_12023/20, MC_UU_12023/25, MC_UU_12023/28] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10106, CL-2008-22-001] Funding Source: researchfish; Public Health Agency [SPI/3315/06] Funding Source: researchfish; Prostate Cancer UK [PG12-49] Funding Source: researchfish; MRC [MC_UU_12023/28] Funding Source: UKRI	National Institute for Health Research(National Institute for Health Research (NIHR)); Novartis Pharmaceuticals UK Limited; Sanofi-Aventis(Sanofi-Aventis); Institute of Cancer Research Biomedical Research Centre; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Public Health Agency; Prostate Cancer UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	DPD, CCP, GA, and JdB acknowledge support from the National Institute for Health Research to the Royal Marsden NHS Trust and The Institute of Cancer Research Biomedical Research Centre. Support for the STAMPEDE trial has been provided by Novartis Pharmaceuticals UK Limited (educational grant, free drug, distribution costs) and Sanofi-Aventis (education grant, free and discounted drug). Affiliations and full details of contributions made by STAMPEDE investigators are provided in the appendix page 11.	Aapro MS, 2011, EUR J CANCER, V47, P8, DOI 10.1016/j.ejca.2010.10.013; Barthel FMS, 2009, STATA J, V9, P505, DOI 10.1177/1536867X0900900401; Beer TM, 2014, NEW ENGL J MED, V371, P424, DOI 10.1056/NEJMoa1405095; Cook RJ, 1996, J ROY STAT SOC A STA, V159, P93, DOI 10.2307/2983471; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; de Bono JS, 2010, LANCET, V376, P1147, DOI 10.1016/S0140-6736(10)61389-X; Dearnaley DP, 2009, LANCET ONCOL, V10, P872, DOI 10.1016/S1470-2045(09)70201-3; Denham JW, 2014, LANCET ONCOL, V15, P1076, DOI 10.1016/S1470-2045(14)70328-6; Fizazi K, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.5005; FOLLMANN DA, 1994, BIOMETRICS, V50, P325, DOI 10.2307/2533376; Franke RM, 2010, J CLIN ONCOL, V28, P4562, DOI 10.1200/JCO.2010.30.7025; Gravis G, 2015, P AM SOC CLIN ONCO S, VGU, P140; Gravis G, 2013, LANCET ONCOL, V14, P149, DOI 10.1016/S1470-2045(12)70560-0; James ND, 2008, CLIN ONCOL-UK, V20, P577, DOI 10.1016/j.clon.2008.07.002; James ND, 2015, JAMA ONCOL, V25, P1; James ND, 2012, LANCET ONCOL, V13, P549, DOI 10.1016/S1470-2045(12)70088-8; James ND, 2015, EUR UROL, V67, P1028, DOI 10.1016/j.eururo.2014.09.032; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Omlin A, 2015, CLIN GENITOURIN CANC, V13, pE205, DOI 10.1016/j.clgc.2015.01.010; Parker C, 2013, NEW ENGL J MED, V369, P213, DOI 10.1056/NEJMoa1213755; Parmar MKB, 2008, JNCI-J NATL CANCER I, V100, P1204, DOI 10.1093/jnci/djn267; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Saad F, 2004, J NATL CANCER I, V96, P879, DOI 10.1093/jnci/djh141; Sandler HM, 2015, P AM SOC CLIN ONCO S, V33; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Schweizer MT, 2013, CANCER-AM CANCER SOC, V119, P3610, DOI 10.1002/cncr.28270; Smith MR, 2009, NEW ENGL J MED, V361, P745, DOI 10.1056/NEJMoa0809003; Smith MR, 2014, J CLIN ONCOL, V13, P27; Smith TJ, 2006, J CLIN ONCOL, V24, P3187, DOI 10.1200/JCO.2006.06.4451; Sweeney CJ, 2015, NEW ENGL J MED, V373, P737, DOI 10.1056/NEJMoa1503747; Sydes MR, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-168; Sydes MR, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-39; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Vale CL, 2016, LANCET ONCOL, V17, P243, DOI 10.1016/S1470-2045(15)00489-1; Wason JMS, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-364; Wirth M, 2015, EUR UROL, V67, P482, DOI 10.1016/j.eururo.2014.02.014	37	1234	1271	5	99	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 19	2016	387	10024					1163	1177		10.1016/S0140-6736(15)01037-5	http://dx.doi.org/10.1016/S0140-6736(15)01037-5			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG9OB	26719232	hybrid, Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000372412000028
J	Margolese, RG; Cecchini, RS; Julian, TB; Ganz, PA; Costantino, JP; Vallow, LA; Albain, KS; Whitworth, PW; Cianfrocca, ME; Brufsky, AM; Gross, HM; Soori, GS; Hopkins, JO; Fehrenbacher, L; Sturtz, K; Wozniak, TF; Seay, TE; Mamounas, EP; Wolmark, N				Margolese, Richard G.; Cecchini, Reena S.; Julian, Thomas B.; Ganz, Patricia A.; Costantino, Joseph P.; Vallow, Laura A.; Albain, Kathy S.; Whitworth, Patrick W.; Cianfrocca, Mary E.; Brufsky, Adam M.; Gross, Howard M.; Soori, Gamini S.; Hopkins, Judith O.; Fehrenbacher, Louis; Sturtz, Keren; Wozniak, Timothy F.; Seay, Thomas E.; Mamounas, Eleftherios P.; Wolmark, Norman			Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial	LANCET			English	Article							INTRADUCTAL BREAST-CANCER; SURGICAL ADJUVANT BREAST; RADIATION-THERAPY; B-17	Background Ductal carcinoma in situ is currently managed with excision, radiotherapy, and adjuvant hormone therapy, usually tamoxifen. We postulated that an aromatase inhibitor would be safer and more effective. We therefore undertook this trial to compare anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy. Methods The double-blind, randomised, phase 3 National Surgical Adjuvant Breast and Bowel Project (NSABP) B-35 trial was done in 333 participating NSABP centres in the USA and Canada. Postmenopausal women with hormone-positive ductal carcinoma in situ treated by lumpectomy with clear resection margins and whole-breast irradiation were enrolled and randomly assigned (1: 1) to receive either oral tamoxifen 20 mg per day (with matching placebo in place of anastrozole) or oral anastrozole 1 mg per day (with matching placebo in place of tamoxifen) for 5 years. Randomisation was stratified by age (< 60 vs >= 60 years) and patients and investigators were masked to treatment allocation. The primary outcome was breast cancer-free interval, defined as time from randomisation to any breast cancer event (local, regional, or distant recurrence, or contralateral breast cancer, invasive disease, or ductal carcinoma in situ), analysed by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00053898, and is complete. Findings Between Jan 1, 2003, and June 15, 2006, 3104 eligible patients were enrolled and randomly assigned to the two treatment groups (1552 to tamoxifen and 1552 to anastrozole). As of Feb 28, 2015, follow-up information was available for 3083 patients for overall survival and 3077 for all other disease-free endpoints, with median follow-up of 9.0 years (IQR 8.2-10.0). In total, 212 breast cancer-free interval events occurred: 122 in the tamoxifen group and 90 in the anastrozole group (HR 0.73 [95% CI 0.56-0.96], p= 0.0234). A significant time-by-treatment interaction (p= 0.0410) became evident later in the study. There was also a significant interaction between treatment and age group (p= 0.0379), showing that anastrozole is superior only in women younger than 60 years of age. Adverse events did not differ between the groups, except for thrombosis or embolism-a known side-effect of tamoxifen-for which there were 17 grade 4 or worse events in the tamoxifen group versus four in the anastrozole group. Interpretation Compared with tamoxifen, anastrozole treatment provided a significant improvement in breast cancer-free interval, mainly in women younger than 60 years of age. This finding means that women will benefit from having a choice of effective agents for ductal carcinoma in situ.	[Margolese, Richard G.; Cecchini, Reena S.; Julian, Thomas B.; Ganz, Patricia A.; Costantino, Joseph P.; Vallow, Laura A.; Albain, Kathy S.; Whitworth, Patrick W.; Cianfrocca, Mary E.; Brufsky, Adam M.; Gross, Howard M.; Soori, Gamini S.; Hopkins, Judith O.; Fehrenbacher, Louis; Sturtz, Keren; Wozniak, Timothy F.; Seay, Thomas E.; Mamounas, Eleftherios P.; Wolmark, Norman] Natl Surg Adjuvant Breast & Bowel Project NSABP, NRG Oncol, Pittsburgh, PA USA; [Margolese, Richard G.] McGill Univ, Jewish Gen Hosp, 3755 Cote St Catherine Rd, Montreal, PQ H3T 1E2, Canada; [Cecchini, Reena S.; Costantino, Joseph P.] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15261 USA; [Julian, Thomas B.; Wolmark, Norman] Allegheny Gen Hosp, Allegheny Canc Ctr, Dept Surg Oncol, Pittsburgh, PA 15212 USA; [Ganz, Patricia A.] Univ Calif Los Angeles, Los Angeles, CA USA; [Vallow, Laura A.] Mayo Clin, Dept Radiat Oncol, Jacksonville, FL 32224 USA; [Albain, Kathy S.; Cianfrocca, Mary E.] SWOG, San Antonio, TX USA; [Albain, Kathy S.] Loyola Univ, Stritch Sch Med, Dept Med, Chicago, IL 60611 USA; [Whitworth, Patrick W.] ALLIANCE ACOSOG, Chicago, IL USA; [Whitworth, Patrick W.] Nashville Breast Ctr, Nashville, TN USA; [Cianfrocca, Mary E.] ECOG ACRIN, Philadelphia, PA USA; [Cianfrocca, Mary E.] Banner MD Anderson Canc Ctr, Dept Hematol Oncol, Gilbert, AZ USA; [Brufsky, Adam M.] Univ Pittsburgh, Magee Womens Hosp, Dept Hematol Oncol, Pittsburgh, PA 15213 USA; [Gross, Howard M.] Dayton Phys LLC, Dayton, OH USA; [Soori, Gamini S.] Missouri Valley Canc Consortium, Omaha, NE USA; [Hopkins, Judith O.] SCOR NCORP, Winston Salem, NC USA; [Hopkins, Judith O.] Forsyth Reg Canc Ctr, Dept Hematol Oncol, Winston Salem, NC USA; [Fehrenbacher, Louis] Kaiser Permanente, Dept Med Oncol, Northern Calif Vallejo, CA USA; [Sturtz, Keren] Colorado Canc Res Program, Dept Med Oncol, Denver, CO USA; [Wozniak, Timothy F.] Christiana Care Hlth Syst, CCOP, Newark, DE USA; [Seay, Thomas E.] Atlanta Reg Community Clin Oncol Program, Atlanta, GA USA; [Mamounas, Eleftherios P.] UF Hlth Canc Ctr, Orlando, FL USA; [Mamounas, Eleftherios P.] Orlando Hlth, Orlando, FL USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Surgical Adjuvant Breast & Bowel Project; McGill University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Allegheny General Hospital; University of California System; University of California Los Angeles; Mayo Clinic; Southwest Oncology Group; Loyola University Chicago; Banner Research; Banner Health; University of Texas System; UTMD Anderson Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kaiser Permanente; Christiana Care Health System	Margolese, RG (corresponding author), McGill Univ, Jewish Gen Hosp, 3755 Cote St Catherine Rd, Montreal, PQ H3T 1E2, Canada.	richard.margolese@mcgill.ca	Cecchini, Rubens/D-9811-2013; Brufsky, Adam/AAE-7470-2020	Cecchini, Rubens/0000-0001-9941-2344; Brufsky, Adam/0000-0001-8080-7960; Cecchini, Reena/0000-0002-9075-9357; Ganz, Patricia/0000-0002-1841-4143	US National Cancer Institute; AstraZeneca Pharmaceuticals LP; NATIONAL CANCER INSTITUTE [U24CA114732, U24CA196067, UG1CA189867, U10CA180868, UG1CA189805, U10CA180822, U10CA180888] Funding Source: NIH RePORTER	US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); AstraZeneca Pharmaceuticals LP(AstraZeneca); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	US National Cancer Institute and AstraZeneca Pharmaceuticals LP.	[Anonymous], 2015, LANCET; Baum M, 2002, LANCET, V359, P2131; Cuzick J, 2014, LANCET, V383, P1041, DOI 10.1016/S0140-6736(13)62292-8; EUSEBI V, 1994, SEMIN DIAGN PATHOL, V11, P223; Fisher B, 1999, LANCET, V353, P1993, DOI 10.1016/S0140-6736(99)05036-9; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; FISHER B, 1993, NEW ENGL J MED, V328, P1581, DOI 10.1056/NEJM199306033282201; Fisher B, 1998, J CLIN ONCOL, V16, P441, DOI 10.1200/JCO.1998.16.2.441; Forbes JF, 2015, LANCET; Nabholtz JM, 2000, J CLIN ONCOL, V18, P3758, DOI 10.1200/JCO.2000.18.22.3758; Narod SA, 2015, JAMA ONCOL, V1, P888, DOI 10.1001/jamaoncol.2015.2510; PAGE DL, 1995, CANCER, V76, P1197, DOI 10.1002/1097-0142(19951001)76:7<1197::AID-CNCR2820760715>3.0.CO;2-0; Wapnir IL, 2011, J NATL CANCER I, V103, P478, DOI 10.1093/jnci/djr027	13	113	114	0	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	2016	387	10021					849	856		10.1016/S0140-6736(15)01168-X	http://dx.doi.org/10.1016/S0140-6736(15)01168-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE9RA	26686957	Green Accepted			2022-12-28	WOS:000370974400029
J	Essink-Bot, ML; Dekker, E				Essink-Bot, Marie-Louise; Dekker, Evelien			Equal access to colorectal cancer screening	LANCET			English	Editorial Material							PARTICIPATION		[Essink-Bot, Marie-Louise] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, POB 22660, NL-1100 DD Amsterdam, Netherlands; [Dekker, Evelien] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, POB 22660, NL-1100 DD Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Essink-Bot, ML (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, POB 22660, NL-1100 DD Amsterdam, Netherlands.	m.l.essink-bot@amc.uva.nl		Dekker, Evelien/0000-0002-4363-0745				Biesecker BB, 2013, AM J HEALTH BEHAV, V37, P351, DOI 10.5993/AJHB.37.3.8; Camilloni L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-464; Cipriano Toni M, 2013, Am Soc Clin Oncol Educ Book, P169, DOI 10.1200/EdBook_AM.2013.33.169; Deutekom M, 2009, EUR J PUBLIC HEALTH, V19, P400, DOI 10.1093/eurpub/ckp051; Gupta S, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju032; Rice N, 2001, J MED ETHICS, V27, P256, DOI 10.1136/jme.27.4.256; von Karsa L, 2013, ENDOSCOPY, V45, P51, DOI 10.1055/s-0032-1325997; von Wagner C, 2011, INT J EPIDEMIOL, V40, P712, DOI 10.1093/ije/dyr008; Wardle J. W., 2015, LANCET	9	13	13	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 20	2016	387	10020					724	726		10.1016/S0140-6736(15)01221-0	http://dx.doi.org/10.1016/S0140-6736(15)01221-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DE1WU	26680216	hybrid			2022-12-28	WOS:000370418000006
J	Walter, JE; Armanios, M; Shah, U; Friedmann, AM; Spitzer, T; Sharatz, SM; Hagen, C				Walter, Jolan E.; Armanios, Mary; Shah, Uzma; Friedmann, Alison M.; Spitzer, Thomas; Sharatz, Steven M.; Hagen, Catherine			Case 41-2015: A 14-Year-Old Boy with Immune and Liver Abnormalities	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMMON VARIABLE IMMUNODEFICIENCY; NODULAR REGENERATIVE HYPERPLASIA; LINKED DYSKERATOSIS-CONGENITA; HOYERAAL-HREIDARSSON-SYNDROME; BONE-MARROW-TRANSPLANTATION; REGULATORY T-CELLS; TELOMERE SYNDROMES; PULMONARY-FIBROSIS; DKC1 GENE; MUTATIONS		[Walter, Jolan E.] Massachusetts Gen Hosp, Div Pediat Allergy Immunol, Boston, MA 02114 USA; [Shah, Uzma] Massachusetts Gen Hosp, Div Pediat Gastroenterol, Boston, MA 02114 USA; [Friedmann, Alison M.] Massachusetts Gen Hosp, Div Pediat Hematol Oncol, Boston, MA 02114 USA; [Spitzer, Thomas] Massachusetts Gen Hosp, Div Bone Marrow Transplantat, Boston, MA 02114 USA; [Sharatz, Steven M.] Massachusetts Gen Hosp, Div Radiol, Boston, MA 02114 USA; [Hagen, Catherine] Massachusetts Gen Hosp, Div Pathol, Boston, MA 02114 USA; [Walter, Jolan E.; Shah, Uzma; Friedmann, Alison M.; Spitzer, Thomas] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Sharatz, Steven M.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Hagen, Catherine] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Armanios, Mary] Johns Hopkins Univ, Sch Med, Dept Med Oncol, Baltimore, MD USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Johns Hopkins University	Walter, JE (corresponding author), Massachusetts Gen Hosp, Div Pediat Allergy Immunol, Boston, MA 02114 USA.		Spitzer, Thomas/AAR-7652-2020					Alder JK, 2015, P NATL ACAD SCI USA, V112, P5099, DOI 10.1073/pnas.1504780112; Alder JK, 2013, HUM MUTAT, V34, P1481, DOI 10.1002/humu.22397; Allenspach EJ, 2013, J ALLERGY CLIN IMMUN, V132, P223, DOI 10.1016/j.jaci.2012.11.052; Alter BP, 2010, BRIT J HAEMATOL, V150, P179, DOI 10.1111/j.1365-2141.2010.08212.x; Armanios M, 2013, J CLIN INVEST, V123, P996, DOI 10.1172/JCI66370; Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246; Armanios M, 2009, ANNU REV GENOM HUM G, V10, P45, DOI 10.1146/annurev-genom-082908-150046; ASTER RH, 1966, J CLIN INVEST, V45, P645, DOI 10.1172/JCI105380; Ayas M, 2013, BONE MARROW TRANSPL, V48, P1168, DOI 10.1038/bmt.2013.35; Bacchetta R, 2006, J CLIN INVEST, V116, P1713, DOI 10.1172/JCI25112; Calado RT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007926; Chapel H, 2009, BRIT J HAEMATOL, V145, P709, DOI 10.1111/j.1365-2141.2009.07669.x; Cossu F, 2002, BRIT J HAEMATOL, V119, P765, DOI 10.1046/j.1365-2141.2002.03822.x; d'Hennezel E, 2009, NEW ENGL J MED, V361, P1710, DOI 10.1056/NEJMc0907093; Dokal I, 2000, BRIT J HAEMATOL, V110, P768, DOI 10.1046/j.1365-2141.2000.02109.x; Fuss IJ, 2013, J CLIN IMMUNOL, V33, P748, DOI 10.1007/s10875-013-9873-6; Gadalla SM, 2013, BIOL BLOOD MARROW TR, V19, P1238, DOI 10.1016/j.bbmt.2013.05.021; Gambineri E, 2003, CURR OPIN RHEUMATOL, V15, P430, DOI 10.1097/00002281-200307000-00010; Gonzalez-Huezo Maria S, 2006, Ann Hepatol, V5, P166; Gorgy AI, 2015, CHEST, V148, P1019, DOI 10.1378/chest.15-0825; Guo N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017858; Jonassaint NL, 2013, AGING CELL, V12, P319, DOI 10.1111/acel.12041; Jyonouchi S, 2011, PEDIAT ALLERG IMM-UK, V22, P313, DOI 10.1111/j.1399-3038.2010.01136.x; Knight SW, 1999, BRIT J HAEMATOL, V107, P335, DOI 10.1046/j.1365-2141.1999.01690.x; Knight SW, 1999, AM J HUM GENET, V65, P50, DOI 10.1086/302446; Knudson M, 2005, BLOOD, V105, P682, DOI 10.1182/blood-2004-04-1673; Parry EM, 2011, J MED GENET, V48, P327, DOI 10.1136/jmg.2010.085100; POWELL BR, 1982, J PEDIATR-US, V100, P731, DOI 10.1016/S0022-3476(82)80573-8; Resnick ES, 2012, BLOOD, V119, P1650, DOI 10.1182/blood-2011-09-377945; Rocha V, 1998, BRIT J HAEMATOL, V103, P243, DOI 10.1046/j.1365-2141.1998.00949.x; ROSENBERG HK, 1991, AM J ROENTGENOL, V157, P119, DOI 10.2214/ajr.157.1.2048509; Silhan LL, 2014, EUR RESPIR J, V44, P178, DOI 10.1183/09031936.00060014; Solder B, 1998, CLIN PEDIATR, V37, P521, DOI 10.1177/000992289803700901; Solder B, 1996, KLIN PADIATR, V208, P344, DOI 10.1055/s-2008-1046495; Stanley SE, 2015, INT J RADIAT ONCOL, V93, P1115, DOI 10.1016/j.ijrobp.2015.08.048; Stanley SE, 2015, CURR OPIN GENET DEV, V33, P1, DOI 10.1016/j.gde.2015.06.004; Stanley SE, 2015, J CLIN INVEST, V125, P563, DOI 10.1172/JCI78554; Sznajer Y, 2003, EUR J PEDIATR, V162, P863, DOI 10.1007/s00431-003-1317-5; Talbot-Smith A, 2009, THORAX, V64, P440, DOI 10.1136/thx.2008.099796; Torgerson TR, 2007, J ALLERGY CLIN IMMUN, V120, P744, DOI 10.1016/j.jaci.2007.08.044; Velazquez I, 2004, AM J HEMATOL, V77, P257, DOI 10.1002/ajh.20183; WANLESS IR, 1990, HEPATOLOGY, V11, P787, DOI 10.1002/hep.1840110512; Warnatz K, 2002, BLOOD, V99, P1544, DOI 10.1182/blood.V99.5.1544; WIEDEMANN HP, 1984, ARCH INTERN MED, V144, P397, DOI 10.1001/archinte.144.2.397; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707	45	2	3	1	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 31	2015	373	27					2664	2676		10.1056/NEJMcpc1408595	http://dx.doi.org/10.1056/NEJMcpc1408595			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ8UH	26716919				2022-12-28	WOS:000367374100013
J	Rahman, NM; Pepperell, J; Rehal, S; Saba, T; Tang, A; Ali, N; West, A; Hettiarachchi, G; Mukherjee, D; Samuel, J; Bentley, A; Dowson, L; Miles, J; Ryan, CF; Yoneda, KY; Chauhan, A; Corcoran, JP; Psallidas, I; Wrightson, JM; Hallifax, R; Davies, HE; Lee, YCG; Dobson, M; Hedley, EL; Seaton, D; Russell, N; Chapman, M; McFadyen, BM; Shaw, RA; Davies, RJO; Maskell, NA; Nunn, AJ; Miller, RF				Rahman, Najib M.; Pepperell, Justin; Rehal, Sunita; Saba, Tarek; Tang, Augustine; Ali, Nabeel; West, Alex; Hettiarachchi, Gihan; Mukherjee, Dipak; Samuel, Johnson; Bentley, Andrew; Dowson, Lee; Miles, Jonathan; Ryan, C. Frank; Yoneda, Ken Y.; Chauhan, Anoop; Corcoran, John P.; Psallidas, Ioannis; Wrightson, John M.; Hallifax, Rob; Davies, Helen E.; Lee, Y. C. Gary; Dobson, Melissa; Hedley, Emma L.; Seaton, Douglas; Russell, Nicky; Chapman, Margaret; McFadyen, Bethan M.; Shaw, Rachel A.; Davies, Robert J. O.; Maskell, Nick A.; Nunn, Andrew J.; Miller, Robert F.			Effect of Opioids vs NSAIDs and Larger vs Smaller Chest Tube Size on Pain Control and Pleurodesis Efficacy Among Patients With Malignant Pleural Effusion The TIME1 Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SMALL-BORE; MANAGEMENT; PULMONOLOGISTS; MINIMIZATION; INFECTION; CATHETER	IMPORTANCE For treatment of malignant pleural effusion, nonsteroidal anti-inflammatory drugs (NSAIDs) are avoided because they may reduce pleurodesis efficacy. Smaller chest tubes may be less painful than larger tubes, but efficacy in pleurodesis has not been proven. OBJECTIVE To assess the effect of chest tube size and analgesia (NSAIDs vs opiates) on pain and clinical efficacy related to pleurodesis in patients with malignant pleural effusion. DESIGN, SETTING, AND PARTICIPANTS A 2x2 factorial phase 3 randomized clinical trial among 320 patients requiring pleurodesis in 16 UK hospitals from 2007 to 2013. INTERVENTIONS Patients undergoing thoracoscopy (n = 206; clinical decision if biopsy was required) received a 24F chest tube and were randomized to receive opiates (n = 103) vs NSAIDs (n = 103), and those not undergoing thoracoscopy (n = 114) were randomized to 1 of 4 groups (24F chest tube and opioids [n = 28]; 24F chest tube and NSAIDs [n = 29]; 12F chest tube and opioids [n = 29]; or 12F chest tube and NSAIDs [n = 28]). MAIN OUTCOMES AND MEASURES Pain while chest tube was in place (0-to100-mm visual analog scale [VAS] 4 times/d; superiority comparison) and pleurodesis efficacy at 3 months (failure defined as need for further pleural intervention; noninferiority comparison; margin, 15%). RESULTS Pain scores in the opiate group (n = 150) vs the NSAID group (n = 144) were not significantly different (mean VAS score, 23.8mm vs 22.1 mm; adjusted difference, -1.5 mm; 95% CI, -5.0 to 2.0 mm; P =.40), but the NSAID group required more rescue analgesia (26.3% vs 38.1%; rate ratio, 2.1; 95% CI, 1.3-3.4; P =.003). Pleurodesis failure occurred in 30 patients (20%) in the opiate group and 33 (23%) in the NSAID group, meeting criteria for noninferiority (difference, -3%; 1-sided 95% CI, -10% to infinity; P =.004 for noninferiority). Pain scores were lower among patients in the 12F chest tube group (n = 54) vs the 24F group (n = 56) (mean VAS score, 22.0mmvs 26.8 mm; adjusted difference, -6.0 mm; 95% CI, -11.7 to -0.2 mm; P =.04) and 12F chest tubes vs 24F chest tubes were associated with higher pleurodesis failure (30% vs 24%), failing to meet noninferiority criteria (difference, -6%; 1-sided 95% CI, -20% to infinity; P =.14 for noninferiority). Complications during chest tube insertion occurred more commonly with 12F tubes (14% vs 24%; odds ratio, 1.91; P =.20). CONCLUSIONS AND RELEVANCE Use of NSAIDs vs opiates resulted in no significant difference in pain scores but was associated with more rescue medication. NSAID use resulted in noninferior rates of pleurodesis efficacy at 3 months. Placement of 12F chest tubes vs 24F chest tubes was associated with a statistically significant but clinically modest reduction in pain but failed to meet noninferiority criteria for pleurodesis efficacy.	[Rahman, Najib M.; Corcoran, John P.; Psallidas, Ioannis; Wrightson, John M.; Hallifax, Rob; Dobson, Melissa; Hedley, Emma L.; Russell, Nicky; Chapman, Margaret; McFadyen, Bethan M.; Shaw, Rachel A.; Davies, Robert J. O.] Churchill Hosp, Oxford Resp Trials Unit, Oxford OX3 7LJ, England; [Rahman, Najib M.; Corcoran, John P.; Psallidas, Ioannis; Wrightson, John M.; Hallifax, Rob; Dobson, Melissa; Hedley, Emma L.; Russell, Nicky; Chapman, Margaret; McFadyen, Bethan M.; Shaw, Rachel A.; Davies, Robert J. O.] Churchill Hosp, Oxford Pleural Dis Unit, Oxford OX3 7LJ, England; [Rahman, Najib M.; Wrightson, John M.] Univ Oxford, Natl Inst Hlth Res, Oxford Biomed Res Ctr, Oxford OX3 7LE, England; [Pepperell, Justin] Musgrove Pk Hosp, Somerset Lung Ctr, Taunton, Somerset, England; [Rehal, Sunita; Nunn, Andrew J.] UCL, Med Res Council, Clin Trials Unit, London, England; [Saba, Tarek; Tang, Augustine] Blackpool Teaching Hosp NHS Fdn Trust, Blackpool, England; [Ali, Nabeel] Kings Mill Hosp, Mansfield, England; [West, Alex; Hettiarachchi, Gihan] Medway Maritime Hosp, Gillingham, England; [Mukherjee, Dipak; Samuel, Johnson] Basildon Univ Hosp, Basildon, England; [Bentley, Andrew] Univ Hosp South Manchester NHS Fdn Trust, Manchester, Lancs, England; [Dowson, Lee] Royal Wolverhampton Hosp NHS Trust, Wolverhampton, W Midlands, England; [Miles, Jonathan] Rotherham Gen Hosp, Rotherham, S Yorkshire, England; [Ryan, C. Frank] Vancouver Coastal Hlth, Vancouver, BC, Canada; [Yoneda, Ken Y.] Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA; [Chauhan, Anoop] Queen Alexandra Hosp, Portsmouth, Hants, England; [Davies, Helen E.] Cardiff & Vale Univ, Hlth Board, Cardiff, S Glam, Wales; [Lee, Y. C. Gary] Univ Western Australia, Sch Med, Crawley, Australia; [Lee, Y. C. Gary] Univ Western Australia, Ctr Asthma Allergy & Resp Res, Crawley, Australia; [Seaton, Douglas] Ipswich Hosp, Dept Resp Med, Ipswich, Suffolk, England; [Maskell, Nick A.] Univ Bristol, Southmead Hosp, Dept Clin Sci, Acad Resp Unit, Bristol, Avon, England; [Miller, Robert F.] UCL, Res Dept Infect & Populat Hlth, Inst Epidemiol & Healthcare, London, England	University of Oxford; University of Oxford; University of Oxford; Musgrove Park Hospital; Medical Research Council Clinical Trials Unit; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; University College London; Medway Maritime Hospital; Wythenshawe Hospital NHS Foundation Trust; Vancouver Coastal Health Research Institute; University of California System; University of California Davis; Portsmouth Hospitals NHS Trust; Queen Alexandra Hospital; University of Western Australia; University of Western Australia; Ipswich Hospital NHS Trust; Ipswich Hospital; Southmead Hospital; University of Bristol; University of London; University College London	Rahman, NM (corresponding author), Univ Oxford, Oxford Resp Trials Unit, Oxford Ctr Resp Med, Nuffield Dept Med, Churchill Hosp Site,Old Rd, Oxford OX3 7LE, England.	najib.rahman@ndm.ox.ac.uk	Lee, Y C Gary/H-5264-2014	Davies, Helen/0000-0001-6102-256X; Rahman, Najib M/0000-0003-1195-1680; Miller, Robert/0000-0003-2067-4291; Rehal, Sunita/0000-0002-2578-5778; Hallifax, Rob/0000-0002-9467-668X; Bentley, Andrew/0000-0002-6883-9246; maskell, nick/0000-0002-1276-6500; Dobson, Melissa/0000-0002-4906-3956	UK Medical Research Council [G0600475]; UK National Institute for Health Research Oxford Biomedical Research Centre Programme; MRC [G0600475, MC_U122888468] Funding Source: UKRI; Medical Research Council [MC_U122888468, G0600475] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK National Institute for Health Research Oxford Biomedical Research Centre Programme; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by grant G0600475 from the UK Medical Research Council. Dr Rahman is funded by the UK Medical Research Council and the UK National Institute for Health Research Oxford Biomedical Research Centre Programme.	Altman DG, 2005, BRIT MED J, V330, P843, DOI 10.1136/bmj.330.7495.843; [Anonymous], 2010, CANC STAT REG EN MB1; Antony VB, 2000, AM J RESP CRIT CARE, V162, P1987, DOI 10.1164/ajrccm.162.5.ats8-00; Bandolier, 2003, BANDOLIER ACUTE PAIN; Ben-Nun A, 2011, WORLD J SURG, V35, P2563, DOI 10.1007/s00268-011-1207-3; Bhatnagar R, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-007045; Clementsen P, 1998, RESP MED, V92, P593, DOI 10.1016/S0954-6111(98)90315-8; Collop NA, 1997, CHEST, V112, P709, DOI 10.1378/chest.112.3.709; Gallagher EJ, 2001, ANN EMERG MED, V38, P633, DOI 10.1067/mem.2001.118863; Horsley A, 2006, CHEST, V130, P1857, DOI 10.1378/chest.130.6.1857; Hunt Ian, 2007, Interact Cardiovasc Thorac Surg, V6, P102; Kahan BC, 2012, STAT MED, V31, P328, DOI 10.1002/sim.4431; Lee YCG, 2003, CHEST, V124, P2229, DOI 10.1378/chest.124.6.2229; Luketich JD, 1998, CLIN J PAIN, V14, P152, DOI 10.1097/00002508-199806000-00011; Norholt SE, 1996, PAIN, V67, P335, DOI 10.1016/0304-3959(96)03126-0; PARKER LA, 1989, CANCER, V64, P1218, DOI 10.1002/1097-0142(19890915)64:6<1218::AID-CNCR2820640609>3.0.CO;2-V; Parulekar W, 2001, CHEST, V120, P19, DOI 10.1378/chest.120.1.19; Rahman NM, 2011, NEW ENGL J MED, V365, P518, DOI 10.1056/NEJMoa1012740; Rahman NM, 2010, CHEST, V137, P536, DOI 10.1378/chest.09-1044; Roberts ME, 2010, THORAX, V65, P32, DOI 10.1136/thx.2010.136994; Shaw P, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002916.PUB2	21	109	112	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 29	2015	314	24					2641	2653		10.1001/jama.2015.16840	http://dx.doi.org/10.1001/jama.2015.16840			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ2MR	26720026	Bronze			2022-12-28	WOS:000366939800019
J	Vivien, L				Vivien, Laurent			Silicon chips lighten up	NATURE			English	Editorial Material									[Vivien, Laurent] Univ Paris Saclay, Univ Paris 11, CNRS, Inst Elect Fondamentale, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Vivien, L (corresponding author), Univ Paris Saclay, Univ Paris 11, CNRS, Inst Elect Fondamentale, F-91405 Orsay, France.	laurent.vivien@u-psud.fr	Vivien, Laurent/ABG-7593-2020; Vivien, Laurent/F-7190-2014	Vivien, Laurent/0000-0002-2980-7225				Baehr-Jones T, 2012, NAT PHOTONICS, V6, P206, DOI 10.1038/nphoton.2012.66; Fedeli JM, 2014, IEEE J SEL TOP QUANT, V20, DOI 10.1109/JSTQE.2013.2295713; Miller DAB, 2009, P IEEE, V97, P1166, DOI 10.1109/JPROC.2009.2014298; Narasimha A., 2008, OPTICAL FIBER COMMUN; Vivien L, 2013, SER OPT OPTOELECTRON, pVII	6	14	14	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2015	528	7583					483	484		10.1038/528483a	http://dx.doi.org/10.1038/528483a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ3GH	26701048				2022-12-28	WOS:000366991900035
J	Arrieta, JM; Mayol, E; Hansman, RL; Herndl, GJ; Dittmar, T; Duarte, CM				Arrieta, Jesus M.; Mayol, Eva; Hansman, Roberta L.; Herndl, Gerhard J.; Dittmar, Thorsten; Duarte, Carlos M.			Response to Comment on "Dilution limits dissolved organic carbon utilization in the deep ocean"	SCIENCE			English	Editorial Material							MICROBIAL-PRODUCTION; MATTER; BACTERIA; GROWTH		[Arrieta, Jesus M.; Duarte, Carlos M.] King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Red Sea Res Ctr, Thuwal 239556900, Saudi Arabia; [Arrieta, Jesus M.; Mayol, Eva; Duarte, Carlos M.] UIB, CSIC, Inst Mediterrani Estudis Avancats IMEDEA, Dept Global Change Res, Esporles 07190, Spain; [Hansman, Roberta L.; Herndl, Gerhard J.] Univ Vienna, Div Biooceanog, Dept Limnol & Biooceanog, A-1090 Vienna, Austria; [Herndl, Gerhard J.] Royal Netherlands Inst Sea Res NIOZ, Dept Biol Oceanog, NL-1790 AB Den Burg, Netherlands; [Dittmar, Thorsten] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm ICBM, ICBM MPI Bridging Grp, Res Grp Marine Geochem, Oldenburg, Germany	King Abdullah University of Science & Technology; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; University of Vienna; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Carl von Ossietzky Universitat Oldenburg	Arrieta, JM (corresponding author), King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Red Sea Res Ctr, Thuwal 239556900, Saudi Arabia.	jesus.arrieta@kaust.edu.sa	Duarte, Carlos M/A-7670-2013; Herndl, Gerhard J./B-1513-2013; Herndl, Gerhard J./S-3011-2019; Duarte Quesada, Carlos Manuel/ABD-6208-2021; Dittmar, Thorsten/L-7796-2013; Arrieta, Jesus M/B-1226-2008	Duarte, Carlos M/0000-0002-1213-1361; Herndl, Gerhard J./0000-0002-2223-2852; Herndl, Gerhard J./0000-0002-2223-2852; Dittmar, Thorsten/0000-0002-3462-0107; Arrieta, Jesus M/0000-0002-0190-6950; Hansman, Roberta/0000-0003-1525-8509	Austrian Science Fund (FWF) [Z 194] Funding Source: researchfish; Austrian Science Fund FWF [Z 194] Funding Source: Medline	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund FWF(Austrian Science Fund (FWF))		Arrieta JM, 2015, SCIENCE, V348, P331, DOI 10.1126/science.1258955; Hansell DA, 2013, ANNU REV MAR SCI, V5, P421, DOI 10.1146/annurev-marine-120710-100757; JANNASCH HW, 1967, LIMNOL OCEANOGR, V12, P264, DOI 10.4319/lo.1967.12.2.0264; Jiao N, 2014, BIOGEOSCIENCES, V11, P5285, DOI 10.5194/bg-11-5285-2014; Jiao NZ, 2015, SCIENCE, V350, DOI 10.1126/science.aab2713; Jiao N, 2010, NAT REV MICROBIOL, V8, P593, DOI 10.1038/nrmicro2386; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; Ogawa H, 2001, SCIENCE, V292, P917, DOI 10.1126/science.1057627; Osterholz H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8422; Sinsabaugh RL., 2003, AQUATIC ECOSYSTEMS I, P479, DOI DOI 10.1080/09593330.2014.903301	10	6	6	4	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2015	350	6267								10.1126/science.aac7249	http://dx.doi.org/10.1126/science.aac7249			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY7LY	26680189	Green Submitted			2022-12-28	WOS:000366591100044
J	McCalla, E; Abakumov, AM; Saubanere, M; Foix, D; Berg, EJ; Rousse, G; Doublet, ML; Gonbeau, D; Novak, P; Van Tendeloo, G; Dominko, R; Tarascon, JM				McCalla, Eric; Abakumov, Artem M.; Saubanere, Matthieu; Foix, Dominique; Berg, Erik J.; Rousse, Gwenaelle; Doublet, Marie-Liesse; Gonbeau, Danielle; Novak, Petr; Van Tendeloo, Gustaaf; Dominko, Robert; Tarascon, Jean-Marie			Visualization of O-O peroxo-like dimers in high-capacity layered oxides for Li-ion batteries	SCIENCE			English	Article							X-RAY-ABSORPTION; ELECTRODE MATERIALS; POSITIVE ELECTRODE; CHARGE COMPENSATION; CATHODE MATERIALS; ANIONIC REDOX; LITHIUM; INTERCALATION; DIFFRACTION; CRYSTAL	Lithium-ion (Li-ion) batteries that rely on cationic redox reactions are the primary energy source for portable electronics. One pathway toward greater energy density is through the use of Li-rich layered oxides. The capacity of this class of materials (>270 milliampere hours per gram) has been shown to be nested in anionic redox reactions, which are thought to form peroxo-like species. However, the oxygen-oxygen (O-O) bonding pattern has not been observed in previous studies, nor has there been a satisfactory explanation for the irreversible changes that occur during first delithiation. By using Li2IrO3 as a model compound, we visualize the O-O dimers via transmission electron microscopy and neutron diffraction. Our findings establish the fundamental relation between the anionic redox process and the evolution of the O-O bonding in layered oxides.	[McCalla, Eric; Rousse, Gwenaelle; Tarascon, Jean-Marie] Coll France, Chim Solide & Energie, FRE 3677, 11 Pl Marcelin Berthelot, F-75231 Paris 05, France; [McCalla, Eric; Saubanere, Matthieu; Foix, Dominique; Doublet, Marie-Liesse; Gonbeau, Danielle; Tarascon, Jean-Marie] FR CNRS 3104, ALISTORE European Res Inst, F-80039 Amiens, France; [McCalla, Eric; Saubanere, Matthieu; Foix, Dominique; Rousse, Gwenaelle; Doublet, Marie-Liesse; Gonbeau, Danielle; Tarascon, Jean-Marie] FR CNRS 3459, RS2E, Paris, France; [McCalla, Eric; Dominko, Robert] Natl Inst Chem, SI-1000 Ljubljana, Slovenia; [Abakumov, Artem M.; Van Tendeloo, Gustaaf] Univ Antwerp, Electron Microscopy Mat Sci EMAT, B-2020 Antwerp, Belgium; [Abakumov, Artem M.] Skolkovo Inst Sci & Technol, Ctr Electrochem Energy Storage, Moscow 143026, Russia; [Saubanere, Matthieu; Doublet, Marie-Liesse] Univ Montpellier, CNRS UMR 5253, Inst Charles Gerhardt, F-34095 Montpellier, France; [Foix, Dominique; Gonbeau, Danielle] Univ Pau, IPREM ECP UMR 5254, F-64053 Pau 9, France; [Berg, Erik J.; Novak, Petr] Paul Scherrer Inst, Electrochem Lab, CH-5232 Villigen, Switzerland; [Rousse, Gwenaelle; Tarascon, Jean-Marie] Univ Paris 06, Sorbonne Univ, F-75005 Paris, France	UDICE-French Research Universities; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); National Institute of Chemistry - Slovenia; University of Antwerp; Skolkovo Institute of Science & Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Pau et des Pays de l'Adour; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; UDICE-French Research Universities; Sorbonne Universite	Tarascon, JM (corresponding author), Coll France, Chim Solide & Energie, FRE 3677, 11 Pl Marcelin Berthelot, F-75231 Paris 05, France.	jean-marie.tarascon@college-de-france.fr	Tarascon, Jean-Marie/B-5952-2016; DOUBLET, Marie-Liesse/C-6514-2016; Berg, Erik J./AAG-9424-2020; ROUSSE, Gwenaelle/N-7748-2013; J. Berg, Erik/G-4999-2017; Abakumov, Artem/N-4901-2019; Dominko, Robert/K-6476-2019; Saubanère, Matthieu/L-7121-2014	DOUBLET, Marie-Liesse/0000-0002-8495-2716; Berg, Erik J./0000-0001-5653-0383; ROUSSE, Gwenaelle/0000-0001-8877-0015; J. Berg, Erik/0000-0001-5653-0383; Dominko, Robert/0000-0002-6673-4459; Saubanère, Matthieu/0000-0002-9900-6175; Abakumov, Artem/0000-0002-7135-4629; Novak, Petr/0000-0001-6993-5021	Fonds de Recherche du Quebec-Nature et Technologies; ALISTORE-European Research Institute; European community I3 networks; Slovenian Research Agency [P2-0148]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; GENCI-CCRT/CINES [cmm6691]; European Research Council (ERC) [670116-ARPEMA]	Fonds de Recherche du Quebec-Nature et Technologies; ALISTORE-European Research Institute; European community I3 networks; Slovenian Research Agency(Slovenian Research Agency - Slovenia); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); GENCI-CCRT/CINES; European Research Council (ERC)(European Research Council (ERC))	E.M. thanks the Fonds de Recherche du Quebec-Nature et Technologies and ALISTORE-European Research Institute for funding this work, as well as the European community I3 networks for funding the neutron scattering research trip. This work was also funded by the Slovenian Research Agency research program P2-0148. This work is partially based on experiments performed at the Institut Laue Langevin. We thank J. Rodriguez-Carvajal for help with neutron scattering experiments and for fruitful discussions. We also thank M. T. Sougrati for performing the Sn-Mossbauer measurements. Use of the Advanced Photon Source at Argonne National Laboratory was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract no. DE-AC02-06CH11357. M.S. and M.-L.D. acknowledge high-performance computational resources from GENCI-CCRT/CINES (grant cmm6691). J.-M.T. acknowledges funding from the European Research Council (ERC) (FP/2014-2020)/ERC Grant-Project670116-ARPEMA.	Armstrong AR, 2006, J AM CHEM SOC, V128, P8694, DOI 10.1021/ja062027+; Aydinol MK, 1997, PHYS REV B, V56, P1354, DOI 10.1103/PhysRevB.56.1354; Batuk D, 2015, ACTA CRYSTALLOGR B, V71, P127, DOI 10.1107/S2052520615005466; Ceder G, 1998, NATURE, V392, P694, DOI 10.1038/33647; Chang CC, 2004, J ELECTROCHEM SOC, V151, pJ91, DOI 10.1149/1.1809584; Ellis BL, 2010, CHEM MATER, V22, P691, DOI 10.1021/cm902696j; Findlay SD, 2010, ULTRAMICROSCOPY, V110, P903, DOI 10.1016/j.ultramic.2010.04.004; Graetz J, 2003, J PHYS CHEM B, V107, P2887, DOI 10.1021/jp026484y; Grasset F, 1997, J MATER CHEM, V7, P1911, DOI 10.1039/a701085k; Gu L, 2015, ADV MATER, V27, P2134, DOI 10.1002/adma.201404620; Ishikawa R, 2011, NAT MATER, V10, P278, DOI 10.1038/NMAT2957; Kobayashi H, 2003, J MATER CHEM, V13, P957, DOI 10.1039/b207282c; Koga H, 2014, J PHYS CHEM C, V118, P5700, DOI 10.1021/jp412197z; Laha S, 2015, PHYS CHEM CHEM PHYS, V17, P3749, DOI 10.1039/c4cp05052e; Lee J, 2014, SCIENCE, V343, P519, DOI 10.1126/science.1246432; Lu ZH, 2002, J ELECTROCHEM SOC, V149, pA778, DOI 10.1149/1.1471541; McCalla E, 2015, J ELECTROCHEM SOC, V162, pA1341, DOI 10.1149/2.0991507jes; McCalla E, 2015, J AM CHEM SOC, V137, P4804, DOI 10.1021/jacs.5b01424; Oishi M, 2015, J POWER SOURCES, V276, P89, DOI 10.1016/j.jpowsour.2014.11.104; Rouxel J, 1996, CHEM-EUR J, V2, P1053, DOI 10.1002/chem.19960020904; Sathiya M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7276; Sathiya M, 2015, NAT MATER, V14, P230, DOI [10.1038/NMAT4137, 10.1038/nmat4137]; Sathiya M, 2013, CHEM COMMUN, V49, P11376, DOI 10.1039/c3cc46842a; Sathiya M, 2013, NAT MATER, V12, P827, DOI [10.1038/nmat3699, 10.1038/NMAT3699]; Sathiya M, 2013, CHEM MATER, V25, P1121, DOI 10.1021/cm400193m; Tarascon JM, 1999, J SOLID STATE CHEM, V147, P410, DOI 10.1006/jssc.1999.8465; Thackeray MM, 2005, J MATER CHEM, V15, P2257, DOI 10.1039/b417616m; Yabuuchi N, 2015, P NATL ACAD SCI USA, V112, P7650, DOI 10.1073/pnas.1504901112; Yin SC, 2006, CHEM MATER, V18, P1901, DOI 10.1021/cm0511769; Yoon WS, 2002, J PHYS CHEM B, V106, P2526, DOI 10.1021/jp013735e	30	523	528	43	835	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2015	350	6267					1516	1521		10.1126/science.aac8260	http://dx.doi.org/10.1126/science.aac8260			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY7LY	26680196	Green Submitted			2022-12-28	WOS:000366591100056
J	Roobol, M				Roobol, Monique			Enforce the clinical guidelines	NATURE			English	Editorial Material							PROSTATE-SPECIFIC ANTIGEN; CANCER ERSPC; FOLLOW-UP; TRIAL		[Roobol, Monique] Erasmus Univ, Dept Urol, NL-3000 DR Rotterdam, Netherlands	Erasmus University Rotterdam	Roobol, M (corresponding author), Erasmus Univ, Dept Urol, NL-3000 DR Rotterdam, Netherlands.	m.roobol@erasmusmc.nl						American Cancer Society, 2015, WHAT ARE KEY STAT PR; Andriole GL, 2012, J NATL CANCER I, V104, P125, DOI 10.1093/jnci/djr500; CATALONA WJ, 1994, J UROLOGY, V151, P1283, DOI 10.1016/S0022-5347(17)35233-3; Eggener SE, 2015, JAMA-J AM MED ASSOC, V314, P825, DOI 10.1001/jama.2015.8033; Nordstrom T, 2013, EUR UROL, V63, P419, DOI 10.1016/j.eururo.2012.10.001; Schroder FH, 2014, LANCET, V384, P2027, DOI 10.1016/S0140-6736(14)60525-0; Schroder FH, 2012, EUR UROL, V62, P745, DOI 10.1016/j.eururo.2012.05.068; Vickers A, 2014, EUR UROL, V66, P188, DOI 10.1016/j.eururo.2013.12.049	8	7	7	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2015	528	7582					S123	S123		10.1038/528S123a	http://dx.doi.org/10.1038/528S123a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY8SM	26672782				2022-12-28	WOS:000366678600002
J	Wadman, M				Wadman, Meredith			When less is more	NATURE			English	Editorial Material							LOCALIZED PROSTATE-CANCER; ACTIVE SURVEILLANCE											Cooperberg MR, 2015, JAMA-J AM MED ASSOC, V314, P80, DOI 10.1001/jama.2015.6036; Eggener SE, 2011, J UROLOGY, V185, P869, DOI 10.1016/j.juro.2010.10.057; Klotz L, 2015, J CLIN ONCOL, V33, P272, DOI 10.1200/JCO.2014.55.1192; Loeb S, 2013, J UROLOGY, V190, P1742, DOI 10.1016/j.juro.2013.05.054; Sweeney CJ, 2015, NEW ENGL J MED, V373, P737, DOI 10.1056/NEJMoa1503747; Thomsen FB, 2014, J SURG ONCOL, V109, P830, DOI 10.1002/jso.23584; Tosoian JJ, 2015, J CLIN ONCOL	7	2	2	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2015	528	7582					S126	S127		10.1038/528S126a	http://dx.doi.org/10.1038/528S126a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY8SM	26672784	Bronze			2022-12-28	WOS:000366678600004
J	Crisp, N				Crisp, Nigel			CHRISTMAS 2015: CALL TO ACTION Everyone has a role in building a health creating society	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material											Crisp, N (corresponding author), House Lords, London SW1A 0PW, England.	crisp@parliament.uk		Crisp, Nigel/0000-0002-9452-095X				[Anonymous], 2013, HLTH LIT SOLID FACTS; Barker D, 2008, NUTR WOMB BETTER NUT; Carers UK Circle University of Leeds, 2011, CALC VAL CAR SUPP; Crisp N., 2015, HOUSE LORDS OFFICIAL; Department for Education, 2010, ACH CHILDR EARL YEAR; Gov. uk, SPEND REV AUT STAT 2; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Marmot M, 2015, HLTH GAP CHALLENGE U; NHS England, 2014, 5 YEAR FORW VIEW; NHS England Public Health England, 2014, SUST RES HLTH PEOPL; Omaswa F, 2014, AFRICAN HLTH LEADERS; Stevenson J, 2014, EXPLAINING LEVELS WE; Thornicroft G, 2011, BRIT J PSYCHIAT, V199, P441, DOI 10.1192/bjp.bp.111.092718	13	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 16	2015	351								h6654	10.1136/bmj.h6654	http://dx.doi.org/10.1136/bmj.h6654			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ4MP	26676121				2022-12-28	WOS:000367077600011
J	Baang, J				Baang, Jihoon			Pericoital application of tenofovir gel reduced risk for herpes simplex virus type 2 in HIV-negative women	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							TRANSMISSION		[Baang, Jihoon] Temple Univ, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Baang, J (corresponding author), Temple Univ, Philadelphia, PA 19122 USA.			Baang, Jihoon/0000-0002-5925-4289				CAMERON DW, 1989, LANCET, V2, P403; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Weiss H, 2004, HERPES S, V11, p24A	5	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	2015	163	12							JC6	10.7326/ACPJC-2015-163-12-006	http://dx.doi.org/10.7326/ACPJC-2015-163-12-006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY4BS	26666808				2022-12-28	WOS:000366354200006
J	Ehrhardt, S; Appel, LJ; Meinert, CL				Ehrhardt, Stephan; Appel, Lawrence J.; Meinert, Curtis L.			Trends in National Institutes of Health Funding for Clinical Trials Registered in ClinicalTrials.gov	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Ehrhardt, Stephan; Meinert, Curtis L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, 615 N Wolfe St, Baltimore, MD 21205 USA; [Appel, Lawrence J.] Johns Hopkins Univ, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Ehrhardt, S (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, 615 N Wolfe St, Baltimore, MD 21205 USA.	sehrhard@jhsph.edu	Ehrhardt, Stephan/D-8957-2017; Appel, Larry/GLT-2608-2022		NIDDK NIH HHS [P30 DK072488] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072488] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		National Institutes of Health Office of Budget, 2015, APPR HIST I CTR 1938	1	70	70	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 15	2015	314	23					2566	2567		10.1001/jama.2015.12206	http://dx.doi.org/10.1001/jama.2015.12206			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY4PV	26670975	Green Accepted, Bronze			2022-12-28	WOS:000366391500024
J	Talley, NJ				Talley, Nicholas J.			Use of olmesartan for >= 1 year was associated with hospitalization for intestinal malabsorption	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ENTEROPATHY		[Talley, Nicholas J.] Univ Newcastle, Callaghan, NSW 2308, Australia	University of Newcastle	Talley, NJ (corresponding author), Univ Newcastle, Callaghan, NSW 2308, Australia.							Marietta EV, 2015, ALIMENT PHARM THER, V42, P1303, DOI 10.1111/apt.13413; Marthey L, 2014, ALIMENT PHARM THER, V40, P1103, DOI 10.1111/apt.12937; Rubio-Tapia A, 2012, MAYO CLIN PROC, V87, P732, DOI 10.1016/j.mayocp.2012.06.003; Rubio-Tapia A, 2010, CLIN GASTROENTEROL H, V8, P344, DOI 10.1016/j.cgh.2009.12.023	4	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	2015	163	12							JC13	10.7326/ACPJC-2015-163-12-013	http://dx.doi.org/10.7326/ACPJC-2015-163-12-013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY4BS	26666803				2022-12-28	WOS:000366354200013
J	Coombes, R				Coombes, Rebecca			Five ways for hospitals to tackle winter pressure	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												rcoombes@bmj.com						BMA, 2013, BEAT EFF WINT PRESS; Health Foundation, HELP HLTH CAR FLOW W; NICE, TRANS INP HOSP SETT	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 10	2015	351								h6674	10.1136/bmj.h6674	http://dx.doi.org/10.1136/bmj.h6674			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY5TG	26656571				2022-12-28	WOS:000366469700004
J	DeAngelis, AM; Qu, X; Zelinka, MD; Hall, A				DeAngelis, Anthony M.; Qu, Xin; Zelinka, Mark D.; Hall, Alex			An observational radiative constraint on hydrologic cycle intensification	NATURE			English	Article							EARTH SYSTEM MODEL; K-DISTRIBUTION; PART I; CLIMATE SENSITIVITY; GASEOUS ABSORPTION; SOLAR-RADIATION; COUPLED MODEL; WATER-VAPOR; CIRCULATION; PARAMETERIZATION	Intensification of the hydrologic cycle is a key dimension of climate change, with substantial impacts on human and natural systems(1,2). A basic measure of hydrologic cycle intensification is the increase in global-mean precipitation per unit surface warming, which varies by a factor of three in current-generation climate models (about 1-3 per cent per kelvin)(3-5). Part of the uncertainty may originate from atmosphere-radiation interactions. As the climate warms, increases in shortwave absorption from atmospheric moistening will suppress the precipitation increase. This occurs through a reduction of the latent heating increase required to maintain a balanced atmospheric energy budget(6,7). Using an ensemble of climate models, here we show that such models tend to underestimate the sensitivity of solar absorption to variations in atmospheric water vapour, leading to an underestimation in the shortwave absorption increase and an overestimation in the precipitation increase. This sensitivity also varies considerably among models due to differences in radiative transfer parameterizations, explaining a substantial portion of model spread in the precipitation response. Consequently, attaining accurate shortwave absorption responses through improvements to the radiative transfer schemes could reduce the spread in the predicted global precipitation increase per degree warming for the end of the twenty-first century by about 35 per cent, and reduce the estimated ensemble-mean increase in this quantity by almost 40 per cent.	[DeAngelis, Anthony M.; Qu, Xin; Hall, Alex] Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA 90095 USA; [Zelinka, Mark D.] Lawrence Livermore Natl Lab, Program Climate Model Diag & Intercomparison, Livermore, CA 94550 USA	University of California System; University of California Los Angeles; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	DeAngelis, AM (corresponding author), Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA 90095 USA.	adeangelis@ucla.edu	Hall, Alex/D-8175-2014; Zelinka, Mark/C-4627-2011	Zelinka, Mark/0000-0002-6570-5445	Regional and Global Climate Modeling Program of the Office of Science of the US Department of Energy; US Department of Energy [DE-AC52-07NA27344]	Regional and Global Climate Modeling Program of the Office of Science of the US Department of Energy; US Department of Energy(United States Department of Energy (DOE))	All authors were supported by the Regional and Global Climate Modeling Program of the Office of Science of the US Department of Energy. The work of M.D.Z. was performed under the auspices of the US Department of Energy by Lawrence Livermore National Laboratory under contract DE-AC52-07NA27344. We acknowledge the World Climate Research Programme's Working Group on Coupled Modelling, which is responsible for CMIP, and we thank the climate modelling groups (listed in Extended Data Table 1) for producing and making available their model output. For CMIP, the US Department of Energy's Program for Climate Model Diagnosis and Intercomparison provided coordinating support and led development of software infrastructure in partnership with the Global Organization for Earth System Science Portals. We acknowledge use of the CERES-EBAF flux data obtained from the National Aeronautics and Space Administration (NASA) Langley Research Center (http://ceres.larc.nasa.gov/order_data.php), the ISCCP-FD data obtained from the NASA Goddard Institute for Space Studies (http://isccp.giss.nasa.gov/projects/flux.html), the SSM/I data obtained from the National Oceanic and Atmospheric Administration (NOAA) National Climatic Data Center (http://www.ncdc.noaa.gov/oa/rsad/ssmi/gridded/index.php), and the RSS data obtained from Remote Sensing Systems (http://www.remss.com/measurements/atmospheric-water-vapor/tpw-1-deg-product). We thank M. Previdi for providing the radiative kernels. We also thank S. A. Klein, K. E. Taylor, P. M. Caldwell, A. A. Lacis, R. Pincus and A. J. Broccoli for discussion on the topic.	Allan RP, 2014, SURV GEOPHYS, V35, P533, DOI 10.1007/s10712-012-9213-z; Allen MR, 2002, NATURE, V419, P224, DOI 10.1038/nature01092; Anderson JL, 2004, J CLIMATE, V17, P4641, DOI 10.1175/JCLI-3223.1; Andrews T, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043991; Andrews T, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/2/025212; Andrews T, 2009, J CLIMATE, V22, P2557, DOI 10.1175/2008JCLI2759.1; Arkin PA, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/3/035201; Bala G, 2010, CLIM DYNAM, V35, P423, DOI 10.1007/s00382-009-0583-y; Bentsen M, 2013, GEOSCI MODEL DEV, V6, P687, DOI 10.5194/gmd-6-687-2013; Bi DH, 2013, AUST METEOROL OCEAN, V63, P41, DOI 10.22499/2.6301.004; Bony S, 2013, NAT GEOSCI, V6, P447, DOI [10.1038/ngeo1799, 10.1038/NGEO1799]; BRIEGLEB BP, 1992, J GEOPHYS RES-ATMOS, V97, P7603, DOI 10.1029/92JD00291; Chylek P., 2011, ATMOS CHEM PHYS DISC, V11, P22893, DOI 10.5194/acpd-11-22893-2011; Collins WD, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006713; Collins W.D., 2004, NCARTTN464STR226, DOI 10.5065/ D63N21CH; Collins WJ, 2011, GEOSCI MODEL DEV, V4, P1051, DOI 10.5194/gmd-4-1051-2011; Collins WD, 2006, J GEOPHYS RES-ATMOS, V111, P18, DOI DOI 10.1029/2005JD006796; Cusack S, 1999, J GEOPHYS RES-ATMOS, V104, P2051, DOI 10.1029/1998JD200063; Devore J. L., 2008, PROBABILITY STAT ENG, p12 446; Dong BW, 2009, J CLIMATE, V22, P3079, DOI 10.1175/2009JCLI2652.1; Donner LJ, 2011, J CLIMATE, V24, P3484, DOI 10.1175/2011JCLI3955.1; Dufresne JL, 2013, CLIM DYNAM, V40, P2123, DOI 10.1007/s00382-012-1636-1; Dunne JP, 2012, J CLIMATE, V25, P6646, DOI 10.1175/JCLI-D-11-00560.1; Edwards JM, 1996, Q J ROY METEOR SOC, V122, P689, DOI 10.1002/qj.49712253107; Ferraro RR, 1996, B AM METEOROL SOC, V77, P891, DOI 10.1175/1520-0477(1996)077<0891:AEYTSO>2.0.CO;2; Fouquart Y., 1980, Contributions to Atmospheric Physics, V53, P35; Freidenreich SM, 1999, J GEOPHYS RES-ATMOS, V104, P31389, DOI 10.1029/1999JD900456; Galin V.Y., 1998, IZV ATMOS OCEAN PHY+, V34, P339; Gent PR, 2011, J CLIMATE, V24, P4973, DOI 10.1175/2011JCLI4083.1; Gregory JM, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018747; HANSEN J, 1983, MON WEATHER REV, V111, P609, DOI 10.1175/1520-0493(1983)111<0609:ETDGMF>2.0.CO;2; Hewitt HT, 2011, GEOSCI MODEL DEV, V4, P223, DOI 10.5194/gmd-4-223-2011; Hourdin F, 2013, CLIM DYNAM, V40, P2193, DOI 10.1007/s00382-012-1343-y; Iacono MJ, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD009944; Jungclaus JH, 2013, J ADV MODEL EARTH SY, V5, P422, DOI 10.1002/jame.20023; Kato S, 1999, J QUANT SPECTROSC RA, V62, P109, DOI 10.1016/S0022-4073(98)00075-2; Kato S, 2013, J CLIMATE, V26, P2719, DOI 10.1175/JCLI-D-12-00436.1; Kato S, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016050; Kharin VV, 2013, CLIMATIC CHANGE, V119, P345, DOI 10.1007/s10584-013-0705-8; Kidwell K. B., 1995, NOAA POLAR ORBITER D; LACIS AA, 1991, J GEOPHYS RES-ATMOS, V96, P9027, DOI 10.1029/90JD01945; LACIS AA, 1974, J ATMOS SCI, V31, P118, DOI 10.1175/1520-0469(1974)031<0118:APFTAO>2.0.CO;2; Lambert FH, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034838; Li J, 2005, J ATMOS SCI, V62, P286, DOI 10.1175/JAS-3396.1; Lu JH, 2009, J HYDROMETEOROL, V10, P347, DOI 10.1175/2008JHM1058.1; MANABE S, 1975, J ATMOS SCI, V32, P3, DOI 10.1175/1520-0469(1975)032<0003:TEODTC>2.0.CO;2; Martin GM, 2006, J CLIMATE, V19, P1274, DOI 10.1175/JCLI3636.1; Mauritsen T, 2015, NAT GEOSCI, V8, P346, DOI 10.1038/NGEO2414; MITCHELL JFB, 1987, Q J ROY METEOR SOC, V113, P293, DOI 10.1256/smsqj.47516; Mlawer E., 1997, P 6 ATM RAD MEAS ARM; MORCRETTE JJ, 1991, J GEOPHYS RES-ATMOS, V96, P9121, DOI 10.1029/89JD01597; Neale R. B., 2010, NCARTN485STR, V1, P1; O'Gorman PA, 2012, SURV GEOPHYS, V33, P585, DOI 10.1007/s10712-011-9159-6; Oreopoulos L, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016821; Paynter D, 2014, J GEOPHYS RES-ATMOS, V119, P10720, DOI 10.1002/2014JD021881; Pendergrass AG, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050067; Pendergrass AG, 2014, J CLIMATE, V27, P8372, DOI 10.1175/JCLI-D-14-00183.1; Pendergrass AG, 2014, J CLIMATE, V27, P757, DOI 10.1175/JCLI-D-13-00163.1; Pincus R, 2015, GEOPHYS RES LETT, V42, P5485, DOI 10.1002/2015GL064291; Previdi M, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/2/025211; Remote Sensing Systems, 2012, MONTHL MEAN TOT PREC; Rose F., 2006, 12 C ATM RAD; Schmidt GA, 2006, J CLIMATE, V19, P153, DOI 10.1175/JCLI3612.1; Schmidt GA, 2014, J ADV MODEL EARTH SY, V6, P141, DOI 10.1002/2013MS000265; Sekiguchi M, 2008, J QUANT SPECTROSC RA, V109, P2779, DOI 10.1016/j.jqsrt.2008.07.013; Stevens B, 2013, J ADV MODEL EARTH SY, V5, P146, DOI 10.1002/jame.20015; Takahashi K, 2009, J CLIMATE, V22, P5667, DOI 10.1175/2009JCLI2674.1; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Trenberth KE, 2011, CLIM RES, V47, P123, DOI 10.3354/cr00953; Voldoire A, 2013, CLIM DYNAM, V40, P2091, DOI 10.1007/s00382-011-1259-y; Volodin EM, 2010, IZV ATMOS OCEAN PHY+, V46, P414, DOI 10.1134/S000143381004002X; Watanabe M, 2010, J CLIMATE, V23, P6312, DOI 10.1175/2010JCLI3679.1; Watanabe S, 2011, GEOSCI MODEL DEV, V4, P845, DOI 10.5194/gmd-4-845-2011; Wielicki BA, 1996, B AM METEOROL SOC, V77, P853, DOI 10.1175/1520-0477(1996)077<0853:CATERE>2.0.CO;2; Wu TW, 2010, CLIM DYNAM, V34, P123, DOI 10.1007/s00382-008-0487-2; Yang FL, 2003, J CLIMATE, V16, P2419, DOI 10.1175/2779.1; Yukimoto S., 2011, TECH REP METEOROL RE, V64, P1; Yukimoto S, 2012, J METEOROL SOC JPN, V90A, P23, DOI 10.2151/jmsj.2012-A02; Zhang YC, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004457	80	83	85	5	84	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 10	2015	528	7581					249	+		10.1038/nature15770	http://dx.doi.org/10.1038/nature15770			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9VH	26659186	Green Submitted			2022-12-28	WOS:000366053300038
J	Aspenberg, P				Aspenberg, Per			ACADEMIC AUTHORSHIP How I was nearly duped into "authoring" a fake paper	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Aspenberg, Per] Linkoping Univ, S-58183 Linkoping, Sweden	Linkoping University	Aspenberg, P (corresponding author), Linkoping Univ, S-58183 Linkoping, Sweden.	per.aspenberg@liu.se							0	1	1	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 8	2015	351								h6605	10.1136/bmj.h6605	http://dx.doi.org/10.1136/bmj.h6605			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY5SV	26646618				2022-12-28	WOS:000366468600007
J	Gupta, R; Arora, VM				Gupta, Reshma; Arora, Vineet M.			Merging the Health System and Education Silos to Better Educate Future Physicians	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gupta, Reshma] VA Los Angeles Healthcare Syst, Los Angeles, CA USA; [Gupta, Reshma] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90024 USA; [Arora, Vineet M.] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Chicago	Gupta, R (corresponding author), Univ Calif Los Angeles, Dept Med, 10940 Wilshire Blvd,Ste 710, Los Angeles, CA 90024 USA.	r44gupta@ucla.edu		Arora, Vineet/0000-0002-4745-7599				Chen C, 2014, JAMA-J AM MED ASSOC, V312, P2385, DOI 10.1001/jama.2014.15973; CLER Evaluation Committee Members, CLER PATHW EXC EXP O; Fleischut PM, 2012, JT COMM J QUAL PATIE, V38, P311, DOI 10.1016/S1553-7250(12)38041-0; Frankel Allan, 2003, Jt Comm J Qual Saf, V29, P16; Pincavage AT, 2014, AM J MED, V127, P96, DOI 10.1016/j.amjmed.2013.09.024; Politsmakher A, 2013, AM J MED, V126, P894, DOI 10.1016/j.amjmed.2013.06.013; The UCSF Center for Healthcare Value, CAR WIS	7	25	25	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 8	2015	314	22					2349	2350		10.1001/jama.2015.13574	http://dx.doi.org/10.1001/jama.2015.13574			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX8XT	26647251				2022-12-28	WOS:000365989100004
J	Levy, M; Thaiss, CA; Zeevi, D; Dohnalova, L; Zilberman-Schapira, G; Mahdi, JA; David, E; Savidor, A; Korem, T; Herzig, Y; Pevsner-Fischer, M; Shapiro, H; Christ, A; Harmelin, A; Halpern, Z; Latz, E; Flavell, RA; Amit, I; Segal, E; Elinav, E				Levy, Maayan; Thaiss, Christoph A.; Zeevi, David; Dohnalova, Lenka; Zilberman-Schapira, Gili; Mahdi, Jemal Ali; David, Eyal; Savidor, Alon; Korem, Tal; Herzig, Yonatan; Pevsner-Fischer, Meirav; Shapiro, Hagit; Christ, Anette; Harmelin, Alon; Halpern, Zamir; Latz, Eicke; Flavell, Richard A.; Amit, Ido; Segal, Eran; Elinav, Eran			Microbiota-Modulated Metabolites Shape the Intestinal Microenvironment by Regulating NLRP6 Inflammasome Signaling	CELL			English	Article							IMMUNE-SYSTEM; GASTROINTESTINAL-TRACT; DIETARY TAURINE; GUT MICROBIOME; COLITIS; MICE; TUMORIGENESIS; INTERFACE; EXPANSION; OBESITY	Host-microbiome co-evolution drives homeostasis and disease susceptibility, yet regulatory principles governing the integrated intestinal hostcommensal microenvironment remain obscure. While inflammasome signaling participates in these interactions, its activators and microbiome-modulating mechanisms are unknown. Here, we demonstrate that the microbiota-associated metabolites taurine, histamine, and spermine shape the host-microbiome interface by co-modulating NLRP6 inflammasome signaling, epithelial IL-18 secretion, and downstream anti-microbial peptide (AMP) profiles. Distortion of this balanced AMP landscape by inflammasome deficiency drives dysbiosis development. Upon fecal transfer, colitis-inducing microbiota hijacks this microenvironment-orchestrating machinery through metabolite-mediated inflammasome suppression, leading to distorted AMP balance favoring its preferential colonization. Restoration of the metabolite-inflammasome-AMP axis reinstates a normal microbiota and ameliorates colitis. Together, we identify microbial modulators of the NLRP6 inflammasome and highlight mechanisms by which microbiome-host interactions cooperatively drive microbial community stability through metabolite-mediated innate immune modulation. Therefore, targeted "postbiotic" metabolomic intervention may restore a normal microenvironment as treatment or prevention of dysbiosis-driven diseases.	[Levy, Maayan; Thaiss, Christoph A.; Dohnalova, Lenka; Zilberman-Schapira, Gili; Mahdi, Jemal Ali; David, Eyal; Herzig, Yonatan; Pevsner-Fischer, Meirav; Shapiro, Hagit; Amit, Ido; Elinav, Eran] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Zeevi, David; Korem, Tal; Segal, Eran] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Zeevi, David; Korem, Tal; Segal, Eran] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Mahdi, Jemal Ali] Ben Gurion Univ Negev, IL-8410501 Beer Sheva, Israel; [Savidor, Alon] Weizmann Inst Sci, Grand Israel Natl Ctr Personalized Med G INCPM, IL-76100 Rehovot, Israel; [Christ, Anette; Latz, Eicke] Univ Bonn, Inst Innate Immun, D-53127 Bonn, Germany; [Christ, Anette; Latz, Eicke] Univ Massachusetts, Dept Med, Worcester, MA 01605 USA; [Harmelin, Alon] Weizmann Inst Sci, Dept Vet Resources, IL-76100 Rehovot, Israel; [Halpern, Zamir] Tel Aviv Univ, Res Ctr Digest Tract & Liver Dis, Tel Aviv Sourasky Med Ctr, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Harmelin, Alon] Tel Aviv Sourasky Med Ctr, Digest Ctr, IL-64239 Tel Aviv, Israel; [Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Ben Gurion University; Weizmann Institute of Science; University of Bonn; University of Massachusetts System; University of Massachusetts Worcester; Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Howard Hughes Medical Institute; Yale University; Yale University	Segal, E (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel.	eran.segal@weizmann.ac.il; eran.elinav@weizmann.ac.il	Korem, Tal/D-4155-2018; Segal, Eran/AAF-4855-2019; Latz, Eicke/H-3951-2014; Shapiro, Hagit/F-8648-2015; Elinav, Eran/ABE-8881-2020	Korem, Tal/0000-0002-0609-0858; Latz, Eicke/0000-0003-1488-5666; Elinav, Eran/0000-0002-5775-2110; Zeevi, David/0000-0002-6492-6078; Dohnalova, Lenka/0000-0002-2761-2547; Segal, Eran/0000-0002-6859-1164	Boehringer Ingelheim Fonds; Ministry of Science, Technology, and Space, Israel; Foulkes Foundation; European Research Council (ERC); Israel Science Foundation (ISF); Yael and Rami Ungar, Israel; Leona M. and Harry B. Helmsley Charitable Trust; Gurwin Family Fund for Scientific Research; Crown Endowment Fund for Immunological Research; estate of Jack Gitlitz; estate of Lydia Hershkovich; Benoziyo Endowment Fund for the Advancement of Science; Adelis Foundation; French National Centre for Scientific Research (CNRS); European Research Council; German-Israel Binational Foundation; Israel Science Foundation; Minerva Foundation; Rising Tide Foundation; Alon Foundation; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034989] Funding Source: NIH RePORTER	Boehringer Ingelheim Fonds(Boehringer Ingelheim); Ministry of Science, Technology, and Space, Israel(Ministry of Science, Technology and Space (MOST), Israel); Foulkes Foundation; European Research Council (ERC)(European Research Council (ERC)European Commission); Israel Science Foundation (ISF)(Israel Science Foundation); Yael and Rami Ungar, Israel; Leona M. and Harry B. Helmsley Charitable Trust; Gurwin Family Fund for Scientific Research; Crown Endowment Fund for Immunological Research; estate of Jack Gitlitz; estate of Lydia Hershkovich; Benoziyo Endowment Fund for the Advancement of Science; Adelis Foundation; French National Centre for Scientific Research (CNRS)(Centre National de la Recherche Scientifique (CNRS)); European Research Council(European Research Council (ERC)European Commission); German-Israel Binational Foundation; Israel Science Foundation(Israel Science Foundation); Minerva Foundation; Rising Tide Foundation; Alon Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the members of the E.E. and E.S. labs, Ilana Kolodkin-Gal, and Yifat Merbl for fruitful discussions and Ayelet Erez and Atan Gross for valuable support. We acknowledge Elena Kartvelishvily for help with electron microscopy, Raya Eilam for assistance with immunofluorescence, and Carmit Bar-Nathan for dedicated GF mouse care taking. We thank Millenium Pharmaceuticals for kindly providing transgenic mice. C.A.T. is the recipient of a Boehringer Ingelheim Fonds PhD Fellowship. D.Z. and T.K. are supported by the Ministry of Science, Technology, and Space, Israel. T.K. is supported by the Foulkes Foundation. E.S. is supported by Jack N. Halpern and Mr. and Mrs. Donald L. Schwarz and by grants from the European Research Council (ERC) and the Israel Science Foundation (ISF). E.E. is supported by Yael and Rami Ungar, Israel; Leona M. and Harry B. Helmsley Charitable Trust; the Gurwin Family Fund for Scientific Research; Crown Endowment Fund for Immunological Research; estate of Jack Gitlitz; estate of Lydia Hershkovich; the Benoziyo Endowment Fund for the Advancement of Science; Adelis Foundation; John L. and Vera Schwartz, Pacific Palisades; Alan Markovitz, Canada; Cynthia Adelson, Canada; French National Centre for Scientific Research (CNRS); estate of Samuel and Alwyn J. Weber; Mr. and Mrs. Donald L. Schwarz, Sherman Oaks; grants funded by the European Research Council; the German-Israel Binational Foundation; the Israel Science Foundation; the Minerva Foundation; the Rising Tide Foundation; and the Alon Foundation scholar award. E.E. is the incumbent of the Rina Gudinski Career Development Chair.	Anand PK, 2012, FUTURE MICROBIOL, V7, P1239, DOI [10.2217/FMB.12.94, 10.2217/fmb.12.94]; Artis D, 2004, P NATL ACAD SCI USA, V101, P13596, DOI 10.1073/pnas.0404034101; Brestoff JR, 2013, NAT IMMUNOL, V14, P676, DOI 10.1038/ni.2640; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen GY, 2011, J IMMUNOL, V186, P7187, DOI 10.4049/jimmunol.1100412; Couturier-Maillard A, 2013, J CLIN INVEST, V123, P700, DOI 10.1172/JCI62236; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Gremel G, 2015, J GASTROENTEROL, V50, P46, DOI 10.1007/s00535-014-0958-7; Grenier JM, 2002, FEBS LETT, V530, P73, DOI 10.1016/S0014-5793(02)03416-6; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Hu B, 2013, P NATL ACAD SCI USA, V110, P9862, DOI 10.1073/pnas.1307575110; Ikuta T, 2013, CARCINOGENESIS, V34, P1620, DOI 10.1093/carcin/bgt083; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kempster SL, 2011, AM J PHYSIOL-GASTR L, V300, pG253, DOI 10.1152/ajpgi.00397.2010; Lupp C, 2007, CELL HOST MICROBE, V2, P204, DOI 10.1016/j.chom.2007.08.002; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Miyoshi H, 2013, NAT PROTOC, V8, P2471, DOI 10.1038/nprot.2013.153; Moon C, 2015, NATURE, V521, P90, DOI 10.1038/nature14139; Normand S, 2011, P NATL ACAD SCI USA, V108, P9601, DOI 10.1073/pnas.1100981108; Shapiro H, 2014, CURR OPIN IMMUNOL, V30, P54, DOI 10.1016/j.coi.2014.07.003; Shimizu M, 2009, ADV EXP MED BIOL, V643, P265, DOI 10.1007/978-0-387-75681-3_27; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Thaiss CA, 2014, CELL HOST MICROBE, V15, P662, DOI 10.1016/j.chom.2014.05.016; Tsuji S, 2001, J BIOL CHEM, V276, P23456, DOI 10.1074/jbc.M103162200; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wlodarska M, 2014, CELL, V156, P1045, DOI 10.1016/j.cell.2014.01.026; Zhao Z, 2008, AMINO ACIDS, V35, P217, DOI 10.1007/s00726-007-0562-8	33	536	565	23	176	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 6	2015	163	6					1428	1443		10.1016/j.cell.2015.10.048	http://dx.doi.org/10.1016/j.cell.2015.10.048			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SE	26638072	Green Accepted, Bronze			2022-12-28	WOS:000366044800018
J	Watts, G				Watts, Geoff			Howard Wilbur Jones	LANCET			English	Biographical-Item																		JONES HG, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 5	2015	386	10010					2250	2250		10.1016/S0140-6736(15)01115-0	http://dx.doi.org/10.1016/S0140-6736(15)01115-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX8ZB	26693534				2022-12-28	WOS:000365993200017
J	Herbst, RS; Baas, P; Kim, DW; Felip, E; Perez-Gracia, JL; Han, JY; Molina, J; Kim, JH; Arvis, CD; Ahn, MJ; Majem, M; Fidler, MJ; de Castro, G; Garrido, M; Lubiniecki, GM; Shentu, Y; Im, E; Dolled-Filhart, M; Garon, EB				Herbst, Roy S.; Baas, Paul; Kim, Dong-Wan; Felip, Enriqueta; Perez-Gracia, Jose L.; Han, Ji-Youn; Molina, Julian; Kim, Joo-Hang; Arvis, Catherine Dubos; Ahn, Myung-Ju; Majem, Margarita; Fidler, Mary J.; de Castro, Gilberto, Jr.; Garrido, Marcelo; Lubiniecki, Gregory M.; Shentu, Yue; Im, Ellie; Dolled-Filhart, Marisa; Garon, Edward B.			Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial	LANCET			English	Article							ANTI-PD-L1 ANTIBODY; BLOCKADE; THERAPY; CHEMOTHERAPY; NIVOLUMAB; PD-L1	Background Despite recent advances in the treatment of advanced non-small-cell lung cancer, there remains a need for effective treatments for progressive disease. We assessed the efficacy of pembrolizumab for patients with previously treated, PD-L1-positive, advanced non-small-cell lung cancer. Methods We did this randomised, open-label, phase 2/3 study at 202 academic medical centres in 24 countries. Patients with previously treated non-small-cell lung cancer with PD-L1 expression on at least 1% of tumour cells were randomly assigned (1:1:1) in blocks of six per stratum with an interactive voice-response system to receive pembrolizumab 2 mg/kg, pembrolizumab 10 mg/kg, or docetaxel 75 mg/m(2) every 3 weeks. The primary endpoints were overall survival and progression-free survival both in the total population and in patients with PD-L1 expression on at least 50% of tumour cells. We used a threshold for significance of p<0.00825 (one-sided) for the analysis of overall survival and a threshold of p<0.001 for progression-free survival. This trial is registered at ClinicalTrials.gov, number NCT01905657. Findings Between Aug 28, 2013, and Feb 27, 2015, we enrolled 1034 patients:345 allocated to pembrolizumab 2 mg/kg, 346 allocated to pembrolizumab 10 mg/kg, and 343 allocated to docetaxel. By Sept 30, 2015, 521 patients had died. In the total population, median overall survival was 10.4 months with pembrolizumab 2 mg/kg, 12.7 months with pembrolizumab 10 mg/kg, and 8.5 months with docetaxel. Overall survival was significantly longer for pembrolizumab 2 mg/kg versus docetaxel (hazard ratio [HR] 0.71, 95% CI 0.58-0.88; p=0.0008) and for pembrolizumab 10 mg/kg versus docetaxel (0.61, 0.49-0.75; p<0.0001). Median progression-free survival was 3.9 months with pembrolizumab 2 mg/kg, 4.0 months with pembrolizumab 10 mg/kg, and 4.0 months with docetaxel, with no significant difference for pembrolizumab 2 mg/kg versus docetaxel (0.88, 0.74-1.05; p=0.07) or for pembrolizumab 10 mg/kg versus docetaxel (HR 0.79, 95% CI 0.66-0.94; p=0.004). Among patients with at least 50% of tumour cells expressing PD-L1, overall survival was significantly longer with pembrolizumab 2 mg/kg than with docetaxel (median 14.9 months vs 8.2 months; HR 0.54, 95% CI 0.38-0.77; p=0.0002) and with pembrolizumab 10 mg/kg than with docetaxel (17.3 months vs 8.2 months; 0.50, 0.36-0.70; p<0.0001). Likewise, for this patient population, progression-free survival was significantly longer with pembrolizumab 2 mg/kg than with docetaxel (median 5.0 months vs 4.1 months; HR 0.59, 95% CI 0.44-0.78; p=0.0001) and with pembrolizumab 10 mg/kg than with docetaxel (5.2 months vs 4.1 months; 0.59, 0.45-0.78; p<0.0001). Grade 3-5 treatment-related adverse events were less common with pembrolizumab than with docetaxel (43 [13%] of 339 patients given 2 mg/kg, 55 [16%] of 343 given 10 mg/kg, and 109 [35%] of 309 given docetaxel). Interpretation Pembrolizumab prolongs overall survival and has a favourable benefit-to-risk profile in patients with previously treated, PD-L1-positive, advanced non-small-cell lung cancer. These data establish pembrolizumab as a new treatment option for this population and validate the use of PD-L1 selection.	[Herbst, Roy S.] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT USA; [Herbst, Roy S.] Smilow Canc Hosp, New Haven, CT USA; [Baas, Paul] Netherlands Canc Inst, Amsterdam, Netherlands; [Baas, Paul] Acad Med Hosp Amsterdam, Amsterdam, Netherlands; [Kim, Dong-Wan] Seoul Natl Univ Hosp, Seoul 110744, South Korea; [Felip, Enriqueta] Vall DHebron Univ Hosp, Barcelona, Spain; [Felip, Enriqueta] Vall dHebron Inst Oncol, Barcelona, Spain; [Perez-Gracia, Jose L.] Univ Navarra Clin, Pamplona, Spain; [Han, Ji-Youn] Natl Canc Ctr, Goyang, South Korea; [Molina, Julian] Mayo Clin, Rochester, MN USA; [Kim, Joo-Hang] CHA Univ, CHA Bundang Med Ctr, Gyeonggi Do, South Korea; [Arvis, Catherine Dubos] Ctr Francois Baclesse, Caen, France; [Ahn, Myung-Ju] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea; [Majem, Margarita] Hosp Santa Creu & Sant Pau, Barcelona, Spain; [Fidler, Mary J.] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [de Castro, Gilberto, Jr.] Inst Canc Estado Sao Paulo, Sao Paulo, Brazil; [Garrido, Marcelo] Pontificia Univ Catolica Chile, Alameda 340, Santiago, Chile; [Lubiniecki, Gregory M.; Shentu, Yue; Im, Ellie; Dolled-Filhart, Marisa] Merck & Co Inc, Kenilworth, NJ USA; [Garon, Edward B.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	Yale University; Netherlands Cancer Institute; University of Amsterdam; Academic Medical Center Amsterdam; Seoul National University (SNU); Seoul National University Hospital; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); University of Navarra; National Cancer Center - Korea (NCC); Mayo Clinic; Pochon Cha University; UNICANCER; Centre Francois Baclesse; Sungkyunkwan University (SKKU); Samsung Medical Center; Hospital of Santa Creu i Sant Pau; Rush University; Pontificia Universidad Catolica de Chile; Merck & Company; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Herbst, RS (corresponding author), Yale Univ, Sch Med, Yale Comprehens Canc Ctr, Thorac Oncol Res Program,Smilow Canc Hosp, 333 Cedar St,WWW221, New Haven, CT 06520 USA.	roy.herbst@yale.edu	Miquel, Josep Maria/AAG-3508-2019; FELIP, ENRIQUETA/AAG-6316-2019; Perez-Gracia, Jose Luis/I-8372-2017; Kim, Dong-Wan/J-5391-2012; de Castro, Gilberto/C-1627-2013	Perez-Gracia, Jose Luis/0000-0003-4941-9075; de Castro, Gilberto/0000-0001-8765-3044; Balmana, Judith/0000-0002-0762-6415; FELIP, ENRIQUETA/0000-0002-7620-0098	Merck Co.	Merck Co.(Merck & Company)	Merck & Co.	Ascierto PA, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-54; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Brahmer JR, 2014, J CLIN ONCOL, V32, P8021, DOI DOI 10.1200/jco.2014.32.15_suppl.8021; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Camidge DR, 2014, NAT REV CLIN ONCOL, V11, P473, DOI 10.1038/nrclinonc.2014.104; Dong HD, 1999, NAT MED, V5, P1365; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; EFRON B, 1977, J AM STAT ASSOC, V72, P557, DOI 10.2307/2286217; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Flotten O, 2015, J THORAC ONCOL S2, V10, P3024; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Garon EB, 2014, LANCET, V384, P665, DOI 10.1016/S0140-6736(14)60845-X; Gettinger S, 2014, CANCER J, V20, P281, DOI 10.1097/PPO.0000000000000063; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Janne PA, 2015, NEW ENGL J MED, V372, P1689, DOI 10.1056/NEJMoa1411817; McLaughlin J, 2016, JAMA ONCOL, V2, P46, DOI 10.1001/jamaoncol.2015.3638; Messina JL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00765; MIETTINEN O, 1985, STAT MED, V4, P213, DOI 10.1002/sim.4780040211; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Papadimitrakopoulou V, 2015, J CLIN ONCOL, V33; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Patnaik A, 2015, ASCO M, V33, P8011, DOI DOI 10.1200/JC0.2015.33.15_; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Schalper KA, 2014, CLIN CANCER RES, V20, P2773, DOI 10.1158/1078-0432.CCR-13-2702; Sequist LV, 2015, NEW ENGL J MED, V372, P1700, DOI 10.1056/NEJMoa1413654; Shaw AT, 2014, NEW ENGL J MED, V370, P2537, DOI 10.1056/NEJMc1404894; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Spira AI, 2015, ASCO M, V33, P8010, DOI DOI 10.HTTPS://D0I.0RG/10.1200/JC0.2015.33.15_; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624	33	3199	3319	19	419	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 9	2016	387	10027					1540	1550		10.1016/S0140-6736(15)01281-7	http://dx.doi.org/10.1016/S0140-6736(15)01281-7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI8HH	26712084				2022-12-28	WOS:000373741600030
J	Verheijen, RHM; Zweemer, RP				Verheijen, Rene H. M.; Zweemer, Ronald P.			Screening to improve ovarian cancer prognosis?	LANCET			English	Editorial Material							WOMEN; VALIDATION; ALGORITHM; MORTALITY; PROSTATE; OUTCOMES; TRIAL; LUNG; RISK		[Verheijen, Rene H. M.; Zweemer, Ronald P.] UMC Utrecht Canc Ctr, Dept Gynaecol Oncol, Div Surg Oncol, NL-3584 CX Utrecht, Netherlands		Verheijen, RHM (corresponding author), UMC Utrecht Canc Ctr, Dept Gynaecol Oncol, Div Surg Oncol, NL-3584 CX Utrecht, Netherlands.	r.verheijen@umcutrecht.nl		Zweemer, Ronald/0000-0003-1829-7773				Brown PO, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000114; Buys SS, 2011, JAMA-J AM MED ASSOC, V305, P2295, DOI 10.1001/jama.2011.766; Goff BA, 2007, CANCER, V109, P221, DOI 10.1002/cncr.22371; Hamilton W, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2998; Hippisley-Cox J, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8009; Jacobs IJ, 2016, LANCET, V387, P945, DOI 10.1016/S0140-6736(15)01224-6; Kobayashi H, 2008, INT J GYNECOL CANCER, V18, P414, DOI 10.1111/j.1525-1438.2007.01035.x; Nagle CM, 2011, J CLIN ONCOL, V29, P2253, DOI 10.1200/JCO.2010.32.2164; Pinsky PF, 2013, INT J CANCER, V132, P2127, DOI 10.1002/ijc.27909; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; Zhu CS, 2011, CANCER PREV RES, V4, P375, DOI 10.1158/1940-6207.CAPR-10-0193	11	3	3	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 5	2016	387	10022					921	923		10.1016/S0140-6736(15)01236-2	http://dx.doi.org/10.1016/S0140-6736(15)01236-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DF8XP	26707055				2022-12-28	WOS:000371644200006
J	Liu, B; Floud, S; Pirie, K; Green, J; Peto, R; Beral, V				Liu, Bette; Floud, Sarah; Pirie, Kirstin; Green, Jane; Peto, Richard; Beral, Valerie		Million Women Study Collaborators	Does happiness itself directly affect mortality? The prospective UK Million Women Study	LANCET			English	Article							CORONARY-HEART-DISEASE; PROSPECTIVE COHORT; POSITIVE AFFECT; FOLLOW-UP; ALL-CAUSE; HEALTH; COMMUNITY; LIFE; POPULATION; LONGEVITY	Background Poor health can cause unhappiness and poor health increases mortality. Previous reports of reduced mortality associated with happiness could be due to the increased mortality of people who are unhappy because of their poor health. Also, unhappiness might be associated with lifestyle factors that can affect mortality. We aimed to establish whether, after allowing for the poor health and lifestyle of people who are unhappy, any robust evidence remains that happiness or related subjective measures of wellbeing directly reduce mortality. Methods The Million Women Study is a prospective study of UK women recruited between 1996 and 2001 and followed electronically for cause-specific mortality. 3 years after recruitment, the baseline questionnaire for the present report asked women to self-rate their health, happiness, stress, feelings of control, and whether they felt relaxed. The main analyses were of mortality before Jan 1, 2012, from all causes, from ischaemic heart disease, and from cancer in women who did not have heart disease, stroke, chronic obstructive lung disease, or cancer at the time they answered this baseline questionnaire. We used Cox regression, adjusted for baseline self-rated health and lifestyle factors, to calculate mortality rate ratios (RRs) comparing mortality in women who reported being unhappy (ie, happy sometimes, rarely, or never) with those who reported being happy most of the time. Findings Of 719 671 women in the main analyses (median age 59 years [IQR 55-63]), 39% (282 619) reported being happy most of the time, 44% (315 874) usually happy, and 17% (121 178) unhappy. During 10 years (SD 2) follow-up, 4% (31 531) of participants died. Self-rated poor health at baseline was strongly associated with unhappiness. But after adjustment for self-rated health, treatment for hypertension, diabetes, asthma, arthritis, depression, or anxiety, and several sociodemographic and lifestyle factors (including smoking, deprivation, and body-mass index), unhappiness was not associated with mortality from all causes (adjusted RR for unhappy vs happy most of the time 0.98, 95% CI 0.94-1.01), from ischaemic heart disease (0.97, 0.87-1.10), or from cancer (0.98, 0.93-1.02). Findings were similarly null for related measures such as stress or lack of control. Interpretation In middle-aged women, poor health can cause unhappiness. After allowing for this association and adjusting for potential confounders, happiness and related measures of wellbeing do not appear to have any direct effect on mortality. Copyright (C) Liu et al. Open Access article distributed under the terms of CC BY.	[Liu, Bette] Univ New S Wales, Fac Med, Sydney, NSW 2052, Australia; [Floud, Sarah; Pirie, Kirstin; Green, Jane; Beral, Valerie] Univ Oxford, Nuffield Dept Populat Hlth, Canc Epidemiol Unit, Oxford, England; [Peto, Richard] Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Oxford, England; [Peto, Richard] Univ Oxford, Nuffield Dept Populat Hlth, Epidemiol Studies Unit, Oxford, England	University of New South Wales Sydney; University of Oxford; University of Oxford; University of Oxford	Liu, B (corresponding author), Univ New S Wales, Sch Publ Hlth & Community Med, Fac Med, Sydney, NSW 2052, Australia.	bette.liu@unsw.edu.au		Pirie, Kirstin/0000-0002-0561-4904; Floud, Sarah/0000-0002-6078-9117	UK Medical Research Council; Cancer Research UK; Cancer Research UK [16491] Funding Source: researchfish; Medical Research Council [MR/K02700X/1] Funding Source: researchfish; MRC [MR/K02700X/1] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	UK Medical Research Council, Cancer Research UK.	Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Berkman LF, 1983, HLTH WAYS LIVING ALA; Blanchflower DG, 2004, J PUBLIC ECON, V88, P1359, DOI 10.1016/S0047-2727(02)00168-8; Blazer DG, 2004, J AM GERIATR SOC, V52, P2052, DOI 10.1111/j.1532-5415.2004.52564.x; Boehm JK, 2012, PSYCHOL BULL, V138, P655, DOI 10.1037/a0027448; Boehm JK, 2011, EUR HEART J, V32, P2672, DOI 10.1093/eurheartj/ehr203; Boehm JK, 2011, HEALTH PSYCHOL, V30, P259, DOI 10.1037/a0023124; Bryson A, 2010, WELL BEING HLTH WORK; Chida Y, 2008, PSYCHOSOM MED, V70, P741, DOI 10.1097/PSY.0b013e31818105ba; Davidson KW, 2010, EUR HEART J, V31, P1065, DOI 10.1093/eurheartj/ehp603; Diener E, 2011, APPL PSYCHOL-HLTH WE, V3, P1, DOI 10.1111/j.1758-0854.2010.01045.x; Fleche S, 2011, OECD EC DEP WORKING, V921; Giltay EJ, 2004, ARCH GEN PSYCHIAT, V61, P1126, DOI 10.1001/archpsyc.61.11.1126; Haller M, 2006, SOC INDIC RES, V75, P169, DOI 10.1007/s11205-004-6297-y; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; KAPLAN GA, 1983, AM J EPIDEMIOL, V117, P292, DOI 10.1093/oxfordjournals.aje.a113541; Koopmans TA, 2010, J HAPPINESS STUD, V11, P113, DOI 10.1007/s10902-008-9127-0; Nabi H, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a118; Office for National Statistics (ONS), 2012, AN EXP SUBJ WELLB DA; Oguz S, 2013, MEASURING NATL WELL; Pirie K, 2013, LANCET, V381, P133, DOI 10.1016/S0140-6736(12)61720-6; Plummer M, 2004, STAT MED, V23, P93, DOI 10.1002/sim.1485; Pressman SD, 2005, PSYCHOL BULL, V131, P925, DOI 10.1037/0033-2909.131.6.925; Roddam AW, 2005, PUBLIC HEALTH NUTR, V8, P201, DOI 10.1079/PHN2004676; Shirai K, 2009, CIRCULATION, V120, P956, DOI 10.1161/CIRCULATIONAHA.108.834176; Steptoe A, 2015, LANCET, V385, P640, DOI 10.1016/S0140-6736(13)61489-0; Strine TW, 2008, J COMMUN HEALTH, V33, P40, DOI 10.1007/s10900-007-9066-4; Tindle HA, 2009, CIRCULATION, V120, P656, DOI 10.1161/CIRCULATIONAHA.108.827642; Townsend PP., 1988, HLTH DEPRIVATION INE; Xu JP, 2010, HEALTH PSYCHOL, V29, P9, DOI 10.1037/a0016767	30	119	121	0	57	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	2016	387	10021					874	881		10.1016/S0140-6736(15)01087-9	http://dx.doi.org/10.1016/S0140-6736(15)01087-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DE9RA	26684609	Green Published, hybrid			2022-12-28	WOS:000370974400032
J	Buss, JA; Agapie, T				Buss, Joshua A.; Agapie, Theodor			Four-electron deoxygenative reductive coupling of carbon monoxide at a single metal site	NATURE			English	Article							ELECTROCHEMICAL REDUCTION; CRYSTAL-STRUCTURE; URANIUM COMPLEX; METHYLIDYNE; CO; HYDROGENATION; HOMOLOGATION; CLEAVAGE; TUNGSTEN; COPPER	Carbon dioxide is the ultimate source of the fossil fuels that are both central to modern life and problematic: their use increases atmospheric levels of greenhouse gases, and their availability is geopolitically constrained(1). Using carbon dioxide as a feedstock to produce synthetic fuels might, in principle, alleviate these concerns. Although many homogeneous and heterogeneous catalysts convert carbon dioxide to carbon monoxide(2), further deoxygenative coupling of carbon monoxide to generate useful multicarbon products is challenging(3). Molybdenum and vanadium nitrogenases are capable of converting carbon monoxide into hydrocarbons under mild conditions, using discrete electron and proton sources(4). Electrocatalytic reduction of carbon monoxide on copper catalysts(5) also uses a combination of electrons and protons, while the industrial Fischer-Tropsch process uses dihydrogen as a combined source of electrons and electrophiles for carbon monoxide coupling at high temperatures and pressures(6). However, these enzymatic and heterogeneous systems are difficult to probe mechanistically. Molecular catalysts have been studied extensively(6-23) to investigate the elementary steps by which carbon monoxide is deoxygenated and coupled, but a single metal site that can efficiently induce the required scission of carbon-oxygen bonds and generate carbon-carbon bonds has not yet been documented. Here we describe a molybdenum compound, supported by a terphenyl-diphosphine ligand, that activates and cleaves the strong carbon-oxygen bond of carbon monoxide, enacts carbon-carbon coupling, and spontaneously dissociates the resulting fragment. This complex four-electron transformation is enabled by the terphenyl-diphosphine ligand(24,25), which acts as an electron reservoir and exhibits the coordinative flexibility needed to stabilize the different intermediates involved in the overall reaction sequence. We anticipate that these design elements might help in the development of efficient catalysts for converting carbon monoxide to chemical fuels, and should prove useful in the broader context of performing complex multi-electron transformations at a single metal site.	[Buss, Joshua A.; Agapie, Theodor] CALTECH, Div Chem & Chem Engn, 1200 East Calif Blvd,MC 127-72, Pasadena, CA 91125 USA	California Institute of Technology	Agapie, T (corresponding author), CALTECH, Div Chem & Chem Engn, 1200 East Calif Blvd,MC 127-72, Pasadena, CA 91125 USA.	agapie@caltech.edu		Buss, Joshua/0000-0002-3347-8583	Caltech; National Science Foundation [CHE-1151918]; GRFP	Caltech; National Science Foundation(National Science Foundation (NSF)); GRFP(National Science Foundation (NSF))	We thank L. M. Henling and M. K. Takase for crystallographic assistance and D. VanderVelde for NMR expertise. We are grateful to Caltech and the National Science Foundation (grant CHE-1151918 to T.A., and GRFP to J.A.B.) for funding.	Appel AM, 2013, CHEM REV, V113, P6621, DOI 10.1021/cr300463y; Ballmann J, 2012, ORGANOMETALLICS, V31, P8516, DOI 10.1021/om300759p; BELMONTE PA, 1983, J AM CHEM SOC, V105, P2643, DOI 10.1021/ja00347a022; BUCHNER W, 1964, HELV CHIM ACTA, V47, P1415, DOI 10.1002/hlca.19640470604; Buss JA, 2014, J AM CHEM SOC, V136, P11272, DOI 10.1021/ja5059923; Carlson RG, 2002, J AM CHEM SOC, V124, P1580, DOI 10.1021/ja017088g; CARNAHAN EM, 1993, ACCOUNTS CHEM RES, V26, P90, DOI 10.1021/ar00027a003; Cassani MC, 1999, ORGANOMETALLICS, V18, P5539, DOI 10.1021/om990536x; CHURCHILL MR, 1982, ORGANOMETALLICS, V1, P766, DOI 10.1021/om00065a022; Costentin C, 2013, CHEM SOC REV, V42, P2423, DOI 10.1039/c2cs35360a; Ellis JE, 2006, INORG CHEM, V45, P3167, DOI 10.1021/ic052110i; Enriquez AE, 2001, J AM CHEM SOC, V123, P4992, DOI 10.1021/ja0035001; EVANS WJ, 1985, J AM CHEM SOC, V107, P3728, DOI 10.1021/ja00298a060; Gardner BM, 2012, P NATL ACAD SCI USA, V109, P9265, DOI 10.1073/pnas.1203417109; Gattrell M, 2006, J ELECTROANAL CHEM, V594, P1, DOI 10.1016/j.jelechem.2006.05.013; Horak KT, 2014, CHEM COMMUN, V50, P4427, DOI 10.1039/c4cc00838c; Hu YL, 2011, SCIENCE, V333, P753, DOI 10.1126/science.1206883; KREISSL FR, 1976, ANGEW CHEM INT EDIT, V15, P632, DOI 10.1002/anie.197606321; LAPOINTE RE, 1986, J AM CHEM SOC, V108, P6382, DOI 10.1021/ja00280a042; Li CW, 2014, NATURE, V508, P504, DOI 10.1038/nature13249; Matsuo T, 2005, J AM CHEM SOC, V127, P17198, DOI 10.1021/ja0567079; MILLER RL, 1993, J AM CHEM SOC, V115, P10422, DOI 10.1021/ja00075a093; Peters JC, 1997, CHEM COMMUN, P1995; Shima T, 2006, J AM CHEM SOC, V128, P8124, DOI 10.1021/ja062348l; Stewart MH, 2007, ORGANOMETALLICS, V26, P5102, DOI 10.1021/om070208u; Suess DLM, 2013, J AM CHEM SOC, V135, P12580, DOI 10.1021/ja406874k; Summerscales OT, 2006, SCIENCE, V311, P829, DOI 10.1126/science.1121784; Watanabe T, 2009, J AM CHEM SOC, V131, P3474, DOI 10.1021/ja9007276; WAYLAND BB, 1989, J CHEM SOC CHEM COMM, P662, DOI 10.1039/c39890000662; West NM, 2011, COORDIN CHEM REV, V255, P881, DOI 10.1016/j.ccr.2010.08.019	30	65	66	8	300	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 7	2016	529	7584					72	75		10.1038/nature16154	http://dx.doi.org/10.1038/nature16154			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6VY	26689364				2022-12-28	WOS:000367944900028
J	Bai, L; Lehnert, BP; Liu, JW; Neubarth, NL; Dickendesher, TL; Nwe, PH; Cassidy, C; Woodbury, CJ; Ginty, DD				Bai, Ling; Lehnert, Brendan P.; Liu, Junwei; Neubarth, Nicole L.; Dickendesher, Travis L.; Nwe, Pann H.; Cassidy, Colleen; Woodbury, C. Jeffery; Ginty, David D.			Genetic Identification of an Expansive Mechanoreceptor Sensitive to Skin Stroking	CELL			English	Article							TRANSCRIPTION FACTORS; SENSORY INNERVATION; MERKEL CELLS; HAIRY SKIN; NEURONS; EXPRESSION; OVEREXPRESSION; ORGANIZATION; RECEPTORS; MICE	Touch perception begins with activation of low-threshold mechanoreceptors (LTMRs) in the periphery. LTMR terminals exhibit tremendous morphological heterogeneity that specifies their mechanical receptivity. In a survey of mammalian skin, we found a preponderance of neurofilament-heavy-chain(+) circumferential endings associated with hair follicles, prompting us to develop a genetic strategy to interrogate these neurons. Targeted in vivo recordings revealed them to be A beta field-LTMRs, identified 50 years ago but largely elusive thereafter. Remarkably, while A beta field-LTMRs are highly sensitive to gentle stroking of the skin, they are unresponsive to hair deflection, and they encode skin indentation in the noxious range across large, spotty receptive fields. Individual A beta field-LTMRs form up to 180 circumferential endings, making them the most anatomically expansive LTMR identified to date. Thus, A beta field-LTMRs are a major mammalian LTMR subtype that forms circumferential endings in hairy skin, and their sensitivity to gentle skin stroking arises through integration across many low-sensitivity circumferential endings.	[Bai, Ling; Lehnert, Brendan P.; Neubarth, Nicole L.; Dickendesher, Travis L.; Nwe, Pann H.; Ginty, David D.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA; [Bai, Ling] Johns Hopkins Univ, Sch Med, Neurosci Training Program, Baltimore, MD 21205 USA; [Liu, Junwei] Johns Hopkins Univ, Dept Civil Engn, Baltimore, MD 21218 USA; [Cassidy, Colleen] Univ Wyoming, Grad Program Neurosci, Laramie, WY 82071 USA; [Woodbury, C. Jeffery] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; University of Wyoming; University of Wyoming	Ginty, DD (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	david_ginty@hms.harvard.edu			NIH [T32 NS007484-14, F32 NS095631-01, NS44049, DE022750, NS34814]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS095631, R37NS034814, R01NS044094, R01NS034814, R29NS034814, T32NS007484] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Michael Rutlin for help with targeting vector design, Lishi Li and Steven Hsiao for the macaque skin images, Hideki Enomoto for Ret<SUP>f(CFP)</SUP> and Ret<SUP>CFP</SUP> mice, Jeremy Nathans for Brn3a<SUP>f(AP)</SUP> mice, Matthew Rasband for the beta IV-spectrin antibody, Tom Ferstl for tissue samples, and Emily Kuehn for AAV virus characterization. We are grateful to Robert LaMotte for assistance with the in vivo physiological recording preparation; Rachel Wilson for use of the Laser Doppler Vibrometer; Maria Erissson (Harvard EM core facility), Ciara Bolger, and Wei-Chung Lee for assistance with the EM analysis; and Matthew Pecot, Zhang Yilei, and members of the Ginty laboratory for valuable comments on the manuscript. This work was supported by NIH grants T32 NS007484-14 (B.P.L.), F32 NS095631-01 (B.P.L.), NS44049 (C.J.W.), DE022750, and NS34814 (D.D.G.). D.D.G. is an Investigator of the Howard Hughes Medical Institute.	Abraira VE, 2013, NEURON, V79, P618, DOI 10.1016/j.neuron.2013.07.051; Albers KM, 1996, J CELL BIOL, V134, P487, DOI 10.1083/jcb.134.2.487; Badea TC, 2009, NEURON, V61, P852, DOI 10.1016/j.neuron.2009.01.020; Badea TC, 2012, J NEUROSCI, V32, P995, DOI 10.1523/JNEUROSCI.4755-11.2012; Bardoni R, 2014, NEURON, V81, P1312, DOI 10.1016/j.neuron.2014.01.044; Boada MD, 2008, J NEUROSCI, V28, P2006, DOI 10.1523/JNEUROSCI.5609-07.2008; BURGESS PR, 1967, J PHYSIOL-LONDON, V190, P541, DOI 10.1113/jphysiol.1967.sp008227; BURGESS PR, 1968, J NEUROPHYSIOL, V31, P833, DOI 10.1152/jn.1968.31.6.833; CHAMBERS MR, 1972, Q J EXP PHYSIOL CMS, V57, P417, DOI 10.1113/expphysiol.1972.sp002177; Djouhri L, 2004, BRAIN RES REV, V46, P131, DOI 10.1016/j.brainresrev.2004.07.015; DOBRY PJK, 1972, BRAIN RES, V44, P385, DOI 10.1016/0006-8993(72)90310-1; Funfschilling U, 2004, J COMP NEUROL, V480, P392, DOI 10.1002/cne.20359; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; HORCH KW, 1976, BRAIN RES, V117, P1, DOI 10.1016/0006-8993(76)90552-7; Ikeda R, 2014, CELL, V157, P664, DOI 10.1016/j.cell.2014.02.026; KOERBER HR, 1988, J NEUROPHYSIOL, V60, P1584, DOI 10.1152/jn.1988.60.5.1584; Lechner SG, 2013, PHYSIOLOGY, V28, P142, DOI 10.1152/physiol.00059.2012; Lesniak DR, 2014, ELIFE, V3, DOI 10.7554/eLife.01488; Li LS, 2014, ELIFE, V3, DOI 10.7554/eLife.01901; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; LOEWENSTEIN WR, 1969, ANN NY ACAD SCI, V156, P892, DOI 10.1111/j.1749-6632.1969.tb14021.x; Luo WQ, 2009, NEURON, V64, P841, DOI 10.1016/j.neuron.2009.11.003; Madisen L, 2015, NEURON, V85, P942, DOI 10.1016/j.neuron.2015.02.022; Maksimovic S, 2014, NATURE, V509, P617, DOI 10.1038/nature13250; McIlwrath SL, 2007, EUR J NEUROSCI, V26, P1801, DOI 10.1111/j.1460-9568.2007.05821.x; MILLARD CL, 1988, J COMP NEUROL, V277, P183, DOI 10.1002/cne.902770203; Niu JW, 2013, J NEUROSCI, V33, P17691, DOI 10.1523/JNEUROSCI.3429-13.2013; RICE FL, 1986, J COMP NEUROL, V252, P186, DOI 10.1002/cne.902520205; Rotolo T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004099; Rutlin M, 2014, CELL, V159, P1640, DOI 10.1016/j.cell.2014.11.038; Uesaka T, 2008, J CLIN INVEST, V118, P1890, DOI 10.1172/JCI34425; Woo SH, 2014, NATURE, V509, P622, DOI 10.1038/nature13251; Woodbury CJ, 2001, J COMP NEUROL, V436, P304; Wu HL, 2012, BIOINORG CHEM APPL, V2012, DOI 10.1155/2012/609796; Yang Y, 2007, J CELL BIOL, V176, P509, DOI 10.1083/jcb.200610128; Zimmerman A, 2014, SCIENCE, V346, P950, DOI 10.1126/science.1254229	36	70	70	2	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2015	163	7					1783	1795		10.1016/j.cell.2015.11.060	http://dx.doi.org/10.1016/j.cell.2015.11.060			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CZ1GN	26687362	Green Accepted, Bronze			2022-12-28	WOS:000366854200023
J	Gornall, J				Gornall, Jonathan			PUBLIC HEALTH NICE told to back off "national policy issues"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jonathan.gornall@me.com						Department of Health, 2015, REP TRIENN REV NAT I; Gornall J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7646; National Institute for Health and Care Excellence, 2014, DEM DIS FRAILT LAT L; National Institute for Health and Care Excellence Charter, 2013, CLAUS 1 5; NICE, 2015, DEM DIS FRAILT LAT L	5	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 17	2015	351								h6766	10.1136/bmj.h6766	http://dx.doi.org/10.1136/bmj.h6766			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ4MS	26681667				2022-12-28	WOS:000367077900003
J	Hodson, R				Hodson, Richard			SMALL ORGAN, BIG REACH	NATURE			English	Editorial Material																			0	8	8	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2015	528	7582					S118	S119		10.1038/528S118a	http://dx.doi.org/10.1038/528S118a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VC0SB	26672780				2022-12-28	WOS:000427116800001
J	Niwa, H				Niwa, Hitoshi			A Stepping Stone to Pluripotency	CELL			English	Editorial Material							MOUSE SOMATIC-CELLS; STEM-CELLS; INDUCTION; STATE	Somatic cells can be reprogrammed into pluripotent stem cells via either expression of transcription factors or addition of small molecule chemicals only. Zhao et al. reveal a unique intermediate state during chemical reprogramming allowing a significant improvement in its efficiency and kinetics.	[Niwa, Hitoshi] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Pluripotent Stem Cell Biol, Chuo Ku, Kumamoto 8600811, Japan	Kumamoto University	Niwa, H (corresponding author), Kumamoto Univ, Inst Mol Embryol & Genet, Dept Pluripotent Stem Cell Biol, Chuo Ku, 2-2-1 Honjo, Kumamoto 8600811, Japan.	niwa@kumamoto-u.ac.jp						Di Stefano B, 2014, NATURE, V506, P235, DOI 10.1038/nature12885; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Kunath T, 2005, DEVELOPMENT, V132, P1649, DOI 10.1242/dev.01715; Shu J, 2013, CELL, V153, P963, DOI 10.1016/j.cell.2013.05.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takahashi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4678; Theunissen TW, 2014, CELL STEM CELL, V14, P720, DOI 10.1016/j.stem.2014.05.002; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhao Y, 2015, CELL, V163, P1678, DOI 10.1016/j.cell.2015.11.017	10	2	2	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2015	163	7					1570	1572		10.1016/j.cell.2015.12.011	http://dx.doi.org/10.1016/j.cell.2015.12.011			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CZ1GN	26687348	Bronze			2022-12-28	WOS:000366854200004
J	Goldberg, DS				Goldberg, Daniel S.			CHRISTMAS 2015: PROFESSIONAL CONSIDERATIONS COI bingo	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							OF-INTEREST		[Goldberg, Daniel S.] E Carolina Univ, Dept Bioeth & Interdisciplinary Studies, Brody Sch Med, Greenville, NC 27858 USA	University of North Carolina; East Carolina University	Goldberg, DS (corresponding author), E Carolina Univ, Dept Bioeth & Interdisciplinary Studies, Brody Sch Med, 600 Moye Blvd,Mailstop 641, Greenville, NC 27858 USA.	goldbergd@ecu.edu						Cain DM, 2005, J LEGAL STUD, V34, P1, DOI 10.1086/426699; Dana J, 2003, JAMA-J AM MED ASSOC, V290, P252, DOI 10.1001/jama.290.2.252; Sah S, 2012, J LAW MED ETHICS, V40, P482, DOI 10.1111/j.1748-720X.2012.00680.x; Sharek Z, 2012, J LAW MED ETHICS, V40, P368, DOI 10.1111/j.1748-720X.2012.00670.x	4	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 16	2015	351								h6577	10.1136/bmj.h6577	http://dx.doi.org/10.1136/bmj.h6577			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CZ4MP	26676237				2022-12-28	WOS:000367077600009
J	Handoll, HHG; Atkinson, G				Handoll, Helen H. G.; Atkinson, Greg			CHRISTMAS 2015: THE PUBLICATION GAME Snowballing citations	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Handoll, Helen H. G.; Atkinson, Greg] Univ Teesside, Hlth & Social Care Inst, Middlesbrough TS1 3BA, Cleveland, England	University of Teesside	Handoll, HHG (corresponding author), Univ Teesside, Hlth & Social Care Inst, Middlesbrough TS1 3BA, Cleveland, England.	h.handoll@tees.ac.uk	Atkinson, Greg/ABA-2278-2021	Atkinson, Greg/0000-0002-5459-9042				BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Handoll HH, 2006, ARCH PHYS MED REHAB, V87, P875, DOI 10.1016/j.apmr.2006.04.006; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Tate DG, 2006, ARCH PHYS MED REHAB, V87, P160, DOI 10.1016/j.apmr.2005.11.013	5	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 14	2015	351								h6309	10.1136/bmj.h6309	http://dx.doi.org/10.1136/bmj.h6309			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ4KY	26666656	Green Submitted			2022-12-28	WOS:000367073200005
J	Stammen, LA; Stalmeijer, RE; Paternotte, E; Pool, AO; Driessen, EW; Scheele, F; Stassen, LPS				Stammen, Lorette A.; Stalmeijer, Renee E.; Paternotte, Emma; Pool, Andrea Oudkerk; Driessen, Erik W.; Scheele, Fedde; Stassen, Laurents P. S.			Training Physicians to Provide High-Value, Cost-Conscious Care A Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED CONTROLLED-TRIAL; ACUTE RESPIRATORY-INFECTIONS; SHARED DECISION-MAKING; HEALTH-CARE; EDUCATIONAL INTERVENTION; LABORATORY TESTS; GENERAL-PRACTITIONERS; EMERGENCY-DEPARTMENT; FAMILY PHYSICIANS; HOUSE OFFICERS	IMPORTANCE Increasing health care expenditures are taxing the sustainability of the health care system. Physicians should be prepared to deliver high-value, cost-conscious care. OBJECTIVE To understand the circumstances in which the delivery of high-value, cost-conscious care is learned, with a goal of informing development of effective educational interventions. DATA SOURCES PubMed, EMBASE, ERIC, and Cochrane databases were searched from inception until September 5, 2015, to identify learners and cost-related topics. STUDY SELECTION Studies were included on the basis of topic relevance, implementation of intervention, evaluation of intervention, educational components in intervention, and appropriate target group. There was no restriction on study design. DATA EXTRACTION AND SYNTHESIS Data extraction was guided by a merged and modified version of a Best Evidence in Medical Education abstraction form and a Cochrane data coding sheet. Articles were analyzed using the realist review method, a narrative review technique that focuses on understanding the underlying mechanisms in interventions. Recurrent patterns were identified in the data through thematic analyses. Resulting themes were discussed within the research team until consensus was reached. MAIN OUTCOMES AND MEASURES Main outcomes were factors that promote education in delivering high-value, cost-conscious care. FINDINGS The initial search identified 2650 articles; 79 met the inclusion criteria, of which 14 were randomized clinical trials. The majority of the studies were conducted in North America (78.5%) using a pre-post interventional design (58.2%; at least 1619 participants); they focused on practicing physicians (36.7%; at least 3448 participants), resident physicians (6.3%; n = 516), and medical students (15.2%; n = 275). Among the 14 randomized clinical trials, 12 addressed knowledge transmission, 7 reflective practice, and 1 supportive environment; 10 (71%) concluded that the intervention was effective. The data analysis suggested that 3 factors aid successful learning: (1) effective transmission of knowledge, related, for example, to general health economics and prices of health services, to scientific evidence regarding guidelines and the benefits and harms of health care, and to patient preferences and personal values (67 articles); (2) facilitation of reflective practice, such as providing feedback or asking reflective questions regarding decisions related to laboratory ordering or prescribing to give trainees insight into their past and current behavior (56 articles); and (3) creation of a supportive environment in which the organization of the health care system, the presence of role models of delivering high-value, cost-conscious care, and a culture of high-value, cost-conscious care reinforce the desired training goals (27 articles). CONCLUSIONS AND RELEVANCE Research on educating physicians to deliver high-value, cost-conscious care suggests that learning by practicing physicians, resident physicians, and medical students is promoted by combining specific knowledge transmission, reflective practice, and a supportive environment. These factors should be considered when educational interventions are being developed.	[Stammen, Lorette A.; Stalmeijer, Renee E.; Pool, Andrea Oudkerk; Driessen, Erik W.] Maastricht Univ, Fac Hlth Med & Life Sci, Dept Educ Dev & Res, NL-6200 MD Maastricht, Netherlands; [Paternotte, Emma; Scheele, Fedde] OLVG Hosp, Dept Med Educ, Amsterdam, Netherlands; [Scheele, Fedde] Vrije Univ Amsterdam, Med Ctr, Dept Med Educ, Amsterdam, Netherlands; [Scheele, Fedde] Vrije Univ Amsterdam, Athena Inst Trans Disciplinary Res, Amsterdam, Netherlands; [Stassen, Laurents P. S.] Maastricht Univ, Med Ctr, Dept Surg, NL-6200 MD Maastricht, Netherlands	Maastricht University; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Maastricht University	Stammen, LA (corresponding author), Maastricht Univ, Fac Hlth Med & Life Sci, Dept Educ Dev & Res, POB 616, NL-6200 MD Maastricht, Netherlands.	l.stammen@maastrichtuniversity.nl	scheele, fedde/L-6742-2019; Stalmeijer, Renee E/AIE-8162-2022	Stalmeijer, Renee E/0000-0001-8690-5326; Scheele, Fedde/0000-0001-9593-257X				Altarum Institute, 2015, HLTH SECT EC IND INS; American College of Physicians, HIGH VAL CAR CURR; [Anonymous], 2004, REALIST SYNTHESIS IN; Attali M, 2006, MT SINAI J MED, V73, P787; Barbarello-Andrews L, 2006, J CLIN OUTCOMES MANA, V13, P615; Bates DW, 1999, AM J MED, V106, P144, DOI 10.1016/S0002-9343(98)00410-0; Bernal-Delgado E, 2002, J EPIDEMIOL COMMUN H, V56, P653, DOI 10.1136/jech.56.9.653; Berwick DM, 2012, JAMA-J AM MED ASSOC, V307, P1513, DOI 10.1001/jama.2012.362; Best Evidence Medical Education Collaboration, BEME DAT COD SHEET; Bhatia RS, 2013, JACC-CARDIOVASC IMAG, V6, P545, DOI 10.1016/j.jcmg.2013.01.010; Blackstone ME, 1995, J TRAUMA, V39, P1041, DOI 10.1097/00005373-199512000-00004; Blumenthal D, 2001, NEW ENGL J MED, V344, P766, DOI 10.1056/NEJM200103083441012; Bornard L, 2011, MED MALADIES INFECT, V41, P480, DOI 10.1016/j.medmal.2010.12.022; Braido F, 2012, EUR ANN ALLERGY CLIN, V44, P193; Cammisa Chris, 2011, Am J Med Qual, V26, P26, DOI 10.1177/1062860610373380; Chandawarkar RY, 2007, ARCH SURG-CHICAGO, V142, P222, DOI 10.1001/archsurg.142.3.222; Cochrane Library, DAT COLL FORM RCT NO; Colbert CY, 2010, ADV HEALTH SCI EDUC, V15, P533, DOI 10.1007/s10459-009-9216-9; Collins TM, 1997, HEALTH SERV RES, V32, P471; Cutler D, 2007, NAT HLTH CAR REF POL; Das AK, 2010, BANGL J PHARMACOL, V5, P92, DOI 10.3329/bjp.v5i2.7146; DAVIDOFF F, 1989, MED CARE, V27, P45, DOI 10.1097/00005650-198901000-00005; de Leon N, 2013, ICU DIR, V4, P322; DOWLING PT, 1989, ACAD MED, V64, P410, DOI 10.1097/00001888-198907000-00017; Duke P, 2013, ABIM FDN CHOOSING WI; Ellemdin S, 2011, SAMJ S AFR MED J, V101, P746; Elligsen M, 2012, INFECT CONT HOSP EP, V33, P354, DOI 10.1086/664757; Englander R, 2006, TEACH LEARN MED, V18, P150, DOI 10.1207/s15328015tlm1802_10; Fakih MG, 2010, ACAD EMERG MED, V17, P337, DOI 10.1111/j.1553-2712.2009.00677.x; Ferris TG, 2005, J CLIN OUTCOMES MANA, V12, P35; Fortuna RJ, 2009, J GEN INTERN MED, V24, P897, DOI 10.1007/s11606-009-1013-x; Gist DL, 1997, WESTERN J MED, V166, P21; Gitelis M, 2015, AM J SURG, V209, P488, DOI 10.1016/j.amjsurg.2014.09.023; Glicken AD, 2007, MED TEACH, V29, P54, DOI 10.1080/01421590601182602; Gregory K D, 1999, Jt Comm J Qual Improv, V25, P619; Hart J, 1997, J INTERN MED, V241, P415, DOI 10.1046/j.1365-2796.1997.137143000.x; Hickey PA, 2003, PROG PEDIATR CARDIOL, V18, P75; Hux JE, 1999, CAN MED ASSOC J, V161, P388; Ijo Immanuel, 2011, Pharmacy Pract (Granada), V9, P106, DOI 10.4321/s1886-36552011000200008; James E, 2014, EUROPEAN J HOSP PHAR, V22, P176; Krinsley James Stephen, 2003, J Intensive Care Med, V18, P330; LANDGREN FT, 1988, MED J AUSTRALIA, V149, P595, DOI 10.5694/j.1326-5377.1988.tb120797.x; Larmour I, 2011, MED J AUSTRALIA, V194, P631, DOI 10.5694/j.1326-5377.2011.tb03145.x; Lee TC, 2014, ANN INTERN MED, V161, pS53, DOI 10.7326/M13-3016; Legare F, 2012, CAN MED ASSOC J, V184, pE726, DOI 10.1503/cmaj.120568; Legare F, 2011, HEALTH EXPECT, V14, P96, DOI 10.1111/j.1369-7625.2010.00616.x; LYLE CB, 1979, J MED EDUC, V54, P856; Mallows JL, 2013, MED J AUSTRALIA, V199, P813, DOI 10.5694/mja13.11298; MANHEIM LM, 1990, MED CARE, V28, P29, DOI 10.1097/00005650-199001000-00005; Marconi Greg P, 2010, Manag Care, V19, P46; Mckay RM, 2011, CAN J INFECT DIS MED, V22, P19, DOI 10.1155/2011/745090; MCPHEE SJ, 1984, J MED EDUC, V59, P722; Miyakis S, 2006, POSTGRAD MED J, V82, P823, DOI 10.1136/pgmj.2006.049551; Moriates C, 2013, JAMA INTERN MED, V173, P308, DOI 10.1001/jamainternmed.2013.2286; Niquille A, 2010, ANN PHARMACOTHER, V44, P650, DOI 10.1345/aph.1M537; OKPARA AU, 1995, FORMULARY, V30, P343; Organisation for Economic Co-operation and Development, 2013, OECD HLTH DAT HLTH E; Owens DK, 2011, ANN INTERN MED, V154, P174, DOI 10.7326/0003-4819-154-3-201102010-00007; PARRINO TA, 1989, AM J MED, V86, P442, DOI 10.1016/0002-9343(89)90343-4; Pasquale TR, 2004, P T, V29, P33; PHILLIPPS L, 1986, Canadian Journal of Hospital Pharmacy, V39, P102; Polinski JM, 2011, CLIN THER, V33, P235, DOI 10.1016/j.clinthera.2011.02.009; Post J, 2013, AM J MED, V126, P838, DOI 10.1016/j.amjmed.2013.05.015; Qureshi N. A., 2011, Eastern Mediterranean Health Journal, V17, P172; Reinhardt UE, 2013, ECONOMIX        0913; Roth EJ, 2001, ARCH PHYS MED REHAB, V82, P633, DOI 10.1053/apmr.2001.22624; Rotman BL, 1996, J AM MED INFORM ASSN, V3, P340, DOI 10.1136/jamia.1996.97035025; Rudy DW, 2001, ACAD MED, V76, P635, DOI 10.1097/00001888-200106000-00016; SCHROEDER SA, 1984, JAMA-J AM MED ASSOC, V252, P225, DOI 10.1001/jama.252.2.225; SELF TH, 1984, DRUG INTEL CLIN PHAR, V18, P241, DOI 10.1177/106002808401800313; Shane R, 1994, Hosp Pharm, V29, P826; Shane R, 1994, HOSP PHARM, V29, P826; Shane R, 1994, HOSP PHARM, V29, P829; Sicotte C, 1996, J BEHAV MED, V19, P367, DOI 10.1007/BF01904763; Sleath B, 1997, AM J HEALTH-SYST PH, V54, P2197, DOI 10.1093/ajhp/54.19.2197; SMITH SR, 1983, J MED EDUC, V58, P146; Sommers BD, 2012, ACAD MED, V87, P719, DOI 10.1097/ACM.0b013e31825373b3; SPIEGEL CT, 1982, J MED EDUC, V57, P769; Stuebing EA, 2011, ARCH SURG-CHICAGO, V146, P524, DOI 10.1001/archsurg.2011.103; Sucov A, 1999, J EMERG MED, V17, P391, DOI 10.1016/S0736-4679(99)00017-7; Sussman AJ, 2004, J CLIN OUTCOMES MANA, V11, P290; Thakkar RN, 2015, AM J CLIN PATHOL, V143, P393, DOI 10.1309/AJCPJS4EEM7UAUBV; Verstappen WHJM, 2003, JAMA-J AM MED ASSOC, V289, P2407, DOI 10.1001/jama.289.18.2407; Vigneswaran Y, 2015, J AM COLL SURGEONS, V220, P1107, DOI 10.1016/j.jamcollsurg.2015.02.030; von Ferber L, 1999, PHARMACOECONOMICS, V16, P273, DOI 10.2165/00019053-199916030-00004; WEIN PJ, 1987, HOSP FORMUL, V22, P299; WEINGARTEN SR, 1994, ANN INTERN MED, V120, P257, DOI 10.7326/0003-4819-120-4-199402150-00001; WHITESIDE ME, 1987, HOSP FORMUL, V22, P561; Willens HJ, 2013, JACC-CARDIOVASC IMAG, V6, P297, DOI 10.1016/j.jcmg.2012.11.009; Wong G, 2013, BMC MED, V11, DOI [10.1186/1741-7015-11-21, 10.1186/1741-7015-11-20]; Yang ZF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102226; ZELEZNIK C, 1979, J MED EDUC, V54, P848; ZIMMERMAN DR, 1994, INQUIRY-J HEALTH CAR, V31, P89; ZISKIND AA, 1994, AM J CARDIOL, V73, P1219, DOI 10.1016/0002-9149(94)90187-2; Zunker RJ, 2000, AM J HEALTH-SYST PH, V57, P753, DOI 10.1093/ajhp/57.8.753	95	115	118	0	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 8	2015	314	22					2384	2400		10.1001/jama.2015.16353	http://dx.doi.org/10.1001/jama.2015.16353			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CX8XT	26647260	Bronze			2022-12-28	WOS:000365989100013
J	van Zuuren, EJ; Fedorowicz, Z				van Zuuren, Esther J.; Fedorowicz, Zbys			Interventions for Rosacea	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CONSENSUS RECOMMENDATIONS; AMERICAN ACNE; MANAGEMENT; SOCIETY		[van Zuuren, Esther J.] Leiden Univ, Med Ctr, Dept Dermatol, NL-2300 RC Leiden, Netherlands; [Fedorowicz, Zbys] Bahrain Branch Cochrane, Awali, Bahrain	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van Zuuren, EJ (corresponding author), Leiden Univ, Med Ctr, Dept Dermatol B1Q, NL-2300 RC Leiden, Netherlands.	e.j.van_zuuren@lumc.nl	van Zuuren, Esther/A-9512-2011; Fedorowicz, Zbys/AAV-1691-2021; Fedorowicz, Zbys/C-6659-2008	van Zuuren, Esther/0000-0002-4780-0182; Fedorowicz, Zbys/0000-0003-3952-965X				Del Rosso JQ, 2014, CUTIS, V93, P18; Del Rosso JQ, 2013, CUTIS, V92, P277; Reinholz M, 2013, J DTSCH DERMATOL GES, V11, P768, DOI 10.1111/ddg.12101; Tanghetti E, 2014, CUTIS, V93, P71; van Zuuren EJ, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003262.pub5	5	7	7	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 8	2015	314	22					2403	2404		10.1001/jama.2015.15287	http://dx.doi.org/10.1001/jama.2015.15287			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX8XT	26647262				2022-12-28	WOS:000365989100015
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Christmas presents	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358					0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 7	2015	351								h6655	10.1136/bmj.h6655	http://dx.doi.org/10.1136/bmj.h6655			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY5SM	26643852	Bronze			2022-12-28	WOS:000366467700014
J	Jacobs, IJ; Menon, U; Ryan, A; Gentry-Maharaj, A; Burnell, M; Kalsi, JK; Amso, NN; Apostolidou, S; Benjamin, E; Cruickshank, D; Crump, DN; Davies, SK; Dawnay, A; Dobbs, S; Fletcher, G; Ford, J; Godfrey, K; Gunu, R; Habib, M; Hallett, R; Herod, J; Jenkins, H; Karpinskyj, C; Leeson, S; Lewis, SJ; Liston, WR; Lopes, A; Mould, T; Murdoch, J; Oram, D; Rabideau, DJ; Reynolds, K; Scott, I; Seif, MW; Sharma, A; Singh, N; Taylor, J; Warburton, F; Widschwendter, M; Williamson, K; Woolas, R; Fallowfield, L; McGuire, AJ; Campbell, S; Parmar, M; Skates, SJ				Jacobs, Ian J.; Menon, Usha; Ryan, Andy; Gentry-Maharaj, Aleksandra; Burnell, Matthew; Kalsi, Jatinderpal K.; Amso, Nazar N.; Apostolidou, Sophia; Benjamin, Elizabeth; Cruickshank, Derek; Crump, Danielle N.; Davies, Susan K.; Dawnay, Anne; Dobbs, Stephen; Fletcher, Gwendolen; Ford, Jeremy; Godfrey, Keith; Gunu, Richard; Habib, Mariam; Hallett, Rachel; Herod, Jonathan; Jenkins, Howard; Karpinskyj, Chloe; Leeson, Simon; Lewis, Sara J.; Liston, William R.; Lopes, Alberto; Mould, Tim; Murdoch, John; Oram, David; Rabideau, Dustin J.; Reynolds, Karina; Scott, Ian; Seif, Mourad W.; Sharma, Aarti; Singh, Naveena; Taylor, Julie; Warburton, Fiona; Widschwendter, Martin; Williamson, Karin; Woolas, Robert; Fallowfield, Lesley; McGuire, Alistair J.; Campbell, Stuart; Parmar, Mahesh; Skates, Steven J.			Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial	LANCET			English	Article							PROPORTIONAL-HAZARDS; POSTMENOPAUSAL WOMEN; RISK; PROSTATE; ALGORITHM; MODELS; LUNG; MULTICENTER; ULTRASOUND; PREVENTION	Background Ovarian cancer has a poor prognosis, with just 40% of patients surviving 5 years. We designed this trial to establish the effect of early detection by screening on ovarian cancer mortality. rvlethods In this randomised controlled trial, we recruited postmenopausal women aged 50-74 years from 13 centres in National Health Service Trusts in England, Wales, and Northern Ireland. Exclusion criteria were previous bilateral oophorectomy or ovarian malignancy, increased risk of familial ovarian cancer, and active non-ovarian malignancy. The trial management system confirmed eligibility and randomly allocated participants in blocks of 32 using computer generated random numbers to annual multimodal screening (MMS) with serum CA125 interpreted with use of the risk of ovarian cancer algorithm, annual transvaginal ultrasound screening (USS), or no screening, in a 1:1:2 ratio. The primary outcome was death due to ovarian cancer by Dec 31, 2014, comparing MMS and USS separately with no screening, ascertained by an outcomes committee masked to randomisation group. All analyses were by modified intention to screen, excluding the small number of women we discovered after randomisation to have a bilateral oophorectomy, have ovarian cancer, or had exited the registry before recruitment. Investigators and participants were aware of screening type. This trial is registered with ClinicalTrials.gov, number NCT00058032. Findings Between June 1, 2001, and Oct 21, 2005, we randomly allocated 202 638 women: 50 640 (25.0%) to MMS, 50 639 (25.0%) to USS, and 101359 (50.0%) to no screening. 202 546 (>99.9%) women were eligible for analysis: 50 624 (>99.9%) women in the MMS group, 50 623 (>99.9%) in the USS group, and 101 299 (>99.9%) in the no screening group. Screening ended on Dec 31, 2011, and included 345 570 MMS and 3 27 775 USS annual screening episodes. At a median follow-up of 11.1 years (IQR 10.0-12.0), we diagnosed ovarian cancer in 1282 (0.6%) women: 338 (0.7%) in the MMS group, 314 (0.6%) in the USS group, and 630 (0.6%) in the no screening group. Of these women, 148 (0.29%) women in the MMS group, 154 (0.30%) in the USS group, and 347 (0.34%) in the no screening group had died of ovarian cancer. The primary analysis using a Cox proportional hazards model gave a mortality reduction over years 0-14 of 15% (95% CI 3 to 30; p=0.10) with MMS and 11% (-7 to 27; p=0.21) with USS. The Royston-Parmar flexible parametric model showed that in the MMS group, this mortality effect was made up of 8% (-20 to 31) in years 0-7 and 23% (1-46) in years 7-14, and in the USS group, of 2% (-27 to 26) in years 0-7 and 21% (-2 to 42) in years 7-14. A prespecified analysis of death from ovarian cancer of MMS versus no screening with exclusion of prevalent cases showed significantly different death rates (p=0.021), with an overall average mortality reduction of 20% (-2 to 40) and a reduction of 8% (-27 to 43) in years 0-7 and 28% (-3 to 49) in years 7-14 in favour of MMS. Interpretation Although the mortality reduction was not significant in the primary analysis, we noted a significant mortality reduction with MMS when prevalent cases were excluded. We noted encouraging evidence of a mortality reduction in years 7-14, but further follow-up is needed before firm conclusions can be reached on the efficacy and cost-effectiveness of ovarian cancer screening.	[Jacobs, Ian J.; Menon, Usha; Ryan, Andy; Gentry-Maharaj, Aleksandra; Burnell, Matthew; Kalsi, Jatinderpal K.; Apostolidou, Sophia; Crump, Danielle N.; Davies, Susan K.; Fletcher, Gwendolen; Ford, Jeremy; Gunu, Richard; Habib, Mariam; Hallett, Rachel; Karpinskyj, Chloe; Lewis, Sara J.; Liston, William R.; Sharma, Aarti; Taylor, Julie; Warburton, Fiona; Widschwendter, Martin; Woolas, Robert] UCL, Inst Womens Hlth, Dept Womens Canc, London W1T 7DN, England; [Jacobs, Ian J.] Univ New S Wales, Sydney, NSW 2052, Australia; [Jacobs, Ian J.] Univ Manchester, Ctr Womens Hlth, Inst Human Dev, Manchester, Lancs, England; [Amso, Nazar N.] Cardiff Univ, Coll Biomed & Life Sci, Sch Med, Obstet & Gynaecol, Cardiff CF10 3AX, S Glam, Wales; [Benjamin, Elizabeth] Univ Coll London Hosp, Dept Pathol Res, Inst Canc, London, England; [Dawnay, Anne] Univ Coll London Hosp, Clin Biochem, London, England; [Mould, Tim] Univ Coll London Hosp, Dept Gynaecol Oncol, London, England; [Cruickshank, Derek] James Cook Univ Hosp, Dept Gynaecol Oncol, Middlesbrough, Cleveland, England; [Dobbs, Stephen] Belfast City Hosp, Dept Gynaecol Oncol, Belfast BT9 7AD, Antrim, North Ireland; [Ford, Jeremy] Qatari Shareholding Co, Malomatia Informat Commun & Technol QATAR, Doha, Qatar; [Godfrey, Keith; Lopes, Alberto] Queen Elizabeth Hosp, Northern Gynaecol Oncol Ctr, Gateshead, Tyne & Wear, England; [Habib, Mariam] Natl Hosp Neurol & Neurosurg, Med Res Council, Ctr Neuromuscular Dis, Queen Sq, London WC1N 3BG, England; [Hallett, Rachel] Bangor Univ, Sch Med Sci, Bangor, Gwynedd, Wales; [Herod, Jonathan] Liverpool Womens Hosp, Dept Gynaecol, Liverpool, Merseyside, England; [Herod, Jonathan] Hamad Med Corp, Womens Hosp, Doha, Qatar; [Jenkins, Howard; Scott, Ian] Royal Derby Hosp, Dept Gynaecol Oncol, Derby, England; [Leeson, Simon] Llandudno Hosp, Dept Gynaecol Oncol, Llandudno, Gwynedd, Wales; [Lopes, Alberto] Derriford Hosp, Plymouth PL6 8DH, Devon, England; [Mould, Tim] Royal Free Hosp, Dept Gynaecol Oncol, Pond St, London NW3 2QG, England; [Murdoch, John] St Michaels Hosp, Dept Gynaecol Oncol, Bristol, Avon, England; [Oram, David; Reynolds, Karina] St Bartholomews Hosp, Dept Gynaecol Oncol, London, England; [Rabideau, Dustin J.; Skates, Steven J.] Massachusetts Gen Hosp, Biostat Ctr, Boston, MA 02114 USA; [Seif, Mourad W.] St Marys Hosp, Cent Manchester Fdn Trust, Manchester M13 0JH, Lancs, England; [Seif, Mourad W.] Univ Manchester, Inst Canc Sci, Manchester, Lancs, England; [Sharma, Aarti] Univ Wales Hosp, Dept Gynaecol Oncol, Heath Pk, Cardiff, S Glam, Wales; [Singh, Naveena] Barts Hlth Natl Hlth Serv Trust, Dept Pathol, London, England; [Warburton, Fiona] Publ Hlth England, London, England; [Williamson, Karin] City Hosp Nottingham, Dept Gynaecol Oncol, Nottingham, England; [Woolas, Robert] Queen Alexandra Hosp, Dept Gynaecol Oncol, Portsmouth, Hants, England; [Fallowfield, Lesley] Univ Sussex, Sussex Hlth Outcomes Res & Educ Canc, Brighton & Sussex Med Sch, Sussex, England; [McGuire, Alistair J.] London Sch Econ, Dept Social Policy, London WC2A 2AE, England; [Campbell, Stuart] Create Hlth Clin, London, England; [Parmar, Mahesh] UCL, Clin Trials Unit, MRC, London, England; [Skates, Steven J.] Harvard Univ, Sch Med, Boston, MA USA	University of London; University College London; University of New South Wales Sydney; University of Manchester; Cardiff University; University College London Hospitals NHS Foundation Trust; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; James Cook University Hospital; Belfast City Hospital; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Bangor University; University of Liverpool; Hamad Medical Corporation; University of Nottingham; Derriford Hospital; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; Queen Mary University London; Harvard University; Massachusetts General Hospital; University of Manchester; University of Manchester; Cardiff University; Barts Health NHS Trust; Public Health England; Nottingham University Hospital NHS Trust; Nottingham City Hospital; Portsmouth Hospitals NHS Trust; Queen Alexandra Hospital; University of Sussex; University of London; London School Economics & Political Science; Medical Research Council Clinical Trials Unit; University of London; University College London; Harvard University; Harvard Medical School	Menon, U (corresponding author), UCL, Inst Womens Hlth, Dept Womens Canc, London W1T 7DN, England.; Jacobs, IJ (corresponding author), Univ New S Wales, Sydney, NSW 2052, Australia.	i.jacobs@unsw.edu.au; u.menon@ucl.ac.uk	de Barros Lopes, Alberto/B-2116-2018; Singh, Naveena/AAH-2651-2020; Menon, Usha/C-4716-2008	de Barros Lopes, Alberto/0000-0002-8796-3891; Menon, Usha/0000-0003-3708-1732; Jacobs, Ian/0000-0002-5005-2672; Amso, Nazar/0000-0002-8646-6623; Apostolidou, Sophia/0000-0003-2659-0451; Widschwendter, Martin/0000-0002-7778-8380; Karpinskyj, Chloe/0000-0003-0870-9287	Medical Research Council; Cancer Research UK; Department of Health; Eve Appeal; Medical Research Council [G9901012, G0801228, G0000735] Funding Source: researchfish; MRC [G0000735, G9901012, G0801228] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [U01CA152990] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Department of Health; Eve Appeal; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Medical Research Council, Cancer Research UK, Department of Health, The Eve Appeal.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; [Anonymous], 2003, WHO CLASSIFICATION T; Barrett J, 2014, BJOG-INT J OBSTET GY, V121, P1071, DOI 10.1111/1471-0528.12870; Buys SS, 2011, JAMA-J AM MED ASSOC, V305, P2295, DOI 10.1001/jama.2011.766; Cancer Research UK, OV CANC SURV STAT OV; Cancer Research UK, OV CANC SURV STAT ON; Cancer Research UK, OVARIAN CANCER STATI; Carpenter B, J STAT SOFT IN PRESS; Daya D, 2014, WHO CLASSIFICATION T, P92; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fleming TR, 2011, COUNTING PROCESSES S; Gentry-Maharaj A, 2013, ULTRASOUND OBST GYN, V41, P73, DOI 10.1002/uog.12262; Holme O, 2014, JAMA-J AM MED ASSOC, V312, P606, DOI 10.1001/jama.2014.8266; Iyer R, 2015, BRIT J CANCER, V112, P475, DOI 10.1038/bjc.2014.630; Izmirlian G, 2014, STAT INTERFACE, V7, P27, DOI 10.4310/SII.2014.v7.n1.a4; JACOBS I, 1988, LANCET, V1, P268; Jacobs IJ, 1996, BMJ-BRIT MED J, V313, P1355, DOI 10.1136/bmj.313.7069.1355; Jacobs IJ, 1999, LANCET, V353, P1207, DOI 10.1016/S0140-6736(98)10261-1; LAGAKOS SW, 1984, BIOMETRICS, V40, P1037, DOI 10.2307/2531154; Liu ZH, 2013, J MED SCREEN, V20, P157, DOI 10.1177/0969141313504088; Loberg M, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0525-z; Lu KH, 2013, CANCER-AM CANCER SOC, V119, P3454, DOI 10.1002/cncr.28183; Menon U, 2005, J CLIN ONCOL, V23, P7919, DOI 10.1200/JCO.2005.01.6642; Menon U, 1999, BRIT J CANCER, V80, P1644, DOI 10.1038/sj.bjc.6690575; Menon U, 2000, BRIT J OBSTET GYNAEC, V107, P165, DOI 10.1111/j.1471-0528.2000.tb11685.x; Menon U, 2015, J CLIN ONCOL, V33, P2062, DOI 10.1200/JCO.2014.59.4945; Menon U, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2079; Menon U, 2009, LANCET ONCOL, V10, P327, DOI 10.1016/S1470-2045(09)70026-9; Oken MM, 2011, JAMA-J AM MED ASSOC, V306, P1865, DOI 10.1001/jama.2011.1591; Prat J, 2014, INT J GYNECOL OBSTET, V124, P1, DOI 10.1016/j.ijgo.2013.10.001; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Schoen RE, 2012, NEW ENGL J MED, V366, P2345, DOI 10.1056/NEJMoa1114635; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; SELF SG, 1991, BIOMETRICS, V47, P975, DOI 10.2307/2532653; SELF SG, 1995, BIOMETRICS, V51, P44, DOI 10.2307/2533313; Sharma A, 2016, ULTRASOUND OBST GYN, V47, P228, DOI 10.1002/uog.14929; Shen Y, 2001, BIOMETRICS, V57, P837, DOI 10.1111/j.0006-341X.2001.00837.x; Skates SJ, 2001, J AM STAT ASSOC, V96, P429, DOI 10.1198/016214501753168145; Skates Steven J, 2003, J Clin Oncol, V21, p206s, DOI 10.1200/JCO.2003.02.955; Warwick J, 2005, J R STAT SOC A STAT, V168, P657, DOI 10.1111/j.1467-985X.2005.00371.x	41	584	600	2	81	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 5	2016	387	10022					945	956		10.1016/S0140-6736(15)01224-6	http://dx.doi.org/10.1016/S0140-6736(15)01224-6			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF8XP	26707054	Green Submitted, Green Published, Green Accepted, hybrid			2022-12-28	WOS:000371644200028
J	Yao, JC; Fazio, N; Singh, S; Buzzoni, R; Carnaghi, C; Wolin, E; Tomasek, J; Raderer, M; Lahner, H; Voi, M; Pacaud, LB; Rouyrre, N; Sachs, C; Valle, JW; Delle Fave, G; Van Cutsem, E; Tesselaar, M; Shimada, Y; Oh, DY; Strosberg, J; Kulke, MH; Pavel, ME				Yao, James C.; Fazio, Nicola; Singh, Simron; Buzzoni, Roberto; Carnaghi, Carlo; Wolin, Edward; Tomasek, Jiri; Raderer, Markus; Lahner, Harald; Voi, Maurizio; Pacaud, Lida Buboteishvili; Rouyrre, Nicolas; Sachs, Carolin; Valle, Juan W.; Delle Fave, Gianfranco; Van Cutsem, Eric; Tesselaar, Margot; Shimada, Yasuhiro; Oh, Do-Youn; Strosberg, Jonathan; Kulke, Matthew H.; Pavel, Marianne E.		RAD001 Adv Neuroendocrine Tumours; Fourth Trial RADIANT-4 Study Grp	Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study	LANCET			English	Article							MUTATIONS; SUNITINIB	Background Effective systemic therapies for patients with advanced, progressive neuroendocrine tumours of the lung or gastrointestinal tract are scarce. We aimed to assess the efficacy and safety of everolimus compared with placebo in this patient population. Methods In the randomised, double-blind, placebo-controlled, phase 3 RADIANT-4 trial, adult patients (aged.1.8 years) with advanced, progressive, well-differentiated, non-functional neuroendocrine tumours of lung or gastrointestinal origin were enrolled from 97 centres in 25 countries worldwide. Eligible patients were randomly assigned in a 2:1 ratio by an interactive voice response system to receive everolimus 10 mg per day orally or identical placebo, both with supportive care. Patients were stratified by tumour origin, performance status, and previous somatostatin analogue treatment. Patients, investigators, and the study sponsor were masked to treatment assignment. The primary endpoint was progression-free survival assessed by central radiology review, analysed by intention to treat. Overall survival was a key secondary endpoint. This trial is registered with ClinicalTrials.gov, number NCT01524783. Findings Between April 3,2012, and Aug 23,2013, a total of 302 patients were enrolled, of whom 205 were allocated to everolimus 10 mg per day and 97 to placebo. Median progression-free survival was 11.0 months (95% CI 9.2-13.3) in the everolimus group and 3.9 months (3.6-7.4) in the placebo group. Everolimus was associated with a 52% reduction in the estimated risk of progression or death (hazard ratio [HR] 0.48 [95% CI 0.35-0.67], p<0.00001). Although not statistically significant, the results of the first pre-planned interim overall survival analysis indicated that everolimus might be associated with a reduction in the risk of death (HR 0.64 [95% CI 0.40-1.05], one-sided 13=0.037, whereas the boundary for statistical significance was 0.0002). Grade 3 or 4 drug -related adverse events were infrequent and included stomatitis (in 18 [9%] of 202 patients in the everolimus group vs 0 of 98 in the placebo group), diarrhoea (15 [7%] vs 2 [2%]), infections (14 [7%] vs 0), anaemia (8 [4%] vs 1 [1%]), fatigue (7 [3%] vs 1 [1%]), and hyperglycaemia (7 [3%] vs 0). Interpretation Treatment with everolimus was associated with significant improvement in progression -free survival in patients with progressive lung or gastrointestinal neuroendocrine tumours. The safety findings were consistent with the known side -effect profile of everolimus. Everolimus is the first targeted agent to show robust anti-tumour activity with acceptable tolerability across a broad range of neuroendocrine tumours, including those arising from the pancreas, lung, and gastrointestinal tract.	[Yao, James C.] Univ Texas MD Anderson Canc Ctr, 1515 Holcombe Blvd,Box 426, Houston, TX 77030 USA; [Fazio, Nicola] IRCCS, Ist Europeo Oncol, Milan, Italy; [Singh, Simron] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Buzzoni, Roberto] Fdn IRCCS, Ist Nazl Tumori, Milan, Italy; [Carnaghi, Carlo] IRCCS Ist Clin Humanitas, Rozzano, Italy; [Wolin, Edward] Univ Kentucky, Markey Canc Ctr, Lexington, KY USA; [Tomasek, Jiri] Masaryk Univ, Fac Med, Masaryk Mem Canc Inst, Brno, Czech Republic; [Raderer, Markus] AKH, Univ Klin Innere Med 1, Vienna, Austria; [Lahner, Harald] Univ Klinikum Essen, Zentrum Innere Med, Essen, Germany; [Voi, Maurizio] Novartis Pharmaceut, E Hanover, NJ USA; [Pacaud, Lida Buboteishvili; Rouyrre, Nicolas; Sachs, Carolin] Novartis Pharma AG, Basel, Switzerland; [Valle, Juan W.] Univ Manchester, Christie Hosp, Inst Canc Studies, Manchester, Lancs, England; [Delle Fave, Gianfranco] Univ Roma La Sapienza, Azienda Osped St Andrea, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Van Cutsem, Eric] Univ Hosp Gasthuisberg Leuven, Leuven, Belgium; [Van Cutsem, Eric] Katholieke Univ Leuven, Leuven, Belgium; [Tesselaar, Margot] Antoni van Leeuwenhoek, Nederlands Kanker Inst, Amsterdam, Netherlands; [Shimada, Yasuhiro] Natl Canc Ctr, 1-1 Tsukiji 5 chome, Tokyo, Japan; [Oh, Do-Youn] Seoul Natl Univ Hosp, Seoul 110744, South Korea; [Strosberg, Jonathan] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA; [Kulke, Matthew H.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Pavel, Marianne E.] Charite, Campus Virchow Klinikum, D-13353 Berlin, Germany	University of Texas System; UTMD Anderson Cancer Center; IRCCS European Institute of Oncology (IEO); University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Humanitas Research Hospital; University of Kentucky; Masaryk Memorial Cancer Institute; Masaryk University Brno; University of Duisburg Essen; Novartis; Novartis; Christie NHS Foundation Trust; Christie Hospital; University of Manchester; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; KU Leuven; University Hospital Leuven; KU Leuven; National Cancer Center - Japan; Seoul National University (SNU); Seoul National University Hospital; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Harvard University; Dana-Farber Cancer Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Yao, JC (corresponding author), Univ Texas MD Anderson Canc Ctr, 1515 Holcombe Blvd,Box 426, Houston, TX 77030 USA.	jyao@mdanderson.org	Van+Cutsem, Eric/ABE-1762-2021; Peeters, Marc/C-5525-2013	Peeters, Marc/0000-0003-4969-2303; fazio, nicola/0000-0001-6869-0704	Novartis Pharmaceuticals Corporation; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER	Novartis Pharmaceuticals Corporation(Novartis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Novartis Pharmaceuticals Corporation.	Bajetta E, 2014, CANCER-AM CANCER SOC, V120, P2457, DOI 10.1002/cncr.28726; Banck MS, 2013, J CLIN INVEST, V123, P2502, DOI 10.1172/JCI67963; Blumenthal GM, 2012, ONCOLOGIST, V17, P1108, DOI 10.1634/theoncologist.2012-0044; Caplin ME, 2014, NEW ENGL J MED, V371, P224, DOI 10.1056/NEJMoa1316158; Choti MA, 2012, J CLIN ONCOL, V30; Fazio N, 2013, CHEST, V143, P955, DOI 10.1378/chest.12-1108; Fernandez-Cuesta L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4518; Francis JM, 2013, NAT GENET, V45, P1483, DOI 10.1038/ng.2821; Klimstra DS, 2010, PANCREAS, V39, P707, DOI 10.1097/MPA.0b013e3181ec124e; Meric-Bernstam F, 2012, CLIN CANCER RES, V18, P1777, DOI 10.1158/1078-0432.CCR-11-2123; Pavel ME, 2012, J CLIN ONCOL, V30; Pavel ME, 2011, LANCET, V378, P2005, DOI 10.1016/S0140-6736(11)61742-X; Raymond E, 2011, NEW ENGL J MED, V364, P501, DOI 10.1056/NEJMoa1003825; Rindi G., 2010, WHO CLASSIFICATION T, P13; Rinke A, 2009, J CLIN ONCOL, V27, P4656, DOI 10.1200/JCO.2009.22.8510; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Yao JC, 2008, J CLIN ONCOL, V26, P4311, DOI 10.1200/JCO.2008.16.7858; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377; Yao JC, 2011, NEW ENGL J MED, V364, P514, DOI 10.1056/NEJMoa1009290; Yao JC., 2012, EUR ONCOL HAEMATOL, V8, P217, DOI DOI 10.17925/EOH.2012.08.4.217	20	713	742	2	72	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 5	2016	387	10022					968	977		10.1016/S0140-6736(15)00817-X	http://dx.doi.org/10.1016/S0140-6736(15)00817-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF8XP	26703889	Green Accepted			2022-12-28	WOS:000371644200030
J	Martin, P				Martin, Peter			Ibrutinib-a new standard treatment for relapsed mantle cell lymphoma?	LANCET			English	Editorial Material							SINGLE-AGENT TEMSIROLIMUS; PHASE-II; BORTEZOMIB; TRIAL		[Martin, Peter] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA	Cornell University	Martin, P (corresponding author), Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA.	pem9019@med.cornell.edu						Advani RH, 2013, J CLIN ONCOL, V31, P88, DOI 10.1200/JCO.2012.42.7906; Ansell SM, 2008, CANCER-AM CANCER SOC, V113, P508, DOI 10.1002/cncr.23580; Campo E, 2015, BLOOD, V125, P48, DOI 10.1182/blood-2014-05-521898; Dreyling M, 2015, LANCET; FISHER RI, 1993, NEW ENGL J MED, V328, P1002, DOI 10.1056/NEJM199304083281404; Fisher RI, 2006, J CLIN ONCOL, V24, P4867, DOI 10.1200/JCO.2006.07.9665; Goy A, 2013, J CLIN ONCOL, V31, P3688, DOI 10.1200/JCO.2013.49.2835; Hess G, 2009, J CLIN ONCOL, V27, P3822, DOI 10.1200/JCO.2008.20.7977; Romaguera JE, 2005, J CLIN ONCOL, V23, P7013, DOI 10.1200/JCO.2005.01.1825; Wang ML, 2013, NEW ENGL J MED, V369, P507, DOI 10.1056/NEJMoa1306220; Witzig TE, 2005, J CLIN ONCOL, V23, P5347, DOI 10.1200/JCO.2005.13.466	11	6	6	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 20	2016	387	10020					728	729		10.1016/S0140-6736(15)01040-5	http://dx.doi.org/10.1016/S0140-6736(15)01040-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE1WU	26673812				2022-12-28	WOS:000370418000008
J	Diamond, J				Diamond, Jared			ARCHAEOLOGY Sources of Chaco wood	NATURE			English	Editorial Material							NEW-MEXICO; CANYON; CONSTRUCTION		[Diamond, Jared] Univ Calif Los Angeles, Dept Geog, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Diamond, J (corresponding author), Univ Calif Los Angeles, Dept Geog, Los Angeles, CA 90095 USA.	jdiamond@geog.ucla.edu						[Anonymous], 2015, CHACO REVISITED NEW; BETANCOURT JL, 1986, AM ANTIQUITY, V51, P370, DOI 10.2307/279950; Bridge M, 2012, J ARCHAEOL SCI, V39, P2828, DOI 10.1016/j.jas.2012.04.028; English NB, 2001, P NATL ACAD SCI USA, V98, P11891, DOI 10.1073/pnas.211305498; Guiterman C. H., 2015, P NAT ACAD SCI US; King R., 2015, CUPOLA BRUNELLESCHI; Lekson S.H., 2006, ARCHAEOLOGY CHACO CA; Reynolds AC, 2005, J ARCHAEOL SCI, V32, P1061, DOI 10.1016/j.jas.2005.01.016; Wills WH, 2014, P NATL ACAD SCI USA, V111, P11584, DOI 10.1073/pnas.1409646111	9	1	1	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 7	2016	529	7584					31	33		10.1038/nature16864	http://dx.doi.org/10.1038/nature16864			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DA6VY	26700808				2022-12-28	WOS:000367944900019
J	Kaletsky, R; Lakhina, V; Arey, R; Williams, A; Landis, J; Ashraf, J; Murphy, CT				Kaletsky, Rachel; Lakhina, Vanisha; Arey, Rachel; Williams, April; Landis, Jessica; Ashraf, Jasmine; Murphy, Coleen T.			The C. elegans adult neuronal IIS/FOXO transcriptome reveals adult phenotype regulators	NATURE			English	Article							LIFE-SPAN; TGF-BETA; PROTEIN; REGENERATION; DAF-16; GENES; EXPRESSION; LONGEVITY; BEHAVIOR; 3-KINASE	Insulin/insulin-like growth factor signalling (IIS) is a critical regulator of an organism's most important biological decisions from growth, development, and metabolism to reproduction and longevity. It primarily does so through the activity of the DAF-16 transcription factor (forkhead box O (FOXO) homologue), whose global targets were identified in Caenorhabditis elegans using whole-worm transcriptional analyses more than a decade ago(1). IIS and FOXO also regulate important neuronal and adult behavioural phenotypes, such as the maintenance of memory(2) and axon regeneration(3) with age, in both mammals(4) and C. elegans, but the neuron-specific IIS/FOXO targets that regulate these functions are still unknown. By isolating adult C. elegans neurons for transcriptional profiling, we identified both the wild-type and IIS/FOXO mutant adult neuronal transcriptomes for the first time. IIS/FOXO neuron-specific targets are distinct from canonical IIS/FOXO-regulated longevity and metabolism targets, and are required for extended memory in IIS daf-2 mutants. The activity of the forkhead transcription factor FKH-9 in neurons is required for the ability of daf-2 mutants to regenerate axons with age, and its activity in non-neuronal tissues is required for the long lifespan of daf-2 mutants. Together, neuron-specific and canonical IIS/FOXO-regulated targets enable the coordinated extension of neuronal activities, metabolism, and longevity under low-insulin signalling conditions.	[Kaletsky, Rachel; Lakhina, Vanisha; Arey, Rachel; Williams, April; Landis, Jessica; Ashraf, Jasmine; Murphy, Coleen T.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Kaletsky, Rachel; Lakhina, Vanisha; Arey, Rachel; Williams, April; Landis, Jessica; Ashraf, Jasmine; Murphy, Coleen T.] Princeton Univ, LSI Genom, Princeton, NJ 08544 USA	Princeton University; Princeton University	Murphy, CT (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.; Murphy, CT (corresponding author), Princeton Univ, LSI Genom, Princeton, NJ 08544 USA.	ctmurphy@princeton.edu		Williams, April/0000-0001-9281-8528; Murphy, Coleen/0000-0002-8257-984X; Lakhina, Vanisha/0000-0002-5872-6838; Arey, Rachel/0000-0001-9941-3945; Kaletsky, Rachel/0000-0002-7176-9154	Keck Scholars Program fellowship; National Institutes of Health Cognitive Aging R01; Ruth L. Kirschstein National Research Service Awards; National Science Foundation; New Jersey Commission on Brain Injury Research fellowships; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG003284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP1GM119167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG046106, R01AG034446] Funding Source: NIH RePORTER	Keck Scholars Program fellowship; National Institutes of Health Cognitive Aging R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Awards(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); New Jersey Commission on Brain Injury Research fellowships; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the C. elegans Genetics Center for strains; WormBase (WS250); L. Parsons for RNA-seq data support; J. Wiggins and the Lewis-Sigler High Throughput Sequencing Core Facility for RNA-seq support; C. DeCoste and the Flow Cytometry Facility for assistance; V. Yao for tissue prediction analysis; R. DiLoreto for chemotaxis assay analysis; and Z. Gitai, the Murphy lab, and W. Mair for discussion. Funding was provided by a Keck Scholars Program fellowship (C.T.M.), National Institutes of Health Cognitive Aging R01 (C.T.M.), Ruth L. Kirschstein National Research Service Awards (R.K., R.A.), National Science Foundation (J.L.) and New Jersey Commission on Brain Injury Research (V.L.) fellowships.	Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Byrne AB, 2014, NEURON, V81, P561, DOI 10.1016/j.neuron.2013.11.019; Chang YW, 2009, J NEUROTRAUM, V26, P979, DOI 10.1089/neu.2008-0762; Chen LZ, 2011, NEURON, V71, P1043, DOI 10.1016/j.neuron.2011.07.009; Chikina MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000417; Ewald CY, 2015, NATURE, V519, P97, DOI 10.1038/nature14021; Ewald CY, 2012, J NEUROSCI, V32, P10156, DOI 10.1523/JNEUROSCI.0495-12.2012; Hammarlund M, 2009, SCIENCE, V323, P802, DOI 10.1126/science.1165527; Hansen M, 2005, PLOS GENET, V1, P119, DOI 10.1371/journal.pgen.0010017; Hoerndli FJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004880; Ikeda DD, 2008, P NATL ACAD SCI USA, V105, P5260, DOI 10.1073/pnas.0711894105; Kauffman AL, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000372; Kodama E, 2006, GENE DEV, V20, P2955, DOI 10.1101/gad.1479906; Lakhina V, 2015, NEURON, V85, P330, DOI 10.1016/j.neuron.2014.12.029; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Luo SJ, 2010, CELL, V143, P299, DOI 10.1016/j.cell.2010.09.013; Murakami H, 2005, J NEUROSCI, V25, P10894, DOI 10.1523/JNEUROSCI.3600-04.2005; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Ohno H, 2014, SCIENCE, V345, P313, DOI 10.1126/science.1250709; Schafer JC, 2006, J CELL SCI, V119, P4088, DOI 10.1242/jcs.03187; Shaw WM, 2007, CURR BIOL, V17, P1635, DOI 10.1016/j.cub.2007.08.058; SJOBERG J, 1989, BRAIN RES, V485, P102, DOI 10.1016/0006-8993(89)90671-9; Spencer WC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112102; Stein GM, 2014, NEUROBIOL LEARN MEM, V115, P86, DOI 10.1016/j.nlm.2014.07.011; Tank EMH, 2011, J NEUROSCI, V31, P9279, DOI 10.1523/JNEUROSCI.6606-10.2011; Tepper RG, 2013, CELL, V154, P676, DOI 10.1016/j.cell.2013.07.006; Tian NM, 2008, DEVELOPMENT, V135, P4081, DOI 10.1242/dev.023572; Tomioka M, 2006, NEURON, V51, P613, DOI 10.1016/j.neuron.2006.07.024; Toth ML, 2012, J NEUROSCI, V32, P8778, DOI 10.1523/JNEUROSCI.1494-11.2012; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Wong AK, 2015, NUCLEIC ACIDS RES, V43, pW128, DOI 10.1093/nar/gkv486; Zhang PC, 2013, CELL METAB, V17, P85, DOI 10.1016/j.cmet.2012.12.013; Zhang SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019505	33	120	135	1	65	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 7	2016	529	7584					92	+		10.1038/nature16483	http://dx.doi.org/10.1038/nature16483			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6VY	26675724	Green Accepted			2022-12-28	WOS:000367944900033
J	Snowden, JM; Tilden, EL; Snyder, J; Quigley, B; Caughey, AB; Cheng, YW				Snowden, Jonathan M.; Tilden, Ellen L.; Snyder, Janice; Quigley, Brian; Caughey, Aaron B.; Cheng, Yvonne W.			Planned Out-of-Hospital Birth and Birth Outcomes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROPENSITY-SCORE; UNITED-STATES; VAGINAL BIRTH; HOME BIRTHS; TRENDS; CARE; INTERVENTIONS; MIDWIFERY; MIDWIVES; DELIVERY	BACKGROUND The frequency of planned out-of-hospital birth in the United States has increased in recent years. The value of studies assessing the perinatal risks of planned out-of-hospital birth versus hospital birth has been limited by cases in which transfer to a hospital is required and a birth that was initially planned as an out-of-hospital birth is misclassified as a hospital birth. METHODS We performed a population-based, retrospective cohort study of all births that occurred in Oregon during 2012 and 2013 using data from newly revised Oregon birth certificates that allowed for the disaggregation of hospital births into the categories of planned in-hospital births and planned out-of-hospital births that took place in the hospital after a woman's intrapartum transfer to the hospital. We assessed perinatal morbidity and mortality, maternal morbidity, and obstetrical procedures according to the planned birth setting (out of hospital vs. hospital). RESULTS Planned out-of-hospital birth was associated with a higher rate of perinatal death than was planned in-hospital birth (3.9 vs. 1.8 deaths per 1000 deliveries, P = 0.003; odds ratio after adjustment for maternal characteristics and medical conditions, 2.43; 95% confidence interval [CI], 1.37 to 4.30; adjusted risk difference, 1.52 deaths per 1000 births; 95% CI, 0.51 to 2.54). The odds for neonatal seizure were higher and the odds for admission to a neonatal intensive care unit lower with planned out-of-hospital births than with planned in-hospital birth. Planned out-of-hospital birth was also strongly associated with unassisted vaginal delivery (93.8%, vs. 71.9% with planned in-hospital births; P<0.001) and with decreased odds for obstetrical procedures. CONCLUSIONS Perinatal mortality was higher with planned out-of-hospital birth than with planned in-hospital birth, but the absolute risk of death was low in both settings.	[Snowden, Jonathan M.; Quigley, Brian; Caughey, Aaron B.] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA; [Snowden, Jonathan M.] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Portland, OR 97201 USA; [Tilden, Ellen L.; Snyder, Janice] Oregon Hlth & Sci Univ, Sch Nursing, Portland, OR 97201 USA; [Cheng, Yvonne W.] Univ Calif Davis, Dept Surg, Sacramento, CA 95817 USA; [Cheng, Yvonne W.] Calif Pacific Med Ctr, Dept Obstet & Gynecol, Div Maternal Fetal Med, San Francisco, CA USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; University of California System; University of California Davis; California Pacific Medical Center	Snowden, JM (corresponding author), Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd,Mail Code L 466, Portland, OR 97239 USA.	snowden@ohsu.edu	Tilden, Ellen/AAU-8439-2021	Tilden, Ellen/0000-0002-2457-1807	Eunice Kennedy Shriver National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD085809, K99HD079658, K12HD043488] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development.	Ananth CV, 2013, PAEDIATR PERINAT EP, V27, P442, DOI 10.1111/ppe.12068; Austin PC, 2010, STAT MED, V29, P2137, DOI 10.1002/sim.3854; Blix E, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-179; Brocklehurst P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7400; Cheng YW, 2013, AM J OBSTET GYNECOL, V209; Cheyney M, 2014, J MIDWIFERY WOM HEAL, V59, P17, DOI 10.1111/jmwh.12172; Cook E, 2014, J MIDWIFERY WOM HEAL, V59, P153, DOI 10.1111/jmwh.12142; de Jonge A, 2015, BJOG-INT J OBSTET GY, V122, P720, DOI 10.1111/1471-0528.13084; de Jonge A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3263; Gregory KD, 2010, SEMIN PERINATOL, V34, P237, DOI 10.1053/j.semperi.2010.03.002; Grunebaum A, 2015, J PERINAT MED, V43, P455, DOI 10.1515/jpm-2014-0003; Grunebaum A, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.10.021; Grunebaum A, 2014, AM J OBSTET GYNECOL, V210, P487, DOI 10.1016/j.ajog.2013.12.003; Grunebaum A, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.06.025; Grunebaum A, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.047; Kirby RS, 2014, AM J OBSTET GYNECOL, V210, P488, DOI 10.1016/j.ajog.2013.12.014; Lain SJ, 2012, MED CARE, V50, pE7, DOI 10.1097/MLR.0b013e31821d2b1d; Lydon-Rochelle MT, 2005, AM J PUBLIC HEALTH, V95, P1948, DOI 10.2105/AJPH.2004.044305; MacDorman Marian F, 2014, NCHS Data Brief, P1; MacDorman MF, 2013, J MIDWIFERY WOM HEAL, V58, P494, DOI 10.1111/jmwh.12092; MacDorman MF, 2012, OBSTET GYNECOL, V119, P737, DOI 10.1097/AOG.0b013e31824bb050; Martin Joyce A, 2013, Natl Vital Stat Rep, V62, P1; Murray-Davis B, 2014, MIDWIFERY, V30, P869, DOI 10.1016/j.midw.2014.01.008; Northam S, 2006, JOGNN-J OBST GYN NEO, V35, P3, DOI 10.1111/J.1552-6909.2006.00016.x; Offerhaus PM, 2014, MIDWIFERY, V30, P560, DOI [10.1016/j.midw.2013.06.013, 10.1016/j.midw.2015.01.013]; OHA (Oregon Health Authority), 2011, PURSUANT HB, V2380; Renfrew MJ, 2014, LANCET, V384, P1129, DOI 10.1016/S0140-6736(14)60789-3; Rooks JP, 1999, J NURSE-MIDWIFERY, V44, P370, DOI 10.1016/S0091-2182(99)00060-9; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Snowden JM, 2011, AM J EPIDEMIOL, V173, P731, DOI 10.1093/aje/kwq472; Stapleton SR, 2013, J MIDWIFERY WOM HEAL, V58, P3, DOI 10.1111/jmwh.12003; The Office of the National Coordinator for Health Information Technology, 2017, STAND NURS TERM LAND; van der Kooy J, 2011, OBSTET GYNECOL, V118, P1037, DOI 10.1097/AOG.0b013e3182319737; Wax JR, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.05.028; Wax JR, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.09.037; Williams R, 2012, STATA J, V12, P308, DOI 10.1177/1536867X1201200209	36	125	128	1	43	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 31	2015	373	27					2642	2653		10.1056/NEJMsa1501738	http://dx.doi.org/10.1056/NEJMsa1501738			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ8UH	26716916	Green Accepted, Bronze			2022-12-28	WOS:000367374100009
J	Baeten, D; Sieper, J; Braun, J; Baraliakos, X; Dougados, M; Emery, P; Deodhar, A; Porter, B; Martin, R; Andersson, M; Mpofu, S; Richards, HB				Baeten, Dominique; Sieper, Joachim; Braun, Juergen; Baraliakos, Xenofon; Dougados, Maxime; Emery, Paul; Deodhar, Atul; Porter, Brian; Martin, Ruvie; Andersson, Mats; Mpofu, Shephard; Richards, Hanno B.		MEASURE 1 & MEASURE 2 Study Grp	Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; RHEUMATOID-ARTHRITIS; ANTIBODY SECUKINUMAB; TH17 CELLS; OPEN-LABEL; EFFICACY; SAFETY; SPONDYLOARTHRITIS; SPONDYLARTHRITIS	BACKGROUND Secukinumab is an anti-interleukin-17A monoclonal antibody that has been shown to control the symptoms of ankylosing spondylitis in a phase 2 trial. We conducted two phase 3 trials of secukinumab in patients with active ankylosing spondylitis. METHODS In two double-blind trials, we randomly assigned patients to receive secukinumab or placebo. In MEASURE 1, a total of 371 patients received intravenous secukinumab (10 mg per kilogram of body weight) or matched placebo at weeks 0, 2, and 4, followed by subcutaneous secukinumab (150 mg or 75 mg) or matched placebo every 4 weeks starting at week 8. In MEASURE 2, a total of 219 patients received subcutaneous secukinumab (150 mg or 75 mg) or matched placebo at baseline; at weeks 1, 2, and 3; and every 4 weeks starting at week 4. At week 16, patients in the placebo group were randomly reassigned to subcutaneous secukinumab at a dose of 150 mg or 75 mg. The primary end point was the proportion of patients with at least 20% improvement in Assessment of Spondyloarthritis International Society (ASAS20) response criteria at week 16. RESULTS In MEASURE 1, the ASAS20 response rates at week 16 were 61%, 60%, and 29% for subcutaneous secukinumab at doses of 150 mg and 75 mg and for placebo, respectively (P< 0.001 for both comparisons with placebo); in MEASURE 2, the rates were 61%, 41%, and 28% for subcutaneous secukinumab at doses of 150 mg and 75 mg and for placebo, respectively (P< 0.001 for the 150-mg dose and P = 0.10 for the 75-mg dose). The significant improvements were sustained through 52 weeks. Infections, including candidiasis, were more common with secukinumab than with placebo during the placebo-controlled period of MEASURE 1. During the entire treatment period, pooled exposure-adjusted incidence rates of grade 3 or 4 neutropenia, candida infections, and Crohn's disease were 0.7, 0.9, and 0.7 cases per 100 patient-years, respectively, in secukinumab-treated patients. CONCLUSIONS Secukinumab at a subcutaneous dose of 150 mg, with either subcutaneous or intravenous loading, provided significant reductions in the signs and symptoms of ankylosing spondylitis at week 16. Secukinumab at a subcutaneous dose of 75 mg resulted in significant improvement only with a higher intravenous loading dose. (Funded by Novartis Pharma; ClinicalTrials.gov numbers, NCT01358175 and NCT01649375.)	[Baeten, Dominique] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Sieper, Joachim] Charite, D-13353 Berlin, Germany; [Braun, Juergen; Baraliakos, Xenofon] Rheumazentrum Ruhrgebiet, Herne, Germany; [Dougados, Maxime] Paris Descartes Univ, Paris, France; [Dougados, Maxime] Hop Cochin, Dept Rheumatol, F-75674 Paris, France; [Emery, Paul] Univ Leeds, Inst Rheumat & Musculoskeletal Med, Leeds Musculoskeletal Biomed Res Unit, Leeds, W Yorkshire, England; [Deodhar, Atul] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Porter, Brian; Martin, Ruvie] Novartis Pharmaceut, E Hanover, NJ USA; [Andersson, Mats; Mpofu, Shephard; Richards, Hanno B.] Novartis Pharmaceut, Basel, Switzerland	University of Amsterdam; Academic Medical Center Amsterdam; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Rheumazentrum Ruhrgebiet; Ruhr University Bochum; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Leeds; Oregon Health & Science University; Novartis; Novartis	Baeten, D (corresponding author), Univ Amsterdam, Acad Med Ctr, Clin Immunol & Rheumatol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	d.l.baeten@amu.uva.nl	Blanco, Francisco J./C-3192-2014; emery, paul/B-3560-2013; Dougados, Maxime/P-5287-2016; blanco, ricardo/AAA-1248-2020; Maslyanskiy, Alexey L/G-7691-2018; Braun, Jürgen/AFT-8107-2022; Baraliakos, Xenofon/AAF-7346-2019; Batalov, Anastas/J-4921-2019	Blanco, Francisco J./0000-0001-9821-7635; blanco, ricardo/0000-0003-2344-2285; Maslyanskiy, Alexey L/0000-0003-2427-4148; Baraliakos, Xenofon/0000-0002-9475-9362; Batalov, Anastas/0000-0001-8857-0574; Gaffney, Karl/0000-0002-7863-9176; Ciurea, Adrian/0000-0002-7870-7132	Novartis Pharma; Versus Arthritis [18475] Funding Source: researchfish	Novartis Pharma; Versus Arthritis(Versus Arthritis)	Supported by Novartis Pharma.	[Anonymous], 2010, COMMON TERMINOLOGY C; Appel H, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3370; Baeten D, 2013, LANCET, V382, P1705, DOI 10.1016/S0140-6736(13)61134-4; Baraliakos X, 2005, ANN RHEUM DIS, V64, P730, DOI 10.1136/ard.2004.029298; Bowness P, 2011, J IMMUNOL, V186, P2672, DOI 10.4049/jimmunol.1002653; Braun J, 2011, ANN RHEUM DIS, V70, P896, DOI 10.1136/ard.2011.151027; Braun J, 2007, LANCET, V369, P1379, DOI 10.1016/S0140-6736(07)60635-7; Bretz F, 2009, STAT MED, V28, P586, DOI 10.1002/sim.3495; Davis JC, 2003, ARTHRITIS RHEUM, V48, P3230, DOI 10.1002/art.11325; Delay ML, 2009, ARTHRITIS RHEUM-US, V60, P2633, DOI 10.1002/art.24763; Dougados M, 2011, LANCET, V377, P2127, DOI 10.1016/S0140-6736(11)60071-8; Doward LC, 2003, ANN RHEUM DIS, V62, P20, DOI 10.1136/ard.62.1.20; Gao Xin, 2012, J Med Econ, V15, P1054, DOI 10.3111/13696998.2012.692341; GARRETT S, 1994, J RHEUMATOL, V21, P2286; Genovese MC, 2013, ANN RHEUM DIS, V72, P863, DOI 10.1136/annrheumdis-2012-201601; Glatigny S, 2012, ARTHRITIS RHEUM-US, V64, P110, DOI 10.1002/art.33321; Haibel H, 2005, ANN RHEUM DIS, V64, P296, DOI 10.1136/ard.2004.023176; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Inman RD, 2008, ARTHRITIS RHEUM-US, V58, P3402, DOI 10.1002/art.23969; Jang JH, 2011, RADIOLOGY, V258, P192, DOI 10.1148/radiol.10100426; Kenna TJ, 2012, ARTHRITIS RHEUM-US, V64, P1420, DOI 10.1002/art.33507; Klein U, 2013, J INVEST DERMATOL, V133, pS172; Landewe R, 2014, ANN RHEUM DIS, V73, P39, DOI 10.1136/annrheumdis-2013-204231; Langley RG, 2014, NEW ENGL J MED, V371, P326, DOI 10.1056/NEJMoa1314258; Noordenbos T, 2012, ARTHRITIS RHEUM-US, V64, P99, DOI 10.1002/art.33396; Shen H, 2009, ARTHRITIS RHEUM-US, V60, P1647, DOI 10.1002/art.24568; Sherlock JP, 2012, NAT MED, V18, P1069, DOI 10.1038/nm.2817; Sieper J, 2009, ANN RHEUM DIS, V68, P1, DOI 10.1136/ard.2008.104018; Sieper J, 2015, ANN RHEUM DIS, V74, P1051, DOI 10.1136/annrheumdis-2013-204963; Sieper J, 2014, ANN RHEUM DIS, V73, P95, DOI 10.1136/annrheumdis-2013-203559; Song IH, 2010, ARTHRITIS RHEUM-US, V62, P1290, DOI 10.1002/art.27383; Song IH, 2011, ANN RHEUM DIS, V70, P1108, DOI 10.1136/ard.2010.145946; van der Heijde D, 2005, ARTHRITIS RHEUM-US, V52, P582, DOI 10.1002/art.20852; van der Heijde D, 2009, ANN RHEUM DIS, V68, P922, DOI 10.1136/ard.2007.087270; van der Heijde D, 2006, ARTHRITIS RHEUM-US, V54, P2136, DOI 10.1002/art.21913; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Ware Jr JE, 2001, SCORE VERSION 2 SF 3	37	638	684	2	46	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 24	2015	373	26					2534	2548		10.1056/NEJMoa1505066	http://dx.doi.org/10.1056/NEJMoa1505066			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ7SG	26699169	Green Published, Bronze			2022-12-28	WOS:000367299700009
J	Burger, JA; Tedeschi, A; Barr, PM; Robak, T; Owen, C; Ghia, P; Bairey, O; Hillmen, P; Bartlett, NL; Li, J; Simpson, D; Grosicki, S; Devereux, S; McCarthy, H; Coutre, S; Quach, H; Gaidano, G; Maslyak, Z; Stevens, DA; Janssens, A; Offner, F; Mayer, J; O'Dwyer, M; Hellmann, A; Schuh, A; Siddiqi, T; Polliack, A; Tam, CS; Suri, D; Cheng, M; Clow, F; Styles, L; James, DF; Kipps, TJ; Keating, M; Jen, J; Jindra, P; Simkovic, M; Braester, A; Ruchlemer, R; Foa, R; Semenzato, G; Hawkins, T; Atanasio, CM; Demirkan, F; Kaynar, L; Pylypenko, H; Fox, C; Thirman, M; Campbell, P; Coughlin, P; Harrup, R; Kuss, B; Turner, P; Wu, KL; Larratt, L; Fineman, R; Marasca, R; Zinzani, PL; Corbett, G; Abrisqueta, P; Delgado, J; Gonzalez-Barca, E; de Oteyza, JP; Arsland, O; Kaplan, P; Oliynyk, H; Hamblin, M; Atkins, J; Barrientos, J; Gasic, S; Hou, JZ; Kingsley, E; Shadman, M; Badoux, X; Gill, D; Opat, S; Bron, D; Van Den Neste, E; Jing, HM; Zhu, J; Vandenberghe, E; Tadmor, T; Cortelezzi, A; Ganly, P; Weinkove, R; Pluta, A; Pristupa, A; Marco, JAG; Vural, F; Yagci, M; Kasych, M; Duncombe, A; Fegan, C; Quackenbush, R; Tirumali, N				Burger, J. A.; Tedeschi, A.; Barr, P. M.; Robak, T.; Owen, C.; Ghia, P.; Bairey, O.; Hillmen, P.; Bartlett, N. L.; Li, J.; Simpson, D.; Grosicki, S.; Devereux, S.; McCarthy, H.; Coutre, S.; Quach, H.; Gaidano, G.; Maslyak, Z.; Stevens, D. A.; Janssens, A.; Offner, F.; Mayer, J.; O'Dwyer, M.; Hellmann, A.; Schuh, A.; Siddiqi, T.; Polliack, A.; Tam, C. S.; Suri, D.; Cheng, M.; Clow, F.; Styles, L.; James, D. F.; Kipps, T. J.; Keating, Michael; Jen, Jie; Jindra, Pavel; Simkovic, Martin; Braester, Andrei; Ruchlemer, Rosa; Foa, Roberto; Semenzato, Gianpietro; Hawkins, Timothy; Atanasio, Carolina Moreno; Demirkan, Fatih; Kaynar, Leylagul; Pylypenko, Halyna; Fox, Christopher; Thirman, Michael; Campbell, Philip; Coughlin, Paul; Harrup, Rosemary; Kuss, Bryone; Turner, Paul; Wu, Ka Lung; Larratt, Loree; Fineman, Riva; Marasca, Roberto; Zinzani, Pier Luigi; Corbett, Gillian; Abrisqueta, Pau; Delgado, Julio; Gonzalez-Barca, Eva; de Oteyza, Jaime Perez; Arsland, Onder; Kaplan, Polina; Oliynyk, Hanna; Hamblin, Michael; Atkins, James; Barrientos, Jaqueline; Gasic, Slavisa; Hou, Jing-Zhou; Kingsley, Edwin; Shadman, Mazyar; Badoux, Xavier; Gill, Devinder; Opat, Stephen; Bron, Dominique; Van Den Neste, Eric; Jing, Hongmei; Zhu, Jun; Vandenberghe, Elisabeth; Tadmor, Tamar; Cortelezzi, Agostino; Ganly, Peter; Weinkove, Robert; Pluta, Andrzej; Pristupa, Alexander; Marco, Jose Antonio Garcia; Vural, Filiz; Yagci, Munci; Kasych, Muzhdaba; Duncombe, Andrew; Fegan, Christopher; Quackenbush, Robert; Tirumali, Nagendra		RESONATE-2 Investigators	Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PREVIOUSLY UNTREATED PATIENTS; TYROSINE KINASE; OPEN-LABEL; CHLORAMBUCIL; FLUDARABINE; CYCLOPHOSPHAMIDE; RITUXIMAB; CANCER; CLL; OBINUTUZUMAB	BACKGROUND Chronic lymphocytic leukemia (CLL) primarily affects older persons who often have coexisting conditions in addition to disease-related immunosuppression and myelosuppression. We conducted an international, open-label, randomized phase 3 trial to compare two oral agents, ibrutinib and chlorambucil, in previously untreated older patients with CLL or small lymphocytic lymphoma. METHODS We randomly assigned 269 previously untreated patients who were 65 years of age or older and had CLL or small lymphocytic lymphoma to receive ibrutinib or chlorambucil. The primary end point was progression-free survival as assessed by an independent review committee. RESULTS The median age of the patients was 73 years. During a median follow-up period of 18.4 months, ibrutinib resulted in significantly longer progression-free survival than did chlorambucil (median, not reached vs. 18.9 months), with a risk of progression or death that was 84% lower with ibrutinib than that with chlorambucil (hazard ratio, 0.16; P<0.001). Ibrutinib significantly prolonged overall survival; the estimated survival rate at 24 months was 98% with ibrutinib versus 85% with chlorambucil, with a relative risk of death that was 84% lower in the ibrutinib group than in the chlorambucil group (hazard ratio, 0.16; P = 0.001). The overall response rate was higher with ibrutinib than with chlorambucil (86% vs. 35%, P<0.001). The rates of sustained increases from baseline values in the hemoglobin and platelet levels were higher with ibrutinib. Adverse events of any grade that occurred in at least 20% of the patients receiving ibrutinib included diarrhea, fatigue, cough, and nausea; adverse events occurring in at least 20% of those receiving chlorambucil included nausea, fatigue, neutropenia, anemia, and vomiting. In the ibrutinib group, four patients had a grade 3 hemorrhage and one had a grade 4 hemorrhage. A total of 87% of the patients in the ibrutinib group are continuing to take ibrutinib. CONCLUSIONS Ibrutinib was superior to chlorambucil in previously untreated patients with CLL or small lymphocytic lymphoma, as assessed by progression-free survival, overall survival, response rate, and improvement in hematologic variables.	[Burger, J. A.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Tedeschi, A.] Azienda Osped Niguarda Ca Granda, Milan, Italy; [Ghia, P.] Univ Vita Salute San Raffaele, Milan, Italy; [Ghia, P.] IRCCS Ist Sci San Raffaele, Milan, Italy; [Gaidano, G.] Amedeo Avogadro Univ Eastern Piedmont, Dept Translat Med, Novara, Italy; [Barr, P. M.] Univ Rochester, Wilmot Canc Inst, Rochester, NY USA; [Robak, T.] Med Univ Lodz, Lodz, Poland; [Robak, T.] Copernicus Mem Hosp, Lodz, Poland; [Grosicki, S.] Med Univ Silesia, Sch Publ Hlth, Dept Canc Prevent, Katowice, Poland; [Hellmann, A.] Med Univ Gdansk, Univ Clin Ctr, Dept Hematol, Gdansk, Poland; [Owen, C.] Tom Baker Canc Clin, Calgary, AB, Canada; [Bairey, O.] Tel Aviv Univ, Beilinson Hosp, Rabin Med Ctr, IL-69978 Tel Aviv, Israel; [Bairey, O.] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Polliack, A.] Hebrew Univ Jerusalem, Sch Med, Hadassah Univ Hosp, IL-91010 Jerusalem, Israel; [Hillmen, P.] Leeds Teaching Hosp, St James Inst Oncol, Leeds, W Yorkshire, England; [Devereux, S.] Kings Coll Hosp London, London, England; [McCarthy, H.] Royal Bournemouth Hosp, Bournemouth, Dorset, England; [Schuh, A.] Univ Oxford, Oxford, England; [Bartlett, N. L.] Washington Univ, Sch Med, St Louis, MO 63130 USA; [Li, J.] Jiangsu Prov Hosp, Nanjing, Jiangsu, Peoples R China; [Simpson, D.] North Shore Hosp, Auckland, New Zealand; [Coutre, S.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Siddiqi, T.] City Hope Natl Med Ctr, Duarte, CA 91010 USA; [Suri, D.; Cheng, M.; Clow, F.; Styles, L.; James, D. F.] Pharmacyclics, Sunnyvale, CA USA; [Kipps, T. J.] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA; [Quach, H.] Univ Melbourne, St Vincents Hosp, Melbourne, Vic, Australia; [Tam, C. S.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Tam, C. S.] St Vincents Hosp, Melbourne, Vic, Australia; [Maslyak, Z.] Natl Acad Med Sci Ukraine, Inst Blood Pathol & Transfus Med, Lvov, Ukraine; [Stevens, D. A.] Norton Canc Inst, Louisville, KY USA; [Janssens, A.] Univ Hosp Leuven, Leuven, Belgium; [Offner, F.] Univ Hosp Ghent, Ghent, Belgium; [Mayer, J.] Fakultni Nemocnice Brno, Brno, Czech Republic; [O'Dwyer, M.] Univ Coll Hosp Galway, Galway, Ireland	University of Texas System; UTMD Anderson Cancer Center; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Eastern Piedmont Amedeo Avogadro; University of Rochester; Medical University Lodz; Medical University Silesia; Fahrenheit Universities; Medical University Gdansk; Tom Baker Cancer Clinic; University of Calgary; Rabin Medical Center; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Hebrew University of Jerusalem; Saint James's University Hospital; University of Leeds; King's College Hospital NHS Foundation Trust; King's College Hospital; University of Oxford; Washington University (WUSTL); Nanjing Medical University; Stanford University; City of Hope; Pharmacyclics; University of California System; University of California San Diego; St Vincent's Hospital Melbourne; University of Melbourne; Peter Maccallum Cancer Center; St Vincent's Hospital Melbourne; National Academy of Medical Sciences of Ukraine; Institute of Blood Pathology & Transfusion Medicine; KU Leuven; University Hospital Leuven; Ghent University; Ghent University Hospital; University Hospital Brno; Ollscoil na Gaillimhe-University of Galway	Burger, JA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Leukemia, 1515 Holcombe Blvd, Houston, TX 77030 USA.	jaburger@mdanderson.org	Barrientos, Jacqueline/AAE-6683-2022; Quach, Hang/AAB-8516-2020; Gaidano, Gianluca/AAW-2773-2021; Ghia, Paolo/K-7138-2016; Hamblin, Mike/AAB-2511-2022; Delgado, Julio/D-4891-2013; Robak, Tadeusz/AAW-7365-2021; Grosicki, Sebastian/AAG-2917-2019; de Oteyza, Jaime Perez/K-5514-2012; Demirkan, Fatih/AAD-6403-2019; Hamblin, Michael R/H-2758-2019; Weinkove, Robert/I-6991-2012; Zinzani, Pier Luigi/J-9182-2016; Kaynar, Leylagul/F-6991-2013; Opat, Stephen/AFR-0783-2022; cortelezzi, agostino/L-2633-2016; Barr, Paul/V-2574-2019; Weinkove, Robert/S-4457-2019; BARCA, EVA GONZALEZ/AAD-6478-2019; Marasca, Roberto/I-8072-2013	Gaidano, Gianluca/0000-0002-4681-0151; Ghia, Paolo/0000-0003-3750-7342; Delgado, Julio/0000-0002-5157-4376; Robak, Tadeusz/0000-0002-3411-6357; de Oteyza, Jaime Perez/0000-0002-8338-2037; Demirkan, Fatih/0000-0002-1172-8668; Hamblin, Michael R/0000-0001-6431-4605; Weinkove, Robert/0000-0003-3645-7988; Zinzani, Pier Luigi/0000-0002-2112-2651; Kaynar, Leylagul/0000-0002-2035-9462; Opat, Stephen/0000-0002-0308-6458; Barr, Paul/0000-0002-9733-401X; Weinkove, Robert/0000-0003-3645-7988; BARCA, EVA GONZALEZ/0000-0002-1323-1508; Marasca, Roberto/0000-0002-6431-6878; Siddiqi, Tanya/0000-0001-5292-8298; Anna, schuh/0000-0002-3938-8490; Vandenberghe, Elisabeth/0000-0002-7731-9437; Coutre, Steven/0000-0001-8420-5748; o'dwyer, michael/0000-0002-6173-7140; Bartlett, Nancy/0000-0001-8470-394X; Grosicki, Sebastian/0000-0003-2644-1050; CORTELEZZI, AGOSTINO/0000-0001-9283-4800; QUACH, HANG/0000-0002-4796-3352; Tam, Constantine/0000-0002-9759-5017	Pharmacyclics; NATIONAL CANCER INSTITUTE [P30CA016672, P01CA081534] Funding Source: NIH RePORTER	Pharmacyclics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by Pharmacyclics and others; RESONATE-2 ClinicalTrials.gov number, NCT01722487.	[Anonymous], 2015, IMBR PRESCR INF SUNN; [Anonymous], 2010, COMMON TERMINOLOGY C; [Anonymous], 2014, IMBR SUMM PROD CHAR; Benjamini O, 2015, LEUKEMIA LYMPHOMA, V56, P1643, DOI 10.3109/10428194.2014.957203; Burger JA, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.326.326; Byrd JC, 2014, NEW ENGL J MED, V371, P213, DOI 10.1056/NEJMoa1400376; Byrd JC, 2015, BLOOD, V125, P2497, DOI 10.1182/blood-2014-10-606038; Casak SJ, 2011, ONCOLOGIST, V16, P97, DOI 10.1634/theoncologist.2010-0306; Catovsky D, 2007, LANCET, V370, P230, DOI 10.1016/S0140-6736(07)61125-8; de Gorter DJJ, 2007, IMMUNITY, V26, P93, DOI 10.1016/j.immuni.2006.11.012; de Rooij MFM, 2012, BLOOD, V119, P2590, DOI 10.1182/blood-2011-11-390989; Eichhorst B, 2011, ANN ONCOL S6, V22, pvi50; Eichhorst B, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.526.526; Eichhorst BF, 2009, BLOOD, V114, P3382, DOI 10.1182/blood-2009-02-206185; Farooqui MZH, 2015, LANCET ONCOL, V16, P169, DOI 10.1016/S1470-2045(14)71182-9; Ghielmini M, 2013, ANN ONCOL, V24, P561, DOI [10.1093/annonc/mds517, 10.1093/annonc/mdr388]; Goede V, 2015, LEUKEMIA, V29, P1602, DOI 10.1038/leu.2015.14; Goede V, 2014, NEW ENGL J MED, V370, P1101, DOI 10.1056/NEJMoa1313984; Gribben JG, 2010, BLOOD, V115, P187, DOI 10.1182/blood-2009-08-207126; Hallek M, 2010, LANCET, V376, P1164, DOI 10.1016/S0140-6736(10)61381-5; Hallek M, 2012, BLOOD; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Herman SEM, 2014, LEUKEMIA, V28, P2188, DOI 10.1038/leu.2014.122; Herman SEM, 2014, BLOOD, V123, P3286, DOI 10.1182/blood-2014-02-548610; Herman SEM, 2011, BLOOD, V117, P6287, DOI 10.1182/blood-2011-01-328484; Hillmen P, 2007, J CLIN ONCOL, V25, P5616, DOI 10.1200/JCO.2007.12.9098; Hillmen P, 2015, LANCET, V385, P1873, DOI 10.1016/S0140-6736(15)60027-7; Jethwa A, 2013, BRIT J HAEMATOL, V163, P496, DOI 10.1111/bjh.12539; Knauf WU, 2009, J CLIN ONCOL, V27, P4378, DOI 10.1200/JCO.2008.20.8389; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Morrison VA, 2002, J CLIN ONCOL, V20, P3878, DOI 10.1200/JCO.2002.08.128; National Comprehensive Cancer Network, 2015, NCCN CLIN PRACT GUID; Ponader S, 2012, BLOOD, V119, P1182, DOI 10.1182/blood-2011-10-386417; Rai KR, 2000, NEW ENGL J MED, V343, P1750, DOI 10.1056/NEJM200012143432402; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Spaargaren M, 2003, J EXP MED, V198, P1539, DOI 10.1084/jem.20011866; Stilgenbauer S, 2007, HAEMATOLOGICA, V92, P1242, DOI 10.3324/haematol.10720; Tam CS, 2008, BLOOD, V112, P975, DOI 10.1182/blood-2008-02-140582; Woyach JA, 2013, J CLIN ONCOL, V31, P440, DOI 10.1200/JCO.2011.41.5646	39	1016	1038	3	106	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 17	2015	373	25					2425	2437		10.1056/NEJMoa1509388	http://dx.doi.org/10.1056/NEJMoa1509388			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY5QD	26639149	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000366461400009
J	Hull, PM; Darroch, SAF; Erwin, DH				Hull, Pincelli M.; Darroch, Simon A. F.; Erwin, Douglas H.			Rarity in mass extinctions and the future of ecosystems	NATURE			English	Review							END-PERMIAN EXTINCTION; HABITAT DESTRUCTION; BASE-LINES; BIODIVERSITY; RECOVERY; DIVERSITY; EVOLUTIONARY; DYNAMICS; POPULATION; EARTHS	The fossil record provides striking case studies of biodiversity loss and global ecosystem upheaval. Because of this, many studies have sought to assess the magnitude of the current biodiversity crisis relative to past crises-a task greatly complicated by the need to extrapolate extinction rates. Here we challenge this approach by showing that the rarity of previously abundant taxa may be more important than extinction in the cascade of events leading to global changes in the biosphere. Mass rarity may provide the most robust measure of our current biodiversity crisis relative to those past, and new insights into the dynamics of mass extinction.	[Hull, Pincelli M.] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; [Darroch, Simon A. F.; Erwin, Douglas H.] Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20013 USA; [Darroch, Simon A. F.] Vanderbilt Univ, Dept Earth & Environm Sci, Nashville, TN 37235 USA	Yale University; Smithsonian Institution; Smithsonian National Museum of Natural History; Vanderbilt University	Hull, PM (corresponding author), Yale Univ, Dept Geol & Geophys, POB 6666, New Haven, CT 06520 USA.	pincelli.hull@yale.edu	/AAD-1732-2020	Darroch, Simon/0000-0003-1922-7136; Erwin, Douglas/0000-0003-2518-5614	NASA Astrobiology Institute; Peter Buck Fellowship at NMNH	NASA Astrobiology Institute; Peter Buck Fellowship at NMNH	This manuscript arose out of discussion sparked by Arizona State University's Origins Project workshop hosted by L. Krauss and M. Laubichler; interdisciplinary training in the first class of the National Science Foundation IGERT programme in the Center for Marine Biodiversity & Conservation (led by N. Knowlton, J. B. C. Jackson, E. Sala, R. Carson, M. Tillman; supported by P. Dockery) at the Scripps Institution of Oceanography; and long association with D. E. G. Briggs and group. This manuscript was greatly improved through discussions with J. B. C. Jackson, K. L. Cramer, M. S. Roth and the Yale Paleontology group. D. H. E. acknowledges support from the NASA Astrobiology Institute. S. A. F. D. acknowledges support from a Peter Buck Fellowship at NMNH.	Alegret L, 2012, P NATL ACAD SCI USA, V109, P728, DOI 10.1073/pnas.1110601109; Alroy J, 2008, P NATL ACAD SCI USA, V105, P11536, DOI 10.1073/pnas.0802597105; ALVAREZ LW, 1980, SCIENCE, V208, P1095, DOI 10.1126/science.208.4448.1095; Bambach RK, 2006, ANNU REV EARTH PL SC, V34, P127, DOI 10.1146/annurev.earth.33.092203.122654; Bambach RK, 2002, P NATL ACAD SCI USA, V99, P6854, DOI 10.1073/pnas.092150999; Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; BENTON MJ, 1991, UNITY OF EVOLUTIONARY BIOLOGY, VOLS 1 AND 2, P89; BENTON MJ, 1995, SCIENCE, V268, P52, DOI 10.1126/science.7701342; Benton MJ, 2001, GEOL J, V36, P211, DOI 10.1002/gj.877.abs; Briggs DEG, 2003, ANNU REV EARTH PL SC, V31, P275, DOI 10.1146/annurev.earth.31.100901.144746; Brusatte SL, 2008, SCIENCE, V321, P1485, DOI 10.1126/science.1161833; Burgess SD, 2014, P NATL ACAD SCI USA, V111, P3316, DOI 10.1073/pnas.1317692111; Casier JG, 1997, GEOBIOS-LYON, V30, P811, DOI 10.1016/S0016-6995(97)80181-7; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; Chen ZQ, 2012, NAT GEOSCI, V5, P375, DOI [10.1038/ngeo1475, 10.1038/NGEO1475]; CRANE PR, 1995, NATURE, V374, P27, DOI 10.1038/374027a0; Crutzen P, 2000, GLOBAL CHANGE NEWSLE, V41, P17; D'Hondt S, 2005, ANNU REV ECOL EVOL S, V36, P295, DOI 10.1146/annurev.ecolsys.35.021103.105715; Dayton PK, 1998, ECOL APPL, V8, P309, DOI 10.1890/1051-0761(1998)008[0309:SBGARE]2.0.CO;2; Deyoung B, 2008, TRENDS ECOL EVOL, V23, P402, DOI 10.1016/j.tree.2008.03.008; Dornelas M, 2014, SCIENCE, V344, P296, DOI 10.1126/science.1248484; Droser ML, 2000, GEOLOGY, V28, P675, DOI 10.1130/0091-7613(2000)028<0675:DOTAES>2.3.CO;2; Dulvy NK, 2003, FISH FISH, V4, P25, DOI 10.1046/j.1467-2979.2003.00105.x; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Edwards EJ, 2010, SCIENCE, V328, P587, DOI 10.1126/science.1177216; Erwin D. H., 2006, EXTINCTION LIFE EART; Erwin DH, 2001, P NATL ACAD SCI USA, V98, P5399, DOI 10.1073/pnas.091092698; Erwin DH, 1998, TRENDS ECOL EVOL, V13, P344, DOI 10.1016/S0169-5347(98)01436-0; Erwin D, 2009, NATURE, V462, P282, DOI 10.1038/462282a; Erwin Douglas H., 1996, P398; Erwin DH, 2014, P NATL ACAD SCI USA, V111, P3203, DOI 10.1073/pnas.1400431111; Finnegan S, 2015, SCIENCE, V348, P567, DOI 10.1126/science.aaa6635; FLESSA KW, 1983, PALEOBIOLOGY, V9, P315, DOI 10.1017/S0094837300007776; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; Gardmark A, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0262; Greenstein BJ, 1998, CORAL REEFS, V17, P249, DOI 10.1007/s003380050125; Hagino K, 2015, MAR MICROPALEONTOL, V116, P28, DOI 10.1016/j.marmicro.2015.01.002; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hanski I, 2002, CONSERV BIOL, V16, P666, DOI 10.1046/j.1523-1739.2002.00342.x; Harnik PG, 2012, P ROY SOC B-BIOL SCI, V279, P4969, DOI 10.1098/rspb.2012.1902; Harnik PG, 2012, TRENDS ECOL EVOL, V27, P608, DOI 10.1016/j.tree.2012.07.010; Harries PJ, 1996, GEOL SOC SP, P41, DOI 10.1144/GSL.SP.1996.001.01.03; Hughes JB, 1997, SCIENCE, V278, P689, DOI 10.1126/science.278.5338.689; Hull P. M., 2011, NAT GEOSCI; Hull Pincelli M., 2013, Paleontological Society Papers, V19, P115; Hull PM, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002082; Jablonski D, 2005, PALEOBIOLOGY, V31, P192, DOI 10.1666/0094-8373(2005)031[0192:MEAM]2.0.CO;2; Jablonski D., 1986, P183; Jablonski D, 2002, P NATL ACAD SCI USA, V99, P8139, DOI 10.1073/pnas.102163299; Jablonski D, 2001, P NATL ACAD SCI USA, V98, P5393, DOI 10.1073/pnas.101092598; Jackson J. B. C., 2014, STATUS TRENDS CARRIB; Jackson JBC, 2001, P NATL ACAD SCI USA, V98, P5411, DOI 10.1073/pnas.091092898; Jackson JBC, 2008, P NATL ACAD SCI USA, V105, P11458, DOI 10.1073/pnas.0802812105; Kaim A, 2011, PALAEOGEOGR PALAEOCL, V308, P190, DOI 10.1016/j.palaeo.2010.04.008; KAUFFMAN EG, 1995, GEOTIMES, V40, P14; Kiessling W, 2011, GLOBAL CHANGE BIOL, V17, P56, DOI 10.1111/j.1365-2486.2010.02204.x; Kolbert E., 2014, 6 EXTINCTION UNNATUR, P1; Levin PS, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0275; Lewis SL, 2015, NATURE, V519, P171, DOI 10.1038/nature14258; Lotze HK, 2011, TRENDS ECOL EVOL, V26, P595, DOI 10.1016/j.tree.2011.07.008; Lotze HK, 2009, TRENDS ECOL EVOL, V24, P254, DOI 10.1016/j.tree.2008.12.004; MacNeil MA, 2015, NATURE, V520, P341, DOI 10.1038/nature14358; Marshall C.R., 2010, QUANTITATIVE METHODS, P291; McCauley DJ, 2015, SCIENCE, V347, DOI 10.1126/science.1255641; McGill BJ, 2015, TRENDS ECOL EVOL, V30, P104, DOI 10.1016/j.tree.2014.11.006; McKinney ML, 1999, CONSERV BIOL, V13, P1273, DOI 10.1046/j.1523-1739.1999.97393.x; Meyer KM, 2011, EARTH PLANET SC LETT, V302, P378, DOI 10.1016/j.epsl.2010.12.033; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Naeem S, 2012, SCIENCE, V336, P1401, DOI 10.1126/science.1215855; NEE S, 1992, J ANIM ECOL, V61, P37, DOI 10.2307/5506; Newbold T, 2015, NATURE, V520, P45, DOI 10.1038/nature14324; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pandolfi JM, 2006, ECOL LETT, V9, P818, DOI 10.1111/j.1461-0248.2006.00933.x; Payne JL, 2005, PALEOBIOLOGY, V31, P269, DOI 10.1666/0094-8373(2005)031[0269:EDOGSA]2.0.CO;2; Peters S. E., 2014, PRISCUM, V21, P1; Peters SE, 2011, GEOL SOC SPEC PUBL, V358, P95, DOI 10.1144/SP358.7; Pietsch C, 2014, EARTH-SCI REV, V137, P65, DOI 10.1016/j.earscirev.2013.12.002; Rabinowitz D., 1981, BIOL ASPECTS RARE PL, P205, DOI DOI 10.1177/004728702237415; RAUP DM, 1982, SCIENCE, V215, P1501, DOI 10.1126/science.215.4539.1501; Regnier C, 2009, CONSERV BIOL, V23, P1214, DOI 10.1111/j.1523-1739.2009.01245.x; Ritterbush KA, 2014, PALAIOS, V29, P652, DOI 10.2110/palo.2013.121; Rong JY, 2006, CAN J EARTH SCI, V43, P23, DOI 10.1139/E05-089; ROTHSCHILD BJ, 1994, MAR ECOL PROG SER, V111, P29, DOI 10.3354/meps111029; Sahney S, 2010, BIOL LETTERS, V6, P544, DOI 10.1098/rsbl.2009.1024; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Schmitz OJ, 2008, ECOLOGY, V89, P2436, DOI 10.1890/07-1030.1; Schoene B, 2010, GEOLOGY, V38, P387, DOI 10.1130/G30683.1; SCHOPF TJM, 1978, PALEOBIOLOGY, V4, P261, DOI 10.1017/S0094837300005996; SCHUBERT JK, 1992, GEOLOGY, V20, P883, DOI 10.1130/0091-7613(1992)020<0883:ETSAPM>2.3.CO;2; Sepkoski J. J., 1986, PATT PROC HIST LIF R, P277, DOI DOI 10.1007/978-3-642-70831-2_15; Sepkoski JJ, 1997, J PALEONTOL, V71, P533, DOI 10.1017/S0022336000040026; SEPKOSKI JJ, 1981, PALEOBIOLOGY, V7, P36, DOI 10.1017/S0094837300003778; Shen SZ, 2011, SCIENCE, V334, P1367, DOI 10.1126/science.1213454; Smith AB, 2012, P ROY SOC B-BIOL SCI, V279, P4489, DOI 10.1098/rspb.2012.1793; Smith JT, 2009, PALEOBIOLOGY, V35, P77, DOI 10.1666/07054.1; Smith JLB, 1939, NATURE, V143, P455, DOI 10.1038/143455a0; Sole RV, 2010, J THEOR BIOL, V267, P193, DOI 10.1016/j.jtbi.2010.08.015; Sperling Erik A., 2013, Paleontological Society Papers, V19, P77; Steffen W, 2011, PHILOS T R SOC A, V369, P842, DOI 10.1098/rsta.2010.0327; SURLYK F, 1984, SCIENCE, V223, P1174, DOI 10.1126/science.223.4641.1174; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Tittensor DP, 2014, SCIENCE, V346, P241, DOI 10.1126/science.1257484; Twitchett RJ, 2007, PALAEOGEOGR PALAEOCL, V252, P132, DOI 10.1016/j.palaeo.2006.11.038; Twitchett RJ, 2000, J GEOL SOC LONDON, V157, P511, DOI 10.1144/jgs.157.2.511; Twitchett RJ, 2001, GEOL J, V36, P341, DOI 10.1002/gj.883.abs; Wagner PJ, 2006, SCIENCE, V314, P1289, DOI 10.1126/science.1133795; Ward PD, 2001, SCIENCE, V292, P1148, DOI 10.1126/science.1058574; Wood R, 1995, PALAIOS, V10, P517, DOI 10.2307/3515091; Wood R., 1999, REEF EVOLUTION; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Worm B, 2011, P NATL ACAD SCI USA, V108, P11942, DOI 10.1073/pnas.1102353108; Zalasiewicz J, 2011, PHILOS T R SOC A, V369, P835, DOI 10.1098/rsta.2010.0339	115	66	67	4	161	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 17	2015	528	7582					345	351		10.1038/nature16160	http://dx.doi.org/10.1038/nature16160			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY8SM	26672552				2022-12-28	WOS:000366678600042
J	Spooner, A				Spooner, Andrew			PERSONAL VIEW Guidelines can require me to recommend care that I think is wrong	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Spooner, Andrew] Grosvenor Med Ctr, Crewe CW1 3HB, England		Spooner, A (corresponding author), Grosvenor Med Ctr, Crewe CW1 3HB, England.	andrewspooner@btinternet.com						Mulley A, 2012, KINGS FUND; Vijan S, 2014, JAMA INTERN MED, V174, P1227, DOI 10.1001/jamainternmed.2014.2894	2	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 17	2015	351								h6713	10.1136/bmj.h6713	http://dx.doi.org/10.1136/bmj.h6713			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ4MS	26680598				2022-12-28	WOS:000367077900002
J	Ruegger, J; Hodgkinson, S; Field-Smith, A; Ahmedzai, SH				Ruegger, Joshua; Hodgkinson, Sarah; Field-Smith, Antonia; Ahmedzai, Sam H.		Guideline Comm	GUIDELINES Care of adults in the last days of life: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ruegger, Joshua; Hodgkinson, Sarah] Royal Coll Physicians, Natl Clin Guidelines Ctr, London NW1 4LE, England; [Field-Smith, Antonia] Royal Surrey Cty Hosp NHS Fdn Trust, Guildford, Surrey, England; [Ahmedzai, Sam H.] Univ Sheffield, Dept Oncol & Metab, Sheffield, S Yorkshire, England	Royal College of Physicians; Royal Surrey County Hospital; University of Sheffield	Ahmedzai, SH (corresponding author), Univ Sheffield, Dept Oncol & Metab, Sheffield, S Yorkshire, England.	s.ahmedzai@sheffield.ac.uk	Grocott, Michael/C-4394-2008	Grocott, Michael/0000-0002-9484-7581; Ahmedzai, Sam/0000-0002-2028-8510				Department of Health, 2013, MORE CARE LESS PATHW; General Medical Council, 2010, TREATM CAR END LIF G; General Medical Council, PRESCR GUID PRESCR U; National Archive, 2005, MENT CAP ACT; National Institute for Health and Care Excellence, 2014, DEV NICE GUID MAN 20; National Institute for Health and Care Excellence, 2015, CAR DYING AD LAST DA	6	9	9	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 16	2015	351								h6631	10.1136/bmj.h6631	http://dx.doi.org/10.1136/bmj.h6631			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ4MP	26676374				2022-12-28	WOS:000367077600010
J	Hawkey, CJ; Allez, M; Clark, MM; Labopin, M; Lindsay, JO; Ricart, E; Rogler, G; Rovira, M; Satsangi, J; Danese, S; Russell, N; Gribben, J; Johnson, P; Larghero, J; Thieblemont, C; Ardizzone, S; Dierickx, D; Ibatici, A; Littlewood, T; Onida, F; Schanz, U; Vermeire, S; Colombel, JF; Jouet, JP; Clark, E; Saccardi, R; Tyndall, A; Travis, S; Farge, D				Hawkey, Christopher J.; Allez, Matthieu; Clark, Miranda M.; Labopin, Myriam; Lindsay, James O.; Ricart, Elena; Rogler, Gerhard; Rovira, Montserrat; Satsangi, Jack; Danese, Silvio; Russell, Nigel; Gribben, John; Johnson, Peter; Larghero, Jerome; Thieblemont, Catherine; Ardizzone, Sandro; Dierickx, Daan; Ibatici, Adalberto; Littlewood, Timothy; Onida, Francesco; Schanz, Urs; Vermeire, Severine; Colombel, Jean-Frederic; Jouet, Jean-Paul; Clark, Elizabeth; Saccardi, Riccardo; Tyndall, Alan; Travis, Simon; Farge, Dominique			Autologous Hematopoetic Stem Cell Transplantation for Refractory Crohn Disease A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEPATIC VENOOCCLUSIVE DISEASE; HIGH-DOSE CYCLOPHOSPHAMIDE; MARROW-TRANSPLANTATION; PULSE CYCLOPHOSPHAMIDE; AUTOIMMUNE-DISEASES; MAINTENANCE THERAPY; SYSTEMIC-SCLEROSIS; EUROPEAN GROUP; OPEN-LABEL; REMISSION	IMPORTANCE Case reports and series suggest hematopoietic stem cell transplantation (HSCT) may benefit some patients with Crohn disease. OBJECTIVE To evaluate the effect of autologous HSCT on refractory Crohn disease. DESIGN, SETTING, AND PARTICIPANTS Parallel-group randomized clinical trial conducted in 11 European transplant units from July 2007 to September 2011, with follow-up through March 2013. Patients were aged 18 to 50 years with impaired quality of life from refractory Crohn disease not amenable to surgery despite treatment with 3 or more immunosuppressive or biologic agents and corticosteroids. INTERVENTIONS All patients underwent stem cell mobilization before 1:1 randomization to immunoablation and HSCT (n = 23) or control treatment (HSCT deferred for 1 year [n = 22]). All were given standard Crohn disease treatment as needed. MAIN OUTCOMES AND MEASURES Sustained disease remission at 1 year, a composite primary end point comprising clinical remission (Crohn Disease Activity Index (CDAI) <150 [range, 0-600]), no use of corticosteroids or immunosuppressive or biologic drugs for at least the last 3 months, and no endoscopic or radiological evidence of active (erosive) disease anywhere in the gastrointestinal (GI) tract. Secondary outcomes were individual components of the primary composite outcome and other measures of disease activity, laboratory results, quality of life and functional status, and GI tract imaging. RESULTS Twenty-three patients underwent HSCT and 22 received standard treatment (controls). There were no statistically significant between-group differences in proportions of patients achieving sustained disease remission, CDAI less than 150 in the last 3 months, or freedom from active disease; there was a statistically significant difference among patients able to discontinue active treatment in the last 3 months. There were 76 serious adverse events in patients undergoing HSCT vs 38 in controls; 1 patient undergoing HSCT died. [GRAPHICS] CONCLUSIONS AND RELEVANCE Among adult patients with refractory Crohn disease not amenable to surgery who had impaired quality of life, HSCT, compared with conventional therapy, did not result in a statistically significant improvement in sustained disease remission at 1 year and was associated with significant toxicity. These findings do not support the widespread use of HSCT for patients with refractory Crohn disease.	[Hawkey, Christopher J.; Clark, Miranda M.] Queens Med Ctr, Sch Clin Sci, Nottingham Digest Dis Ctr, Nottingham NG7 2UH, England; [Allez, Matthieu] Sorbonne Paris Cite Univ, Paris Diderot, INSERM UMRS 1160, Dept Gastroenterol,Hop St Louis,APHP, Paris, France; [Labopin, Myriam] European Grp Blood & Marrow Transplantat, Paris, France; [Lindsay, James O.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Ctr Immunobiol, London, England; [Ricart, Elena] CIBER EHD, Hosp Clin, Dept Gastroenterol, Barcelona, Spain; [Rogler, Gerhard] Univ Zurich, Univ Hosp, Div Gastroenterol & Hepatol, Zurich, Switzerland; [Rovira, Montserrat] Hosp Clin Barcelona, Dept Hematol, Barcelona, Spain; [Satsangi, Jack] Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Gastrointestinal Unit, Edinburgh, Midlothian, Scotland; [Danese, Silvio] Humanitas Res Hosp, IBD Ctr, Milan, Italy; [Russell, Nigel] Univ Nottingham, City Hosp Nottingham, Haematol Sch Med, Nottingham NG7 2RD, England; [Gribben, John] Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Haemato Oncol, London, England; [Johnson, Peter] Western Gen Hosp, Dept Haematol, Edinburgh EH4 2XU, Midlothian, Scotland; [Larghero, Jerome] Univ Paris 07, AP HP Hop St Louis, Biotherapies & Cell Therapy Unit, F-75221 Paris 05, France; [Thieblemont, Catherine] Univ Paris 07, AP HP Hop St Louis, Haematol Transplantat, Paris, France; [Ardizzone, Sandro] L Sacco Univ Hosp, Dept Gastroenterol, IBD Unit, Milan, Italy; [Dierickx, Daan] Belgium Univ Hosp, Univ Hosp Leuven, Dept Hematol, Gasthuisberg, Belgium; [Ibatici, Adalberto] IRCCS San Martino IST, Div Ematol & Trapianto Midollo, Genoa, Italy; [Littlewood, Timothy] Oxford Univ Hosp NHS Trust, Dept Haematol, Oxford, England; [Onida, Francesco] Univ Milan, Fdn IRCCS Osped Maggiore Policlin, Hematol BMT Ctr, Milan, Italy; [Schanz, Urs] Univ Zurich Hosp, Div Hematol, CH-8091 Zurich, Switzerland; [Vermeire, Severine] Univ Hosp Gasthuisberg Herestraat, Dept Gastroenterol, Leuven, Belgium; [Colombel, Jean-Frederic] Hop Huriez, Dept Hepato Gastroenterol, Lille, France; [Colombel, Jean-Frederic] Icahn Sch Med, Dept Gastroenterol, New York, NY USA; [Jouet, Jean-Paul] Hop Claude Huriez, Dept Hematol, Lille, France; [Clark, Elizabeth] European Grp Blood & Marrow Transplantat, EBMT Clin Trials, London, England; [Saccardi, Riccardo] Careggi Univ Hosp, Dept Hematol, European Blood & Marrow Transplantat Grp, Florence, Italy; [Tyndall, Alan] Univ Hosp, Dept Rheumatol, Basel, Switzerland; [Travis, Simon] Oxford Univ Hosp, Translat Gastroenterol Unit, Oxford, England; Univ Paris 07, Hop St Louis, AP HP, Internal Med & Vasc Dis Unit, F-75221 Paris 05, France	University of Nottingham; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of London; Queen Mary University London; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; University of Zurich; University Zurich Hospital; University of Barcelona; Hospital Clinic de Barcelona; University of Edinburgh; Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham; University of London; Queen Mary University London; University of Edinburgh; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Milan; Luigi Sacco Hospital; KU Leuven; University Hospital Leuven; University of Genoa; IRCCS AOU San Martino IST; Oxford University Hospitals NHS Foundation Trust; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Zurich; University Zurich Hospital; Universite de Lille - ISITE; CHU Lille; Icahn School of Medicine at Mount Sinai; Universite de Lille - ISITE; CHU Lille; University of Florence; Azienda Ospedaliero Universitaria Careggi; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Hawkey, CJ (corresponding author), Queens Med Ctr, Sch Clin Sci, Nottingham Digest Dis Ctr, Nottingham NG7 2UH, England.	cj.hawkey@nottingham.ac.uk	Ardizzone, Sandro/J-3251-2017; Thieblemont, Catherine/AAZ-8423-2020; Danese, Silvio/ABH-9571-2020; Onida, Francesco/K-9585-2019; Rogler, Gerhard/O-5308-2015	Ardizzone, Sandro/0000-0001-9915-2992; Thieblemont, Catherine/0000-0002-9941-2448; Danese, Silvio/0000-0001-7341-1351; Rogler, Gerhard/0000-0002-1733-9188; Saccardi, Riccardo/0000-0002-5763-5467; Clark, Miranda/0000-0002-6179-046X; Onida, Francesco/0000-0002-2991-3474; Vermeire, Severine/0000-0001-9942-3019; Hawkey, Chris/0000-0002-6031-1017; Allez, Matthieu/0000-0002-2012-7522; Travis, Simon/0000-0002-2690-4361	European Group for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party; European Crohn and Colitis Organisation (ECCO); MRC [G0800675, G0600329, G0800759] Funding Source: UKRI; Medical Research Council [G0600329, 1202121, G0800759, G0800675] Funding Source: researchfish; Chief Scientist Office [ETM/75, ETM/137] Funding Source: researchfish	European Group for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party; European Crohn and Colitis Organisation (ECCO); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	This study was sponsored by the European Group for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party and the European Crohn and Colitis Organisation (ECCO).	Baumgart DC, 2012, LANCET, V380, P1590, DOI 10.1016/S0140-6736(12)60026-9; BEST WR, 1979, GASTROENTEROLOGY, V77, P843; Burt RK, 2011, LANCET, V378, P498, DOI 10.1016/S0140-6736(11)60982-3; Burt RK, 2010, BLOOD, V116, P6123, DOI 10.1182/blood-2010-06-292391; Cacchione A, 2008, BONE MARROW TRANSPL, V42, P449, DOI 10.1038/bmt.2008.186; Cassinotti A, 2008, GUT, V57, P211, DOI 10.1136/gut.2007.128694; Colombel JF, 2007, GASTROENTEROLOGY, V132, P52, DOI 10.1053/j.gastro.2006.11.041; Corbacioglu S, 2012, LANCET, V379, P1301, DOI 10.1016/S0140-6736(11)61938-7; Daperno M, 2004, GASTROINTEST ENDOSC, V60, P505, DOI 10.1016/S0016-5107(04)01878-4; Dolan P, 2002, MED CARE, V40, P442, DOI 10.1097/00005650-200205000-00009; Engelhardt KR, 2013, J ALLERGY CLIN IMMUN, V131, P825, DOI 10.1016/j.jaci.2012.09.025; Farge D, 2010, HAEMATOL-HEMATOL J, V95, P284, DOI 10.3324/haematol.2009.013458; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; HARVEY RF, 1980, LANCET, V1, P514; Hasselblatt P, 2012, ALIMENT PHARM THER, V36, P725, DOI 10.1111/apt.12032; Hawkey CJ, 2004, BEST PRACT RES CL HA, V17, P317, DOI 10.1016/j.beha.2004.05.006; IRVINE EJ, 1994, GASTROENTEROLOGY, V106, P287, DOI 10.1016/0016-5085(94)90585-1; Janssen HLA, 2000, BLOOD, V96, P2364; KARNOFSKY DA, 1948, CANCER-AM CANCER SOC, V1, P634, DOI 10.1002/1097-0142(194811)1:4<634::AID-CNCR2820010410>3.0.CO;2-L; Kashyap A, 1998, BRIT J HAEMATOL, V103, P651, DOI 10.1046/j.1365-2141.1998.01059.x; Kreisel W, 2003, BONE MARROW TRANSPL, V32, P337, DOI 10.1038/sj.bmt.1704134; Krivan G, 2014, ORVOSI HETILAP, V155, P789, DOI 10.1556/OH.2014.29892; Lopez-Cubero SO, 1998, GASTROENTEROLOGY, V114, P433, DOI 10.1016/S0016-5085(98)70525-6; Muraro PA, 2005, J EXP MED, V201, P805, DOI 10.1084/jem.20041679; Oyama Y, 2005, GASTROENTEROLOGY, V128, P552, DOI 10.1053/j.gastro.2004.11.051; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Sandborn WJ, 2013, NEW ENGL J MED, V369, P711, DOI 10.1056/NEJMoa1215739; Sandborn WJ, 2012, NEW ENGL J MED, V367, P1519, DOI 10.1056/NEJMoa1203572; Snowden JA, 2012, BONE MARROW TRANSPL, V47, P770, DOI 10.1038/bmt.2011.185; Tay J, 2007, BIOL BLOOD MARROW TR, V13, P206, DOI 10.1016/j.bbmt.2006.09.012; Van Assche G, 2010, J CROHNS COLITIS, V4, P7, DOI 10.1016/j.crohns.2009.12.003; van Laar JM, 2014, JAMA-J AM MED ASSOC, V311, P2490, DOI 10.1001/jama.2014.6368	33	107	109	1	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 15	2015	314	23					2524	2534		10.1001/jama.2015.16700	http://dx.doi.org/10.1001/jama.2015.16700			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY4PV	26670970	Bronze, Green Published			2022-12-28	WOS:000366391500019
J	Huang, WY; Mirza, RG; Molitch, ME				Huang, Wenyu; Mirza, Rukhsana G.; Molitch, Mark E.			What Does This Retina Examination Show?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DIABETIC-RETINOPATHY		[Huang, Wenyu; Mirza, Rukhsana G.; Molitch, Mark E.] Northwestern Univ, Feinberg Sch Med, Div Endocrinol Metab & Mol Med, Dept Ophthalmol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Molitch, ME (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Endocrinol Metab & Mol Med, 645 N Michigan Ave,Ste 530, Chicago, IL 60611 USA.	molitch@northwestern.edu						Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Bressler NM, 2011, NEW ENGL J MED, V365, P1520, DOI 10.1056/NEJMct0908432; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Chew EY, 2010, NEW ENGL J MED, V363, P233, DOI 10.1056/NEJMoa1001288; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Mohamed Q, 2007, JAMA-J AM MED ASSOC, V298, P902, DOI 10.1001/jama.298.8.902; Porta M, 2014, DIABETES CARE, V37, P1668, DOI 10.2337/dc13-2101; Wells JA, 2015, NEW ENGL J MED, V372, P1193, DOI 10.1056/NEJMoa1414264; Writing Committee for the Diabetic Retinopathy Clinical Reseach Network, 2015, JAMA, DOI 10.1001/jama.2015.15217; Zhang XZ, 2010, JAMA-J AM MED ASSOC, V304, P649, DOI 10.1001/jama.2010.1111	10	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 15	2015	314	23					2555	2556		10.1001/jama.2015.9162	http://dx.doi.org/10.1001/jama.2015.9162			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY4PV	26670973				2022-12-28	WOS:000366391500022
J	Robinson, GE				Robinson, Gene E.			Dissecting diversity in the social brain	SCIENCE			English	Editorial Material							SEXUAL FIDELITY; PRAIRIE VOLES; OXYTOCIN		[Robinson, Gene E.] Univ Illinois, Neurosci Program, Dept Entomol, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Robinson, GE (corresponding author), Univ Illinois, Neurosci Program, Dept Entomol, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA.	generobi@illinois.edu						CARTER CS, 1993, SCI AM, V268, P100, DOI 10.1038/scientificamerican0693-100; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Gavrilets S, 2012, P NATL ACAD SCI USA, V109, P9923, DOI 10.1073/pnas.1200717109; HOFMANN JE, 1984, AM MIDL NAT, V112, P314, DOI 10.2307/2425438; Okhovat M, 2015, SCIENCE, V350, P1371, DOI 10.1126/science.aac5791; Ophir AG, 2008, P NATL ACAD SCI USA, V105, P1249, DOI 10.1073/pnas.0709116105; Phelps S. M., 2009, COGNITIVE ECOLOGY; Rittschof CC, 2014, ANIM BEHAV, V92, P263, DOI 10.1016/j.anbehav.2014.02.028; Robinson GE, 2008, SCIENCE, V322, P896, DOI 10.1126/science.1159277; WITT DM, 1991, J NEUROENDOCRINOL, V3, P155, DOI 10.1111/j.1365-2826.1991.tb00258.x	10	2	2	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2015	350	6266					1310	1312		10.1126/science.aad8071	http://dx.doi.org/10.1126/science.aad8071			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1JL	26659038				2022-12-28	WOS:000366162400017
J	Greber, BJ; Gerhardy, S; Leitner, A; Leibundgut, M; Salem, M; Boehringer, D; Leulliot, N; Aebersold, R; Panse, VG; Ban, N				Greber, Basil Johannes; Gerhardy, Stefan; Leitner, Alexander; Leibundgut, Marc; Salem, Michele; Boehringer, Daniel; Leulliot, Nicolas; Aebersold, Ruedi; Panse, Vikram Govind; Ban, Nenad			Insertion of the Biogenesis Factor Rei1 Probes the Ribosomal Tunnel during 60S Maturation	CELL			English	Article							EM STRUCTURE DETERMINATION; NUCLEAR EXPORT RECEPTOR; CRYO-EM; SACCHAROMYCES-CEREVISIAE; EUKARYOTIC RIBOSOME; CRYSTAL-STRUCTURE; PRERIBOSOMAL FACTORS; DIAMOND-SYNDROME; BUDDING YEAST; PRE-RIBOSOMES	Eukaryotic ribosome biogenesis depends on several hundred assembly factors to produce functional 40S and 60S ribosomal subunits. The final phase of 60S subunit biogenesis is cytoplasmic maturation, which includes the proofreading of functional centers of the 60S subunit and the release of several ribosome biogenesis factors. We report the cryo-electron microscopy (cryo-EM) structure of the yeast 60S subunit in complex with the biogenesis factors Rei1, Arx1, and Alb1 at 3.4 angstrom resolution. In addition to the network of interactions formed by Alb1, the structure reveals a mechanism for ensuring the integrity of the ribosomal polypeptide exit tunnel. Arx1 probes the entire set of inner-ring proteins surrounding the tunnel exit, and the C terminus of Rei1 is deeply inserted into the ribosomal tunnel, where it forms specific contacts along almost its entire length. We provide genetic and biochemical evidence that failure to insert the C terminus of Rei1 precludes subsequent steps of 60S maturation.	[Greber, Basil Johannes; Leibundgut, Marc; Boehringer, Daniel; Ban, Nenad] ETH, Dept Biol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Gerhardy, Stefan] ETH, Dept Biol, Inst Biochem, CH-8093 Zurich, Switzerland; [Leitner, Alexander; Aebersold, Ruedi] ETH, Dept Biol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Salem, Michele; Leulliot, Nicolas] Univ Paris 05, Sorbonne Paris Cite, CNRS, UMR 8015,Lab Cristallog & RMN Biol,Fac Pharm, F-75006 Paris, France; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; University of Zurich	Panse, VG (corresponding author), ETH, Dept Biol, Inst Biochem, CH-8093 Zurich, Switzerland.	vikram.panse@bc.biol.ethz.ch; ban@mol.biol.ethz.ch	Gerhardy, Stefan/ABI-7973-2020; Leitner, Alexander/U-1601-2019; Leulliot, Nicolas/AAA-7160-2019	Leitner, Alexander/0000-0003-4126-0725; Leulliot, Nicolas/0000-0003-0283-4298; Greber, Basil/0000-0001-9379-7159; Panse, Vikram/0000-0001-7950-5746; Gerhardy, Stefan/0000-0003-1826-5907	Swiss National Science Foundation (SNSF); National Center for Excellence in Research (NCCR) RNA; Disease program of the SNSF; European Research Council under the European Community's Seventh Framework Programme [250071]; ERC Starting Grant [EURIBIO 260676]; European Research Council [ERC-2008-AdG 233226]; Advanced Postdoc Mobility fellowship from the SNSF [160983]; CNRS, University Paris Descartes; RNPGenesis grant from the Agence Nationale de la Recherche (ANR JC RNPGenesis); Institut Universitaire de France	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); National Center for Excellence in Research (NCCR) RNA; Disease program of the SNSF; European Research Council under the European Community's Seventh Framework Programme(European Commission); ERC Starting Grant(European Research Council (ERC)); European Research Council(European Research Council (ERC)European Commission); Advanced Postdoc Mobility fellowship from the SNSF; CNRS, University Paris Descartes; RNPGenesis grant from the Agence Nationale de la Recherche (ANR JC RNPGenesis)(French National Research Agency (ANR)); Institut Universitaire de France	Cryo-EM data were acquired at the Scientific Center for Optical and Electron Microscopy (ScopeM) at ETH Zurich. We thank P. Tittmann (ScopeM) for support. We thank T. Schaefer and S. Arpagaus for support in protein cloning and expression, M. Altvater for generous help with fluorescence microscopy experiments, and A. Geerlof (EMBL) for providing the petM41 vector. We acknowledge the use of the Euler cluster at the Swiss National Supercomputing Centre of ETH Zurich. This work was supported by the Swiss National Science Foundation (SNSF) and the National Center for Excellence in Research (NCCR) RNA and Disease program of the SNSF, the European Research Council grant 250071 under the European Community's Seventh Framework Programme (to N.B.), the ERC Starting Grant EURIBIO 260676 (to V.G.P.), and the European Research Council (ERC-2008-AdG 233226) (R.A.). B.G. was supported by an Advanced Postdoc Mobility fellowship from the SNSF (project 160983). Work at Universite Paris Descartes was supported by CNRS, University Paris Descartes, the RNPGenesis grant from the Agence Nationale de la Recherche (ANR JC RNPGenesis), and the Institut Universitaire de France.	Altvater M, 2014, METHOD CELL BIOL, V122, P437, DOI 10.1016/B978-0-12-417160-2.00020-5; Altvater M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.63; Bassler J, 2012, MOL CELL BIOL, V32, P4898, DOI 10.1128/MCB.00910-12; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Bradatsch B, 2007, MOL CELL, V27, P767, DOI 10.1016/j.molcel.2007.06.034; Bradatsch B, 2012, NAT STRUCT MOL BIOL, V19, P1234, DOI 10.1038/nsmb.2438; Bussiere C, 2012, J CELL BIOL, V197, P747, DOI 10.1083/jcb.201112131; Demoinet E, 2007, RNA, V13, P1570, DOI 10.1261/rna.585007; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Finch AJ, 2011, GENE DEV, V25, P917, DOI 10.1101/gad.623011; Gerhardy S, 2014, CHROMOSOMA, V123, P327, DOI 10.1007/s00412-014-0463-z; Giglione C, 2004, CELL MOL LIFE SCI, V61, P1455, DOI 10.1007/s00018-004-3466-8; Greber BJ, 2014, NATURE, V515, P283, DOI 10.1038/nature13895; Greber BJ, 2014, NATURE, V505, P515, DOI 10.1038/nature12890; Greber BJ, 2012, NAT STRUCT MOL BIOL, V19, P1228, DOI 10.1038/nsmb.2425; Ho JHN, 2000, J CELL BIOL, V151, P1057, DOI 10.1083/jcb.151.5.1057; Hung NJ, 2008, MOL BIOL CELL, V19, P735, DOI 10.1091/mbc.E07-09-0968; Hung NJ, 2006, MOL CELL BIOL, V26, P3718, DOI 10.1128/MCB.26.10.3718-3727.2006; Iwase M, 2004, CELL STRUCT FUNCT, V29, P1, DOI 10.1247/csf.29.1; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karbstein K, 2013, TRENDS CELL BIOL, V23, P242, DOI 10.1016/j.tcb.2013.01.004; Kaschner LA, 2015, BBA-MOL CELL RES, V1853, P1035, DOI 10.1016/j.bbamcr.2015.01.014; Kemmler S, 2009, J CELL BIOL, V186, P863, DOI 10.1083/jcb.200904111; Klinge S, 2012, TRENDS BIOCHEM SCI, V37, P189, DOI 10.1016/j.tibs.2012.02.007; Klinge S, 2011, SCIENCE, V334, P941, DOI 10.1126/science.1211204; Kowalinski E, 2007, FEBS LETT, V581, P4450, DOI 10.1016/j.febslet.2007.08.024; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; Lebreton A, 2006, J CELL BIOL, V173, P349, DOI 10.1083/jcb.200510080; Leidig C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4491; Leidig C, 2013, NAT STRUCT MOL BIOL, V20, P23, DOI 10.1038/nsmb.2447; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Lo KY, 2010, MOL CELL, V39, P196, DOI 10.1016/j.molcel.2010.06.018; Lo KY, 2009, J CELL BIOL, V186, P849, DOI 10.1083/jcb.200904110; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Menne TF, 2007, NAT GENET, V39, P486, DOI 10.1038/ng1994; Merl J, 2010, NUCLEIC ACIDS RES, V38, P3068, DOI 10.1093/nar/gkp1244; Meyer AE, 2007, P NATL ACAD SCI USA, V104, P1558, DOI 10.1073/pnas.0610704104; Meyer AE, 2010, J BIOL CHEM, V285, P961, DOI 10.1074/jbc.M109.038349; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Panse VG, 2010, TRENDS BIOCHEM SCI, V35, P260, DOI 10.1016/j.tibs.2010.01.001; Parnell KM, 2009, MOL CELL BIOL, V29, P4014, DOI 10.1128/MCB.01582-08; Pertschy B, 2007, MOL CELL BIOL, V27, P6581, DOI 10.1128/MCB.00668-07; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Raue U, 2007, J BIOL CHEM, V282, P7809, DOI 10.1074/jbc.M611436200; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Stelter P, 2015, MOL CELL, V58, P854, DOI 10.1016/j.molcel.2015.03.029; Tivol WF, 2008, MICROSC MICROANAL, V14, P375, DOI 10.1017/S1431927608080781; van Noort V, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-7; Walzthoeni T, 2013, CURR OPIN STRUC BIOL, V23, P252, DOI 10.1016/j.sbi.2013.02.008; Yao W, 2007, MOL CELL, V26, P51, DOI 10.1016/j.molcel.2007.02.018; Yao YH, 2010, RNA, V16, P1007, DOI 10.1261/rna.2012310; Zhang YX, 2014, NAT STRUCT MOL BIOL, V21, P1042, DOI 10.1038/nsmb.2908	55	70	71	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2016	164	1-2					91	102		10.1016/j.cell.2015.11.027	http://dx.doi.org/10.1016/j.cell.2015.11.027			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DB2LE	26709046	Bronze			2022-12-28	WOS:000368339300012
J	Zhao, DY; Gish, G; Braunschweig, U; Li, Y; Ni, ZY; Schmitges, FW; Zhong, GQ; Liu, K; Li, WG; Moffat, J; Vedadi, M; Min, JR; Pawson, TJ; Blencowe, BJ; Greenblatt, JF				Zhao, Dorothy Yanling; Gish, Gerald; Braunschweig, Ulrich; Li, Yue; Ni, Zuyao; Schmitges, Frank W.; Zhong, Guoqing; Liu, Ke; Li, Weiguo; Moffat, Jason; Vedadi, Masoud; Min, Jinrong; Pawson, Tony J.; Blencowe, Benjamin J.; Greenblatt, Jack F.			SMN and symmetric arginine dimethylation of RNA polymerase II C-terminal domain control termination	NATURE			English	Article							TRANSCRIPTIONAL PAUSE SITES; SPINAL MUSCULAR-ATROPHY; PROTEIN; METHYLATION; METHYLTRANSFERASE; RECRUITMENT; CHROMATIN; COMPLEX; TDP-43; ALS	The carboxy-terminal domain (CTD) of the RNA polymerase II (RNAP II) subunit POLR2A is a platform for modifications specifying the recruitment of factors that regulate transcription, mRNA processing, and chromatin remodelling. Here we show that a CTD arginine residue (R1810 in human) that is conserved across vertebrates is symmetrically dimethylated (me2s). This R1810me2s modification requires protein arginine methyltransferase 5 (PRMT5) and recruits the Tudor domain of the survival of motor neuron (SMN, also known as GEMIN1) protein, which is mutated in spinal muscular atrophy. SMN interacts with senataxin, which is sometimes mutated in ataxia oculomotor apraxia type 2 and amyotrophic lateral sclerosis. Because POLR2A R1810me2s and SMN, like senataxin, are required for resolving RNA-DNA hybrids created by RNA polymerase II that form R-loops in transcription termination regions, we propose that R1810me2s, SMN, and senataxin are components of an R-loop resolution pathway. Defects in this pathway can influence transcription termination and may contribute to neurodegenerative disorders.	[Zhao, Dorothy Yanling; Braunschweig, Ulrich; Li, Yue; Ni, Zuyao; Schmitges, Frank W.; Zhong, Guoqing; Moffat, Jason; Blencowe, Benjamin J.; Greenblatt, Jack F.] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [Zhao, Dorothy Yanling; Gish, Gerald; Pawson, Tony J.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada; [Zhao, Dorothy Yanling; Moffat, Jason; Pawson, Tony J.; Blencowe, Benjamin J.; Greenblatt, Jack F.] Univ Toronto, Dept Mol Genet, 100 Coll St, Toronto, ON M5S 1A8, Canada; [Li, Yue] Univ Toronto, Dept Comp Sci, Toronto, ON M5S 3G4, Canada; [Liu, Ke; Li, Weiguo; Vedadi, Masoud; Min, Jinrong] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; Structural Genomics Consortium	Greenblatt, JF (corresponding author), Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada.; Greenblatt, JF (corresponding author), Univ Toronto, Dept Mol Genet, 100 Coll St, Toronto, ON M5S 1A8, Canada.	jack.greenblatt@utoronto.ca	Moffat, Jason/AAC-1110-2020; Min, Jinrong/G-3449-2011; Braunschweig, Ulrich/I-1070-2019; Pawson, Tony J/E-4578-2013; Gish, Gerald D/C-7228-2017	Moffat, Jason/0000-0002-5663-8586; Min, Jinrong/0000-0001-5210-3130; Braunschweig, Ulrich/0000-0001-6653-0926; , KE/0000-0002-7082-262X	Ontario Research Fund from the Ontario Ministry of Research and Innovation; CIHR; National Science and Engineering Research Council of Canada Studentship; Ontario Graduate Scholarship; HFSP	Ontario Research Fund from the Ontario Ministry of Research and Innovation; CIHR(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Research Council of Canada Studentship; Ontario Graduate Scholarship(Ontario Graduate Scholarship); HFSP(Human Frontier Science Program)	We thank J. Manley for GST-CTD constructs; D. Reinberg for RNAP II me2a antibodies; D. Eick for wild-type and RNAP II (R1810A) constructs; and S. Leppla for purified S9.6 antibodies. We also thank D. Torti and D. Leung for Illumina library preparation and sequencing, T. Hajian for the purified PRMT5-WDR77 complex, J. Li for purified 8WG16 antibodies, and D. Durocher for constructive criticism and advice during the course of this work. This project was supported by the Ontario Research Fund from the Ontario Ministry of Research and Innovation (to J.F.G. and T.P.) and by CIHR Operating Grants to J.F.G. and B.J.B. D.Y.Z. was supported by a National Science and Engineering Research Council of Canada Studentship and an Ontario Graduate Scholarship. U.B. was supported by a long-term Postdoctoral Fellowship from HFSP. B.J.B. holds the University of Toronto Banbury Chair in Medical Research.	Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Antonysamy S, 2012, P NATL ACAD SCI USA, V109, P17960, DOI 10.1073/pnas.1209814109; Baumer D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000773; Battle DJ, 2006, COLD SPRING HARB SYM, V71, P313, DOI 10.1101/sqb.2006.71.001; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bhatia V, 2014, NATURE, V511, P362, DOI 10.1038/nature13374; BOGUSLAWSKI SJ, 1986, J IMMUNOL METHODS, V89, P123, DOI 10.1016/0022-1759(86)90040-2; Boisvert FM, 2003, MOL CELL PROTEOMICS, V2, P1319, DOI 10.1074/mcp.M300088-MCP200; Boisvert Francois-Michel, 2005, Sci STKE, V2005, pre2, DOI 10.1126/stke.2712005re2; Braunschweig U, 2014, GENOME RES, V24, P1774, DOI 10.1101/gr.177790.114; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Chen C, 2011, NAT REV MOL CELL BIO, V12, P629, DOI 10.1038/nrm3185; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Dhar S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01311; El Hage A, 2010, GENE DEV, V24, P1546, DOI 10.1101/gad.573310; Friesen WJ, 2002, J BIOL CHEM, V277, P8243, DOI 10.1074/jbc.M109984200; Glover-Cutter K, 2008, NAT STRUCT MOL BIOL, V15, P71, DOI 10.1038/nsmb1352; Hadjikyriacou A, 2015, J BIOL CHEM, V290, P16723, DOI 10.1074/jbc.M115.659433; Hatchi E, 2015, MOL CELL, V57, P636, DOI 10.1016/j.molcel.2015.01.011; Hsin JP, 2011, SCIENCE, V334, P683, DOI 10.1126/science.1206034; Ishigaki S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00529; Jonkers I, 2015, NAT REV MOL CELL BIO, V16, P167, DOI 10.1038/nrm3953; Kim SH, 2010, J BIOL CHEM, V285, P34097, DOI 10.1074/jbc.M110.154831; Kwak YT, 2003, MOL CELL, V11, P1055, DOI 10.1016/S1097-2765(03)00101-1; Lagier-Tourenne C, 2012, NAT NEUROSCI, V15, P1488, DOI 10.1038/nn.3230; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Licciardo P, 2003, NUCLEIC ACIDS RES, V31, P999, DOI 10.1093/nar/gkg197; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; Liu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030375; Mak AB, 2010, MOL CELL PROTEOMICS, V9, P811, DOI 10.1074/mcp.M000002-MCP201; Mayer A, 2012, SCIENCE, V336, P1723, DOI 10.1126/science.1219651; Munoz MJ, 2009, CELL, V137, P708, DOI 10.1016/j.cell.2009.03.010; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Pal S, 2007, J CELL PHYSIOL, V213, P306, DOI 10.1002/jcp.21180; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Porrua O, 2015, NAT REV MOL CELL BIO, V16, P190, DOI 10.1038/nrm3943; Rogelj B, 2012, SCI REP-UK, V2, DOI 10.1038/srep00603; Ryan K, 2002, MOL CELL BIOL, V22, P1684, DOI 10.1128/MCB.22.6.1684-1692.2002; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Sikorsky T, 2012, NUCLEIC ACIDS RES, V40, P11748, DOI 10.1093/nar/gks929; Sims RJ, 2011, SCIENCE, V332, P99, DOI 10.1126/science.1202663; Skourti-Stathaki K, 2011, MOL CELL, V42, P794, DOI 10.1016/j.molcel.2011.04.026; Sollier J, 2014, MOL CELL, V56, P777, DOI 10.1016/j.molcel.2014.10.020; Suraweera A, 2009, HUM MOL GENET, V18, P3384, DOI 10.1093/hmg/ddp278; Talbot K, 1997, HUM MOL GENET, V6, P497, DOI 10.1093/hmg/6.3.497; Uhlmann T, 2012, MOL CELL PROTEOMICS, V11, P1489, DOI 10.1074/mcp.M112.020743; Venkatesh S, 2015, NAT REV MOL CELL BIO, V16, P178, DOI 10.1038/nrm3941; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035; Yamazaki T, 2012, CELL REP, V2, P799, DOI 10.1016/j.celrep.2012.08.025; Yang YZ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7428; Yang YZ, 2014, MOL CELL, V53, P484, DOI 10.1016/j.molcel.2014.01.011; Yang YZ, 2010, MOL CELL, V40, P1016, DOI 10.1016/j.molcel.2010.11.024; Young PJ, 2000, HUM MOL GENET, V9, P2869, DOI 10.1093/hmg/9.19.2869; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031; Zhang ZX, 2013, P NATL ACAD SCI USA, V110, P19348, DOI 10.1073/pnas.1319280110	56	129	136	0	52	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 7	2016	529	7584					48	+		10.1038/nature16469	http://dx.doi.org/10.1038/nature16469			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6VY	26700805				2022-12-28	WOS:000367944900023
J	Brady, CJ; Eghrari, AO; Labrique, AB				Brady, Christopher J.; Eghrari, Allen O.; Labrique, Alain B.			Smartphone-Based Visual Acuity Measurement for Screening and Clinical Assessment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								IMPORTANCE Visual acuity is the most frequently performed measure of visual function in clinical practice and most people worldwide living with visual impairment are living in low-and middle-income countries. OBJECTIVE To design and validate a smartphone-based visual acuity test that is not dependent on familiarity with symbols or letters commonly used in the English language. DESIGN, SETTING, AND PARTICIPANTS Validation study conducted from December 11, 2013, to March 4, 2014, comparing results from smartphone-based Peek Acuity to Snellen acuity (clinical normal) charts and the Early Treatment Diabetic Retinopathy Study (ETDRS) logMAR chart (reference standard). This study was nested within the 6-year follow-up of the Nakuru Eye Disease Cohort in central Kenya and included 300 adults aged 55 years and older recruited consecutively. MAIN OUTCOMES AND MEASURES Outcome measures were monocular logMAR visual acuity scores for each test: ETDRS chart logMAR, Snellen acuity, and Peek Acuity. Peek Acuity was compared, in terms of test-retest variability and measurement time, with the Snellen acuity and ETDRS logMAR charts in participants' homes and temporary clinic settings in rural Kenya in 2013 and 2014. RESULTS The 95% CI limits for test-retest variability of smartphone acuity data were +/- 0.029 logMAR. The mean differences between the smartphone-based test and the ETDRS chart and the smartphone-based test and Snellen acuity data were 0.07 (95% CI, 0.05-0.09) and 0.08 (95% CI, 0.06-0.10) logMAR, respectively, indicating that smartphone-based test acuities agreed well with those of the ETDRS and Snellen charts. The agreement of Peek Acuity and the ETDRS chart was greater than the Snellen chart with the ETDRS chart (95% CI, 0.05-0.10; P =.08). The local Kenyan community health care workers readily accepted the Peek Acuity smartphone test; it required minimal training and took no longer than the Snellen test (77 seconds vs 82 seconds; 95% CI, 71-84 seconds vs 73-91 seconds, respectively; P =.13). CONCLUSIONS AND RELEVANCE The study demonstrated that the Peek Acuity smartphone test is capable of accurate and repeatable acuity measurements consistent with published data on the test-retest variability of acuities measured using 5-letter-per-line retroilluminated logMAR charts.	[Brady, Christopher J.; Eghrari, Allen O.] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA; [Labrique, Alain B.] Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Labrique, Alain B.] Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Brady, CJ (corresponding author), Wilmer Eye Inst, Retina Div, 600 N Wolfe St,Maumenee 711, Baltimore, MD 21287 USA.	cbrady5@jhmi.edu	Eghrari, Allen/ABH-4964-2020; Eghrari, Allen/AAI-9282-2021	Eghrari, Allen/0000-0003-2798-038X; Labrique, Alain/0000-0003-2502-7819	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001077] Funding Source: NIH RePORTER; NCATS NIH HHS [KL2 TR001077] Funding Source: Medline; NEI NIH HHS [L30 EY024746, K12 EY015025] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bastawrous A, 2015, JAMA OPHTHALMOL, V133, P930, DOI 10.1001/jamaophthalmol.2015.1468; Burns C, 2014, INNOVATIONS, V9, P33; FERRIS FL, 1982, AM J OPHTHALMOL, V94, P91, DOI 10.1016/0002-9394(82)90197-0; Labrique AB, 2013, GLOB HEALTH-SCI PRAC, V1, P160, DOI 10.9745/GHSP-D-13-00031; Perera C, 2015, EYE, V29, P888, DOI 10.1038/eye.2015.60; Shah N, 2014, INVEST OPHTH VIS SCI, V55, P1386, DOI 10.1167/iovs.13-13340; Tamony Peter, 2015, J Diabetes Sci Technol, V9, P1313, DOI 10.1177/1932296815588559; Tofigh S, 2015, EYE, V29, P1464, DOI 10.1038/eye.2015.138	8	28	28	1	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 29	2015	314	24					2682	+		10.1001/jama.2015.15855	http://dx.doi.org/10.1001/jama.2015.15855			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ2MR	26720028	Green Accepted			2022-12-28	WOS:000366939800023
J	Van Haren, K; Ayscue, P; Waubant, E; Clayton, A; Sheriff, H; Yagi, S; Glenn-Finer, R; Padilla, T; Strober, JB; Aldrovandi, G; Wadford, DA; Chiu, CY; Xia, DX; Harriman, K; Watt, JP; Glaser, CA				Van Haren, Keith; Ayscue, Patrick; Waubant, Emmanuella; Clayton, Anna; Sheriff, Heather; Yagi, Shigeo; Glenn-Finer, Rose; Padilla, Tasha; Strober, Jonathan B.; Aldrovandi, Grace; Wadford, Debra A.; Chiu, Charles Y.; Xia, Dongxiang; Harriman, Kathleen; Watt, James P.; Glaser, Carol A.			Acute Flaccid Myelitis of Unknown Etiology in California, 2012-2015	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ENTEROVIRUS 68; DIFFERENTIAL-DIAGNOSIS; RETROSPECTIVE ANALYSIS; TRANSVERSE MYELITIS; PARALYSIS; CHILDREN; FEATURES; ILLNESS; INFECTIONS; POLIOVIRUS	IMPORTANCE There has been limited surveillance for acute flaccid paralysis in North America since the regional eradication of poliovirus. In 2012, the California Department of Public Health received several reports of acute flaccid paralysis cases of unknown etiology. OBJECTIVE To quantify disease incidence and identify potential etiologies of acute flaccid paralysis cases with evidence of spinal motor neuron injury. DESIGN, SETTING, AND PARTICIPANTS Case series of acute flaccid paralysis in patients with radiological or neurophysiological findings suggestive of spinal motor neuron involvement reported to the California Department of Public Health with symptom onset between June 2012 and July 2015. Patients meeting diagnostic criteria for other acute flaccid paralysis etiologies were excluded. Cerebrospinal fluid, serum samples, nasopharyngeal swab specimens, and stool specimens were submitted to the state laboratory for infectious agent testing. MAIN OUTCOMES AND MEASURES Case incidence and infectious agent association. RESULTS Fifty-nine cases were identified. Median age was 9 years (interquartile range [IQR], 4-14 years; 50 of the cases were younger than 21 years). Symptoms that preceded or were concurrent included respiratory or gastrointestinal illness (n = 54), fever (n = 47), and limb myalgia (n = 41). Fifty-six patients had T2 hyperintensity of spinal gray matter on magnetic resonance imaging and 43 patients had cerebrospinal fluid pleocytosis. During the course of the initial hospitalization, 42 patients received intravenous steroids; 43, intravenous immunoglobulin; and 13, plasma exchange; or a combination of these treatments. Among 45 patients with follow-up data, 38 had persistent weakness at a median follow-up of 9 months (IQR, 3-12 months). Two patients, both immunocompromised adults, died within 60 days of symptom onset. Enteroviruses were the most frequently detected pathogen in either nasopharynx swab specimens, stool specimens, serum samples (15 of 45 patients tested). No pathogens were isolated from the cerebrospinal fluid. The incidence of reported cases was significantly higher during a national enterovirus D68 outbreak occurring from August 2014 through January 2015 (0.16 cases per 100 000 person-years) compared with other monitoring periods (0.028 cases per 100 000 person-years; P <. 001). CONCLUSIONS AND RELEVANCE In this series of patients identified in California from June 2012 through July 2015, clinical manifestations indicated a rare but distinct syndrome of acute flaccid paralysis with evidence of spinal motor neuron involvement. The etiology remains undetermined, most patients were children and young adults, and motor weakness was prolonged.	[Van Haren, Keith] Stanford Univ, Sch Med, Dept Neurol, Palo Alto, CA 94304 USA; [Van Haren, Keith] Lucile Packard Childrens Hosp, Div Child Neurol, Stanford, CA USA; [Ayscue, Patrick] US Ctr Dis Control & Prevent, Atlanta, GA USA; [Ayscue, Patrick; Clayton, Anna; Sheriff, Heather; Yagi, Shigeo; Glenn-Finer, Rose; Padilla, Tasha; Wadford, Debra A.; Xia, Dongxiang; Harriman, Kathleen; Watt, James P.; Glaser, Carol A.] Calif Dept Publ Hlth, Ctr Infect Dis, Div Communicable Dis Control, Richmond, CA USA; [Waubant, Emmanuella; Strober, Jonathan B.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Waubant, Emmanuella; Strober, Jonathan B.; Glaser, Carol A.] Univ Calif San Francisco, Dept Pediat, Benioff Childrens Hosp, San Francisco, CA USA; [Aldrovandi, Grace] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; [Aldrovandi, Grace] Univ So Calif, Los Angeles, CA USA; [Chiu, Charles Y.] Univ Calif San Francisco, Dept Lab Med, Div Infect Dis, San Francisco, CA 94143 USA; [Chiu, Charles Y.] Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA USA; [Chiu, Charles Y.] Univ Calif San Francisco, Viral Diagnost & Discovery Ctr, San Francisco, CA 94143 USA	Stanford University; Lucile Packard Children's Hospital (LPCH); Centers for Disease Control & Prevention - USA; California Department of Public Health; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Children's Hospital Los Angeles; University of Southern California; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Van Haren, K (corresponding author), Stanford Univ, 750 Welch Rd,Ste 317, Palo Alto, CA 94304 USA.	kpv@stanford.edu	Van Haren, Keith P./AGG-1580-2022; Van Haren, Keith/N-8480-2019	Van Haren, Keith/0000-0002-0233-9361; Wadford, Debra/0000-0002-8630-427X; Sheriff, Heather/0000-0001-6422-0588; Chiu, Charles/0000-0003-2915-2094	California Department of Public Health; US Centers for Disease Control and Prevention; Lucile Packard Foundation's McHugh/Sprague Award for Multiple Sclerosis Research; Child Neurology Foundation's Scientific Award; Race to Erase MS; National Multiple Sclerosis Society [RG4861A3/1]; National Institute of Neurological Disorders and Stroke [K23NS087151, R01NS071463]; National Institutes of Health [R01 HL 105704]; University of California, San Francisco, Viral Diagnostics and Discovery Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071463, K23NS087151] Funding Source: NIH RePORTER	California Department of Public Health; US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Lucile Packard Foundation's McHugh/Sprague Award for Multiple Sclerosis Research; Child Neurology Foundation's Scientific Award; Race to Erase MS; National Multiple Sclerosis Society(National Multiple Sclerosis Society); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Francisco, Viral Diagnostics and Discovery Center(University of California System); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by the California Department of Public Health and the US Centers for Disease Control and Prevention. The California Neurologic Surveillance and Testing Program is supported by the California Department of Public Health. Individual academic investigators received indirect support from the Lucile Packard Foundation's McHugh/Sprague Award for Multiple Sclerosis Research, the Child Neurology Foundation's Scientific Award, the Race to Erase MS, and grant RG4861A3/1 from the National Multiple Sclerosis Society. This study was also suported by grants K23NS087151 and R01NS071463 from the National Institute of Neurological Disorders and Stroke. Portions of the viral sequencing efforts were funded by grant R01 HL 105704 from the National Institutes of Health and an award from the University of California, San Francisco, Viral Diagnostics and Discovery Center.	[Anonymous], [No title captured]; Ayscue P, 2014, MMWR-MORBID MORTAL W, V63, P903; Bloch KC, 2015, EMERG INFECT DIS, V21, P1562, DOI 10.3201/eid2109.150295; Blomqvist S, 2002, J CLIN MICROBIOL, V40, P4218, DOI 10.1128/JCM.40.11.4218-4223.2002; Booss J, 2014, HAND CLINIC, V123, P3, DOI 10.1016/B978-0-444-53488-0.00001-8; Ghezzi A, 2001, NEUROL SCI, V22, pS60, DOI 10.1007/s100720100036; Glaser CA, 2006, CLIN INFECT DIS, V43, P1565, DOI 10.1086/509330; Greninger AL, 2015, LANCET INFECT DIS, V15, P671, DOI 10.1016/S1473-3099(15)70093-9; Harzheim M, 2004, J NEUROL SCI, V217, P217, DOI 10.1016/j.jns.2003.10.009; Imamura T, 2014, INFLUENZA OTHER RESP, V8, P21, DOI 10.1111/irv.12206; Jaramillo-Gutierrez G, 2013, J VIROL METHODS, V190, P53, DOI 10.1016/j.jviromet.2013.02.010; JEFFERY DR, 1993, ARCH NEUROL-CHICAGO, V50, P532, DOI 10.1001/archneur.1993.00540050074019; Kelly H, 2006, J PAEDIATR CHILD H, V42, P370, DOI 10.1111/j.1440-1754.2006.00875.x; Khetsuriani Nino, 2006, Morbidity and Mortality Weekly Report, V55, P18; Kreuter JD, 2011, ARCH PATHOL LAB MED, V135, P793, DOI 10.1043/2010-0174-CR.1; KYLLERMAN MG, 1993, PEDIATR NEUROL, V9, P227, DOI 10.1016/0887-8994(93)90091-P; Laxmivandana R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061650; Leake JAD, 2004, PEDIATR INFECT DIS J, V23, P756, DOI 10.1097/01.inf.0000133048.75452.dd; Leshem E, 2015, MMWR-MORBID MORTAL W, V63, P1243; Maloney JA, 2015, AM J NEURORADIOL, V36, P245, DOI 10.3174/ajnr.A4188; Marx A, 2000, EPIDEMIOL REV, V22, P298, DOI 10.1093/oxfordjournals.epirev.a018041; MELNICK JL, 1984, REV INFECT DIS, V6, pS387; Messacar K, 2015, LANCET, V385, P1662, DOI 10.1016/S0140-6736(14)62457-0; Midgley Claire M, 2014, MMWR Morb Mortal Wkly Rep, V63, P798; Mohammadi Dara, 2014, Lancet Neurol, V13, P650, DOI 10.1016/S1474-4422(14)70132-2; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Oberste MS, 2004, J GEN VIROL, V85, P2577, DOI 10.1099/vir.0.79925-0; Ohka S, 2001, TRENDS MICROBIOL, V9, P501, DOI 10.1016/S0966-842X(01)02200-4; Ooi MH, 2010, LANCET NEUROL, V9, P1097, DOI 10.1016/S1474-4422(10)70209-X; Pastula DM, 2014, MMWR-MORBID MORTAL W, V63, P901; Roux A, 2014, POLIO LIKE SYNDROME; Sejvar JJ, 2003, EMERG INFECT DIS, V9, P788, DOI 10.3201/eid0907.030129; SMITH L, 1962, J LAB CLIN MED, V59, P490; Solomon T, 1998, LANCET, V351, P1094, DOI 10.1016/S0140-6736(97)07509-0; Villarruel G. R., 2010, Morbidity and Mortality Weekly Report, V59, P1577; Wilson MR, 2014, NEW ENGL J MED, V370, P2408, DOI 10.1056/NEJMoa1401268; Wong M, 1999, PEDIATR NEUROL, V20, P235, DOI 10.1016/S0887-8994(98)00142-8; Zangwill KM, 2010, PEDIATR NEUROL, V42, P206, DOI 10.1016/j.pediatrneurol.2009.10.012	38	83	83	1	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 29	2015	314	24					2663	2671		10.1001/jama.2015.17275	http://dx.doi.org/10.1001/jama.2015.17275			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ2MR	26720027	Bronze			2022-12-28	WOS:000366939800021
J	Fritz, G; Kroneck, PMH				Fritz, Guenter; Kroneck, Peter M. H.			Sulfate to go	SCIENCE			English	Editorial Material							DISSIMILATORY SULFITE REDUCTASE; ARCHAEOGLOBUS-FULGIDUS; INSIGHTS; RESPIRATION; MECHANISM; ENERGY; SULFUR; DSRC		[Fritz, Guenter] Univ Freiburg, Inst Neuropathol, D-79106 Freiburg, Germany; [Kroneck, Peter M. H.] Univ Konstanz, Dept Biol, D-78457 Constance, Germany	University of Freiburg; University of Konstanz	Fritz, G (corresponding author), Univ Freiburg, Inst Neuropathol, Hugstetter Str 55, D-79106 Freiburg, Germany.	guenter.fritz@uniklinik-freiburg.de; peter.kroneck@uni-konstanz.de	Fritz, Guenter/E-2933-2013	Fritz, Guenter/0000-0002-4571-8812				Beinert H, 2000, EUR J BIOCHEM, V267, P5657, DOI 10.1046/j.1432-1327.2000.01637.x; Crane BR, 1996, CURR OPIN STRUC BIOL, V6, P744, DOI 10.1016/S0959-440X(96)80003-0; Grein F, 2013, BBA-BIOENERGETICS, V1827, P145, DOI 10.1016/j.bbabio.2012.09.001; Hsieh YC, 2010, MOL MICROBIOL, V78, P1101, DOI 10.1111/j.1365-2958.2010.07390.x; Huber C, 1997, SCIENCE, V276, P245, DOI 10.1126/science.276.5310.245; Mander GJ, 2005, FEBS LETT, V579, P4600, DOI 10.1016/j.febslet.2005.07.029; Oliveira TF, 2008, J STRUCT BIOL, V164, P236, DOI 10.1016/j.jsb.2008.07.007; Oliveira TF, 2008, J BIOL CHEM, V283, P34141, DOI 10.1074/jbc.M805643200; Parey K, 2013, METALLOMICS, V5, P302, DOI 10.1039/c2mt20225e; Santos AA, 2015, SCIENCE, V350, P1541, DOI 10.1126/science.aad3558; Schiffer A, 2008, J MOL BIOL, V379, P1063, DOI 10.1016/j.jmb.2008.04.027; THAUER RK, 1977, BACTERIOL REV, V41, P100, DOI 10.1128/MMBR.41.1.100-180.1977	12	2	2	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2015	350	6267					1476	1477		10.1126/science.aad8139	http://dx.doi.org/10.1126/science.aad8139			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY7LY	26680182				2022-12-28	WOS:000366591100034
J	Maciejowski, J; Li, YL; Bosco, N; Campbell, PJ; de Lange, T				Maciejowski, John; Li, Yilong; Bosco, Nazario; Campbell, Peter J.; de Lange, Titia			Chromothripsis and Kataegis Induced by Telomere Crisis	CELL			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; DICENTRIC CHROMOSOMES; GENOMIC REARRANGEMENT; MITOTIC BEHAVIOR; HUMAN-CELLS; DNA-DAMAGE; DYSFUNCTION; FUSION; MUTAGENESIS; MUTATIONS	Telomere crisis occurs during tumorigenesis when depletion of the telomere reserve leads to frequent telomere fusions. The resulting dicentric chromosomes have been proposed to drive genome instability. Here, we examine the fate of dicentric human chromosomes in telomere crisis. We observed that dicentric chromosomes invariably persisted through mitosis and developed into 50-200 mm chromatin bridges connecting the daughter cells. Before their resolution at 3-20 hr after anaphase, the chromatin bridges induced nuclear envelope rupture in interphase, accumulated the cytoplasmic 30 nuclease TREX1, and developed RPA-coated single stranded (ss) DNA. CRISPR knockouts showed that TREX1 contributed to the generation of the ssDNA and the resolution of the chromatin bridges. Post-crisis clones showed chromothripsis and kataegis, presumably resulting from DNA repair and APOBEC editing of the fragmented chromatin bridge DNA. We propose that chromothripsis in human cancer may arise through TREX1-mediated fragmentation of dicentric chromosomes formed in telomere crisis.	[Maciejowski, John; Bosco, Nazario; de Lange, Titia] Rockefeller Univ, Cell Biol & Genet Lab, New York, NY 10065 USA; [Li, Yilong; Campbell, Peter J.] Wellcome Trust Sanger Inst, Hinxton Cambridge CB10 1SA, England	Rockefeller University; Wellcome Trust Sanger Institute	Campbell, PJ (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton Cambridge CB10 1SA, England.	pc8@sanger.ac.uk; delange@mail.rockefeller.edu	de Lange, Titia/B-8263-2011	de Lange, Titia/0000-0002-9267-367X; Maciejowski, John/0000-0001-8134-9308	NIH Cancer Center grant [P30 CA008748]; Wellcome Trust [077012/Z/05/Z]; NCI [5R01CA181090]; Breast Cancer Research Foundation; Wellcome Trust Senior Clinical Fellowship [WT088340MA]; NATIONAL CANCER INSTITUTE [R01CA181090, P30CA008748] Funding Source: NIH RePORTER	NIH Cancer Center grant; Wellcome Trust(Wellcome TrustEuropean Commission); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Breast Cancer Research Foundation; Wellcome Trust Senior Clinical Fellowship(Wellcome Trust); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Prasad Jallepalli for reagents, Martin Hetzer for discussion, and Zhe Yang for performing PCR validation of chromothriptic breakpoints. We thank S. Yu and the de Lange lab for discussion and help with this manuscript. P. Ariel, T. Tong, and A. North of the RU Bio-imaging Core Facility provided expert assistance with microscopy. The MSKCC Cytogenetics Core acknowledges NIH Cancer Center grant P30 CA008748. J.M. is a Merck Fellow of The Jane Coffin Childs Memorial Fund for Medical Research. Work in P.J.C.'s lab was supported by the Wellcome Trust (077012/Z/05/Z), and P.J.C. holds a Wellcome Trust Senior Clinical Fellowship (WT088340MA). This work was supported by grants from the NCI (5R01CA181090) and the Breast Cancer Research Foundation to T.d.L. T.d.L. is an American Cancer Society Research Professor.	Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Bennink ML, 2001, NAT STRUCT BIOL, V8, P606, DOI 10.1038/89646; Bignell GR, 2007, GENOME RES, V17, P1296, DOI 10.1101/gr.6522707; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Capper R, 2007, GENE DEV, V21, P2495, DOI 10.1101/gad.439107; Chan K, 2015, NAT GENET, V47, P1067, DOI 10.1038/ng.3378; Chien FT, 2009, CURR PHARM BIOTECHNO, V10, P474, DOI 10.2174/138920109788922128; Chowdhury D, 2006, MOL CELL, V23, P133, DOI 10.1016/j.molcel.2006.06.005; Davoli T, 2012, CANCER CELL, V21, P765, DOI 10.1016/j.ccr.2012.03.044; Davoli T, 2010, CELL, V141, P81, DOI 10.1016/j.cell.2010.01.031; Forment JV, 2012, NAT REV CANCER, V12, P663, DOI 10.1038/nrc3352; Garsed DW, 2014, CANCER CELL, V26, P653, DOI 10.1016/j.ccell.2014.09.010; Gisselsson D, 2001, P NATL ACAD SCI USA, V98, P12683, DOI 10.1073/pnas.211357798; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; HABER JE, 1984, GENETICS, V106, P185; Hatch EM, 2015, CELL, V161, P1502, DOI 10.1016/j.cell.2015.06.005; Hatch EM, 2013, CELL, V154, P47, DOI 10.1016/j.cell.2013.06.007; Houchmandzadeh B, 1997, J CELL BIOL, V139, P1, DOI 10.1083/jcb.139.1.1; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Kloosterman WP, 2013, CURR OPIN CELL BIOL, V25, P341, DOI 10.1016/j.ceb.2013.02.008; Korbel JO, 2013, CELL, V152, P1226, DOI 10.1016/j.cell.2013.02.023; Lehtinen DA, 2008, J BIOL CHEM, V283, P31649, DOI 10.1074/jbc.M806155200; Letsolo BT, 2010, NUCLEIC ACIDS RES, V38, P1841, DOI 10.1093/nar/gkp1183; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li YL, 2014, NATURE, V508, P98, DOI 10.1038/nature13115; Lin TT, 2014, BRIT J HAEMATOL, V167, P214, DOI 10.1111/bjh.13023; Lin TT, 2010, BLOOD, V116, P1899, DOI 10.1182/blood-2010-02-272104; Lopez V, 2015, GENE DEV, V29, P322, DOI 10.1101/gad.254664.114; Mardin BR, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156505; McClintock B, 1938, GENETICS, V23, P315; McClintock B, 1941, GENETICS, V26, P234; Mehine M, 2013, NEW ENGL J MED, V369, P43, DOI 10.1056/NEJMoa1302736; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Nones K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6224; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Reijns MAM, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.011; Rice GI, 2015, J CLIN IMMUNOL, V35, P235, DOI 10.1007/s10875-015-0147-3; Roberts SA, 2014, NAT REV CANCER, V14, P786, DOI 10.1038/nrc3816; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Roberts SA, 2012, MOL CELL, V46, P424, DOI 10.1016/j.molcel.2012.03.030; Roger L, 2013, JNCI-J NATL CANCER I, V105, P1202, DOI 10.1093/jnci/djt191; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Simpson K, 2015, MOL ONCOL, V9, P1186, DOI 10.1016/j.molonc.2015.02.003; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stimpson KM, 2012, CHROMOSOME RES, V20, P595, DOI 10.1007/s10577-012-9302-3; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Takai KK, 2011, MOL CELL, V44, P647, DOI 10.1016/j.molcel.2011.08.043; van Mameren J, 2009, P NATL ACAD SCI USA, V106, P18231, DOI 10.1073/pnas.0904322106; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Vargas JD, 2012, NUCLEUS-PHILA, V3, P88, DOI 10.4161/nucl.18954; Waclaw B, 2015, NATURE, V525, P261, DOI 10.1038/nature14971; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang CZ, 2015, NATURE, V522, P179, DOI 10.1038/nature14493	64	369	374	2	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2015	163	7					1641	1654		10.1016/j.cell.2015.11.054	http://dx.doi.org/10.1016/j.cell.2015.11.054			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CZ1GN	26687355	Bronze, Green Accepted			2022-12-28	WOS:000366854200012
J	O'Neill, LAJ				O'Neill, Luke A. J.			How Low Cholesterol Is Good for Anti-viral Immunity	CELL			English	Editorial Material								York et al. identify a role for decreased cholesterol biosynthesis in virally infected cells as a critical event in the induction of the anti-viral response. The mechanism involves enhanced signaling by STING in the ER membrane in response to the second messenger cGAMP, promoting increased transcription of type I interferons. The authors suggest that a "lipid code" is being sensed by STING to allow it to signal.	[O'Neill, Luke A. J.] Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin 2, Ireland	Trinity College Dublin	O'Neill, LAJ (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin 2, Ireland.	laoneill@tcd.ie		O'Neill, Luke/0000-0002-4333-2748				Blanc M, 2013, IMMUNITY, V38, P106, DOI 10.1016/j.immuni.2012.11.004; Boshuizen MCS, 2016, CYTOKINE, V77, P220, DOI 10.1016/j.cyto.2015.09.016; Esposito S, 2014, INT J IMMUNOPATH PH, V27, P491, DOI 10.1177/039463201402700404; Ganeshan K, 2014, ANNU REV IMMUNOL, V32, P609, DOI 10.1146/annurev-immunol-032713-120236; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Kelly B, 2015, CELL RES, V25, P771, DOI 10.1038/cr.2015.68; Xiao TS, 2013, MOL CELL, V51, P135, DOI 10.1016/j.molcel.2013.07.004; York AG, 2015, CELL, V163, P1716, DOI 10.1016/j.cell.2015.11.045	8	16	16	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2015	163	7					1572	1574		10.1016/j.cell.2015.12.004	http://dx.doi.org/10.1016/j.cell.2015.12.004			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CZ1GN	26687349	Bronze			2022-12-28	WOS:000366854200005
J	Lenzer, J				Lenzer, Jeanne			Choosing Wisely: setbacks and progress	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jeanne.lenzer@gmail.com						Ahn HS, 2014, NEW ENGL J MED, V371, P1765, DOI 10.1056/NEJMp1409841; American College of Emergency Physicians, ACEP PREP LIST CHOOS; Grady D, 2014, JAMA INTERN MED, V174, P498, DOI 10.1001/jamainternmed.2013.8272; Krumholz HM, 2015, JAMA-J AM MED ASSOC, V314, P355, DOI 10.1001/jama.2015.8035; McCarthy M, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5437; Morden NE, 2014, NEW ENGL J MED, V370, P589, DOI 10.1056/NEJMp1314965; Rau J., 2014, KAISER HLTH NEW 0414; Rosenberg A, 2015, JAMA INTERN MED, V175, P1913, DOI 10.1001/jamainternmed.2015.5441; Rothberg MB, 2014, JAMA INTERN MED, V174, P1623, DOI 10.1001/jamainternmed.2014.3331; Schuur JD, 2014, JAMA INTERN MED, V174, P509, DOI 10.1001/jamainternmed.2013.12688; Stergiopoulos K, 2012, ARCH INTERN MED, V172, P312, DOI 10.1001/archinternmed.2011.1484	11	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 15	2015	351								h6760	10.1136/bmj.h6760	http://dx.doi.org/10.1136/bmj.h6760			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ4ML	26671897				2022-12-28	WOS:000367077200005
J	Pronovost, PJ; Bienvenu, OJ				Pronovost, Peter J.; Bienvenu, O. Joseph			From Shame to Guilt to Love	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Pronovost, Peter J.] Johns Hopkins Med, Armstrong Inst Patient Safety & Qual, Baltimore, MD 21218 USA; [Pronovost, Peter J.] Johns Hopkins Univ, Dept Anesthesiol & Crit Care Med, Baltimore, MD USA; [Pronovost, Peter J.] Johns Hopkins Univ, Dept Surg, Baltimore, MD USA; [Pronovost, Peter J.] Johns Hopkins Univ, Dept Hlth Policy & Management, Baltimore, MD 21218 USA; [Bienvenu, O. Joseph] Johns Hopkins Univ, Dept Psychiat & Behav Sci, Baltimore, MD USA; [Bienvenu, O. Joseph] Johns Hopkins Univ, Dept Mental Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Pronovost, PJ (corresponding author), Johns Hopkins Med, Armstrong Inst Patient Safety & Qual, Baltimore, MD 21218 USA.	ppronovo@jhmi.edu		Bienvenu, Joe/0000-0002-8466-102X				Centers for Medicare & Medicaid Services, EHR INC PROGR; Donabedian A, 2001, Health Aff (Millwood), V20, P137; Fredrickson BL, 2013, LOVE 2 0; Gallagher TH, 2003, JAMA-J AM MED ASSOC, V289, P1001, DOI 10.1001/jama.289.8.1001; Kita J, 2010, READERS DIGEST; Kluger AN, 1996, PSYCHOL BULL, V119, P254, DOI 10.1037/0033-2909.119.2.254; Kohn L.T., 2000, ERR IS HUMAN BUILDIN, VVolume 600; Ofri D., 2014, WHAT DOCTORS FEEL EM; Wise D, GETTING KNOW JUST CU	9	9	9	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 15	2015	314	23					2507	2508		10.1001/jama.2015.11521	http://dx.doi.org/10.1001/jama.2015.11521			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY4PV	26670968				2022-12-28	WOS:000366391500015
J	Whitton, L				Whitton, Lucinda			CHRISTMAS 2015: CALL TO ACTION Hominid spongyform encephalophagy: cooking time 1-11/2 hours, difficulty	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Whitton, Lucinda] Gloucestershire Royal Hosp, Gloucester GL1 3NN, England	Gloucestershire Royal Hospital	Whitton, L (corresponding author), Gloucestershire Royal Hosp, Gloucester GL1 3NN, England.	lucywhitton@gmail.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 14	2015	351								h6310	10.1136/bmj.h6310	http://dx.doi.org/10.1136/bmj.h6310			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ4KY	26668201				2022-12-28	WOS:000367073200006
J	Yu, M; Yang, WJ; Ni, T; Tang, ZY; Nakadai, T; Zhu, J; Roeder, RG				Yu, Ming; Yang, Wenjing; Ni, Ting; Tang, Zhanyun; Nakadai, Tomoyoshi; Zhu, Jun; Roeder, Robert G.			RNA polymerase II-associated factor 1 regulates the release and phosphorylation of paused RNA polymerase II	SCIENCE			English	Article							PAF1 COMPLEX; TRANSCRIPTION ELONGATION; TERMINAL DOMAIN; P-TEFB; CHROMATIN; KINASE; CTD; RECRUITMENT; ROLES; SPT5	Release of promoter-proximal paused RNA polymerase II (Pol II) during early elongation is a critical step in transcriptional regulation in metazoan cells. Paused Pol II release is thought to require the kinase activity of cyclin-dependent kinase 9 (CDK9) for the phosphorylation of DRB sensitivity-inducing factor, negative elongation factor, and C-terminal domain (CTD) serine-2 of Pol II. We found that Pol II-associated factor 1 (PAF1) is a critical regulator of paused Pol II release, that positive transcription elongation factor b (P-TEFb) directly regulates the initial recruitment of PAF1 complex (PAF1C) to genes, and that the subsequent recruitment of CDK12 is dependent on PAF1C. These findings reveal cooperativity among P-TEFb, PAF1C, and CDK12 in pausing release and Pol II CTD phosphorylation.	[Yu, Ming; Tang, Zhanyun; Nakadai, Tomoyoshi; Roeder, Robert G.] Rockefeller Univ, Lab Biochem & Mol Biol, New York, NY 10065 USA; [Yang, Wenjing; Zhu, Jun] NHLBI, Syst Biol Ctr, Bethesda, MD 20892 USA; [Ni, Ting] Fudan Univ, State Key Lab Genet Engn, Shanghai 200438, Peoples R China; [Ni, Ting] Fudan Univ, Minist Educ, Key Lab Contemporary Anthropol, Collaborat Innovat Ctr Genet & Dev,Sch Life Sci, Shanghai 200438, Peoples R China	Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Fudan University; Fudan University	Roeder, RG (corresponding author), Rockefeller Univ, Lab Biochem & Mol Biol, New York, NY 10065 USA.	roeder@rockefeller.edu			Leukemia and Lymphoma Society SCOR grant; National Heart, Lung, and Blood Institute; National Science Foundation of China; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL006058] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society SCOR grant(Leukemia and Lymphoma Society); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank G. Morin for providing the cyclin K cDNA, and S. Malik, S. Murphy, and M. Guermah for critical reading of the manuscript. Supported by a Leukemia and Lymphoma Society SCOR grant (R.G.R.), the intramural research program of the National Heart, Lung, and Blood Institute (W.Y. and J.Z.), and a National Science Foundation of China grant (T.Ni). ChIP-seq and RNA-seq data have been submitted to GEO under accession number GSE62171.	Adelman K, 2006, MOL CELL BIOL, V26, P250, DOI 10.1128/MCB.26.1.250-260.2006; Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Bai XY, 2010, CELL, V142, P133, DOI 10.1016/j.cell.2010.05.028; Bartkowiak B, 2010, GENE DEV, V24, P2303, DOI 10.1101/gad.1968210; Chen FX, 2015, CELL, V162, P1003, DOI 10.1016/j.cell.2015.07.042; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Czudnochowski N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1846; Devaiah BN, 2012, P NATL ACAD SCI USA, V109, P6927, DOI 10.1073/pnas.1120422109; Ghamari A, 2013, GENE DEV, V27, P767, DOI 10.1101/gad.216200.113; He NH, 2011, P NATL ACAD SCI USA, V108, pE636, DOI 10.1073/pnas.1107107108; Jaehning JA, 2010, BBA-GENE REGUL MECH, V1799, P379, DOI 10.1016/j.bbagrm.2010.01.001; Jonkers I, 2014, ELIFE, V3, DOI 10.7554/eLife.02407; Kim J, 2010, CELL, V140, P491, DOI 10.1016/j.cell.2009.12.050; Liu Y, 2009, MOL CELL BIOL, V29, P4852, DOI 10.1128/MCB.00609-09; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Mueller CL, 2004, MOL CELL, V14, P447, DOI 10.1016/S1097-2765(04)00257-6; Nordick K, 2008, EUKARYOT CELL, V7, P1158, DOI 10.1128/EC.00434-07; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Qiu HF, 2012, EMBO J, V31, P3494, DOI 10.1038/emboj.2012.188; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Takahashi A, 2011, MOL CELL, V43, P45, DOI 10.1016/j.molcel.2011.05.014; Tomson BN, 2013, BBA-GENE REGUL MECH, V1829, P116, DOI 10.1016/j.bbagrm.2012.08.011	23	131	135	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2015	350	6266					1383	1386		10.1126/science.aad2338	http://dx.doi.org/10.1126/science.aad2338			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1JL	26659056	Green Accepted			2022-12-28	WOS:000366162400044
J	Cocksedge, S				Cocksedge, Simon			PERSONAL VIEW Let's leave "heartsink" behind	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Cocksedge, Simon] Chapel En Le Frith, High Peak SK23 0RH, Derby, England		Cocksedge, S (corresponding author), Chapel En Le Frith, High Peak SK23 0RH, Derby, England.	cocksedge@doctors.org.uk						Cannon J, 2015, BMA NEWS         JUN; Cocksedge S, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X588457; Moscrop A, 2011, BRIT J GEN PRACT, V61, P346, DOI 10.3399/bjgp11X572490; O'Dowd T, 2011, BRIT J GEN PRACT, V61, P437, DOI 10.3399/bjgp11X583056; ODOWD TC, 1988, BRIT MED J, V297, P528, DOI 10.1136/bmj.297.6647.528	5	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 10	2015	351								h6542	10.1136/bmj.h6542	http://dx.doi.org/10.1136/bmj.h6542			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY5TG	26655400				2022-12-28	WOS:000366469700002
J	McKinnon, MC; Cheng, SH; Garside, R; Masuda, YJ; Miller, DC				McKinnon, Madeleine C.; Cheng, Samantha H.; Garside, Ruth; Masuda, Yuta J.; Miller, Daniel C.			Sustainability: Map the evidence	NATURE			English	Editorial Material									[McKinnon, Madeleine C.] Conservat Int, Monitoring & Evaluat, Arlington, VA 22202 USA; [Cheng, Samantha H.] Univ Calif Los Angeles, Los Angeles, CA USA; [Garside, Ruth] Univ Exeter, Sch Med, European Ctr Environm & Human Hlth, Evidence Synth, Truro, England; [Masuda, Yuta J.] Nature Conservancy, Boston, MA USA; [Miller, Daniel C.] Univ Illinois, Nat Resources & Environm Sci, Urbana, IL 61801 USA	Conservation International; University of California System; University of California Los Angeles; University of Exeter; Nature Conservancy; University of Illinois System; University of Illinois Urbana-Champaign	McKinnon, MC (corresponding author), Conservat Int, Monitoring & Evaluat, Arlington, VA 22202 USA.	mmckinnon@conservation.org		Garside, Ruth/0000-0003-1649-4773				Bottrill M, 2014, ENVIRON EVID, V3, DOI 10.1186/2047-2382-3-16; CEE, 2013, GUIDELINES SYSTEMATI; Fisher B, 2014, CONSERV BIOL, V28, P880, DOI 10.1111/cobi.12221; Gilbert R, 2005, INT J EPIDEMIOL, V34, P874, DOI 10.1093/ije/dyi088; Lu YL, 2015, NATURE, V520, P432, DOI 10.1038/520432a; Pullin AS, 2013, ENVIRON EVID, V2, DOI 10.1186/2047-2382-2-19; Rijsberman F., 2012, WATER SANITATION; Snilstveit B., 2013, EVIDENCE GAP MAPS TO; Trevino J., 2014, WHICH WORLD BANK REP	9	61	61	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2015	528	7581					185	187		10.1038/528185a	http://dx.doi.org/10.1038/528185a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9VH	26659166	Bronze			2022-12-28	WOS:000366053300013
J	Turajlic, S; Larkin, J; Swanton, C				Turajlic, Samra; Larkin, James; Swanton, Charles			SnapShot: Renal Cell Carcinoma	CELL			English	Editorial Material							GENOMIC LANDSCAPE	This SnapShot summarizes current knowledge about the key features in mutational landscape, major pathways, and tumor evolution and heterogeneity in renal cell carcinoma, as well as the most recent advances in therapeutic development. To view this SnapShot, open or download the PDF.	[Turajlic, Samra; Swanton, Charles] Francis Crick Inst, London WC2A 3LY, England; [Turajlic, Samra; Larkin, James] Royal Marsden Hosp, Renal Unit, London SW3 6JJ, England	Francis Crick Institute; Royal Marsden NHS Foundation Trust	Turajlic, S (corresponding author), Francis Crick Inst, 44 Lincolns Inn Fields, London WC2A 3LY, England.			Swanton, Charles/0000-0002-4299-3018; Larkin, James/0000-0001-5569-9523; turajlic, samra/0000-0001-8846-136X	Cancer Research UK [18176] Funding Source: researchfish	Cancer Research UK(Cancer Research UK)		[Anonymous], 2013, NATURE, V499, P43, DOI [10.1038/nature12222, DOI 10.1038/NATURE12222, DOI 10.1038/nature12222]; *CANC GEN ATL RES, 2015, NEJM; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Davis CF, 2014, CANCER CELL, V26, P319, DOI 10.1016/j.ccr.2014.07.014; Durinck S, 2015, NAT GENET, V47, P13, DOI 10.1038/ng.3146; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Guo GW, 2012, NAT GENET, V44, P17, DOI 10.1038/ng.1014; Kovac M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7336; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Scelo G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6135	10	45	45	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 6	2015	163	6							1556.e1	10.1016/j.cell.2015.11.026	http://dx.doi.org/10.1016/j.cell.2015.11.026			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SE	26638079	Bronze			2022-12-28	WOS:000366044800026
J	Williams, R; Ashton, K; Aspinall, R; Bellis, MA; Bosanquet, J; Cramp, ME; Day, N; Dhawan, A; Dillon, J; Dyson, J; Ferguson, J; Foster, G; Gilmore, SI; Glynn, M; Guthrie, JA; Hudson, M; Kelly, D; Langford, A; Newsome, P; O'Grady, J; Pryke, R; Ryder, S; Samyn, M; Sheron, N; Verne, J				Williams, Roger; Ashton, Kathryn; Aspinall, Richard; Bellis, Mark A.; Bosanquet, Joanne; Cramp, Matthew E.; Day, Natalie; Dhawan, Anil; Dillon, John; Dyson, Jessica; Ferguson, James; Foster, Graham; Gilmore, Sir Ian; Glynn, Michael; Guthrie, J. Ashley; Hudson, Mark; Kelly, Deirdre; Langford, Andrew; Newsome, Philip; O'Grady, John; Pryke, Rachel; Ryder, Stephen; Samyn, Marianne; Sheron, Nick; Verne, Julia			Implementation of the Lancet Standing Commission on Liver Disease in the UK	LANCET			English	Article							ALCOHOL; CONSUMPTION; LEDIPASVIR; SOFOSBUVIR; OBESITY; HEALTH; ISSUES; RISK; TAX; HCV		[Williams, Roger; Day, Natalie] Fdn Liver Res, London WC1E 6HX, England; [Ashton, Kathryn] Cardiff Univ, Cardiff CF10 3AX, S Glam, Wales; [Aspinall, Richard] Queen Alexandra Hosp, Portsmouth, Hants, England; [Bellis, Mark A.] Bangor Univ, Bangor, Gwynedd, Wales; [Bosanquet, Joanne; Verne, Julia] Publ Hlth England, London, England; [Cramp, Matthew E.] South West Liver Unit, Plymouth, Devon, England; [Cramp, Matthew E.] Univ Plymouth, Peninsula Sch Med, Plymouth PL4 8AA, Devon, England; [Cramp, Matthew E.] Univ Plymouth, Sch Dent, Plymouth PL4 8AA, Devon, England; [Dhawan, Anil; O'Grady, John; Samyn, Marianne] Kings Coll Hosp London, London, England; [Dillon, John] Univ Dundee, Med Res Inst, Dundee, Scotland; [Dyson, Jessica] Newcastle Upon Tyne Hosp NHS Fdn Trust, Freeman Hosp, Newcastle Upon Tyne, Tyne & Wear, England; [Dyson, Jessica] NIHR Newcastle Biomed Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England; [Ferguson, James] Queen Elizabeth Hosp, Birmingham B15 2TH, W Midlands, England; [Foster, Graham] Queen Marys Univ, London, England; [Gilmore, Sir Ian] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [Glynn, Michael] Barts Hlth NHS Trust, London, England; [Guthrie, J. Ashley] Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England; [Hudson, Mark] Freeman Rd Hosp, Newcastle Upon Tyne, Tyne & Wear, England; [Kelly, Deirdre] Birmingham Childrens Hosp, Birmingham, W Midlands, England; [Langford, Andrew] British Liver Trust, Ringwood, Dorset, England; [Newsome, Philip] Univ Hosp Birmingham, Birmingham, W Midlands, England; [Pryke, Rachel] Winyates Hlth Ctr, Redditch, Dorset, England; [Ryder, Stephen] Univ Nottingham Hosp, Nottingham NG7 2UH, England; [Sheron, Nick] Univ Southampton, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England	University of London; University College London; Cardiff University; Portsmouth Hospitals NHS Trust; Queen Alexandra Hospital; Bangor University; Public Health England; University of Plymouth; University of Plymouth; King's College Hospital NHS Foundation Trust; King's College Hospital; University of Dundee; Newcastle Freeman Hospital; Newcastle Upon Tyne Hospitals NHS Foundation Trust; University of Birmingham; University of London; Queen Mary University London; University of Liverpool; Barts Health NHS Trust; University of Leeds; Newcastle Freeman Hospital; Newcastle University - UK; University of Birmingham; University of Birmingham; University of Nottingham; University of Southampton	Williams, R (corresponding author), Fdn Liver Res, London WC1E 6HX, England.	r.williams@researchinliver.org.uk	Bellis, Mark A./HGA-2019-2022; Newsome, Philip N/D-4495-2018	Newsome, Philip N/0000-0001-6085-3652; Ryder, Stephen David/0000-0001-9649-4444; Foster, Graham/0000-0002-3704-386X; Dillon, John/0000-0002-2164-4476; Sheron, Nick/0000-0001-5232-8292; Aspinall, Richard/0000-0002-5208-8185; Sheron, Nick/0000-0002-6156-8367; Dhawan, Anil/0000-0002-4942-0845	Gilead; Merck; Boehringer Ingelheim; Janssen; Roche; Bristol-Myers Squibb	Gilead(Gilead Sciences); Merck(Merck & Company); Boehringer Ingelheim(Boehringer Ingelheim); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Roche(Roche Holding); Bristol-Myers Squibb(Bristol-Myers Squibb)	MEC declares grant funding and personal fees from Gilead, Merck, Boehringer Ingelheim, Janssen, Roche, and Bristol-Myers Squibb. All other authors declare no competing interests.	Academy of Medical Sciences (AMS), 2004, CALL TIM NAT DRINK M; Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; [Anonymous], 2015, WHAT IS PUBL HLTH AL; [Anonymous], 2014, CENSUS MED WORKFORCE; [Anonymous], 2015, WHATS IMP ME REV CHO; [Anonymous], 2014, WORLD COULD BETTER F; [Anonymous], 2015, BBC NEWS; [Anonymous], 2013, MEAS UN REV PAT WHO; Barry E, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4717; Bleich SN, 2014, AM J PUBLIC HEALTH, V104, P2417, DOI 10.2105/AJPH.2014.302150; Briggs ADM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6189; British Beer and Pub Association, 2013, BRIT BEER PUB ASS HD; British Medical Association, 2015, NO IR MOV CLOS MIN A; British Medical Association, 2014, FOOD THOUGHT PROM HL; Campbell CNJ, 2011, EPIDEMIOL INFECT, V139, P1560, DOI 10.1017/S0950268810002657; Cross TJS, FRONTLINE G IN PRESS; Department of Health Royal College of Nursing, 2015, CAR PEOPL LIV DIS CO; Donnelly L., BRIT POOR DIET MORE; Dyson JK, 2015, GUT, V64, pA257, DOI 10.1136/gutjnl-2015-309861.552; Dyson JK, 2015, J HEPATOL, V62, P208, DOI 10.1016/j.jhep.2014.09.010; Eads L., 2015, THE DRINKS BUSI 0204; Eagle L, RESPONSE GOVT HLTH L; Elliss-Brookes L, 2012, BRIT J CANCER, V107, P1220, DOI 10.1038/bjc.2012.408; Escobar MAC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1072; European Association for Study of the Liver, 2015, HEPAMAP ROADM HEP RE; Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338; Fikree A, 2013, GUT, V62, pA98, DOI 10.1136/gutjnl-2013-304907.216; Gines P, 2012, J HEPATOL, V56, pS13, DOI 10.1016/S0168-8278(12)60003-8; Gordon VM, 2015, GUT, V64, pA9, DOI 10.1136/gutjnl-2015-309861.17; Harhay MO, 2014, EUR J PUBLIC HEALTH, V24, P410, DOI 10.1093/eurpub/ckt134; HM Revenue and Customs, 2015, HMRC ALC CLEAR DAT; Independent Cancer Taskforce, ACH WORLD CLASS CANC; Knai C, 2015, ADDICTION, V110, P1232, DOI 10.1111/add.12855; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Liver Care NHS, 2013, GETT IT RIGHT IMPR E; Long MW, 2015, AM J PREV MED, V49, P112, DOI 10.1016/j.amepre.2015.03.004; Mattes R, 2014, AM J CLIN NUTR, V100, P1663, DOI 10.3945/ajcn.114.096883; McPherson S, 2010, GUT, V59, P1265, DOI 10.1136/gut.2010.216077; Meredith P, 2014, GUT, V63, pA25, DOI 10.1136/gutjnl-2014-307263.52; National Cancer Intelligence Network, 2012, NCIN INF S; National Confidential Enquiry into Patient Outcome and Death, 2015, GASTR HAEM TIM GET C; National End of Life Intelligence Network, 2012, DEATHS LIVER DIS IMP; National Institute for Clinical Excellence, 2015, SOF TREAT CHRON HEP; National Institute for Health and Care Excellence, 2012, NICE CLIN GUID 141 A; NHS Health Scotland, 2014, MON EV SCOTL ALC STR; OECD, 2015, TACKLING HARMFUL ALC; Office for National Statistics, 2012, DEATHS REG ENGL WAL; Public Health England, INFL VACC UPT GP PAT; Public Health England, 2013, IMM INF DIS GREEN BO; Public Health Wales, 2015, ALC BRIEF INT WORK H; Royal College of Radiologists, 2014, INT RAD PROV 2014 SU; Schmidt WP, 2010, EUROSURVEILLANCE, V15, P4; Scottish Government, SEX HLTH BL IN PRESS; Scottish Health Action on Alcohol Problems, 2015, NEW ALC RES UK ED GL; Stockwell T, 2013, ADDICTION, V108, P1172, DOI 10.1111/add.12178; Stockwell Tim, 2012, Am J Public Health, V102, pe103, DOI 10.2105/AJPH.2012.301094; Swinburn B, 2015, LANCET, V385, P2534, DOI 10.1016/S0140-6736(14)61747-5; The Children's Future Fund, FOOD DUT COULD MON P; The Royal College of Radiologists, 2015, CANC TASKF SUBM ROYA; Webb GJ, 2015, CLIN MED, V15, P139, DOI 10.7861/clinmedicine.15-2-139; Welsh Government, 2014, MOD BAS APPR MIN UN; Welsh Government, 2015, TOG HLTH LIV DIS DEL; WHO, 2011, SCAL ACT NONC DIS MU; Williams R, 2014, LANCET, V384, P1953, DOI 10.1016/S0140-6736(14)61838-9; Zhao JH, 2013, ADDICTION, V108, P1059, DOI 10.1111/add.12139	65	52	53	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 21	2015	386	10008					2098	2111		10.1016/S0140-6736(15)00680-7	http://dx.doi.org/10.1016/S0140-6736(15)00680-7			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CX8XF	26700394	Green Published			2022-12-28	WOS:000365987600031
J	Barreto, PD; Rolland, Y				Barreto, Philipe de Souto; Rolland, Yves			Happiness and unhappiness have no direct effect on mortality	LANCET			English	Editorial Material							CORONARY-HEART-DISEASE; HEALTH		[Barreto, Philipe de Souto; Rolland, Yves] CHU Toulouse, Univ Hosp Toulouse, Inst Ageing, Gerontopole Toulouse, F-31000 Toulouse, France; [Barreto, Philipe de Souto; Rolland, Yves] Univ Toulouse 3, UMR INSERM 1027, F-31062 Toulouse, France; [Barreto, Philipe de Souto] Aix Marseille Univ, ADES, CNRS UMR 7268, Marseille, France	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Bordeaux-Montaigne; UDICE-French Research Universities; Aix-Marseille Universite	Barreto, PD (corresponding author), CHU Toulouse, Univ Hosp Toulouse, Inst Ageing, Gerontopole Toulouse, F-31000 Toulouse, France.; Barreto, PD (corresponding author), Univ Toulouse 3, UMR INSERM 1027, F-31062 Toulouse, France.; Barreto, PD (corresponding author), Aix Marseille Univ, ADES, CNRS UMR 7268, Marseille, France.	philipebarreto81@yahoo.com.br	de Souto Barreto, Philipe/A-8426-2018	de Souto Barreto, Philipe/0000-0002-8860-425X				Chida Y, 2008, PSYCHOSOM MED, V70, P741, DOI 10.1097/PSY.0b013e31818105ba; Collins AL, 2008, J GERONTOL B-PSYCHOL, V63, pP321, DOI 10.1093/geronb/63.6.P321; Davidson KW, 2010, EUR HEART J, V31, P1065, DOI 10.1093/eurheartj/ehp603; Diener E, 2011, APPL PSYCHOL-HLTH WE, V3, P1, DOI 10.1111/j.1758-0854.2010.01045.x; King LA, 1998, J PERS SOC PSYCHOL, V75, P156, DOI 10.1037/0022-3514.75.1.156; Koivumaa-Honkanen H, 2000, AM J EPIDEMIOL, V152, P983, DOI 10.1093/aje/152.10.983; Liu B., 2015, LANCET; Lyubomirsky S, 2011, EMOTION, V11, P391, DOI 10.1037/a0022575; Pinquart M, 2001, J GERONTOL B-PSYCHOL, V56, pP195, DOI 10.1093/geronb/56.4.P195; Ryan RM, 2001, ANNU REV PSYCHOL, V52, P141, DOI 10.1146/annurev.psych.52.1.141; Shirai K, 2009, CIRCULATION, V120, P956, DOI 10.1161/CIRCULATIONAHA.108.834176; Tindle HA, 2009, CIRCULATION, V120, P656, DOI 10.1161/CIRCULATIONAHA.108.827642; Veenhoven R, 2008, J HAPPINESS STUD, V9, P449, DOI 10.1007/s10902-006-9042-1	13	2	2	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	2016	387	10021					822	823		10.1016/S0140-6736(15)01222-2	http://dx.doi.org/10.1016/S0140-6736(15)01222-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DE9RA	26684610	hybrid			2022-12-28	WOS:000370974400005
J	Byrd, JC; Harrington, B; O'Brien, S; Jones, JA; Schuh, A; Devereux, S; Chaves, J; Wierda, WG; Awan, FT; Brown, JR; Hillmen, P; Stephens, DM; Ghia, P; Barrientos, JC; Pagel, JM; Woyach, J; Johnson, D; Huang, J; Wang, X; Kaptein, A; Lannutti, BJ; Covey, T; Fardis, M; McGreivy, J; Hamdy, A; Rothbaum, W; Izumi, R; Diacovo, TG; Johnson, AJ; Furman, RR				Byrd, John C.; Harrington, Bonnie; O'Brien, Susan; Jones, Jeffrey A.; Schuh, Anna; Devereux, Steve; Chaves, Jorge; Wierda, William G.; Awan, Farrukh T.; Brown, Jennifer R.; Hillmen, Peter; Stephens, Deborah M.; Ghia, Paolo; Barrientos, Jacqueline C.; Pagel, John M.; Woyach, Jennifer; Johnson, Dave; Huang, Jane; Wang, Xiaolin; Kaptein, Allard; Lannutti, Brian J.; Covey, Todd; Fardis, Maria; McGreivy, Jesse; Hamdy, Ahmed; Rothbaum, Wayne; Izumi, Raquel; Diacovo, Thomas G.; Johnson, Amy J.; Furman, Richard R.			Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TYROSINE KINASE INHIBITOR; B-CELL RECEPTOR; X-LINKED AGAMMAGLOBULINEMIA; OPEN-LABEL; IN-VIVO; IBRUTINIB; BTK; PCI-32765; ACTIVATION; LYMPHOMA	BACKGROUND Irreversible inhibition of Bruton's tyrosine kinase (BTK) by ibrutinib represents an important therapeutic advance for the treatment of chronic lymphocytic leukemia (CLL). However, ibrutinib also irreversibly inhibits alternative kinase targets, which potentially compromises its therapeutic index. Acalabrutinib (ACP-196) is a more selective, irreversible BTK inhibitor that is specifically designed to improve on the safety and efficacy of first-generation BTK inhibitors. METHODS In this uncontrolled, phase 1-2, multicenter study, we administered oral acalabrutinib to 61 patients who had relapsed CLL to assess the safety, efficacy, pharmacokinetics, and pharmacodynamics of acalabrutinib. Patients were treated with acalabrutinib at a dose of 100 to 400 mg once daily in the dose-escalation (phase 1) portion of the study and 100 mg twice daily in the expansion (phase 2) portion. RESULTS The median age of the patients was 62 years, and patients had received a median of three previous therapies for CLL; 31% had chromosome 17p13.1 deletion, and 75% had unmutated immunoglobulin heavy-chain variable genes. No dose-limiting toxic effects occurred during the dose-escalation portion of the study. The most common adverse events observed were headache (in 43% of the patients), diarrhea (in 39%), and increased weight (in 26%). Most adverse events were of grade 1 or 2. At a median follow-up of 14.3 months, the overall response rate was 95%, including 85% with a partial response and 10% with a partial response with lymphocytosis; the remaining 5% of patients had stable disease. Among patients with chromosome 17p13.1 deletion, the overall response rate was 100%. No cases of Richter's transformation (CLL that has evolved into large-cell lymphoma) and only one case of CLL progression have occurred. CONCLUSIONS In this study, the selective BTK inhibitor acalabrutinib had promising safety and efficacy profiles in patients with relapsed CLL, including those with chromosome 17p13.1 deletion.	[Byrd, John C.; Jones, Jeffrey A.; Awan, Farrukh T.; Woyach, Jennifer; Johnson, Amy J.] Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA; [Harrington, Bonnie] Coll Vet Med, Dept Vet Biosci, Columbus, OH USA; [O'Brien, Susan] Univ Calif Irvine, UC Irvine Hlth Chao Family Comprehens Canc Ctr, Orange, CA USA; [Schuh, Anna] Univ Oxford, Oxford, England; [Devereux, Steve] Kings Coll Hosp London, NHS Fdn Trust, London, England; [Hillmen, Peter] St James Univ Hosp, Dept Haematol, Leeds, W Yorkshire, England; [Chaves, Jorge] Northwest Med Specialties, Tacoma, WA USA; [Pagel, John M.] Swedish Canc Inst, Seattle, WA USA; [Wierda, William G.] Univ Texas Houston, Div Canc Med, Dept Leukemia, Houston, TX USA; [Wierda, William G.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Brown, Jennifer R.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Stephens, Deborah M.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [Ghia, Paolo] Univ Vita Salute San Raffaele, Milan, Italy; [Ghia, Paolo] Ist Sci San Raffaele, Milan, Italy; [Barrientos, Jacqueline C.] Hofstra North Shore LIJ Sch Med, Chron Lymphocyt Leukemia Res & Treatment Ctr, Lake Success, NY USA; [Diacovo, Thomas G.] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY USA; [Furman, Richard R.] Weill Cornell Med Ctr, New York Presbyterian, New York, NY USA; [Johnson, Dave; Huang, Jane; Wang, Xiaolin; Kaptein, Allard; Lannutti, Brian J.; Covey, Todd; Fardis, Maria; McGreivy, Jesse; Hamdy, Ahmed; Rothbaum, Wayne; Izumi, Raquel] Acerta Pharma, Oss, Netherlands	University System of Ohio; Ohio State University; University of California System; University of California Irvine; University of Oxford; King's College Hospital NHS Foundation Trust; King's College Hospital; Oxford University Hospitals NHS Foundation Trust; Saint James's University Hospital; Swedish Cancer Institute; Swedish Medical Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Dana-Farber Cancer Institute; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Hofstra University; Northwell Health; Columbia University; Cornell University; NewYork-Presbyterian Hospital	Byrd, JC (corresponding author), B302 Starling Loving Hall,320 W 10th Ave, Columbus, OH 43210 USA.	john.byrd@osumc.edu	Barrientos, Jacqueline/AAE-6683-2022; Jones, Jeffrey A/E-3321-2011; Woyach, Jennifer Ann/F-1087-2015; Awan, Farrukh/L-5642-2016; Ghia, Paolo/K-7138-2016; Devereux, Stephen/B-4766-2009	Awan, Farrukh/0000-0003-1813-9812; Ghia, Paolo/0000-0003-3750-7342; Devereux, Stephen/0000-0002-8046-0386; Stephens, Deborah/0000-0001-9188-5008; Harrington, Bonnie/0000-0003-2658-6188; Anna, schuh/0000-0002-3938-8490	Acerta Pharma; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD081281] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R35CA197734, R01CA177292, R01CA197870, R01CA159296, P30CA016058, P01CA081534, R01CA169162, K23CA178183, T32CA009338, P01CA095426] Funding Source: NIH RePORTER	Acerta Pharma; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by the Acerta Pharma and others; ClinicalTrials.gov number, NCT02029443.	Atkinson BT, 2003, BLOOD, V102, P3592, DOI 10.1182/blood-2003-04-1142; Brown J, 2013, 55 ANN M AM SOC HEM; Byrd JC, 2014, NEW ENGL J MED, V371, P213, DOI 10.1056/NEJMoa1400376; Chen JC, 2008, NAT BIOTECHNOL, V26, P114, DOI 10.1038/nbt1373; de Jong J, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.156; de Rooij MFM, 2012, BLOOD, V119, P2590, DOI 10.1182/blood-2011-11-390989; Dubovsky JA, 2013, BLOOD, V122, P2539, DOI 10.1182/blood-2013-06-507947; Evans EK, 2013, J PHARMACOL EXP THER, V346, P219, DOI 10.1124/jpet.113.203489; Gardner HL, 2014, AM ASS CANC RES ANN; Goede V, 2014, NEW ENGL J MED, V370, P1101, DOI 10.1056/NEJMoa1313984; Hallek M, 2010, LANCET, V376, P1164, DOI 10.1016/S0140-6736(10)61381-5; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Hamazaki Y, 1998, ONCOGENE, V16, P2773, DOI 10.1038/sj.onc.1201799; Herishanu Y, 2011, BLOOD, V117, P563, DOI 10.1182/blood-2010-05-284984; Herman SEM, 2011, BLOOD, V117, P6287, DOI 10.1182/blood-2011-01-328484; Honigberg LA, 2010, P NATL ACAD SCI USA, V107, P13075, DOI 10.1073/pnas.1004594107; Jain P, 2015, BLOOD, V125, P2062, DOI 10.1182/blood-2014-09-603670; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kil LP, 2013, AM J BLOOD RES, V3, P71; Lynch TJ, 2007, ONCOLOGIST, V12, P610, DOI 10.1634/theoncologist.12-5-610; Maddocks KJ, 2015, JAMA ONCOL, V1, P80, DOI 10.1001/jamaoncol.2014.218; Neffendorf JE, 2013, NEW ENGL J MED, V369, P1277, DOI 10.1056/NEJMc1309710; O'Brien S, 2014, LANCET ONCOL, V15, P48, DOI 10.1016/S1470-2045(13)70513-8; Ponader S, 2012, BLOOD, V119, P1182, DOI 10.1182/blood-2011-10-386417; Quiroga MP, 2009, BLOOD, V114, P1029, DOI 10.1182/blood-2009-03-212837; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; SAFFRAN DC, 1994, NEW ENGL J MED, V330, P1488, DOI 10.1056/NEJM199405263302104; Wang ML, 2013, NEW ENGL J MED, V369, P507, DOI 10.1056/NEJMoa1306220; Wilson WH, 2015, NAT MED, V21, P922, DOI 10.1038/nm.3884; Woyach JA, 2014, NEW ENGL J MED, V370, P2286, DOI 10.1056/NEJMoa1400029; Woyach JA, 2014, BLOOD, V123, P1207, DOI 10.1182/blood-2013-07-515361; ZHU QL, 1994, HUM MOL GENET, V3, P1899, DOI 10.1093/hmg/3.10.1899	32	640	664	5	98	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 28	2016	374	4					323	332		10.1056/NEJMoa1509981	http://dx.doi.org/10.1056/NEJMoa1509981			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB8IJ	26641137	Green Accepted			2022-12-28	WOS:000368760100006
J	Hagen, C; Dent, KC; Zeev-Ben-Mordehai, T; Grange, M; Bosse, JB; Whittle, C; Klupp, BG; Siebert, CA; Vasishtan, D; Bauerlein, FJB; Cheleski, J; Werner, S; Guttmann, P; Rehbein, S; Henzler, K; Demmerle, J; Adler, B; Koszinowski, U; Schermelleh, L; Schneider, G; Enquist, LW; Plitzko, JM; Mettenleiter, TC; Grunewald, K				Hagen, Christoph; Dent, Kyle C.; Zeev-Ben-Mordehai, Tzviya; Grange, Michael; Bosse, Jens B.; Whittle, Cathy; Klupp, Barbara G.; Siebert, C. Alistair; Vasishtan, Daven; Baeuerlein, Felix J. B.; Cheleski, Juliana; Werner, Stephan; Guttmann, Peter; Rehbein, Stefan; Henzler, Katja; Demmerle, Justin; Adler, Barbara; Koszinowski, Ulrich; Schermelleh, Lothar; Schneider, Gerd; Enquist, Lynn W.; Plitzko, Juergen M.; Mettenleiter, Thomas C.; Gruenewald, Kay			Structural Basis of Vesicle Formation at the Inner Nuclear Membrane	CELL			English	Article							SIMPLEX-VIRUS 1; EGRESS COMPLEX; PORE COMPLEX; PROTEIN; FLUORESCENCE; ENVELOPMENT; TOMOGRAPHY; MICROSCOPY; MECHANISM; TRANSPORT	Vesicular nucleo-cytoplasmic transport is becoming recognized as a general cellular mechanism for translocation of large cargoes across the nuclear envelope. Cargo is recruited, enveloped at the inner nuclear membrane (INM), and delivered by membrane fusion at the outer nuclear membrane. To understand the structural underpinning for this trafficking, we investigated nuclear egress of progeny herpesvirus capsids where capsid envelopment is mediated by two viral proteins, forming the nuclear egress complex (NEC). Using a multi-modal imaging approach, we visualized the NEC in situ forming coated vesicles of defined size. Cellular electron cryo-tomography revealed a protein layer showing two distinct hexagonal lattices at its membrane-proximal and membrane-distant faces, respectively. NEC coat architecture was determined by combining this information with integrative modeling using small-angle X-ray scattering data. The molecular arrangement of the NEC establishes the basic mechanism for budding and scission of tailored vesicles at the INM.	[Hagen, Christoph; Dent, Kyle C.; Zeev-Ben-Mordehai, Tzviya; Grange, Michael; Whittle, Cathy; Siebert, C. Alistair; Vasishtan, Daven; Cheleski, Juliana; Gruenewald, Kay] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford Particle Imaging Ctr, Div Struct Biol, Oxford OX3 7BN, England; [Dent, Kyle C.] Diamond Light Source Ltd, Didcot OX11 0DE, Oxon, England; [Bosse, Jens B.; Enquist, Lynn W.] Princeton Univ, Princeton Neurosci Inst, Dept Mol Biol, Princeton, NJ 08544 USA; [Klupp, Barbara G.; Mettenleiter, Thomas C.] Friedrich Loeffler Inst, Inst Mol Virol & Cell Biol, D-17493 Greifswald, Germany; [Baeuerlein, Felix J. B.; Plitzko, Juergen M.] Max Planck Inst Biochem, Dept Mol Struct Biol, D-82152 Martinsried, Germany; [Werner, Stephan; Guttmann, Peter; Rehbein, Stefan; Henzler, Katja; Schneider, Gerd] Helmholtz Zentrum Berlin Mat & Energie GmbH, D-12489 Berlin, Germany; [Demmerle, Justin; Schermelleh, Lothar] Univ Oxford, Dept Biochem, Micron Oxford, Oxford OX1 3QU, England; [Adler, Barbara; Koszinowski, Ulrich] Univ Munich, Max Von Pettenkofer Inst, D-80336 Munich, Germany	University of Oxford; Wellcome Centre for Human Genetics; Diamond Light Source; Princeton University; Friedrich Loeffler Institute; Max Planck Society; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); University of Oxford; University of Munich	Mettenleiter, TC (corresponding author), Friedrich Loeffler Inst, Inst Mol Virol & Cell Biol, D-17493 Greifswald, Germany.	thomas.mettenleiter@fli.bund.de; kay@strubi.ox.ac.uk	Mettenleiter, h. c. Thomas C./U-1016-2019; Bosse, Jens Bernhard/D-7336-2011; Grünewald, Kay/AAW-3652-2020; Hagen, Christoph/B-5025-2010; Grange, Michael/AAM-2499-2021; Cheleski, Juliana/K-5591-2013; Demmerle, Justin/B-1539-2016; Schermelleh, Lothar/H-4588-2019; Zeev-Ben-Mordehai, Tzviya/AAD-3270-2021; Plitzko, Juergen M/H-9576-2014; Zeev-Ben-Mordehai, Tzviya/D-7112-2014; Bäuerlein, Felix JB/B-9909-2012; Guttmann, Peter/H-9869-2015	Bosse, Jens Bernhard/0000-0001-7252-5541; Grünewald, Kay/0000-0002-4788-2691; Hagen, Christoph/0000-0003-0327-3744; Demmerle, Justin/0000-0002-4005-1705; Schermelleh, Lothar/0000-0002-1612-9699; Zeev-Ben-Mordehai, Tzviya/0000-0002-2571-550X; Plitzko, Juergen M/0000-0002-6402-8315; Zeev-Ben-Mordehai, Tzviya/0000-0002-2571-550X; Bäuerlein, Felix JB/0000-0002-8889-7371; Guttmann, Peter/0000-0002-0534-238X; Siebert, charles/0000-0002-8126-1979; Grange, Michael/0000-0003-2580-2299; Schneider, Gerd/0000-0001-9448-0524	Wellcome Trust [090895/Z/09/Z, 060208/Z/00/Z, 093305/Z/10/Z, 090532/Z/09/Z, 091911]; German Research Council [DFG GR1990/2, DFG Me 854/12-1]; Leverhulme Trust [RPG-2012-519]; Sao Paulo Research Foundation Fellowship [Fapesp 2013/24972-1]; DFG Fellowship [BO 4158/1-1]; European Community [283570, 226716]	Wellcome Trust(Wellcome TrustEuropean Commission); German Research Council(German Research Foundation (DFG)); Leverhulme Trust(Leverhulme Trust); Sao Paulo Research Foundation Fellowship; DFG Fellowship(German Research Foundation (DFG)); European Community(European Commission)	We thank Wolfram Antonin (Tubingen) for critical discussion and Marion Jasnin, Tim Laugks, Miroslava Schaffer, and Margarete Schuler for help with cryo-FIB in Martinsried. This work was supported by a Wellcome Trust Senior Research Fellowship to K.G. (090895/Z/09/Z), German Research Council grants DFG GR1990/2 to K.G. and DFG Me 854/12-1 to T.C.M., a Leverhulme Trust grant to K.G. (RPG-2012-519), a Wellcome Trust JIF award (060208/Z/00/Z) and a Wellcome Trust equipment grant (093305/Z/10/Z) to the Oxford Particle Imaging Centre, the Wellcome Trust core award 090532/Z/09/Z to the Wellcome Trust Centre for Human Genetics, the Wellcome Trust Strategic Award 091911 supporting advanced microscopy at Micron Oxford, a Wellcome Trust PhD studentship to M.G., a Sao Paulo Research Foundation Fellowship to J.C. (Fapesp 2013/24972-1), and a DFG Fellowship BO 4158/1-1 to J.B.B. We acknowledge the Helmholtz-Zentrum Berlin electron storage ring BESSY II for provision of synchrotron radiation at beamline U41-FSGM. The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under Bio-Struct- X (Grant agreement nos. 283570 and 226716).	Abroi A, 2011, BIOESSAYS, V33, P626, DOI 10.1002/bies.201000126; Bigalke JM, 2015, EMBO J, V34, P2921, DOI 10.15252/embj.201592359; Bigalke JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5131; Briggs JAG, 2013, CURR OPIN STRUC BIOL, V23, P261, DOI 10.1016/j.sbi.2013.02.003; Brown RSH, 2014, P NATL ACAD SCI USA, V111, pE4822, DOI 10.1073/pnas.1415271111; Desai P, 1998, J VIROL, V72, P7563, DOI 10.1128/JVI.72.9.7563-7568.1998; Dubochet J, 2012, J MICROSC-OXFORD, V245, P221, DOI 10.1111/j.1365-2818.2011.03569.x; Forterre P, 2013, CURR OPIN VIROL, V3, P558, DOI 10.1016/j.coviro.2013.06.013; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Funk C, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004957; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Hagen C, 2008, J MICROSC-OXFORD, V230, P288, DOI 10.1111/j.1365-2818.2008.01987.x; Hagen C, 2012, J STRUCT BIOL, V177, P193, DOI 10.1016/j.jsb.2011.12.012; Hatch E, 2014, J CELL BIOL, V205, P133, DOI 10.1083/jcb.201402003; Hoenger A, 2014, PROTOPLASMA, V251, P417, DOI 10.1007/s00709-013-0600-1; Jokhi V, 2013, CELL REP, V3, P988, DOI 10.1016/j.celrep.2013.03.015; Karreman MA, 2011, TRAFFIC, V12, P806, DOI 10.1111/j.1600-0854.2011.01199.x; Klupp BG, 2007, P NATL ACAD SCI USA, V104, P7241, DOI 10.1073/pnas.0701757104; Leigh KE, 2015, P NATL ACAD SCI USA, V112, P9010, DOI 10.1073/pnas.1511140112; Lorenz M, 2015, J BIOL CHEM, V290, P6962, DOI 10.1074/jbc.M114.627521; Loret S, 2008, J VIROL, V82, P8605, DOI 10.1128/JVI.00904-08; Lucic V, 2005, ANNU REV BIOCHEM, V74, P833, DOI 10.1146/annurev.biochem.73.011303.074112; Lye MF, 2015, EMBO J, V34, P2937, DOI 10.15252/embj.201592651; Marko M, 2007, NAT METHODS, V4, P215, DOI 10.1038/nmeth1014; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; McCullough J, 2014, NAT STRUCT MOL BIOL, V21, P1025, DOI 10.1038/nsmb.2928; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Mettenleiter TC, 2013, CELL MICROBIOL, V15, P170, DOI 10.1111/cmi.12044; Mou F, 2009, J VIROL, V83, P5181, DOI 10.1128/JVI.00090-09; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308; Rigort A, 2012, P NATL ACAD SCI USA, V109, P4449, DOI 10.1073/pnas.1201333109; Rose A, 2012, TRENDS CELL BIOL, V22, P509, DOI 10.1016/j.tcb.2012.07.003; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; Sharma M, 2015, J VIROL, V89, P523, DOI 10.1128/JVI.02426-14; Sosa BA, 2014, ELIFE, V3, DOI 10.7554/eLife.03239; Speese SD, 2012, CELL, V149, P832, DOI 10.1016/j.cell.2012.03.032; Strauss MP, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001389; Sundquist WI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006924; Walzer SA, 2015, J BIOL CHEM, V290, P27452, DOI 10.1074/jbc.C115.686527; Webster BM, 2014, CELL, V159, P388, DOI 10.1016/j.cell.2014.09.012; Wild P, 2015, VIRUSES-BASEL, V7, P52, DOI 10.3390/v7010052; Zeev-Ben-Mordehai T, 2015, CELL REP, V13, P2645, DOI 10.1016/j.celrep.2015.11.008	44	126	132	1	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2015	163	7					1692	1701		10.1016/j.cell.2015.11.029	http://dx.doi.org/10.1016/j.cell.2015.11.029			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CZ1GN	26687357	Green Published, hybrid			2022-12-28	WOS:000366854200016
J	Kjeldsen, KK; Korsgaard, NJ; Bjork, AA; Khan, SA; Box, JE; Funder, S; Larsen, NK; Bamber, JL; Colgan, W; van den Broeke, M; Siggaard-Andersen, ML; Nuth, C; Schomacker, A; Andresen, CS; Willerslev, E; Kjaer, KH				Kjeldsen, Kristian K.; Korsgaard, Niels J.; Bjork, Anders A.; Khan, Shfaqat A.; Box, Jason E.; Funder, Svend; Larsen, Nicolaj K.; Bamber, Jonathan L.; Colgan, William; van den Broeke, Michiel; Siggaard-Andersen, Marie-Louise; Nuth, Christopher; Schomacker, Anders; Andresen, Camilla S.; Willerslev, Eske; Kjaer, Kurt H.			Spatial and temporal distribution of mass loss from the Greenland Ice Sheet since AD 1900	NATURE			English	Article							GLACIER; DISCHARGE; MARGINS; ORIGIN	The response of the Greenland Ice Sheet (GIS) to changes in temperature during the twentieth century remains contentious(1), largely owing to difficulties in estimating the spatial and temporal distribution of ice mass changes before 1992, when Greenland-wide observations first became available(2). The only previous estimates of change during the twentieth century are based on empirical modelling(3-5) and energy balance modelling(6,7). Consequently, no observation-based estimates of the contribution from the GIS to the global-mean sea level budget before 1990 are included in the Fifth Assessment Report of the Intergovernmental Panel on Climate Change(8). Here we calculate spatial ice mass loss around the entire GIS from 1900 to the present using aerial imagery from the 1980s. This allows accurate high-resolution mapping of geomorphic features related to the maximum extent of the GIS during the Little Ice Age(9) at the end of the nineteenth century. We estimate the total ice mass loss and its spatial distribution for three periods: 1900-1983 (75.1 +/- 29.4 gigatonnes per year), 1983-2003 (73.8 +/- 40.5 gigatonnes per year), and 2003-2010 (186.4 +/- 18.9 gigatonnes per year). Furthermore, using two surface mass balance models(10,11) we partition the mass balance into a term for surface mass balance (that is, total precipitation minus total sublimation minus runoff) and a dynamic term. We find that many areas currently undergoing change are identical to those that experienced considerable thinning throughout the twentieth century. We also reveal that the surface mass balance term shows a considerable decrease since 2003, whereas the dynamic term is constant over the past 110 years. Overall, our observation-based findings show that during the twentieth century the GIS contributed at least 25.0 +/- 9.4 millimetres of global-mean sea level rise. Our result will help to close the twentieth-century sea level budget, which remains crucial for evaluating the reliability of models used to predict global sea level rise(1,8).	[Kjeldsen, Kristian K.; Korsgaard, Niels J.; Bjork, Anders A.; Funder, Svend; Larsen, Nicolaj K.; Siggaard-Andersen, Marie-Louise; Schomacker, Anders; Willerslev, Eske; Kjaer, Kurt H.] Univ Copenhagen, Ctr GeoGenet, Nat Hist Museum, DK-1350 Copenhagen, Denmark; [Kjeldsen, Kristian K.] Univ Ottawa, Dept Earth Sci, Ottawa, ON K1N 6N5, Canada; [Khan, Shfaqat A.] Tech Univ Denmark, Dept Geodesy, DTU Space Natl Space Inst, DK-2800 Lyngby, Denmark; [Box, Jason E.; Colgan, William; Andresen, Camilla S.] Geol Survey Denmark & Greenland, Dept Marine Geol & Glaciol, DK-1350 Copenhagen, Denmark; [Larsen, Nicolaj K.] Aarhus Univ, Dept Geosci, DK-8000 Aarhus, Denmark; [Bamber, Jonathan L.] Univ Bristol, Bristol Glaciol Ctr, Bristol BS8 1SS, Avon, England; [Colgan, William] York Univ, Dept Earth & Space Sci & Engn, Toronto, ON M3J 1P3, Canada; [van den Broeke, Michiel] Univ Utrecht, Inst Marine & Atmospher Res, NL-80005 Utrecht, Netherlands; [Andresen, Camilla S.] Univ Oslo, Dept Geosci, N-0316 Oslo, Norway	University of Copenhagen; University of Ottawa; Technical University of Denmark; Geological Survey Of Denmark & Greenland; Aarhus University; University of Bristol; York University - Canada; Utrecht University; University of Oslo	Kjaer, KH (corresponding author), Univ Copenhagen, Ctr GeoGenet, Nat Hist Museum, DK-1350 Copenhagen, Denmark.	kurtk@snm.ku.dk	Van den Broeke, Michiel R./F-7867-2011; Bjørk, Anders/B-1625-2013; Box, Jason E/AAE-1654-2019; Kjeldsen, Kristian Kjellerup/A-9592-2013; Box, Jason/H-5770-2013; Andresen, Camilla S./G-2718-2013; Schomacker, Anders/I-6569-2019; Willerslev, Eske/A-9619-2011; Khan, Shfaqat A/B-2664-2012; Bamber, Jonathan/C-7608-2011; Willerslev, Eske/AAA-5686-2019; Larsen, Nicolaj K./A-3509-2012; Khan, Shfaqat Abbas/AAP-6627-2021; Colgan, William/H-1570-2014; Korsgaard, Niels Jákup/D-8256-2013; Kjaer, Kurt/A-4199-2013	Van den Broeke, Michiel R./0000-0003-4662-7565; Bjørk, Anders/0000-0002-4919-792X; Box, Jason E/0000-0003-0052-8705; Kjeldsen, Kristian Kjellerup/0000-0002-8557-5131; Box, Jason/0000-0003-0052-8705; Schomacker, Anders/0000-0002-8031-9008; Willerslev, Eske/0000-0002-7081-6748; Khan, Shfaqat A/0000-0002-2689-8563; Bamber, Jonathan/0000-0002-2280-2819; Larsen, Nicolaj K./0000-0002-0117-1106; Khan, Shfaqat Abbas/0000-0002-2689-8563; Colgan, William/0000-0001-6334-1660; Korsgaard, Niels Jákup/0000-0002-8700-7023; Nuth, Christopher/0000-0002-1063-2832; Andresen, Camilla S./0000-0002-5249-1812; Kjaer, Kurt/0000-0002-8871-5179	Danish Council for Independent Research (FNU) [DFF-0602-02526B, DFF-4181-00126]; Centre for GeoGenetics - Danish National Research Foundation [DNRF94]; Sapere Aude: DFF-Research Talent programme [DFF-4090-00151]; GeoCenter Denmark ("Multi-millennial ice volume changes of the Greenland ice sheet"); Carlsberg Foundation [CF14-0145]; Netherlands Polar Program of the Netherlands Organization of Scientific Research (NWO); European Research Council (EUFP7/ERC) [320816]; Natural Environment Research Council [NE/M000869/1] Funding Source: researchfish; Villum Fonden [00010100, 00007364] Funding Source: researchfish; NERC [NE/M000869/1] Funding Source: UKRI	Danish Council for Independent Research (FNU)(Det Frie Forskningsrad (DFF)Danish Natural Science Research Council); Centre for GeoGenetics - Danish National Research Foundation; Sapere Aude: DFF-Research Talent programme; GeoCenter Denmark ("Multi-millennial ice volume changes of the Greenland ice sheet"); Carlsberg Foundation(Carlsberg Foundation); Netherlands Polar Program of the Netherlands Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Research Council (EUFP7/ERC)(European Research Council (ERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Villum Fonden(Villum Fonden); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study would not have been possible without the aid of The Danish Geodata Agency (GST), who gave us access to their historical aerial photographs. This work is a part of the X_Centuries project funded by the Danish Council for Independent Research (FNU) (grant number DFF-0602-02526B) and the Centre for GeoGenetics supported by the Danish National Research Foundation (DNRF94). K.K.K. acknowledges support from the Danish Council for Independent Research (FNU) and the Sapere Aude: DFF-Research Talent programme (grant number DFF-4090-00151). J.E.B., K.H.K. and N.K.L. acknowledge support by the GeoCenter Denmark ("Multi-millennial ice volume changes of the Greenland ice sheet"). S.A.K. acknowledges supports from the Carlsberg Foundation (grant number CF14-0145) and the Danish Council for Independent Research (FNU) (grant number DFF-4181-00126). M.v.d.B. acknowledges support from the Netherlands Polar Program of the Netherlands Organization of Scientific Research (NWO). C.N. acknowledges support by the European Research Council (EUFP7/ERC grant number 320816). We thank A. J. Long, S. A. Woodroffe, B. M. Vinther, and R. Hurkmans for contribution during the early phase of this study.	Andersen ML, 2015, EARTH PLANET SC LETT, V409, P89, DOI 10.1016/j.epsl.2014.10.015; Arendt A., 2013, R GLACIER INVENTORY; Bamber J, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052552; Bjork AA, 2012, NAT GEOSCI, V5, P427, DOI [10.1038/NGEO1481, 10.1038/ngeo1481]; Blair B., 2010, ICEBRIDGE LVIS L2 GE; Box JE, 2013, J CLIMATE, V26, P6990, DOI 10.1175/JCLI-D-12-00546.1; Box JE, 2013, J CLIMATE, V26, P6974, DOI 10.1175/JCLI-D-12-00518.1; Box JE, 2013, J CLIMATE, V26, P3919, DOI 10.1175/JCLI-D-12-00373.1; Box JE, 2009, J CLIMATE, V22, P4029, DOI 10.1175/2009JCLI2816.1; Carrivick JL, 2012, J GLACIOL, V58, P1176, DOI 10.3189/2012JoG11J148; Church JA, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1137; Church JA, 2011, SURV GEOPHYS, V32, P585, DOI 10.1007/s10712-011-9119-1; Colgan W, 2015, ANN GLACIOL, V56, P105, DOI 10.3189/2015AoG70A967; Csatho B, 2008, J GLACIOL, V54, P131, DOI 10.3189/002214308784409035; Cuffey K. M., 2010, PHYS GLACIERS; Enderlin EM, 2014, GEOPHYS RES LETT, V41, P866, DOI 10.1002/2013GL059010; Ewert H, 2012, J GEODYN, V59-60, P111, DOI 10.1016/j.jog.2011.06.003; Glasser NF, 2011, NAT GEOSCI, V4, P303, DOI [10.1038/ngeo1122, 10.1038/NGEO1122]; Gregory JM, 2013, J CLIMATE, V26, P4476, DOI 10.1175/JCLI-D-12-00319.1; Hay CC, 2015, NATURE, V517, P481, DOI 10.1038/nature14093; Higgins A. K., 1990, POLARFORSCHUNG, V60, P1; Howat IM, 2007, SCIENCE, V315, P1559, DOI 10.1126/science.1138478; Howat IM, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034496; Hurkmans RTWL, 2014, CRYOSPHERE, V8, P1725, DOI 10.5194/tc-8-1725-2014; Jevrejeva S, 2014, GLOBAL PLANET CHANGE, V113, P11, DOI 10.1016/j.gloplacha.2013.12.004; Kaab A., 2005, REMOTE SENSING MOUNT; Khan SA, 2014, CRYOSPHERE, V8, P1497, DOI 10.5194/tc-8-1497-2014; Khan SA, 2015, REP PROG PHYS, V78, DOI 10.1088/0034-4885/78/4/046801; Khan SA, 2014, NAT CLIM CHANGE, V4, P292, DOI [10.1038/nclimate2161, 10.1038/NCLIMATE2161]; Kjaer KH, 2012, SCIENCE, V337, P569, DOI 10.1126/science.1220614; Kjeldsen KK, 2013, J GEOPHYS RES-SOL EA, V118, P698, DOI 10.1029/2012JB009684; Kobashi T, 2013, CLIM PAST, V9, P583, DOI 10.5194/cp-9-583-2013; Krabill W, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021533; Krabill WB, 2014, ICEBRIDGE ATM L2 ICE; Lea JM, 2014, J GLACIOL, V60, P333, DOI 10.3189/2014JoG13J163; Lecavalier BS, 2013, QUATERNARY SCI REV, V63, P73, DOI 10.1016/j.quascirev.2012.11.030; National Snow and Ice Data Center, 2011, ICESAT DESCR DAT REL; Nuth C, 2011, CRYOSPHERE, V5, P271, DOI 10.5194/tc-5-271-2011; PFEFFER WT, 1991, J GEOPHYS RES-OCEANS, V96, P22117, DOI 10.1029/91JC02502; Pritchard HD, 2009, NATURE, V461, P971, DOI 10.1038/nature08471; Rignot E, 2006, SCIENCE, V311, P986, DOI 10.1126/science.1121381; Rignot E, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051634; Rignot E, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046583; Rignot E, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035417; Sasgen I, 2012, EARTH PLANET SC LETT, V333, P293, DOI 10.1016/j.epsl.2012.03.033; Shepherd A, 2012, SCIENCE, V338, P1183, DOI 10.1126/science.1228102; Smith BE, 2009, J GLACIOL, V55, P573, DOI 10.3189/002214309789470879; van Angelen JH, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015485; van den Broeke M, 2009, SCIENCE, V326, P984, DOI 10.1126/science.1178176; VANDEWAL RSW, 1994, GLOBAL PLANET CHANGE, V9, P115, DOI 10.1016/0921-8181(94)90011-6; Wang WL, 2012, J GLACIOL, V58, P734, DOI 10.3189/2012JoG11J187; Weidick A., 2012, GEOL SURV DEN GREENL, V27, P1; Weidick A, 1994, GEOL GREENLAND SURV, V161, P73; Weidick B. A., 2001, MEDDELELSER GRONLAND, V39, P5; Yang L, 2011, PHYSCS PROC, V22, P292, DOI 10.1016/j.phpro.2011.11.046; Zuo Z, 1997, CLIM DYNAM, V13, P835, DOI 10.1007/s003820050200; Zwally H. J., 2011, GLAS ICESAT L2 ANTAR	57	157	159	2	142	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 17	2015	528	7582					396	+		10.1038/nature16183	http://dx.doi.org/10.1038/nature16183			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY8SM	26672555	Green Submitted			2022-12-28	WOS:000366678600052
J	Tian, P				Tian, Peng			THREE GIANTS TIGHTEN THEIR GRIP	NATURE			English	Editorial Material																			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2015	528	7582					S176	S178		10.1038/528S176a	http://dx.doi.org/10.1038/528S176a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY8SM	26673024	Bronze			2022-12-28	WOS:000366678600012
J	[Anonymous]				[Anonymous]			CHRISTMAS 2015: CALL TO ACTION Cover story: call to action figures	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 17	2015	351								h6890	10.1136/bmj.h6890	http://dx.doi.org/10.1136/bmj.h6890			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ4MS	26681343				2022-12-28	WOS:000367077900009
J	Kumar, PD				Kumar, P. Dileep			Review: Digoxin does not affect all-cause mortality but reduces hospital admissions	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Kumar, P. Dileep] McLaren Port Huron Hosp, Port Huron, MI 48060 USA		Kumar, PD (corresponding author), McLaren Port Huron Hosp, Port Huron, MI 48060 USA.							Centers for Medicare & Medicaid Services, 2014, READM RED PROGR; EWY GA, 1969, CIRCULATION, V39, P449, DOI 10.1161/01.CIR.39.4.449; Perry G, 1997, NEW ENGL J MED, V336, P525; Withering W, 1785, ACCOUNT FOXGLOVE SOM; Yancy CW, 2013, CIRCULATION, V128, P1810, DOI 10.1161/CIR.0b013e31829e8807	5	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	2015	163	12							JC11	10.7326/ACPJC-2015-163-12-011	http://dx.doi.org/10.7326/ACPJC-2015-163-12-011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY4BS	26666801				2022-12-28	WOS:000366354200011
J	Gornitzki, C; Larsson, A; Fadeel, B				Gornitzki, Carl; Larsson, Agne; Fadeel, Bengt			CHRISTMAS 2015: THE PUBLICATION GAME Freewheelin' scientists: citing Bob Dylan in the biomedical literature	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Gornitzki, Carl; Larsson, Agne] Karolinska Inst, Univ Lib, S-17177 Stockholm, Sweden; [Fadeel, Bengt] Karolinska Inst, Inst Environm Med, S-17177 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Gornitzki, C (corresponding author), Karolinska Inst, Univ Lib, S-17177 Stockholm, Sweden.	carl.gornitzki@ki.se	Larsson, Agne/B-1874-2017	Larsson, Agne/0000-0001-7488-9365; Gornitzki, Carl/0000-0001-6628-5879; Larsson, Agne/0000-0001-8709-5038				[Anonymous], 1975, BMJ-BRIT MED J, V3, P266; Colman W, 2013, J ANAL PSYCHOL, V58, P470, DOI 10.1111/1468-5922.12028; Davio E, 1970, J Pract Nurs, V20, P23; Feltman R, 2014, WASHINGTON POST; Lilja T, 2013, BBA-GEN SUBJECTS, V1830, P2354, DOI 10.1016/j.bbagen.2012.08.011; Lundberg JON, 1997, NAT MED, V3, P30, DOI 10.1038/nm0197-30; Meletis K, 2003, TRENDS NEUROSCI, V26, P292, DOI 10.1016/S0166-2236(03)00125-5; Michaels S, 2014, GUARDIAN; Shakespeare PG, 2002, BURNS, V28, P1, DOI 10.1016/S0305-4179(01)00118-8; Stepney R, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7179; Vogler F, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00246; Weitzberg E, 2011, J PHYSIOL-LONDON, V589, P5333, DOI 10.1113/jphysiol.2011.220673	12	6	6	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 14	2015	351								h6505	10.1136/bmj.h6505	http://dx.doi.org/10.1136/bmj.h6505			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ4KY	26666240				2022-12-28	WOS:000367073200012
J	Patel, V; Parikh, R; Nandraj, S; Balasubramaniam, P; Narayan, K; Paul, VK; Kumar, AKS; Chatterjee, M; Reddy, KS				Patel, Vikram; Parikh, Rachana; Nandraj, Sunil; Balasubramaniam, Priya; Narayan, Kavita; Paul, Vinod K.; Kumar, A. K. Shiva; Chatterjee, Mirai; Reddy, K. Srinath			Assuring health coverage for all in India	LANCET			English	Review							RISK-FACTORS; URBAN; CORRUPTION; CARE; PROGRAM; POVERTY; PATIENT; SYSTEM; YOJANA; DRUGS	Successive Governments of India have promised to transform India's unsatisfactory health-care system, culminating in the present government's promise to expand health assurance for all. Despite substantial improvements in some health indicators in the past decade, India contributes disproportionately to the global burden of disease, with health indicators that compare unfavourably with other middle-income countries and India's regional neighbours. Large health disparities between states, between rural and urban populations, and across social classes persist. A large proportion of the population is impoverished because of high out-of-pocket health-care expenditures and suffers the adverse consequences of poor quality of care. Here we make the case not only for more resources but for a radically new architecture for India's health-care system. India needs to adopt an integrated national health-care system built around a strong public primary care system with a clearly articulated supportive role for the private and indigenous sectors. This system must address acute as well as chronic health-care needs, off er choice of care that is rational, accessible, and of good quality, support cashless service at point of delivery, and ensure accountability through governance by a robust regulatory framework. In the process, several major challenges will need to be confronted, most notably the very low levels of public expenditure; the poor regulation, rapid commercialisation of and corruption in health care; and the fragmentation of governance of health care. Most importantly, assuring universal health coverage will require the explicit acknowledgment, by government and civil society, of health care as a public good on par with education. Only a radical restructuring of the health-care system that promotes health equity and eliminates impoverishment due to out-of-pocket expenditures will assure health for all Indians by 2022-a fitting way to mark the 75th year of India's independence.	[Patel, Vikram] London Sch Hyg & Trop Med, London WC1, England; [Patel, Vikram; Parikh, Rachana; Nandraj, Sunil; Balasubramaniam, Priya; Narayan, Kavita; Reddy, K. Srinath] Publ Hlth Fdn India, Gurgaon 122002, India; [Balasubramaniam, Priya] Publ Hlth Fdn India, New Delhi, India; [Balasubramaniam, Priya] Royal Norwegian Embassy Universal Hlth Initiat, New Delhi, India; [Paul, Vinod K.] All India Inst Med Sci, Dept Paediat, New Delhi, India; [Chatterjee, Mirai] Sewa, Ahmadabad, Gujarat, India; [Chatterjee, Mirai] VimoSEWA Cooperat, Ahmadabad, Gujarat, India; [Chatterjee, Mirai] Lok Swasthya Hlth Cooperat, Ahmadabad, Gujarat, India; [Reddy, K. Srinath] World Heart Federat, New Delhi, India	University of London; London School of Hygiene & Tropical Medicine; Public Health Foundation of India; Public Health Foundation of India; All India Institute of Medical Sciences (AIIMS) New Delhi	Patel, V (corresponding author), Publ Hlth Fdn India, Gurgaon 122002, India.	vikram.patel@lshtm.ac.uk	, 叶叶叶/ABE-1619-2020	Reddy, K Srinath/0000-0003-3416-3548; Parikh, Rachana/0000-0002-0761-5513	Wellcome Trust Principal Research Fellowship in Clinical Science	Wellcome Trust Principal Research Fellowship in Clinical Science(Wellcome Trust)	We thank Shivangini Kar, Vidhi Gupta, Sutirtha Mazumder, and Natasha D'Lima for their contributions to the section on human resources and drugs and technology; Indranil Mukhopadyay and Pallav Bhatt for their contributions to the section on health finance; and Binira Kansakar and Varada Madge for their contributions to the section on health information systems. Vikram Patel is supported by a Wellcome Trust Principal Research Fellowship in Clinical Science.	Acharya A, 2013, WORLD BANK RES OBSER, V28, P236, DOI 10.1093/wbro/lks009; Adsul Neha, 2013, Indian J Community Med, V38, P223, DOI 10.4103/0970-0218.120157; [Anonymous], 2013, DIABETES ATLAS; Bagcchi S, 2015, LANCET, V386, P1228, DOI 10.1016/S0140-6736(15)00315-3; Bagcchi S, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4813; Bagcchi S, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g4031; Berger D, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3169; Berman P., 2010, Economic and Political Weekly, V45, P65; Bhaumik S, 2012, LANCET, V380, P550, DOI 10.1016/S0140-6736(12)61313-0; Central Bureau of Health Intelligence, 2005, HLTH INFR NAT HLTH P; Central Bureau of Health Intelligence, 2015, NAT HLTH PROF 2015; Central Bureau of Health Intelligence, 2009, HLTH INFR NAT HLTH P; Chattopadhyay Subrata, 2013, Indian J Med Ethics, V10, P153; Confederation of Indian Industry and HOSMAC, 2011, HOSMAC CII WHIT PAP; D'Silva J, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4536; Das J, 2012, HEALTH AFFAIR, V31, P2774, DOI 10.1377/hlthaff.2011.1356; Department of Economic and Social Aff airs, 2011, SEX DIFF CHILDH MORT; Department of Pharmaceuticals, 2013, JAN AUSH SCHEM NEW B; Department of Science and Technology, 2006, MED DEV REG BILL 200; Devadasan N, 2013, HEALTH RES POLICY SY, V11, DOI 10.1186/1478-4505-11-29; Dror DM, 2012, INDIAN J MED RES, V135, P56, DOI 10.4103/0971-5916.93425; Ganesh S R, 2013, Indian J Public Health, V57, P43, DOI 10.4103/0019-557X.111376; Garg CC, 2009, HEALTH POLICY PLANN, V24, P116, DOI 10.1093/heapol/czn046; Gautham Meenakshi, 2011, Indian J Med Res, V134, P627, DOI 10.4103/0971-5916.90987; Global Health Data Exchange, 2019, GLOBAL BURDEN DIS ST; Global Health Watch, 2014, ALT WORLD HLTH REP U; Government of India, GUID JAN SHISH SUR K; Government of India, 2013, GAZETTE INDIA; Gudwani A, 2012, INDIA HEALTHCARE INS; Harikrishnan S, 2014, RACE TIME CHALLENGE; IIPS and Macro International, 2007, NATL FAMILY HLTH SUR, V1; Iyengar S, 2011, ACCESS RURAL POOR PR; Iyer M, 2015, TIMES INDIA; Jain A, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g4184; Jain K., HLTH INSURANCE INDIA; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Kay M, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4312; Krishnan A, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-310; Kumar S., 2003, BMJ-BRIT MED J, V326, P7379; LaForgia G, 2012, DIR DEV, P1, DOI 10.1596/978-0-8213-9618-6; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Malviya A, 2013, ONLINE J HLTH ALLIED, V12, P1; Marten R, 2014, LANCET, V384, P2164, DOI 10.1016/S0140-6736(14)60075-1; May C, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-182; Ministry of Finance, 2014, KEY FEAT BUDG 2014 2; Ministry of Finance, 2014, EC SURV 2013 14; Ministry of Finance, 2015, KEY FEAT BUDG 2015 1; Ministry of Health and Family Welfare, 2011, 5 COMM REV MISS REP; Ministry of Health and Family Welfare, FRAM IMPL NAT RUR HL; Ministry of Health and Family Welfare, 2012, 6 COMM REV MISS REP; Ministry of Health and Family Welfare, 2014, NAT HLTH POL 2015 DR; Ministry of Health and Family Welfare, 2015, UN HLTH MIN LAUNCH P; Ministry of Health and Family Welfare, 2010, 4 COMM REV MISS REP; Ministry of Health and Family Welfare, 2015, RUR HLTH STAT B 2015; Ministry of Health and Family Welfare Government of India, 2015, ALL HEALLTHC PROF CE; Ministry of Health and Family Welfare Government of India, 2015, Q NRHM MIS REP; Ministry of Health and Family Welfare Government of India, 2014, PRESS INFORM BU 1202; Ministry of Health and Family Welfare Government of India, 2014, PRESS INFORM BU 0718; Ministry of Skill Development and Entrepreneurship, 2015, MIN SKILL DEV ENTR S; Ministry of Women and Child Development, 2015, RAP SURV CHILDR 2013; Mishra A, 2012, BMC P, V6, pO17, DOI DOI 10.1186/1753-6561-6-S5-O17; Moreno-Serra R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001087; Mukhopadhyay I., 2013, STRATEGIC PUBLIC HLT; Mukhopadhyay I., 2015, THE HINDU BUSIN 0626; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Narayan K, 2012, PARAMEDICS ALLIED HL; National Crime Records Bureau, 2014, ACC DEATHS SUIC IND; National Health Mission, 2014, 5 YEARS 2009 2014 AC; National Sample Survey Office, 2015, KEY IND SOC CONS IND; National Sample Survey Organization, 2006, MORB HLTH CAR COND A; National Secretariat on Community Action-NRHM, 2010, REV HOP REAL RIGHTS; Office of Registrar General and Census Commissioner Government of India, POP EN DAT; Office of the Registrar General, 2013, VIT STAT IND BAS CIV; Office of the Registrar General & Census Commissioner India, 2011, CENSUS INDIA; Pandey A., 2010, DEMOGRAPHY INDIA, V39, P111; Pandey RM, 2013, INT J CARDIOL, V163, P157, DOI 10.1016/j.ijcard.2011.06.008; Patel V, 2013, EC POLIT WKLY, V48, P73; Patel V, 2012, LANCET, V379, P2343, DOI 10.1016/S0140-6736(12)60606-0; Patel V, 2011, LANCET, V377, P413, DOI 10.1016/S0140-6736(10)61188-9; Paul VK, 2014, INDIAN J PEDIATR, V81, P993, DOI 10.1007/s12098-013-1324-0; Perappadan BS, 2014, HINDU; Planning Commission of India, 2011, EV STUD NAT RUR HLTH; Planning commission of India, 2013, 12 5 YEAR PLAN 2012; Planning Commission of India, 2011, HIGH LEV EXP GROUP R; Powell Jackson T., 2013, EC POLIT WKLY, V48, P53; Prime Minister's Office, 2014, 3 NEW VACC INCL IND; Rao M. G., 2012, HLTH CARE FINANCING; Rao P., 2012, ASCI J MANAGE, V41, P14; Razak F, 2015, JAMA-J AM MED ASSOC, V314, P2164, DOI 10.1001/jama.2015.15666; Reddy KS, 2011, LANCET, V377, P760, DOI 10.1016/S0140-6736(10)61960-5; Registrar General and Census Commissioner, 2014, AHS 2 UPD B 2012 13; Registrar General of India, 2005, SRS B, V39; Registrar General of India, 2014, SRS B, V49; Registrar General of India, 2003, MAT MORT IND 1997 20; Registrar General of India, 2015, MAT MORT RAT B 2011; Reserve Bank of India, 2014, STAT FIN STUD BUDG 2; Selvaraj Sakthivel, 2012, ECON POLIT WEEKLY, V47, P61; Selveraj S, 2014, PUBLICLY FINANCED HL; Semwal V, 2013, INDAN J COMMUNITY HE, V25, P472; Sengupta A, 2005, BMJ-BRIT MED J, V331, P1157, DOI 10.1136/bmj.331.7526.1157; Sharma DC, 2015, LANCET, V386, P517, DOI 10.1016/S0140-6736(15)61462-3; Shepherd-Smith A, 2012, LANCET, V380, P874, DOI 10.1016/S0140-6736(12)61489-5; Soumitra Ghosh, 2011, Economic and Political Weekly, V46, P63; Sreeramareddy CT, 2014, INT J TUBERC LUNG D, V18, P255, DOI 10.5588/ijtld.13.0585; Sudhinaraset M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054978; Sundararaman T., 2015, Economic and Political Weekly, V50, P17; Sundararaman T, 2011, B WORLD HEALTH ORGAN, V89, P73, DOI 10.2471/BLT.09.070862; Sunita Reddy, 2013, Social Change, V43, P245, DOI 10.1177/0049085713492275; Swedish Agency for Growth Policy Analysis, 2013, IND HEALTHC SYST OV; The Gazette of India, 2012, GAZETTE INDIA; The Health Site, 2013, SUPR COURT STANDS FI; The Indian Institution of Public Administration, 2013, STRENGTH PANCH IND C; Travasso C, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4504; van Doorslaer E, 2006, LANCET, V368, P1357, DOI 10.1016/S0140-6736(06)69560-3; Vital Wave Consulting HIS, 2009, HLTH INFORM SYSTEMS; Webb L., 2013, EMORY J INT AFF 0329; WHO, 2014, WHO GLOB HLTH EXP DA; WHO Global Health Observatory, LIF EXP LIF EXP DAT; Willis JR, 2011, INT J QUAL HEALTH C, V23, P487, DOI 10.1093/intqhc/mzr030; World Bank, 2014, WORLD BANK DAT; World Health Organization, 2014, WHO NAT HLTH ACC GLO; World Health Organization (WHO), 2014, MAK FAIR CHOIC PATH	124	111	111	1	42	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 12	2015	386	10011					2422	2435		10.1016/S0140-6736(15)00955-1	http://dx.doi.org/10.1016/S0140-6736(15)00955-1			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CY3EE	26700532				2022-12-28	WOS:000366290400036
J	Woods, A				Woods, Angela			The art of medicine Voices, identity, and meaning-making	LANCET			English	Editorial Material									[Woods, Angela] Univ Durham, Hearing Voice, Durham DH1 1SZ, England; [Woods, Angela] Univ Durham, Sch Med Pharm & Hlth, Ctr Med Humanities, Durham DH1 1SZ, England	Durham University; Durham University	Woods, A (corresponding author), Univ Durham, Hearing Voice, Durham DH1 1SZ, England.	angela.woods@durham.ac.uk			Wellcome Trust [098455] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)			0	5	5	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 12	2015	386	10011					2386	2387		10.1016/S0140-6736(15)01203-9	http://dx.doi.org/10.1016/S0140-6736(15)01203-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CY3EE	26709400	Bronze			2022-12-28	WOS:000366290400018
J	Deng, HS; Gerencser, AA; Jasper, H				Deng, Hansong; Gerencser, Akos A.; Jasper, Heinrich			Signal integration by Ca2+ regulates intestinal stem-cell activity	NATURE			English	Article							TISSUE HOMEOSTASIS; NEURAL ACTIVITY; LIFE-SPAN; DROSOPHILA; GLUTAMATE; PROLIFERATION; CALCINEURIN; CA2+-ATPASE; METABOLISM; INSIGHTS	Somatic stem cells maintain tissue homeostasis by dynamically adjusting proliferation and differentiation in response to stress and metabolic cues. Here we identify Ca2+ signalling as a central regulator of intestinal stem cell (ISC) activity in Drosophila. We show that dietary l-glutamate stimulates ISC division and gut growth. The metabotropic glutamate receptor (mGluR) is required in ISCs for this response, and for an associated modulation of cytosolic Ca2+ oscillations that results in sustained high cytosolic Ca2+ concentrations. High cytosolic Ca2+ concentrations induce ISC proliferation by regulating Calcineurin and CREB-regulated transcriptional co-activator (Crtc). In response to a wide range of dietary and stress stimuli, ISCs reversibly transition between Ca2+ oscillation states that represent poised or activated modes of proliferation, respectively. We propose that the dynamic regulation of intracellular Ca2+ levels allows effective integration of diverse mitogenic signals in ISCs to adapt their proliferative activity to the needs of the tissue.	[Deng, Hansong; Gerencser, Akos A.; Jasper, Heinrich] Buck Inst Res Aging, Novato, CA 94945 USA	Buck Institute for Research on Aging	Jasper, H (corresponding author), Buck Inst Res Aging, 8001 Redwood Blvd, Novato, CA 94945 USA.	hjasper@buckinstitute.org			National Institute on Aging [R01 AG028127]; National Institute on General Medical Sciences [R01 GM100196]; Glenn Foundation for Medical Research postdoctoral fellowship; National Institutes of Health (NIH) [S10OD010414]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028127] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010414] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Glenn Foundation for Medical Research postdoctoral fellowship; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institute on Aging (R01 AG028127), the National Institute on General Medical Sciences (R01 GM100196), and by a Glenn Foundation for Medical Research postdoctoral fellowship to H.D. The Zeiss 7MP was purchased using National Institutes of Health (NIH) grant S10OD010414. We would like to thank G. Hasan, Y. Hirano, A. Toshiro, M. Parmentier, W. Lee, S. X. Hou, M. Montminy, N. Perrimon, B. Ohlstein A. DiAntonio, H. Hayashi, R. W. Daniels, K. Venkatachalam, the Vienna Drosophila RNAi Center, and the Bloomington Stock Center for flies, and Developmental Studies Hybridoma Bank for antibodies. We also thank Jasper laboratory members for discussion.	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Ayyaz A, 2015, NAT CELL BIOL, V17, P736, DOI 10.1038/ncb3174; Ayyaz A, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00098; Biteau B, 2008, CELL STEM CELL, V3, P442, DOI 10.1016/j.stem.2008.07.024; Biteau B, 2011, CELL STEM CELL, V9, P402, DOI 10.1016/j.stem.2011.10.004; Biteau B, 2011, DEVELOPMENT, V138, P1045, DOI 10.1242/dev.056671; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Buchon N, 2013, NAT REV MICROBIOL, V11, P615, DOI 10.1038/nrmicro3074; Buchon N, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-152; Burrin DG, 2009, AM J CLIN NUTR, V90, p850S, DOI 10.3945/ajcn.2009.27462Y; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cognigni P, 2011, CELL METAB, V13, P92, DOI 10.1016/j.cmet.2010.12.010; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Daniels RW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100637; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; Dupont G, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004226; Freedman NJ, 1996, RECENT PROG HORM RES, V51, P319; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Guo LL, 2014, CELL, V156, P109, DOI 10.1016/j.cell.2013.12.018; Ha EM, 2009, DEV CELL, V16, P386, DOI 10.1016/j.devcel.2008.12.015; Hirano Y, 2013, SCIENCE, V339, P443, DOI 10.1126/science.1227170; Hochmuth CE, 2011, CELL STEM CELL, V8, P188, DOI 10.1016/j.stem.2010.12.006; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Julio-Pieper M, 2011, PHARMACOL REV, V63, P35, DOI 10.1124/pr.110.004036; Lee KP, 2008, P NATL ACAD SCI USA, V105, P2498, DOI 10.1073/pnas.0710787105; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lemaitre B, 2013, ANNU REV GENET, V47, P377, DOI 10.1146/annurev-genet-111212-133343; Lewerenz J, 2013, ANTIOXID REDOX SIGN, V18, P522, DOI 10.1089/ars.2011.4391; Li HJ, 2013, CELL REP, V4, P10, DOI 10.1016/j.celrep.2013.05.040; Lin GN, 2008, NATURE, V455, P1119, DOI 10.1038/nature07329; McBride SMJ, 2005, NEURON, V45, P753, DOI 10.1016/j.neuron.2005.01.038; Nakai Y, 2011, J NEUROSCI, V31, P12759, DOI 10.1523/JNEUROSCI.1337-11.2011; Newsholme P, 2003, CELL BIOCHEM FUNCT, V21, P1, DOI 10.1002/cbf.1003; O'Brien LE, 2011, CELL, V147, P603, DOI 10.1016/j.cell.2011.08.048; Periz G, 1999, EMBO J, V18, P5983, DOI 10.1093/emboj/18.21.5983; Reeds PJ, 2000, J NUTR, V130, p978S, DOI 10.1093/jn/130.4.978S; Rival T, 2004, CURR BIOL, V14, P599, DOI 10.1016/j.cub.2004.03.039; Roti G, 2013, CANCER CELL, V23, P390, DOI 10.1016/j.ccr.2013.01.015; Sanyal S, 2006, J COMP PHYSIOL B, V176, P253, DOI 10.1007/s00360-005-0046-7; Shim J, 2013, CELL, V155, P1141, DOI 10.1016/j.cell.2013.10.032; Skorupa DA, 2008, AGING CELL, V7, P478, DOI 10.1111/j.1474-9726.2008.00400.x; Takashima S, 2011, DEV BIOL, V353, P161, DOI 10.1016/j.ydbio.2011.01.039; Takeo S, 2006, CURR BIOL, V16, P1435, DOI 10.1016/j.cub.2006.05.058; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Wang B, 2008, CELL METAB, V7, P434, DOI 10.1016/j.cmet.2008.02.010; Wang LF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004568; Wong CO, 2014, NEURON, V84, P764, DOI 10.1016/j.neuron.2014.09.030; Wu Q, 2005, P NATL ACAD SCI USA, V102, P13289, DOI 10.1073/pnas.0501914102; Xiao WD, 2014, FASEB J, V28, P2073, DOI 10.1096/fj.13-238311; Yan DL, 2007, P NATL ACAD SCI USA, V104, P9475, DOI 10.1073/pnas.0703360104	53	101	105	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2015	528	7581					212	+		10.1038/nature16170	http://dx.doi.org/10.1038/nature16170			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9VH	26633624	Green Accepted			2022-12-28	WOS:000366053300031
J	Pallais, JC; McInnis, M; Saylor, PJ; Wu, RI				Pallais, J. Carl; McInnis, Micheal; Saylor, Philip J.; Wu, Roseann I.			Case 38-2015: A 21-Year-Old Man with Fatigue and Weight Loss	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN CHORIONIC-GONADOTROPIN; BETA-SUBUNIT; BIOLOGY		[Pallais, J. Carl] Massachusetts Gen Hosp, Dept Endocrinol, Boston, MA 02114 USA; [McInnis, Micheal] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Saylor, Philip J.] Massachusetts Gen Hosp, Dept Hematol Oncol, Boston, MA 02114 USA; [Wu, Roseann I.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Pallais, J. Carl] Harvard Univ, Sch Med, Dept Endocrinol, Boston, MA 02115 USA; [McInnis, Micheal] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Saylor, Philip J.] Harvard Univ, Sch Med, Dept Hematol Oncol, Boston, MA 02115 USA; [Wu, Roseann I.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Pallais, JC (corresponding author), Massachusetts Gen Hosp, Dept Endocrinol, Boston, MA 02114 USA.			Wu, Roseann/0000-0001-8073-3965; McInnis, Micheal/0000-0002-5725-3258				Bahn RS, 2011, ENDOCR PRACT, V17, P456, DOI 10.4158/EP.17.3.456; Banet N, 2015, AM J SURG PATHOL, V39, P101, DOI 10.1097/PAS.0000000000000315; Barbesino G, 2013, J CLIN ENDOCR METAB, V98, P2247, DOI 10.1210/jc.2012-4309; Bosl GJ, 1997, NEW ENGL J MED, V337, P242, DOI 10.1056/NEJM199707243370406; Braunstein GD, 2007, NEW ENGL J MED, V357, P1229, DOI 10.1056/NEJMcp070677; CAIN HJ, 1991, CLIN CHEM, V37, P1127; Choi J, 2014, MOL CELL ENDOCRINOL, V383, P203, DOI 10.1016/j.mce.2013.12.009; Cooper DS, 2003, LANCET, V362, P459, DOI 10.1016/S0140-6736(03)14073-1; Gilligan TD, 2010, J CLIN ONCOL, V28, P3388, DOI 10.1200/JCO.2009.26.4481; GLINOER D, 1990, J CLIN ENDOCR METAB, V71, P276, DOI 10.1210/jcem-71-2-276; Hershman JM, 2004, BEST PRACT RES CL EN, V18, P249, DOI 10.1016/j.beem.2004.03.010; Jiang XL, 2014, MOL CELL ENDOCRINOL, V382, P424, DOI 10.1016/j.mce.2013.08.021; KIRSCHNER MA, 1981, CANCER RES, V41, P1447; Lockwood CM, 2009, THYROID, V19, P863, DOI 10.1089/thy.2009.0079; Lopez J. I., 1994, International Urology and Nephrology, V26, P549, DOI 10.1007/BF02767657; MARCILLAC I, 1992, CANCER RES, V52, P3901; Martin DRFZ, 2006, ABDOMINAL PELVIC MRI, P1057; Nagirnaja L, 2010, MOL CELL ENDOCRINOL, V329, P4, DOI 10.1016/j.mce.2010.04.024; Nallu A, 2013, CURR OPIN ONCOL, V25, P266, DOI 10.1097/CCO.0b013e32835ff3e3; Narula HS, 2014, NAT REV ENDOCRINOL, V10, P684, DOI 10.1038/nrendo.2014.139; National Cancer Institute, 2014, SNAPSH AD YOUNG AD C; Oosting SF, 2010, ANN ONCOL, V21, P104, DOI 10.1093/annonc/mdp265; STEIGBIEGEL N, 1964, NEW ENGL J MED, V271, P345, DOI 10.1056/NEJM196408132710704; Stenman UH, 2004, CLIN BIOCHEM, V37, P549, DOI 10.1016/j.clinbiochem.2004.05.008; Stenman UH, 2013, BEST PRACT RES CL EN, V27, P783, DOI 10.1016/j.beem.2013.10.005; Tozzoli R, 2012, AUTOIMMUN REV, V12, P107, DOI 10.1016/j.autrev.2012.07.003; Vardaros Magdalene, 2013, J Gastrointest Cancer, V44, P234, DOI 10.1007/s12029-012-9433-y; Wang L, 2004, MODERN PATHOL, V17, P1573, DOI 10.1038/modpathol.3800226	28	4	4	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 10	2015	373	24					2358	2369		10.1056/NEJMcpc1506821	http://dx.doi.org/10.1056/NEJMcpc1506821			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY0QW	26650156				2022-12-28	WOS:000366111600012
J	Sondheimer, HM; Xierali, IM; Young, GH; Nivet, MA				Sondheimer, Henry M.; Xierali, Imam M.; Young, Geoffrey H.; Nivet, Marc A.			Placement of US Medical School Graduates Into Graduate Medical Education, 2005 Through 2015	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Sondheimer, Henry M.; Xierali, Imam M.; Young, Geoffrey H.; Nivet, Marc A.] Assoc Amer Med Coll, Washington, DC 20010 USA	Association of American Medical Colleges	Sondheimer, HM (corresponding author), Assoc Amer Med Coll, 655 K St NW,Ste 100, Washington, DC 20010 USA.	henry.sondheimer@gmail.com		Xierali, Imam/0000-0002-3378-8063				Association of American Medical Colleges, RES 2014 MED SCH ENR; Association of American Medical Colleges, HDB STUD REC ADM; Iglehart JK, 2013, NEW ENGL J MED, V369, P297, DOI 10.1056/NEJMp1306445; Jolly P, 2015, ACAD MED, V90, P970, DOI 10.1097/ACM.0000000000000649; Walker KO, 2012, J NATL MED ASSOC, V104, P46, DOI 10.1016/S0027-9684(15)30126-7	5	9	9	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 8	2015	314	22					2409	2410		10.1001/jama.2015.15702	http://dx.doi.org/10.1001/jama.2015.15702			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX8XT	26647264	Bronze			2022-12-28	WOS:000365989100017
J	Zalcman, G; Mazieres, J; Margery, J; Greillier, L; Audigier-Valette, C; Moro-Sibilot, D; Molinier, O; Corre, R; Monnet, I; Gounant, V; Riviere, F; Janicot, H; Gervais, R; Locher, C; Milleron, B; Tran, Q; Lebitasy, MP; Morin, F; Creveuil, C; Parienti, JJ; Scherpereel, A				Zalcman, Gerard; Mazieres, Julien; Margery, Jacques; Greillier, Laurent; Audigier-Valette, Clarisse; Moro-Sibilot, Denis; Molinier, Olivier; Corre, Romain; Monnet, Isabelle; Gounant, Valerie; Riviere, Frederic; Janicot, Henri; Gervais, Radj; Locher, Chrystele; Milleron, Bernard; Quan Tran; Lebitasy, Marie-Paule; Morin, Franck; Creveuil, Christian; Parienti, Jean-Jacques; Scherpereel, Arnaud		Frech Cooperative Thoracic	Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial	LANCET			English	Article							ENDOTHELIAL GROWTH-FACTOR; MALIGNANT MESOTHELIOMA; PLUS BEVACIZUMAB; PROGNOSTIC-FACTORS; 1ST-LINE THERAPY; MULTICENTER; CANCER; FLUOROURACIL; CARBOPLATIN; COMBINATION	Background Malignant pleural mesothelioma is an aggressive cancer with poor prognosis, linked to occupational asbestos exposure. Vascular endothelial growth factor is a key mitogen for malignant pleural mesothelioma cells, therefore targeting of vascular endothelial growth factor might prove effective. We aimed to assess the effect on survival of bevacizumab when added to the present standard of care, cisplatin plus pemetrexed, as first-line treatment of advanced malignant pleural mesothelioma. Methods In this randomised, controlled, open-label, phase 3 trial, we recruited patients aged 18-75 years with unresectable malignant pleural mesothelioma who had not received previous chemotherapy, had an Eastern Cooperative Oncology Group performance status of 0-2, had no substantial cardiovascular comorbidity, were not amenable to curative surgery, had at least one evaluable (pleural effusion) or measurable (pleural tumour solid thickening) lesion with CT, and a life expectancy of >12 weeks from 73 hospitals in France. Exclusion criteria were presence of central nervous system metastases, use of antiaggregant treatments (aspirin >= 325 mg per day, clopidogrel, ticlopidine, or dipyridamole), anti-vitamin K drugs at a curative dose, treatment with low-molecular-weight heparin at a curative dose, and treatment with non-steroidal anti-inflammatory drugs. We randomly allocated patients (1: 1; minimisation method used [random factor of 0.8]; patients stratified by histology [epithelioid vs sarcomatoid or mixed histology subtypes], performance status score [0-1 vs 2], study centre, or smoking status [never smokers vs smokers]) to receive intravenously 500 mg/m(2) pemetrexed plus 75 mg/m(2) cisplatin with (PCB) or without (PC) 15 mg/kg bevacizumab in 21 day cycles for up to six cycles, until progression or toxic effects. The primary outcome was overall survival (OS) in the intention-to treat population. Treatment was open label. This IFCT-GFPC-0701 trial is registered with ClinicalTrials.gov, number NCT00651456. Findings From Feb 13, 2008, to Jan 5, 2014, we randomly assigned 448 patients to treatment (223 [50%] to PCB and 225 [50%] to PC). OS was significantly longer with PCB (median 18.8 months [95% CI 15.9-22.6]) than with PC (16.1 months [14.0-17.9]; hazard ratio 0.77 [0.62-0.95]; p=0.0167). Overall, 158 (71%) of 222 patients given PCB and 139 (62%) of 224 patients given PC had grade 3-4 adverse events. We noted more grade 3 or higher hypertension (51 [23%] of 222 vs 0) and thrombotic events (13 [6%] of 222 vs 2 [1%] of 224) with PCB than with PC. Interpretation Addition of bevacizumab to pemetrexed plus cisplatin significantly improved OS in malignant pleural mesothelioma at the cost of expected manageable toxic effects, therefore it should be considered as a suitable treatment for the disease.	[Zalcman, Gerard] Univ Caen, Dept Pulmonol & Thorac Oncol, Ctr Hosp Univ Cote Nacre, F-14032 Caen, France; [Zalcman, Gerard] Univ Paris 07, Dept Thorac Oncol, Hosp Bichat Claude Bernard, AP HP,Ctr Invest Clin,Inst Natl Sante & Rech Med, F-75877 Paris 18, France; [Mazieres, Julien] Larrey Hosp, Dept Pulmonol, Toulouse, France; [Margery, Jacques] Inst Gustave Roussy, Villejuif, France; [Greillier, Laurent] Assistance Publ Hop Marseille, Marseille, France; [Audigier-Valette, Clarisse] Ctr Hosp Intercommunal Toulon, Dept Pulmonol, Toulon, France; [Moro-Sibilot, Denis] CHU Grenoble, Pole Thorax & Vaisseaux, F-38043 Grenoble, France; [Molinier, Olivier] Ctr Hosp Le Mans, Dept Pulmonol, Le Mans, France; [Corre, Romain] Ponchaillou Univ Hosp, Dept Pulmonol, Rennes, France; [Monnet, Isabelle] Ctr Hosp Intercommunal Creteil, Dept Pulmonol, Creteil, France; [Gounant, Valerie] Hop Tenon, AP HP, F-75970 Paris, France; [Riviere, Frederic] Hop Instruct Armees Percy, Dept Pulmonol, Clamart, France; [Janicot, Henri] Gabriel Montpied Univ, Dept Pulmonol, Clermont Ferrand, France; [Gervais, Radj] Ctr Reg Lutte Canc Francois Baclesse, Caen, France; [Locher, Chrystele] Ctr Hosp Meaux, Dept Pulmonol, Meaux, France; [Milleron, Bernard; Quan Tran; Lebitasy, Marie-Paule; Morin, Franck] French Cooperat Thorac Grp, Paris, France; [Creveuil, Christian; Parienti, Jean-Jacques] Ctr Hosp Univ Cote Nacre, Dept Biostat & Clin Res, Caen, France; [Creveuil, Christian; Parienti, Jean-Jacques] Caen Normandy Univ, Equipe Accueil 4655, Caen, France; [Scherpereel, Arnaud] Univ Lille, Pulm & Thorac Oncol Dept, Ctr Hosp Univ Lille, INSERM,U10191,Ctr Infect & Immunite Lille, Lille, France	CHU de Caen NORMANDIE; Universite de Caen Normandie; Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU de Toulouse; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre Hospitalier Le Mans; CHU Rennes; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Clermont Ferrand; UNICANCER; Centre Francois Baclesse; CHU de Caen NORMANDIE; Universite de Caen Normandie; Universite de Caen Normandie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille	Zalcman, G (corresponding author), Univ Paris 07, Dept Thorac Oncol, Hosp Bichat Claude Bernard, AP HP,Ctr Invest Clin,Inst Natl Sante & Rech Med, F-75877 Paris 18, France.	gerard.zalcman@aphp.fr	CREVEUIL, Christian/L-7215-2015; MAZIERES, JULIEN/M-3986-2014; ZALCMAN, Gerard/M-8113-2019; Parienti, Jean-Jacques/AAD-1701-2021	CREVEUIL, Christian/0000-0002-5506-5296; Parienti, Jean-Jacques/0000-0002-4774-5590; Morin, Franck/0000-0002-7510-2787; MAZIERES, JULIEN/0000-0002-5921-7613; MORO-SIBILOT, Denis/0000-0001-6776-8610	Intergroupe Francophone de Cancerologie Thoracique (IFCT); French Ministry of Health (Programme Hospitalier de Recherche Clinique); French League against Cancer; Caen University Hospital; Canceropole North-West; Normandy League against Cancer	Intergroupe Francophone de Cancerologie Thoracique (IFCT); French Ministry of Health (Programme Hospitalier de Recherche Clinique); French League against Cancer; Caen University Hospital; Canceropole North-West; Normandy League against Cancer	Intergroupe Francophone de Cancerologie Thoracique (IFCT).; This study was funded by the Intergroupe Francophone de Cancerologie Thoracique (IFCT). This study was supported by funds from the French Ministry of Health (Programme Hospitalier de Recherche Clinique, 2007), the French League against Cancer funding for IFCT, research subventions for biomarker correlative studies from F Hoffmann-La Roche to IFCT, and funds from Caen University Hospital (Apricus Biosciences 2013), Canceropole North-West (2013), and the Normandy League against Cancer (2014) to GZ. On behalf of all Mesothelioma Avastin Cisplatin Pemetrexed Study investigators (appendix), we acknowledge the dedication of the nursing and medical staff of the participating centres, IFCT clinical research staff and statistician (Alexandra Langlais), and the study participants, without whom this study could not have been completed. We also acknowledge the independent data monitoring committee members (Dominique Valeyre, Aimery De Gramont, Ariane Dunant, and Thierry Berghmans) for their rigorous work, and pathologists from the participating centres and the French Panel MESOPATH. Medical writing assistance was provided by Gardiner-Caldwell Communications.	BAUER P, 1991, STAT MED, V10, P871, DOI 10.1002/sim.4780100609; BOUTIN C, 1995, CHEST, V108, P754, DOI 10.1378/chest.108.3.754; Buikhuisen WA, 2013, LANCET ONCOL, V14, P543, DOI 10.1016/S1470-2045(13)70125-6; Byrne MJ, 2004, ANN ONCOL, V15, P257, DOI 10.1093/annonc/mdh059; Ceresoli GL, 2013, BRIT J CANCER, V109, P552, DOI 10.1038/bjc.2013.368; Ceresoli GL, 2006, J CLIN ONCOL, V24, P1443, DOI 10.1200/JCO.2005.04.3190; Curran D, 1998, J CLIN ONCOL, V16, P145, DOI 10.1200/JCO.1998.16.1.145; Dowell JE, 2012, LUNG CANCER, V77, P567, DOI 10.1016/j.lungcan.2012.05.111; Dubey S, 2010, J THORAC ONCOL, V5, P1655, DOI 10.1097/JTO.0b013e3181ec18db; Garland LL, 2011, J THORAC ONCOL, V6, P1938, DOI 10.1097/JTO.0b013e318229586e; Gelvez-Zapata SM, 2013, INTERACT CARDIOV TH, V16, P533, DOI 10.1093/icvts/ivs542; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Gray R, 2009, J CLIN ONCOL, V27, P4966, DOI 10.1200/JCO.2008.21.6630; Hollen PJ, 2004, CANCER-AM CANCER SOC, V101, P587, DOI 10.1002/cncr.20315; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jackman DM, 2008, CANCER-AM CANCER SOC, V113, P808, DOI 10.1002/cncr.23617; Kahan BC, 2012, STAT MED, V31, P328, DOI 10.1002/sim.4431; Kindler HL, 2012, J CLIN ONCOL, V30, P2509, DOI 10.1200/JCO.2011.41.5869; Labby ZE, 2012, J THORAC ONCOL, V7, P1728, DOI 10.1097/JTO.0b013e318269fe21; Montori VM, 2005, JAMA-J AM MED ASSOC, V294, P2203, DOI 10.1001/jama.294.17.2203; Nowak AK, 2012, J THORAC ONCOL, V7, P1449, DOI 10.1097/JTO.0b013e31825f22ee; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Ohta Y, 1999, BRIT J CANCER, V81, P54, DOI 10.1038/sj.bjc.6690650; Osoba D, 1998, J CLIN ONCOL, V16, P139, DOI 10.1200/JCO.1998.16.1.139; Reck M, 2009, J CLIN ONCOL, V27, P1227, DOI 10.1200/JCO.2007.14.5466; Scherpereel A, 2010, EUR RESPIR J, V35, P479, DOI [10.3779/j.issn.1009-3419.2010.10.14, 10.1183/09031936.00063109]; Steele JPC, 2005, HEMATOL ONCOL CLIN N, V19, P1041, DOI 10.1016/j.hoc.2005.09.009; Strizzi L, 2001, J PATHOL, V193, P468, DOI 10.1002/path.824; Treasure T, 2011, LANCET ONCOL, V12, P763, DOI 10.1016/S1470-2045(11)70149-8; Van Schil PE, 2010, EUR RESPIR J, V36, P1362, DOI 10.1183/09031936.00039510; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; WAGNER J C, 1960, Br J Ind Med, V17, P260; Zalcman G, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.7020; Zhu XL, 2007, AM J KIDNEY DIS, V49, P186, DOI 10.1053/j.ajkd.2006.11.039	34	542	555	4	65	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2016	387	10026					1405	1414		10.1016/S0140-6736(15)01238-6	http://dx.doi.org/10.1016/S0140-6736(15)01238-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI0WH	26719230				2022-12-28	WOS:000373217500033
J	Sing, DK; Fortney, JJ; Nikolov, N; Wakeford, HR; Kataria, T; Evans, TM; Aigrain, S; Ballester, GE; Burrows, AS; Deming, D; Desert, JM; Gibson, NP; Henry, GW; Huitson, CM; Knutson, HA; des Etangs, AL; Pont, F; Showman, AP; Vidal-Madjar, A; Williamson, MH; Wilson, PA				Sing, David K.; Fortney, Jonathan J.; Nikolov, Nikolay; Wakeford, Hannah R.; Kataria, Tiffany; Evans, Thomas M.; Aigrain, Suzanne; Ballester, Gilda E.; Burrows, Adam S.; Deming, Drake; Desert, Jean-Michel; Gibson, Neale P.; Henry, Gregory W.; Huitson, Catherine M.; Knutson, Heather A.; des Etangs, Alain Lecavelier; Pont, Frederic; Showman, Adam P.; Vidal-Madjar, Alfred; Williamson, Michael H.; Wilson, Paul A.			A continuum from clear to cloudy hot-Jupiter exoplanets without primordial water depletion	NATURE			English	Article							TRANSMISSION SPECTRAL SURVEY; HD 189733B; BROWN DWARFS; ATMOSPHERIC CHEMISTRY; GIANT PLANETS; HUBBLE; STARS; SPECTROSCOPY; NITROGEN; CARBON	Thousands of transiting exoplanets have been discovered, but spectral analysis of their atmospheres has so far been dominated by a small number of exoplanets and data spanning relatively narrow wavelength ranges (such as 1.1-1.7 micrometres). Recent studies show that some hot-Jupiter exoplanets have much weaker water absorption features in their near-infrared spectra than predicted(1-5). The low amplitude of water signatures could be explained by very low water abundances(6-8), which may be a sign that water was depleted in the protoplanetary disk at the planet's formation location9, but it is unclear whether this level of depletion can actually occur. Alternatively, these weak signals could be the result of obscuration by clouds or hazes(1-4), as found in some optical spectra(3,4,10,11). Here we report results from a comparative study of ten hot Jupiters covering the wavelength range 0.3-5 micrometres, which allows us to resolve both the optical scattering and infrared molecular absorption spectroscopically. Our results reveal a diverse group of hot Jupiters that exhibit a continuum from clear to cloudy atmospheres. We find that the difference between the planetary radius measured at optical and infrared wavelengths is an effective metric for distinguishing different atmosphere types. The difference correlates with the spectral strength of water, so that strong water absorption lines are seen in clear-atmosphere planets and the weakest features are associated with clouds and hazes. This result strongly suggests that primordial water depletion during formation is unlikely and that clouds and hazes are the cause of weaker spectral signatures.	[Sing, David K.; Nikolov, Nikolay; Wakeford, Hannah R.; Kataria, Tiffany; Evans, Thomas M.; Pont, Frederic] Univ Exeter, Sch Phys, Astrophys Grp, Stocker Rd, Exeter EX4 4QL, Devon, England; [Fortney, Jonathan J.] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Aigrain, Suzanne] Univ Oxford, Dept Phys, Keble Rd, Oxford OX1 3RH, England; [Ballester, Gilda E.; Showman, Adam P.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Burrows, Adam S.] Princeton Univ, Dept Astrophys Sci, Peyton Hall, Princeton, NJ 08544 USA; [Deming, Drake] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Desert, Jean-Michel; Huitson, Catherine M.] Univ Colorado, Dept Astrophys & Planetary Sci, Boulder, CO 80309 USA; [Gibson, Neale P.] European So Observ, Karl Schwarzschild Str 2, D-85748 Garching, Germany; [Henry, Gregory W.; Williamson, Michael H.] Tennessee State Univ, Ctr Excellence Informat Syst, Nashville, TN 37209 USA; [Knutson, Heather A.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [des Etangs, Alain Lecavelier; Vidal-Madjar, Alfred; Wilson, Paul A.] CNRS, Inst Astrophys Paris, UMR 7095, 98 Bis Blvd Arago, F-75014 Paris, France	University of Exeter; University of California System; University of California Santa Cruz; University of Oxford; University of Arizona; Princeton University; University System of Maryland; University of Maryland College Park; University of Colorado System; University of Colorado Boulder; European Southern Observatory; Tennessee State University; California Institute of Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite	Sing, DK (corresponding author), Univ Exeter, Sch Phys, Astrophys Grp, Stocker Rd, Exeter EX4 4QL, Devon, England.	sing@astro.ex.ac.uk	Gibson, Neale/ABG-6112-2021; Wakeford, Hannah/H-7883-2018; Lecavelier des Etangs, Alain/GLU-6503-2022; Nikolov, Nikolay/H-6183-2015	Wakeford, Hannah/0000-0003-4328-3867; Lecavelier des Etangs, Alain/0000-0002-5637-5253; Evans, Thomas/0000-0001-5442-1300; Strom, Dr. Paul/0000-0002-7823-1090; Pont, Frederic/0000-0003-0076-5444; Gibson, Neale/0000-0002-9308-2353; Nikolov, Nikolay/0000-0002-6500-3574; Aigrain, Suzanne/0000-0003-1453-0574; Sing, David/0000-0001-6050-7645	European Research Council under the European Union's Seventh Framework Programme (FP7)/ERC [336792]; STFC [ST/J0016/1]; NASA from the STScI [HST-GO-12473]; CNES; French Agence Nationale de la Recherche (ANR) [ANR-12-BS05-0012]; UK Science and Technology Facilities Council (STFC); NASA; NSF; Tennessee State University; State of Tennessee through its Centers of Excellence programme; STFC [ST/M003515/1, ST/N000919/1, ST/K00106X/1, ST/J001627/1, ST/L000709/1, ST/G002266/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/L000709/1, ST/J001627/1, ST/M003515/1] Funding Source: researchfish	European Research Council under the European Union's Seventh Framework Programme (FP7)/ERC(European Research Council (ERC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); NASA from the STScI; CNES(Centre National D'etudes Spatiales); French Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); UK Science and Technology Facilities Council (STFC)(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); Tennessee State University; State of Tennessee through its Centers of Excellence programme; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This work is based on observations with the NASA/ESA HST, obtained at the Space Telescope Science Institute (STScI) operated by AURA, Inc. This work is also based in part on observations made with the Spitzer Space Telescope, which is operated by the Jet Propulsion Laboratory, California Institute of Technology under a contract with NASA. The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement number 336792. D.K.S., F.P. and N.N. acknowledge support from STFC consolidated grant ST/J0016/1. Support for this work was provided by NASA through grants under the HST-GO-12473 programme from the STScI. A.L.E., P.A.W. and A.V.M. acknowledge support from CNES and the French Agence Nationale de la Recherche (ANR), under programme ANR-12-BS05-0012 'Exo-Atmos'. P.A.W. and H.W. acknowledge support from the UK Science and Technology Facilities Council (STFC). G.W.H. and M.H.W. acknowledge support from NASA, NSF, Tennessee State University and the State of Tennessee through its Centers of Excellence programme.	Burgasser AJ, 2002, ASTROPHYS J, V571, pL151, DOI 10.1086/341343; Burrows A, 2010, ASTROPHYS J, V719, P341, DOI 10.1088/0004-637X/719/1/341; Cushing MC, 2005, ASTROPHYS J, V623, P1115, DOI 10.1086/428040; Deming D, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/2/95; Etangs ALD, 2008, ASTRON ASTROPHYS, V481, pL83, DOI 10.1051/0004-6361:200809388; Evans TM, 2015, MON NOT R ASTRON SOC, V451, P680, DOI 10.1093/mnras/stv910; Fortney JJ, 2008, ASTROPHYS J, V678, P1419, DOI 10.1086/528370; Fortney JJ, 2010, ASTROPHYS J, V709, P1396, DOI 10.1088/0004-637X/709/2/1396; Freedman RS, 2008, ASTROPHYS J SUPPL S, V174, P504, DOI 10.1086/521793; Gibson NP, 2014, MON NOT R ASTRON SOC, V445, P3401, DOI 10.1093/mnras/stu1975; Hayek W, 2012, ASTRON ASTROPHYS, V539, DOI 10.1051/0004-6361/201117868; Helling C, 2008, ASTRON ASTROPHYS, V485, P547, DOI 10.1051/0004-6361:20078220; Henry GW, 1999, PUBL ASTRON SOC PAC, V111, P845, DOI 10.1086/316388; Huitson CM, 2013, MON NOT R ASTRON SOC, V434, P3252, DOI 10.1093/mnras/stt1243; Isaacson H, 2010, ASTROPHYS J, V725, P875, DOI 10.1088/0004-637X/725/1/875; Knutson HA, 2014, ASTROPHYS J, V794, DOI 10.1088/0004-637X/794/2/155; Knutson HA, 2010, ASTROPHYS J, V720, P1569, DOI 10.1088/0004-637X/720/2/1569; Kreidberg L, 2014, NATURE, V505, P69, DOI 10.1038/nature12888; Liang MC, 2004, ASTROPHYS J, V605, pL61, DOI 10.1086/392509; Line MR, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/2/183; Lockwood GW, 2007, ASTROPHYS J SUPPL S, V171, P260, DOI 10.1086/516752; Lodders K, 2002, ICARUS, V155, P393, DOI 10.1006/icar.2001.6740; Lodders K, 1999, ASTROPHYS J, V519, P793, DOI 10.1086/307387; Madhusudhan N, 2014, ASTROPHYS J LETT, V794, DOI 10.1088/2041-8205/794/1/L12; Madhusudhan N, 2014, ASTROPHYS J LETT, V791, DOI 10.1088/2041-8205/791/1/L9; Mandel K, 2002, ASTROPHYS J, V580, pL171, DOI 10.1086/345520; Markwardt CB, 2009, ASTR SOC P, V411, P251; Morley CV, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/2/172; Moses JI, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/1/15; Nikolov N, 2015, MON NOT R ASTRON SOC, V447, P463, DOI 10.1093/mnras/stu2433; Nikolov N, 2014, MON NOT R ASTRON SOC, V437, P46, DOI 10.1093/mnras/stt1859; Oberg KI, 2011, ASTROPHYS J LETT, V743, DOI 10.1088/2041-8205/743/1/L16; Pont F, 2013, MON NOT R ASTRON SOC, V432, P2917, DOI 10.1093/mnras/stt651; Pont F, 2006, MON NOT R ASTRON SOC, V373, P231, DOI 10.1111/j.1365-2966.2006.11012.x; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seager S, 2000, ASTROPHYS J, V537, P916, DOI 10.1086/309088; Seager S, 2005, ASTROPHYS J, V632, P1122, DOI 10.1086/444411; Showman AP, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/1/71; Sing DK, 2015, MON NOT R ASTRON SOC, V446, P2428, DOI 10.1093/mnras/stu2279; Sing DK, 2013, MON NOT R ASTRON SOC, V436, P2956, DOI 10.1093/mnras/stt1782; Sing DK, 2011, MON NOT R ASTRON SOC, V416, P1443, DOI 10.1111/j.1365-2966.2011.19142.x; Sing DK, 2010, ASTRON ASTROPHYS, V510, DOI 10.1051/0004-6361/200913675; Vidal-Madjar A, 2011, ASTRON ASTROPHYS, V527, DOI [10.1051/0004-6361/201015698, 10.1051/0004-6361/201015698e]; Visscher C, 2010, ASTROPHYS J, V716, P1060, DOI 10.1088/0004-637X/716/2/1060; Wakeford HR, 2015, ASTRON ASTROPHYS, V573, DOI 10.1051/0004-6361/201424207; Wakeford HR, 2013, MON NOT R ASTRON SOC, V435, P3481, DOI 10.1093/mnras/stt1536; Wyttenbach A, 2015, ASTRON ASTROPHYS, V577, DOI 10.1051/0004-6361/201525729	55	550	552	5	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 7	2016	529	7584					59	+		10.1038/nature16068	http://dx.doi.org/10.1038/nature16068			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6VY	26675732	Green Submitted, Green Accepted			2022-12-28	WOS:000367944900025
J	Holt, PG; Sly, PD				Holt, Patrick G.; Sly, Peter D.			Environmental Microbial Exposure and Protection against Asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ENDOTOXIN		[Holt, Patrick G.] Telethon Kids Inst, Dept Cell Biol, Perth, WA, Australia; [Sly, Peter D.] Queensland Childrens Med Res Inst, Brisbane, Qld, Australia	Telethon Kids Institute	Holt, PG (corresponding author), Telethon Kids Inst, Dept Cell Biol, Perth, WA, Australia.		Sly, Peter D/F-1486-2010; Holt, Patrick G/H-1548-2011	Sly, Peter D/0000-0001-6305-2201; Holt, Patrick G/0000-0003-1193-0935				Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Holt PG, 2012, NAT MED, V18, P726, DOI 10.1038/nm.2768; Schuijs MJ, 2015, SCIENCE, V349, P1106, DOI 10.1126/science.aac6623; Teo SM, 2015, CELL HOST MICROBE, V17, P704, DOI 10.1016/j.chom.2015.03.008	5	12	12	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 24	2015	373	26					2576	2578		10.1056/NEJMcibr1511291	http://dx.doi.org/10.1056/NEJMcibr1511291			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ7SG	26699175				2022-12-28	WOS:000367299700015
J	Lindemans, CA; Calafiore, M; Mertelsmann, AM; O'Connor, MH; Dudakov, JA; Jenq, RR; Velardi, E; Young, LF; Smith, OM; Lawrence, G; Ivanov, JA; Fu, YY; Takashima, S; Hua, GQ; Martin, ML; O'Rourke, KP; Lo, YH; Mokry, M; Romera-Hernandez, M; Cupedo, T; Dow, LE; Nieuwenhuis, EE; Shroyer, NF; Liu, C; Kolesnick, R; van den Brink, MRM; Hanash, AM				Lindemans, Caroline A.; Calafiore, Marco; Mertelsmann, Anna M.; O'Connor, Margaret H.; Dudakov, Jarrod A.; Jenq, Robert R.; Velardi, Enrico; Young, Lauren F.; Smith, Odette M.; Lawrence, Gillian; Ivanov, Juliet A.; Fu, Ya-Yuan; Takashima, Shuichiro; Hua, Guoqiang; Martin, Maria L.; O'Rourke, Kevin P.; Lo, Yuan-Hung; Mokry, Michal; Romera-Hernandez, Monica; Cupedo, Tom; Dow, Lukas E.; Nieuwenhuis, Edward E.; Shroyer, Noah F.; Liu, Chen; Kolesnick, Richard; van den Brink, Marcel R. M.; Hanash, Alan M.			Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration	NATURE			English	Article							VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; INNATE LYMPHOID-CELLS; IN-VITRO; T-CELL; INFLAMMATION; EXPRESSION; NICHE; LGR5; INDUCTION	Epithelial regeneration is critical for barrier maintenance and organ function after intestinal injury. The intestinal stem cell (ISC) niche provides Wnt, Notch and epidermal growth factor (EGF) signals supporting Lgr5(+) crypt base columnar ISCs for normal epithelial maintenance(1,2). However, little is known about the regulation of the ISC compartment after tissue damage. Using ex vivo organoid cultures, here we show that innate lymphoid cells (ILCs), potent producers of interleukin-22 (IL-22) after intestinal injury(3,4), increase the growth of mouse small intestine organoids in an IL-22-dependent fashion. Recombinant IL-22 directly targeted ISCs, augmenting the growth of both mouse and human intestinal organoids, increasing proliferation and promoting ISC expansion. IL-22 induced STAT3 phosphorylation in Lgr5(+) ISCs, and STAT3 was crucial for both organoid formation and IL-22-mediated regeneration. Treatment with IL-22 in vivo after mouse allogeneic bone marrow transplantation enhanced the recovery of ISCs, increased epithelial regeneration and reduced intestinal pathology and mortality from graft-versus-host disease. ATOH1-deficient organoid culture demonstrated that IL-22 induced epithelial regeneration independently of the Paneth cell niche. Our findings reveal a fundamental mechanism by which the immune system is able to support the intestinal epithelium, activating ISCs to promote regeneration.	[Lindemans, Caroline A.; Calafiore, Marco; Mertelsmann, Anna M.; O'Connor, Margaret H.; Jenq, Robert R.; Lawrence, Gillian; Ivanov, Juliet A.; Fu, Ya-Yuan; Takashima, Shuichiro; van den Brink, Marcel R. M.; Hanash, Alan M.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Lindemans, Caroline A.; Mokry, Michal; Nieuwenhuis, Edward E.] Univ Med Ctr Utrecht, Dept Pediat, NL-3508 AB Utrecht, Netherlands; [Dudakov, Jarrod A.; Velardi, Enrico; Young, Lauren F.; Smith, Odette M.; van den Brink, Marcel R. M.] Mem Sloan Kettering Canc Ctr, Dept Immunol, New York, NY 10065 USA; [Dudakov, Jarrod A.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia; [Jenq, Robert R.; Dow, Lukas E.] Weill Cornell Med, Dept Med, New York, NY 10021 USA; [Hua, Guoqiang] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10065 USA; [Hua, Guoqiang; Martin, Maria L.; Kolesnick, Richard] Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol, New York, NY 10065 USA; [O'Rourke, Kevin P.] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10065 USA; [Lo, Yuan-Hung; Shroyer, Noah F.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Romera-Hernandez, Monica; Cupedo, Tom] Erasmus Univ, Med Ctr, Dept Hematol, NL-3000 CA Rotterdam, Netherlands; [Liu, Chen] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA	Memorial Sloan Kettering Cancer Center; Utrecht University; Utrecht University Medical Center; Memorial Sloan Kettering Cancer Center; Monash University; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Baylor College of Medicine; Erasmus University Rotterdam; Erasmus MC; State University System of Florida; University of Florida	Hanash, AM (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA.	hanasha@mskcc.org	Velardi, Enrico/AAB-7443-2019; Cupedo, Tom/GQQ-0614-2022; Mokry, Michal/AAN-3809-2021; van den Brink, Marcel R. M./HGB-9434-2022; velardi, Enrico/AAC-5440-2022	Velardi, Enrico/0000-0001-8383-0453; Mokry, Michal/0000-0002-5298-4852; Martin, Maria Laura/0000-0001-9359-5856; Dudakov, Jarrod/0000-0001-6220-5632; Shroyer, Noah/0000-0002-5934-2852; Kolesnick, Richard/0000-0002-1686-6162; Fu, Ya-Yuan/0000-0002-3894-0490; Calafiore, Marco/0000-0002-6594-0226; Dow, Lukas/0000-0001-7048-1418	National Institutes of Health [K08-HL115355, R01-HL125571, R01-HL069929, R01-AI100288, R01-AI080455, R01-AI101406, P01-CA023766/Project 4, K99-CA176376, P30-CA008748]; US National Institute of Allergy and Infectious Diseases (NIAID) [HHSN272200900059C]; European Union [GC220918]; Experimental Therapeutics Center of MSKCC; Lymphoma Foundation; Alex's Lemonade Stand; Geoffrey Beene Cancer Research Center at MSKCC; Susan and Peter Solomon Divisional Genomics Program; MSKCC Cycle for Survival; Lucille Castori Center for Microbes, Inflammation Cancer; Innovational Research Incentives Scheme Vidi grant from the Netherlands Organization for Scientific Research (Zon-MW) [91710377]; People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 under REA [289720]; Bio Medical Exchange Program of the Deutscher Akademischer Austauschdienst; Dutch Cancer Society [2013-5883]; mobility grant from the University Medical Center Utrecht; C.J. Martin fellowship from the Australian National Health and Medical Research Council; Scholar Award from the American Society of Hematology; Mechtild Harf Research Grant from the DKMS Foundation for Giving Life; New Investigator Award from the American Society for Blood and Marrow Transplantation; Amy Strelzer Manasevit Research Program; NATIONAL CANCER INSTITUTE [R01CA142826, K99CA176376, P30CA008748, P01CA023766, K22CA181280] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL115355, R01HL069929, R01HL125571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080455, R01AI101406, R01AI100288, U19AI116497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); European Union(European Commission); Experimental Therapeutics Center of MSKCC; Lymphoma Foundation; Alex's Lemonade Stand; Geoffrey Beene Cancer Research Center at MSKCC; Susan and Peter Solomon Divisional Genomics Program; MSKCC Cycle for Survival; Lucille Castori Center for Microbes, Inflammation Cancer; Innovational Research Incentives Scheme Vidi grant from the Netherlands Organization for Scientific Research (Zon-MW); People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 under REA; Bio Medical Exchange Program of the Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD)); Dutch Cancer Society(KWF Kankerbestrijding); mobility grant from the University Medical Center Utrecht; C.J. Martin fellowship from the Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of AustraliaUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Scholar Award from the American Society of Hematology; Mechtild Harf Research Grant from the DKMS Foundation for Giving Life; New Investigator Award from the American Society for Blood and Marrow Transplantation; Amy Strelzer Manasevit Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge the technical assistance of the MSKCC Research Animal Resource Center and Molecular Cytology Core Facility. We also thank H. Clevers, H. Farin, S. Middendorp, C. Wiegerinck, J. van Es, M. van de Wetering, N. Sasaki, J. Sun and M. Li for their advice and critical evaluation of our work. This research was supported by National Institutes of Health award numbers K08-HL115355 (A. M. H.), R01-HL125571 (A. M. H.), R01-HL069929 (M.R.M.vdB.), R01-AI100288 (M.R.M.vdB.), R01-AI080455 (M.R.M.vdB.), R01-AI101406 (M.R.M.vdB.), P01-CA023766/Project 4 (R. J. O'Reilly/M.R.M.vdB.), K99-CA176376 (J.A.D.) and P30-CA008748 (MSKCC Core Grant). Support was also received from the US National Institute of Allergy and Infectious Diseases (NIAID contract HHSN272200900059C), the European Union (award GC220918, C. Blackburn), The Experimental Therapeutics Center of MSKCC funded by Mr William H. Goodwin and Mrs Alice Goodwin, The Lymphoma Foundation, Alex's Lemonade Stand, The Geoffrey Beene Cancer Research Center at MSKCC, The Susan and Peter Solomon Divisional Genomics Program, MSKCC Cycle for Survival, and The Lucille Castori Center for Microbes, Inflammation & Cancer. T.C. was supported by Innovational Research Incentives Scheme Vidi grant 91710377 from the Netherlands Organization for Scientific Research (Zon-MW), and M. R.-H. was supported by the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013 under REA grant agreement no. 289720. A. M. M. was supported by the Bio Medical Exchange Program of the Deutscher Akademischer Austauschdienst. C.A.L. was supported by Dutch Cancer Society clinical fellowship grant 2013-5883 and by a mobility grant from the University Medical Center Utrecht. J.A.D. was supported by a C.J. Martin fellowship from the Australian National Health and Medical Research Council, a Scholar Award from the American Society of Hematology, and the Mechtild Harf Research Grant from the DKMS Foundation for Giving Life. A. M. H. was supported by a Scholar Award from the American Society of Hematology, a New Investigator Award from the American Society for Blood and Marrow Transplantation, and the Amy Strelzer Manasevit Research Program. A provisional patent application has been filed on the use of IL-22 and F-652 as ISC growth factors (US 61/901,151) with A. M. H., C.A.L. and M.R.M.vdB. listed as inventors.	Alpdogan O, 2003, J CLIN INVEST, V112, P1095, DOI 10.1172/JCI200317865; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; Couturier M, 2013, LEUKEMIA, V27, P1527, DOI 10.1038/leu.2013.39; Dudakov JA, 2015, ANNU REV IMMUNOL, V33, P747, DOI 10.1146/annurev-immunol-032414-112123; Dudakov JA, 2012, SCIENCE, V336, P91, DOI 10.1126/science.1218004; Durand A, 2012, P NATL ACAD SCI USA, V109, P8965, DOI 10.1073/pnas.1201652109; Eriguchi Y, 2013, BIOL BLOOD MARROW TR, V19, P1525, DOI 10.1016/j.bbmt.2013.07.027; Eriguchi Y, 2012, BLOOD, V120, P223, DOI 10.1182/blood-2011-12-401166; Hanash AM, 2012, IMMUNITY, V37, P339, DOI 10.1016/j.immuni.2012.05.028; Hernandez PP, 2015, NAT IMMUNOL, V16, P698, DOI 10.1038/ni.3180; Hill GR, 2000, BLOOD, V95, P2754, DOI 10.1182/blood.V95.9.2754.009k25_2754_2759; Jenq RR, 2012, J EXP MED, V209, P902, DOI 10.1084/jem.20112408; Kabiri Z, 2014, DEVELOPMENT, V141, P2206, DOI 10.1242/dev.104976; Levine JE, 2013, BLOOD, V122, P1505, DOI 10.1182/blood-2013-02-485813; Magness ST, 2013, AM J PHYSIOL-GASTR L, V305, pG542, DOI 10.1152/ajpgi.00481.2012; Matthews JR, 2011, CELL DEATH DIFFER, V18, P1934, DOI 10.1038/cdd.2011.77; Metcalfe C, 2014, CELL STEM CELL, V14, P149, DOI 10.1016/j.stem.2013.11.008; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Munneke JM, 2014, BLOOD, V124, P812, DOI 10.1182/blood-2013-11-536888; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Shroyer NF, 2007, GASTROENTEROLOGY, V132, P2478, DOI 10.1053/j.gastro.2007.03.047; Sonnenberg GF, 2015, NAT MED, V21, P698, DOI 10.1038/nm.3892; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takashima S, 2011, J EXP MED, V208, P285, DOI 10.1084/jem.20101559; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; Wang FC, 2013, GASTROENTEROLOGY, V145, P383, DOI 10.1053/j.gastro.2013.04.050; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zhao K, 2014, J INTERF CYTOK RES, V34, P707, DOI 10.1089/jir.2013.0099; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zhou WJ, 2013, NATURE, V501, P107, DOI 10.1038/nature12416	39	574	591	19	208	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2015	528	7583					560	+		10.1038/nature16460	http://dx.doi.org/10.1038/nature16460			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ3GH	26649819	Green Accepted			2022-12-28	WOS:000366991900054
J	Di Domizio, J; Gilliet, M				Di Domizio, Jeremy; Gilliet, Michel			Designer cells finely tuned for therapy	SCIENCE			English	Editorial Material							PSORIASIS; PATHOGENESIS		[Di Domizio, Jeremy; Gilliet, Michel] CHU Vaudois, Dept Dermatol, Univ Lausanne Hosp, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Di Domizio, J (corresponding author), CHU Vaudois, Dept Dermatol, Univ Lausanne Hosp, Lausanne, Switzerland.	michel.gilliet@chuv.ch	Di Domizio, Jeremy/L-1777-2019					Asadullah K, 1999, ARCH DERMATOL, V135, P187, DOI 10.1001/archderm.135.2.187; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Flutter B, 2013, EUR J IMMUNOL, V43, P3138, DOI 10.1002/eji.201343801; Ghoreschi K, 2003, NAT MED, V9, P40, DOI 10.1038/nm804; Griffiths CEM, 2007, LANCET, V370, P263, DOI 10.1016/S0140-6736(07)61128-3; Jacobs-Tulleneers-Thevissen D, 2013, DIABETOLOGIA, V56, P1605, DOI 10.1007/s00125-013-2906-0; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Schukur L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4964	9	5	5	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2015	350	6267					1478	1479		10.1126/science.aad9464	http://dx.doi.org/10.1126/science.aad9464			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY7LY	26680184				2022-12-28	WOS:000366591100036
J	Wu, JP; Yan, Z; Li, ZQ; Yan, CY; Lu, S; Dong, MQ; Yan, N				Wu, Jianping; Yan, Zhen; Li, Zhangqiang; Yan, Chuangye; Lu, Shan; Dong, Mengqiu; Yan, Nieng			Structure of the voltage-gated calcium channel Ca(v)1.1 complex	SCIENCE			English	Article							CA2+ CHANNEL; CRYSTAL-STRUCTURE; SKELETAL-MUSCLE; DIHYDROPYRIDINE RECEPTOR; BETA-SUBUNIT; DOMAIN; INSIGHT; IDENTIFICATION; ALPHA(2)DELTA; VISUALIZATION		[Wu, Jianping; Yan, Zhen; Li, Zhangqiang; Yan, Chuangye; Yan, Nieng] Tsinghua Univ, State Key Lab Membrane Biol, Beijing 100084, Peoples R China; [Wu, Jianping; Yan, Zhen; Li, Zhangqiang; Yan, Chuangye; Yan, Nieng] Tsinghua Univ, Tsinghua Peking Joint Ctr Life Sci, Beijing 100084, Peoples R China; [Wu, Jianping; Yan, Zhen; Li, Zhangqiang; Yan, Chuangye; Yan, Nieng] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, Beijing 100084, Peoples R China; [Wu, Jianping; Yan, Zhen; Li, Zhangqiang; Yan, Chuangye; Yan, Nieng] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Lu, Shan; Dong, Mengqiu] Natl Inst Biol Sci, Beijing 102206, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University; National Institute of Biological Sciences, Beijing	Yan, N (corresponding author), Tsinghua Univ, State Key Lab Membrane Biol, Beijing 100084, Peoples R China.	nyan@tsinghua.edu.cn	Lu, Shan/ABI-5830-2020; Yan, Chuangye/AAJ-5832-2021	Yan, Chuangye/0000-0001-9338-8048; Lu, Shan/0000-0003-4740-0610; Wu, Jianping/0000-0001-9869-7691; Yan, Zhen/0000-0002-1999-8451	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		ADAMS BA, 1990, NATURE, V346, P569, DOI 10.1038/346569a0; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anantharaman V, 2000, TRENDS BIOCHEM SCI, V25, P535, DOI 10.1016/S0968-0004(00)01672-8; Andronache Z, 2007, P NATL ACAD SCI USA, V104, P17885, DOI 10.1073/pnas.0704340104; Arikkath J, 2003, J BIOL CHEM, V278, P1212, DOI 10.1074/jbc.M208689200; Bannister RA, 2013, BBA-BIOMEMBRANES, V1828, P1587, DOI 10.1016/j.bbamem.2012.09.007; Bian F, 2006, BRAIN RES, V1075, P68, DOI 10.1016/j.brainres.2005.12.084; BLOCK BA, 1988, J CELL BIOL, V107, P2587, DOI 10.1083/jcb.107.6.2587; Brohawn SG, 2012, SCIENCE, V335, P436, DOI 10.1126/science.1213808; Buraei Z, 2010, PHYSIOL REV, V90, P1461, DOI 10.1152/physrev.00057.2009; Cao Y, 2011, NATURE, V471, P336, DOI 10.1038/nature09731; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Chen RS, 2007, CELL BIOCHEM BIOPHYS, V47, P178, DOI 10.1007/s12013-007-0002-0; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cloues RK, 2000, J GEN PHYSIOL, V116, P569, DOI 10.1085/jgp.116.4.569; Coffman K, 2014, J BIOL CHEM, V289, P4723, DOI 10.1074/jbc.M113.482067; Davies A, 2007, TRENDS PHARMACOL SCI, V28, P220, DOI 10.1016/j.tips.2007.03.005; DeLano W.L, PYMOL MOL GRAPHICS S; Dolphin AC, 2006, BRIT J PHARMACOL, V147, pS56, DOI 10.1038/sj.bjp.0706442; Dolphin AC, 2013, BBA-BIOMEMBRANES, V1828, P1541, DOI 10.1016/j.bbamem.2012.11.019; Dudley SC, 2000, J GEN PHYSIOL, V116, P679, DOI 10.1085/jgp.116.5.679; Ebashi S, 1968, Prog Biophys Mol Biol, V18, P123, DOI 10.1016/0079-6107(68)90023-0; ELLINOR PT, 1995, NEURON, V15, P1121, DOI 10.1016/0896-6273(95)90100-0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; FATT P, 1953, J PHYSIOL-LONDON, V120, P171, DOI 10.1113/jphysiol.1953.sp004884; Gurnett CA, 1997, J BIOL CHEM, V272, P18508, DOI 10.1074/jbc.272.29.18508; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hu HL, 2015, SCI REP-UK, V5, DOI 10.1038/srep08370; Jensen MO, 2012, SCIENCE, V336, P229, DOI 10.1126/science.1216533; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Kang MG, 2003, J BIOL CHEM, V278, P21315, DOI 10.1074/jbc.R300004200; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; Li RA, 2001, J BIOL CHEM, V276, P11072, DOI 10.1074/jbc.M010862200; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Li Z, 2011, EUR J PHARMACOL, V667, P80, DOI 10.1016/j.ejphar.2011.05.054; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Liu HY, 1996, J BIOL CHEM, V271, P13804, DOI 10.1074/jbc.271.23.13804; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Miller AN, 2012, SCIENCE, V335, P432, DOI 10.1126/science.1213274; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Miyazaki S, 2006, SEMIN CELL DEV BIOL, V17, P233, DOI 10.1016/j.semcdb.2006.02.007; Moran Y, 2014, GENOME BIOL EVOL, V6, P2210, DOI 10.1093/gbe/evu177; Murata K, 2010, J ELECTRON MICROSC, V59, P215, DOI 10.1093/jmicro/dfp059; NOWYCKY MC, 1985, NATURE, V316, P440, DOI 10.1038/316440a0; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; Paulsen CE, 2015, NATURE, V520, P511, DOI 10.1038/nature14367; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POWERS PA, 1992, J BIOL CHEM, V267, P22967; RIOS E, 1987, NATURE, V325, P717, DOI 10.1038/325717a0; Sager C, 2009, NEUROSCIENCE, V158, P45, DOI 10.1016/j.neuroscience.2007.12.046; Saitoh Y, 2015, SCIENCE, V347, P775, DOI 10.1126/science.1261833; Scheres SHW, 2015, J STRUCT BIOL, V189, P114, DOI 10.1016/j.jsb.2014.11.010; Serysheva II, 2002, P NATL ACAD SCI USA, V99, P10370, DOI 10.1073/pnas.162363499; Simske JS, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.25502; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Suzuki H, 2014, SCIENCE, V344, P304, DOI 10.1126/science.1248571; TAKEKURA H, 1994, BIOPHYS J, V67, P793, DOI 10.1016/S0006-3495(94)80539-9; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TANABE T, 1988, NATURE, V336, P134, DOI 10.1038/336134a0; Tang L, 2014, NATURE, V505, P56, DOI 10.1038/nature12775; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Van Petegem F, 2015, J MOL BIOL, V427, P31, DOI 10.1016/j.jmb.2014.08.004; Wang MC, 2002, J MOL BIOL, V323, P85, DOI 10.1016/S0022-2836(02)00890-2; Wolf M, 2003, J MOL BIOL, V332, P171, DOI 10.1016/S0022-2836(03)00899-4; Wu R, 2013, PROTEIN SCI, V22, P564, DOI 10.1002/pro.2237; Xie C, 2005, J GEN PHYSIOL, V126, P205, DOI 10.1085/jgp.200509293; Yan Z, 2015, NATURE, V517, P50, DOI 10.1038/nature14063; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; YANG J, 1993, NATURE, V366, P158, DOI 10.1038/366158a0; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zamponi GW, 2015, PHARMACOL REV, V67, P821, DOI 10.1124/pr.114.009654; Zhang X, 2013, CELL RES, V23, P444, DOI 10.1038/cr.2012.158; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054	78	192	201	7	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2015	350	6267							aad2395	10.1126/science.aad2395	http://dx.doi.org/10.1126/science.aad2395			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY7LY	26680202				2022-12-28	WOS:000366591100049
J	Daunton, A; Langman, G; Goulding, JMR				Daunton, Adam; Langman, Gerald; Goulding, J. M. R.			CASE REVIEW A cutaneous presentation of a common condition	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							METASTATIC CROHNS-DISEASE; HERPES-SIMPLEX-VIRUS		[Daunton, Adam] Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Hosp, Birmingham B15 2GW, W Midlands, England; [Langman, Gerald; Goulding, J. M. R.] Heart England NHS Fdn Trust, Solihull Hosp, Birmingham, W Midlands, England	University of Birmingham; Heart of England NHS Foundation Trust	Daunton, A (corresponding author), Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Hosp, Birmingham B15 2GW, W Midlands, England.	adamdaunton@nhs.net						BARDAZZI F, 1995, ACTA DERM-VENEREOL, V75, P324; Bloget F, 1996, ANN PATHOL, V16, P296; Carranza DC, 2008, J DRUGS DERMATOL, V7, P789; Carter MJ, 2004, GUT, V53, DOI 10.1136/gut.2004.043372; Casson DH, 2000, GUT, V47, P436, DOI 10.1136/gut.47.3.436; Feller ER, 2001, AM FAM PHYSICIAN, V64, P1725; Jaspreet Sarna, 2008, Indian Journal of Sexually Transmitted Diseases, V29, P98, DOI 10.4103/0253-7184.48735; Kurtzman DJB, 2014, J AM ACAD DERMATOL, V71, P804, DOI 10.1016/j.jaad.2014.04.002; LeBoeuf NR, 2010, CLIN EXP DERMATOL, V35, P557, DOI 10.1111/j.1365-2230.2010.03786.x; Lieb JA, 2008, CLIN INFECT DIS, V47, P1440, DOI 10.1086/592976; Lynch PJ, 1994, GENITAL DERMATOLOGY, P216; MOUNTAIN JC, 1970, GUT, V11, P18, DOI 10.1136/gut.11.1.18; PARKS AG, 1965, P ROY SOC MED, V58, P241, DOI 10.1177/003591576505800419; Rice S, 2013, BMC RES NOTES, V6, P1; Schneiderman PI, 2006, CLIN GUIDE DERMATOLO, P697; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	16	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 17	2015	351								h6711	10.1136/bmj.h6711	http://dx.doi.org/10.1136/bmj.h6711			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ4MS	26681202				2022-12-28	WOS:000367077900001
J	Karliner, J				Karliner, Josh			CLIMATE CHANGE The most important global public health agreement of the century	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Karliner, Josh] Hlth Care Without Harm, San Francisco, CA 94102 USA		Karliner, J (corresponding author), Hlth Care Without Harm, San Francisco, CA 94102 USA.	josh@hcwh.org							0	2	2	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 17	2015	351								h6878	10.1136/bmj.h6878	http://dx.doi.org/10.1136/bmj.h6878			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ4MS	26681606				2022-12-28	WOS:000367077900007
J	Chatterjee, AB				Chatterjee, Arjun B.			Review: Corticosteroids reduce mechanical ventilation and ARDS in inpatients with community-acquired pneumonia	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Chatterjee, Arjun B.] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC 27103 USA	Wake Forest University; Wake Forest Baptist Medical Center	Chatterjee, AB (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC 27103 USA.		chatterjee, arjun B/H-2689-2013	chatterjee, arjun B/0000-0001-8221-873X				Annane D, 2015, LANCET, V385, P1484, DOI 10.1016/S0140-6736(14)62391-6; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159	2	0	1	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	2015	163	12							JC2	10.7326/ACPJC-2015-163-12-002	http://dx.doi.org/10.7326/ACPJC-2015-163-12-002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY4BS	26666804				2022-12-28	WOS:000366354200002
J	Chapman, C; Slade, T				Chapman, Cath; Slade, Tim			CHRISTMAS 2015: THE PUBLICATION GAME Rejection of rejection: a novel approach to overcoming barriers to publication	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Chapman, Cath; Slade, Tim] Univ New S Wales, Natl Drug & Alcohol Res Ctr, NHMRC Ctr Res Excellence Mental Hlth & Subst, Sydney, NSW, Australia	University of New South Wales Sydney	Chapman, C (corresponding author), Univ New S Wales, Natl Drug & Alcohol Res Ctr, NHMRC Ctr Res Excellence Mental Hlth & Subst, Sydney, NSW, Australia.	c.chapman@unsw.edu.au	Slade, Tim/O-2031-2019; Chapman, Cath/AAD-7861-2022	Chapman, Cath/0000-0002-2460-6862					0	6	6	1	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 14	2015	351								h6326	10.1136/bmj.h6326	http://dx.doi.org/10.1136/bmj.h6326			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ4KY	26666424				2022-12-28	WOS:000367073200007
J	Danczak, A				Danczak, Avril			CHRISTMAS 2015: PROFESSIONAL CONSIDERATIONS British GPs keep going for longer: is the 12 second interruption history?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							COMMUNICATION; INTERVENTION		[Danczak, Avril] South Manchester NHS Fdn Trust, Univ Hosp, Wythenshawe Hosp,Educ & Res Ctr, Hlth Educ England Nouth West,Cent & South Manches, Manchester M23 9LT, Lancs, England	Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital	Danczak, A (corresponding author), South Manchester NHS Fdn Trust, Univ Hosp, Wythenshawe Hosp,Educ & Res Ctr, Hlth Educ England Nouth West,Cent & South Manches, Southmoor Rd, Manchester M23 9LT, Lancs, England.	avril.danczak@btinternet.com						BECKMAN HB, 1984, ANN INTERN MED, V101, P692, DOI 10.7326/0003-4819-101-5-692; Joos SK, 1996, J GEN INTERN MED, V11, P147, DOI 10.1007/BF02600266; PUTNAM SM, 1988, J GEN INTERN MED, V3, P38, DOI 10.1007/BF02595755; Rabiriowitz I, 2004, BMJ-BRIT MED J, V328, P501, DOI 10.1136/bmj.328.7438.501; Rhoades DR, 2001, FAM MED, V33, P528; Rhodes KV, 2004, ANN EMERG MED, V44, P262, DOI 10.1016/j.annemergmed.2004.02.035; Svab I, 1993, Aten Primaria, V11, P175; Wen L, 2012, DOCTORS DONT LISTEN	8	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 14	2015	351								h6136	10.1136/bmj.h6136	http://dx.doi.org/10.1136/bmj.h6136			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ4KY	26666416				2022-12-28	WOS:000367073200002
J	Debroy, B; Kumar, A				Debroy, Bibek; Kumar, Alok			The road to universal health coverage in India	LANCET			English	Editorial Material									[Debroy, Bibek; Kumar, Alok] NITI Aayog, New Delhi 110001, India		Debroy, B (corresponding author), NITI Aayog, Parliament St, New Delhi 110001, India.	bibek.debroy@gov.in						Banerjee AV, 2008, J EUR ECON ASSOC, V6, P487, DOI 10.1162/JEEA.2008.6.2-3.487; Central Bureau of Health Intelligence, 2015, NAT HLTH PROF 2015; Chaudhury N, 2006, J ECON PERSPECT, V20, P91, DOI 10.1257/089533006776526058; Coffey D, 2014, SOC SCI MED, V114, P89, DOI 10.1016/j.socscimed.2014.05.035; Das J, 2007, J DEV ECON, V83, P1, DOI 10.1016/j.jdeveco.2006.05.004; Jain N, 2015, EC POLITICAL WKLY, V46, P84; [Maternal Mortality Rate and LifeTime Risk; India EAG & Assam South and Other states Maternal Mortality Ratio], 2011, MMR B 2011 13; [Ministry of Statistics and Program Implementation Government of India National Sample Survey Organization], 2015, 71 ROUND KEY IND SOC, P10; Patel V, 2015, LANCET, V386, P2422, DOI 10.1016/S0140-6736(15)00955-1; Planning Commission of India, 2011, HIGH LEV EXP GROUP R; Reddy KS, 2011, LANCET, V377, P760, DOI 10.1016/S0140-6736(10)61960-5; Registrar General India, 2006, SRS B, V40; Registrar General India, 2014, SRS B, V49; Sub-Group of Chief Ministers on Rationalization of Centrally Sponsored Schemes, 2015, REP SUBGROUP CHIEF M	14	4	4	1	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 12	2015	386	10011					E56	E57		10.1016/S0140-6736(15)01173-3	http://dx.doi.org/10.1016/S0140-6736(15)01173-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CY3EE	26700533				2022-12-28	WOS:000366290400001
J	Rosenbaum, JT				Rosenbaum, James T.			The Immune Response - Learning to Leave Well Enough Alone	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INNATE LYMPHOID-CELLS; COMMENSAL BACTERIA		[Rosenbaum, James T.] Casey Eye Inst, Portland, OR 97239 USA; [Rosenbaum, James T.] Legacy Devers Eye Inst, Portland, OR USA	Devers Eye Institute	Rosenbaum, JT (corresponding author), Casey Eye Inst, Portland, OR 97239 USA.							Hepworth MR, 2015, SCIENCE, V348, P1031, DOI 10.1126/science.aaa4812; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; McGonagle D, 2006, PLOS MED, V3, P1242, DOI 10.1371/journal.pmed.0030297; Sonnenberg GF, 2015, NAT MED, V21, P698, DOI 10.1038/nm.3892	4	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 10	2015	373	24					2378	2379		10.1056/NEJMcibr1511284	http://dx.doi.org/10.1056/NEJMcibr1511284			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY0QW	26650158				2022-12-28	WOS:000366111600016
J	McCarthy, M				McCarthy, Michael			Only 22% of UK GPs think NHS works well, down from half in 2013, new survey shows	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Osborn R, 2015, HEALTH AFFAIR, V34, P2104, DOI 10.1377/hlthaff.2015.1018; Schoen C, 2012, HEALTH AFFAIR, V31, P2805, DOI 10.1377/hlthaff.2012.0884	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 7	2015	351								h6639	10.1136/bmj.h6639	http://dx.doi.org/10.1136/bmj.h6639			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY5SM	26643571				2022-12-28	WOS:000366467700012
J	Fulton, O				Fulton, Olivia			WHAT YOUR PATIENT IS THINKING Just relax and concentrate on your breathing	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material															Asthma UK [AUK-AC-2012-01] Funding Source: researchfish	Asthma UK		Scottish Government, ANT CAR PLANN FREQ A	1	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 3	2015	351								h6185	10.1136/bmj.h6185	http://dx.doi.org/10.1136/bmj.h6185			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX9EZ	26634273	Bronze			2022-12-28	WOS:000366009100002
J	Rajpert-De Meyts, E; McGlynn, KA; Okamoto, K; Jewett, MAS; Bokemeyer, C				Rajpert-De Meyts, Ewa; McGlynn, Katherine A.; Okamoto, Keisei; Jewett, Michael A. S.; Bokemeyer, Carsten			Testicular germ cell tumours	LANCET			English	Review							CARCINOMA-IN-SITU; HIGH-DOSE CHEMOTHERAPY; CANCER-STUDY-GROUP; LYMPH-NODE DISSECTION; RANDOMIZED PHASE-III; SUBCENTIMETER RESIDUAL MASS; MEDICAL-RESEARCH-COUNCIL; LONG-TERM SURVIVORS; OF-THE-LITERATURE; FOLLOW-UP	Testicular germ cell tumours are at the crossroads of developmental and neoplastic processes. Their cause has not been fully elucidated but differences in incidences suggest that a combination of genetic and environment factors are involved, with environmental factors predominating early in life. Substantial progress has been made in understanding genetic susceptibility in the past 5 years on the basis of the results of large genome-wide association studies. Testicular germ cell tumours are highly sensitive to radiotherapy and chemotherapy and hence have among the best outcomes of all tumours. Because the tumours occur mainly in young men, preservation of reproductive function, quality of life after treatment, and late effects are crucial concerns. In this Seminar, we provide an overview of advances in the understanding of the epidemiology, genetics, and biology of testicular germ cell tumours. We also summarise the consensus on how to treat testicular germ cell tumours and focus on a few controversies and improvements in the understanding of late effects of treatment and quality of life for survivors.	[Rajpert-De Meyts, Ewa] Rigshosp, Copenhagen Univ Hosp, Dept Growth & Reprod, DK-2100 Copenhagen, Denmark; [Rajpert-De Meyts, Ewa] Int Ctr Res & Res Training Endocrine Disrupting E, Copenhagen, Denmark; [McGlynn, Katherine A.] NCI, Div Canc Epidemiol & Genet, NIH, Rockville, MD USA; [Okamoto, Keisei] Shiga Univ Med Sci, Dept Urol, Shiga 5202192, Japan; [Jewett, Michael A. S.] Univ Hlth Network, Princess Margaret Canc Ctr, Dept Surg Urol, Toronto, ON, Canada; [Jewett, Michael A. S.] Univ Hlth Network, Princess Margaret Canc Ctr, Dept Surg Oncol, Toronto, ON, Canada; [Jewett, Michael A. S.] Univ Toronto, Toronto, ON, Canada; [Bokemeyer, Carsten] Univ Hosp Hamburg Eppendorf, Dept Med, Dept Oncol Haematol Bone Marrow Transplantat, Sect Pneumol, Hamburg, Germany	Rigshospitalet; University of Copenhagen; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Shiga University of Medical Science; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Hamburg; University Medical Center Hamburg-Eppendorf	Okamoto, K (corresponding author), Shiga Univ Med Sci, Dept Urol, Shiga 5202192, Japan.	keisei@belle.shiga-med.ac.jp	Rajpert-De Meyts, Ewa/H-6526-2019	Rajpert-De Meyts, Ewa/0000-0002-5946-7559	Danish Cancer Society; National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIACP010126] Funding Source: NIH RePORTER	Danish Cancer Society(Danish Cancer Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Kahori Minami for assistance in the collection and collation of reference material. Our work was supported by grants from the Danish Cancer Society (to ERDM), and the National Cancer Institute's Intramural Research Program (to KAM), but the supporting institutes had no role in this Seminar.	Alagaratnam S, 2011, INT J ANDROL, V34, pE133, DOI 10.1111/j.1365-2605.2011.01169.x; Albers P, 2003, J CLIN ONCOL, V21, P1505, DOI 10.1200/JCO.2003.07.169; Albers P, 2008, J CLIN ONCOL, V26, P2966, DOI 10.1200/JCO.2007.12.0899; Albers P, 2015, EUR UROL, V68, P1054, DOI 10.1016/j.eururo.2015.07.044; Almstrup K, 2004, CANCER RES, V64, P4736, DOI 10.1158/0008-5472.CAN-04-0679; Almstrup K, 2011, INT J ANDROL, V34, pE21, DOI 10.1111/j.1365-2605.2011.01192.x; Almstrup K, 2010, BRIT J CANCER, V103, P1269, DOI 10.1038/sj.bjc.6605880; ATKIN NB, 1982, LANCET, V2, P1349; Bang AK, 2009, INT J RADIAT ONCOL, V75, P672, DOI 10.1016/j.ijrobp.2008.11.057; Beard CJ, 2015, J NATL COMPR CANC NE, V13, P811, DOI 10.6004/jnccn.2015.0094; Beck SDW, 2009, WORLD J UROL, V27, P485, DOI 10.1007/s00345-009-0452-7; Beyer J, 2013, ANN ONCOL, V24, P878, DOI 10.1093/annonc/mds579; Beyer J, 2010, J CLIN ONCOL, V28, P4906, DOI 10.1200/JCO.2009.26.8128; Biermann K, 2007, J PATHOL, V213, P311, DOI 10.1002/path.2225; Bokemeyer C, 2004, BRIT J CANCER, V91, P683, DOI 10.1038/sj.bjc.6602020; Calabro F, 2012, EUR UROL, V61, P1212, DOI 10.1016/j.eururo.2012.03.038; Carver BS, 2007, J CLIN ONCOL, V25, P5603, DOI 10.1200/JCO.2007.13.6283; Chau C, 2015, ANN ONCOL, V26, P1865, DOI 10.1093/annonc/mdv254; Chia VM, 2010, CANCER EPIDEM BIOMAR, V19, P1151, DOI 10.1158/1055-9965.EPI-10-0031; Christian JA, 2003, J CLIN ONCOL, V21, P871, DOI 10.1200/JCO.2003.05.155; Chung CC, 2013, NAT GENET, V45, P680, DOI 10.1038/ng.2634; Collette L, 1999, JNCI-J NATL CANCER I, V91, P839, DOI 10.1093/jnci/91.10.839; Cook MB, 2011, INT J ANDROL, V34, pE68, DOI 10.1111/j.1365-2605.2011.01171.x; Cook MB, 2010, INT J EPIDEMIOL, V39, P1605, DOI 10.1093/ije/dyq120; Cook MB, 2009, INT J EPIDEMIOL, V38, P1532, DOI 10.1093/ije/dyp287; Culine S, 2007, ANN ONCOL, V18, P917, DOI 10.1093/annonc/mdm062; Culine S, 2008, J CLIN ONCOL, V26, P421, DOI 10.1200/JCO.2007.13.8461; Cvancarova M, 2009, J CLIN ONCOL, V27, P334, DOI 10.1200/JCO.2007.15.3130; Daling JR, 2009, CANCER, V115, P1215, DOI 10.1002/cncr.24159; Daneshmand S, 2011, UROL ONCOL-SEMIN ORI, V29, P842, DOI 10.1016/j.urolonc.2011.05.018; Daugaard G, 2011, ANN ONCOL, V22, P1054, DOI 10.1093/annonc/mdq575; Daugaard G, 2014, J CLIN ONCOL, V32, P3817, DOI 10.1200/JCO.2013.53.5831; De Santis M, 2004, J CLIN ONCOL, V22, P1034, DOI 10.1200/JCO.2004.07.188; de Wit R, 2012, J CLIN ONCOL, V30, P792, DOI 10.1200/JCO.2011.37.0171; Del Mazo J, 2013, INT J DEV BIOL, V57, P225, DOI 10.1387/ijdb.130042jd; Dieckmann KP, 2011, INT J ANDROL, V34, pE7, DOI 10.1111/j.1365-2605.2011.01152.x; Dieckmann KP, 2012, BRIT J CANCER, V107, P1754, DOI 10.1038/bjc.2012.469; Ehrlich Y, 2010, J CLIN ONCOL, V28, P531, DOI 10.1200/JCO.2009.23.0714; Einhorn LH, 2007, NEW ENGL J MED, V357, P340, DOI 10.1056/NEJMoa067749; EINHORN LH, 1989, J CLIN ONCOL, V7, P387, DOI 10.1200/JCO.1989.7.3.387; Fankhauser CD, 2015, BRIT J CANCER, V113, P411, DOI 10.1038/bjc.2015.244; Feldman DR, 2010, J CLIN ONCOL, V28, P1706, DOI 10.1200/JCO.2009.25.1561; Ferlay J, 2014, GLOBOCAN 2012 V1 0 C, V11; Ferlin A, 2010, ENDOCR-RELAT CANCER, V17, P17, DOI 10.1677/ERC-09-0176; Fizazi K, 2008, ANN ONCOL, V19, P259, DOI 10.1093/annonc/mdm472; Fizazi K, 2014, LANCET ONCOL, V15, P1442, DOI 10.1016/S1470-2045(14)70490-5; Fleer J, 2006, SUPPORT CARE CANCER, V14, P251, DOI 10.1007/s00520-005-0879-3; Fossa SD, 2005, JNCI-J NATL CANCER I, V97, P1056, DOI 10.1093/jnci/dji185; Fung C, 2015, J CLIN ONCOL, V33, P3105, DOI 10.1200/JCO.2014.60.3654; Gillis AJM, 2007, J PATHOL, V213, P319, DOI 10.1002/path.2230; Gillis AJM, 2013, MOL ONCOL, V7, P1083, DOI 10.1016/j.molonc.2013.08.002; Goddard NC, 2007, INT J ANDROL, V30, P337, DOI 10.1111/j.1365-2605.2007.00769.x; Goriely A, 2009, NAT GENET, V41, P1247, DOI 10.1038/ng.470; GRIGOR KM, 1993, EUR UROL, V23, P93; Groll RJ, 2007, CRIT REV ONCOL HEMAT, V64, P182, DOI 10.1016/j.critrevonc.2007.04.014; Harris M, 2006, BRIT MED J, V332, P837, DOI 10.1136/bmj.332.7545.837; Haugnes HS, 2007, ANN ONCOL, V18, P241, DOI 10.1093/annonc/mdl372; Heidenreich A, 2009, BJU INT, V104, P1346, DOI 10.1111/j.1464-410X.2009.08857.x; Hemminki K, 2004, BRIT J CANCER, V90, P1765, DOI 10.1038/sj.bjc.6601714; Herr HW, 1997, J UROLOGY, V157, P860, DOI 10.1016/S0022-5347(01)65065-1; Honecker F, 2009, J CLIN ONCOL, V27, P2129, DOI 10.1200/JCO.2008.18.8623; Horwich A, 2014, BRIT J CANCER, V110, P256, DOI 10.1038/bjc.2013.551; Huddart RA, 2005, BRIT J CANCER, V93, P200, DOI 10.1038/sj.bjc.6602677; JEWETT MAS, 1988, J UROLOGY, V139, P1220, DOI 10.1016/S0022-5347(17)42869-2; Jorgensen A, 2013, J PATHOL, V229, P588, DOI 10.1002/path.4154; Kanetsky PA, 2011, HUM MOL GENET, V20, P3109, DOI 10.1093/hmg/ddr207; Kanetsky PA, 2009, NAT GENET, V41, P811, DOI 10.1038/ng.393; Karlsson R, 2013, HUM MOL GENET, V22, P3373, DOI 10.1093/hmg/ddt188; Kawakami T, 2006, ONCOGENE, V25, P3225, DOI 10.1038/sj.onc.1209362; Kharazmi E, 2015, EUR UROL, V68, P283, DOI 10.1016/j.eururo.2014.12.031; Kleinschmidt K, 2009, ONCOLOGY-BASEL, V77, P33, DOI 10.1159/000218202; Kollmannsberger C, 1998, J CLIN ONCOL, V16, P3386, DOI 10.1200/JCO.1998.16.10.3386; Kollmannsberger C, 2008, EXPERT OPIN PHARMACO, V9, P2259, DOI 10.1517/14656566.9.13.2259 ; Kollmannsberger C, 2015, J CLIN ONCOL, V33, P51, DOI 10.1200/JCO.2014.56.2116; Kollmannsberger C, 2010, J CLIN ONCOL, V28, P537, DOI 10.1200/JCO.2009.23.0755; Kondagunta GV, 2005, J CLIN ONCOL, V23, P6549, DOI 10.1200/JCO.2005.19.638; Kristensen DG, 2014, BRIT J CANCER, V110, P668, DOI 10.1038/bjc.2013.727; Kristiansen W, 2012, HUM REPROD, V27, P1525, DOI 10.1093/humrep/des075; Lackner JE, 2009, UROLOGY, V74, P825, DOI 10.1016/j.urology.2009.03.051; Lacson JCA, 2012, CANCER-AM CANCER SOC, V118, P5374, DOI 10.1002/cncr.27554; Lawrentschuk N, 2011, J UROLOGY, V185, P508, DOI 10.1016/j.juro.2010.09.072; Lerro CC, 2010, BRIT J CANCER, V103, P1467, DOI 10.1038/sj.bjc.6605934; Lerro CC, 2014, UROL ONCOL, V32, pe15; Leung E, 2013, BJU INT, V112, P1088, DOI 10.1111/bju.12330; Looijenga LHJ, 2003, CANCER RES, V63, P2244; Lorch A, 2012, J CLIN ONCOL, V30, P800, DOI 10.1200/JCO.2011.38.6391; Lorch A, 2011, J CLIN ONCOL, V29, P2178, DOI 10.1200/JCO.2010.32.6678; Lottrup G, 2013, J CLIN ENDOCR METAB, V98, P2223, DOI 10.1210/jc.2013-1278; Massard C, 2010, ANN ONCOL, V21, P1585, DOI 10.1093/annonc/mdq021; Matson CK, 2011, NATURE, V476, P101, DOI 10.1038/nature10239; Maule M, 2012, INT J ANDROL, V35, P828, DOI 10.1111/j.1365-2605.2012.01286.x; Mazaud-Guittot S, 2013, J CLIN ENDOCR METAB, V98, pE1757, DOI 10.1210/jc.2013-2531; McGlynn KA, 2012, NAT REV UROL, V9, P339, DOI 10.1038/nrurol.2012.61; MEAD GM, 1992, J CLIN ONCOL, V10, P85, DOI 10.1200/JCO.1992.10.1.85; Mead GM, 1997, J CLIN ONCOL, V15, P594; Minami K, 2010, CLIN CANCER RES, V16, P2751, DOI 10.1158/1078-0432.CCR-09-3338; MOLLER H, 1989, J NATL CANCER I, V81, P1668, DOI 10.1093/jnci/81.21.1668-a; Moller H, 1999, BMJ-BRIT MED J, V318, P559, DOI 10.1136/bmj.318.7183.559; Mortensen MS, 2014, EUR UROL, V66, P1172, DOI 10.1016/j.eururo.2014.07.001; Motzer RJ, 2007, J CLIN ONCOL, V25, P247, DOI 10.1200/JCO.2005.05.4528; Nathanson KL, 2005, AM J HUM GENET, V77, P1034, DOI 10.1086/498455; Nettersheim D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082881; Netto GJ, 2008, MODERN PATHOL, V21, P1337, DOI 10.1038/modpathol.2008.127; Nichols CR, 2013, J CLIN ONCOL, V31, P3490, DOI 10.1200/JCO.2012.47.6010; Novotny GW, 2012, ENDOCR-RELAT CANCER, V19, P365, DOI 10.1530/ERC-11-0271; Nur U, 2012, CANCER EPIDEMIOL, V36, P217, DOI 10.1016/j.canep.2011.07.008; Oechsle K, 2011, EUR UROL, V60, P850, DOI 10.1016/j.eururo.2011.06.019; Okamoto K, 2012, INT J UROL, V19, P504, DOI 10.1111/j.1442-2042.2012.02986.x; Oldenburg J, 2013, ANN ONCOL, V24, P125, DOI 10.1093/annonc/mdt304; Oliver RTD, 2011, J CLIN ONCOL, V29, P957, DOI 10.1200/JCO.2009.26.4655; Oosterhuis JW, 2005, NAT REV CANCER, V5, P210, DOI 10.1038/nrc1568; OOSTERHUIS JW, 1989, LAB INVEST, V60, P14; Pathak A, 2015, ENDOCR-RELAT CANCER, V22, P909, DOI 10.1530/ERC-15-0034; PEDERSENBJERGAARD J, 1991, LANCET, V338, P359, DOI 10.1016/0140-6736(91)90490-G; Petersen PM, 2002, J CLIN ONCOL, V20, P1537, DOI 10.1200/JCO.20.6.1537; Pettus JA, 2009, UROLOGY, V73, P328, DOI 10.1016/j.urology.2008.08.501; Pleskacova J, 2010, SEX DEV, V4, P259, DOI 10.1159/000314536; Powles TB, 2005, BJU INT, V95, P1197, DOI 10.1111/j.1464-410X.2005.05504.x; Rajpert-De Meyts E, 2006, HUM REPROD UPDATE, V12, P303, DOI 10.1093/humupd/dmk006; Rapley EA, 2009, NAT GENET, V41, P807, DOI 10.1038/ng.394; Rossen PB, 2009, J CLIN ONCOL, V27, P5993, DOI 10.1200/JCO.2008.19.6931; Ruark E, 2013, NAT GENET, V45, P686, DOI 10.1038/ng.2635; Rud CN, 2013, J UROLOGY, V190, P2074, DOI 10.1016/j.juro.2013.06.023; Rustin GJ, 2007, J CLIN ONCOL, V25, P1310, DOI 10.1200/JCO.2006.08.4889; Schmoll HJ, 2003, J CLIN ONCOL, V21, P4083, DOI 10.1200/JCO.2003.09.035; Shanmugalingam Thurkaa, 2013, Clin Epidemiol, V5, P417, DOI 10.2147/CLEP.S34430; Skaali T, 2011, PSYCHO-ONCOLOGY, V20, P369, DOI 10.1002/pon.1737; Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972; SKAKKEBAEK NE, 1972, LANCET, V2, P516; Skotheim RI, 2005, CANCER RES, V65, P5588, DOI 10.1158/0008-5472.CAN-05-0153; Smiraglia DJ, 2002, ONCOGENE, V21, P3909, DOI 10.1038/sj.onc.1205488; Sobin LH, 2010, CANCER-AM CANCER SOC, V116, P5336, DOI 10.1002/cncr.25537; Sonne SB, 2009, CANCER RES, V69, P5241, DOI 10.1158/0008-5472.CAN-08-4554; Sprauten M, 2012, J CLIN ONCOL, V30, P300, DOI 10.1200/JCO.2011.37.4025; Sturgeon JF, 2011, EUR UROL, V59, P556, DOI 10.1016/j.eururo.2010.12.010; Subramanian VS, 2010, UROL ONCOL-SEMIN ORI, V28, P504, DOI 10.1016/j.urolonc.2008.10.026; Swerdlow AJ, 1997, LANCET, V350, P1723, DOI 10.1016/S0140-6736(97)05526-8; Tandstad T, 2014, ANN ONCOL, V25, P2167, DOI 10.1093/annonc/mdu375; Tandstad T, 2011, J CLIN ONCOL, V29, P719, DOI 10.1200/JCO.2010.30.1044; Tarin TV, 2009, J UROLOGY, V181, P627, DOI 10.1016/j.juro.2008.10.005; Tian QS, 1999, AM J PATHOL, V154, P1643, DOI 10.1016/S0002-9440(10)65419-3; Trabert B, 2013, INT J CANCER, V133, P1900, DOI 10.1002/ijc.28207; Travis LB, 2005, JNCI-J NATL CANCER I, V97, P1354, DOI 10.1093/jnci/dji278; Travis LB, 2010, JNCI-J NATL CANCER I, V102, P1114, DOI 10.1093/jnci/djq216; Turnbull C, 2010, NAT GENET, V42, P604, DOI 10.1038/ng.607; Ulbright TM, 2016, WHO CLASSIFICATION T, P189; Ushida H, 2012, MOL CARCINOGEN, V51, P711, DOI 10.1002/mc.20831; van den Belt-Dusebout AW, 2007, J CLIN ONCOL, V25, P4370, DOI 10.1200/JCO.2006.10.5296; Vergouwe Y, 2001, J UROLOGY, V165, P84, DOI 10.1097/00005392-200101000-00021; Vergouwe Y, 2003, J CLIN ONCOL, V21, P4092, DOI 10.1200/JCO.2003.01.094; VONDERMAASE H, 1986, BRIT MED J, V293, P1398, DOI 10.1136/bmj.293.6559.1398; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wanderas EH, 1997, EUR J CANCER, V33, P253, DOI 10.1016/S0959-8049(96)00458-3; Wermann H, 2010, J PATHOL, V221, P433, DOI 10.1002/path.2725; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; Wethal T, 2007, J Cancer Surviv, V1, P8, DOI 10.1007/s11764-007-0012-3; Willemse PM, 2013, BRIT J CANCER, V109, P60, DOI 10.1038/bjc.2013.226	157	181	184	2	25	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 23	2016	387	10029					1762	1774		10.1016/S0140-6736(15)00991-5	http://dx.doi.org/10.1016/S0140-6736(15)00991-5			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ9OD	26651223				2022-12-28	WOS:000374541900029
J	Maertens, JA; Raad, II; Marr, KA; Patterson, TF; Kontoyiannis, DP; Cornely, OA; Bow, EJ; Rahav, G; Neofytos, D; Aoun, M; Baddley, JW; Giladi, M; Heinz, WJ; Herbrecht, R; Hope, W; Karthaus, M; Lee, DG; Lortholary, O; Morrison, VA; Oren, I; Selleslag, D; Shoham, S; Thompson, GR; Lee, M; Maher, RM; Schmitt-Hoffmann, AH; Zeiher, B; Ullmann, AJ				Maertens, Johan A.; Raad, Issam I.; Marr, Kieren A.; Patterson, Thomas F.; Kontoyiannis, Dimitrios P.; Cornely, Oliver A.; Bow, Eric J.; Rahav, Galia; Neofytos, Dionysios; Aoun, Mickael; Baddley, John W.; Giladi, Michael; Heinz, Werner J.; Herbrecht, Raoul; Hope, William; Karthaus, Meinolf; Lee, Dong-Gun; Lortholary, Olivier; Morrison, Vicki A.; Oren, Ilana; Selleslag, Dominik; Shoham, Shmuel; Thompson, George R., III; Lee, Misun; Maher, Rochelle M.; Schmitt-Hoffmann, Anne-Hortense; Zeiher, Bernhardt; Ullmann, Andrew J.			Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial	LANCET			English	Article							PHARMACODYNAMIC TARGET DETERMINATION; LIPOSOMAL AMPHOTERICIN-B; CELL TRANSPLANT PATIENTS; MYCOSES STUDY-GROUP; EUROPEAN-ORGANIZATION; PULMONARY ASPERGILLOSIS; CLINICAL-PRACTICE; THERAPY; INFECTIONS; CANCER	Background Isavuconazole is a novel triazole with broad-spectrum antifungal activity. The SECURE trial assessed efficacy and safety of isavuconazole versus voriconazole in patients with invasive mould disease. Methods This was a phase 3, double-blind, global multicentre, comparative-group study. Patients with suspected invasive mould disease were randomised in a 1: 1 ratio using an interactive voice-web response system, stratified by geographical region, allogeneic haemopoietic stem cell transplantation, and active malignant disease at baseline, to receive isavuconazonium sulfate 372 mg (prodrug; equivalent to 200 mg isavuconazole; intravenously three times a day on days 1 and 2, then either intravenously or orally once daily) or voriconazole (6 mg/kg intravenously twice daily on day 1, 4 mg/kg intravenously twice daily on day 2, then intravenously 4 mg/kg twice daily or orally 200 mg twice daily from day 3 onwards). We tested non-inferiority of the primary efficacy endpoint of all-cause mortality from first dose of study drug to day 42 in patients who received at least one dose of the study drug (intention-to-treat [ITT] population) using a 10% non-inferiority margin. Safety was assessed in patients who received the first dose of study drug. This study is registered with ClinicalTrials.gov, number NCT00412893. Findings 527 adult patients were randomly assigned (258 received study medication per group) between March 7, 2007, and March 28, 2013. All-cause mortality from first dose of study drug to day 42 for the ITT population was 19% with isavuconazole (48 patients) and 20% with voriconazole (52 patients), with an adjusted treatment difference of -1.0% (95% CI -7.8 to 5.7). Because the upper bound of the 95% CI (5.7%) did not exceed 10%, non-inferiority was shown. Most patients (247 [96%] receiving isavuconazole and 255 [98%] receiving voriconazole) had treatment-emergent adverse events (p=0.122); the most common were gastrointestinal disorders (174 [68%] vs 180 [69%]) and infections and infestations (152 [59%] vs 158 [61%]). Proportions of patients with treatment-emergent adverse events by system organ class were similar overall. However, isavuconazole-treated patients had a lower frequency of hepatobiliary disorders (23 [9%] vs 42 [16%]; p=0.016), eye disorders (39 [15%] vs 69 [27%]; p=0.002), and skin or subcutaneous tissue disorders (86 [33%] vs 110 [42%]; p=0.037). Drug-related adverse events were reported in 109 (42%) patients receiving isavuconazole and 155 (60%) receiving voriconazole (p<0.001). Interpretation Isavuconazole was non-inferior to voriconazole for the primary treatment of suspected invasive mould disease. Isavuconazole was well tolerated compared with voriconazole, with fewer study-drug-related adverse events. Our results support the use of isavuconazole for the primary treatment of patients with invasive mould disease.	[Maertens, Johan A.] Katholieke Univ Leuven, Univ Ziekenhuizen Leuven, Dept Hematol, Louvain, Belgium; [Raad, Issam I.] Univ Texas MD Anderson Canc Ctr, Dept Infect Dis Infect Control & Employee Hlth, Houston, TX 77030 USA; [Marr, Kieren A.; Shoham, Shmuel] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Marr, Kieren A.] Johns Hopkins Univ, Dept Oncol, Baltimore, MD USA; [Neofytos, Dionysios] Johns Hopkins Univ, Div Infect Dis, Baltimore, MD USA; [Patterson, Thomas F.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Patterson, Thomas F.] South Texas Vet Hlth Care Syst, San Antonio, TX USA; [Kontoyiannis, Dimitrios P.] Univ Texas MD Anderson Canc Ctr, Dept Infect Dis, Houston, TX 77030 USA; [Cornely, Oliver A.] Univ Cologne, ZKS Koln Ctr Integrated Oncol CIO Koln Bonn, Cologne Excellence Cluster Cellular Stress Respon, Dept Internal Med,Clin Trials Ctr Cologne,German, D-50931 Cologne, Germany; [Bow, Eric J.] Univ Manitoba, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada; [Bow, Eric J.] Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada; [Bow, Eric J.] CancerCare Manitoba, Infect Control Serv, Winnipeg, MB, Canada; [Rahav, Galia] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel; [Rahav, Galia] Tel Aviv Univ, Sackler Sch Med, Ramat Gan, Israel; [Aoun, Mickael] Inst Jules Bordet, Div Infect Dis, B-1000 Brussels, Belgium; [Baddley, John W.] Univ Alabama Birmingham, Birmingham, AL USA; [Baddley, John W.] Vet Affairs Med Ctr, Birmingham, AL USA; [Giladi, Michael] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Infect Dis Unit, IL-69978 Tel Aviv, Israel; [Giladi, Michael] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Heinz, Werner J.] Univ Wurzburg, Med Ctr, D-97070 Wurzburg, Germany; [Herbrecht, Raoul] Hop Univ Strasbourg, Dept Hematol & Oncol, Strasbourg, France; [Herbrecht, Raoul] Univ Strasbourg, Strasbourg, France; [Hope, William] Univ Liverpool, Dept Mol & Clin Pharmacol, Liverpool L69 3BX, Merseyside, England; [Karthaus, Meinolf] Klinikum Neuperlach, Klin Hamatol & Onkol, Munich, Germany; [Lee, Dong-Gun] Catholic Univ Korea, Seoul St Marys Hosp, Dept Internal Med, Div Infect Dis, Seoul, South Korea; [Lortholary, Olivier] Univ Paris 05, Ctr Infectiol Necker Pasteur, Hop Necker Enfants Malades, IHU Imagine, Paris, France; [Lortholary, Olivier] Inst Pasteur, Ctr Natl Reference Mycoses Invas & Antifong, Paris, France; [Morrison, Vicki A.] Univ Minnesota, Minneapolis, MN USA; [Morrison, Vicki A.] Vet Affairs Med Ctr, Minneapolis, MN USA; [Oren, Ilana] Rambam Hlth Care Campus, Infect Dis Unit, Haifa, Israel; [Oren, Ilana] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel; [Selleslag, Dominik] Algemeen Ziekenhuis St Jan, Brugge, Belgium; [Thompson, George R., III] Univ Calif Davis, Med Ctr, Davis, CA 95616 USA; [Lee, Misun; Maher, Rochelle M.; Zeiher, Bernhardt] Astellas Pharma Global Dev, Northbrook, IL USA; [Schmitt-Hoffmann, Anne-Hortense] Basilea Pharmaceut Int, Basel, Switzerland; [Ullmann, Andrew J.] Univ Wurzburg, Dept Internal Med 2, Infect Dis, Oderdurrbacher Str 6, D-97080 Wurzburg, Germany	KU Leuven; University Hospital Leuven; University of Texas System; UTMD Anderson Cancer Center; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; UTMD Anderson Cancer Center; University of Cologne; University of Manitoba; University of Manitoba; CancerCare Manitoba Foundation; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Institut Jules Bordet; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; University of Wurzburg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Liverpool; Munchen Klinik; Catholic University of Korea; Seoul St. Mary's Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of California System; University of California Davis; Astellas Pharmaceuticals; Basilea Pharmaceutica Ltd.; University of Wurzburg	Ullmann, AJ (corresponding author), Univ Wurzburg, Dept Internal Med 2, Infect Dis, Oderdurrbacher Str 6, D-97080 Wurzburg, Germany.	andrew.ullmann@uni-wuerzburg.de	Cornely, Oliver A./J-5095-2013; Giladi, Michael/AAQ-6176-2020; Giladi, Michael/GVU-6295-2022; Herbrecht, Raoul/GVU-1333-2022; Heinz, Werner/X-4470-2019; Neofytos, Dionysios/ABE-2214-2020; Ullmann, AJ/AAQ-1724-2021; Lee, Dong-Gun/AGF-9891-2022; Herbrecht, Raoul/AAT-1763-2021	Cornely, Oliver A./0000-0001-9599-3137; Heinz, Werner/0000-0002-7833-9202; Neofytos, Dionysios/0000-0001-6970-2869; Lee, Dong-Gun/0000-0003-4655-0641; Herbrecht, Raoul/0000-0002-9381-4876; Patterson, Thomas/0000-0002-9513-7127; Hope, William/0000-0001-6187-878X	Astellas Pharma Global Development; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Astellas Pharma Global Development(Astellas Pharmaceuticals); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Isavuconazole was co-developed by Astellas Pharma US and Basilea Pharmaceutica International. We acknowledge the contributions of the medical director of the SECURE trial, Neddie Zadeikis (Astellas Pharma Global Development during the conduct of the study) in the design and conduct of the study. Editorial assistance was provided by Radhika Bhatia, of Envision Scientific Solutions, funded by Astellas Pharma Global Development.	Astellas Pharma US, 2015, CRES IS SULF PRESCR; Bitar D, 2014, EMERG INFECT DIS, V20, P1149, DOI 10.3201/eid2007.140087; Cornely OA, 2007, CLIN INFECT DIS, V44, P1289, DOI 10.1086/514341; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Denning DW, 1996, CLIN INFECT DIS, V23, P608, DOI 10.1093/clinids/23.3.608; Enoch DA, 2014, J INFECTION, V68, P507, DOI 10.1016/j.jinf.2014.01.007; Espinel-Ingroff A, 2015, ANTIMICROB AGENTS CH, V59, P666, DOI 10.1128/AAC.04055-14; European Medicines Agency, 2015, CRES IS; Falci Diego R, 2013, Infect Drug Resist, V6, P163, DOI 10.2147/IDR.S51340; Herbrecht R, 2010, BONE MARROW TRANSPL, V45, P1227, DOI 10.1038/bmt.2009.334; Herbrecht R, 2002, NEW ENGL J MED, V347, P408, DOI 10.1056/NEJMoa020191; Lanternier F, 2008, CLIN MICROBIOL INFEC, V14, P71, DOI 10.1111/j.1469-0691.2008.01984.x; Lepak AJ, 2013, ANTIMICROB AGENTS CH, V57, P6284, DOI 10.1128/AAC.01355-13; Lepak AJ, 2013, ANTIMICROB AGENTS CH, V57, P5642, DOI 10.1128/AAC.01354-13; Lortholary O, 2011, CLIN MICROBIOL INFEC, V17, P1882, DOI 10.1111/j.1469-0691.2011.03548.x; Luo GPS, 2014, ANTIMICROB AGENTS CH, V58, P2450, DOI 10.1128/AAC.02301-13; Maertens J, 2011, BONE MARROW TRANSPL, V46, P709, DOI 10.1038/bmt.2010.175; Marr KA, 2015, ANN INTERN MED, V162, P81, DOI 10.7326/M13-2508; Miceli MH, 2007, CANCER-AM CANCER SOC, V110, P112, DOI 10.1002/cncr.22738; Mikulska M, 2012, J CHEMOTHERAPY, V24, P311, DOI 10.1179/1973947812Y.0000000051; Park WB, 2012, CLIN INFECT DIS, V55, P1080, DOI 10.1093/cid/cis599; Pascual A, 2012, CLIN INFECT DIS, V55, P381, DOI 10.1093/cid/cis437; Ramos ER, 2011, ONCOLOGIST, V16, P1049, DOI 10.1634/theoncologist.2010-0290; Schmitt-Hoffmann A, 2006, ANTIMICROB AGENTS CH, V50, P279, DOI 10.1128/AAC.50.1.279-285.2006; Segal BH, 2008, CLIN INFECT DIS, V47, P674, DOI 10.1086/590566; Spellberg B, 2010, CLIN INFECT DIS, V51, pS150, DOI 10.1086/653065; Tan K, 2006, J CLIN PHARMACOL, V46, P235, DOI 10.1177/0091270005283837; Tortorano AM, 2014, CLIN MICROBIOL INFEC, V20, P27, DOI 10.1111/1469-0691.12465; US FDA, 2014, DRAFT GUID QUAL BIOM; Walsh TJ, 2008, CLIN INFECT DIS, V46, P327, DOI 10.1086/525258; Walsh TJ, 2007, CLIN INFECT DIS, V44, P2, DOI 10.1086/508774; Wingard JR, 2008, CANCER, V112, P2309, DOI 10.1002/cncr.23441	32	496	506	8	71	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 20	2016	387	10020					760	769		10.1016/S0140-6736(15)01159-9	http://dx.doi.org/10.1016/S0140-6736(15)01159-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE1WU	26684607				2022-12-28	WOS:000370418000035
J	Slavin, MA; Thursky, KA				Slavin, Monica A.; Thursky, Karin A.			Isavuconazole: a role for the newest broad-spectrum triazole	LANCET			English	Editorial Material							ANTIFUNGAL STEWARDSHIP; INVASIVE ASPERGILLOSIS; VORICONAZOLE; THERAPY		[Slavin, Monica A.; Thursky, Karin A.] Peter MacCallum Canc Ctr, Dept Infect Dis, East Melbourne, Vic 3002, Australia; [Slavin, Monica A.; Thursky, Karin A.] Royal Melbourne Hosp, Victorian Infect Dis Serv, Peter Doherty Inst, Melbourne, Vic, Australia; [Thursky, Karin A.] Peter Doherty Inst, NHMRC Natl Ctr Antimicrobial Stewardship, Melbourne, Vic, Australia	Peter Maccallum Cancer Center; Royal Melbourne Hospital	Slavin, MA (corresponding author), Peter MacCallum Canc Ctr, Dept Infect Dis, East Melbourne, Vic 3002, Australia.; Slavin, MA (corresponding author), Royal Melbourne Hosp, Victorian Infect Dis Serv, Peter Doherty Inst, Melbourne, Vic, Australia.	monica.slavin@petermac.org	thursky, karin/AAV-4524-2021	thursky, karin/0000-0002-7400-232X; Slavin, Monica/0000-0002-8443-314X				Ananda-Rajah MR, 2012, CURR OPIN INFECT DIS, V25, P107, DOI 10.1097/QCO.0b013e32834e0680; Ananda-Rajah MR, 2011, ANTIMICROB AGENTS CH, V55, P1953, DOI 10.1128/AAC.01423-10; Ashbee HR, 2014, J ANTIMICROB CHEMOTH, V69, P1162, DOI 10.1093/jac/dkt508; Herbrecht R, 2002, NEW ENGL J MED, V347, P408, DOI 10.1056/NEJMoa020191; Lutsar I, 2003, CLIN INFECT DIS, V36, P1087, DOI 10.1086/374248; Maertens JA, 2015, LANCET; Marr KA, 2015, ANN INTERN MED, V162, P81, DOI 10.7326/M13-2508; Miceli MH, 2015, CLIN INFECT DIS, V61, P1558, DOI 10.1093/cid/civ571; Munoz P, 2015, MYCOSES, V58, P14, DOI 10.1111/myc.12329; Slavin M, 2015, CLIN MICROBIOL INFEC, V21, P490, DOI DOI 10.1016/J.CMI.2014.12.021; Slavin M, 2015, CLIN MICROBIOL INFEC, V21, pe1; Teng JC, 2015, HAEMATOLOGICA, V100, pE462, DOI 10.3324/haematol.2015.126698; Teusink A, 2015, BIOL BLOOD MARROW TR	13	16	17	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 20	2016	387	10020					726	728		10.1016/S0140-6736(15)01218-0	http://dx.doi.org/10.1016/S0140-6736(15)01218-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE1WU	26684608				2022-12-28	WOS:000370418000007
J	Kunstler, G; Falster, D; Coomes, DA; Hui, F; Kooyman, RM; Laughlin, DC; Poorter, L; Vanderwel, M; Vieilledent, G; Wright, SJ; Aiba, M; Baraloto, C; Caspersen, J; Cornelissen, JHC; Gourlet-Fleury, S; Hanewinkel, M; Herault, B; Kattge, J; Kurokawa, H; Onoda, Y; Penuelas, J; Poorter, H; Uriarte, M; Richardson, S; Ruiz-Benito, P; Sun, IF; Stahl, G; Swenson, NG; Thompson, J; Westerlund, B; Wirth, C; Zavala, MA; Zeng, HC; Zimmerman, JK; Zimmermann, NE; Westoby, M				Kunstler, Georges; Falster, Daniel; Coomes, David A.; Hui, Francis; Kooyman, Robert M.; Laughlin, Daniel C.; Poorter, Lourens; Vanderwel, Mark; Vieilledent, Ghislain; Wright, S. Joseph; Aiba, Masahiro; Baraloto, Christopher; Caspersen, John; Cornelissen, J. Hans C.; Gourlet-Fleury, Sylvie; Hanewinkel, Marc; Herault, Bruno; Kattge, Jens; Kurokawa, Hiroko; Onoda, Yusuke; Penuelas, Josep; Poorter, Hendrik; Uriarte, Maria; Richardson, Sarah; Ruiz-Benito, Paloma; Sun, I-Fang; Stahl, Goeran; Swenson, Nathan G.; Thompson, Jill; Westerlund, Bertil; Wirth, Christian; Zavala, Miguel A.; Zeng, Hongcheng; Zimmerman, Jess K.; Zimmermann, Niklaus E.; Westoby, Mark			Plant functional traits have globally consistent effects on competition	NATURE			English	Article							HAWAIIAN METROSIDEROS-POLYMORPHA; LEAF DRY MASS; WIDE-RANGE; ELEVATED CO2; WOOD DENSITY; QUERCUS-ILEX; LONG-TERM; PHOSPHORUS STOICHIOMETRY; PHOTOSYNTHETIC CAPACITY; LITTER DECOMPOSABILITY	Phenotypic traits and their associated trade-offs have been shown to have globally consistent effects on individual plant physiological functions(1-3), but how these effects scale up to influence competition, a key driver of community assembly in terrestrial vegetation, has remained unclear (4). Here we use growth data from more than 3 million trees in over 140,000 plots across the world to show how three key functional traits-wood density, specific leaf area and maximum height-consistently influence competitive interactions. Fast maximum growth of a species was correlated negatively with its wood density in all biomes, and positively with its specific leaf area in most biomes. Low wood density was also correlated with a low ability to tolerate competition and a low competitive effect on neighbours, while high specific leaf area was correlated with a low competitive effect. Thus, traits generate trade-offs between performance with competition versus performance without competition, a fundamental ingredient in the classical hypothesis that the coexistence of plant species is enabled via differentiation in their successional strategies(5). Competition within species was stronger than between species, but an increase in trait dissimilarity between species had little influence in weakening competition. No benefit of dissimilarity was detected for specific leaf area or wood density, and only a weak benefit for maximum height. Our trait-based approach to modelling competition makes generalization possible across the forest ecosystems of the world and their highly diverse species composition.	[Kunstler, Georges] Irstea, UR EMGR, F-38402 St Martin Dheres, France; [Kunstler, Georges] Univ Grenoble Alpes, F-38402 Grenoble, France; [Kunstler, Georges; Falster, Daniel; Kooyman, Robert M.; Westoby, Mark] Macquarie Univ, Dept Biol Sci, N Ryde, NSW 2109, Australia; [Coomes, David A.] Univ Cambridge, Dept Plant Sci, Forest Ecol & Conservat Grp, Cambridge CB2 3EA, England; [Hui, Francis] Australian Natl Univ, Inst Math Sci, Canberra, ACT 0200, Australia; [Kooyman, Robert M.] Royal Bot Gardens & Domain Trust, Natl Herbarium New South Wales, Sydney, NSW 2000, Australia; [Laughlin, Daniel C.] Univ Waikato, Environm Res Inst, Sch Sci, Hamilton 3240, New Zealand; [Poorter, Lourens] Wageningen Univ, Forest Ecol & Forest Management Grp, NL-6708 PB Wageningen, Netherlands; [Vanderwel, Mark] Univ Regina, Dept Biol, Regina, SK S4S 0A2, Canada; [Vieilledent, Ghislain; Gourlet-Fleury, Sylvie] Cirad, UPR BSEF, F-34398 Montpellier, France; [Wright, S. Joseph] Smithsonian Trop Res Inst, Balboa, Panama; [Aiba, Masahiro; Kurokawa, Hiroko] Tohoku Univ, Sch Life Sci, Sendai, Miyagi 9808578, Japan; [Baraloto, Christopher] INRA, UMR Ecol Forets Guyane, F-97387 Kourou, France; [Baraloto, Christopher] Florida Int Univ, Dept Biol Sci, Int Ctr Trop Bot, Miami, FL 33199 USA; [Caspersen, John; Zeng, Hongcheng] Univ Toronto, Fac Forestry, Toronto, ON M5S 3B3, Canada; [Caspersen, John; Zimmermann, Niklaus E.] Swiss Fed Res Inst WSL, Landscape Dynam Unit, CH-8903 Birmensdorf, Switzerland; [Cornelissen, J. Hans C.] Vrije Univ, Dept Ecol Sci, Syst Ecol, NL-1081 HV Amsterdam, Netherlands; [Hanewinkel, Marc] Swiss Fed Res Inst WSL, Forest Resources & Management Unit, CH-8903 Birmensdorf, Switzerland; [Hanewinkel, Marc] Univ Freiburg, Chair Forestry Econ & Planning, D-79106 Freiburg, Germany; [Herault, Bruno] Cirad, UMR Ecol Forets Guyane, F-97387 Kourou, France; [Kattge, Jens] Max Planck Inst Biogeochem, D-07745 Jena, Germany; [Kattge, Jens; Wirth, Christian] German Ctr Integrat Biodivers Res iDiv, D-04103 Leipzig, Germany; [Onoda, Yusuke] Kyoto Univ, Sch Agr, Kyoto 6068502, Japan; [Penuelas, Josep] UAB, CSIC, CREAF, Global Ecol Unit, Catalonia 08193, Spain; [Penuelas, Josep] CREAF, Barcelona 08193, Catalonia, Spain; [Poorter, Hendrik] Forschungszentrum Julich GmbH, Plant Sci IBG 2, D-52425 Julich, Germany; [Uriarte, Maria] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; [Richardson, Sarah] Landcare Res, Lincoln 7640, New Zealand; [Ruiz-Benito, Paloma] Univ Stirling, Sch Nat Sci, Biol & Environm Sci, Stirling FK9 4LA, Scotland; [Ruiz-Benito, Paloma; Zavala, Miguel A.] Univ Alcala, Dept Life Sci, Forest Ecol & Restorat Grp, Alcala De Henares 28805, Madrid, Spain; [Sun, I-Fang] Natl Dong Hwa Univ, Dept Nat Resources & Environm Studies, Hualien 97401, Taiwan; [Stahl, Goeran; Westerlund, Bertil] Swedish Univ Agr Sci SLU, Dept Forest Resource Management, S-90183 Umea, Sweden; [Swenson, Nathan G.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Thompson, Jill] Ctr Ecol & Hydrol, Penicuik EH26 0QB, Midlothian, Scotland; [Thompson, Jill; Zimmerman, Jess K.] Univ Puerto Rico, Dept Environm Sci, San Juan, PR 00936 USA; [Wirth, Christian] Univ Leipzig, Inst Systemat Bot & Funct Biodivers, D-04103 Leipzig, Germany	INRAE; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Macquarie University; University of Cambridge; Australian National University; University of Waikato; Wageningen University & Research; University of Regina; CIRAD; Smithsonian Institution; Smithsonian Tropical Research Institute; Tohoku University; AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; INRAE; State University System of Florida; Florida International University; University of Toronto; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Vrije Universiteit Amsterdam; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Freiburg; AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; Max Planck Society; Kyoto University; Autonomous University of Barcelona; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Consejo Superior de Investigaciones Cientificas (CSIC); Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Helmholtz Association; Research Center Julich; Columbia University; Landcare Research - New Zealand; University of Stirling; Universidad de Alcala; National Dong Hwa University; Swedish University of Agricultural Sciences; University System of Maryland; University of Maryland College Park; UK Centre for Ecology & Hydrology (UKCEH); University of Puerto Rico; University of Puerto Rico Rio Piedras; Leipzig University	Kunstler, G (corresponding author), Irstea, UR EMGR, 2 Rue Papeterie BP 76, F-38402 St Martin Dheres, France.	georges.kunstler@irstea.fr	Thompson, Jill/K-2200-2012; Onoda, Yusuke/L-7179-2015; Wright, Stuart Joseph/M-3311-2013; Kunstler, Georges/F-9179-2012; Zimmermann, Niklaus E./A-4276-2008; Vieilledent, Ghislain/D-8323-2011; Poorter, Hendrik/B-8062-2010; Ruiz-Benito, Paloma/E-5833-2012; Poorter, Lourens/AAL-1709-2021; Poorter, Hendrik/Y-2542-2019; hanewinkel, marc/E-5639-2011; Penuelas, Josep/D-9704-2011; Westerlund, Bertil/AAZ-3815-2020; Wirth, Christian/A-4446-2016; Kooyman, Robert M/H-3347-2017; Aiba, Masahiro/A-1736-2009; Hérault, Bruno/B-2765-2011; Kattge, Jens/J-8283-2016; Zavala, Miguel A./H-3603-2015; Baraloto, Christopher/ABG-2500-2020	Thompson, Jill/0000-0002-4370-2593; Onoda, Yusuke/0000-0001-6245-2342; Wright, Stuart Joseph/0000-0003-4260-5676; Kunstler, Georges/0000-0002-2544-1940; Zimmermann, Niklaus E./0000-0003-3099-9604; Vieilledent, Ghislain/0000-0002-1685-4997; Poorter, Hendrik/0000-0001-9900-2433; Ruiz-Benito, Paloma/0000-0002-2781-5870; Poorter, Hendrik/0000-0001-9900-2433; hanewinkel, marc/0000-0003-4081-6621; Penuelas, Josep/0000-0002-7215-0150; Westerlund, Bertil/0000-0002-1073-8434; Kooyman, Robert M/0000-0003-1985-9547; Hérault, Bruno/0000-0002-6950-7286; Kattge, Jens/0000-0002-1022-8469; Zavala, Miguel A./0000-0003-1456-0132; Baraloto, Christopher/0000-0001-7322-8581; Westoby, Mark/0000-0001-7690-4530; Coomes, David/0000-0002-8261-2582; Hui, Francis/0000-0003-0765-3533; Falster, Daniel/0000-0002-9814-092X; Poorter, Lourens/0000-0003-1391-4875	CEBA [ANR-10-LABX-25-01]; IGBP; DIVERSITAS; GLP; NERC; QUEST; FRB; GIS Climate; Marie Curie International Outgoing Fellowship within European Community [299340]; Macquarie University; Australian Research Council; Direct For Biological Sciences [1546686] Funding Source: National Science Foundation; NERC [ceh020002] Funding Source: UKRI; Natural Environment Research Council [ceh020002] Funding Source: researchfish	CEBA; IGBP; DIVERSITAS; GLP; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); QUEST; FRB; GIS Climate; Marie Curie International Outgoing Fellowship within European Community; Macquarie University; Australian Research Council(Australian Research Council); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We are especially grateful to the researchers whose long-term commitment to establish and maintain forest plots and their associated databases made this study possible, and to those who granted us data access: forest inventories and permanent plots of New Zealand, Spain (MAGRAMA), France, Switzerland, Sweden, US and Canada (for the provinces of Quebec provided by the Ministere des Ressources Naturelles du Quebec, Ontario provided by OnTAP's Growth and Yield Program of the Ontario Ministry of Natural Resources, Saskatchewan, Manitoba, New Brunswick, Newfoundland and Labrador), CTFS (BCI and LTER-Luquillo), Taiwan (Fushan), Cirad (Paracou with funding by CEBA, ANR-10-LABX-25-01), Cirad, MEFCP and ICRA (M'Baiki) and Japan. We thank MPI-BGC Jena, who host TRY, and the international funding networks supporting TRY (IGBP, DIVERSITAS, GLP, NERC, QUEST, FRB and GIS Climate). G.K. was supported by a Marie Curie International Outgoing Fellowship within the 7th European Community Framework Program (Demo-Traits project, no. 299340). The working group that initiated this synthesis was supported by Macquarie University and by Australian Research Council through a fellowship to M.W.	Ackerly DD, 2007, ECOL LETT, V10, P135, DOI 10.1111/j.1461-0248.2006.01006.x; Adams TP, 2007, P ROY SOC B-BIOL SCI, V274, P3039, DOI 10.1098/rspb.2007.0891; Adler PB, 2013, ECOL LETT, V16, P1294, DOI 10.1111/ele.12157; Aiba M, 2009, FUNCT ECOL, V23, P265, DOI 10.1111/j.1365-2435.2008.01500.x; Bagchi R, 2014, NATURE, V506, P85, DOI 10.1038/nature12911; Baraloto C, 2010, ECOL LETT, V13, P1338, DOI 10.1111/j.1461-0248.2010.01517.x; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BURNHAM K.P., 2002, MODEL SELECTION MULT, V2nd, DOI DOI 10.1007/B97636; Canham CD, 2006, ECOL APPL, V16, P540, DOI 10.1890/1051-0761(2006)016[0540:NAOCTC]2.0.CO;2; Castro-Diez P, 1998, OECOLOGIA, V116, P57, DOI 10.1007/s004420050563; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Chesson P, 2012, ECOLOGICAL SYSTEMS, P223; CONDIT R, 1993, FOREST ECOL MANAG, V62, P107, DOI 10.1016/0378-1127(93)90045-O; Condit R, 2013, P NATL ACAD SCI USA, V110, P5064, DOI 10.1073/pnas.1218042110; CONNELL JH, 1983, AM NAT, V122, P661, DOI 10.1086/284165; Cornelissen JHC, 1996, J ECOL, V84, P755, DOI 10.2307/2261337; Cornelissen JHC, 1997, OECOLOGIA, V111, P460, DOI 10.1007/s004420050259; Cornelissen JHC, 1996, J ECOL, V84, P573, DOI 10.2307/2261479; Cornelissen JHC, 2004, FUNCT ECOL, V18, P779, DOI 10.1111/j.0269-8463.2004.00900.x; Cornelissen JHC, 2003, J VEG SCI, V14, P311, DOI 10.1111/j.1654-1103.2003.tb02157.x; Cornwell WK, 2007, FUNCT ECOL, V21, P1063, DOI 10.1111/j.1365-2435.2007.01323.x; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Cornwell WK, 2009, ECOL MONOGR, V79, P109, DOI 10.1890/07-1134.1; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; Fonseca CR, 2000, J ECOL, V88, P964, DOI 10.1046/j.1365-2745.2000.00506.x; Fortunel C, 2009, ECOLOGY, V90, P598, DOI 10.1890/08-0418.1; Freschet GT, 2010, NEW PHYTOL, V186, P879, DOI 10.1111/j.1469-8137.2010.03228.x; Freschet GT, 2010, J ECOL, V98, P362, DOI 10.1111/j.1365-2745.2009.01615.x; Fridman J, 2001, SCAND J FOREST RES, V16, P455, DOI 10.1080/02827580152632856; Garnier E, 2007, ANN BOT-LONDON, V99, P967, DOI 10.1093/aob/mcl215; GAUDET CL, 1988, NATURE, V334, P242, DOI 10.1038/334242a0; Godoy O, 2014, ECOLOGY, V95, P726, DOI 10.1890/13-1157.1; Goldberg DE, 1996, PHILOS T R SOC B, V351, P1377, DOI 10.1098/rstb.1996.0121; Gourlet-Fleury S, 2011, J ECOL, V99, P981, DOI 10.1111/j.1365-2745.2011.01829.x; Han WX, 2005, NEW PHYTOL, V168, P377, DOI 10.1111/j.1469-8137.2005.01530.x; He JS, 2008, OECOLOGIA, V155, P301, DOI 10.1007/s00442-007-0912-y; He JS, 2006, NEW PHYTOL, V170, P835, DOI 10.1111/j.1469-8137.2006.01704.x; Herault B, 2011, J ECOL, V99, P1431, DOI 10.1111/j.1365-2745.2011.01883.x; Herault B, 2010, J APPL ECOL, V47, P821, DOI 10.1111/j.1365-2664.2010.01826.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HilleRisLambers J, 2012, ANNU REV ECOL EVOL S, V43, P227, DOI 10.1146/annurev-ecolsys-110411-160411; Hoof J, 2008, BIOTROPICA, V40, P113, DOI 10.1111/j.1744-7429.2007.00325.x; Ishihara M, 2011, ECOL RES, V26, P1007, DOI 10.1007/s11284-011-0847-y; Johnson PCD, 2014, METHODS ECOL EVOL, V5, P944, DOI 10.1111/2041-210X.12225; Wright SJ, 2010, ECOLOGY, V91, P3664, DOI 10.1890/09-2335.1; Jucker T, 2015, FUNCT ECOL, V29, P1078, DOI 10.1111/1365-2435.12428; Kattge J, 2011, GLOBAL CHANGE BIOL, V17, P2905, DOI 10.1111/j.1365-2486.2011.02451.x; Kattge J, 2009, GLOBAL CHANGE BIOL, V15, P976, DOI 10.1111/j.1365-2486.2008.01744.x; Keddy P.A., 1989, COMPETITION; Kleyer M, 2008, J ECOL, V96, P1266, DOI 10.1111/j.1365-2745.2008.01430.x; Kooyman R, 2012, BIOTROPICA, V44, P668, DOI 10.1111/j.1744-7429.2012.00861.x; Kraft NJB, 2015, P NATL ACAD SCI USA, V112, P797, DOI 10.1073/pnas.1413650112; Kraft NJB, 2014, OIKOS, V123, P1391, DOI 10.1111/oik.01311; Kriticos DJ, 2012, METHODS ECOL EVOL, V3, P53, DOI 10.1111/j.2041-210X.2011.00134.x; Kunstler G, 2012, ECOL LETT, V15, P831, DOI 10.1111/j.1461-0248.2012.01803.x; Kurokawa H, 2008, ECOLOGY, V89, P2645, DOI 10.1890/07-1352.1; Lasky JR, 2014, P NATL ACAD SCI USA, V111, P5616, DOI 10.1073/pnas.1319342111; Lasky JR, 2013, J ECOL, V101, P722, DOI 10.1111/1365-2745.12065; Laughlin DC, 2010, FUNCT ECOL, V24, P493, DOI 10.1111/j.1365-2435.2009.01672.x; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Martin RE, 2007, OECOLOGIA, V151, P387, DOI 10.1007/s00442-006-0604-z; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; McDonald PG, 2003, FUNCT ECOL, V17, P50, DOI 10.1046/j.1365-2435.2003.00698.x; Medlyn BE, 1999, ECOL MODEL, V124, P69, DOI 10.1016/S0304-3800(99)00148-9; Medlyn BE, 1999, PLANT CELL ENVIRON, V22, P1475, DOI 10.1046/j.1365-3040.1999.00523.x; Medlyn BE, 2001, NEW PHYTOL, V149, P247, DOI 10.1046/j.1469-8137.2001.00028.x; Messier J, 2010, ECOL LETT, V13, P838, DOI 10.1111/j.1461-0248.2010.01476.x; Ministerio de Agricultura Alimentacion y Medio Ambiente, INV FOR NAC; Moles AT, 2004, J ECOL, V92, P384, DOI 10.1111/j.0022-0477.2004.00880.x; Moles AT, 2005, SCIENCE, V307, P576, DOI 10.1126/science.1104863; Moles AT, 2005, P NATL ACAD SCI USA, V102, P10540, DOI 10.1073/pnas.0501473102; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Niinemets U, 1999, NEW PHYTOL, V144, P35, DOI 10.1046/j.1469-8137.1999.00466.x; Niinemets U, 2001, ECOLOGY, V82, P453, DOI 10.1890/0012-9658(2001)082[0453:GSCCOL]2.0.CO;2; Niinemets U, 2010, ECOL RES, V25, P693, DOI 10.1007/s11284-010-0712-4; Ogaya R, 2006, BIOL PLANTARUM, V50, P373, DOI 10.1007/s10535-006-0052-y; Ogaya R, 2003, ENVIRON EXP BOT, V50, P137, DOI 10.1016/S0098-8472(03)00019-4; Ogaya R, 2007, PLANT ECOL, V189, P291, DOI 10.1007/s11258-006-9184-6; Onoda Y, 2011, ECOL LETT, V14, P301, DOI 10.1111/j.1461-0248.2010.01582.x; Ordonez JC, 2010, ECOLOGY, V91, P3218, DOI 10.1890/09-1509.1; Ordonez JC, 2010, AM NAT, V175, P225, DOI 10.1086/649582; Ouedraogo DY, 2013, J ECOL, V101, P1459, DOI 10.1111/1365-2745.12165; Pakeman RJ, 2008, J ECOL, V96, P355, DOI 10.1111/j.1365-2745.2007.01336.x; Pakeman RJ, 2009, J VEG SCI, V20, P148, DOI 10.1111/j.1654-1103.2009.05548.x; Penuelas J, 2010, J CHEM ECOL, V36, P1255, DOI 10.1007/s10886-010-9862-7; Penuelas J, 2010, GLOBAL CHANGE BIOL, V16, P2171, DOI 10.1111/j.1365-2486.2009.02054.x; Poorter H, 2009, NEW PHYTOL, V182, P565, DOI 10.1111/j.1469-8137.2009.02830.x; Poorter L, 2008, ECOLOGY, V89, P1908, DOI 10.1890/07-0207.1; Poorter L, 2009, NEW PHYTOL, V181, P890, DOI 10.1111/j.1469-8137.2008.02715.x; Poorter L, 2006, ECOLOGY, V87, P1733, DOI 10.1890/0012-9658(2006)87[1733:LTAGPO]2.0.CO;2; Poorter L, 2006, ECOLOGY, V87, P1289, DOI 10.1890/0012-9658(2006)87[1289:AOMTST]2.0.CO;2; Preston KA, 2006, NEW PHYTOL, V170, P807, DOI 10.1111/j.1469-8137.2006.01712.x; Pyankov VI, 1999, NEW PHYTOL, V143, P131, DOI 10.1046/j.1469-8137.1999.00435.x; Quested HM, 2003, ECOLOGY, V84, P3209, DOI 10.1890/02-0426; R Development Core Team, 2009, R LANG ENV STAT COMP; Rees M, 2001, SCIENCE, V293, P650, DOI 10.1126/science.1062586; Reich PB, 2008, ECOL LETT, V11, P793, DOI 10.1111/j.1461-0248.2008.01185.x; Reich PB, 2009, OECOLOGIA, V160, P207, DOI 10.1007/s00442-009-1291-3; Ricklefs R.E., 2001, EC NATURE; Ruger N, 2012, ECOLOGY, V93, P2626, DOI 10.1890/12-0622.1; Sack L, 2005, NEW PHYTOL, V167, P403, DOI 10.1111/j.1469-8137.2005.01432.x; Sack L, 2004, OIKOS, V107, P110, DOI 10.1111/j.0030-1299.2004.13184.x; Sack L, 2006, AM J BOT, V93, P829, DOI 10.3732/ajb.93.6.829; Sapijanskas J, 2014, ECOLOGY, V95, P2479, DOI 10.1890/13-1366.1; Sardans J, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2008JG000795; Sardans J, 2008, FOREST SCI, V54, P513; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Shipley B, 2002, NEW PHYTOL, V153, P359, DOI 10.1046/j.0028-646X.2001.00320.x; Soudzilovskaia NA, 2013, P NATL ACAD SCI USA, V110, P18180, DOI 10.1073/pnas.1310700110; South A, 2011, R J, V3, P35; Swenson NG, 2012, ECOLOGY, V93, P490, DOI 10.1890/11-1180.1; Thompson J, 2002, ECOL APPL, V12, P1344, DOI 10.1890/1051-0761(2002)012[1344:LUHEAT]2.0.CO;2; Uriarte M, 2004, ECOL MONOGR, V74, P591, DOI 10.1890/03-4031; Uriarte M, 2010, ECOL LETT, V13, P1503, DOI 10.1111/j.1461-0248.2010.01541.x; *USDA, 2019, PLANTS DAT; Villaescusa R., 1998, SEGUNDO INVENTARIO F; Villanueva JA, 2004, TERCER INVENTARIO FO; Wang P, 2010, FUNCT ECOL, V24, P196, DOI 10.1111/j.1365-2435.2009.01612.x; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; WHITTAKER RH, 1970, COMMUNITIES ECOSYSTE; Willis CG, 2010, ECOGRAPHY, V33, P565, DOI 10.1111/j.1600-0587.2009.05975.x; Wilson KB, 2000, TREE PHYSIOL, V20, P565; Wiser SK, 2001, NEW ZEAL J ECOL, V25, P1; Wright IJ, 2007, ANN BOT-LONDON, V99, P1003, DOI 10.1093/aob/mcl066; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright IJ, 2006, NEW PHYTOL, V169, P309, DOI 10.1111/j.1469-8137.2005.01590.x; Zanne AE, 2010, AM J BOT, V97, P207, DOI 10.3732/ajb.0900178	129	489	517	63	943	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 14	2016	529	7585					204	U174		10.1038/nature16476	http://dx.doi.org/10.1038/nature16476			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA7WK	26700807	Green Accepted			2022-12-28	WOS:000368015700035
J	Creel, S; Becker, M; Christianson, D; Droge, E; Hammerschlag, N; Hayward, MW; Karanth, U; Loveridge, A; Macdonald, DW; Matandiko, W; M'soka, J; Murray, D; Rosenblatt, E; Schuette, P				Creel, Scott; Becker, Matthew; Christianson, David; Droege, Egil; Hammerschlag, Neil; Hayward, Matt W.; Karanth, Ullas; Loveridge, Andrew; Macdonald, David W.; Matandiko, Wigganson; M'soka, Jassiel; Murray, Dennis; Rosenblatt, Elias; Schuette, Paul			Questionable policy for large carnivore hunting	SCIENCE			English	Editorial Material							POPULATION-DYNAMICS; HARVEST; WOLVES; LIONS		[Creel, Scott; Droege, Egil; Matandiko, Wigganson; M'soka, Jassiel; Rosenblatt, Elias] Montana State Univ, Bozeman, MT 59717 USA; [Creel, Scott; Becker, Matthew] Zambian Carnivore Programme, Mfuwe, Zambia; [Christianson, David] Univ Arizona, Tucson, AZ 85721 USA; [Hammerschlag, Neil] Univ Miami, Miami, FL 33149 USA; [Hayward, Matt W.] Bangor Univ, Bangor LL57 2UW, Gwynedd, Wales; [Karanth, Ullas] Wildlife Conservat Soc, Bangalore 560070, Karnataka, India; [Loveridge, Andrew; Macdonald, David W.] Univ Oxford, WildCRU, Recanati Kaplan Ctr, Oxford OX13 5QL, Oxon, England; [M'soka, Jassiel] Zambia Wildlife Author, Chilanga, Zambia; [Murray, Dennis] Trent Univ, Peterborough, ON K9J 7B8, Canada; [Schuette, Paul] SUNY Coll Environm Sci & Forestry, Syracuse, NY 13210 USA	Montana State University System; Montana State University Bozeman; University of Arizona; University of Miami; Bangor University; University of Oxford; Trent University; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry	Creel, S (corresponding author), Montana State Univ, Bozeman, MT 59717 USA.	screel@montana.edu	Hayward, Matt W./F-3569-2010	Hayward, Matt W./0000-0002-5574-1653; Rosenblatt, Elias/0000-0001-7241-2109				Adams LG, 2008, WILDLIFE MONOGR, P1, DOI 10.2193/2008-012; [Anonymous], 2015, END SPEC W GRAY WOLF; [Anonymous], 2015, ID WOLF CONS MAN PLA; Ausband DE, 2015, ANIM CONSERV, V18, P415, DOI 10.1111/acv.12187; Cooley HS, 2009, ECOLOGY, V90, P2913, DOI 10.1890/08-1805.1; Creel S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012918; Gude JA, 2012, J WILDLIFE MANAGE, V76, P108, DOI 10.1002/jwmg.201; Jimenez M. D., 2014, NO ROCK MOUNT WOLF R; Jiminez M. D, 2014, US FISH WILDLIFE SER; Karanth KU, 2003, ANIM CONSERV, V6, P141, DOI 10.1017/S1367943003003184; Loveridge AJ, 2007, BIOL CONSERV, V134, P548, DOI 10.1016/j.biocon.2006.09.010; Murray DL, 2010, BIOL CONSERV, V143, P2514, DOI 10.1016/j.biocon.2010.06.018; Rosenblatt E, 2014, BIOL CONSERV, V180, P176, DOI 10.1016/j.biocon.2014.10.006; Smith DW, 2010, J WILDLIFE MANAGE, V74, P620, DOI 10.2193/2008-584; Sparkman AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020868; Whitman K, 2004, NATURE, V428, P175, DOI 10.1038/nature02395	16	40	40	0	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2015	350	6267					1473	1475		10.1126/science.aac4768	http://dx.doi.org/10.1126/science.aac4768			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY7LY	26680181				2022-12-28	WOS:000366591100033
J	Jia, HP				Jia, Hepeng			ALLIANCES FOR SCIENTIFIC SUCCESS	NATURE			English	Editorial Material													Jia, Hepeng/AAX-9841-2020	Jia, Hepeng/0000-0001-8681-394X					0	0	0	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2015	528	7582					S187	S189		10.1038/528S187a	http://dx.doi.org/10.1038/528S187a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY8SM	26673027	Green Published, Bronze			2022-12-28	WOS:000366678600015
J	Wehner, MR; Nead, KT; Linos, K; Linos, E				Wehner, Mackenzie R.; Nead, Kevin T.; Linos, Katerina; Linos, Eleni			CHRISTMAS 2015: FACE TIME Plenty of moustaches but not enough women: cross sectional study of medical leaders	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CAREER SATISFACTION; ACADEMIC MEDICINE; PERCEPTION; CRITERIA; BEARD	Objectives To draw attention to sex related disparities in academic medical leadership by investigating the representation of female leaders compared with leaders with moustaches. Design Cross sectional analysis. Setting Academic medical departments in the United States. Participants Clinical department leaders (n=1018) at the top 50 US medical schools funded by the National Institutes of Health (NIH). Main outcome measures The proportions of female leaders and moustachioed leaders across institutions and specialties (n=20). Additionally, the moustache index: the proportion of women compared with the proportion of moustaches, analyzed with multinomial logistic regression models. Results Women accounted for 13% (137/1018) of department leaders at the top 50 NIH funded medical schools in the US. Moustachioed leaders accounted for 19% (190/1018). The proportion of female department leaders ranged from 0% (0/20) to 26% (5/19) across institutions and 0% (0/53) to 36% (19/53) across specialties. Only seven institutions and five specialties had more than 20% of female department leaders. The overall moustache index of all academic medical departments studied was 0.72 (95% confidence interval 0.58 to 0.90; P=0.004). Only six of 20 specialties had more women than moustaches (moustache index >1). Conclusions Moustachioed individuals significantly outnumber women as leaders of medical departments in the US. We believe that every department and institution should strive for a moustache index >= 1. Known, effective, and evidence based policies to increase the number of women in leadership positions should be prioritized.	[Wehner, Mackenzie R.] Hosp Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA; [Nead, Kevin T.] Hosp Univ Penn, Dept Radiat Oncol, Philadelphia, PA 19104 USA; [Linos, Katerina] Univ Calif Berkeley, Berkeley Law, Berkeley, CA 94720 USA; [Linos, Eleni] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Linos, E (corresponding author), Univ Calif San Francisco, Dept Dermatol, 2340 Sutter St, San Francisco, CA 94143 USA.	linose@derm.ucsf.edu		Linos, Eleni/0000-0002-5856-6301; , Eleni/0000-0003-2538-0700; Wehner, Mackenzie/0000-0002-5579-2282				AAMC, 2013, STAT WOM AC MED PIP; Briscoe F, 2006, IND LABOR RELAT REV, V60, P88, DOI 10.1177/001979390606000105; Burgess DJ, 2012, ACAD MED, V87, P506, DOI 10.1097/ACM.0b013e318248f718; Correll SJ, 2007, AM J SOCIOL, V112, P1297, DOI 10.1086/511799; de Souza AAL, 2003, PSYCHOL REP, V92, P201, DOI 10.2466/pr0.2003.92.1.201; DeCastro R, 2014, ACAD MED, V89, P301, DOI 10.1097/ACM.0000000000000109; Dezso CL, 2012, STRATEGIC MANAGE J, V33, P1072, DOI 10.1002/smj.1955; Dixit A, 2015, J HUM LACT, V31, P434, DOI 10.1177/0890334415585309; Frank E, 1999, ARCH INTERN MED, V159, P1417, DOI 10.1001/archinte.159.13.1417; Goldin C, 2012, MOST EGALITARIAN ALL, DOI [10.3386/w18410, DOI 10.3386/W18410]; Goldin C, 2014, AM ECON REV, V104, P1091, DOI 10.1257/aer.104.4.1091; HELLSTROM A, 1994, EUR J SOC PSYCHOL, V24, P693, DOI 10.1002/ejsp.2420240606; Jena AB, 2015, JAMA-J AM MED ASSOC, V314, P1149, DOI 10.1001/jama.2015.10680; Keeton K, 2007, OBSTET GYNECOL, V109, P949, DOI 10.1097/01.AOG.0000258299.45979.37; Linos K, 2011, AM J POLIT SCI, V55, P678, DOI 10.1111/j.1540-5907.2011.00513.x; Page L, 2012, WOMEN STILL FACE BAR; Phelan JE, 2008, PSYCHOL WOMEN QUART, V32, P406, DOI 10.1111/j.1471-6402.2008.00454.x; ROBINSON DE, 1976, AM J SOCIOL, V81, P1133, DOI 10.1086/226188; Ruhm CJ, 1998, Q J ECON, V113, P285, DOI 10.1162/003355398555586; Terjesen S, 2009, CORP GOV-OXFORD, V17, P320, DOI 10.1111/j.1467-8683.2009.00742.x; Travis EL, 2013, ACAD MED, V88, P1414, DOI 10.1097/ACM.0b013e3182a35456; Uhlmann EL, 2005, PSYCHOL SCI, V16, P474; WOOD DR, 1986, PERCEPT MOTOR SKILL, V62, P769, DOI 10.2466/pms.1986.62.3.769; Yedidia MJ, 2001, ACAD MED, V76, P453, DOI 10.1097/00001888-200105000-00017	24	44	45	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 16	2015	351								h6311	10.1136/bmj.h6311	http://dx.doi.org/10.1136/bmj.h6311			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CZ4MP	26673637	Green Published, hybrid			2022-12-28	WOS:000367077600004
J	Jundi, AS				Jundi, Ayman S.			Bombing Syria without protecting civilians won't counter extremism or reduce refugees	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Jundi, Ayman S.] Lancashire Teaching Hosp NHS Fdn Trust, Emergency Med, Preston, Lancs, England; [Jundi, Ayman S.] Syrian British Med Soc, Damascus, Syria		Jundi, AS (corresponding author), Lancashire Teaching Hosp NHS Fdn Trust, Emergency Med, Preston, Lancs, England.	a.jundi@sb-ms.org							0	1	1	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 15	2015	351								h6803	10.1136/bmj.h6803	http://dx.doi.org/10.1136/bmj.h6803			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ4ML	26671882				2022-12-28	WOS:000367077200011
J	Abe, S				Abe, Shinzo			Japan's vision for a peaceful and healthier world	LANCET			English	Editorial Material							CARE		[Abe, Shinzo] Off Prime Minister Japan, Chiyoda Ku, Tokyo 1000014, Japan		Abe, S (corresponding author), Off Prime Minister Japan, Chiyoda Ku, Tokyo 1000014, Japan.	ezoe-satoshi@mhlw.go.jp						[Anonymous], 1999, DEV FREEDOM; Cabinet Office, 2015, BAS GUID STRENGTH ME; Commission on Human Security, 2003, HUMAN SECURITY NOW P; Ikeda N, 2011, LANCET, V378, P1094, DOI 10.1016/S0140-6736(11)61055-6; Japan International Cooperation Agency, 2015, SIG LOAN AGR KEN; Katsuno K, 2015, NAT REV DRUG DISCOV, V14, P751, DOI 10.1038/nrd4683; Ministry of Foreign Affairs, 2015, BAS DES PEAC HLTH; Ministry of Health Labour and Welfare, 2015, HLTH CAR 2035; Miyata H, 2015, LANCET, V385, P2549, DOI 10.1016/S0140-6736(15)61135-7; Nature, 2015, NATURE, V519, P556; Shibuya K, 2015, LANCET, V386, pE14, DOI 10.1016/S0140-6736(15)60765-6; Summers LH, 2015, LANCET, V386, P2112, DOI 10.1016/S0140-6736(15)00242-1; WHO, 2015, GLOB ACT PLAN ANT RE, DOI DOI 10.1128/MICROBE.10.354.1; World Bank, 2014, UN HLTH COV INCL SUS; World Health Organization (WHO), 2015, WHO CONT FUND EM	15	25	26	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 12	2015	386	10011					2367	2369		10.1016/S0140-6736(15)01172-1	http://dx.doi.org/10.1016/S0140-6736(15)01172-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CY3EE	26700515	Green Published, Bronze			2022-12-28	WOS:000366290400007
J	Cheloufi, S; Elling, U; Hopfgartner, B; Jung, YL; Murn, J; Ninova, M; Hubmann, M; Badeaux, AI; Ang, CE; Tenen, D; Wesche, DJ; Abazova, N; Hogue, M; Tasdemir, N; Brumbaugh, J; Rathert, P; Jude, J; Ferrari, F; Blanco, A; Fellner, M; Wenzel, D; Zinner, M; Vidal, SE; Bell, O; Stadtfeld, M; Chang, HY; Almouzni, G; Lowe, SW; Rinn, J; Wernig, M; Aravin, A; Shi, Y; Park, PJ; Penninger, JM; Zuber, J; Hochedlinger, K				Cheloufi, Sihem; Elling, Ulrich; Hopfgartner, Barbara; Jung, Youngsook L.; Murn, Jernej; Ninova, Maria; Hubmann, Maria; Badeaux, Aimee I.; Ang, Cheen Euong; Tenen, Danielle; Wesche, Daniel J.; Abazova, Nadezhda; Hogue, Max; Tasdemir, Nilgun; Brumbaugh, Justin; Rathert, Philipp; Jude, Julian; Ferrari, Francesco; Blanco, Andres; Fellner, Michaela; Wenzel, Daniel; Zinner, Marietta; Vidal, Simon E.; Bell, Oliver; Stadtfeld, Matthias; Chang, Howard Y.; Almouzni, Genevieve; Lowe, Scott W.; Rinn, John; Wernig, Marius; Aravin, Alexei; Shi, Yang; Park, Peter J.; Penninger, Josef M.; Zuber, Johannes; Hochedlinger, Konrad			The histone chaperone CAF-1 safeguards somatic cell identity	NATURE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; DNA-BINDING PROTEINS; NUCLEAR TRANSFER; STEM-CELLS; IN-VIVO; CHROMATIN; GENOME; MOUSE; HETEROCHROMATIN; PLURIPOTENCY	Cellular differentiation involves profound remodelling of chromatic landscapes, yet the mechanisms by which somatic cell identity is subsequently maintained remain incompletely understood. To further elucidate regulatory pathways that safeguard the somatic state, we performed two comprehensive RNA interference (RNAi) screens targeting chromatin factors during transcription-factor-mediated reprogramming of mouse fibroblasts to induced pluripotent stem cells (iPS cells). Subunits of the chromatin assembly factor-1 (CAF-1) complex, including Chaf1a and Chaf1b, emerged as the most prominent hits from both screens, followed by modulators of lysine sumoylation and heterochromatin maintenance. Optimal modulation of both CAF-1 and transcription factor levels increased reprogramming efficiency by several orders of magnitude and facilitated iPS cell formation in as little as 4 days. Mechanistically, CAF-1 suppression led to a more accessible chromatin structure at enhancer elements early during reprogramming. These changes were accompanied by a decrease in somatic heterochromatin domains, increased binding of Sox2 to pluripotency-specific targets and activation of associated genes. Notably, suppression of CAF-1 also enhanced the direct conversion of B cells into macrophages and fibroblasts into neurons. Together, our findings reveal the histone chaperone CAF-1 to be a novel regulator of somatic cell identity during transcription-factor-induced cell-fate transitions and provide a potential strategy to modulate cellular plasticity in a regenerative setting.	[Cheloufi, Sihem; Wesche, Daniel J.; Abazova, Nadezhda; Hogue, Max; Brumbaugh, Justin; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Canc, Dept Mol Biol, Boston, MA 02114 USA; [Cheloufi, Sihem; Wesche, Daniel J.; Abazova, Nadezhda; Hogue, Max; Brumbaugh, Justin; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Cheloufi, Sihem; Tenen, Danielle; Wesche, Daniel J.; Abazova, Nadezhda; Hogue, Max; Brumbaugh, Justin; Rinn, John; Hochedlinger, Konrad] Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Cheloufi, Sihem; Tenen, Danielle; Wesche, Daniel J.; Abazova, Nadezhda; Hogue, Max; Brumbaugh, Justin; Rinn, John; Hochedlinger, Konrad] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Cheloufi, Sihem; Wesche, Daniel J.; Abazova, Nadezhda; Hogue, Max; Brumbaugh, Justin; Chang, Howard Y.; Lowe, Scott W.; Hochedlinger, Konrad] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Elling, Ulrich; Hubmann, Maria; Wenzel, Daniel; Zinner, Marietta; Bell, Oliver; Penninger, Josef M.] Austrian Acad Sci IMBA, Inst Mol Biotechnol, Vienna Bioctr VBC, A-1030 Vienna, Austria; [Hopfgartner, Barbara; Rathert, Philipp; Jude, Julian; Fellner, Michaela; Zuber, Johannes] Res Inst Mol Pathol IMP, Vienna Bioctr VBC, A-1030 Vienna, Austria; [Jung, Youngsook L.; Ferrari, Francesco; Park, Peter J.] Harvard Univ, Sch Med, Dept Biomed Informat, Boston, MA 02115 USA; [Jung, Youngsook L.; Ferrari, Francesco; Park, Peter J.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Murn, Jernej; Badeaux, Aimee I.; Blanco, Andres; Shi, Yang] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Murn, Jernej; Badeaux, Aimee I.; Blanco, Andres; Shi, Yang] Boston Childrens Hosp, Div Newborn Med, Boston, MA 02115 USA; [Ninova, Maria; Aravin, Alexei] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Ang, Cheen Euong; Wernig, Marius] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Dept Pathol, Stanford, CA 94305 USA; [Ang, Cheen Euong; Wernig, Marius] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Tenen, Danielle; Rinn, John] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA 02142 USA; [Tasdemir, Nilgun; Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Vidal, Simon E.; Stadtfeld, Matthias] NYU, Sch Med, Skirball Inst Biomol Med, Helen L & Martin S Kimmel Ctr Biol & Med,Dept Cel, New York, NY 10016 USA; [Chang, Howard Y.] Stanford Univ, Sch Med, Ctr Personal Dynam Regulomes, Stanford, CA 94305 USA; [Chang, Howard Y.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; [Almouzni, Genevieve] Inst Curie, Ctr Rech, F-75248 Paris, France	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Howard Hughes Medical Institute; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; California Institute of Technology; Stanford University; Stanford University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Memorial Sloan Kettering Cancer Center; New York University; Stanford University; Stanford University; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Hochedlinger, K (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Dept Mol Biol, Boston, MA 02114 USA.	johannes.zuber@imp.ac.at; khochedlinger@mgh.harvard.edu	Murn, Jernej/ABD-3624-2020; Zuber, Johannes/E-7517-2011; Almouzni, Genevieve/ABG-1029-2021; Penninger, Josef M/I-6860-2013; Ferrari, Francesco/H-5007-2012; Ninova, Maria/AAG-9476-2021	Zuber, Johannes/0000-0001-8810-6835; Almouzni, Genevieve/0000-0001-5570-0723; Penninger, Josef M/0000-0002-8194-3777; Ferrari, Francesco/0000-0002-9811-3753; Ninova, Maria/0000-0001-5051-5502; Ang, Cheen Euong/0000-0002-9050-6122; Hartl, Marietta/0000-0002-5184-2414; Park, Peter/0000-0001-9378-960X; Bell, Oliver/0000-0002-7639-5948; Stadtfeld, Matthias/0000-0002-5852-9906; Cheloufi, Sihem/0000-0002-1726-4796; Brumbaugh, Justin/0000-0002-9605-2010; Blanco, M. Andres/0000-0003-4404-2301; Abazova, Nade/0000-0003-3540-9394; Rathert, Philipp/0000-0003-1477-136X; Rinn, John/0000-0002-7231-7539; Jude, Julian/0000-0002-9091-9867	PRCRP at the Department of Defense [CA 120212]; NIH [P50-HG007735, R01 HD058013-06]; IMBA; Austrian National Foundation; cancer center support grant; NCI; ERC GA [341036]; Innovator Award/Era of Hope Award [W81XWH-12-1-0093]; ERC [336860]; Boehringer Ingelheim; MGH; HHMI; Gerald and Darlene Jordan Chair in Regenerative Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD078029, R01HD058013] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA008748, P01CA013106] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG007735] Funding Source: NIH RePORTER	PRCRP at the Department of Defense(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IMBA; Austrian National Foundation; cancer center support grant; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ERC GA; Innovator Award/Era of Hope Award; ERC(European Research Council (ERC)European Commission); Boehringer Ingelheim(Boehringer Ingelheim); MGH; HHMI(Howard Hughes Medical Institute); Gerald and Darlene Jordan Chair in Regenerative Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank B. Kingston, C. Vakoc, M. Tolstorukov and G. Hannon for guidance and discussions, B. Bernstein, K. Plath, K. Chronis, Y. Shen and O. Tam for advice on the ATAC-seq analysis, P. Brown for providing the Dot1l inhibitor, B. Stillman for sharing the Chaf1b antibody and T. Graf for sharing the C10 cell line. We thank C. Nakada and Y. Kiyota (Nikon) for providing software to quantify iPS cell formation and A. Huebner for help with transdifferentiation experiments. We are grateful to H. Hock and the HSCI-CRM flow cytometry core for help with flow data analysis and to W. Mallard for initial RNA-sequencing analysis. We further thank B. Ma, S. Muller, M. Weissenboeck and the IMP/IMBA Biooptics and Transgenic core facility as well the CSF NGS laboratory for technical assistance and all members of the Hochedlinger, Zuber, Penninger, Elling, Shi and Kingston laboratories for their feedback on various aspects of this project. We thank A. Stark, A. Deaton and L. Barrett for critical reading of the manuscript. S. C. was supported by the PRCRP at the Department of Defense (CA 120212). H. Y. C. by was supported by NIH P50-HG007735. U.E. was funded by grants from IMBA and the Austrian National Foundation. S. W. L. was supported by a cancer center support grant and program project grant from the NCI and is an HHMI investigator. J.M.P. was supported by IMBA, ERC GA (number 341036) and the Innovator Award/Era of Hope Award Number W81XWH-12-1-0093. J.Z. was funded by an ERC starting grant (number 336860) and generous institutional funding from Boehringer Ingelheim. K. H. was supported by funds from the MGH, HHMI, NIH (R01 HD058013-06) and the Gerald and Darlene Jordan Chair in Regenerative Medicine.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Auerbach RK, 2009, P NATL ACAD SCI USA, V106, P14926, DOI 10.1073/pnas.0905443106; Ben-Shahar TR, 2009, MOL CELL BIOL, V29, P6353, DOI 10.1128/MCB.01051-09; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Bussmann LH, 2009, CELL STEM CELL, V5, P554, DOI 10.1016/j.stem.2009.10.004; Chanda S, 2014, STEM CELL REP, V3, P282, DOI 10.1016/j.stemcr.2014.05.020; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Davis MPA, 2013, METHODS, V63, P41, DOI 10.1016/j.ymeth.2013.06.027; Dejosez M, 2013, SCIENCE, V341, P1511, DOI 10.1126/science.1241628; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Fellmann C, 2013, CELL REP, V5, P1704, DOI 10.1016/j.celrep.2013.11.020; Hathaway NA, 2012, CELL, V149, P1447, DOI 10.1016/j.cell.2012.03.052; Hoek M, 2003, P NATL ACAD SCI USA, V100, P12183, DOI 10.1073/pnas.1635158100; Houlard M, 2006, PLOS GENET, V2, P1686, DOI 10.1371/journal.pgen.0020181; Huang H, 2010, J CELL SCI, V123, P2853, DOI 10.1242/jcs.063610; Ishiuchi T., 2015, NATURE STRUCT MOL BI; Jullien J, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-17; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Krizhanovsky V, 2009, NATURE, V460, P1085, DOI 10.1038/4601085a; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Matoba S, 2014, CELL, V159, P884, DOI 10.1016/j.cell.2014.09.055; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Pezic D, 2014, GENE DEV, V28, P1410, DOI 10.1101/gad.240895.114; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Premsrirut PK, 2011, CELL, V145, P145, DOI 10.1016/j.cell.2011.03.012; Qin H, 2014, CELL, V158, P449, DOI 10.1016/j.cell.2014.05.040; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Quivy JP, 2008, NAT STRUCT MOL BIOL, V15, P972, DOI 10.1038/nsmb.1470; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Ray-Gallet D, 2011, MOL CELL, V44, P928, DOI 10.1016/j.molcel.2011.12.006; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Sabo PJ, 2004, P NATL ACAD SCI USA, V101, P16837, DOI 10.1073/pnas.0407387101; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Sridharan R, 2013, NAT CELL BIOL, V15, P872, DOI 10.1038/ncb2768; Stadtfeld M, 2010, NAT METHODS, V7, P53, DOI [10.1038/NMETH.1409, 10.1038/nmeth.1409]; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vierbuchen T, 2012, MOL CELL, V47, P827, DOI 10.1016/j.molcel.2012.09.008; Wen DC, 2014, NUCLEUS-AUSTIN, V5, P369, DOI 10.4161/nucl.36231; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yang CS, 2014, CELL REP, V8, P326, DOI 10.1016/j.celrep.2014.07.002; Ye XF, 2003, MOL CELL, V11, P341, DOI 10.1016/S1097-2765(03)00037-6; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334; Zuber J, 2011, NAT BIOTECHNOL, V29, P79, DOI 10.1038/nbt.1720	54	169	178	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2015	528	7581					218	+		10.1038/nature15749	http://dx.doi.org/10.1038/nature15749			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9VH	26659182	Green Accepted, Green Submitted			2022-12-28	WOS:000366053300032
J	Petroni, S; Patel, V; Patton, G				Petroni, Suzanne; Patel, Vikram; Patton, George			Why is suicide the leading killer of older adolescent girls?	LANCET			English	Editorial Material							HEALTH		[Petroni, Suzanne] Int Ctr Res Women, Gender Populat & Dev, Washington, DC 20036 USA; [Patel, Vikram] London Sch Hyg & Trop Med, Ctr Global Mental Hlth, London, England; [Patel, Vikram] Publ Hlth Fdn India, Ctr Chron Condit & Injuries, Gurgaon, India; [Patton, George] Univ Melbourne, Murdoch Childrens Res Inst, Ctr Adolescent Hlth, Melbourne, Vic, Australia	University of London; London School of Hygiene & Tropical Medicine; Public Health Foundation of India; Murdoch Children's Research Institute; University of Melbourne	Petroni, S (corresponding author), Int Ctr Res Women, Gender Populat & Dev, Washington, DC 20036 USA.	spetroni@icrw.org	Ribeiro, Ana Cristina/HHN-7466-2022; Patton, George C/B-5246-2013	Ribeiro, Ana Cristina/0000-0002-0493-8376; Patton, George C/0000-0001-5039-8326	Wellcome Trust [091834, 084674] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		[Anonymous], 2014, REPROD HEALTH MATTER, V22, P52; Brink S., 2015, NPR; Devries KM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001439; FRAUTSCHI S, 1994, INT J GYNECOL OBSTET, V47, P275, DOI 10.1016/0020-7292(94)90574-6; Le Strat Y, 2011, PEDIATRICS, V128, P524, DOI 10.1542/peds.2011-0961; Lilia Diu N., 2015, TELEGRAPH; Lister CE, 2015, J SCHOOL HEALTH, V85, P433, DOI 10.1111/josh.12271; Patel V, 2013, J ADOLESCENT HEALTH, V52, pS36, DOI 10.1016/j.jadohealth.2012.04.016; UNFPA, 2013, STAT WORLD POP 2013; UNICEF, 2014, END CHILD MARR PROGR; Valenti J., 2015, GUARDIAN; WHO, 2014, HLTH WORLDS AD 2 CHA; World Health Organization, 2014, PREV SUIC PREV SUIC; World Health Organization, 2014, AD HLTH RISKS SOL	14	32	32	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 21	2015	386	10008					2031	2032		10.1016/S0140-6736(15)01019-3	http://dx.doi.org/10.1016/S0140-6736(15)01019-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CX8XF	26700380				2022-12-28	WOS:000365987600004
J	Joffe, HV; Chang, C; Sewell, C; Easley, O; Nguyen, C; Dunn, S; Lehrfeld, K; Lee, LM; Kim, MJ; Slagle, AF; Beitz, J				Joffe, Hylton V.; Chang, Christina; Sewell, Catherine; Easley, Olivia; Nguyen, Christine; Dunn, Somya; Lehrfeld, Kimberly; Lee, LaiMing; Kim, Myong-Jin; Slagle, Ashley F.; Beitz, Julie			FDA Approval of Flibanserin - Treating Hypoactive Sexual Desire Disorder	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Joffe, Hylton V.; Chang, Christina; Sewell, Catherine; Easley, Olivia; Nguyen, Christine; Dunn, Somya; Lehrfeld, Kimberly; Lee, LaiMing; Kim, Myong-Jin; Slagle, Ashley F.; Beitz, Julie] Food & Drug Adm, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Joffe, HV (corresponding author), Food & Drug Adm, Silver Spring, MD 20993 USA.							[Anonymous], 2014, RES 2013 NAT SURV DR; [Anonymous], 2010, M ADV COMM REPR HLTH; Nguyen CP, 2015, NEW ENGL J MED, V373, P689, DOI 10.1056/NEJMp1506632; Food and Drug Administration, 2014, PAT DRUG DEV PUBL M; *FOOD DRUG ADM, 2015, ADD TABL FDA STAFF R	5	63	63	2	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 14	2016	374	2					101	104		10.1056/NEJMp1513686	http://dx.doi.org/10.1056/NEJMp1513686			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DA7PQ	26649985	Bronze			2022-12-28	WOS:000367996700002
J	Chen, LY; Xu, JQ; Choi, H; Pozuelo, M; Ma, XL; Bhowmick, S; Yang, JM; Mathaudhu, S; Li, XC				Chen, Lian-Yi; Xu, Jia-Quan; Choi, Hongseok; Pozuelo, Marta; Ma, Xiaolong; Bhowmick, Sanjit; Yang, Jenn-Ming; Mathaudhu, Suveen; Li, Xiao-Chun			Processing and properties of magnesium containing a dense uniform dispersion of nanoparticles	NATURE			English	Article							METAL-MATRIX NANOCOMPOSITES; DEFORMATION-BEHAVIOR; GRAIN-SIZE; STRENGTH; MG; ALLOYS; PARTICLES; ROUTE; STEEL	Magnesium is a light metal, with a density two-thirds that of aluminium, is abundant on Earth and is biocompatible; it thus has the potential to improve energy efficiency and system performance in aerospace, automobile, defence, mobile electronics and biomedical applications(1-5). However, conventional synthesis and processing methods (alloying and thermomechanical processing) have reached certain limits in further improving the properties of magnesium and other metals(6). Ceramic particles have been introduced into metal matrices to improve the strength of the metals(7), but unfortunately, ceramic microparticles severely degrade the plasticity and machinability of metals(7), and nanoparticles, although they have the potential to improve strength while maintaining or even improving the plasticity of metals(8,9), are difficult to disperse uniformly in metal matrices(10-14). Here we show that a dense uniform dispersion of silicon carbide nanoparticles (14 per cent by volume) in magnesium can be achieved through a nanoparticle self-stabilization mechanism in molten metal. An enhancement of strength, stiffness, plasticity and high-temperature stability is simultaneously achieved, delivering a higher specific yield strength and higher specific modulus than almost all structural metals.	[Chen, Lian-Yi; Li, Xiao-Chun] Univ Calif Los Angeles, Dept Mech & Aerosp Engn, Scifacturing Lab, Los Angeles, CA 90095 USA; [Chen, Lian-Yi; Xu, Jia-Quan; Pozuelo, Marta; Yang, Jenn-Ming; Li, Xiao-Chun] Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90095 USA; [Chen, Lian-Yi] Missouri Univ Sci & Technol, Dept Mech & Aerosp Engn, Rolla, MO 65409 USA; [Choi, Hongseok] Clemson Univ, Dept Mech Engn, Clemson, SC 29634 USA; [Ma, Xiaolong] N Carolina State Univ, Dept Mat Sci & Engn, Raleigh, NC 27695 USA; [Bhowmick, Sanjit] Hysitron Inc, Minneapolis, MN 55344 USA; [Mathaudhu, Suveen] Univ Calif Riverside, Dept Mech Engn, Riverside, CA 92521 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Missouri System; Missouri University of Science & Technology; Clemson University; University of North Carolina; North Carolina State University; University of California System; University of California Riverside	Li, XC (corresponding author), Univ Calif Los Angeles, Dept Mech & Aerosp Engn, Scifacturing Lab, Los Angeles, CA 90095 USA.	xcli@seas.ucla.edu	Pozuelo, Marta/A-6906-2011; Ma, Xiaolong/AAK-4002-2021; Choi, Hongseok/J-6014-2015; Chen, Lianyi/B-3156-2008	Pozuelo, Marta/0000-0001-6869-8749; Ma, Xiaolong/0000-0003-1392-2787; Choi, Hongseok/0000-0002-5097-9646; Chen, Lianyi/0000-0003-3720-398X; Mathaudhu, Suveen/0000-0001-6248-5363	National Institute of Standards and Technology (NIST)	National Institute of Standards and Technology (NIST)(National Institute of Standards & Technology (NIST) - USA)	This work is supported in part by the National Institute of Standards and Technology (NIST). We thank Y.-W. Chang, N. Bodzin and T. McLouth at the University of California, Los Angeles, for their help with FIB experiments, micropillar testing and elastic modulus measurements. We also thank C. Cao at the University of California, Los Angeles for his help with measuring the grain size of the as-solidified Mg2Zn samples.	Barnett MR, 2004, ACTA MATER, V52, P5093, DOI 10.1016/j.actamat.2004.07.015; Chen LY, 2013, SCRIPTA MATER, V69, P634, DOI 10.1016/j.scriptamat.2013.07.016; Chen LY, 2012, SCRIPTA MATER, V67, P29, DOI 10.1016/j.scriptamat.2012.03.013; Chen P, 2014, ACTA MATER, V65, P133, DOI 10.1016/j.actamat.2013.11.036; Choi HJ, 2010, MAT SCI ENG A-STRUCT, V527, P1565, DOI 10.1016/j.msea.2009.10.035; Choi WS, 2015, ACTA MATER, V98, P391, DOI 10.1016/j.actamat.2015.06.065; Cordero ZC, 2014, METALL MATER TRANS A, V45A, P3609, DOI 10.1007/s11661-014-2286-1; Erbel R, 2007, LANCET, V369, P1869, DOI 10.1016/S0140-6736(07)60853-8; Eustathopoulos N., 1999, WETTABILITY HIGH TEM, P396; Ferguson JB, 2012, MAT SCI ENG A-STRUCT, V558, P193, DOI 10.1016/j.msea.2012.07.111; Ferkel H, 2001, MAT SCI ENG A-STRUCT, V298, P193, DOI 10.1016/S0921-5093(00)01283-1; Girault B, 2010, ADV ENG MATER, V12, P385, DOI 10.1002/adem.201000089; Gong JC, 2011, ACTA MATER, V59, P5970, DOI 10.1016/j.actamat.2011.06.005; Gu R, 2013, SCRIPTA MATER, V68, P861, DOI 10.1016/j.scriptamat.2013.02.012; Guo EY, 2014, MAT SCI ENG A-STRUCT, V598, P98, DOI 10.1016/j.msea.2014.01.002; Hashim J, 2001, J MATER PROCESS TECH, V119, P324, DOI 10.1016/S0924-0136(01)00975-X; Hutchinson WB, 2010, SCRIPTA MATER, V63, P737, DOI 10.1016/j.scriptamat.2010.05.047; Inoue A, 2002, MATER TRANS, V43, P580, DOI 10.2320/matertrans.43.580; Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P1; Jian WW, 2013, MATER RES LETT, V1, P61, DOI 10.1080/21663831.2013.765927; Knochel P, 2009, NAT CHEM, V1, P740, DOI 10.1038/nchem.459; Liu G, 2013, NAT MATER, V12, P344, DOI [10.1038/NMAT3544, 10.1038/nmat3544]; Lu K, 2010, SCIENCE, V328, P319, DOI 10.1126/science.1185866; LUO A, 1994, J MATER SCI, V29, P5259, DOI 10.1007/BF01171534; Luo AA, 2004, INT MATER REV, V49, P13, DOI 10.1179/095066004225010497; Min YJ, 2008, NAT MATER, V7, P527, DOI 10.1038/nmat2206; Mortensen A, 2010, ANNU REV MATER RES, V40, P243, DOI 10.1146/annurev-matsci-070909-104511; NARDONE VC, 1986, SCRIPTA METALL MATER, V20, P43, DOI 10.1016/0036-9748(86)90210-3; Nie JF, 2013, SCIENCE, V340, P957, DOI 10.1126/science.1229369; Nie JF, 2012, METALL MATER TRANS A, V43A, P3891, DOI 10.1007/s11661-012-1217-2; Oh Y., 2011, US patent, Patent No. [WO2011066018 A1, 2011066018]; Pollock TM, 2010, SCIENCE, V328, P986, DOI 10.1126/science.1182848; Pozuelo M, 2015, MAT SCI ENG A-STRUCT, V633, P200, DOI 10.1016/j.msea.2015.02.062; Schumann S, 2006, MAGNESIUM TECHNOLOGY: METALLURGY, DESIGN DATA, APPLICATIONS, P499; Sillekens WH, 2014, METALL MATER TRANS A, V45A, P3349, DOI 10.1007/s11661-014-2321-2; Somekawa H, 2013, SCRIPTA MATER, V68, P416, DOI 10.1016/j.scriptamat.2012.11.010; Stanford N, 2009, MAT SCI ENG A-STRUCT, V516, P226, DOI 10.1016/j.msea.2009.04.001; Tjong SC, 2007, ADV ENG MATER, V9, P639, DOI 10.1002/adem.200700106; Watanabe H, 2013, J MATER ENG PERFORM, V22, P3450, DOI 10.1007/s11665-013-0651-7; Xiao Yang, 2006, Chinese Journal of Nonferrous Metals, V16, P709; Xu JQ, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/25/255304; Ye J, 2011, SCRIPTA MATER, V64, P292, DOI 10.1016/j.scriptamat.2010.09.047; Zhang D, 2010, APPL SURF SCI, V256, P7043, DOI 10.1016/j.apsusc.2010.05.022; Zhang Z, 2006, SCRIPTA MATER, V54, P1321, DOI 10.1016/j.scriptamat.2005.12.017; Zhilyaev AP, 2008, PROG MATER SCI, V53, P893, DOI 10.1016/j.pmatsci.2008.03.002	45	440	457	33	638	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2015	528	7583					539	+		10.1038/nature16445	http://dx.doi.org/10.1038/nature16445			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ3GH	26701055				2022-12-28	WOS:000366991900049
J	Friis, EM; Crane, PR; Pedersen, KR; Stampanoni, M; Marone, F				Friis, Else Marie; Crane, Peter R.; Pedersen, Kaj Raunsgaard; Stampanoni, Marco; Marone, Federica			Exceptional preservation of tiny embryos documents seed dormancy in early angiosperms	NATURE			English	Article							AMBORELLA AMBORELLACEAE; DISPERSAL SYSTEMS; BASAL ANGIOSPERM; CRETACEOUS PLANT; FOSSIL FLOWERS; EVOLUTION; IMAGE; SIZE; ENDOSPERM; HISTORY	The rapid diversification of angiosperms through the Early Cretaceous period, between about 130-100 million years ago, initiated fundamental changes in the composition of terrestrial vegetation and is increasingly well understood on the basis of a wealth of palaeobotanical discoveries over the past four decades(1-5) and their integration with improved knowledge of living angiosperms(3,6). Prevailing hypotheses, based on evidence both from living and from fossil plants, emphasize that the earliest angiosperms were plants of small stature(7-12) with rapid life cycles(7,8,12,13) that exploited disturbed habitats(3,9,11,13,14) in open(3,9,11,13,14), or perhaps understorey, conditions(15,16). However, direct palaeontogical data relevant to understanding the seed biology and germination ecology of Early Cretaceous angiosperms are sparse. Here we report the discovery of embryos and their associated nutrient storage tissues in exceptionally well-preserved angiosperm seeds from the Early Cretaceous. Synchrotron radiation X-ray tomographic microscopy of the fossil embryos from many taxa reveals that all were tiny at the time of dispersal. These results support hypotheses based on extant plants that tiny embryos and seed dormancy are basic for angiosperms as a whole(17,18). The minute size of the fossil embryos, and the modest nutrient storage tissues dictated by the overall small seed size, is also consistent with the interpretation that many early angiosperms were opportunistic, early successional colonizers of disturbance-prone habitats(2,15,16).	[Friis, Else Marie] Swedish Museum Nat Hist, Dept Palaeobiol, SE-10405 Stockholm, Sweden; [Friis, Else Marie; Crane, Peter R.; Pedersen, Kaj Raunsgaard] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Pedersen, Kaj Raunsgaard] Univ Aarhus, Dept Earth Sci, DK-8000 Aarhus, Denmark; [Stampanoni, Marco; Marone, Federica] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland; [Stampanoni, Marco] Swiss Fed Inst Technol Zurich, Inst Biomed Engn, CH-8092 Zurich, Switzerland	Swedish Museum of Natural History; Yale University; Aarhus University; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich	Friis, EM (corresponding author), Swedish Museum Nat Hist, Dept Palaeobiol, SE-10405 Stockholm, Sweden.	else.marie.friis@nrm.se	Stampanoni, Marco/J-4099-2013; Stampanoni, Marco/AAZ-3033-2021; Marone, Federica/J-4420-2013; Stampanoni, Marco/GRR-9695-2022	Stampanoni, Marco/0000-0001-7486-6681; Stampanoni, Marco/0000-0001-7486-6681; Stampanoni, Marco/0000-0001-7486-6681	Swedish Research Council; Edward P. Bass Distinguished Visiting Fellowship; European Community's Seventh Framework Programme (FP7) [312284]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Edward P. Bass Distinguished Visiting Fellowship; European Community's Seventh Framework Programme (FP7)(European Commission)	We thank A. Lindstrom for assistance with the SRXTM analyses. Research reported here was supported by the Swedish Research Council, the Edward P. Bass Distinguished Visiting Fellowship and by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement n. 312284 (for CALIPSO) for the SRXTM analyses at the SLS.	Baskin CC, 2007, SEED SCI RES, V17, P11, DOI 10.1017/S0960258507383189; Baskin CC, 2014, SEEDS: ECOLOGY, BIOGEOGRAPHY, AND EVOLUTION OF DORMANCY AND GERMINATION, 2ND EDITION, P1, DOI 10.1016/B978-0-12-416677-6.00001-9; DILCHER DL, 1979, REV PALAEOBOT PALYNO, V27, P291, DOI 10.1016/0034-6667(79)90015-0; Doyle J.A., 1976, ORIGIN EARLY EVOLUTI, P139; Doyle JA, 2010, J SYST EVOL, V48, P1, DOI 10.1111/j.1759-6831.2009.00058.x; Eriksson O, 2000, INT J PLANT SCI, V161, P319, DOI 10.1086/314248; Eriksson O, 2000, AM NAT, V156, P47, DOI 10.1086/303367; Feild TS, 2004, PALEOBIOLOGY, V30, P82, DOI 10.1666/0094-8373(2004)030<0082:DADANI>2.0.CO;2; Floyd SK, 2001, PLANT SYST EVOL, V228, P153, DOI 10.1007/s006060170026; Floyd SK, 2000, INT J PLANT SCI, V161, pS57, DOI 10.1086/317579; Forbis TA, 2002, EVOLUTION, V56, P2112, DOI 10.1111/j.0014-3820.2002.tb00137.x; Friedman WE, 2013, AM J BOT, V100, P906, DOI 10.3732/ajb.1200632; Friis E. M., 2011, EARLY FLOWERS ANGIOS; Friis EM, 2015, GRANA, V54, P184, DOI 10.1080/00173134.2015.1060750; Friis EM, 2014, J PALEONTOL, V88, P684, DOI 10.1666/13-099; Friis EM, 2010, PHILOS T R SOC B, V365, P369, DOI 10.1098/rstb.2009.0227; Friis EM, 1997, GRANA, V36, P225, DOI 10.1080/00173139709362611; FRIIS EM, 1995, AM J BOT, V82, P933, DOI 10.2307/2445980; Hughes NF., 1994, ENIGMA ANGIOSPERM OR; Jud NA, 2015, P ROY SOC B-BIOL SCI, V282, P81, DOI 10.1098/rspb.2015.1045; Lee AP, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.3052; Marone F, 2012, J SYNCHROTRON RADIAT, V19, P1029, DOI 10.1107/S0909049512032864; Moles AT, 2005, SCIENCE, V307, P576, DOI 10.1126/science.1104863; Paganin D, 2002, J MICROSC-OXFORD, V206, P33, DOI 10.1046/j.1365-2818.2002.01010.x; Povilus RA, 2015, ANN BOT-LONDON, V115, P211, DOI 10.1093/aob/mcu235; Royer DL, 2010, AM J BOT, V97, P438, DOI 10.3732/ajb.0900290; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Stampanoni M, 2006, PROC SPIE, V6318, DOI 10.1117/12.679497; STEBBINS G. LEDYARD, 1965, ANN MISSOURI BOT GARD, V52, P457, DOI 10.2307/2394810; Stebbins GL, 1976, ORIGIN EARLY EVOLUTI, P300; Sun G, 2002, SCIENCE, V296, P899, DOI 10.1126/science.1069439; Taylor David Winship, 1996, P232, DOI 10.1007/978-0-585-23095-5_9; TAYLOR DW, 1990, SCIENCE, V247, P702, DOI 10.1126/science.247.4943.702; Tobe H, 2000, J PLANT RES, V113, P271, DOI 10.1007/PL00013935; Wing SL, 1998, ANNU REV EARTH PL SC, V26, P379, DOI 10.1146/annurev.earth.26.1.379	35	25	30	1	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2015	528	7583					551	+		10.1038/nature16441	http://dx.doi.org/10.1038/nature16441			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ3GH	26675723	Green Submitted, Green Accepted			2022-12-28	WOS:000366991900052
J	Lavallee, Y; Dingwell, DB; Johnson, JB; Cimarelli, C; Hornby, AJ; Kendrick, JE; von Aulock, FW; Kennedy, B; Andrews, BJ; Wadsworth, FB; Rhodes, E; Chigna, G				Lavallee, Yan; Dingwell, Donald B.; Johnson, Jeffrey B.; Cimarelli, Corrado; Hornby, Adrian J.; Kendrick, Jackie E.; von Aulock, Felix W.; Kennedy, Ben M.; Andrews, Benjamin J.; Wadsworth, Fabian B.; Rhodes, Emma; Chigna, Gustavo			Thermal vesiculation during volcanic eruptions	NATURE			English	Article							MAGMA FRAGMENTATION; MELTING PROCESSES; DOME; SOLUBILITY; GROWTH; ASCENT; FLOW; H2O; CRYSTALLIZATION; CONDUIT	Terrestrial volcanic eruptions are the consequence of magmas ascending to the surface of the Earth. This ascent is driven by buoyancy forces, which are enhanced by bubble nucleation and growth (vesiculation) that reduce the density of magma(1). The development of vesicularity also greatly reduces the 'strength' of magma(2), a material parameter controlling fragmentation and thus the explosive potential of the liquid rock(3). The development of vesicularity in magmas has until now been viewed (both thermodynamically and kinetically) in terms of the pressure dependence of the solubility of water in the magma, and its role in driving gas saturation, exsolution and expansion during decompression. In contrast, the possible effects of the well documented negative temperature dependence of solubility of water in magma has largely been ignored. Recently, petrological constraints have demonstrated that considerable heating of magma may indeed be a common result of the latent heat of crystallization(4) as well as viscous(5,6) and frictional(7) heating in areas of strain localization. Here we present field and experimental observations of magma vesiculation and fragmentation resulting from heating (rather than decompression). Textural analysis of volcanic ash from Santiaguito volcano in Guatemala reveals the presence of chemically heterogeneous filaments hosting micrometre-scale vesicles. The textures mirror those developed by disequilibrium melting induced via rapid heating during fault friction experiments, demonstrating that friction can generate sufficient heat to induce melting and vesiculation of hydrated silicic magma. Consideration of the experimentally determined temperature and pressure dependence of water solubility in magma reveals that, for many ascent paths, exsolution may be more efficiently achieved by heating than by decompression. We conclude that the thermal path experienced by magma during ascent strongly controls degassing, vesiculation, magma strength and the effusive-explosive transition in volcanic eruptions.	[Lavallee, Yan; Hornby, Adrian J.; Kendrick, Jackie E.; von Aulock, Felix W.; Rhodes, Emma] Univ Liverpool, Dept Earth Ocean & Ecol Sci, Liverpool L69 3GP, Merseyside, England; [Dingwell, Donald B.; Cimarelli, Corrado; Wadsworth, Fabian B.] Tech Univ Munich, Dept Earth & Environm Sci, D-80333 Munich, Germany; [Johnson, Jeffrey B.] Boise State Univ, Dept Geosci, Boise, ID 83725 USA; [Kennedy, Ben M.; Rhodes, Emma] Univ Canterbury, Geol Sci, Christchurch 8140, New Zealand; [Andrews, Benjamin J.] Smithsonian Inst, Dept Mineral Sci, Washington, DC 20560 USA; [Chigna, Gustavo] Inst Nacl Sismol Vulcanol Meteorol & Hydrol INSIV, Guatemala City, Guatemala	University of Liverpool; Technical University of Munich; Idaho; Boise State University; University of Canterbury; Smithsonian Institution; Smithsonian National Museum of Natural History	Lavallee, Y (corresponding author), Univ Liverpool, Dept Earth Ocean & Ecol Sci, Liverpool L69 3GP, Merseyside, England.	yan.lavallee@liverpool.ac.uk	Cimarelli, Corrado/A-1047-2011; Dingwell, Donald B/A-4724-2011; Hornby, Adrian/ABE-9636-2020; Andrews, Ben/GRY-6201-2022; Lavallee, Yan/AAC-5259-2020	Dingwell, Donald B/0000-0002-3332-789X; Hornby, Adrian/0000-0002-4969-6163; Cimarelli, Corrado/0000-0002-5707-5930; Andrews, Benjamin/0000-0001-9928-1225; Kendrick, Jackie/0000-0001-5106-3587	European Research Council [306488, 247076]; National Science Foundation EAR [1151662]; European Union [282759]; AXA; Directorate For Geosciences [1151662] Funding Source: National Science Foundation	European Research Council(European Research Council (ERC)European Commission); National Science Foundation EAR; European Union(European Commission); AXA; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank A. Pineda, the staff at the National Institute for Seismology, Vulcanology, Meteorology and Hydrology of Guatemala (INSIVUMEH) and the Policia Nacional Civil de Guatemala for support with the field campaign. This work was supported by a European Research Council Starting Grant to Y.L. on 'Strain Localisation in Magmas' (SLiM, grant number 306488) and an Advanced Grant to D.B.D. on 'Explosive volcanism in the Earth system' (EVOKES, grant number 247076). J.B.J acknowledges the National Science Foundation EAR-grant number 1151662. This work was partially funded by the European Union's seventh programme for research, technological development, and demonstration under grant agreement 282759 (VUELCO), and by an AXA grant 'Risk from Volcanic Ash in the Earth System'. We are grateful to K. Genereau and L. Mastin for constructive reviews.	Blundy J, 2006, NATURE, V443, P76, DOI 10.1038/nature05100; Carslaw H.S., 1986, CONDUCTION HEAT SOLI; Dingwell DB, 1996, SCIENCE, V273, P1054, DOI 10.1126/science.273.5278.1054; GHIORSO MS, 1995, CONTRIB MINERAL PETR, V119, P197, DOI 10.1007/BF00307281; Gonnermann HM, 2003, NATURE, V426, P432, DOI 10.1038/nature02138; Harris AJL, 2002, GEOL SOC AM BULL, V114, P533, DOI 10.1130/0016-7606(2002)114<0533:TTSFOS>2.0.CO;2; Hess KU, 2008, EARTH PLANET SC LETT, V275, P121, DOI 10.1016/j.epsl.2008.08.014; Hirose T, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003207; Holland ASP, 2011, J VOLCANOL GEOTH RES, V202, P153, DOI 10.1016/j.jvolgeores.2011.02.004; HOLTZ F, 1995, AM MINERAL, V80, P94; Hornby AJ, 2015, J GEOPHYS RES-SOL EA, V120, P4034, DOI 10.1002/2014JB011660; Johnson JB, 2008, NATURE, V456, P377, DOI 10.1038/nature07429; Johnson JB, 2014, GEOPHYS RES LETT, V41, P6689, DOI 10.1002/2014GL061310; Kendrick JE, 2014, SOLID EARTH, V5, P199, DOI 10.5194/se-5-199-2014; Kendrick JE, 2014, NAT GEOSCI, V7, P438, DOI 10.1038/ngeo2146; Kendrick JE, 2012, J STRUCT GEOL, V38, P61, DOI 10.1016/j.jsg.2011.10.003; Lavallee Y, 2007, GEOLOGY, V35, P843, DOI 10.1130/G23594A.1; Lin AM, 1998, J ASIAN EARTH SCI, V16, P533, DOI 10.1016/S0743-9547(98)00040-3; Liu Y, 2005, J VOLCANOL GEOTH RES, V143, P219, DOI 10.1016/j.jvolgeores.2004.09.019; Martel C, 2003, CONTRIB MINERAL PETR, V144, P397, DOI 10.1007/s00410-002-0404-3; Mastin LG, 2005, J VOLCANOL GEOTH RES, V143, P17, DOI 10.1016/j.jvolgeores.2004.09.008; Noguchi S, 2008, J VOLCANOL GEOTH RES, V175, P71, DOI 10.1016/j.jvolgeores.2008.03.037; Papale P, 1999, NATURE, V397, P425, DOI 10.1038/17109; Petruk W., 1990, APPL MINERALOGY MINI, P268; Proussevitch AA, 1998, J GEOPHYS RES-SOL EA, V103, P18223, DOI 10.1029/98JB00906; Rosi M, 2004, B VOLCANOL, V66, P307, DOI 10.1007/s00445-003-0312-z; Ryan AG, 2015, AM MINERAL, V100, P774, DOI 10.2138/am-2015-5030; Sahagian D, 1999, NATURE, V402, P589, DOI 10.1038/45099; Scharff L, 2014, GEOPHYS J INT, V197, P926, DOI 10.1093/gji/ggu069; Spray JG, 2010, ANNU REV EARTH PL SC, V38, P221, DOI 10.1146/annurev.earth.031208.100045; Stasiuk MV, 1996, B VOLCANOL, V58, P117, DOI 10.1007/s004450050130; Tuffen H, 2003, GEOLOGY, V31, P1089, DOI 10.1130/G19777.1; Vasseur J, 2013, GEOPHYS RES LETT, V40, P5658, DOI 10.1002/2013GL058105; Wright HMN, 2009, GEOLOGY, V37, P1023, DOI 10.1130/G30199A.1; Zhang YX, 1999, NATURE, V402, P648, DOI 10.1038/45210	35	39	39	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2015	528	7583					544	+		10.1038/nature16153	http://dx.doi.org/10.1038/nature16153			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ3GH	26701056				2022-12-28	WOS:000366991900050
J	Malinsky, M; Challis, RJ; Tyers, AM; Schiffels, S; Terai, Y; Ngatunga, BP; Miska, EA; Durbin, R; Genner, MJ; Turner, GF				Malinsky, Milan; Challis, Richard J.; Tyers, Alexandra M.; Schiffels, Stephan; Terai, Yohey; Ngatunga, Benjamin P.; Miska, Eric A.; Durbin, Richard; Genner, Martin J.; Turner, George F.			Genomic islands of speciation separate cichlid ecomorphs in an East African crater lake	SCIENCE			English	Article							WITH-GENE-FLOW; SYMPATRIC SPECIATION; ADAPTIVE RADIATION; FISH; DIVERGENCE; EVOLUTION; INCOMPATIBILITIES; LANDSCAPE; MALAWI; MODEL	The genomic causes and effects of divergent ecological selection during speciation are still poorly understood. Here we report the discovery and detailed characterization of early-stage adaptive divergence of two cichlid fish ecomorphs in a small (700 meters in diameter) isolated crater lake in Tanzania. The ecomorphs differ in depth preference, male breeding color, body shape, diet, and trophic morphology. With whole-genome sequences of 146 fish, we identified 98 clearly demarcated genomic "islands" of high differentiation and demonstrated the association of genotypes across these islands with divergent mate preferences. The islands contain candidate adaptive genes enriched for functions in sensory perception (including rhodopsin and other twilight-vision-associated genes), hormone signaling, and morphogenesis. Our study suggests mechanisms and genomic regions that may play a role in the closely related mega-radiation of Lake Malawi.	[Malinsky, Milan; Schiffels, Stephan; Miska, Eric A.; Durbin, Richard] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Malinsky, Milan; Miska, Eric A.] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; [Malinsky, Milan; Miska, Eric A.] Univ Cambridge, Dept Genet, Cambridge CB2 1QN, England; [Challis, Richard J.; Tyers, Alexandra M.; Turner, George F.] Bangor Univ, Sch Biol Sci, Bangor LL57 2UW, Gwynedd, Wales; [Terai, Yohey] SOKENDAI, Dept Evolutionary Studies Biosyst, Hayama, Kanagawa 2400193, Japan; [Ngatunga, Benjamin P.] Tanzania Fisheries Res Inst, Dar Es Salaam, Tanzania; [Genner, Martin J.] Univ Bristol, Sch Biol Sci, Bristol BS8 1TQ, Avon, England	Wellcome Trust Sanger Institute; University of Cambridge; University of Cambridge; Bangor University; Graduate University for Advanced Studies - Japan; University of Bristol	Genner, MJ (corresponding author), Univ Bristol, Sch Biol Sci, Life Sci Bldg,24 Tyndall Ave, Bristol BS8 1TQ, Avon, England.	m.genner@bristol.ac.uk; george.turner@bangor.ac.uk	Challis, Richard/ABD-9592-2020; Schiffels, Stephan/D-5675-2018; Malinsky, Milan/J-4087-2019; Durbin, Richard/AAE-7178-2019	Challis, Richard/0000-0002-3502-1122; Schiffels, Stephan/0000-0002-1017-9150; Malinsky, Milan/0000-0002-1462-6317; Durbin, Richard/0000-0002-9130-1006; Turner, George/0000-0003-0099-7261	Royal Society-Leverhulme Trust Africa Awards [AA100023, AA130107]; Wellcome Trust [097677/Z/11/Z, WT098051]; Cancer Research UK; Leverhulme Trust [RF-2014-686]; University of Bristol Research Committee; Bangor University Anniversary Ph.D. studentship; Fisheries Society of the British Isles award;  [PRJNA286304];  [PRJEB1254]; Cancer Research UK [11832] Funding Source: researchfish; Wellcome Trust [104640/Z/14/Z] Funding Source: researchfish; Grants-in-Aid for Scientific Research [26304008] Funding Source: KAKEN	Royal Society-Leverhulme Trust Africa Awards; Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); Leverhulme Trust(Leverhulme Trust); University of Bristol Research Committee; Bangor University Anniversary Ph.D. studentship; Fisheries Society of the British Isles award; ; ; Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by Royal Society-Leverhulme Trust Africa Awards AA100023 and AA130107 (M.J.G., B.P.N. and G.F.T.), Wellcome Trust Ph.D. studentship grant 097677/Z/11/Z (M.M.), Wellcome Trust grant WT098051 (S.S. and R.D.), Wellcome Trust and Cancer Research UK core support and a Wellcome Trust Senior Investigator Award (E.A.M.), Leverhulme Trust Research Fellowship RF-2014-686 (M.J.G.), a University of Bristol Research Committee award (M.G.), a Bangor University Anniversary Ph.D. studentship (A.M.T.), and a Fisheries Society of the British Isles award (G.F.T.). Raw sequencing reads are in the Sequence Read Archive: RAD sequencing (BioProject: PRJNA286304; accession nos. SAMN03768857 to SAMN03768912) and whole-genome sequencing (BioProject PRJEB1254: sample accessions listed in table S16). The RAD-based phylogeny and alignments have been deposited in TreeBase (TB2:S18241). Whole-genome variant calls in the Variant Call Format (VCF), phylogenetic trees, and primer sequences for Sequenom genotyping are available from the Dryad Digital Repository (http://dx.doi.org/10.5061/dryad.770mc). R.D. declares his interests as a founder and non-executive director of Congenica Ltd., that he owns stock in Illumina from previous consulting, and is a scientific advisory board member of Dovetail Inc. We thank R. Schley for generating pharyngeal jaw data; S. Mzighani, J. Kihedu, and the staff of the Tanzanian Fisheries Research Institute for logistical support; A. Smith, H. Sungani, A. Shechonge, P. Parsons, J. Swanstrom, G. Cooke, and J. Bridle for contributions to sampling and aquarium maintenance; the Sanger Institute sequencing core for DNA sequencing; and H. Imai (Kyoto University) for the use of the spectrometer in his laboratory.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Andrew RL, 2013, EVOLUTION, V67, P2468, DOI 10.1111/evo.12106; Arnegard ME, 2014, NATURE, V511, P307, DOI 10.1038/nature13301; Barker P, 2003, QUATERNARY RES, V60, P368, DOI 10.1016/S0033-5894(03)00114-5; Barluenga M, 2006, NATURE, V439, P719, DOI 10.1038/nature04325; Brawand D, 2014, NATURE, V513, P375, DOI 10.1038/nature13726; Coyne J.A., 2004, SPECIATION; Cruickshank TE, 2014, MOL ECOL, V23, P3133, DOI 10.1111/mec.12796; Delalande M., 2008, HYDROLOGIE GEOCHIMIE; Duester G, 2000, EUR J BIOCHEM, V267, P4315, DOI 10.1046/j.1432-1327.2000.01497.x; Durand EY, 2011, MOL BIOL EVOL, V28, P2239, DOI 10.1093/molbev/msr048; Ellegren H, 2012, NATURE, V491, P756, DOI 10.1038/nature11584; Feder JL, 2012, TRENDS GENET, V28, P342, DOI 10.1016/j.tig.2012.03.009; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Joyce DA, 2011, CURR BIOL, V21, pR108, DOI 10.1016/j.cub.2010.11.029; KANESHIRO KY, 1980, EVOLUTION, V34, P437, DOI 10.1111/j.1558-5646.1980.tb04833.x; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Lawson DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002453; Martin CH, 2015, EVOLUTION, V69, P1406, DOI 10.1111/evo.12674; Martin SH, 2015, MOL BIOL EVOL, V32, P244, DOI 10.1093/molbev/msu269; Nadeau NJ, 2012, PHILOS T R SOC B, V367, P343, DOI 10.1098/rstb.2011.0198; Noor MAF, 2009, HEREDITY, V103, P439, DOI 10.1038/hdy.2009.151; O'Quin CT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-287; Poelstra JW, 2014, SCIENCE, V344, P1410, DOI 10.1126/science.1253226; Price TD, 2002, EVOLUTION, V56, P2083; Schiffels S, 2014, NAT GENET, V46, P919, DOI 10.1038/ng.3015; SCHLIEWEN UK, 1994, NATURE, V368, P629, DOI 10.1038/368629a0; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Soria-Carrasco V, 2014, SCIENCE, V344, P738, DOI 10.1126/science.1252136; Stelkens RB, 2010, EVOLUTION, V64, P617, DOI 10.1111/j.1558-5646.2009.00849.x; Sugawara T, 2005, P NATL ACAD SCI USA, V102, P5448, DOI 10.1073/pnas.0405302102; Via S, 2012, PHILOS T R SOC B, V367, P451, DOI 10.1098/rstb.2011.0260; Wagner CE, 2012, NATURE, V487, P366, DOI 10.1038/nature11144; Yamashita T, 2009, J NEUROSCI, V29, P9748, DOI 10.1523/JNEUROSCI.5854-08.2009	34	201	203	5	241	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2015	350	6267					1493	1498		10.1126/science.aac9927	http://dx.doi.org/10.1126/science.aac9927			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY7LY	26680190	Green Submitted, Green Accepted			2022-12-28	WOS:000366591100050
J	Sachdev, H				Sachdev, Hermann			Disclosing boron's thinnest side	SCIENCE			English	Editorial Material									[Sachdev, Hermann] Max Planck Inst Polymer Res, D-55128 Mainz, Germany; [Sachdev, Hermann] Tech Univ Kaiserslautern, Abt Mech Verfahrenstech Particle Proc Engn, D-67663 Kaiserslautern, Germany	Max Planck Society; University of Kaiserslautern	Sachdev, H (corresponding author), Max Planck Inst Polymer Res, Ackermannweg 10, D-55128 Mainz, Germany.	sachdev@mpip-mainz.mpg.de						Balendhran S, 2015, SMALL, V11, P640, DOI 10.1002/smll.201402041; Berner S, 2007, ANGEW CHEM INT EDIT, V46, P5115, DOI 10.1002/anie.200700234; Cai JM, 2010, NATURE, V466, P470, DOI 10.1038/nature09211; Driess M., 2008, MOL CLUSTERS MAIN GR; Franklin AD, 2015, SCIENCE, V349, DOI 10.1126/science.aab2750; Herrmann M, 2013, INT J REFRACT MET H, V39, P53, DOI 10.1016/j.ijrmhm.2012.02.009; Levine JB, 2009, ADV FUNCT MATER, V19, P3519, DOI 10.1002/adfm.200901257; Mannix AJ, 2015, SCIENCE, V350, P1513, DOI 10.1126/science.aad1080; Muller F, 2009, SMALL, V5, P2291, DOI 10.1002/smll.200900158; Piazza ZA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4113; Sachdev H, 2010, DIAM RELAT MATER, V19, P1027, DOI 10.1016/j.diamond.2010.03.021; Spear JC, 2015, NANO TODAY, V10, P301, DOI 10.1016/j.nantod.2015.04.003	12	34	35	0	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2015	350	6267					1468	1469		10.1126/science.aad7021	http://dx.doi.org/10.1126/science.aad7021			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY7LY	26680178				2022-12-28	WOS:000366591100030
J	Reinohl, J; Kaier, K; Reinecke, H; Schmoor, C; Frankenstein, L; Vach, W; Cribier, A; Beyersdorf, F; Bode, C; Zehender, M				Reinoehl, Jochen; Kaier, Klaus; Reinecke, Holger; Schmoor, Claudia; Frankenstein, Lutz; Vach, Werner; Cribier, Alain; Beyersdorf, Friedhelm; Bode, Christoph; Zehender, Manfred			Effect of Availability of Transcatheter Aortic-Valve Replacement on Clinical Practice	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HIGH-RISK PATIENTS; IMPLANTATION; REGISTRY; OUTCOMES; STENOSIS; TAVI	BACKGROUND Since the adoption of transcatheter aortic-valve replacement (TAVR), questions have been raised about its effect on clinical practice in comparison with the effect of surgical aortic-valve replacement, which is considered the current standard of care. Complete nationwide data are useful in examining how the introduction of a new technique influences previous clinical standards. METHODS We analyzed data on characteristics of patients and in-hospital outcomes for all isolated TAVR and surgical aortic-valve replacement procedures performed in Germany from 2007 to 2013. RESULTS In total, 32,581 TAVR and 55,992 surgical aortic-valve replacement procedures were performed. The number of TAVR procedures increased from 144 in 2007 to 9147 in 2013, whereas the number of surgical aortic-valve replacement procedures decreased slightly, from 8622 to 7048. Patients undergoing TAVR were older than those undergoing surgical aortic-valve replacement (mean [+/- SD] age, 81.0 +/- 6.1 years vs. 70.2 +/- 10.0 years) and at higher preoperative risk (estimated logistic EuroSCORE [European System for Cardiac Operative Risk Evaluation], 22.4% vs. 6.3%, on a scale of 0 to 100%, with higher scores indicating greater risk and a score of more than 20% indicating high surgical risk). In-hospital mortality decreased in both groups between 2007 and 2013 (from 13.2% to 5.4% with TAVR and from 3.8% to 2.2% with surgical aortic-valve replacement). The incidences of stroke, bleeding, and pacemaker implantation (but not acute kidney injury) also declined. CONCLUSIONS The use of TAVR increased markedly in Germany between 2007 and 2013; the concomitant reduction in the use of surgical aortic-valve replacement was moderate. Patients undergoing TAVR were older and at higher procedural risk than those undergoing surgical aortic-valve replacement. In-hospital mortality decreased in both groups but to a greater extent among patients undergoing TAVR.	[Reinoehl, Jochen; Kaier, Klaus; Bode, Christoph; Zehender, Manfred] Univ Freiburg, Dept Cardiol & Angiol 1, Heart Ctr, D-79106 Freiburg, Germany; [Beyersdorf, Friedhelm] Univ Freiburg, Dept Cardiovasc Surg, Heart Ctr, D-79106 Freiburg, Germany; [Kaier, Klaus; Vach, Werner] Univ Freiburg, Ctr Med Biometry & Med Informat, Med Ctr, D-79106 Freiburg, Germany; [Schmoor, Claudia] Univ Freiburg, Clin Trials Unit, Med Ctr, D-79106 Freiburg, Germany; [Reinoehl, Jochen; Reinecke, Holger; Frankenstein, Lutz] German Cardiac Soc, Project Grp Diag Related Grp, Dusseldorf, Germany; [Reinecke, Holger] Univ Hosp Muenster, Div Vasc Med, Dept Cardiovasc Med, Munster, Germany; [Frankenstein, Lutz] Heidelberg Univ, Dept Cardiol Angiol & Pulmonol, Heidelberg, Germany; [Cribier, Alain] Rouen Univ Hosp Charles Nicolle, Dept Cardiol, Rouen, France	Universitats Herzzentrum Freiburg; University of Freiburg; Universitats Herzzentrum Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Munster; Ruprecht Karls University Heidelberg; CHU de Rouen	Reinohl, J (corresponding author), Univ Freiburg, Dept Cardiol & Angiol 1, Heart Ctr, Hugstetter Str 55, D-79106 Freiburg, Germany.	jochen.reinoehl@universitaets-herzzentrum.de	Kaier, Klaus/B-4227-2009; Vach, Werner/F-2512-2011; Beyersdorf, Friedhelm/AAK-3718-2020	Kaier, Klaus/0000-0003-0837-6945; Vach, Werner/0000-0003-1865-8399; Beyersdorf, Friedhelm/0000-0003-2975-2751	Heart Center, Freiburg University	Heart Center, Freiburg University	Funded by the Heart Center, Freiburg University.	Abdel-Wahab M, 2014, JAMA-J AM MED ASSOC, V311, P1503, DOI 10.1001/jama.2014.3316; Barreto JA, 2013, JAMA-J AM MED ASSOC, V310, P2078, DOI 10.1001/jama.2013.282437; Brown ML, 2008, J THORAC CARDIOV SUR, V136, P566, DOI 10.1016/j.jtcvs.2007.10.091; Cribier A, 2012, ARCH CARDIOVASC DIS, V105, P146, DOI 10.1016/j.acvd.2012.01.005; Dewey TM, 2008, J THORAC CARDIOV SUR, V135, P180, DOI 10.1016/j.jtcvs.2007.09.011; Di Mario C, 2013, EUROINTERVENTION, V8, P1362, DOI 10.4244/EIJV8I12A209; Gilard M, 2012, NEW ENGL J MED, V366, P1705, DOI 10.1056/NEJMoa1114705; Hamm CW, 2014, EUR HEART J, V35, P1588, DOI 10.1093/eurheartj/eht381; HARKEN DE, 1960, J THORAC CARDIOV SUR, V40, P744, DOI 10.1016/S0022-5223(19)32572-3; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Mack MJ, 2013, JAMA-J AM MED ASSOC, V310, P2069, DOI 10.1001/jama.2013.282043; Moat NE, 2011, J AM COLL CARDIOL, V58, P2130, DOI 10.1016/j.jacc.2011.08.050; Mohr FW, 2014, EUR J CARDIO-THORAC, V46, P808, DOI 10.1093/ejcts/ezu290; Nishimura RA, 2014, J THORAC CARDIOV SUR, V148, pE1, DOI 10.1016/j.jtcvs.2014.05.014; Roques F, 2003, EUR HEART J, V24, P881, DOI 10.1016/S0195-668X(02)00799-6; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109	17	162	164	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 17	2015	373	25					2438	2447		10.1056/NEJMoa1500893	http://dx.doi.org/10.1056/NEJMoa1500893			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY5QD	26672846				2022-12-28	WOS:000366461400010
J	Seeman, N				Seeman, Neil			Use data to challenge mental-health stigma	NATURE			English	Editorial Material									[Seeman, Neil] RIWI Corp, Toronto, ON, Canada; [Seeman, Neil] Univ Toronto, Massey Coll, Toronto, ON, Canada	University of Toronto	Seeman, N (corresponding author), RIWI Corp, Toronto, ON, Canada.	neil@riwi.com							0	5	5	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2015	528	7582					309	309		10.1038/528309a	http://dx.doi.org/10.1038/528309a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY8SM	26672520	Bronze			2022-12-28	WOS:000366678600020
J	Coffey, ECD; Adams, BD				Coffey, E. C. Drake; Adams, Bruce D.			A modified Valsalva maneuver was more effective than standard Valsalva for treating supraventricular tachycardia	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CAROTID-SINUS MASSAGE		[Coffey, E. C. Drake; Adams, Bruce D.] UT Sch Med San Antonio, San Antonio, TX 78229 USA		Coffey, ECD (corresponding author), UT Sch Med San Antonio, San Antonio, TX 78229 USA.							Lim SH, 1998, ANN EMERG MED, V31, P30, DOI 10.1016/S0196-0644(98)70277-X; Richardson DA, 2000, AGE AGEING, V29, P413, DOI 10.1093/ageing/29.5.413; Salerno JC, 2009, ARCH PEDIAT ADOL MED, V163, P268, DOI 10.1001/archpediatrics.2008.547; Smith GD, 2013, COCHRANE DB SYST REV, V3	4	1	1	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	2015	163	12							JC8	10.7326/ACPJC-2015-163-12-008	http://dx.doi.org/10.7326/ACPJC-2015-163-12-008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY4BS	26666810				2022-12-28	WOS:000366354200008
J	Berman, P				Berman, Peter			India's health: more practical solutions needed	LANCET			English	Editorial Material									[Berman, Peter] Harvard Univ, TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Berman, P (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA.	pberman@hsph.harvard.edu						Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Patel V, 2015, LANCET, V386, P2422, DOI 10.1016/S0140-6736(15)00955-1	2	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 12	2015	386	10011					E58	E59		10.1016/S0140-6736(15)01175-7	http://dx.doi.org/10.1016/S0140-6736(15)01175-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CY3EE	26700534				2022-12-28	WOS:000366290400002
J	De Sanctis, MC; Ammannito, E; Raponi, A; Marchi, S; McCord, TB; McSween, HY; Capaccioni, F; Capria, MT; Carrozzo, FG; Ciarniello, M; Longobardo, A; Tosi, F; Fonte, S; Formisano, M; Frigeri, A; Giardino, M; Magni, G; Palomba, E; Turrini, D; Zambon, F; Combe, JP; Feldman, W; Jaumann, R; McFadden, LA; Pieters, CM; Prettyman, T; Toplis, M; Raymond, CA; Russell, CT				De Sanctis, M. C.; Ammannito, E.; Raponi, A.; Marchi, S.; McCord, T. B.; McSween, H. Y.; Capaccioni, F.; Capria, M. T.; Carrozzo, F. G.; Ciarniello, M.; Longobardo, A.; Tosi, F.; Fonte, S.; Formisano, M.; Frigeri, A.; Giardino, M.; Magni, G.; Palomba, E.; Turrini, D.; Zambon, F.; Combe, J. -P.; Feldman, W.; Jaumann, R.; McFadden, L. A.; Pieters, C. M.; Prettyman, T.; Toplis, M.; Raymond, C. A.; Russell, C. T.			Ammoniated phyllosilicates with a likely outer Solar System origin on (1) Ceres	NATURE			English	Article							SURFACE-COMPOSITION; OPTICAL-CONSTANTS; SPECTRAL VARIABILITY; CRYSTALLINE H2O-ICE; CLAY-MINERALS; MU-M; REFLECTANCE; ASTEROIDS; SPECTROSCOPY; TEMPERATURE	Studies of the dwarf planet (1) Ceres using ground-based and orbiting telescopes have concluded that its closest meteoritic analogues are the volatile-rich CI and CM carbonaceous chondrites(1,2). Water in clay minerals(3), ammoniated phyllosilicates(4), or a mixture of Mg(OH)(2) (brucite), Mg2CO3 and iron-rich serpentine(5,6) have all been proposed to exist on the surface. In particular, brucite has been suggested from analysis of the mid-infrared spectrum of Ceres(6). But the lack of spectral data across telluric absorption bands in the wavelength region 2.5 to 2.9 micrometres-where the OH stretching vibration and the H2O bending overtone are found-has precluded definitive identifications. In addition, water vapour around Ceres has recently been reported(7), possibly originating from localized sources. Here we report spectra of Ceres from 0.4 to 5 micrometres acquired at distances from similar to 82,000 to 4,300 kilometres from the surface. Our measurements indicate widespread ammoniated phyllosilicates across the surface, but no detectable water ice. Ammonia, accreted either as organic matter or as ice, may have reacted with phyllosilicates on Ceres during differentiation. This suggests that material from the outer Solar System was incorporated into Ceres, either during its formation at great heliocentric distance or by incorporation of material transported into the main asteroid belt.	[De Sanctis, M. C.; Ammannito, E.; Raponi, A.; Marchi, S.; Capaccioni, F.; Capria, M. T.; Carrozzo, F. G.; Ciarniello, M.; Longobardo, A.; Tosi, F.; Fonte, S.; Formisano, M.; Frigeri, A.; Giardino, M.; Magni, G.; Palomba, E.; Turrini, D.; Zambon, F.] INAF, Ist Astrofis & Planetol Spaziali, I-00133 Rome, Italy; [Ammannito, E.; Russell, C. T.] Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA; [Marchi, S.] SW Res Inst, Boulder, CO 80302 USA; [McCord, T. B.; Combe, J. -P.] Bear Fight Inst, Winthrop, WA 98862 USA; [McSween, H. Y.] Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; [Feldman, W.; Prettyman, T.] Planetary Sci Inst, Tucson, AZ 85719 USA; [Jaumann, R.] German Aerosp Ctr DLR, Inst Planetary Res, D-12489 Berlin, Germany; [McFadden, L. A.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Pieters, C. M.] Brown Univ, Dept Earth Environm & Planetary Sci, Providence, RI 02912 USA; [Toplis, M.] Univ Toulouse 3, Observ Midi Pyrenees, Inst Rech Astrophys & Planetol, F-31400 Toulouse, France; [Raymond, C. A.] CALTECH, Jet Prop Lab, Pasadena, CA USA	Istituto Nazionale Astrofisica (INAF); University of California System; University of California Los Angeles; University of Tennessee System; University of Tennessee Knoxville; Helmholtz Association; German Aerospace Centre (DLR); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Brown University; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	De Sanctis, MC (corresponding author), INAF, Ist Astrofis & Planetol Spaziali, Via Fosso del Cavaliere 100, I-00133 Rome, Italy.	mariacristina.desanctis@iaps.inaf.it	Frigeri, Alessandro/F-2151-2010; Tosi, Federico/F-2321-2018; Frigeri, Alessandro/K-9679-2019; Jaumann, Ralf/N-1001-2018; Russell, Christopher T/E-7745-2012; Formisano, Michelangelo/AAJ-2719-2020; Palomba, Ernesto/E-8287-2017; Zambon, Francesca/J-2855-2018; De Sanctis, Maria Cristina/G-5232-2013; McFadden, Lucy/I-4902-2013	Frigeri, Alessandro/0000-0002-9140-3977; Tosi, Federico/0000-0003-4002-2434; Frigeri, Alessandro/0000-0002-9140-3977; Jaumann, Ralf/0000-0002-9759-6597; Russell, Christopher T/0000-0003-1639-8298; Formisano, Michelangelo/0000-0003-3236-1604; Palomba, Ernesto/0000-0002-9101-6774; Zambon, Francesca/0000-0002-4190-6592; Giardino, Marco/0000-0002-6983-6346; Capaccioni, Fabrizio/0000-0003-1631-4314; De Sanctis, Maria Cristina/0000-0002-3463-4437; Longobardo, Andrea/0000-0002-1797-2741; Turrini, Diego/0000-0002-1923-7740; Prettyman, Thomas/0000-0003-0072-2831; Ciarniello, Mauro/0000-0002-7498-5207; Carrozzo, Filippo Giacomo/0000-0002-0391-6407; McFadden, Lucy/0000-0002-0537-9975; Raponi, Andrea/0000-0003-4996-0099	Italian Space Agency (ASI); National Aeronautic and Space Administration (NASA, USA); Deutsches Zentrum fur Luft- und Raumfahrt (DLR, Germany); Italian Space Agency	Italian Space Agency (ASI)(Agenzia Spaziale Italiana (ASI)); National Aeronautic and Space Administration (NASA, USA); Deutsches Zentrum fur Luft- und Raumfahrt (DLR, Germany); Italian Space Agency(Agenzia Spaziale Italiana (ASI))	We thank the following institutions and agencies, which supported this work: the Italian Space Agency (ASI), the National Aeronautic and Space Administration (NASA, USA) and the Deutsches Zentrum fur Luft- und Raumfahrt (DLR, Germany). The VIR was funded and coordinated by the Italian Space Agency and built by SELEX ES, with the scientific leadership of the Institute for Space Astrophysics and Planetology, Italian National Institute for Astrophysics, Italy, and is operated by the Institute for Space Astrophysics and Planetology, Rome, Italy. A portion of this work was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under contract to NASA. We thank J. L. Bishop and D. Takir for reviews, and D. Takir for providing spectra of carbonaceous chondrites plotted in Fig. 2.	Barucci MA, 2008, ASTRON ASTROPHYS, V479, pL13, DOI 10.1051/0004-6361:20079079; Beck P, 2015, ICARUS, V257, P471, DOI 10.1016/j.icarus.2015.05.031; Bishop JL, 2008, CLAY MINER, V43, P35, DOI 10.1180/claymin.2008.043.1.03; Bishop JL, 2013, J GEOPHYS RES-PLANET, V118, P635, DOI 10.1002/jgre.20066; Bishop JL, 2002, PLANET SPACE SCI, V50, P11, DOI 10.1016/S0032-0633(01)00077-0; Bitsch B, 2015, ASTRON ASTROPHYS, V575, DOI 10.1051/0004-6361/201424964; Borden D, 2001, CLAY CLAY MINER, V49, P444, DOI 10.1346/CCMN.2001.0490510; Carli C, 2014, ICARUS, V235, P207, DOI 10.1016/j.icarus.2014.03.022; CHAPMAN CR, 1973, ICARUS, V19, P507, DOI 10.1016/0019-1035(73)90078-X; Clark RN, 2012, ICARUS, V218, P831, DOI 10.1016/j.icarus.2012.01.008; Cloutis EA, 2011, ICARUS, V212, P180, DOI 10.1016/j.icarus.2010.12.009; Cloutis EA, 2010, PLANET SPACE SCI, V58, P522, DOI 10.1016/j.pss.2009.09.002; De Sanctis MC, 2011, SPACE SCI REV, V163, P329, DOI 10.1007/s11214-010-9668-5; Demeo FE, 2015, ICARUS, V246, P213, DOI 10.1016/j.icarus.2014.04.010; Hapke B., 2012, THEORY REFLECTANCE E; HELFENSTEIN P, 1989, ASTEROIDS II, P557; Hiroi T, 1996, METORIT PLANET SCI, V31, P321, DOI 10.1111/j.1945-5100.1996.tb02068.x; Hiroi T., 1996, LUNAR PLANETARY SCI, VXXVII, P551; HIROI T, 1997, LUNAR PLANET SCI, V28, P577; Hiroi T., 1999, ANTARCT METEOR RES, V12, P108; Howard KT, 2015, GEOCHIM COSMOCHIM AC, V149, P206, DOI 10.1016/j.gca.2014.10.025; Johansen A, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500109; KING TVV, 1992, SCIENCE, V255, P1551, DOI 10.1126/science.255.5051.1551; Kuppers M, 2014, NATURE, V505, P525, DOI 10.1038/nature12918; LEBOFSKY LA, 1981, ICARUS, V48, P453, DOI 10.1016/0019-1035(81)90055-5; Li JY, 2006, ICARUS, V182, P143, DOI 10.1016/j.icarus.2005.12.012; Lodders K, 2003, ASTROPHYS J, V591, P1220, DOI 10.1086/375492; Martin RG, 2012, MON NOT R ASTRON SOC, V425, pL6, DOI 10.1111/j.1745-3933.2012.01290.x; Mastrapa RM, 2008, ICARUS, V197, P307, DOI 10.1016/j.icarus.2008.04.008; Mastrapa RM, 2009, ASTROPHYS J, V701, P1347, DOI 10.1088/0004-637X/701/2/1347; MCCORD TB, 1974, SCIENCE, V186, P352, DOI 10.1126/science.186.4161.352; McKinnon W. B., 2012, P C AST COM MET 2012; Milliken RE, 2009, NAT GEOSCI, V2, P258, DOI 10.1038/NGEO478; Pizzarello S, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/2/161; Raponi A., 2015, THESIS; Rivkin AS, 2006, ICARUS, V185, P563, DOI 10.1016/j.icarus.2006.08.022; Russell CT, 2011, SPACE SCI REV, V163, P3, DOI 10.1007/s11214-011-9836-2; Takir D, 2013, METEORIT PLANET SCI, V48, P1618, DOI 10.1111/maps.12171; Takir D, 2012, ICARUS, V219, P641, DOI 10.1016/j.icarus.2012.02.022; WARREN SG, 1984, APPL OPTICS, V23, P1206, DOI 10.1364/AO.23.001206; Zubko VG, 1996, MON NOT R ASTRON SOC, V282, P1321, DOI 10.1093/mnras/282.4.1321	43	217	217	4	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2015	528	7581					241	+		10.1038/nature16172	http://dx.doi.org/10.1038/nature16172			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9VH	26659184	Green Accepted			2022-12-28	WOS:000366053300036
J	Klooster, K; ten Hacken, NHT; Hartman, JE; Kerstjens, HAM; van Rikxoort, EM; Slebos, DJ				Klooster, Karin; ten Hacken, Nick H. T.; Hartman, Jorine E.; Kerstjens, Huib A. M.; van Rikxoort, Eva M.; Slebos, Dirk-Jan			Endobronchial Valves for Emphysema without Interlobar Collateral Ventilation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LUNG-VOLUME-REDUCTION; OBSTRUCTIVE PULMONARY-DISEASE; MINIMAL IMPORTANT DIFFERENCE; CLINICAL-OUTCOMES; HEALTH-STATUS; THERAPY; TRIAL; COPD; QUESTIONNAIRE; STATEMENT	BACKGROUND Bronchoscopic lung-volume reduction with the use of one-way endobronchial valves is a potential treatment for patients with severe emphysema. To date, the benefits have been modest but have been hypothesized to be much larger in patients without interlobar collateral ventilation than in those with collateral ventilation. METHODS We randomly assigned patients with severe emphysema and a confirmed absence of collateral ventilation to bronchoscopic endobronchial-valve treatment (EBV group) or to continued standard medical care (control group). Primary outcomes were changes from baseline to 6 months in forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), and 6-minute walk distance. RESULTS Eighty-four patients were recruited, of whom 16 were excluded because they had collateral ventilation (13 patients) or because lobar segments were inaccessible to the endobronchial valves (3 patients). The remaining 68 patients (mean [+/-SD] age, 59+/-9 years; 46 were women) were randomly assigned to the EBV group (34 patients) or the control group (34). At baseline, the FEV1 and FVC were 29+/-7% and 77+/-18% of the predicted values, respectively, and the 6-minute walk distance was 374+/-86 m. Intention-to-treat analyses showed significantly greater improvements in the EBV group than in the control group from baseline to 6 months: the increase in FEV1 was greater in the EBV group than in the control group by 140 ml (95% confidence interval [CI], 55 to 225), the increase in FVC was greater by 347 ml (95% CI, 107 to 588), and the increase in the 6-minute walk distance was greater by 74 m (95% CI, 47 to 100) (P<0.01 for all comparisons). By 6 months, 23 serious adverse events had been reported in the EBV group, as compared with 5 in the control group (P<0.001). One patient in the EBV group died. Serious treatment-related adverse events in this group included pneumothorax (18% of patients) and events requiring valve replacement (12%) or removal (15%). CONCLUSIONS Endobronchial-valve treatment significantly improved pulmonary function and exercise capacity in patients with severe emphysema characterized by an absence of interlobar collateral ventilation.	[Klooster, Karin; ten Hacken, Nick H. T.; Hartman, Jorine E.; Kerstjens, Huib A. M.; Slebos, Dirk-Jan] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis, Groningen, Netherlands; [van Rikxoort, Eva M.] Radboud Univ Nijmegen, Med Ctr Nijmegen, Dept Radiol & Nucl Med, NL-6525 ED Nijmegen, Netherlands	University of Groningen; Radboud University Nijmegen	Klooster, K (corresponding author), Univ Med Ctr Groningen, Dept Pulm Dis, AA11,POB 30-001, NL-9700 RB Groningen, Netherlands.	k.klooster@umcg.nl	van Rikxoort, Eva/P-2640-2014; Kerstjens, Huib/N-4754-2017	van Rikxoort, Eva/0000-0001-6418-9760; Kerstjens, Huib/0000-0001-7705-7927; Hartman, Jorine/0000-0001-8765-9673	Netherlands Organization for Health Research and Development (ZonMw) [171101008]; University Medical Center Groningen	Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); University Medical Center Groningen	Supported by a grant (171101008, to the University Medical Center Groningen) from the Netherlands Organization for Health Research and Development (ZonMw) and by innovation funding from the University Medical Center Groningen.	Bestall JC, 1999, THORAX, V54, P581, DOI 10.1136/thx.54.7.581; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Criner GJ, 2011, AM J RESP CRIT CARE, V184, P881, DOI 10.1164/rccm.201103-0455CI; Donohue James F, 2005, COPD, V2, P111; Fishman A, 2003, NEW ENGL J MED, V348, P2059; Gompelmann D, 2014, DTSCH ARZTEBL INT, V111, P827, DOI 10.3238/arztebl.2014.0827; Gompelmann D, 2014, RESPIRATION, V87, P485, DOI 10.1159/000360641; Hartman JE, 2012, EUR RESPIR J, V40, P1137, DOI 10.1183/09031936.00219111; Herth FJF, 2013, EUR RESPIR J, V41, P302, DOI 10.1183/09031936.00015312; Herth FJF, 2012, EUR RESPIR J, V39, P1334, DOI 10.1183/09031936.00161611; Jones Paul W, 2005, COPD, V2, P75; JONES PW, 1992, AM REV RESPIR DIS, V145, P1321, DOI 10.1164/ajrccm/145.6.1321; Kocks JWH, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-62; Koenigkam-Santos M, 2012, EUR J RADIOL, V81, P4161, DOI 10.1016/j.ejrad.2012.06.006; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Miller MR, 2005, EUR RESPIR J, V26, P153, DOI 10.1183/09031936.05.00034505; Puhan MA, 2011, EUR RESPIR J, V37, P784, DOI 10.1183/09031936.00063810; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Sciurba FC, 2010, NEW ENGL J MED, V363, P1233, DOI 10.1056/NEJMoa0900928; Shah PL, 2011, LANCET, V378, P997, DOI 10.1016/S0140-6736(11)61050-7; Toma TP, 2003, LANCET, V361, P931, DOI 10.1016/S0140-6736(03)12762-6; Valipour A, 2014, RESPIRATION, V87, P513, DOI 10.1159/000360642; van Rikxoort EM, 2010, IEEE T MED IMAGING, V29, P1286, DOI 10.1109/TMI.2010.2044799; van Rikxoort EM, 2009, MED PHYS, V36, P2934, DOI 10.1118/1.3147146	24	286	290	0	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 10	2015	373	24					2325	2335		10.1056/NEJMoa1507807	http://dx.doi.org/10.1056/NEJMoa1507807			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY0QW	26650153	Green Published, Bronze			2022-12-28	WOS:000366111600007
J	Leisinger, K				Leisinger, Klaus			Business needs to embrace sustainability targets	NATURE			English	Editorial Material									[Leisinger, Klaus] Univ Basel, Sociol, CH-4003 Basel, Switzerland	University of Basel		klaus.leisinger@globalvaluesalliance.ch							0	9	9	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2015	528	7581					165	165		10.1038/528165a	http://dx.doi.org/10.1038/528165a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX9VH	26659146	Bronze			2022-12-28	WOS:000366053300004
J	Amick, HR; Gartlehner, G; Gaynes, BN; Forneris, C; Asher, GN; Morgan, LC; Coker-Schwimmer, E; Boland, E; Lux, LJ; Gaylord, S; Bann, C; Pierl, CB; Lohr, KN				Amick, Halle R.; Gartlehner, Gerald; Gaynes, Bradley N.; Forneris, Catherine; Asher, Gary N.; Morgan, Laura C.; Coker-Schwimmer, Emmanuel; Boland, Erin; Lux, Linda J.; Gaylord, Susan; Bann, Carla; Pierl, Christiane Barbara; Lohr, Kathleen N.			Comparative benefits and harms of second generation antidepressants and cognitive behavioral therapies in initial treatment of major depressive disorder: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRIMARY-CARE PATIENTS; TREATMENT PREFERENCES; TREATING DEPRESSION; ANXIETY DISORDERS; RANDOMIZED-TRIAL; PSYCHOTHERAPY; MEDICATION; PHARMACOTHERAPY; HEALTH; ACTIVATION	STUDY QUESTION What are the benefits and harms of second generation antidepressants and cognitive behavioral therapies (CBTs) in the initial treatment of a current episode of major depressive disorder in adults? METHODS This was a systematic review including qualitative assessment and meta-analyses using random and fixed effects models. Medline, Embase, the Cochrane Library, the Allied and Complementary Medicine Database, PsycINFO, and the Cumulative Index to Nursing and Allied Health Literature were searched from January1990 through January 2015. The 11 randomized controlled trials included compared a second generation antidepressant CBT. Ten trials compared antidepressant monotherapy with CBT alone; three compared antidepressant monotherapy with antidepressant plus CBT. SUMMARY ANSWER AND LIMITATIONS Meta-analyses found no statistically significant difference in effectiveness between second generation antidepressants and CBT for response (risk ratio 0.91, 0.77 to 1.07), remission (0.98, 0.73 to 1.32), or change in 17 item Hamilton Rating Scale for Depression score (weighted mean difference, -0.38, -2.87 to 2.10). Similarly, no significant differences were found in rates of overall study discontinuation (risk ratio 0.90, 0.49 to 1.65) or discontinuation attributable to lack of efficacy (0.40, 0.05 to 2.91). Although more patients treated with a second generation antidepressant than receiving CBT withdrew from studies because of adverse events, the difference was not statistically significant (risk ratio 3.29, 0.42 to 25.72). No conclusions could be drawn about other outcomes because of lack of evidence. Results should be interpreted cautiously given the low strength of evidence for most outcomes. The scope of this review was limited to trials that enrolled adult patients with major depressive disorder and compared a second generation antidepressant with CBT, and many of the included trials had methodological shortcomings that may limit confidence in some of the findings. WHAT THIS STUDY ADDS Second generation antidepressants and CBT have evidence bases of benefits and harms in major depressive disorder. Available evidence suggests no difference in treatment effects of second generation antidepressants and CBT, either alone or in combination, although small numbers may preclude detection of small but clinically meaningful differences.	[Amick, Halle R.; Coker-Schwimmer, Emmanuel] Univ N Carolina, Sheps Ctr Hlth Serv Res, Chapel Hill, NC 27599 USA; [Gartlehner, Gerald; Morgan, Laura C.; Boland, Erin; Lux, Linda J.; Bann, Carla; Lohr, Kathleen N.] RTI Int, Res Triangle Pk, NC 27709 USA; [Gartlehner, Gerald; Pierl, Christiane Barbara] Danube Univ, Dept Evidence Based Med & Clin Epidemiol, A-3500 Krems, Austria; [Gaynes, Bradley N.; Forneris, Catherine] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27599 USA; [Asher, Gary N.] Univ N Carolina, Dept Family Med, Chapel Hill, NC 27599 USA; [Gaylord, Susan] Univ N Carolina, Dept Phys Med & Rehabil, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; Research Triangle Institute; Danube University Krems; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Amick, HR (corresponding author), Univ N Carolina, Sheps Ctr Hlth Serv Res, 725 Martin Luther King Jr Blvd, Chapel Hill, NC 27599 USA.	amick@med.unc.edu	Gartlehner, Gerald/AAY-2801-2021; Lux, Linda/GPX-3639-2022	Gartlehner, Gerald/0000-0001-5531-3678; Bann, Carla/0000-0001-9305-8305; Lohr, Kathleen/0000-0002-3825-0713	Agency for Healthcare Research and Quality by the RTI-UNC Evidence-based Practice Center [290-2012-00008i]	Agency for Healthcare Research and Quality by the RTI-UNC Evidence-based Practice Center	This project was funded under contract 290-2012-00008i from the Agency for Healthcare Research and Quality by the RTI-UNC Evidence-based Practice Center. The authors of this manuscript are responsible for its content. Statements in this manuscript should not be construed as endorsement by the Agency for Healthcare Research and Quality or the US Department of Health and Human Services.	American Psychiatric Association (APA), 2010, PRACT GUID TREATM PA; American Psychological Association, 2012, REC PSYCH EFF; Berkman ND, 2015, J CLIN EPIDEMIOL, V68, P1312, DOI 10.1016/j.jclinepi.2014.11.023; Brody DS, 1997, J GEN INTERN MED, V12, P403, DOI 10.1046/j.1525-1497.1997.00070.x; Churchill R, 2000, BRIT J GEN PRACT, V50, P905; Cochrane Depression Anxiety and Neurosis Group, 2013, CCDAN TOP LIST INT P; Cooper LA, 2003, MED CARE, V41, P479, DOI 10.1097/00005650-200304000-00004; Cuijpers P, 2014, WORLD PSYCHIATRY, V13, P56, DOI 10.1002/wps.20089; Cuijpers P, 2013, CAN J PSYCHIAT, V58, P376, DOI 10.1177/070674371305800702; Cuijpers P, 2013, WORLD PSYCHIATRY, V12, P137, DOI 10.1002/wps.20038; Cuijpers P, 2008, J CONSULT CLIN PSYCH, V76, P909, DOI 10.1037/a0013075; David D, 2008, J CLIN PSYCHOL, V64, P728, DOI 10.1002/jclp.20487; DeRubeis RJ, 2005, ARCH GEN PSYCHIAT, V62, P409, DOI 10.1001/archpsyc.62.4.409; Dimidjian S, 2006, J CONSULT CLIN PSYCH, V74, P658, DOI 10.1037/0022-006X.74.4.658; Dobson KS, 2008, J CONSULT CLIN PSYCH, V76, P468, DOI 10.1037/0022-006X.76.3.468; Dwight-Johnson M, 2000, J GEN INTERN MED, V15, P527, DOI 10.1046/j.1525-1497.2000.08035.x; Gartlehner G, 2015, COMP EFFECTIVENESS R, V161; Gartlehner G, 2011, ANN INTERN MED, V155, P772, DOI 10.7326/0003-4819-155-11-201112060-00009; Gartlehner G, 2008, DRUG SAFETY, V31, P851, DOI 10.2165/00002018-200831100-00004; Givens JL, 2007, GEN HOSP PSYCHIAT, V29, P182, DOI 10.1016/j.genhosppsych.2006.11.002; Hegerl U, 2010, INT J NEUROPSYCHOPH, V13, P31, DOI 10.1017/S1461145709000224; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Institute of Medicine, 2001, CROSSING QUALITY CHA; Kennedy SH, 2007, AM J PSYCHIAT, V164, P778, DOI 10.1176/appi.ajp.164.5.778; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Lam RW, 2013, BRIT J PSYCHIAT, V203, P358, DOI 10.1192/bjp.bp.112.125237; Landenberger NAD, 2002, PROQUEST INF LEARN; Leykin Y, 2007, J CONSULT CLIN PSYCH, V75, P267, DOI 10.1037/0022-006X.75.2.267; Lohr KN, 2008, METHODS GUIDE EFFECT; McGrath CL, 2013, JAMA PSYCHIAT, V70, P821, DOI 10.1001/jamapsychiatry.2013.143; McHugh RK, 2013, J CLIN PSYCHIAT, V74, P595, DOI 10.4088/JCP.12r07757; Mergl R, 2011, PSYCHOTHER PSYCHOSOM, V80, P39, DOI 10.1159/000318772; Miranda J, 2003, JAMA-J AM MED ASSOC, V290, P57, DOI 10.1001/jama.290.1.57; Mojtabai R, 2014, J CLIN PSYCHIAT, V75, P169, DOI 10.4088/JCP.13m08443; Morey E, 2007, J MENT HEALTH POLICY, V10, P73; Mynors-Wallis LM, 2000, BMJ-BRIT MED J, V320, P26, DOI 10.1136/bmj.320.7226.26; NICE, 2009, DEPR AD REC MAN; Nieuwsma JA, 2012, INT J PSYCHIAT MED, V43, P129, DOI 10.2190/PM.43.2.c; O'Neil ME., 2013, VA DOD CLIN PRACT GU; Priest RG, 1996, BRIT MED J, V313, P858; Qaseem A, 2008, ANN INTERN MED, V149, P725, DOI 10.7326/0003-4819-149-10-200811180-00007; Raue PJ, 2009, PSYCHIAT SERV, V60, P337, DOI 10.1176/appi.ps.60.3.337; Sava FA, 2009, J CLIN PSYCHOL, V65, P36, DOI 10.1002/jclp.20550; Segal ZV, 2006, ARCH GEN PSYCHIAT, V63, P749, DOI 10.1001/archpsyc.63.7.749; Shamsaei F, 2008, HONG KONG J PSYCHIAT, V18, P76; Spielmans GI, 2011, J NERV MENT DIS, V199, P142, DOI 10.1097/NMD.0b013e31820caefb; van Schaik DJF, 2004, GEN HOSP PSYCHIAT, V26, P184, DOI 10.1016/j.genhosppsych.2003.12.001; Wang PS, 2005, ARCH GEN PSYCHIAT, V62, P629, DOI 10.1001/archpsyc.62.6.629; Wittink MN, 2010, PATIENT, V3, P145, DOI 10.2165/11530660-000000000-00000; Xing S, 2011, PRIM CARE COMPANION, V13	50	113	116	0	54	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 8	2015	351								h6019	10.1136/bmj.h6019	http://dx.doi.org/10.1136/bmj.h6019			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CY5SV	26645251	Green Published, hybrid			2022-12-28	WOS:000366468600001
J	Hand, TW				Hand, Timothy W.			Interleukin-18: The Bouncer at the Mucosal Bar	CELL			English	Editorial Material							INFLAMMASOME; HOMEOSTASIS; RESPONSES	The fidelity of the intestinal barrier is critical to maintaining a healthy relationship between the immune system and the microbiota. Levy et al. and Nowarski et al. reveal how microbiota-derived metabolites modulate the activation of the inflammasome to influence the expression of the cytokine IL-18, intestinal barrier function, and intestinal inflammation.	[Hand, Timothy W.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Richard King Mellon Inst Pediat Res, Pittsburgh, PA 15224 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hand, TW (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Richard King Mellon Inst Pediat Res, Pittsburgh, PA 15224 USA.	timothy.hand@chp.edu						Arpaia N, 2014, P NATL ACAD SCI USA, V111, P2058, DOI 10.1073/pnas.1323183111; Dalal SR, 2014, J CLIN INVEST, V124, P4190, DOI 10.1172/JCI72330; Elinav E, 2013, MUCOSAL IMMUNOL, V6, P4, DOI 10.1038/mi.2012.115; Harrison OJ, 2015, MUCOSAL IMMUNOL, V8, P1226, DOI 10.1038/mi.2015.13; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Macia L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7734; Wlodarska M, 2014, CELL, V156, P1045, DOI 10.1016/j.cell.2014.01.026	7	9	11	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 6	2015	163	6					1310	U106		10.1016/j.cell.2015.11.041	http://dx.doi.org/10.1016/j.cell.2015.11.041			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SE	26638066	Bronze			2022-12-28	WOS:000366044800011
J	Garratt, P				Garratt, Peter			The art of medicine Voices and the imaginative ear	LANCET			English	Editorial Material									[Garratt, Peter] Univ Durham, Dept English Studies, Durham DH1 3AY, England	Durham University	Garratt, P (corresponding author), Univ Durham, Dept English Studies, Durham DH1 3AY, England.	peter.garratt@durham.ac.uk			Wellcome Trust [098455] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Blake W, 2000, SELECTED POETRY PROS; Eagleton Terry, 2006, HOW TO READ A POEM; Gill S, 2010, W WORDSWORTH 21 CENT; Matus J., 2009, SHOCK MEMORY UNCONSC; Tennyson Alfred Lord, 2007, SELECTED POEMS; Wood, 2001, PASSION PATHOLOGY VI	6	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 5	2015	386	10010					2248	2249		10.1016/S0140-6736(15)01114-9	http://dx.doi.org/10.1016/S0140-6736(15)01114-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CX8ZB	26693532				2022-12-28	WOS:000365993200016
J	Arinaminpathy, N; Dowdy, D				Arinaminpathy, Nimalan; Dowdy, David			Understanding the incremental value of novel diagnostic tests for tuberculosis	NATURE			English	Article							MIDDLE-INCOME COUNTRIES; XPERT MTB/RIF; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; RESISTANT TUBERCULOSIS; EMPIRICAL-TREATMENT; POTENTIAL IMPACT; HEALTH-SYSTEMS; PREVALENCE; TRANSMISSION	Tuberculosis is a major source of global mortality caused by infection, partly because of a tremendous ongoing burden of undiagnosed disease. Improved diagnostic technology may play an increasingly crucial part in global efforts to end tuberculosis, but the ability of diagnostic tests to curb tuberculosis transmission is dependent on multiple factors, including the time taken by a patient to seek health care, the patient's symptoms, and the patterns of transmission before diagnosis. Novel diagnostic assays for tuberculosis have conventionally been evaluated on the basis of characteristics such as sensitivity and specificity, using assumptions that probably overestimate the impact of diagnostic tests on transmission. We argue for a shift in focus to the evaluation of such tests' incremental value, defining outcomes that reflect each test's purpose (for example, transmissions averted) and comparing systems with the test against those without, in terms of those outcomes. Incremental value can also be measured in units of outcome per incremental unit of resource (for example, money or human capacity). Using a novel, simplified model of tuberculosis transmission that addresses some of the limitations of earlier tuberculosis diagnostic models, we demonstrate that the incremental value of any novel test depends not just on its accuracy, but also on elements such as patient behaviour, tuberculosis natural history and health systems. By integrating these factors into a single unified framework, we advance an approach to the evaluation of new diagnostic tests for tuberculosis that considers the incremental value at the population level and demonstrates how additional data could inform more-effective implementation of tuberculosis diagnostic tests under various conditions.	[Arinaminpathy, Nimalan] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London W2 1PG, England; [Dowdy, David] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA	Imperial College London; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Dowdy, D (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	ddowdy1@jhmi.edu		Arinaminpathy, Nimalan/0000-0001-9502-6876	B. Frank and Kathleen Polk Assistant Professorship in Epidemiology at the John Hopkins Bloomberg School of Public Health; MRC [MR/K010174/1] Funding Source: UKRI; Medical Research Council [MR/K010174/1B, MR/K010174/1] Funding Source: researchfish	B. Frank and Kathleen Polk Assistant Professorship in Epidemiology at the John Hopkins Bloomberg School of Public Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work of D.D. was partially funded by the B. Frank and Kathleen Polk Assistant Professorship in Epidemiology at the John Hopkins Bloomberg School of Public Health.	Abu-Raddad LJ, 2009, P NATL ACAD SCI USA, V106, P13980, DOI 10.1073/pnas.0901720106; Adang E, 2005, HEALTH POLICY, V74, P146, DOI 10.1016/j.healthpol.2004.12.015; Ayles H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005602; Azman AS, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0216-0; Banda HT, 1998, T ROY SOC TROP MED H, V92, P161, DOI 10.1016/S0035-9203(98)90727-1; Bauer M, 2013, QUAL LIFE RES, V22, P2213, DOI 10.1007/s11136-012-0329-x; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Churchyard G., 2014, P C RETR OPP INF IAS; Cobelens F, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001358; Cobelens F, 2012, J INFECT DIS, V205, pS191, DOI 10.1093/infdis/jis188; Corbett EL, 2007, PLOS MED, V4, P164, DOI 10.1371/journal.pmed.0040022; Cowan J, 2015, B WORLD HEALTH ORGAN, V93, P125, DOI 10.2471/BLT.14.138560; Denkinger CM, 2015, J INFECT DIS, V211, pS29, DOI 10.1093/infdis/jiu821; Dowdy DW, 2013, INT J TUBERC LUNG D, V17, P866, DOI 10.5588/ijtld.12.0573; Dowdy DW, 2014, CLIN INFECT DIS, V59, P1123, DOI 10.1093/cid/ciu506; Dowdy DW, 2013, AM J RESP CRIT CARE, V187, P543, DOI 10.1164/rccm.201207-1217OC; Dowdy DW, 2012, P NATL ACAD SCI USA, V109, P9557, DOI 10.1073/pnas.1203517109; Dowdy DW, 2009, B WORLD HEALTH ORGAN, V87, P296, DOI 10.2471/BLT.08.054510; Dowdy DW, 2006, AIDS, V20, P751, DOI 10.1097/01.aids.0000216376.07185.cc; Drummond MF, 2005, METHODS EC EVALUATIO, P396; Durovni B, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001766; Dye C, 1998, LANCET, V352, P1886, DOI 10.1016/S0140-6736(98)03199-7; Dye C, 2012, INDIAN J MED RES, V135, P737; Garcia-Basteiro AL, 2015, LANCET RESP MED, V3, P177, DOI 10.1016/S2213-2600(15)00061-2; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Garnett GP, 2011, LANCET, V378, P515, DOI 10.1016/S0140-6736(10)61505-X; Getahun H, 2015, NEW ENGL J MED, V372, P2127, DOI 10.1056/NEJMra1405427; Glaziou P, 2008, INT J TUBERC LUNG D, V12, P1003; Grandjean L, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001843; Grobbee D.E., 2009, CLIN EPIDEMIOLOGY PR; Harries AD, 1998, INT J TUBERC LUNG D, V2, P999; Herbert N, 2014, LANCET, V383, P1016, DOI 10.1016/S0140-6736(14)60422-0; Ho J, 2015, INT J TUBERC LUNG D, V19, P537, DOI 10.5588/ijtld.14.0798; Hoa NB, 2012, INT J TUBERC LUNG D, V16, P762, DOI 10.5588/ijtld.11.0581; Jenkins HE, 2013, EUR RESPIR J, V42, P1291, DOI 10.1183/09031936.00111812; Kelly JD, 2014, AM J RESP CRIT CARE, V190, P1316, DOI 10.1164/rccm.201408-1500LE; Kik SV, 2015, J INFECT DIS, V211, pS58, DOI 10.1093/infdis/jiu817; Laking G, 2006, HEALTH ECON, V15, P1109, DOI 10.1002/hec.1114; Langley I, 2014, LANCET GLOB HEALTH, V2, pE581, DOI 10.1016/S2214-109X(14)70291-8; Lawn SD, 2013, LANCET INFECT DIS, V13, P349, DOI 10.1016/S1473-3099(13)70008-2; Lawn SD, 2011, AIDS, V25, P2190, DOI 10.1097/QAD.0b013e32834cda4e; Lin HH, 2012, B WORLD HEALTH ORGAN, V90, P739, DOI 10.2471/BLT.11.101436; Lonnroth K, 2015, EUR RESPIR J, V45, P928, DOI 10.1183/09031936.00214014; Mandal S, 2015, INT HEALTH, V7, P114, DOI 10.1093/inthealth/ihv004; Mao TE, 2014, B WORLD HEALTH ORGAN, V92, P573, DOI 10.2471/BLT.13.131581; McNerney R, 2015, INT J INFECT DIS, V32, P81, DOI 10.1016/j.ijid.2015.01.012; Menzies NA, 2015, LANCET INFECT DIS, V15, P16, DOI 10.1016/S1473-3099(14)71026-6; Merker M, 2015, NAT GENET, V47, P242, DOI 10.1038/ng.3195; Millman AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079669; Morrison J, 2008, LANCET INFECT DIS, V8, P359, DOI 10.1016/S1473-3099(08)70071-9; Nakiyingi L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074023; Page-Shipp L, 2014, INT J TUBERC LUNG D, V18, P438, DOI 10.5588/ijtld.13.0638; Pai NP, 2012, DISCOV MED, V13, P35; PHELPS CE, 1988, MED DECIS MAKING, V8, P279, DOI 10.1177/0272989X8800800409; Pho MT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122574; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Ravishankar N, 2009, LANCET, V373, P2113, DOI 10.1016/S0140-6736(09)60881-3; Sachdeva KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131438; Sachdeva KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126065; Salje H, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001674; Schnippel K, 2012, TROP MED INT HEALTH, V17, P1142, DOI 10.1111/j.1365-3156.2012.03028.x; Sohn H, 2014, CLIN INFECT DIS, V58, P970, DOI 10.1093/cid/ciu022; Sreeramareddy CT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-91; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Sun AY, 2014, EUR RESPIR J, V44, P1366, DOI 10.1183/09031936.00111014; Tanimura T, 2014, EUR RESPIR J, V43, P1763, DOI 10.1183/09031936.00193413; TB CARE I, 2014, INT STAND TUB CAR; Theron G, 2014, LANCET INFECT DIS, V14, P527, DOI 10.1016/S1473-3099(13)70360-8; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; Van den Bruel A, 2007, J CLIN EPIDEMIOL, V60, P1116, DOI 10.1016/j.jclinepi.2007.03.015; van Soolingen D, 2014, LANCET RESP MED, V2, P251, DOI 10.1016/S2213-2600(14)70049-9; van't Hoog AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082786; Walker TM, 2013, CLIN MICROBIOL INFEC, V19, P796, DOI 10.1111/1469-0691.12183; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; WHO, 2014, GLOB TUB REP 2014; Yuan C., 2012, PLOS ONE, V7; Zelner JL, 2014, AM J EPIDEMIOL, V180, P853, DOI 10.1093/aje/kwu192; Zwerling A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110558	82	14	14	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					S60	S67		10.1038/nature16045	http://dx.doi.org/10.1038/nature16045			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX3NO	26633767	Green Submitted, hybrid			2022-12-28	WOS:000365606000012
J	Basan, M; Hui, S; Okano, H; Zhang, ZG; Shen, Y; Williamson, JR; Hwa, T				Basan, Markus; Hui, Sheng; Okano, Hiroyuki; Zhang, Zhongge; Shen, Yang; Williamson, James R.; Hwa, Terence			Overflow metabolism in Escherichia coli results from efficient proteome allocation	NATURE			English	Article							GENE-EXPRESSION; ACETATE FORMATION; GROWTH-RATE; FLUX; COORDINATION; TRADEOFFS; MECHANISM; TRANSPORT; REVEALS; CULTURE	Overflow metabolism refers to the seemingly wasteful strategy in which cells use fermentation instead of the more efficient respiration to generate energy, despite the availability of oxygen. Known as the Warburg effect in the context of cancer growth, this phenomenon occurs ubiquitously for fast-growing cells, including bacteria, fungi and mammalian cells, but its origin has remained unclear despite decades of research. Here we study metabolic overflow in Escherichia coli, and show that it is a global physiological response used to cope with changing proteomic demands of energy biogenesis and biomass synthesis under different growth conditions. A simple model of proteomic resource allocation can quantitatively account for all of the observed behaviours, and accurately predict responses to new perturbations. The key hypothesis of the model, that the proteome cost of energy biogenesis by respiration exceeds that by fermentation, is quantitatively confirmed by direct measurement of protein abundances via quantitative mass spectrometry.	[Basan, Markus; Hui, Sheng; Okano, Hiroyuki; Hwa, Terence] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Basan, Markus] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Okano, Hiroyuki; Zhang, Zhongge; Shen, Yang; Hwa, Terence] Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA; [Williamson, James R.] Scripps Res Inst, Dept Chem, Skaggs Inst Chem Biol, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Hwa, Terence] ETH, Inst Theoret Studies, CH-8092 Zurich, Switzerland	University of California System; University of California San Diego; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of California System; University of California San Diego; Scripps Research Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich	Hwa, T (corresponding author), Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA.	hwa@ucsd.edu	Hwa, Terence/J-4012-2013; Hwa, Terry/GOJ-9904-2022; Williamson, James/AAL-2104-2021; Williamson, James R/B-2891-2009	Hwa, Terence/0000-0003-1837-6842; Williamson, James/0000-0002-8772-468X; Williamson, James R/0000-0002-8772-468X; Hui, Sheng/0000-0002-4226-6806	NIH [R01-GM109069]; Simons Foundation [330378]; M. Rossler, the Walter Haefner Foundation; ETH Foundation; SystemsX TPdF; Hong Kong Baptist University [FRG2/11-12/159, SKLP-14-15-P012]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095903, R01GM109069] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; M. Rossler, the Walter Haefner Foundation; ETH Foundation; SystemsX TPdF; Hong Kong Baptist University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to F. J. Bruggeman, E. O'Brien, U. Sauer, M. H. Saier and members of the Hwa and Sauer laboratories for valuable comments, and J. L. Figueroa for artistic contributions to the model illustration in Box 1. This work was supported by the NIH (grant R01-GM109069) and the Simons Foundation (grant 330378). T.H. additionally acknowledges the support of M. Rossler, the Walter Haefner Foundation and the ETH Foundation. M.B. acknowledges support from SystemsX TPdF. Y.S. acknowledges support from Hong Kong Baptist University (grants FRG2/11-12/159 and SKLP-14-15-P012).	Applebee MK, 2011, J BIOL CHEM, V286, P23150, DOI 10.1074/jbc.M110.195305; ARISTIDOU AA, 1995, BIOTECHNOL PROGR, V11, P475, DOI 10.1021/bp00034a019; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bollenbach T, 2009, CELL, V139, P707, DOI 10.1016/j.cell.2009.10.025; BROOKER RJ, 1991, J BIOL CHEM, V266, P4131; Brown SD, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00879-15; CAYLEY S, 1989, J BACTERIOL, V171, P3597, DOI 10.1128/jb.171.7.3597-3602.1989; Chubukov V, 2014, NAT REV MICROBIOL, V12, P327, DOI 10.1038/nrmicro3238; De Mey M, 2007, J IND MICROBIOL BIOT, V34, P689, DOI 10.1007/s10295-007-0244-2; DEDEKEN RH, 1966, J GEN MICROBIOL, V44, P149, DOI 10.1099/00221287-44-2-149; El-Mansi M, 2004, J IND MICROBIOL BIOT, V31, P295, DOI 10.1007/s10295-004-0149-2; ELMANSI EMT, 1989, J GEN MICROBIOL, V135, P2875; Farmer WR, 2000, NAT BIOTECHNOL, V18, P533, DOI 10.1038/75398; Flamholz A, 2013, P NATL ACAD SCI USA, V110, P10039, DOI 10.1073/pnas.1215283110; Galluzzi L, 2013, NAT REV DRUG DISCOV, V12, P829, DOI 10.1038/nrd4145; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Holms H, 1996, FEMS MICROBIOL REV, V19, P85, DOI 10.1111/j.1574-6976.1996.tb00255.x; Huberts DHEW, 2012, FEMS YEAST RES, V12, P118, DOI 10.1111/j.1567-1364.2011.00767.x; Hui S, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145697; Ingraham J. L., 1990, PHYSL BACTERIAL CELL; Keseler IM, 2013, NUCLEIC ACIDS RES, V41, pD605, DOI 10.1093/nar/gks1027; Klumpp S, 2009, CELL, V139, P1366, DOI 10.1016/j.cell.2009.12.001; Kochanowski K, 2013, P NATL ACAD SCI USA, V110, P1130, DOI 10.1073/pnas.1202582110; Kuhlman T, 2007, P NATL ACAD SCI USA, V104, P6043, DOI 10.1073/pnas.0606717104; Levine E, 2007, PLOS BIOL, V5, P1998, DOI 10.1371/journal.pbio.0050229; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Lyons E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016717; Maaloe O., 1979, BIOL REGUL DEV, P487; Macnab R., 1996, ESCHERICHIA COLI SAL, V2nd ed, P119; MAJEWSKI RA, 1990, BIOTECHNOL BIOENG, V35, P732, DOI 10.1002/bit.260350711; MCLAUGHLIN S, 1972, J MEMBRANE BIOL, V9, P361, DOI 10.1007/BF01868062; MEYER HP, 1984, J BIOTECHNOL, V1, P355, DOI 10.1016/0168-1656(84)90027-0; Molenaar D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.82; Nanchen A, 2006, APPL ENVIRON MICROB, V72, P1164, DOI 10.1128/AEM.72.2.1164-1172.2006; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Neijssel O.M., 1996, ESCHERICHIA COLI SAL, V2nd, P1683; Nelson D., 2008, LEHNINGER PRINCIPLES; O'Brien EJ, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.52; Peebo K, 2015, MOL BIOSYST, V11, P1184, DOI 10.1039/c4mb00721b; Pfeiffer T, 2002, Z PHYS CHEM, V216, P51, DOI 10.1524/zpch.2002.216.1.051; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Renilla S, 2012, APPL MICROBIOL BIOT, V93, P2109, DOI 10.1007/s00253-011-3536-4; RHOADS DB, 1976, J GEN PHYSIOL, V67, P325, DOI 10.1085/jgp.67.3.325; Rockwood AL, 1996, ANAL CHEM, V68, P2027, DOI 10.1021/ac951158i; Sanden AM, 2003, BIOTECHNOL BIOENG, V81, P158, DOI 10.1002/bit.10457; Scott M, 2011, CURR OPIN BIOTECH, V22, P559, DOI 10.1016/j.copbio.2011.04.014; Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588; Soupene E, 2003, J BACTERIOL, V185, P5611, DOI 10.1128/JB.185.18.5611-5626.2003; Sperling E, 2008, ANAL CHEM, V80, P4906, DOI 10.1021/ac800080v; Unden G., 2014, ECOSAL PLUS; Valgepea K, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-166; VARMA A, 1994, APPL ENVIRON MICROB, V60, P3724, DOI 10.1128/AEM.60.10.3724-3731.1994; Vazquez A, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-7; Veit A, 2007, APPL MICROBIOL BIOT, V74, P406, DOI 10.1007/s00253-006-0680-3; Vemuri GN, 2006, APPL ENVIRON MICROB, V72, P3653, DOI 10.1128/AEM.72.5.3653-3661.2006; Weinberg R. A., 2013, BIOL CANC; WOLDRINGH CL, 1981, J BACTERIOL, V148, P58, DOI 10.1128/JB.148.1.58-63.1981; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; You CH, 2013, NATURE, V500, P301, DOI 10.1038/nature12446; Zhuang K, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.34	63	313	316	9	188	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					99	+		10.1038/nature15765	http://dx.doi.org/10.1038/nature15765			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX3NO	26632588	Green Accepted			2022-12-28	WOS:000365606000055
J	Grafton, A				Grafton, Anthony			Lisa Jardine (1944-2015)	NATURE			English	Biographical-Item									[Grafton, Anthony] Princeton Univ, Hist, Princeton, NJ 08544 USA	Princeton University	Grafton, A (corresponding author), Princeton Univ, Hist, Princeton, NJ 08544 USA.	grafton@princeton.edu							0	0	0	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					40	40		10.1038/528040a	http://dx.doi.org/10.1038/528040a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX3NO	26632582	Bronze			2022-12-28	WOS:000365606000041
J	Barnett, R				Barnett, Richard			Crucial interventions: between survival and wholeness	LANCET			English	Editorial Material												richard@richardbarnettwriter.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 21	2015	386	10008					2050	2051		10.1016/S0140-6736(15)00964-2	http://dx.doi.org/10.1016/S0140-6736(15)00964-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CX8XF	26713339				2022-12-28	WOS:000365987600014
J	Oberg, K				Oberg, Kjell			Universal everolimus for malignant neuroendocrine tumours?	LANCET			English	Editorial Material							HINDGUT; MIDGUT		[Oberg, Kjell] Univ Uppsala Hosp, Dept Endocrine Oncol, SE-75185 Uppsala, Sweden	Uppsala University; Uppsala University Hospital	Oberg, K (corresponding author), Univ Uppsala Hosp, Dept Endocrine Oncol, SE-75185 Uppsala, Sweden.	kjell.oberg@medsci.uu.se	Oberg, Kjell/AAG-7118-2019					Bosman F., 2010, WHO CLASSIFICATION T, V4th; Caplin ME, 2014, NEW ENGL J MED, V371, P224, DOI 10.1056/NEJMoa1316158; Meric-Bernstam F, 2009, J CLIN ONCOL, V27, P2278, DOI 10.1200/JCO.2008.20.0766; Pavel M, 2012, NEUROENDOCRINOLOGY, V95, P157, DOI 10.1159/000335597; Pavel ME, 2011, LANCET, V378, P2005, DOI 10.1016/S0140-6736(11)61742-X; Raymond E, 2011, NEW ENGL J MED, V364, P501, DOI 10.1056/NEJMoa1003825; Rindi G, 2007, VIRCHOWS ARCH, V451, P757, DOI 10.1007/s00428-007-0452-1; Rinke A, 2009, J CLIN ONCOL, V27, P4656, DOI 10.1200/JCO.2009.22.8510; Strosberg JR, 2011, CANCER-AM CANCER SOC, V117, P268, DOI 10.1002/cncr.25425; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377; Yao JC, 2016, LANCET, V387, P968, DOI 10.1016/S0140-6736(15)00817-X; Yao JC, 2011, NEW ENGL J MED, V364, P514, DOI 10.1056/NEJMoa1009290; Yao JC, 2010, J CLIN ONCOL, V28, P69, DOI 10.1200/JCO.2009.24.2669	13	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 5	2016	387	10022					924	926		10.1016/S0140-6736(15)01234-9	http://dx.doi.org/10.1016/S0140-6736(15)01234-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF8XP	26703890				2022-12-28	WOS:000371644200008
J	McCowan, LM; McKinlay, CJ; Poston, L				McCowan, Lesley M.; McKinlay, Christopher J.; Poston, Lucilla			Interpregnancy weight gain-a modifiable cause of stillbirth?	LANCET			English	Editorial Material							LIFE-STYLE; WOMEN; INTERVENTIONS; OVERWEIGHT; PREGNANCY; RETENTION; OBESITY; RISK		[McCowan, Lesley M.] Univ Auckland, Fac Med & Hlth Sci, Dept Obstet & Gynaecol, Auckland 1142, New Zealand; [McKinlay, Christopher J.] Univ Auckland, Liggins Inst, Auckland 1142, New Zealand; [Poston, Lucilla] Kings Coll London & Kings Hlth Partners, Womens Hlth Acad Ctr, Div Womens Hlth, London, England	University of Auckland; University of Auckland; University of London; King's College London	McCowan, LM (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Dept Obstet & Gynaecol, Auckland 1142, New Zealand.	l.mccowan@auckland.ac.nz	McKinlay, Christopher JD/E-6263-2018	McKinlay, Christopher JD/0000-0003-1088-9467; Poston, Lucilla/0000-0003-1100-2821; McCowan, Lesley/0000-0001-9915-7873	National Institute for Health Research [NF-SI-0512-10104, RP-PG-0407-10452] Funding Source: researchfish; Medical Research Council [MR/L002477/1] Funding Source: Medline; Department of Health [RP-PG-0407-10452] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health		Chen AM, 2004, PEDIATRICS, V113, pE435, DOI 10.1542/peds.113.5.e435; Cnattingius S, 2015, LANCET; Dodd JM, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1285; Flenady V, 2011, LANCET, V377, P1703, DOI 10.1016/S0140-6736(11)60064-0; Gardosi J, 2013, BMJ-BRIT MED J, V346, P108; Koivusalo SB, 2016, DIABETES CARE, V39, P24, DOI 10.2337/dc15-0511; Meehan S, 2014, PEDIATRICS, V133, P863, DOI 10.1542/peds.2013-1480; Phelan S, 2014, AM J CLIN NUTR, V99, P302, DOI 10.3945/ajcn.113.070151; Poston L, 2015, LANCET DIABETES ENDO, V3, P767, DOI 10.1016/S2213-8587(15)00227-2; Rong K, 2014, PUBLIC HEALTH NUTR, P1; Stacey T, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3403; Thangaratinam S, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2088; van der Pligt P, 2013, OBES REV, V14, P792, DOI 10.1111/obr.12053; Vinter CA, 2014, ACTA OBSTET GYN SCAN, V93, P794, DOI 10.1111/aogs.12429; Wisborg M, 2003, EPIDEMIOLOGY, V14, P630, DOI 10.1097/01.ede.0000081992.98728.fb	15	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 6	2016	387	10018					508	510		10.1016/S0140-6736(15)01089-2	http://dx.doi.org/10.1016/S0140-6736(15)01089-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD3PV	26651224				2022-12-28	WOS:000369835800008
J	Shaw, AT; Friboulet, L; Leshchiner, I; Gainor, JF; Bergqvist, S; Brooun, A; Burke, BJ; Deng, YL; Liu, W; Dardaei, L; Frias, RL; Schultz, KR; Logan, J; James, LP; Smeal, T; Timofeevski, S; Katayama, R; Iafrate, AJ; Le, L; McTigue, M; Getz, G; Johnson, TW; Engelman, JA				Shaw, Alice T.; Friboulet, Luc; Leshchiner, Ignaty; Gainor, Justin F.; Bergqvist, Simon; Brooun, Alexei; Burke, Benjamin J.; Deng, Ya-Li; Liu, Wei; Dardaei, Leila; Frias, Rosa L.; Schultz, Kate R.; Logan, Jennifer; James, Leonard P.; Smeal, Tod; Timofeevski, Sergei; Katayama, Ryohei; Iafrate, A. John; Le, Long; McTigue, Michele; Getz, Gad; Johnson, Ted W.; Engelman, Jeffrey A.			Resensitization to Crizotinib by the Lorlatinib ALK Resistance Mutation L1198F	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CELL LUNG-CANCER; ANAPLASTIC LYMPHOMA KINASE; INHIBITOR; EFFICACY; SAFETY; PF-06463922; GEFITINIB; CERITINIB; AP26113; GENE	In a patient who had metastatic anaplastic lymphoma kinase (ALK)-rearranged lung cancer, resistance to crizotinib developed because of a mutation in the ALK kinase domain. This mutation is predicted to result in a substitution of cysteine by tyrosine at amino acid residue 1156 (C1156Y). Her tumor did not respond to a second-generation ALK inhibitor, but it did respond to lorlatinib (PF-06463922), a third-generation inhibitor. When her tumor relapsed, sequencing of the resistant tumor revealed an ALK L1198F mutation in addition to the C1156Y mutation. The L1198F substitution confers resistance to lorlatinib through steric interference with drug binding. However, L1198F paradoxically enhances binding to crizotinib, negating the effect of C1156Y and resensitizing resistant cancers to crizotinib. The patient received crizotinib again, and her cancer-related symptoms and liver failure resolved.	[Shaw, Alice T.; Friboulet, Luc; Gainor, Justin F.; Dardaei, Leila; Frias, Rosa L.; Schultz, Kate R.; Logan, Jennifer; Getz, Gad; Engelman, Jeffrey A.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Iafrate, A. John; Le, Long; Getz, Gad] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Leshchiner, Ignaty; Getz, Gad] MIT, Broad Inst, Cambridge, MA 02139 USA; [Leshchiner, Ignaty; Getz, Gad] Harvard, Cambridge, MA USA; [Bergqvist, Simon; Brooun, Alexei; Burke, Benjamin J.; Deng, Ya-Li; Liu, Wei; James, Leonard P.; Smeal, Tod; Timofeevski, Sergei; McTigue, Michele; Johnson, Ted W.] Pfizer Worldwide Res & Dev, La Jolla, CA USA; [Katayama, Ryohei] Japanese Fdn Canc Res, Tokyo, Japan	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Pfizer; Japanese Foundation for Cancer Research	Shaw, AT (corresponding author), Massachusetts Gen Hosp, Ctr Canc, 32 Fruit St, Boston, MA 02114 USA.	ashaw1@partners.org; ted.w.johnson@pfizer.com	Katayama, Ryohei/K-8537-2014; Frias, Rosa L./AAT-3133-2021; Gainor, Justin/T-5411-2019; friboulet, luc/N-7276-2015	Katayama, Ryohei/0000-0001-7394-895X; friboulet, luc/0000-0002-1129-4978; Leshchiner, Ignaty/0000-0001-8942-9265	Pfizer; NATIONAL CANCER INSTITUTE [R01CA164273] Funding Source: NIH RePORTER	Pfizer(Pfizer); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by Pfizer and others; ClinicalTrials. gov number, NCT01970865	Camidge DR, 2015, J CLIN ONCOL, V33; Ceccon M, 2015, MOL CANCER RES, V13, P775, DOI 10.1158/1541-7786.MCR-14-0157; Choi YL, 2010, NEW ENGL J MED, V363, P1734, DOI 10.1056/NEJMoa1007478; Cortes JE, 2012, NEW ENGL J MED, V367, P2075, DOI 10.1056/NEJMoa1205127; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Fossella FV, 2000, J CLIN ONCOL, V18, P2354, DOI 10.1200/JCO.2000.18.12.2354; Friboulet L, 2014, CANCER DISCOV, V4, P662, DOI 10.1158/2159-8290.CD-13-0846; Gadgeel SM, 2014, LANCET ONCOL, V15, P1119, DOI 10.1016/S1470-2045(14)70362-6; Gouji T, 2014, J THORAC ONCOL, V9, pE27, DOI 10.1097/JTO.0000000000000113; Janne PA, 2015, NEW ENGL J MED, V372, P1689, DOI 10.1056/NEJMoa1411817; Johnson TW, 2014, J MED CHEM, V57, P4720, DOI 10.1021/jm500261q; Katayama R, 2015, RESISTANCE MECH ALK; Katayama R, 2015, CLIN CANCER RES, V21, P2227, DOI 10.1158/1078-0432.CCR-14-2791; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Murugan AK, 2011, CANCER RES, V71, P4403, DOI 10.1158/0008-5472.CAN-10-4041; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Sequist LV, 2015, NEW ENGL J MED, V372, P1700, DOI 10.1056/NEJMoa1413654; Shaw AT, 2014, NEW ENGL J MED, V371, P1963, DOI 10.1056/NEJMoa1406766; Shaw AT, 2014, NEW ENGL J MED, V370, P2537, DOI 10.1056/NEJMc1404894; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Zheng ZL, 2014, NAT MED, V20, P1479, DOI 10.1038/nm.3729; Zou HY, 2015, CANCER CELL, V28, P70, DOI 10.1016/j.ccell.2015.05.010	23	337	361	0	71	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 7	2016	374	1					54	61		10.1056/NEJMoa1508887	http://dx.doi.org/10.1056/NEJMoa1508887			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA1UH	26698910	Green Accepted			2022-12-28	WOS:000367580500008
J	Cleynen, I; Van Moerkercke, W; Billiet, T; Vandecandelaere, P; Vande Casteele, N; Breynaert, C; Ballet, V; Ferrante, M; Noman, M; Van Assche, G; Rutgeerts, P; van den Oord, JJ; Gils, A; Segaert, S; Vermeire, S				Cleynen, Isabelle; Van Moerkercke, Wouter; Billiet, Thomas; Vandecandelaere, Pieter; Vande Casteele, Niels; Breynaert, Christine; Ballet, Vera; Ferrante, Marc; Noman, Maja; Van Assche, Gert; Rutgeerts, Paul; van den Oord, Joost J.; Gils, Ann; Segaert, Siegfried; Vermeire, Severine			Characteristics of Skin Lesions Associated With Anti-Tumor Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; ANTI-TNF AGENTS; RHEUMATOID-ARTHRITIS; CROHNS-DISEASE; LONG-TERM; ANKYLOSING-SPONDYLITIS; SUSCEPTIBILITY LOCI; ULCERATIVE-COLITIS; ALPHA THERAPY; PSORIASIS	Background: A subgroup of patients with inflammatory bowel disease (IBD) treated with anti-tumor necrosis factor (TNF) antibodies develop skin lesions, but the lesions and their clinical course are not well-characterized. Objective: To describe patients treated with anti-TNF antibodies who did and did not develop skin lesions. Design: Retrospective cohort. Setting: Single IBD tertiary referral center. Patients: 917 consecutive patients with IBD who initiated anti-TNF therapy. Measurements: Skin lesions, patient demographic characteristics, treatments, clinical course, and serologic and genetic markers. Results: During a median follow-up of 3.5 years (interquartile range [IQR], 0.5 to 7.4 years), skin lesions associated with the use of anti-TNF therapy developed in 264 of 917 (29%) patients (psoriasiform eczema, 30.6%; eczema, 23.5%; xerosis cutis, 10.6%; palmoplantar pustulosis, 5.3%; psoriasis, 3.8%; other, 26.1%). Lesions typically developed at flexural regions, genitalia, and the scalp, especially the psoriasiform lesions. Thirty-one percent of women and 26% of men developed lesions. Median cumulative doses (2864 mg/y [IQR, 2203 to 3819 mg/y] and 2927 mg/y [IQR, 2377 to 3667 mg/y]) and trough levels (4.2 mu g/mL [IQR, 2.6 to 5.8 mu g/mL] and 4.0 mu g/mL [IQR, 1.6 to 5.9 mu g/mL]) of infliximab were similar in patients with and without lesions. All but 28 patients (11%) were successfully managed without needing to stop therapy because of lesions. Limitation: Retrospective nature and no matched control group of patients not receiving anti-TNF therapy. Conclusion: Skin lesions occur frequently in association with anti-TNF therapy but rarely require discontinuation of therapy. Close surveillance and early referral to a dedicated dermatologist are recommended.	Katholieke Univ Leuven, Leuven, Belgium; Univ Hosp Leuven, Leuven, Belgium; AZ Groeninge, Kortrijk, Belgium; AZ Delta, Roeselare, Belgium	KU Leuven; KU Leuven; University Hospital Leuven	Vermeire, S (corresponding author), Univ Hosp Leuven, Dept Gastroenterol, Herestr 49,Box 701, B-3000 Leuven, Belgium.	severine.vermeire@uzleuven.be	Breynaert, Christine/T-5611-2017	Breynaert, Christine/0000-0002-7368-1068; Vande Casteele, Niels/0000-0003-0854-0274; Vermeire, Severine/0000-0001-9942-3019	Research Foundation Flanders (FWO), Belgium; Geconcerteerde Onderzoekacties of KU Leuven; Janssen Biologics	Research Foundation Flanders (FWO), Belgium(FWO); Geconcerteerde Onderzoekacties of KU Leuven; Janssen Biologics	Research Foundation Flanders (FWO), Belgium; Geconcerteerde Onderzoekacties of KU Leuven; and Janssen Biologics.	Afzali A, 2014, J CROHNS COLITIS, V8, P480, DOI 10.1016/j.crohns.2013.10.013; Baraliakos X, 2011, RHEUMATOLOGY, V50, P1690, DOI 10.1093/rheumatology/ker194; Barthel C, 2014, DIGESTION, V89, P209, DOI 10.1159/000358288; Baumgart DC, 2011, INFLAMM BOWEL DIS, V17, P2512, DOI 10.1002/ibd.21643; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Bouguen G, 2010, ALIMENT PHARM THER, V31, P1178, DOI 10.1111/j.1365-2036.2010.04293.x; Casteele NV, 2012, ALIMENT PHARM THER, V36, P765, DOI 10.1111/apt.12030; Casteele NV, 2012, GUT, V61, P321, DOI 10.1136/gut.2010.236869; Cleynen I, 2012, NAT REV GASTRO HEPAT, V9, P496, DOI 10.1038/nrgastro.2012.125; Colombel JF, 2009, INFLAMM BOWEL DIS, V15, P1308, DOI 10.1002/ibd.20956; de Gannes GC, 2007, ARCH DERMATOL, V143, P223, DOI 10.1001/archderm.143.2.223; Denadai R, 2013, J CROHNS COLITIS, V7, P517, DOI 10.1016/j.crohns.2012.08.007; Ellinghaus D, 2013, NAT GENET, V45, P808, DOI 10.1038/ng.2642; Ellinghaus D, 2012, AM J HUM GENET, V90, P636, DOI 10.1016/j.ajhg.2012.02.020; Ettler J, 2012, CLIN EXP DERMATOL, V37, P639, DOI 10.1111/j.1365-2230.2011.04286.x; Fidder H, 2009, GUT, V58, P501, DOI 10.1136/gut.2008.163642; Goyette P, 2015, NAT GENET, V47, P172, DOI 10.1038/ng.3176; Hanauer SB, 2007, GUT, V56, P161, DOI 10.1136/gut.2005.089953; Hanauer SB, 2006, GASTROENTEROLOGY, V130, P323, DOI 10.1053/j.gastro.2005.11.030; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Harrison MJ, 2009, ANN RHEUM DIS, V68, P209, DOI 10.1136/ard.2007.087288; Heldmann F, 2011, CLIN EXP RHEUMATOL, V29, P672; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hoentjen F, 2009, WORLD J GASTROENTERO, V15, P2067, DOI 10.3748/wjg.15.2067; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kievit W, 2011, RHEUMATOLOGY, V50, P196, DOI 10.1093/rheumatology/keq325; Kircik LH, 2009, J DRUGS DERMATOL, V8, P546; Lolli E, 2015, J CROHNS COLITIS, V9, P699, DOI 10.1093/ecco-jcc/jjv068; Markatseli TE, 2012, CLIN EXP RHEUMATOL, V30, P31; Mateo S, 2014, CLIN EXP DERMATOL, V39, P813, DOI 10.1111/ced.12402; Menter A, 2009, CUTIS, V84, P14; Ngo Benjamin, 2010, Curr Mol Pharmacol, V3, P145; Osorio F, 2012, DERMATOLOGY, V225, P163, DOI 10.1159/000342503; Peyrin-Biroulet L, 2010, Minerva Gastroenterol Dietol, V56, P233; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rahier JF, 2010, CLIN GASTROENTEROL H, V8, P1048, DOI 10.1016/j.cgh.2010.07.022; Reed MR, 2008, INTERN MED J, V38, P781, DOI 10.1111/j.1445-5994.2008.01639.x; Reinisch W, 2011, GUT, V60, P780, DOI 10.1136/gut.2010.221127; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Sandborn WJ, 2012, GASTROENTEROLOGY, V142, P257, DOI 10.1053/j.gastro.2011.10.032; Tammaro A, 2012, INT J IMMUNOPATH PH, V25, P499, DOI 10.1177/039463201202500220; Tillack C, 2014, GUT, V63, P567, DOI 10.1136/gutjnl-2012-302853; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Vande Casteele N, 2015, GASTROENTEROLOGY, V148, P1320, DOI 10.1053/j.gastro.2015.02.031; Wiens A, 2010, PHARMACOTHERAPY, V30, P339, DOI 10.1592/phco.30.4.339; Wong M, 2008, CLIN IMMUNOL, V126, P121, DOI 10.1016/j.clim.2007.08.013	47	88	93	2	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 5	2016	164	1					10	+		10.7326/M15-0729	http://dx.doi.org/10.7326/M15-0729			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA4WC	26641955				2022-12-28	WOS:000367801700006
J	Brunette, TJ; Parmeggiani, F; Huang, PS; Bhabha, G; Ekiert, DC; Tsutakawa, SE; Hura, GL; Tainer, JA; Baker, D				Brunette, T. J.; Parmeggiani, Fabio; Huang, Po-Ssu; Bhabha, Gira; Ekiert, Damian C.; Tsutakawa, Susan E.; Hura, Greg L.; Tainer, John A.; Baker, David			Exploring the repeat protein universe through computational protein design	NATURE			English	Article							X-RAY-SCATTERING; SOFTWARE; ARCHITECTURE; GENERATION; RESOLUTION; STABILITY; SEQUENCE; DATABASE; SCAFFOLD; BINDERS	A central question in protein evolution is the extent to which naturally occurring proteins sample the space of folded structures accessible to the polypeptide chain. Repeat proteins composed of multiple tandem copies of a modular structure unit(1) are widespread in nature and have critical roles in molecular recognition, signalling, and other essential biological processes(2). Naturally occurring repeat proteins have been re-engineered for molecular recognition and modular scaffolding applications(3-5). Here we use computational protein design to investigate the space of folded structures that can be generated by tandem repeating a simple helix-loop-helix-loop structural motif. Eighty-three designs with sequences unrelated to known repeat proteins were experimentally characterized. Of these, 53 are monomeric and stable at 95 degrees C, and 43 have solution X-ray scattering spectra consistent with the design models. Crystal structures of 15 designs spanning a broad range of curvatures are in close agreement with the design models with root mean square deviations ranging from 0.7 to 2.5 angstrom. Our results show that existing repeat proteins occupy only a small fraction of the possible repeat protein sequence and structure space and that it is possible to design novel repeat proteins with precisely specified geometries, opening up a wide array of new possibilities for biomolecular engineering.	[Brunette, T. J.; Parmeggiani, Fabio; Huang, Po-Ssu; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Brunette, T. J.; Parmeggiani, Fabio; Huang, Po-Ssu; Baker, David] Univ Washington, Inst Prot Design, Seattle, WA 98195 USA; [Bhabha, Gira] UCSF, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Ekiert, Damian C.] UCSF, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Tsutakawa, Susan E.; Hura, Greg L.; Tainer, John A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging, Berkeley, CA 94720 USA; [Hura, Greg L.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; [Tainer, John A.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Santa Cruz; University of Texas System; UTMD Anderson Cancer Center; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Baker, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	dabaker@uw.edu	Parmeggiani, Fabio/P-3661-2019; Tainer, John/GWQ-4878-2022; Baker, David/K-8941-2012; Parmeggiani, Fabio/B-9344-2016	Parmeggiani, Fabio/0000-0001-8548-1090; Tainer, John/0000-0003-1659-2429; Baker, David/0000-0001-7896-6217; Parmeggiani, Fabio/0000-0001-8548-1090; Huang, Possu/0000-0002-7948-2895; Tsutakawa, Susan/0000-0002-4918-4571; Ekiert, Damian/0000-0002-2570-0404; Hura, Greg/0000-0003-0501-8464	National Science Foundation (NSF) [MCB-1445201, CHE-1332907]; Defense Threat Reduction Agency (DTRA); Air Force Office of Scientific Research (AFOSR) [FA950-12-10112]; Howard Hughes Medical Institute [HHMI-027779]; Swiss National Science Foundation Postdoc Fellowship [PBZHP3-125470]; Human Frontier Science Program Long-Term Fellowship [LT000070/2009-L]; National Institutes of Health grant MINOS (Macromolecular Insights on Nucleic Acids Optimized by Scattering) [GM105404]; United States Department of Energy program Integrated Diffraction Analysis Technologies (IDAT); Damon Runyon Cancer Research Foundation [DRG-2140-12]; Merck fellowship of the Damon Runyon Cancer Research Foundation [DRG-2136-12]; NIH [K99GM112982]; Robert A. Welch Distinguished Chair in Chemistry; Office of Science, Office of Basic Energy Sciences, of the US Department of Energy [DE-AC02-05CH11231]; UC Office of the President, Multicampus Research Programs and Initiatives [MR-15-338599]; Sandler Foundation; National Institutes of Health; National Institute of General Medical Sciences; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105404, K99GM112982] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005136] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1445201] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency); Air Force Office of Scientific Research (AFOSR)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Swiss National Science Foundation Postdoc Fellowship(Swiss National Science Foundation (SNSF)); Human Frontier Science Program Long-Term Fellowship(Human Frontier Science Program); National Institutes of Health grant MINOS (Macromolecular Insights on Nucleic Acids Optimized by Scattering)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy program Integrated Diffraction Analysis Technologies (IDAT); Damon Runyon Cancer Research Foundation; Merck fellowship of the Damon Runyon Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Distinguished Chair in Chemistry; Office of Science, Office of Basic Energy Sciences, of the US Department of Energy(United States Department of Energy (DOE)); UC Office of the President, Multicampus Research Programs and Initiatives; Sandler Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank D. Kim and members of the protein production facility at the Institute for Protein Design. This work was facilitated though the use of advanced computational, storage and networking infrastructure provided by the Hyak supercomputer system at the University of Washington. This work was supported in part by grants from the National Science Foundation (NSF) (MCB-1445201 and CHE-1332907), the Defense Threat Reduction Agency (DTRA), the Air Force Office of Scientific Research (AFOSR) (FA950-12-10112) and the Howard Hughes Medical Institute (HHMI-027779). F.P. was the recipient of a Swiss National Science Foundation Postdoc Fellowship (PBZHP3-125470) and a Human Frontier Science Program Long-Term Fellowship (LT000070/2009-L). SAXS work at the Advanced Light Source SIBLYS beamline was supported by the National Institutes of Health grant MINOS (Macromolecular Insights on Nucleic Acids Optimized by Scattering) GM105404 and by United States Department of Energy program Integrated Diffraction Analysis Technologies (IDAT). D.C.E. is a Damon Runyon Fellow supported by the Damon Runyon Cancer Research Foundation (Grant DRG-2140-12). G.B. is a recipient of the Merck fellowship of the Damon Runyon Cancer Research Foundation (DRG-2136-12) and is supported by NIH grant K99GM112982. J.A.T. is supported by a Robert A. Welch Distinguished Chair in Chemistry. We thank J. Holton for advice on S-SAD data collection, and the staff of ALS 8.2.1 and 8.3.1 for beamline support. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under Contract No. DE-AC02-05CH11231. ALS beamline 8.3.1 is supported by the UC Office of the President, Multicampus Research Programs and Initiatives grant MR-15-338599 and the Program for Breakthrough Biomedical Research, which is partially funded by the Sandler Foundation. ALS beamline 8.2.1 and the Berkeley Center for Structural Biology are supported in part by the National Institutes of Health, National Institute of General Medical Sciences, and the Howard Hughes Medical Institute.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Binz HK, 2003, J MOL BIOL, V332, P489, DOI 10.1016/S0022-2836(03)00896-9; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Classen S, 2013, J APPL CRYSTALLOGR, V46, P1, DOI 10.1107/S0021889812048698; Classen S, 2010, J SYNCHROTRON RADIAT, V17, P774, DOI 10.1107/S0909049510028566; Coquille S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6729; Cortajarena AL, 2011, PROTEIN SCI, V20, P336, DOI 10.1002/pro.564; Cortajarena AL, 2010, ACS CHEM BIOL, V5, P545, DOI 10.1021/cb9002464; Di Domenico T, 2014, NUCLEIC ACIDS RES, V42, pD352, DOI 10.1093/nar/gkt1175; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Huang P.-S., 2015, NATURE CHEM BIOL; Huang PS, 2014, SCIENCE, V346, P481, DOI 10.1126/science.1257481; Huang PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024109; Hura GL, 2013, NAT METHODS, V10, P453, DOI 10.1038/nmeth.2453; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kajava AV, 2012, J STRUCT BIOL, V179, P279, DOI 10.1016/j.jsb.2011.08.009; Kobe B, 2000, TRENDS BIOCHEM SCI, V25, P509, DOI 10.1016/S0968-0004(00)01667-4; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lee J, 2011, P NATL ACAD SCI USA, V108, P126, DOI 10.1073/pnas.1015032108; Lee SC, 2012, P NATL ACAD SCI USA, V109, P3299, DOI 10.1073/pnas.1113193109; Main ERG, 2003, STRUCTURE, V11, P497, DOI 10.1016/S0969-2126(03)00076-5; Marcotte EM, 1999, J MOL BIOL, V293, P151, DOI 10.1006/jmbi.1999.3136; Mosavi LK, 2002, P NATL ACAD SCI USA, V99, P16029, DOI 10.1073/pnas.252537899; Park K, 2015, NAT STRUCT MOL BIOL, V22, P167, DOI 10.1038/nsmb.2938; Parmeggiani F, 2008, J MOL BIOL, V376, P1282, DOI 10.1016/j.jmb.2007.12.014; Parmeggiani F, 2015, J MOL BIOL, V427, P563, DOI 10.1016/j.jmb.2014.11.005; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Rambo RP, 2013, ANNU REV BIOPHYS, V42, P415, DOI 10.1146/annurev-biophys-083012-130301; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Ramisch S, 2014, P NATL ACAD SCI USA, V111, P17875, DOI 10.1073/pnas.1413638111; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tripp KW, 2007, J MOL BIOL, V365, P1187, DOI 10.1016/j.jmb.2006.09.092; Urvoas A, 2010, J MOL BIOL, V404, P307, DOI 10.1016/j.jmb.2010.09.048; Varadamsetty G, 2012, J MOL BIOL, V424, P68, DOI 10.1016/j.jmb.2012.08.029; Voet ARD, 2014, P NATL ACAD SCI USA, V111, P15102, DOI 10.1073/pnas.1412768111; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yadid I, 2007, J MOL BIOL, V365, P10, DOI 10.1016/j.jmb.2006.09.055	47	144	151	3	130	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 24	2015	528	7583					580	+		10.1038/nature16162	http://dx.doi.org/10.1038/nature16162			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ3GH	26675729	Green Accepted, Green Submitted			2022-12-28	WOS:000366991900058
J	Ishikawa, T; Hayes, SA; Keskin, S; Corthey, G; Hada, M; Pichugin, K; Marx, A; Hirscht, J; Shionuma, K; Onda, K; Okimoto, Y; Koshihara, S; Yamamoto, T; Cui, HB; Nomura, M; Oshima, Y; Abdel-Jawad, M; Kato, R; Miller, RJD				Ishikawa, Tadahiko; Hayes, Stuart A.; Keskin, Sercan; Corthey, Gaston; Hada, Masaki; Pichugin, Kostyantyn; Marx, Alexander; Hirscht, Julian; Shionuma, Kenta; Onda, Ken; Okimoto, Yoichi; Koshihara, Shin-ya; Yamamoto, Takashi; Cui, Hengbo; Nomura, Mitsushiro; Oshima, Yugo; Abdel-Jawad, Majed; Kato, Reizo; Miller, R. J. Dwayne			Direct observation of collective modes coupled to molecular orbital-driven charge transfer	SCIENCE			English	Article							ATOMIC MOTIONS; STATE; PHASE	Correlated electron systems can undergo ultrafast photoinduced phase transitions involving concerted transformations of electronic and lattice structure. Understanding these phenomena requires identifying the key structural modes that couple to the electronic states. We report the ultrafast photoresponse of the molecular crystal Me4P[Pt(dmit)(2)](2), which exhibits a photoinduced charge transfer similar to transitions between thermally accessible states, and demonstrate how femtosecond electron diffraction can be applied to directly observe the associated molecular motions. Even for such a complex system, the key large-amplitude modes can be identified by eye and involve a dimer expansion and a librational mode. The dynamics are consistent with the time-resolved optical study, revealing how the electronic, molecular, and lattice structures together facilitate ultrafast switching of the state.	[Ishikawa, Tadahiko; Shionuma, Kenta; Okimoto, Yoichi; Koshihara, Shin-ya] Tokyo Inst Technol, Dept Chem & Mat Sci, Meguro Ku, Tokyo 1528551, Japan; [Hayes, Stuart A.; Keskin, Sercan; Corthey, Gaston; Hada, Masaki; Pichugin, Kostyantyn; Marx, Alexander; Hirscht, Julian; Miller, R. J. Dwayne] Max Planck Inst Struct & Dynam Matter, Ctr Free Electron Laser Sci, D-22761 Hamburg, Germany; [Hayes, Stuart A.; Keskin, Sercan; Corthey, Gaston; Marx, Alexander; Hirscht, Julian; Miller, R. J. Dwayne] Univ Hamburg, Hamburg Ctr Ultrafast Imaging, D-22761 Hamburg, Germany; [Hada, Masaki; Onda, Ken] Tokyo Inst Technol, JST PRESTO, Midori Ku, Yokohama, Kanagawa 2268502, Japan; [Koshihara, Shin-ya] JST CREST, Kawaguchi, Saitama 3320012, Japan; [Yamamoto, Takashi] Ehime Univ, Grad Sch Sci & Engn, Matsuyama, Ehime 7908577, Japan; [Cui, Hengbo; Nomura, Mitsushiro; Oshima, Yugo; Abdel-Jawad, Majed; Kato, Reizo] RIKEN, Condensed Mol Mat Lab, Wako, Saitama 3510198, Japan; [Miller, R. J. Dwayne] Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada; [Miller, R. J. Dwayne] Univ Toronto, Dept Phys, Toronto, ON M5S 3H6, Canada	Tokyo Institute of Technology; Max Planck Society; University of Hamburg; Japan Science & Technology Agency (JST); Tokyo Institute of Technology; Japan Science & Technology Agency (JST); Ehime University; RIKEN; University of Toronto; University of Toronto	Miller, RJD (corresponding author), Max Planck Inst Struct & Dynam Matter, Ctr Free Electron Laser Sci, Luruper Chaussee 149, D-22761 Hamburg, Germany.	dwayne.miller@mpsd.mpg.de	Hada, Masaki/M-7309-2019; Hada, Masaki/N-8445-2018; Abdel-Jawad, Majed/ABE-3246-2020; Ishikawa, Tadahiko/B-9878-2015; Koshihara, Shinya/ABA-1213-2021; Onda, Ken/H-3389-2014; Oshima, Yugo/H-1031-2013; Okimoto, Yoichi/K-6099-2012; Kato, Reizo/I-1073-2014; Koshihara, Shinya/B-5095-2015	Hada, Masaki/0000-0001-8148-0971; Hada, Masaki/0000-0001-8148-0971; Abdel-Jawad, Majed/0000-0003-4591-6998; Ishikawa, Tadahiko/0000-0001-7018-654X; Onda, Ken/0000-0003-1724-2009; Oshima, Yugo/0000-0001-9822-8262; Kato, Reizo/0000-0002-2606-4657; Koshihara, Shinya/0000-0002-7119-2017; Okimoto, Yoichi/0000-0003-0095-4579	Max Planck Society; Centre for Free Electron Laser Science; Hamburg Centre for Ultrafast Imaging; Ministry of Education, Culture, Supports, Science, and Technology of Japan [15H02103]; CREST, JST [15H02103]; Alexander von Humboldt Foundation; Japan Science Technology Agency (JST), PRESTO	Max Planck Society(Max Planck SocietyFoundation CELLEX); Centre for Free Electron Laser Science; Hamburg Centre for Ultrafast Imaging; Ministry of Education, Culture, Supports, Science, and Technology of Japan; CREST, JST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Japan Science Technology Agency (JST), PRESTO	We thank G. Sciaini and G. Moriena for help constructing the FED apparatus; W. Kazub, M. Lorenc, and A. Moreac for their help in the early stage of the optical study; and T. Tsumuraya for information concerning the band calculation. The electron diffraction work was funded by the Max Planck Society in collaboration with the Centre for Free Electron Laser Science and the Hamburg Centre for Ultrafast Imaging. This work was also partially supported by Grants-in-Aid for Scientific Research (A) (no. 15H02103) from the Ministry of Education, Culture, Supports, Science, and Technology of Japan, and CREST, JST. G.C. thanks the Alexander von Humboldt Foundation for support. M.H. acknowledges the Japan Science Technology Agency (JST), PRESTO, for funding the project "Molecular technology and creation of new functions." The authors declare no conflicts of interest.	Beaud P, 2014, NAT MATER, V13, P923, DOI [10.1038/nmat4046, 10.1038/NMAT4046]; Braun M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.248301; Cammarata M, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.227402; Consani C, 2009, ANGEW CHEM INT EDIT, V48, P7184, DOI 10.1002/anie.200902728; Eichberger M, 2010, NATURE, V468, P799, DOI 10.1038/nature09539; Elsaesser T, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4855115; Fritz DM, 2007, SCIENCE, V315, P633, DOI 10.1126/science.1135009; Fukazawa N, 2013, J PHYS CHEM C, V117, P13187, DOI 10.1021/jp403193a; Gao M, 2013, NATURE, V496, P343, DOI 10.1038/nature12044; Ichikawa H, 2011, NAT MATER, V10, P101, DOI 10.1038/nmat2929; Ishikawa T, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.115108; Jean-Ruel H, 2013, J PHYS CHEM B, V117, P15894, DOI 10.1021/jp409245h; Kawakami Y, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.066403; Miller RJD, 2014, ANNU REV PHYS CHEM, V65, P583, DOI 10.1146/annurev-physchem-040412-110117; Minitti MP, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.255501; Nishioka K, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.094716; Okamoto H, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.165202; Siwick BJ, 2003, SCIENCE, V302, P1382, DOI 10.1126/science.1090052; Sokolowski-Tinten K, 2003, NATURE, V422, P287, DOI 10.1038/nature01490; TAJIMA H, 1991, SOLID STATE COMMUN, V79, P337, DOI 10.1016/0038-1098(91)90557-C; Tamura M, 2005, CHEM PHYS LETT, V411, P133, DOI 10.1016/j.cplett.2005.06.026; Tamura M, 2004, CHEM PHYS LETT, V387, P448, DOI 10.1016/j.cplett.2004.02.053; Vorontsov II, 2009, J AM CHEM SOC, V131, P6566, DOI 10.1021/ja900921p; Williamson JC, 1997, NATURE, V386, P159, DOI 10.1038/386159a0; Zewail AH, 2010, SCIENCE, V328, P187, DOI 10.1126/science.1166135	26	94	94	3	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2015	350	6267					1501	1505		10.1126/science.aab3480	http://dx.doi.org/10.1126/science.aab3480			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY7LY	26680192				2022-12-28	WOS:000366591100052
J	Csatho, BM				Csatho, Beata M.			CLIMATE SCIENCE A history of Greenland's ice loss	NATURE			English	Editorial Material									[Csatho, Beata M.] SUNY Buffalo, Dept Geol Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Csatho, BM (corresponding author), SUNY Buffalo, Dept Geol Sci, Buffalo, NY 14260 USA.	bcsatho@buffalo.edu						Church JA, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1137; Csatho B, 2008, J GLACIOL, V54, P131, DOI 10.3189/002214308784409035; Khan SA, 2014, CRYOSPHERE, V8, P1497, DOI 10.5194/tc-8-1497-2014; Kjeldsen KK, 2015, NATURE, V528, P396, DOI 10.1038/nature16183; van den Broeke M, 2009, SCIENCE, V326, P984, DOI 10.1126/science.1178176; Weidick A., 1968, GRONLANDS GEOL UNDER, V73	6	0	0	0	18	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 17	2015	528	7582					341	343		10.1038/528341a	http://dx.doi.org/10.1038/528341a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY8SM	26672549				2022-12-28	WOS:000366678600040
J	Shenoy, ES; Lai, PS; Shepard, JAO; Kradin, RL				Shenoy, Erica S.; Lai, Peggy S.; Shepard, Jo-Anne O.; Kradin, Richard L.			Case 39-2015: A 22-Year-Old Man with Hypoxemia and Shock	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PNEUMONIC TULAREMIA; PANDEMIC INFLUENZA; DEATH; RISK; COMPLICATIONS; OUTBREAK		[Shenoy, Erica S.; Lai, Peggy S.; Kradin, Richard L.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Shepard, Jo-Anne O.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Kradin, Richard L.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Shenoy, Erica S.; Lai, Peggy S.; Kradin, Richard L.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Shepard, Jo-Anne O.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Kradin, Richard L.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Shenoy, ES (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.		Shenoy, Erica/AAD-7521-2021					[Anonymous], 2013, Wkly Epidemiol Rec, V88, P137; Boucher HW, 2008, CLIN INFECT DIS, V46, pS344, DOI 10.1086/533590; Cent. Dis. Control Prev, 2015, GUID CLIN US RT PCR; Centers for Disease Control and Prevention, 2015, HIGHL PATH AS AV INF; Chambers BS, 2015, CELL REP, V12, P1, DOI 10.1016/j.celrep.2015.06.005; Feldman KA, 2001, NEW ENGL J MED, V345, P1601, DOI 10.1056/NEJMoa011374; Food and Drug Administration, 2014, CAUT US RAP TESTS DE; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Grilli E, 2012, J CLIN VIROL, V55, P356, DOI 10.1016/j.jcv.2012.08.010; Lee CS, 2011, J CLIN MICROBIOL, V49, P1702, DOI 10.1128/JCM.02247-10; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Mertz D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5061; Mills B, 2014, J INVEST MED HIGH IM, V2, DOI 10.1177/2324709614530560; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Morgan OW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009694; Reed C, 2014, CLIN INFECT DIS, V59, P166, DOI 10.1093/cid/ciu285; Runfola JK, 2015, MMWR-MORBID MORTAL W, V64, P429; Shah NS, 2015, INFECT CONT HOSP EP, V36, P1251, DOI 10.1017/ice.2015.170; TEUTSCH SM, 1979, NEW ENGL J MED, V301, P826, DOI 10.1056/NEJM197910113011507; Thompson M. G., 2010, Morbidity and Mortality Weekly Report, V59, P1057; Voirin N, 2009, J HOSP INFECT, V71, P1, DOI 10.1016/j.jhin.2008.08.013; Voore N, 2012, CAN MED ASSOC J, V184, P1924, DOI 10.1503/cmaj.111473; YELDANDI AV, 1994, HUM PATHOL, V25, P47, DOI 10.1016/0046-8177(94)90170-8	23	1	1	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 17	2015	373	25					2456	2466		10.1056/NEJMcpc1507212	http://dx.doi.org/10.1056/NEJMcpc1507212			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY5QD	26672848				2022-12-28	WOS:000366461400014
J	Tomer, R; Lovett-Barron, M; Kauvar, I; Andalman, A; Burns, VM; Sankaran, S; Grosenick, L; Broxton, M; Yang, S; Deisseroth, K				Tomer, Raju; Lovett-Barron, Matthew; Kauvar, Isaac; Andalman, Aaron; Burns, Vanessa M.; Sankaran, Sethuraman; Grosenick, Logan; Broxton, Michael; Yang, Samuel; Deisseroth, Karl			SPED Light Sheet Microscopy: Fast Mapping of Biological System Structure and Function	CELL			English	Article							ILLUMINATION; SCALE; RESOLUTION; NEOCORTEX	The goal of understanding living nervous systems has driven interest in high-speed and large field-of-view volumetric imaging at cellular resolution. Light sheet microscopy approaches have emerged for cellular-resolution functional brain imaging in small organisms such as larval zebrafish, but remain fundamentally limited in speed. Here, we have developed SPED light sheet microscopy, which combines large volumetric field-of-view via an extended depth of field with the optical sectioning of light sheet microscopy, thereby eliminating the need to physically scan detection objectives for volumetric imaging. SPED enables scanning of thousands of volumes-per-second, limited only by camera acquisition rate, through the harnessing of optical mechanisms that normally result in unwanted spherical aberrations. We demonstrate capabilities of SPED microscopy by performing fast sub-cellular resolution imaging of CLARITY mouse brains and cellular-resolution volumetric Ca2+ imaging of entire zebrafish nervous systems. Together, SPED light sheet methods enable high-speed cellular-resolution volumetric mapping of biological system structure and function.	[Tomer, Raju; Lovett-Barron, Matthew; Andalman, Aaron; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Tomer, Raju; Lovett-Barron, Matthew; Kauvar, Isaac; Andalman, Aaron; Burns, Vanessa M.; Sankaran, Sethuraman; Grosenick, Logan; Yang, Samuel; Deisseroth, Karl] Stanford Univ, CNC Program, Stanford, CA 94305 USA; [Kauvar, Isaac; Yang, Samuel] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Burns, Vanessa M.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Broxton, Michael] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu	Andalman, Aaron S/C-7694-2011	Yang, Samuel/0000-0003-2460-6456; Lovett-Barron, Matthew/0000-0003-1425-5277	Helen Hay Whitney Foundation; NSF-GRFP fellowship; DARPA Neuro-FAST program; NIMH; NIDA; NSF; Simons Foundation; Tarlton Foundation; Wiegers Family Fund; Nancy and James Grosfeld Foundation; H.L. Snyder Medical Foundation; Samuel and Betsy Reeves Fund	Helen Hay Whitney Foundation; NSF-GRFP fellowship(National Science Foundation (NSF)NSF - Office of the Director (OD)); DARPA Neuro-FAST program; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NSF(National Science Foundation (NSF)); Simons Foundation; Tarlton Foundation; Wiegers Family Fund; Nancy and James Grosfeld Foundation; H.L. Snyder Medical Foundation; Samuel and Betsy Reeves Fund	We thank the entire Deisseroth lab for thoughtful comments, with particular gratitude to Sean Quirin for initial advice on deconvolution and Ailey K. Crow for help with the initial bead sample preparation. M.L-B. and A.A. are supported by the Helen Hay Whitney Foundation. I.K. is supported by an NSF-GRFP fellowship. K.D. is supported by the DARPA Neuro-FAST program, NIMH, NIDA, NSF, the Simons Foundation, the Tarlton Foundation, the Wiegers Family Fund, the Nancy and James Grosfeld Foundation, the H.L. Snyder Medical Foundation, and the Samuel and Betsy Reeves Fund. We are grateful to Misha Ahrens for providing Tg(elavl3:H2B-GCaMP6s) fish, and we thank Philippe Mourrain and his lab, as well as Connie Lee, Alice Shi On Hong, and Nandini Pichamoorthy for assistance with zebrafish husbandry. COLM, SPED, CLARITY, and LFM protocols and software resources are freely available online at clarityresourcecenter.org.	Abrahamsson S, 2015, OPT EXPRESS, V23, P7734, DOI 10.1364/OE.23.007734; Abrahamsson S, 2013, NAT METHODS, V10, P60, DOI [10.1038/NMETH.2277, 10.1038/nmeth.2277]; Bouchard MB, 2015, NAT PHOTONICS, V9, P113, DOI [10.1038/NPHOTON.2014.323, 10.1038/nphoton.2014.323]; Broxton M, 2013, OPT EXPRESS, V21, P25418, DOI 10.1364/OE.21.025418; Chen F, 2015, SCIENCE, V347, P543, DOI 10.1126/science.1260088; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chhetri RK, 2015, NAT METHODS, V12, P1171, DOI 10.1038/nmeth.3632; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Cohen N, 2014, OPT EXPRESS, V22, P24817, DOI 10.1364/OE.22.024817; Deisseroth K, 2015, NAT NEUROSCI, V18, P1213, DOI 10.1038/nn.4091; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Dunsby C, 2008, OPT EXPRESS, V16, P20306, DOI 10.1364/OE.16.020306; Fahrbach FO, 2013, OPT EXPRESS, V21, P21010, DOI 10.1364/OE.21.021010; Freeman J, 2015, CURR OPIN NEUROBIOL, V32, P156, DOI 10.1016/j.conb.2015.04.002; Freeman J, 2014, NAT METHODS, V11, P941, DOI [10.1038/NMETH.3041, 10.1038/nmeth.3041]; Gao L, 2012, CELL, V151, P1370, DOI 10.1016/j.cell.2012.10.008; Grosenick L, 2009, I S BIOMED IMAGING, P1263, DOI 10.1109/ISBI.2009.5193292; Holekamp TF, 2008, NEURON, V57, P661, DOI 10.1016/j.neuron.2008.01.011; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Keller PJ, 2015, NAT METHODS, V12, P27, DOI 10.1038/nmeth.3214; Lemon WC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8924; Lerner TN, 2015, CELL, V162, P635, DOI 10.1016/j.cell.2015.07.014; Levoy M., 2006, P SIGGRAPH, V25; Lovett-Barron M, 2014, SCIENCE, V343, P857, DOI 10.1126/science.1247485; Panier T, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00065; Pitrone PG, 2013, NAT METHODS, V10, P598, DOI 10.1038/nmeth.2507; Planchon TA, 2011, NAT METHODS, V8, P417, DOI [10.1038/NMETH.1586, 10.1038/nmeth.1586]; Prevedel R, 2014, NAT METHODS, V11, P727, DOI [10.1038/NMETH.2964, 10.1038/nmeth.2964]; Quirin S, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00029; Quirin S, 2013, OPT EXPRESS, V21, P16007, DOI 10.1364/OE.21.016007; Rajasethupathy P, 2015, NATURE, V526, P653, DOI 10.1038/nature15389; Reynaud EG, 2015, NAT METHODS, V12, P30, DOI 10.1038/nmeth.3222; Stelzer EHK, 2015, NAT METHODS, V12, P23, DOI 10.1038/nmeth.3219; Tomer R, 2014, NAT PROTOC, V9, P1682, DOI 10.1038/nprot.2014.123; Viadimirov N, 2014, NAT METHODS, V11, P883, DOI 10.1038/nmeth.3040; Wolf S, 2015, NAT METHODS, V12, P379, DOI 10.1038/nmeth.3371; Wu YC, 2013, NAT BIOTECHNOL, V31, P1032, DOI 10.1038/nbt.2713; YUSTE R, 1991, NEURON, V6, P333, DOI 10.1016/0896-6273(91)90243-S	40	159	162	0	71	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2015	163	7					1796	1806		10.1016/j.cell.2015.11.061	http://dx.doi.org/10.1016/j.cell.2015.11.061			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CZ1GN	26687363	Bronze, Green Accepted			2022-12-28	WOS:000366854200024
J	Guarnizo-Herreno, CC; Tsakos, G; Sheiham, A; Marmot, MG; Kawachi, I; Watt, RG				Guarnizo-Herreno, Carol C.; Tsakos, Georgios; Sheiham, Aubrey; Marmot, Michael G.; Kawachi, Ichiro; Watt, Richard G.			CHRISTMAS 2015: FACE TIME Austin Powers bites back: a cross sectional comparison of US and English national oral health surveys	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SOCIOECONOMIC INEQUALITIES; UNITED-STATES; ADULTS; DISPARITIES; DISADVANTAGE	Objective To compare oral health in the US and England and to assess levels of educational and income related oral health inequalities between both countries. Design Cross sectional analysis of US and English national surveys. Setting Non-institutionalised adults living in their own homes. Participants Oral health measures and socioeconomic indicators were assessed in nationally representative samples: the Adult Dental Health Survey 2009 for England, and the US National Health and Nutrition Examination Survey 2005-08. Adults aged >= 25 years were included in analyses with samples of 8719 (England) and 9786 (US) for analyses by education, and 7184 (England) and 9094 (US) for analyses by income. Main outcome measures Number of missing teeth, self rated oral health, and oral impacts on daily life were outcomes. Educational attainment and household income were used as socioeconomic indicators. Age standardised estimates of oral health were compared between countries and across educational and income groups. Regression models were fitted, and relative and absolute inequalities were measured using the relative index of inequality (RII) and the slope index of inequality (SII). Results The mean number of missing teeth was significantly higher in the US (7.31 (standard error 0.15)) than in England (6.97 (0.09)), while oral impacts were higher in England. There was evidence of significant social gradients in oral health in both countries, although differences in oral health by socioeconomic position varied according to the oral health measure used. Consistently higher RII and SII values were found in the US than in England, particularly for self rated oral health. RII estimates for self rated oral health by education were 3.67 (95% confidence interval 3.23 to 4.17) in the US and 1.83 (1.59 to 2.11) in England. In turn, SII values were 42.55 (38.14 to 46.96) in the US and 18.43 (14.01 to 22.85) in England. Conclusions The oral health of US citizens is not better than the English, and there are consistently wider educational and income oral health inequalities in the US compared with England.	[Guarnizo-Herreno, Carol C.; Tsakos, Georgios; Sheiham, Aubrey; Marmot, Michael G.; Watt, Richard G.] UCL, Dept Epidemiol & Publ Hlth, London WC1E 7HB, England; [Guarnizo-Herreno, Carol C.] Univ Nacl Colombia, Fac Odontol, Dept Salud Colect, Bogota, Colombia; [Kawachi, Ichiro] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA	University of London; University College London; Universidad Nacional de Colombia; Harvard University; Harvard T.H. Chan School of Public Health	Guarnizo-Herreno, CC (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London WC1E 7HB, England.	c.guarnizo-herreno.11@ucl.ac.uk	Marmot, M G/Y-3920-2019	Marmot, M G/0000-0002-2431-6419; Tsakos, Georgios/0000-0002-5086-235X; Watt, Richard/0000-0001-6229-8584	ESRC [ES/F02679X/1] Funding Source: UKRI; MRC [G0902037, G0701830, G0601647, G1000616] Funding Source: UKRI; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Economic and Social Research Council [ES/F02679X/1] Funding Source: researchfish; Medical Research Council [G0701830, G0601647, G8802774, G19/35, G1000616, G0100222, G0902037] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		[Anonymous], 2013, IN INST MOB FAM LIF; [Anonymous], 1997, AUST POW SER; Avendano M, 2009, AM J PUBLIC HEALTH, V99, P540, DOI 10.2105/AJPH.2008.139469; Bambra C, 2009, J EPIDEMIOL COMMUN H, V63, P38, DOI 10.1136/jech.2007.070292; Banks J, 2006, JAMA-J AM MED ASSOC, V295, P2037, DOI 10.1001/jama.295.17.2037; Blinkhorn Anthony S, 2009, N S W Public Health Bull, V20, P52, DOI 10.1071/NB08067; Borrell LN, 2004, COMMUNITY DENT ORAL, V32, P363, DOI 10.1111/j.1600-0528.2004.00177.x; Borrell LN, 2011, COMMUNITY DENT ORAL, V39, P361, DOI 10.1111/j.1600-0528.2010.00603.x; Crocombe LA, 2009, AUST DENT J, V54, P147, DOI 10.1111/j.1834-7819.2009.01108.x; Dye BA, 2011, J PUBLIC HEALTH DENT, V71, P54, DOI 10.1111/j.1752-7325.2010.00202.x; Grumsen Stine, 2009, J Hist Dent, V57, P75; Guarnizo-Herreno CC, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-827; Huang DL, 2015, J PUBLIC HEALTH DENT, V75, P85, DOI 10.1111/jphd.12072; Hwang SS, 2011, MATERN CHILD HLTH J, V15, P722, DOI 10.1007/s10995-010-0643-2; Lantz PM, 2001, SOC SCI MED, V53, P29, DOI 10.1016/S0277-9536(00)00319-1; Locker D, 2009, J PUBLIC HEALTH DENT, V69, P1, DOI 10.1111/j.1752-7325.2008.00087.x; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1; Martinson ML, 2012, AM J PUBLIC HEALTH, V102, P2049, DOI 10.2105/AJPH.2012.300929; McDonough P, 2010, SOC SCI MED, V70, P251, DOI 10.1016/j.socscimed.2009.10.001; O'Sullivan I, 2011, FDN REPORT ADULT DEN; Robine JM, 2003, EUR J PUBLIC HEALTH, V13, P6, DOI 10.1093/eurpub/13.suppl_1.6; Sabbah W, 2009, SOC SCI MED, V68, P298, DOI 10.1016/j.socscimed.2008.10.030; Shelley D, 2011, J URBAN HEALTH, V88, P651, DOI 10.1007/s11524-011-9555-8; Slade GD, 2005, BRIT DENT J, V198, P489, DOI 10.1038/sj.bdj.4812252; Soe KK, COMMUNITY DENT HLTH; Springfield, 1993, SIMPSONS; Tartt D, 2013, THE GOLDFINCH; Tsakos G, 2011, AM J PUBLIC HEALTH, V101, P1892, DOI 10.2105/AJPH.2011.300215	29	15	15	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 16	2015	351								h6543	10.1136/bmj.h6543	http://dx.doi.org/10.1136/bmj.h6543			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CZ4MP	26676027	Green Published, hybrid			2022-12-28	WOS:000367077600008
J	Maki, DG				Maki, Dennis G.			Risk for septic arthritis was increased in adults with incident diagnosis of gout	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MONOARTHRITIS; JOINT		[Maki, Dennis G.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Maki, DG (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA.							GORDON C, 1989, ANN RHEUM DIS, V48, P737, DOI 10.1136/ard.48.9.737; Kim H, 2010, J CLIN LAB ANAL, V24, P175, DOI 10.1002/jcla.20384; Lenski M, 2014, CLIN BIOCHEM, V47, P49, DOI 10.1016/j.clinbiochem.2013.10.019; Ma LL, 2009, CAN MED ASSOC J, V180, P59, DOI 10.1503/cmaj.080183; Margaretten ME, 2007, JAMA-J AM MED ASSOC, V297, P1478, DOI 10.1001/jama.297.13.1478; Papanicolas LE, 2012, J RHEUMATOL, V39, P157, DOI 10.3899/jrheum.110368	6	1	2	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	2015	163	12							JC12	10.7326/ACPJC-2015-163-12-012	http://dx.doi.org/10.7326/ACPJC-2015-163-12-012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY4BS	26666802				2022-12-28	WOS:000366354200012
J	Stanbrook, MB				Stanbrook, Matthew B.			Review: Combination umeclidinium/vilanterol improved health status more than umeclidinium in COPD	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Stanbrook, Matthew B.] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University Health Network Toronto	Stanbrook, MB (corresponding author), Univ Toronto, Univ Hlth Network, Toronto, ON, Canada.							Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2015, GLOBAL STRATEGY DIAG; Rodrigo GJ, 2014, CHEST, V146, P309, DOI 10.1378/chest.13-2807	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	2015	163	12							JC10	10.7326/ACPJC-2015-163-12-010	http://dx.doi.org/10.7326/ACPJC-2015-163-12-010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY4BS	26666800				2022-12-28	WOS:000366354200010
J	Steinman, BA; Frankcombe, LM; Mann, ME; Miller, SK; England, MH				Steinman, B. A.; Frankcombe, L. M.; Mann, M. E.; Miller, S. K.; England, M. H.			Response to Comment on "Atlantic and Pacific multidecadal oscillations and Northern Hemisphere temperatures"	SCIENCE			English	Editorial Material							GLOBAL-WARMING SLOWDOWN; CLIMATE VARIABILITY; HIATUS	Kravtsov et al. claim that we incorrectly assess the statistical independence of simulated samples of internal climate variability and that we underestimate uncertainty in our calculations of observed internal variability. Their analysis is fundamentally flawed, owing to the use of model ensembles with too few realizations and the fact that no one model can adequately represent the forced signal.	[Steinman, B. A.] Univ Minnesota, Large Lakes Observ, Duluth, MN 55812 USA; [Steinman, B. A.] Univ Minnesota, Dept Earth & Environm Sci, Duluth, MN 55812 USA; [Frankcombe, L. M.; England, M. H.] Univ New S Wales, Australian Res Council Ctr Excellence Climate Sys, Sydney, NSW, Australia; [Frankcombe, L. M.; England, M. H.] Univ New S Wales, Climate Change Res Ctr, Sydney, NSW, Australia; [Mann, M. E.; Miller, S. K.] Penn State Univ, Dept Meteorol, University Pk, PA 16802 USA; [Mann, M. E.; Miller, S. K.] Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA	University of Minnesota System; University of Minnesota Duluth; University of Minnesota System; University of Minnesota Duluth; University of New South Wales Sydney; University of New South Wales Sydney; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Steinman, BA (corresponding author), Univ Minnesota, Large Lakes Observ, Duluth, MN 55812 USA.	bsteinma@d.umn.edu	Frankcombe, Leela M/C-7003-2012; Mann, Michael E/B-8472-2017; England, Matthew H/A-7539-2011	Frankcombe, Leela M/0000-0001-6578-3200; Mann, Michael E/0000-0003-3067-296X; England, Matthew H/0000-0001-9696-2930				Chen XY, 2014, SCIENCE, V345, P897, DOI 10.1126/science.1254937; Dai AG, 2015, NAT CLIM CHANGE, V5, P555, DOI 10.1038/nclimate2605; England MH, 2014, NAT CLIM CHANGE, V4, P222, DOI [10.1038/NCLIMATE2106, 10.1038/nclimate2106]; Frankcombe LM, 2015, J CLIMATE, V28, P8184, DOI 10.1175/JCLI-D-15-0069.1; Guemas V, 2013, NAT CLIM CHANGE, V3, P649, DOI [10.1038/nclimate1863, 10.1038/NCLIMATE1863]; Kosaka Y, 2013, NATURE, V501, P403, DOI 10.1038/nature12534; Kravtsov S, 2015, SCIENCE, V350, DOI 10.1126/science.aab3570; Mann ME, 2014, GEOPHYS RES LETT, V41, P3211, DOI 10.1002/2014GL059233; Meehl GA, 2013, J CLIMATE, V26, P7298, DOI 10.1175/JCLI-D-12-00548.1; Steinman BA, 2015, SCIENCE, V347, P988, DOI 10.1126/science.1257856; Trenberth KE, 2013, EARTHS FUTURE, V1, P19, DOI 10.1002/2013EF000165; Wyatt MG, 2012, CLIM DYNAM, V38, P929, DOI 10.1007/s00382-011-1071-8	12	11	12	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2015	350	6266								10.1126/science.aac5208	http://dx.doi.org/10.1126/science.aac5208			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1JL	26659049				2022-12-28	WOS:000366162400029
J	Compton, WM; Blanco, C; Wargo, EM				Compton, Wilson M.; Blanco, Carlos; Wargo, Eric M.			Integrating Addiction Services Into General Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Compton, Wilson M.; Blanco, Carlos; Wargo, Eric M.] NIDA, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Compton, WM (corresponding author), NIDA, NIH, 6001 Execut Blvd,MSC 9581, Bethesda, MD 20892 USA.	wcompton@nida.nih.gov	Blanco, Carlos/I-4906-2013	Blanco, Carlos/0000-0001-6187-3057				American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; [Anonymous], 2005, NIH PUB; Barry CL, 2011, NEW ENGL J MED, V365, P973, DOI 10.1056/NEJMp1108649; Blanco C, 2014, JAMA PSYCHIAT, V71, P1246, DOI 10.1001/jamapsychiatry.2014.1206; Grant BF, 2015, JAMA PSYCHIAT, V72, P757, DOI 10.1001/jamapsychiatry.2015.0584; McLellan AT, 2014, J SUBST ABUSE TREAT, V46, P541, DOI 10.1016/j.jsat.2014.02.001; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6	7	12	12	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 8	2015	314	22					2401	2402		10.1001/jama.2015.12741	http://dx.doi.org/10.1001/jama.2015.12741			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX8XT	26647261				2022-12-28	WOS:000365989100014
J	Khasnabis, C; Mirza, Z; MacLachlan, M				Khasnabis, Chapal; Mirza, Zafar; MacLachlan, Malcolm			Opening the GATE to inclusion for people with disabilities	LANCET			English	Editorial Material									[Khasnabis, Chapal] WHO, Publ Hlth Innovat & Intellectual Property Div, CH-1211 Geneva, Switzerland; [Mirza, Zafar] WHO, Publ Hlth Innovat & Intellectual Property Div, Dept Essential Medicines & Hlth Prod, CH-1211 Geneva, Switzerland; [Mirza, Zafar] WHO, Hlth Syst & Innovat Cluster, CH-1211 Geneva, Switzerland; [MacLachlan, Malcolm] Univ Dublin Trinity Coll, Ctr Global Hlth, Dublin D2, Ireland; [MacLachlan, Malcolm] Univ Dublin Trinity Coll, Sch Psychol, Dublin D2, Ireland; [MacLachlan, Malcolm] Univ Stellenbosch, Ctr Rehabil Studies, ZA-7600 Stellenbosch, South Africa	World Health Organization; World Health Organization; World Health Organization; Trinity College Dublin; Trinity College Dublin; Stellenbosch University	MacLachlan, M (corresponding author), Univ Dublin Trinity Coll, Ctr Global Hlth, Dublin D2, Ireland.	malcolm.maclachlan@tcd.ie	Khasnabis, Chapal/ABH-3391-2021		World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Cook A., 2015, ASSISTIVE TECHNOLOGI; Evans Joanna, 2015, Human-Computer Interaction. Interaction Technologies. 17th International Conference, HCI International 2015. Proceedings: LNCS 9170, P406, DOI 10.1007/978-3-319-20916-6_38; Harniss M, 2015, DISABIL REHABIL-ASSI, V10, P267, DOI 10.3109/17483107.2015.1039607; Kar Sitanshu Sekhar, 2010, Indian J Community Med, V35, P10, DOI 10.4103/0970-0218.62546; MacLachlan M, 2009, DISABILITY & INTERNATIONAL DEVELOPMENT: TOWARDS INCLUSIVE GLOBAL HEALTH, P1, DOI 10.1007/978-0-387-93840-0; MacLachlan M, 2014, AM PSYCHOL, V69, P851, DOI 10.1037/a0037852; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; WHO, 2011, WORLD REPORT ON DISABILITY, P1; World Health Organization, 2015, WHO MOD LIST ESS MED; World Health Organization, ASS DEV TECHN WHAT W; World Health Organization, WHO GLOB DIS ACT PLA	11	63	64	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 5	2015	386	10010					2229	2230		10.1016/S0140-6736(15)01093-4	http://dx.doi.org/10.1016/S0140-6736(15)01093-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CX8ZB	26681277	Green Accepted			2022-12-28	WOS:000365993200007
J	Islam, R; Ma, RC; Preiss, PM; Tai, ME; Lukin, A; Rispoli, M; Greiner, M				Islam, Rajibul; Ma, Ruichao; Preiss, Philipp M.; Tai, M. Eric; Lukin, Alexander; Rispoli, Matthew; Greiner, Markus			Measuring entanglement entropy in a quantum many-body system	NATURE			English	Article							TRAPPED IONS; STATES; INTERFERENCE; SIMULATIONS	Entanglement is one of the most intriguing features of quantum mechanics. It describes non-local correlations between quantum objects, and is at the heart of quantum information sciences. Entanglement is now being studied in diverse fields ranging from condensed matter to quantum gravity. However, measuring entanglement remains a challenge. This is especially so in systems of interacting delocalized particles, for which a direct experimental measurement of spatial entanglement has been elusive. Here, we measure entanglement in such a system of itinerant particles using quantum interference of many-body twins. Making use of our single-site-resolved control of ultracold bosonic atoms in optical lattices, we prepare two identical copies of a many-body state and interfere them. This enables us to directly measure quantum purity, Renyi entanglement entropy, and mutual information. These experiments pave the way for using entanglement to characterize quantum phases and dynamics of strongly correlated many-body systems.	[Islam, Rajibul; Ma, Ruichao; Preiss, Philipp M.; Tai, M. Eric; Lukin, Alexander; Rispoli, Matthew; Greiner, Markus] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University	Greiner, M (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	greiner@physics.harvard.edu	Ma, Ruichao/P-3604-2014	Ma, Ruichao/0000-0003-4516-874X	Gordon Foundation EPiQS Initiative [GBMF3795]; Betty Moore Foundation EPiQS Initiative [GBMF3795]; NSF through the Center for Ultracold Atoms; Army Research Office; DARPA OLE programme; MURI programme; Air Force Office of Scientific Research MURI programme; NSF Graduate Research Fellowship; Direct For Mathematical & Physical Scien [1125846] Funding Source: National Science Foundation	Gordon Foundation EPiQS Initiative; Betty Moore Foundation EPiQS Initiative; NSF through the Center for Ultracold Atoms; Army Research Office; DARPA OLE programme; MURI programme; Air Force Office of Scientific Research MURI programme; NSF Graduate Research Fellowship(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank D. Abanin, J. I. Cirac, M. Cramer, A. Daley, A. DelMaestro, E. Demler, M. Endres, S. Gopalakrishnan, M. Headrick, A. Kaufman, M. Knap, T. Monz, A. Pal, H. Pichler, S. Sachdev, B. Swingle, P. Zoller, and M. Zwierlein for useful discussions. This work was supported by grants from the Gordon and Betty Moore Foundations EPiQS Initiative (grant GBMF3795), the NSF through the Center for Ultracold Atoms, the Army Research Office with funding from the DARPA OLE programme and a MURI programme, an Air Force Office of Scientific Research MURI programme, and an NSF Graduate Research Fellowship (to M.R.).	Alves CM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.110501; Amico L, 2008, REV MOD PHYS, V80, P517, DOI 10.1103/RevModPhys.80.517; Aspect A, 1999, NATURE, V398, P189, DOI 10.1038/18296; Aspuru-Guzik A, 2012, NAT PHYS, V8, P285, DOI [10.1038/NPHYS2253, 10.1038/nphys2253]; Bakr WS, 2010, SCIENCE, V329, P547, DOI 10.1126/science.1192368; Bardarson JH, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.017202; Bartlett SD, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.097903; Bloch I, 2012, NAT PHYS, V8, P267, DOI [10.1038/nphys2259, 10.1038/NPHYS2259]; Bouwmeester D, 1999, PHYS REV LETT, V82, P1345, DOI 10.1103/PhysRevLett.82.1345; Bovino FA, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.240407; Brun TA, 2004, QUANTUM INFORM COMPU, V4, P401; Calabrese P, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/50/504005; Cramer M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3161; Daley AJ, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.020505; Eisert J, 2010, REV MOD PHYS, V82, P277, DOI 10.1103/RevModPhys.82.277; Ekert AK, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.217901; Fukuhara T, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.035302; Guhne O, 2009, PHYS REP, V474, P1, DOI 10.1016/j.physrep.2009.02.004; Haffner H, 2005, NATURE, V438, P643, DOI 10.1038/nature04279; HONG CK, 1987, PHYS REV LETT, V59, P2044, DOI 10.1103/PhysRevLett.59.2044; Horodecki R, 1996, PHYS REV A, V54, P1838, DOI 10.1103/PhysRevA.54.1838; Horodecki R, 2009, REV MOD PHYS, V81, P865, DOI 10.1103/RevModPhys.81.865; Houck AA, 2012, NAT PHYS, V8, P292, DOI [10.1038/nphys2251, 10.1038/NPHYS2251]; Isakov SV, 2011, NAT PHYS, V7, P772, DOI 10.1038/nphys2036; James DFV, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.052312; Jiang HC, 2012, NAT PHYS, V8, P902, DOI [10.1038/nphys2465, 10.1038/NPHYS2465]; Kaufman AM, 2014, SCIENCE, V345, P306, DOI 10.1126/science.1250057; Li H, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.010504; Lopes R, 2015, NATURE, V520, P66, DOI 10.1038/nature14331; Mintert F, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.140505; Nielsen, 2010, QUANTUM COMPUTATION; Nishioka T, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/50/504008; Palmer RN, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.042335; Pan JW, 2012, REV MOD PHYS, V84, DOI 10.1103/RevModPhys.84.777; Pichler H, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/6/063003; Rigol M, 2008, NATURE, V452, P854, DOI 10.1038/nature06838; Schmid C, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.260505; Schuch N, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.087904; Schuch N, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.030504; Terhal BM, 2001, PHYS REV LETT, V86, P5807, DOI 10.1103/PhysRevLett.86.5807; Trotzky S, 2012, NAT PHYS, V8, P325, DOI [10.1038/nphys2232, 10.1038/NPHYS2232]; Trotzky S, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.265303; Vidal G, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.040502; Vidal G, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.227902; Walborn SP, 2006, NATURE, V440, P1022, DOI 10.1038/nature04627; Wolf MM, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.070502; Zanardi P, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.031123; Zhang Y, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.067202	51	637	640	11	132	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					77	83		10.1038/nature15750	http://dx.doi.org/10.1038/nature15750			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX3NO	26632587	Green Submitted			2022-12-28	WOS:000365606000051
J	Nouvellet, P; Garske, T; Mills, HL; Nedjati-Gilani, G; Hinsley, W; Blake, IM; Van Kerkhove, MD; Cori, A; Dorigatti, I; Jombart, T; Riley, S; Fraser, C; Donnelly, CA; Ferguson, NM				Nouvellet, Pierre; Garske, Tini; Mills, Harriet L.; Nedjati-Gilani, Gemma; Hinsley, Wes; Blake, Isobel M.; Van Kerkhove, Maria D.; Cori, Anne; Dorigatti, Ilaria; Jombart, Thibaut; Riley, Steven; Fraser, Christophe; Donnelly, Christl A.; Ferguson, Neil M.			The role of rapid diagnostics in managing Ebola epidemics	NATURE			English	Article							VIRUS DISEASE; INFECTION	Ebola emerged in West Africa around December 2013 and swept through Guinea, Sierra Leone and Liberia, giving rise to 27,748 confirmed, probable and suspected cases reported by 29 July 2015. Case diagnoses during the epidemic have relied on polymerase chain reaction-based tests. Owing to limited laboratory capacity and local transport infrastructure, the delays from sample collection to test results being available have often been 2 days or more. Point-of-care rapid diagnostic tests offer the potential to substantially reduce these delays. We review Ebola rapid diagnostic tests approved by the World Health Organization and those currently in development. Such rapid diagnostic tests could allow early triaging of patients, thereby reducing the potential for nosocomial transmission. In addition, despite the lower test accuracy, rapid diagnostic test-based diagnosis may be beneficial in some contexts because of the reduced time spent by uninfected individuals in health-care settings where they may be at increased risk of infection; this also frees up hospital beds. We use mathematical modelling to explore the potential benefits of diagnostic testing strategies involving rapid diagnostic tests alone and in combination with polymerase chain reaction testing. Our analysis indicates that the use of rapid diagnostic tests with sensitivity and specificity comparable with those currently under development always enhances control, whether evaluated at a health-care-unit or population level. If such tests had been available throughout the recent epidemic, we estimate, for Sierra Leone, that their use in combination with confirmatory polymerase chain-reaction testing might have reduced the scale of the epidemic by over a third.	[Nouvellet, Pierre; Garske, Tini; Mills, Harriet L.; Nedjati-Gilani, Gemma; Hinsley, Wes; Blake, Isobel M.; Van Kerkhove, Maria D.; Cori, Anne; Dorigatti, Ilaria; Jombart, Thibaut; Riley, Steven; Fraser, Christophe; Donnelly, Christl A.; Ferguson, Neil M.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London W2 1PG, England; [Van Kerkhove, Maria D.] Inst Pasteur, Ctr Global Hlth, F-75724 Paris 15, France	Imperial College London; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Ferguson, NM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, Norfolk Pl, London W2 1PG, England.	neil.ferguson@imperial.ac.uk	Fraser, Christophe/A-8109-2008; Ferguson, Neil/B-8578-2008; Cori, Anne/AFL-1641-2022	Fraser, Christophe/0000-0003-2399-9657; Ferguson, Neil/0000-0002-1154-8093; Cori, Anne/0000-0002-8443-9162; Riley, Steven/0000-0001-7904-4804; Dorigatti, Ilaria/0000-0001-9959-0706; nouvellet, pierre/0000-0002-6094-5722; Blake, Isobel/0000-0002-3977-1318; Van Kerkhove, Maria/0000-0002-6135-0018	Medical Research Council; Bill and Melinda Gates Foundation; MIDAS network of the National Institute of General Medical Sciences (National Institutes of Health); Health Protection Research Units of the National Institute for Health Research; European Union [278433-PREDEMICS]; Wellcome Trust; Medical Research Council [MR/K010174/1, MR/K010174/1B, G0600719B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10252, HPRU-2012-10080, NF-SI-0513-10125] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM110721] Funding Source: NIH RePORTER; MRC [MR/K010174/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); MIDAS network of the National Institute of General Medical Sciences (National Institutes of Health); Health Protection Research Units of the National Institute for Health Research; European Union(European Commission); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank J.-C. Manuguerra for sharing preliminary results on the effectiveness of the REVAMP RDT and L. Simonsen for early discussions. We furthermore acknowledge research funding from the Medical Research Council, the Bill and Melinda Gates Foundation, the MIDAS network of the National Institute of General Medical Sciences (National Institutes of Health), the Health Protection Research Units of the National Institute for Health Research, the European Union Seventh Framework Programme [FP7/2007-2013] under Grant Agreement no 278433-PREDEMICS, and the Wellcome Trust.	Altona Diagnostics, 2014, REALSTAR FIL SCREEN; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Bhadelia N, 2015, LANCET, V386, P833, DOI 10.1016/S0140-6736(15)61119-9; Broadhurst MJ, 2015, LANCET, V386, P867, DOI 10.1016/S0140-6736(15)61042-X; Cepheid, 2015, CEPH XPERT EB ASS; Chua AC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003734; Corgenix, 2015, REEBOV ANT RAP TEST; Food and Drug Administration, 2014, EB VIR EM US AUTH; Manuguerra J.-C., 2015, P 3 INT C TARG INF D; National Center for Emerging and Zoonotic Infectious Diseases CDC, 2015, LASS FEV; Pathmanathan I, 2014, MMWR-MORBID MORTAL W, V63, P1172; Pigott DM, 2014, ELIFE, V3, DOI [10.7554/eLife.02851, 10.7554/eLife.04395]; Saijo M, 2006, CLIN VACCINE IMMUNOL, V13, P444, DOI 10.1128/CVI.13.4.444-451.2006; Strecker T, 2015, CLIN INFECT DIS, V61, P669, DOI 10.1093/cid/civ397; Towner JS, 2004, J VIROL, V78, P4330, DOI 10.1128/JVI.78.8.4330-4341.2004; WHO, 2015, EB SIT REP; WHO Ebola Response Team, 2015, NEW ENGL J MED, V372, P584, DOI 10.1056/NEJMc1414992; World Health Organization, 2015, WHO EM US ASS LIST P; World Health Organization, 2014, EB SIT REP; World Health Organization, 2015, WHO EM QUAL ASS MECH; World Health Organization, 2014, LAB DIAGN EB VIR DIS; World Health Organization, 2015, WHO EM US ASS LIST E; Zachariah R, 2015, LANCET INFECT DIS, V15, P989, DOI 10.1016/S1473-3099(15)00160-7	23	72	75	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					S109	S116		10.1038/nature16041	http://dx.doi.org/10.1038/nature16041			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX3NO	26633764	Green Accepted, Green Submitted, hybrid			2022-12-28	WOS:000365606000018
J	Sharma, M; Ying, R; Tarr, G; Barnabas, R				Sharma, Monisha; Ying, Roger; Tarr, Gillian; Barnabas, Ruanne			Systematic review and meta-analysis of community and facility-based HIV testing to address linkage to care gaps in sub-Saharan Africa	NATURE			English	Review							FEMALE SEX WORKERS; CLUSTER-RANDOMIZED-TRIAL; NIMH PROJECT ACCEPT; ANTIRETROVIRAL THERAPY INITIATION; SOUTH-AFRICA; CAPE-TOWN; COST-EFFECTIVENESS; HEALTH FACILITIES; CLIENT CHARACTERISTICS; INTERVENTION TRIAL	HIV testing and counselling is the first crucial step for linkage to HIV treatment and prevention. However, despite high HIV burden in sub-Saharan Africa, testing coverage is low, particularly among young adults and men. Community-based HIV testing and counselling (testing outside of health facilities) has the potential to reduce coverage gaps, but the relative impact of different modalities is not well assessed. We conducted a systematic review of HIV testing modalities, characterizing community (home, mobile, index, key populations, campaign, workplace and self-testing) and facility approaches by population reached, HIV positivity, CD4 count at diagnosis and linkage. Of 2,520 abstracts screened, 126 met eligibility criteria. Community HIV testing and counselling had high coverage and uptake and identified HIV-positive people at higher CD4 counts than facility testing. Mobile HIV testing reached the highest proportion of men of all modalities examined (50%, 95% confidence interval (CI) = 47-54%) and home with self-testing reached the highest proportion of young adults (66%, 95% CI = 65-67%). Few studies evaluated HIV testing for key populations (commercial sex workers and men who have sex with men), but these interventions yielded high HIV positivity (38%, 95% CI = 19-62%) combined with the highest proportion of first-time testers (78%, 95% CI = 63-88%), indicating service gaps. Community testing with facilitated linkage (for example, counsellor follow-up to support linkage) achieved high linkage to care (95%, 95% CI = 87-98%) and antiretroviral initiation (75%, 95% CI = 68-82%). Expanding home and mobile testing, self-testing and outreach to key populations with facilitated linkage can increase the proportion of men, young adults and high-risk individuals linked to HIV treatment and prevention, and decrease HIV burden.	[Sharma, Monisha; Tarr, Gillian; Barnabas, Ruanne] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Ying, Roger; Barnabas, Ruanne] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Barnabas, Ruanne] Univ Washington, Sch Med, Seattle, WA 98105 USA; [Barnabas, Ruanne] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Sharma, M (corresponding author), Univ Washington, Dept Epidemiol, 1959 NE Pacific St, Seattle, WA 98195 USA.	msharma04@gmail.com		Tarr, Gillian/0000-0001-7372-1034	Bill & Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007140] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors declare no competing financial interests. Financial support for this publication has been provided by the Bill & Melinda Gates Foundation.	Abdallah Tajeldin M, 2012, J Infect Public Health, V5, P63, DOI 10.1016/j.jiph.2011.10.001; Abdurahman S, 2015, HIV AIDS-RES PALLIAT, V7, P157, DOI 10.2147/HIV.S81649; Adebajo S., 2015, SEX TRANSM INFECT; Agaba PA, 2014, HIV MED, V15, P396, DOI 10.1111/hiv.12125; Ahmed S, 2013, AIDS CARE, V25, P85, DOI 10.1080/09540121.2012.686597; Akhigbe Roland E, 2013, J Nat Sci Biol Med, V4, P163, DOI 10.4103/0976-9668.107283; Aliyu HB, 2012, JAIDS-J ACQ IMM DEF, V61, P221, DOI 10.1097/QAI.0b013e3182683b04; Angotti N, 2009, SOC SCI MED, V68, P2263, DOI 10.1016/j.socscimed.2009.02.041; Ansa GA, 2014, T ROY SOC TROP MED H, V108, P560, DOI 10.1093/trstmh/tru110; Appiah LT, 2009, AIDS PATIENT CARE ST, V23, P365, DOI 10.1089/apc.2008.0224; Arendt V, 2007, TROP DOCT, V37, P45, DOI 10.1258/004947507779951899; Armbruster B, 2011, JAIDS-J ACQ IMM DEF, V58, pE29, DOI 10.1097/QAI.0b013e31822a9fa8; Arthur GR, 2005, JAIDS-J ACQ IMM DEF, V40, P329, DOI 10.1097/01.qai.0000166376.23846.38; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Barnabas RV, 2014, LANCET HIV, V1, pE68, DOI 10.1016/S2352-3018(14)70024-4; Bassett IV, 2014, HIV MED, V15, P367, DOI 10.1111/hiv.12115; Bassett IV, 2007, JAIDS-J ACQ IMM DEF, V46, P181, DOI 10.1097/QAI.0b013e31814277c8; Bassett IV, 2015, AIDS BEHAV, V19, P1888, DOI 10.1007/s10461-015-1012-3; Bassett IV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085197; Bekker LG, 2015, LANCET, V385, P72, DOI 10.1016/S0140-6736(14)60974-0; Bemelmans M, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-1; Bigogo G, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-376; Bondo M, 2001, East Afr Med J, V78, P395; Brown LB, 2011, JAIDS-J ACQ IMM DEF, V56, P437, DOI 10.1097/QAI.0b013e318202bf7d; Bwambale FM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-263; Cawley C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062212; Chamie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084317; Charurat ME, 2015, JAIDS-J ACQ IMM DEF, V68, pS114, DOI 10.1097/QAI.0000000000000439; Cherutich P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036797; Chirawu P, 2010, AIDS CARE, V22, P81, DOI 10.1080/09540120903012577; Choko AT, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001873; Choko AT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001102; Clouse K, 2014, TROP MED INT HEALTH, V19, P1411, DOI 10.1111/tmi.12387; Coates TJ, 2014, LANCET GLOB HEALTH, V2, pE267, DOI 10.1016/S2214-109X(14)70032-4; Corbett EL, 2007, AIDS, V21, P483, DOI 10.1097/QAD.0b013e3280115402; Corbett EL, 2006, PLOS MED, V3, P1005, DOI 10.1371/journal.pmed.0030238; Cornell M, 2011, TROP MED INT HEALTH, V16, P828, DOI 10.1111/j.1365-3156.2011.02767.x; Creek TL, 2006, JAIDS-J ACQ IMM DEF, V43, P210, DOI 10.1097/01.qai.0000230525.71717.5d; Dalal S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027293; Dalal W, 2013, JAIDS-J ACQ IMM DEF, V62, pE47, DOI 10.1097/QAI.0b013e318276bea0; Doherty T, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3481; Duvall S, 2015, JAIDS-J ACQ IMM DEF, V68, pS189, DOI 10.1097/QAI.0000000000000450; Fetene NW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-362; Figueroa C, 2015, AIDS BEHAV, V19, P1949, DOI 10.1007/s10461-015-1097-8; Fiscus SA, 2007, J INFECT DIS, V195, P416, DOI 10.1086/510755; Forsythe S, 2002, HEALTH POLICY PLANN, V17, P187, DOI 10.1093/heapol/17.2.187; Fylkesnes K, 2004, TROP MED INT HEALTH, V9, P566, DOI 10.1111/j.1365-3156.2004.01231.x; Fylkesnes K, 2013, SOC SCI MED, V86, P9, DOI 10.1016/j.socscimed.2013.02.036; Genberg BL, 2015, LANCET HIV, V2, pE20, DOI 10.1016/S2352-3018(14)00034-4; Gonzalez R, 2012, HIV MED, V13, P581, DOI 10.1111/j.1468-1293.2012.01018.x; Govender S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090754; Govindasamy D, 2011, JAIDS-J ACQ IMM DEF, V58, P344, DOI 10.1097/QAI.0b013e31822e0c4c; Grabbe KL, 2010, JAIDS-J ACQ IMM DEF, V54, P317, DOI 10.1097/QAI.0b013e3181ced126; Granich R, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/412643; Gresenguet G, 2002, JAIDS-J ACQ IMM DEF, V31, P106, DOI 10.1097/00126334-200209010-00014; Haskew J, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1367-4; Hausler HP, 2006, B WORLD HEALTH ORGAN, V84, P528, DOI 10.2471/BLT.04.018606; Helleringer S, 2009, JAIDS-J ACQ IMM DEF, V51, P185, DOI 10.1097/QAI.0b013e31819c1726; Hensen B, 2015, AIDS BEHAV, V19, P492, DOI 10.1007/s10461-014-0866-0; Hoffmann CJ, 2011, JAIDS-J ACQ IMM DEF, V58, P269, DOI 10.1097/QAI.0b013e31823219d1; Hood JE, 2012, AIDS BEHAV, V16, P1902, DOI 10.1007/s10461-012-0253-7; Isingo R, 2012, TROP MED INT HEALTH, V17, pe15, DOI 10.1111/j.1365-3156.2011.02877.x; Iwuji CC, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-230; Kahn JG, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-346; Kalibala S, 2014, AIDS BEHAV, V18, pS405, DOI 10.1007/s10461-014-0830-z; Kayigamba FR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095459; Kharsany ABM, 2010, AIDS CARE, V22, P533, DOI 10.1080/09540120903254005; Kiene SM, 2010, AIDS PATIENT CARE ST, V24, P117, DOI 10.1089/apc.2009.0269; Kikaya V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083614; Kimaiyo S, 2010, East Afr Med J, V87, P100; Kouassi-M'Bengue A., 2011, ASIAN PACIFIC J TROP, V1, P275; Kranzer K, 2012, HIV MED, V13, P132, DOI 10.1111/j.1468-1293.2011.00947.x; Kranzer K, 2008, TROP MED INT HEALTH, V13, P1341, DOI 10.1111/j.1365-3156.2008.02148.x; Kranzer K, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17383; Kurth AE, 2015, J INT AIDS SOC, V18, P23, DOI 10.7448/IAS.18.2.19433; Labhardt ND, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001768; LaCourse SM, 2015, JAIDS-J ACQ IMM DEF, V69, pE31, DOI 10.1097/QAI.0000000000000542; Larson BA, 2012, JAIDS-J ACQ IMM DEF, V61, pE13, DOI 10.1097/QAI.0b013e31825eec60; Larson BA, 2010, B WORLD HEALTH ORGAN, V88, P675, DOI 10.2471/BLT.09.068981; Leblanc NM, 2015, J ASSOC NURSE AIDS C, V26, P281, DOI 10.1016/j.jana.2014.09.006; Leon N, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-350; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lugada E, 2010, JAIDS-J ACQ IMM DEF, V55, P245, DOI 10.1097/QAI.0b013e3181e9e069; Lugada E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012435; Mabuto T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102267; MacPherson P, 2015, TROP MED INT HEALTH, V20, P1015, DOI 10.1111/tmi.12517; MacPherson P, 2014, JAMA-J AM MED ASSOC, V312, P372, DOI 10.1001/jama.2014.6493; MacPherson P, 2012, TROP MED INT HEALTH, V17, P507, DOI 10.1111/j.1365-3156.2011.02946.x; Maheswaran H, 2012, JAIDS-J ACQ IMM DEF, V59, pE43, DOI 10.1097/QAI.0b013e3182414ed7; McConnel CE, 2005, SAMJ S AFR MED J, V95, P968; Medley A, 2013, AIDS BEHAV, V17, P224, DOI 10.1007/s10461-012-0344-5; Meehan SA, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0658-2; Menzies N, 2009, AIDS, V23, P395, DOI 10.1097/QAD.0b013e328321e40b; Michelo C, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-279; Mine M, 2015, JAIDS-J ACQ IMM DEF, V68, P365, DOI 10.1097/QAI.0000000000000434; Mirkuzie AH, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-196; Molesworth AM, 2010, JAIDS-J ACQ IMM DEF, V55, P625, DOI 10.1097/QAI.0b013e3181f98628; Moodley J, 2014, SAJOG-S AFR J OBSTET, V20, P8, DOI 10.7196/SAJOG.603; Morin SF, 2006, JAIDS-J ACQ IMM DEF, V41, P218, DOI 10.1097/01.qai.0000179455.01068.ab; Mulogo EM, 2013, AFR HEALTH SCI, V13, P423, DOI 10.4314/ahs.v13i2.32; Mulogo EM, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-54; Mulongo S, 2015, JAIDS-J ACQ IMM DEF, V68, pS248, DOI 10.1097/QAI.0000000000000449; Musheke M, 2013, BMC PUBLIC HEALTH, V13, DOI [10.1186/1471-2458-13-220, 10.1186/1472-6963-13-97]; Mutale W, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-347; Mwangi Mary, 2014, Open AIDS J, V8, P7, DOI 10.2174/1874613601408010007; Naik R, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19843; Naik R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-824; Negin J, 2009, TROP MED INT HEALTH, V14, P849, DOI 10.1111/j.1365-3156.2009.02304.x; Ng'ang'a A, 2014, JAIDS-J ACQ IMM DEF, V66, pS27, DOI 10.1097/QAI.0000000000000102; Nglazi MD, 2012, JAIDS-J ACQ IMM DEF, V59, pE28, DOI 10.1097/QAI.0b013e31824445f0; Novitsky V, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19918; Nsanzimana S, 2015, LANCET HIV, V2, pE208, DOI 10.1016/S2352-3018(15)00024-7; Nyblade LC, 2001, J ACQ IMMUN DEF SYND, V28, P463, DOI 10.1097/00042560-200112150-00010; Nyigo V, 2014, HIV AIDS-RES PALLIAT, V6, P75, DOI 10.2147/HIV.S54610; O'Laughlin KN, 2014, JAIDS-J ACQ IMM DEF, V67, P409, DOI 10.1097/QAI.0000000000000317; Obure CD, 2012, SEX TRANSM INFECT, V88, P498, DOI 10.1136/sextrans-2012-050544; Pai NP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079772; Parker LA, 2015, TROP MED INT HEALTH, V20, P893, DOI 10.1111/tmi.12501; Paulin HN, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1388-z; Rhodes SD, 2010, AIDS EDUC PREV, V22, P173, DOI 10.1521/aeap.2010.22.3.173; Rosenberg NE, 2013, AIDS, V27, P2765, DOI 10.1097/01.aids.0000432454.68357.6a; Sabapathy K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001351; Sekandi JN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-730; Shapiro AE, 2012, AM J RESP CRIT CARE, V185, P1110, DOI 10.1164/rccm.201111-1941OC; Shisana O, 2004, SAMJ S AFR MED J, V94, P283; Siedner MJ, 2015, CLIN INFECT DIS, V60, P1120, DOI 10.1093/cid/ciu1137; Silvestri DM, 2011, JAIDS-J ACQ IMM DEF, V56, pE9, DOI 10.1097/QAI.0b013e3181fdb629; Stover J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111956; Suthar AB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001496; Sweat M, 2000, LANCET, V356, P113, DOI 10.1016/S0140-6736(00)02447-8; Sweat M, 2011, LANCET INFECT DIS, V11, P525, DOI 10.1016/S1473-3099(11)70060-3; Tchendjou PT, 2011, JAIDS-J ACQ IMM DEF, V57, pS9, DOI 10.1097/QAI.0b013e31821ec6e2; Terris-Prestholt F, 2006, SEX TRANSM DIS, V33, pS111, DOI 10.1097/01.olq.0000175389.10289.ba; Thielman NM, 2006, AM J PUBLIC HEALTH, V96, P114, DOI 10.2105/AJPH.2004.056796; Topp Stephanie M, 2012, J Int AIDS Soc, V15, P17352, DOI 10.7448/IAS.15.2.17352; Topp SM, 2011, B WORLD HEALTH ORGAN, V89, P328, DOI 10.2471/BLT.10.084442; Tumwebaze H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051620; Tumwesigye E, 2010, AIDS PATIENT CARE ST, V24, P735, DOI 10.1089/apc.2010.0096; UNAIDS, 2014, FAST TRACK ENDING TH; UNAIDS, 2015, THE GAP REPORT; UNICEF, 2012, UGANDA FAST FACTS; Uwimana J, 2012, TROP MED INT HEALTH, V17, P488, DOI 10.1111/j.1365-3156.2011.02951.x; Van der Borght SF, 2010, AIDS CARE, V22, P195, DOI 10.1080/09540120903111486; Van Rie A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105428; van Rooyen H, 2013, AIDS BEHAV, V17, P2946, DOI 10.1007/s10461-012-0368-x; van Rooyen H, 2013, JAIDS-J ACQ IMM DEF, V64, pE1, DOI 10.1097/QAI.0b013e31829b567d; van Schaik N, 2010, SAMJ S AFR MED J, V100, P671, DOI 10.7196/SAMJ.4162; van Zyl MA, 2015, AIDS CARE, V27, P921, DOI 10.1080/09540121.2015.1015483; Wachira J, 2014, JAIDS-J ACQ IMM DEF, V65, pE58, DOI 10.1097/QAI.0b013e3182a14f9e; Wachira J, 2012, CLIN INFECT DIS, V54, P275, DOI 10.1093/cid/cir789; Wanyenze RK, 2008, B WORLD HEALTH ORGAN, V86, P302, DOI 10.2471/BLT.07.042580; Waxman MJ, 2007, AIDS PATIENT CARE ST, V21, P981, DOI 10.1089/apc.2007.0075; Welz T, 2007, AIDS, V21, P1467, DOI 10.1097/QAD.0b013e3280ef6af2; Wheeler T, 2015, JAIDS-J ACQ IMM DEF, V68, pS69, DOI 10.1097/QAI.0000000000000534; Wolff B, 2005, HEALTH POLICY PLANN, V20, P109, DOI 10.1093/heapol/czi013; World Health Organization, 2015, CONSOLIDATED GUIDELI	157	328	330	8	53	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					S77	S85		10.1038/nature16044	http://dx.doi.org/10.1038/nature16044			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX3NO	26633769	hybrid, Green Accepted			2022-12-28	WOS:000365606000014
J	Levine, JM				Levine, Jonathan M.			A trail map for trait-based studies	NATURE			English	Editorial Material							FUNCTIONAL TRAITS; COEXISTENCE; COMMUNITY		[Levine, Jonathan M.] ETH, Inst Integrat Biol, Dept Environm Syst Sci, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Levine, JM (corresponding author), ETH, Inst Integrat Biol, Dept Environm Syst Sci, CH-8092 Zurich, Switzerland.	jlevine@ethz.ch	Levine, Jonathan/A-7167-2014	Levine, Jonathan/0000-0003-2857-7904				Ackerly DD, 2007, ECOL LETT, V10, P135, DOI 10.1111/j.1461-0248.2006.01006.x; Adler PB, 2013, ECOL LETT, V16, P1294, DOI 10.1111/ele.12157; Alexander JM, 2015, NATURE, V525, P515, DOI 10.1038/nature14952; Diaz S, 2016, NATURE, V529, P167, DOI 10.1038/nature16489; Kattge J, 2011, GLOBAL CHANGE BIOL, V17, P2905, DOI 10.1111/j.1365-2486.2011.02451.x; Kraft NJB, 2015, P NATL ACAD SCI USA, V112, P797, DOI 10.1073/pnas.1413650112; Kunstler G, 2016, NATURE, V529, P204, DOI 10.1038/nature16476; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403	10	30	32	4	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 14	2016	529	7585					163	164		10.1038/nature16862	http://dx.doi.org/10.1038/nature16862			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA7WK	26700809				2022-12-28	WOS:000368015700025
J	von Moltke, J; Ji, M; Liang, HE; Locksley, RM				von Moltke, Jakob; Ji, Ming; Liang, Hong-Erh; Locksley, Richard M.			Tuft-cell-derived IL-25 regulates an intestinal ILC2-epithelial response circuit	NATURE			English	Article							INNATE LYMPHOID-CELLS; CHEMOSENSORY CELLS; TYPE-2 IMMUNITY; PROMOTES; INFLAMMATION; EXPRESSION; BITTER; IL-13	Parasitic helminths and allergens induce a type 2 immune response leading to profound changes in tissue physiology, including hyperplasia of mucus-secreting goblet cells(1) and smooth muscle hypercontractility(2). This response, known as 'weep and sweep', requires interleukin (IL)-13 production by tissue-resident group 2 innate lymphoid cells (ILC2s) and recruited type 2 helper T cells (T(H)2 cells)(3). Experiments in mice and humans have demonstrated requirements for the epithelial cytokines IL-33, thymic stromal lymphopoietin (TSLP) and IL-25 in the activation of ILC2s(4-11), but the sources and regulation of these signals remain poorly defined. In the small intestine, the epithelium consists of at least five distinct cellular lineages(12), including the tuft cell, whose function is unclear. Here we show that tuft cells constitutively express IL-25 to sustain ILC2 homeostasis in the resting lamina propria in mice. After helminth infection, tuft-cell-derived IL-25 further activates ILC2s to secrete IL-13, which acts on epithelial crypt progenitors to promote differentiation of tuft and goblet cells, leading to increased frequencies of both. Tuft cells, ILC2s and epithelial progenitors therefore comprise a response circuit that mediates epithelial remodelling associated with type 2 immunity in the small intestine, and perhaps at other mucosal barriers populated by these cells.	[von Moltke, Jakob; Ji, Ming; Liang, Hong-Erh; Locksley, Richard M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Ji, Ming; Locksley, Richard M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Locksley, Richard M.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Locksley, RM (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	locksley@medicine.ucsf.edu			National Institutes of Health [AI026918, AI030663, HL107202]; Diabetes Endocrinology Research Center [DK063720]; Howard Hughes Medical Institute (HHMI); Sandler Asthma Basic Research Center at the University of California, San Francisco; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026918, R01AI030663, R37AI026918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK098722, P30DK063720] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Endocrinology Research Center; Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Sandler Asthma Basic Research Center at the University of California, San Francisco(University of California System); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Consengco, R. Noyes, and Z. Wang for technical expertise, Y. Nusse for mice, members of the Locksley laboratory for helpful discussions, and R. Vance, M. Fontana, M. Anderson, and O. Klein for comments on the manuscript. This work was supported by the National Institutes of Health (AI026918, AI030663, HL107202), a Diabetes Endocrinology Research Center grant (DK063720), the Howard Hughes Medical Institute (HHMI), and the Sandler Asthma Basic Research Center at the University of California, San Francisco. J.v.M. is an HHMI Fellow of the Damon Runyon Cancer Research Foundation (DRG-2162-13).	Angkasekwinai P, 2007, J EXP MED, V204, P1509, DOI 10.1084/jem.20061675; Ballantyne SJ, 2007, J ALLERGY CLIN IMMUN, V120, P1324, DOI 10.1016/j.jaci.2007.07.051; Bezencon C, 2008, J COMP NEUROL, V509, P514, DOI 10.1002/cne.21768; Bjerknes M, 2012, DEV BIOL, V362, P194, DOI 10.1016/j.ydbio.2011.12.009; CASTRO GA, 1976, GASTROENTEROLOGY, V71, P620; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Deckmann K, 2014, P NATL ACAD SCI USA, V111, P8287, DOI 10.1073/pnas.1402436111; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Gerbe F, 2012, CELL MOL LIFE SCI, V69, P2907, DOI 10.1007/s00018-012-0984-7; Grencis RK, 2015, ANNU REV IMMUNOL, V33, P201, DOI 10.1146/annurev-immunol-032713-120218; Han HW, 2014, J CLIN INVEST, V124, P5442, DOI 10.1172/JCI77798; Hurst SD, 2002, J IMMUNOL, V169, P443, DOI 10.4049/jimmunol.169.1.443; Kang ZZ, 2012, IMMUNITY, V36, P821, DOI 10.1016/j.immuni.2012.03.021; Krasteva G, 2011, P NATL ACAD SCI USA, V108, P9478, DOI 10.1073/pnas.1019418108; Lee RJ, 2014, J CLIN INVEST, V124, P1393, DOI 10.1172/JCI72094; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; McKenzie GJ, 1998, CURR BIOL, V8, P339, DOI 10.1016/S0960-9822(98)70134-4; MILLER HRP, 1979, NOUV REV FR HEMATOL, V21, P31; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Owyang AM, 2006, J EXP MED, V203, P843, DOI 10.1084/jem.20051496; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; REINECKER HC, 1995, P NATL ACAD SCI USA, V92, P8353, DOI 10.1073/pnas.92.18.8353; Sato Toshiro, 2013, Methods Mol Biol, V945, P319, DOI 10.1007/978-1-62703-125-7_19; Saunders CJ, 2014, P NATL ACAD SCI USA, V111, P6075, DOI 10.1073/pnas.1402251111; Van Dyken SJ, 2014, IMMUNITY, V40, P414, DOI 10.1016/j.immuni.2014.02.003; Voehringer D, 2006, J EXP MED, V203, P1435, DOI 10.1084/jem.20052448; Zhao AP, 2010, J IMMUNOL, V185, P6921, DOI 10.4049/jimmunol.1000450	31	638	641	6	135	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 14	2016	529	7585					221	U243		10.1038/nature16161	http://dx.doi.org/10.1038/nature16161			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA7WK	26675736	Green Accepted			2022-12-28	WOS:000368015700039
J	Blinderman, CD; Billings, JA				Blinderman, Craig D.; Billings, J. Andrew			Comfort Care for Patients Dying in the Hospital	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							OBSTRUCTIVE PULMONARY-DISEASE; OPIOID-INDUCED CONSTIPATION; OF-LIFE DISCUSSIONS; PALLIATIVE CARE; DOUBLE-BLIND; ADVANCED CANCER; MANAGEMENT; PAIN; END; SYMPTOMS		[Blinderman, Craig D.] Columbia Univ, Med Ctr, Adult Palliat Care Serv, Dept Med, 601 W 168th St,Suite 38, New York, NY 10032 USA; [Billings, J. Andrew] Harvard Univ, Sch Med, Div Palliat Care, Massachusetts Gen Hosp,Dept Med, Boston, MA 02115 USA; [Billings, J. Andrew] Harvard Univ, Sch Med, Ctr Palliat Care, Boston, MA 02115 USA	Columbia University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School	Blinderman, CD (corresponding author), Columbia Univ, Med Ctr, Adult Palliat Care Serv, Dept Med, 601 W 168th St,Suite 38, New York, NY 10032 USA.	cdb21@columbis.edu						Acosta A, 2015, GASTROENTEROL CLIN N, V44, P97, DOI 10.1016/j.gtc.2014.11.008; Back AL, 2005, CA-CANCER J CLIN, V55, P164, DOI 10.3322/canjclin.55.3.164; Bausewein C, 2013, DTSCH ARZTEBL INT, V110, P563, DOI 10.3238/arztebl.2013.0563; Ben-Aharon I, 2008, J CLIN ONCOL, V26, P2396, DOI 10.1200/JCO.2007.15.5796; Bernacki RE, 2014, JAMA INTERN MED, V174, P1994, DOI 10.1001/jamainternmed.2014.5271; Billings JA, 2012, CRIT CARE MED, V40, P625, DOI 10.1097/CCM.0b013e318228235d; Blinderman CD, 2012, JAMA-J AM MED ASSOC, V307, P917, DOI 10.1001/jama.2012.236; Blinderman CD, 2010, J PAIN SYMPTOM MANAG, V39, P309, DOI 10.1016/j.jpainsymman.2009.11.242; Breitbart W, 2000, ONCOLOGY-NY, V14, P695; Breitbart W, 1996, AM J PSYCHIAT, V153, P231; Brody H, 1997, NEW ENGL J MED, V336, P652, DOI 10.1056/NEJM199702273360910; Bruera E, 2004, J PAIN SYMPTOM MANAG, V28, P381, DOI 10.1016/j.jpainsymman.2004.01.009; Bruera E, 2013, J CLIN ONCOL, V31, P111, DOI 10.1200/JCO.2012.44.6518; Bull J, 2015, J PALLIAT MED, V18, P593, DOI 10.1089/jpm.2014.0362; Bush SH, 2014, J PAIN SYMPTOM MANAG, V48, P215, DOI 10.1016/j.jpainsymman.2014.05.009; Candy B, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004770.pub2; Caraceni A, 2012, LANCET ONCOL, V13, pE58, DOI 10.1016/S1470-2045(12)70040-2; Cherny NI, 2009, PALLIATIVE MED, V23, P581, DOI 10.1177/0269216309107024; Chung KF, 2005, EXPERT OPIN INV DRUG, V14, P19, DOI 10.1517/13543784.14.1.19; Clayton JM, 2007, MED J AUSTRALIA, V186, pS83; Clayton JM, 2007, MED J AUST S, V186, pS79; Clayton JM, 2007, MED J AUSTRALIA, V186, pS77, DOI DOI 10.5694/J.1326-5377.2007.TB01100.X; Cranston JM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004769.pub2; Currow DC, 2015, J PAIN SYMPTOM MANAG, V49, P814, DOI 10.1016/j.jpainsymman.2014.09.013; Davis MP, 2010, J PAIN SYMPTOM MANAG, V39, P756, DOI 10.1016/j.jpainsymman.2009.08.010; Dean M, 2004, J PAIN SYMPTOM MANAG, V28, P497, DOI 10.1016/j.jpainsymman.2004.02.021; Dy SM, 2010, CANCER J, V16, P507, DOI 10.1097/PPO.0b013e3181f45877; Ekstrom MP, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g445; Elkington H, 2005, PALLIATIVE MED, V19, P485, DOI 10.1191/0269216305pm1056oa; Galbraith S, 2010, J PAIN SYMPTOM MANAG, V39, P831, DOI 10.1016/j.jpainsymman.2009.09.024; Gilron I, 2005, NEW ENGL J MED, V352, P1324, DOI 10.1056/NEJMoa042580; Glare P, 2011, CLIN INTERV AGING, V6, P243, DOI 10.2147/CIA.S13109; Good P, 2008, COCHRANE DB SYST REV, V4; Goy ER, 2011, J PAIN SYMPTOM MANAG, V41, P394, DOI 10.1016/j.jpainsymman.2010.04.015; Grassi L, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0550-8; Hall Margaret Jean, 2013, NCHS Data Brief, P1; Haywood A, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010756.pub2; Higginson IJ, 2010, CANCER J, V16, P423, DOI 10.1097/PPO.0b013e3181f684e5; Holbrook AM, 2000, CAN MED ASSOC J, V162, P225; Hui D, 2014, J PAIN SYMPTOM MANAG; Hui D, 2015, CANCER-AM CANCER SOC, V121, P960, DOI 10.1002/cncr.29048; Inouye SK, 2014, LANCET, V383, P911, DOI 10.1016/S0140-6736(13)60688-1; Institute of Medicine, 2014, DYING AM IMPR QUAL H; Jensen MP, 2003, J PAIN, V4, P2, DOI 10.1054/jpai.2003.1; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; Kutner JS, 2015, JAMA INTERN MED, V175, P691, DOI 10.1001/jamainternmed.2015.0289; Levenson JW, 2000, J AM GERIATR SOC, V48, pS101, DOI 10.1111/j.1532-5415.2000.tb03119.x; Lindqvist O, 2013, J PALLIAT MED, V16, P38, DOI 10.1089/jpm.2012.0205; Lokker ME, 2014, J PAIN SYMPTOM MANAG, V47, P105, DOI 10.1016/j.jpainsymman.2013.03.011; Lonergan E, 2009, COCHRANE DB SYST REV, V4; Longford E., 2015, BMJ SUPPORT PALLIAT, V5, P119, DOI [10.1136/bmjspcare-2014-000838.44, DOI 10.1136/BMJSPCARE-2014-000838.44]; Lupu D, 2010, J PAIN SYMPTOM MANAG, V40, P899, DOI 10.1016/j.jpainsymman.2010.07.004; Mack JW, 2010, J CLIN ONCOL, V28, P1203, DOI 10.1200/JCO.2009.25.4672; Mahler DA, 2015, CHEST, V147, P232, DOI 10.1378/chest.14-0800; Marciniuk DD, 2011, CAN RESPIR J, V18, P69, DOI 10.1155/2011/745047; McCarthy EP, 2000, J AM GERIATR SOC, V48, pS110, DOI 10.1111/j.1532-5415.2000.tb03120.x; McNicol E, 2003, J PAIN, V4, P231, DOI 10.1016/S1526-5900(03)00556-X; McNicol ED, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006146.pub2; Morice AH, 2007, AM J RESP CRIT CARE, V175, P312, DOI 10.1164/rccm.200607-892OC; Morita T, 2001, J PAIN SYMPTOM MANAG, V21, P282, DOI 10.1016/S0885-3924(01)00258-5; Nakagawa S, 2010, J PALLIAT MED, V13, P535, DOI 10.1089/jpm.2009.0336; Parsons HA, 2008, J PALLIAT MED, V11, P1319, DOI 10.1089/jpm.2008.0155; PORTENOY RK, 1987, MED CLIN N AM, V71, P233, DOI 10.1016/S0025-7125(16)30867-7; Portenoy RK, 2014, J CLIN ONCOL, V32, P1662, DOI 10.1200/JCO.2013.52.5188; Puntillo K, 2004, AM J CRIT CARE, V13, P292, DOI 10.4037/ajcc2004.13.4.292; Puntillo KA, 2010, CRIT CARE MED, V38, P2155, DOI 10.1097/CCM.0b013e3181f267ee; Quigley C, 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD004847; Quill TE, 2013, NEW ENGL J MED, V368, P1173, DOI 10.1056/NEJMp1215620; Quill TE, 2009, ANN INTERN MED, V151, P421, DOI 10.7326/0003-4819-151-6-200909150-00007; Ryan NM, 2015, EXPERT OPIN PHARMACO, V16, P135, DOI 10.1517/14656566.2015.981524; Savard J, 2001, J CLIN ONCOL, V19, P895, DOI 10.1200/JCO.2001.19.3.895; Schuckit MA, 2014, NEW ENGL J MED, V371, P2109, DOI 10.1056/NEJMra1407298; Simon ST, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007354.pub2; Swarm RA, 2013, J NATL COMPR CANC NE, V11, P992, DOI 10.6004/jnccn.2013.0119; Tarumi Y, 2013, J PAIN SYMPTOM MANAG, V45, P2, DOI 10.1016/j.jpainsymman.2012.02.008; Teno JM, 2004, JAMA-J AM MED ASSOC, V291, P88, DOI 10.1001/jama.291.1.88; Thomas J, 2008, NEW ENGL J MED, V358, P2332, DOI 10.1056/NEJMoa0707377; Truog RD, 2008, CRIT CARE MED, V36, P953, DOI 10.1097/CCM.0B013E3181659096; Tulsky James A, 2005, J Palliat Med, V8 Suppl 1, pS95; Uronis H, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006429.pub2; Villa A, 2015, THER CLIN RISK MANAG, V11, P45, DOI 10.2147/TCRM.S76282; Wee B, 2008, COCHRANE DB SYST REV, V1; White C, 2007, J PALLIAT MED, V10, P345, DOI 10.1089/jpm.2006.0112; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665; Yuen JK, 2011, J GEN INTERN MED, V26, P791, DOI 10.1007/s11606-011-1632-x; Zhao I, 2008, PALLIATIVE MED, V22, P693, DOI 10.1177/0269216308095024	86	101	107	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 24	2015	373	26					2549	2561		10.1056/NEJMra1411746	http://dx.doi.org/10.1056/NEJMra1411746			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ7SG	26699170	Bronze			2022-12-28	WOS:000367299700010
J	Nicholls, H				Nicholls, Henry			Wild at heart	NATURE			English	Editorial Material												henry@henrynicholls.com							0	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2015	528	7583					474	475		10.1038/528474a	http://dx.doi.org/10.1038/528474a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ3GH	26701039	Bronze			2022-12-28	WOS:000366991900026
J	Bourzac, K				Bourzac, Katherine			An immune one-two punch	NATURE			English	Editorial Material																		Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; DiPaola RS, 2015, EUR UROL, V68, P365, DOI 10.1016/j.eururo.2014.12.010; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294	3	2	2	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2015	528	7582					S134	S136		10.1038/528S134a	http://dx.doi.org/10.1038/528S134a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY8SM	26672788				2022-12-28	WOS:000366678600008
J	Hodson, R				Hodson, Richard			PROSTATE CANCER 4 BIG QUESTIONS	NATURE			English	Editorial Material																			0	10	12	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2015	528	7582					S137	S137		10.1038/528S137a	http://dx.doi.org/10.1038/528S137a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VC0SD	26672789	Bronze			2022-12-28	WOS:000427120500001
J	Wang, ZN; Roberts, AB; Buffa, JA; Levison, BS; Zhu, WF; Org, E; Gu, XD; Huang, Y; Zamanian-Daryoush, M; Culley, MK; DiDonato, AJ; Fu, XM; Hazen, JE; Krajcik, D; DiDonato, JA; Lusis, AJ; Hazen, SL				Wang, Zeneng; Roberts, Adam B.; Buffa, Jennifer A.; Levison, Bruce S.; Zhu, Weifei; Org, Elin; Gu, Xiaodong; Huang, Ying; Zamanian-Daryoush, Maryam; Culley, Miranda K.; DiDonato, Anthony J.; Fu, Xiaoming; Hazen, Jennie E.; Krajcik, Daniel; DiDonato, Joseph A.; Lusis, Aldons J.; Hazen, Stanley L.			Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis	CELL			English	Article							CONTAINING MONOOXYGENASE 3; N-OXIDE; INTESTINAL MICROBIOTA; PROGNOSTIC VALUE; CHOLINE; METABOLISM; PHOSPHATIDYLCHOLINE; DEGRADATION; DISEASE; BETAINE	Trimethylamine (TMA) N-oxide (TMAO), a gut-microbiota-dependent metabolite, both enhances atherosclerosis in animal models and is associated with cardiovascular risks in clinical studies. Here, we investigate the impact of targeted inhibition of the first step in TMAO generation, commensal microbial TMA production, on diet-induced atherosclerosis. A structural analog of choline, 3,3-dimethyl-1-butanol (DMB), is shown to non-lethally inhibit TMA formation from cultured microbes, to inhibit distinct microbial TMA lyases, and to both inhibit TMA production from physiologic polymicrobial cultures (e.g., intestinal contents, human feces) and reduce TMAO levels in mice fed a high-choline or L-carnitine diet. DMB inhibited choline diet-enhanced endogenous macrophage foam cell formation and atherosclerotic lesion development in apolipoprotein e(-/-) mice without alterations in circulating cholesterol levels. The present studies suggest that targeting gut microbial production of TMA specifically and non-lethal microbial inhibitors in general may serve as a potential therapeutic approach for the treatment of cardiometabolic diseases.	[Wang, Zeneng; Roberts, Adam B.; Buffa, Jennifer A.; Levison, Bruce S.; Zhu, Weifei; Gu, Xiaodong; Huang, Ying; Zamanian-Daryoush, Maryam; Culley, Miranda K.; DiDonato, Anthony J.; Fu, Xiaoming; Hazen, Jennie E.; Krajcik, Daniel; DiDonato, Joseph A.; Hazen, Stanley L.] Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44195 USA; [Org, Elin; Lusis, Aldons J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Cardiol, Los Angeles, CA 90095 USA; [Hazen, Stanley L.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cleveland Clinic Foundation	Wang, ZN (corresponding author), Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44195 USA.	wangz2@ccf.org; hazens@ccf.org	Hazen, Stanley L/ABD-5845-2021; Org, Elin/AAJ-9631-2021; Wang, Zeneng/AAK-6119-2021	Org, Elin/0000-0001-8688-9717; Roberts, Adam/0000-0003-3539-804X; Org, Elin/0000-0003-1451-9375; Levison, Bruce/0000-0002-1816-368X	NIH; Office of Dietary Supplements [R01 HL103866, P20 HL113452, R01106000, P01H28481]; American Heart Association Scientist Development grants; Esperion; Procter Gamble; Astra Zeneca; Pfizer; Roche; Takeda; Cleveland Heart Laboratory; Siemens; Frantz Biomarkers, LLC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL028481, R01HL103866, P20HL113452] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK106000] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Scientist Development grants(American Heart Association); Esperion; Procter Gamble(Procter & Gamble); Astra Zeneca(AstraZeneca); Pfizer(Pfizer); Roche(Roche Holding); Takeda(Takeda Pharmaceutical Company Ltd); Cleveland Heart Laboratory; Siemens(Siemens AG); Frantz Biomarkers, LLC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank B. Sullivan and M. Wagner for technical assistance. This research was supported by NIH and Office of Dietary Supplements grants R01 HL103866, P20 HL113452, R01106000, and P01H28481. Z.W. and W.Z. were partially supported by American Heart Association Scientist Development grants. S.L.H. is also partially supported by a gift from the Leonard Krieger fund. MS studies were performed on instrumentation housed within a facility partially supported by a Center of Innovation Award by AB SCIEX.; Z.W., B.S.L., and S.L.H. are named as co-inventors on patents held by the Cleveland Clinic relating to cardiovascular diagnostics and/or therapeutics. S.L.H. reports having been paid as a consultant for the following companies: Esperion and Procter & Gamble. S.L.H. reports receiving research funds or support from Astra Zeneca, Pfizer, Procter & Gamble, Roche, and Takeda. Z.W., B.S.L., and S.L.H. report having the right to receive royalty payments for inventions or discoveries related to cardiovascular diagnostics and/or therapeutics from the Cleveland Heart Laboratory, and S.L.H. also from the following companies: Siemens, Esperion, and Frantz Biomarkers, LLC.	Baglione Julie, 2006, V129, P83; Bain MA, 2005, CURR DRUG METAB, V6, P227, DOI 10.2174/1389200054021807; BARLOW P, 1985, BIOCHEM PHARMACOL, V34, P3117, DOI 10.1016/0006-2952(85)90156-X; Bennett BJ, 2013, CELL METAB, V17, P49, DOI 10.1016/j.cmet.2012.12.011; Brown JM, 2015, ANNU REV MED, V66, P343, DOI 10.1146/annurev-med-060513-093205; CAFIERO M, 1951, Boll Soc Ital Biol Sper, V27, P1426; Cashman JR, 2003, CURR DRUG METAB, V4, P151, DOI 10.2174/1389200033489505; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; Craciun S, 2012, P NATL ACAD SCI USA, V109, P21307, DOI 10.1073/pnas.1215689109; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Gregory JC, 2015, J BIOL CHEM, V290, P5647, DOI 10.1074/jbc.M114.618249; Koch R., 1880, NAT MED; Koeth RA, 2014, CELL METAB, V20, P799, DOI 10.1016/j.cmet.2014.10.006; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Lever M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114969; Mente A, 2015, CAN J CARDIOL, V31, P1189, DOI 10.1016/j.cjca.2015.06.016; Miao J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7498; MOLLER B, 1986, ARCH MICROBIOL, V145, P85, DOI 10.1007/BF00413032; Petschow B, 2013, ANN NY ACAD SCI, V1306, P1, DOI 10.1111/nyas.12303; Renshaw RA, 1938, J AM CHEM SOC, V60, P946, DOI 10.1021/ja01271a055; Romano KA, 2015, MBIO, V6, DOI 10.1128/mBio.02481-14; SANDHU SS, 1986, CAN J MICROBIOL, V32, P743, DOI 10.1139/m86-135; Shih DM, 2015, J LIPID RES, V56, P22, DOI 10.1194/jlr.M051680; TAN QH, 1981, CARCINOGENESIS, V2, P1135, DOI 10.1093/carcin/2.11.1135; Tang WHW, 2014, J AM COLL CARDIOL, V64, P1908, DOI 10.1016/j.jacc.2014.02.617; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Troseid M, 2015, J INTERN MED, V277, P717, DOI 10.1111/joim.12328; Wang Z, 2007, NAT MED, V13, P1176, DOI 10.1038/nm1637; Wang ZN, 2014, ANAL BIOCHEM, V455, P35, DOI 10.1016/j.ab.2014.03.016; Wang ZN, 2014, EUR HEART J, V35, P904, DOI 10.1093/eurheartj/ehu002; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Warrier M, 2015, CELL REP, V10, P326, DOI 10.1016/j.celrep.2014.12.036; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344	34	715	779	7	199	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2015	163	7					1585	1595		10.1016/j.cell.2015.11.055	http://dx.doi.org/10.1016/j.cell.2015.11.055			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CZ1GN	26687352	Green Accepted, Bronze			2022-12-28	WOS:000366854200008
J	Schwartz, ES				Schwartz, Eben S.			CHRISTMAS 2015: ALL IN THE MIND Certificate in Reverse Psychology probably not worth it	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Schwartz, Eben S.] ProHlth Waukesha Mem Hosp, Neuropsychol Serv, Waukesha, WI 53213 USA		Schwartz, ES (corresponding author), ProHlth Waukesha Mem Hosp, Neuropsychol Serv, Waukesha, WI 53213 USA.	eben.schwartz@phci.org							0	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 16	2015	351								h6296	10.1136/bmj.h6296	http://dx.doi.org/10.1136/bmj.h6296			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ4MP	26676308				2022-12-28	WOS:000367077600003
J	Burch, HB; Cooper, DS				Burch, Henry B.; Cooper, David S.			Management of Graves Disease A Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							ANTITHYROID DRUG-THERAPY; THYROID-HORMONE LEVELS; QUALITY-OF-LIFE; INDUCED AGRANULOCYTOSIS; RADIOIODINE THERAPY; METHIMAZOLE TREATMENT; RECEPTOR ANTIBODIES; CLINICAL-FEATURES; EARLY-PREGNANCY; HYPERTHYROIDISM	IMPORTANCE Graves disease is the most common cause of persistent hyperthyroidism in adults. Approximately 3% of women and 0.5% of men will develop Graves disease during their lifetime. OBSERVATIONS We searched PubMed and the Cochrane database for English-language studies published from June 2000 through October 5, 2015. Thirteen randomized clinical trials, 5 systematic reviews and meta-analyses, and 52 observational studies were included in this review. Patients with Graves disease may be treated with antithyroid drugs, radioactive iodine (RAI), or surgery (near-total thyroidectomy). The optimal approach depends on patient preference, geography, and clinical factors. A 12- to 18-month course of antithyroid drugs may lead to a remission in approximately 50% of patients but can cause potentially significant (albeit rare) adverse reactions, including agranulocytosis and hepatotoxicity. Adverse reactions typically occur within the first 90 days of therapy. Treating Graves disease with RAI and surgery result in gland destruction or removal, necessitating life-long levothyroxine replacement. Use of RAI has also been associated with the development or worsening of thyroid eye disease in approximately 15% to 20% of patients. Surgery is favored in patients with concomitant suspicious or malignant thyroid nodules, coexisting hyperparathyroidism, and in patients with large goiters or moderate to severe thyroid eye disease who cannot be treated using a ntithyroid drugs. However, surgery is associated with potential complications such as hypoparathyroidism and vocal cord paralysis in a small proportion of patients. In pregnancy, antithyroid drugs are the primary therapy, but some women with Graves disease opt to receive definitive therapy with RAI or surgery prior to becoming pregnant to avoid potential teratogenic effects of antithyroid drugs during pregnancy. CONCLUSIONS AND RELEVANCE Management of Graves disease includes treatment with antithyroid drugs, RAI, or thyroidectomy. The optimal approach depends on patient preference and specific patient clinical features such as age, history of arrhythmia or ischemic heart disease, size of goiter, and severity of thyrotoxicosis. Physicians should be familiar with the advantages and disadvantages of each therapy to best counsel their patients.	[Burch, Henry B.] Walter Reed Natl Mil Med Ctr, Dept Med, Serv Endocrinol, Bethesda, MD USA; [Burch, Henry B.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Cooper, David S.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21287 USA	Walter Reed National Military Medical Center; Uniformed Services University of the Health Sciences - USA; Johns Hopkins University	Cooper, DS (corresponding author), Johns Hopkins Univ, Sch Med, Div Endocrinol Diabet & Metab, 1830 E Monument St,Ste 333, Baltimore, MD 21287 USA.	dscooper@jhmi.edu						Abraham-Nordling M, 2005, THYROID, V15, P1279, DOI 10.1089/thy.2005.15.1279; Acharya SH, 2008, CLIN ENDOCRINOL, V69, P943, DOI 10.1111/j.1365-2265.2008.03279.x; Alexander EK, 2002, J CLIN ENDOCR METAB, V87, P1073, DOI 10.1210/jc.87.3.1073; American Academy of Pediatrics Committee on Drugs, 2001, Pediatrics, V108, P776; AMINO N, 1982, J CLIN ENDOCR METAB, V55, P108, DOI 10.1210/jcem-55-1-108; Andersen SL, 2013, J CLIN ENDOCR METAB, V98, P4373, DOI 10.1210/jc.2013-2831; Andersohn F, 2007, ANN INTERN MED, V146, P657, DOI 10.7326/0003-4819-146-9-200705010-00009; Andrade VA, 1999, J CLIN ENDOCR METAB, V84, P4012, DOI 10.1210/jc.84.11.4012; Andres E, 2011, EXPERT REV HEMATOL, V4, P143, DOI [10.1586/ehm.11.12, 10.1586/EHM.11.12]; Azizi F, 2005, EUR J ENDOCRINOL, V152, P695, DOI 10.1530/eje.1.01904; Azizi F, 2000, J CLIN ENDOCR METAB, V85, P3233, DOI 10.1210/jc.85.9.3233; Bahn RS, 2012, CLIN PHARMACOL THER, V91, P577, DOI 10.1038/clpt.2012.10; Bahn RS, 2011, THYROID, V21, P593, DOI 10.1089/thy.2010.0417; Bahn RS, 2010, NEW ENGL J MED, V362, P726, DOI 10.1056/NEJMra0905750; Bahn Rebecca S, 2009, Thyroid, V19, P673, DOI 10.1089/thy.2009.0169; Bartalena L, 2016, CLIN ENDOCRINOL, V84, P115, DOI 10.1111/cen.12688; Bartalena L, 1998, NEW ENGL J MED, V338, P73, DOI 10.1056/NEJM199801083380201; Bartalena L, 2014, J ENDOCRINOL INVEST, V37, P691, DOI 10.1007/s40618-014-0097-2; Boelaert K, 2010, J CLIN ENDOCR METAB, V95, P2715, DOI 10.1210/jc.2009-2495; Braga M, 2002, THYROID, V12, P135, DOI 10.1089/105072502753522365; BURCH HB, 1993, ENDOCRIN METAB CLIN, V22, P263, DOI 10.1016/S0889-8529(18)30165-8; BURCH HB, 1994, ANN INTERN MED, V121, P553, DOI 10.7326/0003-4819-121-8-199410150-00001; Burch HB, 2001, J CLIN ENDOCR METAB, V86, P3016, DOI 10.1210/jc.86.7.3016; Burch HB, 2013, WERNER INGBARS THYRO, P434; Burch HB, 2012, J CLIN ENDOCR METAB, V97, P4549, DOI 10.1210/jc.2012-2802; Carella C, 2006, THYROID, V16, P295, DOI 10.1089/thy.2006.16.295; CHEN JJS, 1986, J CLIN ENDOCR METAB, V63, P102; Cooper D S, 1982, Am J Med, V73, P867; Cooper DS, 2013, LANCET DIABETES ENDO, V1, P238, DOI 10.1016/S2213-8587(13)70086-X; Cooper DS, 2005, NEW ENGL J MED, V352, P905, DOI 10.1056/NEJMra042972; Cooper DS, 2003, J CLIN ENDOCR METAB, V88, P3474, DOI 10.1210/jc.2003-030185; Dale J, 2001, CLIN ENDOCRINOL, V55, P233, DOI 10.1046/j.1365-2265.2001.01329.x; De Groot L, 2012, J CLIN ENDOCR METAB, V97, P2543, DOI 10.1210/jc.2011-2803; Elfenbein DM, 2015, ANN SURG ONCOL, V22, P1196, DOI 10.1245/s10434-014-4095-6; Emiliano AB, 2010, J CLIN ENDOCR METAB, V95, P2227, DOI 10.1210/jc.2009-2752; Erbil Y, 2007, J CLIN ENDOCR METAB, V92, P2182, DOI 10.1210/jc.2007-0229; Feroci F, 2014, SURGERY, V155, P529, DOI 10.1016/j.surg.2013.10.017; Frost L, 2004, ARCH INTERN MED, V164, P1675, DOI 10.1001/archinte.164.15.1675; Gao Y, 2008, RHEUMATOLOGY, V47, P1515, DOI 10.1093/rheumatology/ken321; Gao Y, 2009, NEPHROLOGY, V14, P33, DOI 10.1111/j.1440-1797.2009.01100.x; GEFFNER DL, 1992, AM J MED, V93, P61, DOI 10.1016/0002-9343(92)90681-Z; HAMBURGER JI, 1992, THYROID, V2, P219, DOI 10.1089/thy.1992.2.219; HANCOCK SL, 1991, NEW ENGL J MED, V325, P599, DOI 10.1056/NEJM199108293250902; Harper L, 2004, CLIN ENDOCRINOL, V60, P671, DOI 10.1111/j.1365-2265.2004.02029.x; HOWARD JE, 1967, J AMER MED ASSOC, V202, P706, DOI 10.1001/jama.202.8.706; Ide A, 2014, THYROID, V24, P1027, DOI 10.1089/thy.2013.0585; In H, 2009, J AM COLL SURGEONS, V209, P170, DOI 10.1016/j.jamcollsurg.2009.03.025; Jin J, 2012, AM J SURG, V204, P199, DOI 10.1016/j.amjsurg.2011.10.010; Karga H, 2004, CLIN ENDOCRINOL, V61, P466, DOI 10.1111/j.1365-2265.2004.02110.x; Kashiwai T, 2003, ENDOCR J, V50, P45, DOI 10.1507/endocrj.50.45; Kobayashi S, 2014, THYROID, V24, P796, DOI 10.1089/thy.2013.0476; Korelitz JJ, 2013, THYROID, V23, P758, DOI 10.1089/thy.2012.0488; Krassas GE, 2010, ENDOCR REV, V31, P702, DOI 10.1210/er.2009-0041; KRIPLANI A, 1994, EUR J OBSTET GYN R B, V54, P159, DOI 10.1016/0028-2243(94)90276-3; Kubota S, 2006, ENDOCR J, V53, P603, DOI 10.1507/endocrj.K06-057; Langley RW, 2003, ENDOCRIN METAB CLIN, V32, P519, DOI 10.1016/S0889-8529(03)00010-0; LAURBERG P, 1986, ACTA ENDOCRINOL-COP, V111, P39, DOI 10.1530/acta.0.1110039; Laurberg P, 2008, EUR J ENDOCRINOL, V158, P69, DOI 10.1530/EJE-07-0450; Laurberg P, 2006, EUR J ENDOCRINOL, V155, P783, DOI 10.1530/eje.1.02295; Liu XM, 2015, EUR J ENDOCRINOL, V172, P321, DOI 10.1530/EJE-14-0704; Luewan S, 2011, ARCH GYNECOL OBSTET, V283, P243, DOI 10.1007/s00404-010-1362-z; Matos-Santos A, 2001, CLIN ENDOCRINOL, V55, P15, DOI 10.1046/j.1365-2265.2001.01332.x; MCCRUDEN DC, 1987, CLIN ENDOCRINOL, V26, P33, DOI 10.1111/j.1365-2265.1987.tb03636.x; MCDERMOTT MT, 1983, AM J MED, V75, P353, DOI 10.1016/0002-9343(83)91217-2; McLeod DSA, 2014, JAMA-J AM MED ASSOC, V311, P1563, DOI 10.1001/jama.2013.285606; Nakamura H, 2007, J CLIN ENDOCR METAB, V92, P2157, DOI 10.1210/jc.2006-2135; Nakamura H, 2013, J CLIN ENDOCR METAB, V98, P4776, DOI 10.1210/jc.2013-2569; Navarro VJ, 2006, NEW ENGL J MED, V354, P731, DOI 10.1056/NEJMra052270; Neumann S, 2014, ENDOCRINOLOGY, V155, P310, DOI 10.1210/en.2013-1835; Nystrom HF, 2013, CLIN ENDOCRINOL, V78, P768, DOI 10.1111/cen.12060; Okamura K, 2014, J CLIN ENDOCR METAB, V99, P3995, DOI 10.1210/jc.2013-4466; Otsuka F, 2012, CLIN ENDOCRINOL, V77, P310, DOI 10.1111/j.1365-2265.2012.04365.x; Patel NN, 2006, THYROID, V16, P593, DOI 10.1089/thy.2006.16.593; Patil-Sisodia K, 2010, ENDOCR PRACT, V16, P118, DOI 10.4158/EP09233.RA; PERRILD H, 1983, CLIN ENDOCRINOL, V18, P139, DOI 10.1111/j.1365-2265.1983.tb03196.x; PRUMMEL MF, 1993, JAMA-J AM MED ASSOC, V269, P479, DOI 10.1001/jama.269.4.479; Robinson J, 2014, EUR THYROID J, V3, P245, DOI 10.1159/000367990; Ron E, 1998, JAMA-J AM MED ASSOC, V280, P347, DOI 10.1001/jama.280.4.347; Ross DS, 2011, NEW ENGL J MED, V364, P542, DOI 10.1056/NEJMct1007101; ROTI E, 1988, ARCH INTERN MED, V148, P1919, DOI 10.1001/archinte.148.9.1919; Rotondi M, 2008, J CLIN ENDOCR METAB, V93, P3985, DOI 10.1210/jc.2008-0966; Sahu MT, 2010, ARCH GYNECOL OBSTET, V281, P215, DOI 10.1007/s00404-009-1105-1; Schwartz KM, 2002, J CLIN ENDOCR METAB, V87, P438, DOI 10.1210/jc.87.2.438; Sheffield JS, 2004, AM J OBSTET GYNECOL, V190, P211, DOI 10.1016/S0002-9378(03)00944-X; Sheng WH, 1999, QJM-INT J MED, V92, P455, DOI 10.1093/qjmed/92.8.455; Shiber S, 2014, THYROID, V24, P1515, DOI 10.1089/thy.2014.0218; Sisson JC, 2011, THYROID, V21, P335, DOI 10.1089/thy.2010.0403; Sosa JA, 1998, ANN SURG, V228, P320, DOI 10.1097/00000658-199809000-00005; Stagnaro-Green A, 2011, THYROID, V21, P1081, DOI 10.1089/thy.2011.0087; Sundaresh V, 2013, J CLIN ENDOCR METAB, V98, P3671, DOI 10.1210/jc.2013-1954; TAJIRI J, 1990, ARCH INTERN MED, V150, P621, DOI 10.1001/archinte.150.3.621; Takata K, 2009, THYROID, V19, P559, DOI 10.1089/thy.2008.0364; TALLSTEDT L, 1992, NEW ENGL J MED, V326, P1733, DOI 10.1056/NEJM199206253262603; Traisk F, 2009, J CLIN ENDOCR METAB, V94, P3700, DOI 10.1210/jc.2009-0747; Uchida T, 2014, ENDOCRINE, V47, P506, DOI 10.1007/s12020-014-0171-8; US Food and Drug Administration, MED GUID PROP TABL; Vitti P, 1997, THYROID, V7, P369, DOI 10.1089/thy.1997.7.369; Walter MA, 2006, EUR J NUCL MED MOL I, V33, P730, DOI 10.1007/s00259-006-0092-8; Walter MA, 2007, BRIT MED J, V334, P514, DOI 10.1136/bmj.39114.670150.BE; Wang MT, 2014, BRIT J CLIN PHARMACO, V78, P619, DOI 10.1111/bcp.12336; Warnock AL, 2014, ENDOCRINE METABOLIC, DOI [10.1210/EME.9781936704811.d-111, DOI 10.1210/EME.9781936704811.D-111]; Wiersinga WM, 2012, BEST PRACT RES CL EN, V26, P359, DOI 10.1016/j.beem.2011.11.001; Woeber Kenneth A, 2002, Endocr Pract, V8, P222; Yang J, 2015, THYROID, V25, P278, DOI 10.1089/thy.2014.0350; Yoshihara A, 2012, J CLIN ENDOCR METAB, V97, P2396, DOI 10.1210/jc.2011-2860; YOUNG ET, 1988, Q J MED, V66, P175	106	155	172	2	57	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 15	2015	314	23					2544	2554		10.1001/jama.2015.16535	http://dx.doi.org/10.1001/jama.2015.16535			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY4PV	26670972				2022-12-28	WOS:000366391500021
J	Stupp, R; Taillibert, S; Kanner, AA; Kesari, S; Steinberg, DM; Toms, SA; Taylor, LP; Lieberman, F; Silvani, A; Fink, KL; Barnett, GH; Zhu, JJ; Henson, JW; Engelhard, HH; Chen, TC; Tran, DD; Sroubek, J; Iran, ND; Hottinger, AF; Landolfi, J; Desai, R; Caroli, M; Kew, Y; Honnorat, J; Idbaih, A; Kirson, ED; Weinberg, U; Palti, Y; Hegi, ME; Ram, Z				Stupp, Roger; Taillibert, Sophie; Kanner, Andrew A.; Kesari, Santosh; Steinberg, David M.; Toms, Steven A.; Taylor, Lynne P.; Lieberman, Frank; Silvani, Antonio; Fink, Karen L.; Barnett, Gene H.; Zhu, Jay-Jiguang; Henson, John W.; Engelhard, Herbert H.; Chen, Thomas C.; Tran, David D.; Sroubek, Jan; Iran, Nam D.; Hottinger, Andreas F.; Landolfi, Joseph; Desai, Rajiv; Caroli, Manuela; Kew, Yvonne; Honnorat, Jerome; Idbaih, Ahmed; Kirson, Eilon D.; Weinberg, Uri; Palti, Yoram; Hegi, Monika E.; Ram, Zvi			Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEWLY-DIAGNOSED GLIOBLASTOMA; ALTERNATING ELECTRIC-FIELDS; QUALITY-OF-LIFE; PHASE-III TRIAL; RECURRENT GLIOBLASTOMA; ADJUVANT TEMOZOLOMIDE; TREATMENT MODALITY; OPEN-LABEL; RADIOTHERAPY; NOVOTTF-100A	iMPORTANCE Glioblastoma is the most devastating primary malignancy of the central nervous system in adults. Most patients die within 1 to 2 years of diagnosis. Tumor-treating fields (TTFields) are a locoregionally delivered antimitotic treatment that interferes with cell division and organelle assembly. OBJECTIVE To evaluate the efficacy and safety of TTFields used in combination with temozolomide maintenance treatment after chemoradiation therapy for patients with glioblastoma. DESIGN, SETTING, AND PARTICIPANTS After completion of chemoradiotherapy, patients with glioblastoma were randomized (2:1) to receive maintenance treatment with either TTFields plus temozolomide (n = 466) or temozolomide alone (n = 229) (median time from diagnosis to randomization, 3.8 months in both groups). The study enrolled 695 of the planned 700 patients between July 2009 and November 2014 at 83 centers in the United States, Canada, Europe, Israel, and South Korea. The trial was terminated based on the results of this planned interim analysis. INTERVENTIONS Treatment with TTFields was delivered continuously (>18 hours/day) via 4 transducer arrays placed on the shaved scalp and connected to a portable medical device. Temozolomide (150-200 mg/m(2)/d) was given for 5 days of each 28-day cycle. MAIN OUTCOMES AND MEASURES The primary end point was progression-free survival in the intent-to-treat population (significance threshold of .01) with overall survival in the per-protocol population (n = 280) as a powered secondary end point (significance threshold of .006). This prespecified interim analysis was to be conducted on the first 315 patients after at least 18 months of follow-up. RESULTS The interim analysis included 210 patients randomized to TTFields plus temozolomide and 105 randomized to temozolomide alone, and was conducted at a median follow-up of 38 months (range, 18-60 months). Median progression-free survival in the intent-to-treat population was 7.1 months (95% Cl, 5.9-8.2 months) in the TTFields plus temozolomide group and 4.0 months (95% Cl, 3.3-5.2 months) in the temozolomide alone group (hazard ratio [HR], 0.62 [98.7% Cl, 0.43-0.89]; P =.001). Median overall survival in the per-protocol population was 20.5 months (95% Cl, 16.7-25.0 months) in the TTFields plus temozolomide group (n = 196) and 15.6 months (95% Cl, 13.3-19.1 months) in the temozolomide alone group (n = 84) (HR, 0.64 [99.4% Cl, 0.42-0.98]; P =.004). CONCLUSIONS AND RELEVANCE In this interim analysis of 315 patients with glioblastoma who had completed standard chemoradiation therapy, adding TTFields to maintenance temozolomide chemotherapy significantly prolonged progression-free and overall survival.	[Stupp, Roger] Univ Zurich Hosp, CH-8091 Zurich, Switzerland; [Stupp, Roger] Univ Zurich, Zurich, Switzerland; [Stupp, Roger; Hottinger, Andreas F.; Hegi, Monika E.] Lausanne Univ Hosp CHUV, Lausanne, Switzerland; [Taillibert, Sophie; Idbaih, Ahmed] Univ Paris 06, La Pitie Salpetriere Univ Hosp, Assistance Publ Hop Paris, Paris, France; [Kanner, Andrew A.; Ram, Zvi] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, IL-69978 Tel Aviv, Israel; [Kesari, Santosh] Univ Calif San Diego, San Diego, CA 92103 USA; [Steinberg, David M.] Tel Aviv Univ, IL-69978 Tel Aviv, Israel; [Toms, Steven A.] Geisinger Hlth Syst, Danville, PA USA; [Taylor, Lynne P.] Tufts Med Ctr, Boston, MA USA; [Lieberman, Frank] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Silvani, Antonio] Ist Nazl Neurol Carlo Besta, Milan, Italy; [Fink, Karen L.; Zhu, Jay-Jiguang] Baylor Univ, Med Ctr, Dallas, TX USA; [Barnett, Gene H.] Cleveland Clin Fdn, Cleveland, OH 44195 USA; [Zhu, Jay-Jiguang] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [Henson, John W.] Swedish Neurosci Inst, Seattle, WA USA; [Engelhard, Herbert H.] Univ Illinois, Chicago, IL USA; [Chen, Thomas C.] Univ So Calif, Los Angeles, CA USA; [Tran, David D.] Washington Univ, Barnes Jewish Hosp, St Louis, MO USA; [Sroubek, Jan] Na Homolce Hosp, Prague, Czech Republic; [Iran, Nam D.] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA; [Landolfi, Joseph] New Jersey Neurosci Inst, Edison, NJ USA; [Desai, Rajiv] Maine Med Ctr, Portland, OR USA; [Caroli, Manuela] Fdn Osped Maggiore Policlin, Milan, Italy; [Kew, Yvonne] Houston Methodist Hosp, Houston, TX USA; [Honnorat, Jerome] Univ Claude Bernard Lyon 1, Hosp Civils Lyon, Lyon, France; [Kirson, Eilon D.; Weinberg, Uri; Palti, Yoram] Novocure, Haifa, Israel	University of Zurich; University Zurich Hospital; University of Zurich; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; University of California System; University of California San Diego; Tel Aviv University; Geisinger Health System; Tufts Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; IRCCS Istituto Neurologico Besta; Baylor University; Baylor University Medical Center; Cleveland Clinic Foundation; University of Texas System; University of Texas Health Science Center Houston; Swedish Medical Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Southern California; Barnes-Jewish Hospital; Washington University (WUSTL); Na Homolce Hospital; H Lee Moffitt Cancer Center & Research Institute; IRCCS Ca Granda Ospedale Maggiore Policlinico; The Methodist Hospital System; The Methodist Hospital - Houston; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Novocure Limited	Stupp, R (corresponding author), Univ Zurich Hosp, Dept Oncol, CH-8091 Zurich, Switzerland.	roger.stupp@usz.ch	Taylor, Lynne P./S-8154-2019; Hegi, Monika/O-4796-2015; Honnorat, jerome/G-6394-2017; Caroli, Manuela/AAB-9019-2019; Silvani, Antonio/AAA-4600-2019; Sroubek, Jan/AAO-6261-2021; Stupp, Roger/L-3303-2019; Kesari, Santosh/E-8461-2013; Idbaih, Ahmed/N-8746-2017	Taylor, Lynne P./0000-0001-5946-3796; Hegi, Monika/0000-0003-0855-6495; Honnorat, jerome/0000-0002-4721-5952; Silvani, Antonio/0000-0002-4791-1042; Sroubek, Jan/0000-0003-0833-7444; Engelhard, Herbert/0000-0003-4993-9265; Idbaih, Ahmed/0000-0001-5290-1204; Kanner, Andrew Ariye/0000-0002-0812-8573	Novocure Ltd.	Novocure Ltd.	The study was funded by Novocure Ltd.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Chinot OL, 2014, NEW ENGL J MED, V370, P709, DOI 10.1056/NEJMoa1308345; Chvetzoff G, 2003, J NATL CANCER I, V95, P19, DOI 10.1093/jnci/95.1.19; DeMets D L, 1995, Cancer Treat Res, V75, P1; DEMETS DL, 1994, STAT MED, V13, P1341, DOI 10.1002/sim.4780131308; Fonkem E, 2012, EXPERT REV NEUROTHER, V12, P895, DOI 10.1586/ERN.12.80; Gilbert MR, 2014, NEW ENGL J MED, V370, P699, DOI 10.1056/NEJMoa1308573; Gilbert MR, 2013, J CLIN ONCOL, V31, P4085, DOI 10.1200/JCO.2013.49.6968; Gutin Philip H, 2012, Am Soc Clin Oncol Educ Book, P126, DOI 10.14694/EdBook_AM.2012.32.126; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Kirson ED, 2004, CANCER RES, V64, P3288, DOI 10.1158/0008-5472.CAN-04-0083; Kirson ED, 2007, P NATL ACAD SCI USA, V104, P10152, DOI 10.1073/pnas.0702916104; Kirson Eilon D, 2009, BMC Med Phys, V9, P1, DOI 10.1186/1756-6649-9-1; Lacouture Mario E, 2014, Semin Oncol, V41 Suppl 4, pS1, DOI 10.1053/j.seminoncol.2014.03.011; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2014, LANCET ONCOL, V15, P1100, DOI 10.1016/S1470-2045(14)70379-1; Stupp R, 2012, EUR J CANCER, V48, P2192, DOI 10.1016/j.ejca.2012.04.011; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Taphoorn MJB, 2010, EUR J CANCER, V46, P1033, DOI 10.1016/j.ejca.2010.01.012; Team RC., 2022, LANG ENV STAT COMP; Vlassenbroeck I, 2008, J MOL DIAGN, V10, P332, DOI 10.2353/jmoldx.2008.070169; Westphal M, 2015, EUR J CANCER, V51, P522, DOI 10.1016/j.ejca.2014.12.019	25	715	732	4	116	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 15	2015	314	23					2535	2543		10.1001/jama.2015.16669	http://dx.doi.org/10.1001/jama.2015.16669			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY4PV	26670971	Bronze, Green Published			2022-12-28	WOS:000366391500020
J	Olenski, AR; Abola, MV; Jena, AB				Olenski, Andrew R.; Abola, Matthew V.; Jena, Anupam B.			CHRISTMAS 2015: POLITICAL SCIENCE Do heads of government age more quickly? Observational study comparing mortality between elected leaders and runners-up in national elections of 17 countries	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								Objectives To determine whether being elected to head of government is associated with accelerated mortality by studying survival differences between people elected to office and unelected runner-up candidates who never served. Design Observational study. Setting Historical survival data on elected and runner-up candidates in parliamentary or presidential elections in Australia, Austria, Canada, Denmark, Finland, France, Germany, Greece, Ireland, Italy, New Zealand, Norway, Poland, Spain, Sweden, United Kingdom, and United States, from 1722 to 2015. Participants Elected and runner-up political candidates. Main outcome measure Observed number of years alive after each candidate's last election, relative to what would be expected for an average person of the same age and sex as the candidate during the year of the election, based on historical French and British life tables. Observed post-election life years were compared between elected candidates and runners-up, adjusting for life expectancy at time of election. A Cox proportional hazards model (adjusted for candidate's life expectancy at the time of election) considered years until death (or years until end of study period for those not yet deceased by 9 September 2015) for elected candidates versus runners-up. Results The sample included 540 candidates: 279 winners and 261 runners-up who never served. A total of 380 candidates were deceased by 9 September 2015. Candidates who served as a head of government lived 4.4 (95% confidence interval 2.1 to 6.6) fewer years after their last election than did candidates who never served (17.8 v 13.4 years after last election; adjusted difference 2.7 (0.6 to 4.8) years). In Cox proportional hazards analysis, which considered all candidates (alive or deceased), the mortality hazard for elected candidates relative to runners-up was 1.23 (1.00 to 1.52). Conclusions Election to head of government is associated with a substantial increase in mortality risk compared with candidates in national elections who never served.	[Olenski, Andrew R.; Jena, Anupam B.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Abola, Matthew V.] Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA; [Jena, Anupam B.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Jena, Anupam B.] Natl Bur Econ Res, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Case Western Reserve University; Harvard University; Massachusetts General Hospital; National Bureau of Economic Research	Jena, AB (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	jena@hcp.med.harvard.edu	Abola, Matthew V/F-4869-2015; Abola, Matthew V./M-4214-2019	Abola, Matthew V/0000-0001-8084-3515; Abola, Matthew V./0000-0001-8084-3515; Olenski, Andrew/0000-0002-7461-0536	Office of the Director, National Institutes of Health (NIH early independence award) [1DP5OD017897-01]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017897] Funding Source: NIH RePORTER	Office of the Director, National Institutes of Health (NIH early independence award)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	ABJ had support from the Office of the Director, National Institutes of Health (NIH early independence award, grant 1DP5OD017897-01). The research conducted was independent of any involvement from the sponsors of the study. Study sponsors were not involved in study design, data interpretation, writing of the manuscript, or the decision to submit the article for publication.	[Anonymous], 2015, HUM MORT DAT; [Anonymous], 2015, HUM MORT DAT UK; GOLDBLATT P, 1991, AM J IND MED, V20, P285, DOI 10.1002/ajim.4700200303; Hanna J, 2011, DO PRESIDENTS AGE FA; Link BG, 2013, AM SOCIOL REV, V78, P192, DOI 10.1177/0003122413477419; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; MCMICHAEL AJ, 1976, J OCCUP ENVIRON MED, V18, P165, DOI 10.1097/00043764-197603000-00009; Olshansky SJ, 2011, JAMA-J AM MED ASSOC, V306, P2328, DOI 10.1001/jama.2011.1786; Park M, 2009, ADVICE OBAMA BATTLIN; Rablen MD, 2008, J HEALTH ECON, V27, P1462, DOI 10.1016/j.jhealeco.2008.06.001; Redelmeier DA, 2001, ANN INTERN MED, V134, P955, DOI 10.7326/0003-4819-134-10-200105150-00009; Sylvestre MP, 2006, ANN INTERN MED, V145, P361, DOI 10.7326/0003-4819-145-5-200609050-00009	12	11	11	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 14	2015	351								h6424	10.1136/bmj.h6424	http://dx.doi.org/10.1136/bmj.h6424			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ4KY	26666894	Green Published, hybrid			2022-12-28	WOS:000367073200009
J	Contreras, JL; Reichman, JH				Contreras, Jorge L.; Reichman, Jerome H.			Sharing by design: Data and decentralized commons	SCIENCE			English	Editorial Material									[Contreras, Jorge L.] Univ Utah, SJ Quinney Coll Law, Salt Lake City, UT 84112 USA; [Contreras, Jorge L.] Univ Utah, Dept Human Genet, Salt Lake City, UT USA; [Reichman, Jerome H.] Duke Univ, Sch Law, Durham, NC 27706 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Duke University	Contreras, JL (corresponding author), Univ Utah, SJ Quinney Coll Law, Salt Lake City, UT 84112 USA.	jorge.contreras@law.utah.edu		Contreras, Jorge/0000-0002-7899-3060	NHGRI NIH HHS [P50 HG003391, P50HG003391] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003391] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Belmont Forum Steering Committee, 2015, PLAC STAND E INFR DA; Contreras JL, 2010, SCIENCE, V329, P393, DOI 10.1126/science.1189253; Frischmann B. M., 2014, GOVERNING KNOWLEDGE; Group on Earth Observations (GEOSS), 2015, CISC VIS NETW IND GL; Institute of Medicine, 2015, SHAR CLIN TRIAL DAT; International Council for Science, 2011, WORLD DAT SYST STRAT; Knoppers BM, 2011, GENOME MED, V3, DOI 10.1186/gm262; Murray-Rust Peter, 2010, PANTON PRINCIPLES PR; Ostrom E., 1990, GOVERNING COMMONS EV; Palfrey J. G., 2012, INTEROP PROMISE PERI; Reichman J., 2003, LAW CONTEMP PROBL, V66, P314; Reichman J. H., 2016, GOVERNING DIGITALLY; Wilbanks J., 2014, PRIVACY BIG DATA PUB	13	29	28	3	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2015	350	6266					1312	1314		10.1126/science.aaa7485	http://dx.doi.org/10.1126/science.aaa7485			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY1JL	26659039	Green Accepted, Green Submitted			2022-12-28	WOS:000366162400018
J	Cole, EA				Cole, Ellen Aronofsky			My Life as a (Fake) Patient	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 10	2015	373	24					2302	2303		10.1056/NEJMp1508706	http://dx.doi.org/10.1056/NEJMp1508706			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CY0QW	26650151				2022-12-28	WOS:000366111600004
J	Gouge, J; Satia, K; Guthertz, N; Widya, M; Thompson, AJ; Cousin, P; Dergai, O; Hernandez, N; Vannini, A				Gouge, Jerome; Satia, Karishma; Guthertz, Nicolas; Widya, Marcella; Thompson, Andrew James; Cousin, Pascal; Dergai, Oleksandr; Hernandez, Nouria; Vannini, Alessandro			Redox Signaling by the RNA Polymerase III TFIIB-Related Factor Brf2	CELL			English	Article							TRANSCRIPTION FACTOR-TFIIIB; CORE PROMOTER ELEMENT; TATA-BINDING PROTEIN; NF-KAPPA-B; CRYSTAL-STRUCTURE; TERNARY COMPLEX; CANCER; INITIATION; SUBUNIT; TBP	TFIIB-related factor 2 (Brf2) is a member of the family of TFIIB-like core transcription factors. Brf2 recruits RNA polymerase (Pol) III to type III gene-external promoters, including the U6 spliceosomal RNA and selenocysteine tRNA genes. Found only in vertebrates, Brf2 has been linked to tumorigenesis but the underlying mechanisms remain elusive. We have solved crystal structures of a human Brf2-TBP complex bound to natural promoters, obtaining a detailed view of the molecular interactions occurring at Brf2-dependent Pol III promoters and highlighting the general structural and functional conservation of human Pol II and Pol III pre-initiation complexes. Surprisingly, our structural and functional studies unravel a Brf2 redox-sensing module capable of specifically regulating Pol III transcriptional output in living cells. Furthermore, we establish Brf2 as a central redox-sensing transcription factor involved in the oxidative stress pathway and provide a mechanistic model for Brf2 genetic activation in lung and breast cancer.	[Gouge, Jerome; Satia, Karishma; Guthertz, Nicolas; Widya, Marcella; Thompson, Andrew James; Vannini, Alessandro] Inst Canc Res, Div Struct Biol, London SW7 3RP, England; [Cousin, Pascal; Dergai, Oleksandr; Hernandez, Nouria] Univ Lausanne, Fac Biol & Med, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Lausanne	Vannini, A (corresponding author), Inst Canc Res, Div Struct Biol, London SW7 3RP, England.	alessandro.vannini@icr.ac.uk	Thompson, Andrew/B-1463-2014	Thompson, Andrew/0000-0003-2413-3281; Vannini, Alessandro/0000-0001-7212-5425; Guthertz, Nicolas/0000-0001-7247-1176; Hernandez, Nouria/0000-0003-1465-4585; Gouge, Jerome/0000-0003-4734-5412	University of Lausanne; Swiss National Science Foundation (SNSF) [31003A_132958]; Career Development Faculty Program of the ICR; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/K014390/1]; BBSRC [BB/K014390/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K014390/1] Funding Source: researchfish	University of Lausanne; Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Career Development Faculty Program of the ICR; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank N. Cronin at The Institute of Cancer Research (ICR) for help with the crystallization setup and data collection. We thank the staff at beamlines ID29 and ID23eh1 of the European Synchrotron Radiation Facility (France) and at beamlines I24 and IO3 of Diamond Light Source (UK) for help with data collection. We thank the laboratories of Chris Lord and Pascal Meier for help with siRNA and FACS analysis, Tracy Berg for help with qRT-PCR, and Fredrik Wallberg of the ICR Flow Cytometry Facility and Sarah Hanrahan of the Proteomics Core Facility. We thank Richard Maraia and Aneeshkumar Arimbasseri for critical reading of an early version of the manuscript and Sonja Christoph for support throughout the project. P.C., O.D., and N.H. were supported by the University of Lausanne and by Swiss National Science Foundation (SNSF) grant 31003A_132958. A.V. acknowledges the support of the Career Development Faculty Program of the ICR. Part of this work was supported by a Biotechnology and Biological Sciences Research Council (BBSRC) new-investigator award (BB/K014390/1) to A.V.	Anandapadamanaban M, 2013, NAT STRUCT MOL BIOL, V20, P1008, DOI 10.1038/nsmb.2611; Anestal K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001846; Arimbasseri A.G., 2013, TRANSCRIPTION, V5; Biaglow JE, 2005, CANCER BIOL THER, V4, P6; Brigelius-Flohe Regina, 2012, Int J Cell Biol, V2012, P486147, DOI 10.1155/2012/486147; Brigelius-Flohe R, 2011, ANTIOXID REDOX SIGN, V15, P2335, DOI 10.1089/ars.2010.3534; Brun I, 1997, EMBO J, V16, P5730, DOI 10.1093/emboj/16.18.5730; Cabarcas S, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-47; Cabart P, 2001, J BIOL CHEM, V276, P43056, DOI 10.1074/jbc.M108515200; Carriere L, 2012, NUCLEIC ACIDS RES, V40, P270, DOI 10.1093/nar/gkr737; Deng WS, 2005, GENE DEV, V19, P2418, DOI 10.1101/gad.342405; Emmink BL, 2014, CANCER RES, V74, P6717, DOI 10.1158/0008-5472.CAN-14-1645; GHOSH G, 1995, NATURE, V373, P303, DOI 10.1038/373303a0; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; He Y, 2013, NATURE, V495, P481, DOI 10.1038/nature11991; HENRY RW, 1995, NATURE, V374, P653, DOI 10.1038/374653a0; Honda S, 2015, RNA BIOL, V12, P501, DOI 10.1080/15476286.2015.1031951; James Faresse N., 2012, PLOS GENET, V8; Jameson RR, 2002, J NUTR, V132, P1830, DOI 10.1093/jn/132.7.1830; Jones DP, 2006, ANTIOXID REDOX SIGN, V8, P1865, DOI 10.1089/ars.2006.8.1865; Juo ZS, 2003, NATURE, V422, P534, DOI 10.1038/nature01534; Kasaikina MV, 2012, BBA-MOL CELL RES, V1823, P1633, DOI 10.1016/j.bbamcr.2012.02.018; KASSAVETIS GA, 1992, CELL, V71, P1055, DOI 10.1016/0092-8674(92)90399-W; KASSAVETIS GA, 1995, P NATL ACAD SCI USA, V92, P9786, DOI 10.1073/pnas.92.21.9786; Kassavetis GA, 1999, EMBO J, V18, P5042, DOI 10.1093/emboj/18.18.5042; Knutson BA, 2011, SCIENCE, V333, P1637, DOI 10.1126/science.1207699; Lagrange T, 1998, GENE DEV, V12, P34, DOI 10.1101/gad.12.1.34; Lefevre S, 2011, NAT STRUCT MOL BIOL, V18, P352, DOI 10.1038/nsmb.1996; Lo Conte M, 2013, J BIOL CHEM, V288, P26480, DOI 10.1074/jbc.R113.467738; LOBO SM, 1992, CELL, V71, P1029, DOI 10.1016/0092-8674(92)90397-U; Lockwood WW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000315; LOPEZDELEON A, 1992, CELL, V71, P211, DOI 10.1016/0092-8674(92)90350-L; Lu M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088032; Lu M, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0553-4; Muhlbacher W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5310; Naidu S, 2011, SCIENCE, V333, P1640, DOI 10.1126/science.1207656; Naiki T, 2014, CARCINOGENESIS, V35, P1962, DOI 10.1093/carcin/bgu048; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; Oler AJ, 2010, NAT STRUCT MOL BIOL, V17, P620, DOI 10.1038/nsmb.1801; Pineda-Molina E, 2001, BIOCHEMISTRY-US, V40, P14134, DOI 10.1021/bi011459o; Protozanova E, 2004, J MOL BIOL, V342, P775, DOI 10.1016/j.jmb.2004.07.075; Sanchez-Garcia F, 2014, CELL, V159, P1461, DOI 10.1016/j.cell.2014.10.048; Saxena A, 2005, MOL CELL BIOL, V25, P9406, DOI 10.1128/MCB.25.21.9406-9418.2005; Schramm L, 2000, GENE DEV, V14, P2650, DOI 10.1101/gad.836400; Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Teichmann M, 2000, P NATL ACAD SCI USA, V97, P14200, DOI 10.1073/pnas.97.26.14200; Vannini A, 2012, MOL CELL, V45, P439, DOI 10.1016/j.molcel.2012.01.023; WANG ZX, 1995, P NATL ACAD SCI USA, V92, P7026, DOI 10.1073/pnas.92.15.7026; White RJ, 2011, NAT REV GENET, V12, P459, DOI 10.1038/nrg3001; Wilson KA, 2014, NUCLEIC ACIDS RES, V42, P6726, DOI 10.1093/nar/gku269; Wu CC, 2012, P NATL ACAD SCI USA, V109, P19232, DOI 10.1073/pnas.1211665109; Yoo MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071427	54	61	61	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 6	2015	163	6					1375	1387		10.1016/j.cell.2015.11.005	http://dx.doi.org/10.1016/j.cell.2015.11.005			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SE	26638071	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000366044800017
J	Wu, L; van den Hoogen, LL; Slater, H; Walker, PGT; Ghani, AC; Drakeley, CJ; Okell, LC				Wu, Lindsey; van den Hoogen, Lotus L.; Slater, Hannah; Walker, Patrick G. T.; Ghani, Azra C.; Drakeley, Chris J.; Okell, Lucy C.			Comparison of diagnostics for the detection of asymptomatic Plasmodium falciparum infections to inform control and elimination strategies	NATURE			English	Article							INTENSE MALARIA TRANSMISSION; POLYMERASE-CHAIN-REACTION; OF-CARE DETECTION; HIGH PREVALENCE; ENDEMIC AREA; REAL-TIME; TESTS; MICROSCOPY; PERFORMANCE; CHILDREN	The global burden of malaria has been substantially reduced over the past two decades. Future efforts to reduce malaria further will require moving beyond the treatment of clinical infections to targeting malaria transmission more broadly in the community. As such, the accurate identification of asymptomatic human infections, which can sustain a large proportion of transmission, is becoming a vital component of control and elimination programmes. We determined the relationship across common diagnostics used to measure malaria prevalence - polymerase chain reaction (PCR), rapid diagnostic test and microscopy - for the detection of Plasmodium falciparum infections in endemic populations based on a pooled analysis of cross-sectional data. We included data from more than 170,000 individuals comparing the detection by rapid diagnostic test and microscopy, and 30,000 for detection by rapid diagnostic test and PCR. The analysis showed that, on average, rapid diagnostic tests detected 41% (95% confidence interval = 26-66%) of PCR-positive infections. Data for the comparison of rapid diagnostic test to PCR detection at high transmission intensity and in adults were sparse. Prevalence measured by rapid diagnostic test and microscopy was comparable, although rapid diagnostic test detected slightly more infections than microscopy. On average, microscopy captured 87% (95% confidence interval = 74-102%) of rapid diagnostic test-positive infections. The extent to which higher rapid diagnostic test detection reflects increased sensitivity, lack of specificity or both, is unclear. Once the contribution of asymptomatic individuals to the infectious reservoir is better defined, future analyses should ideally establish optimal detection limits of new diagnostics for use in control and elimination strategies.	[Wu, Lindsey; van den Hoogen, Lotus L.; Drakeley, Chris J.] Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Immunol & Infect, London WC1E 7HT, England; [Slater, Hannah; Walker, Patrick G. T.; Ghani, Azra C.; Okell, Lucy C.] Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC Ctr Outbreak Anal & Modelling, Dept Infect Dis Epidemiol, London W2 1PG, England	University of London; London School of Hygiene & Tropical Medicine; Imperial College London	Wu, L (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Immunol & Infect, Keppel St, London WC1E 7HT, England.	lindsey.wu@lshtm.ac.uk	Ghani, Azra/B-8560-2009	Ghani, Azra/0000-0002-0007-4910; van den Hoogen, Lotus Leonie/0000-0003-4945-9085; Slater, Hannah/0000-0003-4291-7899; Walker, Patrick/0000-0002-9596-9628; Okell, Lucy/0000-0001-7202-6873; Wu, Lindsey/0000-0001-6552-3716	Bill and Melinda Gates Foundation (BMGF) Diagnostics Modelling Consortium; UK Medical Research Council (MRC); UK Department for International Development (DFID) under the MRC/DFID Concordat Agreement; UK MRC; BMGF; Medicines for Malaria Venture; UK DFID; Wellcome Trust [091924]; MRC [MR/K010174/1, G1002387, MR/L012189/1] Funding Source: UKRI; Medical Research Council [MR/K010174/1, 1487553, MR/L012189/1, G1002387, MR/K010174/1B] Funding Source: researchfish	Bill and Melinda Gates Foundation (BMGF) Diagnostics Modelling Consortium; UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development (DFID) under the MRC/DFID Concordat Agreement(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BMGF; Medicines for Malaria Venture; UK DFID; Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank F. Mwingira and I. Felger (Tanzania), I. Harris and Q. Cheng (Solomon Islands), B. Yilmaz, S. Portugal and M. Soares (Mali), S. Mharakurwa and S. Volkman (Zambia), S. Staedke and G. Dorsey (Uganda), C. Proietti and T. Bousema (Uganda), J. Stevenson, G. Stresman and J. Cox (Kenya), H. Kafy, A. Bashir, E. Malik, A. Mnzava, K. Subramaniam, K. Elmardi, I. Kleinschmidt and M. Donnelly (Sudan), M. Al-Selwei, S. Al-Eryani, A. Mnzava, A. Al-Samei, K. Mustafa, H. Atta, H. Al-Yarie, G. Zamanai and C. Barwa (Yemen) for kindly sharing their data from prevalence surveys, and the Demographic and Health Survey Programme for providing survey data. We would also like to thank L. Grignard, N. Alexander and J. Cook for sharing their expertise on statistical and diagnostic methods. This study was funded by the Bill and Melinda Gates Foundation (BMGF) Diagnostics Modelling Consortium. P.W. and L.O. acknowledge funding from fellowships jointly funded by the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat Agreement. L.W. acknowledges doctoral training funding from the UK MRC. A. G. acknowledges support from the BMGF, the Medicines for Malaria Venture, the UK MRC and the UK DFID. C.D. is funded by the Wellcome Trust grant number 091924.	Abeku T. A., 2008, MALAR J, V7; Andrews L, 2005, AM J TROP MED HYG, V73, P191, DOI 10.4269/ajtmh.2005.73.191; [Anonymous], MAL RAP DIAGN TEST P; [Anonymous], 2012, DEM HLTH SURV; [Anonymous], 2014, MAL CONTR MAL EL MAN; Anthony MP, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-316; Aydin-Schmidt B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103905; Aydin-Schmidt B, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-349; Bousema T, 2014, NAT REV MICROBIOL, V12, P833, DOI 10.1038/nrmicro3364; Bousema T, 2011, CLIN MICROBIOL REV, V24, P377, DOI 10.1128/CMR.00051-10; Brown T, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-333; Cook J., 2014, J INFECT DIS, V211; Cook J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0573-y; Cordray MS, 2012, AM J TROP MED HYG, V87, P223, DOI 10.4269/ajtmh.2012.11-0685; Dal-Bianco MP, 2007, AM J TROP MED HYG, V77, P939, DOI 10.4269/ajtmh.2007.77.939; Dondorp AM, 2005, PLOS MED, V2, P788, DOI 10.1371/journal.pmed.0020204; Endeshaw T, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-118; Falade CO, 2009, ANN TROP MED PARASIT, V103, P383, DOI 10.1179/136485909X451807; Fancony C, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-284; Faucher JF, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-224; Florey L, 2014, DHS ANAL STUDIES; Ganguly S, 2013, J CLIN MICROBIOL, V51, P1439, DOI 10.1128/JCM.03437-12; Gitonga CW, 2012, AM J TROP MED HYG, V87, P1004, DOI 10.4269/ajtmh.2012.12-0215; Golassa L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-352; Goncalves L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040633; Guerra CA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-17; Harris I, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-254; Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0; Houze S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-211; Ishengoma DS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-176; Keating J, 2009, ACTA TROP, V112, P277, DOI 10.1016/j.actatropica.2009.08.011; Kyabayinze DJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-221; Laurent A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-294; *MALERA CONS GROUP, 2011, PLOS MED, V0008; Mboera LEG, 2006, ANN TROP MED PARASIT, V100, P115, DOI 10.1179/136485906X78571; McMorrow ML, 2011, CLIN MICROBIOL INFEC, V17, P1624, DOI 10.1111/j.1469-0691.2011.03639.x; Mharakurwa S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-89; Mouatcho JC, 2013, J MED MICROBIOL, V62, P1491, DOI 10.1099/jmm.0.052506-0; Mwingira F, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-433; Neumann C G, 2008, East Afr Med J, V85, P544; Ochola LB, 2006, LANCET INFECT DIS, V6, P582, DOI 10.1016/S1473-3099(06)70579-5; Ofosu-Okyere A, 2001, PARASITOLOGY, V123, P113, DOI 10.1017/S0031182001008162; Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Ouattara AF, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-306; Pollitt LC, 2011, AM NAT, V177, P358, DOI 10.1086/658175; Proietti C, 2013, PARASITE IMMUNOL, V35, P164, DOI 10.1111/pim.12031; Rockett RJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-48; Satoguina J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-274; Schneider P, 2004, MOL BIOCHEM PARASIT, V137, P35, DOI 10.1016/j.molbiopara.2004.03.018; Sharp SJ, 2000, STAT MED, V19, P3251, DOI 10.1002/1097-0258(20001215)19:23<3251::AID-SIM625>3.0.CO;2-2; Shekalaghe SA, 2007, TROP MED INT HEALTH, V12, P547, DOI 10.1111/j.1365-3156.2007.01821.x; Slater HC, 2015, NATURE, V528, pS94, DOI 10.1038/nature16040; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Sousa-Figueiredo JC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-245; Stauffer WM, 2006, PEDIATR INFECT DIS J, V25, P948, DOI 10.1097/01.inf.0000235747.28644.6f; Stevenson JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077641; Stone W, 2015, TRENDS PARASITOL, V31, P287, DOI 10.1016/j.pt.2015.04.004; Stresman GH, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-265; Swarthout TD, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-58; Tietje K, 2014, TRENDS PARASITOL, V30, P259, DOI 10.1016/j.pt.2014.03.003; Tiono AB, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-30; Tusting LS, 2014, ADV PARASIT, V84, P151, DOI 10.1016/B978-0-12-800099-1.00003-X; United Nations, 2010, WORLD POPULATION PRO; Wanji S, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-89; WHO, 2013, WORLD MALARIA REPORT 2013, P1; World Health Organisation, 2010, PAR CONF MAL DIAGN; Ye Y, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-160; Yeka A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118901; Yilmaz B, 2014, CELL, V159, P1277, DOI 10.1016/j.cell.2014.10.053	70	130	130	2	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					S86	S93		10.1038/nature16039	http://dx.doi.org/10.1038/nature16039			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX3NO	26633770	Green Submitted, hybrid			2022-12-28	WOS:000365606000015
J	Marchalik, D; Jurecic, A				Marchalik, Daniel; Jurecic, Ann			We, the animals	LANCET			English	Editorial Material									[Marchalik, Daniel] Georgetown Univ, Sch Med, Dept Urol & Literature & Med Track, Washington, DC 20007 USA; [Jurecic, Ann] Rutgers State Univ, Dept English, New Brunswick, NJ 08903 USA	Georgetown University; Rutgers State University New Brunswick	Marchalik, D (corresponding author), Georgetown Univ, Sch Med, Dept Urol & Literature & Med Track, Washington, DC 20007 USA.	dan.marchalik@gmail.com		Marchalik, Daniel/0000-0002-6912-1252					0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 28	2015	386	10009					2132	2132		10.1016/S0140-6736(15)01058-2	http://dx.doi.org/10.1016/S0140-6736(15)01058-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX8YW	26638955	Bronze			2022-12-28	WOS:000365992600017
J	Wu, S; Powers, S; Zhu, W; Hannun, YA				Wu, Song; Powers, Scott; Zhu, Wei; Hannun, Yusuf A.			Substantial contribution of extrinsic risk factors to cancer development	NATURE			English	Article								Recent research has highlighted a strong correlation between tissue-specific cancer risk and the lifetime number of tissue-specific stem-cell divisions. Whether such correlation implies a high unavoidable intrinsic cancer risk has become a key public health debate with the dissemination of the 'bad luck' hypothesis. Here we provide evidence that intrinsic risk factors contribute only modestly (less than similar to 10-30% of lifetime risk) to cancer development. First, we demonstrate that the correlation between stem-cell division and cancer risk does not distinguish between the effects of intrinsic and extrinsic factors. We then show that intrinsic risk is better estimated by the lower bound risk controlling for total stem-cell divisions. Finally, we show that the rates of endogenous mutation accumulation by intrinsic processes are not sufficient to account for the observed cancer risks. Collectively, we conclude that cancer risk is heavily influenced by extrinsic factors. These results are important for strategizing cancer prevention, research and public health.	[Wu, Song; Powers, Scott; Zhu, Wei] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA; [Wu, Song; Powers, Scott; Zhu, Wei; Hannun, Yusuf A.] SUNY Stony Brook, Stony Brook Cancer Ctr, Hlth Sci Ctr, Stony Brook, NY 11794 USA; [Powers, Scott; Hannun, Yusuf A.] SUNY Stony Brook, Dept Pathol, Hlth Sci Ctr, Stony Brook, NY 11794 USA; [Hannun, Yusuf A.] SUNY Stony Brook, Dept Med, Hlt Sci Ctr, Stony Brook, NY 11794 USA; [Hannun, Yusuf A.] SUNY Stony Brook, Dept Biochem, Hlt Sci Ctr, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Wu, S (corresponding author), SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA.	Song.Wu@stonybrook.edu; Yusuf.Hannun@sbumed.org	wang, edwin/G-5372-2010	Powers, Scott/0000-0003-2769-1932	NCI [97132, 168409]; Stony Brook NYSTEM award [C026716]; NATIONAL CANCER INSTITUTE [R01CA087584, R01CA172517, P01CA097132, P30CA045508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118128] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Stony Brook NYSTEM award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Obeid for constructive comments. This work was supported in part by NCI grants 97132 and 168409 and Stony Brook NYSTEM award C026716.	Alexandrov LB, 2014, CURR OPIN GENET DEV, V24, P52, DOI 10.1016/j.gde.2013.11.014; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Altenberg L., 2015, STAT PROBLEMS PAPER; Ashford NA, 2015, SCIENCE, V347, P727, DOI 10.1126/science.aaa6246; BLOT WJ, 1988, CANCER RES, V48, P3282; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Bozic I, 2013, SCIENCE, V342, P938, DOI 10.1126/science.1247887; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Dela Cruz CS, 2011, CLIN CHEST MED, V32, P605, DOI 10.1016/j.ccm.2011.09.001; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Frisch M, 1997, NEW ENGL J MED, V337, P1350, DOI 10.1056/NEJM199711063371904; Gotay C, 2015, SCIENCE, V347, P728, DOI 10.1126/science.aaa6462; Gray J, 2009, INT J OCCUP ENV HEAL, V15, P43; Haggar Fatima A, 2009, Clin Colon Rectal Surg, V22, P191, DOI 10.1055/s-0029-1242458; Johnson .T, 2007, ALIMENT PHARM THER, V26, P161, DOI 10.1111/j.1365-2036.2007.03371.x; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Kamangar F, 2009, GASTROENTEROL CLIN N, V38, P27, DOI 10.1016/j.gtc.2009.01.004; Koh HK, 1996, ARCH DERMATOL, V132, P436, DOI 10.1001/archderm.132.4.436; O'Callaghan M, 2015, SCIENCE, V347, P729, DOI 10.1126/science.aaa6212; Parkin DM, 2011, BRIT J CANCER, V105, pS66, DOI 10.1038/bjc.2011.486; Potter JD, 2015, SCIENCE, V347, P727, DOI 10.1126/science.aaa6507; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; *SEER PROGR, 2015, SEER STAT DAT INC; Sell S, 2004, CRIT REV ONCOL HEMAT, V51, P1, DOI 10.1016/j.critrevonc.2004.04.007; SHIMIZU H, 1991, BRIT J CANCER, V63, P963, DOI 10.1038/bjc.1991.210; Song MY, 2015, SCIENCE, V347, P728, DOI 10.1126/science.aaa6094; Tomasetti C, 2015, SCIENCE, V347, P729, DOI 10.1126/science.aaa6592; Tomasetti C, 2015, P NATL ACAD SCI USA, V112, P118, DOI 10.1073/pnas.1421839112; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Tomasetti C, 2013, P NATL ACAD SCI USA, V110, P1999, DOI 10.1073/pnas.1221068110; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Webb PM, 2001, GUT, V49, P347, DOI 10.1136/gut.49.3.347; Wild C, 2015, SCIENCE, V347, P728, DOI 10.1126/science.aaa6799	35	378	393	2	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 7	2016	529	7584					43	47		10.1038/nature16166	http://dx.doi.org/10.1038/nature16166			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6VY	26675728	Green Accepted			2022-12-28	WOS:000367944900041
J	Feldman, AM; Haller, JA; DeKosky, ST				Feldman, Arthur M.; Haller, Julia A.; DeKosky, Steven T.			Valsartan/Sacubitril for Heart Failure Reconciling Disparities Between Preclinical and Clinical Investigations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ALZHEIMERS-DISEASE; NEPRILYSIN		[Feldman, Arthur M.] Temple Univ, Lewis Katz Sch Med, Dept Med, Philadelphia, PA 19140 USA; [Feldman, Arthur M.] Temple Univ, Lewis Katz Sch Med, Dept Physiol, Philadelphia, PA 19140 USA; [Haller, Julia A.] Wills Eye Inst, Philadelphia, PA USA; Thomas Jefferson Univ, Philadelphia, PA 19107 USA; [DeKosky, Steven T.] Univ Florida, Coll Med, Dept Neurol, McKnight Brain Inst, Gainesville, FL 32611 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Jefferson University; Jefferson University; State University System of Florida; University of Florida	Feldman, AM (corresponding author), Temple Univ, Lewis Katz Sch Med, Dept Med, 3500 N Broad St,Ste 1150, Philadelphia, PA 19140 USA.	arthur.feldman@tuhs.temple.edu		DeKosky, Steven/0000-0003-3743-2758				Baranello RJ, 2015, CURR ALZHEIMER RES, V12, P32, DOI 10.2174/1567205012666141218140953; Erickson MA, 2013, J CEREBR BLOOD F MET, V33, P1500, DOI 10.1038/jcbfm.2013.135; Krucoff MW, 2015, JAMA-J AM MED ASSOC, V314, P1691, DOI 10.1001/jama.2015.11036; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; Nalivaeva NN, 2014, FRONT AGING NEUROSCI, V6, DOI [10.3389/tnagi.2014.00235, 10.3389/fnagi.2014.00235]; Ohno-Matsui K, 2011, PROG RETIN EYE RES, V30, P217, DOI 10.1016/j.preteyeres.2011.02.004; Parthasarathy R, 2015, EXP EYE RES, V138, P134, DOI 10.1016/j.exer.2015.06.027; US Food and Drug Administration, NEW DRUG APPL APPR L	8	27	27	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2016	315	1					25	26		10.1001/jama.2015.17632	http://dx.doi.org/10.1001/jama.2015.17632			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA0YH	26641736				2022-12-28	WOS:000367523000008
J	Marth, CJ; Gallego, GM; Lee, JC; Lebold, TP; Kulyk, S; Kou, KGM; Qin, J; Lilien, R; Sarpong, R				Marth, C. J.; Gallego, G. M.; Lee, J. C.; Lebold, T. P.; Kulyk, S.; Kou, K. G. M.; Qin, J.; Lilien, R.; Sarpong, R.			Network-analysis-guided synthesis of weisaconitine D and liljestrandinine	NATURE			English	Article							ASYMMETRIC DIELS-ALDER; DEVELOPMENT KIT CDK; SOURCE JAVA LIBRARY; MOLECULAR-OXYGEN; CHEMISTRY; ALKALOIDS; OLEFINS	General strategies for the chemical synthesis of organic compounds, especially of architecturally complex natural products, are not easily identified. Here we present a method to establish a strategy for such syntheses, which uses network analysis. This approach has led to the identification of a versatile synthetic intermediate that facilitated syntheses of the diterpenoid alkaloids weisaconitine D and liljestrandinine, and the core of gomandonine. We also developed a web-based graphing program that allows network analysis to be easily performed on molecules with complex frameworks. The diterpenoid alkaloids comprise some of the most architecturally complex and functional-group-dense secondary metabolites isolated. Consequently, they present a substantial challenge for chemical synthesis. The synthesis approach described here is a notable departure from other single-target-focused strategies adopted for the syntheses of related structures. Specifically, it affords not only the targeted natural products, but also intermediates and derivatives in the three families of diterpenoid alkaloids (C-18, C-19 and C-20), and so provides a unified synthetic strategy for these natural products. This work validates the utility of network analysis as a starting point for identifying strategies for the syntheses of architecturally complex secondary metabolites.	[Marth, C. J.; Gallego, G. M.; Lee, J. C.; Lebold, T. P.; Kulyk, S.; Kou, K. G. M.; Sarpong, R.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Qin, J.; Lilien, R.] Cadre Res Labs, Chicago, IL 60654 USA	University of California System; University of California Berkeley	Sarpong, R (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	rsarpong@berkeley.edu	Kou, Kevin GM/A-5046-2015	Kou, Kevin GM/0000-0002-4676-8846; Qin, Jason/0000-0003-3510-7994; Sarpong, Richmond/0000-0002-0028-6323	National Institute of General Medical Sciences [RO1 GM084906]; National Science Foundation; NIH [5F31GM095238, S10-RR027172, SRR023679A, 1S10RR016634-01]; NSERC (Canada); NSF [CHE 9633007, CHE-0130862]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027172, S10RR016634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084906, F31GM095238] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSERC (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSF(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by award no. RO1 GM084906 from the National Institute of General Medical Sciences. C.J.M. acknowledges a National Science Foundation graduate fellowship. G.M.G. is grateful to the NIH (5F31GM095238) for a graduate fellowship. T.P.L. and K.G.M.K. acknowledge postdoctoral fellowships from the NSERC (Canada). We are grateful to X.-Y. Liu for copies of <SUP>1</SUP>H and <SUP>13</SUP>C NMR spectra for liljestrandinine (3). X-ray crystallography was performed by A. DiPasquale (NIH Shared Instrumentation Grant S10-RR027172). The AV-600, AV-500, DRX-500 and AVB-400 NMR instruments were partially supported by NIH grant SRR023679A, NIH grant 1S10RR016634-01, NSF grant CHE 9633007 and NSF grant CHE-0130862, respectively. We acknowledge E. Fisher (Pfizer) for contributions toward a practical synthesis of diene 8. We thank K. Owens for help with generating '.sdf' files, and A. Chen, N. Kelly and K. Evens for the preparation of starting materials. We acknowledge M. Weber for computational calculations pertaining to allylic alcohol 21 and its isomer.	Anger T, 2001, J MED CHEM, V44, P115, DOI 10.1021/jm000155h; Bandyopadhyaya AK, 2010, BIOORG MED CHEM LETT, V20, P6680, DOI 10.1016/j.bmcl.2010.09.008; Catterall WA, 2007, TOXICON, V49, P124, DOI 10.1016/j.toxicon.2006.09.022; Chan TYK, 2009, CLIN TOXICOL, V47, P279, DOI 10.1080/15563650902904407; Cheng H, 2012, TETRAHEDRON, V68, P1171, DOI 10.1016/j.tet.2011.11.063; Cherney EC, 2014, J AM CHEM SOC, V136, P12592, DOI [10.1021/ja507321j, 10.1021/ja507321J]; Corey E. J., 1989, LOGIC CHEM SYNTHESIS, P43; COREY EJ, 1975, J AM CHEM SOC, V97, P6116, DOI 10.1021/ja00854a026; Cuerva JM, 2006, ANGEW CHEM INT EDIT, V45, P5522, DOI 10.1002/anie.200600831; EVANS DA, 1988, J AM CHEM SOC, V110, P6917, DOI 10.1021/ja00228a068; Farina V, 2006, CHEM REV, V106, P2734, DOI 10.1021/cr040700c; Furstner A, 2007, ANGEW CHEM INT EDIT, V46, P3410, DOI 10.1002/anie.200604335; Hoffmann R. W, 2009, ELEMENTS SYNTHESIS P; Hudlicky T., 2007, WAY SYNTHESIS EVOLUT; ISAYAMA S, 1990, B CHEM SOC JPN, V63, P1305, DOI 10.1246/bcsj.63.1305; ISAYAMA S, 1989, CHEM LETT, P573, DOI 10.1246/cl.1989.573; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Kwok R, 2010, NATURE, V463, P288, DOI 10.1038/463288a; Lee J, 2009, ORG LETT, V11, P5598, DOI 10.1021/ol902309z; Legault C., 2009, CYLVIEW 1 0 B; MACMILLAN J, 1999, COMPREHENSIVE NATURA, V2, P217; MARX JN, 1972, J ORG CHEM, V37, P4489, DOI 10.1021/jo00799a602; Negishi EI, 2011, ANGEW CHEM INT EDIT, V50, P6738, DOI 10.1002/anie.201101380; Nishiyama Y, 2014, J AM CHEM SOC, V136, P6598, DOI 10.1021/ja503023h; Nusim S. H., 2009, DRUGS PHARM SCI, V205; Orimoto K, 2013, ORG LETT, V15, P768, DOI 10.1021/ol303381c; Oyama H, 2015, TETRAHEDRON-ASYMMETR, V26, P262, DOI 10.1016/j.tetasy.2015.01.012; Pinheiro ED, 2008, ANTIVIR RES, V79, P143, DOI 10.1016/j.antiviral.2008.05.001; Prabhakaran J, 2000, SYNLETT, P658; Quideau S, 2003, ARKIVOC, P106, DOI 10.3998/ark.5550190.0004.613; Schaefer B., 2014, NATURAL PRODUCTS CHE, P209; Schotes C, 2012, J AM CHEM SOC, V134, P1331, DOI 10.1021/ja210372u; Schotes C, 2010, J AM CHEM SOC, V132, P3652, DOI 10.1021/ja910039e; Service RF, 1999, SCIENCE, V285, P184, DOI 10.1126/science.285.5425.184; Shenvi RA, 2009, ACCOUNTS CHEM RES, V42, P530, DOI 10.1021/ar800182r; Shi Y, 2013, J AM CHEM SOC, V135, P14313, DOI 10.1021/ja4064958; Steinbeck C, 2006, CURR PHARM DESIGN, V12, P2111, DOI 10.2174/138161206777585274; Steinbeck C, 2003, J CHEM INF COMP SCI, V43, P493, DOI 10.1021/ci025584y; Vakhitova YV, 2013, RUSS J BIOORG CHEM+, V39, P92, DOI 10.1134/S1068162013010111; White MC, 2012, SYNLETT, P2746, DOI 10.1055/s-0032-1317701; WIESNER K, 1974, J AM CHEM SOC, V96, P4990, DOI 10.1021/ja00822a048; WIESNER K, 1975, PURE APPL CHEM, V41, P93, DOI 10.1351/pac197541010093; Yokota S., 2008, Japanese patent, Patent No. [2008-024670, 2008024670]	43	77	77	2	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2015	528	7583					493	498		10.1038/nature16440	http://dx.doi.org/10.1038/nature16440			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ3GH	26675722	Green Accepted, Green Submitted			2022-12-28	WOS:000366991900040
J	Schaapveld, M; Aleman, BMP; van Eggermond, AM; Janus, CPM; Krol, ADG; van der Maazen, RWM; Roesink, J; Raemaekers, JMM; de Boer, JP; Zijlstra, JM; van Imhoff, GW; Petersen, EJ; Poortmans, PMP; Beijert, M; Lybeert, ML; Mulder, I; Visser, O; Louwman, MWJ; Krul, IM; Lugtenburg, PJ; van Leeuwen, FE				Schaapveld, Michael; Aleman, Berthe M. P.; van Eggermond, Anna M.; Janus, Cecile P. M.; Krol, Augustinus D. G.; van der Maazen, Richard W. M.; Roesink, Judith; Raemaekers, John M. M.; de Boer, Jan Paul; Zijlstra, Josee M.; van Imhoff, Gustaaf W.; Petersen, Eefke J.; Poortmans, Philip M. P.; Beijert, Max; Lybeert, Marnix L.; Mulder, Ina; Visser, Otto; Louwman, Marieke W. J.; Krul, Inge M.; Lugtenburg, Pieternella J.; van Leeuwen, Flora E.			Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COLLABORATIVE BRITISH COHORT; LUNG-CANCER; STOMACH-CANCER; FOLLOW-UP; DISEASE; RADIOTHERAPY; CHEMOTHERAPY; SURVIVORS; MALIGNANCY; NEOPLASMS	BACKGROUND Survivors of Hodgkin's lymphoma are at increased risk for treatment-related subsequent malignant neoplasms. The effect of less toxic treatments, introduced in the late 1980s, on the long-term risk of a second cancer remains unknown. METHODS We enrolled 3905 persons in the Netherlands who had survived for at least 5 years after the initiation of treatment for Hodgkin's lymphoma. Patients had received treatment between 1965 and 2000, when they were 15 to 50 years of age. We compared the risk of a second cancer among these patients with the risk that was expected on the basis of cancer incidence in the general population. Treatment-specific risks were compared within the cohort. RESULTS With a median follow-up of 19.1 years, 1055 second cancers were diagnosed in 908 patients, resulting in a standardized incidence ratio (SIR) of 4.6 (95% confidence interval [CI], 4.3 to 4.9) in the study cohort as compared with the general population. The risk was still elevated 35 years or more after treatment (SIR, 3.9; 95% CI, 2.8 to 5.4), and the cumulative incidence of a second cancer in the study cohort at 40 years was 48.5% (95% CI, 45.4 to 51.5). The cumulative incidence of second solid cancers did not differ according to study period (1965-1976, 1977-1988, or 1989-2000) (P = 0.71 for heterogeneity). Although the risk of breast cancer was lower among patients who were treated with supradiaphragmatic-field radiotherapy not including the axilla than among those who were exposed to mantle-field irradiation (hazard ratio, 0.37; 95% CI, 0.19 to 0.72), the risk of breast cancer was not lower among patients treated in the 1989-2000 study period than among those treated in the two earlier periods. A cumulative procarbazine dose of 4.3 g or more per square meter of body-surface area (which has been associated with premature menopause) was associated with a significantly lower risk of breast cancer (hazard ratio for the comparison with no chemotherapy, 0.57; 95% CI, 0.39 to 0.84) but a higher risk of gastrointestinal cancer (hazard ratio, 2.70; 95% CI, 1.69 to 4.30). CONCLUSIONS The risk of second solid cancers did not appear to be lower among patients treated in the most recent calendar period studied (1989-2000) than among those treated in earlier periods. The awareness of an increased risk of second cancer remains crucial for survivors of Hodgkin's lymphoma. (Funded by the Dutch Cancer Society.)	[Schaapveld, Michael; van Eggermond, Anna M.; Mulder, Ina; Krul, Inge M.; van Leeuwen, Flora E.] Netherlands Canc Inst, Dept Epidemiol, NL-1066 CX Amsterdam, Netherlands; [Aleman, Berthe M. P.] Netherlands Canc Inst, Dept Radiat Oncol, NL-1066 CX Amsterdam, Netherlands; [de Boer, Jan Paul] Netherlands Canc Inst, Dept Hematol, NL-1066 CX Amsterdam, Netherlands; [Zijlstra, Josee M.] Vrije Univ Amsterdam, Med Ctr Amsterdam, Dept Hematol, Amsterdam, Netherlands; [Schaapveld, Michael; Mulder, Ina; Visser, Otto; Louwman, Marieke W. J.] Univ Med Ctr Utrecht, Netherlands Comprehens Canc Org, Utrecht, Netherlands; [Roesink, Judith] Univ Med Ctr Utrecht, Dept Radiat Oncol, Utrecht, Netherlands; [Petersen, Eefke J.] Univ Med Ctr Utrecht, Dept Hematol, Utrecht, Netherlands; [Janus, Cecile P. M.] Erasmus MC, Dept Radiat Oncol, Inst Canc, Rotterdam, Netherlands; [Lugtenburg, Pieternella J.] Erasmus MC, Dept Hematol, Inst Canc, Rotterdam, Netherlands; [Krol, Augustinus D. G.] Leiden Univ, Med Ctr, Dept Radiat Oncol, Leiden, Netherlands; [van der Maazen, Richard W. M.; Poortmans, Philip M. P.] Radboud Univ Nijmegen, Med Ctr, Dept Radiat Oncol, NL-6525 ED Nijmegen, Netherlands; [Mulder, Ina] Canisius Wilhelmina Hosp, Dept Educ & Sci, Nijmegen, Netherlands; [Raemaekers, John M. M.] Radboud Univ Nijmegen, Med Ctr, Dept Hematol, Arnhem, Netherlands; [van Imhoff, Gustaaf W.] Univ Groningen, Univ Med Ctr Groningen, Dept Hematol, Groningen, Netherlands; [Beijert, Max] Univ Groningen, Univ Med Ctr Groningen, Dept Radiat Oncol, Groningen, Netherlands; [Poortmans, Philip M. P.] Dr Bernard Verbeeten Inst, Dept Radiat Oncol, Tilburg, Netherlands; [Lybeert, Marnix L.] Catharina Hosp, Dept Radiotherapy, Eindhoven, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Vrije Universiteit Amsterdam; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen; Canisius-Wilhelmina Hospital; Radboud University Nijmegen; University of Groningen; University of Groningen; Instituut Verbeeten; Catharina Hospital	van Leeuwen, FE (corresponding author), Netherlands Canc Inst, Dept Epidemiol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	f.v.leeuwen@nki.nl	van der Maazen, R.W.M./L-4498-2015; Poortmans, P.M.P./L-4581-2015; Schaapveld, Michael/ABC-9714-2020; Louwman, Marieke WJ/N-5267-2018	Louwman, Marieke WJ/0000-0001-9011-6741; Janus, Cecile/0000-0003-3860-8698; Krol, Stijn/0000-0002-3257-3634; Schaapveld, Michael/0000-0003-4390-7182	Dutch Cancer Society [2010-4720]	Dutch Cancer Society(KWF Kankerbestrijding)	Supported by a grant (2010-4720) from the Dutch Cancer Society.	Aleman BMP, 2007, BLOOD, V109, P1878, DOI 10.1182/blood-2006-07-034405; Bhatia S, 2003, J CLIN ONCOL, V21, P4386, DOI 10.1200/JCO.2003.11.059; Boshuizen Hendriek C, 2010, Epidemiol Perspect Innov, V7, P4, DOI 10.1186/1742-5573-7-4; BRESLOW NE, 1987, IARC SCI PUBLICATION, V82; Cooke R, 2013, BRIT J CANCER, V108, P2399, DOI 10.1038/bjc.2013.219; De Bruin ML, 2009, J CLIN ONCOL, V27, P4239, DOI 10.1200/JCO.2008.19.9174; De Bruin ML, 2009, BLOOD, V113, P3679, DOI 10.1182/blood-2008-10-184705; Diehl V, 2004, LANCET ONCOL, V5, P19, DOI 10.1016/S1470-2045(03)01320-2; Dores GM, 2014, ANN ONCOL, V25, P2073, DOI 10.1093/annonc/mdu287; Dores GM, 2002, J CLIN ONCOL, V20, P3484, DOI 10.1200/JCO.2002.09.038; Ederer F., 1959, INSTRUCTIONS IBM 650; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Hodgson DC, 2007, J CLIN ONCOL, V25, P1489, DOI 10.1200/JCO.2006.09.0936; Kooistra HAM, 2015, LEUKEMIA LYMPHOMA, V56, P230, DOI 10.3109/10428194.2014.910658; Maraldo MV, 2013, ANN ONCOL, V24, P2113, DOI 10.1093/annonc/mdt156; Morton LM, 2014, HAEMATOLOGICA, V99, pE193, DOI 10.3324/haematol.2014.108258; Morton LM, 2013, J CLIN ONCOL, V31, P3369, DOI 10.1200/JCO.2013.50.6832; Ng AK, 2002, BLOOD, V100, P1989, DOI 10.1182/blood-2002-02-0634; Ng AK, 2013, J CLIN ONCOL, V31, P2282, DOI 10.1200/JCO.2012.46.5732; Specht L, 2014, INT J RADIAT ONCOL, V89, P854, DOI 10.1016/j.ijrobp.2013.05.005; Swerdlow AJ, 2000, J CLIN ONCOL, V18, P498, DOI 10.1200/JCO.2000.18.3.498; Swerdlow AJ, 2001, J CLIN ONCOL, V19, P1610, DOI 10.1200/JCO.2001.19.6.1610; Swerdlow AJ, 2012, J CLIN ONCOL, V30, P2745, DOI 10.1200/JCO.2011.38.8835; Swerdlow AJ, 2011, J CLIN ONCOL, V29, P4096, DOI 10.1200/JCO.2011.34.8268; Travis LB, 2003, JAMA-J AM MED ASSOC, V290, P465, DOI 10.1001/jama.290.4.465; Travis LB, 2002, JNCI-J NATL CANCER I, V94, P182, DOI 10.1093/jnci/94.3.182; van den Belt-Dusebout AW, 2009, INT J RADIAT ONCOL, V75, P1420, DOI 10.1016/j.ijrobp.2009.01.073; van Eggermond AM, 2014, BLOOD, V124, P319, DOI 10.1182/blood-2013-10-532184; van Leeuwen FE, 2000, J CLIN ONCOL, V18, P487, DOI 10.1200/JCO.2000.18.3.487; VANLEEUWEN FE, 1995, JNCI-J NATL CANCER I, V87, P1530, DOI 10.1093/jnci/87.20.1530; VANLEEUWEN FE, 1994, J CLIN ONCOL, V12, P312, DOI 10.1200/JCO.1994.12.2.312; ZARATEOSORNO A, 1992, AM J SURG PATHOL, V16, P885, DOI 10.1097/00000478-199209000-00007	32	345	350	2	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 24	2015	373	26					2499	2511		10.1056/NEJMoa1505949	http://dx.doi.org/10.1056/NEJMoa1505949			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ7SG	26699166	Green Published, Bronze			2022-12-28	WOS:000367299700006
J	Husmann, D; Uchino, S; Krinner, S; Lebrat, M; Giamarchi, T; Esslinger, T; Brantut, JP				Husmann, Dominik; Uchino, Shun; Krinner, Sebastian; Lebrat, Martin; Giamarchi, Thierry; Esslinger, Tilman; Brantut, Jean-Philippe			Connecting strongly correlated superfluids by a quantum point contact	SCIENCE			English	Article							CONDUCTANCE; TRANSITION; TRANSPORT	Point contacts provide simple connections between macroscopic particle reservoirs. In electric circuits, strong links between metals, semiconductors, or superconductors have applications for fundamental condensed-matter physics as well as quantum information processing. However, for complex, strongly correlated materials, links have been largely restricted to weak tunnel junctions. We studied resonantly interacting Fermi gases connected by a tunable, ballistic quantum point contact, finding a nonlinear current-bias relation. At low temperature, our observations agree quantitatively with a theoretical model in which the current originates from multiple Andreev reflections. In a wide contact geometry, the competition between superfluidity and thermally activated transport leads to a conductance minimum. Our system offers a controllable platform for the study of mesoscopic devices based on strongly interacting matter.	[Husmann, Dominik; Krinner, Sebastian; Lebrat, Martin; Esslinger, Tilman; Brantut, Jean-Philippe] ETH, Inst Quantum Elect, CH-8093 Zurich, Switzerland; [Uchino, Shun; Giamarchi, Thierry] Univ Geneva, Dept Quantum Matter Phys, CH-1211 Geneva, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Geneva	Esslinger, T (corresponding author), ETH, Inst Quantum Elect, CH-8093 Zurich, Switzerland.	esslinger@phys.ethz.ch	Husmann, Dominik/AAM-4052-2021; Esslinger, Tilman/M-9022-2016; Giamarchi, Thierry/B-5735-2008; Brantut, Jean-Philippe/G-2793-2013; Uchino, Shun/D-3881-2017	Husmann, Dominik/0000-0003-4291-1075; Esslinger, Tilman/0000-0002-8333-107X; Giamarchi, Thierry/0000-0001-7409-5071; Lebrat, Martin/0000-0002-2123-6026; Brantut, Jean-Philippe/0000-0002-4610-6682; Uchino, Shun/0000-0002-3007-1753	Swiss National Center of Competence in Research Quantum Science and Technology; European Research Council; EU Seventh Framework Programme project Simulators and Interfaces with Quantum Systems; Swiss National Science Foundation; Army Research Office-Multidisciplinary University Research Initiative Non-equilibrium Many-body Dynamics grant [W911NF-14-1-0003]	Swiss National Center of Competence in Research Quantum Science and Technology; European Research Council(European Research Council (ERC)European Commission); EU Seventh Framework Programme project Simulators and Interfaces with Quantum Systems; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Army Research Office-Multidisciplinary University Research Initiative Non-equilibrium Many-body Dynamics grant	We acknowledge discussions with C. Berthod, J. von Delft, E. Demler, C. Grenier, P. Torma, J. Blatter, and M. Zaccanti. We acknowledge financing from Swiss National Center of Competence in Research Quantum Science and Technology, the European Research Council project Synthetic Quantum Many-Body Systems, the EU Seventh Framework Programme project Simulators and Interfaces with Quantum Systems, Swiss National Science Foundation under division II and the Ambizione program, and the Army Research Office-Multidisciplinary University Research Initiative Non-equilibrium Many-body Dynamics grant (W911NF-14-1-0003). Data are available upon request to T.E.	Albiez M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.010402; AVENEL O, 1988, PHYS REV LETT, V60, P416, DOI 10.1103/PhysRevLett.60.416; AVERIN D, 1995, PHYS REV LETT, V75, P1831, DOI 10.1103/PhysRevLett.75.1831; BLONDER GE, 1982, PHYS REV B, V25, P4515, DOI 10.1103/PhysRevB.25.4515; Bolech CJ, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.024517; Bolech CJ, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.127001; Brantut JP, 2013, SCIENCE, V342, P713, DOI 10.1126/science.1242308; Buchler HP, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.067007; Cao C, 2011, SCIENCE, V331, P58, DOI 10.1126/science.1195219; Cuevas JC, 1996, PHYS REV B, V54, P7366, DOI 10.1103/PhysRevB.54.7366; Davis JC, 2002, REV MOD PHYS, V74, P741, DOI 10.1103/RevModPhys.74.741; Fischer O, 2007, REV MOD PHYS, V79, P353, DOI 10.1103/RevModPhys.79.353; Giamarchi T., 2003, QUANTUM PHYS ONE DIM, V121; Ho TL, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.090402; Jendrzejewski F, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.045305; Kamenev A., 2011, FIELD THEORY NONEQUI; Krinner S, 2015, NATURE, V517, P64, DOI 10.1038/nature14049; Ku MJH, 2012, SCIENCE, V335, P563, DOI 10.1126/science.1214987; Labouvie R, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.050601; LeBlanc LJ, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.025302; Leggett AJ, 2006, QUANTUM LIQUIDS BOSE; Liu BY, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.051602; MASLOV DL, 1995, PHYS REV B, V52, pR5539; Nascimbene S, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.215303; PONOMARENKO VV, 1995, PHYS REV B, V52, pR8666, DOI 10.1103/PhysRevB.52.R8666; Ramanathan A, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.130401; Safi I, 1995, PHYS REV B, V52, P17040, DOI 10.1103/PhysRevB.52.R17040; Sagi Y, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.075301; Scheer E, 1997, PHYS REV LETT, V78, P3535, DOI 10.1103/PhysRevLett.78.3535; Schirotzek A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.140403; Stadler D, 2012, NATURE, V491, P736, DOI 10.1038/nature11613; VANDERPOST N, 1994, PHYS REV LETT, V73, P2611, DOI 10.1103/PhysRevLett.73.2611; Zagoskin A M, 1998, GRAD TEXT C; Zurn G, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.135301; Zwerger W., 2011, BCS BEC CROSSOVER UN, V836; Zwierlein MW, 2005, NATURE, V435, P1047, DOI 10.1038/nature03858	36	88	90	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2015	350	6267					1498	1501		10.1126/science.aac9584	http://dx.doi.org/10.1126/science.aac9584			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY7LY	26680191	Green Submitted			2022-12-28	WOS:000366591100051
J	Tan, LM; Zhang, KX; Pecot, MY; Nagarkar-Jaiswal, S; Lee, PT; Takemura, SY; McEwen, JM; Nern, A; Xu, SW; Tadros, W; Chen, ZQ; Zinn, K; Bellen, HJ; Morey, M; Zipursky, SL				Tan, Liming; Zhang, Kelvin Xi; Pecot, Matthew Y.; Nagarkar-Jaiswal, Sonal; Lee, Pei-Tseng; Takemura, Shin-ya; McEwen, Jason M.; Nern, Aljoscha; Xu, Shuwa; Tadros, Wael; Chen, Zhenqing; Zinn, Kai; Bellen, Hugo J.; Morey, Marta; Zipursky, S. Lawrence			Ig Superfamily Ligand and Receptor Pairs Expressed in Synaptic Partners in Drosophila	CELL			English	Article							RICH REPEAT PROTEINS; AXON GUIDANCE; VISUAL-SYSTEM; LAYER SPECIFICITY; SELF-AVOIDANCE; GENE-FUNCTION; OPTIC LOBE; C-ELEGANS; IN-VIVO; FAMILY	Information processing relies on precise patterns of synapses between neurons. The cellular recognition mechanisms regulating this specificity are poorly understood. In the medulla of the Drosophila visual system, different neurons form synaptic connections in different layers. Here, we sought to identify candidate cell recognition molecules underlying this specificity. Using RNA sequencing (RNA-seq), we show that neurons with different synaptic specificities express unique combinations of mRNAs encoding hundreds of cell surface and secreted proteins. Using RNA-seq and protein tagging, we demonstrate that 21 paralogs of the Dpr family, a subclass of immunoglobulin (Ig)-domain containing proteins, are expressed in unique combinations in homologous neurons with different layer-specific synaptic connections. Dpr interacting proteins (DIPs), comprising nine paralogs of another subclass of Ig-containing proteins, are expressed in a complementary layer-specific fashion in a subset of synaptic partners. We propose that pairs of Dpr/DIP paralogs contribute to layer-specific patterns of synaptic connectivity.	[Tan, Liming; Zhang, Kelvin Xi; Pecot, Matthew Y.; McEwen, Jason M.; Xu, Shuwa; Tadros, Wael; Zipursky, S. Lawrence] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, HHMI, Los Angeles, CA 90095 USA; [Nagarkar-Jaiswal, Sonal; Bellen, Hugo J.] Baylor Coll Med, HHMI, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lee, Pei-Tseng; Bellen, Hugo J.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Takemura, Shin-ya; Nern, Aljoscha] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA; [Chen, Zhenqing] NYU, Dept Biol, New York, NY 10003 USA; [Zinn, Kai] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Morey, Marta] Univ Barcelona, Fac Biol, Dept Genet, E-08028 Barcelona, Spain; [Morey, Marta] Univ Barcelona, Inst Biomed IBUB, E-08028 Barcelona, Spain	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Howard Hughes Medical Institute; New York University; California Institute of Technology; University of Barcelona; University of Barcelona	Morey, M (corresponding author), Univ Barcelona, Fac Biol, Dept Genet, E-08028 Barcelona, Spain.	mmorey@ub.edu; lzipursky@mednet.ucla.edu	Ramonell, Marta Morey/AAS-1160-2020; Ramonell, Marta Morey/F-8864-2015	Ramonell, Marta Morey/0000-0001-9732-1983; Ramonell, Marta Morey/0000-0001-9732-1983; Takemura, Shin-ya/0000-0003-2400-6426; Tadros, Wael/0000-0001-8703-2803; Bellen, Hugo/0000-0001-5992-5989; Chen, Zhenqing/0000-0002-9214-9480; Zipursky, Stephen/0000-0001-5630-7181	China Scholarship Council (CSC); University of California, Los Angeles (UCLA) Philip Whitcome Training Program; Canadian Institute of Health Research Fellowship; Jane Coffin Childs Memorial Fund for Medical Research; Robert A. and Renee E. Belfer Family Foundation; Target A.L.S.; Human Frontiers Science Program; National Institute of Health [R01GM067858, R01NS62821, R01NS28182]; Ramon y Cajal contract [RYC-2011-09479]; Ministerio de Economia y Competitividad grant [BFU2012-32282]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS028182, R01NS028182, R01NS062821] Funding Source: NIH RePORTER	China Scholarship Council (CSC)(China Scholarship Council); University of California, Los Angeles (UCLA) Philip Whitcome Training Program; Canadian Institute of Health Research Fellowship(Canadian Institutes of Health Research (CIHR)); Jane Coffin Childs Memorial Fund for Medical Research; Robert A. and Renee E. Belfer Family Foundation; Target A.L.S.; Human Frontiers Science Program(Human Frontier Science Program); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ramon y Cajal contract(Spanish Government); Ministerio de Economia y Competitividad grant(Spanish Government); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Orkun Akin, John Carlson, Claude Desplan, Yasushi Hiromi, Frank Laski, Cheng-yu Lee for sharing reagents; members of our laboratory for discussion; Louis K. Scheffer and Ian Meinertzhagen for discussions, sharing results from the EM studies at Janelia Research Campus (HHMI) and comments on the manuscript; Kaushiki Menon and Robert Carrillo (Zinn group) for communicating results prior to publication; Donghui Cheng, Tanya Stoyanova and Owen Witte for assistance in FACS purification of cells; Dorian Gunning for generating Bsh antibody; and Barret Pfeiffer and Gerald Rubin (JRC/HHMI) for reagents to construct the markers for R7 neurons. The work was supported by a Graduate Student Fellowship from the China Scholarship Council (CSC) and a Graduate Student Fellowship from the University of California, Los Angeles (UCLA) Philip Whitcome Training Program (L.T.); the Canadian Institute of Health Research Fellowship (K.X.Z.); Jane Coffin Childs Memorial Fund for Medical Research (M.P.); the Robert A. and Renee E. Belfer Family Foundation (S.N.-J.); Target A.L.S. (P.-T.L.); a Long-Term Fellowship from the Human Frontiers Science Program (W.T.); grants from National Institute of Health (R01GM067858 (H.J.B.), R01NS62821 (K.Z.), and R01NS28182 (K.Z.); a Ramon y Cajal contract (RYC-2011-09479) and a Ministerio de Economia y Competitividad grant (BFU2012-32282) (M.M.). H.J.B. and S.L.Z. are investigators of Howard Hughes Medical Institute.	Borst A, 2014, NAT REV NEUROSCI, V15, P590, DOI 10.1038/nrn3799; Cang JH, 2013, ANNU REV NEUROSCI, V36, P51, DOI 10.1146/annurev-neuro-062012-170341; Chen Y, 2014, NEURON, V81, P280, DOI 10.1016/j.neuron.2013.12.021; de Wit J, 2011, ANNU REV CELL DEV BI, V27, P697, DOI 10.1146/annurev-cellbio-092910-154111; Duan X, 2014, CELL, V158, P793, DOI 10.1016/j.cell.2014.06.047; Fischbach KF, 2009, J NEUROGENET, V23, P48, DOI 10.1080/01677060802471668; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; Fisher B., 2012, BDGP INSITU HOMEPAGE; Fradkin LG, 2002, P NATL ACAD SCI USA, V99, P13663, DOI 10.1073/pnas.212511099; Hadjieconomou D, 2011, CURR OPIN NEUROBIOL, V21, P76, DOI 10.1016/j.conb.2010.07.012; Hong WZ, 2012, NATURE, V484, P201, DOI 10.1038/nature10926; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Johnson KG, 2006, NEURON, V49, P517, DOI 10.1016/j.neuron.2006.01.026; Kenzelmann D, 2007, CELL MOL LIFE SCI, V64, P1452, DOI 10.1007/s00018-007-7108-9; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; Kopczynski CC, 1996, SCIENCE, V271, P1867, DOI 10.1126/science.271.5257.1867; Krishnaswamy A, 2015, NATURE, V524, P466, DOI 10.1038/nature14682; Kurusu M, 2008, NEURON, V59, P972, DOI 10.1016/j.neuron.2008.07.037; Kvon EZ, 2014, NATURE, V512, P91, DOI 10.1038/nature13395; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langley J N, 1895, J Physiol, V18, P280; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lefebvre JL, 2012, NATURE, V488, P517, DOI 10.1038/nature11305; Linnemannstons K, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004443; Matsuoka RL, 2011, NATURE, V470, P259, DOI 10.1038/nature09675; Miura SK, 2013, CELL, V155, P1166, DOI 10.1016/j.cell.2013.10.018; Morante J, 2008, CURR BIOL, V18, P553, DOI 10.1016/j.cub.2008.02.075; Nagarkar-Jaiswal S, 2015, ELIFE, V4, DOI 10.7554/eLife.05338; Nakamura M, 2002, J NEUROSCI, V22, P3463; Nern A, 2008, NEURON, V58, P34, DOI 10.1016/j.neuron.2008.03.022; O'Donnell M, 2009, ANNU REV NEUROSCI, V32, P383, DOI 10.1146/annurev.neuro.051508.135614; Ozkan E, 2013, CELL, V154, P228, DOI 10.1016/j.cell.2013.06.006; Pecot MY, 2014, NEURON, V82, P320, DOI 10.1016/j.neuron.2014.02.045; Pecot MY, 2013, NEURON, V77, P299, DOI 10.1016/j.neuron.2012.11.007; Pipes GCT, 2001, DEVELOPMENT, V128, P4545; Schmitt AM, 2006, NATURE, V439, P31, DOI 10.1038/nature04334; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shen K, 2003, CELL, V112, P619, DOI 10.1016/S0092-8674(03)00113-2; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; Sink H, 2001, CELL, V105, P57, DOI 10.1016/S0092-8674(01)00296-3; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Takemura SY, 2008, J COMP NEUROL, V509, P493, DOI 10.1002/cne.21757; Takemura SY, 2015, P NATL ACAD SCI USA, V112, P13711, DOI 10.1073/pnas.1509820112; Takemura S, 2013, NATURE, V500, P175, DOI 10.1038/nature12450; Timofeev K, 2012, NEURON, V75, P80, DOI 10.1016/j.neuron.2012.04.037; Triplett JW, 2012, SEMIN CELL DEV BIOL, V23, P7, DOI 10.1016/j.semcdb.2011.10.026; Venken KJT, 2014, METHODS, V68, P15, DOI 10.1016/j.ymeth.2014.02.025; Venken KJT, 2011, NAT METHODS, V8, P737, DOI 10.1038/nmeth.1662; Ward A, 2015, NEURON, V85, P1013, DOI 10.1016/j.neuron.2015.02.003; Winberg ML, 2001, NEURON, V32, P53, DOI 10.1016/S0896-6273(01)00446-9; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469; Yamagata M, 2012, J NEUROSCI, V32, P14402, DOI 10.1523/JNEUROSCI.3193-12.2012; Zipursky SL, 2006, TRENDS BIOCHEM SCI, V31, P581, DOI 10.1016/j.tibs.2006.08.003; Zipursky SL, 2013, ANNU REV NEUROSCI, V36, P547, DOI 10.1146/annurev-neuro-062111-150414	58	101	101	0	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2015	163	7					1756	1769		10.1016/j.cell.2015.11.021	http://dx.doi.org/10.1016/j.cell.2015.11.021			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CZ1GN	26687360	Green Accepted, Bronze			2022-12-28	WOS:000366854200021
J	Tan, TR; Gaebler, JP; Lin, Y; Wan, Y; Bowler, R; Leibfried, D; Wineland, DJ				Tan, T. R.; Gaebler, J. P.; Lin, Y.; Wan, Y.; Bowler, R.; Leibfried, D.; Wineland, D. J.			Multi-element logic gates for trapped-ion qubits	NATURE			English	Article							QUANTUM; STATE	Precision control over hybrid physical systems at the quantum level is important for the realization of many quantum-based technologies. In the field of quantum information processing (QIP) and quantum networking, various proposals discuss the possibility of hybrid architectures(1) where specific tasks are delegated to the most suitable subsystem. For example, in quantum networks, it may be advantageous to transfer information from a subsystem that has good memory properties to another subsystem that is more efficient at transporting information between nodes in the network. For trapped ions, a hybrid system formed of different species introduces extra degrees of freedom that can be exploited to expand and refine the control of the system. Ions of different elements have previously been used in QIP experiments for sympathetic cooling(2), creation of entanglement through dissipation(3), and quantum non-demolition measurement of one species with another(4). Here we demonstrate an entangling quantum gate between ions of different elements which can serve as an important building block of QIP, quantum networking, precision spectroscopy, metrology, and quantum simulation. A geometric phase gate between a Be-9(+) ion and a Mg-25(+) ion is realized through an effective spin-spin interaction generated by state-dependent forces induced with laser beams(5-9). Combined with single-qubit gates and same-species entangling gates, this mixed-element entangling gate provides a complete set of gates over such a hybrid system for universal QIP(10-12). Using a sequence of such gates, we demonstrate a CNOT (controlled-NOT) gate and a SWAP gate(13). We further demonstrate the robustness of these gates against thermal excitation and show improved detection in quantum logic spectroscopy(14). We also observe a strong violation of a CHSH (Clauser-Horne-Shimony-Holt)-type Bell inequality(15) on entangled states composed of different ion species.	[Tan, T. R.; Gaebler, J. P.; Lin, Y.; Wan, Y.; Bowler, R.; Leibfried, D.; Wineland, D. J.] NIST, Boulder, CO 80305 USA	National Institute of Standards & Technology (NIST) - USA	Tan, TR (corresponding author), NIST, 325 Broadway, Boulder, CO 80305 USA.	tingrei.tan@nist.gov	Tan, Ting Rei/D-4687-2019	Tan, Ting Rei/0000-0003-4520-6419; Wan, Yong/0000-0003-2613-6072; Gaebler, John/0000-0002-2616-7410	Office of the Director of National Intelligence (ODNI) Intelligence Advanced Research Projects Activity (IARPA), ONR; NIST Quantum Information Program; US Army Research Office through MURI grant [W911NF-11-1-0400]	Office of the Director of National Intelligence (ODNI) Intelligence Advanced Research Projects Activity (IARPA), ONR; NIST Quantum Information Program; US Army Research Office through MURI grant	We thank J. Bollinger and D. Hume for comments on the manuscript. This work was supported by the Office of the Director of National Intelligence (ODNI) Intelligence Advanced Research Projects Activity (IARPA), ONR, and the NIST Quantum Information Program. Y.W. was supported by the US Army Research Office through MURI grant W911NF-11-1-0400. This paper is a contribution by NIST and not subject to US copyright.	BARENCO A, 1995, PHYS REV A, V52, P3457, DOI 10.1103/PhysRevA.52.3457; Blakestad RB, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.032314; Bremner MJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.247902; Chou CW, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.070802; Huang P, 2004, P SOC PHOTO-OPT INS, V5524, P125, DOI 10.1117/12.559790; Hume DB, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.120502; Langer C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.060502; Leibfried D, 2003, NATURE, V422, P412, DOI 10.1038/nature01492; LEVITT MH, 1986, PROG NUCL MAG RES SP, V18, P61, DOI 10.1016/0079-6565(86)80005-X; Lin Y, 2013, NATURE, V504, P415, DOI 10.1038/nature12801; Milburn GJ, 2000, FORTSCHR PHYS, V48, P801, DOI 10.1002/1521-3978(200009)48:9/11<801::AID-PROP801>3.0.CO;2-1; Moehring DL, 2007, J OPT SOC AM B, V24, P300, DOI 10.1364/JOSAB.24.000300; Monroe C, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.022317; Monroe C, 2013, SCIENCE, V339, P1164, DOI 10.1126/science.1231298; MONROE C, 1995, PHYS REV LETT, V75, P4011, DOI 10.1103/PhysRevLett.75.4011; NIELSEN MA, 2000, QUANTUM COMPUTATION, P23; Ozeri R, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.042329; Rowe MA, 2001, NATURE, V409, P791, DOI 10.1038/35057215; Sackett CA, 2000, NATURE, V404, P256, DOI 10.1038/35005011; Schmidt PO, 2005, SCIENCE, V309, P749, DOI 10.1126/science.1114375; Schulte M., 2015, QUANTUM ALGORITHMIC; Solano E, 1999, PHYS REV A, V59, pR2539, DOI 10.1103/PhysRevA.59.R2539; Turchette QA, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.063418; Wallquist M, 2009, PHYS SCRIPTA, VT137, DOI 10.1088/0031-8949/2009/T137/014001; Zhang J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.027903	31	108	111	0	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2015	528	7582					380	+		10.1038/nature16186	http://dx.doi.org/10.1038/nature16186			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY8SM	26672553	Green Submitted			2022-12-28	WOS:000366678600048
J	Fleming, DA				Fleming, David A.			The Moral Agency of Physician Organizations: Meeting Obligations to Advocate for Patients and the Public	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Fleming, David A.] Univ Missouri, Sch Med, Columbia, MO 65212 USA	University of Missouri System; University of Missouri Columbia	Fleming, DA (corresponding author), Univ Missouri, Sch Med, Hlth Sci Ctr MA412, 1 Hosp Dr, Columbia, MO 65212 USA.	flemingd@health.missouri.edu						Edelstein L, 1967, ANCIENT MED SELECTED; Feinberg J, 1970, DOING DESERVING ESSA; FRENCH PA, 1979, AM PHILOS QUART, V16, P207; LADD J, 1970, MONIST, V54, P488, DOI 10.5840/monist197054433; PELLEGRINO ED, 1990, B NEW YORK ACAD MED, V66, P221; Risser DT, 2015, INTERNET ENCY PHILOS; Snyder L, 2012, ANN INTERN MED, V156, DOI 10.7326/0003-4819-156-1-201201031-00001; Velasquez MG., 1983, BUSINESS PROFESSIONA, V2, P1, DOI [10.5840/bpej19832349, DOI 10.5840/bpej19832349]; Weinberger SE, 2011, ANN INTERN MED, V155, P386, DOI 10.7326/0003-4819-155-6-201109200-00007	9	5	5	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	2015	163	12					918	+		10.7326/M15-2527	http://dx.doi.org/10.7326/M15-2527			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY4BS	26666781				2022-12-28	WOS:000366354200017
J	Araujo, R; Ferreira, JJ; Antonini, A; Bloem, BR				Araujo, Rui; Ferreira, Joaquim J.; Antonini, Angelo; Bloem, Bastiaan R.			CHRISTMAS 2015: POLITICAL SCIENCE "Gunslinger's gait": a new cause of unilaterally reduced arm swing	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PARKINSONS-DISEASE; RESEARCH CRITERIA	Objective To postulate a new possible cause of a unilaterally reduced arm swing in addition to the known medical conditions such as shoulder pathology, Erb's palsy, stroke, and Parkinson's disease. Methods Analysis of YouTube videos depicting the gait of highly ranked Russian officials. Results We found a similar walking pattern in President Vladimir Putin, Prime Minister Dmitry Medvedev and three other highly ranked Russian officials, all presenting with a consistently reduced right arm swing in the absence of other overt neurological abnormalities. Conclusions We propose that this new gait pattern, which we term "gunslinger's gait," may result from a behavioural adaptation, possibly triggered by KGB or other forms of weapons training where trainees are taught to keep their right hand close to the chest while walking, allowing them to quickly draw a gun when faced with a foe. This should be included in the differential diagnosis of a unilaterally reduced arm swing.	[Araujo, Rui] Coimbra Hosp & Univ Ctr, Dept Neurol, Coimbra, Portugal; [Ferreira, Joaquim J.] Univ Lisbon, Fac Med, Inst Mol Med, Clin Pharmacol Unit, P-1699 Lisbon, Portugal; [Antonini, Angelo] IRCCS San Camillo, Dept Parkinsons Dis, Venice, Italy; [Bloem, Bastiaan R.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behaviour, Dept Neurol, NL-6525 ED Nijmegen, Netherlands	Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Lisboa; IRCCS Ospedale San Camillo; Radboud University Nijmegen	Bloem, BR (corresponding author), Coimbra Hosp & Univ Ctr, Dept Neurol, Coimbra, Portugal.	bas.bloem@radboudumc.nl	Antonini, Angelo/H-9726-2019; Bloem, Bastiaan/H-8013-2014	Antonini, Angelo/0000-0003-1040-2807; Bloem, Bastiaan/0000-0002-6371-3337; Araujo, Rui/0000-0002-3610-3437	National Parkinson Foundation	National Parkinson Foundation	BRB was supported by a research grant of the National Parkinson Foundation.	Bakker MJ, 2006, LANCET NEUROL, V5, P513, DOI 10.1016/S1474-4422(06)70470-7; Berg D, 2015, MOVEMENT DISORD, V30, P1600, DOI 10.1002/mds.26431; Berg D, 2014, MOVEMENT DISORD, V29, P454, DOI 10.1002/mds.25844; Berg D, 2013, LANCET NEUROL, V12, P514, DOI 10.1016/S1474-4422(13)70047-4; Bloem BR, 2004, CLIN DISORDERS BALAN, V2, P173; Blomfield A, 2008, TELEGRAPH; Boettcher LB, 2015, NEUROSURG FOCUS, V39, DOI 10.3171/2015.4.FOCUS1563; Dolmatov AI, 1993, KGB ALPHA TEAM TRAIN; Gerstenbrand F, 1999, EUR J NEUROL, V6, P121, DOI 10.1111/j.1468-1331.1999.tb00003.x; Gessen M., 2022, NEW YORKER; Goldman JG, 2014, CURR OPIN NEUROL, V27, P434, DOI 10.1097/WCO.0000000000000112; HomeEnglish, 2015, V PUT; Kolesnikov A, 2008, KOMMERSANT; LEES AJ, 1992, MOVEMENT DISORD, V7, P110, DOI 10.1002/mds.870070203; Mereu F, 2008, MOSCOW TIMES; Nurnberger L, 2015, MOVEMENT DISORD, V30, P386, DOI 10.1002/mds.26127; Osborn A, 2009, TELEGRAPH; Parfitt T, 2008, OBSERVER; Roxburgh A, 2013, STRONGMAN V PUTIN ST; Stamelou M, 2011, NEW ENGL J MED, V365, P1160, DOI 10.1056/NEJMc1107673; Uitti RJ, 2005, NEUROLOGY, V64, P1925, DOI 10.1212/01.WNL.0000163993.82388.C8; van der Hoorn A, 2012, MOVEMENT DISORD, V27, P206, DOI 10.1002/mds.24007	22	8	8	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 14	2015	351								h6141	10.1136/bmj.h6141	http://dx.doi.org/10.1136/bmj.h6141			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ4KY	26666758	Green Published, hybrid			2022-12-28	WOS:000367073200003
J	Nielsen, MJ				Nielsen, Maryke J.			CHRISTMAS 2015: PROFESSIONAL CONSIDERATIONS Three weeks among the Korowai people	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Nielsen, Maryke J.] Mersey Deanery, Liverpool L18 0HA, Merseyside, England		Nielsen, MJ (corresponding author), Mersey Deanery, Liverpool L18 0HA, Merseyside, England.	maryke.nielsen@gmail.com		Nielsen, Maryke Joanne/0000-0001-7148-520X				Department of Health Department for International Development, ENG GLOB HLTH	1	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 14	2015	351								h6469	10.1136/bmj.h6469	http://dx.doi.org/10.1136/bmj.h6469			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ4KY	26668210				2022-12-28	WOS:000367073200011
J	Ahnert, SE; Marsh, JA; Hernandez, H; Robinson, CV; Teichmann, SA				Ahnert, Sebastian E.; Marsh, Joseph A.; Hernandez, Helena; Robinson, Carol V.; Teichmann, Sarah A.			Principles of assembly reveal a periodic table of protein complexes	SCIENCE			English	Article							QUATERNARY STRUCTURE; MACROMOLECULAR ASSEMBLIES; MASS-SPECTROMETRY; PREDICTION; EVOLUTION; DYNAMICS; DOCKING; CLASSIFICATION; STOICHIOMETRY; PATHWAYS	Structural insights into protein complexes have had a broad impact on our understanding of biological function and evolution. In this work, we sought a comprehensive understanding of the general principles underlying quaternary structure organization in protein complexes. We first examined the fundamental steps by which protein complexes can assemble, using experimental and structure-based characterization of assembly pathways. Most assembly transitions can be classified into three basic types, which can then be used to exhaustively enumerate a large set of possible quaternary structure topologies. These topologies, which include the vast majority of observed protein complex structures, enable a natural organization of protein complexes into a periodic table. On the basis of this table, we can accurately predict the expected frequencies of quaternary structure topologies, including those not yet observed. These results have important implications for quaternary structure prediction, modeling, and engineering.	[Ahnert, Sebastian E.; Teichmann, Sarah A.] Univ Cambridge, Cavendish Lab, Theory Condensed Matter Grp, Cambridge CB3 0HE, England; [Marsh, Joseph A.] Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Med Res Council Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Marsh, Joseph A.; Teichmann, Sarah A.] European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England; [Hernandez, Helena; Robinson, Carol V.] Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England; [Teichmann, Sarah A.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	University of Cambridge; University of Edinburgh; European Molecular Biology Laboratory (EMBL); University of Oxford; Wellcome Trust Sanger Institute	Ahnert, SE (corresponding author), Univ Cambridge, Cavendish Lab, Theory Condensed Matter Grp, JJ Thomson Ave, Cambridge CB3 0HE, England.	saraht@ebi.ac.uk		robinson, carol/0000-0001-7829-5505; Marsh, Joseph/0000-0003-4132-0628; Teichmann, Sarah/0000-0002-6294-6366	Royal Society; Human Frontier Science Program; Medical Research Council [G1000819]; Lister Institute for Preventative Medicine; MRC [G1000819] Funding Source: UKRI	Royal Society(Royal Society of London); Human Frontier Science Program(Human Frontier Science Program); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lister Institute for Preventative Medicine; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank C. Wolberger, A. Wittinghofer, B. Luisi, A. Meinhart, T. Schoneberg, L. Tong, J. Kadlec, and V. Rubio for providing protein complex samples; H. Rees for assistance with manual quaternary structure assignments and identification of literature-derived assembly pathways; and P. Beltrao, S. Edelstein, T. Flock, D. Gfeller, M. Hein, F. Krueger, R. Laskowski, E. Levy, S. MacKinnon, I. Moal, E. Natan, T. Perica, B. Stauch, S. Velankar, S. Wodak, and X. Zhang for helpful discussions and comments on the manuscript. This work was supported by the Royal Society (S.E.A. and C.V.R.), the Human Frontier Science Program (J.A.M.), the Medical Research Council (grant G1000819 to H.H. and C.V.R.), and the Lister Institute for Preventative Medicine (S.A.T.).	Alber F, 2008, ANNU REV BIOCHEM, V77, P443, DOI 10.1146/annurev.biochem.77.060407.135530; Aloy P, 2004, NAT BIOTECHNOL, V22, P1317, DOI 10.1038/nbt1018; DiMaio F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020450; Esquivel-Rodriguez J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S2-S6; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Hall Z, 2012, STRUCTURE, V20, P1596, DOI 10.1016/j.str.2012.07.001; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Henrick K, 1998, TRENDS BIOCHEM SCI, V23, P358, DOI 10.1016/S0968-0004(98)01253-5; Hernandez H, 2007, NAT PROTOC, V2, P715, DOI 10.1038/nprot.2007.73; Inbar Y, 2005, J MOL BIOL, V349, P435, DOI 10.1016/j.jmb.2005.03.039; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; King NP, 2012, SCIENCE, V336, P1171, DOI 10.1126/science.1219364; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lai YT, 2012, SCIENCE, V336, P1129, DOI 10.1126/science.1219351; LEVITT M, 1976, NATURE, V261, P552, DOI 10.1038/261552a0; Levy ED, 2008, NATURE, V453, P1262, DOI 10.1038/nature06942; Levy ED, 2007, STRUCTURE, V15, P1364, DOI 10.1016/j.str.2007.09.019; Levy ED, 2006, PLOS COMPUT BIOL, V2, P1395, DOI 10.1371/journal.pcbi.0020155; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; Marsh JA, 2015, ANNU REV BIOCHEM, V84, P551, DOI 10.1146/annurev-biochem-060614-034142; Marsh JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7394; Marsh JA, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001870; Marsh JA, 2014, BIOESSAYS, V36, P209, DOI 10.1002/bies.201300134; Marsh JA, 2013, CELL, V153, P461, DOI 10.1016/j.cell.2013.02.044; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; ORENGO CA, 1994, NATURE, V372, P631, DOI 10.1038/372631a0; Perica T, 2012, BIOCHEM SOC T, V40, P475, DOI 10.1042/BST20120056; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Rappsilber J, 2011, J STRUCT BIOL, V173, P530, DOI 10.1016/j.jsb.2010.10.014; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Taylor WR, 2002, NATURE, V416, P657, DOI 10.1038/416657a; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang J, 2014, CURR OPIN STRUC BIOL, V27, P79, DOI 10.1016/j.sbi.2014.05.009; Zhang QC, 2012, NATURE, V490, P556, DOI 10.1038/nature11503	36	139	142	7	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2015	350	6266							aaa2245	10.1126/science.aaa2245	http://dx.doi.org/10.1126/science.aaa2245			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1JL	26659058	Green Accepted			2022-12-28	WOS:000366162400031
J	Reczek, CR; Chandel, NS				Reczek, Colleen R.; Chandel, Navdeep S.			Revisiting vitamin C and cancer	SCIENCE			English	Editorial Material							OXIDATIVE STRESS; ASCORBATE; CELLS		[Reczek, Colleen R.] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA; Northwestern Univ, Robert H Lurie Canc Ctr, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Reczek, CR (corresponding author), Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA.	nav@northwestern.edu						CAMERON E, 1976, P NATL ACAD SCI USA, V73, P3685, DOI 10.1073/pnas.73.10.3685; Chandel NS, 2014, NEW ENGL J MED, V371, P177, DOI 10.1056/NEJMcibr1405701; Chen Q, 2008, P NATL ACAD SCI USA, V105, P11105, DOI 10.1073/pnas.0804226105; CREAGAN ET, 1979, NEW ENGL J MED, V301, P687, DOI 10.1056/NEJM197909273011303; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Espey MG, 2011, FREE RADICAL BIO MED, V50, P1610, DOI 10.1016/j.freeradbiomed.2011.03.007; Glasauer A, 2014, J CLIN INVEST, V124, P117, DOI 10.1172/JCI71714; Kuehne A, 2015, MOL CELL, V59, P359, DOI 10.1016/j.molcel.2015.06.017; Ma Y, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007154; MOERTEL CG, 1985, NEW ENGL J MED, V312, P137, DOI 10.1056/NEJM198501173120301; Piskounova E, 2015, NATURE, V527, P186, DOI 10.1038/nature15726; Tian WH, 2014, J BIOL CHEM, V289, P3339, DOI 10.1074/jbc.M113.538157; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Wheaton WW, 2014, ELIFE, V3, DOI 10.7554/eLife.02242; Yun J, 2015, SCIENCE, V350, P1391, DOI 10.1126/science.aaa5004	15	34	34	0	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2015	350	6266					1317	1318		10.1126/science.aad8671	http://dx.doi.org/10.1126/science.aad8671			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1JL	26659042				2022-12-28	WOS:000366162400021
J	Sherwood, S				Sherwood, Steven			CLIMATE SCIENCE The Sun and the rain	NATURE			English	Editorial Material							ATMOSPHERIC SHORTWAVE ABSORPTION		[Sherwood, Steven] Univ New S Wales, Climate Change Res Ctr, Sydney, NSW 2052, Australia; [Sherwood, Steven] Univ New S Wales, ARC Ctr Climate Syst Sci, Sydney, NSW 2052, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Sherwood, S (corresponding author), Univ New S Wales, Climate Change Res Ctr, Sydney, NSW 2052, Australia.	s.sherwood@unsw.edu.au	Sherwood, Steven/B-5673-2008	Sherwood, Steven/0000-0001-7420-8216				DeAngelis AM, 2015, NATURE, V528, P249, DOI 10.1038/nature15770; Fildier B, 2015, GEOPHYS RES LETT, V42, P8749, DOI 10.1002/2015GL065931; GOLDBLATT C, 2009, J R METEOROL SOC, V135, P619, DOI DOI 10.1002/QJ.403; Halevy I, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD011915; HORVATH H, 1993, ATMOS ENVIRON A-GEN, V27, P293, DOI 10.1016/0960-1686(93)90104-7; Klein SA, 2015, CURR CLIM CHANGE REP, V1, P276, DOI 10.1007/s40641-015-0027-1; Klocke D, 2011, J CLIMATE, V24, P6092, DOI 10.1175/2011JCLI4193.1; O'Gorman PA, 2012, SURV GEOPHYS, V33, P585, DOI 10.1007/s10712-011-9159-6; Pincus R, 2015, GEOPHYS RES LETT, V42, P5485, DOI 10.1002/2015GL064291; Sherwood SC, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012585; Takahashi K, 2009, J CLIMATE, V22, P5667, DOI 10.1175/2009JCLI2674.1	11	2	2	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2015	528	7581					200	201		10.1038/528200a	http://dx.doi.org/10.1038/528200a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9VH	26659179				2022-12-28	WOS:000366053300025
J	Jagger, C; Matthews, FE; Wohland, P; Fouweather, T; Stephan, BCM; Robinson, L; Arthur, A; Brayne, C				Jagger, Carol; Matthews, Fiona E.; Wohland, Pia; Fouweather, Tony; Stephan, Blossom C. M.; Robinson, Louise; Arthur, Antony; Brayne, Carol		Med Res Council Cognitive Function	A comparison of health expectancies over two decades in England: results of the Cognitive Function and Ageing Study I and II	LANCET			English	Article							DISABILITY-FREE LIFE; ACTIVITY LIMITATIONS; ELDERLY-PEOPLE; AGE 65; TRENDS; OLDER; POPULATION; PREVALENCE; INDICATORS; IMPAIRMENT	Background Whether rises in life expectancy are increases in good-quality years is of profound importance worldwide, with population ageing. We investigate how various health expectancies have changed in England between 1991 and 2011, with identical study design and methods in each decade. Methods Baseline data from the Cognitive Function and Ageing Studies in populations aged 65 years or older in three geographically defined centres in England (Cambridgeshire, Newcastle, and Nottingham) provided prevalence estimates for three health measures: self-perceived health (defined as excellent-good, fair, or poor); cognitive impairment (defined as moderate-severe, mild, or none, as assessed by Mini-Mental State Examination score); and disability in activities of daily living (defined as none, mild, or moderate-severe). Health expectancies for the three regions combined were calculated by the Sullivan method, which applies the age-specific and sex-specific prevalence of the health measure to a standard life table for the same period. Findings Between 1991 and 2011, gains in life expectancy at age 65 years (4.5 years for men and 3.6 years for women) were accompanied by equivalent gains in years free of any cognitive impairment (4.2 years [95% CI 4.2-4.3] for men and 4.4 years [4.3-4.5] for women) and decreased years with mild or moderate-severe cognitive impairment. Gains were also identified in years in excellent or good self-perceived health (3.8 years [95% CI 3.5-4.1] for men and 3.1 years [2.7-3.4] for women). Gains in disability-free years were much smaller than those in excellent-good self-perceived health or those free from cognitive impairment, especially for women (0.5 years [0.2-0.9] compared with 2.6 years [2.3-2.9] for men), mostly because of increased mild disability. Interpretation During the past two decades in England, we report an absolute compression (ie, reduction) of cognitive impairment, a relative compression of self-perceived health (ie, proportion of life spent healthy is increasing), and dynamic equilibrium of disability (ie, less severe disability is increasing but more severe disability is not). Reasons for these patterns are unknown but might include increasing obesity during previous decades. Our findings have wide-ranging implications for health services and for extension of working life. Copyright (C) Jagger et al. Open Access article distributed under the terms of CC BY.	[Jagger, Carol; Matthews, Fiona E.; Wohland, Pia; Fouweather, Tony; Stephan, Blossom C. M.; Robinson, Louise] Newcastle Univ, Inst Hlth & Soc, Fac Med, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England; [Jagger, Carol; Matthews, Fiona E.; Wohland, Pia; Stephan, Blossom C. M.] Newcastle Univ, Inst Ageing, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England; [Matthews, Fiona E.] Cambridge Inst Publ Hlth, MRC Biostat Unit, Cambridge, England; [Arthur, Antony] Univ E Anglia, Sch Hlth Sci, Norwich NR4 7TJ, Norfolk, England; [Brayne, Carol] Univ Cambridge, Cambridge Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England	Newcastle University - UK; Newcastle University - UK; MRC Biostatistics Unit; University of Cambridge; University of East Anglia; University of Cambridge	Jagger, C (corresponding author), Newcastle Univ, Inst Hlth & Soc, Campus Ageing & Vital, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.	carol.jagger@newcastle.ac.uk	Matthews, Fiona/O-6932-2015; Wohland, Pia/H-3096-2016; Brayne, Carol/AAA-4285-2020; Comas-Herrera, Adelina/Q-7107-2019; Comas-Herrera, Adelina/A-2325-2011; Wohland, Pia/AAV-8877-2020; Dening, Tom/E-1335-2013	Matthews, Fiona/0000-0002-1728-2388; Wohland, Pia/0000-0002-6893-5852; Brayne, Carol/0000-0001-5307-663X; Comas-Herrera, Adelina/0000-0002-9860-9062; Comas-Herrera, Adelina/0000-0002-9860-9062; Dening, Tom/0000-0003-3387-4241; Robinson, Louise/0000-0003-0209-2503; Arthur, Antony/0000-0001-8617-5714; Jagger, Carol/0000-0002-6377-9926	UK Medical Research Council (MRC) [G0601022]; UK National Institute for Health Research (NIHR) comprehensive clinical research networks in West Anglia and Trent; Dementias and Neurodegenerative Disease Research Network in Newcastle; MRC; UK National Health Service (NHS); MRC [U105292687]; AXA Research Fund; Economic and Social Research Council [RES-062-23-2970]; Economic and Social Research Council [ES/I017399/1] Funding Source: researchfish; Medical Research Council [G9901400, MC_U105292687, G0601022] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10084, NIHR-RP-011-043] Funding Source: researchfish; ESRC [ES/I017399/1] Funding Source: UKRI; MRC [G0601022, G9901400, MC_U105292687] Funding Source: UKRI	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK National Institute for Health Research (NIHR) comprehensive clinical research networks in West Anglia and Trent; Dementias and Neurodegenerative Disease Research Network in Newcastle; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK National Health Service (NHS); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); AXA Research Fund(AXA Research Fund); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	CFAS II was supported by the UK Medical Research Council (MRC; research grant G0601022) and received support from the UK National Institute for Health Research (NIHR) comprehensive clinical research networks in West Anglia and Trent, and the Dementias and Neurodegenerative Disease Research Network in Newcastle. MRC CFAS (including CFAS I areas) was funded by the MRC and the UK National Health Service (NHS). FEM is supported by the MRC (grant number U105292687). CJ is supported by the AXA Research Fund. TW and PW are supported by the Economic and Social Research Council (grant number RES-062-23-2970). We thank the participants, their families, the family doctors and their staff, and the primary care trusts for their cooperation and support. We thank the CFAS II fieldwork interviewers at Cambridge, Nottingham, and Newcastle for their valuable contribution. This research was done within the UK NIHR collaboration for leadership in applied health research and care for Cambridgeshire and Peterborough and the Cambridge Biomedical Research Centre infrastructures, Nottingham city and Nottinghamshire county NHS primary care trusts, and UK NIHR Biomedical Research Centre for Ageing and Age-related Disease Award to Newcastle Upon Tyne Hospital Foundation Trust.	BRAYNE C, 1990, INT J GERIATR PSYCH, V5, P309, DOI 10.1002/gps.930050507; Cambois E, 2008, EUR J AGEING, V5, P287, DOI 10.1007/s10433-008-0097-1; Donald IP, 2010, AGE AGEING, V39, P337, DOI 10.1093/ageing/afq015; Dubois MF, 2006, DEMENT GERIATR COGN, V22, P327, DOI 10.1159/000095593; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Freedman VA, 2013, DEMOGRAPHY, V50, P661, DOI 10.1007/s13524-012-0167-z; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; Heikkinen E, 2011, AGING CLIN EXP RES, V23, P126, DOI 10.3275/6932; Jagger C, 2001, J AM GERIATR SOC, V49, P404, DOI 10.1046/j.1532-5415.2001.49083.x; Jagger C., 2011, BMC GERIATR, P11; Jagger C, 2007, J GERONTOL A-BIOL, V62, P408, DOI 10.1093/gerona/62.4.408; Jagger C, 2011, INT HANDB POPUL, V2, P551, DOI 10.1007/978-90-481-9996-9_26; Jagger C, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-156; Jeune B, 2008, EUR J AGEING, V5, P279, DOI 10.1007/s10433-008-0100-x; KRAMER M, 1980, ACTA PSYCHIAT SCAND, V62, P382, DOI 10.1111/j.1600-0447.1980.tb07714.x; Kulminski AM, 2008, EXP GERONTOL, V43, P1052, DOI 10.1016/j.exger.2008.09.007; Lievre A, 2008, J AGING HEALTH, V20, P456, DOI 10.1177/0898264308315857; Lin SF, 2012, AM J PUBLIC HEALTH, V102, P2157, DOI 10.2105/AJPH.2011.300602; Litwin H, 2012, J AGING HEALTH, V24, P846, DOI 10.1177/0898264312436714; Manton KG, 2008, J GERONTOL B-PSYCHOL, V63, pS269, DOI 10.1093/geronb/63.5.S269; MANTON KG, 1982, MILBANK FUND Q, V60, P183, DOI 10.2307/3349767; Marmot M, 2010, FAIR SOC HLTH LIVES; Marmot M, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6576; Martin LG, 2012, J EPIDEMIOL COMMUN H, V66, P874, DOI 10.1136/jech-2011-200251; Mathers CD, 2015, LANCET, V385, P540, DOI 10.1016/S0140-6736(14)60569-9; Matthews FE, 2013, LANCET, V382, P1405, DOI 10.1016/S0140-6736(13)61570-6; Moe JO, 2011, EUR J AGEING, V8, P49, DOI 10.1007/s10433-011-0179-3; Office for National Statistics, 2014, DIS FREE LIF EXP UPP; Office for National Statistics, 2012, HLTH EXP BIRTH AG 65; Office for National Statistics, 2012, ANN MID POP EST ENGL; Palacios-Cena D, 2012, J AM MED DIR ASSOC, V13, P136, DOI 10.1016/j.jamda.2010.05.007; Sagardui-Villamor J, 2005, J GERONTOL A-BIOL, V60, P1028, DOI 10.1093/gerona/60.8.1028; Sarkeala T, 2011, EUR J AGEING, V8, P87, DOI 10.1007/s10433-011-0188-2; SULLIVAN DF, 1971, HSMHA HEALTH REP, V86, P347, DOI 10.2307/4594169; Suzman R. M., 2003, DETERMINING HLTH EXP, P35; Townsend PP., 1988, HLTH DEPRIVATION INE; van Gool CH, 2011, INT J EPIDEMIOL, V40, P1056, DOI 10.1093/ije/dyr009; Van Oyen H, 2008, EUR J AGEING, V5, P137, DOI 10.1007/s10433-008-0082-8; Oyen H, 2006, SOZ PRAVENTIV MED, V51, P153, DOI 10.1007/s00038-006-0035-y; VERBRUGGE LM, 1994, SOC SCI MED, V38, P1, DOI 10.1016/0277-9536(94)90294-1	40	95	96	2	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 20	2016	387	10020					779	786		10.1016/S0140-6736(15)00947-2	http://dx.doi.org/10.1016/S0140-6736(15)00947-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DE1WU	26680218	Green Published, Green Submitted, Green Accepted, hybrid			2022-12-28	WOS:000370418000037
J	Lyons, SK; Amatangelo, KL; Behrenstneyer, AK; Bercovici, A; Blois, JL; Davis, M; DiMichele, WA; Du, A; Eronen, JT; Faith, JT; Graves, GR; Jud, N; Labandeira, C; Looy, CM; McGill, B; Miller, JH; Patterson, D; Pineda-Munoz, S; Potts, R; Riddle, B; Terry, R; Toth, A; Ulrich, W; Villasenor, A; Wing, S; Anderson, H; Anderson, J; Waller, D; Gotelli, NJ				Lyons, S. Kathleen; Amatangelo, Kathryn L.; Behrenstneyer, Anna K.; Bercovici, Antoine; Blois, Jessica L.; Davis, Matt; DiMichele, William A.; Du, Andrew; Eronen, Jussi T.; Faith, J. Tyler; Graves, Gary R.; Jud, Nathan; Labandeira, Conrad; Looy, Cindy M.; McGill, Brian; Miller, Joshua H.; Patterson, David; Pineda-Munoz, Silvia; Potts, Richard; Riddle, Brett; Terry, Rebecca; Toth, Aniko; Ulrich, Werner; Villasenor, Amelia; Wing, Scott; Anderson, Heidi; Anderson, John; Waller, Donald; Gotelli, Nicholas J.			Holocene shifts in the assembly of plant and animal communities implicate human impacts	NATURE			English	Article							NULL MODEL ANALYSIS; SPECIES COOCCURRENCE; ASSOCIATIONS; DISTRIBUTIONS; BIODIVERSITY; QUATERNARY; EXTINCTIONS; DISPERSAL; DYNAMICS; PATTERNS	Understanding how ecological communities are organized and how they change through time is critical to predicting the effects of climate change(1). Recent work documenting the co-occurrence structure of modern communities found that most significant species pairs co-occur less frequently than would be expected by chance(2,3). However, little is known about how co-occurrence structure changes through time. Here we evaluate changes in plant and animal community organization over geological time by quantifying the co-occurrence structure of 359,896 unique taxon pairs in 80 assemblages spanning the past 300 million years. Co-occurrences of most taxon pairs were statistically random, but a significant fraction were spatially aggregated or segregated. Aggregated pairs dominated from the Carboniferous period (307 million years ago) to the early Holocene epoch (11,700 years before present), when there was a pronounced shift to more segregated pairs, a trend that continues in modern assemblages. The shift began during the Holocene and coincided with increasing human population size(4,5) and the spread of agriculture in North America(6,7). Before the shift, an average of 64% of significant pairs were aggregated; after the shift, the average dropped to 37%. The organization of modern and late Holocene plant and animal assemblages differs fundamentally from that of assemblages over the past 300 million years that predate the large-scale impacts of humans. Our results suggest that the rules governing the assembly of communities have recently been changed by human activity.	[Lyons, S. Kathleen; Behrenstneyer, Anna K.; Bercovici, Antoine; Davis, Matt; DiMichele, William A.; Labandeira, Conrad; Toth, Aniko; Wing, Scott] Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20013 USA; [Amatangelo, Kathryn L.] SUNY Coll Brockport, Dept Environm Sci & Biol, Brockport, NY 14420 USA; [Blois, Jessica L.] Univ Calif Merced, Sch Nat Sci, 5200 North Lake Rd, Merced, CA 95343 USA; [Davis, Matt] Yale Univ, Dept Geol & Geophys, POB 6666, New Haven, CT 06520 USA; [Du, Andrew; Patterson, David; Villasenor, Amelia] George Washington Univ, Dept Anthropol, Ctr Adv Study Hominid Paleobiol, Hominid Paleobiol Doctoral Program, Washington, DC 20052 USA; [Eronen, Jussi T.] Univ Helsinki, Dept Geosci & Geog, POB 64, FIN-00014 Helsinki, Finland; [Faith, J. Tyler] Univ Queensland, Sch Social Sci, Brisbane, Qld 4072, Australia; [Graves, Gary R.] Smithsonian Inst, Natl Museum Nat Hist, Dept Vertebrate Zool, Washington, DC 20013 USA; [Graves, Gary R.] Univ Copenhagen, Ctr Macroecol Evolut & Climate, DK-2100 Copenhagen, Denmark; [Jud, Nathan] Univ Maryland, Biol Sci Grad Program, College Pk, MD 20742 USA; [Jud, Nathan] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Labandeira, Conrad] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Labandeira, Conrad] Capital Normal Univ, Key Lab Insect Evolut & Environm Changes, Beijing 100048, Peoples R China; [Looy, Cindy M.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Looy, Cindy M.] Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA; [McGill, Brian] Univ Maine, Sch Biol & Ecol, Orono, ME 04469 USA; [McGill, Brian] Univ Maine, Sustainabil Solut Initiat, Orono, ME 04469 USA; [Miller, Joshua H.] Univ Cincinnati, Dept Geol, Cincinnati, OH 45221 USA; [Pineda-Munoz, Silvia] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Potts, Richard] Smithsonian Inst, Natl Museum Nat Hist, Human Origins Program, Dept Anthropol, Washington, DC 20013 USA; [Riddle, Brett] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA; [Terry, Rebecca] Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA; [Ulrich, Werner] Nicholas Copernicus Univ, Chair Ecol & Biogeog, Lwowska 1, PL-87100 Torun, Poland; [Anderson, Heidi; Anderson, John] Univ Witwatersrand, Evolutionary Studies Inst, Jorissen St, ZA-2001 Johannesburg, South Africa; [Waller, Donald] Univ Wisconsin, Dept Bot, Madison, WI 53706 USA; [Gotelli, Nicholas J.] Univ Vermont, Dept Biol, Burlington, VT 05405 USA	Smithsonian Institution; Smithsonian National Museum of Natural History; State University of New York (SUNY) System; University of California System; University of California Merced; Yale University; George Washington University; University of Helsinki; University of Queensland; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Copenhagen; University System of Maryland; University of Maryland College Park; State University System of Florida; University of Florida; University System of Maryland; University of Maryland College Park; Capital Normal University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono; University System of Ohio; University of Cincinnati; Macquarie University; Smithsonian Institution; Smithsonian National Museum of Natural History; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Oregon State University; Nicolaus Copernicus University; University of Witwatersrand; University of Wisconsin System; University of Wisconsin Madison; University of Vermont	Lyons, SK (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20013 USA.	lyonss2@si.edu	Blois, Jessica/G-5893-2011; Telford, Richard/C-1668-2008; Graves, Gary R/P-1003-2017; Pineda-Munoz, Silvia/AAR-2292-2020; Terry, Rebecca/L-7019-2017; Eronen, Jussi T./B-7978-2013; Tóth, Anikó/AAT-6084-2021; McGill, Brian J/A-3476-2008; Jud, Nathan/AAI-2384-2020; Villasenor, Amelia/AAR-5965-2021; aubertin, rebeckah/O-9624-2015	Blois, Jessica/0000-0003-4048-177X; Telford, Richard/0000-0001-9826-3076; Graves, Gary R/0000-0003-1406-5246; Pineda-Munoz, Silvia/0000-0003-0597-4456; Terry, Rebecca/0000-0002-9803-6292; Eronen, Jussi T./0000-0002-0390-8044; Tóth, Anikó/0000-0002-3063-1917; McGill, Brian J/0000-0002-0850-1913; Jud, Nathan/0000-0001-6100-9779; Lyons, S. Kathleen/0000-0001-5112-2508; Du, Andrew/0000-0002-7381-5089; aubertin, rebeckah/0000-0002-0558-7571; DiMichele, William/0000-0002-7270-220X; Ulrich, Werner/0000-0002-8715-6619; Faith, J. Tyler/0000-0002-1101-7161; Wing, Scott/0000-0002-2954-8905; Villasenor, Amelia/0000-0002-4385-946X	National Museum of Natural History Program grant [NSF-DEB 1257625]; Division Of Environmental Biology [1257625] Funding Source: National Science Foundation	National Museum of Natural History Program grant; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank G. Dietl for comments that improved the manuscript. Support for this research was provided by a National Museum of Natural History Program grant to the Evolution of Terrestrial Ecosystems Program (ETE) and NSF-DEB 1257625. This is ETE publication 338.	[Anonymous], 2003, DEFORESTING EARTH PR; Augustin L, 2004, NATURE, V429, P623, DOI 10.1038/nature02599; Bambach RK, 2006, ANNU REV EARTH PL SC, V34, P127, DOI 10.1146/annurev.earth.33.092203.122654; Barnosky AD, 2008, P NATL ACAD SCI USA, V105, P11543, DOI 10.1073/pnas.0801918105; Behrensmeyer AK, 2000, PALEOBIOLOGY, V26, P103, DOI 10.1666/0094-8373(2000)26[103:TAP]2.0.CO;2; Blois JL, 2014, ECOGRAPHY, V37, P1095, DOI 10.1111/ecog.00779; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; Bowen GJ, 2015, NAT GEOSCI, V8, P44, DOI [10.1038/ngeo2316, 10.1038/NGEO2316]; Capinha C, 2015, SCIENCE, V348, P1248, DOI 10.1126/science.aaa8913; Connor EF, 2013, ECOLOGY, V94, P2403, DOI 10.1890/12-1471.1; CONNOR EF, 1979, AM NAT, V113, P791, DOI 10.1086/283438; Delcourt PA, 2004, PREHISTORIC NATIVE A; Dornelas M, 2014, SCIENCE, V344, P296, DOI 10.1126/science.1248484; Efron B, 2005, J AM STAT ASSOC, V100, P1, DOI 10.1198/016214505000000033; Gotelli NJ, 2012, OIKOS, V121, P171, DOI 10.1111/j.1600-0706.2011.20301.x; Gotelli NJ, 2010, OECOLOGIA, V162, P463, DOI 10.1007/s00442-009-1474-y; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.2307/177478; Gotelli NJ, 2002, ECOLOGY, V83, P2091, DOI 10.2307/3072040; Grayson DK, 2001, J WORLD PREHIST, V15, P1, DOI 10.1023/A:1011165119141; Haddad NM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500052; Jackson ST, 2004, ANNU REV EARTH PL SC, V32, P495, DOI 10.1146/annurev.earth.32.101802.120435; Kidwell SM, 2002, ANNU REV ECOL SYST, V33, P561, DOI 10.1146/annurev.ecolsys.33.030602.152151; Lyons SK, 2005, AM NAT, V165, pE168, DOI 10.1086/429699; Marlon JR, 2013, QUATERNARY SCI REV, V65, P5, DOI 10.1016/j.quascirev.2012.11.029; Ruddiman WF, 2009, QUATERNARY SCI REV, V28, P3011, DOI 10.1016/j.quascirev.2009.05.022; Smith BD, 2009, P NATL ACAD SCI USA, V106, P6561, DOI 10.1073/pnas.0901846106; STONE L, 1990, OECOLOGIA, V85, P74, DOI 10.1007/BF00317345; Thompson JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072540; Toth AB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093092; Ulrich W., 2010, PAIRS FORTRAN PROGRA; Ulrich W., 2008, PAIRS FORTRAN PROGRA; Ulrich W, 2007, ECOLOGY, V88, P1824, DOI 10.1890/06-1208.1; Ulrich W, 2010, ECOLOGY, V91, P3384, DOI 10.1890/09-2157.1; van Kleunen M, 2015, NATURE, V525, P100, DOI 10.1038/nature14910; Wagner PJ, 2006, SCIENCE, V314, P1289, DOI 10.1126/science.1133795; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilf P, 1999, SCIENCE, V284, P2153, DOI 10.1126/science.284.5423.2153; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; Zeder MA, 2009, CURR ANTHROPOL, V50, P681, DOI 10.1086/605553	39	107	108	4	134	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 7	2016	529	7584					80	U183		10.1038/nature16447	http://dx.doi.org/10.1038/nature16447			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6VY	26675730				2022-12-28	WOS:000367944900030
J	Lee, CS; Hwang, JH				Lee, Chang-Seop; Hwang, Jeong-Hwan			Scrub Typhus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lee, Chang-Seop; Hwang, Jeong-Hwan] Chonbuk Natl Univ, Jeonju 561756, South Korea	Jeonbuk National University	Lee, CS (corresponding author), Chonbuk Natl Univ, Jeonju 561756, South Korea.	lcsmd@jbnu.ac.kr							0	9	9	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 17	2015	373	25					2455	2455		10.1056/NEJMicm1503639	http://dx.doi.org/10.1056/NEJMicm1503639			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY5QD	26672847				2022-12-28	WOS:000366461400012
J	Sohn, E				Sohn, Emily			Screening: Diagnostic dilemma	NATURE			English	Editorial Material							PROSTATE-CANCER MORTALITY; ANTIGEN											Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; CATALONA WJ, 1991, NEW ENGL J MED, V324, P1156, DOI 10.1056/NEJM199104253241702; Jemal A, 2015, JAMA-J AM MED ASSOC, V314, P2054, DOI 10.1001/jama.2015.14905; SAKR WA, 1994, IN VIVO, V8, P439; Sammon JD, 2015, JAMA-J AM MED ASSOC, V314, P2075, DOI 10.1001/jama.2015.7273; Schroder FH, 2014, LANCET, V384, P2027, DOI 10.1016/S0140-6736(14)60525-0; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Shteynshlyuger A, 2011, J UROLOGY, V185, P828, DOI 10.1016/j.juro.2010.10.079	8	14	15	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2015	528	7582					S120	S122		10.1038/528S120a	http://dx.doi.org/10.1038/528S120a			0	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VC0SZ	26672781				2022-12-28	WOS:000427275000001
J	Adams, B				Adams, Ben			ACADEMIC AUTHORSHIP Time to kill the scientific "author"?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												benjohnadams26@gmail.com						Aspenberg P, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6605; Wager E, 2015, PEERJ, V3, DOI 10.7717/peerj.1154	2	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 8	2015	351								h6560	10.1136/bmj.h6560	http://dx.doi.org/10.1136/bmj.h6560			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY5SV	26646439				2022-12-28	WOS:000366468600006
J	Boutros, M; Heigwer, F; Laufer, C				Boutros, Michael; Heigwer, Florian; Laufer, Christina			Microscopy-Based High-Content Screening	CELL			English	Article							GENOME-WIDE RNAI; EMBRYONIC STEM-CELLS; LOSS-OF-FUNCTION; GENETIC INTERACTIONS; DROSOPHILA-MELANOGASTER; SIRNA SCREEN; IDENTIFICATION; DESIGN; INTERFERENCE; CRISPR-CAS9	Image-based screening is used to measure a variety of phenotypes in cells and whole organisms. Combined with perturbations such as RNA interference, small molecules, and mutations, such screens are a powerful method for gaining systematic insights into biological processes. Screens have been applied to study diverse processes, such as protein-localization changes, cancer cell vulnerabilities, and complex organismal phenotypes. Recently, advances in imaging and image-analysis methodologies have accelerated large-scale perturbation screens. Here, we describe the state of the art for image-based screening experiments and delineate experimental approaches and image-analysis approaches as well as discussing challenges and future directions, including leveraging CRISPR/Cas9-mediated genome engineering.	[Boutros, Michael; Heigwer, Florian; Laufer, Christina] Heidelberg Univ, German Canc Res Ctr DKFZ, Div Signaling & Funct Genom, D-69120 Heidelberg, Germany; [Boutros, Michael; Heigwer, Florian; Laufer, Christina] Heidelberg Univ, Dept Cell & Mol Biol, D-69120 Heidelberg, Germany; [Boutros, Michael] German Canc Consortium DKTK, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Boutros, M (corresponding author), Heidelberg Univ, German Canc Res Ctr DKFZ, Div Signaling & Funct Genom, Neuenheimer Feld 580, D-69120 Heidelberg, Germany.	m.boutros@dkfz.de	Boutros, Michael/C-3566-2008; Heigwer, Florian/O-5114-2019	Boutros, Michael/0000-0002-9458-817X; Heigwer, Florian/0000-0002-8230-1485	ERC Advanced Grant ("Syngene") from the European Commission	ERC Advanced Grant ("Syngene") from the European Commission	We thank members of the Boutros lab for helpful comments on the manuscript. Research in the lab of M.B. is supported by an ERC Advanced Grant ("Syngene") from the European Commission.	Benes M, 2015, J MICROSC-OXFORD, V257, P65, DOI 10.1111/jmi.12186; Bier E, 2005, NAT REV GENET, V6, P9, DOI 10.1038/nrg1503; Bjorklund M, 2006, NATURE, V439, P1009, DOI 10.1038/nature04469; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Boutros M, 2008, NAT REV GENET, V9, P554, DOI 10.1038/nrg2364; Carpenter AE, 2007, NAT CHEM BIOL, V3, P461, DOI 10.1038/nchembio.2007.15; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Chong YT, 2015, CELL, V161, P1413, DOI 10.1016/j.cell.2015.04.051; Danuser G, 2011, CELL, V147, P973, DOI 10.1016/j.cell.2011.11.001; Dermitzakis ET, 2012, NAT REV GENET, V13, P215, DOI 10.1038/nrg3115; Desbordes SC, 2008, CELL STEM CELL, V2, P602, DOI 10.1016/j.stem.2008.05.010; Desbordes SC, 2013, NAT PROTOC, V8, P111, DOI 10.1038/nprot.2012.139; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Eggert US, 2004, PLOS BIOL, V2, P2135, DOI 10.1371/journal.pbio.0020379; Eliceiri KW, 2012, NAT METHODS, V9, P697, DOI [10.1038/nmeth.2084, 10.1038/NMETH.2084]; Fischer B, 2015, ELIFE, V4, DOI 10.7554/eLife.05464; Fuchs F, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.25; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Held M, 2010, NAT METHODS, V7, P747, DOI 10.1038/nmeth.1486; Honarnejad K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080645; Horn T, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r61; Jones TR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-482; Karim FD, 1996, GENETICS, V143, P315; Karlas A, 2010, NATURE, V463, P818, DOI 10.1038/nature08760; Kiger A A, 2003, J Biol, V2, P27, DOI 10.1186/1475-4924-2-27; Kimura Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep10710; Kittler R, 2004, NATURE, V432, P1036, DOI 10.1038/nature03159; Kittler R, 2007, NAT METHODS, V4, P337, DOI 10.1038/NMETH1025; Laufer C, 2014, NAT PROTOC, V9, P2341, DOI 10.1038/nprot.2014.160; Laufer C, 2013, NAT METHODS, V10, P427, DOI [10.1038/NMETH.2436, 10.1038/nmeth.2436]; Liberali P, 2015, NAT REV GENET, V16, P18, DOI 10.1038/nrg3768; Liberali P, 2014, CELL, V157, P1473, DOI 10.1016/j.cell.2014.04.029; Link W, 2009, J BIOL CHEM, V284, P28392, DOI 10.1074/jbc.M109.038984; Liu T, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r26; Loo LH, 2007, NAT METHODS, V4, P445, DOI 10.1038/NMETH1032; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mohr S, 2010, ANNU REV BIOCHEM, V79, P37, DOI 10.1146/annurev-biochem-060408-092949; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Morgan TH, 1910, SCIENCE, V32, P120, DOI 10.1126/science.32.812.120; Mullard A, 2013, NAT REV DRUG DISCOV, V12, P173, DOI 10.1038/nrd3956; Neumann B, 2006, NAT METHODS, V3, P385, DOI 10.1038/NMETH876; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Nieland TJF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091744; Nir O, 2010, GENOME RES, V20, P372, DOI 10.1101/gr.100248.109; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Orvedahl A, 2011, NATURE, V480, P113, DOI 10.1038/nature10546; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pau G, 2010, BIOINFORMATICS, V26, P979, DOI 10.1093/bioinformatics/btq046; Ramadan N, 2007, NAT PROTOC, V2, P2245, DOI 10.1038/nprot.2007.250; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rank K, 1992, IEEE T IMAGE PROCESS, V1, P431, DOI 10.1109/83.148617; Roguev A, 2013, NAT METHODS, V10, P432, DOI [10.1038/nmeth.2398, 10.1038/NMETH.2398]; Roy A, 2010, CURR PHARM BIOTECHNO, V11, P764, DOI 10.2174/138920110792927757; Sailem HZ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6825; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sepp KJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000111; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Simpson JC, 2012, NAT CELL BIOL, V14, P764, DOI 10.1038/ncb2510; Singh S, 2014, J BIOMOL SCREEN, V19, P640, DOI 10.1177/1087057114528537; Snijder B, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.9; Sommer C, 2013, J CELL SCI, V126, P5529, DOI 10.1242/jcs.123604; St Johnston D, 2002, NAT REV GENET, V3, P176, DOI 10.1038/nrg751; Sundaramurthy V, 2013, CELL HOST MICROBE, V13, P129, DOI 10.1016/j.chom.2013.01.008; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Thompson GC, 2014, J CELL BIOCHEM, V115, P1849, DOI 10.1002/jcb.24882; Vizeacoumar FJ, 2010, J CELL BIOL, V188, P69, DOI 10.1083/jcb.200909013; Wang XY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5828; Wang YL, 2007, METHOD CELL BIOL, V81, P435, DOI 10.1016/S0091-679X(06)81020-4; Wheeler DB, 2004, NAT METHODS, V1, P127, DOI 10.1038/NMETH711; Yin Z, 2013, NAT CELL BIOL, V15, P860, DOI 10.1038/ncb2764; Young DW, 2008, NAT CHEM BIOL, V4, P59, DOI 10.1038/nchembio.2007.53; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	75	198	201	2	88	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 6	2015	163	6					1314	1325		10.1016/j.cell.2015.11.007	http://dx.doi.org/10.1016/j.cell.2015.11.007			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SE	26638068	Bronze			2022-12-28	WOS:000366044800013
J	Waugh, P				Waugh, Patricia			The art of medicine The novelist as voice hearer	LANCET			English	Editorial Material									[Waugh, Patricia] Univ Durham, Dept English Studies, Durham DH1 3AY, England	Durham University	Waugh, P (corresponding author), Univ Durham, Dept English Studies, Durham DH1 3AY, England.	p.n.waugh@durham.ac.uk			Wellcome Trust [098455] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bakhtin M.M., 1963, PROBLEMS DOSTOEVSKYS; Lee H, 1997, VIRGINIA WOOLF BIOGR; Trombley, 1982, ALL SUMMER SHE WAS M; Woolf V., 2002, MOMENTS BEING AUTOBI; Woolf Virginia., 1925, DALLOWAY	5	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 5	2015	386	10010					E54	E55		10.1016/S0140-6736(15)01118-6	http://dx.doi.org/10.1016/S0140-6736(15)01118-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CX8ZB	26693533	Bronze			2022-12-28	WOS:000365993200003
J	Medley, GF; Hollingsworth, TD; Olliaro, PL; Adams, ER				Medley, Graham F.; Hollingsworth, T. Deirdre; Olliaro, Piero L.; Adams, Emily R.			Health-seeking behaviour, diagnostics and transmission dynamics in the control of visceral leishmaniasis in the Indian subcontinent	NATURE			English	Article							ELIMINATION; METAANALYSIS; MANAGEMENT; OUTBREAK; BIHAR; NEPAL	Countries in the Indian subcontinent have committed to reducing the incidence of kala-azar, a clinical manifestation of visceral leishmaniasis, to below 1 in 10,000 by 2020. We address the role of timing of use and accuracy of diagnostics in kala-azar control and elimination. We use empirical data on health-seeking behaviour and health-system performance from the Indian state of Bihar, Bangladesh and Nepal to parameterize a mathematical model. Diagnosis of cases is key to case management, control and surveillance. Treatment of cases prevents onward transmission, and we show that the differences in time to diagnosis in these three settings explain the observed differences in incidence. Shortening the time from health-care seeking to diagnosis is likely to lead to dramatic reductions in incidence in Bihar, bringing the incidence down to the levels seen in Bangladesh and Nepal. The results emphasize the importance of maintaining population and health-system awareness, particularly as transmission and disease incidence decline. We explore the possibility of diagnosing patients before the onset of clinical kala-azar (before 14 days fever), and show that this could have a marked impact on incidence, even for a moderately sensitive test. However, limited specificity (that results in false positives) is a major barrier to such a strategy. Diagnostic tests of high specificity used at an early stage of active infection, even if sensitivity is only moderate, could have a key role in the control of kala-azar, and prevent its resurgence when paired with the passive health-care system and tests of high sensitivity, such as the test for rK39 antibody response.	[Medley, Graham F.] Univ London London Sch Hyg & Trop Med, Global Hlth & Dev, London WC1E 7HT, England; [Hollingsworth, T. Deirdre; Adams, Emily R.] Univ Warwick, Sch Life Sci, WIDER, Coventry CV4 7AL, W Midlands, England; [Hollingsworth, T. Deirdre] Univ Warwick, Warwick Math Inst, Coventry CV4 7AL, W Midlands, England; [Olliaro, Piero L.] WHO, WHO Special Programme Res & Training Trop Dis TDR, World Bank, UNICEF,UNDP, CH-1211 Geneva, Switzerland; [Olliaro, Piero L.] Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford OX3 7FZ, England; [Adams, Emily R.] Univ Liverpool, Liverpool Sch Trop Med, Dept Parasitol, Res Ctr Drugs & Diagnost, Liverpool L3 5QA, Merseyside, England	University of London; London School of Hygiene & Tropical Medicine; University of Warwick; University of Warwick; The World Bank; World Health Organization; University of Oxford; Liverpool School of Tropical Medicine; University of Liverpool	Adams, ER (corresponding author), Univ Warwick, Sch Life Sci, WIDER, Coventry CV4 7AL, W Midlands, England.	emily.adams@lstmed.ac.uk	Hollingsworth, Deirdre/D-2421-2009; Medley, Graham/B-7289-2008	Hollingsworth, Deirdre/0000-0001-5962-4238; Medley, Graham/0000-0002-0030-7278; Adams, Emily/0000-0002-0816-2835	Bill and Melinda Gates Foundation through the Diagnostics Modelling Consortium based at Imperial College; NTD Modelling Consortium by the Bill and Melinda Gates Foundation; Task Force for Global Health	Bill and Melinda Gates Foundation through the Diagnostics Modelling Consortium based at Imperial College; NTD Modelling Consortium by the Bill and Melinda Gates Foundation; Task Force for Global Health	The authors thank D. Mondal, O. Courtenay, C. Bern, L. Chapman, A. Ghani and S. Laney for informative discussions. G.F.M. and E.R.A. gratefully acknowledge funding from the Bill and Melinda Gates Foundation through the Diagnostics Modelling Consortium based at Imperial College. G.F.M., E.R.A. and T.D.H. gratefully acknowledge funding of the NTD Modelling Consortium by the Bill and Melinda Gates Foundation in partnership with the Task Force for Global Health. The views, opinions, assumptions or any other information set out in this article are solely those of the authors. P.L.O. is a staff member of the WHO; the authors alone are responsible for the views expressed in this publication, which do not necessarily represent the decisions, policy, or views of the WHO.	Adams ER, 2010, AM J TROP MED HYG, V82, P591, DOI 10.4269/ajtmh.2010.09-0369; ADDY M, 1992, B WORLD HEALTH ORGAN, V70, P341; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Bern C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000599; Boelaert M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009135.pub2; Boettcher JP, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0767-5; Chappuis F, 2006, BMJ-BRIT MED J, V333, P723, DOI 10.1136/bmj.38917.503056.7C; Das S, 2014, T ROY SOC TROP MED H, V108, P679, DOI 10.1093/trstmh/tru146; Das VNR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002774; de Ruiter CM, 2014, J CLIN MICROBIOL, V52, P3147, DOI 10.1128/JCM.00372-14; DYE C, 1988, T ROY SOC TROP MED H, V82, P843, DOI 10.1016/0035-9203(88)90013-2; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Hasker E, 2010, TROP MED INT HEALTH, V15, P55, DOI 10.1111/j.1365-3156.2010.02562.x; Hasker E, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002657; Matlashewski G, 2014, LANCET GLOB HEALTH, V2, pE683, DOI 10.1016/S2214-109X(14)70318-3; McCall LI, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003053; Mondal D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000355; Muniaraj Mayilsamy, 2014, Trop Parasitol, V4, P10, DOI 10.4103/2229-5070.129143; Rock KS, 2015, TRENDS PARASITOL, V31, P251, DOI 10.1016/j.pt.2015.03.007; Stauch A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002810; Stauch A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001405; Sundar S, 2002, CLIN DIAGN LAB IMMUN, V9, P951, DOI 10.1128/CDLI.9.5.951-958.2002	22	49	50	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					S102	S108		10.1038/nature16042	http://dx.doi.org/10.1038/nature16042			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX3NO	26633763	Green Accepted, Green Submitted, hybrid			2022-12-28	WOS:000365606000017
J	Fernyhough, C				Fernyhough, Charles			Listening to the voices	LANCET			English	Editorial Material							AUDITORY VERBAL HALLUCINATIONS; PHENOMENOLOGY; HEARING; ART		[Fernyhough, Charles] Univ Durham, Dept Psychol, Durham DH1 3LE, England	Durham University	Fernyhough, C (corresponding author), Univ Durham, Dept Psychol, Durham DH1 3LE, England.	c.p.fernyhough@durham.ac.uk	Fernyhough, Charles/A-1057-2010	Fernyhough, Charles/0000-0002-3822-710X	Wellcome Trust [098455] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alderson-Day B, 2015, PSYCHOL BULL, V141, P931, DOI 10.1037/bul0000021; Bernini M, 2014, SAMUEL BECKETT TODAY, V26, P193, DOI 10.1163/9789401211635_015; Fernyhough C, 2014, LANCET, V384, P1090, DOI 10.1016/S0140-6736(14)61665-2; Fernyhough Charles, 2015, WORKING KNOWLEDGE TR; Johns LC, 2014, SCHIZOPHRENIA BULL, V40, pS255, DOI 10.1093/schbul/sbu005; Laroi F, 2012, SCHIZOPHRENIA BULL, V38, P724, DOI 10.1093/schbul/sbs061; Saunders C, 2016, EDINBURGH C IN PRESS; Saunders Corinne, 2015, Lancet, V386, P2136; Vilhauer RP, 2015, INT J SOC PSYCHIATR, V61, P58, DOI 10.1177/0020764014535757; Waugh Patricia, 2015, J BRIT ACAD, V3, P35; Woods A, 2015, LANCET PSYCHIAT, V2, P323, DOI 10.1016/S2215-0366(15)00006-1; Woods A, 2014, SCHIZOPHRENIA BULL, V40, pS246, DOI 10.1093/schbul/sbu003	12	0	0	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 28	2015	386	10009					2124	2125		10.1016/S0140-6736(15)00988-5	http://dx.doi.org/10.1016/S0140-6736(15)00988-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX8YW	26638949				2022-12-28	WOS:000365992600011
J	Natt, B; Raz, Y				Natt, Bhupinder; Raz, Yuval			Air Bronchogram	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Natt, Bhupinder; Raz, Yuval] Univ Arizona, Med Ctr, Tucson, AZ 85721 USA	University of Arizona	Natt, B (corresponding author), Univ Arizona, Med Ctr, Tucson, AZ 85721 USA.	bnatt@deptofmed.arizona.edu		Raz, Yuval/0000-0002-2402-0466					0	0	0	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 31	2015	373	27					2663	2663		10.1056/NEJMicm1503806	http://dx.doi.org/10.1056/NEJMicm1503806			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ8UH	26716918				2022-12-28	WOS:000367374100011
J	Epstein, RM; Back, AL				Epstein, Ronald M.; Back, Anthony L.			Responding to Suffering	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MEDICINE		[Epstein, Ronald M.] Univ Rochester, Sch Med & Dent, Dept Family Med, Rochester, NY USA; [Epstein, Ronald M.] Univ Rochester, Sch Med & Dent, Dept Psychiat, Rochester, NY 14642 USA; [Epstein, Ronald M.] Univ Rochester, Sch Med & Dent, Dept Oncol, Rochester, NY USA; [Back, Anthony L.] Univ Washington, Dept Med, Div Oncol, Seattle, WA 98195 USA	University of Rochester; University of Rochester; University of Rochester; University of Washington; University of Washington Seattle	Epstein, RM (corresponding author), Univ Rochester, Sch Med & Dent, Dept Family Med, Rochester, NY USA.	ronald_epstein@urmc.rochester.edu						Back AL, 2015, J PALLIAT MED, V18, P26, DOI 10.1089/jpm.2014.0115; Beckman HB, 2012, ACAD MED, V87, P815, DOI 10.1097/ACM.0b013e318253d3b2; Candib LM, 2002, PATIENT EDUC COUNS, V48, P43, DOI 10.1016/S0738-3991(02)00098-8; CASSEL EJ, 1982, NEW ENGL J MED, V306, P639, DOI 10.1056/NEJM198203183061104; Coulehan J, 2009, PERSPECT BIOL MED, V52, P585, DOI 10.1353/pbm.0.0130; Garden R, 2009, J GEN INTERN MED, V24, P122, DOI 10.1007/s11606-008-0849-9; Shapiro J, 2011, MED HUMANIT, V37, P68, DOI 10.1136/jmh.2011.007328	7	16	16	1	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 29	2015	314	24					2623	2624		10.1001/jama.2015.13004	http://dx.doi.org/10.1001/jama.2015.13004			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ2MR	26720023				2022-12-28	WOS:000366939800014
J	Gronke, K; Diefenbach, A				Gronke, Konrad; Diefenbach, Andreas			Innate immunity repairs gut lining	NATURE			English	Editorial Material							VERSUS-HOST-DISEASE; STEM-CELLS; TISSUES		[Gronke, Konrad; Diefenbach, Andreas] Johannes Gutenberg Univ Mainz, Med Ctr, Immunol Res Ctr, D-55131 Mainz, Germany; [Gronke, Konrad; Diefenbach, Andreas] Inst Med Microbiol & Hyg, D-55131 Mainz, Germany; [Gronke, Konrad] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany	Johannes Gutenberg University of Mainz; Max Planck Society	Gronke, K (corresponding author), Johannes Gutenberg Univ Mainz, Med Ctr, Immunol Res Ctr, D-55131 Mainz, Germany.	diefenbach@uni-mainz.de	Diefenbach, Andreas/T-2589-2018	Diefenbach, Andreas/0000-0002-9176-9530				Aparicio-Domingo P, 2015, J EXP MED, V212, P1783, DOI 10.1084/jem.20150318; Blazar BR, 2012, NAT REV IMMUNOL, V12, P443, DOI 10.1038/nri3212; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Eberl G, 2005, NAT REV IMMUNOL, V5, P413, DOI 10.1038/nri1600; Hanash AM, 2012, IMMUNITY, V37, P339, DOI 10.1016/j.immuni.2012.05.028; Lindemans CA, 2015, NATURE, V528, P560, DOI 10.1038/nature16460; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007	11	6	8	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2015	528	7583					488	489		10.1038/nature16325	http://dx.doi.org/10.1038/nature16325			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ3GH	26649826				2022-12-28	WOS:000366991900039
J	Kimmey, JM; Huynh, JP; Weiss, LA; Park, S; Kambal, A; Debnath, J; Virgin, HW; Stallings, CL				Kimmey, Jacqueline M.; Huynh, Jeremy P.; Weiss, Leslie A.; Park, Sunmin; Kambal, Amal; Debnath, Jayanta; Virgin, Herbert W.; Stallings, Christina L.			Unique role for ATG5 in neutrophil-mediated immunopathology during M. tuberculosis infection	NATURE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; INTERFERON-GAMMA; ALVEOLAR MACROPHAGES; LUNG INFLAMMATION; AUTOPHAGY; CELLS; MICE; MOUSE; RESPONSES; ATG16L1	Mycobacterium tuberculosis, a major global health threat, replicates in macrophages in part by inhibiting phagosome-lysosome fusion, until interferon-gamma (IFN gamma) activates the macrophage to traffic M. tuberculosis to the lysosome. How IFN gamma elicits this effect is unknown, but many studies suggest a role for macroautophagy (herein termed autophagy), a process by which cytoplasmic contents are targeted for lysosomal degradation(1). The involvement of autophagy has been defined based on studies in cultured cells where M. tuberculosis co-localizes with autophagy factors ATG5, ATG12, ATG16L1, p62, NDP52, BECN1 and LC3 (refs 2-6), stimulation of autophagy increases bacterial killing(6-8), and inhibition of autophagy increases bacterial survival(1,2,4,6,7). Notably, these studies reveal modest (similar to 1.5-3-fold change) effects on M. tuberculosis replication. By contrast, mice lacking ATG5 in monocyte-derived cells and neutrophils (polymorponuclear cells, PMNs) succumb to M. tuberculosis within 30 days(4,9), an extremely severe phenotype similar to mice lacking IFN gamma signalling(10,11). Importantly, ATG5 is the only autophagy factor that has been studied during M. tuberculosis infection in vivo and autophagy-independent functions of ATG5 have been described(12-18). For this reason, we used a genetic approach to elucidate the role for multiple autophagy-related genes and the requirement for autophagy in resistance to M. tuberculosis infection in vivo. Here we show that, contrary to expectation, autophagic capacity does not correlate with the outcome of M. tuberculosis infection. Instead, ATG5 plays a unique role in protection against M. tuberculosis by preventing PMN-mediated immunopathology. Furthermore, while Atg5 is dispensable in alveolar macrophages during M. tuberculosis infection, loss of Atg5 in PMNs can sensitize mice to M. tuberculosis. These findings shift our understanding of the role of ATG5 during M. tuberculosis infection, reveal new outcomes of ATG5 activity, and shed light on early events in innate immunity that are required to regulate disease pathology and bacterial replication.	[Kimmey, Jacqueline M.; Huynh, Jeremy P.; Weiss, Leslie A.; Stallings, Christina L.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Park, Sunmin; Kambal, Amal; Virgin, Herbert W.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Debnath, Jayanta] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Debnath, Jayanta] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA	Washington University (WUSTL); Washington University (WUSTL); University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Stallings, CL (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.	stallings@wusm.wustl.edu	Kimmey, Jacqueline/GXV-9323-2022	Kimmey, Jacqueline M/0000-0003-1330-8525; Debnath, Jayanta/0000-0002-8745-4069; Virgin, Herbert/0000-0001-8580-7628	Beckman Young Investigator Award from the Arnold and Mabel Beckman Foundation; National Science Foundation Graduate Research Fellowship [DGE-1143954]; NIGMS Cell and Molecular Biology Training Grant [GM007067];  [U19 AI109725]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007067] Funding Source: NIH RePORTER	Beckman Young Investigator Award from the Arnold and Mabel Beckman Foundation; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NIGMS Cell and Molecular Biology Training Grant; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	C.L.S. is supported by a Beckman Young Investigator Award from the Arnold and Mabel Beckman Foundation. J.M.K. is supported by a National Science Foundation Graduate Research Fellowship DGE-1143954 and the NIGMS Cell and Molecular Biology Training Grant GM007067. J.P.H. is supported by a National Science Foundation Graduate Research Fellowship DGE-1143954. H.W.V., S.P. and A.K. are supported by U19 AI109725. We would like to acknowledge D. Kreamalmeyer for assistance with the mouse colonies and T. Malek and L. D. Sibley for providing the 1A8 hybridoma.	Abram CL, 2014, J IMMUNOL METHODS, V408, P89, DOI 10.1016/j.jim.2014.05.009; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Castillo EF, 2012, P NATL ACAD SCI USA, V109, pE3168, DOI 10.1073/pnas.1210500109; Choi J, 2014, IMMUNITY, V40, P924, DOI 10.1016/j.immuni.2014.05.006; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Deretic V, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a018481; Dutta RK, 2012, INT J BIOCHEM CELL B, V44, P942, DOI 10.1016/j.biocel.2012.02.021; Fattah EA, 2015, J IMMUNOL, V194, P5407, DOI 10.4049/jimmunol.1402277; FLEMING TJ, 1993, J IMMUNOL, V151, P2399; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hwang S, 2012, CELL HOST MICROBE, V11, P397, DOI 10.1016/j.chom.2012.03.002; Jakubzick C, 2008, J EXP MED, V205, P2839, DOI 10.1084/jem.20081430; Jayaswal S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000839; Jia W, 2011, J IMMUNOL, V186, P5313, DOI 10.4049/jimmunol.1002404; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Juarez E, 2012, EUR J IMMUNOL, V42, P880, DOI 10.1002/eji.201142105; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kanayama M, 2015, J IMMUNOL, V194, P5465, DOI 10.4049/jimmunol.1403249; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Lee EJ, 2011, AUTOPHAGY, V7, P689, DOI 10.4161/auto.7.7.15450; Leemans JC, 2001, J IMMUNOL, V166, P4604, DOI 10.4049/jimmunol.166.7.4604; Lin HH, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.428; Malhotra R, 2015, AUTOPHAGY, V11, P145, DOI 10.1080/15548627.2014.998917; Marino G, 2010, J CLIN INVEST, V120, P2331, DOI 10.1172/JCI42601; Martinez J, 2015, NAT CELL BIOL, V17, P893, DOI 10.1038/ncb3192; Maskey D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3130; McAlpine F, 2013, AUTOPHAGY, V9, P361, DOI 10.4161/auto.23066; Nandi B, 2011, J EXP MED, V208, P2251, DOI 10.1084/jem.20110919; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sakowski ET, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005076; Seto S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0086017; Wang JL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003697; Watson RO, 2012, CELL, V150, P803, DOI 10.1016/j.cell.2012.06.040; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Zhao ZJ, 2008, CELL HOST MICROBE, V4, P458, DOI 10.1016/j.chom.2008.10.003	36	229	234	2	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2015	528	7583					565	+		10.1038/nature16451	http://dx.doi.org/10.1038/nature16451			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ3GH	26649827	Green Accepted, Green Submitted			2022-12-28	WOS:000366991900055
J	Gagyor, I; Bleidorn, J; Kochen, MM; Schmiemann, G; Wegscheider, K; Hummers-Pradier, E				Gagyor, Ildiko; Bleidorn, Jutta; Kochen, Michael M.; Schmiemann, Guido; Wegscheider, Karl; Hummers-Pradier, Eva			Ibuprofen versus fosfomycin for uncomplicated urinary tract infection in women: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ANTIBIOTIC USE; NATURAL COURSE; PLACEBO; MANAGEMENT; RESISTANCE; CYSTITIS; BACTERIURIA; SYMPTOMS; POINT; CARE	STUDY QUESTION Can treatment of the symptoms of uncomplicated urinary tract infection (UTI) with ibuprofen reduce the rate of antibiotic prescriptions without a significant increase in symptoms, recurrences, or complications? METHODS Women aged 18-65 with typical symptoms of UTI and without risk factors or complications were recruited in 42 German general practices and randomly assigned to treatment with a single dose of fosfomycin 3 g (n = 246; 243 analysed) or ibuprofen 3x400 mg (n = 248; 241 analysed) for three days (and the respective placebo dummies in both groups). In both groups additional antibiotic treatment was subsequently prescribed as necessary for persistent, worsening, or recurrent symptoms. The primary endpoints were the number of all courses of antibiotic treatment on days 0-28 (for UTI or other conditions) and burden of symptoms on days 0-7. The symptom score included dysuria, frequency/urgency, and low abdominal pain. STUDY ANSWER AND LIMITATIONS The 248 women in the ibuprofen group received significantly fewer course of antibiotics, had a significantly higher total burden of symptoms, and more had pyelonephritis. Four serious adverse events occurred that lead to hospital referrals; one of these was potentially related to the trial drug. Results have to be interpreted carefully as they might apply to women with mild to moderate symptoms rather than to all those with an uncomplicated UTI. WHAT THIS PAPER ADDS Two thirds of women with uncomplicated UTI treated symptomatically with ibuprofen recovered without any antibiotics. Initial symptomatic treatment is a possible approach to be discussed with women willing to avoid immediate antibiotics and to accept a somewhat higher burden of symptoms. FUNDING, COMPETING INTERESTS, DATA SHARING German Federal Ministry of Education and Research (BMBF) No 01KG1105. Patient level data are available from the corresponding author. Patient consent was not obtained but the data are anonymised and risk of identification is low.	[Gagyor, Ildiko; Hummers-Pradier, Eva] Univ Med Ctr Gottingen, Dept Gen Practice, D-37073 Gottingen, Germany; [Bleidorn, Jutta] Hannover Med Sch, Inst Gen Practice, D-30625 Hannover, Germany; [Kochen, Michael M.] Univ Med Ctr, Div Gen Practice, Dept Med, D-79110 Freiburg, Germany; [Schmiemann, Guido] Univ Bremen, Dept Hlth Serv Res, Inst Publ Hlth & Nursing Res, D-28359 Bremen, Germany; [Wegscheider, Karl] Univ Med Ctr Hamburg Eppendorf, Dept Med Biometry & Epidemiol, D-20246 Hamburg, Germany	University of Gottingen; Hannover Medical School; University of Freiburg; University of Bremen; University of Hamburg; University Medical Center Hamburg-Eppendorf	Gagyor, I (corresponding author), Univ Med Ctr Gottingen, Dept Gen Practice, Humboldtallee 38, D-37073 Gottingen, Germany.	igagyor@gwdg.de	Gagyor, Ildiko/AAG-9765-2021; Schmiemann, Guido/AAP-7098-2020	Gagyor, Ildiko/0000-0002-7974-7603; Schmiemann, Guido/0000-0002-2846-6561	German Federal Ministry of Education and Research (BMBF) [01KG1105]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The trial was funded by the German Federal Ministry of Education and Research (BMBF) No 01KG1105. The funder had no role in trial design, data collection, analysis, or reporting.	Baerheim A, 1999, SCAND J PRIM HEALTH, V17, P170, DOI 10.1080/028134399750002593; Bates J, 2014, BMC FAM PRACT, V15, DOI 10.1186/s12875-014-0187-4; Bleidorn J, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-30; Butler CC, 2007, BRIT J GEN PRACT, V57, P785; Cai T, 2012, CLIN INFECT DIS, V55, P771, DOI 10.1093/cid/cis534; Cals JWL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1374; Centers for Disease Control and Prevention, 2013, ANTIBIOTIC RESISTANC; Christiaens TCM, 2002, BRIT J GEN PRACT, V52, P729; Donnan PT, 2004, BRIT MED J, V328, P1297, DOI 10.1136/bmj.328.7451.1297; Donovan JL, 2014, J CLIN EPIDEMIOL, V67, P912, DOI 10.1016/j.jclinepi.2014.03.010; Falagas ME, 2009, J INFECTION, V58, P91, DOI 10.1016/j.jinf.2008.12.009; Ferry SA, 2004, SCAND J INFECT DIS, V36, P296, DOI 10.1080/00365540410019642; Foxman B, 2014, INFECT DIS CLIN N AM, V28, P1, DOI 10.1016/j.idc.2013.09.003; Gagyor I, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-146; Giesen LGM, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-78; Gottesman BS, 2009, CLIN INFECT DIS, V49, P869, DOI 10.1086/605530; Gyssens IC, 2011, INT J ANTIMICROB AG, V38, P11, DOI 10.1016/j.ijantimicag.2011.09.002; Hanania NA, 2009, DRUGS, V69, P1205, DOI 10.2165/00003495-200969090-00005; Hooton TM, 2012, NEW ENGL J MED, V366, P1028, DOI 10.1056/NEJMcp1104429; Julious SA, 2004, STAT MED, V23, P1921, DOI 10.1002/sim.1783; Knottnerus BJ, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-71; Leydon GM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c279; Linde M, 2006, CEPHALALGIA, V26, P712, DOI 10.1111/j.1468-2982.2006.01097.x; Little P, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c199; Little P, 2014, LANCET INFECT DIS, V14, P213, DOI 10.1016/S1473-3099(13)70294-9; Loudon K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2147; Mauch H, 2005, HARNWEGSINFEKTIONEN; Obad J, 2015, EUR J PHARM SCI, V71, P93, DOI 10.1016/j.ejps.2015.02.011; Ong DSY, 2008, J ANTIMICROB CHEMOTH, V62, P587, DOI 10.1093/jac/dkn230; Patrick DM, 2009, CAN MED ASSOC J, V180, P416, DOI 10.1503/cmaj.080626; Scottish Intercollegiate Guidelines Network, MAN SUSP BACT UR TRA; van Pinxteren B, 2013, HUISARTS WET, V56, P270; Vik I, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0693-y; Wild Diane J, 2005, Health Qual Life Outcomes, V3, P42, DOI 10.1186/1477-7525-3-42; Willems CSJ, 2014, FAM PRACT, V31, P149, DOI 10.1093/fampra/cmt077; World Health Organization, 2014, ANT RES GLOB REP SUR, DOI DOI 10.1007/S13312-014-0374-3	36	151	160	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 23	2015	351								h6544	10.1136/bmj.h6544	http://dx.doi.org/10.1136/bmj.h6544			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ7QI	26698878	Green Published, hybrid			2022-12-28	WOS:000367294200001
J	Martin, KC; Schuman, EM				Martin, K. C.; Schuman, E. M.			Opting in or out of the network	SCIENCE			English	Editorial Material							TRITONIA; MEMORY; SWIM		[Martin, K. C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Schuman, E. M.] Max Planck Inst Brain Res, D-60438 Frankfurt, Germany	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Max Planck Society	Martin, KC (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, 695 Charles East Young Dr South, Los Angeles, CA 90095 USA.	kcmartin@mednet.ucla.edu; erin.schuman@brain.mpg.de	Schuman, Erin M/D-6204-2011		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045324] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS045324] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bailey CH, 2008, PROG BRAIN RES, V169, P179, DOI 10.1016/S0079-6123(07)00010-6; Brown GD, 1996, BEHAV NEUROSCI, V110, P478; Frost WN, 1998, NEUROBIOL LEARN MEM, V69, P126, DOI 10.1006/nlme.1997.3816; GETTING PA, 1980, J NEUROPHYSIOL, V44, P151, DOI 10.1152/jn.1980.44.1.151; Hawkins RD, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a021709; Hill ES, 2015, CURR BIOL, V25, P2879, DOI 10.1016/j.cub.2015.09.033; Hill ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040579; Kandel ER, 2014, CELL, V157, P163, DOI 10.1016/j.cell.2014.03.001; Marder E, 2012, NEURON, V76, P1, DOI 10.1016/j.neuron.2012.09.010; SCHUMAN EM, 1994, J NEUROSCI, V14, P1613, DOI 10.1523/JNEUROSCI.14-03-01613.1994	11	1	1	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2015	350	6267					1477	1478		10.1126/science.aad9467	http://dx.doi.org/10.1126/science.aad9467			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY7LY	26680183	Green Accepted			2022-12-28	WOS:000366591100035
J	Murayama, Y; Uhlmann, F				Murayama, Yasuto; Uhlmann, Frank			DNA Entry into and Exit out of the Cohesin Ring by an Interlocking Gate Mechanism	CELL			English	Article							SISTER-CHROMATID COHESION; FISSION YEAST; CHROMOSOMES DEPENDS; ATP HYDROLYSIS; WAPL CONTROLS; CONDENSIN; COMPLEX; ESTABLISHMENT; ASSOCIATION; MAINTENANCE	Structural maintenance of chromosome (SMC) complexes are proteinaceous rings that embrace DNA to enable vital chromosomal functions. The ring is formed by two SMC subunits, closed at a pair of ATPase heads, whose interaction is reinforced by a kleisin subunit. Using biochemical analysis of fission-yeast cohesin, we find that a similar series of events facilitates both topological entrapment and release of DNA. DNA-sensing lysines trigger ATP hydrolysis to open the SMC head interface, whereas the Wapl subunit disengages kleisin, but only after ATP rebinds. This suggests an interlocking gate mechanism for DNA transport both into and out of the cohesin ring. The entry direction is facilitated by a cohesin loader that appears to fold cohesin to expose the DNA sensor. Our results provide a model for dynamic DNA binding by all members of the SMC family and explain how lysine acetylation of cohesin establishes enduring sister chromatid cohesion.	[Murayama, Yasuto; Uhlmann, Frank] Francis Crick Inst, Lincolns Inn Fields Lab, London WC2A 3LY, England	Francis Crick Institute	Murayama, Y (corresponding author), Tokyo Inst Technol, Tokyo 1528550, Japan.	ymurayama@bio.titech.ac.jp; frank.uhlmann@crick.ac.uk		Uhlmann, Frank/0000-0002-3527-6619	European Research Council; Japanese Society for the Promotion of Science (JSPS); The Francis Crick Institute [10198] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); The Francis Crick Institute	We would like to thank A. Alidoust and N. Patel for fermentation; H. Iwasaki for his generous support during the revision process; F. Beckouet and K. Nasmyth for communicating unpublished results; and W. Chao, M. Singleton, T. Toda, and members of our laboratory for discussions and for critical reading of the manuscript. This work was supported by the European Research Council. Y.M. acknowledges support through a fellowship from the Japanese Society for the Promotion of Science (JSPS).	Arumugam P, 2003, CURR BIOL, V13, P1941, DOI 10.1016/j.cub.2003.10.036; Arumugam P, 2006, CURR BIOL, V16, P1998, DOI 10.1016/j.cub.2006.09.002; Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Bernard P, 2008, EMBO J, V27, P111, DOI 10.1038/sj.emboj.7601955; Buheitel J, 2013, EMBO J, V32, P666, DOI 10.1038/emboj.2013.7; Chan KL, 2012, CELL, V150, P961, DOI 10.1016/j.cell.2012.07.028; Chao WCH, 2015, CELL REP, V12, P719, DOI 10.1016/j.celrep.2015.06.071; Cheng TMK, 2015, ELIFE, V4, DOI 10.7554/eLife.05565; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Cuylen S, 2011, NAT STRUCT MOL BIOL, V18, P894, DOI 10.1038/nsmb.2087; Duan XY, 2009, J BIOL CHEM, V284, P8507, DOI 10.1074/jbc.M809139200; Gerlich D, 2006, CURR BIOL, V16, P1571, DOI 10.1016/j.cub.2006.06.068; Gligoris TG, 2014, SCIENCE, V346, P963, DOI 10.1126/science.1256917; Gruber S, 2006, CELL, V127, P523, DOI 10.1016/j.cell.2006.08.048; Guacci V, 2015, MOL BIOL CELL, V26, P117, DOI 10.1091/mbc.E14-08-1268; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Haeusler RA, 2008, GENE DEV, V22, P2204, DOI 10.1101/gad.1675908; Hara K, 2014, NAT STRUCT MOL BIOL, V21, P864, DOI 10.1038/nsmb.2880; Hirano T, 2012, GENE DEV, V26, P1659, DOI 10.1101/gad.194746.112; Hu B, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv670; Hu B, 2011, CURR BIOL, V21, P12, DOI 10.1016/j.cub.2010.12.004; in 't Veld PJH, 2014, SCIENCE, V346, P968, DOI 10.1126/science.1256904; Jeppsson K, 2014, NAT REV MOL CELL BIO, V15, P601, DOI 10.1038/nrm3857; Kanno T, 2015, CELL REP, V12, P1471, DOI 10.1016/j.celrep.2015.07.048; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Lammens A, 2004, CURR BIOL, V14, P1778, DOI 10.1016/j.cub.2004.09.044; Lengronne A, 2006, MOL CELL, V23, P787, DOI 10.1016/j.molcel.2006.08.018; Lopez-Serra L, 2014, NAT GENET, V46, P1147, DOI 10.1038/ng.3080; Lopez-Serra L, 2013, CURR BIOL, V23, P64, DOI 10.1016/j.cub.2012.11.030; Mc Intyre J, 2007, EMBO J, V26, P3783, DOI 10.1038/sj.emboj.7601793; Murayama Y, 2014, NATURE, V505, P367, DOI 10.1038/nature12867; Nasmyth K, 2011, NAT CELL BIOL, V13, P1170, DOI 10.1038/ncb2349; Nativio R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000739; Palecek J, 2006, J BIOL CHEM, V281, P36952, DOI 10.1074/jbc.M608004200; Piazza I, 2014, NAT STRUCT MOL BIOL, V21, P560, DOI 10.1038/nsmb.2831; Rojowska A, 2014, EMBO J, V33, P2847, DOI 10.15252/embj.201488889; Rowland BD, 2009, MOL CELL, V33, P763, DOI 10.1016/j.molcel.2009.02.028; Sakai A, 2003, EMBO J, V22, P2764, DOI 10.1093/emboj/cdg247; Sutani T, 2009, CURR BIOL, V19, P492, DOI 10.1016/j.cub.2009.01.062; Tanaka K, 2001, EMBO J, V20, P5779, DOI 10.1093/emboj/20.20.5779; Thadani R, 2012, CURR BIOL, V22, pR1012, DOI 10.1016/j.cub.2012.10.023; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; Uhlmann F, 2006, CURR BIOL, V16, pR102, DOI 10.1016/j.cub.2006.01.023; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; Weitzer S, 2003, CURR BIOL, V13, P1930, DOI 10.1016/j.cub.2003.10.030; Wilhelm L, 2015, ELIFE, V4, DOI 10.7554/eLife.06659; Yoshimura SH, 2002, CURR BIOL, V12, P508, DOI 10.1016/S0960-9822(02)00719-4	48	143	143	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2015	163	7					1628	1640		10.1016/j.cell.2015.11.030	http://dx.doi.org/10.1016/j.cell.2015.11.030			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CZ1GN	26687354	hybrid, Green Published			2022-12-28	WOS:000366854200011
J	Wculek, SK; Malanchi, I				Wculek, Stefanie K.; Malanchi, Ilaria			Neutrophils support lung colonization of metastasis-initiating breast cancer cells	NATURE			English	Article							STEM-CELLS; TUMOR-METASTASIS; MICE; RECRUITMENT; LEUKOTRIENES; PROGRESSION; EXPRESSION; MEDIATOR; IMMUNE; NICHE	Despite progress in the development of drugs that efficiently target cancer cells, treatments for metastatic tumours are often ineffective. The now well-established dependency of cancer cells on their microenvironment(1) suggests that targeting the non-cancer-cell component of the tumour might form a basis for the development of novel therapeutic approaches. However, the as-yet poorly characterized contribution of host responses during tumour growth and metastatic progression represents a limitation to exploiting this approach. Here we identify neutrophils as the main component and driver of metastatic establishment within the (pre-) metastatic lung microenvironment in mouse breast cancer models. Neutrophils have a fundamental role in inflammatory responses and their contribution to tumorigenesis is still controversial(2-4). Using various strategies to block neutrophil recruitment to the pre-metastatic site, we demonstrate that neutrophils specifically support metastatic initiation. Importantly, we find that neutrophil-derived leukotrienes aid the colonization of distant tissues by selectively expanding the sub-pool of cancer cells that retain high tumorigenic potential. Genetic or pharmacological inhibition of the leukotriene-generating enzyme arachidonate 5-lipoxygenase (Alox5) abrogates neutrophil pro-metastatic activity and consequently reduces metastasis. Our results reveal the efficacy of using targeted therapy against a specific tumour microenvironment component and indicate that neutrophil Alox5 inhibition may limit metastatic progression.	[Wculek, Stefanie K.; Malanchi, Ilaria] Francis Crick Inst, Lincolns Inn Fields Labs, London WC2A 3LY, England	Francis Crick Institute	Malanchi, I (corresponding author), Francis Crick Inst, Lincolns Inn Fields Labs, 44 Lincolns Inn Fields, London WC2A 3LY, England.	ilaria.malanchi@crick.ac.uk	Wculek, Stefanie K/F-9626-2016	Wculek, Stefanie K/0000-0001-5565-8561; Malanchi, Ilaria/0000-0003-4867-3311	Cancer Research UK; Cancer Research UK [14257] Funding Source: researchfish; The Francis Crick Institute [10112] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); The Francis Crick Institute	We thank C. Reis e Sousa, E. Sahai, P. Scaffidi and J. Huelsken for scientific discussions, critical reading of the manuscript and sharing cell lines and mouse strains. We also thank members of the tumour-stroma interactions in cancer development (TSI) laboratory of The Crick Institute for scientific discussions, critical reading of the manuscript and practical support. We thank L. Jones for help in analysing the human breast cancer samples. We are grateful to R. Moore, E. Nye, B. Spencer-Dene and J. Bee for technical support with mice and mouse tissue. We also thank the Flow Cytometry Unit, the Bioinformatics & Biostatistics Unit and the In vivo Imaging Facility for technical assistance. We are grateful to Cancer Research UK for the funding that has allowed this work.	Bald T, 2014, NATURE, V507, P109, DOI 10.1038/nature13111; Bao Y, 2011, EUR J IMMUNOL, V41, P2535, DOI 10.1002/eji.201141979; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Cao YA, 2004, P NATL ACAD SCI USA, V101, P221, DOI 10.1073/pnas.2637010100; CHEN XS, 1994, NATURE, V372, P179, DOI 10.1038/372179a0; Cho NK, 2013, AM J CANCER RES, V3, P347; Coffelt SB, 2015, NATURE, V522, P345, DOI 10.1038/nature14282; Condamine T, 2015, ANNU REV MED, V66, P97, DOI 10.1146/annurev-med-051013-052304; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Donskov F, 2013, SEMIN CANCER BIOL, V23, P200, DOI 10.1016/j.semcancer.2013.02.001; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Finisguerra V, 2015, NATURE, V522, P349, DOI 10.1038/nature14407; Galdiero MR, 2013, IMMUNOBIOLOGY, V218, P1402, DOI 10.1016/j.imbio.2013.06.003; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Han YW, 2012, BREAST CANCER RES TR, V131, P483, DOI 10.1007/s10549-011-1799-1; Hiraga T, 2011, ONCOL REP, V25, P289, DOI 10.3892/or_00001073; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Ivanova A, 2005, GENESIS, V43, P129, DOI 10.1002/gene.20162; Kanaoka Y, 2004, J IMMUNOL, V173, P1503, DOI 10.4049/jimmunol.173.3.1503; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Korkaya H, 2011, J CLIN INVEST, V121, P3804, DOI 10.1172/JCI57099; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Lo PK, 2012, ONCOGENE, V31, P2614, DOI [10.1038/onc.2011.439, 10.1038/onc.2012.147]; Luu NT, 2003, J VASC RES, V40, P467, DOI 10.1159/000074296; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Oskarsson T, 2014, CELL STEM CELL, V14, P306, DOI 10.1016/j.stem.2014.02.002; Park MK, 2012, BBA-MOL CELL RES, V1823, P2120, DOI 10.1016/j.bbamcr.2012.09.004; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Snoussi K, 2005, EUR CYTOKINE NETW, V16, P253; Tkalcevic J, 2000, IMMUNITY, V12, P201, DOI 10.1016/S1074-7613(00)80173-9; Tsuyada A, 2012, CANCER RES, V72, P2768, DOI 10.1158/0008-5472.CAN-11-3567; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Wenzel SE, 1996, ANN PHARMACOTHER, V30, P858, DOI 10.1177/106002809603000725; Yan HH, 2010, CANCER RES, V70, P6139, DOI 10.1158/0008-5472.CAN-10-0706; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522	39	606	632	6	173	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2015	528	7582					413	+		10.1038/nature16140	http://dx.doi.org/10.1038/nature16140			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY8SM	26649828	Green Accepted, Green Submitted			2022-12-28	WOS:000366678600056
J	Nemeth, B; Scheres, LJJ; Lijfering, WM; Rosendaal, FR				Nemeth, Banne; Scheres, Luuk J. J.; Lijfering, Willem M.; Rosendaal, Frits R.			CHRISTMAS 2015: INFECTION CONTROL Bloodcurdling movies and measures of coagulation: Fear Factor crossover trial	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ANXIETY	Objective To assess whether, as has been hypothesised since medieval times, acute fear can curdle blood. Design Crossover trial. Setting Main meeting room of Leiden University's Department of Clinical Epidemiology, the Netherlands, converted to a makeshift cinema. Participants 24 healthy volunteers aged <= 30 years recruited among students, alumni, and employees of the Leiden University Medical Center: 14 were assigned to watch a frightening (horror) movie followed by a non-threatening (educational) movie and 10 to watch the movies in reverse order. The movies were viewed more than a week apart at the same time of day and both lasted approximately 90 minutes. Main outcome measures The primary outcome measures were markers, or "fear factors" of coagulation activity: blood coagulant factor VIII, D-dimer, thrombin-antithrombin complexes, and prothrombin fragments 1+2. The secondary outcome was participant reported fear experienced during each movie using a visual analogue fear scale. Results All participants completed the study. The horror movie was perceived to be more frightening than the educational movie on a visual analogue fear scale (mean difference 5.4, 95% confidence interval 4.7 to 6.1). The difference in factor VIII levels before and after watching the movies was higher for the horror movie than for the educational movie (mean difference of differences 11.1 IU/dL (111 IU/L), 95% confidence interval 1.2 to 21.0 IU/dL). The effect of either movie on levels of thrombin-antithrombin complexes, D-dimer, and prothrombin fragments 1+2 did not differ. Conclusion Frightening (in this case, horror) movies are associated with an increase of blood coagulant factor VIII without actual thrombin formation in young and healthy adults.	[Nemeth, Banne; Scheres, Luuk J. J.; Lijfering, Willem M.; Rosendaal, Frits R.] Leiden Univ, Dept Clin Epidemiol, Med Ctr, NL-2300 RC Leiden, Netherlands; [Nemeth, Banne] Leiden Univ, Dept Orthopaed Surg, Med Ctr, NL-2300 RC Leiden, Netherlands; [Scheres, Luuk J. J.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Rosendaal, Frits R.] Leiden Univ, Einthoven Lab Expt Vasc Med, Med Ctr, NL-2300 RC Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Rosendaal, FR (corresponding author), Leiden Univ, Dept Clin Epidemiol, Med Ctr, NL-2300 RC Leiden, Netherlands.	f.r.rosendaal@lumc.nl	Nemeth, Banne/AAA-3701-2019; Rosendaal, Frits/Q-3842-2017; Scheres, Luuk/ABF-5160-2021; Lijfering, Willem/J-7442-2019; Stefanadis, Christodoulos/ABH-2232-2020; Nemeth, Banne/AAP-8022-2020	Nemeth, Banne/0000-0002-1214-5923; Rosendaal, Frits/0000-0003-2558-7496; Scheres, Luuk/0000-0001-5282-5520; Lijfering, Willem/0000-0002-4638-4623; Stefanadis, Christodoulos/0000-0001-5974-6454; Nemeth, Banne/0000-0002-1214-5923	Department of Clinical Epidemiology, Leiden University Medical Center	Department of Clinical Epidemiology, Leiden University Medical Center	This study was sponsored by the Department of Clinical Epidemiology, Leiden University Medical Center.	Anderson S., 2005, COLLINS ENGLISH DICT; [Anonymous], 2014, YEAR CHAMP SAM GOLDW; Benarde MA, 1973, OUR PRECARIOUS HABIT; Geiser F, 2008, PSYCHOTHER PSYCHOSOM, V77, P377, DOI 10.1159/000151518; INGRAM GIC, 1968, BRIT J HAEMATOL, V15, P326; Knowles E., 2005, OXFORD DICT PHRASE F, P86; Kraaijenhagen RA, 2000, THROMB HAEMOSTASIS, V83, P5; MANNUCCI PM, 1977, LANCET, V1, P869; Mannucci PM, 1997, BLOOD, V90, P2515, DOI 10.1182/blood.V90.7.2515.2515_2515_2521; Pitsavos C, 2006, ATHEROSCLEROSIS, V185, P320, DOI 10.1016/j.atherosclerosis.2005.06.001; Thrall G, 2007, THROMB RES, V120, P819, DOI 10.1016/j.thromres.2007.01.004; van Westerloo DJ, 2011, MOL MED, V17, P180, DOI 10.2119/molmed.2010.00204; VANDENBROUCKE JP, 1992, LANCET, V340, P800, DOI 10.1016/0140-6736(92)92351-F	13	4	4	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 16	2015	351								h6367	10.1136/bmj.h6367	http://dx.doi.org/10.1136/bmj.h6367			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ4MP	26673787	hybrid, Green Published			2022-12-28	WOS:000367077600006
J	Smaill, F				Smaill, Fiona			In early HIV infection, immediate vs deferred antiretroviral therapy reduced serious illnesses at 3 years Comment	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Smaill, Fiona] McMaster Univ, Hamilton, ON, Canada	McMaster University	Smaill, F (corresponding author), McMaster Univ, Hamilton, ON, Canada.							AIDSinfo, 2015, STAT HHS PAN ANT GUI; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Shah M, 2015, CLIN INFECT DIS; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2015, PROGR UPD MAX TREAT	5	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	2015	163	12							JC4	10.7326/ACPJC-2015-163-12-004	http://dx.doi.org/10.7326/ACPJC-2015-163-12-004			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY4BS	26666806				2022-12-28	WOS:000366354200004
J	Baraban, JH; Changala, PB; Mellau, GC; Stanton, JF; Merer, AJ; Field, RW				Baraban, Joshua H.; Changala, P. Bryan; Mellau, Georg Ch.; Stanton, John F.; Merer, Anthony J.; Field, Robert W.			Spectroscopic characterization of isomerization transition states	SCIENCE			English	Article							(A)OVER-TILDE(1)A(U) STATE; VIBRATIONAL SPACINGS; DIATOMIC-MOLECULES; ACETYLENE; DISSOCIATION; ENERGY; ROTATION; MODEL; HCN	Transition state theory is central to our understanding of chemical reaction dynamics. We demonstrate amethod for extracting transition state energies and properties froma characteristic pattern found in frequency-domain spectra of isomerizing systems. This pattern-a dip in the spacings of certain barrier-proximal vibrational levels-can be understood using the concept of effective frequency, omega(eff). The method is applied to the cis-trans conformational change in the S-1 state of C2H2 and the bond-breaking HCN-HNC isomerization. In both cases, the barrier heights derived from spectroscopic data agree extremely well with previous ab initio calculations. We also show that it is possible to distinguish between vibrational modes that are actively involved in the isomerization process and those that are passive bystanders.	[Baraban, Joshua H.; Changala, P. Bryan; Field, Robert W.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Mellau, Georg Ch.] Univ Giessen, Inst Phys Chem, D-35392 Giessen, Germany; [Stanton, John F.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Merer, Anthony J.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada; [Merer, Anthony J.] Acad Sinica, Inst Atom & Mol Sci, Taipei 10617, Taiwan	Massachusetts Institute of Technology (MIT); Justus Liebig University Giessen; University of Texas System; University of Texas Austin; University of British Columbia; Academia Sinica - Taiwan	Field, RW (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	rwfield@mit.edu	Baraban, Joshua H/R-5960-2017; Mellau, Georg Christopher/A-8886-2017	Baraban, Joshua H/0000-0002-4523-704X; Mellau, Georg Christopher/0000-0001-8209-5733	NSF Graduate Research Fellowship [DGE 1144083]; Alexander von Humboldt Foundation Feodor Lynen fellowship for experienced researchers; U.S. Department of Energy [DE-FG0287ER13671]	NSF Graduate Research Fellowship(National Science Foundation (NSF)); Alexander von Humboldt Foundation Feodor Lynen fellowship for experienced researchers(Alexander von Humboldt Foundation); U.S. Department of Energy(United States Department of Energy (DOE))	We thank M. Joyeux for providing the HCN-HNC pseudopotentials. Supported by NSF Graduate Research Fellowship DGE 1144083 (P.B.C.), an Alexander von Humboldt Foundation Feodor Lynen fellowship for experienced researchers (G.C.M.), and U.S. Department of Energy grant DE-FG0287ER13671.	Arrhenius S., 1889, Z PHYS CHEM, V4U, P226, DOI [10.1515/zpch-1889-0416, DOI 10.1515/ZPCH-1889-0416]; BACIC Z, 1987, J CHEM PHYS, V86, P3065; Baraban JH, 2012, MOL PHYS, V110, P2725, DOI 10.1080/00268976.2012.706328; Baraban JH, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3570823; Baraban JH, 2012, MOL PHYS, V110, P2707, DOI 10.1080/00268976.2012.706329; Birge RT, 1926, PHYS REV, V28, P0259, DOI 10.1103/PhysRev.28.259; Bowman JM, 2011, ANNU REV PHYS CHEM, V62, P531, DOI 10.1146/annurev-physchem-032210-103518; Child MS, 2007, ADV CHEM PHYS, V136, P39, DOI 10.1002/9780470175422.ch2; Child MS, 1998, J PHYS A-MATH GEN, V31, P657, DOI 10.1088/0305-4470/31/2/022; Child MS, 2001, J PHYS CHEM A, V105, P10791, DOI 10.1021/jp012582s; DIXON RN, 1964, T FARADAY SOC, V60, P1363, DOI 10.1039/tf9646001363; Evans MG, 1935, T FARADAY SOC, V31, P0875, DOI 10.1039/tf9353100875; Eyring H, 1931, Z PHYS CHEM B-CHEM E, V12, P279; Eyring H, 1935, J CHEM PHYS, V3, P107, DOI 10.1063/1.1749604; Fukushima M, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3640024; Harris GJ, 2006, MON NOT R ASTRON SOC, V367, P400, DOI 10.1111/j.1365-2966.2005.09960.x; Ishikawa H, 1999, ANNU REV PHYS CHEM, V50, P443, DOI 10.1146/annurev.physchem.50.1.443; Jacobson MP, 2001, J CHEM PHYS, V114, P262, DOI 10.1063/1.1330746; Joyeux M, 2005, ADV CHEM PHYS, V130, P267; Larese D, 2011, J MOL STRUCT, V1006, P611, DOI 10.1016/j.molstruc.2011.10.016; Lauvergnat D, 2001, CHEM PHYS LETT, V350, P345, DOI 10.1016/S0009-2614(01)01300-8; LEROY RJ, 1970, J CHEM PHYS, V52, P3869, DOI 10.1063/1.1673585; Leroy RJ, 1970, CHEM PHYS LETT, V5, P42, DOI 10.1016/0009-2614(70)80125-7; LIGHT JC, 1987, J CHEM PHYS, V87, P4008, DOI 10.1063/1.452904; Mellau GC, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3598942; Merer AJ, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2939246; Merer AJ, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3599091; Moiseyev N., 2011, NONHERMITIAN QUANTUM; OXTOBY DW, 1976, J CHEM PHYS, V65, P1676, DOI 10.1063/1.433301; POLANYI JC, 1995, ACCOUNTS CHEM RES, V28, P119, DOI 10.1021/ar00051a005; ROSS SC, 1994, J CHEM PHYS, V100, P4110, DOI 10.1063/1.466348; SLATER NB, 1957, NATURE, V180, P1352, DOI 10.1038/1801352a0; STANTON JF, 1994, J CHEM PHYS, V101, P356, DOI 10.1063/1.468142; Steeves AH, 2008, MOL PHYS, V106, P1867, DOI 10.1080/00268970802353327; Steeves AH, 2009, J MOL SPECTROSC, V256, P256, DOI 10.1016/j.jms.2009.05.005; TOBIASON JD, 1993, J CHEM PHYS, V99, P928, DOI 10.1063/1.465357; Townsend D, 2004, SCIENCE, V306, P1158, DOI 10.1126/science.1104386; van Mourik T, 2001, J CHEM PHYS, V115, P3706, DOI 10.1063/1.1383586; WATSON JKG, 1982, J MOL SPECTROSC, V95, P101, DOI 10.1016/0022-2852(82)90242-9; Wigner E, 1938, T FARADAY SOC, V34, P0029, DOI 10.1039/tf9383400029; Yang SB, 2003, J PHYS CHEM A, V107, P8345, DOI 10.1021/jp027763o	41	37	36	1	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2015	350	6266					1338	1342		10.1126/science.aac9668	http://dx.doi.org/10.1126/science.aac9668			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1JL	26659051	Green Submitted			2022-12-28	WOS:000366162400033
J	Isaacs, D; Isaacs, S; Fitzgerald, D				Isaacs, David; Isaacs, Stephen; Fitzgerald, Dominic			CHRISTMAS 2015: PROFESSIONAL CONSIDERATIONS MEMEs: modern evolutionary medical euphemisms	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Isaacs, David; Fitzgerald, Dominic] Childrens Hosp Westmead, Westmead, NSW 2145, Australia	University of Sydney	Isaacs, D (corresponding author), Childrens Hosp Westmead, Westmead, NSW 2145, Australia.	david.isaacs@health.nsw.gov.au						CHRISTY NP, 1979, NEW ENGL J MED, V300, P979, DOI 10.1056/NEJM197904263001710; Dawkins R, 1989, SELFISH GENE; Isaacs D, 2015, J PAEDIATR CHILD H, V51, P569, DOI 10.1111/jpc.12864; Lettau LA, 2000, CLIN INFECT DIS, V31, P734, DOI 10.1086/313994; Tayler M, 2005, PATIENT EDUC COUNS, V57, P321, DOI 10.1016/j.pec.2004.09.001	5	4	4	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 11	2015	351								h6107	10.1136/bmj.h6107	http://dx.doi.org/10.1136/bmj.h6107			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY5TJ	26658831				2022-12-28	WOS:000366470100001
J	Kravtsov, S; Wyatt, MG; Curry, JA; Tsonis, AA				Kravtsov, S.; Wyatt, M. G.; Curry, J. A.; Tsonis, A. A.			Comment on "Atlantic and Pacific multidecadal oscillations and Northern Hemisphere temperatures"	SCIENCE			English	Editorial Material								Steinman et al. (Reports, 27 February 2015, p. 988) argue that appropriately rescaled multimodel ensemble-mean time series provide an unbiased estimate of the forced climate response in individual model simulations. However, their procedure for demonstrating the validity of this assertion is flawed, and the residual intrinsic variability so defined is in fact dominated by the actual forced response of individual models.	[Kravtsov, S.; Tsonis, A. A.] Univ Wisconsin, Dept Math Sci, Atmospher Sci Grp, Milwaukee, WI 53201 USA; [Wyatt, M. G.] Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; [Curry, J. A.] Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA	University of Wisconsin System; University of Wisconsin Milwaukee; University of Colorado System; University of Colorado Boulder; University System of Georgia; Georgia Institute of Technology	Kravtsov, S (corresponding author), Univ Wisconsin, Dept Math Sci, Atmospher Sci Grp, POB 413, Milwaukee, WI 53201 USA.	kravtsov@uwm.edu	Kravtsov, Sergey/ABA-2061-2020	Kravtsov, Sergey/0000-0003-3653-9596	NSF [OCE-1243158, AGS-1408897]; Directorate For Geosciences [1243158] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank Steinman et al. for making their data and analysis code publicly available. This research was supported by NSF grants OCE-1243158 (S.K.) and AGS-1408897 (S.K. and A.A.T.). All data and MATLAB (MathWorks, Natick, MA) scripts for this paper are available for downloading from http://pantherfile.uwm.edu/kravtsov/www/downloads/KWCT2015.	Rajaratnam B, 2015, CLIMATIC CHANGE, V133, P129, DOI 10.1007/s10584-015-1495-y; Steinman BA, 2015, SCIENCE, V347, P988, DOI 10.1126/science.1257856	2	10	10	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2015	350	6266								10.1126/science.aab3570	http://dx.doi.org/10.1126/science.aab3570			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1JL	26659048				2022-12-28	WOS:000366162400028
J	Moran, MA				Moran, Mary Ann			The global ocean microbiome	SCIENCE			English	Review							DISSOLVED ORGANIC-MATTER; MARINE-BACTERIA; COMMUNITY STRUCTURE; ATTACHED BACTERIA; NITROGEN-FIXATION; GENOME SEQUENCE; HIGH ABUNDANCE; DIVERSITY; PHYTOPLANKTON; CARBON	The microbiome of the largest environment on Earth has been gradually revealing its secrets over four decades of study. Despite the dispersed nature of substrates and the transience of surfaces, marine microbes drive essential transformations in all global elemental cycles. Much has been learned about the microbes that carry out key biogeochemical processes, but there are still plenty of ambiguities about the factors important in regulating activity, including the role of microbial interactions. Identifying the molecular "currencies" exchanged within the microbial community will provide key information on microbiome function and its vulnerability to environmental change.	[Moran, Mary Ann] Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Moran, MA (corresponding author), Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA.	mmoran@uga.edu		Moran, Mary Ann/0000-0002-0702-8167	NSF [OCE-1356010, OCE-1342694]; Gordon and Betty Moore Foundation [538.01]; Directorate For Geosciences [1356010, 1342694] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	J. T. Hollibaugh, K. Ross, M. Landa, A. Burns, and B. Nowinski provided helpful discussions and C. English assisted with graphics. This work was supported by NSF grants OCE-1356010 and OCE-1342694 and, in part, by the Gordon and Betty Moore Foundation through grant 538.01.	Acinas SG, 1999, APPL ENVIRON MICROB, V65, P514; Acinas SG, 2004, NATURE, V430, P551, DOI 10.1038/nature02649; ALLDREDGE AL, 1987, SCIENCE, V235, P689, DOI 10.1126/science.235.4789.689; Amin SA, 2015, NATURE, V522, P98, DOI 10.1038/nature14488; Amin SA, 2009, P NATL ACAD SCI USA, V106, P17071, DOI 10.1073/pnas.0905512106; Arrieta JM, 2015, SCIENCE, V348, P331, DOI 10.1126/science.1258955; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; Azam F, 1984, NATO C 4, V13, P345; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Beja O, 2002, NATURE, V415, P630, DOI 10.1038/415630a; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Beja O, 2013, ENCY BIODIVERSITY, V6, P280; BELL W, 1972, BIOL BULL, V143, P265, DOI 10.2307/1540052; BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467a0; Bertrand EM, 2015, P NATL ACAD SCI USA, V112, P9938, DOI 10.1073/pnas.1501615112; Brown MV, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.28; Bruhn JB, 2007, APPL ENVIRON MICROB, V73, P442, DOI 10.1128/AEM.02238-06; Brum JR, 2015, SCIENCE, V348, DOI 10.1126/science.1261498; Chin WC, 1998, NATURE, V391, P568, DOI 10.1038/35345; Curson ARJ, 2011, NAT REV MICROBIOL, V9, P849, DOI 10.1038/nrmicro2653; Cuvelier ML, 2010, P NATL ACAD SCI USA, V107, P14679, DOI 10.1073/pnas.1001665107; de Vargas C, 2015, SCIENCE, V348, DOI 10.1126/science.1261605; DeLong EE, 2005, NAT REV MICROBIOL, V3, P459, DOI 10.1038/nrmicro1158; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; DELONG EF, 1993, LIMNOL OCEANOGR, V38, P924, DOI 10.4319/lo.1993.38.5.0924; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; DROOP MR, 1966, NATURE, V211, P1096, DOI 10.1038/2111096a0; Durham BP, 2015, P NATL ACAD SCI USA, V112, P453, DOI 10.1073/pnas.1413137112; Eakins B. W., 2010, VOLUMES WORLDS OCEAN; Foster RA, 2011, ISME J, V5, P1484, DOI 10.1038/ismej.2011.26; Frigaard NU, 2006, NATURE, V439, P847, DOI 10.1038/nature04435; FUHRMAN JA, 1992, NATURE, V356, P148, DOI 10.1038/356148a0; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Fuhrman JA, 2008, P NATL ACAD SCI USA, V105, P7774, DOI 10.1073/pnas.0803070105; Fuhrman JA, 2006, P NATL ACAD SCI USA, V103, P13104, DOI 10.1073/pnas.0602399103; Fuhrman JA, 2009, NATURE, V459, P193, DOI 10.1038/nature08058; Geng HF, 2010, CURR OPIN BIOTECH, V21, P332, DOI 10.1016/j.copbio.2010.03.013; Gifford SM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00185; Gifford SM, 2011, ISME J, V5, P461, DOI 10.1038/ismej.2010.141; GIOVANNONI SJ, 1990, NATURE, V345, P60, DOI 10.1038/345060a0; Giovannoni SJ, 2005, NATURE, V437, P343, DOI 10.1038/nature04158; Giovannoni SJ, 2014, ISME J, V8, P1553, DOI 10.1038/ismej.2014.60; Giovannoni SJ, 2012, SCIENCE, V335, P671, DOI 10.1126/science.1198078; Gram L, 2002, APPL ENVIRON MICROB, V68, P4111, DOI 10.1128/AEM.68.8.4111-4116.2002; Grossart HP, 2007, FEMS MICROBIOL LETT, V266, P194, DOI 10.1111/j.1574-6968.2006.00520.x; Hansell DA, 2009, OCEANOGRAPHY, V22, P202, DOI 10.5670/oceanog.2009.109; HOLLIBAUGH JT, 1983, LIMNOL OCEANOGR, V28, P1104, DOI 10.4319/lo.1983.28.6.1104; Howard EC, 2008, ENVIRON MICROBIOL, V10, P2397, DOI 10.1111/j.1462-2920.2008.01665.x; Howard EC, 2006, SCIENCE, V314, P649, DOI 10.1126/science.1130657; IRIBERRI J, 1987, APPL ENVIRON MICROB, V53, P2308, DOI 10.1128/AEM.53.10.2308-2314.1987; JACKSON GA, 1987, LIMNOL OCEANOGR, V32, P1253, DOI 10.4319/lo.1987.32.6.1253; Kashtan N, 2014, SCIENCE, V344, P416, DOI 10.1126/science.1248575; Kiene RP, 2000, J SEA RES, V43, P209, DOI 10.1016/S1385-1101(00)00023-X; Kiorboe T, 2001, LIMNOL OCEANOGR, V46, P1309, DOI 10.4319/lo.2001.46.6.1309; Koch BP, 2005, GEOCHIM COSMOCHIM AC, V69, P3299, DOI 10.1016/j.gca.2005.02.027; Kolber ZS, 2001, SCIENCE, V292, P2492, DOI 10.1126/science.1059707; Lauro FM, 2009, P NATL ACAD SCI USA, V106, P15527, DOI 10.1073/pnas.0903507106; Lechtenfeld OJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7711; Lederberg J, 2001, SCIENTIST, V15, P8; Lindell D, 2005, NATURE, V438, P86, DOI 10.1038/nature04111; Luo HW, 2015, TRENDS MICROBIOL, V23, P577, DOI 10.1016/j.tim.2015.05.004; Luo HW, 2013, MBIO, V4, DOI 10.1128/mBio.00373-13; Marchetti A, 2015, ISME J, V9, P2745, DOI 10.1038/ismej.2015.74; Marinov I, 2010, BIOGEOSCIENCES, V7, P3941, DOI 10.5194/bg-7-3941-2010; Mayali X, 2008, APPL ENVIRON MICROB, V74, P2595, DOI 10.1128/AEM.02191-07; Moore CM, 2013, NAT GEOSCI, V6, P701, DOI [10.1038/NGEO1765, 10.1038/ngeo1765]; Moran MA, 2004, NATURE, V432, P910, DOI 10.1038/nature03170; Moran MA, 2007, NAT REV MICROBIOL, V5, P792, DOI 10.1038/nrmicro1746; Morris JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016805; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Ottesen EA, 2014, SCIENCE, V345, P207, DOI 10.1126/science.1252476; Palovaara J, 2014, P NATL ACAD SCI USA, V111, pE3650, DOI 10.1073/pnas.1402617111; Pedros-Alio C, 2012, ANNU REV MAR SCI, V4, P449, DOI 10.1146/annurev-marine-120710-100948; Persson OP, 2009, ENVIRON MICROBIOL, V11, P1348, DOI 10.1111/j.1462-2920.2008.01861.x; Pester M, 2011, CURR OPIN MICROBIOL, V14, P300, DOI 10.1016/j.mib.2011.04.007; POMEROY LR, 1974, BIOSCIENCE, V24, P499, DOI 10.2307/1296885; PROCTOR LM, 1990, NATURE, V343, P60, DOI 10.1038/343060a0; Quinn PK, 2011, NATURE, V480, P51, DOI 10.1038/nature10580; Reisch CR, 2011, NATURE, V473, P208, DOI 10.1038/nature10078; Riebesell U, 2009, P NATL ACAD SCI USA, V106, P20602, DOI 10.1073/pnas.0813291106; Rooney-Varga JN, 2005, MICROB ECOL, V49, P163, DOI 10.1007/s00248-003-1057-0; Satinsky BM, 2014, P NATL ACAD SCI USA, V111, P11085, DOI 10.1073/pnas.1402782111; Satinsky BM, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-17; SCHMIDT TM, 1991, J BACTERIOL, V173, P4371, DOI 10.1128/JB.173.14.4371-4378.1991; Seyedsayamdost MR, 2011, NAT CHEM, V3, P331, DOI [10.1038/nchem.1002, 10.1038/NCHEM.1002]; Sherr EB, 2008, MICROBIAL ECOLOGY OC, P27, DOI DOI 10.1002/9780470281840; Shi XG, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00555; Simo R, 2001, TRENDS ECOL EVOL, V16, P287, DOI 10.1016/S0169-5347(01)02152-8; Stepanauskas R, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00258; Stocker R, 2008, P NATL ACAD SCI USA, V105, P4209, DOI 10.1073/pnas.0709765105; Stocker R, 2012, SCIENCE, V338, P628, DOI 10.1126/science.1208929; STOECKER DK, 1987, NATURE, V326, P790, DOI 10.1038/326790a0; Sunagawa S, 2015, SCIENCE, V348, DOI 10.1126/science.1261359; Swingley WD, 2007, J BACTERIOL, V189, P683, DOI 10.1128/JB.01390-06; Taylor GT, 2012, P NATL ACAD SCI USA, V109, P19315, DOI 10.1073/pnas.1207514109; Teeling H, 2012, SCIENCE, V336, P608, DOI 10.1126/science.1218344; Thompson AW, 2012, SCIENCE, V337, P1546, DOI 10.1126/science.1222700; Varaljay VA, 2015, ISME J, V9, P1677, DOI 10.1038/ismej.2015.23; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Verdugo P, 2004, MAR CHEM, V92, P67, DOI 10.1016/j.marchem.2004.06.017; VILLAREAL TA, 1991, MAR ECOL PROG SER, V76, P201, DOI 10.3354/meps076201; Worden AZ, 2004, LIMNOL OCEANOGR, V49, P168, DOI 10.4319/lo.2004.49.1.0168; Yutin N, 2007, ENVIRON MICROBIOL, V9, P1464, DOI 10.1111/j.1462-2920.2007.01265.x; Yutin N, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-34; Zehr JP, 2008, SCIENCE, V322, P1110, DOI 10.1126/science.1165340; Ziervogel K, 2008, ENVIRON MICROBIOL, V10, P289, DOI 10.1111/j.1462-2920.2007.01451.x	106	104	111	13	309	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2015	350	6266							aac8455	10.1126/science.aac8455	http://dx.doi.org/10.1126/science.aac8455			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1JL	26659059				2022-12-28	WOS:000366162400030
J	Richman, DD				Richman, Douglas D.			HIV Cure by killing	NATURE			English	Editorial Material							ANTIRETROVIRAL THERAPY; INFECTED-CELLS; VIRUS		[Richman, Douglas D.] Univ Calif San Diego, Ctr AIDS Res, La Jolla, CA 92093 USA; [Richman, Douglas D.] Veteran Affairs San Diego Healthcare Syst, San Diego, CA USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Richman, DD (corresponding author), Univ Calif San Diego, Ctr AIDS Res, La Jolla, CA 92093 USA.	drichman@ucsd.edu						Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Bargou R, 2008, SCIENCE, V321, P974, DOI 10.1126/science.1158545; BERG J, 1991, P NATL ACAD SCI USA, V88, P4723, DOI 10.1073/pnas.88.11.4723; Deng K, 2015, NATURE, V517, P381, DOI 10.1038/nature14053; Elliott JH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004473; Pegu A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9447; Rasmussen TA, 2014, LANCET HIV, V1, pE13, DOI 10.1016/S2352-3018(14)70014-1; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Sung JAM, 2015, J CLIN INVEST, V125, P4077, DOI 10.1172/JCI82314; TRAUNECKER A, 1991, EMBO J, V10, P3655, DOI 10.1002/j.1460-2075.1991.tb04932.x	10	2	2	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2015	528	7581					198	199		10.1038/nature16321	http://dx.doi.org/10.1038/nature16321			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9VH	26633623				2022-12-28	WOS:000366053300024
J	Shamshina, JL; Kelley, SP; Gurau, G; Rogers, RD				Shamshina, Julia L.; Kelley, Steven P.; Gurau, Gabriela; Rogers, Robin D.			Develop ionic liquid drugs	NATURE			English	Editorial Material							CRYSTALS		[Shamshina, Julia L.; Gurau, Gabriela] 525 Solut, Tuscaloosa, AL 35401 USA; [Kelley, Steven P.] Univ Alabama, Dept Chem, Tuscaloosa, AL 35487 USA; [Gurau, Gabriela] McGill Univ, Green Chem, Montreal, PQ, Canada; [Rogers, Robin D.] McGill Univ, Green Chem & Green Chem, Montreal, PQ, Canada	University of Alabama System; University of Alabama Tuscaloosa; McGill University; McGill University	Shamshina, JL (corresponding author), 525 Solut, Tuscaloosa, AL 35401 USA.	robin.rogers@mcgill.ca	Rogers, Robin D./N-4067-2019	Rogers, Robin D./0000-0001-9843-7494; Shamshina, Julia/0000-0003-0708-764X; Kelley, Steven/0000-0001-6755-4495				Aitipamula S, 2012, CRYST GROWTH DES, V12, P2147, DOI 10.1021/cg3002948; Hauss DJ, 2007, ADV DRUG DELIVER REV, V59, P667, DOI 10.1016/j.addr.2007.05.006; Heinrich P. Stahl, 2008, PHARM SALTS PROPERTI; Kelley SP, 2013, CRYST GROWTH DES, V13, P965, DOI 10.1021/cg4000439; Shadid M, 2015, MEDCHEMCOMM, V6, P1837, DOI 10.1039/c5md00290g; Shamshina JL, 2013, EXPERT OPIN DRUG DEL, V10, P1367, DOI 10.1517/17425247.2013.808185; Stahly GP, 2007, CRYST GROWTH DES, V7, P1007, DOI 10.1021/cg060838j; Stoimenovski J, 2010, PHARM RES-DORDR, V27, P521, DOI 10.1007/s11095-009-0030-0; Wang H, 2014, CHEM SCI, V5, P3449, DOI 10.1039/c4sc01036a	9	137	144	10	184	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2015	528	7581					188	189		10.1038/528188a	http://dx.doi.org/10.1038/528188a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9VH	26659168	Bronze			2022-12-28	WOS:000366053300014
J	Ioannides, KLH; Mamtani, M; Shofer, FS; Small, DS; Hennessy, S; Abella, BS; Scott, KR				Ioannides, Kimon L. H.; Mamtani, Mira; Shofer, Frances S.; Small, Dylan S.; Hennessy, Sean; Abella, Benjamin S.; Scott, Kevin R.			Medical Students in the Emergency Department and Patient Length of Stay	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							RESIDENTS		[Ioannides, Kimon L. H.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Mamtani, Mira; Shofer, Frances S.; Abella, Benjamin S.; Scott, Kevin R.] Univ Penn, Dept Emergency Med, Philadelphia, PA 19104 USA; [Small, Dylan S.] Univ Penn, Wharton Sch, Dept Stat, Philadelphia, PA 19104 USA; [Hennessy, Sean] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Scott, KR (corresponding author), Dept Emergency Med, 3400 Spruce St, Philadelphia, PA 19104 USA.	kevin.scott@uphs.upenn.edu	Scott, Kevin/ABE-5066-2020; Ioannides, Kimon/R-7211-2019	Ioannides, Kimon/0000-0002-6384-2235; Abella, Benjamin/0000-0003-2521-0891; Scott, Kevin/0000-0003-1862-2855; Mamtani, Mira/0000-0002-5927-2532				Dehon E, 2015, SOUTH MED J, V108, P245, DOI 10.14423/SMJ.0000000000000264; DeLaney M, 2013, ACAD MED, V88, P1723, DOI 10.1097/ACM.0b013e3182a7f1f8; Goldfarb S, 2013, NEW ENGL J MED, V369, P1087, DOI 10.1056/NEJMp1306457; Hiller K, 2014, J EMERG MED, V47, P216, DOI 10.1016/j.jemermed.2013.09.040; Pines JM, 2012, ANN EMERG MED, V60, P293, DOI 10.1016/j.annemergmed.2012.01.024; Pitts SR, 2014, JAMA-J AM MED ASSOC, V312, P2394, DOI 10.1001/jama.2014.16172	6	4	4	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 8	2015	314	22					2411	2413		10.1001/jama.2015.16476	http://dx.doi.org/10.1001/jama.2015.16476			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX8XT	26647265	Green Published, Bronze			2022-12-28	WOS:000365989100018
J	Romley, JA; Gong, C; Jena, AB; Goldman, DP; Williams, B; Peters, A				Romley, John A.; Gong, Cynthia; Jena, Anupam B.; Goldman, Dana P.; Williams, Bradley; Peters, Anne			Association between use of warfarin with common sulfonylureas and serious hypoglycemic events: retrospective cohort analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ADVERSE DRUG EVENTS; MEDICARE CLAIMS; THERAPY; MANAGEMENT; MORTALITY; DISEASE; PEOPLE; CANCER; RISK	STUDY QUESTION Is warfarin use associated with an increased risk of serious hypoglycemic events among older people treated with the sulfonylureas glipizide and glimepiride? METHODS This was a retrospective cohort analysis of pharmacy and medical claims from a 20% random sample of Medicare fee for service beneficiaries aged 65 years or older. It included 465 918 beneficiaries with diabetes who filled a prescription for glipizide or glimepiride between 2006 and 2011 (4 355 418 person quarters); 71 895 (15.4%) patients also filled a prescription for warfarin (416 479 person quarters with warfarin use). The main outcome measure was emergency department visit or hospital admission with a primary diagnosis of hypoglycemia in person quarters with concurrent fills of warfarin and glipizide/glimepiride compared with the rates in quarters with glipizide/glimepiride fills only, Multivariable logistic regression was used to adjust for individual characteristics. Secondary outcomes included fall related fracture and altered consciousness/mental status. SUMMARY ANSWER AND LIMITATIONS In quarters with glipizide/glimepiride use, hospital admissions or emergency department visits for hypoglycemia were more common in person quarters with concurrent warfarin use compared with quarters without warfarin use (294/416 479 v 1903/3 938 939; adjusted odds ratio 1.22, 95% confidence interval 1.05 to 1.42). The risk of hypoglycemia associated with concurrent use was higher among people using warfarin for the first time, as well as in those aged 65-74 years. Concurrent use of warfarin and glipizide/glimepiride was also associated with hospital admission or emergency department visit for fall related fractures (3919/416 479 v 20 759/3 938 939; adjusted odds ratio 1.47, 1.41 to 1.54) and altered consciousness/mental status (2490/416 479 v 14 414/3 938 939; adjusted odds ratio 1.22, 1.16 to 1.29). Unmeasured factors could be correlated with both warfarin use and serious hypoglycemic events, leading to confounding. The findings may not generalize beyond the elderly Medicare population. WHAT THIS STUDY ADDS A substantial positive association was seen between use of warfarin with glipizide/glimepiride and hospital admission/emergency department visits for hypoglycemia and related diagnoses, particularly in patients starting warfarin. The findings suggest the possibility of a significant drug interaction between these medications.	[Romley, John A.; Goldman, Dana P.] Leonard D Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA USA; [Romley, John A.] Univ So Calif, Price Sch Publ Policy, Los Angeles, CA 90089 USA; [Gong, Cynthia; Williams, Bradley] Univ So Calif, Sch Pharm, Los Angeles, CA 90089 USA; [Jena, Anupam B.; Goldman, Dana P.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Goldman, Dana P.] Univ So Calif, Sch Pharm, Price Sch Publ Policy, Los Angeles, CA 90089 USA; [Goldman, Dana P.] Univ So Calif, Dornsife Coll Letters Arts & Sci, Los Angeles, CA 90089 USA; [Peters, Anne] Univ So Calif, Keck Sch Med, Beverly Hills, CA 90211 USA	University of Southern California; University of Southern California; Harvard University; Harvard Medical School; University of Southern California; University of Southern California; University of Southern California	Peters, A (corresponding author), Univ So Calif, Keck Sch Med, 150 N Robertson Blvd,Suite 210, Beverly Hills, CA 90211 USA.	momofmax@mac.com	Goldman, Dana P/E-7667-2013	Goldman, Dana P/0000-0001-8498-6396; Peters, Anne/0000-0003-0520-0776	National Institute on Aging [5P01AG033559-03]; Commonwealth Fund [20150135]; Leonard D. Schaeffer Center for Health Policy and Economics at University of Southern California; NIH Office of Director (early independence award) [1DP5OD01789701]; NATIONAL INSTITUTE ON AGING [P01AG033559] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017897] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Commonwealth Fund; Leonard D. Schaeffer Center for Health Policy and Economics at University of Southern California; NIH Office of Director (early independence award); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	JAR and DPG receive support from the National Institute on Aging (5P01AG033559-03), the Commonwealth Fund (20150135), and the Leonard D. Schaeffer Center for Health Policy and Economics at the University of Southern California. ABJ receives support from the NIH Office of the Director (early independence award, 1DP5OD01789701). The authors are independent from these funding organizations, which played no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.	Agency for Healthcare Quality and Research, 2015, NAT STAT ALL STAYS; American Pharmacists Association and National Association of Chain Drug Stores Foundation, 2008, MED THER MAN PHARM P; [Anonymous], 2015, DIABETES CARE, V38, pS4, DOI 10.2337/dc15-S003; Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; Benet LZ, 2002, CLIN PHARMACOL THER, V71, P115, DOI 10.1067/mcp.2002.121829; Bisgaier J, 2011, PEDIATRICS, V127, pE1428, DOI 10.1542/peds.2011-0011; Budnitz DS, 2006, JAMA-J AM MED ASSOC, V296, P1858, DOI 10.1001/jama.296.15.1858; Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053; Cai SB, 2010, MED CARE, V48, P233, DOI 10.1097/MLR.0b013e3181ca2810; Carroll Norman V, 2005, J Manag Care Pharm, V11, P307; Centers for Medicar and Medicaid Services, 2015, MED THER MAN; Centers for Medicar and Medicaid Services, 2015, RISK ADJ; Centers for Medicar and Medicaid Services, 2015, QUAL MEAS; Deppen SA, 2014, JAMA-J AM MED ASSOC, V312, P1227, DOI 10.1001/jama.2014.11488; Deusenberry CM, 2012, PHARMACOTHERAPY, V32, P613, DOI 10.1002/j.1875-9114.2011.01088.x; Dimick JB, 2010, HEALTH SERV RES, V45, P1614, DOI 10.1111/j.1475-6773.2010.01158.x; ElDesoky Ehab S, 2007, Am J Ther, V14, P488, DOI 10.1097/01.mjt.0000183719.84390.4d; Fick D, 2012, J AM GERIATR SOC, V60, P616, DOI 10.1111/j.1532-5415.2012.03923.x; Food and Drug Administration, 2015, COUM HIGHL PRESCR IN; Gorina Y, 2011, HEALTH SERV RES, V46, P1610, DOI 10.1111/j.1475-6773.2011.01277.x; Gurwitz JH, 2004, ARCH INTERN MED, V164, P1957, DOI 10.1001/archinte.164.18.1957; Gurwitz JH, 2003, JAMA-J AM MED ASSOC, V289, P1107, DOI 10.1001/jama.289.9.1107; Hebert P L, 1999, Am J Med Qual, V14, P270, DOI 10.1177/106286069901400607; Hirsh J, 2003, CIRCULATION, V107, P1692, DOI 10.1161/01.CIR.0000063575.17904.4E; Holbrook AM, 2005, ARCH INTERN MED, V165, P1095, DOI 10.1001/archinte.165.10.1095; Ioannidis JPA, 2013, JAMA-J AM MED ASSOC, V309, P1410, DOI 10.1001/jama.2013.3150; Jena AB, 2013, J GEN INTERN MED, V28, P223, DOI 10.1007/s11606-012-2211-5; Johnston SS, 2012, DIABETES OBES METAB, V14, P634, DOI 10.1111/j.1463-1326.2012.01583.x; Luber SD, 1996, AM J EMERG MED, V14, P543, DOI 10.1016/S0735-6757(96)90094-7; Mallet L, 2007, LANCET, V370, P185, DOI 10.1016/S0140-6736(07)61092-7; McCahill LE, 2012, JAMA-J AM MED ASSOC, V307, P467, DOI 10.1001/jama.2012.43; McGivney MS, 2007, J AM PHARM ASSOC, V47, P620, DOI 10.1331/JAPhA.2007.06129; McLean AJ, 2004, PHARMACOL REV, V56, P163, DOI 10.1124/pr.56.2.4; Mcnaughton CD, 2011, CLIN DIABETES, V29, P51, DOI DOI 10.2337/DIACLIN.29.2.51; National Center for Health Statistics, 2014, SPEC FEAT PRESCR DRU; Newton-Cheh C, 2009, CIRCULATION, V120, P2062, DOI 10.1161/CIRCULATIONAHA.109.879049; O'Mahony D, 2015, AGE AGEING, V44, P213, DOI 10.1093/ageing/afu145; Osborne NH, 2015, JAMA-J AM MED ASSOC, V313, P496, DOI 10.1001/jama.2015.25; Prasad V, 2013, JAMA-J AM MED ASSOC, V309, P241, DOI 10.1001/jama.2012.96867; Rendell M, 2004, DRUGS, V64, P1339, DOI 10.2165/00003495-200464120-00006; Romley JA, 2012, DIABETES TECHNOL THE, V14, P904, DOI 10.1089/dia.2012.0075; ROWE JW, 1976, J GERONTOL, V31, P155, DOI 10.1093/geronj/31.2.155; Sakshaug JW, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-150; Salvi F, 2012, DRUG SAFETY, V35, P29, DOI 10.1007/BF03319101; Schinasi L, 2011, EPIDEMIOLOGY, V22, P208, DOI 10.1097/EDE.0b013e3182093c8b; Steinman MA, 2011, J AM GERIATR SOC, V59, P1513, DOI 10.1111/j.1532-5415.2011.03500.x; Steinman MA, 2010, JAMA-J AM MED ASSOC, V304, P1592, DOI 10.1001/jama.2010.1482; Triplitt C., 2006, DIABETES SPECTR, V19, P202, DOI [10.2337/diaspect.19.4.202, DOI 10.2337/DIASPECT.19.4.202]; Whitmer RA, 2009, JAMA-J AM MED ASSOC, V301, P1565, DOI 10.1001/jama.2009.460; Wolters Kluwer, 2015, LEX ONL	50	25	27	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 7	2015	351								h6223	10.1136/bmj.h6223	http://dx.doi.org/10.1136/bmj.h6223			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY5SM	26643108	Green Published, hybrid			2022-12-28	WOS:000366467700002
J	Forbes, JF; Sestak, I; Howell, A; Bonanni, B; Bundred, N; Levy, C; von Minckwitz, G; Eiermann, W; Neven, P; Stierer, M; Holcombe, C; Coleman, RE; Jones, L; Ellis, I; Cuzick, J				Forbes, John F.; Sestak, Ivana; Howell, Anthony; Bonanni, Bernardo; Bundred, Nigel; Levy, Christelle; von Minckwitz, Gunter; Eiermann, Wolfgang; Neven, Patrick; Stierer, Michael; Holcombe, Chris; Coleman, Robert E.; Jones, Louise; Ellis, Ian; Cuzick, Jack		IBIS-II Investigators	Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial	LANCET			English	Article							SURGICAL ADJUVANT BREAST; FOLLOW-UP; RADIOTHERAPY; ESTROGEN	Background Third-generation aromatase inhibitors are more effective than tamoxifen for preventing recurrence in postmenopausal women with hormone-receptor-positive invasive breast cancer. However, it is not known whether anastrozole is more effective than tamoxifen for women with hormone-receptor-positive ductal carcinoma in situ (DCIS). Here, we compare the efficacy of anastrozole with that of tamoxifen in postmenopausal women with hormone-receptor-positive DCIS. Methods In a double-blind, multicentre, randomised placebo-controlled trial, we recruited women who had been diagnosed with locally excised, hormone-receptor-positive DCIS. Eligible women were randomly assigned in a 1: 1 ratio by central computer allocation to receive 1 mg oral anastrozole or 20 mg oral tamoxifen every day for 5 years. Randomisation was stratified by major centre or hub and was done in blocks (six, eight, or ten). All trial personnel, participants, and clinicians were masked to treatment allocation and only the trial statistician had access to treatment allocation. The primary endpoint was all recurrence, including recurrent DCIS and new contralateral tumours. All analyses were done on a modified intention-to-treat basis (in all women who were randomised and did not revoke consent for their data to be included) and proportional hazard models were used to compute hazard ratios and corresponding confidence intervals. This trial is registered at the ISRCTN registry, number ISRCTN37546358. Results Between March 3, 2003, and Feb 8, 2012, we enrolled 2980 postmenopausal women from 236 centres in 14 countries and randomly assigned them to receive anastrozole (1449 analysed) or tamoxifen (1489 analysed). Median follow-up was 7.2 years (IQR 5.6-8.9), and 144 breast cancer recurrences were recorded. We noted no statistically significant difference in overall recurrence (67 recurrences for anastrozole vs 77 for tamoxifen; HR 0.89 [95% CI 0.64-1.23]). The non-inferiority of anastrozole was established (upper 95% CI <1.25), but its superiority to tamoxifen was not (p= 0.49). A total of 69 deaths were recorded (33 for anastrozole vs 36 for tamoxifen; HR 0.93 [95% CI 0.58-1.50], p= 0.78), and no specific cause was more common in one group than the other. The number of women reporting any adverse event was similar between anastrozole (1323 women, 91%) and tamoxifen (1379 women, 93%); the side-effect profiles of the two drugs differed, with more fractures, musculoskeletal events, hypercholesterolaemia, and strokes with anastrozole and more muscle spasm, gynaecological cancers and symptoms, vasomotor symptoms, and deep vein thromboses with tamoxifen. Conclusions No clear efficacy differences were seen between the two treatments. Anastrozole offers another treatment option for postmenopausal women with hormone-receptor-positive DCIS, which may be be more appropriate for some women with contraindications for tamoxifen. Longer follow-up will be necessary to fully evaluate treatment differences. Copyright (C) Forbes et al. Open Access article distributed under the terms of CC BY.	[Forbes, John F.] Univ Newcastle, Australia & New Zealand Breast Canc Trials Grp, Waratah, NSW, Australia; [Sestak, Ivana; Cuzick, Jack] Queen Mary Univ London, Ctr Canc Prevent, Wolfson Inst Prevent Med, London, England; [Jones, Louise] Queen Mary Univ London, Barts Canc Inst, London, England; [Howell, Anthony] Genesis Breast Canc Prevent Ctr, Manchester, Lancs, England; [Bonanni, Bernardo] European Inst Oncol, Div Canc Prevent & Genet, Milan, Italy; [Bundred, Nigel] Univ S Manchester Hosp, Manchester M20 8LR, Lancs, England; [Levy, Christelle] Ctr Francois Baclesse, F-14021 Caen, France; [von Minckwitz, Gunter] German Breast Grp, Frankfurt, Germany; [Eiermann, Wolfgang] Interdisziplinares Onkol Zentrum, Munich, Germany; [Neven, Patrick] Univ Leuven, KU Leuven, Dept Oncol, Leuven, Belgium; [Stierer, Michael] Austrian Breast & Colorectal Canc Study Grp, Vienna, Austria; [Holcombe, Chris] Royal Liverpool Univ Hosp, Linda McCartney Ctr, Liverpool, Merseyside, England; [Coleman, Robert E.] Weston Pk Hosp, Dept Oncol & Metab, Sheffield, S Yorkshire, England; [Ellis, Ian] Univ Nottingham, Dept Histopathol, Nottingham NG7 2RD, England	University of Newcastle; University of London; Queen Mary University London; University of London; Queen Mary University London; IRCCS European Institute of Oncology (IEO); Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; UNICANCER; Centre Francois Baclesse; German Breast Group; KU Leuven; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; Weston Park Hospital; University of Nottingham	Cuzick, J (corresponding author), Wolfson Inst Prevent Med, Ctr Canc Prevent, Charterhouse Sq, London EC1M 6BQ, England.	j.cuzick@qmul.ac.uk	Vaidya, Jayant S/F-7717-2010; Bonanni, Bernardo/AAM-7928-2020; Greil, Richard F/C-7673-2017; Sestak, Ivana/H-7305-2014; Evans, D Gareth/AAB-4308-2022; McIntosh, Stuart/J-9512-2012; Vaidya, Jayant S/A-7218-2008	Vaidya, Jayant S/0000-0003-1760-1278; Greil, Richard F/0000-0002-4462-3694; Sestak, Ivana/0000-0001-6999-2851; Evans, D Gareth/0000-0002-8482-5784; McIntosh, Stuart/0000-0002-4123-9611; Vaidya, Jayant S/0000-0003-1760-1278; Keckstein, Joerg/0000-0002-3943-3300; Guerrieri Gonzaga, Aliana/0000-0003-1915-1688; Howell, Anthony/0000-0002-6233-719X; Maggiorotto, Furio/0000-0003-3308-117X; Ellis, Ian/0000-0001-5292-8474	Cancer Research UK; National Health and Medical Research Council Australia; Breast Cancer Research Fund; AstraZeneca; Sanofi Aventis; Cancer Research UK [16893, 16891] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); Breast Cancer Research Fund; AstraZeneca(AstraZeneca); Sanofi Aventis(Sanofi-Aventis); Cancer Research UK(Cancer Research UK)	Cancer Research UK, National Health and Medical Research Council Australia, Breast Cancer Research Fund, AstraZeneca, Sanofi Aventis.	Abe O, 2005, LANCET, V366, P2087; Allred DC, 2012, J CLIN ONCOL, V30, P1268, DOI 10.1200/JCO.2010.34.0141; Brown SB, 2015, STEROIDS, V99, P8, DOI 10.1016/j.steroids.2014.12.013; Buzdar A, 2006, LANCET ONCOL, V7, P633, DOI 10.1016/S1470-2045(06)70767-7; Cox D. R., 1984, ANAL SURVIVAL DATA; COX DR, 1972, J R STAT SOC B, V34, P187; Cuzick Jack, 2014, Lancet, V383, P1041, DOI 10.1016/S0140-6736(13)62292-8; Cuzick J, 2015, LANCET ONCOL, V16, P67, DOI 10.1016/S1470-2045(14)71171-4; Cuzick J, 2011, J NATL CANCER I, V103, P744, DOI 10.1093/jnci/djr079; Cuzick J, 2011, LANCET ONCOL, V12, P21, DOI 10.1016/S1470-2045(10)70266-7; Cuzick J, 2010, LANCET ONCOL, V11, P1135, DOI 10.1016/S1470-2045(10)70257-6; Dodwell D, 2007, BRIT J CANCER, V97, P725, DOI 10.1038/sj.bjc.6603945; Dowsett M, 2008, J CLIN ONCOL, V26, P1059, DOI 10.1200/JCO.2007.12.9437; Fisher B, 1999, LANCET, V353, P1993, DOI 10.1016/S0140-6736(99)05036-9; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; FISHER B, 1994, J NATL CANCER I, V86, P527, DOI 10.1093/jnci/86.7.527; Francis A, 2015, EUR J CANCER, V51, P2296, DOI 10.1016/j.ejca.2015.07.017; Gapstur SM, 2015, LANCET, V385, P1835, DOI 10.1016/S0140-6736(14)61687-1; Goodwin A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000563.pub7; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Margolese RG, 2015, LANCET; Mokbel K, 2006, LANCET ONCOL, V7, P756, DOI 10.1016/S1470-2045(06)70861-0; Powles TJ, 2007, JNCI-J NATL CANCER I, V99, P283, DOI 10.1093/jnci/djk050; Rennert G, 2009, J CLIN ONCOL, V27, P4542, DOI 10.1200/JCO.2009.22.0764; Worni M, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv263	26	108	113	0	32	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	2016	387	10021					866	873		10.1016/S0140-6736(15)01129-0	http://dx.doi.org/10.1016/S0140-6736(15)01129-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE9RA	26686313	Green Accepted, Green Published, Green Submitted, hybrid			2022-12-28	WOS:000370974400031
J	Zaccardi, F; Htike, ZZ; Webb, DR; Khunti, K; Davies, MJ				Zaccardi, Francesco; Htike, Zin Zin; Webb, David R.; Khunti, Kamlesh; Davies, Melanie J.			Benefits and Harms of Once-Weekly Glucagon-like Peptide-1 Receptor Agonist Treatments A Systematic Review and Network Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							TYPE-2 DIABETES-MELLITUS; METFORMIN-TREATED PATIENTS; OPEN-LABEL; INSULIN GLARGINE; DOUBLE-BLIND; WEEKLY DULAGLUTIDE; GLYCEMIC CONTROL; CONTROLLED-TRIAL; JAPANESE PATIENTS; DAILY LIRAGLUTIDE	Background: Once-weekly glucagon-like peptide-1 receptor agonists (GLP-1RAs) are new drugs for the treatment of type 2 diabetes. Purpose: To summarize evidence for the cardiometabolic efficacy and adverse effects of once-weekly GLP-1RAs in adults with type 2 diabetes. Data Sources: Electronic databases (PubMed, Web of Science, Cochrane Central Register of Controlled Trials, U.S. Food and Drug Administration, European Medicines Agency, ClinicalTrials.gov) and congress abstracts from inception through 26 September 2015. Study Selection: Randomized, controlled trials (>= 24 weeks of follow-up) studying albiglutide, dulaglutide, once-weekly exenatide, semaglutide, and taspoglutide and reporting a cardiometabolic (primary outcome, hemoglobin A(1c) [HbA(1c)]) or safety outcome. Data Extraction: Extraction was done in duplicate, and risk of bias was assessed. No language restriction was applied. Data Synthesis: 34 trials (21 126 participants) were included. Compared with placebo, all once-weekly GLP-1RAs reduced HbA1c and fasting plasma glucose; taspoglutide, 20 mg, once-weekly exenatide, and dulaglutide, 1.5 mg, reduced body weight. Among once-weekly GLP-1RAs, the greatest differences were found between dulaglutide, 1.5 mg, and taspoglutide, 10 mg, for HbA1c (-0.4% [95% CI, -0.7% to -0.2%]), once-weekly exenatide and albiglutide for fasting plasma glucose (-0.7 mmol/L [CI, -1.1 to -0.2 mmol/L]; -12.6 mg/dL [CI, -19.8 to -3.6 mg/dL]), and taspoglutide, 20 mg, and dulaglutide, 0.75 mg, for body weight (-1.5 kg [CI, -2.2 to -0.8]). Clinically marginal or no differences were found for blood pressure, blood lipid levels, and C-reactive protein levels. Once-weekly exenatide increased heart rate compared with albiglutide and dulaglutide (1.4 to 3.2 beats/min). Among once-weekly GLP-1RAs, the risk for hypoglycemia was similar, whereas taspoglutide, 20 mg, had the greatest risk for nausea (odds ratios, 1.9 to 5.9). Limitation: Data were unavailable for semaglutide, definitions of outcomes were heterogeneous, the last-observation-carried-forward imputation method was used in 73% of trials, and publication bias is possible. Conclusion: Compared with other once-weekly GLP-1RAs, dulaglutide, 1.5 mg; once-weekly exenatide; and taspoglutide, 20 mg, showed a greater reduction of HbA1c, fasting plasma glucose, and body weight. Taspoglutide, 20 mg, had the highest risk for nausea; risk for hypoglycemia among once-weekly GLP-1RAs was similar.	[Zaccardi, Francesco; Htike, Zin Zin; Webb, David R.; Khunti, Kamlesh; Davies, Melanie J.] Univ Leicester, Diabet Res Ctr, Leicester LE5 4PW, Leics, England	University of Leicester	Zaccardi, F (corresponding author), Leicester Gen Hosp, Diabet Res Ctr, Gwendolen Rd, Leicester LE5 4PW, Leics, England.	fz43@le.ac.uk	/ABC-9527-2021	Davies, Melanie/0000-0002-9987-9371; Webb, David/0000-0002-3932-3339	Sanofi Aventis	Sanofi Aventis(Sanofi-Aventis)	From Sanofi Aventis to the University of Leicester.	Ahren B, 2014, DIABETES CARE, V37, P2141, DOI 10.2337/dc14-0024; Araki E, 2015, DIABETES OBES METAB, V17, DOI 10.1111/dom.12540; Bergenstal Richard M, 2012, Diabetes Ther, V3, P13, DOI 10.1007/s13300-012-0013-8; Bergenstal RM, 2010, LANCET, V376, P431, DOI 10.1016/S0140-6736(10)60590-9; Blevins T, 2011, J CLIN ENDOCR METAB, V96, P1301, DOI 10.1210/jc.2010-2081; Blonde L, 2015, LANCET, V385, P2057, DOI 10.1016/S0140-6736(15)60936-9; Buse JB, 2013, LANCET, V381, P117, DOI 10.1016/S0140-6736(12)61267-7; Buse JB, 2009, LANCET, V374, P39, DOI 10.1016/S0140-6736(09)60659-0; Chaimani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076654; Davies M, 2013, DIABETES CARE, V36, P1368, DOI 10.2337/dc12-1333; DeFronzo RA, 2010, DIABETIC MED, V27, P309, DOI 10.1111/j.1464-5491.2010.02941.x; Diamant M, 2014, LANCET DIABETES ENDO, V2, P464, DOI 10.1016/S2213-8587(14)70029-4; Diamant M, 2010, LANCET, V375, P2234, DOI 10.1016/S0140-6736(10)60406-0; Drucker DJ, 2010, DIABETES CARE, V33, P428, DOI 10.2337/dc09-1499; Drucker DJ, 2008, LANCET, V372, P1240; Dungan KM, 2014, LANCET, V384, P1349, DOI 10.1016/S0140-6736(14)60976-4; Giorgino F, 2015, DIABETES CARE; Harbord RM, 2008, STATA J, V8, P493, DOI 10.1177/1536867X0800800403; Henry RR, 2012, J CLIN ENDOCR METAB, V97, P2370, DOI 10.1210/jc.2011-3253; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hoaglin DC, 2011, VALUE HEALTH, V14, P429, DOI 10.1016/j.jval.2011.01.011; Hollander P, 2013, OBESITY, V21, P238, DOI 10.1002/oby.20042; Holst JJ, 2011, DIABETES CARE, V34, pS251, DOI 10.2337/dc11-s227; Home PD, 2015, DIABETES OBES METAB, V17, P179, DOI 10.1111/dom.12414; Hutton B, 2015, ANN INTERN MED, V162, P777, DOI 10.7326/M14-2385; Inagaki N, 2012, CLIN THER, V34, P1892, DOI 10.1016/j.clinthera.2012.07.007; Inzucchi SE, 2015, DIABETOLOGIA, V58, P429, DOI 10.1007/s00125-014-3460-0; Inzucchi SE, 2013, NEW ENGL J MED, V368, P193, DOI 10.1056/NEJMc1212738; Jackson D, 2014, STAT MED, V33, P3639, DOI 10.1002/sim.6188; Jansen JP, 2014, VALUE HEALTH, V17, P157, DOI 10.1016/j.jval.2014.01.004; Ji LN, 2013, J DIABETES INVEST, V4, P53, DOI 10.1111/j.2040-1124.2012.00238.x; Kapitza C, 2009, DIABETIC MED, V26, P1156, DOI 10.1111/j.1464-5491.2009.02854.x; Majumdar SK, 2013, ENDOCRINE, V44, P47, DOI 10.1007/s12020-013-9884-3; Medical Research Council Biostatistics Unit, 2015, I WHIT STAT SOFTW LI; Miyagawa J, 2015, DIABETES OBES METAB, V17, DOI 10.1111/dom.12534; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Multiple Treatments Meta-Analysis, 2015, US STATA NETW MET; Nauck M, 2013, DIABETIC MED, V30, P109, DOI 10.1111/dme.12003; Nauck M, 2013, AM DIAB ASS 73 SCI S; Pratley RE, 2013, DIABETES OBES METAB, V15, P234, DOI 10.1111/dom.12009; Pratley RE, 2014, LANCET DIABETES ENDO, V2, P289, DOI 10.1016/S2213-8587(13)70214-6; Raz I, 2012, DIABETES CARE, V35, P485, DOI 10.2337/dc11-1942; Reusch J, 2014, DIABETES OBES METAB, V16, P1257, DOI 10.1111/dom.12382; Rosenstock J, 2014, DIABETES CARE, V37, P2317, DOI 10.2337/dc14-0001; Rosenstock J, 2013, DIABETES CARE, V36, P498, DOI 10.2337/dc12-0709; Russell-Jones D, 2012, DIABETES CARE, V35, P252, DOI 10.2337/dc11-1107; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Scott DA, 2013, DIABETES OBES METAB, V15, P213, DOI 10.1111/dom.12007; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Stack CB, 2013, ANN INTERN MED, V159, P285, DOI 10.7326/0003-4819-159-4-201308200-00009; Sun F, 2012, EXP DIABETES RES, V2012, DOI DOI 10.1155/2012/230624; Sun F, 2015, DIABETES RES CLIN PR, V110, P26, DOI 10.1016/j.diabres.2015.07.015; Sun F, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/157201; Sun F, 2015, ENDOCRINE, V48, P794, DOI 10.1007/s12020-014-0373-0; Sun F, 2015, CLIN THER, V37, P225, DOI 10.1016/j.clinthera.2014.11.008; Sun F, 2015, DIABETES TECHNOL THE, V17, P35, DOI 10.1089/dia.2014.0188; Sun F, 2012, DIABETES RES CLIN PR, V98, P386, DOI 10.1016/j.diabres.2012.09.004; Sutton A, 2008, PHARMACOECONOMICS, V26, P753, DOI 10.2165/00019053-200826090-00006; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Umpierrez G, 2014, DIABETES CARE, V37, P2168, DOI 10.2337/dc13-2759; Wang W, 2015, 51 EASD M STOCKH SWE; Weinstock RS, 2015, DIABETES OBES METAB, V17, P849, DOI 10.1111/dom.12479; Weissman P, 2014, DIABETOLOGIA, V57, P2475, DOI 10.1007/s00125-014-3360-3; White IR, 2012, RES SYNTH METHODS, V3, P111, DOI 10.1002/jrsm.1045; White IR, 2011, STATA J, V11, P255, DOI 10.1177/1536867X1101100206; Wysham C, 2014, DIABETES CARE, V37, P2159, DOI [10.2337/dc13-2760, 10.2337/dc15-er07b]; Zhong XH, 2015, DIABETES RES CLIN PR, V109, P451, DOI 10.1016/j.diabres.2015.05.048; Zintzaras E, 2014, CLIN THER, V36, P1443, DOI 10.1016/j.clinthera.2014.06.035	69	64	65	0	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 19	2016	164	2					102	+		10.7326/M15-1432	http://dx.doi.org/10.7326/M15-1432			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB0CI	26642233				2022-12-28	WOS:000368175800014
J	Veenstra, CM; Regenbogen, SE; Hawley, ST; Abrahamse, P; Banerjee, M; Morris, AM				Veenstra, Christine M.; Regenbogen, Scott E.; Hawley, Sarah T.; Abrahamse, Paul; Banerjee, Mousumi; Morris, Arden M.			Association of Paid Sick Leave With Job Retention and Financial Burden Among Working Patients With Colorectal Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Veenstra, Christine M.; Hawley, Sarah T.; Abrahamse, Paul] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Regenbogen, Scott E.; Morris, Arden M.] Univ Michigan, Ctr Healthcare Outcomes & Policy, 1500 E Med Ctr Dr,TC2421F, Ann Arbor, MI 48109 USA; [Banerjee, Mousumi] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Morris, AM (corresponding author), Univ Michigan, Ctr Healthcare Outcomes & Policy, 1500 E Med Ctr Dr,TC2421F, Ann Arbor, MI 48109 USA.	ammsurg@med.umich.edu		Morris, Arden/0000-0001-5795-2940				Langa KM, 2004, VALUE HEALTH, V7, P186, DOI 10.1111/j.1524-4733.2004.72334.x; Regenbogen SE, 2014, CANCER-AM CANCER SOC, V120, P3074, DOI 10.1002/cncr.28812; Veenstra CM, 2014, MED CARE, V52, P957, DOI 10.1097/MLR.0000000000000241; Zafar SY, 2013, ONCOLOGIST, V18, P381, DOI 10.1634/theoncologist.2012-0279	4	27	27	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 29	2015	314	24					2688	2690		10.1001/jama.2015.12383	http://dx.doi.org/10.1001/jama.2015.12383			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ2MR	26717032	Bronze			2022-12-28	WOS:000366939800025
J	[Anonymous]				[Anonymous]			The Optimum Population for the United States (Reprinted from JAMA, vol, 115, pg 2282-2283, 1940)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		[Anonymous], 1937, JAMA-J AM MED ASSOC, V109, P1726; [Anonymous], 1937, JAMA-J AM MED ASSOC, V109, P1638; [Anonymous], 1938, JAMA-J AM MED ASSOC, V111, P1189; [Anonymous], 1938, JAMA-J AM MED ASSOC, V111, P1103; Burch G. I., 1940, POPULATION B; 1940, JAMA, V115, P2282	6	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 29	2015	314	24					2695	2695		10.1001/jama.2014.12168	http://dx.doi.org/10.1001/jama.2014.12168			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ2MR	26720037				2022-12-28	WOS:000366939800033
J	Rodriguez-Colon, G; Palestine, AG				Rodriguez-Colon, Gabriela; Palestine, Alan G.			Polychondritis with Auricular and Ocular Involvement	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rodriguez-Colon, Gabriela; Palestine, Alan G.] Univ Colorado, Sch Med, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Rodriguez-Colon, G (corresponding author), Univ Colorado, Sch Med, Aurora, CO 80045 USA.	alan.palestine@ucdenver.edu							0	0	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 24	2015	373	26					2562	2562		10.1056/NEJMicm1501692	http://dx.doi.org/10.1056/NEJMicm1501692			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ7SG	26699171				2022-12-28	WOS:000367299700011
J	Vogt, M				Vogt, Meike			Adrift in an ocean of change	SCIENCE			English	Editorial Material							COCCOLITHOPHORES; ACIDIFICATION		[Vogt, Meike] ETH, Inst Biogeochem & Pollutant Dynam, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Vogt, M (corresponding author), ETH, Inst Biogeochem & Pollutant Dynam, Zurich, Switzerland.	meike.vogt@env.ethz.ch	Vogt, Meike/I-7457-2017	Vogt, Meike/0000-0002-0608-1935				Beaufort L, 2011, NATURE, V476, P80, DOI 10.1038/nature10295; Beaugrand G, 2013, NAT CLIM CHANGE, V3, P263, DOI 10.1038/NCLIMATE1753; Buitenhuis ET, 2013, EARTH SYST SCI DATA, V5, P227, DOI 10.5194/essd-5-227-2013; de Vargas C, 2015, SCIENCE, V348, DOI 10.1126/science.1261605; Dutkiewicz S, 2015, NAT CLIM CHANGE, V5, P1002, DOI [10.1038/NCLIMATE2722, 10.1038/nclimate2722]; Hutchins D., 2015, NAT GEOSCI, V6, P790; McMahon KW, 2015, SCIENCE, V350, P1530, DOI 10.1126/science.aaa9942; O'Dea SA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6363; Reid PC, 1998, NATURE, V391, P546, DOI 10.1038/35290; Rivero-Calle S, 2015, SCIENCE, V350, P1533, DOI 10.1126/science.aaa8026; Schluter L, 2014, NAT CLIM CHANGE, V4, P1024, DOI 10.1038/NCLIMATE2379; Sunagawa S, 2015, SCIENCE, V348, DOI 10.1126/science.1261359	12	5	6	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2015	350	6267					1466	1468		10.1126/science.aad6946	http://dx.doi.org/10.1126/science.aad6946			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY7LY	26680177				2022-12-28	WOS:000366591100029
J	Chow, KT; Gale, M				Chow, Kwan T.; Gale, Michael, Jr.			SnapShot: Interferon Signaling	CELL			English	Editorial Material							RECEPTOR; STATS	Interferons (IFNs) are crucial cytokines of antimicrobial, antitumor, and immunomodulatory activity. The three types of IFN (I, II, and III) are classified by their receptor specificity and sequence homology. IFNs are produced and secreted by cells in response to specific stimuli. Here, we review the subsequent IFN signaling events occurring through unique receptors leading to regulation of gene expression for modulation of innate and adaptive immunity. To view this SnapShot, open or download the PDF.	[Chow, Kwan T.; Gale, Michael, Jr.] Univ Washington, Sch Med, Ctr Innate Immun & Immune Dis, Dept Immunol, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle	Chow, KT (corresponding author), Univ Washington, Sch Med, Ctr Innate Immun & Immune Dis, Dept Immunol, 750 Republican St, Seattle, WA 98109 USA.		Chow, Kwan/AAH-6782-2019	Chow, Kwan/0000-0003-1012-0797; Gale, Michael/0000-0002-6332-7436	Croucher Foundation; NIH [AI04002, AI083019]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083019, R01AI104002] Funding Source: NIH RePORTER	Croucher Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank all colleagues who have worked to define the IFN field and apologize to those whose work could not be cited due to space constraints. Supported by the Croucher Foundation and by NIH grants AI04002 and AI083019.	de Weerd NA, 2013, NAT IMMUNOL, V14, P901, DOI 10.1038/ni.2667; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Kearney SJ, 2013, J IMMUNOL, V191, P3384, DOI 10.4049/jimmunol.1203510; Levy DE, 2012, IMMUNITY, V36, P553, DOI 10.1016/j.immuni.2012.04.003; Liu BS, 2011, BLOOD, V117, P2385, DOI 10.1182/blood-2010-07-298976; ODENDALL C, 2008, PLOS PATHOG, V4; Odendall C, 2015, CURR OPIN VIROL, V12, P47, DOI 10.1016/j.coviro.2015.02.003; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Yang JB, 2008, CELL RES, V18, P443, DOI 10.1038/cr.2008.41	10	30	34	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2015	163	7							1808.e1	10.1016/j.cell.2015.12.008	http://dx.doi.org/10.1016/j.cell.2015.12.008			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CZ1GN	26687364	Bronze			2022-12-28	WOS:000366854200027
J	Cohn, R; Morantte, I; Ruta, V				Cohn, Raphael; Morantte, Ianessa; Ruta, Vanessa			Coordinated and Compartmentalized Neuromodulation Shapes Sensory Processing in Drosophila	CELL			English	Article							VENTRAL TEGMENTAL AREA; MUSHROOM BODY NEURONS; BASAL GANGLIA; OLFACTORY MEMORY; DOPAMINE NEURONS; SYNAPTIC PLASTICITY; NEURAL CIRCUITS; OUTPUT NEURONS; REWARD; INPUT	Learned and adaptive behaviors rely on neural circuits that flexibly couple the same sensory input to alternative output pathways. Here, we show that the Drosophila mushroom body functions like a switchboard in which neuromodulation reroutes the same odor signal to different behavioral circuits, depending on the state and experience of the fly. Using functional synaptic imaging and electrophysiology, we reveal that dopaminergic inputs to the mushroom body modulate synaptic transmission with exquisite spatial specificity, allowing individual neurons to differentially convey olfactory signals to each of their postsynaptic targets. Moreover, we show that the dopaminergic neurons function as an interconnected network, encoding information about both an animal's external context and internal state to coordinate synaptic plasticity throughout the mushroom body. Our data suggest a general circuit mechanism for behavioral flexibility in which neuromodulatory networks act with synaptic precision to transform a single sensory input into different patterns of output activity.	[Cohn, Raphael; Morantte, Ianessa; Ruta, Vanessa] Rockefeller Univ, Lab Neurophysiol & Behav, New York, NY 10065 USA	Rockefeller University	Ruta, V (corresponding author), Rockefeller Univ, Lab Neurophysiol & Behav, New York, NY 10065 USA.	ruta@rockefeller.edu		Ruta, Vanessa/0000-0002-4963-2768	David Rockefeller Graduate Student Fellowship; New York Stem Cell Foundation; Pew Biomedical Scholar Award; McKnight Scholar Award; Alfred P. Sloan Foundation; Irma T. Hirschl Award; Sinsheimer Foundation Award; NIH New Innovator Award [DP2 NS0879422013]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [DP2NS087942] Funding Source: NIH RePORTER	David Rockefeller Graduate Student Fellowship; New York Stem Cell Foundation; Pew Biomedical Scholar Award; McKnight Scholar Award; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Irma T. Hirschl Award; Sinsheimer Foundation Award; NIH New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Leslie Vosshall, Cori Bargmann, Richard Axel, Larry Abbott, Sandeep Datta, Barbara Noro, Daisuke Hattori, Meg Younger, and members of the V.R. lab for valuable discussion. We thank Donovan Ventimiglia, Tim Ryan, Ari Zolin, Eliezer Pickholtz, and Josh Salvi for technical advice. R.C. was supported by a David Rockefeller Graduate Student Fellowship. V.R. is a New York Stem Cell Foundation Robertson Neuroscience Investigator. This work was supported by the New York Stem Cell Foundation, a Pew Biomedical Scholar Award, a McKnight Scholar Award, the Alfred P. Sloan Foundation, an Irma T. Hirschl Award, a Sinsheimer Foundation Award, and an NIH New Innovator Award (DP2 NS0879422013).	Aso Y, 2014, ELIFE, V3, DOI 10.7554/eLife.04580; Aso Y, 2014, ELIFE, V3, DOI 10.7554/eLife.04577; Aso Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002768; Bargmann CI, 2012, BIOESSAYS, V34, P458, DOI 10.1002/bies.201100185; Beier KT, 2015, CELL, V162, P622, DOI 10.1016/j.cell.2015.07.015; BENINGER RJ, 1983, BRAIN RES REV, V6, P173, DOI 10.1016/0165-0173(83)90038-3; Berry JA, 2015, CELL, V161, P1656, DOI 10.1016/j.cell.2015.05.027; Berry JA, 2012, NEURON, V74, P530, DOI 10.1016/j.neuron.2012.04.007; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Caron SJC, 2013, NATURE, V497, P113, DOI 10.1038/nature12063; Claridge-Chang A, 2009, CELL, V139, P405, DOI 10.1016/j.cell.2009.08.034; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Fiorillo CD, 2013, J NEUROSCI, V33, P4710, DOI 10.1523/JNEUROSCI.3883-12.2013; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Grillner S, 2005, TRENDS NEUROSCI, V28, P364, DOI 10.1016/j.tins.2005.05.004; Gruntman E, 2013, NAT NEUROSCI, V16, P1821, DOI 10.1038/nn.3547; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Hige T, 2015, NATURE, V526, P258, DOI 10.1038/nature15396; Huang YY, 2004, P NATL ACAD SCI USA, V101, P3236, DOI 10.1073/pnas.0308280101; Huetteroth W, 2015, CURR BIOL, V25, P751, DOI 10.1016/j.cub.2015.01.036; Kazama H, 2008, NEURON, V58, P401, DOI 10.1016/j.neuron.2008.02.030; Keene AC, 2007, NAT REV NEUROSCI, V8, P341, DOI 10.1038/nrn2098; Kim YC, 2007, J NEUROSCI, V27, P7640, DOI 10.1523/JNEUROSCI.1167-07.2007; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Lammel S, 2014, NEUROPHARMACOLOGY, V76, P351, DOI 10.1016/j.neuropharm.2013.03.019; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Lerner TN, 2015, CELL, V162, P635, DOI 10.1016/j.cell.2015.07.014; Lewis LPC, 2015, CURR BIOL, V25, P2203, DOI 10.1016/j.cub.2015.07.015; Lin SW, 2014, NAT NEUROSCI, V17, P1536, DOI 10.1038/nn.3827; Liu C, 2012, NATURE, V488, P512, DOI 10.1038/nature11304; Mao ZM, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.005.2009; Marder E, 2012, NEURON, V76, P1, DOI 10.1016/j.neuron.2012.09.010; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Owald D, 2015, NEURON, V86, P417, DOI 10.1016/j.neuron.2015.03.025; Pelkey KA, 2007, CURR OPIN NEUROBIOL, V17, P366, DOI 10.1016/j.conb.2007.04.008; Qin HT, 2012, CURR BIOL, V22, P608, DOI 10.1016/j.cub.2012.02.014; Redgrave P, 2006, NAT REV NEUROSCI, V7, P967, DOI 10.1038/nrn2022; Regehr WG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005702; Rice ME, 2011, NEUROSCIENCE, V198, P112, DOI 10.1016/j.neuroscience.2011.08.066; Ruta V, 2010, NATURE, V468, P686, DOI 10.1038/nature09554; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Sejourne J, 2011, NAT NEUROSCI, V14, P903, DOI 10.1038/nn.2846; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Tanaka NK, 2008, J COMP NEUROL, V508, P711, DOI 10.1002/cne.21692; Tritsch NX, 2012, NEURON, V76, P33, DOI 10.1016/j.neuron.2012.09.023; Waddell S, 2013, CURR OPIN NEUROBIOL, V23, P324, DOI 10.1016/j.conb.2013.01.005; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Yamagata N, 2015, P NATL ACAD SCI USA, V112, P578, DOI 10.1073/pnas.1421930112; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919	50	191	193	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2015	163	7					1742	1755		10.1016/j.cell.2015.11.019	http://dx.doi.org/10.1016/j.cell.2015.11.019			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CZ1GN	26687359	Green Accepted, Bronze			2022-12-28	WOS:000366854200020
J	Osso, LA; Chan, JR				Osso, Lindsay A.; Chan, Jonah R.			Astrocytes Underlie Neuroinflammatory Memory Impairment	CELL			English	Editorial Material								Neuroinflammation is being increasingly recognized as a potential mediator of cognitive impairments in various neurological conditions. Habbas et al. demonstrate that the pro-inflammatory cytokine tumor necrosis factor alpha signals through astrocytes to alter synaptic transmission and impair cognition in a mouse model of multiple sclerosis.	[Osso, Lindsay A.; Chan, Jonah R.] Univ Calif San Francisco, Neurosci Grad Program, San Francisco, CA 94158 USA; [Osso, Lindsay A.; Chan, Jonah R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Chan, JR (corresponding author), Univ Calif San Francisco, Neurosci Grad Program, San Francisco, CA 94158 USA.	jonah.chan@ucsf.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062796] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS062796, R01NS062796] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Acharjee S, 2013, BRAIN BEHAV IMMUN, V33, P164, DOI 10.1016/j.bbi.2013.07.003; Habbas S, 2015, CELL, V163, P1730, DOI 10.1016/j.cell.2015.11.023; Haydon PG, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020438; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; Oberheim NA, 2012, METHODS MOL BIOL, V814, P23, DOI 10.1007/978-1-61779-452-0_3; Peterson P.K., 2014, NEUROINFLAMMATIONNEU; Santello M, 2011, NEURON, V69, P988, DOI 10.1016/j.neuron.2011.02.003; Yirmiya R, 2011, BRAIN BEHAV IMMUN, V25, P181, DOI 10.1016/j.bbi.2010.10.015; Yong VW, 2010, NEUROSCIENTIST, V16, P408, DOI 10.1177/1073858410371379	10	16	16	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2015	163	7					1574	1576		10.1016/j.cell.2015.12.001	http://dx.doi.org/10.1016/j.cell.2015.12.001			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CZ1GN	26687350	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000366854200006
J	Smith, TC				Smith, Tara C.			CHRISTMAS 2015: INFECTION CONTROL Zombie infections: epidemiology, treatment, and prevention	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Smith, Tara C.] Kent State Univ, Coll Publ Hlth, Dept Biostat Environm Hlth Sci & Epidemiol, Kent, OH 44242 USA	University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Smith, TC (corresponding author), Kent State Univ, Coll Publ Hlth, Dept Biostat Environm Hlth Sci & Epidemiol, Kent, OH 44242 USA.	tsmit176@kent.edu		Smith, Tara C./0000-0003-3747-1116				ACKERMANN HW, 1991, J AM FOLKLORE, V104, P466, DOI 10.2307/541551; Alemi AA, 2015, AM PHYS SOC MARCH M; Boyle D, 2002, 28 DAYS LATER; Brooks M., 2003, ZOMBIE SURVIVAL; Brooks Max, 2006, WORLD WAR Z; Centers for Disease Control and Prevention, ZOMB PREP; Cruse C, 2015, THE RETURNED; Cummings P., 2001, NEUROPATHOLOGY ZOMBI; Darabont F., 2010, THE WALKING DEAD; DAVIS EW, 1983, J ETHNOPHARMACOL, V9, P85, DOI 10.1016/0378-8741(83)90029-6; Druckmann N, 2013, THE LAST OF US; Eisner B, 2010, THE CRAZIES; Fleischer R., 2009, ZOMBIELAND; Fresnadillo JC, 2007, 28 WEEKS LATER; Grant J. M., 2010, OUTING AGE 2010 PUBL; Grant M., 2012, BLACKOUT; Kirkman Robert, 2003, THE WALKING DEAD; Littlewood R, 1997, LANCET, V350, P1094, DOI 10.1016/S0140-6736(97)04449-8; Maberry J., 2011, ROT AND RUIN; Maberry J., 2012, FLESH AND BONE; MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036; Matheson R., 1954, I AM LEGEND; Mogk M, 2011, EVERTYTHING YOU EVER; Nasiruddin M, 2013, EMERG INFECT DIS, V19, P809, DOI 10.3201/eid1905.AD1905; Niles S., 2007, 28 DAYS LATER AFTER; Pauls C, 2012, DECK Z; Romero G, 1973, THE CRAZIES; Romero G.A., 1968, NIGHT LIVING DEAD; Schlozman S., 2011, THE ZOMBIE AUTOPSIES; Stanley D, 2012, J CLIN NURS, V21, P1606, DOI 10.1111/j.1365-2702.2011.03920.x; Wright E., 2004, SHAUN OF THE DEAD; Yardley J., 2007, NY TIMES	33	6	6	1	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 14	2015	351								h6423	10.1136/bmj.h6423	http://dx.doi.org/10.1136/bmj.h6423			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ4KY	26668070				2022-12-28	WOS:000367073200008
J	Derivery, E; Seum, C; Daeden, A; Loubery, S; Holtzer, L; Julicher, F; Gonzalez-Gaitan, M				Derivery, Emmanuel; Seum, Carole; Daeden, Alicia; Loubery, Sylvain; Holtzer, Laurent; Juelicher, Frank; Gonzalez-Gaitan, Marcos			Polarized endosome dynamics by spindle asymmetry during asymmetric cell division	NATURE			English	Article							SARA ENDOSOMES; DROSOPHILA-NEUROBLASTS; NOTCH TRAFFICKING; RAB PROTEINS; MICROTUBULES; PATRONIN; DOMAINS; PATHWAY; FATE; NUMB	During asymmetric division, fate determinants at the cell cortex segregate unequally into the two daughter cells. It has recently been shown that Sara (Smad anchor for receptor activation) signalling endosomes in the cytoplasm also segregate asymmetrically during asymmetric division(1,2). Biased dispatch of Sara endosomes mediates asymmetric Notch/Delta signalling during the asymmetric division of sensory organ precursors in Drosophila(1). In flies, this has been generalized to stem cells in the gut(3) and the central nervous system(1), and, in zebrafish, to neural precursors of the spinal cord(4). However, the mechanism of asymmetric endosome segregation is not understood. Here we show that the plus-end kinesin motor Klp98A targets Sara endosomes to the central spindle, where they move bidirectionally on an antiparallel array of microtubules. The microtubule depolymerizing kinesin Klp10A and its antagonist Patronin generate central spindle asymmetry. This asymmetric spindle, in turn, polarizes endosome motility, ultimately causing asymmetric endosome dispatch into one daughter cell. We demonstrate this mechanism by inverting the polarity of the central spindle by polar targeting of Patronin using nanobodies (single-domain antibodies). This spindle inversion targets the endosomes to the wrong cell. Our data uncover the molecular and physical mechanism by which organelles localized away from the cellular cortex can be dispatched asymmetrically during asymmetric division.	[Derivery, Emmanuel; Seum, Carole; Daeden, Alicia; Loubery, Sylvain; Holtzer, Laurent; Gonzalez-Gaitan, Marcos] Univ Geneva, Fac Sci, Dept Biochem, CH-1211 Geneva, Switzerland; [Juelicher, Frank] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany	University of Geneva; Max Planck Society	Gonzalez-Gaitan, M (corresponding author), Univ Geneva, Fac Sci, Dept Biochem, 30 Quai Ernest Ansermet, CH-1211 Geneva, Switzerland.	emmanuel.derivery@unige.ch; julicher@pks.mpg.de; marcos.gonzalez@unige.ch	Julicher, Frank/B-1828-2009; Holtzer, Laurent/B-9016-2008	Julicher, Frank/0000-0003-4731-9185; Loubery, Sylvain/0000-0001-7061-9456; Holtzer, Laurent/0000-0002-4421-6597; Gonzalez-Gaitan, Marcos/0000-0002-6295-7321; daeden, alicia/0000-0002-2141-9607	Human Frontier Science Program; Marie-Curie Intra-European Fellowship; Departement de l'Instruction Publique of the Canton of Geneva; SNF; SystemsX epiPhysX program; NCCR Chemical Biology program; ERC; Polish-Swiss research programs	Human Frontier Science Program(Human Frontier Science Program); Marie-Curie Intra-European Fellowship(European Commission); Departement de l'Instruction Publique of the Canton of Geneva; SNF; SystemsX epiPhysX program; NCCR Chemical Biology program; ERC(European Research Council (ERC)European Commission); Polish-Swiss research programs	We thank A. Gautreau, in whose laboratory the GBP was cloned, for allowing us to use it before his own publication. We thank A. Gautreau, R. Vale, A. Houdusse, A. Roux, A. Trushko and V. Stoppin-Mellet for discussions and advices. We thank N. Chiaruttini for the preparation of liposomes and for insights throughout the project. We thank R. Le Borgne, S. Eaton, S. De Renzis, F. Karch, W. Zhong and R. Stanewsky for flies. We thank P. Kapusta from Picoquant for help with FLIM data analysis. We thank V. Stoppin-Mellet, M. Vantard and J. Gaillard for the gift of GFP-MAP65-1. We are indebted to J. Teyssier, E. Allemann and N. Boulens for letting us use their scanning electron microscopes. E.D. is supported by a Long term Fellowship of the Human Frontier Science Program. L.H. and S.L. are supported by a Marie-Curie Intra-European Fellowship. M.G.G. is supported by Departement de l'Instruction Publique of the Canton of Geneva, the SNF, the SystemsX epiPhysX program, the NCCR Chemical Biology program, the ERC (Sara and Morphogen) and the Polish-Swiss research programs.	Bellaiche Y, 2001, NAT CELL BIOL, V3, P50, DOI 10.1038/35050558; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Bitan A, 2012, DEVELOPMENT, V139, P1987, DOI 10.1242/dev.076893; Bokel C, 2006, SCIENCE, V314, P1135, DOI 10.1126/science.1132524; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Connell JW, 2009, TRAFFIC, V10, P42, DOI 10.1111/j.1600-0854.2008.00847.x; Coumailleau F, 2009, NATURE, V458, P1051, DOI 10.1038/nature07854; Derivery E, 2009, DEV CELL, V17, P712, DOI 10.1016/j.devcel.2009.09.010; Dunst S, 2015, DEV CELL, V33, P351, DOI 10.1016/j.devcel.2015.03.022; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Ems-McClung SC, 2010, SEMIN CELL DEV BIOL, V21, P276, DOI 10.1016/j.semcdb.2010.01.016; EUTENEUER U, 1980, J CELL BIOL, V87, P509, DOI 10.1083/jcb.87.2.509; Fabrowski P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3244; Fededa JP, 2012, NAT CELL BIOL, V14, P440, DOI 10.1038/ncb2482; Forer A, 1998, CHROMOSOME RES, V6, P533, DOI 10.1023/A:1009224322399; Furthauer M, 2009, TRAFFIC, V10, P792, DOI 10.1111/j.1600-0854.2009.00914.x; Gell C, 2010, METHOD CELL BIOL, V95, P221, DOI 10.1016/S0091-679X(10)95013-9; Glotzer M, 2009, NAT REV MOL CELL BIO, V10, P9, DOI 10.1038/nrm2609; Gong WJ, 2004, GENETICS, V168, P1467, DOI 10.1534/genetics.104.030874; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Goodwin SS, 2010, CELL, V143, P263, DOI 10.1016/j.cell.2010.09.022; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; Hendershott MC, 2014, P NATL ACAD SCI USA, V111, P5860, DOI 10.1073/pnas.1404133111; Hoepfner S, 2005, CELL, V121, P437, DOI 10.1016/j.cell.2005.02.017; Iwaki T, 2003, BIOTECHNIQUES, V35, P482, DOI 10.2144/03353bm08; Januschke J, 2013, NAT CELL BIOL, V15, P241, DOI 10.1038/ncb2671; Januschke J, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1245; Januschke J, 2010, J CELL BIOL, V188, P693, DOI 10.1083/jcb.200905024; Jauffred B, 2013, DEVELOPMENT, V140, P2657, DOI 10.1242/dev.087338; Jauffred Bertrand, 2012, Methods Mol Biol, V839, P19, DOI 10.1007/978-1-61779-510-7_2; Jiang K, 2014, DEV CELL, V28, P295, DOI 10.1016/j.devcel.2014.01.001; Karpova N, 2006, CELL MOTIL CYTOSKEL, V63, P301, DOI 10.1002/cm.20124; Kirchhofer A, 2010, NAT STRUCT MOL BIOL, V17, P133, DOI 10.1038/nsmb.1727; Korten T, 2008, LAB CHIP, V8, P1441, DOI 10.1039/b803585g; Krahn MP, 2010, CURR BIOL, V20, P636, DOI 10.1016/j.cub.2010.01.065; Kressmann S, 2015, NAT CELL BIOL, V17, P333, DOI 10.1038/ncb3119; Kural C, 2012, METHOD ENZYMOL, V505, P59, DOI 10.1016/B978-0-12-388448-0.00012-7; Lai EC, 2001, DEV BIOL, V231, P217, DOI 10.1006/dbio.2000.0124; LaPointe NE, 2009, J NEUROSCI RES, V87, P440, DOI 10.1002/jnr.21850; Loubery S, 2014, CURR BIOL, V24, P2142, DOI 10.1016/j.cub.2014.07.054; Loubery S, 2014, METHOD ENZYMOL, V534, P301, DOI 10.1016/B978-0-12-397926-1.00017-2; Lu BW, 1999, MOL CELL, V4, P883, DOI 10.1016/S1097-2765(00)80218-X; Lukinavicius G, 2014, NAT METHODS, V11, P731, DOI [10.1038/NMETH.2972, 10.1038/nmeth.2972]; Matsuo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080392; Mayer B, 2005, CURR BIOL, V15, P1847, DOI 10.1016/j.cub.2005.08.067; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Minestrini G, 2002, J CELL SCI, V115, P725; Montagne C, 2014, DEVELOPMENT, V141, P2014, DOI 10.1242/dev.104240; Mummery-Widmer JL, 2009, NATURE, V458, P987, DOI 10.1038/nature07936; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Schiel JA, 2011, J CELL SCI, V124, P1411, DOI 10.1242/jcs.081448; Seum C, 2007, PLOS GENET, V3, P709, DOI 10.1371/journal.pgen.0030076; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Soppina V, 2014, P NATL ACAD SCI USA, V111, P5562, DOI 10.1073/pnas.1400759111; Stoppin-Mellet V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056808; Tang HY, 2005, MOL CELL BIOL, V25, P2899, DOI 10.1128/MCB.25.8.2899-2909.2005; Tarantino N, 2014, J CELL BIOL, V204, P231, DOI 10.1083/jcb.201307172; Thorn KS, 2000, J CELL BIOL, V151, P1093, DOI 10.1083/jcb.151.5.1093; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233; Wang HF, 2013, J CELL BIOL, V203, P35, DOI 10.1083/jcb.201306001; Wang SW, 1997, DEVELOPMENT, V124, P4435; Yang D, 2008, NAT STRUCT MOL BIOL, V15, P1278, DOI 10.1038/nsmb.1512; Yeh E, 2000, EMBO J, V19, P4827, DOI 10.1093/emboj/19.17.4827; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	65	80	83	3	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2015	528	7581					280	+		10.1038/nature16443	http://dx.doi.org/10.1038/nature16443			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9VH	26659188	Green Published			2022-12-28	WOS:000366053300045
J	Cole, TB				Cole, Thomas B.			Liber Divinorum Operum (Book of Divine Works)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 8	2015	314	22					2336	2337		10.1001/jama.2014.12133	http://dx.doi.org/10.1001/jama.2014.12133			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX8XT	26647248				2022-12-28	WOS:000365989100001
J	Khan, MR; Li, LY; Perez-Sanchez, C; Saraf, A; Florens, L; Slaughter, BD; Unruh, JR; Si, K				Khan, Mohammed Repon; Li, Liying; Perez-Sanchez, Consuelo; Saraf, Anita; Florens, Laurence; Slaughter, Brian D.; Unruh, Jay R.; Si, Kausik			Amyloidogenic Oligomerization Transforms Drosophila Orb2 from a Translation Repressor to an Activator	CELL			English	Article							LONG-TERM-MEMORY; MESSENGER-RNA; SYNAPTIC PLASTICITY; NEURONAL ISOFORM; APLYSIA CPEB; PROTEIN-SYNTHESIS; IN-VITRO; PRION; POLYADENYLATION; PERSISTENCE	Memories are thought to be formed in response to transient experiences, in part through changes in local protein synthesis at synapses. In Drosophila, the amyloidogenic (prion-like) state of the RNA binding protein Orb2 has been implicated in long-term memory, but how conformational conversion of Orb2 promotes memory formation is unclear. Combining in vitro and in vivo studies, we find that the monomeric form of Orb2 represses translation and removes mRNA poly(A) tails, while the oligomeric form enhances translation and elongates the poly(A) tails and imparts its translational state to the monomer. The CG13928 protein, which binds only to monomeric Orb2, promotes deadenylation, whereas the putative poly(A) binding protein CG4612 promotes oligomeric Orb2-dependent translation. Our data support a model in which monomeric Orb2 keeps target mRNA in a translationally dormant state and experience-dependent conversion to the amyloidogenic state activates translation, resulting in persistent alteration of synaptic activity and stabilization of memory.	[Khan, Mohammed Repon; Li, Liying; Perez-Sanchez, Consuelo; Saraf, Anita; Florens, Laurence; Slaughter, Brian D.; Unruh, Jay R.; Si, Kausik] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Khan, Mohammed Repon; Li, Liying; Si, Kausik] Univ Kansas, Dept Mol & Integrat Physiol, Med Ctr, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Si, K (corresponding author), Stowers Inst Med Res, 1000 East 50th St, Kansas City, MO 64110 USA.	ksi@stowers.org		Florens, Laurence/0000-0002-9310-6650; Unruh, Jay/0000-0003-3077-4990	NIMH NIH HHS [R01 MH101440] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101440] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Benoit B, 1999, NUCLEIC ACIDS RES, V27, P3771, DOI 10.1093/nar/27.19.3771; Cai X, 2014, CELL, V156, P1207, DOI 10.1016/j.cell.2014.01.063; Coll O, 2014, METHODS MOL BIOL, V1125, P53, DOI 10.1007/978-1-62703-971-0_5; CRICK F, 1984, NATURE, V312, P101, DOI 10.1038/312101a0; Didelot G, 2006, SCIENCE, V313, P851, DOI 10.1126/science.1127215; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Drisaldi B, 2015, CELL REP, V11, P1694, DOI 10.1016/j.celrep.2015.04.061; Dudai Y, 2002, CURR OPIN NEUROBIOL, V12, P211, DOI 10.1016/S0959-4388(02)00305-7; Fioriti L, 2015, NEURON, V86, P1433, DOI 10.1016/j.neuron.2015.05.021; Fiumara F, 2010, CELL, V143, P1121, DOI 10.1016/j.cell.2010.11.042; Heinrich SU, 2011, P NATL ACAD SCI USA, V108, P2999, DOI 10.1073/pnas.1019368108; Hosoda N, 2011, EMBO J, V30, P1311, DOI 10.1038/emboj.2011.37; Huang WH, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00367; Jeske M, 2008, METHOD ENZYMOL, V448, P107, DOI 10.1016/S0076-6879(08)02606-2; Kacsoh BZ, 2015, GENETICS, V199, P1143, DOI 10.1534/genetics.114.172221; Kapust RB, 2000, PROTEIN EXPRES PURIF, V19, P312, DOI 10.1006/prep.2000.1251; Keleman K, 2007, NAT NEUROSCI, V10, P1587, DOI 10.1038/nn1996; Kruttner S, 2015, CELL REP, V11, P1953, DOI 10.1016/j.celrep.2015.05.037; Kruttner S, 2012, NEURON, V76, P383, DOI 10.1016/j.neuron.2012.08.028; Kwak JE, 2008, P NATL ACAD SCI USA, V105, P14644, DOI 10.1073/pnas.0803185105; Kwon I, 2013, CELL, V155, P1049, DOI 10.1016/j.cell.2013.10.033; Lie YS, 2000, BIOCHEM BIOPH RES CO, V270, P473, DOI 10.1006/bbrc.2000.2453; LISMAN J, 1994, TRENDS NEUROSCI, V17, P406, DOI 10.1016/0166-2236(94)90014-0; LYNCH G, 1984, SCIENCE, V224, P1057, DOI 10.1126/science.6144182; Majumdar A, 2012, CELL, V148, P515, DOI 10.1016/j.cell.2012.01.004; Mastushita-Sakai T, 2010, P NATL ACAD SCI USA, V107, P11987, DOI 10.1073/pnas.1004433107; Mustroph A, 2009, METHODS MOL BIOL, V553, P109, DOI 10.1007/978-1-60327-563-7_6; Pavlopoulos E, 2011, CELL, V147, P1369, DOI 10.1016/j.cell.2011.09.056; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Raveendra BL, 2013, NAT STRUCT MOL BIOL, V20, P495, DOI 10.1038/nsmb.2503; Richter JD, 2007, TRENDS BIOCHEM SCI, V32, P279, DOI 10.1016/j.tibs.2007.04.004; Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Si K, 2003, CELL, V115, P893, DOI 10.1016/S0092-8674(03)01021-3; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; Smibert CA, 1996, GENE DEV, V10, P2600, DOI 10.1101/gad.10.20.2600; Smith RWP, 2014, BIOCHEM SOC T, V42, P1229, DOI 10.1042/BST20140111; Stephan JS, 2015, CELL REP, V11, P1772, DOI 10.1016/j.celrep.2015.04.060; Tompa P, 1998, NEUROSCIENCE, V86, P1037; Udagawa T, 2012, MOL CELL, V47, P253, DOI 10.1016/j.molcel.2012.05.016; White-Grindley E, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001786; Xu SW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004380; Xu SW, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003079	44	66	67	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 6	2015	163	6					1468	1483		10.1016/j.cell.2015.11.020	http://dx.doi.org/10.1016/j.cell.2015.11.020			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SE	26638074	Green Accepted, Bronze			2022-12-28	WOS:000366044800020
J	Roberts, AW; Davids, MS; Pagel, JM; Kahl, BS; Puvvada, SD; Gerecitano, JF; Kipps, TJ; Anderson, MA; Brown, JR; Gressick, L; Wong, S; Dunbar, M; Zhu, M; Desai, MB; Cerri, E; Enschede, SH; Humerickhouse, RA; Wierda, WG; Seymour, JF				Roberts, Andrew W.; Davids, Matthew S.; Pagel, John M.; Kahl, Brad S.; Puvvada, Soham D.; Gerecitano, John F.; Kipps, Thomas J.; Anderson, Mary Ann; Brown, Jennifer R.; Gressick, Lori; Wong, Shekman; Dunbar, Martin; Zhu, Ming; Desai, Monali B.; Cerri, Elisa; Enschede, Sari Heitner; Humerickhouse, Rod A.; Wierda, William G.; Seymour, John F.			Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTERNATIONAL WORKSHOP; DOSE-ESCALATION; PHASE-I; FLUDARABINE; INHIBITOR; RITUXIMAB; CYCLOPHOSPHAMIDE; APOPTOSIS; IBRUTINIB; CLL	BACKGROUND New treatments have improved outcomes for patients with relapsed chronic lymphocytic leukemia (CLL), but complete remissions remain uncommon. Venetoclax has a distinct mechanism of action; it targets BCL2, a protein central to the survival of CLL cells. METHODS We conducted a phase 1 dose-escalation study of daily oral venetoclax in patients with relapsed or refractory CLL or small lymphocytic lymphoma (SLL) to assess safety, pharmacokinetic profile, and efficacy. In the dose-escalation phase, 56 patients received active treatment in one of eight dose groups that ranged from 150 to 1200 mg per day. In an expansion cohort, 60 additional patients were treated with a weekly stepwise ramp-up in doses as high as 400 mg per day. RESULTS The majority of the study patients had received multiple previous treatments, and 89% had poor prognostic clinical or genetic features. Venetoclax was active at all dose levels. Clinical tumor lysis syndrome occurred in 3 of 56 patients in the dose-escalation cohort, with one death. After adjustments to the dose-escalation schedule, clinical tumor lysis syndrome did not occur in any of the 60 patients in the expansion cohort. Other toxic effects included mild diarrhea (in 52% of the patients), upper respiratory tract infection (in 48%), nausea (in 47%), and grade 3 or 4 neutropenia (in 41%). A maximum tolerated dose was not identified. Among the 116 patients who received venetoclax, 92 (79%) had a response. Response rates ranged from 71 to 79% among patients in subgroups with an adverse prognosis, including those with resistance to fludarabine, those with chromosome 17p deletions (deletion 17p CLL), and those with unmutated IGHV. Complete remissions occurred in 20% of the patients, including 5% who had no minimal residual disease on flow cytometry. The 15-month progression-free survival estimate for the 400-mg dose groups was 69%. CONCLUSIONS Selective targeting of BCL2 with venetoclax had a manageable safety profile and induced substantial responses in patients with relapsed CLL or SLL, including those with poor prognostic features.	[Roberts, Andrew W.; Anderson, Mary Ann] Royal Melbourne Hosp, Dept Clin Haematol, Parkville, Vic 3050, Australia; [Roberts, Andrew W.; Anderson, Mary Ann] Royal Melbourne Hosp, Bone Marrow Transplantat Unit, Parkville, Vic 3050, Australia; [Roberts, Andrew W.; Anderson, Mary Ann] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Div Canc & Haematol, Parkville, Vic 3050, Australia; [Roberts, Andrew W.; Seymour, John F.] Victorian Comprehens Canc Ctr, Parkville, Vic, Australia; [Roberts, Andrew W.; Seymour, John F.] Univ Melbourne, Melbourne, Vic, Australia; [Seymour, John F.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Davids, Matthew S.; Brown, Jennifer R.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Pagel, John M.] Swedish Med Ctr, Seattle, WA USA; [Kahl, Brad S.] Washington Univ, St Louis, MO 63130 USA; [Puvvada, Soham D.] Univ Arizona, Tucson, AZ USA; [Gerecitano, John F.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Gerecitano, John F.] Weill Cornell Med Coll, New York, NY USA; [Kipps, Thomas J.] Univ Calif San Diego, San Diego, CA 92103 USA; [Gressick, Lori; Wong, Shekman; Dunbar, Martin; Zhu, Ming; Desai, Monali B.; Cerri, Elisa; Enschede, Sari Heitner; Humerickhouse, Rod A.] AbbVie, N Chicago, IL USA; [Wierda, William G.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	Royal Melbourne Hospital; Royal Melbourne Hospital; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; Peter Maccallum Cancer Center; Harvard University; Dana-Farber Cancer Institute; Swedish Medical Center; Washington University (WUSTL); University of Arizona; Memorial Sloan Kettering Cancer Center; Cornell University; University of California System; University of California San Diego; AbbVie; University of Texas System; UTMD Anderson Cancer Center	Roberts, AW (corresponding author), Royal Melbourne Hosp, Melbourne, Vic 3050, Australia.	andrew.roberts@mh.org.au	Roberts, Andrew W./C-6736-2012; Seymour, John/K-7326-2019	Roberts, Andrew W./0000-0002-7341-5720; Seymour, John/0000-0003-2188-6835; Anderson, Mary Ann/0000-0002-3515-0215	AbbVie; Genentech; NATIONAL CANCER INSTITUTE [P01CA081534] Funding Source: NIH RePORTER	AbbVie(AbbVie); Genentech(Roche HoldingGenentech); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by AbbVie and Genentech; ClinicalTrials.gov number, NCT01328626.	Advani RH, 2013, J CLIN ONCOL, V31, P88, DOI 10.1200/JCO.2012.42.7906; Brown JR, 2014, BLOOD, V123, P3390, DOI 10.1182/blood-2013-11-535047; Byrd JC, 2014, NEW ENGL J MED, V371, P213, DOI 10.1056/NEJMoa1400376; Byrd JC, 2006, J CLIN ONCOL, V24, P437, DOI 10.1200/JCO.2005.03.1021; Byrd JC, 2015, BLOOD, V125, P2497, DOI 10.1182/blood-2014-10-606038; Byrd JC, 2013, NEW ENGL J MED, V369, P32, DOI 10.1056/NEJMoa1215637; Cheson BD, 1999, J CLIN ONCOL, V17, P1244, DOI 10.1200/JCO.1999.17.4.1244; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Fischer K, 2011, J CLIN ONCOL, V29, P3559, DOI 10.1200/JCO.2010.33.8061; Fornecker LM, 2015, AM J HEMATOL, V90, P511, DOI 10.1002/ajh.23999; Furman RR, 2014, NEW ENGL J MED, V370, P997, DOI 10.1056/NEJMoa1315226; Green DR, 2013, NAT MED, V19, P131, DOI 10.1038/nm.3076; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Howard SC, 2011, NEW ENGL J MED, V364, P1844, DOI 10.1056/NEJMra0904569; Jain P, 2015, BLOOD, V125, P2062, DOI 10.1182/blood-2014-09-603670; Keating MJ, 2002, BLOOD, V99, P3554, DOI 10.1182/blood.V99.10.3554; Le Tourneau C, 2009, JNCI-J NATL CANCER I, V101, P708, DOI 10.1093/jnci/djp079; Leverson JD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4642; Lin KI, 2009, BLOOD, V113, P3168, DOI 10.1182/blood-2008-10-184853; Maddocks KJ, 2015, JAMA ONCOL, V1, P80, DOI 10.1001/jamaoncol.2014.218; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; Moore VD, 2007, J CLIN INVEST, V117, P112, DOI 10.1172/JCI28281; National Cancer Institute, 2009, COMM TERM CRIT ADV E; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Park CM, 2008, J MED CHEM, V51, P6902, DOI 10.1021/jm800669s; Rawstron AC, 2013, LEUKEMIA, V27, P142, DOI 10.1038/leu.2012.216; Robak T, 2010, J CLIN ONCOL, V28, P1756, DOI 10.1200/JCO.2009.26.4556; Roberts AW, 2012, J CLIN ONCOL, V30, P488, DOI 10.1200/JCO.2011.34.7898; Robertson LE, 1996, LEUKEMIA, V10, P456; Seymour F, 2011, HAEMATOLOGICA, V96, P227; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Tam CS, 2014, BLOOD, V124, P3059, DOI 10.1182/blood-2014-06-583765; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Wierda W, 2005, J CLIN ONCOL, V23, P4070, DOI 10.1200/JCO.2005.12.516; Wilson WH, 2010, LANCET ONCOL, V11, P1149, DOI 10.1016/S1470-2045(10)70261-8; Woyach JA, 2014, NEW ENGL J MED, V370, P2286, DOI 10.1056/NEJMoa1400029; Zenz T, 2012, BLOOD, V119, P4101, DOI 10.1182/blood-2011-11-312421	37	1202	1242	8	184	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 28	2016	374	4					311	322		10.1056/NEJMoa1513257	http://dx.doi.org/10.1056/NEJMoa1513257			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB8IJ	26639348	Green Accepted, Bronze			2022-12-28	WOS:000368760100005
J	Acharya, L; Aghajan, ZM; Vuong, C; Moore, JJ; Mehta, MR				Acharya, Lavanya; Aghajan, Zahra M.; Vuong, Cliff; Moore, Jason J.; Mehta, Mayank R.			Causal Influence of Visual Cues on Hippocampal Directional Selectivity	CELL			English	Article							FREELY-MOVING RATS; UP-DOWN STATES; HEAD-DIRECTION; PLACE CELLS; ENTORHINAL CORTEX; NEURAL SPIKING; UNIT-ACTIVITY; NEURONS; REPRESENTATION; INTEGRATION	Hippocampal neurons show selectivity with respect to visual cues in primates, including humans, but this has never been found in rodents. To address this long-standing discrepancy, we measured hippocampal activity from rodents during real-world random foraging. Surprisingly, similar to 25% of neurons exhibited significant directional modulation with respect to visual cues. To dissociate the contributions of visual and vestibular cues, we made similar measurements in virtual reality, in which only visual cues were informative. Here, we found significant directional modulation despite the severe loss of vestibular information, challenging prevailing theories of directionality. Changes in the amount of angular information in visual cues induced corresponding changes in head-directional modulation at the neuronal and population levels. Thus, visual cues are sufficient for-and play a predictable, causal role in-generating directionally selective hippocampal responses. These results dissociate hippocampal directional and spatial selectivity and bridge the gap between primate and rodent studies.	[Acharya, Lavanya; Aghajan, Zahra M.; Vuong, Cliff; Moore, Jason J.; Mehta, Mayank R.] Univ Calif Los Angeles, Integrat Ctr Learning & Memory, WM Keck Ctr Neurophys, Los Angeles, CA 90095 USA; [Acharya, Lavanya; Aghajan, Zahra M.; Vuong, Cliff; Moore, Jason J.; Mehta, Mayank R.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; [Acharya, Lavanya] Univ Calif Los Angeles, Biomed Engn Interdept Program, Los Angeles, CA 90095 USA; [Aghajan, Zahra M.; Vuong, Cliff; Mehta, Mayank R.] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Moore, Jason J.; Mehta, Mayank R.] Univ Calif Los Angeles, Neurosci Interdept Program, Los Angeles, CA 90095 USA; [Mehta, Mayank R.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA; [Mehta, Mayank R.] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Mehta, MR (corresponding author), Univ Calif Los Angeles, Integrat Ctr Learning & Memory, WM Keck Ctr Neurophys, Los Angeles, CA 90095 USA.	mayankmehta@ucla.edu	Acharya, Lavanya/S-8153-2019	M. Aghajan, Zahra/0000-0003-4245-3975; Acharya, Lavanya/0000-0003-2419-5650; Mehta, Mayank/0000-0003-2005-2468	NIH [5R01MH092925-02]; W.M. Keck Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092925] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W.M. Keck Foundation(W.M. Keck Foundation); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank B. Popeney for help with behavioral training, J. Cushman and N. Agarwal for help with electrophysiology, P. Ravassard and A. Kees for technical support and help with surgeries, and B. Willers and V. Sagar for discussions on analysis methods. This work was supported by grants to M.R.M. from NIH 5R01MH092925-02 and from the W.M. Keck Foundation. Results presented in this manuscript were uploaded to the preprint server BioRxiv (http://biorxiv.org/lookup/doi/10.1101/017210).	Aghajan ZM, 2015, NAT NEUROSCI, V18, P121, DOI 10.1038/nn.3884; Alexander AS, 2015, NAT NEUROSCI, V18, P1143, DOI 10.1038/nn.4058; Andersen P., 2006, HIPPOCAMPUS BOOK; Battaglia FP, 2004, J NEUROSCI, V24, P4541, DOI 10.1523/JNEUROSCI.4896-03.2004; Blair HT, 1996, BEHAV NEUROSCI, V110, P643, DOI 10.1037/0735-7044.110.4.643; Boccara CN, 2010, NAT NEUROSCI, V13, P987, DOI 10.1038/nn.2602; Burgess N, 2005, HIPPOCAMPUS, V15, P149, DOI 10.1002/hipo.20058; Calton JL, 2003, J NEUROSCI, V23, P9719; Cushman JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080465; Deshmukh SS, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00069; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Hahn TTG, 2007, P NATL ACAD SCI USA, V104, P5169, DOI 10.1073/pnas.0700222104; Hahn TTG, 2006, NAT NEUROSCI, V9, P1359, DOI 10.1038/nn1788; Hahn TTG, 2012, NAT NEUROSCI, V15, P1531, DOI 10.1038/nn.3236; Jacobs J, 2010, P NATL ACAD SCI USA, V107, P6487, DOI 10.1073/pnas.0911213107; Killian NJ, 2012, NATURE, V491, P761, DOI 10.1038/nature11587; KNIERIM JJ, 1995, J NEUROSCI, V15, P1648, DOI 10.1523/JNEUROSCI.15-03-01648.1995; Knierim JJ, 2002, J NEUROSCI, V22, P6254; Kraus BJ, 2013, NEURON, V78, P1090, DOI 10.1016/j.neuron.2013.04.015; Lepage KQ, 2012, J NEUROSCI METH, V205, P295, DOI 10.1016/j.jneumeth.2011.12.021; MacDonald CJ, 2011, NEURON, V71, P737, DOI 10.1016/j.neuron.2011.07.012; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; Mehta MR, 2015, HIPPOCAMPUS, V25, P756, DOI 10.1002/hipo.22472; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MULLER RU, 1987, J NEUROSCI, V7, P1951; MULLER RU, 1994, J NEUROSCI, V14, P7235; Nitz DA, 2012, NAT NEUROSCI, V15, P1365, DOI 10.1038/nn.3213; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; ONO T, 1993, J NEUROPHYSIOL, V70, P1516, DOI 10.1152/jn.1993.70.4.1516; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Peyrache A, 2015, NAT NEUROSCI, V18, P569, DOI 10.1038/nn.3968; Ravassard P, 2013, SCIENCE, V340, P1342, DOI 10.1126/science.1232655; Rolls ET, 1995, HIPPOCAMPUS, V5, P409, DOI 10.1002/hipo.450050504; Rolls ET, 1999, HIPPOCAMPUS, V9, P467; Rubin A, 2014, J NEUROSCI, V34, P1067, DOI 10.1523/JNEUROSCI.5393-12.2014; Shapiro ML, 1997, HIPPOCAMPUS, V7, P624, DOI 10.1002/(SICI)1098-1063(1997)7:6<624::AID-HIPO5>3.0.CO;2-E; Stackman RW, 2002, HIPPOCAMPUS, V12, P291, DOI 10.1002/hipo.1112; Suzuki WA, 1997, J NEUROPHYSIOL, V78, P1062, DOI 10.1152/jn.1997.78.2.1062; Taube JS, 2007, ANNU REV NEUROSCI, V30, P181, DOI 10.1146/annurev.neuro.29.051605.112854; TAUBE JS, 1990, J NEUROSCI, V10, P420; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; Ulanoysky N, 2011, HIPPOCAMPUS, V21, P150, DOI 10.1002/hipo.20731; Whitlock JR, 2012, NEURON, V73, P789, DOI 10.1016/j.neuron.2011.12.028; WIENER SI, 1989, J NEUROSCI, V9, P2737; Winter SS, 2015, SCIENCE, V347, P870, DOI 10.1126/science.1259591; Yoshida M, 2009, J NEUROSCI, V29, P4945, DOI 10.1523/JNEUROSCI.5154-08.2009; Zhang KC, 1999, NEURAL COMPUT, V11, P75, DOI 10.1162/089976699300016809	51	74	74	1	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2016	164	1-2					197	207		10.1016/j.cell.2015.12.015	http://dx.doi.org/10.1016/j.cell.2015.12.015			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DB2LE	26709045	Bronze, Green Submitted			2022-12-28	WOS:000368339300020
J	Khan, JA; Mendelson, A; Kunisaki, Y; Birbrair, A; Kou, Y; Arnal-Estape, A; Pinho, S; Ciero, P; Nakahara, F; Ma'ayan, A; Bergman, A; Merad, M; Frenette, PS				Khan, Jalal A.; Mendelson, Avital; Kunisaki, Yuya; Birbrair, Alexander; Kou, Yan; Arnal-Estape, Anna; Pinho, Sandra; Ciero, Paul; Nakahara, Fumio; Ma'ayan, Avi; Bergman, Aviv; Merad, Miriam; Frenette, Paul S.			Fetal liver hematopoietic stem cell niches associate with portal vessels	SCIENCE			English	Article							SELF-RENEWAL; PROGENITORS; HOMEOSTASIS; QUIESCENCE	Whereas the cellular basis of the hematopoietic stem cell (HSC) niche in the bone marrow has been characterized, the nature of the fetal liver niche is not yet elucidated. We show that Nestin(+)NG2(+) pericytes associate with portal vessels, forming a niche promoting HSC expansion. Nestin(+)NG2(+) cells and HSCs scale during development with the fractal branching patterns of portal vessels, tributaries of the umbilical vein. After closure of the umbilical inlet at birth, portal vessels undergo a transition from Neuropilin-1(+)Ephrin-B2(+) artery to EphB4(+) vein phenotype, associated with a loss of periportal Nestin(+)NG2(+) cells and emigration of HSCs away from portal vessels. These data support a model in which HSCs are titrated against a periportal vascular niche with a fractal-like organization enabled by placental circulation.	[Khan, Jalal A.; Mendelson, Avital; Kunisaki, Yuya; Birbrair, Alexander; Arnal-Estape, Anna; Pinho, Sandra; Ciero, Paul; Nakahara, Fumio; Frenette, Paul S.] Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10467 USA; [Khan, Jalal A.; Mendelson, Avital; Kunisaki, Yuya; Birbrair, Alexander; Arnal-Estape, Anna; Pinho, Sandra; Nakahara, Fumio; Frenette, Paul S.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10467 USA; [Frenette, Paul S.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Bergman, Aviv] Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10467 USA; [Khan, Jalal A.; Merad, Miriam] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Kou, Yan; Ma'ayan, Avi] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Frenette, PS (corresponding author), Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10467 USA.	paul.frenette@einstein.yu.edu	Pinho, Sandra/GWC-8029-2022; Ma'ayan, Avi/AAG-3131-2019; Frenette, Paul S/J-8272-2012; Birbrair, Alexander/H-2497-2012; Arnal-Estapé, Anna/A-4091-2011	Ma'ayan, Avi/0000-0002-6904-1017; Frenette, Paul S/0000-0003-0862-9922; Birbrair, Alexander/0000-0003-1015-2561; Arnal-Estapé, Anna/0000-0003-0490-7040; Mendelson, Avital/0000-0002-1120-9593; Pinho, Sandra/0000-0002-5241-7364; Nakahara, Fumio/0000-0003-1515-8284	National Institutes of Health (NIH); Integrated Training in Pharmacological Science program [NIGMS T32 063754]; National Heart, Lung, and Blood Institute (NHLBI) Ruth L. Kirschstein National Research Service Award (NRSA) [F30 943257]; NHLBI Ruth L. Kirschstein NRSA [F32 HL123224]; NIH [R01 DK056638, R01 HL116340, R01 HL069438]; NYSTEM grants [C029154, C029570];  [R01 grants HL097700];  [DK056638];  [HL069438];  [R01 grants CA164468];  [DA033788];  [U54HL127624];  [U54CA189201];  [R01GM098316]; NATIONAL CANCER INSTITUTE [R01CA173861, R01CA190400, R01CA164468, U54CA189201] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097700, F32HL123224, R01HL069438, U54HL127624, R01HL116340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098316] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033788] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [15K15364] Funding Source: KAKEN	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Integrated Training in Pharmacological Science program; National Heart, Lung, and Blood Institute (NHLBI) Ruth L. Kirschstein National Research Service Award (NRSA); NHLBI Ruth L. Kirschstein NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYSTEM grants; ; ; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to the National Institutes of Health (NIH) for support: Integrated Training in Pharmacological Science program (NIGMS T32 063754) and National Heart, Lung, and Blood Institute (NHLBI) Ruth L. Kirschstein National Research Service Award (NRSA) predoctoral M.D./Ph.D. fellowship (F30 943257) to J.A.K.; NHLBI Ruth L. Kirschstein NRSA postdoctoral fellowship F32 HL123224 to A.Me.; R01 grants HL097700, DK056638, and HL069438 to P.S.F.; and R01 grants CA164468 and DA033788 to A.Be. S.P. is a New York Stem Cell Foundation-Druckenmiller Fellow. A.Ma. is supported by U54HL127624, U54CA189201, and R01GM098316. We thank A. L. Kolodkin for providing antibody to Nrp1 and L. Silberstein for RNA-sequencing recommendations. We thank O. Uche and L. Tesfa for technical assistance with sorting and K. O'Connell for technical assistance with Vevo Ultrasound imaging technology. We are also grateful to the New York State Department of Health (NYSTEM Program) for shared facility (C029154) and research support (N13G-262). This work was funded by NIH grants R01 DK056638, R01 HL116340, R01 HL069438, and NYSTEM grants (C029154 and C029570). J.A.K. designed and analyzed experiments in this study. Y.Ku. performed transplantations. J.A.K. and Y.Ku. performed the in vivo experiments. J.A.K., Y.Ku., and A. Me. performed whole-mount experiments; J.A.K., A.A.-E., P.C., A.Me, and A.Bi. performed immunostaining. J.A.K. and S.P. performed the LTC-IC experiments; A.Me. and S.P. performed differentiation assays; J.A.K., F.N., and A.Me. performed expression analyses; J.A.K. performed the RNA-sequencing experiments; Y.Ko., A.Ma., and J.A.K. analyzed the RNA-sequencing data; J.A.K. and A. Be. performed computational modeling and statistical analysis of the data; and J.A.K. and P.S.F. wrote the manuscript. The authors declare no competing financial interests.	Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Bowie MB, 2007, BLOOD, V109, P5043, DOI 10.1182/blood-2006-08-037770; Bruns I, 2014, NAT MED, V20, P1315, DOI 10.1038/nm.3707; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chou S, 2010, P NATL ACAD SCI USA, V107, P7799, DOI 10.1073/pnas.1003586107; Christensen JL, 2004, PLOS BIOL, V2, P368, DOI 10.1371/journal.pbio.0020075; de Bruijn MFTR, 2000, EMBO J, V19, P2465, DOI 10.1093/emboj/19.11.2465; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Ema H, 2000, BLOOD, V95, P2284, DOI 10.1182/blood.V95.7.2284.007k14_2284_2288; Gekas C, 2005, DEV CELL, V8, P365, DOI 10.1016/j.devcel.2004.12.016; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Hahn HK, 2005, MATH BIOSCI INTERAC, P55, DOI 10.1007/3-7643-7412-8_5; Kim I, 2006, BLOOD, V108, P737, DOI 10.1182/blood-2005-10-4135; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Lachmann A, 2010, BIOINFORMATICS, V26, P2438, DOI 10.1093/bioinformatics/btq466; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Moore KA, 1997, P NATL ACAD SCI USA, V94, P4011, DOI 10.1073/pnas.94.8.4011; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Sheridan JM, 2009, GENESIS, V47, P346, DOI 10.1002/dvg.20505; Tanaka M, 2009, MECH DEVELOP, V126, P665, DOI 10.1016/j.mod.2009.06.939; Voehringer D, 2008, J IMMUNOL, V180, P4742, DOI 10.4049/jimmunol.180.7.4742; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Wolber FM, 2002, EXP HEMATOL, V30, P1010, DOI 10.1016/S0301-472X(02)00881-0; Zhao M, 2014, NAT MED, V20, P1321, DOI 10.1038/nm.3706; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895	27	147	152	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 8	2016	351	6269					176	180		10.1126/science.aad0084	http://dx.doi.org/10.1126/science.aad0084			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XQ	26634440	Green Accepted			2022-12-28	WOS:000367806500043
J	Cuevas, S; Haines, A				Cuevas, Soledad; Haines, Andy			Health benefits of a carbon tax	LANCET			English	Editorial Material							AIR-QUALITY; CO-BENEFITS		[Cuevas, Soledad] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1H 9SH, England; [Haines, Andy] London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1H 9SH, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Cuevas, S (corresponding author), London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1H 9SH, England.	soledad.cuevas@lshtm.ac.uk		Cuevas Garcia-Dorado, Soledad/0000-0002-4897-5240; Haines, Andy/0000-0002-8053-4605				Alexandre K, 2015, STATE TRENDS CARBON; Avi-Yonah R.S., 2011, STANFORD ENV LAW J, DOI 10.2139/ssrn.1109167; Beck M, 2015, RESOUR ENERGY ECON, V41, P40, DOI 10.1016/j.reseneeco.2015.04.005; Cao J, 2008, COBENEFITS MITIGATIN; Coady D, 2015, LARGE GLOBAL ENERGY; Dessus S, 2003, ENVIRON RESOUR ECON, V25, P287, DOI 10.1023/A:1024469430532; DOWER RC, 1992, RIGHT CLIMATE CARBON; Kennedy K, 2015, PUTTING PRICE CARBON; Markandya A, 2009, INT J ENV RES PUB HE, V6, P759, DOI 10.3390/ijerph6020759; Parry I.W., 2014, GETTING ENERGY PRICE; Scovronick N, 2015, LANCET, V386, pE28, DOI 10.1016/S0140-6736(15)61043-1; Thompson TM, 2014, NAT CLIM CHANGE, V4, P917, DOI [10.1038/nclimate2342, 10.1038/NCLIMATE2342]; Watts N, 2015, LANCET, V386, P1861, DOI 10.1016/S0140-6736(15)60854-6; West JJ, 2013, NAT CLIM CHANGE, V3, P885, DOI [10.1038/NCLIMATE2009, 10.1038/nclimate2009]; Wilkinson P, 2010, LANCET, V375, P804, DOI 10.1016/S0140-6736(10)60343-1; Williams RC, 2014, RESOUR FUTURE DISCUS, V68, P195	16	8	8	0	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 2	2016	387	10013					7	9		10.1016/S0140-6736(15)00994-0	http://dx.doi.org/10.1016/S0140-6736(15)00994-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CZ9ZU	26686959				2022-12-28	WOS:000367457300007
J	Berra, K; Rippe, J; Manson, JE				Berra, Kathy; Rippe, James; Manson, JoAnn E.			Making Physical Activity Counseling a Priority in Clinical Practice The Time for Action Is Now	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CORONARY-HEART-DISEASE; PRIMARY-CARE; TRIAL; INTERVENTIONS		[Berra, Kathy] Stanford Univ, Stanford Prevent Res Ctr, Sch Med, Stanford, CA 94305 USA; [Rippe, James] Univ Cent Florida, Orlando, FL 32816 USA; [Rippe, James] Rippe Lifestyle Inst, Shrewsbury, MA USA; [Manson, JoAnn E.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA	Stanford University; State University System of Florida; University of Central Florida; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Manson, JE (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, 900 Commonwealth Ave, Boston, MA 02215 USA.	jmanson@rics.bwh.harvard.edu						Albright CL, 2000, AM J PREV MED, V18, P225, DOI 10.1016/S0749-3797(99)00155-5; Centers for Disease Control and Prevention, 2012, 2012 NAMCS MICR FIL; Chow CK, 2015, JAMA-J AM MED ASSOC, V314, P1255, DOI 10.1001/jama.2015.10945; Kraus WE, 2015, CIRCULATION, V131, P1932, DOI 10.1161/CIR.0000000000000203; Lin JS, 2014, ANN INTERN MED, V161, P568, DOI 10.7326/M14-0130; Maruthur NM, 2009, CIRCULATION, V119, P2026, DOI 10.1161/CIRCULATIONAHA.108.809491; Simons-Morton DG, 2001, JAMA-J AM MED ASSOC, V286, P677; Whitlock EP, 2002, AM J PREV MED, V22, P267, DOI 10.1016/S0749-3797(02)00415-4; Yang K, 2011, METAB SYNDR RELAT D, V9, P231, DOI 10.1089/met.2010.0112	9	86	87	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 29	2015	314	24					2617	2618		10.1001/jama.2015.16244	http://dx.doi.org/10.1001/jama.2015.16244			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ2MR	26662069				2022-12-28	WOS:000366939800011
J	Sonnenburg, ED; Sonnenburg, JL				Sonnenburg, Erica D.; Sonnenburg, Justin L.			A personal forecast	NATURE			English	Editorial Material							PREDICTION		[Sonnenburg, Erica D.; Sonnenburg, Justin L.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA	Stanford University	Sonnenburg, ED (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.	jsonnenburg@stanford.edu						Bauer P, 2015, NATURE, V525, P47, DOI 10.1038/nature14956; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414; Willett W, 2002, AM J CLIN NUTR, V76, p274S, DOI 10.1093/ajcn/76.1.274S; Wu H, 2015, TRENDS ENDOCRIN MET, V26, P758, DOI 10.1016/j.tem.2015.09.011; Zeevi D, 2015, CELL, V163, P1079, DOI 10.1016/j.cell.2015.11.001	7	6	6	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2015	528	7583					484	486		10.1038/528484a	http://dx.doi.org/10.1038/528484a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ3GH	26701049				2022-12-28	WOS:000366991900036
J	Arie, S				Arie, Sophie			2015: a year in review	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CONFLICTS-OF-INTEREST; ASSISTED DYING BILL; PAROXETINE; MEDICINE; ENGLAND; DOCTORS					sarie@bmj.com						Brendel K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h393; Cohen D, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1654; Davis J, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4437; Delamothe T, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4349; Doshi P, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4629; Dyer C, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4917; Freemantle N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4596; Goldacre B, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h3397; Gornall J, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5826; Gornall J, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h231; Hurley R, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4385; Kales HC, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h369; Le Noury J, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4320; Limb M, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6859; Loder E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2957; Oxtoby K, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6719; Price A, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4461; Reefhuis J, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3190; Rimmer A, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5624; Steinbrook R, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2942	20	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 23	2015	351								h6921	10.1136/bmj.h6921	http://dx.doi.org/10.1136/bmj.h6921			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ7QI	26696537				2022-12-28	WOS:000367294200003
J	Belzig, W				Belzig, Wolfgang			Josephson contacts of neutral strongly interacting fermions	SCIENCE			English	Editorial Material									[Belzig, Wolfgang] Univ Konstanz, Dept Phys, Constance, Germany	University of Konstanz	Belzig, W (corresponding author), Univ Konstanz, Dept Phys, Constance, Germany.	wolfgang.belzig@uni-konstanz.de	Belzig, Wolfgang/A-4267-2009; Belzig, Wolfgang/X-8197-2019	Belzig, Wolfgang/0000-0002-5109-2203				AVERIN D, 1995, PHYS REV LETT, V75, P1831, DOI 10.1103/PhysRevLett.75.1831; Bretheau L, 2013, NATURE, V499, P312, DOI 10.1038/nature12315; Cuevas JC, 1996, PHYS REV B, V54, P7366, DOI 10.1103/PhysRevB.54.7366; Husmann D, 2015, SCIENCE, V350, P1498, DOI 10.1126/science.aac9584; JOSEPHSON BD, 1962, PHYS LETT, V1, P251, DOI 10.1016/0031-9163(62)91369-0; Klapwijk TM, 2014, J EXP THEOR PHYS+, V119, P997, DOI 10.1134/S106377611412005X; Lloyd S., 1996, SCIENCE, V273, P5278; Pillet JD, 2010, NAT PHYS, V6, P965, DOI 10.1038/NPHYS1811; Valtolina G, 2015, SCIENCE, V350, P1505, DOI 10.1126/science.aac9725	9	0	0	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2015	350	6267					1470	1470		10.1126/science.aad6876	http://dx.doi.org/10.1126/science.aad6876			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY7LY	26680179				2022-12-28	WOS:000366591100031
J	Cook, PF; Reichmuth, C; Rouse, AA; Libby, LA; Dennison, SE; Carmichael, OT; Kruse-Elliott, KT; Bloom, J; Singh, B; Fravel, VA; Barbosa, L; Stuppino, JJ; Van Bonn, WG; Gulland, FMD; Ranganath, C				Cook, Peter F.; Reichmuth, Colleen; Rouse, Andrew A.; Libby, Laura A.; Dennison, Sophie E.; Carmichael, Owen T.; Kruse-Elliott, Kris T.; Bloom, Josh; Singh, Baljeet; Fravel, Vanessa A.; Barbosa, Lorraine; Stuppino, Jim J.; Van Bonn, William G.; Gulland, Frances M. D.; Ranganath, Charan			Algal toxin impairs sea lion memory and hippocampal connectivity, with implications for strandings	SCIENCE			English	Article							DOMOIC ACID TOXICOSIS; ZALOPHUS-CALIFORNIANUS; LESIONS; CORTEX	Domoic acid (DA) is a naturally occurring neurotoxin known to harm marine animals. DA-producing algal blooms are increasing in size and frequency. Although chronic exposure is known to produce brain lesions, the influence of DA toxicosis on behavior in wild animals is unknown. We showed, in a large sample of wild sea lions, that spatial memory deficits are predicted by the extent of right dorsal hippocampal lesions related to natural exposure to DA and that exposure also disrupts hippocampal-thalamic brain networks. Because sea lions are dynamic foragers that rely on flexible navigation, impaired spatial memory may affect survival in the wild.	[Cook, Peter F.] Emory Univ, Ctr Neuropolicy, Atlanta, GA 30322 USA; [Cook, Peter F.; Reichmuth, Colleen; Rouse, Andrew A.] Univ Calif Santa Cruz, Inst Marine Sci, Pinniped Cognit & Sensory Syst Lab, Santa Cruz, CA 95060 USA; [Libby, Laura A.; Singh, Baljeet; Ranganath, Charan] Univ Calif Davis, Dynam Memory Lab, Ctr Neurosci, Davis, CA 95618 USA; [Dennison, Sophie E.; Kruse-Elliott, Kris T.; Bloom, Josh; Stuppino, Jim J.] AnimalScan Adv Vet Imaging, Redwood City, CA 94063 USA; [Carmichael, Owen T.] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [Fravel, Vanessa A.; Barbosa, Lorraine; Gulland, Frances M. D.] Marine Mammal Ctr, Sausalito, CA 94965 USA; [Van Bonn, William G.] Shedd Aquarium, Chicago, IL 60605 USA	Emory University; University of California System; University of California Santa Cruz; University of California System; University of California Davis; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Cook, PF (corresponding author), Emory Univ, Ctr Neuropolicy, Atlanta, GA 30322 USA.	pfcook@emory.edu	Rouse, Andrew/GRR-3609-2022; Carmichael, Owen/N-1955-2017	Rouse, Andrew/0000-0003-3504-5906; Dennison, Sophie/0000-0001-9962-6852; Carmichael, Owen/0000-0002-0576-0047; Cook, Peter/0000-0002-8064-5217				BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bohbot VD, 1998, NEUROPSYCHOLOGIA, V36, P1217, DOI 10.1016/S0028-3932(97)00161-9; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Floresco SB, 1997, J NEUROSCI, V17, P1880; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; Goldstein T, 2008, P ROY SOC B-BIOL SCI, V275, P267, DOI 10.1098/rspb.2007.1221; LYAMIN OI, 1992, NEUROSCI LETT, V143, P263, DOI 10.1016/0304-3940(92)90279-G; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; O'Keefe J., 2014, NOB LECT SPAT CELLS; OLTON DS, 1978, BRAIN RES, V139, P295, DOI 10.1016/0006-8993(78)90930-7; Parent JM, 1997, J NEUROSCI, V17, P3727; ROBERTS WW, 1962, J COMP PHYSIOL PSYCH, V55, P695, DOI 10.1037/h0045168; Scholin CA, 2000, NATURE, V403, P80, DOI 10.1038/47481; Silvagni PA, 2005, VET PATHOL, V42, P184, DOI 10.1354/vp.42-2-184; Silver MW, 2010, P NATL ACAD SCI USA, V107, P20762, DOI 10.1073/pnas.1006968107; Thomas K, 2010, MAR MAMMAL SCI, V26, P36, DOI 10.1111/j.1748-7692.2009.00314.x; Weise MJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027113	18	57	58	0	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2015	350	6267					1545	1547		10.1126/science.aac5675	http://dx.doi.org/10.1126/science.aac5675			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY7LY	26668068				2022-12-28	WOS:000366591100063
J	Palmer, MJ; Fukuyama, F; Relman, DA				Palmer, Megan J.; Fukuyama, Francis; Relman, David A.			A more systematic approach to biological risk	SCIENCE			English	Editorial Material							HEALTH		[Palmer, Megan J.; Relman, David A.] Stanford Univ, Ctr Int Secur & Cooperat, Stanford, CA 94305 USA; [Fukuyama, Francis] Stanford Univ, Ctr Democracy Dev & Rule Law, Stanford, CA 94305 USA; [Fukuyama, Francis] Stanford Univ, Freeman Spogli Inst Int Studies, Stanford, CA 94305 USA; [Fukuyama, Francis; Relman, David A.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Relman, David A.] Stanford Univ, Dept Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Relman, DA (corresponding author), Stanford Univ, Ctr Int Secur & Cooperat, Stanford, CA 94305 USA.	relman@stanford.edu		Palmer, Megan/0000-0001-8310-2325; Relman, David A./0000-0001-8331-1354				Akbari OS, 2015, SCIENCE, V349, P927, DOI 10.1126/science.aac7932; Bernard KW, 2013, BIOSECUR BIOTERROR, V11, P157, DOI 10.1089/bsp.2013.8522; Committee for Comprehensive Review of DoD Laboratory Procedures Processes and Protocols Associated with Inactivating Bacillus anthracis Spores, 2015, REV COMM REP IN LIV; Fineberg HV, 2015, SCIENCE, V347, P929, DOI 10.1126/science.aaa7711; GAO, 2015, PREL OBS FED EFF ADD; Lipsitch M., 2015, FOREIGN AFF; OSTP DHHS, 2014, US GOV GAIN OF FUNCT; Oye KA, 2014, SCIENCE, V345, P626, DOI 10.1126/science.1254287; Relman DA, 2014, J INFECT DIS, V209, P170, DOI 10.1093/infdis/jit529; Rogers M., 1975, ROLL STONE, V187, P37; Sharples F, 2015, POTENTIAL RISKS BENE; United States Government, 2014, US GOV POL I OV LIF; White House, 2015, NEXT STEPS ENH BIOS; White House, 2015, ENH BIOS BIOS US; Wright S, 2001, PERSPECT BIOL MED, V44, P235, DOI 10.1353/pbm.2001.0040; Young A, 2015, US TODAY	16	16	16	2	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2015	350	6267					1471	1473		10.1126/science.aad8849	http://dx.doi.org/10.1126/science.aad8849			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY7LY	26680180				2022-12-28	WOS:000366591100032
J	Santos, AA; Venceslau, SS; Grein, F; Leavitt, WD; Dahl, C; Johnston, DT; Pereira, IAC				Santos, Andre A.; Venceslau, Sofia S.; Grein, Fabian; Leavitt, William D.; Dahl, Christiane; Johnston, David T.; Pereira, Ines A. C.			A protein trisulfide couples dissimilatory sulfate reduction to energy conservation	SCIENCE			English	Article							SULFITE REDUCTASES; ARCHAEOGLOBUS-FULGIDUS; TRANSFER-RNA; NEW-MODEL; RESPIRATION; INSIGHTS; BIOSYNTHESIS; MECHANISM; PATHWAY; COMPLEX	Microbial sulfate reduction has governed Earth's biogeochemical sulfur cycle for at least 2.5 billion years. However, the enzymatic mechanisms behind this pathway are incompletely understood, particularly for the reduction of sulfite-a key intermediate in the pathway. This critical reaction is performed by DsrAB, a widespread enzyme also involved in other dissimilatory sulfur metabolisms. Using in vitro assays with an archaeal DsrAB, supported with genetic experiments in a bacterial system, we show that the product of sulfite reduction by DsrAB is a protein-based trisulfide, in which a sulfite-derived sulfur is bridging two conserved cysteines of DsrC. Physiological studies also reveal that sulfate reduction rates are determined by cellular levels of DsrC. Dissimilatory sulfate reduction couples the four-electron reduction of the DsrC trisulfide to energy conservation.	[Santos, Andre A.; Venceslau, Sofia S.; Grein, Fabian; Pereira, Ines A. C.] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, P-2780156 Oeiras, Portugal; [Leavitt, William D.; Johnston, David T.] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; [Dahl, Christiane] Univ Bonn, Inst Mikrobiol & Biotechnol, Bonn, Germany	Universidade Nova de Lisboa; Harvard University; University of Bonn	Pereira, IAC (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, P-2780156 Oeiras, Portugal.	ipereira@itqb.unl.pt	iMed.ULisboa, CellFun/A-4244-2014; Venceslau, Sofia/M-2882-2016; Grein, Fabian/HGC-3042-2022; Santos, André A/A-3313-2017; Pereira, Inês/C-2748-2009; Dahl, Christiane/H-4786-2019	Venceslau, Sofia/0000-0001-8774-1351; Santos, André A/0000-0002-3248-1051; Pereira, Inês/0000-0003-3283-4520; Dahl, Christiane/0000-0001-8288-7546	NSF-EAR [1225980]; Fundacao para a Ciencia e a Tecnologia (FCT), Portugal [UID/Multi/04551/2013, PTDC/QUI-BIQ/100591/2008, PTDC/BBB-BQB/0684/2012]; Deutsche Forschungsgemeinschaft, Germany [Da 351/6-2]; FCT [SFRH/BD/77940/2011, SFRH/BPD/79823/2011]; NSF-Graduate Research Fellowship Program; Fossett Fellowship from Washington University in St. Louis	NSF-EAR(National Science Foundation (NSF)); Fundacao para a Ciencia e a Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); Deutsche Forschungsgemeinschaft, Germany(German Research Foundation (DFG)); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); NSF-Graduate Research Fellowship Program(National Science Foundation (NSF)); Fossett Fellowship from Washington University in St. Louis	We thank R. Soares for the mass spectrometry measurements, C. Leitao for HPLC technical support, and H. Santos and L. Gafeira for providing A. fulgidus. We also thank J. Wall for plasmids for genetic manipulation of D. vulgaris, A. Ramos for technical assistance, A. Masterson for synthesis of the trithionate standard, A. Bradley for detailed discussions, and W. Martin for critical reading of the manuscript. This work was funded by grants from NSF-EAR (1225980 to D.T.J. and I.A.C.P.), from Fundacao para a Ciencia e a Tecnologia (FCT), Portugal (UID/Multi/04551/2013, PTDC/QUI-BIQ/100591/2008, and PTDC/BBB-BQB/0684/2012) and Deutsche Forschungsgemeinschaft, Germany (Da 351/6-2). A.S. and S.S.V. are recipients of FCT fellowships (SFRH/BD/77940/2011 and SFRH/BPD/79823/2011). W.D.L. acknowledges support by an NSF-Graduate Research Fellowship Program and the Fossett Fellowship from Washington University in St. Louis. The data reported in this paper are provided in the supplementary materials.	Bradley AS, 2011, GEOBIOLOGY, V9, P446, DOI 10.1111/j.1472-4669.2011.00292.x; Brunner B, 2005, GEOCHIM COSMOCHIM AC, V69, P4759, DOI 10.1016/j.gca.2005.04.015; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; Canfield DE, 2010, SCIENCE, V330, P1375, DOI 10.1126/science.1196889; Crane BR, 1996, CURR OPIN STRUC BIOL, V6, P744, DOI 10.1016/S0959-440X(96)80003-0; Grein F, 2013, BBA-BIOENERGETICS, V1827, P145, DOI 10.1016/j.bbabio.2012.09.001; Grein F, 2010, J BACTERIOL, V192, P6369, DOI 10.1128/JB.00849-10; Hedderich R, 2005, BIOL CHEM, V386, P961, DOI 10.1515/BC.2005.112; Hsieh YC, 2010, MOL MICROBIOL, V78, P1101, DOI 10.1111/j.1365-2958.2010.07390.x; Ida T, 2014, P NATL ACAD SCI USA, V111, P7606, DOI 10.1073/pnas.1321232111; Ikeuchi Y, 2006, MOL CELL, V21, P97, DOI 10.1016/j.molcel.2005.11.001; Keller KL, 2014, APPL ENVIRON MICROB, V80, P855, DOI 10.1128/AEM.02963-13; Leavitt WD, 2015, FRONT MICROBIOL, V6, DOI [10.3389/fmicb.2075.01392, 10.3389/fmicb.2015.01392]; Liu YC, 2012, J BIOL CHEM, V287, P36683, DOI 10.1074/jbc.M112.405688; Muller AL, 2015, ISME J, V9, P1152, DOI 10.1038/ismej.2014.208; Nielsen RW, 2011, ANTIOXID REDOX SIGN, V15, P67, DOI 10.1089/ars.2010.3677; Oliveira TF, 2008, J BIOL CHEM, V283, P34141, DOI 10.1074/jbc.M805643200; Parey K, 2013, METALLOMICS, V5, P302, DOI 10.1039/c2mt20225e; Parey K, 2010, BIOCHEMISTRY-US, V49, P8912, DOI 10.1021/bi100781f; Paul BD, 2012, NAT REV MOL CELL BIO, V13, P499, DOI 10.1038/nrm3391; PECK HD, 1982, PHILOS T R SOC B, V298, P443, DOI 10.1098/rstb.1982.0091; Pires RH, 2006, BIOCHEMISTRY-US, V45, P249, DOI 10.1021/bi0515265; Simon J, 2013, ADV MICROB PHYSIOL, V62, P45, DOI 10.1016/B978-0-12-410515-7.00002-0; Stewart FJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00134; Venceslau SS, 2014, BBA-BIOENERGETICS, V1837, P1148, DOI 10.1016/j.bbabio.2014.03.007; Wagner M, 1998, J BACTERIOL, V180, P2975, DOI 10.1128/JB.180.11.2975-2982.1998	26	128	131	6	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2015	350	6267					1541	1545		10.1126/science.aad3558	http://dx.doi.org/10.1126/science.aad3558			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY7LY	26680199				2022-12-28	WOS:000366591100062
J	de Taeye, SW; Ozorowski, G; de la Pena, AT; Guttman, M; Julien, JP; van den Kerkhof, TLGM; Burger, JA; Pritchard, LK; Pugach, P; Yasmeen, A; Crampton, J; Hu, J; Bontjer, I; Torres, JL; Arendt, H; DeStefano, J; Koff, WC; Schuitemaker, H; Eggink, D; Berkhout, B; Dean, H; LaBranche, C; Crotty, S; Crispin, M; Montefiori, DC; Klasse, PJ; Lee, KK; Moore, JP; Wilson, IA; Ward, AB; Sanders, RW				de Taeye, Steven W.; Ozorowski, Gabriel; de la Pena, Alba Torrents; Guttman, Miklos; Julien, Jean-Philippe; van den Kerkhof, Tom L. G. M.; Burger, Judith A.; Pritchard, Laura K.; Pugach, Pavel; Yasmeen, Anila; Crampton, Jordan; Hu, Joyce; Bontjer, Ilja; Torres, Jonathan L.; Arendt, Heather; DeStefano, Joanne; Koff, Wayne C.; Schuitemaker, Hanneke; Eggink, Dirk; Berkhout, Ben; Dean, Hansi; LaBranche, Celia; Crotty, Shane; Crispin, Max; Montefiori, David C.; Klasse, P. J.; Lee, Kelly K.; Moore, John P.; Wilson, Ian A.; Ward, Andrew B.; Sanders, Rogier W.			Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes	CELL			English	Article							NEUTRALIZING ANTIBODY-RESPONSE; GLYCOPROTEIN COMPLEX; AFFINITY MATURATION; CRYSTAL-STRUCTURE; ENV TRIMERS; GP41; GP120; QUATERNARY; DESIGN; REGION	The envelope glycoprotein trimer mediates HIV-1 entry into cells. The trimer is flexible, fluctuating between closed and more open conformations and sometimes sampling the fully open, CD4-bound form. We hypothesized that conformational flexibility and transient exposure of non-neutralizing, immunodominant epitopes could hinder the induction of broadly neutralizing antibodies (bNAbs). We therefore modified soluble Env trimers to stabilize their closed, ground states. The trimer variants were indeed stabilized in the closed conformation, witha reducedability toundergo receptor-induced conformational changes and a decreased exposure of non-neutralizing V3-directed antibody epitopes. In rabbits, the stabilized trimers induced similar autologous Tier-1BorTier-2NAb titers to those elicited by the corresponding wild-type trimers but lower levels of V3-directed Tier-1A NAbs. Stabilized, closed trimers might therefore be useful components of vaccines aimed at inducing bNAbs.	[de Taeye, Steven W.; de la Pena, Alba Torrents; van den Kerkhof, Tom L. G. M.; Burger, Judith A.; Bontjer, Ilja; Eggink, Dirk; Berkhout, Ben; Sanders, Rogier W.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Ozorowski, Gabriel; Julien, Jean-Philippe; Torres, Jonathan L.; Wilson, Ian A.; Ward, Andrew B.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr & Collaborat AIDS, Scripps CHAVI ID, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Guttman, Miklos; Lee, Kelly K.] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA; [van den Kerkhof, Tom L. G. M.; Schuitemaker, Hanneke] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands; [Pritchard, Laura K.; Crispin, Max] Univ Oxford, Dept Biochem, Oxford Glycobiol Inst, Oxford OX1 3QU, England; [Pugach, Pavel; Yasmeen, Anila; Klasse, P. J.; Moore, John P.; Sanders, Rogier W.] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA; [Crampton, Jordan; Hu, Joyce; Crotty, Shane] Ctr HIV 1 AIDS Vaccine Immunol & Immunogen Discov, La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA; [Arendt, Heather; DeStefano, Joanne; Koff, Wayne C.; Dean, Hansi] Int AIDS Vaccine Initiat, New York, NY 10004 USA; [LaBranche, Celia; Montefiori, David C.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	University of Amsterdam; International AIDS Vaccine Initiative; Scripps Research Institute; University of Washington; University of Washington Seattle; University of Amsterdam; Academic Medical Center Amsterdam; University of Oxford; Cornell University; La Jolla Institute for Immunology; International AIDS Vaccine Initiative; Duke University; Scripps Research Institute	Sanders, RW (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	r.w.sanders@amc.uva.nl	Ward, Andrew B/F-9203-2014; Crotty, Shane/AAE-8446-2019; Ward, Andrew/ABD-7728-2021; Ozorowski, Gabriel/HCH-0634-2022; Crispin, Max/AAG-4098-2020; Klasse, P.J./AEX-0142-2022; Crotty, Shane/AAC-6703-2019	Ward, Andrew B/0000-0001-7153-3769; Ward, Andrew/0000-0001-7153-3769; Crispin, Max/0000-0002-1072-2694; Klasse, P.J./0000-0001-8222-278X; Crotty, Shane/0000-0002-6484-6262; Julien, Jean-Philippe/0000-0001-7602-3995; Crampton, Jordan/0000-0002-7390-9683; Torres, Jonathan/0000-0003-0137-8497	Center for Infectious Disease Control of the Netherlands National Institute for Public Health and the Environment; National Institutes of Health [P01 AI82362, P01 AI110657, R21 AI112389, UM1 AI100663]; NIAID [HHSN27201100016C]; International AIDS Vaccine Initiative (IAVI); Bill and Melinda Gates Foundation through the Collaboration for AIDS Vaccine Discovery (CAVD); Aids fonds Netherlands [2012041]; Netherlands Organization for Scientific Research (NWO); European Research Council [ERC-StG-2011-280829-SHEV]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI082362, R21AI112389, P01AI110657, UM1AI100663] Funding Source: NIH RePORTER	Center for Infectious Disease Control of the Netherlands National Institute for Public Health and the Environment; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); International AIDS Vaccine Initiative (IAVI); Bill and Melinda Gates Foundation through the Collaboration for AIDS Vaccine Discovery (CAVD); Aids fonds Netherlands; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Hermann Katinger, Mark Connors, James Robinson, Dennis Burton, John Mascola, Peter Kwong, and William Olson for donating antibodies and reagents directly or through the NIH AIDS Research and Reference Reagent Program. The Amsterdam Cohort Studies on HIV infection and AIDS, a collaboration between the Amsterdam Health Service, the Academic Medical Center of the University of Amsterdam, Sanquin Blood Supply Foundation, Medical Center Jan van Goyen, and the HIV Focus Center of the DC-Clinics, is part of the Netherlands HIV Monitoring Foundation and is financially supported by the Center for Infectious Disease Control of the Netherlands National Institute for Public Health and the Environment. This work was supported by National Institutes of Health Grants P01 AI82362 and P01 AI110657, R21 AI112389, UM1 AI100663 (Scripps CHAVI-ID), and NIAID contract number HHSN27201100016C (to D.C.M.); by the International AIDS Vaccine Initiative (IAVI); by the Bill and Melinda Gates Foundation through the Collaboration for AIDS Vaccine Discovery (CAVD); and by the Aids fonds Netherlands, grant 2012041. R.W.S. is a recipient of a Vidi grant from the Netherlands Organization for Scientific Research (NWO) and a Starting Investigator Grant from the European Research Council (ERC-StG-2011-280829-SHEV). The electron microscopy data were collected at The Scripps Research Institute Electron Microscopy Facility.	Binley JM, 2002, J VIROL, V76, P2606, DOI 10.1128/JVI.76.6.2606-2616.2002; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; Bonomelli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023521; Chaudhury S, 2014, J IMMUNOL, V193, P2073, DOI 10.4049/jimmunol.1401054; Derking R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004767; Dey AK, 2008, VIROLOGY, V372, P187, DOI 10.1016/j.virol.2007.10.018; Do Kwon Y, 2015, NAT STRUCT MOL BIOL, V22, P522, DOI 10.1038/nsmb.3051; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Dosenovic P, 2015, CELL, V161, P1505, DOI 10.1016/j.cell.2015.06.003; Eggink D, 2014, J VIROL, V88, P699, DOI 10.1128/JVI.02608-13; Euler Z, 2010, J INFECT DIS, V201, P1045, DOI 10.1086/651144; Finzi A, 2010, MOL CELL, V37, P656, DOI 10.1016/j.molcel.2010.02.012; Garces F, 2015, IMMUNITY, V43, P1053, DOI 10.1016/j.immuni.2015.11.007; Garrity RR, 1997, J IMMUNOL, V159, P279; Guenaga J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004570; Guttman M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7144; Guttman M, 2014, STRUCTURE, V22, P974, DOI 10.1016/j.str.2014.05.001; Guttman M, 2013, J VIROL, V87, P11462, DOI 10.1128/JVI.01681-13; Haim H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002101; HALL B F, 1991, Immunology Today, V12, pA22; Harris AK, 2013, J VIROL, V87, P7191, DOI 10.1128/JVI.03284-12; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Huang JH, 2014, NATURE, V515, P138, DOI 10.1038/nature13601; Jardine JG, 2015, SCIENCE, V349, P156, DOI 10.1126/science.aac5894; Julien JP, 2015, P NATL ACAD SCI USA, V112, P11947, DOI 10.1073/pnas.1507793112; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003342; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Kassa A, 2009, J VIROL, V83, P8364, DOI 10.1128/JVI.00594-09; Kassa A, 2009, J VIROL, V83, P4476, DOI 10.1128/JVI.02110-08; Klasse PJ, 2013, J VIROL, V87, P9873, DOI 10.1128/JVI.01226-13; Leaman DP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003184; Lee JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9167; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; MARRACK P, 1994, CELL, V76, P323, DOI 10.1016/0092-8674(94)90339-5; McGuire AT, 2014, SCIENCE, V346, P1380, DOI 10.1126/science.1259206; Munro JB, 2014, SCIENCE, V346, P759, DOI 10.1126/science.1254426; Novotny LA, 2003, J IMMUNOL, V171, P1978, DOI 10.4049/jimmunol.171.4.1978; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Pritchard LK, 2015, J VIROL, V89, P8932, DOI 10.1128/JVI.01190-15; Pritchard LK, 2015, CELL REP, V11, P1604, DOI 10.1016/j.celrep.2015.05.017; Pugach P, 2015, J VIROL, V89, P3380, DOI 10.1128/JVI.03473-14; Ringe RP, 2015, J VIROL, V89, P12189, DOI 10.1128/JVI.01768-15; Ringe RP, 2013, P NATL ACAD SCI USA, V110, P18256, DOI 10.1073/pnas.1314351110; Sanders RW, 2015, SCIENCE, V349, DOI 10.1126/science.aac4223; Sanders RW, 2014, NATURE, V514, P437, DOI 10.1038/nature13926; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Scharf L, 2015, CELL, V162, P1379, DOI 10.1016/j.cell.2015.08.035; Sharma SK, 2015, CELL REP, V11, P539, DOI 10.1016/j.celrep.2015.03.047; Sliepen K, 2015, VIROLOGY, V486, P116, DOI 10.1016/j.virol.2015.08.002; Sok D, 2014, P NATL ACAD SCI USA, V111, P17624, DOI 10.1073/pnas.1415789111; Yasmeen A, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-41; Zhang Y, 2013, J EXP MED, V210, P457, DOI 10.1084/jem.20120150	57	241	256	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2015	163	7					1702	1715		10.1016/j.cell.2015.11.056	http://dx.doi.org/10.1016/j.cell.2015.11.056			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CZ1GN	26687358	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000366854200017
J	Sudhof, TC				Suedhof, Thomas C.			REPRODUCIBILITY Experimental mismatch in neural circuits	NATURE			English	Editorial Material							CORTEX		[Suedhof, Thomas C.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Suedhof, Thomas C.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Sudhof, TC (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	tcs1@stanford.edu						Buetfering C, 2014, NAT NEUROSCI, V17, P710, DOI 10.1038/nn.3696; Chaumont J, 2013, P NATL ACAD SCI USA, V110, P16223, DOI 10.1073/pnas.1302310110; Emiliani V, 2015, J NEUROSCI, V35, P13917, DOI 10.1523/JNEUROSCI.2916-15.2015; Johansen JP, 2012, BIOL PSYCHIAT, V71, P1053, DOI 10.1016/j.biopsych.2011.10.023; Kawai R, 2015, NEURON, V86, P800, DOI 10.1016/j.neuron.2015.03.024; Kravitz AV, 2013, BRAIN RES, V1511, P21, DOI 10.1016/j.brainres.2012.11.018; Otchy TM, 2015, NATURE, V528, P358, DOI 10.1038/nature16442; Rothwell PE, 2014, CELL, V158, P198, DOI 10.1016/j.cell.2014.04.045; Squire LR, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a021766	9	15	15	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2015	528	7582					338	339		10.1038/nature16323	http://dx.doi.org/10.1038/nature16323			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY8SM	26649825				2022-12-28	WOS:000366678600038
J	Zhao, Y; Zhao, T; Guan, JY; Zhang, X; Fu, Y; Ye, JQ; Zhu, JL; Meng, GF; Ge, J; Yang, SS; Cheng, L; Du, YQ; Zhao, CR; Wang, T; Su, LL; Yang, WF; Deng, HK				Zhao, Yang; Zhao, Ting; Guan, Jingyang; Zhang, Xu; Fu, Yao; Ye, Junqing; Zhu, Jialiang; Meng, Gaofan; Ge, Jian; Yang, Susu; Cheng, Lin; Du, Yaqin; Zhao, Chaoran; Wang, Ting; Su, Linlin; Yang, Weifeng; Deng, Hongkui			A XEN-like State Bridges Somatic Cells to Pluripotency during Chemical Reprogramming	CELL			English	Article							EMBRYONIC STEM-CELLS; PRIMITIVE ENDODERM; MOUSE BLASTOCYSTS; INDUCTION; EXPRESSION; SEGREGATION; EPIBLAST; SOX17	Somatic cells can be reprogrammed into pluripotent stem cells (PSCs) by using pure chemicals, providing a different paradigm to study somatic reprogramming. However, the cell fate dynamics and molecular events that occur during the chemical reprogramming process remain unclear. We now show that the chemical reprogramming process requires the early formation of extra-embryonic endoderm (XEN)-like cells and a late transition from XEN-like cells to chemically- induced (Ci)PSCs, a unique route that fundamentally differs from the pathway of transcription factor-induced reprogramming. Moreover, precise manipulation of the cell fate transition in a step-wise manner through the XEN-like state allows us to identify small-molecule boosters and establish a robust chemical reprogramming system with a yield up to 1,000-fold greater than that of the previously reported protocol. These findings demonstrate that chemical reprogramming is a promising approach to manipulate cell fates.	[Zhao, Yang; Zhao, Ting; Guan, Jingyang; Zhang, Xu; Fu, Yao; Ye, Junqing; Zhu, Jialiang; Meng, Gaofan; Ge, Jian; Yang, Susu; Cheng, Lin; Du, Yaqin; Zhao, Chaoran; Wang, Ting; Su, Linlin; Deng, Hongkui] Peking Univ, Hlth Sci Ctr, Ctr Mol & Translat Med,State Key Lab Nat & Biomim, Stem Cell Res Ctr,Sch Basic Med Sci,Dept Cell Bio, Beijing 100191, Peoples R China; [Zhao, Yang; Zhao, Ting; Guan, Jingyang; Zhang, Xu; Fu, Yao; Ye, Junqing; Zhu, Jialiang; Meng, Gaofan; Ge, Jian; Yang, Susu; Cheng, Lin; Du, Yaqin; Zhao, Chaoran; Wang, Ting; Su, Linlin; Deng, Hongkui] Peking Univ, Peking Tsinghua Ctr Life Sci, Coll Life Sci, MOE Key Lab Cell Proliferat & Differentiat, Beijing 100191, Peoples R China; [Zhao, Ting] Peking Univ, Tsinghua Univ, Coll Life Sci, Natl Inst Biol Sci Joint Grad Program, Beijing 100871, Peoples R China; [Ye, Junqing; Meng, Gaofan; Deng, Hongkui] Peking Univ, Shenzhen Grad Sch, Key Lab Chem Genom, Shenzhen Stem Cell Engn Lab, Shenzhen 518055, Peoples R China; [Yang, Weifeng] Beijing Vitalstar Biotechnol Co Ltd, Beijing 100012, Peoples R China	Peking University; Peking University; Peking University; Tsinghua University; Peking University; University Town of Shenzhen	Zhao, Y (corresponding author), Peking Univ, Hlth Sci Ctr, Ctr Mol & Translat Med,State Key Lab Nat & Biomim, Stem Cell Res Ctr,Sch Basic Med Sci,Dept Cell Bio, Beijing 100191, Peoples R China.	yangzhao@pku.edu.cn; hongkui_deng@pku.edu.cn	Zhang, Xu/G-7395-2011	Zhang, Xu/0000-0002-9817-4492; Ge, Jian/0000-0001-5745-6605; Guan, Jingyang/0000-0002-1638-3339; Fu, Yao/0000-0002-1086-1248	National Basic Research Program of China (973 Program) [2012CB966401]; National Natural Science Foundation of China [91310305, 31521004]; National Science and Technology Major Project [2013ZX10001003]; Ministry of Science and Technology [2013DFG30680]; Key New Drug Creation and Manufacturing Program [2011ZX09102-010-03]; Ministry of Education of China (111 Project); BeiHao Stem Cell and Regenerative Medicine Translational Research Institute	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Key New Drug Creation and Manufacturing Program; Ministry of Education of China (111 Project); BeiHao Stem Cell and Regenerative Medicine Translational Research Institute	We thank Dr. Janet Rossant for the gift of embryo-derived XEN cell line. We thank Shuguang Duo, Jiebin Dong, Qiong Huo, Weifeng Lai, Yin Ji, Xiaochen Li, and Hongxia Lv for technical assistance. We thank the Core Facilities at School of Life Sciences, Peking University for assistance with confocal microscopy and high content imaging. We thank Dr. Tuoping Luo and Dr. Chao Tang for helpful suggestions. This work was supported by the National Basic Research Program of China (973 Program 2012CB966401), the National Natural Science Foundation of China (91310305 and 31521004), the National Science and Technology Major Project (2013ZX10001003), Ministry of Science and Technology (2013DFG30680), Key New Drug Creation and Manufacturing Program (2011ZX09102-010-03), and Ministry of Education of China (111 Project) to H.D. This work was supported in part by a grant from BeiHao Stem Cell and Regenerative Medicine Translational Research Institute.	Aksoy I, 2013, EMBO J, V32, P938, DOI 10.1038/emboj.2013.31; Buganim Y, 2014, CELL STEM CELL, V15, P295, DOI 10.1016/j.stem.2014.07.003; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Chou BK, 2013, CELL STEM CELL, V13, P261, DOI 10.1016/j.stem.2013.08.004; GURDON JB, 1962, DEV BIOL, V4, P256, DOI 10.1016/0012-1606(62)90043-X; Hansson J, 2012, CELL REP, V2, P1579, DOI 10.1016/j.celrep.2012.10.014; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Kunath T, 2005, DEVELOPMENT, V132, P1649, DOI 10.1242/dev.01715; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li WL, 2013, CELL STEM CELL, V13, P270, DOI 10.1016/j.stem.2013.08.002; Lim CY, 2008, CELL STEM CELL, V3, P543, DOI 10.1016/j.stem.2008.08.004; McDonald ACH, 2014, CELL REP, V9, P780, DOI 10.1016/j.celrep.2014.09.026; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Niakan KK, 2010, GENE DEV, V24, P312, DOI 10.1101/gad.1833510; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Shu J, 2015, CELL RES, V25, P169, DOI 10.1038/cr.2015.6; Shu J, 2013, CELL, V153, P963, DOI 10.1016/j.cell.2013.05.001; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takahashi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4678; Wang W, 2011, P NATL ACAD SCI USA, V108, P18283, DOI 10.1073/pnas.1100893108; Xenopoulos P, 2015, CELL REP, V10, P1508, DOI 10.1016/j.celrep.2015.02.010; Yamanaka Y, 2010, DEVELOPMENT, V137, P715, DOI 10.1242/dev.043471; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Ye J., 2015, CELL RES	29	142	160	5	110	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2015	163	7					1678	1691		10.1016/j.cell.2015.11.017	http://dx.doi.org/10.1016/j.cell.2015.11.017			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CZ1GN	26686652	Bronze			2022-12-28	WOS:000366854200015
J	Zhou, YY				Zhou, Yingying			THE RAPID RISE OF A RESEARCH NATION	NATURE			English	Editorial Material																			0	24	24	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2015	528	7582					S170	S173		10.1038/528S170a	http://dx.doi.org/10.1038/528S170a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY8SM	26673023	Bronze			2022-12-28	WOS:000366678600011
J	Hougaard, A; Lindberg, U; Arngrim, N; Larsson, HBW; Olesen, J; Amin, FM; Ashina, M; Haddock, BT				Hougaard, Anders; Lindberg, Ulrich; Arngrim, Nanna; Larsson, Henrik B. W.; Olesen, Jes; Amin, Faisal Mohammad; Ashina, Messoud; Haddock, Bryan T.			CHRISTMAS 2015: ALL IN THE MIND Evidence of a Christmas spirit network in the brain: functional MRI study	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								Objective To detect and localise the Christmas spirit in the human brain. Design Single blinded, cross cultural group study with functional magnetic resonance imaging (fMRI). Setting Functional imaging unit and department of clinical physiology, nuclear medicine and PET in Denmark. Participants 10 healthy people from the Copenhagen area who routinely celebrate Christmas and 10 healthy people living in the same area who have no Christmas traditions. Main outcome measures Brain activation unique to the group with Christmas traditions during visual stimulation with images with a Christmas theme. Methods Functional brain scans optimised for detection of the blood oxygen level dependent (BOLD) response were performed while participants viewed a series of images with Christmas themes interleaved with neutral images having similar characteristics but containing nothing that symbolises Christmas. After scanning, participants answered a questionnaire about their Christmas traditions and the associations they have with Christmas. Brain activation maps from scanning were analysed for Christmas related activation in the "Christmas" and "non-Christmas" groups individually. Subsequently, differences between the two groups were calculated to determine Christmas specific brain activation. Results Significant clusters of increased BOLD activation in the sensory motor cortex, the premotor and primary motor cortex, and the parietal lobule (inferior and superior) were found in scans of people who celebrate Christmas with positive associations compared with scans in a group having no Christmas traditions and neutral associations. These cerebral areas have been associated with spirituality, somatic senses, and recognition of facial emotion among many other functions. Conclusions There is a "Christmas spirit network" in the human brain comprising several cortical areas. This network had a significantly higher activation in a people who celebrate Christmas with positive associations as opposed to a people who have no Christmas traditions and neutral associations. Further research is necessary to understand this and other potential holiday circuits in the brain. Although merry and intriguing, these findings should be interpreted with caution.	[Hougaard, Anders; Arngrim, Nanna; Olesen, Jes; Amin, Faisal Mohammad; Ashina, Messoud] Univ Copenhagen, Fac Hlth & Med Sci, Rigshosp, Danish Headache Ctr, Glostrup, Denmark; [Hougaard, Anders; Arngrim, Nanna; Olesen, Jes; Amin, Faisal Mohammad; Ashina, Messoud] Univ Copenhagen, Fac Hlth & Med Sci, Rigshosp, Dept Neurol, Glostrup, Denmark; [Lindberg, Ulrich; Larsson, Henrik B. W.; Haddock, Bryan T.] Univ Copenhagen, Fac Hlth & Med Sci, Rigshosp, Funct Imaging Unit, Glostrup, Denmark; [Lindberg, Ulrich; Larsson, Henrik B. W.; Haddock, Bryan T.] Univ Copenhagen, Fac Hlth & Med Sci, Rigshosp, Dept Clin Physiol Nucl Med & PET, Glostrup, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Haddock, BT (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Rigshosp, Funct Imaging Unit, Glostrup, Denmark.	bryan.haddock@regionh.dk	Ashina, Messoud/AFU-1246-2022; Lindberg, Ulrich/AAL-6538-2020; Amin, Faisal Mohammad/I-2002-2019	Ashina, Messoud/0000-0003-0951-5804; Lindberg, Ulrich/0000-0002-0004-6354; Olesen, Jes/0000-0002-6712-2702; Amin, Faisal Mohammad/0000-0003-3803-3599				Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Adolphs R, 2000, J NEUROSCI, V20, P2683; Amin Faisal Mohammad, 2012, Ugeskr Laeger, V174, P3082; Balconi M, 2013, BRAIN COGNITION, V83, P114, DOI 10.1016/j.bandc.2013.07.003; Bennett C.M., 2010, J SERENDIPITOUS UNEX, V1, P1, DOI [DOI 10.1016/S1053-8119(09)71202-9, 10.1016/S1053-8119(09)71202-9]; Ferrari PF, 2003, EUR J NEUROSCI, V17, P1703, DOI 10.1046/j.1460-9568.2003.02601.x; Hougaard A, 2015, EUR J NEUROL, V22, P702, DOI 10.1111/ene.12636; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Lane RD, 1997, AM J PSYCHIAT, V154, P926; Pedersen ET, 2009, BRAIN PERFUSION IMAG; Urgesi C, 2010, NEURON, V65, P309, DOI 10.1016/j.neuron.2010.01.026	11	5	5	3	30	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 16	2015	351								h6266	10.1136/bmj.h6266	http://dx.doi.org/10.1136/bmj.h6266			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ4MP	26676562	Green Published, hybrid			2022-12-28	WOS:000367077600002
J	Bhargava, S; Loewenstein, G				Bhargava, Saurabh; Loewenstein, George			Choosing a Health Insurance Plan Complexity and Consequences	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Bhargava, Saurabh; Loewenstein, George] Carnegie Mellon Univ, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Loewenstein, G (corresponding author), Carnegie Mellon Univ, Dept Social & Decis Sci, 208 Porter Hall, Pittsburgh, PA 15213 USA.	gl20@andrew.cmu.edu	Loewenstein, George/G-7616-2014	Loewenstein, George/0000-0003-2790-0474				Baicker K, 2015, Q J ECON, V130, P1623, DOI 10.1093/qje/qjv029; Bhargava S, 21160 NAT BUR EC RES; Gabaix X, 2006, Q J ECON, V121, P505, DOI 10.1162/qjec.2006.121.2.505; Johnson EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081521; Koh HK, 2015, JAMA-J AM MED ASSOC, V314, P1225, DOI 10.1001/jama.2015.9978; Loewenstein G, 2013, J HEALTH ECON, V32, P850, DOI 10.1016/j.jhealeco.2013.04.004	7	27	27	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 15	2015	314	23					2505	2506		10.1001/jama.2015.15176	http://dx.doi.org/10.1001/jama.2015.15176			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY4PV	26670967				2022-12-28	WOS:000366391500014
J	O'Malley, PG				O'Malley, Patrick G.			In veterans with PTSD, mindfulness-based group therapy reduced symptom severity	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[O'Malley, Patrick G.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA	O'Malley, PG (corresponding author), Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.							Steenkamp MM, 2015, JAMA-J AM MED ASSOC, V314, P489, DOI 10.1001/jama.2015.8370	1	5	5	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	2015	163	12							JC9	10.7326/ACPJC-2015-163-12-009	http://dx.doi.org/10.7326/ACPJC-2015-163-12-009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY4BS	26666811				2022-12-28	WOS:000366354200009
J	Welck, M; Rafferty, M; Eltz, S; Al-Nammari, SS; Eseonu, KC				Welck, Matthew; Rafferty, Michael; Eltz, Stephanie; Al-Nammari, Shafic Said; Eseonu, Kelechi Chika			Management of ankle injuries	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LATERAL LIGAMENTS; OSTEOCHONDRAL LESIONS; SYNDESMOSIS INJURY; SPRAIN; ACCURACY; RUPTURES; TALUS		[Welck, Matthew; Rafferty, Michael; Eltz, Stephanie] Wexham Pk Hosp, Dept Orthopaed, Slough SL2 4HL, Berks, England; [Al-Nammari, Shafic Said] Barts & London NHS Trust, Dept Trauma & Orthopaed, London, England; [Eseonu, Kelechi Chika] John Radcliffe Hosp, Dept Orthopaed Surg, Oxford OX3 9DU, England	Barts Health NHS Trust; University of Oxford	Welck, M (corresponding author), Wexham Pk Hosp, Dept Orthopaed, Slough SL2 4HL, Berks, England.	matthewwelck@doctors.org.uk						Alonso A, 1998, J ORTHOP SPORT PHYS, V27, P276, DOI 10.2519/jospt.1998.27.4.276; Bachmann LM, 2003, BMJ-BRIT MED J, V326, P417, DOI 10.1136/bmj.326.7386.417; Bell SJ, 2006, AM J SPORT MED, V34, P975, DOI 10.1177/0363546505282616; Bencardino J, 1999, Magn Reson Imaging Clin N Am, V7, P131; Bendahou M, 2014, AM J EMERG MED, V32, P1005, DOI 10.1016/j.ajem.2014.05.054; Bennett MH, 2005, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD004713.PUB2; Breitenseher MJ, 1997, J COMPUT ASSIST TOMO, V21, P280, DOI 10.1097/00004728-199703000-00022; Cheung Y, 2001, Magn Reson Imaging Clin N Am, V9, P507; Chilvers Margaret, 2008, Foot Ankle Clin, V13, P315, DOI 10.1016/j.fcl.2008.01.003; Dattani R, 2008, J BONE JOINT SURG BR, V90B, P405, DOI 10.1302/0301-620X.90B4.19750; Doherty C, 2014, SPORTS MED, V44, P123, DOI 10.1007/s40279-013-0102-5; Garozzo D, 2003, J ORTHOPAED TRAUMATO, V4, P142; Girard P, 1999, FOOT ANKLE INT, V20, P246, DOI 10.1177/107110079902000407; Han SH, 2007, FOOT ANKLE INT, V28, P336, DOI 10.3113/FAI.2007.0336; Hannon CP, 2014, BONE JOINT J, V96B, P164, DOI 10.1302/0301-620X.96B2.31637; Hupperets MDW, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2684; KANNUS P, 1991, J BONE JOINT SURG AM, V73A, P305, DOI 10.2106/00004623-199173020-00021; Kerkhoffs GMMJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000380.pub2; Kerkhoffs GMMJ, 2003, ACTA ORTHOP SCAND, V74, P69, DOI 10.1080/00016470310013699; Kim TH, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009065.pub2; Labovitz JM, 1998, FOOT ANKLE INT, V19, P661, DOI 10.1177/107110079801901003; LAUGEHANSEN N, 1950, ARCH SURG-CHICAGO, V60, P957, DOI 10.1001/archsurg.1950.01250010980011; Leddy JJ, 2002, MED SCI SPORT EXER, V34, P57, DOI 10.1097/00005768-200201000-00010; LIU SH, 1994, ARTHROSCOPY, V10, P215, DOI 10.1016/S0749-8063(05)80097-0; Mintz DN, 2003, ARTHROSCOPY, V19, P353, DOI 10.1053/jars.2003.50041; Osborne MD, 2003, SPORTS MED, V33, P1145, DOI 10.2165/00007256-200333150-00005; Pourkazemi F, 2014, J SCI MED SPORT, V17, P568, DOI 10.1016/j.jsams.2014.01.005; RAMSEY PL, 1976, J BONE JOINT SURG AM, V58, P356, DOI 10.2106/00004623-197658030-00010; RENFREW DL, 1985, SKELETAL RADIOL, V14, P121, DOI 10.1007/BF00349747; Rosenfeld Peter, 2007, Foot Ankle Clin, V12, P643, DOI 10.1016/j.fcl.2007.07.001; STIELL IG, 1992, ANN EMERG MED, V21, P384, DOI 10.1016/S0196-0644(05)82656-3; Struijs PAA, 2015, BMJ CLIN EVID; Tiemstra JD, 2012, AM FAM PHYSICIAN, V85, P1170; Umans HR, 2008, SEMIN MUSCULOSKEL R, V12, P146, DOI 10.1055/s-2008-1078702; van den Bekerom MPJ, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001250.pub2; van Rijn RM, 2008, AM J MED, V121, P324, DOI 10.1016/j.amjmed.2007.11.018; VERHAVEN EFC, 1991, AM J SPORT MED, V19, P583, DOI 10.1177/036354659101900605; Weber BG, 1972, VERLETZUNGEN OBEREN; Wester JU, 1996, J ORTHOP SPORT PHYS, V23, P332, DOI 10.2519/jospt.1996.23.5.332; Wolfe MW, 2001, AM FAM PHYSICIAN, V63, P93	40	1	1	1	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 15	2015	351								h6698	10.1136/bmj.h6698	http://dx.doi.org/10.1136/bmj.h6698			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ4ML	26671820				2022-12-28	WOS:000367077200003
J	Tsiganis, K				Tsiganis, Kleomenis			PLANETARY SCIENCE How the Solar System didn't form	NATURE			English	Editorial Material							GRADUAL ACCUMULATION; ACCRETION; MARS		[Tsiganis, Kleomenis] Aristotle Univ Thessaloniki, Dept Phys, GR-54124 Thessaloniki, Greece	Aristotle University of Thessaloniki	Tsiganis, K (corresponding author), Aristotle Univ Thessaloniki, Dept Phys, GR-54124 Thessaloniki, Greece.	tsiganis@auth.gr	Tsiganis, Kleomenis/AAF-5316-2020	Tsiganis, Kleomenis/0000-0003-3334-6190				Armitage P.J., 2010, ASTROPHYSICS PLANET; Izidoro A, 2015, MON NOT R ASTRON SOC, V453, P3619, DOI 10.1093/mnras/stv1835; Levison HF, 2015, P NATL ACAD SCI USA, V112, P14180, DOI 10.1073/pnas.1513364112; Morbidelli A, 2005, NATURE, V435, P462, DOI 10.1038/nature03540; Raymond SN, 2006, ICARUS, V183, P265, DOI 10.1016/j.icarus.2006.03.011	9	3	3	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2015	528	7581					202	204		10.1038/nature16322	http://dx.doi.org/10.1038/nature16322			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9VH	26633629				2022-12-28	WOS:000366053300027
J	Valenzano, DR; Benayoun, BA; Singh, PP; Zhang, E; Etter, PD; Hu, CK; Clement-Ziza, M; Willemsen, D; Cui, RF; Harel, I; Machado, BE; Yee, MC; Sharp, SC; Bustamante, CD; Beyer, A; Johnson, EA; Brunet, A				Valenzano, Dario Riccardo; Benayoun, Berenice A.; Singh, Param Priya; Zhang, Elisa; Etter, Paul D.; Hu, Chi-Kuo; Clement-Ziza, Mathieu; Willemsen, David; Cui, Rongfeng; Harel, Itamar; Machado, Ben E.; Yee, Muh-Ching; Sharp, Sabrina C.; Bustamante, Carlos D.; Beyer, Andreas; Johnson, Eric A.; Brunet, Anne			The African Turquoise Killifish Genome Provides Insights into Evolution and Genetic Architecture of Lifespan	CELL			English	Article							FISH NOTHOBRANCHIUS FURZERI; HUMAN LONGEVITY; CAENORHABDITIS-ELEGANS; VERTEBRATE MODEL; MUTATIONS; PROGRANULIN; STRESS; RESISTANCE; ALIGNMENT; DATABASE	Lifespan is a remarkably diverse trait ranging from a few days to several hundred years in nature, but the mechanisms underlying the evolution of lifespan differences remain elusive. Here we de novo assemble a reference genome for the naturally short-lived African turquoise killifish, providing a unique resource for comparative and experimental genomics. The identification of genes under positive selection in this fish reveals potential candidates to explain its compressed lifespan. Several aging genes are under positive selection in this short-lived fish and long-lived species, raising the intriguing possibility that the same gene could underlie evolution of both compressed and extended lifespans. Comparative genomics and linkage analysis identify candidate genes associated with lifespan differences between various turquoise killifish strains. Remarkably, these genes are clustered on the sex chromosome, suggesting that short lifespan might have co-evolved with sex determination. Our study provides insights into the evolutionary forces that shape lifespan in nature.	[Valenzano, Dario Riccardo; Benayoun, Berenice A.; Singh, Param Priya; Zhang, Elisa; Hu, Chi-Kuo; Harel, Itamar; Machado, Ben E.; Yee, Muh-Ching; Sharp, Sabrina C.; Bustamante, Carlos D.; Brunet, Anne] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Etter, Paul D.; Johnson, Eric A.] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Clement-Ziza, Mathieu] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Valenzano, Dario Riccardo; Willemsen, David; Cui, Rongfeng] Max Planck Inst Biol Ageing, D-50931 Cologne, Germany; [Beyer, Andreas] Univ Cologne, Cellular Networks & Syst Biol, CECAD, D-50931 Cologne, Germany; [Brunet, Anne] Stanford Univ, Glenn Labs Biol Aging, Stanford, CA 94305 USA	Stanford University; University of Oregon; University of Cologne; Max Planck Society; University of Cologne; Stanford University	Valenzano, DR (corresponding author), Max Planck Inst Biol Ageing, D-50931 Cologne, Germany.	dario.valenzano@age.mpg.de; anne.brunet@stanford.edu	Singh, Param P/AAU-7841-2020; Clément-Ziza, Mathieu/J-4146-2012; Beyer, Andreas/AAQ-5519-2020; Cui, Rongfeng/H-8844-2019; Beyer, Andreas/A-3352-2009; Benayoun, Bérénice A./K-7048-2012	Clément-Ziza, Mathieu/0000-0003-2763-249X; Beyer, Andreas/0000-0002-3891-2123; Cui, Rongfeng/0000-0002-8146-6958; Beyer, Andreas/0000-0002-3891-2123; Benayoun, Bérénice A./0000-0002-7401-4777; Valenzano, Dario Riccardo/0000-0002-8761-8289; Harel, Itamar/0000-0001-9749-8279; Bustamante, Carlos D./0000-0002-4187-7920; Singh, Param Priya/0000-0002-3325-8767	NIH [DP1AG044848]; Glenn Laboratories for the Biology of Aging; Max Planck Society; Max Planck Institute for Biology of Ageing; Dean's fellowship at Stanford and NIH [K99AG049934]; Stanford Center for Computational Evolutionary and Human Genomics fellowship; Life Sciences Research Foundation fellowship; Damon Runyon fellowship; Rothschild fellowship; HFSP fellowship; German Federal Ministry of Education and Research; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [DP1AG044848, K99AG049934] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Laboratories for the Biology of Aging; Max Planck Society(Max Planck Society); Max Planck Institute for Biology of Ageing; Dean's fellowship at Stanford and NIH; Stanford Center for Computational Evolutionary and Human Genomics fellowship; Life Sciences Research Foundation fellowship; Damon Runyon fellowship; Rothschild fellowship; HFSP fellowship; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Robert Piskol, Duygu Ucar, Erik Lenhert, Joanna Kelley, and Julian Catchen for their help with genome analysis. We thank Jonathan Pritchard and Yang Li for helping with evolutionary analyses, statistics, and the manuscript. We thank Dmitri Petrov and David Enard for their help with the evolutionary analysis. We thank Art Owen for his help with statistics. We thank David Kingsley, Felicity Jones, and Frank Chan for helping with QTL analysis and the manuscript. We thank members of the Brunet lab for help on the manuscript. We thank Aaron Daugherty, Ben Dulken, Katja Hebestreit, Andrew McKay, and Robin Yeo for helping with independent code verification. We thank Aimee Kao for helpful discussion about GRN. This work was supported by NIH DP1AG044848 (A. Brunet), the Glenn Laboratories for the Biology of Aging (A. Brunet.), the Max Planck Society and the Max Planck Institute for Biology of Ageing (D.R.V., D.W. and R.C.), the Dean's fellowship at Stanford and NIH K99AG049934 (B.A.B.), the Stanford Center for Computational Evolutionary and Human Genomics fellowship (P.P.S.), the Life Sciences Research Foundation fellowship (C.K.H.), the Damon Runyon, Rothschild, and HFSP fellowships (I.H.), and the German Federal Ministry of Education and Research (A. Beyer., M.C.Z., Grant: Sybacol).	Ahmed Z, 2010, AM J PATHOL, V177, P311, DOI 10.2353/ajpath.2010.090915; Austad SN, 2010, J COMP PATHOL, V141, pS10, DOI 10.1016/j.jcpa.2009.10.024; Ayyadevara S, 2007, MECH AGEING DEV, V128, P196, DOI 10.1016/j.mad.2006.11.025; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Ballew BJ, 2013, HUM GENET, V132, P473, DOI 10.1007/s00439-013-1265-8; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Budovsky A, 2013, TRENDS GENET, V29, P559, DOI 10.1016/j.tig.2013.08.003; Cellerino A., 2015, BIOL REV CAMB PHILOS; Chen HY, 2012, CURR BIOL, V22, P2140, DOI 10.1016/j.cub.2012.09.021; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Clement-Ziza M, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145123; Conneely KN, 2012, AGING CELL, V11, P475, DOI 10.1111/j.1474-9726.2012.00808.x; De Luca G, 2013, AGING CELL, V12, P695, DOI 10.1111/acel.12094; de Magalhaes JP, 2009, AGING CELL, V8, P65, DOI 10.1111/j.1474-9726.2008.00442.x; De-Fraja C, 2000, INT J DEV NEUROSCI, V18, P439, DOI 10.1016/S0736-5748(00)00007-1; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Etter PD, 2011, METHODS MOL BIOL, V772, P157, DOI 10.1007/978-1-61779-228-1_9; Flachsbart F, 2009, P NATL ACAD SCI USA, V106, P2700, DOI 10.1073/pnas.0809594106; GOTTLIEB S, 1994, GENETICS, V137, P107; Holt C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-491; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Judy ME, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003714; Kaeberlein M, 2011, AGING CELL, V10, P185, DOI 10.1111/j.1474-9726.2010.00665.x; Kapahi P, 2010, CELL METAB, V11, P453, DOI 10.1016/j.cmet.2010.05.001; Keane M, 2015, CELL REP, V10, P112, DOI 10.1016/j.celrep.2014.12.008; Kennedy BK, 2014, CELL, V159, P708, DOI 10.1016/j.cell.2014.10.039; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kirschner J, 2012, AGING CELL, V11, P252, DOI 10.1111/j.1474-9726.2011.00780.x; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Soto-Jimenez LM, 2014, CURR TOP MED CHEM, V14, P418, DOI 10.2174/1568026613666131204110628; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nadalin F, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S14-S8; Patterson GI, 1997, GENE DEV, V11, P2679, DOI 10.1101/gad.11.20.2679; Penn O, 2010, MOL BIOL EVOL, V27, P1759, DOI 10.1093/molbev/msq066; Pesch B, 2004, TOXICOL LETT, V151, P283, DOI 10.1016/j.toxlet.2004.01.025; Proitsi P, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.12.036; Raeder H, 2006, NAT GENET, V38, P54, DOI 10.1038/ng1708; Reichwald K, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r16; Seim I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3212; Simpson JT, 2012, GENOME RES, V22, P549, DOI 10.1101/gr.126953.111; Soerensen M, 2012, EXP GERONTOL, V47, P379, DOI 10.1016/j.exger.2012.02.010; Souza-Pinto NC, 1999, NUCLEIC ACIDS RES, V27, P1935, DOI 10.1093/nar/27.8.1935; Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105; Terzibasi E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003866; Valdesalicil S, 2003, P ROY SOC B-BIOL SCI, V270, pS189, DOI 10.1098/rsbl.2003.0048; Valenzano DR, 2009, GENETICS, V183, P1385, DOI 10.1534/genetics.109.108670; Vilchez D, 2012, NATURE, V489, P263, DOI 10.1038/nature11315; Vogel H, 1999, P NATL ACAD SCI USA, V96, P10770, DOI 10.1073/pnas.96.19.10770; Wang J, 2010, J NEUROCHEM, V112, P1305, DOI 10.1111/j.1471-4159.2009.06546.x; Worley KC, 2014, NAT GENET, V46, P850, DOI 10.1038/ng.3042; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	56	117	117	2	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 6	2015	163	6					1539	1554		10.1016/j.cell.2015.11.008	http://dx.doi.org/10.1016/j.cell.2015.11.008			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SE	26638078	Green Accepted, Bronze			2022-12-28	WOS:000366044800024
J	Chakravorty, M; Al-Mohammad, A; Brown, P; Allahabadia, A; Grech, E				Chakravorty, Mithun; Al-Mohammad, Abdallah; Brown, Peter; Allahabadia, Amit; Grech, Ever			CASE REVIEW A man with a murmur and missing heart	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							AORTIC-VALVE		[Chakravorty, Mithun; Al-Mohammad, Abdallah] No Gen Hosp, Sheffield S5 7AU, S Yorkshire, England; [Brown, Peter] No Gen Hosp, Dept Radiol, Sheffield S5 7AU, S Yorkshire, England; [Allahabadia, Amit; Grech, Ever] Sheffield Teaching Hosp NHS Trust, Sheffield, S Yorkshire, England	Northern General Hospital; Northern General Hospital; University of Sheffield	Chakravorty, M (corresponding author), No Gen Hosp, Sheffield S5 7AU, S Yorkshire, England.	mithun.chakravorty@gmail.com	Al-Mohammad, Abdallah/I-5663-2019	Al-Mohammad, Abdallah/0000-0001-6517-8692				Chambers J, 2004, J HEART VALVE DIS, V13, P344; Cooke RA, 1996, HEART, V76, P88, DOI 10.1136/hrt.76.1.88; Duerden RS, 2006, IMAGING, V18, P178; Im E, 2013, YONSEI MED J, V54, P596, DOI 10.3349/ymj.2013.54.3.596; Khouzam RN, 2007, J CLIN ULTRASOUND, V35, P196, DOI 10.1002/jcu.20312; Larose E, 2014, MRI EVALUATION AORTI, P179; Lindman BR, 2013, CIRC RES, V113, P223, DOI 10.1161/CIRCRESAHA.111.300084; Yang CS, 2016, CATHETER CARDIO INTE, V87, P488, DOI 10.1002/ccd.26033	8	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 4	2015	351								h5386	10.1136/bmj.h5386	http://dx.doi.org/10.1136/bmj.h5386			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX9FA	26637475				2022-12-28	WOS:000366009200001
J	Pettigrew, LM; De Maeseneer, J; Anderson, MIP; Essuman, A; Kidd, MR; Haines, A				Pettigrew, Luisa M.; De Maeseneer, Jan; Anderson, Maria-Inez Padula; Essuman, Akye; Kidd, Michael R.; Haines, Andy			Primary health care and the Sustainable Development Goals	LANCET			English	Editorial Material							MIDDLE-INCOME COUNTRIES; ALMA-ATA; REBIRTH; SYSTEMS; INTERVENTIONS		[Pettigrew, Luisa M.] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Dept Hlth Serv Res & Policy, London WC1 9SH, England; [Haines, Andy] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Dept Social & Environm Hlth Res, London WC1 9SH, England; [De Maeseneer, Jan] Univ Ghent, Dept Family Med & Primary Hlth Care, B-9000 Ghent, Belgium; [Anderson, Maria-Inez Padula] Univ Estado Rio De Janeiro, Dept Family & Community Med, Rio De Janeiro, Brazil; [Essuman, Akye] Univ Ghana, Sch Publ Hlth, Dept Community Hlth, Family Med Unit, Accra, Ghana; [Kidd, Michael R.] Flinders Univ S Australia, Fac Med Nursing & Hlth Sci, Adelaide, SA 5001, Australia	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Ghent University; Universidade do Estado do Rio de Janeiro; University of Ghana; Flinders University South Australia	Pettigrew, LM (corresponding author), London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Dept Hlth Serv Res & Policy, London WC1 9SH, England.	luisa.pettigrew@lshtm.ac.uk	Anderson, Maria Inez Padula/AAH-2379-2020; Pettigrew, Luisa/I-9981-2019	Pettigrew, Luisa/0000-0001-6427-6696; Haines, Andy/0000-0002-8053-4605				Beaglehole R, 2008, LANCET, V372, P940, DOI 10.1016/S0140-6736(08)61404-X; Bhutta ZA, 2008, LANCET, V372, P972, DOI 10.1016/S0140-6736(08)61407-5; Campbell J, 2015, B WORLD HEALTH ORGAN, V93, P590, DOI 10.2471/BLT.15.162198; De Maeseneer J, 2013, AFR J PRIM HEALTH CA, V5, DOI 10.4102/phcfm.v5i1.507; De Maeseneer J, 2012, LANCET, V379, P1860, DOI 10.1016/S0140-6736(11)61135-5; Gibbons DC, 2012, J ROY SOC MED, V105, P422, DOI 10.1258/jrsm.2012.120178; Harzheim E., 2013, REV BRASILEIRA MEDIC, V8, P274, DOI 10.5712/rbmfc8(29)829; Johns Hopkins Primary Care Policy Centre, 2015, PRIM CAR ASS TOOLS; Kaner EFS, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004148.pub4; Kidd MR, 2015, LANCET, V386, P737, DOI 10.1016/S0140-6736(15)61532-X; Kringos DE, 2015, BUILDING PRIMARY CAR, V38, P172; Kruk ME, 2010, SOC SCI MED, V70, P904, DOI 10.1016/j.socscimed.2009.11.025; Lewin S, 2008, LANCET, V372, P928, DOI 10.1016/S0140-6736(08)61403-8; Rao M, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.23693; Schafer Willemijn L A, 2013, Qual Prim Care, V21, P67; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Walley J, 2008, LANCET, V372, P1001, DOI 10.1016/S0140-6736(08)61409-9; WHO, 2008, PHARMAFORUM 0121	18	58	57	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 28	2015	386	10009					2119	2121		10.1016/S0140-6736(15)00949-6	http://dx.doi.org/10.1016/S0140-6736(15)00949-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CX8YW	26638948				2022-12-28	WOS:000365992600008
J	Dietl, GP				Dietl, Gregory P.			ECOLOGY Different worlds	NATURE			English	Editorial Material							UNIFORMITARIANISM; SCIENCE		[Dietl, Gregory P.] Paleontol Res Inst, Ithaca, NY 14850 USA; [Dietl, Gregory P.] Cornell Univ, Dept Earth & Atmospher Sci, Ithaca, NY USA	Cornell University	Dietl, GP (corresponding author), Paleontol Res Inst, Ithaca, NY 14850 USA.; Dietl, GP (corresponding author), Cornell Univ, Dept Earth & Atmospher Sci, Ithaca, NY USA.							Baker VR, 2014, ANTHROPOCENE, V5, P76, DOI 10.1016/j.ancene.2014.09.001; Blois JL, 2014, ECOGRAPHY, V37, P1095, DOI 10.1111/ecog.00779; Connor EF, 2013, ECOLOGY, V94, P2403, DOI 10.1890/12-1471.1; FUNTOWICZ SO, 1993, FUTURES, V25, P739, DOI 10.1016/0016-3287(93)90022-L; Gotelli NJ, 2010, OECOLOGIA, V162, P463, DOI 10.1007/s00442-009-1474-y; Knight J, 2014, ANTHROPOCENE, V5, P71, DOI 10.1016/j.ancene.2014.06.001; Lyons SK, 2016, NATURE, V529, P80, DOI 10.1038/nature16447	7	3	3	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 7	2016	529	7584					29	30		10.1038/nature16329	http://dx.doi.org/10.1038/nature16329			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6VY	26675725				2022-12-28	WOS:000367944900017
J	Scammell, TE				Scammell, Thomas E.			Narcolepsy	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SLEEP LATENCY TEST; DIAGNOSING NARCOLEPSY; CATAPLEXY; OREXIN; HYPOCRETIN; NEURONS; ONSET; HYPERSOMNIA; PROTECTION; PEPTIDES	Narcolepsy, one of the most common causes of chronic sleepiness, affects about 1 in 2000 people. Despite the frequency of narcolepsy, the average time from the onset of symptoms to diagnosis is 5 to 15 years, and narcolepsy may remain undiagnosed in as many as half of all affected people with narcolepsy, since many clinicians are unfamiliar with this disorder. 1 Fortunately, awareness of narcolepsy and other sleep disorders is increasing, and over the past several years researchers have made great progress in understanding narcolepsy. Clinicians now recognize two types of narcolepsy. Type 1 is caused by extensive loss of hypothalamic neurons that produce the neuropeptides orexin-A and -B (also referred to as hypocretin-1 and -2); type 2 includes most of the same symptoms, but its cause is unknown. This review focuses on the symptoms and pathologic and neurobiologic features of narcolepsy and provides a framework for diagnosis and effective treatment.	[Scammell, Thomas E.] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; [Scammell, Thomas E.] Boston Childrens Hosp, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Boston Children's Hospital	Scammell, TE (corresponding author), Beth Israel Deaconess Med Ctr, 330 Brookline Ave, Boston, MA 02215 USA.	tscammel@bidmc.harvard.edu			Jazz Pharmaceuticals; Eisai; Vertex Pharmaceuticals; Prexa Pharmaceuticals; Merck	Jazz Pharmaceuticals(Jazz Pharmaceuticals); Eisai(Eisai Co Ltd); Vertex Pharmaceuticals(Vertex Pharmaceuticals); Prexa Pharmaceuticals; Merck(Merck & Company)	Dr. Scammell reports receiving consulting fees from Jazz Pharmaceuticals, Eisai, Vertex Pharmaceuticals, Prexa Pharmaceuticals, and Merck, fees for providing expert testimony on behalf of Jazz Pharmaceuticals in a case involving a patent for sodium oxybate, and grant support from Eisai. No other potential conflict of interest relevant to this article was reported.	Andlauer O, 2013, JAMA NEUROL, V70, P891, DOI 10.1001/jamaneurol.2013.1589; [Anonymous], 2014, INT CLASSIFICATION S, V3rd; Aran A, 2009, SLEEP, V32, P979, DOI 10.1093/sleep/32.8.979; Baumann CR, 2014, SLEEP, V37, P1035, DOI 10.5665/sleep.3756; Behn CGD, 2010, SLEEP, V33, P297, DOI 10.1093/sleep/33.3.297; Blouin AM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2461; Boscolo-Berto R, 2012, SLEEP MED REV, V16, P431, DOI 10.1016/j.smrv.2011.09.001; Bourgin P, 2008, LANCET NEUROL, V7, P649, DOI 10.1016/S1474-4422(08)70140-6; Burgess CR, 2013, J NEUROSCI, V33, P9734, DOI 10.1523/JNEUROSCI.5632-12.2013; Burgess CR, 2012, J NEUROSCI, V32, P12305, DOI 10.1523/JNEUROSCI.2630-12.2012; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Crocker A, 2005, NEUROLOGY, V65, P1184, DOI 10.1212/01.WNL.0000168173.71940.ab; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Donadio V, 2014, NEUROLOGY, V83, P1080, DOI 10.1212/WNL.0000000000000793; Estabrooke IV, 2001, J NEUROSCI, V21, P1656, DOI 10.1523/JNEUROSCI.21-05-01656.2001; Faraco J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003270; Goldbart A, 2014, SLEEP, V37, P1043, DOI 10.5665/sleep.3758; Han F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003880; Han F, 2011, ANN NEUROL, V70, P410, DOI 10.1002/ana.22587; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Lecendreux M, 2014, PEDIATR DRUGS, V16, P363, DOI 10.1007/s40272-014-0083-3; Lee MG, 2005, J NEUROSCI, V25, P6716, DOI 10.1523/JNEUROSCI.1887-05.2005; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Littner MR, 2005, SLEEP, V28, P113, DOI 10.1093/sleep/28.1.113; Mahlios J, 2013, CURR OPIN NEUROBIOL, V23, P767, DOI 10.1016/j.conb.2013.04.013; Meletti S, 2015, J NEUROSCI, V35, P11583, DOI 10.1523/JNEUROSCI.0840-15.2015; Mignot EJM, 2012, NEUROTHERAPEUTICS, V9, P739, DOI 10.1007/s13311-012-0150-9; Mitler MM, 1998, ANN NEUROL, V43, P88; Nishino S, 2005, SLEEP MED REV, V9, P269, DOI 10.1016/j.smrv.2005.03.004; Nohynek H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033536; Ohayon MM, 2013, SLEEP MED, V14, P488, DOI 10.1016/j.sleep.2013.03.002; Oishi Y, 2013, J NEUROSCI, V33, P9743, DOI 10.1523/JNEUROSCI.0499-13.2013; Ollila HM, 2015, AM J HUM GENET, V96, P136, DOI 10.1016/j.ajhg.2014.12.010; Partinen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033723; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Pizza F, 2013, EUR NEUROL, V70, P22, DOI 10.1159/000348719; Plazzi G, 2011, BRAIN, V134, P3477, DOI 10.1093/brain/awr244; Reiter J, 2015, SLEEP, V38, P859, DOI 10.5665/sleep.4728; Robertson SD, 2009, MOL NEUROBIOL, V39, P73, DOI 10.1007/s12035-009-8053-4; Rogers AE, 1997, NEUROLOGY, V48, P1550, DOI 10.1212/WNL.48.6.1550; Roth T, 2013, J CLIN SLEEP MED, V9, P955, DOI 10.5664/jcsm.3004; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Scammell TE, 2015, TREATMENT NARCOLEPSY; Tafti M, 2014, SLEEP, V37, P19, DOI 10.5665/sleep.3300; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Thannickal TC, 2009, SLEEP, V32, P993, DOI 10.1093/sleep/32.8.993; Thorpy MJ, 2014, SLEEP MED, V15, P502, DOI 10.1016/j.sleep.2014.01.015; Trotti LM, 2013, J CLIN SLEEP MED, V9, P789, DOI 10.5664/jcsm.2922; Vienne J, 2010, J NEUROSCI, V30, P14194, DOI 10.1523/JNEUROSCI.3145-10.2010; Wamsley E, 2014, SLEEP, V37, P419, DOI 10.5665/sleep.3428	50	245	257	5	102	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 31	2015	373	27					2654	2662		10.1056/NEJMra1500587	http://dx.doi.org/10.1056/NEJMra1500587			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ8UH	26716917				2022-12-28	WOS:000367374100010
J	Bai, Y; Muller, DB; Srinivas, G; Garrido-Oter, R; Potthoff, E; Rott, M; Dombrowski, N; Munch, PC; Spaepen, S; Remus-Emsermann, M; Huttel, B; McHardy, AC; Vorholt, JA; Schulze-Lefert, P				Bai, Yang; Mueller, Daniel B.; Srinivas, Girish; Garrido-Oter, Ruben; Potthoff, Eva; Rott, Matthias; Dombrowski, Nina; Muench, Philipp C.; Spaepen, Stijn; Remus-Emsermann, Mitja; Huettel, Bruno; McHardy, Alice C.; Vorholt, Julia A.; Schulze-Lefert, Paul			Functional overlap of the Arabidopsis leaf and root microbiota	NATURE			English	Article							PLANT; COMMUNITY; ASSOCIATION; NUTRITION; SEQUENCES; INSIGHTS; GROWTH	Roots and leaves of healthy plants host taxonomically structured bacterial assemblies, and members of these communities contribute to plant growth and health. We established Arabidopsis leaf-and root-derived microbiota culture collections representing the majority of bacterial species that are reproducibly detectable by culture-independent community sequencing. We found an extensive taxonomic overlap between the leaf and root microbiota. Genome drafts of 400 isolates revealed a large overlap of genome-encoded functional capabilities between leaf-and root-derived bacteria with few significant differences at the level of individual functional categories. Using defined bacterial communities and a gnotobiotic Arabidopsis plant system we show that the isolates form assemblies resembling natural microbiota on their cognate host organs, but are also capable of ectopic leaf or root colonization. While this raises the possibility of reciprocal relocation between root and leaf microbiota members, genome information and recolonization experiments also provide evidence for microbiota specialization to their respective niche.	[Bai, Yang; Srinivas, Girish; Garrido-Oter, Ruben; Rott, Matthias; Dombrowski, Nina; Spaepen, Stijn; Schulze-Lefert, Paul] Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, D-50829 Cologne, Germany; [Mueller, Daniel B.; Potthoff, Eva; Remus-Emsermann, Mitja; Vorholt, Julia A.] ETH, Inst Microbiol, CH-8093 Zurich, Switzerland; [Garrido-Oter, Ruben] Univ Dusseldorf, Dept Algorithm Bioinformat, D-40225 Dusseldorf, Germany; [Garrido-Oter, Ruben; McHardy, Alice C.; Schulze-Lefert, Paul] Max Planck Inst Plant Breeding Res, Cluster Excellence Plant Sci CEPLAS, D-50829 Cologne, Germany; [Muench, Philipp C.; McHardy, Alice C.] Helmholtz Ctr Infect Res, Computat Biol Infect Res, D-38124 Braunschweig, Germany; [Muench, Philipp C.] Univ Munich, Max von Pettenkofer Inst, German Ctr Infect Res DZIF, Partner Site LMU Munich, D-80336 Munich, Germany; [Muench, Philipp C.] German Ctr Infect Res DZIF, Partner Site Hannover Braunschweig, D-38124 Braunschweig, Germany; [Huettel, Bruno] Max Planck Inst Plant Breeding Res, Max Planck Genome Ctr, D-50829 Cologne, Germany	Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich; Heinrich Heine University Dusseldorf; Max Planck Society; University of Cologne; Helmholtz Association; Helmholtz-Center for Infection Research; German Center for Infection Research; University of Munich; German Center for Infection Research; Max Planck Society	Vorholt, JA (corresponding author), ETH, Inst Microbiol, CH-8093 Zurich, Switzerland.	jvorholt@ethz.ch; schlef@mpipz.mpg.de	Dombrowski, Nina/L-8535-2017; Vorholt, Julia/K-3514-2016; Schulze-Lefert, Paul/B-6707-2011; McHardy, Alice C/K-9377-2018; Bai, Yang/AAH-1518-2019; McHardy, Alice/ABF-2322-2020; Spaepen, Stijn/H-5646-2019; Remus-Emsermann, Mitja NP/R-3776-2016	Dombrowski, Nina/0000-0003-1917-2577; Vorholt, Julia/0000-0002-6011-4910; McHardy, Alice C/0000-0003-2370-3430; McHardy, Alice/0000-0003-2370-3430; Spaepen, Stijn/0000-0001-5465-8287; Remus-Emsermann, Mitja NP/0000-0002-6378-9526; Bai, Yang/0000-0003-2652-7022	Max Planck Society; European Research Council; 'Cluster of Excellence on Plant Sciences' program - Deutsche Forschungsgemeinschaft; German Center for Infection Research (DZIF); ETH Zurich [ETH-41 14-2]; Swiss National Research Foundation [310030B_152835]	Max Planck Society(Max Planck SocietyFoundation CELLEX); European Research Council(European Research Council (ERC)European Commission); 'Cluster of Excellence on Plant Sciences' program - Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Center for Infection Research (DZIF); ETH Zurich(ETH Zurich); Swiss National Research Foundation(Swiss National Science Foundation (SNSF))	We thank D. Lundberg, S. Lebeis, S. Herrera-Paredes, S. Biswas and J. Dangl for sharing the calcined clay utilization protocol before publication; M. Kisielow of the ETH Zurich Flow Cytometry Core Facility for help with bacterial cell sorting as well as M. Baltisberger, D. Jolic and D. Weigel for their help in finding natural Arabidopsis populations; E. Kemen and M. Agler for sharing the Illumina Mi-Seq protocol for profiling of defined communities before publication and A. Sczyrba for his advice with the genome assembly. This work was supported by funds to P.S.-L. from the Max Planck Society, a European Research Council advanced grant (ROOTMICROBIOTA), the 'Cluster of Excellence on Plant Sciences' program funded by the Deutsche Forschungsgemeinschaft, the German Center for Infection Research (DZIF), by funds to J.A.V. from ETH Zurich (ETH Research Grant ETH-41 14-2), a grant from the Swiss National Research Foundation (310030B_152835), and a European Research Council advanced grant (PhyMo).	Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Bodenhausen N, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004283; Bodenhausen N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056329; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bulgarelli D, 2015, CELL HOST MICROBE, V17, P392, DOI 10.1016/j.chom.2015.01.011; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Chelius MK, 2001, MICROB ECOL, V41, P252, DOI 10.1007/s002480000087; Chi F, 2005, APPL ENVIRON MICROB, V71, P7271, DOI 10.1128/AEM.71.11.7271-7278.2005; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Delmotte N, 2009, P NATL ACAD SCI USA, V106, P16428, DOI 10.1073/pnas.0905240106; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Droge J, 2015, BIOINFORMATICS, V31, P817, DOI 10.1093/bioinformatics/btu745; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edwards J, 2015, P NATL ACAD SCI USA, V112, pE911, DOI 10.1073/pnas.1414592112; Faure D, 2009, PLANT SOIL, V321, P279, DOI 10.1007/s11104-008-9839-2; Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108; Guttman DS, 2014, NAT REV GENET, V15, P797, DOI 10.1038/nrg3748; Hacquard S, 2015, CELL HOST MICROBE, V17, P603, DOI 10.1016/j.chom.2015.04.009; Horton MW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6320; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Lebeis SL, 2015, SCIENCE, V349, P860, DOI 10.1126/science.aaa8764; Lebeis SL, 2012, NEW PHYTOL, V196, P341, DOI 10.1111/j.1469-8137.2012.04336.x; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Maignien L, 2014, MBIO, V5, DOI 10.1128/mBio.00682-13; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Ramachandran VK, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r106; Rosenberg E., 2013, HOLOGENOME CONCEPT H; Schlaeppi K, 2014, P NATL ACAD SCI USA, V111, P585, DOI 10.1073/pnas.1321597111; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Subramanian S, 2015, CELL, V161, P36, DOI 10.1016/j.cell.2015.03.013; Tritt A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042304; Vorholt JA, 2012, NAT REV MICROBIOL, V10, P828, DOI 10.1038/nrmicro2910; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Wu M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r151; Zarraonaindia I, 2015, MBIO, V6, DOI 10.1128/mBio.02527-14	44	575	620	81	881	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 17	2015	528	7582					364	+		10.1038/nature16192	http://dx.doi.org/10.1038/nature16192			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY8SM	26633631				2022-12-28	WOS:000366678600045
J	Beattie, GA				Beattie, Gwyn A.			MICROBIOMES Curating communities from plants	NATURE			English	Editorial Material									[Beattie, Gwyn A.] Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA 50014 USA	Iowa State University	Beattie, GA (corresponding author), Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA 50014 USA.	gbeattie@iastate.edu						Alivisatos AP, 2015, SCIENCE, V350, P507, DOI 10.1126/science.aac8480; Bai Y, 2015, NATURE, V528, P364, DOI 10.1038/nature16192; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Dubilier N, 2015, NATURE, V526, P631, DOI 10.1038/526631a; Edwards J, 2015, P NATL ACAD SCI USA, V112, pE911, DOI 10.1073/pnas.1414592112; Horton MW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6320; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Schlaeppi K, 2014, P NATL ACAD SCI USA, V111, P585, DOI 10.1073/pnas.1321597111	9	20	20	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2015	528	7582					340	341		10.1038/nature16319	http://dx.doi.org/10.1038/nature16319			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY8SM	26633626				2022-12-28	WOS:000366678600039
J	Tang, ZH; Luo, OJ; Li, XW; Zheng, MZ; Zhu, JJ; Szalaj, P; Trzaskoma, P; Magalska, A; Wlodarczyk, J; Ruszczycki, B; Michalski, P; Piecuch, E; Wang, P; Wang, DJ; Tian, SZ; Penrad-Mobayed, M; Sachs, LM; Ruan, XA; Wei, CL; Liu, ET; Wilczynski, GM; Plewczynski, D; Li, GL; Ruan, YJ				Tang, Zhonghui; Luo, Oscar Junhong; Li, Xingwang; Zheng, Meizhen; Zhu, Jacqueline Jufen; Szalaj, Przemyslaw; Trzaskoma, Pawel; Magalska, Adriana; Wlodarczyk, Jakub; Ruszczycki, Blazej; Michalski, Paul; Piecuch, Emaly; Wang, Ping; Wang, Danjuan; Tian, Simon Zhongyuan; Penrad-Mobayed, May; Sachs, Laurent M.; Ruan, Xiaoan; Wei, Chia-Lin; Liu, Edison T.; Wilczynski, Grzegorz M.; Plewczynski, Dariusz; Li, Guoliang; Ruan, Yijun			CTCF-Mediated Human 3D Genome Architecture Reveals Chromatin Topology for Transcription	CELL			English	Article							IN-SITU HYBRIDIZATION; CHROMOSOMES; PRINCIPLES; RESOLUTION; BINDING	Spatial genome organization and its effect on transcription remains a fundamental question. We applied an advanced chromatin interaction analysis by paired-end tag sequencing (ChIA-PET) strategy to comprehensively map higher-order chromosome folding and specific chromatin interactions mediated by CCCTC-binding factor (CTCF) and RNA polymerase II (RNAPII) with haplotype specificity and nucleotide resolution in different human cell lineages. We find that CTCF/cohesin-mediated interaction anchors serve as structural foci for spatial organization of constitutive genes concordant with CTCF-motif orientation, whereas RNAPII interacts within these structures by selectively drawing cell-type-specific genes toward CTCF foci for coordinated transcription. Furthermore, we show that haplotype variants and allelic interactions have differential effects on chromosome configuration, influencing gene expression, and may provide mechanistic insights into functions associated with disease susceptibility. 3D genome simulation suggests a model of chromatin folding around chromosomal axes, where CTCF is involved in defining the interface between condensed and open compartments for structural regulation. Our 3D genome strategy thus provides unique insights in the topological mechanism of human variations and diseases.	[Tang, Zhonghui; Luo, Oscar Junhong; Li, Xingwang; Zheng, Meizhen; Zhu, Jacqueline Jufen; Michalski, Paul; Piecuch, Emaly; Wang, Ping; Wang, Danjuan; Tian, Simon Zhongyuan; Ruan, Xiaoan; Liu, Edison T.; Ruan, Yijun] Jackson Lab Genom Med, Farmington, CT 06030 USA; [Li, Xingwang; Li, Guoliang; Ruan, Yijun] Huazhong Agr Univ, Coll Life Sci & Technol, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Hubei, Peoples R China; [Zhu, Jacqueline Jufen; Ruan, Yijun] Univ Connecticut, Ctr Hlth, Dept Genet & Genome Sci, Farmington, CT 06030 USA; [Szalaj, Przemyslaw] Med Univ Bialystok, Ctr Bioinformat & Data Anal, PL-15089 Bialystok, Poland; [Szalaj, Przemyslaw] Hasselt Univ, I BioStat, B-3590 Diepenbeek, Belgium; [Szalaj, Przemyslaw; Plewczynski, Dariusz] Univ Warsaw, Ctr New Technol, PL-02097 Warsaw, Poland; [Trzaskoma, Pawel; Magalska, Adriana; Wlodarczyk, Jakub; Ruszczycki, Blazej; Wilczynski, Grzegorz M.] M Nencki Inst Expt Biol, PL-02093 Warsaw, Poland; [Penrad-Mobayed, May] Univ Paris 07, CNRS, F-75205 Paris, France; [Penrad-Mobayed, May] Inst Jacques Monod, F-75205 Paris, France; [Sachs, Laurent M.] CNRS, F-75231 Paris, France; [Sachs, Laurent M.] Museum Natl Hist Nat, F-75231 Paris, France; [Wei, Chia-Lin] Joint Genome Inst, Walnut Creek, CA 94598 USA; [Li, Guoliang] Huazhong Agr Univ, Coll Informat, Wuhan 430070, Hubei, Peoples R China	Jackson Laboratory; Huazhong Agricultural University; University of Connecticut; Medical University of Bialystok; Hasselt University; University of Warsaw; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Huazhong Agricultural University	Ruan, YJ (corresponding author), Jackson Lab Genom Med, 10 Discovery Dr, Farmington, CT 06030 USA.	yijun.ruan@jax.org	Ruszczycki, Blazej/AAC-6385-2020; Luo, Oscar Junhong/G-3293-2018; Sachs, Laurent/AAE-1504-2020; Li, Guoliang/D-8014-2012; Luo, Junhong/N-8583-2019; Wlodarczyk, Jakub/A-2253-2015	Ruszczycki, Blazej/0000-0002-0262-1463; Li, Guoliang/0000-0003-1601-6640; Wlodarczyk, Jakub/0000-0001-8343-2340; Magalska, Adriana/0000-0002-0517-7134; Tang, Zhonghui/0000-0003-2907-3986; Wilczynski, Grzegorz/0000-0001-6667-0291; Plewczynski, Dariusz/0000-0002-3840-7610; zheng, meizhen/0000-0001-5569-1812; Luo, Oscar Junhong/0000-0002-1266-3069; Trzaskoma, Pawel/0000-0002-5823-6572	Director Innovation Fund of The Jackson Laboratory; NCI [R01 CA186714]; NHGRI [R25HG007631]; NIDDK [U54DK107967 (4DN)]; Roux family; China "111 project'' [B07041]; Polish National Science Centre [UMO-2012/05/E/NZ4/02997, 2014/15/B/ST6/05082, UMO-2013/09/B/NZ2/00121, DEC-2012/06/M/NZ3/00163]; National Leading Research Centre in Bialystok; European Union under the European Social Fund; NATIONAL CANCER INSTITUTE [R01CA186714, P30CA034196] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R25HG007631] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK107967] Funding Source: NIH RePORTER	Director Innovation Fund of The Jackson Laboratory; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Roux family; China "111 project''; Polish National Science Centre; National Leading Research Centre in Bialystok; European Union under the European Social Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Y.R. is supported by the Director Innovation Fund of The Jackson Laboratory, NCI R01 CA186714, NHGRI R25HG007631, NIDDK U54DK107967 (4DN), and the Roux family as the Florine Roux Endowed Chair in Genomics and Computational Biology. X.L. is supported in part by China "111 project'' (B07041). Polish National Science Centre supports G.M.W. [UMO-2012/05/E/NZ4/02997]; D.P. and P.S. [2014/15/B/ST6/05082; UMO-2013/09/B/NZ2/00121]; and J.W. [DEC-2012/06/M/NZ3/00163]. D.P. and P.S. are also supported by National Leading Research Centre in Bialystok and the European Union under the European Social Fund. The authors thank C.Z. Zhang for initial DNA-FISH, Agnieszka Walczak and Katarzyna Krawczyk for FISH discussion, Rafael Casellas, Michael Stitzel, and Duygu Ucar for manuscript discussion, and Gosia Popiel for help on preparing Figure S7. Some of the genome sequences described in this research were derived from a HeLa cell line. Henrietta Lacks, and the HeLa cell line that was established from her tumor cells without her knowledge or consent in 1951, have made significant contributions to scientific progress and advances in human health. We are grateful to Henrietta Lacks, now deceased, and to her surviving family members for their contributions to biomedical research. The request to use HeLa data for this research was approved by the NIH Director based on the recommendations of the Advisory Committee to the Director and the evaluation by its HeLa Genome Data Access Working Group (http://acd.od.nih.gov/hlgda.htm). The HeLa genomic datasets used for analysis described in this manuscript were obtained from the database of Genotypes and Phenotypes (dbGaP) through dbGaP: phs000640.	Bickmore WA, 2013, ANNU REV GENOM HUM G, V14, P67, DOI 10.1146/annurev-genom-091212-153515; Boyle S, 2011, CHROMOSOME RES, V19, P901, DOI 10.1007/s10577-011-9245-0; Cremer Marion, 2008, V463, P205, DOI 10.1007/978-1-59745-406-3_15; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Guo Y, 2015, CELL, V162, P900, DOI 10.1016/j.cell.2015.07.038; Hall M.H., 2015, BRAIN STRUCT FUNCT; He QY, 2015, NAT BIOTECHNOL, V33, P395, DOI 10.1038/nbt.3121; Horakova AH, 2012, HUM MOL GENET, V21, P4367, DOI 10.1093/hmg/dds270; Kalhor R, 2012, NAT BIOTECHNOL, V30, P90, DOI 10.1038/nbt.2057; Leung D, 2015, NATURE, V518, P350, DOI 10.1038/nature14217; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li G, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r22; Liang ZY, 2015, CELL, V161, P1124, DOI 10.1016/j.cell.2015.04.030; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; McDaniell R, 2010, SCIENCE, V328, P235, DOI 10.1126/science.1184655; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Morgan GT, 2002, CHROMOSOME RES, V10, P177, DOI 10.1023/A:1015227020652; Nativio R, 2011, HUM MOL GENET, V20, P1363, DOI 10.1093/hmg/ddr018; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Penrad-Mobayed M, 2010, METHODS, V51, P37, DOI 10.1016/j.ymeth.2010.01.014; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Rozowsky J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.54; Selvaraj S, 2013, NAT BIOTECHNOL, V31, P1111, DOI 10.1038/nbt.2728; Sims RJ, 2004, CURR OPIN CELL BIOL, V16, P263, DOI 10.1016/j.ceb.2004.04.004; Verlaan DJ, 2009, AM J HUM GENET, V85, P377, DOI 10.1016/j.ajhg.2009.08.007; Zhang YB, 2013, NATURE, V504, P306, DOI 10.1038/nature12716	29	543	562	3	117	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2015	163	7					1611	1627		10.1016/j.cell.2015.11.024	http://dx.doi.org/10.1016/j.cell.2015.11.024			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CZ1GN	26686651	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000366854200010
J	Kunkel, TA				Kunkel, Thomas A.			Celebrating DNA's Repair Crew	CELL			English	Editorial Material							EXCISION-REPAIR; ESCHERICHIA-COLI; MISMATCH; PHOTOLYASE; DAMAGE	This year, the Nobel Prize in Chemistry has been awarded to Tomas Lindahl, Aziz Sancar, and Paul Modrich for their seminal studies of the mechanisms by which cells from bacteria to man repair DNA damage that is generated by normal cellular metabolism and stress from the environment. These studies beautifully illustrate the remarkable power of DNA repair to influence life from evolution through disease susceptibility.	[Kunkel, Thomas A.] NIEHS, Genome Integr & Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Kunkel, TA (corresponding author), NIEHS, Genome Integr & Struct Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	kunkel@niehs.nih.gov	Kunkel, Thomas A./D-5088-2019	Kunkel, Thomas A./0000-0002-9900-1788				Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; LAHUE RS, 1989, SCIENCE, V245, P160, DOI 10.1126/science.2665076; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3610, DOI 10.1021/bi00769a018; Lindsey-Boltz LA, 2014, J BIOL CHEM, V289, P5074, DOI 10.1074/jbc.M113.542787; Liu YY, 2010, J BIOL CHEM, V285, P5974, DOI 10.1074/jbc.M109.076109; MODRICH P, 1991, ANNU REV GENET, V25, P229, DOI 10.1146/annurev.ge.25.120191.001305; Mu D, 1997, MOL CELL BIOL, V17, P760, DOI 10.1128/MCB.17.2.760; Petit C, 1999, BIOCHIMIE, V81, P15, DOI 10.1016/S0300-9084(99)80034-0; Prasad R, 2011, MOL BIOL+, V45, P536, DOI 10.1134/S0026893311040091; SANCAR A, 1978, GENE, V4, P295, DOI 10.1016/0378-1119(78)90047-1; Sancar A, 2010, FEBS LETT, V584, P2618, DOI 10.1016/j.febslet.2010.03.017; SANCAR GB, 1987, J BIOL CHEM, V262, P492; Scharer OD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012609	15	16	16	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 6	2015	163	6					1301	1303		10.1016/j.cell.2015.11.028	http://dx.doi.org/10.1016/j.cell.2015.11.028			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SE	26638062	Bronze			2022-12-28	WOS:000366044800008
J	Alsbaiee, A; Smith, BJ; Xiao, LL; Ling, YH; Helbling, DE; Dichtel, WR				Alsbaiee, Alaaeddin; Smith, Brian J.; Xiao, Leilei; Ling, Yuhan; Helbling, Damian E.; Dichtel, William R.			Rapid removal of organic micropollutants from water by a porous beta-cyclodextrin polymer	NATURE			English	Article							PERSONAL CARE PRODUCTS; WASTE-WATER; BISPHENOL-A; EMERGING CONTAMINANTS; ADSORPTION; PHARMACEUTICALS; PESTICIDES; EXPOSURE; CHITOSAN; SURFACE	The global occurrence in water resources of organic micropollutants, such as pesticides and pharmaceuticals, has raised concerns about potential negative effects on aquatic ecosystems and human health(1-5). Activated carbons are the most widespread adsorbent materials used to remove organic pollutants from water but they have several deficiencies, including slow pollutant uptake (of the order of hours)(6,7) and poor removal of many relatively hydrophilic micropollutants(8). Furthermore, regenerating spent activated carbon is energy intensive (requiring heating to 500-900 degrees Celsius) and does not fully restore performance(9,10). Insoluble polymers of beta-cyclodextrin, an inexpensive, sustainably produced macrocycle of glucose, are likewise of interest for removing micropollutants from water by means of adsorption(11). beta-cyclodextrin is known to encapsulate pollutants to form well-defined host-guest complexes, but until now cross-linked beta-cyclodextrin polymers have had low surface areas and poor removal performance compared to conventional activated carbons(11-13). Here we crosslink beta-cyclodextrin with rigid aromatic groups, providing a high-surface-area, mesoporous polymer of beta-cyclodextrin. It rapidly sequesters a variety of organic micropollutants with adsorption rate constants 15 to 200 times greater than those of activated carbons and non-porous beta-cyclodextrin adsorbent materials(7,8,11-13). In addition, the polymer can be regenerated several times using a mild washing procedure with no loss in performance. Finally, the polymer outperformed a leading activated carbon for the rapid removal of a complex mixture of organic micropollutants at environmentally relevant concentrations. These findings demonstrate the promise of porous cyclodextrin-based polymers for rapid, flow-through water treatment.	[Alsbaiee, Alaaeddin; Smith, Brian J.; Xiao, Leilei; Dichtel, William R.] Cornell Univ, Dept Chem & Chem Biol, Baker Lab, Ithaca, NY 14853 USA; [Ling, Yuhan; Helbling, Damian E.] Cornell Univ, Sch Civil & Environm Engn, Ithaca, NY 14853 USA	Cornell University; Cornell University	Dichtel, WR (corresponding author), Cornell Univ, Dept Chem & Chem Biol, Baker Lab, Ithaca, NY 14853 USA.	damian.helbling@cornell.edu; wdichtel@cornell.edu	Dichtel, William R/A-5503-2009	Dichtel, William R/0000-0002-3635-6119; Helbling, Damian/0000-0003-2588-145X; Ling, Yuhan/0000-0002-4365-8908; Smith, Brian/0000-0002-2329-190X	National Science Foundation (NSF) through Center for Sustainable Polymers [CHE-1413862]; NSF [DMR-1120296]; Direct For Mathematical & Physical Scien [1413862] Funding Source: National Science Foundation	National Science Foundation (NSF) through Center for Sustainable Polymers(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the National Science Foundation (NSF) through the Center for Sustainable Polymers (CHE-1413862). This research made use of the Cornell Center for Materials Research User Facilities, which are supported by the NSF (DMR-1120296). We acknowledge I. Keresztes for help with NMR spectroscopy, and M. Matsumoto for the design of the schematic of the polymer in Fig. 1a.	Aoki N, 2003, CARBOHYD POLYM, V52, P219, DOI 10.1016/S0144-8617(02)00308-9; Benner J, 2013, WATER RES, V47, P5955, DOI 10.1016/j.watres.2013.07.015; Bisby R, 2012, SPECTROSC-INT J, V27, P533, DOI 10.1155/2012/518353; Budd PM, 2004, CHEM COMMUN, P230, DOI 10.1039/b311764b; Chiang PC, 1997, WATER SCI TECHNOL, V35, P279, DOI 10.2166/wst.1997.0287; Crini G, 2002, J SEP SCI, V25, P789, DOI 10.1002/1615-9314(20020901)25:13<789::AID-JSSC789>3.0.CO;2-J; Daughton CG, 1999, ENVIRON HEALTH PERSP, V107, P907, DOI 10.2307/3434573; Garcia-Zubiri IX, 2009, J COLLOID INTERF SCI, V337, P11, DOI 10.1016/j.jcis.2009.04.071; Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5; Huntscha S, 2012, J CHROMATOGR A, V1268, P74, DOI 10.1016/j.chroma.2012.10.032; Ike M, 2006, WATER SCI TECHNOL, V53, P153, DOI 10.2166/wst.2006.189; Kidd KA, 2007, P NATL ACAD SCI USA, V104, P8897, DOI 10.1073/pnas.0609568104; Kim YH, 2011, MICROPOR MESOPOR MAT, V138, P184, DOI 10.1016/j.micromeso.2010.09.007; Kitaoka M, 2002, J INCL PHENOM MACRO, V44, P429, DOI 10.1023/A:1023024004103; Kostich MS, 2014, ENVIRON POLLUT, V184, P354, DOI 10.1016/j.envpol.2013.09.013; Kovalova L, 2013, ENVIRON SCI POLLUT R, V20, P3607, DOI 10.1007/s11356-012-1432-9; Kyzas GZ, 2013, CARBOHYD POLYM, V91, P198, DOI 10.1016/j.carbpol.2012.08.016; Latch DE, 2005, ENVIRON TOXICOL CHEM, V24, P517, DOI 10.1897/04-243R.1; Liang LP, 2015, FRONT ENV SCI ENG, V9, P16, DOI 10.1007/s11783-014-0697-2; Liu HH, 2011, WATER RES, V45, P3499, DOI 10.1016/j.watres.2011.04.004; Lo Meo P, 2014, POLYM CHEM-UK, V5, P4499, DOI 10.1039/c4py00325j; McKinlay R, 2008, ENVIRON INT, V34, P168, DOI 10.1016/j.envint.2007.07.013; Morin-Crini N, 2013, PROG POLYM SCI, V38, P344, DOI 10.1016/j.progpolymsci.2012.06.005; Murray KE, 2010, ENVIRON POLLUT, V158, P3462, DOI 10.1016/j.envpol.2010.08.009; Ngah WSW, 2011, CARBOHYD POLYM, V83, P1446, DOI 10.1016/j.carbpol.2010.11.004; Occupational Safety and Health Administration (OSHA) Standard USA, 2012, 19101003 OSHA; ONeil M.J., 2006, MERCK INDEX ENCY CHE, V14th; Orfao JJM, 2006, J COLLOID INTERF SCI, V296, P480, DOI 10.1016/j.jcis.2005.09.063; Oulton RL, 2010, J ENVIRON MONITOR, V12, P1956, DOI 10.1039/c0em00068j; Putra EK, 2009, WATER RES, V43, P2419, DOI 10.1016/j.watres.2009.02.039; Richardson SD, 2014, ANAL CHEM, V86, P2813, DOI 10.1021/ac500508t; San Miguel G, 2001, WATER RES, V35, P2740, DOI 10.1016/S0043-1354(00)00549-2; Schwarzenbach RP, 2006, SCIENCE, V313, P1072, DOI 10.1126/science.1127291; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Zhou LC, 2014, APPL SURF SCI, V292, P735, DOI 10.1016/j.apsusc.2013.12.041	35	1087	1128	156	2877	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 14	2016	529	7585					190	U146		10.1038/nature16185	http://dx.doi.org/10.1038/nature16185			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA7WK	26689365				2022-12-28	WOS:000368015700032
J	Sabir, JSM; Lam, TTY; Ahmed, MMM; Li, LF; Shen, YY; Abo-Aba, SEM; Qureshi, MI; Abu-Zeid, M; Zhang, Y; Khiyami, MA; Alharbi, NS; Hajrah, NH; Sabir, MJ; Mutwakil, MHZ; Kabli, SA; Alsulaimany, FAS; Obaid, AY; Zhou, BP; Smith, DK; Holmes, EC; Zhu, HC; Guan, Y				Sabir, Jamal S. M.; Lam, Tommy T. -Y.; Ahmed, Mohamed M. M.; Li, Lifeng; Shen, Yongyi; Abo-Aba, Salah E. M.; Qureshi, Muhammad I.; Abu-Zeid, Mohamed; Zhang, Yu; Khiyami, Mohammad A.; Alharbi, Njud S.; Hajrah, Nahid H.; Sabir, Meshaal J.; Mutwakil, Mohammed H. Z.; Kabli, Saleh A.; Alsulaimany, Faten A. S.; Obaid, Abdullah Y.; Zhou, Boping; Smith, David K.; Holmes, Edward C.; Zhu, Huachen; Guan, Yi			Co-circulation of three camel coronavirus species and recombination of MERS-CoVs in Saudi Arabia	SCIENCE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; MIDDLE-EAST; DROMEDARY CAMELS; ANTIBODIES; IDENTIFICATION; LIVESTOCK; TRACT	Outbreaks of Middle East respiratory syndrome (MERS) raise questions about the prevalence and evolution of the MERS coronavirus (CoV) in its animal reservoir. Our surveillance in Saudi Arabia in 2014 and 2015 showed that viruses of the MERS-CoV species and a human CoV 229E-related lineage co-circulated at high prevalence, with frequent co-infections in the upper respiratory tract of dromedary camels. Including a betacoronavirus 1 species, we found that dromedary camels share three CoV species with humans. Several MERS-CoV lineages were present in camels, including a recombinant lineage that has been dominant since December 2014 and that subsequently led to the human outbreaks in 2015. Camels therefore serve as an important reservoir for the maintenance and diversification of the MERS-CoVs and are the source of human infections with this virus.	[Sabir, Jamal S. M.; Ahmed, Mohamed M. M.; Abo-Aba, Salah E. M.; Qureshi, Muhammad I.; Abu-Zeid, Mohamed; Alharbi, Njud S.; Hajrah, Nahid H.; Sabir, Meshaal J.; Mutwakil, Mohammed H. Z.; Kabli, Saleh A.; Alsulaimany, Faten A. S.; Guan, Yi] King Abdulaziz Univ, Fac Sci, Dept Biol Sci, Biotechnol Res Grp, Jeddah 21589, Saudi Arabia; [Lam, Tommy T. -Y.; Zhang, Yu; Zhou, Boping; Zhu, Huachen; Guan, Yi] Univ Hong Kong, Shenzhen Peoples Hosp 3, State Key Lab Emerging Infect Dis, Shenzhen Branch, Shenzhen, Peoples R China; [Lam, Tommy T. -Y.; Li, Lifeng; Shen, Yongyi; Zhang, Yu; Zhu, Huachen; Guan, Yi] Shantou Univ, Univ Hong Kong, Joint Inst Virol, Shantou, Peoples R China; [Lam, Tommy T. -Y.; Li, Lifeng; Shen, Yongyi; Zhang, Yu; Smith, David K.; Zhu, Huachen; Guan, Yi] Univ Hong Kong, Sch Publ Hlth, Ctr Influenza Res, Hong Kong, Hong Kong, Peoples R China; [Lam, Tommy T. -Y.; Li, Lifeng; Shen, Yongyi; Zhang, Yu; Smith, David K.; Zhu, Huachen; Guan, Yi] Univ Hong Kong, Sch Publ Hlth, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Holmes, Edward C.] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Charles Perkins Ctr, Sch Biol Sci, Sydney, NSW 2006, Australia; [Holmes, Edward C.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Ahmed, Mohamed M. M.] City Sci Res & Technol Applicat, Genet Engn & Biotechnol Res Inst, Dept Nucle Acids Res, Alexandria, Egypt; [Abo-Aba, Salah E. M.; Abu-Zeid, Mohamed] Natl Res Ctr, Genet Engn & Biotechnol Div, Microbial Genet Dept, Giza, Egypt; [Khiyami, Mohammad A.] King Abdulaziz City Sci & Technol, Riyadh 11442, Saudi Arabia; [Obaid, Abdullah Y.] King Abdulaziz Univ, Fac Sci, Dept Chem, Jeddah 21589, Saudi Arabia	King Abdulaziz University; China Construction Bank; University of Hong Kong; Shantou University; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Sydney; University of Sydney; Egyptian Knowledge Bank (EKB); City of Scientific Research & Technological Applications (SRTA-City); Egyptian Knowledge Bank (EKB); National Research Centre (NRC); King Abdulaziz City for Science & Technology; King Abdulaziz University	Zhu, HC (corresponding author), Univ Hong Kong, Shenzhen Peoples Hosp 3, State Key Lab Emerging Infect Dis, Shenzhen Branch, Shenzhen, Peoples R China.	zhuhch@hku.hk; yguan@hku.hk	Sabir, Jamal S M/C-8102-2014; Holmes, Edward/Y-2789-2019; Holmes, Edward/GVR-9499-2022; Ahmed, Mohamed/E-7818-2011; Shen, Yongyi/GWU-8031-2022; Hajrah, Nahid/AAT-2659-2021; Seleman, Mohamed/J-8211-2017; Zhu, Huachen/A-8252-2017; alsulaimany, Faten/AAW-6562-2020; Hajrah, Nahid/AAY-3196-2020; Lam, Tsan Yuk/D-4837-2012	Holmes, Edward/0000-0001-9596-3552; Hajrah, Nahid/0000-0001-6404-1627; Seleman, Mohamed/0000-0003-2059-5796; Zhu, Huachen/0000-0003-2711-0501; Smith, David/0000-0003-3608-0586; Lam, Tsan Yuk/0000-0002-9769-1527; Shen, Yongyi/0000-0001-7660-5522; Guan, Yi/0000-0001-6057-9243	Deanship of Scientific Research of King Abdulaziz University [DSR 46-130-35-HiCi]; Development Committee of Basic Sciences at King Abdulaziz University; Shenzhen Peacock Plan High-End Talents Program [KQTD201203]; Li Ka Shing Foundation; Theme-based Research Scheme [T11-705/14-N]; National Health and Medical Research Council of Australia [AF30]	Deanship of Scientific Research of King Abdulaziz University; Development Committee of Basic Sciences at King Abdulaziz University; Shenzhen Peacock Plan High-End Talents Program; Li Ka Shing Foundation; Theme-based Research Scheme; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	We thank C.-H. Yip, C.-L. Cheung, Y. Chai, C. Ma, T. Gan, Z. Jin, Z. Ou, P. Huang, J. Zhou, and G. Yu for technical assistance and P. Kellam, A. Bin Saeed, M. Cotten, M. A. Barry, and A. M. Somily for making sequences available before their formal publication. This study was supported by the Deanship of Scientific Research (DSR 46-130-35-HiCi) of King Abdulaziz University; the Vice President for Educational Affairs A. O. Alyoubi under the umbrella of the Development Committee of Basic Sciences at King Abdulaziz University; the Shenzhen Peacock Plan High-End Talents Program (award KQTD201203); and the Li Ka Shing Foundation and Theme-based Research Scheme (award T11-705/14-N). E.C.H. is supported by an Australia Fellowship from the National Health and Medical Research Council of Australia (award AF30). All authors declare no competing financial interests. The sequences generated by this study were deposited in GenBank under accession numbers KT368824 to KT368916; additional data can be found in the supplementary materials.	Adney DR, 2014, EMERG INFECT DIS, V20, P1999, DOI 10.3201/eid2012.141280; Alagaili AN, 2014, MBIO, V5, DOI [10.1128/mBio.00884-14, 10.1128/mBio.01482-14]; Bermingham A, 2012, EUROSURVEILLANCE, V17, P6; Corman VM, 2014, EMERG INFECT DIS, V20, P1319, DOI 10.3201/eid2008.140596; Corman VM, 2014, J VIROL, V88, P11297, DOI 10.1128/JVI.01498-14; Crossley BM, 2012, VIRUSES-BASEL, V4, P3689, DOI 10.3390/v4123689; Crossley BM, 2010, J VET DIAGN INVEST, V22, P94, DOI 10.1177/104063871002200118; de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13; Farag Elmoubasher A. B. A., 2015, Infection Ecology & Epidemiology, V5, P28305, DOI 10.3402/iee.v5.28305; Haagmans BL, 2014, LANCET INFECT DIS, V14, P140, DOI 10.1016/S1473-3099(13)70690-X; Hemida MG, 2013, EUROSURVEILLANCE, V18, P21, DOI 10.2807/1560-7917.ES2013.18.50.20659; Khalafalla AI, 2015, EMERG INFECT DIS, V21, P1153, DOI 10.3201/eid2107.150070; Kim Y. J., 2015, GENOME ANNOUNC, V3; Meyer B, 2014, EMERG INFECT DIS, V20, P552, DOI 10.3201/eid2004.131746; Muller MA, 2015, LANCET INFECT DIS, V15, P559, DOI 10.1016/S1473-3099(15)70090-3; Perera RA, 2013, EUROSURVEILLANCE, V18, P8, DOI 10.2807/1560-7917.ES2013.18.36.20574; Reusken CBEM, 2013, LANCET INFECT DIS, V13, P859, DOI 10.1016/S1473-3099(13)70164-6; Wernery U, 2015, EMERG INFECT DIS, V21, P1019, DOI 10.3201/eid2106.150038; Woo PCY, 2014, EMERG INFECT DIS, V20, P560, DOI 10.3201/eid2004.131769; World Health Organization, 2015, MIDD E RESP SYNDR CO; Xie Q, 2015, SCI CHINA LIFE SCI, V58, P818, DOI 10.1007/s11427-015-4903-7; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	23	267	274	1	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2016	351	6268					81	84		10.1126/science.aac8608	http://dx.doi.org/10.1126/science.aac8608			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ8QM	26678874	Green Published			2022-12-28	WOS:000367364200047
J	Doyle, L; Hallinan, J; Bolduc, J; Parmeggiani, F; Baker, D; Stoddard, BL; Bradley, P				Doyle, Lindsey; Hallinan, Jazmine; Bolduc, Jill; Parmeggiani, Fabio; Baker, David; Stoddard, Barry L.; Bradley, Philip			Rational design of alpha-helical tandem repeat proteins with closed architectures	NATURE			English	Article							COMPUTATIONAL DESIGN; PEPTIDE-BINDING; DNA; CLASSIFICATION; RECOGNITION; SCAFFOLDS; SEQUENCE; BINDERS; SUITE	Tandem repeat proteins, which are formed by repetition of modular units of protein sequence and structure, play important biological roles as macromolecular binding and scaffolding domains, enzymes, and building blocks for the assembly of fibrous materials(1,2). The modular nature of repeat proteins enables the rapid construction and diversification of extended binding surfaces by duplication and recombination of simple building blocks(3,4). The overall architecture of tandem repeat protein structures-which is dictated by the internal geometry and local packing of the repeat building blocks-is highly diverse, ranging from extended, super-helical folds that bind peptide, DNA, and RNA partners(5-9), to closed and compact conformations with internal cavities suitable for small molecule binding and catalysis(10). Here we report the development and validation of computational methods for de novo design of tandem repeat protein architectures driven purely by geometric criteria defining the inter-repeat geometry, without reference to the sequences and structures of existing repeat protein families. We have applied these methods to design a series of closed alpha-solenoid(11) repeat structures (alpha-toroids) in which the inter-repeat packing geometry is constrained so as to juxtapose the amino (N) and carboxy (C) termini; several of these designed structures have been validated by X-ray crystallography. Unlike previous approaches to tandem repeat protein engineering(12-20), our design procedure does not rely on template sequence or structural information taken from natural repeat proteins and hence can produce structures unlike those seen in nature. As an example, we have successfully designed and validated closed alpha-solenoid repeats with a left-handed helical architecture that-to our knowledge-is not yet present in the protein structure database(21).	[Doyle, Lindsey; Hallinan, Jazmine; Bolduc, Jill; Stoddard, Barry L.; Bradley, Philip] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Parmeggiani, Fabio; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Parmeggiani, Fabio; Baker, David; Bradley, Philip] Univ Washington, Inst Prot Design, Seattle, WA 98195 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Bradley, Philip] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98019 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Bradley, P (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N, Seattle, WA 98109 USA.	pbradley@fredhutch.org	Parmeggiani, Fabio/P-3661-2019; Baker, David/K-8941-2012; Parmeggiani, Fabio/B-9344-2016	Parmeggiani, Fabio/0000-0001-8548-1090; Baker, David/0000-0001-7896-6217; Parmeggiani, Fabio/0000-0001-8548-1090; Doyle, Lindsey/0000-0002-0008-473X	National Institutes of Health [R21GM106117, R01GM49857]; Swiss National Science Foundation Postdoc Fellowship [PBZHP3-125470]; Human Frontier Science Program Long-Term Fellowship [LT000070/2009-L]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049857, R01GM115545, R21GM106117] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020069] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation Postdoc Fellowship(Swiss National Science Foundation (SNSF)); Human Frontier Science Program Long-Term Fellowship(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Scientific Computing at the Fred Hutchinson Cancer Research Center for providing the computational infrastructure necessary for this project. This research was supported by the following research grants: National Institutes of Health R21GM106117 to P.B. and R01GM49857 to B.L.S., and Swiss National Science Foundation Postdoc Fellowship PBZHP3-125470 and Human Frontier Science Program Long-Term Fellowship LT000070/2009-L to F.P.	Abe S, 2015, RSC ADV, V5, P21366, DOI 10.1039/c4ra16748a; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Andrade MA, 2001, J STRUCT BIOL, V134, P117, DOI 10.1006/jsbi.2001.4392; Aurora R, 1998, PROTEIN SCI, V7, P21, DOI 10.1002/pro.5560070103; Barkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002910; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Boersma YL, 2011, CURR OPIN BIOTECH, V22, P849, DOI 10.1016/j.copbio.2011.06.004; Cheng H, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003926; Dantas G, 2007, J MOL BIOL, V366, P1209, DOI 10.1016/j.jmb.2006.11.080; Deng D, 2012, SCIENCE, V335, P720, DOI 10.1126/science.1215670; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Grove TZ, 2008, CURR OPIN STRUC BIOL, V18, P507, DOI 10.1016/j.sbi.2008.05.008; Grove TZ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0051; He J, 2012, STRUCTURE, V20, P513, DOI 10.1016/j.str.2011.12.015; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Jimenez-Menendez N, 2010, NAT STRUCT MOL BIOL, V17, P891, DOI 10.1038/nsmb.1859; Kajander T, 2007, ACTA CRYSTALLOGR D, V63, P800, DOI 10.1107/S0907444907024353; Kajava AV, 2012, J STRUCT BIOL, V179, P279, DOI 10.1016/j.jsb.2011.08.009; Kobe B, 2000, TRENDS BIOCHEM SCI, V25, P509, DOI 10.1016/S0968-0004(00)01667-4; Koga N, 2012, NATURE, V491, P222, DOI 10.1038/nature11600; Lanci CJ, 2012, P NATL ACAD SCI USA, V109, P7304, DOI [10.1073/pnas.1112595109, 10.1073/pnas.111259510]; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Main ERG, 2003, STRUCTURE, V11, P497, DOI 10.1016/S0969-2126(03)00076-5; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Mak ANS, 2010, STRUCTURE, V18, P1321, DOI 10.1016/j.str.2010.07.006; Marcotte EM, 1999, J MOL BIOL, V293, P151, DOI 10.1006/jmbi.1999.3136; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park K, 2015, NAT STRUCT MOL BIOL, V22, P167, DOI 10.1038/nsmb.2938; Parmeggiani F, 2008, J MOL BIOL, V376, P1282, DOI 10.1016/j.jmb.2007.12.014; Parmeggiani F, 2015, J MOL BIOL, V427, P563, DOI 10.1016/j.jmb.2014.11.005; Ramisch S, 2014, P NATL ACAD SCI USA, V111, P17875, DOI 10.1073/pnas.1413638111; Reichen C, 2014, J STRUCT BIOL, V185, P147, DOI 10.1016/j.jsb.2013.07.012; Sillitoe I, 2015, NUCLEIC ACIDS RES, V43, pD376, DOI 10.1093/nar/gku947; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Skubak P, 2004, ACTA CRYSTALLOGR D, V60, P2196, DOI 10.1107/S0907444904019079; Urvoas A, 2010, J MOL BIOL, V404, P307, DOI 10.1016/j.jmb.2010.09.048; Voet ARD, 2014, P NATL ACAD SCI USA, V111, P15102, DOI 10.1073/pnas.1412768111; Walden H, 2010, ACTA CRYSTALLOGR D, V66, P352, DOI 10.1107/S0907444909038207; Wang XQ, 2002, CELL, V110, P501, DOI 10.1016/S0092-8674(02)00873-5; Wierenga RK, 2001, FEBS LETT, V492, P193, DOI 10.1016/S0014-5793(01)02236-0; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wintjens RT, 1996, J MOL BIOL, V255, P235, DOI 10.1006/jmbi.1996.0020	46	81	84	3	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2015	528	7583					585	+		10.1038/nature16191	http://dx.doi.org/10.1038/nature16191			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ3GH	26675735	Green Accepted			2022-12-28	WOS:000366991900059
J	Urry, M				Urry, Meg			Scientists must work harder on equality	NATURE			English	Editorial Material									[Urry, Meg] Yale Univ, Phys & Astron, New Haven, CT 06520 USA; [Urry, Meg] Yale Univ, Yale Ctr Astron & Astrophys, New Haven, CT USA	Yale University; Yale University	Urry, M (corresponding author), Yale Univ, Phys & Astron, New Haven, CT 06520 USA.	meg.urry@yale.edu	Urry, Meg/G-7381-2011	Urry, Meg/0000-0002-0745-9792				Lincoln AE, 2012, SOC STUD SCI, V42, P307, DOI 10.1177/0306312711435830; Mason MA, 2002, ACADEME, V88, P21, DOI 10.2307/40252436; Moss-Racusin CA, 2012, P NATL ACAD SCI USA, V109, P16474, DOI 10.1073/pnas.1211286109; Pohlhaus JR, 2011, ACAD MED, V86, P759, DOI 10.1097/ACM.0b013e31821836ff; Reid IN, 2014, PUBL ASTRON SOC PAC, V126, P923, DOI 10.1086/678964; Shipman C., 2014, THE CONFIDENCE CODE; Sugimoto CR, 2013, NATURE, V504, P211, DOI 10.1038/504211a; Trix F, 2003, DISCOURSE SOC, V14, P191, DOI 10.1177/0957926503014002277; West JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066212	9	22	23	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2015	528	7583					471	473		10.1038/528471a	http://dx.doi.org/10.1038/528471a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ3GH	26701038	Bronze			2022-12-28	WOS:000366991900025
J	Ahuja, S; Mukund, S; Deng, LB; Khakh, K; Chang, E; Ho, HD; Shriver, S; Young, C; Lin, S; Johnson, JP; Wu, P; Li, J; Coons, M; Tam, C; Brillantes, B; Sampang, H; Mortara, K; Bowman, KK; Clark, KR; Estevez, A; Xie, ZW; Verschoof, H; Grimwood, M; Dehnhardt, C; Andrez, JC; Focken, T; Sutherlin, DP; Safina, BS; Starovasnik, MA; Ortwine, DF; Franke, Y; Cohen, CJ; Hackos, DH; Koth, CM; Payandeh, J				Ahuja, Shivani; Mukund, Susmith; Deng, Lunbin; Khakh, Kuldip; Chang, Elaine; Ho, Hoangdung; Shriver, Stephanie; Young, Clint; Lin, Sophia; Johnson, J. P., Jr.; Wu, Ping; Li, Jun; Coons, Mary; Tam, Christine; Brillantes, Bobby; Sampang, Honorio; Mortara, Kyle; Bowman, Krista K.; Clark, Kevin R.; Estevez, Alberto; Xie, Zhiwei; Verschoof, Henry; Grimwood, Michael; Dehnhardt, Christoph; Andrez, Jean-Christophe; Focken, Thilo; Sutherlin, Daniel P.; Safina, Brian S.; Starovasnik, Melissa A.; Ortwine, Daniel F.; Franke, Yvonne; Cohen, Charles J.; Hackos, David H.; Koth, Christopher M.; Payandeh, Jian			Structural basis of Nav1.7 inhibition by an isoform-selective small-molecule antagonist	SCIENCE			English	Article							GATED SODIUM-CHANNELS; VOLTAGE-SENSOR; CRYSTAL-STRUCTURE; FAST INACTIVATION; PHARMACOLOGY; ACTIVATION; MUTATIONS; RECEPTOR; BINDING; TOXINS		[Ahuja, Shivani; Mukund, Susmith; Ho, Hoangdung; Shriver, Stephanie; Wu, Ping; Coons, Mary; Tam, Christine; Brillantes, Bobby; Sampang, Honorio; Mortara, Kyle; Bowman, Krista K.; Estevez, Alberto; Starovasnik, Melissa A.; Franke, Yvonne; Koth, Christopher M.; Payandeh, Jian] Genentech Inc, Dept Biol Struct, San Francisco, CA 94080 USA; [Deng, Lunbin; Hackos, David H.] Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA; [Khakh, Kuldip; Chang, Elaine; Young, Clint; Lin, Sophia; Johnson, J. P., Jr.; Xie, Zhiwei; Verschoof, Henry; Cohen, Charles J.] Xenon Pharmaceut Inc, Dept Biol, Burnaby, BC V5G 4W8, Canada; [Li, Jun; Sutherlin, Daniel P.; Safina, Brian S.] Genentech Inc, Dept Discovery Chem, San Francisco, CA 94080 USA; [Clark, Kevin R.] Genentech Inc, Dept Biochem & Cellular Pharmacol, San Francisco, CA 94080 USA; [Grimwood, Michael; Dehnhardt, Christoph; Andrez, Jean-Christophe; Focken, Thilo] Xenon Pharmaceut Inc, Dept Chem, Burnaby, BC V5G 4W8, Canada	Roche Holding; Genentech; Roche Holding; Genentech; Xenon Pharmaceuticals Inc.; Roche Holding; Genentech; Roche Holding; Genentech; Xenon Pharmaceuticals Inc.	Hackos, DH (corresponding author), Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA.	hackos.david@gene.com; koth.christopher@gene.com; payandeh.jian@gene.com		Estevez, Alberto/0000-0002-9141-5003; Johnson Jr., J.P./0000-0002-5762-5138; Koth, Christopher/0000-0003-3939-8856				Alabi AA, 2007, NATURE, V450, P370, DOI 10.1038/nature06266; Bagneris C, 2014, P NATL ACAD SCI USA, V111, P8428, DOI 10.1073/pnas.1406855111; BEAN BP, 1984, P NATL ACAD SCI-BIOL, V81, P6388, DOI 10.1073/pnas.81.20.6388; Bosmans F, 2008, NATURE, V456, P202, DOI 10.1038/nature07473; Bosmans F, 2010, TRENDS PHARMACOL SCI, V31, P175, DOI 10.1016/j.tips.2009.12.007; Campos FV, 2008, J GEN PHYSIOL, V132, P251, DOI 10.1085/jgp.200809995; Capes DL, 2013, J GEN PHYSIOL, V142, P101, DOI 10.1085/jgp.201310998; CATTERALL WA, 1995, ANNU REV BIOCHEM, V64, P493, DOI 10.1146/annurev.biochem.64.1.493; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Chanda B, 2002, J GEN PHYSIOL, V120, P629, DOI 10.1085/jgp.20028679; Cohen CJ, 2011, CURR PHARM BIOTECHNO, V12, P1715; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Dib-Hajj SD, 2013, NAT REV NEUROSCI, V14, P49, DOI 10.1038/nrn3404; Dong YY, 2015, SCIENCE, V347, P1256, DOI 10.1126/science.1261512; England S, 2010, FUTURE MED CHEM, V2, P775, DOI [10.4155/fmc.10.26, 10.4155/FMC.10.26]; FELLER DJ, 1985, J BIOL CHEM, V260, P1542; Fertleman CR, 2006, NEURON, V52, P767, DOI 10.1016/j.neuron.2006.10.006; Fozzard HA, 2005, CURR PHARM DESIGN, V11, P2671, DOI 10.2174/1381612054546833; Goldberg YP, 2007, CLIN GENET, V71, P311, DOI 10.1111/j.1399-0004.2007.00790.x; Gupta K, 2015, ELIFE, V4, DOI 10.7554/eLife.06774; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; HILLE B, 1977, J GEN PHYSIOL, V69, P497, DOI 10.1085/jgp.69.4.497; HILLE B, 1975, BIOPHYS J, V15, P615, DOI 10.1016/S0006-3495(75)85842-5; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hite RK, 2014, ELIFE, V3, DOI 10.7554/eLife.04366; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Kalso E, 1998, EUR J PAIN-LONDON, V2, P3; Knapp O, 2012, TOXINS, V4, P1236, DOI 10.3390/toxins4111236; Lee SY, 2004, NATURE, V430, P232, DOI 10.1038/nature02632; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; McCormack K, 2013, P NATL ACAD SCI USA, V110, pE2724, DOI 10.1073/pnas.1220844110; Middleton RE, 2002, BIOCHEMISTRY-US, V41, P14734, DOI 10.1021/bi026546a; Milescu M, 2007, J GEN PHYSIOL, V130, P497, DOI 10.1085/jgp.200709869; Milescu M, 2009, NAT STRUCT MOL BIOL, V16, P1080, DOI 10.1038/nsmb.1679; Murray JK, 2015, J MED CHEM, V58, P2299, DOI 10.1021/jm501765v; Norinder U, 2013, BIOORG MED CHEM LETT, V23, P261, DOI 10.1016/j.bmcl.2012.10.102; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Ottosson NE, 2015, SCI REP-UK, V5, DOI 10.1038/srep13278; Padilla K, 2009, NEUROSCI LETT, V465, P138, DOI 10.1016/j.neulet.2009.08.071; Payandeh J, 2015, J MOL BIOL, V427, P3, DOI 10.1016/j.jmb.2014.08.010; Payandeh J, 2012, NATURE, V486, P135, DOI 10.1038/nature11077; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Peretz A, 2010, P NATL ACAD SCI USA, V107, P15637, DOI 10.1073/pnas.0911294107; Pless SA, 2014, J GEN PHYSIOL, V143, P645, DOI 10.1085/jgp.201311036; Ruiz MD, 2015, J MED CHEM, V58, P7093, DOI 10.1021/jm501981g; SANGUINETTI MC, 1984, J MOL CELL CARDIOL, V16, P667, DOI 10.1016/S0022-2828(84)80631-8; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; Silberberg SD, 2007, NEURON, V54, P263, DOI 10.1016/j.neuron.2007.03.020; Smith JJ, 2005, J BIOL CHEM, V280, P11127, DOI 10.1074/jbc.M412552200; STRICHARTZ GR, 1973, J GEN PHYSIOL, V62, P37, DOI 10.1085/jgp.62.1.37; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; Takeshita K, 2014, NAT STRUCT MOL BIOL, V21, P352, DOI 10.1038/nsmb.2783; Tao X, 2010, SCIENCE, V328, P67, DOI 10.1126/science.1185954; Wilson MJ, 2011, P NATL ACAD SCI USA, V108, P10302, DOI 10.1073/pnas.1107027108; Xu YP, 2008, NATURE, V451, P826, DOI 10.1038/nature06618; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; Yang Y, 2004, J MED GENET, V41, P171, DOI 10.1136/jmg.2003.012153; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054	60	207	210	4	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2015	350	6267							aac5464	10.1126/science.aac5464	http://dx.doi.org/10.1126/science.aac5464			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY7LY	26680203				2022-12-28	WOS:000366591100048
J	Lin, TQ; Chen, IW; Liu, FX; Yang, CY; Bi, H; Xu, FF; Huang, FQ				Lin, Tianquan; Chen, I-Wei; Liu, Fengxin; Yang, Chongyin; Bi, Hui; Xu, Fangfang; Huang, Fuqiang			Nitrogen-doped mesoporous carbon of extraordinary capacitance for electrochemical energy storage	SCIENCE			English	Article							QUANTUM CAPACITANCE; GRAPHENE; SUPERCAPACITORS; ELECTRODES; PERFORMANCE	Carbon-based supercapacitors can provide high electrical power, but they do not have sufficient energy density to directly compete with batteries. We found that a nitrogen-doped ordered mesoporous few-layer carbon has a capacitance of 855 farads per gram in aqueous electrolytes and can be bipolarly charged or discharged at a fast, carbon-like speed. The improvement mostly stems from robust redox reactions at nitrogen-associated defects that transform inert graphene-like layered carbon into an electrochemically active substance without affecting its electric conductivity. These bipolar aqueous-electrolyte electrochemical cells offer power densities and lifetimes similar to those of carbon-based supercapacitors and can store a specific energy of 41 watt-hours per kilogram (19.5 watt-hours per liter).	[Lin, Tianquan; Liu, Fengxin; Yang, Chongyin; Bi, Hui; Xu, Fangfang; Huang, Fuqiang] Chinese Acad Sci, State Key Lab High Performance Ceram & Superfine, Shanghai Inst Ceram, Shanghai 200050, Peoples R China; [Lin, Tianquan; Liu, Fengxin; Yang, Chongyin; Bi, Hui; Xu, Fangfang; Huang, Fuqiang] Chinese Acad Sci, CAS Key Lab Mat Energy Convers, Shanghai Inst Ceram, Shanghai 200050, Peoples R China; [Lin, Tianquan; Huang, Fuqiang] Peking Univ, Beijing Natl Lab Mol Sci, Coll Chem & Mol Engn, Beijing 100871, Peoples R China; [Lin, Tianquan; Huang, Fuqiang] Peking Univ, State Key Lab Rare Earth Mat Chem & Applicat, Coll Chem & Mol Engn, Beijing 100871, Peoples R China; [Chen, I-Wei] Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA	Chinese Academy of Sciences; Shanghai Institute of Ceramics, CAS; Chinese Academy of Sciences; Shanghai Institute of Ceramics, CAS; Chinese Academy of Sciences; Peking University; Peking University; University of Pennsylvania	Huang, FQ (corresponding author), Chinese Acad Sci, State Key Lab High Performance Ceram & Superfine, Shanghai Inst Ceram, Shanghai 200050, Peoples R China.	huangfq@mail.sic.ac.cn	Yang, Chongyin/P-8092-2019; Lin, Tianquan/I-3030-2012	Yang, Chongyin/0000-0002-7127-3087; Lin, Tianquan/0000-0001-7664-2526; Chen, I-Wei/0000-0002-4045-4467	National Natural Science Foundation of China [51125006, 91122034, 61376056, 51402336]; Science and Technology Commission of Shanghai [14YF1406500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai(Science & Technology Commission of Shanghai Municipality (STCSM))	Supported by National Natural Science Foundation of China grants 51125006, 91122034, 61376056, and 51402336 and Science and Technology Commission of Shanghai grant 14YF1406500.	ARDIZZONE S, 1990, ELECTROCHIM ACTA, V35, P263, DOI 10.1016/0013-4686(90)85068-X; Augustyn V, 2013, NAT MATER, V12, P518, DOI [10.1038/nmat3601, 10.1038/NMAT3601]; Brezesinski K, 2010, J AM CHEM SOC, V132, P6982, DOI 10.1021/ja9106385; Brezesinski T, 2010, NAT MATER, V9, P146, DOI [10.1038/NMAT2612, 10.1038/nmat2612]; Burke A. F., 2014, ENCY AUTOMOTIVE ENG, P1; Burke A, 2011, J POWER SOURCES, V196, P514, DOI 10.1016/j.jpowsour.2010.06.092; Casanovas J, 1996, J AM CHEM SOC, V118, P8071, DOI 10.1021/ja960338m; Chmiola J, 2006, SCIENCE, V313, P1760, DOI [10.1126/science.1132195, 10.1126/science/1132195]; El-Kady MF, 2012, SCIENCE, V335, P1326, DOI 10.1126/science.1216744; Gao Q, 2012, ENERG ENVIRON SCI, V5, P9611, DOI 10.1039/c2ee22284a; Huang JS, 2008, ANGEW CHEM INT EDIT, V47, P520, DOI 10.1002/anie.200703864; Khomenko V, 2005, ELECTROCHIM ACTA, V50, P2499, DOI 10.1016/j.electacta.2004.10.078; Lang XY, 2011, NAT NANOTECHNOL, V6, P232, DOI 10.1038/nnano.2011.13; Li HL, 2009, J POWER SOURCES, V190, P578, DOI 10.1016/j.jpowsour.2009.01.052; Linden D., 2001, HDB BATTERIES; Lota G, 2005, CHEM PHYS LETT, V404, P53, DOI 10.1016/j.cplett.2005.01.074; Simon P, 2008, NAT MATER, V7, P845, DOI 10.1038/nmat2297; Snook GA, 2011, J POWER SOURCES, V196, P1, DOI 10.1016/j.jpowsour.2010.06.084; Stoller MD, 2010, ENERG ENVIRON SCI, V3, P1294, DOI 10.1039/c0ee00074d; Surendranath Y, 2010, J AM CHEM SOC, V132, P16501, DOI 10.1021/ja106102b; Vora PM, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.155114; Wang DW, 2012, CHEM-EUR J, V18, P5345, DOI 10.1002/chem.201102806; Wei DC, 2009, NANO LETT, V9, P1752, DOI 10.1021/nl803279t; Xia JL, 2009, NAT NANOTECHNOL, V4, P505, DOI [10.1038/NNANO.2009.177, 10.1038/nnano.2009.177]; Yang XW, 2013, SCIENCE, V341, P534, DOI 10.1126/science.1239089; Zhang LL, 2012, ENERG ENVIRON SCI, V5, P9618, DOI 10.1039/c2ee23442d; Zhao DY, 1998, SCIENCE, V279, P548, DOI 10.1126/science.279.5350.548; Zhu YW, 2011, SCIENCE, V332, P1537, DOI 10.1126/science.1200770	28	1562	1590	115	2409	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2015	350	6267					1508	1513		10.1126/science.aab3798	http://dx.doi.org/10.1126/science.aab3798			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY7LY	26680194				2022-12-28	WOS:000366591100054
J	Mannix, AJ; Zhou, XF; Kiraly, B; Wood, JD; Alducin, D; Myers, BD; Liu, XL; Fisher, BL; Santiago, U; Guest, JR; Yacaman, MJ; Ponce, A; Oganov, AR; Hersam, MC; Guisinger, NP				Mannix, Andrew J.; Zhou, Xiang-Feng; Kiraly, Brian; Wood, Joshua D.; Alducin, Diego; Myers, Benjamin D.; Liu, Xiaolong; Fisher, Brandon L.; Santiago, Ulises; Guest, Jeffrey R.; Yacaman, Miguel Jose; Ponce, Arturo; Oganov, Artem R.; Hersam, Mark C.; Guisinger, Nathan P.			Synthesis of borophenes: Anisotropic, two-dimensional boron polymorphs	SCIENCE			English	Article							ATOMIC-SCALE CHARACTERIZATION; CLUSTERS; GRAPHENE; MONOLAYER; AG(111); GROWTH	At the atomic-cluster scale, pure boron is markedly similar to carbon, forming simple planar molecules and cage-like fullerenes. Theoretical studies predict that two-dimensional (2D) boron sheets will adopt an atomic configuration similar to that of boron atomic clusters. We synthesized atomically thin, crystalline 2D boron sheets (i.e., borophene) on silver surfaces under ultrahigh-vacuum conditions. Atomic-scale characterization, supported by theoretical calculations, revealed structures reminiscent of fused boron clusters with multiple scales of anisotropic, out-of-plane buckling. Unlike bulk boron allotropes, borophene shows metallic characteristics that are consistent with predictions of a highly anisotropic, 2D metal.	[Mannix, Andrew J.; Kiraly, Brian; Fisher, Brandon L.; Guest, Jeffrey R.; Guisinger, Nathan P.] Argonne Natl Lab, Ctr Nanoscale Mat, Argonne, IL 60439 USA; [Mannix, Andrew J.; Kiraly, Brian; Wood, Joshua D.; Myers, Benjamin D.; Hersam, Mark C.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; [Zhou, Xiang-Feng; Oganov, Artem R.] SUNY Stony Brook, Dept Geosci, Ctr Mat Design, Stony Brook, NY 11794 USA; [Zhou, Xiang-Feng; Oganov, Artem R.] SUNY Stony Brook, Inst Adv Computat Sci, Stony Brook, NY 11794 USA; [Zhou, Xiang-Feng] Nankai Univ, Sch Phys, Tianjin 300071, Peoples R China; [Alducin, Diego; Santiago, Ulises; Yacaman, Miguel Jose; Ponce, Arturo] Univ Texas San Antonio, Dept Phys, San Antonio, TX 78249 USA; [Myers, Benjamin D.] Northwestern Univ, NUANCE Ctr, Evanston, IL 60208 USA; [Liu, Xiaolong; Hersam, Mark C.] Northwestern Univ, Appl Phys Grad Program, Evanston, IL 60208 USA; [Oganov, Artem R.] Skolkovo Innovat Ctr, Skolkovo Inst Sci & Technol, Moscow 143026, Russia; [Oganov, Artem R.] Moscow Inst Phys & Technol, Dolgoprudny City 141700, Moscow Region, Russia; [Hersam, Mark C.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA	United States Department of Energy (DOE); Argonne National Laboratory; Northwestern University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Nankai University; University of Texas System; University of Texas at San Antonio (UTSA); Northwestern University; Northwestern University; Skolkovo Institute of Science & Technology; Moscow Institute of Physics & Technology; Northwestern University	Oganov, AR (corresponding author), Skolkovo Innovat Ctr, Skolkovo Inst Sci & Technol, 5 Nobel St, Moscow 143026, Russia.	artem.oganov@stonybrook.edu; m-hersam@northwestern.edu; nguisinger@anl.gov	yacaman, miguel jose/B-5622-2009; Liu, Xiaolong/P-6477-2019; Kiraly, Brian/V-3119-2017; Yacaman, Miguel Jose/B-8150-2013; Hersam, Mark/B-6739-2009; Oganov, Artem R./O-8234-2019; Oganov, Artem R./AAA-1478-2021; Guest, Jeffrey R/B-2715-2009; Zhou, Xiang-Feng/A-1714-2010; Oganov, Artem R/A-1213-2008; Ponce, Arturo/L-4712-2013	Liu, Xiaolong/0000-0002-6186-5257; Oganov, Artem R./0000-0001-7082-9728; Guest, Jeffrey R/0000-0002-9756-8801; Zhou, Xiang-Feng/0000-0001-8651-9273; Oganov, Artem R/0000-0001-7082-9728; Ponce, Arturo/0000-0001-5529-6468; Mannix, Andrew/0000-0003-4788-1506; Santiago Cortes, Cesar Ulises/0000-0003-2259-5984	Center for Nanoscale Materials, a U.S. Department of Energy Office of Science User Facility [DE-AC02-06CH11357]; International Institute for Nanotechnology, Materials Research Science and Engineering Centers [NSF DMR-1121262]; Keck Foundation; State of Illinois; Northwestern University; U.S. Department of Energy SISGR [DE-FG02-09ER16109]; Office of Naval Research [N00014-14-1-0669]; National Science Foundation Graduate Fellowship Program [DGE-1324585, DGE-0824162]; National Science Foundation of China [11174152]; National 973 Program of China [2012CB921900]; Program for New Century Excellent Talents in University [NCET-12-0278]; Defense Advanced Research Projects Agency [W31P4Q1210008]; Government of Russian Federation [14.A12.31.0003]; National Institute on Minority Health and Health Disparities (NIMHD) in the program Research Centers in Minority Institutions Program (RCMI) Nanotechnology and Human Health Core [G12MD007591]; NSF PREM DMR [DMR-0934218]; Welch Foundation [AX-1615]; Department of Defense [64756-RT-REP]; National Institute on Minority Health and Health Disparities [G12MD007591] Funding Source: NIH RePORTER	Center for Nanoscale Materials, a U.S. Department of Energy Office of Science User Facility(United States Department of Energy (DOE)); International Institute for Nanotechnology, Materials Research Science and Engineering Centers; Keck Foundation(W.M. Keck Foundation); State of Illinois; Northwestern University; U.S. Department of Energy SISGR(United States Department of Energy (DOE)); Office of Naval Research(Office of Naval Research); National Science Foundation Graduate Fellowship Program(National Science Foundation (NSF)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Program of China(National Basic Research Program of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Government of Russian Federation; National Institute on Minority Health and Health Disparities (NIMHD) in the program Research Centers in Minority Institutions Program (RCMI) Nanotechnology and Human Health Core; NSF PREM DMR(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Welch Foundation(The Welch Foundation); Department of Defense(United States Department of Defense); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was performed, in part, at the Center for Nanoscale Materials, a U.S. Department of Energy Office of Science User Facility under Contract No. DE-AC02-06CH11357. This work was also performed, in part, at the NUANCE Center, supported by the International Institute for Nanotechnology, Materials Research Science and Engineering Centers (NSF DMR-1121262), the Keck Foundation, the State of Illinois, and Northwestern University. A.J.M., B.K., J.D.W., X.L., J.R.G, M.C.H., and N.P.G acknowledge support by the U.S. Department of Energy SISGR (contract no. DE-FG02-09ER16109), the Office of Naval Research (grant no. N00014-14-1-0669), and the National Science Foundation Graduate Fellowship Program (DGE-1324585 and DGE-0824162). X.-F.Z thanks the National Science Foundation of China (grant no. 11174152), the National 973 Program of China (grant no. 2012CB921900), and the Program for New Century Excellent Talents in University (grant no. NCET-12-0278). U.S. thanks the National Council of Science and Technology, CONACyT (proposal no. 250836). A.R.O acknowledges support from the Defense Advanced Research Projects Agency (grant no. W31P4Q1210008) and the Government of Russian Federation (no. 14.A12.31.0003). D.A., M.J.Y, and A.P. acknowledge support by the National Institute on Minority Health and Health Disparities (NIMHD) in the program Research Centers in Minority Institutions Program (RCMI) Nanotechnology and Human Health Core (grant G12MD007591), the NSF PREM DMR (grant no. DMR-0934218), the Welch Foundation (grant no. AX-1615), and the Department of Defense (grant no. 64756-RT-REP).	Berner S, 2007, ANGEW CHEM INT EDIT, V46, P5115, DOI 10.1002/anie.200700234; Boustani I, 1997, PHYS REV B, V55, P16426, DOI 10.1103/PhysRevB.55.16426; Eremets MI, 2001, SCIENCE, V293, P272, DOI 10.1126/science.1062286; Feng BJ, 2012, NANO LETT, V12, P3507, DOI 10.1021/nl301047g; Guo QM, 2010, SURF SCI, V604, P1820, DOI 10.1016/j.susc.2010.07.013; Ho B, 2007, STRUCTURE CHEM CRYST; Ishikawa R, 2011, NAT MATER, V10, P278, DOI 10.1038/NMAT2957; Kiraly B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3804; Kliewer J, 2000, SCIENCE, V288, P1399, DOI 10.1126/science.288.5470.1399; Kolmogorov AN, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.224507; Lau KC, 2007, J PHYS CHEM C, V111, P2906, DOI 10.1021/jp066719w; Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996; Liu F, 2010, J MATER CHEM, V20, P2197, DOI 10.1039/b919260c; Liu HS, 2013, SCI REP-UK, V3, DOI 10.1038/srep03238; Liu YY, 2013, ANGEW CHEM INT EDIT, V52, P3156, DOI 10.1002/anie.201207972; Muller F, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.113406; Oganov AR, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2210932; Oganov AR, 2009, NATURE, V457, P863, DOI 10.1038/nature07736; Ogitsu T, 2013, CHEM REV, V113, P3425, DOI 10.1021/cr300356t; Okamoto H, 1992, J PHASE EQUILIBRIA, V13, P211, DOI [10.1007/BF02667492, DOI 10.1007/BF02667492]; Penev ES, 2012, NANO LETT, V12, P2441, DOI 10.1021/nl3004754; Piazza ZA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4113; Rasool HI, 2011, J AM CHEM SOC, V133, P12536, DOI 10.1021/ja200245p; Sergeeva AP, 2014, ACCOUNTS CHEM RES, V47, P1349, DOI 10.1021/ar400310g; Tang H, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.115501; Zhai HJ, 2003, NAT MATER, V2, P827, DOI 10.1038/nmat1012; Zhai HJ, 2014, NAT CHEM, V6, P727, DOI [10.1038/NCHEM.1999, 10.1038/nchem.1999]; Zhou XF, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.085502; Zhu Q, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.195317	29	1559	1580	62	1278	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2015	350	6267					1513	1516		10.1126/science.aad1080	http://dx.doi.org/10.1126/science.aad1080			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY7LY	26680195	Green Accepted			2022-12-28	WOS:000366591100055
J	Ball, P				Ball, Philip			Why synthesize?	NATURE			English	Editorial Material							DISCOVERY; RING					p.ball@btinternet.com						Fukaya K, 2015, ORG LETT, V17, P2570, DOI 10.1021/acs.orglett.5b01173; Fukaya K, 2015, ORG LETT, V17, P2574, DOI 10.1021/acs.orglett.5b01174; Gillis EP, 2007, J AM CHEM SOC, V129, P6716, DOI 10.1021/ja0716204; Kanan MW, 2004, NATURE, V431, P545, DOI 10.1038/nature02920; Kleiner RE, 2011, CHEM SOC REV, V40, P5707, DOI 10.1039/c1cs15076f; Li JQ, 2015, SCIENCE, V347, P1221, DOI 10.1126/science.aaa5414; Nicolaou KC, 2000, ANGEW CHEM INT EDIT, V39, P44; O'Connor M., 1963, POINTERS PATHWAYS RE, V41; Parr BT, 2015, NATURE, V525, P507, DOI 10.1038/nature14902; Whitesides GM, 2015, ANGEW CHEM INT EDIT, V54, P3196, DOI 10.1002/anie.201410884; Zou YK, 2015, J AM CHEM SOC, V137, P7095, DOI 10.1021/jacs.5b04728	11	18	19	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2015	528	7582					327	329		10.1038/528327a	http://dx.doi.org/10.1038/528327a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY8SM	26672538	Bronze			2022-12-28	WOS:000366678600027
J	Deweerdt, S				Deweerdt, Sarah			Prognosis: Proportionate response	NATURE			English	Editorial Material																		Bryant RJ, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv095; Cuzick J, 2015, BRIT J CANCER, V113, P382, DOI 10.1038/bjc.2015.223; Hamidreza A., 2015, UROLOGY, V85, P423; Prensner JR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003180; Roy HK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115999; Stattin P, 2015, EUR UROL, V68, P207, DOI 10.1016/j.eururo.2015.01.009; Tomlins S. A., 2015, EUR UROL; Weinreb JC, 2015, EUR UROL	8	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2015	528	7582					S124	S125		10.1038/528S124a	http://dx.doi.org/10.1038/528S124a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VC0SY	26672783				2022-12-28	WOS:000427270600001
J	O'Meara, S				O'Meara, Sarah			AT THE VERY HEART OF PROGRESS	NATURE			English	Editorial Material																			0	3	3	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2015	528	7582					S179	S181		10.1038/528S179a	http://dx.doi.org/10.1038/528S179a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY8SM	26673025	Bronze			2022-12-28	WOS:000366678600013
J	Chong, CAKY				Chong, Christopher A. K. Y.			CHRISTMAS 2015: PROFESSIONAL CONSIDERATIONS Are you pharmiscuous? Take our quiz!	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Chong, Christopher A. K. Y.] Lakeridge Hlth Oshawa, Oshawa, ON, Canada		Chong, CAKY (corresponding author), Lakeridge Hlth Oshawa, Oshawa, ON, Canada.	caky.chong@gmail.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 16	2015	351								h6353	10.1136/bmj.h6353	http://dx.doi.org/10.1136/bmj.h6353			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ4MP	26672994				2022-12-28	WOS:000367077600005
J	Vinkers, CH; Tijdink, JK; Otte, WM				Vinkers, Christiaan H.; Tijdink, Joeri K.; Otte, Willem M.			CHRISTMAS 2015: THE PUBLICATION GAME Use of positive and negative words in scientific PubMed abstracts between 1974 and 2014: retrospective analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIALS; SPIN	Objective To investigate whether language used in science abstracts can skew towards the use of strikingly positive and negative words over time. Design Retrospective analysis of all scientific abstracts in PubMed between 1974 and 2014. Methods The yearly frequencies of positive, negative, and neutral words (25 preselected words in each category), plus 100 randomly selected words were normalised for the total number of abstracts. Subanalyses included pattern quantification of individual words, specificity for selected high impact journals, and comparison between author affiliations within or outside countries with English as the official majority language. Frequency patterns were compared with 4% of all books ever printed and digitised by use of Google Books Ngram Viewer. Main outcome measures Frequencies of positive and negative words in abstracts compared with frequencies of words with a neutral and random connotation, expressed as relative change since 1980. Results The absolute frequency of positive words increased from 2.0% (1974-80) to 17.5% (2014), a relative increase of 880% over four decades. All 25 individual positive words contributed to the increase, particularly the words "robust," "novel," "innovative," and "unprecedented," which increased in relative frequency up to 15 000%. Comparable but less pronounced results were obtained when restricting the analysis to selected journals with high impact factors. Authors affiliated to an institute in a non-English speaking country used significantly more positive words. Negative word frequencies increased from 1.3% (1974-80) to 3.2% (2014), a relative increase of 257%. Over the same time period, no apparent increase was found in neutral or random word use, or in the frequency of positive word use in published books. Conclusions Our lexicographic analysis indicates that scientific abstracts are currently written with more positive and negative words, and provides an insight into the evolution of scientific writing. Apparently scientists look on the bright side of research results. But whether this perception fits reality should be questioned.	[Vinkers, Christiaan H.] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Psychiat, NL-3584 CX Utrecht, Netherlands; [Tijdink, Joeri K.] Vrije Univ Amsterdam Med Ctr, Dept Internal Med, Amsterdam, Netherlands; [Otte, Willem M.] Univ Med Ctr Utrecht, Dept Child Neurol, Brain Ctr Rudolf Magnus, NL-3584 CX Utrecht, Netherlands; [Otte, Willem M.] Univ Med Ctr Utrecht, Ctr Image Sci, Biomed MR Imaging & Spect, NL-3584 CX Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Vinkers, CH (corresponding author), Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Psychiat, NL-3584 CX Utrecht, Netherlands.	c.h.vinkers@umcutrecht.nl	Otte, Willem M./J-6140-2019; Otte, Willem M/I-1228-2013; Vinkers, Christiaan/AAV-1720-2020	Otte, Willem M./0000-0003-1511-6834; Otte, Willem M/0000-0003-1511-6834; Tijdink, Joeri/0000-0002-1826-2274; Vinkers, Christiaan/0000-0003-3698-0744				Abola MV, 2015, JAMA ONCOL, DOI [10.1001/jamaoncol.2015.3931, DOI 10.1001/JAMAONCOL.2015.3931.26512913]; Boutron I, 2014, J CLIN ONCOL, V32, P4120, DOI 10.1200/JCO.2014.56.7503; Boutron I, 2010, JAMA-J AM MED ASSOC, V303, P2058, DOI 10.1001/jama.2010.651; Boyack KW, 2013, EUR J CLIN INVEST, V43, P1339, DOI 10.1111/eci.12171; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Dodds PS, 2015, P NATL ACAD SCI USA, V112, P2389, DOI 10.1073/pnas.1411678112; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Fraser AG, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6815; Ioannidis JPA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001747; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Lazarus C, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0079-x; Lockyer S, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-371; Macleod MR, 2014, LANCET, V383, P101, DOI 10.1016/S0140-6736(13)62329-6; McCarthy Michael, 2015, BMJ, V351, ph5803, DOI 10.1136/bmj.h5803; Michel JB, 2011, SCIENCE, V331, P176, DOI 10.1126/science.1199644; Ochodo EA, 2013, RADIOLOGY, V267, P581, DOI 10.1148/radiol.12120527; Patel SV, 2013, DIS COLON RECTUM, V56, P1388, DOI 10.1097/01.dcr.0000436466.50341.c5; Publish or perish, 2015, NATURE, V521, P259; Ridker PM, 2013, CIRCULATION, V127, P155, DOI 10.1161/CIRCULATIONAHA.112.155952; Sumner P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7015	20	80	80	5	32	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 14	2015	351								h6467	10.1136/bmj.h6467	http://dx.doi.org/10.1136/bmj.h6467			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ4KY	26668206	Green Published, hybrid			2022-12-28	WOS:000367073200010
J	Watts, G				Watts, Geoff			Aubrey Sheiham Obituary	LANCET			English	Biographical-Item																		SHEIHAM A, PUBLICATION LIST	1	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 12	2015	386	10011					2388	2388		10.1016/S0140-6736(15)01204-0	http://dx.doi.org/10.1016/S0140-6736(15)01204-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY3EE	26709401				2022-12-28	WOS:000366290400019
J	Valette, X; du Cheyron, D				Valette, Xavier; du Cheyron, Damien			Cullen's and Grey Turner's Signs in Acute Pancreatitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Valette, Xavier; du Cheyron, Damien] Caen Univ Hosp, Caen, France	CHU de Caen NORMANDIE; Universite de Caen Normandie	Valette, X (corresponding author), Caen Univ Hosp, Caen, France.	ducheyron-d@-chu-caen.fr							0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 10	2015	373	24							e28	10.1056/NEJMicm1504339	http://dx.doi.org/10.1056/NEJMicm1504339			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY0QW	26650175				2022-12-28	WOS:000366111600011
J	Mata, DA; Ramos, MA; Bansal, N; Khan, R; Guille, C; Di Angelantonio, E; Sen, S				Mata, Douglas A.; Ramos, Marco A.; Bansal, Narinder; Khan, Rida; Guille, Constance; Di Angelantonio, Emanuele; Sen, Srijan			Prevalence of Depression and Depressive Symptoms Among Resident Physicians A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EMERGENCY-MEDICINE RESIDENTS; HEALTH QUESTIONNAIRE; PRIMARY-CARE; MOOD STATES; BURNOUT; ANXIETY; STRESS; ASSOCIATION; DISTRESS; WORK	IMPORTANCE Physicians in training are at high risk for depression. However, the estimated prevalence of this disorder varies substantially between studies. OBJECTIVE To provide a summary estimate of depression or depressive symptom prevalence among resident physicians. DATA SOURCES AND STUDY SELECTION Systematic search of EMBASE, ERIC, MEDLINE, and PsycINFO for studies with information on the prevalence of depression or depressive symptoms among resident physicians published between January 1963 and September 2015. Studies were eligible for inclusion if they were published in the peer-reviewed literature and used a validated method to assess for depression or depressive symptoms. DATA EXTRACTION AND SYNTHESIS Information on study characteristics and depression or depressive symptom prevalence was extracted independently by 2 trained investigators. Estimates were pooled using random-effects meta-analysis. Differences by study-level characteristics were estimated usingmeta-regression. MAIN OUTCOMES AND MEASURES Point or period prevalence of depression or depressive symptoms as assessed by structured interview or validated questionnaire. RESULTS Data were extracted from 31 cross-sectional studies (9447 individuals) and 23 longitudinal studies (8113 individuals). Three studies used clinical interviews and 51 used self-report instruments. The overall pooled prevalence of depression or depressive symptoms was 28.8% (4969/17 560 individuals, 95% CI, 25.3%-32.5%), with high between-study heterogeneity (Q = 1247, tau(2) = 0.39, I-2 = 95.8%, P < .001). Prevalence estimates ranged from 20.9% for the 9-item Patient Health Questionnaire with a cutoff of 10 or more (741/3577 individuals, 95% CI, 17.5%-24.7%, Q = 14.4, tau(2) = 0.04, I-2 = 79.2%) to 43.2% for the 2-item PRIME-MD (1349/2891 individuals, 95% CI, 37.6%-49.0%, Q = 45.6, tau(2) = 0.09, I-2 = 84.6%). There was an increased prevalence with increasing calendar year (slope = 0.5% increase per year, adjusted for assessment modality; 95% CI, 0.03%-0.9%, P = .04). In a secondary analysis of 7 longitudinal studies, the median absolute increase in depressive symptoms with the onset of residency training was 15.8% (range, 0.3%-26.3%; relative risk, 4.5). No statistically significant differences were observed between cross-sectional vs longitudinal studies, studies of only interns vs only upper-level residents, or studies of nonsurgical vs both nonsurgical and surgical residents. CONCLUSIONS AND RELEVANCE In this systematic review, the summary estimate of the prevalence of depression or depressive symptoms among resident physicians was 28.8%, ranging from 20.9% to 43.2% depending on the instrument used, and increased with calendar year. Further research is needed to identify effective strategies for preventing and treating depression among physicians in training.	[Mata, Douglas A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Ramos, Marco A.] Yale Univ, Yale Sch Med, Dept Psychiat, New Haven, CT USA; [Bansal, Narinder; Di Angelantonio, Emanuele] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Khan, Rida] Baylor Coll Med, Texas Med Ctr, Dept Med, Houston, TX 77030 USA; [Guille, Constance] Med Univ S Carolina, Dept Psychiat & Behav Sci, Charleston, SC USA; [Sen, Srijan] Univ Michigan, Dept Psychiat, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Yale University; University of Cambridge; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Medical University of South Carolina; University of Michigan System; University of Michigan	Mata, DA (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	dmata@bwh.harvard.edu	Mata, Douglas A./P-1040-2019; Sen, Srijan/J-8053-2013; DiAngelantonio, Emanuele/ABE-6852-2020	Mata, Douglas A./0000-0002-8059-8668; Di Angelantonio, Emanuele/0000-0001-8776-6719; Ramos, Marco/0000-0002-1649-7547; Bansal, Narinder/0000-0002-6925-1719; Sen, Srijan/0000-0003-4495-495X	US Department of State Fulbright Scholarship; National Institutes of Health (NIH) [R01MH101459]; NIH [TG 2T32GM07205]; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research Council [MR/L003120/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10165] Funding Source: researchfish; MRC [MR/L003120/1] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH064299, K23MH095109, R01MH101459] Funding Source: NIH RePORTER	US Department of State Fulbright Scholarship; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by a US Department of State Fulbright Scholarship (D.A.M.), National Institutes of Health (NIH) funding (R01MH101459 to S.S.), and NIH Medical Scientist Training Program funding (TG 2T32GM07205 to M.A.R.).	*ACCR COUNC GRAD M, 2002, REP ACGME WORK GROUP; Al-Ghafri G, 2014, ASIAN J PSYCHIATR, V8, P59, DOI 10.1016/j.ajp.2013.10.014; Al-Maddah Esraa M, 2015, Sultan Qaboos Univ Med J, V15, pe78; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; [Anonymous], FIN REP DOCT WORK RE; Baer L, 2000, PSYCHOTHER PSYCHOSOM, V69, P35, DOI 10.1159/000012364; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Becker JL, 2006, AM J OBSTET GYNECOL, V195, P1444, DOI 10.1016/j.ajog.2006.06.075; Beckman TJ, 2012, J GEN INTERN MED, V27, P325, DOI 10.1007/s11606-011-1891-6; BIGGS JT, 1978, BRIT J PSYCHIAT, V132, P381, DOI 10.1192/bjp.132.4.381; Borenstein M, 2010, RES SYNTH METHODS, V1, P97, DOI 10.1002/jrsm.12; Brown TA, 1997, BEHAV RES THER, V35, P79, DOI 10.1016/S0005-7967(96)00068-X; Buddeberg-Fischer B, 2005, Z PSYCHOSOM MED PSYC, V51, P163, DOI 10.13109/zptm.2005.51.2.163; Buddeberg-Fischer B, 2009, Z PSYCHOSOM MED PSYC, V55, P37, DOI 10.13109/zptm.2009.55.1.37; Campbell J, 2010, ACAD MED, V85, P1630, DOI 10.1097/ACM.0b013e3181f0c4e7; Clarke DM, 2009, MED J AUSTRALIA, V190, pS54; Cruz EP, 2006, MED INTERNA MEX, V22, P282; Cubero DIG, 2016, J CANCER EDUC, V31, P582, DOI 10.1007/s13187-015-0850-z; Daskivich Timothy J, 2015, J Grad Med Educ, V7, P143, DOI 10.4300/JGME-07-01-42; Costa EFD, 2012, REV ASSOC MED BRAS, V58, P53; de Oliveira GS, 2013, ANESTH ANALG, V117, P182, DOI 10.1213/ANE.0b013e3182917da9; Demir F, 2007, TURK PSIKIYATR DERG, V18, P31; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; Dyrbye LN, 2014, ACAD MED, V89, P443, DOI 10.1097/ACM.0000000000000134; Dyrbye LN, 2006, ACAD MED, V81, P354, DOI 10.1097/00001888-200604000-00009; Earle Lynda, 2005, Can Fam Physician, V51, P242; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fahrenkopf AM, 2008, BRIT MED J, V336, P488, DOI 10.1136/bmj.39469.763218.BE; FORD CV, 1984, SOUTHERN MED J, V77, P1435, DOI 10.1097/00007611-198411000-00019; Glassman AH, 1998, AM J PSYCHIAT, V155, P4, DOI 10.1176/ajp.155.1.4; Godenick M T, 1995, Fam Med, V27, P646; Goebert D, 2009, ACAD MED, V84, P236, DOI 10.1097/ACM.0b013e31819391bb; Gopal R, 2005, ARCH INTERN MED, V165, P2595, DOI 10.1001/archinte.165.22.2595; Govardhan Lakshmi Magavi, 2012, Conn Med, V76, P389; Hainer BL, 1998, ACAD MED, V73, P1305, DOI 10.1097/00001888-199812000-00023; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hasanovic M, 2008, PSYCHIAT DANUB, V20, P277; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hsieh Yi-Hsuan, 2011, Chang Gung Med J, V34, P278; HSU K, 1987, AM J PSYCHIAT, V144, P1561; Ito M, 2015, MED EDUC, V49, P215, DOI 10.1111/medu.12620; Jimenez-Lopez Jose Luis, 2015, Rev Med Inst Mex Seguro Soc, V53, P20; Joules NWDTA, 2014, OPEN J DEPRESSION, P89, DOI DOI 10.4236/OJD.2014.33013; Katz ED, 2006, ACAD EMERG MED, V13, P284, DOI 10.1197/j.aem.2005.10.009; Kerr LK, 2001, WESTERN J MED, V175, P349, DOI 10.1136/ewjm.175.5.349; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; KIRSLING RA, 1989, PSYCHOL REP, V65, P355, DOI 10.2466/pr0.1989.65.2.355; Kleim B, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00640; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lam TP, 2010, MED TEACH, V32, pE120, DOI 10.3109/01421590903449894; Landrigan CP, 2008, PEDIATRICS, V122, P250, DOI 10.1542/peds.2007-2306; Moher David, 2009, Open Med, V3, pe123; Myers M, 2003, ACAD PSYCHIATR, V27, P19, DOI 10.1176/appi.ap.27.1.19; Oriel K, 2004, FAM MED, V36, P248; Pereira-Lima K, 2015, PSYCHOL HEALTH MED, V20, P353, DOI 10.1080/13548506.2014.936889; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raviola G, 2002, CULT MED PSYCHIAT, V26, P55, DOI 10.1023/A:1015289132151; REUBEN DB, 1985, ARCH INTERN MED, V145, P286, DOI 10.1001/archinte.145.2.286; REVICKI DA, 1993, J COMMUNITY APPL SOC, V3, P273, DOI 10.1002/casp.2450030405; Rosen IM, 2006, ACAD MED, V81, P82, DOI 10.1097/00001888-200601000-00020; Sakata Y, 2008, J OCCUP HEALTH, V50, P498, DOI 10.1539/joh.L8043; Sanchez M.J.B., 2008, PSIQUIATR BIOL, V15, P147, DOI [10.1016/S1134-5934(08)76485-6, DOI 10.1016/S1134-5934(08)76485-6]; SCHNEIDER SE, 1993, PSYCHOL REP, V72, P1145, DOI 10.2466/pr0.1993.72.3c.1145; Sen S, 2013, JAMA INTERN MED, V173, P657, DOI 10.1001/jamainternmed.2013.351; Sen S, 2010, ARCH GEN PSYCHIAT, V67, P557, DOI 10.1001/archgenpsychiatry.2010.41; Shanafelt TD, 2003, AM J MED, V114, P513, DOI 10.1016/S0002-9343(03)00117-7; Shanafelt TD, 2002, ANN INTERN MED, V136, P358, DOI 10.7326/0003-4819-136-5-200203050-00008; SPIELBERGER CD, 1983, MANUAL STATE TRAIT P; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; STEINERT Y, 1991, CAN FAM PHYSICIAN, V37, P2130; Sterne JAC, 2002, STAT MED, V21, P1513, DOI 10.1002/sim.1184; Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8; Stoesser K, 2014, FAM MED, V46, P797; VALKO RJ, 1975, DIS NERV SYST, V36, P26; van Houwelingen HC, 2002, STAT MED, V21, P589, DOI 10.1002/sim.1040; Velasquez-Perez L, 2013, GAC MED MEX, V149, P183; Wada K, 2007, IND HEALTH, V45, P750, DOI 10.2486/indhealth.45.750; Waldman SV, 2009, ACAD PSYCHIATR, V33, P296, DOI 10.1176/appi.ap.33.4.296; WARING EM, 1974, BRIT J PSYCHIAT, V125, P10, DOI 10.1192/bjp.125.1.10; Weigl M, 2012, INT ARCH OCC ENV HEA, V85, P559, DOI 10.1007/s00420-011-0706-8; West CP, 2006, JAMA-J AM MED ASSOC, V296, P1071, DOI 10.1001/jama.296.9.1071; West CP, 2012, MAYO CLIN PROC, V87, P1138, DOI 10.1016/j.mayocp.2012.07.021; West CP, 2009, JAMA-J AM MED ASSOC, V302, P1294, DOI 10.1001/jama.2009.1389; WILKINSON MJB, 1988, J ROY COLL GEN PRACT, V38, P311; Williams JW, 2002, GEN HOSP PSYCHIAT, V24, P225, DOI 10.1016/S0163-8343(02)00195-0; Yi MS, 2006, AMBUL PEDIATR, V6, P84, DOI 10.1016/j.ambp.2005.10.002; Yousuf A, 2011, J PAK MED ASSOC, V61, P968	89	603	614	4	76	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 8	2015	314	22					2373	2383		10.1001/jama.2015.15845	http://dx.doi.org/10.1001/jama.2015.15845			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CX8XT	26647259	Green Accepted, Bronze			2022-12-28	WOS:000365989100012
J	Nowarski, R; Jackson, R; Gagliani, N; de Zoete, MR; Palm, NW; Bailis, W; Low, JS; Harman, CCD; Graham, M; Elinav, E; Flavell, RA				Nowarski, Roni; Jackson, Ruaidhri; Gagliani, Nicola; de Zoete, Marcel R.; Palm, Noah W.; Bailis, Will; Low, Jun Siong; Harman, Christian C. D.; Graham, Morven; Elinav, Eran; Flavell, Richard A.			Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis	CELL			English	Article							INFLAMMATORY-BOWEL-DISEASE; TNF-ALPHA PRODUCTION; CROHNS-DISEASE; ULCERATIVE-COLITIS; INTESTINAL INFLAMMATION; BINDING-PROTEIN; MURINE COLITIS; GOBLET CELLS; CUTTING EDGE; PANETH CELLS	The intestinal mucosal barrier controlling the resident microbiome is dependent on a protective mucus layer generated by goblet cells, impairment of which is a hallmark of the inflammatory bowel disease, ulcerative colitis. Here, we show that IL-18 is critical in driving the pathologic breakdown of barrier integrity in a model of colitis. Deletion of Il18 or its receptor Il18r1 in intestinal epithelial cells (D/EC) conferred protection from colitis and mucosal damage in mice. In contrast, deletion of the IL-18 negative regulator Il18bp resulted in severe colitis associated with loss of mature goblet cells. Colitis and goblet cell loss were rescued in Il18bp(-/-);Il18r(Delta/EC) mice, demonstrating that colitis severity is controlled at the level of IL-18 signaling in intestinal epithelial cells. IL-18 inhibited goblet cell maturation by regulating the transcriptional program instructing goblet cell development. These results inform on the mechanism of goblet cell dysfunction that underlies the pathology of ulcerative colitis.	[Nowarski, Roni; Jackson, Ruaidhri; Gagliani, Nicola; de Zoete, Marcel R.; Palm, Noah W.; Bailis, Will; Low, Jun Siong; Harman, Christian C. D.; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Graham, Morven] Yale Univ, Sch Med, Ctr Cellular & Mol Imaging, New Haven, CT 06520 USA; [Elinav, Eran] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Flavell, Richard A.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Weizmann Institute of Science; Howard Hughes Medical Institute; Yale University	Flavell, RA (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.	richard.flavell@yale.edu	de Zoete, Marcel R/O-3012-2014; Elinav, Eran/ABE-8881-2020; de Zoete, Marcel/ABA-7918-2021	Elinav, Eran/0000-0002-5775-2110; Low, Jun Siong/0000-0002-1775-0778; Palm, Noah/0000-0001-7262-9455; de Zoete, Marcel/0000-0002-6561-5810; Gagliani, Nicola/0000-0001-8514-1395	Cancer Research Institute; Netherlands Organization of Scientific Research; Cancer Research Institute Irvington Fellowship Program; Howard Hughes Medical Institute International Student Research Fellowship; Jane Coffin Childs Fund Postdoctoral Fellowship; Howard Hughes Medical Institute; Blavatnik Family Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735, P30DK034989] Funding Source: NIH RePORTER	Cancer Research Institute; Netherlands Organization of Scientific Research(Netherlands Organization for Scientific Research (NWO)); Cancer Research Institute Irvington Fellowship Program; Howard Hughes Medical Institute International Student Research Fellowship(Howard Hughes Medical Institute); Jane Coffin Childs Fund Postdoctoral Fellowship; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Blavatnik Family Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank Caroline Lieber, Judith Stein, Jon Alderman, Cindy Hughes, and Elizabeth Hughes-Picard for technical assistance. N.G. is supported by the Dr. Keith Landesman Memorial Fellowship of the Cancer Research Institute, M.R.d.Z. is supported by a Rubicon Fellowship from the Netherlands Organization of Scientific Research, N.W.P. and W.B. are supported by the Cancer Research Institute Irvington Fellowship Program, C.C.D.H. is supported by a Howard Hughes Medical Institute International Student Research Fellowship, and R.N. is supported by the Jane Coffin Childs Fund Postdoctoral Fellowship. This work was supported in part by the Howard Hughes Medical Institute and the Blavatnik Family Foundation (R.A.F.).	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Adolph TE, 2013, NATURE, V503, P272, DOI 10.1038/nature12599; Asquith M, 2010, J EXP MED, V207, P1573, DOI 10.1084/jem.20101330; Bamias G, 2012, CYTOKINE, V59, P451, DOI 10.1016/j.cyto.2012.06.014; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Becker C, 2006, NAT PROTOC, V1, P2900, DOI 10.1038/nprot.2006.446; Bergstrom KSB, 2008, INFECT IMMUN, V76, P796, DOI 10.1128/IAI.00093-07; Bersudsky M, 2014, GUT, V63, P598, DOI 10.1136/gutjnl-2012-303329; Born TL, 1998, J BIOL CHEM, V273, P29445, DOI 10.1074/jbc.273.45.29445; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Danese S, 2011, NEW ENGL J MED, V365, P1713, DOI 10.1056/NEJMra1102942; Dinarello CA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00289; Dupaul-Chicoine J, 2010, IMMUNITY, V32, P367, DOI 10.1016/j.immuni.2010.02.012; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Fantuzzi G, 1999, J CLIN INVEST, V104, P761, DOI 10.1172/JCI7501; Fantuzzi G, 2003, J LEUKOCYTE BIOL, V74, P889, DOI 10.1189/jlb.0503230; Fellermann K, 2003, EUR J GASTROEN HEPAT, V15, P627, DOI 10.1097/00042737-200306000-00008; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Gagliani N, 2014, INT IMMUNOL, V26, P495, DOI 10.1093/intimm/dxu066; Gersemann M, 2009, DIFFERENTIATION, V77, P84, DOI 10.1016/j.diff.2008.09.008; Gregorieff A, 2009, GASTROENTEROLOGY, V137, P1333, DOI 10.1053/j.gastro.2009.06.044; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hoshino K, 1999, J IMMUNOL, V162, P5041; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Kanai T, 2001, GASTROENTEROLOGY, V121, P875, DOI 10.1053/gast.2001.28021; Kaser A, 2011, CELL MOL LIFE SCI, V68, P3643, DOI 10.1007/s00018-011-0827-y; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Katz JP, 2002, DEVELOPMENT, V129, P2619; Lopetuso LR, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00181; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Malvin NP, 2012, MUCOSAL IMMUNOL, V5, P194, DOI 10.1038/mi.2011.65; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; McCauley HA, 2015, TRENDS MOL MED, V21, P492, DOI 10.1016/j.molmed.2015.06.003; MCCORMICK DA, 1990, J CLIN PATHOL, V43, P143, DOI 10.1136/jcp.43.2.143; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Monteleone G, 1999, J IMMUNOL, V163, P143; NAKAMURA K, 1989, INFECT IMMUN, V57, P590, DOI 10.1128/IAI.57.2.590-595.1989; Netea MG, 2006, NAT MED, V12, P650, DOI 10.1038/nm1415; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Noah TK, 2010, EXP CELL RES, V316, P452, DOI 10.1016/j.yexcr.2009.09.020; Novick D, 1999, IMMUNITY, V10, P127, DOI 10.1016/S1074-7613(00)80013-8; Nuding S, 2007, GUT, V56, P1240, DOI 10.1136/gut.2006.118646; Oficjalska K, 2015, J IMMUNOL, V194, P1252, DOI 10.4049/jimmunol.1400501; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Pizarro TT, 1999, J IMMUNOL, V162, P6829; Rongvaux A, 2014, CELL, V159, P1563, DOI 10.1016/j.cell.2014.11.037; Salcedo R, 2010, J EXP MED, V207, P1625, DOI 10.1084/jem.20100199; Saleh M, 2011, NAT REV IMMUNOL, V11, P9, DOI 10.1038/nri2891; Schreiber S, 2005, NAT REV GENET, V6, P376, DOI 10.1038/nrg1607; Shroyer NF, 2005, GENE DEV, V19, P2412, DOI 10.1101/gad.1353905; Siegmund B, 2001, AM J PHYSIOL-REG I, V281, pR1264, DOI 10.1152/ajpregu.2001.281.4.R1264; Siegmund B, 2010, IMMUNITY, V32, P300, DOI 10.1016/j.immuni.2010.03.010; Sivakumar PV, 2002, GUT, V50, P812, DOI 10.1136/gut.50.6.812; Strugala V, 2008, INT J CLIN PRACT, V62, P762, DOI 10.1111/j.1742-1241.2007.01665.x; Takagi H, 2003, SCAND J GASTROENTERO, V38, P837, DOI 10.1080/00365520310004047; Takeda K, 1998, IMMUNITY, V8, P383, DOI 10.1016/S1074-7613(00)80543-9; Takeuchi M, 1997, CELL TISSUE RES, V289, P499, DOI 10.1007/s004410050895; Ten Hove T, 2001, GASTROENTEROLOGY, V121, P1372, DOI 10.1053/gast.2001.29579; TRABUCCHI E, 1986, INT J TISSUE REACT, V8, P79; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wehkamp J, 2007, CURR OPIN GASTROEN, V23, P370, DOI 10.1097/MOG.0b013e328136c580; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003	68	300	317	7	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 6	2015	163	6					1444	1456		10.1016/j.cell.2015.10.072	http://dx.doi.org/10.1016/j.cell.2015.10.072			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SE	26638073	Green Accepted, Bronze			2022-12-28	WOS:000366044800019
J	Phillips, A; Shroufi, A; Vojnov, L; Cohn, J; Roberts, T; Ellman, T; Bonner, K; Rousseau, C; Garnett, G; Cambiano, V; Nakagawa, F; Ford, D; Bansi-Matharu, L; Miners, A; Lundgren, JD; Eaton, JW; Parkes-Ratanshi, R; Katz, Z; Maman, D; Ford, N; Vitoria, M; Doherty, M; Dowdy, D; Nichols, B; Murtagh, M; Wareham, M; Palamountain, KM; Musanhu, CC; Stevens, W; Katzenstein, D; Ciaranello, A; Barnabas, R; Braithwaite, RS; Bendavid, E; Nathoo, KJ; van de Vijver, D; Wilson, DP; Holmes, C; Bershteyn, A; Walker, S; Raizes, E; Jani, I; Nelson, LJ; Peeling, R; Terris-Prestholt, F; Murungu, J; Mutasa-Apollo, T; Hallett, TB; Revill, P				Phillips, Andrew; Shroufi, Amir; Vojnov, Lara; Cohn, Jennifer; Roberts, Teri; Ellman, Tom; Bonner, Kimberly; Rousseau, Christine; Garnett, Geoff; Cambiano, Valentina; Nakagawa, Fumiyo; Ford, Deborah; Bansi-Matharu, Loveleen; Miners, Alec; Lundgren, Jens D.; Eaton, Jeffrey W.; Parkes-Ratanshi, Rosalind; Katz, Zachary; Maman, David; Ford, Nathan; Vitoria, Marco; Doherty, Meg; Dowdy, David; Nichols, Brooke; Murtagh, Maurine; Wareham, Meghan; Palamountain, Kara M.; Musanhu, Christine Chakanyuka; Stevens, Wendy; Katzenstein, David; Ciaranello, Andrea; Barnabas, Ruanne; Braithwaite, R. Scott; Bendavid, Eran; Nathoo, Kusum J.; van de Vijver, David; Wilson, David P.; Holmes, Charles; Bershteyn, Anna; Walker, Simon; Raizes, Elliot; Jani, Ilesh; Nelson, Lisa J.; Peeling, Rosanna; Terris-Prestholt, Fern; Murungu, Joseph; Mutasa-Apollo, Tsitsi; Hallett, Timothy B.; Revill, Paul		Working Grp Modelling	Sustainable HIV treatment in Africa through viral-load-informed differentiated care	NATURE			English	Article							DRIED BLOOD SPOTS; CD4 CELL COUNT; 1ST-LINE ANTIRETROVIRAL THERAPY; STRATALL ANRS 12110/ESTHER; RESOURCE-LIMITED SETTINGS; COST-EFFECTIVENESS; DRUG-RESISTANCE; OUTCOMES; QUANTIFICATION; IMPLEMENTATION	There are inefficiencies in current approaches to monitoring patients on antiretroviral therapy in sub-Saharan Africa. Patients typically attend clinics every 1 to 3 months for clinical assessment. The clinic costs are comparable with the costs of the drugs themselves and CD4 counts are measured every 6 months, but patients are rarely switched to second-line therapies. To ensure sustainability of treatment programmes, a transition to more cost-effective delivery of antiretroviral therapy is needed. In contrast to the CD4 count, measurement of the level of HIV RNA in plasma (the viral load) provides a direct measure of the current treatment effect. Viral-load-informed differentiated care is a means of tailoring care so that those with suppressed viral load visit the clinic less frequently and attention is focussed on those with unsuppressed viral load to promote adherence and timely switching to a second-line regimen. The most feasible approach to measuring viral load in many countries is to collect dried blood spot samples for testing in regional laboratories; however, there have been concerns over the sensitivity and specificity of this approach to define treatment failure and the delay in returning results to the clinic. We use modelling to synthesize evidence and evaluate the cost-effectiveness of viral-load-informed differentiated care, accounting for limitations of dried blood sample testing. We find that viral-load-informed differentiated care using dried blood sample testing is cost-effective and is a recommended strategy for patient monitoring, although further empirical evidence as the approach is rolled out would be of value. We also explore the potential benefits of point-of-care viral load tests that may become available in the future.	[Phillips, Andrew; Cambiano, Valentina; Nakagawa, Fumiyo; Bansi-Matharu, Loveleen] UCL, Dept Infect & Populat Hlth, London NW3 2PF, England; [Shroufi, Amir; Ellman, Tom; Maman, David] Medecinssans Frontieres MSF SA, SAMU, ZA-7700 Cape Town, South Africa; [Vojnov, Lara; Katz, Zachary; Wareham, Meghan] Clinton Hlth Access Initiat, Boston, MA 02127 USA; [Cohn, Jennifer; Roberts, Teri] Med Sans Frontieres, Access Campaign, CH-1202 Geneva, Switzerland; [Bonner, Kimberly] Med Sans Frontieres, CH-1211 Geneva 21, Switzerland; [Rousseau, Christine; Garnett, Geoff] Bill & Melinda Gates Fdn, Seattle, WA 98199 USA; [Ford, Deborah] UCL, Inst Clin Trials & Methodol, MRC Clin Trials Unit, London WC2B 6NH, England; [Miners, Alec] London Sch Hyg & Trop Med, Hlth Serv Res & Policy, London WC1H 9SY, England; [Lundgren, Jens D.] Univ Copenhagen, Rigshosp, Dept Infect Dis, CHIP, DK-92100 Copenhagen, Denmark; [Eaton, Jeffrey W.; Hallett, Timothy B.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London W2 1PG, England; [Parkes-Ratanshi, Rosalind] Makerere Univ, Coll Hlth Sci, IDI, Kampala, Uganda; [Ford, Nathan; Vitoria, Marco; Doherty, Meg] WHO, HIV AIDS & Global Hepatitis Programme, CH-1211 Geneva, Switzerland; [Dowdy, David] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Nichols, Brooke; van de Vijver, David] Erasmus MC, Dept Virosci, NL-3000 CA Rotterdam, Netherlands; [Murtagh, Maurine] Univ London London Sch Hyg & Trop Med, Int Diagnost Ctr, London WC1E 7HT, England; [Palamountain, Kara M.] Northwestern Univ, Kellogg Sch Management, Evanston, IL 60208 USA; [Musanhu, Christine Chakanyuka] WHO Country Off, Harare, Zimbabwe; [Stevens, Wendy] Univ Witwatersrand, Dept Mol Med & Haematol, ZA-2050 Johannesburg, South Africa; [Katzenstein, David] Stanford Univ, Med Ctr, Div Infect Dis, Stanford, CA 94305 USA; [Ciaranello, Andrea] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Barnabas, Ruanne] Univ Washington, Med Global Hlth & Epidemiol, Seattle, WA 98104 USA; [Braithwaite, R. Scott] NYU, Sch Med, Dept Populat Hlth, New York, NY 10016 USA; [Bendavid, Eran] Stanford Univ, Dept Med, Div Gen Med Disciplines, Stanford, CA 94305 USA; [Nathoo, Kusum J.] Univ Zimbabwe, Coll Hlth Sci, Dept Paediat & Child Hlth, Harare, Zimbabwe; [Wilson, David P.] Univ New S Wales, Sydney, NSW 2052, Australia; [Holmes, Charles] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Bershteyn, Anna] Inst Dis Modeling, Bellevue, WA 98005 USA; [Walker, Simon; Revill, Paul] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England; [Raizes, Elliot] CDC, Care & Treatment Branch, Ctr Global Hlth, Div Global HIV AIDS GAP, Atlanta, GA 30333 USA; [Jani, Ilesh] Minist Hlth, INS, Maputo, Mozambique; [Nelson, Lisa J.] US Dept State, Off US Global AIDS Coordinator & Hlth Diplomacy S, Washington, DC 20520 USA; [Peeling, Rosanna] London Sch Hyg & Trop Med, Dept Clin Res, London WC1E 7HT, England; [Terris-Prestholt, Fern] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1H 9SH, England; [Murungu, Joseph; Mutasa-Apollo, Tsitsi] Minist Hlth & Child Care, Harare, Zimbabwe	University of London; University College London; Doctors Without Borders; Doctors Without Borders; Bill & Melinda Gates Foundation; Medical Research Council Clinical Trials Unit; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; Rigshospitalet; University of Copenhagen; Imperial College London; Makerere University; World Health Organization; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Erasmus University Rotterdam; Erasmus MC; University of London; London School of Hygiene & Tropical Medicine; Northwestern University; University of Witwatersrand; Stanford University; Harvard University; Massachusetts General Hospital; University of Washington; University of Washington Seattle; New York University; Stanford University; University of Zimbabwe; University of New South Wales Sydney; University of York - UK; Centers for Disease Control & Prevention - USA; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Phillips, A (corresponding author), UCL, Dept Infect & Populat Hlth, Rowland Hill St, London NW3 2PF, England.	andrew.phillips@ucl.ac.uk	, Andrea/ABB-3330-2021; Lundgren, Jens/AAE-6876-2019; Nichols, Brooke E./V-5496-2019; Parkes-Ratanshi, Rosalind/AAR-5409-2020; Garnett, Geoffrey P/A-9312-2008; Phillips, Andrew N/B-4427-2008	, Andrea/0000-0002-4268-3263; Nichols, Brooke E./0000-0003-4682-4999; Parkes-Ratanshi, Rosalind/0000-0001-9297-1311; Phillips, Andrew N/0000-0003-2384-4807; Braithwaite, Ronald Scott/0000-0001-7067-3655; Eaton, Jeffrey/0000-0001-7728-728X; Bonner, Kimberly/0000-0002-6942-4050; Terris-Prestholt, Fern/0000-0003-1693-5196; van de Vijver, David/0000-0001-5877-8526; Maman, David/0000-0002-9839-3011; Revill, Paul/0000-0001-8632-0600; Hallett, Timothy/0000-0002-9681-0424; katzenstein, david/0000-0002-8593-4560; Nakagawa, Fumiyo/0000-0002-6646-8744; Walker, Simon Mark/0000-0002-5750-3691; Lundgren, Jens/0000-0001-8901-7850; Vojnov, Lara/0000-0003-0488-1012	HIV Modelling Consortium; Bill and Melinda Gates Foundation; World Health Organization; HIV Diagnostics Modelling Consortium; Danish National Research Foundation [DNRF:126]; MRC [MR/K010174/1, MC_UU_12023/26] Funding Source: UKRI; Medical Research Council [MR/K010174/1, MR/K010174/1B, MC_UU_12023/26, MC_UU_12023/23] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI045008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA015612, R01DA015612] Funding Source: NIH RePORTER	HIV Modelling Consortium; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); World Health Organization(World Health Organization); HIV Diagnostics Modelling Consortium; Danish National Research Foundation(Danmarks Grundforskningsfond); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding for the study was received from the HIV Modelling Consortium, the Bill and Melinda Gates Foundation, the World Health Organization and the HIV Diagnostics Modelling Consortium. We are grateful for the use of cluster computing facilities at UCL, Legion@UCL, without which this work would not have been possible. J. L. is supported by the Danish National Research Foundation (DNRF:126).	Andreotti M, 2010, J CLIN VIROL, V47, P4, DOI 10.1016/j.jcv.2009.11.006; Arredondo M, 2012, J CLIN MICROBIOL, V50, P569, DOI 10.1128/JCM.00418-11; Babigumira JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018193; Bendavid E., 2008, ARCH INTERN MED, V17, P168; Boyer S, 2013, LANCET INFECT DIS, V13, P577, DOI 10.1016/S1473-3099(13)70073-2; Braithwaite R. S., 2013, AIDS S1, V28, pS73; Braithwaite RS, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-38; Cambiano V., 2015, J INFECT DIS; Cambiano V, 2014, AIDS, V28, pS15, DOI 10.1097/QAD.0000000000000082; Cambiano V, 2013, J INFECT DIS, V207, pS57, DOI 10.1093/infdis/jit111; Claxton K, 2010, 54 U YORK CTR HLTH E, P54; Decroo T, 2014, TROP MED INT HEALTH, V19, P514, DOI 10.1111/tmi.12278; Duncombe C, 2015, TROP MED INT HEALTH, V20, P430, DOI 10.1111/tmi.12460; Estill J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057611; Estill J, 2012, AIDS, V26, P1403, DOI 10.1097/QAD.0b013e3283536988; Fajardo E, 2014, J CLIN MICROBIOL, V52, P1343, DOI 10.1128/JCM.03519-13; Fox MP, 2012, JAIDS-J ACQ IMM DEF, V60, P428, DOI 10.1097/QAI.0b013e3182557785; Garrido C, 2009, J CLIN MICROBIOL, V47, P1031, DOI 10.1128/JCM.02099-08; Grimsrud A, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19984; Hamers RL, 2012, AIDS, V26, P1663, DOI 10.1097/QAD.0b013e3283560678; Hyle EP, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001725; Johannessen A, 2009, CLIN INFECT DIS, V49, P976, DOI 10.1086/605502; Johnston V, 2012, JAIDS-J ACQ IMM DEF, V61, P370, DOI 10.1097/QAI.0b013e318266ee3f; Jourdain G, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001494; Kahn JG, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6884; Keebler D, 2014, LANCET GLOB HEALTH, V2, pE35, DOI 10.1016/S2214-109X(13)70048-2; Kimmel AD, 2010, JAIDS-J ACQ IMM DEF, V54, P258, DOI 10.1097/QAI.0b013e3181d0db97; Laurent C, 2011, LANCET INFECT DIS, V11, P825, DOI 10.1016/S1473-3099(11)70168-2; Ledergerber B, 2004, LANCET, V364, P51, DOI 10.1016/S0140-6736(04)16589-6; Madec Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082724; Marconi A, 2009, CLIN MICROBIOL INFEC, V15, P93, DOI 10.1111/j.1469-0691.2008.02116.x; Mavedzenge SN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126878; Menzies NA, 2011, AIDS, V25, P1753, DOI 10.1097/QAD.0b013e3283463eec; Mermin J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6792; MSF, ART ADH CLUB REP TOO; MSF, 2015, COMM ART GROUP TOOLK; MSF Access Campaign, 2014, UNT WEB ANT PRIC RED; MSF and UNAIDS, 2012, CLOS HOM; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; Ondoa P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/102598; Parkin NT, 2014, AIDS REV, V16, P160; Phillips AN, 2008, LANCET, V371, P1443, DOI 10.1016/S0140-6736(08)60624-8; Phillips AN, 2014, LANCET HIV, V1, pE85, DOI 10.1016/S2352-3018(14)70021-9; Phillips AN, 2011, AIDS, V25, P843, DOI 10.1097/QAD.0b013e328344037a; Pirillo MF, 2011, J ANTIMICROB CHEMOTH, V66, P2823, DOI 10.1093/jac/dkr383; Rasschaert F, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18910; Roberts T, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17324; Rutstein SE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124748; Rutstein SE, 2014, J CLIN VIROL, V60, P392, DOI 10.1016/j.jcv.2014.05.005; Saag M., 2012, 19 C RETR OPP INF; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Siapka M, 2014, B WORLD HEALTH ORGAN, V92, P499, DOI 10.2471/BLT.13.127639; Simons S., 2015, WAYS REDUCE COSTS IM; Smit PW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086461; Tagar E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108304; Terris-Prestholt F, 2015, AIDS, V29, P1261, DOI 10.1097/QAD.0000000000000727; UNAIDS, 2014, LANDM HIV DIAGN ACC; UNAIDS and MSF, 2015, COMM BAS ART DEL; UNITAID, 2015, HIV AIDS DIAGN TECHN; Ware NC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001369; Woods E., 2015, COUNTRY LEVEL COST E; World Bank, 2015, COUNTR LEND DAT; World Health Organization, 2014, TECHN OP CONS IMPL H	63	118	120	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					S68	S76		10.1038/nature16046	http://dx.doi.org/10.1038/nature16046			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX3NO	26633768	Green Accepted, hybrid, Green Submitted			2022-12-28	WOS:000365606000013
J	Rolston, S				Rolston, Steven			QUANTUM PHYSICS Getting the measure of entanglement	NATURE			English	Editorial Material									[Rolston, Steven] Univ Maryland, Dept Phys, Joint Quantum Inst, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Rolston, S (corresponding author), Univ Maryland, Dept Phys, Joint Quantum Inst, College Pk, MD 20742 USA.	rolston@umd.edu	rolston, steven l/L-5175-2013	rolston, steven l/0000-0003-1671-4190				Bakr WS, 2010, SCIENCE, V329, P547, DOI 10.1126/science.1192368; Bell B., 1964, PHYSICS, V1, P195; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; Hensen B, 2015, NATURE, V526, P682, DOI 10.1038/nature15759; HONG CK, 1987, PHYS REV LETT, V59, P2044, DOI 10.1103/PhysRevLett.59.2044; Horodecki R, 2009, REV MOD PHYS, V81, P865, DOI 10.1103/RevModPhys.81.865; Islam R, 2015, NATURE, V528, P77, DOI 10.1038/nature15750	7	0	0	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					48	49		10.1038/528048a	http://dx.doi.org/10.1038/528048a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX3NO	26632586				2022-12-28	WOS:000365606000046
J	Mok, TSK; Loong, HH				Mok, Tony S. K.; Loong, Herbert H.			Are we ready for immune checkpoint inhibitors for advanced non-small-cell lung cancer?	LANCET			English	Editorial Material							ADENOCARCINOMA; DOCETAXEL; NIVOLUMAB; GEFITINIB		[Mok, Tony S. K.; Loong, Herbert H.] Chinese Univ Hong Kong, State Key Lab Oncol South China, Fac Med, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; State Key Lab Oncology South China	Mok, TSK (corresponding author), Chinese Univ Hong Kong, State Key Lab Oncol South China, Fac Med, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China.	tony@clo.cuhk.edu.hk	Mok, Tony Shu Kam/B-2310-2019; Loong, Herbert/J-5413-2017	Mok, Tony Shu Kam/0000-0002-8251-0551; Loong, Herbert/0000-0002-6607-1106				Ahamadi M, 2014, ANN M POP APPR GROUP; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Herbst RS, 2015, LANCET; Lindauer A, 2014, ANN M POP APPR GROUP; Lopes GD, 2012, CANCER-AM CANCER SOC, V118, P1032, DOI 10.1002/cncr.26372; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; *US FDA, 2015, FDA APPR KEYTR ADV N	10	8	8	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 9	2016	387	10027					1488	1490		10.1016/S0140-6736(15)01308-2	http://dx.doi.org/10.1016/S0140-6736(15)01308-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI8HH	26712085				2022-12-28	WOS:000373741600006
J	Prantzos, N				Prantzos, Nikos			COSMOLOGY Rare isotopic insight into the Universe	NATURE			English	Editorial Material							ABUNDANCE		[Prantzos, Nikos] Inst Astrophys, F-75014 Paris, France; [Prantzos, Nikos] Univ Paris 06, Paris, France	UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Prantzos, N (corresponding author), Inst Astrophys, F-75014 Paris, France.; Prantzos, N (corresponding author), Univ Paris 06, Paris, France.	prantzos@iap.fr	Prantzos, Nikos/Q-6667-2018					Aver E, 2015, J COSMOL ASTROPART P, V7, P011; Cooke RJ, 2015, ASTROPHYS J LETT, V812, DOI 10.1088/2041-8205/812/1/L12; Cooke RJ, 2014, ASTROPHYS J, V781, DOI 10.1088/0004-637X/781/1/31; Cyburt R. H., 2015, PREPRINT; Izotov YI, 2014, MON NOT R ASTRON SOC, V445, P778, DOI 10.1093/mnras/stu1771; Planck Collaboration XIII, 2015, PREPRINT	6	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 7	2016	529	7584					33	34		10.1038/nature16326	http://dx.doi.org/10.1038/nature16326			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6VY	26649823				2022-12-28	WOS:000367944900020
J	Domcke, S; Bardet, AF; Ginno, PA; Hartl, D; Burger, L; Schubeler, D				Domcke, Silvia; Bardet, Anais Flore; Ginno, Paul Adrian; Hartl, Dominik; Burger, Lukas; Schuebeler, Dirk			Competition between DNA methylation and transcription factors determines binding of NRF1	NATURE			English	Article							EMBRYONIC STEM-CELLS; HUMAN GENOME; GROUND-STATE; MOUSE GENOME; IN-VIVO; GENE; ELEMENTS; EXPRESSION; SEQUENCE; ABSENCE	Eukaryotic transcription factors (TFs) are key determinants of gene activity, yet they bind only a fraction of their corresponding DNA sequence motifs in any given cell type(1). Chromatin has the potential to restrict accessibility of binding sites; however, in which context chromatin states are instructive for TF binding remains mainly unknown(1,2). To explore the contribution of DNA methylation to constrained TF binding, we mapped DNase-I-hypersensitive sites in murine stem cells in the presence and absence of DNA methylation. Methylation-restricted sites are enriched for TF motifs containing CpGs, especially for those of NRF1. In fact, the TF NRF1 occupies several thousand additional sites in the unmethylated genome, resulting in increased transcription. Restoring de novo methyltransferase activity initiates remethylation at these sites and outcompetes NRF1 binding. This suggests that binding of DNA-methylation-sensitive TFs relies on additional determinants to induce local hypomethylation. In support of this model, removal of neighbouring motifs in cis or of a TF in trans causes local hypermethylation and subsequent loss of NRF1 binding. This competition between DNA methylation and TFs in vivo reveals a case of cooperativity between TFs that acts indirectly via DNA methylation. Methylation removal by methylation-insensitive factors enables occupancy of methylation-sensitive factors, a principle that rationalizes hypomethylation of regulatory regions.	[Domcke, Silvia; Bardet, Anais Flore; Ginno, Paul Adrian; Hartl, Dominik; Burger, Lukas; Schuebeler, Dirk] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Domcke, Silvia; Hartl, Dominik; Schuebeler, Dirk] Univ Basel, Fac Sci, CH-4003 Basel, Switzerland; [Burger, Lukas] Swiss Inst Bioinformat, CH-4058 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; University of Basel; Swiss Institute of Bioinformatics	Schubeler, D (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	dirk@fmi.ch	Bardet, Anais Flore/L-6964-2019	Domcke, Silvia/0000-0002-4102-7774	Novartis Research Foundation; European Union (NoE 'EpiGeneSys') [FP7-HEALTH-2010-257082]; European Union ('Blueprint' consortium) [FP7-282510]; European Research Council (EpiGePlas); Swiss initiative in Systems Biology (RTD Cell Plasticity); EMBO postdoctoral long-term fellowships; Boehringer Ingelheim Fonds	Novartis Research Foundation; European Union (NoE 'EpiGeneSys'); European Union ('Blueprint' consortium); European Research Council (EpiGePlas); Swiss initiative in Systems Biology (RTD Cell Plasticity); EMBO postdoctoral long-term fellowships; Boehringer Ingelheim Fonds(Boehringer Ingelheim)	We are grateful to S. Dessus-Babus, K. Jacobeit and T. Roloff (FMI) for processing deep-sequencing samples, to C. Wirbelauer for technical assistance and to A. Arnold for technical advice. We thank M. Stadler and D. Gaidatzis for bioinformatic advice and members of our laboratory, N. Thomae (FMI) and M. Lorincz (UBC Vancouver) for comments on the manuscript. We apologize to colleagues whose work we could not cite owing to space limitations. Research in the laboratory of D. S. is supported by the Novartis Research Foundation, the European Union (NoE 'EpiGeneSys' FP7-HEALTH-2010-257082 and the 'Blueprint' consortium FP7-282510), the European Research Council (EpiGePlas) and the Swiss initiative in Systems Biology (RTD Cell Plasticity). A.F.B. and P.A.G. are supported by EMBO postdoctoral long-term fellowships and S. D. and D.H. by predoctoral fellowships from the Boehringer Ingelheim Fonds.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arnold P, 2013, GENOME RES, V23, P60, DOI 10.1101/gr.142661.112; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Bardet AF, 2013, BIOINFORMATICS, V29, P2705, DOI 10.1093/bioinformatics/btt470; Baubec T, 2013, CELL, V153, P480, DOI 10.1016/j.cell.2013.03.011; BECKER PB, 1987, CELL, V51, P435, DOI 10.1016/0092-8674(87)90639-8; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Feldmann A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003994; Ficz G, 2013, CELL STEM CELL, V13, P351, DOI 10.1016/j.stem.2013.06.004; Gaidatzis D, 2015, BIOINFORMATICS, V31, P1130, DOI 10.1093/bioinformatics/btu781; Habibi E, 2013, CELL STEM CELL, V13, P360, DOI 10.1016/j.stem.2013.06.002; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hon GC, 2012, GENOME RES, V22, P246, DOI 10.1101/gr.125872.111; Hu SH, 2013, ELIFE, V2, DOI 10.7554/eLife.00726; Iwafuchi-Doi M, 2014, GENE DEV, V28, P2679, DOI 10.1101/gad.253443.114; Jermann P, 2014, P NATL ACAD SCI USA, V111, pE3415, DOI 10.1073/pnas.1400672111; John Sam, 2013, Curr Protoc Mol Biol, VChapter 27, DOI 10.1002/0471142727.mb2127s103; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Jorgensen HF, 2009, NATURE, V457, pE4, DOI 10.1038/nature07783; Karimi MM, 2011, CELL STEM CELL, V8, P676, DOI 10.1016/j.stem.2011.04.004; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Krebs AR, 2014, ELIFE, V3, DOI 10.7554/eLife.04094; Kumari D, 2001, J BIOL CHEM, V276, P4357, DOI 10.1074/jbc.M009629200; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lienert F, 2011, NAT GENET, V43, P1091, DOI 10.1038/ng.946; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Maurano MT, 2015, CELL REP, V12, P1184, DOI 10.1016/j.celrep.2015.07.024; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Schubeler D, 2000, MOL CELL BIOL, V20, P9103, DOI 10.1128/MCB.20.24.9103-9112.2000; Schubeler D, 2015, NATURE, V517, P321, DOI 10.1038/nature14192; Sherwood RI, 2014, NAT BIOTECHNOL, V32, P171, DOI 10.1038/nbt.2798; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Slattery M, 2014, TRENDS BIOCHEM SCI, V39, P381, DOI 10.1016/j.tibs.2014.07.002; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; TATE PH, 1993, CURR OPIN GENET DEV, V3, P226, DOI 10.1016/0959-437X(93)90027-M; Tippmann SC, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.23; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; VIRBASIUS CMA, 1993, GENE DEV, V7, P2431, DOI 10.1101/gad.7.12a.2431; WEIH F, 1991, EMBO J, V10, P2559, DOI 10.1002/j.1460-2075.1991.tb07796.x; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019; Xie W, 2012, CELL, V148, P816, DOI 10.1016/j.cell.2011.12.035; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	54	269	272	5	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2015	528	7583					575	+		10.1038/nature16462	http://dx.doi.org/10.1038/nature16462			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ3GH	26675734				2022-12-28	WOS:000366991900057
J	Kim, K; Song, B; Fernandez-Hurtado, V; Lee, W; Jeong, WH; Cui, LJ; Thompson, D; Feist, J; Reid, MTH; Garcia-Vidal, FJ; Cuevas, JC; Meyhofer, E; Reddy, P				Kim, Kyeongtae; Song, Bai; Fernandez-Hurtado, Victor; Lee, Woochul; Jeong, Wonho; Cui, Longji; Thompson, Dakotah; Feist, Johannes; Reid, M. T. Homer; Garcia-Vidal, Francisco J.; Cuevas, Juan Carlos; Meyhofer, Edgar; Reddy, Pramod			Radiative heat transfer in the extreme near field	NATURE			English	Article							THERMAL-RADIATION	Radiative transfer of energy at the nanometre length scale is of great importance to a variety of technologies including heat-assisted magnetic recording(1), near-field thermophotovoltaics(2) and lithography(3). Although experimental advances have enabled elucidation of near-field radiative heat transfer in gaps as small as 20-30 nanometres (refs 4-6), quantitative analysis in the extreme near field (less than 10 nanometres) has been greatly limited by experimental challenges. Moreover, the results of pioneering measurements(7,8) differed from theoretical predictions by orders of magnitude. Here we use custom-fabricated scanning probes with embedded thermocouples(9,10), in conjunction with new microdevices capable of periodic temperature modulation, to measure radiative heat transfer down to gaps as small as two nanometres. For our experiments we deposited suitably chosen metal or dielectric layers on the scanning probes and microdevices, enabling direct study of extreme near-field radiation between silica-silica, silicon nitride-silicon nitride and gold-gold surfaces to reveal marked, gap-size-dependent enhancements of radiative heat transfer. Furthermore, our state-of-the-art calculations of radiative heat transfer, performed within the theoretical framework of fluctuational electrodynamics, are in excellent agreement with our experimental results, providing unambiguous evidence that confirms the validity of this theory(11-13) for modelling radiative heat transfer in gaps as small as a few nanometres. This work lays the foundations required for the rational design of novel technologies that leverage nanoscale radiative heat transfer.	[Kim, Kyeongtae; Song, Bai; Lee, Woochul; Jeong, Wonho; Cui, Longji; Thompson, Dakotah; Meyhofer, Edgar; Reddy, Pramod] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Fernandez-Hurtado, Victor; Feist, Johannes; Garcia-Vidal, Francisco J.; Cuevas, Juan Carlos] Univ Autonoma Madrid, Dept Fis Teor Mat Condensada, E-28049 Madrid, Spain; [Fernandez-Hurtado, Victor; Feist, Johannes; Garcia-Vidal, Francisco J.; Cuevas, Juan Carlos] Univ Autonoma Madrid, Condensed Matter Phys Ctr IFIMAC, E-28049 Madrid, Spain; [Reid, M. T. Homer] MIT, Dept Math, Cambridge, MA 02139 USA; [Garcia-Vidal, Francisco J.] Donostia Int Phys Ctr, Donostia San Sebastian 20018, Spain; [Reddy, Pramod] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Autonomous University of Madrid; Autonomous University of Madrid; Massachusetts Institute of Technology (MIT); University of Michigan System; University of Michigan	Cuevas, JC (corresponding author), Univ Autonoma Madrid, Dept Fis Teor Mat Condensada, E-28049 Madrid, Spain.	juancarlos.cuevas@uam.es; meyhofer@umich.edu; pramodr@umich.edu	Feist, Johannes/J-7394-2012; Song, Bai/GYQ-7055-2022; Lee, Woochul/B-8753-2013; Cuevas, Juan Carlos/P-2258-2019; Cui, Longji/A-4033-2017; Cui, Longji/C-8883-2017; Lee, Woochul/GMW-8587-2022; Garcia-Vidal, Francisco J./B-8280-2011; Cuevas, Juan Carlos/B-7813-2012	Feist, Johannes/0000-0002-7972-0646; Song, Bai/0000-0003-3013-9831; Lee, Woochul/0000-0002-0911-961X; Cui, Longji/0000-0003-0469-3230; Lee, Woochul/0000-0002-0911-961X; Garcia-Vidal, Francisco J./0000-0003-4354-0982; Cuevas, Juan Carlos/0000-0001-7421-0682; Fernandez Hurtado, Victor/0000-0002-0102-9011; Meyhofer, Edgar/0000-0001-5719-6030; Kim, Kyongtae/0000-0003-4360-0148	US Department of Energy Basic Energy Sciences through a grant from the Scanning Probe Microscopy Division [DE-SC0004871]; Army Research Office [W911NF-12-1-0612]; Office of Naval Research [N00014-13-1-0320]; National Science Foundation [CBET 1235691]; Spanish Ministry of Economy and Competitiveness (MINECO) [FIS2014-53488-P]; Comunidad de Madrid [S2013/MIT-2740]; "la Caixa" Foundation; European Research Council [290981]; European Union [FP7-PEOPLE-2013-CIG-618229]; Spanish MINECO [MAT2011-28581-C02-01, MAT2014-53432-C5-5-R]	US Department of Energy Basic Energy Sciences through a grant from the Scanning Probe Microscopy Division(United States Department of Energy (DOE)); Army Research Office; Office of Naval Research(Office of Naval Research); National Science Foundation(National Science Foundation (NSF)); Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); Comunidad de Madrid(Comunidad de Madrid); "la Caixa" Foundation(La Caixa Foundation); European Research Council(European Research Council (ERC)European Commission); European Union(European Commission); Spanish MINECO(Spanish Government)	P.R. acknowledges support from US Department of Energy Basic Energy Sciences through a grant from the Scanning Probe Microscopy Division under award no. DE-SC0004871 (fabrication of scanning thermal probes). E.M. and P.R. acknowledge support from the Army Research Office under grant W911NF-12-1-0612 (fabrication of microdevices). P.R. acknowledges support from the Office of Naval Research under grant award no. N00014-13-1-0320 (instrumentation). E.M. and P.R. acknowledge support from the National Science Foundation under grant CBET 1235691 (thermal characterization). J.C.C. acknowledges financial support from the Spanish Ministry of Economy and Competitiveness (MINECO) (contract no. FIS2014-53488-P) and the Comunidad de Madrid (contract no. S2013/MIT-2740) and V.F.-H. from "la Caixa" Foundation. F.J.G.-V. and J.F. acknowledge support from the European Research Council (ERC-2011-AdG Proposal No. 290981), the European Union Seventh Framework Programme (FP7-PEOPLE-2013-CIG-618229), and the Spanish MINECO (MAT2011-28581-C02-01 and MAT2014-53432-C5-5-R). The authors acknowledge the Lurie Nanofabrication Facility for facilitating the nanofabrication of devices.	Altfeder I, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.166101; Basu S, 2009, INT J ENERG RES, V33, P1203, DOI 10.1002/er.1607; Challener WA, 2009, NAT PHOTONICS, V3, P220, DOI 10.1038/NPHOTON.2009.26; Chapuis PO, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.035431; Chiloyan V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7755; De Wilde Y, 2006, NATURE, V444, P740, DOI 10.1038/nature05265; Jones AC, 2012, NANO LETT, V12, P1475, DOI 10.1021/nl204201g; Joulain K, 2005, SURF SCI REP, V57, P59, DOI 10.1016/j.surfrep.2004.12.002; Kim K, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4902075; Kim K, 2012, ACS NANO, V6, P4248, DOI 10.1021/nn300774n; Kittel A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.224301; Lee W, 2013, NATURE, V498, P209, DOI 10.1038/nature12183; Mulet JP, 2002, MICROSCALE THERM ENG, V6, P209, DOI 10.1080/10893950290053321; Mulet JP, 2001, APPL PHYS LETT, V78, P2931, DOI 10.1063/1.1370118; Otey CR, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.154301; Pendry JB, 1999, J PHYS-CONDENS MAT, V11, P6621, DOI 10.1088/0953-8984/11/35/301; Planck M., 1914, THEORY HEAT RAD; POLDER D, 1971, PHYS REV B, V4, P3303, DOI 10.1103/PhysRevB.4.3303; Reid MTH, 2015, IEEE T ANTENN PROPAG, V63, P3588, DOI 10.1109/TAP.2015.2438393; Rodriguez AW, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.054305; Rodriguez AW, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.220302; Rousseau E, 2009, NAT PHOTONICS, V3, P514, DOI 10.1038/NPHOTON.2009.144; Rytov S.M., 1953, THEORY ELECT FLUCTUA; Rytov SM., 1989, PRINCIPLES STAT RADI, DOI 10.1007/978-3-642-72685-9; Sadat S, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4802239; Shen S, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4723713; Shen S, 2009, NANO LETT, V9, P2909, DOI 10.1021/nl901208v; Singer F, 2015, J QUANT SPECTROSC RA, V154, P55, DOI 10.1016/j.jqsrt.2014.11.016; Song B, 2015, AIP ADV, V5, DOI 10.1063/1.4919048; Song B, 2015, NAT NANOTECHNOL, V10, P253, DOI [10.1038/nnano.2015.6, 10.1038/NNANO.2015.6]; Wischnath UF, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2955764; Worbes L, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.134302	32	261	261	13	236	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2015	528	7582					387	391		10.1038/nature16070	http://dx.doi.org/10.1038/nature16070			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY8SM	26641312				2022-12-28	WOS:000366678600050
J	Perie, L; Duffy, KR; Kok, L; de Boer, RJ; Schumacher, TN				Perie, Leila; Duffy, Ken R.; Kok, Lianne; de Boer, Rob J.; Schumacher, Ton N.			The Branching Point in Erythro-Myeloid Differentiation	CELL			English	Article							HEMATOPOIETIC STEM-CELLS; LINEAGE COMMITMENT; IN-VIVO; MULTIPOTENT PROGENITORS; CLONAL ANALYSIS; BONE-MARROW; T-CELLS; MARKS; PU.1; IDENTIFICATION	Development of mature blood cell progenies from hematopoietic stem cells involves the transition through lineage-restricted progenitors. The first branching point along this developmental process is thought to separate the erythro-myeloid and lymphoid lineage fate by yielding two intermediate progenitors, the common myeloid and the common lymphoid progenitors (CMPs and CLPs). Here, we use single-cell lineage tracing to demonstrate that so-called CMPs are highly heterogeneous with respect to cellular output, with most individual CMPs yielding either only erythrocytes or only myeloid cells after transplantation. Furthermore, based on the labeling of earlier progenitors, we show that the divergence between the myeloid and erythroid lineage develops within multipotent progenitors (MPP). These data provide evidence for a model of hematopoietic branching in which multiple distinct lineage commitments occur in parallel within the MPP pool.	[Perie, Leila; Kok, Lianne; Schumacher, Ton N.] Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands; [Perie, Leila; de Boer, Rob J.] Univ Utrecht, Theoret Biol & Bioinformat, NL-3584 CH Utrecht, Netherlands; [Duffy, Ken R.] Maynooth Univ, Hamilton Inst, Maynooth, Co Kildare, Ireland; [Perie, Leila] PSL Res Univ, Inst Curie, CNRS UMR168, F-75005 Paris, France; [Perie, Leila] Univ Paris 06, Sorbonne Univ, F-75005 Paris, France	Netherlands Cancer Institute; Utrecht University; Maynooth University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; UDICE-French Research Universities; Sorbonne Universite	Perie, L (corresponding author), Netherlands Canc Inst, Div Immunol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	leila.perie@curie.fr; t.schumacher@nki.nl	Duffy, Ken/D-7955-2011; de Boer, Rob/B-6050-2011; Schumacher, Ton/Y-2432-2019	Duffy, Ken/0000-0001-5587-9356; de Boer, Rob/0000-0002-2130-691X; Schumacher, Ton/0000-0003-0517-8804; Perie, Leila/0000-0003-0798-4498; Kok, Lianne/0000-0002-0445-7548	Human Frontier Science Program [RGP0060/2012]; Netherlands Organization for Scientific Research grant [TOPGO.L.10.042]; ERC grant Life-His-T; Science Foundation Ireland grant [12 IP 1263]; ATIP-Avenir grant from CNRS; Bettencourt-Schueller Foundation; Labex CelTisPhyBio [ANR-10-LBX-0038]; Idex Paris-Science-Lettres Program [ANR-10-IDEX-0001-02 PSL]	Human Frontier Science Program(Human Frontier Science Program); Netherlands Organization for Scientific Research grant(Netherlands Organization for Scientific Research (NWO)); ERC grant Life-His-T; Science Foundation Ireland grant(Science Foundation Ireland); ATIP-Avenir grant from CNRS; Bettencourt-Schueller Foundation; Labex CelTisPhyBio; Idex Paris-Science-Lettres Program	The authors thank A. Pfauth and F. van Diepen for cell sorting, J. Urbanus for lentivirus production, A. Velds and R. Kluin for computational assistance, and S. Naik for discussion. The data and the code presented in this manuscript are available upon request. This work was supported by Human Frontier Science Program grant RGP0060/2012 (to T.S. and K.D.), Netherlands Organization for Scientific Research grant TOPGO.L.10.042 (to T.S. and R.J.d.B.), ERC grant Life-His-T (to T.S.), Science Foundation Ireland grant 12 IP 1263 (to K.D.), an ATIP-Avenir grant from CNRS and Bettencourt-Schueller Foundation (to L.P.), and grants from the Labex CelTisPhyBio (No. ANR-10-LBX-0038) and Idex Paris-Science-Lettres Program (ANR-10-IDEX-0001-02 PSL) (to L.P.).	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Arinobu Y, 2007, CELL STEM CELL, V1, P416, DOI 10.1016/j.stem.2007.07.004; Benz C, 2012, CELL STEM CELL, V10, P273, DOI 10.1016/j.stem.2012.02.007; Boyer SW, 2011, CELL STEM CELL, V9, P64, DOI 10.1016/j.stem.2011.04.021; Busch K, 2015, NATURE, V518, P542, DOI 10.1038/nature14242; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Forsberg EC, 2006, CELL, V126, P415, DOI 10.1016/j.cell.2006.06.037; Franziska P., 2015, CELL, V163, P1663; Gerlach C, 2013, SCIENCE, V340, P635, DOI 10.1126/science.1235487; Gerrits A, 2010, BLOOD, V115, P2610, DOI 10.1182/blood-2009-06-229757; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Lai AY, 2006, J EXP MED, V203, P1867, DOI 10.1084/jem.20060697; Lu R, 2011, NAT BIOTECHNOL, V29, P928, DOI 10.1038/nbt.1977; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Miyawaki K, 2015, STEM CELLS, V33, P976, DOI 10.1002/stem.1906; Naik SH, 2014, EXP HEMATOL, V42, P598, DOI 10.1016/j.exphem.2014.05.003; Naik SH, 2013, NATURE, V496, P229, DOI 10.1038/nature12013; Nakorn TN, 2003, P NATL ACAD SCI USA, V100, P205, DOI 10.1073/pnas.262655099; Notta F., 2015, SCIENCE; Nutt SL, 2005, J EXP MED, V201, P221, DOI 10.1084/jem.20041535; Pietras EM, 2015, CELL STEM CELL, V17, P35, DOI 10.1016/j.stem.2015.05.003; R Development Core Team, 2014, R LANG ENV STAT COMP; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sanjuan-Pla A, 2013, NATURE, V502, P232, DOI 10.1038/nature12495; Schepers K, 2008, J EXP MED, V205, P2309, DOI 10.1084/jem.20072462; Schumacher TNM, 2010, NAT REV IMMUNOL, V10, P621, DOI 10.1038/nri2822; Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824; Takano H, 2004, J EXP MED, V199, P295, DOI 10.1084/jem.20030929; Terszowski G, 2005, BLOOD, V105, P1937, DOI 10.1182/blood-2004-09-3459; Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314	34	111	111	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2015	163	7					1655	1662		10.1016/j.cell.2015.11.059	http://dx.doi.org/10.1016/j.cell.2015.11.059			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CZ1GN	26687356	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000366854200013
J	Weir, K				Weir, Kirsten			Microbiology: Inflammatory evidence	NATURE			English	Editorial Material							PROSTATE-CANCER											Gurel B, 2014, CANCER EPIDEM BIOMAR, V23, P847, DOI 10.1158/1055-9965.EPI-13-1126; Lambert JR, 2015, PROSTATE, V75, P255, DOI 10.1002/pros.22911; Nakai Y, 2007, CANCER RES, V67, P1378, DOI 10.1158/0008-5472.CAN-06-1336; RAVICH A, 1951, NEW YORK STATE J MED, V51, P1519; Sutcliffe S, 2007, INT J CANCER, V121, P2688, DOI 10.1002/ijc.23032	5	4	5	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2015	528	7582					S130	S131		10.1038/528S130a	http://dx.doi.org/10.1038/528S130a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY8SM	26672786	Bronze			2022-12-28	WOS:000366678600006
J	Forslund, K; Hildebrand, F; Nielsen, T; Falony, G; Le Chatelier, E; Sunagawa, S; Prifti, E; Vieira-Silva, S; Gudmundsdottir, V; Pedersen, HK; Arumugam, M; Kristiansen, K; Voigt, AY; Vestergaard, H; Hercog, R; Costea, PI; Kultima, JR; Li, JH; Jorgensen, T; Levenez, F; Dore, J; Nielsen, HB; Brunak, S; Raes, J; Hansen, T; Wang, J; Ehrlich, SD; Bork, P; Pedersen, O				Forslund, Kristoffer; Hildebrand, Falk; Nielsen, Trine; Falony, Gwen; Le Chatelier, Emmanuelle; Sunagawa, Shinichi; Prifti, Edi; Vieira-Silva, Sara; Gudmundsdottir, Valborg; Pedersen, Helle Krogh; Arumugam, Manimozhiyan; Kristiansen, Karsten; Voigt, Anita Yvonne; Vestergaard, Henrik; Hercog, Rajna; Costea, Paul Igor; Kultima, Jens Roat; Li, Junhua; Jorgensen, Torben; Levenez, Florence; Dore, Joel; Nielsen, H. Bjorn; Brunak, Soren; Raes, Jeroen; Hansen, Torben; Wang, Jun; Ehrlich, S. Dusko; Bork, Peer; Pedersen, Oluf		MetaHIT Consortium	Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota	NATURE			English	Article							SP-NOV.; IDENTIFICATION; CLOSTRIDIUM; METAGENOME; GENOMES; HEALTH; COLI; LIFE; RAT	In recent years, several associations between common chronic human disorders and altered gut microbiome composition and function have been reported(1,2). In most of these reports, treatment regimens were not controlled for and conclusions could thus be confounded by the effects of various drugs on the microbiota, which may obscure microbial causes, protective factors or diagnostically relevant signals. Our study addresses disease and drug signatures in the human gut microbiome of type 2 diabetes mellitus (T2D). Two previous quantitative gut metagenomics studies of T2D patients that were unstratified for treatment yielded divergent conclusions regarding its associated gut microbial dysbiosis(3,4). Here we show, using 784 available human gut metagenomes, how antidiabetic medication confounds these results, and analyse in detail the effects of the most widely used antidiabetic drug metformin. We provide support for microbial mediation of the therapeutic effects of metformin through short-chain fatty acid production, as well as for potential microbiota-mediated mechanisms behind known intestinal adverse effects in the form of a relative increase in abundance of Escherichia species. Controlling for metformin treatment, we report a unified signature of gut microbiome shifts in T2D with a depletion of butyrate-producing taxa(3,4). These in turn cause functional microbiome shifts, in part alleviated by metformin-induced changes. Overall, the present study emphasizes the need to disentangle gut microbiota signatures of specific human diseases from those of medication.	[Forslund, Kristoffer; Hildebrand, Falk; Sunagawa, Shinichi; Voigt, Anita Yvonne; Hercog, Rajna; Costea, Paul Igor; Kultima, Jens Roat; Bork, Peer] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; [Hildebrand, Falk; Falony, Gwen; Vieira-Silva, Sara; Raes, Jeroen] Katholieke Univ Leuven, VIB Ctr Biol Dis, B-3000 Leuven, Belgium; [Hildebrand, Falk; Raes, Jeroen] Vrije Univ Brussel, Dept Biosci Engn, B-1040 Brussels, Belgium; [Nielsen, Trine; Arumugam, Manimozhiyan; Vestergaard, Henrik; Hansen, Torben; Pedersen, Oluf] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn, Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark; [Falony, Gwen; Vieira-Silva, Sara; Raes, Jeroen] Katholieke Univ Leuven, Rega Inst Med Res, Dept Microbiol & Immunol, Lab Mol Bacteriol, B-3000 Leuven, Belgium; [Le Chatelier, Emmanuelle; Prifti, Edi; Levenez, Florence; Dore, Joel; Ehrlich, S. Dusko] INRA, MICALIS, F-78352 Jouy En Josas, France; [Le Chatelier, Emmanuelle; Prifti, Edi; Levenez, Florence; Dore, Joel; Ehrlich, S. Dusko] INRA, Metagenopolis, F-78352 Jouy En Josas, France; [Prifti, Edi] Inst Cardiometab & Nutr, F-75013 Paris, France; [Gudmundsdottir, Valborg; Pedersen, Helle Krogh; Nielsen, H. Bjorn; Brunak, Soren] Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Kristiansen, Karsten; Wang, Jun] Univ Copenhagen, Dept Biol, DK-2100 Copenhagen, Denmark; [Voigt, Anita Yvonne] Univ Heidelberg Hosp, Inst Pathol, Dept Appl Tumor Biol, D-69120 Heidelberg, Germany; [Voigt, Anita Yvonne; Bork, Peer] Heidelberg Univ, Mol Med Partnership Unit, D-69120 Heidelberg, Germany; [Voigt, Anita Yvonne; Bork, Peer] European Mol Biol Lab, D-69120 Heidelberg, Germany; [Li, Junhua; Wang, Jun] Bejing Genom Inst BGI Shenzhen, Shenzhen 518083, Peoples R China; [Jorgensen, Torben] Capital Reg Denmark, Res Ctr Prevent & Hlth, DK-2600 Glostrup, Denmark; [Jorgensen, Torben] Univ Copenhagen, Fac Hlth & Med Sci, Dept Publ Hlth, DK-2600 Copenhagen, Denmark; [Jorgensen, Torben] Aalborg Univ, Fac Med, DK-9100 Aalborg, Denmark; [Brunak, Soren] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn, Ctr Prot Res,Dis Syst Biol, DK-2200 Copenhagen, Denmark; [Hansen, Torben] Univ Southern Denmark, Fac Hlth Sci, DK-5000 Odense, Denmark; [Wang, Jun] King Abdulaziz Univ, Princess Al Jawhara Albrahim Ctr Excellence Res H, Jeddah 80205, Saudi Arabia; [Wang, Jun] Macau Univ Sci & Technol, Taipa, Macau, Peoples R China; [Wang, Jun] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Wang, Jun] Univ Hong Kong, State Key Lab Pharmaceut Biotechnol, Hong Kong, Hong Kong, Peoples R China; [Ehrlich, S. Dusko] Kings Coll London, Guys Hosp, Dent Inst Cent Off, Ctr Host Microbiome Interact, London SE1 9RT, England; [Bork, Peer] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Bork, Peer] Univ Wurzburg, Dept Bioinformat, D-97074 Wurzburg, Germany	European Molecular Biology Laboratory (EMBL); Flanders Institute for Biotechnology (VIB); KU Leuven; Vrije Universiteit Brussel; Novo Nordisk Foundation; University of Copenhagen; KU Leuven; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; Technical University of Denmark; University of Copenhagen; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); Beijing Genomics Institute (BGI); University of Copenhagen; Aalborg University; Novo Nordisk Foundation; University of Copenhagen; University of Southern Denmark; King Abdulaziz University; Macau University of Science & Technology; University of Hong Kong; University of Hong Kong; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Wurzburg	Ehrlich, SD (corresponding author), INRA, MICALIS, F-78352 Jouy En Josas, France.	dusko.ehrlich@jouy.inra.fr; bork@embl.de; oluf@sund.ku.dk	Borruel, Natalia/AFO-6891-2022; Prifti, Edi/F-3967-2019; Sunagawa, Shinichi/Q-5950-2019; Vieira-Silva, Sara/ABE-1247-2021; Ho, Igor Osorio/AAG-8616-2020; Nielsen, Henrik/B-8961-2019; Guarner, Francisco/ABF-1192-2020; GUEDON, Eric/N-8624-2019; Pedersen, Oluf/Z-1731-2019; LE CHATELIER, Emmanuelle/O-1243-2017; Arumugam, Manimozhiyan/AAJ-2394-2020; Guedon, Eric/S-5635-2016; Knol, Jan/A-2178-2010; BLOTTIERE, Hervé M/C-6120-2011; Forslund, Sofia K/Y-2393-2019; Falony, Gwen/AAN-5011-2020; Li, Junhua/AAG-3919-2019; Ehrlich, S./Y-2423-2019; Knol, Jan/AAL-6487-2020; Pedersen, Oluf/AAG-8015-2020; raes, jeroen/D-7835-2018; Tap, Julien/E-5760-2010; Arumugam, Manimozhiyan/E-1211-2011; Jørgensen, Torben/Z-1335-2018; Bork, Peer/F-1813-2013; Dore, Joel/ABA-8921-2020; Kristiansen, Karsten/J-5148-2014; Hildebrand, Falk/K-1914-2014; Sicheritz-Ponten, Thomas/A-4325-2017; Brunak, Soren/O-6621-2016	Borruel, Natalia/0000-0002-4449-2292; Prifti, Edi/0000-0001-8861-1305; Sunagawa, Shinichi/0000-0003-3065-0314; Vieira-Silva, Sara/0000-0002-4616-7602; Nielsen, Henrik/0000-0003-2281-5713; Guarner, Francisco/0000-0002-4051-0836; GUEDON, Eric/0000-0002-0901-4447; Pedersen, Oluf/0000-0002-3321-3972; LE CHATELIER, Emmanuelle/0000-0002-2724-0536; Arumugam, Manimozhiyan/0000-0002-0886-9101; Guedon, Eric/0000-0002-0901-4447; Knol, Jan/0000-0002-2103-5961; BLOTTIERE, Hervé M/0000-0002-8390-0607; Falony, Gwen/0000-0003-2450-0782; Li, Junhua/0000-0001-6784-1873; Ehrlich, S./0000-0002-7563-4046; Knol, Jan/0000-0002-2103-5961; raes, jeroen/0000-0002-1337-041X; Tap, Julien/0000-0001-8998-5413; Arumugam, Manimozhiyan/0000-0002-0886-9101; Bork, Peer/0000-0002-2627-833X; Kristiansen, Karsten/0000-0002-6024-0917; Derrien, Muriel/0000-0001-8841-9153; Gudmundsdottir, Valborg/0000-0002-7459-1603; Costea, Paul Igor/0000-0003-1645-3947; Hildebrand, Falk/0000-0002-0078-8948; Nielsen, Trine/0000-0002-2066-7895; Voigt, Anita Yvonne/0000-0002-6794-0385; Forslund, Sofia K/0000-0003-4285-6993; Jorgensen, Torben/0000-0001-9453-2830; Hansen, Torben/0000-0001-8748-3831; Burgdorf, Kristoffer/0000-0001-5814-6844; Sicheritz-Ponten, Thomas/0000-0001-6615-1141; Brunak, Soren/0000-0003-0316-5866; Vestergaard, Henrik/0000-0003-3090-269X; Pelletier, Eric/0000-0003-4228-1712; Varela Castro, Encarna/0000-0001-6334-9320; Pedersen, Helle Krogh/0000-0001-9609-7377; Chaysavanh, Manichanh/0000-0002-2287-4003	European Community [HEALTH-F4-2007-201052, HEALTH-2012-305312, HEALTH-2010-261376]; Metagenopolis grant [ANR-11-DPBS-0001]; European Research Council [268985]; European Union [600375]; Lundbeck Foundation Centre for Applied Medical Genomics in Personalized Disease Prediction, Prevention and Care (LuCamp); Novo Nordisk Foundation [NNF14CC0001]; European Molecular Biology Laboratory (EMBL); Novo Nordisk Foundation; Innovation Fund Denmark through the MicrobDiab project	European Community(European Commission); Metagenopolis grant; European Research Council(European Research Council (ERC)European Commission); European Union(European Commission); Lundbeck Foundation Centre for Applied Medical Genomics in Personalized Disease Prediction, Prevention and Care (LuCamp); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Molecular Biology Laboratory (EMBL); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Innovation Fund Denmark through the MicrobDiab project	The authors wish to thank A. Forman, T. Lorentzen, B. Andreasen, G. J. Klavsen and M. J. Nielsen for technical assistance, and T. F. Toldsted and G. Lademann for management assistance. J. Nielsen and F. Backhed are thanked for providing access to T2D metagenome data and metformin treatment status before publication<SUP>4</SUP>. V. Benes and the GeneCore facility of EMBL Heidelberg are thanked for their assistance with the metformin signature validation experiments, as is Y. Yuan for assistance with computer infrastructure. This research has received funding from European Community's Seventh Framework Program (FP7/2007-2013): MetaHIT, grant agreement HEALTH-F4-2007-201052, MetaCardis, grant agreement HEALTH-2012-305312, International Human Microbiome Standards, grant agreement HEALTH-2010-261376, as well as from the Metagenopolis grant ANR-11-DPBS-0001, from the European Research Council CancerBiome project, contract number 268985, and from the European Union HORIZON 2020 programme, under Marie Sklodowska-Curie grant agreement 600375. Additional funding came from The Lundbeck Foundation Centre for Applied Medical Genomics in Personalized Disease Prediction, Prevention and Care (LuCamp, http://www.lucamp.org), the Novo Nordisk Foundation (grant NNF14CC0001), and the European Molecular Biology Laboratory (EMBL). The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent Research Center at the University of Copenhagen partially funded by an unrestricted donation from the Novo Nordisk Foundation (http://www.metabol.ku.dk). Additional funding for the validation experiments was provided by the Innovation Fund Denmark through the MicrobDiab project.	Abeel T, 2010, BIOINFORMATICS, V26, P392, DOI 10.1093/bioinformatics/btp630; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Arumugam M, 2010, BIOINFORMATICS, V26, P2977, DOI 10.1093/bioinformatics/btq536; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biltoft-Jensen A., 2005, DFVF PUBLICATION, V11; Cabreiro F, 2013, CELL, V153, P228, DOI 10.1016/j.cell.2013.02.035; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Croset M, 2001, DIABETES, V50, P740, DOI 10.2337/diabetes.50.4.740; CZYZYK A, 1968, DIABETES, V17, P492, DOI 10.2337/diab.17.8.492; De Vadder F, 2014, CELL, V156, P84, DOI 10.1016/j.cell.2013.12.016; de Vos WM, 2013, NATURE, V498, P48, DOI 10.1038/nature12251; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1658/1100-9233(2003)014[0927:VAPORF]2.0.CO;2; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gerritsen J, 2014, INT J SYST EVOL MICR, V64, P1600, DOI 10.1099/ijs.0.059543-0; Haraldsdottir J., 1998, PORTIONSSTORLEKER NO; Hildebrand F, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-30; Hildebrand F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r4; Hildebrand F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-514; Hothorn T, 2006, AM STAT, V60, P257, DOI 10.1198/000313006X118430; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kultima JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047656; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Lee H, 2014, APPL ENVIRON MICROB, V80, P5935, DOI 10.1128/AEM.01357-14; Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Madden T., 2002, NCBI HDB; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Messori S, 2013, VET MICROBIOL, V162, P173, DOI 10.1016/j.vetmic.2012.09.001; Moller A., 2002, FODEVAREDATABANKEN V; Napolitano A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100778; Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939; Pernicova I, 2014, NAT REV ENDOCRINOL, V10, P143, DOI 10.1038/nrendo.2013.256; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Sato J, 2014, DIABETES CARE, V37, P2343, DOI 10.2337/dc13-2817; Schellenberg ES, 2013, ANN INTERN MED, V159, P543, DOI 10.7326/0003-4819-159-8-201310150-00007; Shin NR, 2014, GUT, V63, P727, DOI 10.1136/gutjnl-2012-303839; Shreiner AB, 2015, CURR OPIN GASTROEN, V31, P69, DOI 10.1097/MOG.0000000000000139; Song YL, 2004, ANAEROBE, V10, P179, DOI 10.1016/j.anaerobe.2004.04.004; Sunagawa S, 2015, SCIENCE, V348, DOI 10.1126/science.1261359; Sunagawa S, 2013, NAT METHODS, V10, P1196, DOI [10.1038/NMETH.2693, 10.1038/nmeth.2693]; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Winter SE, 2013, SCIENCE, V339, P708, DOI 10.1126/science.1232467; World Health Organization, 1999, WHONCDNCS992; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071108	52	1138	1203	26	592	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2015	528	7581					262	+		10.1038/nature15766	http://dx.doi.org/10.1038/nature15766			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9VH	26633628	Green Accepted, Green Submitted			2022-12-28	WOS:000366053300041
J	Nguyen, LV; Pellacani, D; Lefort, S; Kannan, N; Osako, T; Makarem, M; Cox, CL; Kennedy, W; Beer, P; Carles, A; Moksa, M; Bilenky, M; Balani, S; Babovic, S; Sun, I; Rosin, M; Aparicio, S; Hirst, M; Eaves, CJ				Nguyen, Long V.; Pellacani, Davide; Lefort, Sylvain; Kannan, Nagarajan; Osako, Tomo; Makarem, Maisam; Cox, Claire L.; Kennedy, William; Beer, Philip; Carles, Annaick; Moksa, Michelle; Bilenky, Misha; Balani, Sneha; Babovic, Sonja; Sun, Ivan; Rosin, Miriam; Aparicio, Samuel; Hirst, Martin; Eaves, Connie J.			Barcoding reveals complex clonal dynamics of de novo transformed human mammary cells	NATURE			English	Article							EPITHELIAL STEM-CELLS; BREAST-CANCER; DIVERSE GROWTH; EXPRESSION; THERAPY	Most human breast cancers have diversified genomically and biologically by the time they become clinically evident(1-3). Early events involved in their genesis and the cellular context in which these events occur have thus been difficult to characterize. Here we present the first formal evidence of the shared and independent ability of basal cells and luminal progenitors, isolated from normal human mammary tissue and transduced with a single oncogene (KRASG12D), to produce serially transplantable, polyclonal, invasive ductal carcinomas within 8 weeks of being introduced either subrenally or subcutaneously into immunodeficient mice(4). DNA barcoding(5,6) of the initial cells revealed a dramatic change in the numbers and sizes of clones generated from them within 2 weeks, and the first appearance of many 'new' clones in tumours passaged into secondary recipients. Both primary and secondary tumours were phenotypically heterogeneous and primary tumours were categorized transcriptionally as 'normal-like'. This system challenges previous concepts that carcinogenesis in normal human epithelia is necessarily a slow process requiring the acquisition of multiple driver mutations. It also presents the first description of initial events that accompany the genesis and evolution of malignant human mammary cell populations, thereby contributing new understanding of the rapidity with which heterogeneity in their properties can develop.	[Nguyen, Long V.; Pellacani, Davide; Lefort, Sylvain; Kannan, Nagarajan; Makarem, Maisam; Cox, Claire L.; Kennedy, William; Beer, Philip; Balani, Sneha; Babovic, Sonja; Eaves, Connie J.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Pellacani, Davide; Eaves, Connie J.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 2B5, Canada; [Kannan, Nagarajan; Osako, Tomo; Aparicio, Samuel] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 2B5, Canada; [Osako, Tomo; Aparicio, Samuel] British Columbia Canc Agcy, Dept Mol Oncol, Vancouver, BC V5Z 1L3, Canada; [Carles, Annaick; Moksa, Michelle; Bilenky, Misha; Hirst, Martin] Univ British Columbia, Dept Microbiol & Immunol, Ctr High Throughput Biol, Vancouver, BC V6T 1Z4, Canada; [Bilenky, Misha; Hirst, Martin] British Columbia Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada; [Sun, Ivan; Rosin, Miriam] Simon Fraser Univ, Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada; [Sun, Ivan; Rosin, Miriam] British Columbia Canc Agcy, Canc Control Unit, Vancouver, BC V5Z 1L3, Canada	British Columbia Cancer Agency; University of British Columbia; University of British Columbia; British Columbia Cancer Agency; University of British Columbia; British Columbia Cancer Agency; Simon Fraser University; British Columbia Cancer Agency	Eaves, CJ (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 675 West 10th Ave, Vancouver, BC V5Z 1L3, Canada.	ceaves@bccrc.ca	Hirst, Martin/B-7684-2016	Aparicio, Samuel/0000-0002-0487-9599; Eaves, Connie/0000-0002-3452-1926; Nguyen, Long/0000-0002-3347-438X; Lefort, Sylvain/0000-0001-7320-4256; Beer, Philip/0000-0003-3056-5419; Kannan, Nagarajan/0000-0002-8825-2178	Canadian Cancer Society Research Institute; Canadian Breast Cancer Foundation; Canadian Breast Cancer Research Alliance; Canadian Institutes of Health Research (CIHR); MITACS Elevate Fellowship; Molecular Oncologic Pathology Fellowship from CIHR; Terry Fox Foundation; Sumitomo Life Welfare and Culture Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Takashi Tsuruo Memorial Fund; Canada Research Chair	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Canadian Breast Cancer Research Alliance; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); MITACS Elevate Fellowship; Molecular Oncologic Pathology Fellowship from CIHR(Canadian Institutes of Health Research (CIHR)); Terry Fox Foundation; Sumitomo Life Welfare and Culture Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Takashi Tsuruo Memorial Fund; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	We thank D. Wilkinson, G. Edin and M. Hale for technical support, E. Bovill, J. Boyle, S. Bristol, P. Gdalevitch, A. Seal, J. Sproul and N. van Laeken for access to discarded reduction mammoplasty tissue, T. Nielsen and N. Poulin for discussions, the Centre for Translational and Applied Genomics (BC Cancer Agency) for assistance with IHC, and T. MacDonald for assistance with rodent husbandry. This work was supported by grants from the Canadian Cancer Society Research Institute, the Canadian Breast Cancer Foundation and the Canadian Breast Cancer Research Alliance. L.V.N. received a Vanier Canada Graduate Scholarship from the Canadian Institutes of Health Research (CIHR), and N.K. was supported by a MITACS Elevate Fellowship. T.O. was supported by a Molecular Oncologic Pathology Fellowship from CIHR and the Terry Fox Foundation, and by grants from the Sumitomo Life Welfare and Culture Foundation, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, and the Takashi Tsuruo Memorial Fund. S. A. is supported by a Canada Research Chair.	Bhang HEC, 2015, NAT MED, V21, P440, DOI 10.1038/nm.3841; Butterfield YS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102398; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Eirew P, 2015, NATURE, V518, P422, DOI 10.1038/nature13952; Eirew P, 2010, NAT PROTOC, V5, P1945, DOI 10.1038/nprot.2010.148; Eirew P, 2008, NAT MED, V14, P1384, DOI 10.1038/nm.1791; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Gascard P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7351; Imren S, 2004, J CLIN INVEST, V114, P953, DOI 10.1172/JCI200421838; Kannan N, 2014, P NATL ACAD SCI USA, V111, P7789, DOI 10.1073/pnas.1403813111; Kannan N, 2013, STEM CELL REP, V1, P28, DOI 10.1016/j.stemcr.2013.04.003; Keller PJ, 2012, P NATL ACAD SCI USA, V109, P2772, DOI 10.1073/pnas.1017626108; Kreso A, 2013, SCIENCE, V339, P543, DOI 10.1126/science.1227670; Lakhani S.R., 2012, WHO CLASSIFICATION T; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Logan AC, 2004, HUM GENE THER, V15, P976, DOI 10.1089/hum.2004.15.976; Nguyen LV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6871; Nguyen LV, 2014, CELL STEM CELL, V14, P253, DOI 10.1016/j.stem.2013.12.011; Paquet ER, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju357; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Tsuda H, 1998, JPN J CLIN ONCOL, V28, P486, DOI 10.1093/jjco/28.8.486	24	76	80	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2015	528	7581					267	+		10.1038/nature15742	http://dx.doi.org/10.1038/nature15742			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9VH	26633636				2022-12-28	WOS:000366053300042
J	Palmer, BF; Clegg, DJ				Palmer, Biff F.; Clegg, Deborah J.			Hyperkalemia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MANAGEMENT		[Palmer, Biff F.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Clegg, Deborah J.] Cedars Sinai Med Ctr, Biomed Res Dept, Diabet & Obes Res Div, Beverly Hills, CA USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Cedars Sinai Medical Center	Palmer, BF (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	biff.palmer@utsouthwestern.edu						Centers for Medicare and Medicaid Services, CLIN LAB FEE SCHED; Kovesdy CP, 2014, NAT REV NEPHROL, V10, P653, DOI 10.1038/nrneph.2014.168; Montague BT, 2008, CLIN J AM SOC NEPHRO, V3, P324, DOI 10.2215/CJN.04611007; Palmer BF, 1995, J INVEST MED, V43, P516; Palmer BF, 2004, NEW ENGL J MED, V351, P585, DOI 10.1056/NEJMra035279; Palmer BF, 2015, NEW ENGL J MED, V373, P548, DOI 10.1056/NEJMra1503102; Palmer BF, 2015, CLIN J AM SOC NEPHRO, V10, P1050, DOI 10.2215/CJN.08580813; Palmer BF, 2010, AM J KIDNEY DIS, V56, P387, DOI 10.1053/j.ajkd.2010.01.020; Perazella MA, 2000, DRUG SAFETY, V22, P227, DOI 10.2165/00002018-200022030-00006; Sarafidis PA, 2012, CLIN J AM SOC NEPHRO, V7, P1234, DOI 10.2215/CJN.01150112	10	12	12	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 8	2015	314	22					2405	2406		10.1001/jama.2015.9230	http://dx.doi.org/10.1001/jama.2015.9230			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX8XT	26647263				2022-12-28	WOS:000365989100016
J	Lakhina, V; Murphy, CT				Lakhina, Vanisha; Murphy, Coleen T.			Genome Sequencing Fishes out Longevity Genes	CELL			English	Editorial Material							SHORT-LIVED VERTEBRATE; NOTHOBRANCHIUS-FURZERI; LIFE-SPAN; MODEL	Understanding the molecular basis underlying aging is critical if we are to fully understand how and why we age- and possibly how to delay the aging process. Up until now, most longevity pathways were discovered in invertebrates because of their short lifespans and availability of genetic tools. Now, Reichwald et al. and Valenzano et al. independently provide a reference genome for the short-lived African turquoise killifish, establishing its role as a vertebrate system for aging research.	[Lakhina, Vanisha; Murphy, Coleen T.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Lakhina, Vanisha; Murphy, Coleen T.] Princeton Univ, LSI Genom, Princeton, NJ 08544 USA	Princeton University; Princeton University	Murphy, CT (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	ctmurphy@princeton.edu		Lakhina, Vanisha/0000-0002-5872-6838; Murphy, Coleen/0000-0002-8257-984X				Di Cicco E, 2011, EXP GERONTOL, V46, P249, DOI 10.1016/j.exger.2010.10.011; Harel I, 2015, CELL, V160, P1013, DOI 10.1016/j.cell.2015.01.038; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kirschner J, 2012, AGING CELL, V11, P252, DOI 10.1111/j.1474-9726.2011.00780.x; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Valenzano DR, 2011, G3-GENES GENOM GENET, V1, P531, DOI 10.1534/g3.111.001271; Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038	7	2	2	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 6	2015	163	6					1312	1313		10.1016/j.cell.2015.11.040	http://dx.doi.org/10.1016/j.cell.2015.11.040			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SE	26638067	Bronze			2022-12-28	WOS:000366044800012
J	McKenney, PT; Pamer, EG				McKenney, Peter T.; Pamer, Eric G.			From Hype to Hope: The Gut Microbiota in Enteric Infectious Disease	CELL			English	Review							CLOSTRIDIUM-DIFFICILE INFECTION; DAMAGE-RESPONSE FRAMEWORK; STEM-CELL TRANSPLANTATION; INTESTINAL MICROBIOTA; COMMENSAL BACTERIA; DIURNAL OSCILLATIONS; ANTIBIOTIC-TREATMENT; CIRCADIAN CLOCK; IMMUNE-SYSTEM; BILE-ACIDS	One of the clearest functions of the gut microbiota in humans is resistance to colonization by enteric bacterial pathogens. Reconstitution of the microbiota offers an exciting therapeutic approach, but great challenges must be overcome.	[McKenney, Peter T.; Pamer, Eric G.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Immunol Program, New York, NY 10065 USA; [Pamer, Eric G.] Mem Sloan Kettering Canc Ctr, Lucille Castori Ctr Microbes Inflammat & Canc, New York, NY 10065 USA; [Pamer, Eric G.] Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis Serv, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Pamer, EG (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Immunol Program, New York, NY 10065 USA.	pamere@mskcc.org			NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042135, R01AI095706] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA008748] Funding Source: Medline; NIAID NIH HHS [R01 AI042135, R01 AI095706] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Alang N, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv004; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Brestoff JR, 2013, NAT IMMUNOL, V14, P676, DOI 10.1038/ni.2640; Britton RA, 2014, GASTROENTEROLOGY, V146, P1547, DOI 10.1053/j.gastro.2014.01.059; Bucci V, 2014, J MOL BIOL, V426, P3907, DOI 10.1016/j.jmb.2014.03.017; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Carmody RN, 2015, CELL HOST MICROBE, V17, P72, DOI 10.1016/j.chom.2014.11.010; Casadevall A, 2003, NAT REV MICROBIOL, V1, P17, DOI 10.1038/nrmicro732; Casadevall A, 2015, INFECT IMMUN, V83, P2, DOI 10.1128/IAI.02627-14; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Devlin AS, 2015, NAT CHEM BIOL, V11, P685, DOI [10.1038/NCHEMBIO.1864, 10.1038/nchembio.1864]; Donia MS, 2014, CELL, V158, P1402, DOI 10.1016/j.cell.2014.08.032; Earle KA, 2015, CELL HOST MICROBE, V18, P478, DOI 10.1016/j.chom.2015.09.002; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Faith JJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008051; Ferreyra JA, 2014, CELL HOST MICROBE, V16, P770, DOI 10.1016/j.chom.2014.11.003; Ferreyra JA, 2014, CELL MICROBIOL, V16, P993, DOI [10.1111/cmi.12300, 10.1111/cmi.123]; Fuentes S, 2014, ISME J, V8, P1621, DOI 10.1038/ismej.2014.13; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Ganal SC, 2012, IMMUNITY, V37, P171, DOI 10.1016/j.immuni.2012.05.020; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Johansson MEV, 2015, CELL HOST MICROBE, V18, P582, DOI 10.1016/j.chom.2015.10.007; Johansson MEV, 2014, GUT, V63, P281, DOI 10.1136/gutjnl-2012-303207; Kelly CR, 2014, AM J GASTROENTEROL, V109, P1065, DOI 10.1038/ajg.2014.133; Kernbauer E, 2014, NATURE, V516, P94, DOI 10.1038/nature13960; Kommineni S, 2015, NATURE, V526, P719, DOI 10.1038/nature15524; Lahti L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5344; Lee SM, 2013, NATURE, V501, P426, DOI 10.1038/nature12447; Littman DR, 2011, CELL HOST MICROBE, V10, P311, DOI 10.1016/j.chom.2011.10.004; Mani S, 2014, ANNU REV PHARMACOL, V54, P559, DOI 10.1146/annurev-pharmtox-011613-140007; Manor O, 2014, CELL METAB, V20, P742, DOI 10.1016/j.cmet.2014.07.021; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Miles J., 2015, MICROBE MAG, V10, P370, DOI [10.1128/microbe.10.370.1, DOI 10.1128/MICROBE.10.370.1]; Milshteyn A, 2014, CHEM BIOL, V21, P1211, DOI 10.1016/j.chembiol.2014.08.006; Mukherji A, 2013, CELL, V153, P812, DOI 10.1016/j.cell.2013.04.020; Ng KM, 2013, NATURE, V502, P96, DOI 10.1038/nature12503; Nguyen KD, 2013, SCIENCE, V341, P1483, DOI 10.1126/science.1240636; Petersson J, 2011, AM J PHYSIOL-GASTR L, V300, pG327, DOI 10.1152/ajpgi.00422.2010; Petrof EO, 2014, GASTROENTEROLOGY, V146, P1573, DOI 10.1053/j.gastro.2014.01.004; Rajilic-Stojanovic M, 2014, FEMS MICROBIOL REV, V38, P996, DOI 10.1111/1574-6976.12075; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Reeves AE, 2012, INFECT IMMUN, V80, P3786, DOI 10.1128/IAI.00647-12; Ridlon JM, 2015, ACTA PHARM SIN B, V5, P99, DOI 10.1016/j.apsb.2015.01.006; Ridlon JM, 2013, J LIPID RES, V54, P2437, DOI 10.1194/jlr.M038869; Schubert AM, 2014, MBIO, V5, DOI 10.1128/mBio.01021-14; Smith K, 2007, SEMIN IMMUNOL, V19, P59, DOI 10.1016/j.smim.2006.10.002; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Stecher B, 2013, FEMS MICROBIOL REV, V37, P793, DOI 10.1111/1574-6976.12024; Stecher B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000711; Stein RR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003388; Taur Y, 2014, BLOOD, V124, P1174, DOI 10.1182/blood-2014-02-554725; Taur Y, 2012, CLIN INFECT DIS, V55, P905, DOI 10.1093/cid/cis580; Thaiss CA, 2014, CELL, V159, P514, DOI 10.1016/j.cell.2014.09.048; Theriot CM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4114; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; Ubeda C, 2013, INFECT IMMUN, V81, P965, DOI 10.1128/IAI.01197-12; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Weingarden A, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0070-0; Weingarden AR, 2014, AM J PHYSIOL-GASTR L, V306, pG310, DOI 10.1152/ajpgi.00282.2013; Wlodarska M, 2011, INFECT IMMUN, V79, P1536, DOI 10.1128/IAI.01104-10; Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047; Yaung SJ, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145866; Yu XF, 2013, SCIENCE, V342, P727, DOI 10.1126/science.1243884; Zarrinpar A, 2014, CELL METAB, V20, P1006, DOI 10.1016/j.cmet.2014.11.008; Zhou HP, 2014, STEROIDS, V86, P62, DOI 10.1016/j.steroids.2014.04.016	73	111	118	2	71	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 6	2015	163	6					1326	1332		10.1016/j.cell.2015.11.032	http://dx.doi.org/10.1016/j.cell.2015.11.032			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SE	26638069	Green Accepted, Bronze			2022-12-28	WOS:000366044800014
J	Zauderer, MG				Zauderer, Marjorie G.			A new standard for malignant pleural mesothelioma	LANCET			English	Editorial Material							PHASE-II TRIAL; MULTICENTER; TARGETS; THERAPY		[Zauderer, Marjorie G.] Mem Sloan Kettering Canc Ctr, Dept Med, Thorac Oncol Serv, Div Solid Tumor Oncol, New York, NY 10065 USA; [Zauderer, Marjorie G.] Weill Cornell Med Coll, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cornell University	Zauderer, MG (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Thorac Oncol Serv, Div Solid Tumor Oncol, New York, NY 10065 USA.; Zauderer, MG (corresponding author), Weill Cornell Med Coll, New York, NY 10065 USA.	zauderem@mskcc.org			NCI NIH HHS [P30 CA008748] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Buikhuisen WA, 2013, LANCET ONCOL, V14, P543, DOI 10.1016/S1470-2045(13)70125-6; Dubey S, 2010, J THORAC ONCOL, V5, P1655, DOI 10.1097/JTO.0b013e3181ec18db; Hellmann MD, 2016, JAMA ONCOL, V2, P167, DOI 10.1001/jamaoncol.2015.4345; Jahan T, 2012, LUNG CANCER, V76, P393, DOI 10.1016/j.lungcan.2011.11.014; Kindler HL, 2012, J CLIN ONCOL, V30, P2509, DOI 10.1200/JCO.2011.41.5869; Ladanyi M, 2012, CLIN CANCER RES, V18, P4485, DOI 10.1158/1078-0432.CCR-11-2375; Nowak AK, 2012, J THORAC ONCOL, V7, P1449, DOI 10.1097/JTO.0b013e31825f22ee; Ohta Y, 1999, BRIT J CANCER, V81, P54, DOI 10.1038/sj.bjc.6690650; Pastan I, 2014, CANCER RES, V74, P2907, DOI 10.1158/0008-5472.CAN-14-0337; Stahel RA, 2015, ANN ONCOL, V26, P1649, DOI 10.1093/annonc/mdv101; Strizzi L, 2001, J PATHOL, V193, P468, DOI 10.1002/path.824; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Zalcman G, 2015, LANCET	13	7	8	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2016	387	10026					1352	1354		10.1016/S0140-6736(15)01311-2	http://dx.doi.org/10.1016/S0140-6736(15)01311-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI0WH	26719231	Green Accepted			2022-12-28	WOS:000373217500009
J	Colaprete, A; Sarantos, M; Wooden, DH; Stubbs, TJ; Cook, AM; Shirley, M				Colaprete, A.; Sarantos, M.; Wooden, D. H.; Stubbs, T. J.; Cook, A. M.; Shirley, M.			How surface composition and meteoroid impacts mediate sodium and potassium in the lunar exosphere	SCIENCE			English	Article							ATMOSPHERE; MOON; DISCOVERY; SHOWER	Despite being trace constituents of the lunar exosphere, sodium and potassium are the most readily observed species due to their bright line emission. Measurements of these species by the Ultraviolet and Visible Spectrometer (UVS) on the Lunar Atmosphere and Dust Environment Explorer (LADEE) have revealed unambiguous temporal and spatial variations indicative of a strong role for meteoroid bombardment and surface composition in determining the composition and local time dependence of the Moon's exosphere. Observations show distinct lunar day (monthly) cycles for both species as well as an annual cycle for sodium. The first continuous measurements for potassium show a more repeatable variation across lunations and an enhancement over KREEP (Potassium Rare Earth Elements and Phosphorus) surface regions, revealing a strong dependence on surface composition.	[Colaprete, A.; Wooden, D. H.; Cook, A. M.; Shirley, M.] NASA Ames Res Ctr, Space Sci Div, Mountain View, CA 94035 USA; [Sarantos, M.] NASA Goddard Space Flight Ctr, Heliophys Sci Div, Greenbelt, MD USA; [Sarantos, M.] Univ Maryland, Baltimore, MD 21201 USA; [Stubbs, T. J.] NASA Goddard Space Flight Ctr, Solar Syst Explorat Div, Greenbelt, MD USA; [Cook, A. M.] Millennium Engn & Integrat Serv, Moffett Field, CA 94035 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System of Maryland; University of Maryland Baltimore; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Colaprete, A (corresponding author), NASA Ames Res Ctr, Space Sci Div, Mountain View, CA 94035 USA.	anthony.colaprete-1@nasa.gov	Sarantos, Menelaos/O-6644-2019; Stubbs, Timothy/AAO-5357-2020; Stubbs, Timothy/I-5139-2013	Sarantos, Menelaos/0000-0003-0728-2971; Stubbs, Timothy/0000-0002-5524-645X; Stubbs, Timothy/0000-0002-5524-645X	NASA Lunar Quest Program; NASA [NNX14AG14A, NNX13AP94G, NNX13AO74G]	NASA Lunar Quest Program; NASA(National Aeronautics & Space Administration (NASA))	We thank R. Killen for constructive discussions and the three reviewers who helped to greatly improve this paper. LADEE UVS was supported through the NASA Lunar Quest Program. Additional funding for M.S. was through NASA grants NNX14AG14A, NNX13AP94G, and NNX13AO74G. All LADEE UVS data are available online at the NASA Planetary Data System (PDS), including all raw and calibrated spectra and derived sodium and potassium line strengths.	Berezhnoy AA, 2014, PLANET SPACE SCI, V96, P90, DOI 10.1016/j.pss.2014.03.008; Colaprete Anthony, 2014, Space Science Reviews, V185, P63, DOI 10.1007/s11214-014-0112-0; Elphic RC, 2014, SPACE SCI REV, V185, P3, DOI 10.1007/s11214-014-0113-z; Horanyi M, 2015, NATURE, V522, P324, DOI 10.1038/nature14479; Hunten DM, 1998, ICARUS, V136, P298, DOI 10.1006/icar.1998.6023; Hunten DM, 1997, ADV SPACE RES-SERIES, V19, P1551, DOI 10.1016/S0273-1177(97)00368-2; Jolliff BL, 2000, J GEOPHYS RES-PLANET, V105, P4197, DOI 10.1029/1999JE001103; Kagitani M, 2010, PLANET SPACE SCI, V58, P1660, DOI 10.1016/j.pss.2010.07.025; Kagitani M, 2009, EARTH PLANETS SPACE, V61, P1025, DOI 10.1186/BF03352953; Killen RM, 2015, ICARUS, V250, P230, DOI 10.1016/j.icarus.2014.11.035; KOZLOWSKI RWH, 1990, GEOPHYS RES LETT, V17, P2253, DOI 10.1029/GL017i012p02253; Lawrence DJ, 1998, SCIENCE, V281, P1484, DOI 10.1126/science.281.5382.1484; Matta M, 2009, ICARUS, V204, P409, DOI 10.1016/j.icarus.2009.06.017; POTTER AE, 1988, SCIENCE, V241, P675, DOI 10.1126/science.241.4866.675; Potter AE, 2000, J GEOPHYS RES-PLANET, V105, P15073, DOI 10.1029/1999JE001213; Sarantos M, 2010, ICARUS, V205, P364, DOI 10.1016/j.icarus.2009.07.039; Smith SM, 1999, GEOPHYS RES LETT, V26, P1649, DOI 10.1029/1999GL900314; Sprague AL, 2012, CAN J PHYS, V90, P725, DOI 10.1139/p2012-072; SPRAGUE AL, 1992, ICARUS, V96, P27, DOI 10.1016/0019-1035(92)90004-Q; Stern SA, 1999, REV GEOPHYS, V37, P453, DOI 10.1029/1999RG900005; Stubbs T. J., 2015, 46 LUN PLAN SCI C HE, P2984; Tenishev V, 2013, ICARUS, V226, P1538, DOI 10.1016/j.icarus.2013.08.021; Verani S, 1998, PLANET SPACE SCI, V46, P1003, DOI 10.1016/S0032-0633(98)00024-5	23	43	43	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2016	351	6270					249	252		10.1126/science.aad2380	http://dx.doi.org/10.1126/science.aad2380			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA9AM	26678876				2022-12-28	WOS:000368098600034
J	Storm, EE; Durinck, S; Melo, FDE; Tremayne, J; Kljavin, N; Tan, C; Ye, XF; Chiu, C; Pham, T; Hongo, JA; Bainbridge, T; Firestein, R; Blackwood, E; Metcalfe, C; Stawiski, EW; Yauch, RL; Wu, Y; de Sauvage, FJ				Storm, Elaine E.; Durinck, Steffen; de Sousa e Melo, Felipe; Tremayne, Jarrod; Kljavin, Noelyn; Tan, Christine; Ye, Xiaofen; Chiu, Cecilia; Thinh Pham; Hongo, Jo-Anne; Bainbridge, Travis; Firestein, Ron; Blackwood, Elizabeth; Metcalfe, Ciara; Stawiski, Eric W.; Yauch, Robert L.; Wu, Yan; de Sauvage, Frederic J.			Targeting PTPRK-RSPO3 colon tumours promotes differentiation and loss of stem-cell function	NATURE			English	Article							COLORECTAL-CANCER; WNT/BETA-CATENIN; SMALL-INTESTINE; READ ALIGNMENT; IN-VITRO; CRYPT; IDENTIFICATION; MAINTENANCE; HOMEOSTASIS	Colorectal cancer remains a major unmet medical need, prompting large-scale genomics efforts in the field to identify molecular drivers for which targeted therapies might be developed(1-3). We previously reported the identification of recurrent translocations in R-spondin genes present in a subset of colorectal tumours(4). Here we show that targeting RSPO3 in PTPRK-RSPO3-fusion-positive human tumour xenografts inhibits tumour growth and promotes differentiation. Notably, genes expressed in the stem-cell compartment of the intestine were among those most sensitive to anti-RSPO3 treatment. This observation, combined with functional assays, suggests that a stem-cell compartment drives PTPRK-RSPO3 colorectal tumour growth and indicates that the therapeutic targeting of stem-cell properties within tumours may be a clinically relevant approach for the treatment of colorectal tumours.	[Storm, Elaine E.; de Sousa e Melo, Felipe; Kljavin, Noelyn; de Sauvage, Frederic J.] Genentech Inc, Mol Oncol, 1 DNA Way, San Francisco, CA 94080 USA; [Durinck, Steffen; Stawiski, Eric W.] Genentech Inc, Mol Biol, 1 DNA Way, San Francisco, CA 94080 USA; [Tremayne, Jarrod; Blackwood, Elizabeth; Metcalfe, Ciara] Genentech Inc, Translat Oncol, 1 DNA Way, San Francisco, CA 94080 USA; [Tan, Christine; Chiu, Cecilia; Hongo, Jo-Anne; Wu, Yan] Genentech Inc, Antibody Engn, 1 DNA Way, San Francisco, CA 94080 USA; [Ye, Xiaofen; Yauch, Robert L.] Genentech Inc, Discovery Oncol, 1 DNA Way, San Francisco, CA 94080 USA; [Thinh Pham; Firestein, Ron] Genentech Inc, Res Pathol, 1 DNA Way, San Francisco, CA 94080 USA; [Bainbridge, Travis] Genentech Inc, Prot Chem, 1 DNA Way, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	de Sauvage, FJ (corresponding author), Genentech Inc, Mol Oncol, 1 DNA Way, San Francisco, CA 94080 USA.	desauvage.fred@gene.com	de Sauvage, Frederic/ABE-8400-2020	de Sauvage, Frederic/0000-0002-5275-2584				Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; De Sousa E Melo F, 2013, NAT MED, V19, P614, DOI 10.1038/nm.3174; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dow LE, 2015, CELL, V161, P1539, DOI 10.1016/j.cell.2015.05.033; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Kim KA, 2006, CELL CYCLE, V5, P23, DOI 10.4161/cc.5.1.2305; Kosinski C, 2007, P NATL ACAD SCI USA, V104, P15418, DOI 10.1073/pnas.0707210104; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Madan B., 2015, ONCOGENE; Metcalfe C, 2014, CELL STEM CELL, V14, P149, DOI 10.1016/j.stem.2013.11.008; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Sadanandam A, 2014, CELL CYCLE, V13, P353, DOI 10.4161/cc.27769; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Scholer-Dahirel A, 2011, P NATL ACAD SCI USA, V108, P17135, DOI 10.1073/pnas.1104182108; Schuijers J, 2015, CELL STEM CELL, V16, P158, DOI 10.1016/j.stem.2014.12.006; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Tso KY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1172; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Wu CJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4149; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109	36	154	162	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 7	2016	529	7584					97	+		10.1038/nature16466	http://dx.doi.org/10.1038/nature16466			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6VY	26700806				2022-12-28	WOS:000367944900034
J	Easter, JS; Haukoos, JS; Meehan, WP; Novack, V; Edlow, JA				Easter, Joshua S.; Haukoos, Jason S.; Meehan, William P.; Novack, Victor; Edlow, Jonathan A.			Will Neuroimaging Reveal a Severe Intracranial Injury in This Adult With Minor Head Trauma? The Rational Clinical Examination Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEW-ORLEANS CRITERIA; DIAGNOSTIC MANAGEMENT STRATEGIES; COMPUTED-TOMOGRAPHY; BRAIN-INJURY; EMERGENCY-DEPARTMENT; COST-EFFECTIVENESS; UNITED-STATES; CT; RULE; PERFORMANCE	IMPORTANCE Adults with apparently minor head trauma (Glasgow Coma Scale [GCS] scores >= 13 who appear well on examination) may have severe intracranial injuries requiring prompt intervention. Findings from clinical examination can aid in determining which adults with minor trauma have severe intracranial injuries visible on computed tomography (CT). OBJECTIVE To assess systematically the accuracy of symptoms and signs in adults with minor head trauma in order to identify those with severe intracranial injuries. DATA SOURCES We performed a systematic search of MEDLINE (1966-2015) and the Cochrane Library to identify studies assessing the diagnosis of intracranial injuries. STUDY SELECTION Studies were included that measured the performance of findings for identifying intracranial injury with a reference standard of neuroimaging or follow-up evaluation. Fourteen studies (range, 431-7955 patients) met inclusion criteria with patients having GCS scores between 13 and 15 and 50% or more older than 18 years. DATA EXTRACTION AND SYNTHESIS Three authors independently performed critical appraisal and data extraction. RESULTS The prevalence of severe intracranial injury (requiring prompt intervention) among the 23 079 patients with minor head trauma was 7.1%(95% CI, 6.8%-7.4%) and the prevalence of injuries leading to death or requiring neurosurgical intervention was 0.9% (95% CI, 0.78%-1.0%). The presence of physical examination findings suggestive of skull fracture (likelihood ratio [LR], 16; 95% CI, 3.1-59; specificity, 99%), GCS score of 13 (LR, 4.9; 95% CI, 2.8-8.5; specificity, 97%), 2 or more vomiting episodes (LR, 3.6; 95% CI, 3.1-4.1; specificity, 92%), any decline in GCS score (LR range, 3.4-16; specificity range, 91%-99%;), and pedestrians struck by motor vehicles (LR range, 3.0-4.3; specificity range, 96%-97%) were associated with severe intracranial injury on CT. Among patients with apparent minor head trauma, the absence of any of the features of the Canadian CT Head Rule (>= 65 years; >= 2 vomiting episodes, amnesia >30 minutes, pedestrian struck, ejected from vehicle, fall >1 m, suspected skull fracture, or GCS score <15 at 2 hours) had an LR of 0.04 (95% CI, 0-0.65), lowering the probability of severe injury to 0.31% (95% CI, 0%-4.7%). The absence of all the New Orleans Criteria findings (>60 years, intoxication, headache, vomiting, amnesia, seizure, or trauma above the clavicle) had an LR of 0.08 (95% CI, 0.01-0.84), lowering the probability of severe intracranial injury to 0.61% (95% CI, 0.08%-6.0%). CONCLUSIONS AND RELEVANCE Combinations of history and physical examination features in clinical decision rules can identify patients with minor head trauma at low risk of severe intracranial injuries. Certain findings, including signs of skull fracture, GCS score of 13, 2 or more vomiting episodes, decrease in GCS score, and pedestrians struck by motor vehicles, may help identify patients at increased risk of severe intracranial injuries.	[Easter, Joshua S.] Bon Secours St Marys Hosp, Dept Emergency Med, Richmond Emergency Phys, Richmond, VA USA; [Easter, Joshua S.] Univ Virginia, Dept Emergency Med, Charlottesville, VA 22908 USA; [Haukoos, Jason S.] Univ Colorado, Dept Emergency Med, Denver Hlth, Denver, CO 80202 USA; [Meehan, William P.] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Meehan, William P.] Boston Childrens Hosp, Brain Injury Ctr, Boston, MA USA; [Novack, Victor] Soroka Univ, Med Ctr, Clin Res Ctr, Beer Sheva, Israel; [Novack, Victor] Ben Gurion Univ Negev, Fac Hlth Sci, IL-84105 Beer Sheva, Israel; [Edlow, Jonathan A.] Beth Israel Deaconess Med Ctr, Dept Emergency Med, Boston, MA 02215 USA; [Haukoos, Jason S.] Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA	University of Virginia; Denver Health Medical Center; University of Colorado System; University of Colorado Denver; Harvard University; Boston Children's Hospital; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Harvard University; Beth Israel Deaconess Medical Center; Colorado School of Public Health	Easter, JS (corresponding author), Univ Virginia, Dept Emergency Med, POB 800699, Charlottesville, VA 22908 USA.	je9m@hscmail.mcc.virginia.edu	Edlow, Jonathan A/F-7128-2016		Agency for Healthcare Research and Quality [K12 HS019464-01, K02 HS017526]; National Institute of Allergy and Infectious Diseases [R01AI106057]; National Football League Players Association; National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K12HS019464, K02HS017526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106057] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Football League Players Association; National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by grants K12 HS019464-01, Physician Scientist Award (Dr Easter), and K02 HS017526, an Independent Scientist Award (Dr Haukoos), both from the Agency for Healthcare Research and Quality, R01AI106057 from the National Institute of Allergy and Infectious Diseases (Dr Haukoos), the National Football League Players Association (Dr Meehan), and the National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament (Dr Meehan).	Boyle A, 2004, EMERG MED J, V21, P426, DOI 10.1136/emj.2002.002063; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cheung PSY, 2007, INJURY, V38, P76, DOI 10.1016/j.injury.2006.08.059; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Department of Health and Human Services CfDCaP, 2014, HEADS FACTS PHYS MIL; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Fabbri A, 2005, J NEUROTRAUM, V22, P1419, DOI 10.1089/neu.2005.22.1419; Fabbri A, 2004, J NEUROL NEUROSUR PS, V75, P410, DOI 10.1136/jnnp.2003.016113; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Finkelstein E., 2006, INCIDENCE EC BURDEN, DOI [10.1093/acprof:oso/9780195179484.001.0001, DOI 10.1093/ACPROF:OSO/9780195179484.001.0001]; Hanson HR, 2013, PEDIATRICS, V132, pE859, DOI 10.1542/peds.2013-1704; HASSELBLAD V, 1995, PSYCHOL BULL, V117, P167, DOI 10.1037/0033-2909.117.1.167; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Holmes MW, 2013, ARCH DIS CHILD, V98, P939, DOI 10.1136/archdischild-2012-302820; Ibanez J, 2004, J NEUROSURG, V100, P825, DOI 10.3171/jns.2004.100.5.0825; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Macaskill P, 2010, COCHRANE HDB SYSTEMA, V1st; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Melnick ER, 2015, JT COMM J QUAL PATIE, V41, P313, DOI 10.1016/S1553-7250(15)41041-4; Melnick ER, 2012, JT COMM J QUAL PATIE, V38, P483, DOI 10.1016/S1553-7250(12)38064-1; Ono K, 2007, NEUROL MED-CHIR, V47, P291, DOI 10.2176/nmc.47.291; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Pandor A, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15270; Papa L, 2012, ACAD EMERG MED, V19, P2, DOI 10.1111/j.1553-2712.2011.01247.x; Ro YS, 2011, ACAD EMERG MED, V18, P597, DOI 10.1111/j.1553-2712.2011.01094.x; Rosengren David, 2004, Emerg Med Australas, V16, P195, DOI 10.1111/j.1742-6723.2004.00563.x; Simel DL, 2009, J CLIN EPIDEMIOL, V62, P1292, DOI 10.1016/j.jclinepi.2009.02.007; Simel DL., 2009, RATIONAL CLIN EXAMIN, V2 ed, P9; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Smits M, 2007, RADIOLOGY, V245, P831, DOI 10.1148/radiol.2452061509; Smits M, 2007, ANN INTERN MED, V146, P397, DOI 10.7326/0003-4819-146-6-200703200-00004; Smits M, 2010, RADIOLOGY, V254, P532, DOI 10.1148/radiol.2541081672; Stein SC, 2009, ANN EMERG MED, V53, P180, DOI 10.1016/j.annemergmed.2008.01.002; Stiell IG, 2010, CAN MED ASSOC J, V182, P1527, DOI 10.1503/cmaj.091974; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Sultan HY, 2004, EMERG MED J, V21, P420, DOI 10.1136/emj.2003.011353; Thurman DJ, 2001, HEAD TRAUMA, P327; Yates PJ, 2006, J NEUROL NEUROSUR PS, V77, P699, DOI 10.1136/jnnp.2005.081901	43	42	45	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 29	2015	314	24					2672	2681		10.1001/jama.2015.16316	http://dx.doi.org/10.1001/jama.2015.16316			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ2MR	26717031				2022-12-28	WOS:000366939800022
J	Desruelles, F				Desruelles, Francois			A Lousy Diagnosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material												desruelles.f@wanadoo.fr							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 24	2015	373	26							e31	10.1056/NEJMicm1414986	http://dx.doi.org/10.1056/NEJMicm1414986			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CZ7SG	26699186				2022-12-28	WOS:000367299700001
J	Geisler, WM; Uniyal, A; Lee, JY; Lensing, SY; Johnson, S; Perry, RCW; Kadrnka, CM; Kerndt, PR				Geisler, William M.; Uniyal, Apurva; Lee, Jeannette Y.; Lensing, Shelly Y.; Johnson, Shacondra; Perry, Raymond C. W.; Kadrnka, Carmel M.; Kerndt, Peter R.			Azithromycin versus Doxycycline for Urogenital Chlamydia trachomatis Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONGONOCOCCAL URETHRITIS; PERSISTENCE; RESISTANT; EFFICACY; THERAPY; RATES; RNA	BACKGROUND Urogenital Chlamydia trachomatis infection remains prevalent and causes substantial reproductive morbidity. Recent studies have raised concern about the efficacy of azithromycin for the treatment of chlamydia infection. METHODS We conducted a randomized trial comparing oral azithromycin with doxycycline for the treatment of urogenital chlamydia infection among adolescents in youth correctional facilities, to evaluate the noninferiority of azithromycin (1 g in one dose) to doxycycline (100 mg twice daily for 7 days). The treatment was directly observed. The primary end point was treatment failure at 28 days after treatment initiation, with treatment failure determined on the basis of nucleic acid amplification testing, sexual history, and outer membrane protein A (OmpA) genotyping of C. trachomatis strains. RESULTS Among the 567 participants enrolled, 284 were randomly assigned to receive azithromycin, and 283 were randomly assigned to receive doxycycline. A total of 155 participants in each treatment group (65% male) made up the per-protocol population. There were no treatment failures in the doxycycline group. In the azithromycin group, treatment failure occurred in 5 participants (3.2%; 95% confidence interval, 0.4 to 7.4%). The observed difference in failure rates between the treatment groups was 3.2 percentage points, with an upper boundary of the 90% confidence interval of 5.9 percentage points, which exceeded the prespecified absolute 5-percentage-point cutoff for establishing the noninferiority of azithromycin. CONCLUSIONS In the context of a closed population receiving directly observed treatment for urogenital chlamydia infection, the efficacy of azithromycin was 97%, and the efficacy of doxycycline was 100%. The noninferiority of azithromycin was not established in this setting. (Funded by the National Institute of Allergy and Infectious Diseases; ClinicalTrials.gov number, NCT00980148.)	[Geisler, William M.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Uniyal, Apurva; Kerndt, Peter R.] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA; [Kerndt, Peter R.] Univ So Calif, Dept Internal Med, Los Angeles, CA 90089 USA; [Perry, Raymond C. W.; Kadrnka, Carmel M.] Juvenile Court Hlth Serv, Los Angeles Cty Dept Hlth Serv, Los Angeles, CA USA; [Lee, Jeannette Y.; Lensing, Shelly Y.] Univ Arkansas Med Sci, Dept Biostat, Little Rock, AR 72205 USA; [Johnson, Shacondra] FHI 360, Durham, NC USA	University of Alabama System; University of Alabama Birmingham; University of Southern California; University of Southern California; University of Arkansas System; University of Arkansas Medical Sciences; FHI 360	Geisler, WM (corresponding author), Univ Alabama Birmingham, 703 19th St S,242 Zeigler Res Bldg, Birmingham, AL 35294 USA.	wgeisler@uab.edu			Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health [HHSN266200400073C]; ActivBiotics Pharma	Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ActivBiotics Pharma	Supported by the Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health (contract number HHSN266200400073C).; Dr. Geisler reports receiving grant support from ActivBiotics Pharma. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 1999, STAT MED, V18, P1905; [Anonymous], 2012, GLOB INC PREV SEL CU; Bachmann LH, 1999, SEX TRANSM DIS, V26, P272, DOI 10.1097/00007435-199905000-00006; Batteiger BE, 2010, J INFECT DIS, V201, P42, DOI 10.1086/648734; Bauer HM, 2004, SEX TRANSM DIS, V31, P409, DOI 10.1097/01.OLQ.0000130456.03464.EA; BEATTY WL, 1994, MICROBIOL REV, V58, P686, DOI 10.1128/MMBR.58.4.686-699.1994; Briere EC, 2014, MMWR RECOMM REP, V63, P1; Centers for Disease Control and Prevention, 2014, SEX TRANSM DIS SURV; Chernesky M, 2014, J CLIN MICROBIOL, V52, P2305, DOI 10.1128/JCM.03552-13; Dean D, 2000, J INFECT DIS, V182, P909, DOI 10.1086/315778; Gaydos CA, 1998, J INFECT DIS, V177, P417, DOI 10.1086/514207; Geisler WM, 2014, ANTIMICROB AGENTS CH, V58, P4014, DOI 10.1128/AAC.02521-14; JONES RB, 1990, J INFECT DIS, V162, P1309, DOI 10.1093/infdis/162.6.1309; Kapil R, 2015, J CLIN MICROBIOL, V53, P546, DOI 10.1128/JCM.02483-14; Khosropour CM, 2014, SEX TRANSM INFECT, V90, P3, DOI 10.1136/sextrans-2013-051174; KROHN K, 1991, EUR J CLIN MICROBIOL, V10, P864, DOI 10.1007/BF01975844; Lau CY, 2002, SEX TRANSM DIS, V29, P497, DOI 10.1097/00007435-200209000-00001; Manhart LE, 2013, CLIN INFECT DIS, V56, P934, DOI 10.1093/cid/cis1022; Mertz KJ, 2002, SEX TRANSM DIS, V29, P834, DOI 10.1097/00007435-200212000-00016; Morre SA, 1998, J CLIN PATHOL-MOL PA, V51, P149; Piaggio G, 2012, JAMA-J AM MED ASSOC, V308, P2594, DOI 10.1001/jama.2012.87802; Renault CA, 2011, SEX HEALTH, V8, P69, DOI 10.1071/SH10030; Reveneau N, 2005, ANTIMICROB AGENTS CH, V49, P1787, DOI 10.1128/AAC.49.5.1787-1793.2005; Robertson AA, 2005, SEX TRANSM DIS, V32, P115, DOI 10.1097/01.olq.0000151419.11934.1b; Schwebke JR, 2011, CLIN INFECT DIS, V52, P163, DOI 10.1093/cid/ciq074; Somani Jyoti, 2000, Journal of Infectious Diseases, V181, P1421, DOI 10.1086/315372; Takahashi Satoshi, 2008, Journal of Infection and Chemotherapy, V14, P409, DOI 10.1007/s10156-008-0643-y; WORKOWSKI KA, 1993, JAMA-J AM MED ASSOC, V270, P2071, DOI 10.1001/jama.270.17.2071; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1; WORM AM, 1995, GENITOURIN MED, V71, P244; Wyrick PB, 2010, J INFECT DIS, V201, pS88, DOI 10.1086/652394	31	74	80	1	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 24	2015	373	26					2512	2521		10.1056/NEJMoa1502599	http://dx.doi.org/10.1056/NEJMoa1502599			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ7SG	26699167	Bronze, Green Accepted			2022-12-28	WOS:000367299700007
J	Rustic, GT; Koutavas, A; Marchitto, TM; Linsley, BK				Rustic, Gerald T.; Koutavas, Athanasios; Marchitto, Thomas M.; Linsley, Braddock K.			Dynamical excitation of the tropical Pacific Ocean and ENSO variability by Little Ice Age cooling	SCIENCE			English	Article							INTERTROPICAL CONVERGENCE ZONE; NORTHERN-HEMISPHERE; CLIMATE; RECONSTRUCTION; OSCILLATION; TEMPERATURE; REANALYSIS	Tropical Pacific Ocean dynamics during the Medieval Climate Anomaly (MCA) and the Little Ice Age (LIA) are poorly characterized due to a lack of evidence from the eastern equatorial Pacific. We reconstructed sea surface temperature, El Nino-Southern Oscillation (ENSO) activity, and the tropical Pacific zonal gradient for the past millennium from Galapagos ocean sediments. We document a mid-millennium shift (MMS) in ocean-atmosphere circulation around 1500-1650 CE, from a state with dampened ENSO and strong zonal gradient to one with amplified ENSO and weak gradient. The MMS coincided with the deepest LIA cooling and was probably caused by a southward shift of the intertropical convergence zone. The peak of the MCA (900-1150 CE) was a warm period in the eastern Pacific, contradicting the paradigm of a persistent La Nina pattern.	[Rustic, Gerald T.; Koutavas, Athanasios] CUNY Coll Staten Isl, Dept Engn Sci & Phys, Staten Isl, NY 10314 USA; [Rustic, Gerald T.; Koutavas, Athanasios] CUNY, Grad Ctr, Doctoral Program Earth & Environm Sci, New York, NY 10016 USA; [Rustic, Gerald T.; Koutavas, Athanasios; Linsley, Braddock K.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Marchitto, Thomas M.] Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; [Marchitto, Thomas M.] Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA	City University of New York (CUNY) System; College of Staten Island (CUNY); City University of New York (CUNY) System; Columbia University; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Rustic, GT (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, 61 Route 9W, Palisades, NY 10964 USA.	grustic@ldeo.columbia.edu		Linsley, Braddock/0000-0003-2085-0662	Lamont-Doherty Earth Observatory Climate Center; Professional Staff Congress-City University of New York; College of Staten Island; NSF [OCE-1103482]	Lamont-Doherty Earth Observatory Climate Center; Professional Staff Congress-City University of New York; College of Staten Island; NSF(National Science Foundation (NSF))	Funding support was provided by the Lamont-Doherty Earth Observatory Climate Center, Professional Staff Congress-City University of New York, a Provost's Research Award to A.K. from the College of Staten Island, and NSF grant OCE-1103482 to T.M.M. We thank T. Herbert and the crew of R/V Knorr during cruise KNR195-5 for core collection. Data from this study are available through the NOAA National Centers for Environmental Information World Data Center for Paleoclimatology.	Carton JA, 2008, MON WEATHER REV, V136, P2999, DOI 10.1175/2007MWR1978.1; Chiang JCH, 2005, CLIM DYNAM, V25, P477, DOI 10.1007/s00382-005-0040-5; Clement AC, 1996, J CLIMATE, V9, P2190, DOI 10.1175/1520-0442(1996)009<2190:AODT>2.0.CO;2; Cobb KM, 2003, NATURE, V424, P271, DOI 10.1038/nature01779; Collins M, 2010, NAT GEOSCI, V3, P391, DOI 10.1038/NGEO868; Cook ER, 2004, SCIENCE, V306, P1015, DOI 10.1126/science.1102586; Crowley TJ, 2013, EARTH SYST SCI DATA, V5, P187, DOI 10.5194/essd-5-187-2013; Deser C, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043321; Emile-Geay J, 2013, J CLIMATE, V26, P2302, DOI [10.1175/JCLI-D-11-00511.1, 10.1175/JCLI-D-11-00510.1]; England MH, 2014, NAT CLIM CHANGE, V4, P222, DOI [10.1038/NCLIMATE2106, 10.1038/nclimate2106]; Haug GH, 2001, SCIENCE, V293, P1304, DOI 10.1126/science.1059725; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Karnauskas KB, 2012, J CLIMATE, V25, P5943, DOI 10.1175/JCLI-D-11-00421.1; Kosaka Y, 2013, NATURE, V501, P403, DOI 10.1038/nature12534; Koutavas A, 2006, GEOLOGY, V34, P993, DOI 10.1130/G22810A.1; Koutavas A, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2012PA002378; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Li JB, 2011, NAT CLIM CHANGE, V1, P114, DOI [10.1038/nclimate1086, 10.1038/NCLIMATE1086]; LINSLEY BK, 1994, J GEOPHYS RES-OCEANS, V99, P9977, DOI 10.1029/94JC00360; Ljungqvist FC, 2010, GEOGR ANN A, V92A, P339, DOI 10.1111/j.1468-0459.2010.00399.x; Mann ME, 2009, SCIENCE, V326, P1256, DOI 10.1126/science.1177303; Mantua NJ, 2002, J OCEANOGR, V58, P35, DOI 10.1023/A:1015820616384; McPhaden MJ, 2006, SCIENCE, V314, P1740, DOI 10.1126/science.1132588; Moberg A, 2005, NATURE, V433, P613, DOI 10.1038/nature03265; Newton A, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027234; Oppo DW, 2009, NATURE, V460, P1113, DOI 10.1038/nature08233; Sachs JP, 2009, NAT GEOSCI, V2, P519, DOI 10.1038/ngeo554; Schneider T, 2014, NATURE, V513, P45, DOI 10.1038/nature13636; Steinhilber F, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040142; Thompson LG, 2013, SCIENCE, V340, P945, DOI 10.1126/science.1234210; Tierney JE, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001871; Vecchi G. A., 2008, EOS T AM GEOPHYS UN, V89, P81, DOI DOI 10.1029/2008EO090002; Zhang PZ, 2008, SCIENCE, V322, P940, DOI 10.1126/science.1163965	33	76	79	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2015	350	6267					1537	1541		10.1126/science.aac9937	http://dx.doi.org/10.1126/science.aac9937			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY7LY	26634438				2022-12-28	WOS:000366591100061
J	Butt, CA				Butt, Carrie A.			Le Discret (The Silence)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 15	2015	314	23					2482	2483		10.1001/jama.2014.12147	http://dx.doi.org/10.1001/jama.2014.12147			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY4PV	26670958				2022-12-28	WOS:000366391500001
J	Dhabangi, A; Ainomugisha, B; Cserti-Gazdewich, C; Ddungu, H; Kyeyune, D; Musisi, E; Opoka, R; Stowell, CP; Dzik, WH				Dhabangi, Aggrey; Ainomugisha, Brenda; Cserti-Gazdewich, Christine; Ddungu, Henry; Kyeyune, Dorothy; Musisi, Ezra; Opoka, Robert; Stowell, Christopher P.; Dzik, Walter H.			Effect of Transfusion of Red Blood Cells With Longer vs Shorter Storage Duration on Elevated Blood Lactate Levels in Children With Severe Anemia The TOTAL Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IN-VITRO MARKERS; CEREBRAL OXYGENATION; AFRICAN CHILDREN; AGE; DEFORMABILITY; CLEARANCE; THERAPY; SEPSIS; IMPACT; TIME	IMPORTANCE Although millions of transfusions are given annually worldwide, the effect of red blood cell (RBC) unit storage duration on oxygen delivery is uncertain. OBJECTIVE To determine if longer-storage RBC units are not inferior to shorter-storage RBC units for tissue oxygenation as measured by reduction in blood lactate levels and improvement in cerebral tissue oxygen saturation among children with severe anemia. DESIGN, SETTING, AND PARTICIPANTS Randomized noninferiority trial of 290 children (aged 6-60 months), most with malaria or sickle cell disease, presenting February 2013 through May 2015 to a university-affiliated national referral hospital in Kampala, Uganda, with a hemoglobin level of 5 g/dL or lower and a lactate level of 5 mmol/L or higher. INTERVENTIONS Patients were randomly assigned to receive RBC units stored 25 to 35 days (longer-storage group; n = 145) vs 1 to 10 days (shorter-storage group; n = 145). All units were leukoreduced prior to storage. All patients received 10 mL/kg of RBCs during hours 0 through 2 and, if indicated per protocol, an additional 10 mL/kg during hours 4 through 6. MAIN OUTCOMES AND MEASURES The primary outcome was the proportion of patients with a lactate level of 3 mmol/L or lower at 8 hours using a margin of noninferiority equal to an absolute difference of 25%. Secondary measures included noninvasive cerebral tissue oxygen saturation during the first transfusion, clinical and laboratory changes up to 24 hours, and survival and health at 30 days after transfusion. Adverse events were monitored up to 24 hours. RESULTS In the total population of 290 children, the mean (SD) presenting hemoglobin level was 3.7 g/dL (1.3) and mean lactate level was 9.3 mmol/L (3.4). Median (interquartile range) RBC unit storage was 8 days (7-9) for shorter storage vs 32 days (30-34) for longer storage without overlap. The proportion achieving the primary end point was 0.61(95% Cl, 0.52 to 0.69) in the longer-storage group vs 0.58 (95% Cl, 0.49 to 0.66) in the shorter-storage group (between-group difference, 0.03 [95% Cl, -0.07 tool, P < .001), meeting the prespecified margin of noninferiority. Mean lactate levels were not statistically different between the 2 groups at 0, 2, 4, 6, 8, or 24 hours. Kaplan-Meier analysis and global nonlinear regression revealed no statistical difference in lactate reduction between the 2 groups. Clinical assessment, cerebral oxygen saturation, electrolyte abnormalities, adverse events, survival, and 30-day recovery were also not significantly different between the groups. CONCLUSIONS AND RELEVANCE Among children with lactic acidosis due to severe anemia, transfusion of longer-storage compared with shorter-storage RBC units did not result in inferior reduction of elevated blood lactate levels. These findings have relevance regarding the efficacy of stored RBC transfusion for patients with critical tissue hypoxia and lactic acidosis due to anemia.	[Dhabangi, Aggrey] Makerere Univ, Child Hlth & Dev Ctr, Kampala, Uganda; [Ainomugisha, Brenda] Mulago Hosp, Kampala, Uganda; [Cserti-Gazdewich, Christine] Univ Toronto, Univ Hlth Network, Lab Med Program, Toronto, ON, Canada; [Ddungu, Henry] Makerere Univ, Uganda Canc Inst, Kampala, Uganda; [Kyeyune, Dorothy; Musisi, Ezra] Uganda Natl Blood Transfus Serv, Kampala, Uganda; [Opoka, Robert] Makerere Univ, Mulago Hosp, Dept Paediat, Kampala, Uganda; [Stowell, Christopher P.; Dzik, Walter H.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Blood Transfus Serv, Boston, MA 02114 USA	Makerere University; Mulago National Referral Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Makerere University; Makerere University; Mulago National Referral Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Dzik, WH (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Blood Transfus Serv, 55 Fruit St,Room J-224, Boston, MA 02114 USA.	sdzik@mgh.harvard.edu	Cserti-Gazdewich, Christine/AAK-7413-2021	Cserti-Gazdewich, Christine/0000-0002-5297-6406	National Institutes of Health [1R21HL109518-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL109518] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The study was fully funded by grant 1R21HL109518-01A1 from the National Institutes of Health. Nonin Corporation supplied the equipment used for noninvasive cerebral oxygen measurements.	Alapan Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep07173; Bennett-Guerrero E, 2007, P NATL ACAD SCI USA, V104, P17063, DOI 10.1073/pnas.0708160104; Brunskill SJ, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010801.pub2; Cserti-Gazdewich CM, 2012, BRIT J HAEMATOL, V159, P223, DOI 10.1111/bjh.12014; Dhabangi A, 2014, TRANSFUSION, V54, P2802, DOI 10.1111/trf.12872; Dhabangi A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-55; Dzik WH, 2013, TRANSFUSION, V53, P3110, DOI 10.1111/trf.12171; Eckstein M, 2015, VOX SANG, V108, P359, DOI 10.1111/vox.12235; Fergusson DA, 2012, JAMA-J AM MED ASSOC, V308, P1443, DOI 10.1001/2012.jama.11953; Frank SM, 2013, ANESTH ANALG, V116, P975, DOI 10.1213/ANE.0b013e31828843e6; HEATON A, 1989, BRIT J HAEMATOL, V71, P131, DOI 10.1111/j.1365-2141.1989.tb06286.x; Hebert PC, 2004, CRIT CARE CLIN, V20, P187, DOI 10.1016/j.ccc.2004.01.001; Hebert PC, 2004, CRIT CARE CLIN, V20, P225, DOI 10.1016/j.ccc.2003.12.006; Jansen TC, 2010, AM J RESP CRIT CARE, V182, P752, DOI 10.1164/rccm.200912-1918OC; Jones AE, 2010, JAMA-J AM MED ASSOC, V303, P739, DOI 10.1001/jama.2010.158; Kiguli S, 2015, BMC MED, V13, DOI 10.1186/s12916-014-0246-7; Kraut JA, 2014, NEW ENGL J MED, V371, P2309, DOI 10.1056/NEJMra1309483; Lacroix J, 2015, NEW ENGL J MED, V372, P1410, DOI 10.1056/NEJMoa1500704; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Nguyen HB, 2004, CRIT CARE MED, V32, P1637, DOI 10.1097/01.CCM.0000132904.35713.A7; Radwanski K, 2013, TRANSFUSION, V53, P3128, DOI 10.1111/trf.12143; Leal-Noval SR, 2008, CRIT CARE MED, V36, P1290, DOI 10.1097/CCM.0b013e3181692dfc; Roberson RS, 2012, MT SINAI J MED, V79, P66, DOI 10.1002/msj.21284; Sadaka F, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-46; Steiner ME, 2015, NEW ENGL J MED, V372, P1419, DOI 10.1056/NEJMoa1414219; Triulzi DJ, 2010, TRANSFUS APHER SCI, V43, P95, DOI 10.1016/j.transci.2010.05.013; Vamvakas EC, 2010, TRANSFUSION, V50, P600, DOI 10.1111/j.1537-2995.2009.02465.x; Walsh TS, 2004, CRIT CARE MED, V32, P364, DOI 10.1097/01.CCM.0000108878.23703.E0; Wang D, 2012, TRANSFUSION, V52, P1184, DOI 10.1111/j.1537-2995.2011.03466.x; World Health Organization, BLOOD SAF AV; Zimring JC, 2015, BLOOD, V125, P2185, DOI 10.1182/blood-2014-11-567750	31	131	132	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 15	2015	314	23					2514	2523		10.1001/jama.2015.13977	http://dx.doi.org/10.1001/jama.2015.13977			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY4PV	26637812	Bronze			2022-12-28	WOS:000366391500018
J	Lipscombe, L				Lipscombe, Lorraine			In high-risk pregnant women, an individualized lifestyle intervention reduced gestational diabetes mellitus	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Lipscombe, Lorraine] Womens Coll Hosp, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Womens College Hospital	Lipscombe, L (corresponding author), Womens Coll Hosp, Toronto, ON, Canada.			Lipscombe, Lorraine/0000-0001-7412-7993				Bain E, 2015, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD010443.PUB2; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801	4	2	2	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	2015	163	12							JC7	10.7326/ACPJC-2015-163-12-007	http://dx.doi.org/10.7326/ACPJC-2015-163-12-007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY4BS	26666809				2022-12-28	WOS:000366354200007
J	Perneger, T				Perneger, Thomas			CHRISTMAS 2015: ALL IN THE MIND Debunking the curse of the rainbow jersey: historical cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							REGRESSION	Objective To understand the underlying mechanism of the "curse of the rainbow jersey," the lack of wins that purportedly affects the current cycling world champion. Design Historical cohort study. Setting On the road. Participants Professional cyclists who won the World Championship Road Race or the Tour of Lombardy, 1965-2013. Main outcome measures Number of professional wins per season in the year when the target race was won (year 0) and in the two following years (years 1 and 2; the world champion wears the rainbow jersey in year 1). The following hypotheses were tested: the "spotlight effect" (that is, people notice when a champion loses), the "marked man hypothesis" (the champion, who must wear a visible jersey, is marked closely by competitors), and "regression to the mean" (a successful season will be generally followed by a less successful one). Results On average, world champions registered 5.04 wins in year 0, 3.96 in year 1, and 3.47 in year 2; meanwhile, winners of the Tour of Lombardy registered 5.08, 4.22, and 3.83 wins. In a regression model that accounted for the propensity to win of each rider, the baseline year accrued more wins than did the other years (win ratio 1.49, 95% confidence interval 1.24 to 1.80), but the year in the rainbow jersey did not differ significantly from other cycling seasons. Conclusions The cycling world champion is significantly less successful during the year when he wears the rainbow jersey than in the previous year, but this is best explained by regression to the mean, not by a curse.	[Perneger, Thomas] Univ Geneva, Univ Hosp Geneva, Div Clin Epidemiol, CH-1211 Geneva, Switzerland; [Perneger, Thomas] Univ Geneva, Fac Med, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva	Perneger, T (corresponding author), Univ Geneva, Univ Hosp Geneva, Div Clin Epidemiol, CH-1211 Geneva, Switzerland.	thomas.perneger@hcuge.ch						AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Barnett AG, 2005, INT J EPIDEMIOL, V34, P215, DOI 10.1093/ije/dyh299; Cummings SR, 2000, JAMA-J AM MED ASSOC, V283, P1318, DOI 10.1001/jama.283.10.1318; Galton F., 1886, J ANTHR I, V15, P246, DOI 10.2307%2F2841583; Healy G, 2013, CURSE RAINBOW JERSEY; Hughes JP, 2015, ANN EPIDEMIOL, V25, P439, DOI 10.1016/j.annepidem.2015.03.013; Johnson S, 1756, LIT MAGAZINE, V2, P39; McCullagh P., 1989, GEN LINEAR MODELS, DOI [10. 1007/978-1-4899-3242-6, DOI 10.1007/978-1-4899-3242-6, 10.1007/978-1-4899-3242-6]; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124	9	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 14	2015	351								h6304	10.1136/bmj.h6304	http://dx.doi.org/10.1136/bmj.h6304			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ4KY	26668173	Green Published, hybrid			2022-12-28	WOS:000367073200004
J	Suderow, HJ				Suderow, Hermann J.			Opening the gate on superconductivity	SCIENCE			English	Editorial Material							STATE		[Suderow, Hermann J.] Univ Autonoma Madrid, Lab Bajas Temp, Dept Fis Mat Condensada,Unidad Asociada CSIC, Inst Nicolas Cabrera Ctr Condensed Matter Phys IF, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC)	Suderow, HJ (corresponding author), Univ Autonoma Madrid, Lab Bajas Temp, Dept Fis Mat Condensada,Unidad Asociada CSIC, Inst Nicolas Cabrera Ctr Condensed Matter Phys IF, E-28049 Madrid, Spain.	hermann.suderow@uam.es	Suderow, Hermann/L-6612-2013	Suderow, Hermann/0000-0002-5902-1880				Aoki D., 2011, J PHYS SOC JPN, V81; Bauer E, 2012, LECT NOTES PHYS, V847, P1, DOI 10.1007/978-3-642-24624-1; Buzdin AI, 2005, REV MOD PHYS, V77, P935, DOI 10.1103/RevModPhys.77.935; Canfield PC, 1998, PHYS TODAY, V51, P40, DOI 10.1063/1.882396; Chubukov A, 2015, PHYS TODAY, V68, P46, DOI 10.1063/PT.3.2818; Lu JM, 2015, SCIENCE, V350, P1353, DOI 10.1126/science.aab2277; Mak KF, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.136805; Roldan R, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.054515; Saito Y, 2015, SCIENCE, V350, P409, DOI 10.1126/science.1259440; van Delft D, 2010, PHYS TODAY, V63, P38, DOI 10.1063/1.3490499; Xi XX, 2016, NAT PHYS, V12, P139, DOI [10.1038/NPHYS3538, 10.1038/nphys3538]; Xiao D, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.196802	12	3	3	0	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2015	350	6266					1316	1317		10.1126/science.aad7086	http://dx.doi.org/10.1126/science.aad7086			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1JL	26659041				2022-12-28	WOS:000366162400020
J	Gonzalez, C				Gonzalez, Cayetano			CELL DIVISION A last-minute decision	NATURE			English	Editorial Material									[Gonzalez, Cayetano] Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain; [Gonzalez, Cayetano] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; ICREA	Gonzalez, C (corresponding author), Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain.	gonzalez@irbbarcelona.org	Gonzalez, Cayetano/K-3055-2019; Gonzalez, Cayetano/K-3933-2019	Gonzalez, Cayetano/0000-0002-5259-3608; 	ICREA Funding Source: Custom	ICREA(ICREA)		Coumailleau F, 2009, NATURE, V458, P1051, DOI 10.1038/nature07854; Derivery E, 2015, NATURE, V528, P280, DOI 10.1038/nature16443; Goodwin SS, 2010, CELL, V143, P263, DOI 10.1016/j.cell.2010.09.022; Hoepfner S, 2005, CELL, V121, P437, DOI 10.1016/j.cell.2005.02.017; Knoblich JA, 2001, NAT REV MOL CELL BIO, V2, P11, DOI 10.1038/35048085	5	2	2	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2015	528	7581					196	197		10.1038/528196a	http://dx.doi.org/10.1038/528196a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9VH	26659177				2022-12-28	WOS:000366053300022
J	Woerner, AC; Frottin, F; Hornburg, D; Feng, LR; Meissner, F; Patra, M; Tatzelt, J; Mann, M; Winklhofer, KF; Hartl, FU; Hipp, MS				Woerner, Andreas C.; Frottin, Frederic; Hornburg, Daniel; Feng, Li R.; Meissner, Felix; Patra, Maria; Tatzelt, Joerg; Mann, Matthias; Winklhofer, Konstanze F.; Hartl, F. Ulrich; Hipp, Mark S.			Cytoplasmic protein aggregates interfere with nucleocytoplasmic transport of protein and RNA	SCIENCE			English	Article							MESSENGER-RNA; HUNTINGTONS-DISEASE; REPEAT EXPANSION; TRANSGENIC MICE; CAG REPEAT; PROTEOSTASIS; NUCLEUS; ASSOCIATION; INCLUSIONS; MEMBRANE	Amyloid-like protein aggregation is associated with neurodegeneration and other pathologies. The nature of the toxic aggregate species and their mechanism of action remain elusive. Here, we analyzed the compartment specificity of aggregate toxicity using artificial beta-sheet proteins, as well as fragments of mutant huntingtin and TAR DNA binding protein-43 (TDP-43). Aggregation in the cytoplasm interfered with nucleocytoplasmic protein and RNA transport. In contrast, the same proteins did not inhibit transport when forming inclusions in the nucleus at or around the nucleolus. Protein aggregation in the cytoplasm, but not the nucleus, caused the sequestration and mislocalization of proteins containing disordered and low-complexity sequences, including multiple factors of the nuclear import and export machinery. Thus, impairment of nucleocytoplasmic transport may contribute to the cellular pathology of various aggregate deposition diseases.	[Woerner, Andreas C.; Frottin, Frederic; Feng, Li R.; Hartl, F. Ulrich; Hipp, Mark S.] Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18, D-82152 Martinsried, Germany; [Hornburg, Daniel; Meissner, Felix; Mann, Matthias] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany; [Patra, Maria; Tatzelt, Joerg; Winklhofer, Konstanze F.] Univ Munich, Adolf Butenandt Inst, Neurobiochem, D-80336 Munich, Germany; [Tatzelt, Joerg] Ruhr Univ Bochum, Inst Biochem & Pathobiochem, Dept Biochem Neurodegenerat Dis, D-44801 Bochum, Germany; [Mann, Matthias; Winklhofer, Konstanze F.; Hartl, F. Ulrich; Hipp, Mark S.] Munich Cluster Syst Neurol SyNergy, D-80336 Munich, Germany; [Winklhofer, Konstanze F.] Ruhr Univ Bochum, Inst Biochem & Pathobiochem, Dept Mol Cell Biol, D-44801 Bochum, Germany	Max Planck Society; Max Planck Society; University of Munich; Ruhr University Bochum; University of Munich; Ruhr University Bochum	Hartl, FU (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	uhartl@biochem.mpg.de; hipp@biochem.mpg.de	MEISSNER, Felix/C-8767-2015; Hipp, Mark/AAA-4238-2022; Hartl, F. Ulrich/Y-8206-2019; Feng, Li Rebekah/Y-9204-2019	MEISSNER, Felix/0000-0003-1000-7989; Feng, Li Rebekah/0000-0003-0445-4088; Tatzelt, Jorg/0000-0001-5017-5528; Winklhofer, Konstanze/0000-0002-7256-8231; Hipp, Mark/0000-0002-0497-3016; Frottin, Frederic/0000-0002-2756-7838	European Commission [FP7 GA ERC-2012-SyG_318987-ToPAG]; Munich Cluster for Systems Neurology; German Research Foundation; Hans and Ilse Breuer Foundation	European Commission(European CommissionEuropean Commission Joint Research Centre); Munich Cluster for Systems Neurology; German Research Foundation(German Research Foundation (DFG)); Hans and Ilse Breuer Foundation	We thank R. Klein, K. Schulz-Trieglaff, and I. Dudanova from the Max Planck Institute of Neurobiology for help with the preparation of primary neurons and brain slices, and J. Cox, F. Hosp, and M. Duerrbaum for support with proteomic data analysis. We thank C. Klaips and D. Balchin for critically reading the manuscript. The research leading to these results has received funding from the European Commission under grant FP7 GA ERC-2012-SyG_318987-ToPAG (to A.C.W., D.H., M.M., F.U.H., and M.S.H.), the Munich Cluster for Systems Neurology (K.F.W, M.M, F.U.H. and M.S.H.), the German Research Foundation (J.T., K.F.W.), and the Hans and Ilse Breuer Foundation (M.P.). F.U.H has an advisory position with Proteostasis Therapeutics Inc.. Data from the mass spectrometry analysis described in this manuscript can be found in the supplementary materials.	BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; Bolognesi B, 2010, ACS CHEM BIOL, V5, P735, DOI 10.1021/cb1001203; CARTER KC, 1991, J CELL BIOL, V115, P1191, DOI 10.1083/jcb.115.5.1191; CHAN WY, 1989, BIOCHEMISTRY-US, V28, P1033, DOI 10.1021/bi00429a017; Cheng H, 2006, CELL, V127, P1389, DOI 10.1016/j.cell.2006.10.044; Chi BK, 2013, NUCLEIC ACIDS RES, V41, P1294, DOI 10.1093/nar/gks1188; Freibaum BD, 2015, NATURE, V525, P129, DOI 10.1038/nature14974; Hackam AS, 1999, HUM MOL GENET, V8, P25, DOI 10.1093/hmg/8.1.25; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Hornburg D, 2014, MOL CELL PROTEOMICS, V13, P3410, DOI 10.1074/mcp.M113.037291; Jakhria T, 2014, J BIOL CHEM, V289, P35781, DOI 10.1074/jbc.M114.586222; Jovicic A, 2015, NAT NEUROSCI, V18, P1226, DOI 10.1038/nn.4085; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Li H, 1999, HUM MOL GENET, V8, P1227, DOI 10.1093/hmg/8.7.1227; Liu KY, 2015, HUM MOL GENET, V24, P1602, DOI 10.1093/hmg/ddu574; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Nalavade R, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.276; Nesterov EE, 2005, ANGEW CHEM INT EDIT, V44, P5452, DOI 10.1002/anie.200500845; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Szebeni A, 1999, PROTEIN SCI, V8, P905; Taylor RC, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004440; Visa N, 1996, CELL, V84, P253, DOI 10.1016/S0092-8674(00)80980-0; West MW, 1999, P NATL ACAD SCI USA, V96, P11211, DOI 10.1073/pnas.96.20.11211; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Yang CX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015878; Zhang K, 2015, NATURE, V525, P56, DOI 10.1038/nature14973	31	262	264	1	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 8	2016	351	6269					173	176		10.1126/science.aad2033	http://dx.doi.org/10.1126/science.aad2033			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XQ	26634439	Green Submitted			2022-12-28	WOS:000367806500042
J	Matzke, NJ				Matzke, Nicholas J.			The evolution of antievolution policies after Kitzmiller v. Dover	SCIENCE			English	Editorial Material									[Matzke, Nicholas J.] Australian Natl Univ, Canberra, ACT 2601, Australia; [Matzke, Nicholas J.] Univ Tennessee, Natl Inst Math & Biol Synth, Knoxville, TN 37996 USA	Australian National University; University of Tennessee System; University of Tennessee Knoxville	Matzke, NJ (corresponding author), Australian Natl Univ, GPO Box 4, Canberra, ACT 2601, Australia.	nick.matzke@anu.edu.au	Matzke, Nicholas/L-4109-2015	Matzke, Nicholas/0000-0002-8698-7656	Div Of Biological Infrastructure [1300426] Funding Source: National Science Foundation	Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Bleckmann CA, 2006, BIOSCIENCE, V56, P151, DOI 10.1641/0006-3568(2006)056[0151:EACIS]2.0.CO;2; Branch G, 2010, ANNU REV GENOM HUM G, V11, P317, DOI 10.1146/annurev-genom-082509-141815; Gavryushkina A., 2015, ARXIVORG150604797; Gavryushkina A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003919; Howe CJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001069; Matzke N. J., 2009, IS IT SCI PHILOS QUE; National Center for Science Education, 2015, AC FREED BILLS STAT; Padian K., 2009, BIOCHEMIST, V31, P8	8	18	18	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2016	351	6268					28	30		10.1126/science.aad4057	http://dx.doi.org/10.1126/science.aad4057			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ8QM	26678877				2022-12-28	WOS:000367364200027
J	Anderson, K				Anderson, Kevin			Talks in the city of light generate more heat	NATURE			English	Editorial Material									[Anderson, Kevin] Tyndall Ctr Climate Change Res, Norwich, Norfolk, England	University of East Anglia	Anderson, K (corresponding author), Tyndall Ctr Climate Change Res, Norwich, Norfolk, England.	kevin.anderson@manchester.ac.uk							0	46	46	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2015	528	7583					437	437		10.1038/528437a	http://dx.doi.org/10.1038/528437a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ3GH	26701018	Bronze			2022-12-28	WOS:000366991900008
J	Pennisi, E				Pennisi, Elizabeth			Beetle horns and book writing	SCIENCE			English	Editorial Material								By day, Douglas Emlen studies insect weaponry, but at night, military history is his preferred reading. Eight years ago, these interests merged unexpectedly. As a professor of ecology and biology at the University of Montana in Missoula, he had spent 20 years examining the mating and territorial behavior of dung and rhinoceros beetles, well known for their very large horns, to understand why some insects spend so much energy building big weapons. Asked to write a review about weapons systems across the animal kingdom, he dug into the file cabinets full of papers on the subject that he had collected over the years. The more he read about tusks, horns, claws, antlers, and other weapons, the more enthralled he became. So, when the journal made him cut 10,000 words from the manuscript, he decided it was time to branch out and write a book for a general audience.				SciCareerEditor@aaas.org							0	1	1	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2015	350	6267					1578	1578		10.1126/science.350.6267.1578	http://dx.doi.org/10.1126/science.350.6267.1578			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY7LY	26680201				2022-12-28	WOS:000366591100066
J	Phadnis, N; Baker, ECP; Cooper, JC; Frizzell, KA; Hsieh, E; de la Cruz, AFA; Shendure, J; Kitzman, JO; Malik, HS				Phadnis, Nitin; Baker, Emily Clare P.; Cooper, Jacob C.; Frizzell, Kimberly A.; Hsieh, Emily; de la Cruz, Aida Flor A.; Shendure, Jay; Kitzman, Jacob O.; Malik, Harmit S.			An essential cell cycle regulation gene causes hybrid inviability in Drosophila	SCIENCE			English	Article							LETHAL HYBRIDS; MELANOGASTER; SIMULANS; PROTEIN	Speciation, the process by which new biological species arise, involves the evolution of reproductive barriers, such as hybrid sterility or inviability between populations. However, identifying hybrid incompatibility genes remains a key obstacle in understanding the molecular basis of reproductive isolation. We devised a genomic screen, which identified a cell cycle-regulation gene as the cause of male inviability in hybrids resulting from a cross between Drosophila melanogaster and D. simulans. Ablation of the D. simulans allele of this gene is sufficient to rescue the adult viability of hybrid males. This dominantly acting cell cycle regulator causes mitotic arrest and, thereby, inviability of male hybrid larvae. Our genomic method provides a facile means to accelerate the identification of hybrid incompatibility genes in other model and nonmodel systems.	[Phadnis, Nitin; Cooper, Jacob C.; Frizzell, Kimberly A.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Baker, Emily Clare P.; Hsieh, Emily; de la Cruz, Aida Flor A.; Malik, Harmit S.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Shendure, Jay; Kitzman, Jacob O.] Univ Washington, Genome Sci, Seattle, WA 98195 USA; [Shendure, Jay] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Kitzman, Jacob O.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Malik, Harmit S.] Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98109 USA	Utah System of Higher Education; University of Utah; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Phadnis, N (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	nitin.phadnis@utah.edu; hsmalik@fhcrc.org	Malik, Harmit S/I-5591-2019; Shendure, Jay/AAU-3684-2021	Malik, Harmit S/0000-0001-6005-0016; Kitzman, Jacob/0000-0002-6145-882X; Baker, EmilyClare/0000-0002-7875-2144; HSIEH, EMILY/0000-0002-9415-9703	Howard Hughes Medical Institute-Life Sciences Research Foundation (HHMI-LSRF) postdoctoral fellowship; Mario Cappecchi-endowed assistant professorship; NIH Developmental Biology Training Grant [5T32 HD0741]; NSF [DGE-071824]; NIH [R01 GM115914, HG006283, R01 GM074108]; Mathers Foundation; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115914, R01GM074108] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020069] Funding Source: NIH RePORTER	Howard Hughes Medical Institute-Life Sciences Research Foundation (HHMI-LSRF) postdoctoral fellowship; Mario Cappecchi-endowed assistant professorship; NIH Developmental Biology Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank T. Levin, M. Levine, M. Patel, Naina Phadnis, B. Ross, and S. Zanders for their comments on the manuscript and members of the Malik, Peichel, and Phadnis labs for discussions. This work was supported by a Howard Hughes Medical Institute-Life Sciences Research Foundation (HHMI-LSRF) postdoctoral fellowship (N.P.); a Mario Cappecchi-endowed assistant professorship (N.P.); an NIH Developmental Biology Training Grant 5T32 HD0741 (J.C.C.); graduate research fellowship DGE-071824 from the NSF (J.O.K.); grants from the NIH: R01 GM115914 (N.P.), HG006283 (J.S.), and R01 GM074108 (H.S.M.); and especially a grant from the Mathers Foundation (H.S.M.). J.S. and H.S.M. are investigators of HHMI. The data reported in this paper are tabulated in the supplementary materials and archived at the following databases: primary read data at the Sequence Read Archive under accession number PRJNA290665 and gfzf sequences at GenBank under accession numbers KU064780 to KU064795.	Ambrus AM, 2009, GENETICS, V183, P79, DOI 10.1534/genetics.109.104661; Ashton-Beaucage D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001809; Barbash DA, 2003, P NATL ACAD SCI USA, V100, P5302, DOI 10.1073/pnas.0836927100; Barbash DA, 2010, GENETICS, V186, P1, DOI 10.1534/genetics.110.121459; Bolkan BJ, 2007, GENETICS, V177, P2233, DOI 10.1534/genetics.107.079939; Brideau NJ, 2006, SCIENCE, V314, P1292, DOI 10.1126/science.1133953; Dai MS, 2004, GENE, V342, P49, DOI 10.1016/j.gene.2004.07.043; GATTI M, 1989, GENE DEV, V3, P438, DOI 10.1101/gad.3.4.438; HUTTER P, 1987, NATURE, V327, P331, DOI 10.1038/327331a0; Kondo S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001350; Loveall BJ, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-92; Maheshwari S, 2008, MOL BIOL EVOL, V25, P2421, DOI 10.1093/molbev/msn190; Muller HJ, 1940, NATURE, V146, P199, DOI 10.1038/146199b0; Orr HA, 1997, GENETICS, V145, P1031; Phadnis N, 2011, GENETICS, V189, P1001, DOI 10.1534/genetics.111.132324; Pontecorvo G, 1943, J GENET, V45, P51, DOI 10.1007/BF02982774; PROVINE WB, 1991, GENETICS, V129, P1; Provost E, 2006, GENETICS, V172, P207, DOI 10.1534/genetics.105.044669; Quackenbush LS, 1910, SCIENCE, V32, P183, DOI 10.1126/science.32.814.183; SANCHEZ L, 1983, ROUX ARCH DEV BIOL, V192, P48, DOI 10.1007/BF00848770; Satyaki PRV, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004240; SEILER T, 1974, EXPERIENTIA, V30, P709; Sturtevant AH, 1920, GENETICS, V5, P488; Thomae AW, 2013, DEV CELL, V27, P412, DOI 10.1016/j.devcel.2013.10.001; WATANABE TK, 1979, JPN J GENET, V54, P325, DOI 10.1266/jjg.54.325	25	34	34	2	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2015	350	6267					1552	1555		10.1126/science.aac7504	http://dx.doi.org/10.1126/science.aac7504			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY7LY	26680200	Green Accepted			2022-12-28	WOS:000366591100065
J	Ross, FM				Ross, Frances M.			Opportunities and challenges in liquid cell electron microscopy	SCIENCE			English	Review							IN-SITU OBSERVATION; LI-ION BATTERIES; NANOCRYSTAL GROWTH; MORPHOLOGICAL EVOLUTION; NANOPARTICLE DYNAMICS; LEAD DENDRITES; NUCLEATION; GRAPHENE; WATER; RESOLUTION		[Ross, Frances M.] IBM TJ Watson Res Ctr, Yorktown Hts, NY 10598 USA	International Business Machines (IBM)	Ross, FM (corresponding author), IBM TJ Watson Res Ctr, 1101 Kitchawan Rd, Yorktown Hts, NY 10598 USA.	fmross@us.ibm.com	Ross, Frances/P-8919-2015	Ross, Frances/0000-0003-0838-9770	Division Of Materials Research [1310639] Funding Source: National Science Foundation	Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		Abellan P, 2014, NANO LETT, V14, P1293, DOI 10.1021/nl404271k; Abrams IM, 1944, SCIENCE, V100, P273, DOI 10.1126/science.100.2595.273; Adachi K, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047540; Adiga V. P., U. S. Patent Application Ser, Patent No. [14/ 817,551, 14871551]; Bhattacharya D, 2014, MICROSC MICROANAL, V20, P407, DOI 10.1017/S1431927614000476; Browning ND, 2012, CURR OPIN SOLID ST M, V16, P23, DOI 10.1016/j.cossms.2011.07.001; Butler E. P., 1981, DYNAMIC EXPT ELECT M; Cazade PA, 2014, J PHYS CHEM C, V118, P5061, DOI 10.1021/jp4098638; Chee SW, 2015, CHEM COMMUN, V51, P168, DOI 10.1039/c4cc06443g; Chee SW, 2014, MICROSC MICROANAL, V20, P462, DOI 10.1017/S1431927614000221; Chen Q, 2013, NANO LETT, V13, P4556, DOI 10.1021/nl402694n; Creemer JF, 2008, ULTRAMICROSCOPY, V108, P993, DOI 10.1016/j.ultramic.2008.04.014; Danev R, 2001, ULTRAMICROSCOPY, V88, P243, DOI 10.1016/S0304-3991(01)00088-2; DANILATOS GD, 1991, J MICROSC-OXFORD, V162, P391, DOI 10.1111/j.1365-2818.1991.tb03149.x; De Clercq A, 2014, J PHYS CHEM LETT, V5, P2126, DOI 10.1021/jz500690a; de Jonge N, 2009, P NATL ACAD SCI USA, V106, P2159, DOI 10.1073/pnas.0809567106; de Jonge N, 2011, NAT NANOTECHNOL, V6, P695, DOI [10.1038/NNANO.2011.161, 10.1038/nnano.2011.161]; Degen K, 2012, RSC ADV, V2, P2408, DOI 10.1039/c2ra01163h; DEGENNES PG, 1985, REV MOD PHYS, V57, P827, DOI 10.1103/RevModPhys.57.827; den Heijer M, 2014, APL MATER, V2, DOI 10.1063/1.4863596; DOUBLE DD, 1978, P ROY SOC LOND A MAT, V359, P435, DOI 10.1098/rspa.1978.0050; Dukes Madeline J, 2014, Microsc Microanal, V20, P338, DOI 10.1017/S1431927613013858; Dukes MJ, 2010, ACS NANO, V4, P4110, DOI 10.1021/nn1010232; Evans JE, 2011, NANO LETT, V11, P2809, DOI 10.1021/nl201166k; FUKAMI A, 1991, FRONT SED, P321; Gai PL, 2002, MICROSC MICROANAL, V8, P21, DOI 10.1017/S1431927601010054; Grogan JM, 2014, NANO LETT, V14, P359, DOI 10.1021/nl404169a; Grogan JM, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.061405; Grogan JM, 2010, J MICROELECTROMECH S, V19, P885, DOI 10.1109/JMEMS.2010.2051321; Gu M, 2013, NANO LETT, V13, P6106, DOI 10.1021/nl403402q; Helveg S, 2004, NATURE, V427, P426, DOI 10.1038/nature02278; Holtz ME, 2014, NANO LETT, V14, P1453, DOI 10.1021/nl404577c; Hoppe SM, 2013, LANGMUIR, V29, P9958, DOI 10.1021/la401288g; Huang JY, 2010, SCIENCE, V330, P1515, DOI 10.1126/science.1195628; Jensen E, 2014, MICROSC MICROANAL, V20, P445, DOI 10.1017/S1431927614000300; Jiang YY, 2014, NANO LETT, V14, P3761, DOI 10.1021/nl500670q; Jungjohann KL, 2013, NANO LETT, V13, P2964, DOI 10.1021/nl4014277; Jungjohann KL, 2012, MICROSC MICROANAL, V18, P621, DOI 10.1017/S1431927612000104; Kashyap S, 2014, ACS NANO, V8, P9097, DOI 10.1021/nn502551y; Kraus T, 2013, LANGMUIR, V29, P8427, DOI 10.1021/la401584z; Leenheer AJ, 2015, J MICROELECTROMECH S, V24, P1061, DOI 10.1109/JMEMS.2014.2380771; Lewis EA, 2014, CHEM COMMUN, V50, P10019, DOI 10.1039/c4cc02743d; Li DS, 2012, SCIENCE, V336, P1014, DOI 10.1126/science.1219643; Liao HG, 2014, SCIENCE, V345, P916, DOI 10.1126/science.1253149; Liao HG, 2013, CHEM COMMUN, V49, P11720, DOI 10.1039/c3cc47473a; Liao HG, 2013, J AM CHEM SOC, V135, P5038, DOI 10.1021/ja310612p; Liao HG, 2012, SCIENCE, V336, P1011, DOI 10.1126/science.1219185; Liu Y, 2013, CHEM MATER, V25, P2927, DOI 10.1021/cm303522z; Lu JY, 2014, NANO LETT, V14, P2111, DOI 10.1021/nl500766j; Mattia D, 2008, MICROFLUID NANOFLUID, V5, P289, DOI 10.1007/s10404-008-0293-5; Mehdi BL, 2015, NANO LETT, V15, P2168, DOI 10.1021/acs.nanolett.5b00175; Mehdi BL, 2014, MICROSC MICROANAL, V20, P484, DOI 10.1017/S1431927614000488; Miller BK, 2014, MICROSC MICROANAL, V20, P815, DOI 10.1017/S1431927614000749; Mirsaidov U, 2013, LAB CHIP, V13, P2874, DOI 10.1039/c3lc50304f; Mirsaidov U, 2012, SOFT MATTER, V8, P7108, DOI 10.1039/c2sm25331c; Mirsaidov UM, 2012, P NATL ACAD SCI USA, V109, P7187, DOI 10.1073/pnas.1200457109; Mirsaidov UM, 2012, BIOPHYS J, V102, pL15, DOI [10.1016/j.bpj.2012.01.009, 10.1016/j.bpj.2012.10.009]; Mohanty N, 2011, NANO LETT, V11, P1270, DOI 10.1021/nl104292k; Mueller C, 2013, J PHYS CHEM LETT, V4, P2339, DOI 10.1021/jz401067k; Nielsen MH, 2014, SCIENCE, V345, P1158, DOI 10.1126/science.1254051; Nielsen MH, 2012, FARADAY DISCUSS, V159, P105, DOI 10.1039/c2fd20050c; Niu KY, 2013, NANO LETT, V13, P5715, DOI 10.1021/nl4035362; Noh KW, 2012, ULTRAMICROSCOPY, V116, P34, DOI 10.1016/j.ultramic.2012.03.012; Norton M. M., 2015, B AM PHYS SOC, V60; Parent LR, 2012, ACS NANO, V6, P3589, DOI 10.1021/nn300671g; Park C, 2015, IEEE T PATTERN ANAL, V37, P611, DOI 10.1109/TPAMI.2014.2346202; Park J, 2015, NANO LETT, V15, P4737, DOI 10.1021/acs.nanolett.5b01636; Park J, 2012, ACS NANO, V6, P2078, DOI 10.1021/nn203837m; PARSONS DF, 1974, SCIENCE, V186, P407, DOI 10.1126/science.186.4162.407; Peckys DB, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500165; Peckys DB, 2015, JOVE-J VIS EXP, DOI 10.3791/53186; Peckys DB, 2014, MICROSC MICROANAL, V20, P346, DOI 10.1017/S1431927614000099; Peckys DB, 2013, SCI REP-UK, V3, DOI 10.1038/srep02626; Peckys DB, 2011, NANO LETT, V11, P1733, DOI 10.1021/nl200285r; Plamper FA, 2013, MACROMOL RAPID COMM, V34, P855, DOI 10.1002/marc.201300053; Pohlmann ES, 2015, NANO LETT, V15, P2329, DOI 10.1021/nl504481k; Proetto MT, 2014, J AM CHEM SOC, V136, P1162, DOI 10.1021/ja408513m; Radisic A, 2006, SURF SCI, V600, P1817, DOI 10.1016/j.susc.2006.02.025; Radisic A, 2006, J PHYS CHEM B, V110, P7862, DOI 10.1021/jp057549a; Radisic A, 2006, NANO LETT, V6, P238, DOI 10.1021/nl052175i; Ring EA, 2011, J MICROSC-OXFORD, V243, P273, DOI 10.1111/j.1365-2818.2011.03501.x; Ring EA, 2012, MICRON, V43, P1078, DOI 10.1016/j.micron.2012.01.010; Ring EA, 2010, MICROSC MICROANAL, V16, P622, DOI 10.1017/S1431927610093669; Ross FM, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/11/114501; Ruan CY, 2004, SCIENCE, V304, P80, DOI 10.1126/science.1094818; Ruska E, 1942, KOLLOID Z, V100, P212, DOI 10.1007/BF01519549; Sacci RL, 2014, CHEM COMMUN, V50, P2104, DOI 10.1039/c3cc49029g; Sadki S, 2000, CHEM SOC REV, V29, P283, DOI 10.1039/a807124a; Schneider N.M., 2014, MICROSC MICROANAL, V20, P1530, DOI [10.1017/S1431927614009386, DOI 10.1017/S1431927614009386]; Schneider NM, 2014, J PHYS CHEM C, V118, P22373, DOI 10.1021/jp507400n; Simon P, 2008, MICRON, V39, P229, DOI 10.1016/j.micron.2006.11.012; Sinclair R, 2013, MRS BULL, V38, P1065, DOI 10.1557/mrs.2013.285; Smeets PJM, 2015, NAT MATER, V14, P394, DOI [10.1038/nmat4193, 10.1038/NMAT4193]; Stokes D, 2008, PRINCIPLES PRACTICE; Sugi H, 2008, P NATL ACAD SCI USA, V105, P17396, DOI 10.1073/pnas.0809581105; Sun MH, 2013, SCI REP-UK, V3, DOI 10.1038/srep03227; Sutter E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5946; Tai KP, 2014, MICROSC MICROANAL, V20, P330, DOI 10.1017/S1431927613014128; Unocic RR, 2014, MICROSC MICROANAL, V20, P452, DOI 10.1017/S1431927614000166; Varano AC, 2015, CHEM COMMUN, V51, P16176, DOI 10.1039/c5cc05744b; Wang CM, 2010, J MATER RES, V25, P1541, DOI 10.1557/JMR.2010.0198; Wang CH, 2014, ADV MATER, V26, P3410, DOI 10.1002/adma.201306069; Wang CM, 2015, MRS BULL, V40, P46, DOI 10.1557/mrs.2014.283; White ER, 2012, LANGMUIR, V28, P3695, DOI 10.1021/la2048486; White ER, 2012, ACS NANO, V6, P6308, DOI 10.1021/nn3017469; White ER, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.055201; Williamson MJ, 2003, NAT MATER, V2, P532, DOI 10.1038/nmat944; Woehl TJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep06854; Woehl TJ, 2014, NANO LETT, V14, P373, DOI 10.1021/nl4043328; Woehl TJ, 2012, ACS NANO, V6, P8599, DOI 10.1021/nn303371y; Wojcik M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8384; Wu J., 2014, MICROSC MICROANAL, V20, P1508, DOI [10.1017/S1431927614009271, DOI 10.1017/S1431927614009271]; Xin HLL, 2012, NANO LETT, V12, P1470, DOI 10.1021/nl2041854; Yuk JM, 2012, SCIENCE, V336, P61, DOI 10.1126/science.1217654; Zeng ZY, 2014, NANO LETT, V14, P1745, DOI 10.1021/nl403922u; Zheng HM, 2012, NANO LETT, V12, P5644, DOI 10.1021/nl302788g; Zheng HM, 2009, NANO LETT, V9, P2460, DOI 10.1021/nl9012369; Zheng HM, 2009, SCIENCE, V324, P1309, DOI 10.1126/science.1172104; Zhong X., 2014, MICROSC MICROANA SS3, V20, P1514, DOI [10.1017/S1431927614009301, DOI 10.1017/S1431927614009301]; Zhu GM, 2014, CHEM COMMUN, V50, P9447, DOI 10.1039/c4cc03500c	120	336	340	16	438	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2015	350	6267							aaa9886	10.1126/science.aaa9886	http://dx.doi.org/10.1126/science.aaa9886			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY7LY	26680204	Green Published			2022-12-28	WOS:000366591100047
J	Cyranoski, D				Cyranoski, David			THE CHANGING FACE OF INDUSTRY	NATURE			English	Editorial Material																			0	0	0	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2015	528	7582					S184	S186		10.1038/528S184a	http://dx.doi.org/10.1038/528S184a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY8SM	26673026	Bronze			2022-12-28	WOS:000366678600014
J	Denkov, N; Tcholakova, S; Lesov, I; Cholakova, D; Smoukov, SK				Denkov, Nikolai; Tcholakova, Slavka; Lesov, Ivan; Cholakova, Diana; Smoukov, Stoyan K.			Self-shaping of oil droplets via the formation of intermediate rotator phases upon cooling	NATURE			English	Article							LIQUID-CRYSTAL; DESIGN; MICROFLUIDICS; FABRICATION; NANOFIBERS; NUCLEATION	Revealing the chemical and physical mechanisms underlying symmetry breaking and shape transformations is key to understanding morphogenesis(1). If we are to synthesize artificial structures with similar control and complexity to biological systems, we need energy-and material-efficient bottom-up processes to create building blocks of various shapes that can further assemble into hierarchical structures. Lithographic top-down processing(2) allows a high level of structural control in microparticle production but at the expense of limited productivity. Conversely, bottom-up particle syntheses(3-8) have higher material and energy efficiency, but are more limited in the shapes achievable. Linear hydrocarbons are known to pass through a series of metastable plastic rotator phases before freezing(9,10). Here we show that by using appropriate cooling protocols, we can harness these phase transitions to control the deformation of liquid hydrocarbon droplets and then freeze them into solid particles, permanently preserving their shape. Upon cooling, the droplets spontaneously break their shape symmetry several times, morphing through a series of complex regular shapes owing to the internal phase-transition processes. In this way we produce particles including micrometre-sized octahedra, various polygonal platelets, O-shapes, and fibres of submicrometre diameter, which can be selectively frozen into the corresponding solid particles. This mechanism offers insights into achieving complex morphogenesis from a system with a minimal number of molecular components.	[Denkov, Nikolai; Tcholakova, Slavka; Lesov, Ivan; Cholakova, Diana] Univ Sofia, Fac Chem & Pharm, Dept Chem & Pharmaceut Engn, Sofia 1164, Bulgaria; [Smoukov, Stoyan K.] Univ Cambridge, Dept Mat Sci & Met, Act & Intelligent Mat Lab, Cambridge CB3 0FS, England	University of Sofia; University of Cambridge	Smoukov, SK (corresponding author), Univ Cambridge, Dept Mat Sci & Met, Act & Intelligent Mat Lab, Cambridge CB3 0FS, England.	sks46@cam.ac.uk	Smoukov, Stoyan/GRR-7290-2022; Denkov, Nikolai Denkov/A-2065-2008; Lesov, Ivan/E-6358-2016; Cholakova, Diana/AAZ-9189-2020; Tcholakova, Slavka S/C-2103-2018	Denkov, Nikolai Denkov/0000-0003-1118-7635; Lesov, Ivan/0000-0002-0366-7922; Tcholakova, Slavka S/0000-0001-8091-7529; Smoukov, Stoyan/0000-0003-1738-818X; Cholakova, Diana/0000-0001-6654-6418	European Research Council (ERC) [280078]; European Commission [286205]	European Research Council (ERC)(European Research Council (ERC)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was funded by the European Research Council (ERC) grant to S.K.S., EMATTER (#280078). The study falls under the umbrella of European networks COST MP 1106 and 1305 and the capacity building project BeyondEverest of the European Commission (grant no. 286205).	Alargova RG, 2004, ADV MATER, V16, P1653, DOI 10.1002/adma.200400112; Bloss FD., 1961, INTRO METHODS OPTICA, V116, P485, DOI 10.1524/zkri.1961.116.3-6.485; Bowick MJ, 2009, ADV PHYS, V58, P449, DOI 10.1080/00018730903043166; Champion JA, 2007, J CONTROL RELEASE, V121, P3, DOI 10.1016/j.jconrel.2007.03.022; Decuzzi P, 2010, J CONTROL RELEASE, V141, P320, DOI 10.1016/j.jconrel.2009.10.014; Deitzel JM, 2001, POLYMER, V42, P261, DOI 10.1016/S0032-3861(01)00336-6; Dendukuri D, 2009, ADV MATER, V21, P4071, DOI 10.1002/adma.200803386; Evans E.A., 1980, MECH THERMODYNAMICS; Gratton SEA, 2008, P NATL ACAD SCI USA, V105, P11613, DOI 10.1073/pnas.0801763105; Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P1; Jeong J, 2014, P NATL ACAD SCI USA, V111, P1742, DOI 10.1073/pnas.1315121111; Jung HT, 2001, P NATL ACAD SCI USA, V98, P1353, DOI 10.1073/pnas.041420998; Kim JW, 2007, ANGEW CHEM INT EDIT, V46, P1819, DOI 10.1002/anie.200604206; Li Y, 2013, SOFT MATTER, V9, P11461, DOI 10.1039/c3sm52394b; Makgwane PR, 2014, J NANOSCI NANOTECHNO, V14, P1338, DOI 10.1166/jnn.2014.9129; MIYANO K, 1979, J CHEM PHYS, V71, P4108, DOI 10.1063/1.438181; NEVILLE AC, 1985, BIOESSAYS, V3, P4, DOI 10.1002/bies.950030103; Peddireddy K, 2013, LANGMUIR, V29, P15682, DOI 10.1021/la4038588; Peddireddy K, 2013, OPT EXPRESS, V21, P30233, DOI 10.1364/OE.21.030233; Peng X., 2003, NATURE, V2, P145; Sirota EB, 1999, SCIENCE, V283, P529, DOI 10.1126/science.283.5401.529; Smoukov SK, 2015, ADV MATER, V27, P2642, DOI 10.1002/adma.201404616; STONE HA, 1994, ANNU REV FLUID MECH, V26, P65, DOI 10.1146/annurev.fluid.26.1.65; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Ueno S, 2003, CRYST GROWTH DES, V3, P935, DOI 10.1021/cg0300230; Wittebrood MM, 1996, PHYS REV E, V54, P5232, DOI 10.1103/PhysRevE.54.5232; Xiao JY, 2011, NANOSCALE, V3, P1383, DOI 10.1039/c0nr00814a; Zhang LY, 2013, LIQ CRYST, V40, P1263, DOI 10.1080/02678292.2013.805829	28	90	91	10	164	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2015	528	7582					392	+		10.1038/nature16189	http://dx.doi.org/10.1038/nature16189			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY8SM	26649824	Green Accepted			2022-12-28	WOS:000366678600051
J	Dennis, J; Crayford, T				Dennis, John; Crayford, Tim			Parliamentary privilege-mortality in members of the Houses of Parliament compared with the UK general population: retrospective cohort analysis, 1945-2011	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								Objective To examine mortality in members of the two UK Houses of Parliament compared with the general population, 1945-2011. Design Retrospective cohort analysis of death rates and predictors of mortality in Members of Parliament (MPs) and members of the House of Lords (Lords). Setting UK. Participants 4950 MPs and Lords first joining the UK parliament in 1945-2011. Main outcome measure Standardised mortality ratios, comparing all cause death rates of MPs and Lords from first election or appointment with those in the age, sex, and calendar year matched general population. Results Between 1945 and 2011, mortality was lower in MPs (standardised mortality ratio 0.72, 95% confidence interval 0.67 to 0.76) and Lords (0.63, 0.60 to 0.67) than in the general population. Over the same period, death rates among MPs also improved more quickly than in the general population. For every 100 expected deaths, 22 fewer deaths occurred among MPs first elected in 1990-99 compared with MPs first elected in 1945-49. Labour party MPs had 19% higher death rates compared with the general population than did Conservative MPs (relative mortality ratio 1.19, 95% confidence interval 1.01 to 1.40). The effect of political party on mortality disappeared when controlling for education level. Conclusions From 1945 to 2011, MPs and Lords experienced lower mortality than the UK general population, and, at least until 1999, the mortality gap between newly elected MPs and the general population widened. Even among MPs, educational background was an important predictor of mortality, and education possibly explains much of the mortality difference between Labour and Conservative MPs. Social inequalities are alive and well in UK parliamentarians, and at least in terms of mortality, MPs are likely to have never had it so good.	[Dennis, John] Univ Exeter, Sch Med, Exeter EX1 2LU, Devon, England	University of Exeter	Dennis, J (corresponding author), Univ Exeter, Sch Med, Exeter EX1 2LU, Devon, England.	j.dennis@exeter.ac.uk		Dennis, John/0000-0002-7171-732X				Allen N, 2009, TELEGRAPH; [Anonymous], 2010, ED BACKGR MEMB PARL; Beamish D, UK PEERAGE CREATIONS; Dickman PW, 2015, STATA J, V15, P186, DOI 10.1177/1536867X1501500112; Gulliford MC, 2009, AM J EPIDEMIOL, V169, P455, DOI 10.1093/aje/kwn342; Levesque LE, 2010, BMJ, V340, pb5087, DOI DOI 10.1136/BMJ.B5087; Noteboom W M, 1991, Ned Tijdschr Geneeskd, V135, P2425; PINCHERL.G, 1969, BRIT J PREV SOC MED, V23, P72; Rayment L, 2015, PEERAGES ENGLAND SCO; Sylvestre MP, 2006, ANN INTERN MED, V145, P361, DOI 10.7326/0003-4819-145-5-200609050-00009; Warden J, 1989, BMJ-BRIT MED J, V298, P909	11	2	2	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 14	2015	351								h6563	10.1136/bmj.h6563	http://dx.doi.org/10.1136/bmj.h6563			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ4KY	26666644	Green Published, hybrid			2022-12-28	WOS:000367073200013
J	Tsai, JW				Tsai, Jessica W.			The MD-Ph.D. double agent	SCIENCE			English	Editorial Material									[Tsai, Jessica W.] Boston Childrens Hosp, Pediat, Boston, MA 02115 USA; [Tsai, Jessica W.] Boston Med Ctr, Boston, MA USA	Harvard University; Boston Children's Hospital; Boston Medical Center	Tsai, JW (corresponding author), Boston Childrens Hosp, Pediat, Boston, MA 02115 USA.	SciCareerEditor@aaas.org		Tsai, Jessica/0000-0003-0540-4330					0	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2015	350	6266					1434	1434		10.1126/science.350.6266.1434	http://dx.doi.org/10.1126/science.350.6266.1434			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY1JL	26659057				2022-12-28	WOS:000366162400047
J	Zolas, N; Goldschlag, N; Jarmin, R; Stephan, P; Owen-Smith, J; Rosen, RF; Allen, BM; Weinberg, BA; Lane, JI				Zolas, Nikolas; Goldschlag, Nathan; Jarmin, Ron; Stephan, Paula; Owen-Smith, Jason; Rosen, Rebecca F.; Allen, Barbara McFadden; Weinberg, Bruce A.; Lane, Julia I.			Wrapping it up in a person: Examining employment and earnings outcomes for Ph.D. recipients	SCIENCE			English	Article							KNOWLEDGE SPILLOVERS	In evaluating research investments, it is important to establish whether the expertise gained by researchers in conducting their projects propagates into the broader economy. For eight universities, it was possible to combine data from the UMETRICS project, which provided administrative records on graduate students supported by funded research, with data from the U.S. Census Bureau. The analysis covers 2010-2012 earnings and placement outcomes of people receiving doctorates in 2009-2011. Almost 40% of supported doctorate recipients, both federally and nonfederally funded, entered industry and, when they did, they disproportionately got jobs at large and high-wage establishments in high-tech and professional service industries. Although Ph.D. recipients spread nationally, there was also geographic clustering in employment near the universities that trained and employed the researchers. We also show large differences across fields in placement outcomes.	[Zolas, Nikolas; Goldschlag, Nathan; Jarmin, Ron; Lane, Julia I.] US Bur Census, Washington, DC 20233 USA; [Stephan, Paula] Georgia State Univ, Dept Econ, Atlanta, GA 30302 USA; [Stephan, Paula; Weinberg, Bruce A.] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Owen-Smith, Jason] Univ Michigan, Ann Arbor, MI 48103 USA; [Rosen, Rebecca F.; Lane, Julia I.] NYU, New York, NY 10012 USA; [Allen, Barbara McFadden] CIC, Champaign, IL 61820 USA; [Weinberg, Bruce A.] Ohio State Univ, Dept Econ, Columbus, OH 43210 USA; [Weinberg, Bruce A.; Lane, Julia I.] Inst Study Labor IZA, D-53113 Bonn, Germany; [Lane, Julia I.] Univ Strasbourg, F-67085 Strasbourg, France; [Lane, Julia I.] Amer Inst Res, Washington, DC 20007 USA	University System of Georgia; Georgia State University; National Bureau of Economic Research; University of Michigan System; University of Michigan; New York University; University System of Ohio; Ohio State University; IZA Institute Labor Economics; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; American Institutes for Research	Weinberg, BA (corresponding author), Ohio State Univ, Dept Econ, 1945 North High St, Columbus, OH 43210 USA.	weinberg.27@osu.edu	Owen-Smith, Jason/B-3665-2012	Weinberg, Bruce/0000-0001-8856-1803; Goldschlag, Nathan/0000-0003-4655-8985; Owen-Smith, Jason/0000-0001-8007-1121; Lane, Julia/0000-0002-8139-2960; Jarmin, Ron/0000-0002-4348-7715; Rosen, Rebecca/0000-0002-0680-6246	NSF SciSIP Awards [1064220, 1262447]; NSF Education and Human Resources Division of Graduate Education Awards [1348691, 1547507, 1348701, 1535399, 1535370]; NSF National Center for Science and Engineering Statistics award [1423706]; NIH [P01AG039347]; Ewing Marion Kauffman Foundation; Alfred P. Sloan Foundation; NATIONAL INSTITUTE ON AGING [P01AG039347] Funding Source: NIH RePORTER; Direct For Biological Sciences [1457350] Funding Source: National Science Foundation; Direct For Education and Human Resources [1547507] Funding Source: National Science Foundation; SBE Off Of Multidisciplinary Activities [1262447] Funding Source: National Science Foundation	NSF SciSIP Awards; NSF Education and Human Resources Division of Graduate Education Awards; NSF National Center for Science and Engineering Statistics award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ewing Marion Kauffman Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Direct For Education and Human Resources(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR)); SBE Off Of Multidisciplinary Activities(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This research was supported by NSF SciSIP Awards 1064220 and 1262447; NSF Education and Human Resources Division of Graduate Education Awards 1348691, 1547507, 1348701, 1535399, and 1535370; NSF National Center for Science and Engineering Statistics award 1423706; NIH P01AG039347; and the Ewing Marion Kauffman and Alfred P. Sloan Foundations. Data were generously provided by the Committee on Institutional Cooperation and its member institutions. We thank W. Cheng, C. Conrad, C. Jones, E. Klochikhin, and J. Tokle for research support; G. Carr, M. Harrison, D. Mayo, M. Sweet, J. Van Horn, and S. Willis for help with data issues; and J. Walsh, R. Weiss, and C. Whitacre for their continuing support. The research agenda draws on work with many coauthors, but particularly work with J. Mairesse and M. Pezzoni. Opinions expressed are those of the authors to do not necessarily represent the views of the Census Bureau.	Becker G. S., 2009, HUMAN CAPITAL THEORE; Cronin B., 2014, SCHOLARLY METRICS MI; Davis SJ, 2009, STUD INCOME, V68, P329; Decker R, 2014, J ECON PERSPECT, V28, P3, DOI 10.1257/jep.28.3.3; Haltiwanger J, 2013, REV ECON STAT, V95, P347, DOI 10.1162/REST_a_00288; JAFFE AB, 1993, Q J ECON, V108, P577, DOI 10.2307/2118401; Jarmin R. S., 2002, 0217 US CENS BUR CTR; Kantor S, 2014, REV ECON STAT, V96, P171, DOI 10.1162/REST_a_00357; Lane J, 2010, NATURE, V464, P488, DOI 10.1038/464488a; Lane JI, 2015, RES POLICY, V44, P1659, DOI 10.1016/j.respol.2014.12.013; Marburger JH, 2005, SCIENCE, V308, P1087, DOI 10.1126/science.1114801; National Science Foundation Committee of Visitors, 2013, BUS R D INN SURV; Sauermann H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036307; Sayer Derek, 2014, GUARDIAN; Shu P., 2015, LONG TERM IMPACT BUS; Stephan P, 2006, INNOV POLICY ECON, V7, P71, DOI 10.1086/ipe.7.25056190; Sumell A.J., 2009, SCI ENG CAREERS US A, P257; Syverson C, 2011, J ECON LIT, V49, P326, DOI 10.1257/jel.49.2.326; Weinberg BA, 2014, SCIENCE, V344, P41, DOI 10.1126/science.1250055; Whittington KB, 2009, ADMIN SCI QUART, V54, P90, DOI 10.2189/asqu.2009.54.1.90	20	44	45	2	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2015	350	6266					1367	1371		10.1126/science.aac5949	http://dx.doi.org/10.1126/science.aac5949			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY1JL	26659054	Green Accepted			2022-12-28	WOS:000366162400040
J	[Anonymous]				[Anonymous]			To the Young Doctors of 1895 (Reprinted from JAMA, vol 24, pg 857, 1895)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		1895, JAMA, V24, P857	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 8	2015	314	22					2422	2422		10.1001/jama.2014.12140	http://dx.doi.org/10.1001/jama.2014.12140			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX8XT	26647273				2022-12-28	WOS:000365989100024
J	Kargel, JS; Leonard, GJ; Shugar, DH; Haritashya, UK; Bevington, A; Fielding, EJ; Fujita, K; Geertsema, M; Miles, ES; Steiner, J; Anderson, E; Bajracharya, S; Bawden, GW; Breashears, DF; Byers, A; Collins, B; Dhital, MR; Donnellan, A; Evans, TL; Geai, ML; Glasscoe, MT; Green, D; Gurung, DR; Heijenk, R; Hilborn, A; Hudnut, K; Huyck, C; Immerzeel, WW; Jiang, LM; Jibson, R; Kaab, A; Khanal, NR; Kirschbaum, D; Kraaijenbrink, PDA; Lamsal, D; Liu, SY; Lv, MY; McKinney, D; Nahirnick, NK; Nan, ZT; Ojha, S; Olsenholler, J; Painter, TH; Pleasants, M; Pratima, KC; Yuan, QI; Raup, BH; Regmi, D; Rounce, DR; Sakai, A; Donghui, S; Shea, JM; Shrestha, AB; Shukla, A; Stumm, D; van der Kooij, M; Voss, K; Xin, W; Weihs, B; Wolfe, D; Wu, LZ; Yao, XJ; Yoder, MR; Young, N				Kargel, J. S.; Leonard, G. J.; Shugar, D. H.; Haritashya, U. K.; Bevington, A.; Fielding, E. J.; Fujita, K.; Geertsema, M.; Miles, E. S.; Steiner, J.; Anderson, E.; Bajracharya, S.; Bawden, G. W.; Breashears, D. F.; Byers, A.; Collins, B.; Dhital, M. R.; Donnellan, A.; Evans, T. L.; Geai, M. L.; Glasscoe, M. T.; Green, D.; Gurung, D. R.; Heijenk, R.; Hilborn, A.; Hudnut, K.; Huyck, C.; Immerzeel, W. W.; Jiang Liming; Jibson, R.; Kaab, A.; Khanal, N. R.; Kirschbaum, D.; Kraaijenbrink, P. D. A.; Lamsal, D.; Liu Shiyin; Lv Mingyang; McKinney, D.; Nahirnick, N. K.; Nan Zhuotong; Ojha, S.; Olsenholler, J.; Painter, T. H.; Pleasants, M.; Pratima, K. C.; Yuan, Q. I.; Raup, B. H.; Regmi, D.; Rounce, D. R.; Sakai, A.; Donghui, Shangguan; Shea, J. M.; Shrestha, A. B.; Shukla, A.; Stumm, D.; van der Kooij, M.; Voss, K.; Xin, Wang; Weihs, B.; Wolfe, D.; Wu Lizong; Yao Xiaojun; Yoder, M. R.; Young, N.			Geomorphic and geologic controls of geohazards induced by Nepal's 2015 Gorkha earthquake	SCIENCE			English	Article							2008 WENCHUAN EARTHQUAKE; INDUCED LANDSLIDES; LARGE ROCKSLIDES; GLACIERS; DISPLACEMENT; TOPOGRAPHY; CALIFORNIA; AFTERSHOCK; MOUNTAINS; HIMALAYAS	The Gorkha earthquake (magnitude 7.8) on 25 April 2015 and later aftershocks struck South Asia, killing similar to 9000 people and damaging a large region. Supported by a large campaign of responsive satellite data acquisitions over the earthquake disaster zone, our team undertook a satellite image survey of the earthquakes' induced geohazards in Nepal and China and an assessment of the geomorphic, tectonic, and lithologic controls on quake-induced landslides. Timely analysis and communication aided response and recovery and informed decision-makers. We mapped 4312 coseismic and postseismic landslides. We also surveyed 491 glacier lakes for earthquake damage but found only nine landslide-impacted lakes and no visible satellite evidence of outbursts. Landslide densities correlate with slope, peak ground acceleration, surface downdrop, and specific metamorphic lithologies and large plutonic intrusions.	[Kargel, J. S.; Leonard, G. J.] Univ Arizona, Dept Hydrol & Water Resources, Tucson, AZ 85721 USA; [Shugar, D. H.] Univ Washington, Sch Interdisciplinary Arts & Sci, Tacoma, WA USA; [Haritashya, U. K.; Pleasants, M.] Univ Dayton, Dept Geol, Dayton, OH 45469 USA; [Bevington, A.; Geertsema, M.; Heijenk, R.] Minist Forests Lands & Nat Resource Operat, Prince George, BC, Canada; [Fielding, E. J.; Donnellan, A.; Glasscoe, M. T.; Lamsal, D.; Ojha, S.; Painter, T. H.] CALTECH, Jet Prop Lab, Pasadena, CA USA; [Fujita, K.; Sakai, A.] Nagoya Univ, Grad Sch Environm Studies, Nagoya, Aichi 4648601, Japan; [Miles, E. S.] Univ Cambridge, Scott Polar Res Inst, Cambridge CB2 1ER, England; [Steiner, J.] Fed Inst Technol ETH, Inst Environm Engn, Zurich, Switzerland; [Anderson, E.] NASA, George C Marshall Space Flight Ctr, Huntsville, AL 35812 USA; [Bajracharya, S.; Gurung, D. R.; Khanal, N. R.; Shea, J. M.; Shrestha, A. B.; Stumm, D.] Int Ctr Integrated Mt Dev, Kathmandu, Nepal; [Bawden, G. W.; Green, D.] NASA Headquarters, Washington, DC USA; [Breashears, D. F.] GlacierWorks, Marblehead, MA USA; [Byers, A.] Mt Inst, Elkins, WV USA; [Collins, B.] US Geol Survey, Menlo Pk, CA 94025 USA; [Dhital, M. R.] Tribhuvan Univ, Cent Dept Geol, Kathmandu, Nepal; [Evans, T. L.; Hilborn, A.; Nahirnick, N. K.] Univ Victoria, Dept Geog, Victoria, BC, Canada; [Geai, M. L.] CVA Engn, Suresnes, France; [Hudnut, K.] US Geol Survey, Earthquake Sci Ctr, Pasadena, CA 91106 USA; [Huyck, C.] ImageCat, Long Beach, CA USA; [Immerzeel, W. W.; Kraaijenbrink, P. D. A.] Univ Utrecht, Fac Geosci, Utrecht, Netherlands; [Jiang Liming] Chinese Acad Sci, Inst Geodesy & Geophys, State Key Lab Geodesy & Earths Dynam, Wuhan, Hubei Province, Peoples R China; [Jibson, R.] US Geol Survey, Golden, CO USA; [Kaab, A.] Univ Oslo, Dept Geosci, Oslo, Norway; [Kirschbaum, D.] NASA, Goddard Space Flight Ctr, Hydrol Sci Lab, Greenbelt, MD 20771 USA; [Liu Shiyin; Yuan, Q. I.; Donghui, Shangguan] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Lanzhou, Peoples R China; [Lv Mingyang; Wu Lizong] Nanjing Univ, Sch Earth Sci & Engn, Nanjing 210008, Jiangsu, Peoples R China; [McKinney, D.] Univ Texas Austin, Dept Civil Architectural & Environm Engn, Austin, TX 78712 USA; [Nan Zhuotong] Nanjing Normal Univ, Sch Geog Sci, Nanjing, Jiangsu, Peoples R China; [Olsenholler, J.] Texas A&M Univ, Dept Geog, College Stn, TX USA; [Pratima, K. C.] Univ Arizona, Sch Nat Resources & Environm, Arizona Remote Sensing Ctr, Tucson, AZ USA; [Raup, B. H.] Univ Colorado, Natl Snow & Ice Data Ctr, Boulder, CO 80309 USA; [Regmi, D.] Himalayan Res Ctr, Kathmandu, Nepal; [Rounce, D. R.] Univ Texas Austin, Environm & Water Resources Engn, Austin, TX 78712 USA; [Shukla, A.] Wadia Inst Himalayan Geol, Dehra Dun, India; [Shukla, A.; van der Kooij, M.] MacDonald Dettwiler & Associates GSI, Ottawa, ON, Canada; [Voss, K.] Univ Calif Santa Barbara, Dept Geog, Santa Barbara, CA 93106 USA; [Xin, Wang] Hunan Univ Sci & Technol, Coll Architecture & Urban Planning, Xiangtan, Peoples R China; [Weihs, B.] Kansas State Univ, Dept Geog, Manhattan, KS 66506 USA; [Wolfe, D.] Global Land Ice Measurements Space GLIMS Steward, Anchorage, AK USA; [Yao Xiaojun] Northwest Normal Univ, Coll Geog Sci & Environm, Beijing, Peoples R China; [Yoder, M. R.] Univ Calif Davis, Dept Phys, Davis, CA 95616 USA; [Young, N.] Univ Tasmania, Antarctic Climate & Ecosyst Cooperat Res Ctr, Hobart, Tas, Australia	University of Arizona; University of Washington; University of Washington Tacoma; University of Dayton; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Nagoya University; University of Cambridge; Swiss Federal Institutes of Technology Domain; ETH Zurich; National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; National Aeronautics & Space Administration (NASA); United States Department of the Interior; United States Geological Survey; Tribhuvan University; University of Victoria; United States Department of the Interior; United States Geological Survey; Utrecht University; Chinese Academy of Sciences; Institute of Geodesy & Geophysics, CAS; United States Department of the Interior; United States Geological Survey; University of Oslo; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; Nanjing University; University of Texas System; University of Texas Austin; Nanjing Normal University; Texas A&M University System; Texas A&M University College Station; University of Arizona; University of Colorado System; University of Colorado Boulder; University of Texas System; University of Texas Austin; Department of Science & Technology (India); Wadia Institute of Himalayan Geology (WIHG); University of California System; University of California Santa Barbara; Hunan University of Science & Technology; Kansas State University; University of California System; University of California Davis; Antarctic Climate & Ecosystems Cooperative Research Centre (ACE CRC); University of Tasmania	Kargel, JS (corresponding author), Univ Arizona, Dept Hydrol & Water Resources, Tucson, AZ 85721 USA.	kargel@hwr.arizona.edu; dshugar@uw.edu; uharitashya1@udayton.edu	Liu, Shiyin/AAT-4278-2020; Weihs, Brandon/GZH-2856-2022; Hudnut, Kenneth W/B-1945-2009; Painter, Thomas/B-7806-2016; Lv, Mingyang/AAZ-7579-2021; Painter, Thomas H./AAC-9493-2019; Fielding, Eric Jameson/A-1288-2007; Kirschbaum, Dalia/F-9596-2012; Bevington, Alexandre R/AAD-1233-2022; Fielding, Eric/L-8187-2019; Hudnut, Kenneth W/AAB-4549-2020; Fujita, Koji/E-6104-2010; Donnellan, Andrea/AAB-4367-2020; Sakai, Akiko/M-5413-2013; Kääb, Andreas/AAG-8769-2020; Miles, Evan/J-1286-2019; Painter, Thomas/P-1284-2019; NAN, ZHUOTONG/D-7518-2018	Hudnut, Kenneth W/0000-0002-3168-4797; Painter, Thomas H./0000-0002-7963-5812; Fielding, Eric Jameson/0000-0002-6648-8067; Kirschbaum, Dalia/0000-0001-5547-2839; Bevington, Alexandre R/0000-0002-9249-4444; Fielding, Eric/0000-0002-6648-8067; Hudnut, Kenneth W/0000-0002-3168-4797; Fujita, Koji/0000-0003-3753-4981; Donnellan, Andrea/0000-0001-6843-8373; Sakai, Akiko/0000-0002-6320-6212; Kääb, Andreas/0000-0002-6017-6564; Miles, Evan/0000-0001-5446-8571; NAN, ZHUOTONG/0000-0002-7930-3850; Haritashya, Umesh/0000-0001-9527-954X; Shea, Joseph/0000-0002-4557-1283; Pleasants, Mark/0000-0002-9864-5282; Anderson, Eric/0000-0001-5056-4347; Kraaijenbrink, Philip/0000-0002-0126-8602; Heijenk, Renee/0000-0002-7073-913X; Voss, Katalyn/0000-0001-8946-8213; Steiner, Jakob/0000-0002-0063-0067; Immerzeel, Walter/0000-0002-2010-9543; Shugar, Dan/0000-0002-6279-8420; Xiaojun, Yao/0000-0003-3127-9473	NASA SERVIR Applied Science Team; NASA Cryosphere Program; Hakai Institute; NASA; ICIMOD; Chinese Academy of Sciences [784]; National Natural Science Foundation of China [41431070, 41321063]; ICER [1516912] Funding Source: National Science Foundation; Grants-in-Aid for Scientific Research [26257202] Funding Source: KAKEN	NASA SERVIR Applied Science Team; NASA Cryosphere Program; Hakai Institute; NASA(National Aeronautics & Space Administration (NASA)); ICIMOD; Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); ICER(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	J.S.K., G.J.L., and U.K.H. thank the NASA SERVIR Applied Science Team and NASA Cryosphere Program for support. D.H.S. thanks the Hakai Institute for support. Part of this research was sponsored by the NASA Earth Surface and Interior focus area and performed at the Jet Propulsion Laboratory, California Institute of Technology. We gratefully acknowledge support from several "citizen scientists" who provided key observations and reports from various locations in Nepal: D. Rai, J.B. Rai, N. Sapkota, M. Dhan Rai, and M. Gotame, who made on-site inspections and photo documentation of Thulagi (Dona) Lake, Rolpa Lake, Kali Gandaki, and "Lower Pisang" landslide dammed lake. ASTER data are courtesy of NASA/GSFC/METI/Japan Space Systems, the U.S./Japan ASTER Science Team, and GLIMS. We especially laud DigitalGlobe's decision to acquire and make available a vast volume of data for analysis related to Gorkha earthquake response. We thank C. Liang for processing the ALOS-2 wide-swath interferogram. Original ALOS-2 data are copyright 2015 JAXA. This study was partially supported by core funds of ICIMOD contributed by the governments of Afghanistan, Australia, Austria, Bangladesh, Bhutan, China, India, Myanmar, Nepal, Norway, Pakistan, Switzerland, and the United Kingdom. This study was partially supported by the Hundred Talents Program of the Chinese Academy of Sciences (grant 784) and the National Natural Science Foundation of China (grants 41431070 and 41321063). The two chief databases produced by this work are available at ICIMOD (landslides, http://rds.icimod.org/Home/DataDetail?metadataId=24055; and glacial lakes, http://rds.icimod.org/Home/DataDetail?metadataId=24065).	[Anonymous], 2000, GLOBAL LAND ICE MEAS; Arendt A., 2014, RANDOLPH GLACIER INV; Blatter H, 1998, J GLACIOL, V44, P457, DOI 10.3189/S0022143000001970; Bo N., 1998, SLIDING ICE SNOW PHY, P391; British Geological Survey, 2015, NEP EARTHQ RESP 2015; Byers A. C., 2015, POSTEARTHQUAKE ASSES; Cadwalladr Carole, 2015, GUARDIAN; Carey M, 2005, GLOBAL PLANET CHANGE, V47, P122, DOI 10.1016/j.gloplacha.2004.10.007; Cecchine G., 2013, US MILITARY RESPONSE; Chen LW, 2009, EARTHQ ENG ENG VIB, V8, P219, DOI 10.1007/s11803-009-9033-4; Chou H. T., 2013, EARTHQ IND LANDSL P, P45; Clague JJ, 2000, QUATERNARY SCI REV, V19, P1763, DOI 10.1016/S0277-3791(00)00090-1; Collins BD, 2015, US GEOL SURV OPEN FI; Dai FC, 2011, J ASIAN EARTH SCI, V40, P883, DOI 10.1016/j.jseaes.2010.04.010; Deline P., 2015, SNOW ICE RELATED HAZ, P521, DOI [10.1016/B978-0-12-394849-6.00015-9, DOI 10.1016/B978-0-12-394849-6.00015-9]; Dhital M. R., 2015, GEOLOGY NEPAL HIMALA, DOI 10.1007/978-3-319-02496-7; Dunning SA, 2006, LANDSLIDES, V3, P107, DOI 10.1007/s10346-005-0032-x; Evans SG, 2009, GEOMORPHOLOGY, V105, P314, DOI 10.1016/j.geomorph.2008.10.008; Fujita K, 2013, NAT HAZARD EARTH SYS, V13, P1827, DOI 10.5194/nhess-13-1827-2013; Fujita K, 2011, P NATL ACAD SCI USA, V108, P14011, DOI 10.1073/pnas.1106242108; Galetzka J, 2015, SCIENCE, V349, P1091, DOI 10.1126/science.aac6383; Geertsema M., 2013, TREATISE GEOMORPHOLO, V7, P217, DOI [10.1016/B978-0-12-374739-6.00168-8, DOI 10.1016/B978-0-12-374739-6.00168-8]; Geertsema M., 2011, INNOVATIONS, V15, P17; Haeberli W, 2004, J GLACIOL, V50, P533, DOI 10.3189/172756504781829710; Harp E.L., 2003, GSA TODAY, V13, P4, DOI [DOI 10.1130/1052-5173(2003)013<0004:, 10.1130/1052-5173(2003)0132.0.co;2, DOI 10.1130/1052-5173(2003)0132.0.CO;2]; Harp EL, 2011, ENG GEOL, V122, P9, DOI 10.1016/j.enggeo.2010.06.013; Harp EL, 1996, B SEISMOL SOC AM, V86, pS319; Hewitt K, 2006, PROG PHYS GEOG, V30, P365, DOI 10.1191/0309133306pp486ra; ICIMOD, 2011, GLAC LAK GLAC LAK OU, P99; Immerzeel WW, 2014, WATER RESOUR RES, V50, P2212, DOI 10.1002/2013WR014506; Jaiswal K, 2011, EARTHQ SPECTRA, V27, P775, DOI 10.1193/1.3606398; Jarvis A, 2008, HOLE FILLED SEAMLESS; Jibson R. W., 2011, FIELD RECONNAISSANCE; Jibson RW, 2004, EARTHQ SPECTRA, V20, P669, DOI 10.1193/1.1778173; Kargel J.S., 2010, EOS, V91, P394, DOI DOI 10.1029/2010EO430002; Keefer DK, 2002, SURV GEOPHYS, V23, P473, DOI 10.1023/A:1021274710840; Lee SJ, 2009, B SEISMOL SOC AM, V99, P314, DOI 10.1785/0120080020; Liang C., 2015, INTERFEROGRAM ALOS2, DOI [10.7283/S2KW2R, DOI 10.7283/S2KW2R]; Lindsey EO, 2015, GEOPHYS RES LETT, V42, P6655, DOI 10.1002/2015GL065385; Ma S, 2007, B SEISMOL SOC AM, V97, P2066, DOI 10.1785/0120070040; McCalpin J. P., 2002, RIDGE TOP SPREADING; Meunier P, 2008, EARTH PLANET SC LETT, V275, P221, DOI 10.1016/j.epsl.2008.07.020; Moore PL, 2009, ANN GLACIOL, V50, P1, DOI 10.3189/172756409789624319; Nason R. D., 1971, SAN FERNANDO CALIFOR, P97; OGATA Y, 1988, J AM STAT ASSOC, V83, P9, DOI 10.1080/01621459.1988.10478560; Parameswaran RM, 2015, J ASIAN EARTH SCI, V111, P161, DOI 10.1016/j.jseaes.2015.07.030; Parker RN, 2015, EARTH SURF DYNAM, V3, P501, DOI 10.5194/esurf-3-501-2015; Parker RN, 2011, NAT GEOSCI, V4, P449, DOI [10.1038/NGEO1154, 10.1038/ngeo1154]; Ragettli S, 2015, ADV WATER RESOUR, V78, P94, DOI 10.1016/j.advwatres.2015.01.013; Sato HP, 2009, LANDSLIDES, V6, P153, DOI 10.1007/s10346-009-0147-6; Schwanghart W, 2016, SCIENCE, V351, P147, DOI 10.1126/science.aac9865; Shugar DH, 2012, J GEOPHYS RES-EARTH, V117, DOI 10.1029/2011JF002011; Shugar DH, 2011, SEDIMENTOLOGY, V58, P1762, DOI 10.1111/j.1365-3091.2011.01238.x; STOCKLIN J, 1980, J GEOL SOC LONDON, V137, P1, DOI 10.1144/gsjgs.137.1.0001; van Aardt JAN, 2011, PHOTOGRAMM ENG REM S, V77, P943, DOI 10.14358/PERS.77.9.943; Vilimek V, 2005, LANDSLIDES, V2, P107, DOI 10.1007/s10346-005-0052-6; Walsh LS, 2012, J GEOPHYS RES-EARTH, V117, DOI 10.1029/2011JF001984; Weidinger J. T., 2011, LECT NOTEEARTH SCI, P243; Weidinger JT, 2006, ENG GEOL, V83, P201, DOI 10.1016/j.enggeo.2005.06.032; Xu C, 2015, GEOMORPHOLOGY, V248, P77, DOI 10.1016/j.geomorph.2015.07.002; Xu C, 2014, LANDSLIDES, V11, P441, DOI 10.1007/s10346-013-0404-6; Yuan RM, 2013, B SEISMOL SOC AM, V103, P2344, DOI 10.1785/0120110233	62	250	267	29	322	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 8	2016	351	6269							aac8353	10.1126/science.aac8353	http://dx.doi.org/10.1126/science.aac8353			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XQ	26676355	Green Published			2022-12-28	WOS:000367806500032
J	Smith, JM				Smith, Jeanette M.			Christmas Night (The Blessing of the Oxen)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 29	2015	314	24					2602	2603		10.1001/jama.2014.12161	http://dx.doi.org/10.1001/jama.2014.12161			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ2MR	26720013				2022-12-28	WOS:000366939800001
J	Masood, E				Masood, Ehsan			Maurice Strong (1929-2015) OBITUARY	NATURE			English	Biographical-Item												ehsan.masood@researchresearch.com						STRONG M, PUBLICATION LIST	1	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2015	528	7583					480	480		10.1038/528480a	http://dx.doi.org/10.1038/528480a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ3GH	26701047	Bronze			2022-12-28	WOS:000366991900033
J	Sitbon, O; Channick, R; Chin, KM; Frey, A; Gaine, S; Galie, N; Ghofrani, HA; Hoeper, MM; Lang, IM; Preiss, R; Rubin, LJ; Di Scala, L; Tapson, V; Adzerikho, I; Liu, JM; Moiseeva, O; Zeng, XF; Simonneau, G; McLaughlin, VV				Sitbon, Olivier; Channick, Richard; Chin, Kelly M.; Frey, Aline; Gaine, Sean; Galie, Nazzareno; Ghofrani, Hossein-Ardeschir; Hoeper, Marius M.; Lang, Irene M.; Preiss, Ralph; Rubin, Lewis J.; Di Scala, Lilla; Tapson, Victor; Adzerikho, Igor; Liu, Jinming; Moiseeva, Olga; Zeng, Xiaofeng; Simonneau, Gerald; McLaughlin, Vallerie V.		GRIPHON Investigators	Selexipag for the Treatment of Pulmonary Arterial Hypertension	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROSTACYCLIN RECEPTOR AGONIST; 5 INHIBITOR THERAPY; ORAL TREPROSTINIL; DIAGNOSIS; MANAGEMENT; ANTAGONIST; SURVIVAL; TIME	BACKGROUND In a phase 2 trial, selexipag, an oral selective IP prostacyclin-receptor agonist, was shown to be beneficial in the treatment of pulmonary arterial hypertension. METHODS In this event-driven, phase 3, randomized, double-blind, placebo-controlled trial, we randomly assigned 1156 patients with pulmonary arterial hypertension to receive placebo or selexipag in individualized doses (maximum dose, 1600 mu g twice daily). Patients were eligible for enrollment if they were not receiving treatment for pulmonary arterial hypertension or if they were receiving a stable dose of an endothelin-receptor antagonist, a phosphodiesterase type 5 inhibitor, or both. The primary end point was a composite of death from any cause or a complication related to pulmonary arterial hypertension up to the end of the treatment period (defined for each patient as 7 days after the date of the last intake of selexipag or placebo). RESULTS A primary end-point event occurred in 397 patients -41.6% of those in the placebo group and 27.0% of those in the selexipag group (hazard ratio in the selexipag group as compared with the placebo group, 0.60; 99% confidence interval, 0.46 to 0.78; P< 0.001). Disease progression and hospitalization accounted for 81.9% of the events. The effect of selexipag with respect to the primary end point was similar in the subgroup of patients who were not receiving treatment for the disease at baseline and in the subgroup of patients who were already receiving treatment at baseline (including those who were receiving a combination of two therapies). By the end of the study, 105 patients in the placebo group and 100 patients in the selexipag group had died from any cause. Overall, 7.1% of patients in the placebo group and 14.3% of patients in the selexipag group discontinued their assigned regimen prematurely because of adverse events. The most common adverse events in the selexipag group were consistent with the known side effects of prostacyclin, including headache, diarrhea, nausea, and jaw pain. CONCLUSIONS Among patients with pulmonary arterial hypertension, the risk of the primary composite end point of death or a complication related to pulmonary arterial hypertension was significantly lower with selexipag than with placebo. There was no significant difference in mortality between the two study groups. (Funded by Actelion Pharmaceuticals; GRIPHON ClinicalTrials.gov number, NCT01106014.)	[Sitbon, Olivier; Simonneau, Gerald] Univ Paris Saclay, Univ Paris Sud, INSERM, Unite Mixte Rech Sante 999,Hop Bicetre,AP HP, Le Kremlin Bicetre, France; [Channick, Richard] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Chin, Kelly M.] UT Southwestern Med Ctr, Dallas, TX USA; [Frey, Aline; Preiss, Ralph; Di Scala, Lilla] Actel Pharmaceut, Allschwil, Switzerland; [Gaine, Sean] Mater Misericordiae Univ Hosp, Natl Pulm Hypertens Unit, Dublin, Ireland; [Galie, Nazzareno] Univ Bologna, Dept Expt Diagnost & Specialty Med DIMES, Bologna, Italy; [Ghofrani, Hossein-Ardeschir] Univ Giessen, D-35390 Giessen, Germany; [Ghofrani, Hossein-Ardeschir] German Ctr Lung Res, Marburg Lung Ctr, Giessen, Germany; [Hoeper, Marius M.] Hannover Med Sch, Dept Resp Med, Hannover, Germany; [Hoeper, Marius M.] German Ctr Lung Res, Hannover, Germany; [Ghofrani, Hossein-Ardeschir] Univ London Imperial Coll Sci Technol & Med, Dept Med, London SW7 2AZ, England; [Lang, Irene M.] Med Univ Vienna, Dept Internal Med 2, Div Cardiol, Allgemeines Krankenhaus, Vienna, Austria; [Rubin, Lewis J.] Univ Calif San Diego, Div Pulm & Crit Care Med, San Diego, CA 92103 USA; [Tapson, Victor] Cedars Sinai Med Ctr, Div Pulm & Crit Care Med, Los Angeles, CA 90048 USA; [Adzerikho, Igor] Minsk Reg Clin Hosp, Minsk, BELARUS; [Liu, Jinming] Shanghai Pulm Hosp, Dept Pulm Circulat, Shanghai, Peoples R China; [Zeng, Xiaofeng] Peking Union Med Coll Hosp, Dept Rheumatol, Beijing, Peoples R China; [Moiseeva, Olga] Fed Almazov North West Med Res Ctr, St Petersburg, Russia; [McLaughlin, Vallerie V.] Univ Michigan Hlth Syst, Div Cardiovasc Med, Dept Internal Med, Ann Arbor, MI USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Harvard University; Massachusetts General Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas; Actelion Pharmaceuticals Ltd; Mater Misericordiae University Hospital; University College Dublin; University of Bologna; Justus Liebig University Giessen; Hannover Medical School; Imperial College London; Medical University of Vienna; University of California System; University of California San Diego; Cedars Sinai Medical Center; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Almazov National Medical Research Centre; University of Michigan System; University of Michigan	Sitbon, O (corresponding author), CHU Bicetre, Serv Pneumol & Soins Intensifs, 78 Rue Gen Leclerc, F-94275 Le Kremlin Bicetre, France.	olivier.sitbon@bct.aphp.fr	HACHULLA, ERIC/R-8488-2018; Evtushenko, Alexey/H-8346-2014; Chazova, Irina/B-8688-2017; Ghofrani, Hossein Ardeschir/AAD-2856-2022; Schulman, Sam/I-7559-2019; Simonneau, Gerald/ABE-6614-2020; Hoeper, Marius C/Z-1546-2019; Sitbon, Olivier/I-3623-2019; Ghofrani, Ardeschir/AAD-5293-2020; Austin, Eric Douglas/A-6070-2013; Moiseeva, Olga/AAN-1762-2020; Evtushenko, Alexey/J-4544-2017; Söderberg, Stefan/AAG-3881-2019	HACHULLA, ERIC/0000-0001-7432-847X; Evtushenko, Alexey/0000-0002-0519-783X; Chazova, Irina/0000-0002-9822-4357; Schulman, Sam/0000-0002-8512-9043; Hoeper, Marius C/0000-0001-9086-2293; Sitbon, Olivier/0000-0002-1942-1951; Ghofrani, Ardeschir/0000-0002-2029-4419; Austin, Eric Douglas/0000-0002-1709-9022; Moiseeva, Olga/0000-0002-7817-3847; Evtushenko, Alexey/0000-0001-8475-4667; Söderberg, Stefan/0000-0001-9225-1306; Hubbert, Laila/0000-0002-6578-8826; Adzeriho, Igor'/0000-0001-6572-8842; Lang, Irene/0000-0003-0485-2692; Gaine, Sean/0000-0002-5941-684X; sharma, kamal/0000-0001-5866-2566; Chin, Kelly/0000-0002-1214-6723; Brutsche, Martin/0000-0002-1612-3609; JAIS, XAVIER/0000-0002-4104-7994; Olschewski, Horst/0000-0002-2834-7466; Williams, Paul Graham/0000-0001-7940-8081	Actelion Pharmaceuticals; Actelion; GlaxoSmithKline; Bayer; Pfizer; United Therapeutics; Gilead Sciences; GeNO; Daiichi Sankyo; Novartis; Daiichi-Sankyo; Merck; Arena; Lung Biotechnology; Janssen; Eli Lilly; Ikaria	Actelion Pharmaceuticals; Actelion; GlaxoSmithKline(GlaxoSmithKline); Bayer(Bayer AG); Pfizer(Pfizer); United Therapeutics; Gilead Sciences(Gilead Sciences); GeNO; Daiichi Sankyo(Daiichi Sankyo Company Limited); Novartis(Novartis); Daiichi-Sankyo(Daiichi Sankyo Company Limited); Merck(Merck & Company); Arena(Australian Renewable Energy Agency (ARENA)); Lung Biotechnology; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Eli Lilly(Eli Lilly); Ikaria	Supported by Actelion Pharmaceuticals.; Dr. Sitbon reports receiving fees for serving on a steering committee from Actelion, fees for writing assistance from Actelion and GlaxoSmithKline, consulting and lecture fees from Actelion, Bayer, GlaxoSmithKline, Pfizer, and United Therapeutics, and fees for serving on advisory boards and grant support from Actelion, Bayer, GlaxoSmithKline, and Pfizer; Dr. Channick, receiving fees for serving on advisory boards from Bayer and Actelion, consulting fees from Bayer, and grant support from United Therapeutics and Actelion; Dr. Chin, receiving consulting fees from Actelion, Bayer, and Gilead Sciences and grant support from Actelion, Gilead Sciences, and GeNO; Dr. Frey, Dr. Preiss, and Dr. Di Scalla, being employees of Actelion; Dr. Gaine, receiving fees for serving on advisory boards from Bayer, Actelion, Novartis, Pfizer, and Daiichi Sankyo, fees for serving on data and safety monitoring boards from GlaxoSmithKline, United Therapeutics, and Novartis, fees for serving on a steering committee from Actelion, lecture fees from Bayer, GlaxoSmithKline, United Therapeutics, and Actelion, and travel support from Bayer, GlaxoSmithKline, Actelion, Novartis, and Daiichi-Sankyo; Dr. Galie, receiving personal fees and grant support from Actelion, Bayer, GlaxoSmithKline, and Pfizer; Dr. Ghofrani, receiving fees for serving on steering committees from Bayer, Gilead Sciences, GlaxoSmithKline, Merck, Novartis, and Pfizer, consulting fees from Actelion, Bayer, Gilead Sciences, GlaxoSmithKline, Merck, Novartis, and Pfizer, lecture fees from Actelion, Bayer, GlaxoSmithKline, Novartis, and Pfizer, and grant support from Actelion, Bayer, Novartis, and Pfizer; Dr. Hoeper, receiving consulting and lecture fees from Pfizer, Bayer, and GlaxoSmithKline; Dr. Lang, receiving fees for serving on a data and safety monitoring board from Novartis, lecture fees from Actelion, Bayer, GlaxoSmithKline, and United Therapeutics, and grant support from Actelion, Bayer, and United Therapeutics; Dr. Rubin, receiving fees for serving on an advisory board from United Therapeutics and consulting fees and travel support from Actelion, Arena, GeNO, Lung Biotechnology, Gilead Sciences, and United Therapeutics; Dr. Tapson, receiving fees for serving on steering committees from Actelion, Bayer, and United Therapeutics, consulting fees from Actelion, Gilead Sciences, Bayer, Daiichi Sankyo, and Janssen, lecture fees from Gilead Sciences and Janssen, and grant support from Actelion, Bayer, United Therapeutics, and Janssen; Dr. Moiseeva, receiving lecture fees and grant support from Actelion and Bayer; Dr. Zeng, receiving grant and travel support and study drugs and equipment from Actelion; Dr. Simonneau, receiving consulting fees, lecture fees, and travel support from Actelion, Bayer, Eli Lilly, GlaxoSmithKline, Novartis, and Pfizer, and grant support from Actelion and Bayer; and Dr. McLaughlin, receiving fees for serving on advisory boards and steering committees, consulting fees, and travel support from Bayer, Gilead Sciences, United Therapeutics, Actelion, and Ikaria, and grant support from Bayer, Actelion, Ikaria, and Novartis. No other potential conflict of interest relevant to this article was reported.	Barst RJ, 1996, NEW ENGL J MED, V334, P296, DOI 10.1056/NEJM199602013340504; Benza RL, 2012, CHEST, V142, P448, DOI 10.1378/chest.11-1460; Cuzick J, 2005, LANCET, V365, P1308, DOI 10.1016/S0140-6736(05)61026-4; Farber HW, 2013, J HEART LUNG TRANSPL, V32, P1114, DOI 10.1016/j.healun.2013.08.010; Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317; Galie N, 2013, J AM COLL CARDIOL, V62, pD60, DOI 10.1016/j.jacc.2013.10.031; Galie N, 2009, CIRCULATION, V119, P2894, DOI 10.1161/CIRCULATIONAHA.108.839274; Ghofrani HA, 2013, NEW ENGL J MED, V369, P319, DOI 10.1056/NEJMoa1209657; Humbert M, 2010, CIRCULATION, V122, P156, DOI 10.1161/CIRCULATIONAHA.109.911818; Kuwano K, 2008, J PHARMACOL EXP THER, V326, P691, DOI 10.1124/jpet.108.138305; Kuwano K, 2007, J PHARMACOL EXP THER, V322, P1181, DOI 10.1124/jpet.107.124248; McLaughlin VV, 2006, AM J RESP CRIT CARE, V174, P1257, DOI 10.1164/rccm.200603-358OC; McLaughlin VV, 2013, CLIN CHEST MED, V34, P825, DOI 10.1016/j.ccm.2013.09.003; McLaughlin VV, 2013, CHEST, V143, P324, DOI 10.1378/chest.11-3060; McLaughlin VV, 2010, J AM COLL CARDIOL, V55, P1915, DOI 10.1016/j.jacc.2010.01.027; McLaughlin VV, 2009, J AM COLL CARDIOL, V54, pS97, DOI 10.1016/j.jacc.2009.04.007; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; Morrison K, 2012, J PHARMACOL EXP THER, V343, P547, DOI 10.1124/jpet.112.197152; Morrison K, 2010, J PHARMACOL EXP THER, V335, P249, DOI 10.1124/jpet.110.169748; Pulido T, 2013, NEW ENGL J MED, V369, P809, DOI 10.1056/NEJMoa1213917; Rajkumar R, 2010, AM J PHYSIOL-HEART C, V298, pH1235, DOI 10.1152/ajpheart.00254.2009; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Simonneau G, 2012, EUR RESPIR J, V40, P874, DOI 10.1183/09031936.00137511; Tapson VE, 2012, CHEST, V142, P1383, DOI 10.1378/chest.11-2212; Tapson VF, 2013, CHEST, V144, P952, DOI 10.1378/chest.12-2875	25	525	562	4	88	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 24	2015	373	26					2522	2533		10.1056/NEJMoa1503184	http://dx.doi.org/10.1056/NEJMoa1503184			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ7SG	26699168	Green Published			2022-12-28	WOS:000367299700008
J	Carrillo, RA; Ozkan, E; Menon, KP; Nagarkar-Jaiswal, S; Lee, PT; Jeon, M; Birnbaum, ME; Bellen, HJ; Garcia, KC; Zinn, K				Carrillo, Robert A.; Oezkan, Engin; Menon, Kaushiki P.; Nagarkar-Jaiswal, Sonal; Lee, Pei-Tseng; Jeon, Mili; Birnbaum, Michael E.; Bellen, Hugo J.; Garcia, K. Christopher; Zinn, Kai			Control of Synaptic Connectivity by a Network of Drosophila IgSF Cell Surface Proteins	CELL			English	Article							SPECTRAL PREFERENCE; RECEPTOR; GROWTH; CIRCUIT; IMMUNOGLOBULIN; MELANOGASTER; SPECIFICITY; SURVIVAL; SIGNALS; SCREEN	We have defined a network of interacting Drosophila cell surface proteins in which a 21-member IgSF subfamily, the Dprs, binds to a nine-member subfamily, the DIPs. The structural basis of the Dpr-DIP interaction code appears to be dictated by shape complementarity within the Dpr-DIP binding interface. Each of the six dpr and DIP genes examined here is expressed by a unique subset of larval and pupal neurons. In the neuromuscular system, interactions between Dpr11 and DIP-gamma affect presynaptic terminal development, trophic factor responses, and neurotransmission. In the visual system, dpr11 is selectively expressed by R7 photoreceptors that use Rh4 opsin (yR7s). Their primary synaptic targets, Dm8 amacrine neurons, express DIP-gamma. In dpr11 or DIP-gamma mutants, yR7 terminals extend beyond their normal termination zones in layer M6 of the medulla. DIP-gamma is also required for Dm8 survival or differentiation. Our findings suggest that Dpr-DIP interactions are important determinants of synaptic connectivity.	[Carrillo, Robert A.; Menon, Kaushiki P.; Jeon, Mili; Zinn, Kai] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Oezkan, Engin] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Nagarkar-Jaiswal, Sonal; Lee, Pei-Tseng; Bellen, Hugo J.] Baylor Coll Med, Jan & Dan Duncan Neurol Res Inst, Howard Hughes Med Inst, Dept Mol & Human Genet,Program Dev Biol,TCH, Houston, TX 77030 USA; [Oezkan, Engin; Jeon, Mili; Birnbaum, Michael E.; Garcia, K. Christopher] Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Oezkan, Engin; Jeon, Mili; Birnbaum, Michael E.; Garcia, K. Christopher] Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Biol Struct, Stanford, CA 94305 USA	California Institute of Technology; University of Chicago; Baylor College of Medicine; Howard Hughes Medical Institute; Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University	Ozkan, E (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA.	eozkan@uchicago.edu; zinnk@caltech.edu		Carrillo, Robert/0000-0002-2067-9861; Bellen, Hugo/0000-0001-5992-5989; Ozkan, Engin/0000-0002-0263-6729; Birnbaum, Michael/0000-0002-2281-3518	NIH RO1 grant [NS62821]; NIH R37 grant [NS28182]; Howard Hughes Medical Institute (HHMI); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; NIH, NIGMS [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067858, P41GM103393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS028182, R01NS062821, R01NS028182] Funding Source: NIH RePORTER	NIH RO1 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH R37 grant; Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Maximilien Courgeon, Claude Desplan, and Takashi Suzuki for advice on OL experiments, Takashi Suzuki for Rh4 > Brp-short<SUP>mCherry</SUP>, Chihon Lee for Dm8 and Tm5a/b GAL4 drivers, Elizabeth Gavis for UAS-CD4-tdTomato, and the Bloomington Drosophila Stock Center (BDSC) for other lines. We thank Larry Zipursky and Liming Tan for discussions and communication of data before publication. We thank Alexander Borst and Namrata Bali for discussions; Elena Armand, Suzanne Fischer, Deepa Waghray, and Kelsey Carter for technical assistance; and Violana Nesterova for help with Figure 5A. This work was supported by NIH RO1 grant NS62821 and R37 grant NS28182 to K.Z. and by the Howard Hughes Medical Institute (HHMI) (H.J.B. and K.C.G. labs). Stanford Synchrotron Radiation Lightsource beamlines 11-1 and 12-2 at SLAC National Accelerator Lab are supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences (DE-AC02-76SF00515). The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by the NIH, NIGMS (including P41GM103393).	Berger-Muller S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083732; Carrillo RA, 2010, NEURON, V68, P32, DOI 10.1016/j.neuron.2010.09.005; Dong XH, 2006, J BIOL CHEM, V281, P10610, DOI 10.1074/jbc.M513459200; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; Fouquet W, 2009, J CELL BIOL, V186, P129, DOI 10.1083/jcb.200812150; Gao SY, 2008, NEURON, V60, P328, DOI 10.1016/j.neuron.2008.08.010; Goldman TD, 2007, PLOS GENET, V3, P2278, DOI 10.1371/journal.pgen.0030216; GOODMAN CS, 1984, SCIENCE, V225, P1271, DOI 10.1126/science.6474176; Hsiao HY, 2012, JOVE-J VIS EXP, DOI 10.3791/4347; Karuppudurai T, 2014, NEURON, V81, P603, DOI 10.1016/j.neuron.2013.12.010; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Krishnaswamy A, 2015, NATURE, V524, P466, DOI 10.1038/nature14682; Kurusu M, 2008, NEURON, V59, P972, DOI 10.1016/j.neuron.2008.07.037; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Maisak MS, 2013, NATURE, V500, P212, DOI 10.1038/nature12320; Menon KP, 2015, MOL CELL NEUROSCI, V67, P126, DOI 10.1016/j.mcn.2015.06.010; Menon KP, 2013, WIRES DEV BIOL, V2, P647, DOI 10.1002/wdev.108; Menon KP, 2009, J NEUROSCI, V29, P5558, DOI 10.1523/JNEUROSCI.0520-09.2009; Morante J, 2008, CURR BIOL, V18, P553, DOI 10.1016/j.cub.2008.02.075; Nagarkar-Jaiswal S, 2015, ELIFE, V4, DOI 10.7554/eLife.05338; Nahm M, 2013, NEURON, V77, P680, DOI 10.1016/j.neuron.2012.12.015; Nakamura M, 2002, J NEUROSCI, V22, P3463; O'Connor-Giles KM, 2008, NEURON, V58, P507, DOI 10.1016/j.neuron.2008.03.007; O'Connor-Giles KM, 2008, FLY, V2, DOI 10.4161/fly.7133; Ozkan E, 2014, CELL, V156, P482, DOI 10.1016/j.cell.2014.01.004; Ozkan E, 2013, CELL, V154, P228, DOI 10.1016/j.cell.2013.06.006; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Pecot MY, 2014, NEURON, V82, P320, DOI 10.1016/j.neuron.2014.02.045; Rivera-Alba M, 2011, CURR BIOL, V21, P2000, DOI 10.1016/j.cub.2011.10.022; Samanta D, 2012, P NATL ACAD SCI USA, V109, P14836, DOI 10.1073/pnas.1212912109; Sawaya MR, 2008, CELL, V134, P1007, DOI 10.1016/j.cell.2008.07.042; Schuldiner O, 2008, DEV CELL, V14, P227, DOI 10.1016/j.devcel.2007.11.001; Scott EK, 2002, J COMP NEUROL, V454, P470, DOI 10.1002/cne.10467; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Sweeney ST, 2002, NEURON, V36, P403, DOI 10.1016/S0896-6273(02)01014-0; Takemura S, 2013, NATURE, V500, P175, DOI 10.1038/nature12450; Tan LM, 2015, CELL, V163, P1756, DOI 10.1016/j.cell.2015.11.021; Tsuneizumi K, 1997, NATURE, V389, P627, DOI 10.1038/39362; Venken KJT, 2011, NAT METHODS, V8, P737, DOI 10.1038/nmeth.1662; Verdino P, 2010, SCIENCE, V329, P1210, DOI 10.1126/science.1187996; Walther RF, 2006, NAT PROTOC, V1, P2635, DOI 10.1038/nprot.2006.379; Wernet MF, 2006, NATURE, V440, P174, DOI 10.1038/nature04615; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8	43	91	91	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2015	163	7					1770	1782		10.1016/j.cell.2015.11.022	http://dx.doi.org/10.1016/j.cell.2015.11.022			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CZ1GN	26687361	Green Accepted, Bronze			2022-12-28	WOS:000366854200022
J	Gennaris, A; Ezraty, B; Henry, C; Agrebi, R; Vergnes, A; Oheix, E; Bos, J; Leverrier, P; Espinosa, L; Szewczyk, J; Vertommen, D; Iranzo, O; Collet, JF; Barras, F				Gennaris, Alexandra; Ezraty, Benjamin; Henry, Camille; Agrebi, Rym; Vergnes, Alexandra; Oheix, Emmanuel; Bos, Julia; Leverrier, Pauline; Espinosa, Leon; Szewczyk, Joanna; Vertommen, Didier; Iranzo, Olga; Collet, Jean-Francois; Barras, Frederic			Repairing oxidized proteins in the bacterial envelope using respiratory chain electrons	NATURE			English	Article							METHIONINE SULFOXIDE REDUCTASES; GENES; IDENTIFICATION; PERFORMANCE; CATALYSIS; SOFTWARE; REVEALS; TARGET; ROLES; DSBD	The reactive species of oxygen and chlorine damage cellular components, potentially leading to cell death. In proteins, the sulfur-containing amino acid methionine is converted to methionine sulfoxide, which can cause a loss of biological activity. To rescue proteins with methionine sulfoxide residues, living cells express methionine sulfoxide reductases (Msrs) in most subcellular compartments, including the cytosol, mitochondria and chloroplasts(1-3). Here we report the identification of an enzymatic system, MsrPQ, repairing proteins containing methionine sulfoxide in the bacterial cell envelope, a compartment particularly exposed to the reactive species of oxygen and chlorine generated by the host defence mechanisms. MsrP, a molybdo-enzyme, and MsrQ, a haem-binding membrane protein, are widely conserved throughout Gram-negative bacteria, including major human pathogens. MsrPQ synthesis is induced by hypochlorous acid, a powerful antimicrobial released by neutrophils. Consistently, MsrPQ is essential for the maintenance of envelope integrity under bleach stress, rescuing a wide series of structurally unrelated periplasmic proteins from methionine oxidation, including the primary periplasmic chaperone SurA. For this activity, MsrPQ uses electrons from the respiratory chain, which represents a novel mechanism to import reducing equivalents into the bacterial cell envelope. A remarkable feature of MsrPQ is its capacity to reduce both rectus (R-) and sinister (S-) diastereoisomers of methionine sulfoxide, making this oxidoreductase complex functionally different from previously identified Msrs. The discovery that a large class of bacteria contain a single, non-stereospecific enzymatic complex fully protecting methionine residues from oxidation should prompt a search for similar systems in eukaryotic subcellular oxidizing compartments, including the endoplasmic reticulum.	[Gennaris, Alexandra; Agrebi, Rym; Leverrier, Pauline; Szewczyk, Joanna; Collet, Jean-Francois] WELBIO, B-1200 Brussels, Belgium; [Gennaris, Alexandra; Agrebi, Rym; Leverrier, Pauline; Szewczyk, Joanna; Vertommen, Didier; Collet, Jean-Francois] Catholic Univ Louvain, Duve Inst, B-1200 Brussels, Belgium; [Gennaris, Alexandra; Agrebi, Rym; Leverrier, Pauline; Szewczyk, Joanna; Collet, Jean-Francois] Brussels Ctr Redox Biol, B-1200 Brussels, Belgium; [Ezraty, Benjamin; Henry, Camille; Vergnes, Alexandra; Bos, Julia; Espinosa, Leon; Barras, Frederic] Aix Marseille Univ, CNRS, Lab Chim Bacterienne, UMR 7283,Inst Microbiol Mediterranee, F-13009 Marseille, France; [Oheix, Emmanuel; Iranzo, Olga] Aix Marseille Univ, Cent Marseille, CNRS, iSm2,UMR 7313, F-13397 Marseille, France	WELBIO; Universite Catholique Louvain; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Aix-Marseille Universite	Collet, JF (corresponding author), WELBIO, Ave Hippocrate 75, B-1200 Brussels, Belgium.	jfcollet@uclouvain.be; barras@imm.cnrs.fr	Espinosa, Leon/V-8410-2017; Vergnes, Alexandra/AAM-2842-2020	Oheix, Emmanuel/0000-0001-5731-4906; Barras, Frederic/0000-0003-3458-2574; Henry, Camille/0000-0002-4011-6767; Leverrier, Pauline/0000-0003-2465-8491; Ezraty, Benjamin/0000-0003-3818-6907; Vertommen, Didier/0000-0001-7648-8282; Collet, Jean-Francois/0000-0001-8069-7036; Bos, Julia/0000-0002-4947-4675	Indo-French Center for the Promotion of Advanced Research CEFIPRA [5105-2]; Fonds Maurange, Fondation Roi Baudouin; FRS-FNRS; European Research Council [282335-Sulfenic]; Centre National de la Recherche Scientifique (CNRS); Fondation pour la Recherche Medicale (FRM); Aix-Marseille Universite	Indo-French Center for the Promotion of Advanced Research CEFIPRA; Fonds Maurange, Fondation Roi Baudouin; FRS-FNRS(Fonds de la Recherche Scientifique - FNRS); European Research Council(European Research Council (ERC)European Commission); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Aix-Marseille Universite	We thank A. Boujtat, G. Herinckx and J.-P. Szikora for technical and computational help and the members of the Barras and Collet laboratories for discussions. We are indebted to M. Sabaty and D. Pignol for sharing unpublished information, to T. Silhavy, T. Palmer, E. Bouveret and D. Hughes for providing strains and plasmids, to T. Lowther and M. Reglier for advice and discussions and to N. Typas, T. Mignot, J. Messens, J. Bardwell and F.-A. Wollman for reading the manuscript and providing comments. A. G. and J.S. are research fellows of the Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture, P.L. is 'Chargee de Recherche' and J.-F.C. is 'Maitre de Recherche' of the Fonds de la Recherche Scientifique-FNRS (FRS-FNRS). E.O. is supported by a grant from the Indo-French Center for the Promotion of Advanced Research CEFIPRA '(5105-2)'. R.A. is supported by the Fonds Maurange, Fondation Roi Baudouin. This work was supported, in part, by grants from the FRS-FNRS and from the European Research Council (FP7/2007-2013) ERC independent researcher starting grant 282335-Sulfenic to J.-F.C. and funding by the Centre National de la Recherche Scientifique (CNRS), Fondation pour la Recherche Medicale (FRM) and Aix-Marseille Universite to the F.B. team.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arts IS, 2013, MBIO, V4, DOI 10.1128/mBio.00912-13; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Boschi-Muller S, 2008, ARCH BIOCHEM BIOPHYS, V474, P266, DOI 10.1016/j.abb.2008.02.007; BREMER E, 1984, J BACTERIOL, V158, P1084, DOI 10.1128/JB.158.3.1084-1093.1984; Brokx SJ, 2005, BIOCHEMISTRY-US, V44, P10339, DOI 10.1021/bi050621a; Brot N, 2006, J BIOL CHEM, V281, P32668, DOI 10.1074/jbc.M604971200; Cascales E, 2002, J BACTERIOL, V184, P754, DOI 10.1128/JB.184.3.754-759.2002; Cho SH, 2013, ANTIOXID REDOX SIGN, V18, P1690, DOI 10.1089/ars.2012.4962; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Denoncin K, 2012, PROTEOMICS, V12, P1391, DOI 10.1002/pmic.201100633; Ezraty B, 2005, BBA-PROTEINS PROTEOM, V1703, P221, DOI 10.1016/j.bbapap.2004.08.017; Goemans C, 2014, BBA-MOL CELL RES, V1843, P1517, DOI 10.1016/j.bbamcr.2013.10.014; Gottlieb HE, 1997, J ORG CHEM, V62, P7512, DOI 10.1021/jo971176v; Grimaud R, 2001, J BIOL CHEM, V276, P48915, DOI 10.1074/jbc.M105509200; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hitchcock A, 2010, MICROBIOL-SGM, V156, P2994, DOI 10.1099/mic.0.042788-0; Holland HL, 1999, TETRAHEDRON-ASYMMETR, V10, P2833, DOI 10.1016/S0957-4166(99)00271-2; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Koc A, 2004, P NATL ACAD SCI USA, V101, P7999, DOI 10.1073/pnas.0307929101; LAVINE TF, 1947, J BIOL CHEM, V169, P477; Le DT, 2008, BIOCHEMISTRY-US, V47, P6685, DOI 10.1021/bi800422s; Lee BC, 2011, FREE RADICAL BIO MED, V50, P221, DOI 10.1016/j.freeradbiomed.2010.11.008; Lherbet C, 2004, BIOORG MED CHEM LETT, V14, P3451, DOI 10.1016/j.bmcl.2004.04.072; Loschi L, 2004, J BIOL CHEM, V279, P50391, DOI 10.1074/jbc.M408876200; LOWE RH, 1964, BIOCHIM BIOPHYS ACTA, V85, P377, DOI 10.1016/0926-6569(64)90301-3; Mandin P, 2009, MOL MICROBIOL, V72, P551, DOI 10.1111/j.1365-2958.2009.06665.x; Melnyk RA, 2015, MBIO, V6, DOI 10.1128/mBio.00233-15; Miller JH., 1992, SHORT COURSE BACTERI, P72; Overmars L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-209; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PHILIPPE H, 1993, NUCLEIC ACIDS RES, V21, P5264, DOI 10.1093/nar/21.22.5264; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; ROBERTS DM, 1985, BIOCHEMISTRY-US, V24, P5090, DOI 10.1021/bi00340a020; Ruiz N, 2005, CELL, V121, P307, DOI 10.1016/j.cell.2005.02.014; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Sklar JG, 2007, GENE DEV, V21, P2473, DOI 10.1101/gad.1581007; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Spector D, 2003, BIOCHEM BIOPH RES CO, V302, P284, DOI 10.1016/S0006-291X(03)00163-3; Stewart EJ, 1998, EMBO J, V17, P5543, DOI 10.1093/emboj/17.19.5543; Tarrago L, 2012, BIOCHEMISTRY-MOSCOW+, V77, P1097, DOI 10.1134/S0006297912100021; Tsvetkov PO, 2005, BIOCHIMIE, V87, P473, DOI 10.1016/j.biochi.2004.11.020; Urano H, 2015, MICROBIOL-SGM, V161, P729, DOI 10.1099/mic.0.000026; Vertommen D, 2008, MOL MICROBIOL, V67, P336, DOI 10.1111/j.1365-2958.2007.06030.x; Vizcaino J. A., 2004, NAT BIOTECHNOL, V30, P223; Workun GJ, 2008, MICROBIOL MOL BIOL R, V72, P228, DOI 10.1128/MMBR.00041-07	49	90	92	4	70	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 17	2015	528	7582					409	+		10.1038/nature15764	http://dx.doi.org/10.1038/nature15764			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY8SM	26641313	Green Published, Green Accepted			2022-12-28	WOS:000366678600055
J	Habbas, S; Santello, M; Becker, D; Stubbe, H; Zappia, G; Liaudet, N; Klaus, FR; Kollias, G; Fontana, A; Pryce, CR; Suter, T; Volterra, A				Habbas, Samia; Santello, Mirko; Becker, Denise; Stubbe, Hiltrud; Zappia, Giovanna; Liaudet, Nicolas; Klaus, Federica R.; Kollias, George; Fontana, Adriano; Pryce, Christopher R.; Suter, Tobias; Volterra, Andrea			Neuroinflammatory TNF alpha Impairs Memory via Astrocyte Signaling	CELL			English	Article							NECROSIS-FACTOR-ALPHA; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; SYNAPTIC PLASTICITY; MULTIPLE-SCLEROSIS; GLUTAMATE EXOCYTOSIS; COGNITIVE DEFICITS; DENTATE GYRUS; MOUSE MODEL; IN-VITRO; RECEPTOR	The occurrence of cognitive disturbances upon CNS inflammation or infection has been correlated with increased levels of the cytokine tumor necrosis factor-alpha (TNF alpha). To date, however, no specific mechanism via which this cytokine could alter cognitive circuits has been demonstrated. Here, we show that local increase of TNF alpha in the hippocampal dentate gyrus activates astrocyte TNF receptor type 1 (TNFR1), which in turn triggers an astrocyte-neuron signaling cascade that results in persistent functional modification of hippocampal excitatory synapses. Astrocytic TNFR1 signaling is necessary for the hippocampal synaptic alteration and contextual learning-memory impairment observed in experimental autoimmune encephalitis (EAE), an animal model of multiple sclerosis (MS). This process may contribute to the pathogenesis of cognitive disturbances in MS, as well as in other CNS conditions accompanied by inflammatory states or infections.	[Habbas, Samia; Santello, Mirko; Becker, Denise; Stubbe, Hiltrud; Zappia, Giovanna; Liaudet, Nicolas; Volterra, Andrea] Univ Lausanne, Dept Fundamental Neurosci, Rue Bugnon 9, CH-1005 Lausanne, Switzerland; [Klaus, Federica R.; Pryce, Christopher R.] Univ Zurich, Hosp Psychiat, Dept Psychiat Psychotherapy & Psychosomat, CH-8008 Zurich, Switzerland; [Klaus, Federica R.; Pryce, Christopher R.] Univ Zurich, Neurosci Ctr Zurich, CH-8008 Zurich, Switzerland; [Klaus, Federica R.; Pryce, Christopher R.] ETH, CH-8008 Zurich, Switzerland; [Kollias, George] BSRC Alexander Fleming, Vari 16672, Greece; [Fontana, Adriano] Univ Zurich, Inst Expt Immunol Inflammat & Sickness Behav, CH-8057 Zurich, Switzerland; [Suter, Tobias] Univ Zurich Hosp, Neuroimmunol & MS Res, CH-8091 Zurich, Switzerland	University of Lausanne; University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Alexander Fleming Biomedical Sciences Research Center; University of Zurich; University of Zurich; University Zurich Hospital	Volterra, A (corresponding author), Univ Lausanne, Dept Fundamental Neurosci, Rue Bugnon 9, CH-1005 Lausanne, Switzerland.	andrea.volterra@unil.ch	Santello, Mirko/F-9007-2014; Kollias, George/A-7079-2012	Santello, Mirko/0000-0002-7709-4127; Kollias, George/0000-0003-1867-3150; Volterra, Andrea/0000-0003-1069-1602; Klaus, Federica/0000-0002-7197-0632; Becker, Denise/0000-0003-0132-9986; Suter, Tobias/0000-0002-5048-2867; Liaudet, Nicolas/0000-0002-0749-5857	ERC Advanced grant [340368]; Swiss National Science Foundation (SNSF) (through the National Centers of Competence in Research (NCCR)); SNSF grant [31003A-141137]; NCCR "Synapsy"; FBM, University of Lausanne; SNSF; Clinical Research Priority Program Multiple Sclerosis of the University of Zurich; Swiss National Science Foundation (SNSF) [31003A-140999]	ERC Advanced grant; Swiss National Science Foundation (SNSF) (through the National Centers of Competence in Research (NCCR)); SNSF grant; NCCR "Synapsy"; FBM, University of Lausanne; SNSF(Swiss National Science Foundation (SNSF)); Clinical Research Priority Program Multiple Sclerosis of the University of Zurich; Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	We thank G. Stocca and H. Sigrist for help in two-photon imaging and in AT-EAE fear conditioning experiments, respectively, N. Nevian for biocytin staining, I. Savtchouk for comments to the manuscript, F. Kirchhoff for providing hGFAPcreT2 mice, and T. Nevian for providing access to his lab equipment for some electrophysiology experiments. We thank E. Seifritz for support and expert advice on the translational study of behavioral pathology. This research was supported by an ERC Advanced grant (340368 "Astromnesis'') and by the Swiss National Science Foundation (SNSF) (grant 31003A-140999, and through the National Centers of Competence in Research (NCCR) "Synapsy'' and "Transcure'') (to A.V.), and by a SNSF grant (31003A-141137) (to C.R.P.). S.H. received a post-doctoral fellowship from NCCR "Synapsy;'' M.S. received a PhD fellowship from FBM, University of Lausanne. F.R.K. received an MD-PhD fellowship from the SNSF; A.F. is a Senior Research Professor for Neuroscience of the Gemeinnutzige Hertie Stiftung; and T.S. is supported by the Clinical Research Priority Program Multiple Sclerosis of the University of Zurich.	Acharjee S, 2013, BRAIN BEHAV IMMUN, V33, P164, DOI 10.1016/j.bbi.2013.07.003; Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; Araque A, 2014, NEURON, V81, P728, DOI 10.1016/j.neuron.2014.02.007; Belarbi K, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-23; Bezzi P, 2001, NAT NEUROSCI, V4, P702, DOI 10.1038/89490; Centonze D, 2009, J NEUROSCI, V29, P3442, DOI 10.1523/JNEUROSCI.5804-08.2009; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Clark IA, 2010, PHARMACOL THERAPEUT, V128, P519, DOI 10.1016/j.pharmthera.2010.08.007; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Cunningham AJ, 1996, NEUROSCI LETT, V203, P17, DOI 10.1016/0304-3940(95)12252-4; Denny CA, 2014, NEURON, V83, P189, DOI 10.1016/j.neuron.2014.05.018; Domercq M, 2006, J BIOL CHEM, V281, P30684, DOI 10.1074/jbc.M606429200; Eugster HP, 1999, EUR J IMMUNOL, V29, P626, DOI 10.1002/(SICI)1521-4141(199902)29:02<626::AID-IMMU626>3.3.CO;2-1; Gabbita SP, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-99; Gold SM, 2010, BIOL PSYCHIAT, V68, P553, DOI 10.1016/j.biopsych.2010.04.025; Goussakov IV, 2000, J NEUROSCI, V20, P3434, DOI 10.1523/JNEUROSCI.20-09-03434.2000; Gregory AP, 2012, NATURE, V488, P508, DOI 10.1038/nature11307; Gu Y, 2012, NAT NEUROSCI, V15, P1700, DOI 10.1038/nn.3260; Haji N, 2012, EXP NEUROL, V237, P296, DOI 10.1016/j.expneurol.2012.07.010; Halassa MM, 2009, NEURON, V61, P213, DOI 10.1016/j.neuron.2008.11.024; Han J, 2012, CELL, V148, P1039, DOI 10.1016/j.cell.2012.01.037; Han XN, 2013, CELL STEM CELL, V12, P342, DOI 10.1016/j.stem.2012.12.015; He P, 2007, J CELL BIOL, V178, P829, DOI 10.1083/jcb.200705042; Hirrlinger PG, 2006, GLIA, V54, P11, DOI 10.1002/glia.20342; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Kassiotis G, 2001, J EXP MED, V193, P427, DOI 10.1084/jem.193.4.427; Larsen RS, 2011, NAT NEUROSCI, V14, P338, DOI 10.1038/nn.2750; Lee HS, 2014, P NATL ACAD SCI USA, V111, pE3343, DOI 10.1073/pnas.1410893111; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; McAlpine FE, 2008, J INFLAMM RES, V1, P29; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Pribiag H, 2013, J NEUROSCI, V33, P15879, DOI 10.1523/JNEUROSCI.0530-13.2013; RENNO T, 1995, J IMMUNOL, V154, P944; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Santello M, 2012, TRENDS NEUROSCI, V35, P638, DOI 10.1016/j.tins.2012.06.001; Santello M, 2011, NEURON, V69, P988, DOI 10.1016/j.neuron.2011.02.003; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Swardfager W, 2013, NAT REV NEUROL, V9, P301, DOI 10.1038/nrneurol.2013.93; Terrando N, 2010, P NATL ACAD SCI USA, V107, P20518, DOI 10.1073/pnas.1014557107; Tombaugh GC, 2002, J NEUROSCI, V22, P9932; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; Victoratos P, 2006, IMMUNITY, V24, P65, DOI 10.1016/j.immuni.2005.11.013; Wang S, 2011, NANO LETT, V11, P3431, DOI 10.1021/nl2018838; Xu ZZ, 2010, NAT MED, V16, P592, DOI 10.1038/nm.2123; Yang G, 2013, P NATL ACAD SCI USA, V110, P10306, DOI 10.1073/pnas.1222895110; Yirmiya R, 2011, BRAIN BEHAV IMMUN, V25, P181, DOI 10.1016/j.bbi.2010.10.015	50	193	198	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2015	163	7					1730	1741		10.1016/j.cell.2015.11.023	http://dx.doi.org/10.1016/j.cell.2015.11.023			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CZ1GN	26686654	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000366854200019
J	Vasilyev, M				Vasilyev, Michael			Matched filtering of ultrashort pulses	SCIENCE			English	Editorial Material							SPATIAL MODES; GENERATION		[Vasilyev, Michael] Univ Texas Arlington, Dept Elect Engn, Arlington, TX 76019 USA	University of Texas System; University of Texas Arlington	Vasilyev, M (corresponding author), Univ Texas Arlington, Dept Elect Engn, Arlington, TX 76019 USA.	vasilyev@uta.edu		Vasilyev, Michael/0000-0001-6718-8640				Annamalai M, 2013, OPT EXPRESS, V21, P28134, DOI 10.1364/OE.21.028134; Annamalai M, 2011, OPT EXPRESS, V19, P26710, DOI 10.1364/OE.19.026710; Ataie V, 2015, SCIENCE, V350, P1343, DOI 10.1126/science.aac8446; Bhagwat AR, 2013, OPT LETT, V38, P2858, DOI 10.1364/OL.38.002858; Caplan DO, 2008, OPT FIBER COMMUN REP, P109, DOI 10.1007/s10297-006-0079-z; Chalopin B, 2011, OPT EXPRESS, V19, P4405, DOI 10.1364/OE.19.004405; McKinstrie CJ, 2009, OPT COMMUN, V282, P583, DOI 10.1016/j.optcom.2008.10.037; Papoulis A., 2001, PROBABILITY RANDOM V, V4th ed.; Patera G, 2010, EUR PHYS J D, V56, P123, DOI 10.1140/epjd/e2009-00299-9; Shapiro JH, 1997, J OPT SOC AM B, V14, P232, DOI 10.1364/JOSAB.14.000232; Wasilewski W, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.063819; Wu BB, 2006, OPT EXPRESS, V14, P3738, DOI 10.1364/OE.14.003738; Yu NK, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.020506	13	4	4	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2015	350	6266					1314	1315		10.1126/science.aad7804	http://dx.doi.org/10.1126/science.aad7804			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1JL	26659040				2022-12-28	WOS:000366162400019
J	Ghani, AC; Burgess, DH; Reynolds, A; Rousseau, C				Ghani, Azra C.; Burgess, Deborah Hay; Reynolds, Alison; Rousseau, Christine			Expanding the role of diagnostic and prognostic tools for infectious diseases in resource-poor settings INTRODUCTION	NATURE			English	Editorial Material							DRIED BLOOD SPOTS		[Ghani, Azra C.; Reynolds, Alison] Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC Ctr Outbreak Anal & Modelling, Dept Infect Dis Epidemiol, London W2 1PG, England; [Burgess, Deborah Hay] Kimataifa Diagnost & Devices Consulting, Seattle, WA 98012 USA; [Rousseau, Christine] Bill & Melinda Gates Fdn, Seattle, WA 98109 USA	Imperial College London; Bill & Melinda Gates Foundation	Ghani, AC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC Ctr Outbreak Anal & Modelling, Dept Infect Dis Epidemiol, Norfolk Pl, London W2 1PG, England.	a.ghani@imperial.ac.uk	Ghani, Azra/B-8560-2009	Ghani, Azra/0000-0002-0007-4910	MRC [MR/K010174/1] Funding Source: UKRI; Medical Research Council [MR/K010174/1] Funding Source: Medline; Medical Research Council [MR/K010174/1B] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Bill and Melinda Gates Foundation, 2007, MEL FRENCH GAT MAL F; Choko AT, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001873; Corran PH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-195; Fonjungo P. N., 2015, CLIN INFECT DIS; Hay Burgess Deborah C, 2006, Nature, V444 Suppl 1, P1; Jani I. V., 2011, LANCET, V378, P1572; McNerney R, 2015, CURR OPIN PULM MED, V21, P304, DOI 10.1097/MCP.0000000000000161; Rao VB, 2013, TRENDS PARASITOL, V29, P164, DOI 10.1016/j.pt.2013.01.005; Smit PW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086461; Strategic Evaluation Advisory and Development Consulting, 2011, AN POCT VCT PERF S A; Tran TM, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-393; United Nations, 2015, MILL DEV GOAS REP; Vlaminck J., 2015, TRENDS PARASITOL; WHO, 2015, GLOB TECHN STRAT MAL; World Health Organization, 2012, ACCELERATING WORK TO; World Health Organization, 2008, CONS TECHN OP REC CL	16	16	16	2	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					S50	S52		10.1038/nature16038	http://dx.doi.org/10.1038/nature16038			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX3NO	26633765	Green Submitted, hybrid			2022-12-28	WOS:000365606000010
J	Guo, JT; Zeng, WZ; Chen, QF; Lee, C; Chen, LP; Yang, Y; Cang, CL; Ren, DJ; Jiang, YX				Guo, Jiangtao; Zeng, Weizhong; Chen, Qingfeng; Lee, Changkeun; Chen, Liping; Yang, Yi; Cang, Chunlei; Ren, Dejian; Jiang, Youxing			Structure of the voltage-gated two-pore channel TPC1 from Arabidopsis thaliana	NATURE			English	Article							OF-FUNCTION ALLELE; SHAKER K+ CHANNEL; GATING-CHARGE; CRYSTAL-STRUCTURE; ION CHANNELS; WILD-TYPE; CALCIUM; SODIUM; NAADP; PERSPECTIVE	Two-pore channels (TPCs) contain two copies of a Shaker-like six-transmembrane (6-TM) domain in each subunit and are ubiquitously expressed in both animals and plants as organellar cation channels. Here we present the crystal structure of a vacuolar two-pore channel from Arabidopsis thaliana, AtTPC1, which functions as a homodimer. AtTPC1 activation requires both voltage and cytosolic Ca2+. Ca2+ binding to the cytosolic EF-hand domain triggers conformational changes coupled to the pair of pore-lining inner helices from the first 6-TM domains, whereas membrane potential only activates the second voltage-sensing domain, the conformational changes of which are coupled to the pair of inner helices from the second 6-TM domains. Luminal Ca2+ or Ba2+ can modulate voltage activation by stabilizing the second voltage-sensing domain in the resting state and shift voltage activation towards more positive potentials. Our Ba-2-bound AtTPC1 structure reveals a voltage sensor in the resting state, providing hitherto unseen structural insight into the general voltage-gating mechanism among voltage-gated channels.	[Guo, Jiangtao; Zeng, Weizhong; Chen, Qingfeng; Lee, Changkeun; Chen, Liping; Yang, Yi; Jiang, Youxing] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Zeng, Weizhong; Chen, Qingfeng; Lee, Changkeun; Chen, Liping; Yang, Yi; Jiang, Youxing] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Cang, Chunlei; Ren, Dejian] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Pennsylvania	Jiang, YX (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.; Jiang, YX (corresponding author), Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA.	youxing.jiang@utsouthwestern.edu	Cang, Chunlei/D-9185-2019; chen, qingfeng/J-6844-2017	Cang, Chunlei/0000-0002-3302-0927	US Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; National Institutes of Health, National Institute of General Medical Sciences; Howard Hughes Medical Institute; Office of Science, Office of Basic Energy Sciences, of the US Department of Energy [DE-AC02-05CH11231]; National Institutes of Health [GM079179, NS055293, NS074257]; Welch Foundation [I-1578]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074257, R01NS055293] Funding Source: NIH RePORTER	US Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Office of Science, Office of Basic Energy Sciences, of the US Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank N. Nguyen for manuscript preparation, R. Hedrich at University of Wurzburg and M.X. Zhu at University of Texas Health Science Center at Houston for providing clones of plant and animal TPC genes. The experimental results reported in this article derive from work performed at Argonne National Laboratory, Structural Biology Center (19ID) and GM/CA (23ID) at the Advanced Photon Source, and from work performed at the Berkeley Center for Structural Biology at the Advanced Light Source (ALS). Argonne is operated by UChicago Argonne, LLC, for the US Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357. The Berkeley Center for Structural Biology is supported in part by the National Institutes of Health, National Institute of General Medical Sciences, and the Howard Hughes Medical Institute. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under contract no. DE-AC02-05CH11231. This work was supported in part by the Howard Hughes Medical Institute and by grants from the National Institutes of Health (GM079179 to Y. J.; NS055293 and NS074257 to D. R.) and the Welch Foundation (Grant I-1578 to Y. J.). The authors declare no competing financial interests.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; AMODEO G, 1994, PLANT PHYSIOL, V105, P999, DOI 10.1104/pp.105.3.999; [Anonymous], PYMOL MOL GRAPH SYST; ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; Bezanilla F, 2002, J GEN PHYSIOL, V120, P465, DOI 10.1085/jgp.20028660; Bonaventure G, 2007, PLANT CELL PHYSIOL, V48, P1775, DOI 10.1093/pcp/pcm151; Bonaventure G, 2007, PLANT J, V49, P889, DOI 10.1111/j.1365-313X.2006.03002.x; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cang CL, 2014, NAT CHEM BIOL, V10, P463, DOI 10.1038/nchembio.1522; Cang CL, 2013, CELL, V152, P778, DOI 10.1016/j.cell.2013.01.023; Choi WG, 2014, P NATL ACAD SCI USA, V111, P6497, DOI 10.1073/pnas.1319955111; Clayton GM, 2008, P NATL ACAD SCI USA, V105, P1511, DOI 10.1073/pnas.0711533105; Dadacz-Narloch B, 2011, PLANT CELL, V23, P2696, DOI 10.1105/tpc.111.086751; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fortelle E., 1997, METHOD ENZYMOL, P472; Furuichi T, 2001, PLANT CELL PHYSIOL, V42, P900, DOI 10.1093/pcp/pce145; Gandhi CS, 2002, J GEN PHYSIOL, V120, P455, DOI 10.1085/jgp.20028678; HEDRICH R, 1987, NATURE, V329, P833, DOI 10.1038/329833a0; Hedrich R, 2011, MOL PLANT, V4, P428, DOI 10.1093/mp/ssr017; Horn R, 2002, J GEN PHYSIOL, V120, P449, DOI 10.1085/jgp.20028658; Ishibashi K, 2000, BIOCHEM BIOPH RES CO, V270, P370, DOI 10.1006/bbrc.2000.2435; Jha A, 2014, EMBO J, V33, P501, DOI 10.1002/embj.201387035; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Larisch N, 2012, TRAFFIC, V13, P1012, DOI 10.1111/j.1600-0854.2012.01366.x; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li QF, 2014, NAT STRUCT MOL BIOL, V21, P244, DOI 10.1038/nsmb.2768; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAPAZIAN DM, 1987, SCIENCE, V237, P749, DOI 10.1126/science.2441470; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Peiter E, 2005, NATURE, V434, P404, DOI 10.1038/nature03381; Pitt SJ, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004854; Rahman T, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005450; Ruas M, 2015, EMBO J, V34, P1743, DOI 10.15252/embj.201490009; Ruta V, 2005, CELL, V123, P463, DOI 10.1016/j.cell.2005.08.041; Sakurai Y, 2015, SCIENCE, V347, P995, DOI 10.1126/science.1258758; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Schulze C, 2011, PLANT J, V68, P424, DOI 10.1111/j.1365-313X.2011.04697.x; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Takeshita K, 2014, NAT STRUCT MOL BIOL, V21, P352, DOI 10.1038/nsmb.2783; Tao X, 2010, SCIENCE, V328, P67, DOI 10.1126/science.1185954; Vieira-Pires RS, 2010, J GEN PHYSIOL, V136, P585, DOI 10.1085/jgp.201010508; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wang X, 2012, CELL, V151, P372, DOI 10.1016/j.cell.2012.08.036; WARD JM, 1994, PLANT CELL, V6, P669; Xu HX, 2015, ANNU REV PHYSIOL, V77, P57, DOI 10.1146/annurev-physiol-021014-071649; Xu YP, 2010, CELL, V142, P580, DOI 10.1016/j.cell.2010.07.013; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	57	160	164	3	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2016	531	7593					196	+		10.1038/nature16446	http://dx.doi.org/10.1038/nature16446			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF9EZ	26689363	Green Accepted, Green Submitted			2022-12-28	WOS:000371665100033
J	Johnston, SRD				Johnston, Stephen R. D.			Endocrine treatment for ductal carcinoma in situ: balancing risks and benefits	LANCET			English	Editorial Material							BREAST-CANCER; TAMOXIFEN; WOMEN; DCIS		[Johnston, Stephen R. D.] Royal Marsden NHS Fdn Trust, Dept Med, London SW3 6JJ, England	Royal Marsden NHS Foundation Trust	Johnston, SRD (corresponding author), Royal Marsden NHS Fdn Trust, Dept Med, London SW3 6JJ, England.	stephen.johnston@rmh.nhs.uk						Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Allred DC, 2012, J CLIN ONCOL, V30, P1268, DOI 10.1200/JCO.2010.34.0141; [Anonymous], 2015, LANCET; Buzdar A, 2006, LANCET ONCOL, V7, P633, DOI 10.1016/S1470-2045(06)70767-7; Cuzick J, 2011, LANCET ONCOL, V12, P21, DOI 10.1016/S1470-2045(10)70266-7; Cuzick J, 2010, LANCET ONCOL, V11, P1135, DOI 10.1016/S1470-2045(10)70257-6; Dowsett M, 2015, LANCET, V386, P1341, DOI 10.1016/S0140-6736(15)61074-1; Fisher B, 1999, LANCET, V353, P1993, DOI 10.1016/S0140-6736(99)05036-9; Forbes JF, 2015, LANCET; George WD, 2003, LANCET, V362, P95, DOI 10.1016/S0140-6736(03)13859-7; Margolese RG, 2015, LANCET; Nofech-Mozes S, 2005, ADV ANAT PATHOL, V12, P256, DOI 10.1097/01.pap.0000184177.65919.5e; Van Zee K. J., 2014, DIS BREAST, P337	13	4	4	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	2016	387	10021					819	821		10.1016/S0140-6736(15)01219-2	http://dx.doi.org/10.1016/S0140-6736(15)01219-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE9RA	26686312	hybrid			2022-12-28	WOS:000370974400004
J	Ruperto, N; Pistorio, A; Oliveira, S; Zulian, F; Cuttica, R; Ravelli, A; Fischbach, M; Magnusson, B; Sterba, G; Avcin, T; Brochard, K; Corona, F; Dressler, F; Gerloni, V; Apaz, MT; Bracaglia, C; Cespedes-Cruz, A; Cimaz, R; Couillault, G; Joos, R; Quartier, P; Russo, R; Tardieu, M; Wulff, N; Bica, B; Dolezalova, P; Ferriani, V; Flato, B; Bernard-Medina, AG; Herlin, T; Trachana, M; Meini, A; Allain-Launay, E; Pilkington, C; Vargova, V; Wouters, C; Angioloni, S; Martini, A				Ruperto, Nicolino; Pistorio, Angela; Oliveira, Sheila; Zulian, Francesco; Cuttica, Ruben; Ravelli, Angelo; Fischbach, Michel; Magnusson, Bo; Sterba, Gary; Avcin, Tadej; Brochard, Karine; Corona, Fabrizia; Dressler, Frank; Gerloni, Valeria; Apaz, Maria T.; Bracaglia, Claudia; Cespedes-Cruz, Adriana; Cimaz, Rolando; Couillault, Gerard; Joos, Rik; Quartier, Pierre; Russo, Ricardo; Tardieu, Marc; Wulff, Nico; Bica, Blanca; Dolezalova, Pavla; Ferriani, Virginia; Flato, Berit; Bernard-Medina, Ana G.; Herlin, Troels; Trachana, Maria; Meini, Antonella; Allain-Launay, Emma; Pilkington, Clarissa; Vargova, Veronika; Wouters, Carine; Angioloni, Simona; Martini, Alberto		Paediat Rheumatology Int Trials	Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial	LANCET			English	Article							IDIOPATHIC INFLAMMATORY MYOPATHIES; SYSTEMIC-LUPUS-ERYTHEMATOSUS; VALIDATED DISEASE-ACTIVITY; INTRAVENOUS IMMUNOGLOBULIN; DAMAGE INDEXES; THERAPY; POLYMYOSITIS; MULTICENTER; EFFICACY; CRITERIA	Background Most data for treatment of dermatomyositis and juvenile dermatomyositis are from anecdotal, nonrandomised case series. We aimed to compare, in a randomised trial, the efficacy and safety of prednisone alone with that of prednisone plus either methotrexate or ciclosporin in children with new-onset juvenile dermatomyositis. Methods We did a randomised trial at 54 centres in 22 countries. We enrolled patients aged 18 years or younger with new-onset juvenile dermatomyositis who had received no previous treatment and did not have cutaneous or gastrointestinal ulceration. We randomly allocated 139 patients via a computer-based system to prednisone alone or in combination with either ciclosporin or methotrexate. We did not mask patients or investigators to treatment assignments. Our primary outcomes were the proportion of patients achieving a juvenile dermatomyositis PRINTO 20 level of improvement (20% improvement in three of six core set variables at 6 months), time to clinical remission, and time to treatment failure. We compared the three treatment groups with the Kruskal-Wallis test and Friedman's test, and we analysed survival with Kaplan-Meier curves and the log-rank test. Analysis was by intention to treat. Here, we present results after at least 2 years of treatment (induction and maintenance phases). This trial is registered with ClinicalTrials.gov, number NCT00323960. Findings Between May 31, 2006, and Nov 12, 2010, 47 patients were randomly assigned prednisone alone, 46 were allocated prednisone plus ciclosporin, and 46 were randomised prednisone plus methotrexate. Median duration of follow-up was 35.5 months. At month 6, 24 (51%) of 47 patients assigned prednisone, 32 (70%) of 46 allocated prednisone plus ciclosporin, and 33 (72%) of 46 administered prednisone plus methotrexate achieved a juvenile dermatomyositis PRINTO 20 improvement (p= 0.0228). Median time to clinical remission was 41.9 months in patients assigned prednisone plus methotrexate but was not observable in the other two treatment groups (2.45 fold [95% CI 1.2-5.0] increase with prednisone plus methotrexate; p= 0.012). Median time to treatment failure was 16.7 months in patients allocated prednisone, 53.3 months in those assigned prednisone plus ciclosporin, but was not observable in patients randomised to prednisone plus methotrexate (1.95 fold [95% CI 1.20-3.15] increase with prednisone; p= 0.009). Median time to prednisone discontinuation was 35.8 months with prednisone alone compared with 29.4-29.7 months in the combination groups (p= 0.002). A significantly greater proportion of patients assigned prednisone plus ciclosporin had adverse events, affecting the skin and subcutaneous tissues, gastrointestinal system, and general disorders. Infections and infestations were significantly increased in patients assigned prednisone plus ciclosporin and prednisone plus methotrexate. No patients died during the study. Interpretation Combined treatment with prednisone and either ciclosporin or methotrexate was more effective than prednisone alone. The safety profile and steroid-sparing effect favoured the combination of prednisone plus methotrexate.	[Ruperto, Nicolino; Ravelli, Angelo; Angioloni, Simona; Martini, Alberto] Ist Giannina Gaslini, Reumatol, Pediat 2, PRINTO Coordinating Ctr, I-16147 Genoa, Italy; [Pistorio, Angela] Ist Giannina Gaslini, Epidemiol Biostat & Com, I-16147 Genoa, Italy; [Oliveira, Sheila] Univ Fed Rio de Janeiro, Inst Puericultura & Pediat Martagao Gesteira, Rio De Janeiro, Brazil; [Zulian, Francesco] Unita Reumatol Pediat, Clin Pediat 1, Padua, Italy; [Cuttica, Ruben] Hosp Gen Ninos Pedro Elizalde, Rheumatol Sect, Buenos Aires, DF, Argentina; [Ravelli, Angelo; Martini, Alberto] Univ Genoa, Dipartimento Pediat, Genoa, Italy; [Fischbach, Michel] Hop Univ Hautepierre, Pediat 1, Strasbourg, France; [Magnusson, Bo] Karolinska Univ Hosp, Pediat Rheumatol Unit, Stockholm, Sweden; [Sterba, Gary] Hosp Clin Caracas, Caracas, Venezuela; [Avcin, Tadej] Univ Med Ctr Ljubljana, Univ Childrens Hosp, Dept Allergol Rheumatol & Clin Immunol, Ljubljana, Slovenia; [Brochard, Karine] Hop Enfants, Paediat Nephrol & Internist Med, Toulouse, France; [Corona, Fabrizia] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Clin Pediat De Marchi 2, Milan, Italy; [Dressler, Frank] Hannover Med Sch, Kinderklin, D-30623 Hannover, Germany; [Gerloni, Valeria] Ist Gaetano Pini, Div Reumatol, Milan, Italy; [Apaz, Maria T.] Univ Catolica Cordoba, Rheumatol, Clin Univ Privada Reina Fabiola, Cordoba, Argentina; [Bracaglia, Claudia] Osped Pediat Bambino Gesu, Reumatol, Rome, Italy; [Cespedes-Cruz, Adriana] Ctr Med Nacl La Raza, Reumatol Pediat, Mexico City, DF, Mexico; [Cimaz, Rolando] Azienda Ospedaliero Univ Meyer, Florence, Italy; [Couillault, Gerard] Hop Enfants, Dijon, France; [Joos, Rik] Univ Ziekenhuis Gent, Ctr Kinderreumatol, Ghent, Belgium; [Quartier, Pierre] Univ Paris 05, Hop Necker Enfants Malades, IMAGINE Inst, Unite Immunol Hematol & Rhumatol Pediat, Paris, France; [Russo, Ricardo] Hosp Pediat Juan P Garrahan, Serv Inmunol Reumatol, Buenos Aires, DF, Argentina; [Tardieu, Marc] Hopitaux Univ Paris Sud, Assistance Publ Hopitaux Paris, Paris, France; [Tardieu, Marc] Univ Paris Sud, Paris, France; [Wulff, Nico] Wilhelmina Childrens Hosp, Dept Pediat Immunol & Rheumatol, Utrecht, Netherlands; [Bica, Blanca] Hosp Univ Clementino Fraga Filho, UFRJ, Med Clin, Reumatol, Rio De Janeiro, Brazil; [Dolezalova, Pavla] Charles Univ Prague, Pediat Rheumatol Unit, Prague, Czech Republic; [Dolezalova, Pavla] Gen Univ Hosp, Dept Pediat & Adolescent Med, Prague, Czech Republic; [Ferriani, Virginia] Univ Sao Paulo, Hosp Clin Faculdade Med Ribeirao Preto, Dept Pediat, Div Immunol Allergy & Rheumatol, BR-14049 Ribeirao Preto, Brazil; [Flato, Berit] Oslo Univ Hosp, Rikshospitalet, Dept Rheumatol, N-0450 Oslo, Norway; [Bernard-Medina, Ana G.] Hosp Civil Guadalajara Fray Antonio Alcalde, Serv Reumatol, Guadalajara, Jalisco, Mexico; [Herlin, Troels] Aarhus Univ, Skejby Sygehus Hosp, Dept Pediat, Aarhus, Denmark; [Trachana, Maria] Aristotle Univ Thessaloniki, Ippokrat Hosp, Dept Pediat 1, Ippokrat Gen Hosp, GR-54006 Thessaloniki, Greece; [Meini, Antonella] Univ Brescia, Clin Pediat, Spedali Civili, Unita Immunol & Reumatol Pediat, Brescia, Italy; [Allain-Launay, Emma] CHU Clin Med Pediat, Nantes, France; [Pilkington, Clarissa] UCL, Ctr Paediat & Adolescent Rheumatol, Great Ormond St Hosp Sick Children, London, England; [Vargova, Veronika] Detska Fakultna Nemocn, Dept Pediat 1, Kosice, Slovakia; [Wouters, Carine] Univ Hosp Gasthuisberg, Dept Pediat, Div Pediat Rheumatol, Leuven, Belgium	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; Universidade Federal do Rio de Janeiro; University of Genoa; CHU Strasbourg; Karolinska Institutet; Karolinska University Hospital; University Medical Centre Ljubljana; CHU de Toulouse; IRCCS Ca Granda Ospedale Maggiore Policlinico; Hannover Medical School; ASST Gaetano Pini CTO; Catholic University of Cordoba; IRCCS Bambino Gesu; Instituto Mexicano del Seguro Social; CHU Dijon Bourgogne; Ghent University; Ghent University Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Hospital de Pediatria Doctor Juan Garrahan; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Saclay; Wilhelmina Kinderziekenhuis; Universidade Federal do Rio de Janeiro; Charles University Prague; General University Hospital Prague; Universidade de Sao Paulo; University of Oslo; National Hospital Norway; Aarhus University; Aristotle University of Thessaloniki; Hospital Spedali Civili Brescia; University of Brescia; Nantes Universite; CHU de Nantes; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; KU Leuven; University Hospital Leuven	Ruperto, N (corresponding author), Ist Giannina Gaslini, Pediat 2, Paediat Rheumatol Int Trials Org PRINTO, EULAR Ctr Excellence Rheumatol,Rheumatol, I-16147 Genoa, Italy.	nicolaruperto@gaslini.org	Ferriani, Virginia PL/E-2209-2012; Ruperto, Nicolino/K-3349-2018; Bracaglia, Claudia/K-6886-2016; Oliveira, Sheila/F-5213-2016; Dolezalova, Pavla/N-6408-2017; Russo, Ricardo/O-7775-2018; Pistorio, Angela/D-1375-2009; Bracaglia, Claudia/AAF-7969-2021; RAVELLI, ANGELO/J-8161-2016; CIMAZ, Rolando/AAA-9058-2019; Russo, Ricardo O./GPW-9094-2022; Zulian, Francesco/AAC-6600-2022	Ruperto, Nicolino/0000-0001-8407-7782; Oliveira, Sheila/0000-0002-2426-716X; Dolezalova, Pavla/0000-0001-8375-661X; Russo, Ricardo/0000-0002-1256-8483; Pistorio, Angela/0000-0002-6895-8720; Bracaglia, Claudia/0000-0002-9834-9619; RAVELLI, ANGELO/0000-0001-9658-0385; CIMAZ, Rolando/0000-0002-3260-4226; Zulian, Francesco/0000-0002-2479-3485; Vargova, Veronika/0000-0003-1248-2564; Wouters, Carine/0000-0002-6426-8845; Quartier, Pierre/0000-0002-1769-549X; MARTINI, Alberto/0000-0001-7642-1459	Italian Agency of Drug Evaluation; Istituto Giannina Gaslini (Genoa, Italy); Myositis Association (USA); Italian Agency of Drug Evaluation (AIFA); ReumaFonds [LLP-10] Funding Source: researchfish	Italian Agency of Drug Evaluation; Istituto Giannina Gaslini (Genoa, Italy); Myositis Association (USA); Italian Agency of Drug Evaluation (AIFA); ReumaFonds	Italian Agency of Drug Evaluation, Istituto Giannina Gaslini (Genoa, Italy), Myositis Association (USA).; The Italian Agency of Drug Evaluation (AIFA), the Istituto Giannina Gaslini (Genoa, Italy), and the Myositis Association (USA) provided funding for the work of the PRINTO coordinating centre. We thank the children and their families who participated in this study; Simona Angioloni, Luca Villa, Michele Pesce, Irene Gregorini, and Chiara Pallotti from the PRINTO coordinating centre; and staff at the PRINTO participating centres: Graciela Espada, Stella Maris Garay (Argentina); Roberto Marini (Brazil); Marine Desjonqueres, Chantal Job Deslandre, Anne Pagnier, Georges Picherot, Christine Soler (France); Yosef Uziel (Israel); Patrizia Barone, Loredana Lepore, Silvana Martino (Italy); Valda Stanevicha (Latvia); Ruben Burgos-Vargas (Mexico); Rebecca Ten Cate (Netherlands); Jelena Vojinovic (Serbia); Anders Fasth (Sweden); and Elizabeth Candell Chalom (USA).	Al-Mayouf S, 2000, CLIN RHEUMATOL, V19, P138, DOI 10.1007/s100670050032; Al-Mayouf SM, 2000, J RHEUMATOL, V27, P2498; [Anonymous], 1996, CHQ USERS MANUAL; Bode RK, 2003, ARTHRIT RHEUM-ARTHR, V49, P7, DOI 10.1002/art.10924; BOHAN A, 1975, NEW ENGL J MED, V292, P403, DOI 10.1056/NEJM197502202920807; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Feldman BM, 2008, LANCET, V371, P2201, DOI 10.1016/S0140-6736(08)60955-1; Gordon PA, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003643.pub4; Guseinova D, 2011, CLIN EXP RHEUMATOL, V29, P117; Hasija R, 2011, ARTHRITIS RHEUM-US, V63, P3142, DOI 10.1002/art.30475; HECKMATT J, 1989, LANCET, V1, P1063, DOI 10.1016/S0140-6736(89)92456-2; Lovell DJ, 1999, ARTHRITIS RHEUM-US, V42, P2213, DOI 10.1002/1529-0131(199910)42:10<2213::AID-ANR25>3.0.CO;2-8; Mendez EP, 2003, ARTHRIT RHEUM-ARTHR, V49, P300, DOI 10.1002/art.11122; Oddis CV, 2013, ARTHRITIS RHEUM-US, V65, P314, DOI 10.1002/art.37754; Oddis CV, 2005, ARTHRITIS RHEUM, V52, P2607, DOI 10.1002/art.21291; Ramanan AV, 2005, PEDIAT RHEUMATOL ONL, V3, P1; Ravelli A, 2010, ARTHRIT CARE RES, V62, P63, DOI 10.1002/acr.20015; Rider L., 1996, Arthritis and Rheumatism, V39, pS191; Rider LG, 1997, ARTHRITIS RHEUM-US, V40, P1976, DOI 10.1002/art.1780401109; Rider Lisa G., 1996, Current Opinion in Rheumatology, V8, P495; Ruperto N, 2003, RHEUMATOLOGY, V42, P1452, DOI 10.1093/rheumatology/keg403; Ruperto N, 2005, ARTHRITIS RHEUM, V52, P2854, DOI 10.1002/art.21230; Ruperto N, 2001, CLIN EXP RHEUMATOL, V19, pS1; Ruperto N, 2008, ARTHRIT RHEUM-ARTHR, V59, P4, DOI 10.1002/art.23248; Ruperto N, 2011, ARCH DIS CHILD, V96, P596, DOI 10.1136/adc.2010.188946; Ruperto N, 2010, ARTHRIT CARE RES, V62, P1533, DOI 10.1002/acr.20280; SANSOME A, 1995, ARCH DIS CHILD, V72, P25, DOI 10.1136/adc.72.1.25; SINGH G, 1994, ARTHRITIS RHEUM, V37, P1761, DOI 10.1002/art.1780371209	28	123	137	0	27	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 13	2016	387	10019					671	678		10.1016/S0140-6736(15)01021-1	http://dx.doi.org/10.1016/S0140-6736(15)01021-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD3QH	26645190				2022-12-28	WOS:000369837100026
J	Collins, LF; Geadas, C; Ellner, JJ				Collins, Lauren F.; Geadas, Carolina; Ellner, Jerrold J.			Diagnosis of Latent Tuberculosis Infection: Too Soon to Pull the Plug on the Tuberculin Skin Test	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ASSAY		[Collins, Lauren F.] Duke Univ, Med Ctr, Med Educ Off, Durham, NC 27710 USA; Boston Med Ctr, Boston, MA 02118 USA; Boston Univ, Sch Med, Boston, MA 02118 USA	Duke University; Boston Medical Center; Boston University	Ellner, JJ (corresponding author), Boston Med Ctr, Div Infect Dis, Crosstown Bldg,801 Massachusetts Ave, Boston, MA 02118 USA.	jerrold.ellner@bmc.org		Collins, Lauren/0000-0002-0170-5454	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI111276, U01AI065663] Funding Source: NIH RePORTER; NIAID NIH HHS [1U19AI111276, 5UO1AI065663] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anibarro L, 2011, SCAND J INFECT DIS, V43, P424, DOI 10.3109/00365548.2011.558912; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Kasaie P, 2014, AM J RESP CRIT CARE, V189, P845, DOI 10.1164/rccm.201310-1846OC; Lee SW, 2011, EUR RESPIR J, V37, P1447, DOI 10.1183/09031936.00089510; Mahan CS, 2012, AM J TROP MED HYG, V86, P690, DOI 10.4269/ajtmh.2012.11-0553; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Metcalfe JZ, 2013, AM J RESP CRIT CARE, V187, P206, DOI 10.1164/rccm.201203-0430OC; Rangaka MX, 2012, LANCET INFECT DIS, V12, P45, DOI 10.1016/S1473-3099(11)70210-9; Ribeiro-Rodrigues R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096564; Slater ML, 2013, AM J RESP CRIT CARE, V188, P1005, DOI 10.1164/rccm.201305-0831OC	10	8	9	1	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 19	2016	164	2					122	+		10.7326/M15-1522	http://dx.doi.org/10.7326/M15-1522			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB0CI	26642354				2022-12-28	WOS:000368175800017
J	Kiermaier, E; Moussion, C; Veldkamp, CT; Gerardy-Schahn, R; de Vries, I; Williams, LG; Chaffee, GR; Phillips, AJ; Freiberger, F; Imre, R; Taleski, D; Payne, RJ; Braun, A; Forster, R; Mechtler, K; Muhlenhoff, M; Volkman, BF; Sixt, M				Kiermaier, Eva; Moussion, Christine; Veldkamp, Christopher T.; Gerardy-Schahn, Rita; de Vries, Ingrid; Williams, Larry G.; Chaffee, Gary R.; Phillips, Andrew J.; Freiberger, Friedrich; Imre, Richard; Taleski, Deni; Payne, Richard J.; Braun, Asolina; Foerster, Reinhold; Mechtler, Karl; Muehlenhoff, Martina; Volkman, Brian F.; Sixt, Michael			Polysialylation controls dendritic cell trafficking by regulating chemokine recognition	SCIENCE			English	Article							POLYSIALIC ACID; LYMPH-NODE; POLYSIALYLTRANSFERASE; NEUROPILIN-2; HOMEOSTASIS; MIGRATION; CCL21; ENTRY	The addition of polysialic acid to N-and/or O-linked glycans, referred to as polysialylation, is a rare posttranslational modification that is mainly known to control the developmental plasticity of the nervous system. Here we show that CCR7, the central chemokine receptor controlling immune cell trafficking to secondary lymphatic organs, carries polysialic acid. This modification is essential for the recognition of the CCR7 ligand CCL21. As a consequence, dendritic cell trafficking is abrogated in polysialyltransferase-deficient mice, manifesting as disturbed lymph node homeostasis and unresponsiveness to inflammatory stimuli. Structure-function analysis of chemokine-receptor interactions reveals that CCL21 adopts an autoinhibited conformation, which is released upon interaction with polysialic acid. Thus, we describe a glycosylation-mediated immune cell trafficking disorder and its mechanistic basis.	[Kiermaier, Eva; Moussion, Christine; de Vries, Ingrid; Sixt, Michael] IST Austria, A-3400 Klosterneuburg, Austria; [Veldkamp, Christopher T.; Williams, Larry G.; Chaffee, Gary R.; Phillips, Andrew J.] Univ Wisconsin, Dept Chem, Whitewater, WI 53190 USA; [Veldkamp, Christopher T.; Volkman, Brian F.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Gerardy-Schahn, Rita; Freiberger, Friedrich; Muehlenhoff, Martina] Hannover Med Sch, Inst Cellular Chem, D-30625 Hannover, Germany; [Imre, Richard; Mechtler, Karl] AFFiRiS AG, Vienna Bioctr, Res Inst Mol Pathol, A-1030 Vienna, Austria; [Taleski, Deni; Payne, Richard J.] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia; [Braun, Asolina; Foerster, Reinhold] Hannover Med Sch MHH, Inst Immunol, D-30625 Hannover, Germany	Institute of Science & Technology - Austria; University of Wisconsin System; Medical College of Wisconsin; Hannover Medical School; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Sydney; Hannover Medical School	Kiermaier, E (corresponding author), IST Austria, Campus 1, A-3400 Klosterneuburg, Austria.	eva.kiermaier@ist.ac.at; sixt@ist.ac.at	Volkman, Brian F./ABE-7312-2020; Mechtler, Karl/AAF-2717-2019; Volkman, Brian F./ABE-7306-2020; Payne, Richard/AAH-3666-2021	Volkman, Brian F./0000-0002-6681-5179; Mechtler, Karl/0000-0002-3392-9946; Volkman, Brian F./0000-0002-6681-5179; Payne, Richard/0000-0002-3618-9226; Sixt, Michael/0000-0002-6620-9179; Forster, Reinhold/0000-0001-6190-7923; Braun, Asolina/0000-0002-2646-5362; Kiermaier, Eva/0000-0001-6165-5738	European Research Council [ERC GA 281556, ERC GA 322645]; STROMA (Stromal Cell-Immune Cell Interactions in Health and Disease) Initial Training Network of the European Commission Framework Programme; Austrian Science Foundation (FWF) [FWF TRP 308-N15]; U.S. NIH [1R15CA159202-01, R01AI058072, R01GM09738]; Austrian Science Fund (FWF) [TRP 308] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R15CA159202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM009738, R01GM097381] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); STROMA (Stromal Cell-Immune Cell Interactions in Health and Disease) Initial Training Network of the European Commission Framework Programme; Austrian Science Foundation (FWF)(Austrian Science Fund (FWF)); U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Schuchner and E. Ogris for kindly providing the antibody to GFP, M. Helmbrecht and A. Huber for providing Nrp2<SUP>-/-</SUP> mice, the IST Scientific Support Facilities for excellent services, and J. Renkawitz and K. Vaahtomeri for critically reading the manuscript. The data described in this manuscript are tabulated in the main paper and in the supplementary materials. This work was supported by the European Research Council (grants ERC GA 281556 to M.S. and ERC GA 322645 to R.F.), funding from the STROMA (Stromal Cell-Immune Cell Interactions in Health and Disease) Initial Training Network of the European Commission Framework Programme, a START award from the Austrian Science Foundation (FWF) to M.S., grant FWF TRP 308-N15 to K.M., and U.S. NIH grants 1R15CA159202-01 to C.T.V. and R01AI058072 and R01GM09738 to B.F.V.	Al-Saraireh YMJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073366; Bax M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006987; Braun A, 2011, NAT IMMUNOL, V12, P879, DOI 10.1038/ni.2085; Curreli S, 2007, J BIOL CHEM, V282, P30346, DOI 10.1074/jbc.M702965200; Drake PM, 2008, J IMMUNOL, V181, P6850, DOI 10.4049/jimmunol.181.10.6850; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; Falconer RA, 2012, CURR CANCER DRUG TAR, V12, P925; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Harduin-Lepers Anne, 2012, Front Biosci (Elite Ed), V4, P499; Hirose J, 2001, J BIOL CHEM, V276, P5228, DOI 10.1074/jbc.M007542200; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Love M, 2012, BIOCHEMISTRY-US, V51, P733, DOI 10.1021/bi201601k; MACATONIA SE, 1987, J EXP MED, V166, P1654, DOI 10.1084/jem.166.6.1654; Moussion C, 2011, NATURE, V479, P542, DOI 10.1038/nature10540; Muhlenhoff M, 2013, NEUROCHEM RES, V38, P1134, DOI 10.1007/s11064-013-0979-2; Rey-Gallardo A, 2011, GLYCOBIOLOGY, V21, P655, DOI 10.1093/glycob/cwq216; Rey-Gallardo A, 2010, GLYCOBIOLOGY, V20, P1139, DOI 10.1093/glycob/cwq078; Rollenhagen M, 2013, J BIOL CHEM, V288, P22880, DOI 10.1074/jbc.M113.463927; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Schnaar RL, 2014, PHYSIOL REV, V94, P461, DOI 10.1152/physrev.00033.2013; Vedkamp CT, 2015, BIOCHEMISTRY-US, V54, P4163, DOI 10.1021/acs.biochem.5b00560; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; Wendland M, 2011, IMMUNITY, V35, P945, DOI 10.1016/j.immuni.2011.10.017	23	105	108	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 8	2016	351	6269					186	190		10.1126/science.aad0512	http://dx.doi.org/10.1126/science.aad0512			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XQ	26657283	Green Accepted, Bronze			2022-12-28	WOS:000367806500045
J	Schwanghart, W; Bernhardt, A; Stolle, A; Hoelzmann, P; Adhikari, BR; Andermann, C; Tofelde, S; Merchel, S; Rugel, G; Fort, M; Korup, O				Schwanghart, Wolfgang; Bernhardt, Anne; Stolle, Amelie; Hoelzmann, Philipp; Adhikari, Basanta R.; Andermann, Christoff; Tofelde, Stefanie; Merchel, Silke; Rugel, Georg; Fort, Monique; Korup, Oliver			Repeated catastrophic valley infill following medieval earthquakes in the Nepal Himalaya	SCIENCE			English	Article							INDUCED LANDSLIDES; IMPACT	Geomorphic footprints of past large Himalayan earthquakes are elusive, although they are urgently needed for gauging and predicting recovery times of seismically perturbed mountain landscapes. We present evidence of catastrophic valley infill following at least three medieval earthquakes in the Nepal Himalaya. Radiocarbon dates from peat beds, plant macrofossils, and humic silts in fine-grained tributary sediments near Pokhara, Nepal's second-largest city, match the timing of nearby M > 8 earthquakes in similar to 1100, 1255, and 1344 C.E. The upstream dip of tributary valley fills and x-ray fluorescence spectrometry of their provenance rule out local sources. Instead, geomorphic and sedimentary evidence is consistent with catastrophic fluvial aggradation and debris flows that had plugged several tributaries with tens of meters of calcareous sediment from a Higher Himalayan source >60 kilometers away.	[Schwanghart, Wolfgang; Bernhardt, Anne; Stolle, Amelie; Tofelde, Stefanie; Korup, Oliver] Univ Potsdam, Inst Earth & Environm Sci, Potsdam, Germany; [Hoelzmann, Philipp] Free Univ Berlin, Inst Geog Sci, Berlin, Germany; [Adhikari, Basanta R.] Tribhuvan Univ, Inst Engn, Kathmandu, Nepal; [Andermann, Christoff] German Ctr Geosci GFZ, Helmholtz Zentrum Potsdam, Potsdam, Germany; [Merchel, Silke; Rugel, Georg] Helmholtz Inst Freiberg Resource Technol, Helmholtz Zentrum Dresden Rossendorf, Dresden, Germany; [Fort, Monique] Univ Paris Diderot SPC, CNRS, Dept Geog, UMR Prodig 8586, Paris, France	University of Potsdam; Free University of Berlin; Tribhuvan University; Institute of Engineering (IOE) - Nepal; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Schwanghart, W (corresponding author), Univ Potsdam, Inst Earth & Environm Sci, Potsdam, Germany.	w.schwanghart@geo.uni-potsdam.de	Hoelzmann, Philipp/H-7008-2019; Bernhardt, Anne/HGA-8205-2022; Schwanghart, Wolfgang/G-4205-2010; Adhikari, Basanta Raj/Q-2988-2019; Schwanghart, Wolfgang/U-2681-2019; Andermann, Christoff/J-7935-2013	Hoelzmann, Philipp/0000-0001-8709-8474; Andermann, Christoff/0000-0003-0921-8455; Merchel, Silke/0000-0002-8755-3980; Korup, Oliver/0000-0002-9084-1895	German Research Foundation [KO 3937/9]; Potsdam Research Cluster for Georisk Analysis (PROGRESS); Helmholtz Postdoc Program of the German Helmholtz Association [PD-039]	German Research Foundation(German Research Foundation (DFG)); Potsdam Research Cluster for Georisk Analysis (PROGRESS); Helmholtz Postdoc Program of the German Helmholtz Association	Funded by the German Research Foundation (KO 3937/9) and the Potsdam Research Cluster for Georisk Analysis (PROGRESS). We thank B. Sitaula for arranging logistical support; Alpine Consultancy Pvt. Ltd. Nepal and the Department of Survey, Nepal, for digital topographic data; J. Jansen, M. Roschlaub, E. Schonfeldt, J. Seidemann, and J. T. Weidinger for help with fieldwork; and H. Wittmann-Oelze for processing the Bhim Kali sample at GFZ-HELGES, Potsdam. C. A. acknowledges support from the Helmholtz Postdoc Program (PD-039) of the German Helmholtz Association. Author contributions: O.K. designed and drafted the project; W.S., A. B., A.S., B.R.A., C. A., M.F., and O.K. carried out the fieldwork; W.S., A. B., and A.S. analyzed the digital topographic and sedimentary data; P.H. assisted with the XRF and XRD analyses; S.T. prepared samples for <SUP>10</SUP>Be exposure dating; S.M., G.R., and C. A. ran the <SUP>10</SUP>Be AMS analysis; and W.S., A. B., A.S., and O.K. wrote the manuscript with inputs from all co-authors. Supporting data are available in the supplementary materials.	[Anonymous], 2010, EARTHQ VULN PROF PRE; Baker V. R., 1983, MODERN ANCIENT FLUVI, P229, DOI DOI 10.1002/9781444303773.CH18; Berryman KR, 2012, SCIENCE, V336, P1690, DOI 10.1126/science.1218959; Bilham R, 2001, SCIENCE, V293, P1442, DOI 10.1126/science.1062584; Bollinger L, 2004, TECTONICS, V23, DOI 10.1029/2003TC001564; Bollinger L, 2014, J GEOPHYS RES-SOL EA, V119, P7123, DOI 10.1002/2014JB010970; Carling PA, 2013, EARTH-SCI REV, V125, P87, DOI 10.1016/j.earscirev.2013.06.002; Ekstrom G, 2013, SCIENCE, V339, P1416, DOI 10.1126/science.1232887; Evans SG, 2009, ENG GEOL, V108, P96, DOI 10.1016/j.enggeo.2009.06.020; Evans SG, 2009, GEOMORPHOLOGY, V105, P314, DOI 10.1016/j.geomorph.2008.10.008; Fort M, 1987, Z GEOMORPH S, V63, P9; Fort M, 2010, GEOMORPHOLOGICAL LANDSCAPES OF THE WORLD, P265, DOI 10.1007/978-90-481-3055-9_27; Gabet EJ, 2004, GEOMORPHOLOGY, V63, P131, DOI 10.1016/j.geomorph.2004.03.011; Galetzka J, 2015, SCIENCE, V349, P1091, DOI 10.1126/science.aac6383; Hovius N, 2011, EARTH PLANET SC LETT, V304, P347, DOI 10.1016/j.epsl.2011.02.005; Kargel JS, 2016, SCIENCE, V351, DOI 10.1126/science.aac8353; Keefer DK, 2002, SURV GEOPHYS, V23, P473, DOI 10.1023/A:1021274710840; Koi T, 2008, GEOMORPHOLOGY, V101, P692, DOI 10.1016/j.geomorph.2008.03.007; Korup O, 2007, QUATERNARY SCI REV, V26, P3406, DOI 10.1016/j.quascirev.2007.10.012; Lave J, 2005, SCIENCE, V307, P1302, DOI 10.1126/science.1104804; Li G, 2014, GEOCHEM GEOPHY GEOSY, V15, P833, DOI 10.1002/2013GC005067; Mugnier JL, 2013, EARTH-SCI REV, V127, P30, DOI 10.1016/j.earscirev.2013.09.003; Parsons AJ, 2016, J MAPS, V12, P100, DOI 10.1080/17445647.2014.984784; PEARCE AJ, 1986, GEOLOGY, V14, P52, DOI 10.1130/0091-7613(1986)14<52:EOELOS>2.0.CO;2; Robinson DM, 2014, TECTONICS, V33, P2143, DOI 10.1002/2014TC003564; Sapkota SN, 2013, NAT GEOSCI, V6, P71, DOI [10.1038/ngeo1669, 10.1038/NGEO1669]; Shang YJ, 2003, GEOMORPHOLOGY, V54, P225, DOI 10.1016/S0169-555X(02)00358-6; Survey Department Government of Nepal, 1996, TOP MAP POKH AR; WALTHAM AC, 1972, GEOL MAG, V109, P205, DOI 10.1017/S0016756800039248; Yanites BJ, 2010, GEOLOGY, V38, P639, DOI 10.1130/G30883.1	30	37	40	1	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 8	2016	351	6269					147	150		10.1126/science.aac9865	http://dx.doi.org/10.1126/science.aac9865			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XQ	26676354				2022-12-28	WOS:000367806500035
J	Haagmans, BL; van den Brand, JMA; Raj, VS; Volz, A; Wohlsein, P; Smits, SL; Schipper, D; Bestebroer, TM; Okba, N; Fux, R; Bensaid, A; Foz, DS; Kuiken, T; Baumgartner, W; Segales, J; Sutter, G; Osterhaus, ADME				Haagmans, Bart L.; van den Brand, Judith M. A.; Raj, V. Stalin; Volz, Asisa; Wohlsein, Peter; Smits, Saskia L.; Schipper, Debby; Bestebroer, Theo M.; Okba, Nisreen; Fux, Robert; Bensaid, Albert; Foz, David Solanes; Kuiken, Thijs; Baumgaertner, Wolfgang; Segales, Joaquim; Sutter, Gerd; Osterhaus, Albert D. M. E.			An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels	SCIENCE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; RECEPTOR-BINDING DOMAIN; SAUDI-ARABIA; SPIKE PROTEIN; MOUSE MODEL; ANTIBODIES; TRACT; REPLICATION; EXPOSURE; EFFICACY	Middle East respiratory syndrome coronavirus (MERS-CoV) infections have led to an ongoing outbreak in humans, which was fueled by multiple zoonotic MERS-CoV introductions from dromedary camels. In addition to the implementation of hygiene measures to limit further camel-to-human and human-to-human transmissions, vaccine-mediated reduction of MERS-CoV spread from the animal reservoir may be envisaged. Here we show that a modified vaccinia virus Ankara (MVA) vaccine expressing the MERS-CoV spike protein confers mucosal immunity in dromedary camels. Compared with results for control animals, we observed a significant reduction of excreted infectious virus and viral RNA transcripts in vaccinated animals upon MERS-CoV challenge. Protection correlated with the presence of serum neutralizing antibodies to MERS-CoV. Induction of MVA-specific antibodies that cross-neutralize camelpox virus would also provide protection against camelpox.	[Haagmans, Bart L.; van den Brand, Judith M. A.; Raj, V. Stalin; Smits, Saskia L.; Schipper, Debby; Bestebroer, Theo M.; Okba, Nisreen; Kuiken, Thijs; Osterhaus, Albert D. M. E.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [Volz, Asisa; Fux, Robert; Sutter, Gerd] Univ Munich, Inst Infect Dis & Zoonoses, German Ctr Infect Res DZIF, Munich, Germany; [Wohlsein, Peter; Baumgaertner, Wolfgang] Univ Vet Med, Dept Pathol, Hannover, Germany; [Bensaid, Albert; Foz, David Solanes; Segales, Joaquim] Univ Autonoma Barcelona, IRTA, CReSA, Bellaterra 08193, Spain; [Segales, Joaquim] Univ Autonoma Barcelona, Fac Vet, Dept Sanitat & Anat Anim, Bellaterra 08193, Spain; [Osterhaus, Albert D. M. E.] Artemis One Hlth, Utrecht, Netherlands; [Osterhaus, Albert D. M. E.] Univ Vet Med, Res Ctr Emerging Infect & Zoonoses RIZ, Hannover, Germany	Erasmus University Rotterdam; Erasmus MC; German Center for Infection Research; University of Munich; University of Veterinary Medicine Hannover, Foundation; Autonomous University of Barcelona; IRTA; Autonomous University of Barcelona; University of Veterinary Medicine Hannover, Foundation	Haagmans, BL (corresponding author), Erasmus MC, Dept Virosci, Rotterdam, Netherlands.	b.haagmans@erasmusmc.nl; gerd.sutter@lmu.de; albert.osterhaus@tiho-hannover.de	Okba, Nisreen MA/K-9984-2017; Segalés, Joaquim/AAB-4815-2020; Raj, V Stalin/E-9670-2016; Bensaid, Albert/K-1960-2017; Segalés, Joaquim/A-4933-2011; Haagmans, Bart/E-9791-2015	Okba, Nisreen MA/0000-0002-2394-1079; Segalés, Joaquim/0000-0002-1539-7261; Raj, V Stalin/0000-0003-2250-8481; Bensaid, Albert/0000-0001-6493-3756; Segalés, Joaquim/0000-0002-1539-7261; Haagmans, Bart/0000-0001-6221-2015; Fux, Robert/0000-0002-1149-1613; Sutter, Gerd/0000-0001-6143-082X; Baumgartner, Wolfgang/0000-0001-8151-5644; Kuiken, Thijs/0000-0001-5501-9049	Nederlandse Organisatie voor Wetenschappelijk Onderzoek [91213066]; Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony, Germany; Zoonotic Anticipation and Preparedness Initiative (ZAPI project) [Innovative Medicines Initiative (IMI) grant] [115760]; IMI; European Commission	Nederlandse Organisatie voor Wetenschappelijk Onderzoek(Netherlands Organization for Scientific Research (NWO)European Commission); Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony, Germany; Zoonotic Anticipation and Preparedness Initiative (ZAPI project) [Innovative Medicines Initiative (IMI) grant]; IMI; European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank F. van der Panne for figure preparation and P. van Run, S. Jany, X. Abad, I. Cordon, M. Jesus Navas, M. Mora, and all animal caretakers from the CReSA biosecurity level 3 laboratories and animal facilities for technical assistance. This study was funded by Nederlandse Organisatie voor Wetenschappelijk Onderzoek (grant 91213066) and was supported in part by the Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony, Germany. Animal model development was performed as part of the Zoonotic Anticipation and Preparedness Initiative (ZAPI project) [Innovative Medicines Initiative (IMI) grant 115760], with assistance and financial support from IMI and the European Commission and contributions from the EFPIA partners. B.L.H., V.S.R., T.M.B., G.S., and A.D.M.E.O. have applied for patents on MERS-CoV. A.D.M.E.O. is chief scientific officer of Viroclinics Biosciences. A.D.M.E.O and T.K. hold certificates of shares in Viroclinics Biosciences. Nucleotide sequence data are available in GenBank under accession numbers KT966879 and KT966880.	Adney DR, 2014, EMERG INFECT DIS, V20, P1999, DOI 10.3201/eid2012.141280; Alagaili Abdulaziz N, 2014, mBio, V5, pe00884, DOI 10.1128/mBio.00884-14; Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742; Chan RWY, 2014, LANCET RESP MED, V2, P813, DOI 10.1016/S2213-2600(14)70158-4; de Wit E, 2013, P NATL ACAD SCI USA, V110, P16598, DOI 10.1073/pnas.1310744110; Du LY, 2013, J VIROL, V87, P9939, DOI 10.1128/JVI.01048-13; Duraffour S, 2011, ANTIVIR RES, V92, P167, DOI 10.1016/j.antiviral.2011.09.003; Haagmans BL, 2015, J VIROL, V89, P6131, DOI 10.1128/JVI.00661-15; Haagmans BL, 2014, LANCET INFECT DIS, V14, P140, DOI 10.1016/S1473-3099(13)70690-X; HAFEZ SM, 1992, VACCINE, V10, P533, DOI 10.1016/0264-410X(92)90353-L; Hemida MG, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.23.20828; Hemida MG, 2014, EMERG INFECT DIS, V20, P1231, DOI 10.3201/eid2007.140571; Khalafalla AI, 2015, EMERG INFECT DIS, V21, P1153, DOI 10.3201/eid2107.150070; Memish ZA, 2014, EMERG INFECT DIS, V20, P1012, DOI 10.3201/eid2006.140402; Mou H, 2013, J VIROL, V87, P9379, DOI 10.1128/JVI.01277-13; Muller MA, 2015, LANCET INFECT DIS, V15, P559, DOI 10.1016/S1473-3099(15)70090-3; Muller MA, 2014, EMERG INFECT DIS, V20, P2093, DOI 10.3201/eid2012.141026; Muthumani K, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac7462; Pascal KE, 2015, P NATL ACAD SCI USA, V112, P8738, DOI 10.1073/pnas.1510830112; Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005; Reusken CBEM, 2015, EMERG INFECT DIS, V21, P1422, DOI 10.3201/eid2108.150481; Reusken CBEM, 2014, EMERG INFECT DIS, V20, P1370, DOI 10.3201/eid2008.140590; Reusken CBEM, 2013, LANCET INFECT DIS, V13, P859, DOI 10.1016/S1473-3099(13)70164-6; Song F, 2013, J VIROL, V87, P11950, DOI 10.1128/JVI.01672-13; Stittelaar KJ, 2000, J VIROL, V74, P4236, DOI 10.1128/JVI.74.9.4236-4243.2000; van Boheemen S, 2012, MBIO, V3, DOI 10.1128/mBio.00473-12; VENNEMA H, 1990, J VIROL, V64, P1407, DOI 10.1128/JVI.64.3.1407-1409.1990; Volz A, 2015, J VIROL, V89, P8651, DOI 10.1128/JVI.00614-15; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhao JC, 2015, J VIROL, V89, P6117, DOI 10.1128/JVI.00446-15; Zhao JC, 2014, P NATL ACAD SCI USA, V111, P4970, DOI 10.1073/pnas.1323279111; Zumla A, 2015, LANCET, V386, P995, DOI 10.1016/S0140-6736(15)60454-8	32	186	199	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2016	351	6268					77	81		10.1126/science.aad1283	http://dx.doi.org/10.1126/science.aad1283			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ8QM	26678878	Green Published			2022-12-28	WOS:000367364200046
J	Huang, W; Thomas, B; Flynn, RA; Gavzy, SJ; Wu, L; Kim, SV; Hall, JA; Miraldi, ER; Ng, CP; Rigo, FW; Meadows, S; Montoya, NR; Herrera, NG; Domingos, AI; Rastinejad, F; Myers, RM; Fuller-Pace, FV; Bonneau, R; Chang, HY; Acuto, O; Littman, DR				Huang, Wendy; Thomas, Benjamin; Flynn, Ryan A.; Gavzy, Samuel J.; Wu, Lin; Kim, Sangwon V.; Hall, Jason A.; Miraldi, Emily R.; Ng, Charles P.; Rigo, Frank W.; Meadows, Sarah; Montoya, Nina R.; Herrera, Natalia G.; Domingos, Ana I.; Rastinejad, Fraydoon; Myers, Richard M.; Fuller-Pace, Frances V.; Bonneau, Richard; Chang, Howard Y.; Acuto, Oreste; Littman, Dan R.			RETRACTED: DDX5 and its associated lncRNA Rmrp modulate T(H)17 cell effector functions (Retracted article. See vol. 562, pg. 150, 2018)	NATURE			English	Article; Retracted Publication							ROR-GAMMA-T; LONG NONCODING RNA; P68 DDX5; HELICASE P68; TH17 CELLS; PHASE-I; DIFFERENTIATION; TRANSCRIPTION; PROTEINS; SUSCEPTIBILITY	T helper 17 (T(H)17) lymphocytes protect mucosal barriers from infections, but also contribute to multiple chronic inflammatory diseases. Their differentiation is controlled by ROR gamma t, a ligand-regulated nuclear receptor. Here we identify the RNA helicase DEAD-box protein 5 (DDX5) as a ROR gamma t partner that coordinates transcription of selective T(H)17 genes, and is required for T(H)17-mediated inflammatory pathologies. Surprisingly, the ability of DDX5 to interact with ROR gamma t and coactivate its targets depends on intrinsic RNA helicase activity and binding of a conserved nuclear long noncoding RNA (lncRNA), Rmrp, which is mutated in patients with cartilage-hair hypoplasia. A targeted Rmrp gene mutation in mice, corresponding to a gene mutation in cartilage-hair hypoplasia patients, altered lncRNA chromatin occupancy, and reduced the DDX5-ROR gamma t interaction and ROR gamma t target gene transcription. Elucidation of the link between Rmrp and the DDX5-ROR gamma t complex reveals a role for RNA helicases and lncRNAs in tissue-specific transcriptional regulation, and provides new opportunities for therapeutic intervention in T(H)17-dependent diseases.	[Huang, Wendy; Gavzy, Samuel J.; Wu, Lin; Kim, Sangwon V.; Hall, Jason A.; Miraldi, Emily R.; Ng, Charles P.; Montoya, Nina R.; Herrera, Natalia G.; Littman, Dan R.] NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10016 USA; [Thomas, Benjamin; Acuto, Oreste] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Flynn, Ryan A.; Chang, Howard Y.] Stanford Univ, Ctr Personal Dynam Regulomes, Stanford, CA 94305 USA; [Miraldi, Emily R.; Bonneau, Richard] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Miraldi, Emily R.; Bonneau, Richard] NYU, Courant Inst Math Sci, Dept Comp Sci, New York, NY 10012 USA; [Miraldi, Emily R.; Bonneau, Richard] Simons Fdn, Simons Ctr Data Anal, New York, NY 10010 USA; [Rigo, Frank W.] ISIS Pharmaceut, Carlsbad, CA 92010 USA; [Meadows, Sarah; Myers, Richard M.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Domingos, Ana I.] Inst Gulbenkian Ciencias, P-2780156 Oeiras, Portugal; [Rastinejad, Fraydoon] Sanford Burnham Prebys Med Discovery Inst, Integrat Metab Program, Orlando, FL 32827 USA; [Fuller-Pace, Frances V.] Univ Dundee, Div Canc Res, Dundee DD1 9SY, Scotland; [Littman, Dan R.] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA	New York University; University of Oxford; Stanford University; New York University; New York University; Isis Pharmaceuticals Inc; HudsonAlpha Institute for Biotechnology; Instituto Gulbenkian de Ciencia; Sanford Burnham Prebys Medical Discovery Institute; University of Dundee; Howard Hughes Medical Institute; New York University	Littman, DR (corresponding author), NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10016 USA.	dan.littman@med.nyu.edu	Bonneau, Richard/ABD-6737-2021; Bonneau, Richard/GZL-2900-2022	Flynn, Ryan/0000-0001-5013-0442; Domingos, Ana/0000-0002-7938-4814; Gavzy, Samuel/0000-0002-4880-0301	Cancer Research Institute Irvington Postdoctoral Fellowship; Institutional NRSA [T32 CA009161_Levy]; National Multiple Sclerosis Society postdoctoral fellowship [FG 2089-A-1]; Crohn's and Colitis Foundation of America [329388]; Dale and Betty Frey Fellowship of the Damon Runyon Cancer Research Foundation [2105-12]; HHMI Exceptional Research Opportunities Program; NIH [F30 1F30CA189514-01, P50-HG007735, R01HG004361, R01AI080885, R01DK103358]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [F30CA189514, P30CA016087, T32CA009161] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004361, P50HG007735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080885, T32AI100853, R01AI121436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103358, R01DK101520] Funding Source: NIH RePORTER	Cancer Research Institute Irvington Postdoctoral Fellowship; Institutional NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society postdoctoral fellowship(National Multiple Sclerosis Society); Crohn's and Colitis Foundation of America; Dale and Betty Frey Fellowship of the Damon Runyon Cancer Research Foundation; HHMI Exceptional Research Opportunities Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. V. Pokrovskii for unpublished ATAC-seq data and L. X. Garmire for suggestions on our manuscript. This work was supported by a Cancer Research Institute Irvington Postdoctoral Fellowship (W.H.), Institutional NRSA T32 CA009161_Levy (W.H.), National Multiple Sclerosis Society postdoctoral fellowship FG 2089-A-1 (L.W.), Career Development Award (329388) from the Crohn's and Colitis Foundation of America (S.V.K.), Dale and Betty Frey Fellowship of the Damon Runyon Cancer Research Foundation 2105-12 (J.A.H.), HHMI Exceptional Research Opportunities Program (N.R.M. and N.H.), NIH F30 1F30CA189514-01 (R.A.F.), NIH P50-HG007735 and R01HG004361 (H.Y.C.), NIH R01AI080885 (D.R.L.), NIH R01DK103358 (R.B. and D.R.L.), and the Howard Hughes Medical Institute (H.Y.C. and D.R.L.).	Arun G, 2012, MOL CELL BIOL, V32, P3140, DOI 10.1128/MCB.00006-12; Bacchetta J, 2009, PEDIATR NEPHROL, V24, P2449, DOI 10.1007/s00467-009-1256-0; Bates GJ, 2005, EMBO J, V24, P543, DOI 10.1038/sj.emboj.7600550; Bonafe L, 2005, PLOS GENET, V1, P444, DOI 10.1371/journal.pgen.0010047; Bonasio R, 2014, ANNU REV GENET, V48, P433, DOI 10.1146/annurev-genet-120213-092323; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Calo E, 2015, NATURE, V518, P249, DOI 10.1038/nature13923; Caretti G, 2006, DEV CELL, V11, P547, DOI 10.1016/j.devcel.2006.08.003; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Chien YH, 2013, TRENDS IMMUNOL, V34, P151, DOI 10.1016/j.it.2012.11.004; Chu C, 2012, JOVE-J VIS EXP, DOI 10.3791/3912; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Clark EL, 2008, CANCER RES, V68, P7938, DOI 10.1158/0008-5472.CAN-08-0932; Croswell A, 2009, INFECT IMMUN, V77, P2741, DOI 10.1128/IAI.00006-09; Dardenne E, 2014, CELL REP, V7, P1900, DOI 10.1016/j.celrep.2014.05.010; Esakova O, 2010, RNA, V16, P1725, DOI 10.1261/rna.2214510; Flynn RA, 2015, RNA, V21, P135, DOI 10.1261/rna.047803.114; Fuller-Pace FV, 2011, FUTURE ONCOL, V7, P239, DOI 10.2217/FON.11.1; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Genovese MC, 2010, ARTHRITIS RHEUM-US, V62, P929, DOI 10.1002/art.27334; Gomez JA, 2013, CELL, V152, P743, DOI 10.1016/j.cell.2013.01.015; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; HSIEH CL, 1990, GENOMICS, V6, P540, DOI 10.1016/0888-7543(90)90483-B; Huang YL, 2002, J BIOL CHEM, V277, P12810, DOI 10.1074/jbc.M200182200; Huh JR, 2013, ACS MED CHEM LETT, V4, P79, DOI 10.1021/ml300286h; Huh JR, 2011, NATURE, V472, P486, DOI 10.1038/nature09978; Ilik IA, 2013, MOL CELL, V51, P156, DOI 10.1016/j.molcel.2013.07.001; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jalal C, 2007, NUCLEIC ACIDS RES, V35, P3590, DOI 10.1093/nar/gkm058; Jensen ED, 2008, J CELL BIOCHEM, V103, P1438, DOI 10.1002/jcb.21526; Kang HS, 2007, PHYSIOL GENOMICS, V31, P281, DOI 10.1152/physiolgenomics.00098.2007; Kim SV, 2013, SCIENCE, V340, P1456, DOI 10.1126/science.1237013; Kondo Y, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0606-5; Lee YJ, 2013, NAT IMMUNOL, V14, P1146, DOI 10.1038/ni.2731; Leppkes M, 2009, GASTROENTEROLOGY, V136, P257, DOI 10.1053/j.gastro.2008.10.018; Lin CR, 2005, MOL CELL BIOL, V25, P7484, DOI 10.1128/MCB.25.17.7484-7493.2005; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Maenner S, 2013, MOL CELL, V51, P174, DOI 10.1016/j.molcel.2013.06.011; Makitie O, 1998, EUR J PEDIATR, V157, P816, DOI 10.1007/s004310050943; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Meng LY, 2015, NATURE, V518, P409, DOI 10.1038/nature13975; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nicol SM, 2013, ONCOGENE, V32, P3461, DOI 10.1038/onc.2012.426; O'Malley BW, 2009, CANCER RES, V69, P8217, DOI 10.1158/0008-5472.CAN-09-2223; Ostanin DV, 2009, AM J PHYSIOL-GASTR L, V296, pG135, DOI 10.1152/ajpgi.90462.2008; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; Rosenbluh J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026270; Sano T, 2015, CELL; Santori FR, 2015, CELL METAB, V21, P286, DOI 10.1016/j.cmet.2015.01.004; Stanley S, 2013, CELL METAB, V18, P596, DOI 10.1016/j.cmet.2013.09.002; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Wang Y, 2014, IMMUNITY, V40, P355, DOI 10.1016/j.immuni.2014.01.002; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wortham NC, 2009, ONCOGENE, V28, P4053, DOI 10.1038/onc.2009.261; Yang JF, 2014, TRENDS PHARMACOL SCI, V35, P493, DOI 10.1016/j.tips.2014.07.006; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279	60	131	138	0	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2015	528	7583					517	+		10.1038/nature16193	http://dx.doi.org/10.1038/nature16193			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ3GH	26675721	Green Accepted, Green Published			2022-12-28	WOS:000366991900044
J	Mercier, FE; Scadden, DT				Mercier, Francois E.; Scadden, David T.			Not All Created Equal: Lineage Hard-Wiring in the Production of Blood	CELL			English	Editorial Material							STEM-CELL HIERARCHY	The multiple cell types comprising blood have been thought to emerge from progenitors with progressively narrower lineage options. New data suggest that lineage fate may be determined earlier than thought and that myeloid progenitor populations are aggregates of individual lineage-restricted cells.	[Mercier, Francois E.; Scadden, David T.] Massachusetts Gen Hosp, Ctr Regenerat Med & Canc Ctr, Boston, MA 02114 USA; [Mercier, Francois E.; Scadden, David T.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Mercier, Francois E.; Scadden, David T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University	Scadden, DT (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med & Canc Ctr, 185 Cambridge St, Boston, MA 02114 USA.	david_scadden@harvard.edu						Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Chao MP, 2008, COLD SH Q B, V73, P439, DOI 10.1101/sqb.2008.73.031; Perie L, 2015, CELL, V163, P1655, DOI 10.1016/j.cell.2015.11.059; Sanjuan-Pla A, 2013, NATURE, V502, P232, DOI 10.1038/nature12495; Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824; Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007	7	17	17	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2015	163	7					1568	1570		10.1016/j.cell.2015.12.013	http://dx.doi.org/10.1016/j.cell.2015.12.013			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CZ1GN	26687347	Bronze			2022-12-28	WOS:000366854200003
J	Okwara, C; Cangemi, D				Okwara, Chinemerem; Cangemi, David			Achalasia with Megaesophagus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Okwara, Chinemerem; Cangemi, David] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Okwara, C (corresponding author), Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA.	chinemerem.okwara@phhs.org							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 17	2015	373	25							e30	10.1056/NEJMicm1502835	http://dx.doi.org/10.1056/NEJMicm1502835			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY5QD	26672871				2022-12-28	WOS:000366461400013
J	Shaw, DM				Shaw, David M.			CHRISTMAS 2015: CALL TO ACTION The ghost of donor passed	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								I am an angry ghost. I died in a car crash last month. I'm not very happy about that, but that's not why I'm angry. I was a registered organ donor, and my wife didn't respect my wish to donate my organs. I'm a bit upset with her about that, but I'm really angry because the medical team let my wife, who was in great distress, over-rule my wishes without asking her to reconsider. When she told the medical team that she was too upset to agree to donation, they simply accepted that in order to avoid upsetting her further. I'm angry because they did that despite knowing that they are supposed to respect the wishes of registered donors. It was as if I wasn't there. No-one spoke for me. I'm also angry because my wife now regrets her decision and there's nothing she can do about it. She hates the fact that she disrespected my last wish, and this has caused arguments with my parents too. She was denied the opportunity to use my death to save and improve lives. This is the medical team's fault. And I'm angry because two other people have died because they didn't get my organs. They're my ghost friends. We're all angry that their deaths are partly due to the ease with which my wife was able to over-rule my wishes. They are angry because their families are in extreme distress. All of this is because of the failure of the medical team, which should not have given in to my wife without a fight. I am an angry ghost. I have very many reasons to be angry. And I have very many ghostly	[Shaw, David M.] Univ Basel, Inst Biomed Eth, CH-4056 Basel, Switzerland	University of Basel	Shaw, DM (corresponding author), Univ Basel, Inst Biomed Eth, CH-4056 Basel, Switzerland.	david.shaw@unibas.ch						NHS Blood and Transplant, ANN ACT REP 2014 15; Shaw D, 2015, ANAESTHESIA, V70, P10, DOI 10.1111/anae.12931; Shaw D, 2012, WE SHOULD NOT LET FA, V345, pe5275; Shaw D, 2014, INTENS CARE MED, V40, P96, DOI 10.1007/s00134-013-3096-4	4	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 16	2015	351								h6244	10.1136/bmj.h6244	http://dx.doi.org/10.1136/bmj.h6244			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ4MP	26673170				2022-12-28	WOS:000367077600001
J	Anglaret, X				Anglaret, X.			In HIV-1, immediate vs deferred antiretroviral therapy and isoniazid vs no isoniazid reduced severe illness at 30 mo	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Anglaret, X.] Univ Bordeaux, Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux	Anglaret, X (corresponding author), Univ Bordeaux, Bordeaux, France.	xavier.anglaret@isped.u-bordeaux2.fr	Anglaret, Xavier/T-2757-2019	Anglaret, Xavier/0000-0003-3319-8423					0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	2015	163	12							JC5	10.7326/ACPJC-2015-163-12-005	http://dx.doi.org/10.7326/ACPJC-2015-163-12-005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY4BS	26666807				2022-12-28	WOS:000366354200005
J	Lowe, J; Howlett, DC				Lowe, James; Howlett, David C.			A case of double vision	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Lowe, James] Eastbourne Dist Gen Hosp, Eastbourne, E Sussex, England; [Howlett, David C.] East Sussex Hosp NHS Trust, Dept Radiol, Eastbourne, E Sussex, England		Lowe, J (corresponding author), Eastbourne Dist Gen Hosp, Eastbourne, E Sussex, England.	james.lowe1@nhs.net							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 15	2015	351								h6706	10.1136/bmj.h6706	http://dx.doi.org/10.1136/bmj.h6706			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ4ML	26671690				2022-12-28	WOS:000367077200004
J	Feily, A				Feily, Amir			Squamous-Cell Carcinoma of the Nail Bed	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Feily, Amir] Univ Tehran Med Sci, Skin & Stem Cell Res Ctr, Tehran, Iran	Tehran University of Medical Sciences	Feily, A (corresponding author), Univ Tehran Med Sci, Skin & Stem Cell Res Ctr, Tehran, Iran.	dr.feily@yahoo.com		Feily, Amir/0000-0001-6846-1346					0	2	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 10	2015	373	24					2357	2357		10.1056/NEJMicm1502637	http://dx.doi.org/10.1056/NEJMicm1502637			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY0QW	26650155				2022-12-28	WOS:000366111600010
J	Zecevic, J; Vanbutsele, G; de Jong, KP; Martens, JA				Zecevic, Jovana; Vanbutsele, Gina; de Jong, Krijn P.; Martens, Johan A.			Nanoscale intimacy in bifunctional catalysts for selective conversion of hydrocarbons	NATURE			English	Article							HYDROCRACKING CATALYSTS; ZEOLITES; NANOPARTICLES; HYDROISOMERIZATION; ACID; ISOMERIZATION; PARAFFINS; PLATINUM; CRYSTALS; OLEFINS	The ability to control nanoscale features precisely is increasingly being exploited to develop and improve monofunctional catalysts(1-4). Striking effects might also be expected in the case of bifunctional catalysts, which are important in the hydrocracking of fossil and renewable hydrocarbon sources to provide high-quality diesel fuel(5-7). Such bifunctional hydrocracking catalysts contain metal sites and acid sites, and for more than 50 years the so-called intimacy criterion(8) has dictated the maximum distance between the two types of site, beyond which catalytic activity decreases. A lack of synthesis and material-characterization methods with nanometre precision has long prevented in-depth exploration of the intimacy criterion, which has often been interpreted simply as 'the closer the better' for positioning metal and acid sites(8-11). Here we show for a bifunctional catalyst-comprising an intimate mixture of zeolite Y and alumina binder, and with platinum metal controllably deposited on either the zeolite or the binder-that closest proximity between metal and zeolite acid sites can be detrimental. Specifically, the selectivity when cracking large hydrocarbon feedstock molecules for high-quality diesel production is optimized with the catalyst that contains platinum on the binder, that is, with a nanoscale rather than closest intimacy of the metal and acid sites. Thus, cracking of the large and complex hydrocarbon molecules that are typically derived from alternative sources, such as gas-to-liquid technology, vegetable oil or algal oil(6,7), should benefit especially from bifunctional catalysts that avoid locating platinum on the zeolite (the traditionally assumed optimal location). More generally, we anticipate that the ability demonstrated here to spatially organize different active sites at the nanoscale will benefit the further development and optimization of the emerging generation of multifunctional catalysts(12-15).	[Zecevic, Jovana; de Jong, Krijn P.] Univ Utrecht, Debye Inst Nanomat Sci, Inorgan Chem & Catalysis, NL-3584 CG Utrecht, Netherlands; [Vanbutsele, Gina; Martens, Johan A.] Katholieke Univ Leuven, Ctr Surface Chem & Catalysis, B-3001 Leuven, Belgium	Utrecht University; KU Leuven	Martens, JA (corresponding author), Katholieke Univ Leuven, Ctr Surface Chem & Catalysis, Celestijnenlaan 200F Postbus 2461, B-3001 Leuven, Belgium.	k.p.dejong@uu.nl; johan.martens@biw.kuleuven.be	Zecevic, Jovana/H-4553-2016; de Jong, Krijn P/C-5319-2009	Zecevic, Jovana/0000-0002-7771-2319; Martens, Johan/0000-0002-9292-2357	NRSC-C; European Research Council, EU FP7 ERC Advanced [338846]; Flemish government via the Methusalem program	NRSC-C; European Research Council, EU FP7 ERC Advanced; Flemish government via the Methusalem program	This work has been supported by the NRSC-C and the European Research Council, EU FP7 ERC Advanced Grant no. 338846. (J.Z. and K.P.deJ.), and by the Flemish government via the Methusalem program (J.A.M.). We thank J. D. Meeldijk for assistance with ultramicrotomy and electron microscopy; M. Rigutto (Shell Projects and Technology) for the zeolite-alumina extrudates; R. Oord and J. Ruiz-Martinez for ammonia TPD measurements; and M. De Prins and S. Radhakrishnan for help with the catalytic experiments.	Awala H, 2015, NAT MATER, V14, P447, DOI [10.1038/NMAT4173, 10.1038/nmat4173]; Batalha N, 2013, J CATAL, V307, P122, DOI 10.1016/j.jcat.2013.07.014; Boubnov A, 2012, APPL CATAL B-ENVIRON, V126, P315, DOI 10.1016/j.apcatb.2012.07.029; Bouchy C, 2009, OIL GAS SCI TECHNOL, V64, P91, DOI 10.2516/ogst/2008047; Burnens G, 2011, J CATAL, V282, P145, DOI 10.1016/j.jcat.2011.06.007; Cho HR, 2015, CATAL TODAY, V246, P143, DOI 10.1016/j.cattod.2014.09.029; COONRADT HL, 1964, IND ENG CHEM PROC DD, V3, P38, DOI 10.1021/i260009a010; Cui CH, 2013, NAT MATER, V12, P765, DOI [10.1038/NMAT3668, 10.1038/nmat3668]; de Jong KP, 2010, ANGEW CHEM INT EDIT, V49, P10074, DOI 10.1002/anie.201004360; Francis J, 2011, APPL CATAL A-GEN, V409, P140, DOI 10.1016/j.apcata.2011.09.040; Galvis HMT, 2012, SCIENCE, V335, P835, DOI 10.1126/science.1215614; Gao J, 2015, SCIENCE, V348, P686, DOI 10.1126/science.aaa7048; Gommes CJ, 2015, ANGEW CHEM INT EDIT, V54, P11804, DOI 10.1002/anie.201505359; Guisnet M, 2013, CATAL TODAY, V218, P123, DOI 10.1016/j.cattod.2013.04.028; Huber GW, 2005, SCIENCE, V308, P1446, DOI 10.1126/science.1111166; Huybrechts W, 2003, APPL CATAL A-GEN, V243, P1, DOI 10.1016/S0926-860X(02)00536-7; Kim J, 2013, J CATAL, V301, P187, DOI 10.1016/j.jcat.2013.02.015; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Landau MV, 2003, IND ENG CHEM RES, V42, P2773, DOI 10.1021/ie020899o; Luo WH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7540; MARTENS JA, 1995, ANGEW CHEM INT EDIT, V34, P2528, DOI 10.1002/anie.199525281; MARTENS JA, 1986, APPL CATAL, V20, P283; MARTENS JA, 2001, STUD SURF SCI CATAL, V137, P633, DOI DOI 10.1016/S0167-2991(01)80256-1; Peng XB, 2015, ANGEW CHEM INT EDIT, V54, P4553, DOI 10.1002/anie.201411708; Prieto G, 2013, NAT MATER, V12, P34, DOI [10.1038/NMAT3471, 10.1038/nmat3471]; Schreier M, 2005, NANOTECHNOLOGY, V16, pS582, DOI 10.1088/0957-4484/16/7/036; Tran NH, 2010, FUEL, V89, P265, DOI 10.1016/j.fuel.2009.08.015; Van Santen RA, 2009, ACCOUNTS CHEM RES, V42, P57, DOI 10.1021/ar800022m; WEISZ PB, 1962, ADV CATAL, V13, P137, DOI 10.1016/S0360-0564(08)60287-4; Weitkamp J, 2012, CHEMCATCHEM, V4, P292, DOI 10.1002/cctc.201100315; Yamada Y, 2011, NAT CHEM, V3, P372, DOI [10.1038/NCHEM.1018, 10.1038/nchem.1018]; Zecevic J, 2013, ACS NANO, V7, P3698, DOI 10.1021/nn400707p; ZHANG AH, 1995, IND ENG CHEM RES, V34, P1074, DOI 10.1021/ie00043a008	33	325	338	47	645	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2015	528	7581					245	+		10.1038/nature16173	http://dx.doi.org/10.1038/nature16173			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9VH	26659185	Green Published, Green Accepted			2022-12-28	WOS:000366053300037
J	MacVicar, BA				MacVicar, Brian A.			Driving the Early Auditory Network the Old-Fashioned Way	CELL			English	Editorial Material							CHANNELS; SYSTEM	Spontaneous neuronal activity during the development of the auditory sensory system is important in establishing mature connectivity. Wang et al. show that glia-like cells drive spontaneous spiking in neighboring cochlear inner hair cells via a process that involves osmotic cell shrinkage and the secretion of potassium ions.	[MacVicar, Brian A.] Univ British Columbia, Dept Psychiat, Fac Med, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	MacVicar, BA (corresponding author), Univ British Columbia, Dept Psychiat, Fac Med, Djavad Mowafaghian Ctr Brain Hlth, 2215 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.	bmacvicar@brain.ubc.ca	MacVicar, Brian/AAI-7729-2020	MacVicar, Brian/0000-0003-4596-4623				Blankenship AG, 2010, NAT REV NEUROSCI, V11, P18, DOI 10.1038/nrn2759; BORMANN J, 1988, P NATL ACAD SCI USA, V85, P9336, DOI 10.1073/pnas.85.23.9336; Frizzell RA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009563; Huang F, 2012, PHARMACOL REV, V64, P1, DOI 10.1124/pr.111.005009; Kofuji P, 2004, NEUROSCIENCE, V129, P1045, DOI 10.1016/j.neurscience.2004.06.008; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; Tritsch NX, 2007, NATURE, V450, P50, DOI 10.1038/nature06233; Tritsch NX, 2010, NAT NEUROSCI, V13, P1050, DOI 10.1038/nn.2604; Wang R. C., 2015, CELL, V163, P1348	10	1	1	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 6	2015	163	6					1307	1308		10.1016/j.cell.2015.11.039	http://dx.doi.org/10.1016/j.cell.2015.11.039			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SE	26638064	Bronze			2022-12-28	WOS:000366044800009
J	Elhatisari, S; Lee, D; Rupak, G; Epelbaum, E; Krebs, H; Lahde, TA; Luu, T; Meissner, UG				Elhatisari, Serdar; Lee, Dean; Rupak, Gautam; Epelbaum, Evgeny; Krebs, Hermann; Laehde, Timo A.; Luu, Thomas; Meissner, Ulf-G.			Ab initio alpha-alpha scattering	NATURE			English	Article							NUMERICAL-SIMULATION; NUCLEAR; LATTICE; ENERGY; SYMMETRY; CAPTURE; STATES; STARS	Processes such as the scattering of alpha particles (He-4), the triple-alpha reaction, and alpha capture play a major role in stellar nucleosynthesis. In particular, alpha capture on carbon determines the ratio of carbon to oxygen during helium burning, and affects subsequent carbon, neon, oxygen, and silicon burning stages. It also substantially affects models of thermonuclear type Ia supernovae, owing to carbon detonation in accreting carbon-oxygen white-dwarf stars(1-3). In these reactions, the accurate calculation of the elastic scattering of alpha particles and alpha-like nuclei-nuclei with even and equal numbers of protons and neutrons-is important for understanding background and resonant scattering contributions. First-principles calculations of processes involving alpha particles and alpha-like nuclei have so far been impractical, owing to the exponential growth of the number of computational operations with the number of particles. Here we describe an ab initio calculation of alpha-alpha scattering that uses lattice Monte Carlo simulations. We use lattice effective field theory to describe the low-energy interactions of protons and neutrons, and apply a technique called the 'adiabatic projection method' to reduce the eight-body system to a two-cluster system. We take advantage of the computational efficiency and the more favourable scaling with system size of auxiliary-field Monte Carlo simulations to compute an ab initio effective Hamiltonian for the two clusters. We find promising agreement between lattice results and experimental phase shifts for s-wave and d-wave scattering. The approximately quadratic scaling of computational operations with particle number suggests that it should be possible to compute alpha scattering and capture on carbon and oxygen in the near future. The methods described here can be applied to ultracold atomic few-body systems as well as to hadronic systems using lattice quantum chromodynamics to describe the interactions of quarks and gluons.	[Elhatisari, Serdar; Luu, Thomas; Meissner, Ulf-G.] Univ Bonn, Helmholtz Inst Strahlen & Kernphys, D-53115 Bonn, Germany; [Elhatisari, Serdar; Luu, Thomas; Meissner, Ulf-G.] Univ Bonn, Bethe Ctr Theoret Phys, D-53115 Bonn, Germany; [Lee, Dean] N Carolina State Univ, Dept Phys, Raleigh, NC 27695 USA; [Rupak, Gautam] Mississippi State Univ, Dept Phys & Astron, Mississippi State, MS 39762 USA; [Rupak, Gautam] Mississippi State Univ, Ctr Computat Sci HPC2, Mississippi State, MS 39762 USA; [Epelbaum, Evgeny; Krebs, Hermann] Ruhr Univ Bochum, Inst Theoret Phys 2, D-44870 Bochum, Germany; [Laehde, Timo A.; Luu, Thomas; Meissner, Ulf-G.] Forschungszentrum Julich, Inst Adv Simulat, Inst Kernphys, D-52425 Julich, Germany; [Laehde, Timo A.; Luu, Thomas; Meissner, Ulf-G.] Forschungszentrum Julich, Julich Ctr Hadron Phys, D-52425 Julich, Germany; [Meissner, Ulf-G.] Forschungszentrum Julich, JARA High Performance Comp, D-52425 Julich, Germany	Helmholtz Association; University of Bonn; University of Bonn; University of North Carolina; North Carolina State University; Mississippi State University; Mississippi State University; Ruhr University Bochum; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich	Lee, D (corresponding author), N Carolina State Univ, Dept Phys, Raleigh, NC 27695 USA.	dean_lee@ncsu.edu	Epelbaum, Evgeny/P-3265-2018; Epelbaum, Evgeny/X-6951-2019; Elhatisari, Serdar/Z-1910-2018; Elhatisari, Serdar/GLT-6574-2022; Lee, Dean/AAK-8783-2020; Elhatisari, serdar/X-5059-2019	Epelbaum, Evgeny/0000-0002-7613-0210; Epelbaum, Evgeny/0000-0002-7613-0210; Lee, Dean/0000-0002-3630-567X; Elhatisari, serdar/0000-0002-7951-1991; Meissner, Ulf-G./0000-0003-1254-442X; Luu, Thomas/0000-0002-1119-8978; Krebs, Hermann/0000-0002-2263-0308; Lahde, Timo Arvid/0000-0003-3251-1035; Rupak, Gautam/0000-0001-6683-177X	Deutsche Forschungsgemeinschaft (Sino-German) [CRC 110]; Helmholtz Association [VH-VI-417]; BMBF [05P12PDFTE]; US Department of Energy [DE-FG02-03ER41260]; US National Science Foundation [PHY-1307453]; EU HadronPhysics3 project; ERC [259218 NUCLEAREFT]; Magnus Ehrnrooth Foundation of the Finnish Society of Sciences and Letters; Division Of Physics [1307453] Funding Source: National Science Foundation	Deutsche Forschungsgemeinschaft (Sino-German)(German Research Foundation (DFG)); Helmholtz Association(Helmholtz Association); BMBF(Federal Ministry of Education & Research (BMBF)); US Department of Energy(United States Department of Energy (DOE)); US National Science Foundation(National Science Foundation (NSF)); EU HadronPhysics3 project; ERC(European Research Council (ERC)European Commission); Magnus Ehrnrooth Foundation of the Finnish Society of Sciences and Letters; Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We acknowledge discussions with G. Hale and partial financial support from the Deutsche Forschungsgemeinschaft (Sino-German CRC 110), the Helmholtz Association (contract no. VH-VI-417), BMBF (grant no. 05P12PDFTE), the US Department of Energy (DE-FG02-03ER41260), and US National Science Foundation grant no. PHY-1307453. Further support was provided by the EU HadronPhysics3 project, the ERC project no. 259218 NUCLEAREFT, and the Magnus Ehrnrooth Foundation of the Finnish Society of Sciences and Letters. The computational resources were provided by the Julich Supercomputing Centre at Forschungszentrum Julich and by RWTH Aachen.	Acharya B, 2013, NUCL PHYS A, V913, P103, DOI 10.1016/j.nuclphysa.2013.05.021; AFZAL SA, 1969, REV MOD PHYS, V41, P247, DOI 10.1103/RevModPhys.41.247; Beane SR, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.132001; Berkowitz E, 2015, PREPRINT; BETHE HA, 1949, PHYS REV, V76, P38, DOI 10.1103/PhysRev.76.38; Borasoy B, 2007, EUR PHYS J A, V34, P185, DOI 10.1140/epja/i2007-10500-9; CARLSON J, 1984, NUCL PHYS A, V424, P47, DOI 10.1016/0375-9474(84)90127-1; Chang E, 2015, PREPRINT; Chen JW, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.242302; Cordon AC, 2008, PHYS REV C, V78, DOI 10.1103/PhysRevC.78.054002; Elhatisari S, 2014, PHYS REV C, V90, DOI 10.1103/PhysRevC.90.064001; Epelbaum E, 2010, EUR PHYS J A, V45, P335, DOI 10.1140/epja/i2010-11009-x; Epelbaum E, 2009, REV MOD PHYS, V81, P1773, DOI 10.1103/RevModPhys.81.1773; Epelbaum E, 2009, EUR PHYS J A, V40, P199, DOI 10.1140/epja/i2009-10755-0; Epelbaum E, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.252501; Epelbaum E, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.192501; Epelbaum E, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.142501; Gazit D, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.102502; GOTTLIEB S, 1987, PHYS REV D, V35, P2531, DOI 10.1103/PhysRevD.35.2531; Hagen G, 2012, PHYS REV C, V86, DOI 10.1103/PhysRevC.86.021602; HEYDENBURG NP, 1956, PHYS REV, V104, P123, DOI 10.1103/PhysRev.104.123; Higa R, 2008, NUCL PHYS A, V809, P171, DOI 10.1016/j.nuclphysa.2008.06.003; Hupin G, 2014, PHYS REV C, V90, DOI 10.1103/PhysRevC.90.061601; Imbriani G, 2001, ASTROPHYS J, V558, P903, DOI 10.1086/322288; JACKSON JD, 1950, REV MOD PHYS, V22, P77, DOI 10.1103/RevModPhys.22.77; Ji C, 2014, PHYS REV C, V90, DOI 10.1103/PhysRevC.90.044004; Kaplan DB, 1996, PHYS LETT B, V365, P244, DOI 10.1016/0370-2693(95)01277-X; Klein N, 2015, PHYS LETT B, V747, P511, DOI 10.1016/j.physletb.2015.06.040; Konig S, 2013, J PHYS G NUCL PARTIC, V40, DOI 10.1088/0954-3899/40/4/045106; Kong XW, 2000, NUCL PHYS A, V665, P137, DOI 10.1016/S0375-9474(99)00406-6; KOONIN SE, 1986, J STAT PHYS, V43, P985, DOI 10.1007/BF02628325; Lahde TA, 2015, EUR PHYS J A, V51, DOI 10.1140/epja/i2015-15092-1; Lahde TA, 2014, PHYS LETT B, V732, P110, DOI 10.1016/j.physletb.2014.03.023; Lee D, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.182501; Lee D, 2009, PROG PART NUCL PHYS, V63, P117, DOI 10.1016/j.ppnp.2008.12.001; Lu BN, 2015, PHYS REV D, V92, DOI 10.1103/PhysRevD.92.014506; Lu BN, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.034507; Mehen T, 1999, PHYS REV LETT, V83, P931, DOI 10.1103/PhysRevLett.83.931; Meissner U.-G, 2015, PREPRINT; Navratil P, 2011, PREPRINT; Navratil P, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.042503; NILSON R, 1958, PHYS REV, V109, P850, DOI 10.1103/PhysRev.109.850; Nollett KM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.022502; Orlandini G, 2014, FEW-BODY SYST, V55, P907, DOI 10.1007/s00601-013-0772-4; Orlov Yu. V., 2015, PREPRINT; Page PR, 2005, AIP CONF PROC, V769, P390, DOI 10.1063/1.1945030; Pine M, 2013, EUR PHYS J A, V49, DOI 10.1140/epja/i2013-13151-3; Quaglioni S, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.092501; Rauscher T, 2002, ASTROPHYS J, V576, P323, DOI 10.1086/341728; Rokash A, 2015, PHYS REV C, V92, DOI 10.1103/PhysRevC.92.054612; Rupak G, 2003, NUCL PHYS A, V717, P73, DOI 10.1016/S0375-9474(03)00638-9; Rupak G, 2015, PHYS LETT B, V741, P301, DOI 10.1016/j.physletb.2014.12.055; Rupak G, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.032502; Rupak G, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.222501; Ryberg E, 2014, EUR PHYS J A, V50, DOI 10.1140/epja/i2014-14170-2; SCALETTAR RT, 1986, PHYS REV B, V34, P7911, DOI 10.1103/PhysRevB.34.7911; Stratonovich R. L., 1958, SOV PHYS DOKL, V2, P416, DOI DOI 10.1103/PHYSREVLETT.3.77; Tilley DR, 2004, NUCL PHYS A, V745, P155, DOI 10.1016/j.nuclphysa.2004.09.059; TOMBRELLO TA, 1963, PHYS REV, V129, P2252, DOI 10.1103/PhysRev.129.2252; Wiescher M, 2012, ANNU REV ASTRON ASTR, V50, P165, DOI 10.1146/annurev-astro-081811-125543; Wigner E, 1937, PHYS REV, V51, P106, DOI 10.1103/PhysRev.51.106; Wlazlowski G, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.182503; WOOSLEY SE, 1973, ASTROPHYS J SUPPL S, V26, P231, DOI 10.1086/190282; Zhang XL, 2014, PHYS REV C, V89, DOI 10.1103/PhysRevC.89.051602	70	104	105	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					111	+		10.1038/nature16067	http://dx.doi.org/10.1038/nature16067			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX3NO	26632590	Green Submitted			2022-12-28	WOS:000365606000058
J	Li, WW; Yu, HQ; Rittmann, BE				Li, Wen-Wei; Yu, Han-Qing; Rittmann, Bruce E.			Chemistry: Reuse water pollutants	NATURE			English	Editorial Material									[Li, Wen-Wei] Univ Sci & Technol China, Chinese Acad Sci, Key Lab Urban Pollutant Convers, Hefei 230026, Peoples R China; [Yu, Han-Qing] Univ Sci & Technol China, Chinese Acad Sci, Key Lab Urban Pollutant Convers, Wastewater Syst & Sustainabil, Hefei 230026, Peoples R China; [Rittmann, Bruce E.] Arizona State Univ, Environm Engn, Tempe, AZ USA; [Rittmann, Bruce E.] Arizona State Univ, Swette Ctr Environm Biotechnol, Tempe, AZ USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Li, WW (corresponding author), Univ Sci & Technol China, Chinese Acad Sci, Key Lab Urban Pollutant Convers, Hefei 230026, Peoples R China.	hqyu@ustc.edu.cn; rittmann@asu.edu	Li, Wen-Wei/B-6332-2015; Yu, Han-Qing/F-7925-2010	Li, Wen-Wei/0000-0001-9280-0045; 				Heidrich ES, 2011, ENVIRON SCI TECHNOL, V45, P827, DOI 10.1021/es103058w; Koppelaar RHEM, 2013, GLOBAL ENVIRON CHANG, V23, P1454, DOI 10.1016/j.gloenvcha.2013.09.002; Li WW, 2014, ENERG ENVIRON SCI, V7, P911, DOI 10.1039/c3ee43106a; McCarty PL, 2011, ENVIRON SCI TECHNOL, V45, P7100, DOI 10.1021/es2014264; Peccia J, 2015, ENVIRON SCI TECHNOL, V49, P8271, DOI 10.1021/acs.est.5b01931; Rittmann B. E., 2001, ENV BIOTECHNOLOGY PR; Rittmann BE, 2011, CHEMOSPHERE, V84, P846, DOI 10.1016/j.chemosphere.2011.02.001; Smith AL, 2014, ENVIRON SCI TECHNOL, V48, P5972, DOI 10.1021/es5006169; United States Environmental Protection Agency, 2012, GLOB ANTHR NONCO2 GR; Verstraete W, 2009, BIORESOURCE TECHNOL, V100, P5537, DOI 10.1016/j.biortech.2009.05.047	10	219	229	31	442	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					29	31		10.1038/528029a	http://dx.doi.org/10.1038/528029a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX3NO	26632573	Bronze			2022-12-28	WOS:000365606000031
J	Slater, HC; Ross, A; Ouedraogo, AL; White, LJ; Nguon, C; Walker, PGT; Ngor, P; Aguas, R; Silal, SP; Dondorp, AM; La Barre, P; Burton, R; Sauerwein, RW; Drakeley, C; Smith, TA; Bousema, T; Ghani, AC				Slater, Hannah C.; Ross, Amanda; Ouedraogo, Andre Lin; White, Lisa J.; Nguon, Chea; Walker, Patrick G. T.; Ngor, Pengby; Aguas, Ricardo; Silal, Sheetal P.; Dondorp, Arjen M.; La Barre, Paul; Burton, Robert; Sauerwein, Robert W.; Drakeley, Chris; Smith, Thomas A.; Bousema, Teun; Ghani, Azra C.			Assessing the impact of next-generation rapid diagnostic tests on Plasmodium falciparum malaria elimination strategies	NATURE			English	Article							MEDIATED ISOTHERMAL AMPLIFICATION; TREATMENT INTERVENTION; ASYMPTOMATIC MALARIA; INFECTIOUS RESERVOIR; COST-EFFECTIVENESS; MODEL; ADMINISTRATIONS; TRANSMISSION; PERFORMANCE; MICROSCOPY	Mass-screen-and-treat and targeted mass-drug-administration strategies are being considered as a means to interrupt transmission of Plasmodium falciparum malaria. However, the effectiveness of such strategies will depend on the extent to which current and future diagnostics are able to detect those individuals who are infectious to mosquitoes. We estimate the relationship between parasite density and onward infectivity using sensitive quantitative parasite diagnostics and mosquito feeding assays from Burkina Faso. We find that a diagnostic with a lower detection limit of 200 parasites per microlitre would detect 55% of the infectious reservoir (the combined infectivity to mosquitoes of the whole population weighted by how often each individual is bitten) whereas a test with a limit of 20 parasites per microlitre would detect 83% and 2 parasites per microlitre would detect 95% of the infectious reservoir. Using mathematical models, we show that increasing the diagnostic sensitivity from 200 parasites per microlitre (equivalent to microscopy or current rapid diagnostic tests) to 2 parasites per microlitre would increase the number of regions where transmission could be interrupted with a mass-screen-and-treat programme from an entomological inoculation rate below 1 to one of up to 4. The higher sensitivity diagnostic could reduce the number of treatment rounds required to interrupt transmission in areas of lower prevalence. We predict that mass-screen-and-treat with a highly sensitive diagnostic is less effective than mass drug administration owing to the prophylactic protection provided to uninfected individuals by the latter approach. In low-transmission settings such as those in Southeast Asia, we find that a diagnostic tool with a sensitivity of 20 parasites per microlitre may be sufficient for targeted mass drug administration because this diagnostic is predicted to identify a similar village population prevalence compared with that currently detected using polymerase chain reaction if treatment levels are high and screening is conducted during the dry season. Along with other factors, such as coverage, choice of drug, timing of the intervention, importation of infections, and seasonality, the sensitivity of the diagnostic can play a part in increasing the chance of interrupting transmission.	[Slater, Hannah C.; Walker, Patrick G. T.; Ghani, Azra C.] Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC Ctr Outbreak Anal & Modelling, Dept Infect Dis Epidemiol, London W2 1PG, England; [Ross, Amanda; Smith, Thomas A.] Swiss Trop & Publ Hlth Inst, CH-4002 Basel, Switzerland; [Ross, Amanda; Smith, Thomas A.] Univ Basel, CH-4001 Basel, Switzerland; [Ouedraogo, Andre Lin] Inst Dis Modelling, Bellevue, WA 98005 USA; [Ouedraogo, Andre Lin] Ctr Natl Rech & Format Paludisme, Dept Biomed Sci, Ouagadougou, Burkina Faso; [White, Lisa J.; Ngor, Pengby; Aguas, Ricardo; Dondorp, Arjen M.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok 10400, Thailand; [White, Lisa J.; Dondorp, Arjen M.] Univ Oxford, Nuffield Dept Med, Ctr Trop Med, Oxford OX3 7LJ, England; [Nguon, Chea; Ngor, Pengby] Minist Hlth, Natl Malaria Ctr, Phnom Penh 12302, Cambodia; [Silal, Sheetal P.] Univ Cape Town, Dept Stat Sci, ZA-7701 Cape Town, South Africa; [La Barre, Paul; Burton, Robert] PATH, Seattle, WA 98121 USA; [Sauerwein, Robert W.; Bousema, Teun] Radboud Univ Nijmegen, Med Ctr, NL-6525 HP Nijmegen, Netherlands; [Drakeley, Chris; Bousema, Teun] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	Imperial College London; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; University of Cape Town; Radboud University Nijmegen; University of London; London School of Hygiene & Tropical Medicine	Slater, HC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC Ctr Outbreak Anal & Modelling, Dept Infect Dis Epidemiol, Norfolk Pl, London W2 1PG, England.	hannah.slater@imperial.ac.uk	Bousema, Teun/N-3574-2014; Ghani, Azra/B-8560-2009; Sauerwein, Robert/C-8519-2013; Smith, Thomas/B-5569-2015; Silal, Sheetal/AAB-1873-2020; White, Lisa/AAC-9396-2020	Bousema, Teun/0000-0003-2666-094X; Smith, Thomas/0000-0002-3650-9381; Silal, Sheetal/0000-0002-3007-5383; White, Lisa/0000-0002-6523-185X; Ghani, Azra/0000-0002-0007-4910; Ross, Amanda/0000-0001-6027-5645; Slater, Hannah/0000-0003-4291-7899; Walker, Patrick/0000-0002-9596-9628	Bill and Melinda Gates Foundation [OPP1110500, OPP1032350]; Wellcome-Trust Major Overseas Programme in SE Asia [106698/Z/14/Z]; Gottfried und Julia Bangerter-Rhyner Stiftung; Novartis Foundation for Medical Biological Research [13A13]; Bill & Melinda Gates Foundation (DIAMETER) [OPP1053616]; Netherlands Organization for Higher Education in the Tropics [CF29132006]; Global Good Fund, Bellevue, Washington, USA; Ministry of Health of Burkina Faso; Bill & Melinda Gates Foundation (AFIRM) [OPP1034789]; European Research Council [ERC-2014-StG 639776]; Medicines for Malaria Venture; UK MRC; UK Department for International Development; MRC [MR/K010174/1, MR/L012189/1] Funding Source: UKRI; Medical Research Council [MR/L012189/1, MR/K010174/1, MR/K010174/1B] Funding Source: researchfish	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wellcome-Trust Major Overseas Programme in SE Asia; Gottfried und Julia Bangerter-Rhyner Stiftung; Novartis Foundation for Medical Biological Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Bill & Melinda Gates Foundation (DIAMETER); Netherlands Organization for Higher Education in the Tropics; Global Good Fund, Bellevue, Washington, USA; Ministry of Health of Burkina Faso; Bill & Melinda Gates Foundation (AFIRM); European Research Council(European Research Council (ERC)European Commission); Medicines for Malaria Venture; UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work of L.J.W. is supported by the Bill and Melinda Gates Foundation (OPP1110500) and the Wellcome-Trust Major Overseas Programme in SE Asia (106698/Z/14/Z). The work of A.R. and T.S. (Swiss TPH) is supported by Bill & Melinda Gates Foundation grant OPP1032350 and additionally the Gottfried und Julia Bangerter-Rhyner Stiftung and the Novartis Foundation for Medical Biological Research (13A13). P.B. and R.B. (PATH) gratefully acknowledges the support of the Bill & Melinda Gates Foundation (DIAMETER, OPP1053616). A.L.O. is supported by the Netherlands Organization for Higher Education in the Tropics (grant CF29132006), the Global Good Fund, Bellevue, Washington, USA and the Ministry of Health of Burkina Faso. The work of C.J.D. and T.B. is supported by the Bill & Melinda Gates Foundation (AFIRM, OPP1034789); T.B. is further supported by a fellowship of the European Research Council (ERC-2014-StG 639776). A.C.G., H.S. and P.W. acknowledge support from the Bill and Melinda Gates Foundation, the Medicines for Malaria Venture, the UK MRC and the UK Department for International Development.	Aguas R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001767; Baker J, 2005, J INFECT DIS, V192, P870, DOI 10.1086/432010; Baker J., 2010, MALARIA J, V9, P1; Banoo S, 2010, NAT REV MICROBIOL, pS17, DOI [10.1038/nrmico1523, 10.1038/nrmicro1523]; Bell D, 2006, NAT REV MICROBIOL, V4, P682, DOI 10.1038/nrmicro1474; Bousema T, 2014, NAT REV MICROBIOL, V12, P833, DOI 10.1038/nrmicro3364; Bretscher MT, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-21; Bretscher MT, 2011, EPIDEMICS-NETH, V3, P109, DOI 10.1016/j.epidem.2011.03.002; Central Statistical Office & Ministry of Health, 2012, ZAMB NAT MAL IND SUR; Churcher TS, 2014, SCIENCE, V344, P1230, DOI 10.1126/science.1251449; Cook J, 2015, J INFECT DIS, V211, P1476, DOI 10.1093/infdis/jiu655; Cooke AH, 1999, AM J TROP MED HYG, V60, P173, DOI 10.4269/ajtmh.1999.60.173; Gerardin J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0751-y; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Griffin JT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4136; Griffin JT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000324; Hofmann N, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001788; Hopkins H, 2013, J INFECT DIS, V208, P645, DOI 10.1093/infdis/jit184; Killeen GF, 2006, AM J TROP MED HYG, V75, P38, DOI 10.4269/ajtmh.2006.75.2_suppl.0750038; Maire N, 2006, AM J TROP MED HYG, V75, P19, DOI 10.4269/ajtmh.2006.75.19; Maude RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037166; Maude RJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-31; Morris U, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0731-2; MORU Tropical Health Network, 2015, 1 PAT ENR CAMB TARG; National Centre for Parasitology E.a.M.C. & Malaria Consortium, 2010, CAMB MAL SURV; National Weather Service Climate Prediction Center, 2006, AFR RAINF EST; Okell LC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6606; Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241; Okell LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020179; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Ouedraogo A. L., 2013, MALARIAWORLD J, V4; Ouedraogo A. L., 2015, J INF DIS; Ouedraogo AL, 2008, ACTA TROP, V105, P28, DOI 10.1016/j.actatropica.2007.09.003; Ross A, 2006, AM J TROP MED HYG, V75, P32, DOI 10.4269/ajtmh.2006.75.32; Schneider P, 2004, MOL BIOCHEM PARASIT, V137, P35, DOI 10.1016/j.molbiopara.2004.03.018; Shute G. T., 1988, Malaria: principles and practice of malariology. Volume 1., P781; Silumbe K, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0722-3; Slater HC, 2014, J INFECT DIS, V210, P1972, DOI 10.1093/infdis/jiu351; Smith T, 2008, PARASITOLOGY, V135, P1507, DOI 10.1017/S0031182008000371; Smith T, 2006, AM J TROP MED HYG, V75, P1; Song JP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-57; Stone W, 2015, TRENDS PARASITOL, V31, P287, DOI 10.1016/j.pt.2015.04.004; Tiono AB, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-79; von Seidlein L, 2003, TRENDS PARASITOL, V19, P452, DOI 10.1016/j.pt.2003.08.003; von Seidlein L, 2015, EXPERT REV ANTI-INFE, V13, P715, DOI 10.1586/14787210.2015.1031744; Walker M, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-014-0402-2; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119; Wu L, 2015, NATURE, V528, pS86, DOI 10.1038/nature16039	49	88	88	0	31	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					S94	S101		10.1038/nature16040	http://dx.doi.org/10.1038/nature16040			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX3NO	26633771	hybrid, Green Submitted			2022-12-28	WOS:000365606000016
